PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Matsuzuka, T; Suzuki, M; Saijo, S; Ikeda, M; Matsui, T; Nomoto, Y; Nomoto, M; Imaizumi, M; Tada, Y; Omori, K				Matsuzuka, Takashi; Suzuki, Masahiro; Saijo, Satoshi; Ikeda, Masakazu; Matsui, Takamichi; Nomoto, Yukio; Nomoto, Mika; Imaizumi, Mitsuyoshi; Tada, Yasuhiro; Omori, Koichi			Stiffness of salivary gland and tumor measured by new ultrasonic techniques: Virtual touch quantification and IQ	AURIS NASUS LARYNX			English	Article						Normal salivary gland; Head and neck tumor; Salivary gland tumor; Acoustic radiation force impulse (ARFI); Virtual touch tissue quantification (VTQ); Virtual touch tissue imaging quantification (VTIQ)	NORMAL BREAST-TISSUE; QUANTITATIVE ELASTOGRAPHY; PAROTID-GLAND; RADIATION; LESIONS; DIAGNOSIS; MASSES; LIVER	Objective: To evaluate normal salivary gland stiffness and compare the diagnostic performance of virtual touch quantification (VTQ) and virtual touch imaging quantification (VTIQ) for head and neck tumor. Methods: A total of 92 measurements were examined, comprising 77 normal salivary glands, 11 benign tumors and four malignant tumors. Examinations were made to evaluate normal salivary gland stiffness and compare the diagnostic performances of new ultrasonic techniques regarding head and neck tumor. Results: The mean values of VTQ and VTIQ for the normal salivary group (NSG) were 1.92 and 2.06 m/s, respectively. The VTQ and VTIQvalues were correlative, and there were no statistical differences in each mean value between the normal parotid glands and submandibular glands. For the benign tumor group (BTG), four of the 11 values were non-numeric and were considered above the measurable range. The mean VTIQ value for the BTG was 4.24 m/s. For the malignant tumor group (MTG), all four VTQ values were non-numeric. The mean VTIQvalue for the MTG was 6.52 m/s. For the mean VTIQvalues, significant differences were observed among the three groups. The optimum VTQ cutoff value to detect malignant tumors was above the measurable range, and that of VTIQ was 4.83 m/s. Conclusion: The VTQ and VTIQ values were correlative for the salivary glands, and the stiffnesses of normal parotid glands were almost same as those of submandibular glands. 'VTQ and VTIQ values could be applied for the preoperative diagnosis in salivary gland lesions. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Matsuzuka, Takashi; Suzuki, Masahiro; Saijo, Satoshi; Ikeda, Masakazu; Matsui, Takamichi; Nomoto, Yukio; Nomoto, Mika; Imaizumi, Mitsuyoshi; Tada, Yasuhiro; Omori, Koichi] Fukushima Med Univ, Sch Med, Dept Otolaryngol, Fukushima 9601295, Japan	Matsuzuka, T (reprint author), Fukushima Med Univ, Sch Med, Dept Otolaryngol, 1 Hikarigaoka, Fukushima 9601295, Japan.	tmtzk@fmu.ac.jp					Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662; Gallotti A, 2010, RADIOL MED, V115, P889, DOI 10.1007/s11547-010-0504-5; Tozaki M, 2013, ULTRASOUND MED BIOL, V39, P2233, DOI 10.1016/j.ultrasmedbio.2013.07.012; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; Badea AF, 2013, MED ULTRASON, V15, P173; Wojcinski S, 2013, ULTRASOUND MED BIOL, V39, P2226, DOI 10.1016/j.ultrasmedbio.2013.06.014; Mansour N, 2012, ULTRASCHALL MED, V33, P283, DOI 10.1055/s-0031-1299130; D'Onofrio M, 2010, AM J ROENTGENOL, V195, P132, DOI 10.2214/AJR.09.3923; Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Bai M, 2012, J ULTRAS MED, V31, P289; Golatta M, 2013, EUR J RADIOL, V82, pE676, DOI 10.1016/j.ejrad.2013.06.029; Kato H, 2008, AM J NEURORADIOL, V29, P865, DOI 10.3174/ajnr.A0974; Tryggvason G, 2013, LARYNGOSCOPE, V123, P158, DOI 10.1002/lary.23613; Wojcinski Sebastian, 2013, Int J Womens Health, V5, P619, DOI 10.2147/IJWH.S50953; Zhang Y., 2012, PLOS ONE, V7	17	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					128	133		10.1016/j.anl.2014.08.021		6	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500006		
J	Nishikubo, K; Mise, K; Ameya, M; Hirose, K; Kobayashi, T; Hyodo, M				Nishikubo, Kaori; Mise, Kazuyo; Ameya, Misato; Hirose, Kahori; Kobayashi, Taisuke; Hyodo, Masamitsu			Quantitative evaluation of age-related alteration of swallowing function: Videofluoroscopic and manometric studies	AURIS NASUS LARYNX			English	Article						Aging; Swallowing reflex; Upper esophageal sphincter; Laryngeal elevation	PHARYNGEAL; REFLEX; YOUNG	Objective: Swallowing function progressively deteriorates with advancing age, leading to high morbidity and mortality in the elderly population. To establish strategies for treatment of age-related swallowing disorders, the mechanisms of such disorders must be quantitatively clarified. The purpose of this paper was to elucidate the swallowing function of healthy elderly individuals by comparison with that of young adults by videofluorographic and manometric examinations. Methods: The subjects were 70 healthy volunteers with no history of diseases affecting swallowing function. They were classified into three groups according to age: the young adult group (21-32 years of age, n = 8), early elderly group (60-69 years of age, n = 39), and late elderly group (70-83 years of age, n = 23). Their swallowing functions were quantitatively evaluated by videofluorographic and manometric studies. Results: Videofluorographic examination showed no significant differences in the moving distances of the hyoid bone and larynx in the pharyngeal swallowing phase between the young and elderly groups. The pharyngeal transit time (PIT) of the bolus in the elderly group was longer and the percentage of laryngeal elevation (%LE) was lower than those in the young group. Manometric examination revealed higher hypopharyngeal swallowing pressure in the elderly groups. The traveling velocity of the swallowing pressure in the upper esophageal sphincter (UES) region and the UES relaxation time decreased with aging. Reduction of the UES pressure during the pharyngeal swallowing phase was insufficient in 15.4% of the early elderly group and 30.4% of the late elderly group. Additionally, the UES zone was broadened in 20.5% of the early elderly group and 26.1% of the late elderly group. Conclusion: Videofluorographic and manometric examinations quantitatively demonstrated that the swallowing reflex was delayed and UES opening was impaired by aging. UES dysfunction may develop secondary by increased tonicity and decreased elasticity of the cricopharyngeal muscle. Stimulation of oropharyngeal sensory function 4nd exercising the laryngeal levator muscles may be effective for age-related swallowing disorders. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nishikubo, Kaori; Hirose, Kahori; Kobayashi, Taisuke; Hyodo, Masamitsu] Kochi Med Sch, Dept Otolaryngol Head & Neck Surg, Nankoku, Kochi 7838505, Japan; [Mise, Kazuyo; Ameya, Misato] Ehime Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Matsuyama, Ehime 790, Japan	Nishikubo, K (reprint author), Kochi Med Sch, Dept Otolaryngol Head & Neck Surg, Nankoku shi, Nankoku, Kochi 7838505, Japan.	nishikuboka@gmail.com					Almy TP, 1971, DISORDERS MOTILITY T, P1234; Kuhl V, 2003, J NEUROL, V250, P333, DOI 10.1007/s00415-003-1007-2; MORTELLITI AJ, 1990, ARCH OTOLARYNGOL, V116, P1062; Kawamura O, 2004, GASTROENTEROLOGY, V127, P57, DOI 10.1053/j.gastro.03.065; Ebihara T, 2005, J AM GERIATR SOC, V53, P824, DOI 10.1111/j.1532-5415.2005.53261.x; Shaker R, 2003, GERONTOLOGY, V49, P12, DOI 10.1159/000066504; Kern M, 1999, ANN OTO RHINOL LARYN, V108, P982; Aviv JE, 1998, DYSPHAGIA, V13, P87, DOI 10.1007/PL00009561; EKBERG O, 1991, AM J ROENTGENOL, V156, P1181; Leonard R, 2004, DYSPHAGIA, V19, P182, DOI 10.1007/s00455-004-0005-6; Aviv JE, 1997, AM J MED, V103, p74S, DOI 10.1016/S0002-9343(97)00327-6; Cohen BR, 1968, HDB PHYSL 6, V4, P1841; Dejaeger E., 1994, Dysphagia, V9, P156, DOI 10.1007/BF00341259; Furukawa K, 1984, J OTOLARYNGOL JPN, V87, P169; Im Ikjae, 2012, Ann Rehabil Med, V36, P220, DOI 10.5535/arm.2012.36.2.220; Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429; Leonard R, 2008, DYSPHAGIA ASSESSMENT, P233; Logemann JA, 1998, EVALUATION TREATMENT; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P71; Michel JF, 1987, J VOICE, V1, P53, DOI 10.1016/S0892-1997(87)80025-5; Omae Y, 2003, J JPN BRONCHOESOPHAG, V154, P1; Rugiu M G, 2007, Acta Otorhinolaryngol Ital, V27, P306; Shin T, 1995, OTO RHINO LARVNGOLOG, V88, P553; Taguchi A, 2004, DYSPHAGIA, V19, P241, DOI 10.1007/s00455-004-0017-2; Tracy J F, 1989, Dysphagia, V4, P90, DOI 10.1007/BF02407151	25	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					134	138		10.1016/j.anl.2014.07.002		5	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500007		
J	Tateya, I; Omori, K; Kojima, H; Naito, Y; Hirano, S; Yamashita, M; Ito, J				Tateya, Ichiro; Omori, Koichi; Kojima, Hisayoshi; Naito, Yasushi; Hirano, Shigeru; Yamashita, Masaru; Ito, Juichi			Type II thyroplasty changes cortical activation in patients with spasmodic dysphonia	AURIS NASUS LARYNX			English	Article						Spasmodic dysphonia; Supplementary motor area; Thyroplasty; Positron emission tomography	SUPPLEMENTARY MOTOR AREA; WRITERS CRAMP; DYSTONIA; VOCALIZATION; DYSFUNCTION; MOVEMENTS; FEEDBACK; PET	Objective: Spasmodic dysphonia (SD) is a complex neurological communication disorder characterized by a choked, strain-strangled vocal quality with voice stoppages in phonation. Its symptoms are exacerbated by situations where communication failures are anticipated, and reduced when talking with animals or small children. Symptoms are also reduced following selected forms of treatment. It is reasonable to assume that surgical alteration reducing symptoms would also alter brain activity, though demonstration of such a phenomenon has not been documented. The objective of this study is to reveal brain activity of SD patients before and after surgical treatment. Methods: We performed lateralization thyroplasties on three adductor SD patients and compared pre- and post-operative positron emission tomography recordings made during vocalization. Results: Pre-operatively, cordal supplementary motor area (SMA), bilateral auditory association areas, and thalamus were activated while reading aloud. Such activity was not observed in normal subjects. Type II thyroplasty was performed according to Isshiki's method and the strained voice was significantly reduced or eliminated in all three patients. Post-operative PET showed normal brain activation pattern with a significant decrease in cordal SMA, bilateral auditory association areas and thalamus, and a significant increase in rostral SMA compared with pre-operative recordings. Conclusion: This is the first report showing that treatment to a peripheral organ, which reverses voice symptoms, also reverses dysfunctional patterns of the central nervous system in patients with SD. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Tateya, Ichiro; Hirano, Shigeru; Ito, Juichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068507, Japan; [Omori, Koichi] Fukushima Med Univ, Dept Otolaryngol, Fukushima, Japan; [Kojima, Hisayoshi] Kojima ENT Clin, Kyoto, Japan; [Naito, Yasushi] Kobe City Med Ctr, Gen Hosp, Dept Otolaryngol, Kyoto, Japan; [Yamashita, Masaru] Kitano Hosp, Dept Otolaryngol, Osaka, Japan	Tateya, I (reprint author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, 54 Shogoin Kawahara, Kyoto 6068507, Japan.	tateya@ent.kuhp.kyoto-u.ac.jp			Japan Ministry of Health, Labour, and Welfare	The authors wish to thank Professor Diane M. Bless for her valuable comments, Dr. Koichi Ishizu for his help in performing PET scanning, Dr. Bernard Rousseau and Dr. Doug Montequin for helpful discussions, and Ms. Jessica Adsit for her assistance in preparation of our manuscript. This study was supported by a research grant for Intractable Diseases from the Japan Ministry of Health, Labour, and Welfare.	MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; CEBALLOSBAUMANN AO, 1995, ANN NEUROL, V37, P363, DOI 10.1002/ana.410370313; LUDLOW CL, 1995, ANN OTO RHINOL LARYN, V104, P928; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Ibanez V, 1999, NEUROLOGY, V53, P96; Preibisch C, 2001, J NEUROL, V248, P10, DOI 10.1007/s004150170263; Naumann M, 1998, MOVEMENT DISORD, V13, P319, DOI 10.1002/mds.870130219; FREEDMAN M, 1984, NEUROLOGY, V34, P409; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; CeballosBaumann AO, 1997, BRAIN, V120, P571, DOI 10.1093/brain/120.4.571; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Hirano S, 1997, NEUROREPORT, V8, P2379, DOI 10.1097/00001756-199707070-00055; Roy N, 1996, ANN OTO RHINOL LARYN, V105, P851; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653; Ashtekar CS, 2003, DEV MED CHILD NEUROL, V45, P634, DOI 10.1017/S0012162203001154; Boecker H, 1998, J NEUROPHYSIOL, V79, P1070; Brin M F, 1998, Adv Neurol, V78, P237; CHASE RA, 1958, J SPEECH HEAR DISORD, V23, P583; Hirano M, 1981, CLIN EXAMINATION VOI; Hirano S, 1996, NEUROREPORT, V8, P363, DOI 10.1097/00001756-199612200-00071; Hirano S, 2001, AM J OTOLARYNG, V22, P219, DOI 10.1053/ajot.2001.23436; Isshiki N, 2001, LARYNGOSCOPE, V111, P615, DOI 10.1097/00005537-200104000-00011; Isshild N., 1981, VOCAL FOLD PHYSL, P193; Odergren T, 1998, MOVEMENT DISORD, V13, P497, DOI 10.1002/mds.870130321; Passingham RE, 1996, ADV NEUROL, V70, P105; Penfield W, 1954, EPILEPSY FUNCTIONAL; Perlmutter J S, 1998, Adv Neurol, V78, P161; Rodriquez A A, 1994, Electromyogr Clin Neurophysiol, V34, P403; Sakurai Y, 2001, COGNITIVE BRAIN RES, V12, P161, DOI 10.1016/S0926-6410(01)00023-4; SCHAEFER S, 1985, ANN OTO RHINOL LARYN, V94, P595; Talairach J., 1988, COPLANAR STEREOTAXIC; Thickbroom GW, 2000, BRAIN RES, V874, P233, DOI 10.1016/S0006-8993(00)02588-9; YAMAMOTO T, 1995, J NEUROL NEUROSUR PS, V59, P438, DOI 10.1136/jnnp.59.4.438	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					139	144		10.1016/j.anl.2014.08.012		6	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500008		
J	Nishikawa, D; Hanai, N; Ozawa, T; Hirakawa, H; Suzuki, H; Nakashima, T; Hasegawa, Y				Nishikawa, Daisuke; Hanai, Nobuhiro; Ozawa, Taijiro; Hirakawa, Hitoshi; Suzuki, Hidenori; Nakashima, Tsutomu; Hasegawa, Yasuhisa			Role of induction chemotherapy for N3 head and neck squamous cell carcinoma	AURIS NASUS LARYNX			English	Article						Head and neck cancer; N3 neck disease; Induction chemotherapy; Distant metastasis	PHASE-III TRIAL; STAGE-IV HEAD; DISTANT METASTASES; UNRESECTABLE HEAD; CANCER; CHEMORADIOTHERAPY; DISSECTION; CISPLATIN; FLUOROURACIL; DOCETAXEL	Objective: The treatment of head and neck squamous cell carcinoma (HNSCC) with N3 (>6 cm) lymph nodes remains difficult, and the best treatment strategy has not been elucidated. The aim of this study was to evaluate the outcomes of various treatment modalities. Methods: Sixty-nine patients with HNSCC and N3 neck disease treated with definitive therapy in our institute between 1987 and 2013 were included in the analysis. We compared the clinical outcomes of radiotherapy (RT) alone, chemoradiotherapy (CRT) and surgery with or without induction chemotherapy (ICT). Results: The overall survival (OS) at three years for the patients with N3 neck disease was 41%. The three-year OS rates of patients treated with definitive surgery and definitive CRT were 41% and 48%, respectively. There were no significant differences between these two treatments (P = 0.82). The OS of patients who received ICT followed by definitive therapy was significantly better than that of patients who did not (P < 0.001). The most common recurrence pattern was distant metastases. The rate of distant metastases was 61% of all treatment failures (20/33). Conclusion: The high rate of distant metastases in patients with N3 neck disease suggests that prevention of distant metastases can improve survival. Based-on this study, we consider that ICT may play an important role in the treatment of N3 neck disease. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nishikawa, Daisuke; Hanai, Nobuhiro; Ozawa, Taijiro; Hirakawa, Hitoshi; Suzuki, Hidenori; Hasegawa, Yasuhisa] Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Nakashima, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4648601, Japan	Hasegawa, Y (reprint author), Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	hasegawa@aichi-cc.jp	Nakashima, Tsutomu/B-8259-2012	Nakashima, Tsutomu/0000-0003-3930-9120	Ministry of Health, Labour and Welfare, Japan [H24-Gannrinshou-Ippan-006]	This study was supported by a Health and Labour Sciences Research Grant for Clinical Cancer Research (H24-Gannrinshou-Ippan-006) from the Ministry of Health, Labour and Welfare, Japan.	Adams G, 2014, HEAD NECK-J SCI SPEC, V36, P1200, DOI 10.1002/hed.23434; PACCAGNELLA A, 1994, J NATL CANCER I, V86, P265, DOI 10.1093/jnci/86.4.265; Prestwich RJ, 2011, INT J RADIAT ONCOL, V81, pE237, DOI 10.1016/j.ijrobp.2011.03.043; Coca-Pelaz A, 2012, HEAD NECK-J SCI SPEC, V34, P771, DOI 10.1002/hed.21804; Hitt R, 2014, ANN ONCOL, V25, P216, DOI 10.1093/annonc/mdt461; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; Brizel DM, 2004, INT J RADIAT ONCOL, V58, P1418, DOI 10.1016/j.ijrobp.2003.09.004; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Dragovic AF, 2013, HEAD NECK-J SCI SPEC, V35, P381, DOI 10.1002/hed.22977; McHam SA, 2003, HEAD NECK-J SCI SPEC, V25, P791, DOI 10.1002/hed.10293; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI [10.1016/S1470-2045(10)70279-5, 10.1016/S1420-2045(10)20279-5]; Igidbashian L, 2010, INT J RADIAT ONCOL, V77, P414, DOI 10.1016/j.ijrobp.2009.05.034; Karakaya E, 2013, ORAL ONCOL, V49, P55, DOI 10.1016/j.oraloncology.2012.07.010; Hitt R, 2005, J CLIN ONCOL, V23, P8636, DOI 10.1200/JCO.2004.00.1990; Ballonoff A, 2008, LARYNGOSCOPE, V118, P995, DOI 10.1097/MLG.0b013e31816a7120; Cohen EEW, 2012, J CLIN ONCOL S, V30; Corry J, 2008, HEAD NECK-J SCI SPEC, V30, P737, DOI 10.1002/hed.20769; Layland Michael K, 2005, Laryngoscope, V115, P629; Smyth JK, 2011, LARYNGOSCOPE, V121, P1881, DOI 10.1002/lary.21968; WOLF GT, 1991, NEW ENGL J MED, V324, P1685; Yao M, 2012, INT J RADIAT ONCOL, V83, P684, DOI 10.1016/j.ijrobp.2011.07.014	23	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					150	155		10.1016/j.anl.2014.10.007		6	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500010		
J	Nabekura, T; Nagano, Y; Matsuda, K; Tono, T				Nabekura, Takashi; Nagano, Yuki; Matsuda, Keiji; Tono, Tetsuya			A case of cochlear implantation in a patient with Epstein syndrome	AURIS NASUS LARYNX			English	Article						Cochlear implantation; Epstein syndrome; MYH9 gene	LOCALIZATION; STEREOCILIA; DEAFNESS; IIA	Epstein syndrome is a rare autosomal dominant platelet disorder characterized by thrombocytopenia, giant platelets, and sensorineural hearing loss. It is included among four overlapping syndromes, the others being May-Hegglin anomaly, Fechtner syndrome, and Sebastian syndrome. It is now established that all four disorders are caused by mutations in the MYH9 gene. We report the case of a patient with Epstein syndrome in whom bilateral profound hearing impairment developed and cochlear implantation was carried out. A cochlear implant was successfully used with a speech discrimination score of 100% on a Japanese sentence recognition test. This report offers the second description of the performance of a cochlear implant in a patient with Epstein syndrome. This case study may offer hope for patients and their family members with this kind of mutation. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nabekura, Takashi; Nagano, Yuki; Matsuda, Keiji; Tono, Tetsuya] Miyazaki Univ, Dept Otorhinolaryngol, Miyazaki, Japan	Nabekura, T (reprint author), Dept Otorhinolaryngol, 5200 Kihara, Miyazaki 8891692, Japan.	takashi_nabekura@med.miyazaki-u.ac.jp					Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; Nishiyama N, 2013, AURIS NASUS LARYNX, V40, P409, DOI 10.1016/j.anl.2012.07.005; Min SY, 2014, TRANSPL P, V46, P654, DOI 10.1016/j.transproceed.2013.11.144; Hildebrand MS, 2006, LARYNGOSCOPE, V116, P2211, DOI 10.1097/01.mlg.0000242089.72880.f8; Lalwani AK, 2008, BRAIN RES, V1197, P13, DOI 10.1016/j.brainres.2007.12.058; Mhatre AN, 2006, J NEUROSCI RES, V84, P809, DOI 10.1002/jnr.20993; Pecci A, 2008, HUM MUTAT, V29, P409, DOI 10.1002/humu.20661	8	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					160	162		10.1016/j.anl.2014.09.004		3	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500012		
J	Yamaguchi, T; Oka, H; Kijima, C; Sano, H; Watanabe, H; Okamoto, M				Yamaguchi, Tomoko; Oka, Hidehiro; Kijima, Chihiro; Sano, Hajime; Watanabe, Hiroyuki; Okamoto, Makito			A case of atypical teratoid/rhabdoid tumor in the internal auditory canal	AURIS NASUS LARYNX			English	Article						Internal auditory canal tumor; Rapidly progressive hearing loss; Facial palsy	CENTRAL-NERVOUS-SYSTEM; CHILDHOOD; INFANCY	Objective: The case of a thirteen-year-old woman showing an atypical teratoid/rhabdoid tumor (AT/RT) primarily occurred in the internal auditory canal was presented. Results: There was a delay in diagnosing AT/RT because of the first histological diagnosis of benign neurofibroma. If we had changed the surgical approach to one which was middle cranial fossa-based or translabyrinthine in the second or third operation, we might have reached an earlier final diagnosis. Although we faced a dilemma about whether to sacrifice facial nerve function for dissection of the tumor, we should have considered the possibility of malignancy at an earlier stage. Conclusion: This is a case report of AT/RT in the internal auditory canal presenting with progressive hearing loss as the initial symptom. Although no previous reports of AT/RT primarily occurring in the internal auditory canal are existent, this rare form of the disease should be considered in future evaluations as a differential diagnosis for internal auditory canal tumor. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Yamaguchi, Tomoko; Sano, Hajime; Watanabe, Hiroyuki; Okamoto, Makito] Kitasato Univ Hosp, Dept Otolaryngol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Oka, Hidehiro; Kijima, Chihiro] Kitasato Univ Hosp, Dept Neurosurg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Yamaguchi, T (reprint author), Kitasato Univ Hosp, Dept Otolaryngol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	ytomoko@med.kitasato-u.ac.jp					KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Wong TT, 2005, CANCER, V104, P2156, DOI 10.1002/cncr.21430; Burger PC, 1998, AM J SURG PATHOL, V22, P1083, DOI 10.1097/00000478-199809000-00007; Schittenhelm J, 2011, NEUROPATHOLOGY, V31, P461, DOI 10.1111/j.1440-1789.2010.01189.x; Arcaro A, 2007, BIOCHEM J, V406, P57, DOI 10.1042/BJ20070309; von Hoff K, 2011, PEDIATR BLOOD CANCER, V57, P978, DOI 10.1002/pbc.23236; Han L, 2011, AM J NEURORADIOL, V32, P103, DOI 10.3174/ajnr.A2361; Judkins AR, 2007, WHO CLASSIFICATION T, P147; Kleihues P., 2000, PATHOLOGY GENETICS T, P123; Oka H, 1999, NEUROL MED-CHIR, V39, P510, DOI 10.2176/nmc.39.510; Rorke LB, 1996, J NEUROSURG, V85, P56, DOI 10.3171/jns.1996.85.1.0056	11	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					163	166		10.1016/j.anl.2014.09.005		4	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500013		
J	Okamiya, T; Takahashi, K; Kamada, H; Hirato, J; Motoi, T; Fukumoto, S; Chikamatsu, K				Okamiya, Tomofumi; Takahashi, Katsumasa; Kamada, Hideo; Hirato, Junko; Motoi, Toru; Fukumoto, Seiji; Chikamatsu, Kazuaki			Oncogenic osteomalacia caused by an occult paranasal sinus tumor	AURIS NASUS LARYNX			English	Article						Oncogenic osteomalacia; FDG-PET; Systemic venous sampling; FGF23	DIAGNOSIS; PET/CT; FGF-23; FGF23	Oncogenic osteomalacia (OOM) is a rare bone disease characterized by inadequate bone mineralization and is caused by a humoral factor mainly produced by benign mesenchymal tumors. We report a case of OOM caused by an occult phosphaturic mesenchymal tumor in the paranasal sinus. The causative tumor was small and localized in the ethmoid sinus, and the patient did not exhibit any nasal symptoms. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) depicted the location of the occult tumor, and systemic venous sampling followed by assessments of the samples' fibroblast growth factor 23 (FGF23) concentrations confirmed that the tumor secreted FGF23. The tumor was resected via an external surgical approach, resulting in the complete relief of the patient's symptoms. The combination of FDG-PET and systemic venous sampling to assess serum FGF23 levels is useful for identifying small asymptomatic OOM-associated tumors. Such tumors are rare, but a significant proportion of them develop in the head and neck region, and complete resection is the most effective treatment. It is important that ENT surgeons are aware of the characteristics of OOM. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Okamiya, Tomofumi; Takahashi, Katsumasa; Chikamatsu, Kazuaki] Gunma Univ, Dept Otorhinolaryngol Head & Neck Surg, Maebashi, Gunma 3718511, Japan; [Kamada, Hideo] Gunma Univ Hosp, Gunma Med Career Ctr, Maebashi, Gumma, Japan; [Hirato, Junko] Gunma Univ Hosp, Dept Pathol, Maebashi, Gumma, Japan; [Motoi, Toru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Pathol, Tokyo, Japan; [Fukumoto, Seiji] Tokyo Univ Hosp, Dept Med, Div Nephrol & Endocrinol, Tokyo, Japan	Okamiya, T (reprint author), Gunma Univ, Dept Otorhinolaryngol Head & Neck Surg, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	okamy@gunma-u.ac.jp					Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Imel EA, 2012, J CLIN ENDOCR METAB, V97, P696, DOI 10.1210/jc.2011-1319; MCCANCE RA, 1947, Q J MED, V16, P33; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Takeuchi Y, 2004, J CLIN ENDOCR METAB, V89, P3979, DOI 10.1210/jc.2004-0406; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Dupond JL, 2005, BONE, V36, P375, DOI 10.1016/j.bone.2005.01.001; Fletcher CDM, 2013, WHO CLASSIFICATION T, P211; Gonzalez-Compta X, 1998, J LARYNGOL OTOL, V112, P389; Ito N, 2010, J INTERN MED, V268, P390, DOI 10.1111/j.1365-2796.2010.02262.x; Jadhav S, 2014, CLIN ENDOCRINOL, V81, P31, DOI 10.1111/cen.12426; Khadgawat R, 2009, SINGAP MED J, V50, P55; Kominek P, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-16; RYAN EA, 1984, AM J MED, V77, P501, DOI 10.1016/0002-9343(84)90112-8	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					167	169		10.1016/j.anl.2014.10.001		3	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500014		
J	Matsunaga, M; Nakagawa, T; Sakamoto, T; Ito, J				Matsunaga, Mami; Nakagawa, Takayuki; Sakamoto, Tatsunori; Ito, Juichi			Sphenoid esthesioneuroblastoma arising from the hindmost olfactory filament	AURIS NASUS LARYNX			English	Article						Olfactory neuroblastomas; Sphenoid sinus; Ectopic tumor; Endoscopic surgery	EPITHELIUM; RESECTION	Esthesioneuroblastoma (ENB), or olfactory neuroblastoma, is a rare malignant neoplasm arising from the olfactory neuroepithelium. Typically, ENBs are found in the olfactory cleft with extension to the ethmoid sinuses or anterior skull base. Here we report a case of ENB located in the sphenoid sinus, which had been considered as an ectopic ENB. However, endoscopic resection revealed the continuity of the tumor with the hindmost olfactory filament. The present case suggests that an ENB in the sphenoid sinus was not ectopic, but arose from the normal olfactory neuroepithelium. This continuity of the ENB with this filament indicated that the tumor was not ectopic, and that there was possible tumor invasion into the olfactory neuroepithelium in the cribriform niche. Therefore, pathological examination of the olfactory neuroepithelium in the cribriform niche may be necessary in case of sphenoid ENBs. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Matsunaga, Mami; Nakagawa, Takayuki; Sakamoto, Tatsunori; Ito, Juichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068507, Japan	Nakagawa, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kawaharacho 54, Kyoto 6068507, Japan.	tnakagawa@ent.kuhp.kyoto-u.ac.jp	Sakamoto, Tatsunori/N-3046-2015	Sakamoto, Tatsunori/0000-0001-6669-7013			DULGUEROV P, 1992, LARYNGOSCOPE, V102, P843, DOI 10.1288/00005537-199208000-00001; KADISH S, 1976, CANCER, V37, P1571, DOI 10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L; Say P, 2004, AM J RHINOL, V18, P157; Dulguerov P, 2001, LANCET ONCOL, V2, P683, DOI 10.1016/S1470-2045(01)00558-7; MORAN DT, 1982, BRAIN RES, V253, P39, DOI 10.1016/0006-8993(82)90671-0; Leopold DA, 2000, LARYNGOSCOPE, V110, P417, DOI 10.1097/00005537-200003000-00016; FOOTE RL, 1993, INT J RADIAT ONCOL, V27, P835; Kodama S, 2009, NEUROSURGERY, V65, P112, DOI 10.1227/01.NEU.0000346268.69786.88; Lin JH, 2009, PITUITARY, V12, P70, DOI 10.1007/s11102-007-0081-3; Seccia V, 2010, OTOLARYNG HEAD NECK, V142, P460, DOI 10.1016/j.otohns.2009.09.027; Vi Lund, 2010, RHINOL S, V1, P1; Wormald R, 2011, EUR ARCH OTO-RHINO-L, V268, P555, DOI 10.1007/s00405-010-1423-8	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					170	172		10.1016/j.anl.2014.10.003		3	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500015		
J	Cheng, LL; Yin, CB; Chien, HP				Cheng, Leilei; Yin, Changbin; Chien, Hsiaoping			Demand for milk quantity and safety in urban China: evidence from Beijing and Harbin	AUSTRALIAN JOURNAL OF AGRICULTURAL AND RESOURCE ECONOMICS			English	Article						China; food safety; milk consumption; ordered choice model; willingness-to-pay	DAIRY-PRODUCTS; FOOD DEMAND; CONSUMPTION; SECTOR	Urban households account for most of the milk consumption in China, but their consumption is hampered by safety concerns. Using survey data collected in Beijing and Harbin in 2010, this paper simultaneously analyses urban households' milk consumption using a multiple linear model and their willingness-to-pay for milk safety using an ordered choice model. The results of this study show that as income increases, urban households consume more milk and are willing to pay a higher premium for milk safety. Modern food marketing channels play a positive role in stimulating milk consumption and building consumers' confidence in milk safety. The growth in the elderly population influences milk consumption positively, but their demand for milk safety is negatively affected by higher price. The combined analysis of households' demand for milk quantity and safety may be useful to the Chinese government in promoting the development of the domestic milk industry and to dairy firms in exploring the milk market in China.	[Cheng, Leilei] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China; [Yin, Changbin] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China; [Chien, Hsiaoping] Japan Int Res Ctr Agr Sci, Social Sci Div, Tsukuba, Ibaraki, Japan	Cheng, LL (reprint author), Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China.	yinchangbin@caas.cn			Institute of Agricultural Resources and Regional Planning of Chinese Academy of Agricultural Sciences project 'Design and Evaluation of a Recycling-based Agricultural Production System in Upland Farming Areas of Northern China'; Japan International Research Center for Agricultural Sciences; Ministry of Agriculture of China [200903011]	The article was written when Cheng was visiting the Social Science Division, Japan International Research Center for Agricultural Sciences. We would like to thank the editors and an anonymous reviewer for their helpful and constructive comments and suggestions. This research was financially supported by the Institute of Agricultural Resources and Regional Planning of Chinese Academy of Agricultural Sciences project 'Design and Evaluation of a Recycling-based Agricultural Production System in Upland Farming Areas of Northern China', the Japan International Research Center for Agricultural Sciences visiting research fellowship program 2012, and the Ministry of Agriculture of China (Grant No. 200903011).	Jia XP, 2012, FOOD POLICY, V37, P390, DOI 10.1016/j.foodpol.2012.03.008; Fuller F, 2007, AUST J AGR RESOUR EC, V51, P459, DOI 10.1111/j.1467-8489.2007.00379.x; MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103; Wang ZG, 2008, FOOD POLICY, V33, P27, DOI 10.1016/j.foodpol.2007.05.006; Liu RD, 2013, FOOD CONTROL, V33, P93, DOI 10.1016/j.foodcont.2013.01.051; Bernard JC, 2009, AM J AGR ECON, V91, P826, DOI 10.1111/j.1467-8276.2009.01258.x; Bai JF, 2008, AUST J AGR RESOUR EC, V52, P133, DOI 10.1111/j.1467-8489.2008.00401.x; Beijing Municipal Bureau of Statistics, 2012, BEIJ STAT YB 2011; CORNICK J, 1994, AM J AGR ECON, V76, P74, DOI 10.2307/1243922; Dong FX, 2006, FOOD POLICY, V31, P260, DOI 10.1016/j.foodpol.2006.02.007; Food and Agricultural Policy Research Institute (FAPRI), 2011, FAPRI ISU 2011 WORLD; Fuller F, 2006, FOOD POLICY, V31, P201, DOI 10.1016/j.foodpol.2006.03.002; Harbin Municipal Bureau of Statistics, 2012, HARB STAT YB 2011; HEIEN DM, 1988, AM J AGR ECON, V70, P219, DOI 10.2307/1242060; Hu D, 2006, International Agri-Food Chains and Networks: Management and Organization, P373; Lin L., 2009, RENEWABLE AGR FOOD S, V25, P69; Liu Y., 2011, CHINA DAIRY SECTOR E; Ministry of Agriculture of China (MOA), 2012, CHIN DAIR YB 2011; Mo D, 2012, J DAIRY SCI, V95, P2282, DOI 10.3168/jds.2011-4720; Ortega D. L., 2011, AM J AGR ECON, V94, P489; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; UNPD, 2010, WORLD POP PROSP 2010; Yen ST, 2004, J COMP ECON, V32, P564, DOI 10.1016/j.jce.2004.04.005; Zhang CP, 2010, CHINA ECON REV, V20, pS45, DOI 10.1016/j.chieco.2010.05.008; Zheng ZH, 2009, REV AGR ECON, V31, P873, DOI 10.1111/j.1467-9353.2009.01471.x	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-985X	1467-8489		AUST J AGR RESOUR EC	Aust. J. Agr. Resour. Econ.	APR	2015	59	2					275	287		10.1111/1467-8489.12065		13	Agricultural Economics & Policy; Economics	Agriculture; Business & Economics	CF5FI	WOS:000352581800008		
J	Islam, MS; Islam, MN; Hoque, MA; Nishino, N; Kato, T; Kim, HJ; Ito, A; Yoshida, M				Islam, Md Shahidul; Islam, Md Nurul; Hoque, Md Ashraful; Nishino, Norikazu; Kato, Tamaki; Kim, Hyun-Jung; Ito, Akihiro; Yoshida, Minoru			An efficient synthesis of SK-658 and its analogs as potent histone deacetylase inhibitors	BIOORGANIC CHEMISTRY			English	Article						Histone deacetylase inhibitor; Zinc binding group; SK-658 analogs; SS-hybrid	CYCLIC TETRAPEPTIDES; BICYCLIC TETRAPEPTIDES; SAHA ANALOGS; DESIGN; DISULFIDE; BEARING; LIGAND	SK-658 is a potent histone deacetylase (HDAC) inhibitor that showed higher activity than SAHA due to the presence of extended hydrophobic group. We designed and synthesized thioester and SS-hybrid bearing SK-658 analogs as HDAC inhibitors. All the compounds were active in nano molar range and showed higher inhibitory activity than SAHA and SK-658. Among these, disulfide compounds showed the highest activity. (C) 2015 Elsevier Inc. All rights reserved.	[Islam, Md Shahidul; Islam, Md Nurul; Hoque, Md Ashraful; Nishino, Norikazu; Kato, Tamaki] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan; [Islam, Md Shahidul; Islam, Md Nurul] Rajshahi Univ, Fac Sci, Dept Chem, Rajshahi 6205, Bangladesh; [Hoque, Md Ashraful] Rajshahi Univ, Fac Sci, Dept Biochem & Mol Biol, Rajshahi 6205, Bangladesh; [Kim, Hyun-Jung] BioRunxInc, Seoul 110749, South Korea; [Ito, Akihiro; Yoshida, Minoru] RIKEN Adv Sci Inst, Chem Genet Lab, Chem Genom Res Grp, Saitama 3510198, Japan	Islam, MS (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan.	shahidulchem@yahoo.com	Yoshida, Minoru/C-8049-2014		Kitakyushu Foundation for the Advancement of Industry, Science and Technology (FAIS); Japan Student Services Organization (JASSO); Saneyoshi Scholarship Foundation	This study was supported by Kitakyushu Foundation for the Advancement of Industry, Science and Technology (FAIS), Japan Student Services Organization (JASSO) and Saneyoshi Scholarship Foundation.	Nishino N, 2003, ORG LETT, V5, P5079, DOI 10.1021/ol036098e; Suzuki T, 2004, BIOORG MED CHEM LETT, V14, P3313, DOI 10.1016/j.bmcl.2004.03.063; Nishino N, 2008, BIOORGAN MED CHEM, V16, P437, DOI 10.1016/j.bmc.2007.09.021; Jones P, 2006, BIOORG MED CHEM LETT, V16, P5948, DOI 10.1016/j.bmcl.2006.09.002; Komatsu Y, 2001, CANCER RES, V61, P4459; Zain J, 2010, EXPERT REV HEMATOL, V3, P187, DOI [10.1586/ehm.10.9, 10.1586/EHM.10.9]; Islam MN, 2014, BIOORGAN MED CHEM, V22, P3862, DOI 10.1016/j.bmc.2014.06.031; Mwakwari SC, 2010, J MED CHEM, V53, P6100, DOI 10.1021/jm100507q; Furumai R, 2002, CANCER RES, V62, P4916; Hoque MA, 2014, AMINO ACIDS, V46, P2435, DOI 10.1007/s00726-014-1800-5; Islam NM, 2010, BIOORG MED CHEM LETT, V20, P997, DOI 10.1016/j.bmcl.2009.12.054; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Bhuiyan MPI, 2006, BIOORGAN MED CHEM, V14, P3438, DOI 10.1016/j.bmc.2005.12.063; Wang DF, 2004, J MED CHEM, V47, P3409, DOI 10.1021/jm0498497; Suzuki T, 2006, J MED CHEM, V49, P4809, DOI 10.1021/jm060554y; Islam MS, 2012, AMINO ACIDS, V42, P2103, DOI 10.1007/s00726-011-0947-6; Breslow R., 1993, PTC Int. Appl., Patent No. [WO 93/07148, 9307148]; Hoque MA, 2014, BIOORGAN MED CHEM, V22, P3850, DOI 10.1016/j.bmc.2014.06.029; Hoque MA, 2012, BIOORG MED CHEM LETT, V22, P6770, DOI 10.1016/j.bmcl.2012.03.004; Jose B, 2004, BIOORG MED CHEM LETT, V14, P5343, DOI 10.1016/j.bmcl.2004.08.016; Kapustin GV, 2003, ORG LETT, V5, P3053, DOI 10.1021/ol035056n; Butler KV, 2008, CURR PHARM DESIGN, V14, P505; Nishino N, 2004, BIOORG MED CHEM LETT, V14, P2427, DOI 10.1016/j.bmcl.2004.03.018; Shargel L., 1993, APPL BIOPHARMACEUTIC, P77; Shivashimpi GM, 2007, BIOORGAN MED CHEM, V15, P7830, DOI 10.1016/j.bmc.2007.08.041; Suzuki N, 2009, J MED CHEM, V52, P2909, DOI 10.1021/jm900125m	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0045-2068	1090-2120		BIOORG CHEM	Bioorganic Chem.	APR	2015	59						145	150		10.1016/j.bioorg.2015.02.009		6	Biochemistry & Molecular Biology; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CF0DC	WOS:000352211900014		
J	Aoki, M; Yamaguchi, R; Yamamoto, T; Ishimaru, Y; Ono, T; Sakamoto, A; Narahara, S; Sugiuchi, H; Hirose, E; Yamaguchi, Y				Aoki, Manabu; Yamaguchi, Rui; Yamamoto, Takatoshi; Ishimaru, Yasuji; Ono, Tomomichi; Sakamoto, Arisa; Narahara, Shinji; Sugiuchi, Hiroyuki; Hirose, Eiji; Yamaguchi, Yasuo			Granulocyte-macrophage colony-stimulating factor primes interleukin-13 production by macrophages via protease-activated receptor-2	BLOOD CELLS MOLECULES AND DISEASES			English	Article						Interleukin-13; Granulocyte-macrophage colony-stimulating factor; Macrophage; Neutrophil elastase; Protease activated receptor-2; Fibrosis	INDUCED PULMONARY-FIBROSIS; NECROSIS-FACTOR-ALPHA; NEUTROPHIL ELASTASE; CHRONIC-PANCREATITIS; INFLAMMATORY RESPONSE; TYPE-2 MACROPHAGES; TISSUE FIBROSIS; MONOCYTE; CELLS; POLARIZATION	Chronic inflammation is often linked to the presence of type 2-polarized macrophages, which are induced by the T helper type 2 cytokines interleukin-4 and interleukin-13 (IL-13). IL-13 is a key mediator of tissue fibrosis caused by T helper type 2-based inflammation. Human neutrophil elastase (HNE) plays a pivotal role in the pathogenesis of pulmonary fibrosis. This study investigated the priming effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on IL-13 expression by macrophages stimulated with HNE. Adherent macrophages were obtained from primary cultures of human mononuclear cells. Expression of IL-13 mRNA and protein by GM-CSF-dependent macrophages was investigated after stimulation with HNE, using the polymerase chain reaction and enzyme-linked immunosorbent assay. GM-CSF had a priming effect on IL-13 mRNA and protein expression by macrophages stimulated with HNE, while this effect was not observed for various other cytokines. GM-CSF-dependent macrophages showed a significant increase in the expression of protease activated receptor-2 (PAR-2) mRNA and protein. The response of IL-13 mRNA to HNE was significantly decreased by pretreatment with alphal-antitrypsin, a PAR-2 antibody (SAM11), or a PAR-2 antagonist (ENMD-1068). These findings suggest that stimulation with HNE can induce IL-13 production by macrophages, especially GM-CSF-dependent macrophages. Accordingly, neutrophil elastase may have a key role in fibrosis associated with chronic inflammation. (C) 2015 Elsevier Inc. All rights reserved.	[Aoki, Manabu; Yamaguchi, Rui; Yamamoto, Takatoshi; Ishimaru, Yasuji; Ono, Tomomichi; Sakamoto, Arisa; Narahara, Shinji; Sugiuchi, Hiroyuki; Hirose, Eiji; Yamaguchi, Yasuo] Kumamoto Hlth Sci Univ, Grad Sch Med Sci, Kumamoto 8615598, Japan	Yamaguchi, Y (reprint author), Kumamoto Hlth Sci Univ, Grad Sch Med Sci, Kitaku Izumi Machi 325, Kumamoto 8615598, Japan.	yamaguti@kumamoto-hsu.ac.jp			Kumamoto Health Science University special fellowship [24-A-02]	This study was supported by Kumamoto Health Science University special fellowship grant No. 24-A-02.	Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Meyer-Hoffert U, 2009, FRONT BIOSCI, V14, P3409, DOI 10.2741/4062; BURGESS AW, 1980, BLOOD, V56, P947; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Shao MXG, 2005, J IMMUNOL, V175, P4009; Kaviratne M, 2004, J IMMUNOL, V173, P4020; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Chua F, 2007, AM J PATHOL, V170, P65, DOI 10.2353/ajpath.2007.060352; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Saurer L, 2000, GASTROENTEROLOGY, V118, P356, DOI 10.1016/S0016-5085(00)70218-6; Zhou MT, 2010, WORLD J GASTROENTERO, V16, P2094, DOI 10.3748/wjg.v16.i17.2094; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Elkord E, 2005, IMMUNOLOGY, V114, P204, DOI 10.1111/j.1365-2567.2004.02076.x; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Lohman RJ, 2012, FASEB J, V26, P2877, DOI 10.1096/fj.11-201004; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Takemasa A, 2012, EUR RESPIR J, V40, P1475, DOI 10.1183/09031936.00127011; Coccia EM, 1999, INT IMMUNOL, V11, P1075, DOI 10.1093/intimm/11.7.1075; Nhu QM, 2012, INNATE IMMUN-LONDON, V18, P193, DOI 10.1177/1753425910395044; Benabid R, 2012, J BIOL CHEM, V287, P34883, DOI 10.1074/jbc.M112.361352; Arndt Claudia, 2012, Methods Mol Biol, V869, P465, DOI 10.1007/978-1-61779-821-4_40; DORING G, 1994, AM J RESP CRIT CARE, V150, pS114; Farkas G, 2007, EUR CYTOKINE NETW, V18, P31; Goecke H, 2000, SURGERY, V128, P806, DOI 10.1067/msy.2000.108613; INADA K, 1991, MICROBIOL IMMUNOL, V35, P303; KOHNO S, 1993, MICROBIOL IMMUNOL, V37, P207; Lu KW, 2011, BBA-BIOMEMBRANES, V1808, P2366, DOI 10.1016/j.bbamem.2011.06.013; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Pungpapong S, 2007, PANCREATOLOGY, V7, P491, DOI 10.1159/000108966; SHAW RJ, 1990, J CELL BIOL, V111, P2139, DOI 10.1083/jcb.111.5.2139; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006; STRIETER RM, 1989, AM J RESP CELL MOL, V1, P57; Torre D, 2003, J INFECTION, V47, P296, DOI 10.1016/S0163-4453(03)00065-3	37	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1079-9796	1096-0961		BLOOD CELL MOL DIS	Blood Cells Mol. Dis.	APR	2015	54	4					353	359		10.1016/j.bcmd.2015.01.007		7	Hematology	Hematology	CG2HB	WOS:000353094400009		
J	Nozaki, Y; Fujita, K; Wada, K; Yoneda, M; Kessoku, T; Shinohara, Y; Imajo, K; Ogawa, Y; Nakamuta, M; Saito, S; Masaki, N; Nagashima, Y; Terauchi, Y; Nakajima, A				Nozaki, Yuichi; Fujita, Koji; Wada, Koichiro; Yoneda, Masato; Kessoku, Takaomi; Shinohara, Yoshiyasu; Imajo, Kento; Ogawa, Yuji; Nakamuta, Makoto; Saito, Satoru; Masaki, Naohiko; Nagashima, Yoji; Terauchi, Yasuo; Nakajima, Atsushi			Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model	BMC GASTROENTEROLOGY			English	Article						NOS; NASH; Inflammation; Fibrosis; NF-kB	NITRIC-OXIDE SYNTHASE; TRIGLYCERIDE TRANSFER PROTEIN; NF-KAPPA-B; INSULIN-RESISTANCE; OBESE MICE; STEATOSIS; DISEASE; DAMAGE; INHIBITION; ENDOTOXIN	Background: Although many of the factors and molecules closely associated with non-alcoholic steatohepatitis (NASH) have been reported, the role of inducible nitric oxide synthase (iNOS)-derived nitric oxide (NO) on the progression of NASH remains unclear. We therefore investigated the role of iNOS-derived NO in NASH pathogenesis with a long-term follow-up study using systemic iNOS-knockout mice under high-fat diet (HFD) conditions. Methods: iNOS-knockout and wild-type mice were fed a basal or HFD for 10 or 48 weeks. Lipid accumulation, fibrosis, and inflammation were evaluated, and various factors and molecules closely associated with NASH were analyzed. Results: Marked fibrosis and inflammation (indicators of NASH) were observed in the livers of iNOS-knockout mice compared to wild-type mice after 48 weeks of a HFD; however, lipid accumulation in iNOS-knockout mice livers was less than in the wild-type. Increased expressions of various cytokines that are transcriptionally controlled by NF-kB in iNOS-deficient mice livers were observed during HFD conditions. Conclusions: iNOS-derived NO may play a protective role against the progression to NASH during an HFD by preventing fibrosis and inflammation, which are mediated by NF-kB activation in Kupffer cells. A lack of iNOS-derived NO accelerates progression to NASH without excessive lipid accumulation.	[Nozaki, Yuichi; Fujita, Koji; Yoneda, Masato; Kessoku, Takaomi; Shinohara, Yoshiyasu; Imajo, Kento; Ogawa, Yuji; Saito, Satoru; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Div Gastroenterol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Nozaki, Yuichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Shinjuku Ku, Tokyo 1628655, Japan; [Wada, Koichiro] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Suita, Osaka 5650871, Japan; [Nakamuta, Makoto] Natl Hosp Org, Kyushu Med Ctr, Dept Gastroenterol, Chou Ku, Fukuoka 8108563, Japan; [Masaki, Naohiko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa 2728516, Japan; [Nagashima, Yoji] Yokohama City Univ, Grad Sch Med, Dept Mol Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Nakajima, A (reprint author), Yokohama City Univ, Grad Sch Med, Div Gastroenterol, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.	nakajima-tky@umin.ac.jp			National Institute of Biomedical Innovation; Japan Science and Technology Agency; National Center for Global Health and Medicine [26A-107]	This study was supported in part by a grant from the National Institute of Biomedical Innovation, a grant program "Collaborative Development of Innovative Seeds" from the Japan Science and Technology Agency to A.N., and a grant for National Center for Global Health and Medicine (26A-107) to Y.N.. The skillful technical assistance of Machiko Hiraga, Tamiyo Taniguchi and Shizuko Kobayashi is gratefully acknowledged.	Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Connelly L, 2001, J IMMUNOL, V166, P3873; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fujita K, 2008, GUT, V57, P1583, DOI 10.1136/gut.2007.144550; Nozaki Y, 2009, J HEPATOL, V51, P548, DOI 10.1016/j.jhep.2009.05.017; NATHAN C, 1992, FASEB J, V6, P3051; Cha HN, 2010, EXP GERONTOL, V45, P711, DOI 10.1016/j.exger.2010.05.004; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Endo H, 2009, GUT, V58, P1637, DOI 10.1136/gut.2009.183624; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Chen T, 2003, CURR MOL MED, V3, P519, DOI 10.2174/1566524033479582; Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099; Yoneda M, 2009, HEPATOL RES, V39, P963, DOI 10.1111/j.1872-034X.2009.00539.x; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Letteron P, 2003, HEPATOLOGY, V38, P133, DOI 10.1053/jhep.2003.50309; Salamone F, 2012, TRANSL RES, V159, P477, DOI 10.1016/j.trsl.2011.12.003; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Fujita K, 2009, HEPATOLOGY, V50, P772, DOI 10.1002/hep.23094; Usui S, 2002, J LIPID RES, V43, P805; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Becerril S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010962; Cornejo P, 2007, NITRIC OXIDE-BIOL CH, V16, P143, DOI 10.1016/j.niox.2006.06.003; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gu Q, 2014, HEPATOLOGY; PENG HB, 1995, J BIOL CHEM, V270, P14214; Rockey DC, 1997, AM J PHYSIOL-GASTR L, V273, pG124; Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128; Shindo N, 2010, J HEPATOL, V52, P903, DOI 10.1016/j.jhep.2009.12.033; Soufi N, 2014, J BIOL CHEM; Toshima G, 2013, J BIOL MACROMOL, V13, P21; Vos TA, 1997, GASTROENTEROLOGY, V113, P1323, DOI 10.1053/gast.1997.v113.pm9322528; WANG GS, 1995, BIOCHEM PHARMACOL, V49, P1277, DOI 10.1016/0006-2952(95)00061-4	36	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-230X			BMC GASTROENTEROL	BMC Gastroenterol.	APR 1	2015	15								42	10.1186/s12876-015-0269-3		14	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF4NJ	WOS:000352525800002		
J	Sekimoto, T; Kurogi, S; Funamoto, T; Ota, T; Watanabe, S; Sakamoto, T; Hamada, H; Chosa, E				Sekimoto, T.; Kurogi, S.; Funamoto, T.; Ota, T.; Watanabe, S.; Sakamoto, T.; Hamada, H.; Chosa, E.			Possible association of single nucleotide polymorphisms in the 3 ' untranslated region of HOXB9 with acetabular overcoverage	BONE & JOINT RESEARCH			English	Article						Acetabular overcoverage; HOXB9; SNP; Pincer-type FAI; Case-control study	FEMOROACETABULAR IMPINGEMENT; DEVELOPMENTAL DYSPLASIA; HIP; GENES; OSTEOARTHRITIS; SUSCEPTIBILITY; EXPRESSION; GROWTH; RETROVERSION; MUTATIONS	Objectives Excessive acetabular coverage is the most common cause of pincer-type femoroacetabular impingement. To date, an association between acetabular over-coverage and genetic variations has not been studied. In this study we investigated the association between single nucleotide polymorphisms (SNPs) of paralogous Homeobox (HOX) 9 genes and acetabular coverage in Japanese individuals to identify a possible genetic variation associated with acetabular over-coverage. Methods We investigated 19 total SNPs in the four HOX9 paralogs, then focused in detail on seven of those located in the 3' untranslated region of HOXB9 (rs8844, rs3826541, rs3826540, rs7405887, rs2303485, rs2303486, rs79931349) using a case-control association study. The seven HOXB9 SNPs were genotyped in 316 subjects who had all undergone radiological examination. The association study was performed by both single-locus and haplotype-based analyses. Results The genotype and allele frequencies of the five HOXB9 SNPs showed significant association with acetabular over-coverage compared with controls (rs7405887 OR = 3.16, p = 5.29E-6, 95% CI 1.91 to 5.25). A significant difference was also detected when haplotypes were evaluated (OR = 2.59, p = 2.61E-5, 95% CI 1.65 to 4.08). The two HOXB9 SNPs (rs2303485, rs2303486) were associated with decreased acetabular coverage (rs2303485 OR = 0.524, p = 0.0091, 95% CI 0.322 to 0.855; rs2303486 OR = 0.519, p = 0.011, 95% CI 0.312 to 0.865). Conclusions The five HOXB9 SNPs (rs8844, rs3826541, rs3826540, rs7405887, rs79931349) were associated with acetabular over-coverage. On the other hand, the two SNPs (rs2303485 and rs2303486) were associated with the lower acetabular coverage. The association of rs2303486 would be consistent with the previous study. Therefore, the HOXB9 SNPs might be involved in the morphogenesis of acetabular coverage, and could be an independent risk factor for developing pincer-type femoroacetabular impingement.	[Sekimoto, T.; Kurogi, S.; Funamoto, T.; Ota, T.; Watanabe, S.; Sakamoto, T.; Hamada, H.; Chosa, E.] Miyazaki Univ, Miyazaki, Japan	Sekimoto, T (reprint author), Miyazaki Univ, Miyazaki, Japan.	sekkin@med.miyazaki-u.ac.jp			Hip Joint Foundation of Japan	This study was supported by a Grant-in-Aid from the Hip Joint Foundation of Japan. We thank W. Souma, I. Tsuchimochi, Y. Ozawa and A. Saito for their technical support in the laboratory.	Nelson CE, 1996, DEVELOPMENT, V122, P1449; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; Shrestha B, 2012, FEBS J, V279, P3715, DOI 10.1111/j.1742-4658.2012.08733.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Anderson SE, 2010, RADIOLOGY, V257, P8, DOI 10.1148/radiol.10091480; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Monazzam S, 2013, CLIN ORTHOP RELAT R, V471, P2578, DOI 10.1007/s11999-013-3001-z; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Ziegler J, 2008, ORTHOPADE, V37, P515, DOI 10.1007/s00132-008-1238-0; Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108; Jamali AA, 2007, J ORTHOP RES, V25, P758, DOI 10.1002/jor.20380; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/ng2005; Sekimoto T, 1998, GENES CELLS, V3, P51, DOI 10.1046/j.1365-2443.1998.00167.x; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Reynolds D, 1999, J BONE JOINT SURG BR, V81B, P281, DOI 10.1302/0301-620X.81B2.8291; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Cohen J., 1988, STAT POWER ANAL BEHA; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Dai J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2540; Hao Z, 2014, J ORTHOP RES, V32, P179, DOI 10.1002/jor.22507; Iida A, 2006, J HUM GENET, V51, P151, DOI 10.1007/s10038-005-0337-6; International HapMap Consortium, 2003, NAT, V426, P789; Lehmann HP, 2000, PEDIATRICS, V105, P57; Leunig M, 2005, UNFALLCHIRURG, V108, P9, DOI 10.1007/s00113-004-0902-z; Mabuchi A, 2006, AM J HUM GENET, V79, P163, DOI 10.1086/505088; Rouault K, 2009, OSTEOARTHR CARTILAGE, V17, P1099, DOI 10.1016/j.joca.2008.12.012; Sekimoto T, 2013, J ORTHOP RES, V31, P957, DOI 10.1002/jor.22310	36	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2046-3758			BONE JOINT RES	Bone Jt. Res.	APR	2015	4	4					50	55		10.1302/2046-3758.44.2000349		6	Cell & Tissue Engineering; Orthopedics	Cell Biology; Orthopedics	CF7IK	WOS:000352729500001		
J	Ohshima, M; Taguchi, A; Tsuda, H; Sato, Y; Yamahara, K; Harada-Shiba, M; Miyazato, M; Ikeda, T; Iida, H; Tsuji, M				Ohshima, Makiko; Taguchi, Akihiko; Tsuda, Hidetoshi; Sato, Yoshiaki; Yamahara, Kenichi; Harada-Shiba, Mariko; Miyazato, Mikiya; Ikeda, Tomoaki; Iida, Hidehiro; Tsuji, Masahiro			Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia ischemia	BRAIN & DEVELOPMENT			English	Article						Cell transfusion; Dexamethasone; MK-801; Mesenchymal stem cell; Mononuclear cell; Intraperitoneal injection; Intravenous injection; Neonatal hypoxic ischemic encephalopathy; Primate	CORD BLOOD-CELLS; MARROW MONONUCLEAR-CELLS; FOCAL CEREBRAL-ISCHEMIA; BRAIN-INJURY; BONE-MARROW; STEM-CELLS; RAT MODEL; DEXAMETHASONE; DAMAGE; TRANSPLANTATION	Background and purpose: Most therapeutic agents are administered intravenously (IV) in clinical settings and intraperitoneally (IP) in preclinical studies with neonatal rodents; however, it remains unclear whether intraperitoneal (IP) injection is truly an acceptable alternative for intravenous (IV) injection in preclinical studies. The objective of our study is to clarify the differences in the therapeutic effects of drugs and in the distribution of infused cells after an IP or IV injection in animals with brain injury. Methods: Dexamethasone or MK-801, an N-methyl-D-aspartate receptor antagonist was administered either IF or IV in a mouse model of neonatal hypoxic ischemic encephalopathy. Green fluorescent protein-expressing mesenchymal stem cells (MSCs) or mononuclear cells (MNCs) were injected IF or IV in the mouse model. Two hours and 24 h after the administration of the cells, we investigated the cell distributions by immunohistochemical staining. We also investigated distribution of IV administered MNCs labeled with 2-[F-18]fluoro-2-deoxy-D-glucose in a juvenile primate, a macaque with stroke 1 h after the administration. Results: IF and IV administration of dexamethasone attenuated the brain injury to a similar degree. IF administration of MK-801 attenuated brain injury, whereas IV administration of MK-801 did not. The IV group showed a significantly greater number of infused cells in the lungs and brains in the MSC cohort and in the spleen, liver, and lung in the MNC cohort compared to the IF group. In the macaque, MNCs were detected in the spleen and liver in large amounts, but not in the brain and lungs. Conclusions: This study demonstrated that the administration route influences the effects of drugs and cell distribution. Therefore, a preclinical study may need to be performed using the optimal administration route used in a clinical setting. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ohshima, Makiko; Tsuda, Hidetoshi; Yamahara, Kenichi; Harada-Shiba, Mariko; Tsuji, Masahiro] Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka 5658565, Japan; [Taguchi, Akihiko] Inst Biomed Res Innovat, Dept Regenerat Med Res, Kobe, Hyogo, Japan; [Sato, Yoshiaki] Nagoya Univ Hosp, Ctr Maternal Neonatal Care, Div Neonatol, Nagoya, Aichi, Japan; [Miyazato, Mikiya] Natl Cerebral & Cardiovasc Ctr, Dept Biochem, Suita, Osaka, Japan; [Ikeda, Tomoaki] Mie Univ, Sch Med, Dept Obstet & Gynecol, Tsu, Mie 514, Japan; [Iida, Hidehiro] Natl Cerebral & Cardiovasc Ctr, Dept Investigat Radiol, Suita, Osaka, Japan	Tsuji, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	tsuji.masahiro.ri@ncvc.go.jp			JSPS KAKENHI [24591617]	This work was supported by the JSPS KAKENHI, Grant No. 24591617. We are grateful to the National BioResource Project in Japan (http://www.anim.med.kyoto-u.ac.jp/NBR/) for providing the rat strain LEW-TgN(CAG-EGFP)1Ys. We would also like to thank Manami Sone and Man Furuta for their technical assistance.	Al Katheeri NA, 2004, VET RES COMMUN, V28, P525, DOI 10.1023/B:VERC.0000040243.30199.1f; Rosenkranz K, 2012, CELL TISSUE RES, V348, P429, DOI 10.1007/s00441-012-1401-0; de Paula S, 2012, NEUROSCIENCE, V210, P431, DOI 10.1016/j.neuroscience.2012.03.009; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; VEZZANI A, 1989, J PHARMACOL EXP THER, V249, P278; Bae SH, 2012, CELL TRANSPLANT, V21, P2497, DOI 10.3727/096368912X640457; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; Hosono T, 2010, EUR J APPL PHYSIOL, V109, P35, DOI 10.1007/s00421-009-1156-9; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; de Paula S, 2009, PEDIATR RES, V65, P631, DOI 10.1203/PDR.0b013e31819ed5c8; Ohnishi S, 2007, J MOL CELL CARDIOL, V42, P88, DOI 10.1016/j.yjmcc.2006.10.003; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Nakano-Doi A, 2010, STEM CELLS, V28, P1292, DOI 10.1002/stem.454; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI [10.1111/j.1582-4934.2008.00671.x, 10.1111/j.1582-4934.2009.00671.x]; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; TUOR UI, 1993, STROKE, V24, P452; Geissler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020194; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P351, DOI 10.1089/scd.2009.0049; Lee JA, 2010, PEDIATR RES, V67, P42, DOI 10.1203/PDR.0b013e3181bf594b; Tsuji M, 2012, EXP NEUROL, V233, P214, DOI 10.1016/j.expneurol.2011.10.004; Rosenkranz K, 2010, J NEUROSCI RES, V88, P1223, DOI 10.1002/jnr.22292; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Brehm M, 2002, HERZ, V27, P611, DOI 10.1007/s00059-002-2435-y; Carbonaro DA, 2006, MOL THER, V13, P1110, DOI 10.1016/j.ymthe.2006.02.013; Castillo-Melendez M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00194; CHUMAS PD, 1993, J NEUROSURG, V79, P414, DOI 10.3171/jns.1993.79.3.0414; Dalous J, 2013, STEM CELLS DEV, V22, P169, DOI 10.1089/scd.2012.0183; Daly TM, 1999, P NATL ACAD SCI USA, V96, P2296, DOI 10.1073/pnas.96.5.2296; Earp JC, 2008, J PHARMACOL EXP THER, V326, P546, DOI 10.1124/jpet.108.137414; Glascock JJ, 2011, JOVE-J VIS EXP, V56, P2968; HAGBERG H, 1994, BIOL NEONATE, V66, P205; HATTORI H, 1989, NEUROLOGY, V39, P713; Ikeda T, 2002, BEHAV BRAIN RES, V136, P161, DOI 10.1016/S0166-4328(02)00107-9; Kienstra KA, 2007, J AM ASSOC LAB ANIM, V46, P50; KOSTRON H, 1983, SURG NEUROL, V20, P48, DOI 10.1016/0090-3019(83)90105-2; Margaill I, 1996, J CEREBR BLOOD F MET, V16, P107; MCDONALD JW, 1987, EUR J PHARMACOL, V140, P359, DOI 10.1016/0014-2999(87)90295-0; Ohshima M, 2012, EXP NEUROL, V233, P481, DOI 10.1016/j.expneurol.2011.11.025; Rosenkranz K, 2013, ANN ANAT, V195, P122, DOI 10.1016/j.aanat.2012.09.003; Sabir H, 2012, STROKE, V43, P3364, DOI 10.1161/STROKEAHA.112.674481; Samtani MN, 2005, BIOPHARM DRUG DISPOS, V26, P85, DOI 10.1002/bdd.435; Sands MS, 1999, LAB ANIM SCI, V49, P328; WALLACE MC, 1992, J NEUROSURG, V76, P127, DOI 10.3171/jns.1992.76.1.0127; Wasielewski B, 2012, BRAIN RES, V1487, P39, DOI 10.1016/j.brainres.2012.05.066; Wegener N, 2011, NEUROSCI LETT, V503, P68, DOI 10.1016/j.neulet.2011.08.012	55	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	APR	2015	37	4					376	386		10.1016/j.braindev.2014.06.010		11	Clinical Neurology	Neurosciences & Neurology	CF6IF	WOS:000352659700003		
J	Nakazawa, M; Akasaka, M; Hasegawa, T; Suzuki, T; Shima, T; Takanashi, J; Yamamoto, A; Ishidou, Y; Kikuchi, K; Niijima, S; Shimizu, T; Okumura, A				Nakazawa, Mika; Akasaka, Manami; Hasegawa, Takeshi; Suzuki, Tomonori; Shima, Taiki; Takanashi, Jun-ichi; Yamamoto, Atsuko; Ishidou, Yuuki; Kikuchi, Kenjiro; Niijima, Shinichi; Shimizu, Toshiaki; Okumura, Akihisa			Efficacy and safety of fosphenytoin for acute encephalopathy in children	BRAIN & DEVELOPMENT			English	Article						Fosphenytoin; Acute encephalopathy; Acute encephalopathy with biphasic seizures and late reduced diffusion; Efficacy; Safety	STATUS EPILEPTICUS; SEIZURES; PHENYTOIN; VALPROATE	Purpose: To evaluate the efficacy and safety of fosphenytoin (fPHT) for the treatment of seizures in children with acute encephalopathy. Methods: Using responses from physicians on the Annual Zao Conference on Pediatric Neurology mailing list we chose patients who met the following criteria: clinical diagnosis of acute encephalopathy and use of intravenous fPHT for the treatment of seizures. We divided the patients into two groups: acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) and other encephalopathies. The efficacy of fPHT was considered effective when a cessation of seizures was achieved. Results: Data of 38 children were obtained (median age, 27 months). Eighteen children were categorized into the AESD group and 20 into the other encephalopathies group. fPHT was administered in 48 clinical events. The median loading dose of fPHT was 22.5 mg/kg and was effective in 34 of 48 (71%) events. The rate of events in which fPHT was effective did not differ according to the presence or absence of prior antiepileptic treatment, subtype of acute encephalopathy, or the type of seizures. One patient experienced apnea and oral dyskinesia as adverse effects of fPHT, whereas arrhythmia, hypotension, obvious reduction of consciousness, local irritation, phlebitis and purple grove syndrome were not observed in any patient. Conclusion: fPHT is effective and well tolerated among children with acute encephalopathy. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Nakazawa, Mika; Shima, Taiki; Shimizu, Toshiaki; Okumura, Akihisa] Juntendo Univ, Fac Med, Dept Pediat, Tokyo 1138421, Japan; [Nakazawa, Mika; Niijima, Shinichi] Juntendo Univ, Nerima Hosp, Dept Pediat, Tokyo 1138421, Japan; [Akasaka, Manami] Iwate Med Univ, Fac Med, Dept Pediat, Morioka, Iwate, Japan; [Hasegawa, Takeshi] Soka Municipal Hosp, Dept Pediat, Soka, Saitama, Japan; [Suzuki, Tomonori] Kawaguchi Municipal Med Ctr, Dept Pediat, Kawaguchi, Saitama, Japan; [Shima, Taiki] Nagano Childrens Hosp, Dept Neuropediat, Toyoshina, Nagano, Japan; [Takanashi, Jun-ichi] Kameda Med Ctr, Dept Pediat, Kamogawa, Chiba, Japan; [Yamamoto, Atsuko] Tsuchiura Kyodo Gen Hosp, Dept Pediat, Ibaraki, Japan; [Ishidou, Yuuki] St Marys Hosp, Dept Pediat, Tokyo, Japan; [Kikuchi, Kenjiro] Saitama Childrens Med Ctr, Div Neurol, Omiya, Saitama, Japan; [Okumura, Akihisa] Aichi Med Univ, Dept Pediat, Nagakute, Aichi, Japan	Nakazawa, M (reprint author), Juntendo Univ, Fac Med, Dept Pediat, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	mknakaza@juntendo.ac.jp			Ministry of Health, Labor, and Welfare [H24-Shinkou-Ippan-002, H22-Nanji-Ippan-028]	This work was partly supported by Grants from the Ministry of Health, Labor, and Welfare (H24-Shinkou-Ippan-002 and H22-Nanji-Ippan-028).	Agarwal P, 2007, SEIZURE-EUR J EPILEP, V16, P527, DOI 10.1016/j.seizure.2007.04.012; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Trinka E, 2009, EPILEPSIA, V50, P40, DOI 10.1111/j.1528-1167.2009.02368.x; Tada H, 2004, NEUROLOGY, V63, P1854; Abend NS, 2013, SEIZURE-EUR J EPILEP, V22, P467, DOI 10.1016/j.seizure.2013.03.008; Takeoka M, 1998, J CHILD NEUROL, V13, P537; Takanashi J, 2009, AM J NEURORADIOL, V30, P132, DOI 10.3174/ajnr.A1247; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Bialer M, 2009, EPILEPSIA, V50, P44, DOI 10.1111/j.1528-1167.2009.02348.x; Komatsu M, 2010, BRAIN DEV-JPN, V32, P472, DOI 10.1016/j.braindev.2009.09.012; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Fischer JH, 2003, CLIN PHARMACOKINET, V42, P33, DOI 10.2165/00003088-200342010-00002; Eriksson Kai, 2009, Expert Opin Drug Metab Toxicol, V5, P695, DOI 10.1517/17425250902997975; Mizuguchi M, 1997, BRAIN DEV-JPN, V19, P81, DOI 10.1016/S0387-7604(96)00063-0	16	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	APR	2015	37	4					418	422		10.1016/j.braindev.2014.06.009		5	Clinical Neurology	Neurosciences & Neurology	CF6IF	WOS:000352659700008		
J	Okanishi, T; Yamamoto, H; Hosokawa, T; Ando, N; Nagayama, Y; Hashimoto, Y; Maihara, T; Goto, T; Kubota, T; Kawaguchi, C; Yoshida, H; Sugiura, K; Itomi, S; Ohno, K; Takanashi, J; Hayakawa, M; Otsubo, H; Okumura, A				Okanishi, Tohru; Yamamoto, Hiroyuki; Hosokawa, Takatoshi; Ando, Naoki; Nagayama, Yoshihisa; Hashimoto, Yuji; Maihara, Toshiro; Goto, Tomohide; Kubota, Tetsuo; Kawaguchi, Chiharu; Yoshida, Hiroshi; Sugiura, Katsumi; Itomi, Seiko; Ohno, Koyo; Takanashi, Jun-ichi; Hayakawa, Masahiro; Otsubo, Hiroshi; Okumura, Akihisa			Diffusion-weighted MRI for early diagnosis of neonatal herpes simplex encephalitis	BRAIN & DEVELOPMENT			English	Article						Magnetic resonance imaging; Cortical lesions; Diffusion weighted imaging; Herpes simplex encephalitis; Early diagnosis; Neonate	RESONANCE-IMAGING FINDINGS; VIRUS TYPE-2 ENCEPHALITIS; ARTERIAL ISCHEMIC-STROKE; INFECTIONS; PREDICTORS; CHILDREN; INJURY	Aim: To determine the early changes and evolutions of brain diffusion-weighted imaging (DWI), and analyze prognostic factors of the early changes among patients with neonatal herpes simplex encephalitis (NHSE). Method: We selected patients who developed encephalitis by 28 d after birth; had herpes simplex infection; and who underwent magnetic resonance imaging, including DWI, 7 d of symptom onset. Thirty-two DWI scans between 0 and 28 d after onset in 13 patients and the clinical data were recruited. The distribution, evolution of the lesions, and neurological outcome were analyzed. Results: DWI frequently showed multiple cortical lesions in both hemispheres in the early period and both hemispheres on DWI (8/9 scans at <= 48 h, 7/7 patients). As time from onset increased, the cortical lesions tended to coincide with subcortical white matter lesions beneath the initial cortical lesions (p < 0.01). Lesions from the cortex extended to the subcortical white matter in 7 patients. Deep cerebral lesions, involving basal ganglia, internal capsules, thalamus, were also found in 9 patients 7 d of onset. The distributions of deep cerebral lesions (none/unilateral/bilateral) 7 d of onset showed significant correlations with neurological prognoses (gross motor functions: p <0.01; developmental or intellectual quotient scores: p <0.01). Interpretation: Cortical lesions were main findings of DWI in NHSE in the early period. Bilateral deep cerebral lesions..<,7 d were highly indicative of poor motor and cognitive outcomes. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Okanishi, Tohru] Seirei Hamamatsu Gen Hosp, Dept Child Neurol, Hamamatsu, Shizuoka 4308558, Japan; [Yamamoto, Hiroyuki] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Hosokawa, Takatoshi] Kochi Med Sch, Dept Pediat, Nankoku, Kochi, Japan; [Okanishi, Tohru; Ando, Naoki] Nagoya City Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan; [Nagayama, Yoshihisa] Niigata City Gen Hosp, Maternal & Perinatal Care Ctr, Niigata, Japan; [Hashimoto, Yuji] Chiba Kaihin Municipal Hosp, Dept Pediat, Chiba, Japan; [Maihara, Toshiro] Hyogo Prefectural Tsukaguthi Hosp, Dept Pediat, Amagasaki, Hyogo, Japan; [Goto, Tomohide] Tokyo Metropolitan Childrens Med Ctr, Div Neurol, Tokyo, Japan; [Kubota, Tetsuo] Anjo Kosei Hosp, Dept Pediat, Anjo, Aichi, Japan; [Kawaguchi, Chiharu] Nara City Hosp, Dept Pediat, Nara, Japan; [Yoshida, Hiroshi] Tsuruoka Municipal Shonai Hosp, Dept Pediat, Sakata, Yamagata, Japan; [Sugiura, Katsumi] Yamada Red Cross Hosp, Dept Pediat, Hamamatsu, Shizuoka, Japan; [Itomi, Seiko] Japanese Red Cross Nagoya Daiichi Hosp, Dept Pediat, Nagoya, Aichi, Japan; [Ohno, Koyo] Tottori Prefectural Cent Hosp, Dept Pediat, Tottori, Japan; [Takanashi, Jun-ichi] Kameda Med Ctr, Dept Pediat, Kamogawa, Chiba, Japan; [Hayakawa, Masahiro] Nagoya Univ Hosp, Matern & Perinatal Care Ctr, Nagoya, Aichi, Japan; [Otsubo, Hiroshi] Hosp Sick Children, Dept Neurophysiol, Div Neurol, Toronto, ON M5G 1X8, Canada; [Okumura, Akihisa] Aichi Med Univ, Dept Pediat, Nagakute, Aichi, Japan	Okanishi, T (reprint author), Seirei Hamamatsu Gen Hosp, Dept Child Neurol, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka 4308558, Japan.	okanishipediatrics@gmail.com					Wraige E, 2005, DEV MED CHILD NEUROL, V47, P252, DOI 10.1017/S0012162205000484; Dhawan A, 2006, J PAEDIATR CHILD H, V42, P824, DOI 10.1111/j.1440-1754.2006.00986.x; Dudink J, 2009, AM J NEURORADIOL, V30, P998, DOI 10.3174/ajnr.A1480; Goergen SK, 2014, CLIN RADIOL, V69, P72, DOI 10.1016/j.crad.2013.09.001; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Kubota T, 2007, BRAIN DEV-JPN, V29, P171, DOI 10.1016/j.braindev.2006.08.003; Vossough A, 2008, NEURORADIOLOGY, V50, P355, DOI 10.1007/s00234-007-0349-3; Steiner I, 2011, CURR OPIN NEUROL, V24, P268, DOI 10.1097/WCO.0b013e328346be6f; ENZMANN D, 1990, J COMPUT ASSIST TOMO, V14, P453, DOI 10.1097/00004728-199005000-00025; Kimberlin DW, 2001, PEDIATRICS, V108, P223, DOI 10.1542/peds.108.2.223; Verboon-Maciolek MA, 2008, ANN NEUROL, V64, P266, DOI 10.1002/ana.21445; Jan W, 2003, NEURORADIOLOGY, V45, P634, DOI 10.1007/s00234-003-1035-8; Breningstall GN, 2010, PEDIATR NEUROL, V42, P298, DOI 10.1016/j.pediatrneurol.2009.11.008; BROWN RS, 1977, DEV MED CHILD NEUROL, V19, P407; Gutierrez KM, 2011, INFECT DIS FETUS NEW, P813, DOI 10.1016/B978-1-4160-6400-8.00026-2; Hirata O, 2011, NEUROPEDIATRICS, V42, P156, DOI 10.1055/s-0031-1285876; Kimberlin David, 2004, Herpes, V11 Suppl 2, p65A; Kirkham FJ, 2013, DEV MED CHILD NEUROL, V55, P107, DOI 10.1111/j.1469-8749.2012.04410.x; Malm G, 1999, ARCH DIS CHILD, V81, pF24; Pelligra G, 2007, PEDIATRICS, V120, pE442, DOI 10.1542/peds.2006-3757; Rutherford MA, 2012, ARCH DIS CHILD-FETAL, V97, pF377, DOI 10.1136/fetalneonatal-2010-196451; Teixeira J, 2001, NEURORADIOLOGY, V43, P1031; Toth C, 2003, CAN J NEUROL SCI, V30, P36; Whitley R, 2004, CURR OPIN INFECT DIS, V17, P243, DOI 10.1097/01.qco.0000129622.38777.4f	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	APR	2015	37	4					423	431		10.1016/j.braindev.2014.07.006		9	Clinical Neurology	Neurosciences & Neurology	CF6IF	WOS:000352659700009		
J	Ueda, F; Aburano, H; Yoshie, Y; Matsui, O; Gabata, T				Ueda, Fumiaki; Aburano, Hiroyuki; Yoshie, Yuichi; Matsui, Osamu; Gabata, Toshifumi			Striatal hemihypoplasia: An early embryonic variant of cerebral hemiatrophy	BRAIN & DEVELOPMENT			English	Article						Hemihypoplasia; Hemiatrophy; Striatum; Internal capsule	CHILDHOOD; NUCLEUS; CAUDATE	We present a case of hemihypoplasia of the striatum with ipsilateral cerebral hemispheric atrophy. The head of the caudate nucleus and putamen were hypoplastic, and gray matter cell bridges between them located in the anterior limb of the internal capsule were sparse. Cerebral atrophy was accompanied by ipsilateral mesial temporal sclerosis without thalamic atrophy. The anterior limb of the internal capsule showed no signal abnormalities or volume loss. These imaging findings and the hyperintensity at the fundus striati suggest an early embryonic insult of lateral striatal elevation. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ueda, Fumiaki; Aburano, Hiroyuki; Yoshie, Yuichi; Gabata, Toshifumi] Kanazawa Univ Hosp, Dept Radiol, Kanazawa, Ishikawa 9208641, Japan; [Matsui, Osamu] Kanazawa Univ, Dept Adv Med Imaging, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan	Ueda, F (reprint author), Kanazawa Univ Hosp, Dept Radiol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	fumiaki@staff.kanazawa-u.ac.jp					Atalar MH, 2007, PEDIATR INT, V49, P70, DOI 10.1111/j.1442-200X.2007.02299.x; BARKOVICH AJ, 1990, AM J NEURORADIOL, V11, P1087; Dix JE, 1997, RADIOLOGY, V203, P269; HEWITT W, 1961, J ANAT, V95, P191; HEWITT W, 1958, J ANAT, V92, P377; LEAO M, 1994, J MED GENET, V31, P969, DOI 10.1136/jmg.31.12.969; O'Rahilly R, 2006, EMBRYONIC HUMAN BRAI, P205	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	APR	2015	37	4					439	441		10.1016/j.braindev.2014.06.014		3	Clinical Neurology	Neurosciences & Neurology	CF6IF	WOS:000352659700011		
J	Tamaura, M; Shimbo, H; Iai, M; Yamashita, S; Osaka, H				Tamaura, Moe; Shimbo, Hiroko; Iai, Mizue; Yamashita, Sumimasa; Osaka, Hitoshi			Seizure recurrence following pyridoxine withdrawal in a patient with pyridoxine-dependent epilepsy	BRAIN & DEVELOPMENT			English	Article						Pyridoxine-dependent epilepsy; Pyridoxine; ALDH7A1 gene	DEFICIENCY; ANTIQUITIN	Pyridoxine-dependent epilepsy (PDE) is an autosomal recessive disorder characterized by early onset and recurrent seizures that can be controlled by a high dose of pyridoxine. PDE is caused by mutations in ALDH7A1, which encodes antiquitin. Antiquitin converts a-aminoadipic semialdehyde to a-aminoadipic acid. Seizure recurrence after pyridoxine withdrawal is a criterion for diagnosis, but PDE can be diagnosed conclusively by genetic testing for mutations in the ALDH7A1 gene. In this case study, we report the long-term follow-up of a patient suspected with PDE. She experienced prolonged generalized tonic seizures and was hospitalized in an intensive care unit following pyridoxine withdrawal. Later, we identified a compound heterozygous mutation, c.1216G>A, p.Gly406Arg, and a novel splice donor site mutation, IVS9+5G>A. Confirmation of these mutations would have prevented an unsafe withdrawal test. This case suggests the importance of the genetic determination of PDE to avoid the diagnostic withdrawal of pyridoxine. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Tamaura, Moe; Shimbo, Hiroko; Iai, Mizue; Yamashita, Sumimasa; Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Div Neurol, Yokohama, Kanagawa, Japan; [Osaka, Hitoshi] Jichi Med Sch, Dept Pediat, Shimotsuke, Tochigi 3290498, Japan	Osaka, H (reprint author), Jichi Med Sch, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	hosaka@jichi.ac.jp					Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Mills PB, 2010, BRAIN, V133, P2148, DOI 10.1093/brain/awq143; Baxter P, 2001, DEV MED CHILD NEUROL, V43, P416, DOI 10.1017/S0012162201000779; Struys EA, 2010, FEBS LETT, V584, P181, DOI 10.1016/j.febslet.2009.11.055; GOSPE SM, 1994, LANCET, V343, P1133, DOI 10.1016/S0140-6736(94)90236-4; Gospe SM, 1998, NEUROLOGY, V51, P74; Gospe SM, 1998, J PEDIATR-US, V132, P919, DOI 10.1016/S0022-3476(98)70384-1; Kanno J, 2007, MOL GENET METAB, V91, P384, DOI 10.1016/j.ymgme.2007.02.010; Proudfoot Malcolm, 2013, JIMD Rep, V10, P103, DOI 10.1007/8904_2012_210; Stockler S, 2011, MOL GENET METAB, V104, P48, DOI 10.1016/j.ymgme.2011.05.014	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	APR	2015	37	4					442	445		10.1016/j.braindev.2014.07.008		4	Clinical Neurology	Neurosciences & Neurology	CF6IF	WOS:000352659700012		
J	Inui, T; Kobayashi, T; Kobayashi, S; Sato, R; Endo, W; Kikuchi, A; Nakayama, T; Uematsu, M; Takayanagi, M; Kato, M; Saitsu, H; Matsumoto, N; Kure, S; Haginoya, K				Inui, Takehiko; Kobayashi, Tomoko; Kobayashi, Satoru; Sato, Ryo; Endo, Wakaba; Kikuchi, Atsuo; Nakayama, Tojo; Uematsu, Mitsugu; Takayanagi, Masaru; Kato, Mitsuhiro; Saitsu, Hirotomo; Matsumoto, Naomichi; Kure, Shigeo; Haginoya, Kazuhiro			Efficacy of long term weekly ACTH therapy for intractable epilepsy	BRAIN & DEVELOPMENT			English	Article						ACTH; Intractable epilepsy; Infantile spasms; Atypical absence seizure; LIS1; Lissencephaly	BENIGN PARTIAL EPILEPSY; INFANTILE SPASMS	Background: Adrenocorticotropic hormone (ACTH) therapy is the first-line therapy for infantile spasms, and is effective for many other intractable epilepsies. While spasms may respond to ACTH for weeks, a substantial proportion of patients develop recurrent seizures over a yearly period. To maintain efficacy, we treated two children with intractable epilepsy with weekly ACTH therapy for 1 year and described the changes in clinical seizures, electroencephalograms, developmental assessments and side effects. Subjects and methods: A girl with infantile spasms due to lissencephaly and a boy with atypical absence seizures were studied. In both cases, seizures were frequent and resistant to antiepileptic drugs; electroencephalograms showed continuous epileptiform activities, and the patients' development was delayed and stagnant prior to ACTH treatment. The initial ACTH therapy (daily 0.015 mg/kg for 2 weeks, 0.015 mg/kg every 2 days for 1 week, 0.0075 mg/kg every 2 days for 1 week), was transiently effective in both cases. The second-round ACTH therapy consisted of the initial ACTH therapy protocol followed by weekly ACTH injections (0.015 mg/kg or 0.0075 mg/kg) for 1 year. Both cases were followed for at least 1 year after therapy. Results: In both patients, clinical seizures were completely controlled during and 1 year after the second-round ARCH therapy. Continuous epileptiform discharges disappeared, while intermittent interictal epileptiform discharges remained. Both patients showed some developmental gains after achieving seizure control. No serious side effects were recorded. Conclusion: Further studies are warranted to determine if a long-term weekly ACTH is a safe and effective treatment for intractable epilepsy. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Inui, Takehiko; Kobayashi, Satoru; Sato, Ryo; Endo, Wakaba; Haginoya, Kazuhiro] Takuto Rehabil Ctr Children, Dept Pediat Neurol, Sendai, Miyagi 9820241, Japan; [Kobayashi, Tomoko; Sato, Ryo; Endo, Wakaba; Kikuchi, Atsuo; Nakayama, Tojo; Uematsu, Mitsugu; Kure, Shigeo; Haginoya, Kazuhiro] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan; [Kobayashi, Satoru] Nagoya City West Med Ctr, Dept Pediat, Nagoya, Aichi, Japan; [Takayanagi, Masaru] Sendai City Hosp, Dept Pediat, Sendai, Miyagi, Japan; [Kato, Mitsuhiro] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan	Haginoya, K (reprint author), Takuto Rehabil Ctr Children, Dept Pediat Neurol, 20 Shishioto, Sendai, Miyagi 9820241, Japan.	khaginoya@kha.biglobe.ne.jp					Pellock JM, 2010, EPILEPSIA, V51, P2175, DOI 10.1111/j.1528-1167.2010.02657.x; Okumura A, 2006, SEIZURE-EUR J EPILEP, V15, P469, DOI 10.1016/j.seizure.2006.05.010; Go CY, 2012, NEUROLOGY, V78, P1974, DOI 10.1212/WNL.0b013e318259e2cf; Inutsuka M, 2006, BRAIN DEV-JPN, V28, P281, DOI 10.1016/j.braindev.2005.09.004; Fujii A, 2010, PEDIATR NEUROL, V43, P411, DOI 10.1016/j.pediatrneurol.2010.06.018; Haberlandt E, 2010, PEDIATR NEUROL, V42, P21, DOI [10.1016/j.pediatrneurol.2009.07.011, 10.1016/j.pediatmeurol.2009.07.011]; Kobayashi S, 2013, SEIZURE-EUR J EPILEP, V22, P242, DOI 10.1016/j.seizure.2012.12.003; Mohamed BP, 2011, EPILEPSIA, V52, P746, DOI 10.1111/j.1528-1167.2010.02963.x; Oguni H, 2005, EPILEPSIA, V46, P709, DOI 10.1111/j.1528-1167.2005.37504.x; Okanishi T, 2008, PEDIATR NEUROL, V38, P445, DOI 10.1016/j.pediatrneurol.2008.02.009	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	APR	2015	37	4					449	454		10.1016/j.braindev.2014.07.004		6	Clinical Neurology	Neurosciences & Neurology	CF6IF	WOS:000352659700014		
J	Shiihara, T; Watanabe, M; Moriyama, K; Uematsu, M; Sameshima, K				Shiihara, Takashi; Watanabe, Mio; Moriyama, Kengo; Uematsu, Mitsugu; Sameshima, Kiyoko			A novel PLPI frameshift mutation causing a milder form of Pelizaeus Merzbacher disease	BRAIN & DEVELOPMENT			English	Article						Pelizaeus-Merzbacher disease; Spastic paraplegia 2; Proteolipid protein; Myelination; Magnetic resonance imaging; mRNA; Nonsensemediated decay	SPASTIC PARAPLEGIA TYPE-2; DISORDERS; PHENOTYPE; DELETION; DEFECTS; PROTEIN; GENE	Background: Pelizaeus Merzbacher disease (PMD), a hypomyelinating leukodystrophy, and the related but less severe allelic spastic paraplegia 2 (SPG2) are caused by mutations in the proteolipid protein 1 (PLP1) gene. Magnetic resonance imaging (MRI) is pivotal for diagnosing these disorders. The severity of PMD/SPG2 varies, and for a milder form of PMD, there have been some reports of near-normal findings in T1-weighted-images but abnormal findings in T2-weighted images. Patient: We report the case of a 5-year-old boy diagnosed with a milder form of PMD caused by a novel PLP1 mutation in exon 3: c.300delC (p.I100IfsX13). He had delayed development from several months of age and was able to walk with support at 19 months in spite of the spasticity in his lower extremities. Hypomyelination was noted at 12 months by brain MRI. Motor nerve conduction studies showed decreased velocities with reduced amplitudes. Follow-up MRI at 1-year intervals from 18 months until 55 months of age showed gradual myelination progress. Discussion: The single nucleotide deletion identified in this patient can cause a frameshift and premature termination of PLP1. Via the nonsense-mediated mRNA decay mechanism of this mutation will result in loss-of-function, leading to a milder form of PMD. The present case is compatible with previously reported cases of milder form of PMD. We incidentally identified progressive myelination in this patient by T1-weighted images obtained by serial MRI. This finding adds to our understanding of the pathological stages of a milder form of PMD. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Shiihara, Takashi; Watanabe, Mio; Moriyama, Kengo] Gunma Childrens Med Ctr, Dept Neurol, Gunma 3778577, Japan; [Uematsu, Mitsugu] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 9808574, Japan; [Sameshima, Kiyoko] Gunma Childrens Med Ctr, Div Med Genet, Gunma 3778577, Japan	Shiihara, T (reprint author), Gunma Childrens Med Ctr, Dept Neurol, 779 Shimohakoda,Hokkitsu Machi, Gunma 3778577, Japan.	shiihara-ind@umin.net		Shiihara, Takashi/0000-0002-0852-7451			Garbern JY, 2002, BRAIN, V125, P551, DOI 10.1093/brain/awf043; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Cailloux F, 2000, EUR J HUM GENET, V8, P837, DOI 10.1038/sj.ejhg.5200537; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Osaka H, 2010, BRAIN DEV-JPN, V32, P703, DOI 10.1016/j.braindev.2009.11.004; Grossi S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-40; Matsufuji M, 2013, PEDIATR NEUROL, V49, P477, DOI 10.1016/j.pediatrneurol.2013.07.012; Torisu H, 2012, BRAIN DEV-JPN, V34, P852, DOI 10.1016/j.braindev.2012.02.006; Woodward Karen J., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000677	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	APR	2015	37	4					455	458		10.1016/j.braindev.2014.06.011		4	Clinical Neurology	Neurosciences & Neurology	CF6IF	WOS:000352659700015		
J	Sanmaneechai, O; Likasitwattanakul, S; Sangruchi, T; Nishino, I				Sanmaneechai, Oranee; Likasitwattanakul, Surachai; Sangruchi, Tumtip; Nishino, Ichizo			Ophthalmoplegia in congenital neuromuscular disease with uniform type 1 fiber	BRAIN & DEVELOPMENT			English	Article						CNMDU1; Congenital myopathy; Limitation of extraoccular muscle movement; Ptosis	MYOPATHY	Congenital neuromuscular disease with uniform type 1 fiber (CNMDU1) is a rare type of congenital myopathy. It is characterized by early onset of symptoms, mild proximal muscle weakness, hyporeflexia or areflexia, normal serum creatine kinase (CK) levels and myopathic electromyography finding, uniform type 1 fibers, and nonprogression. We report a 2-year-old boy who presented with congenital hypotonia, breathing and feeding difficulty, myopathic facies, proximal muscle weakness, ptosis, total external ophthalmoplegia and delayed motor developmental milestones. Normal serum muscle enzyme and short duration of motor unit potentials on electromyography were noted. Muscle biopsy showed uniformity of type 1 fibers (greater than 99%) and moderate variation in fiber size without specific structural abnormality. Total external ophthalmoplegia may be one of the important clinical manifestations of CNMDUl. It is important to recognize this disorder because it is nonprogressive in nature. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Sanmaneechai, Oranee; Likasitwattanakul, Surachai] Mahidol Univ, Dept Pediat, Div Neurol, Fac Med,Siriraj Hosp, Bangkok 10700, Thailand; [Sangruchi, Tumtip] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pathol, Bangkok 10700, Thailand; [Nishino, Ichizo] NCNP, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan	Sanmaneechai, O (reprint author), Mahidol Univ, Dept Pediat, Div Neurol, Fac Med,Siriraj Hosp, Bangkok 10700, Thailand.	oranee141@gmail.com					Bharucha-Goebel DX, 2013, NEUROLOGY, V80, P1584, DOI 10.1212/WNL.0b013e3182900380; Dubowitz V, 2007, MUSCLE BIOPSY PRACTI; GIOMETTI CS, 1990, MUSCLE NERVE, V13, P209, DOI 10.1002/mus.880130307; JONG YJ, 1991, BRAIN DEV-JPN, V13, P444; Jung EY, 1997, PEDIATR NEUROL, V16, P56, DOI 10.1016/S0887-8994(96)00231-7; Na SJ, 2004, YONSEI MED J, V45, P150; OH SJ, 1983, ARCH NEUROL-CHICAGO, V40, P147; Sakamoto HM, 2006, BRAIN DEV-JPN, V28, P202, DOI 10.1016/j.braindev.2005.06.008; Sato I, 2008, NEUROLOGY, V70, P114	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	APR	2015	37	4					459	462		10.1016/j.braindev.2014.07.009		4	Clinical Neurology	Neurosciences & Neurology	CF6IF	WOS:000352659700016		
J	Arita, H; Narita, Y; Yoshida, A; Hashimoto, N; Yoshimine, T; Ichimura, K				Arita, Hideyuki; Narita, Yoshitaka; Yoshida, Akihiko; Hashimoto, Naoya; Yoshimine, Toshiki; Ichimura, Koichi			IDH1/2 mutation detection in gliomas	BRAIN TUMOR PATHOLOGY			English	Review						Glioma; IDH1; IDH2	LOW-GRADE GLIOMAS; MAGNETIC-RESONANCE-SPECTROSCOPY; PREDICT LONGER SURVIVAL; CENTRAL-NERVOUS-SYSTEM; CODON 132 MUTATION; BRAIN-TUMOR GROUP; IDH2 MUTATIONS; OLIGODENDROGLIAL TUMORS; ANAPLASTIC GLIOMAS; DIFFUSE GLIOMAS	Somatic mutations of isocitrate dehydrogenase 1 and 2 (IDH1/2) are strongly associated with pathological subtypes, genetic profiles, and clinical features in gliomas. The IDH1/2 status is currently regarded as one of the most important molecular markers in gliomas and should be assessed accurately and robustly. However, the methods used for IDH1/2 testing are not fully standardized. The purpose of this paper is to review the clinical significance of IDH1/2 mutations and the methods used for IDH1/2 testing. The optimal method for IDH1/2 testing varies depending on a number of factors, including the purpose, sample types, sample number, or laboratory equipment. It is therefore important to acknowledge the advantages and disadvantages of each method.	[Arita, Hideyuki; Narita, Yoshitaka] Natl Canc Ctr, Dept Neurosurgery & Neurooncol, Tokyo, Japan; [Arita, Hideyuki; Hashimoto, Naoya; Yoshimine, Toshiki] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan; [Yoshida, Akihiko] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo, Japan; [Ichimura, Koichi] Natl Canc Ctr, Div Brain Tumor Translat Res, Tokyo, Japan	Arita, H (reprint author), Osaka Univ, Grad Sch Med, Dept Neurosurg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	h-arita@nsurg.med.osaka-u.ac.jp			JSPS KAKENHI [26861171, 25462283]; National Cancer Center Research and Development Fund [23-A-50]	This work was supported by JSPS KAKENHI Grant Numbers 26861171 (H.A.), 25462283 (K.I.) and by the National Cancer Center Research and Development Fund 23-A-50 (K.I.).	Andronesi OC, 2012, SCI TRANSL MED, V4; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Kaneko MK, 2011, BIOCHEM BIOPH RES CO, V406, P608, DOI 10.1016/j.bbrc.2011.02.102; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mulholland S, 2012, INT J CANCER, V131, P1104, DOI 10.1002/ijc.26499; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Pope WB, 2012, J NEURO-ONCOL, V107, P197, DOI 10.1007/s11060-011-0737-8; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Weller M, 2012, NEURO-ONCOLOGY, V14, P100, DOI 10.1093/neuonc/nos206; Metellus P, 2010, ACTA NEUROPATHOL, V120, P719, DOI 10.1007/s00401-010-0777-8; Ichimura K, 2012, BRAIN TUMOR PATHOL, V29, P131, DOI 10.1007/s10014-012-0090-4; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; Pang B, 2013, DIAGN MOL PATHOL, V22, P28, DOI 10.1097/PDM.0b013e31826c7ff8; Capper D, 2010, AM J SURG PATHOL, V34, P1199, DOI 10.1097/PAS.0b013e3181e7740d; Sonoda Y, 2009, CANCER SCI, V100, P1996, DOI 10.1111/j.1349-7006.2009.01270.x; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Agarwal S, 2013, NEURO-ONCOLOGY, V15, P718, DOI 10.1093/neuonc/not015; van den Bent MJ, 2010, ACTA NEUROPATHOL, V120, P297, DOI 10.1007/s00401-010-0725-7; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Horbinski C, 2013, ACTA NEUROPATHOL, V125, P621, DOI 10.1007/s00401-013-1106-9; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Horbinski C, 2009, J NEUROPATH EXP NEUR, V68, P1319, DOI 10.1097/NEN.0b013e3181c391be; Hartmann C, 2011, CLIN CANCER RES, V17, P4588, DOI 10.1158/1078-0432.CCR-10-3194; Takano S, 2011, BRAIN TUMOR PATHOL, V28, P115, DOI 10.1007/s10014-011-0023-7; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ward PS, 2012, ONCOGENE, V31, P2491, DOI 10.1038/onc.2011.416; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Mukasa A, 2012, CANCER SCI, V103, P587, DOI 10.1111/j.1349-7006.2011.02175.x; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Qi ST, 2011, ONCOL REP, V26, P1479, DOI 10.3892/or.2011.1428; van den Bent MJ, 2013, J NEURO-ONCOL, V112, P173, DOI 10.1007/s11060-013-1056-z; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Arita H, 2014, BRAIN TUMOR IN PRESS; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Boisselier B, 2010, HUM MUTAT, V31, P1360, DOI 10.1002/humu.21365; Cykowski MD, 2012, DIAGN MOL PATHOL, V21, P214, DOI 10.1097/PDM.0b013e31825d802b; Felsberg J, 2010, ACTA NEUROPATHOL, V119, P501, DOI 10.1007/s00401-010-0647-4; Horbinski C, 2010, J MOL DIAGN, V12, P487, DOI 10.2353/jmoldx.2010.090228; Kato Kaneko M, 2013, TOHOKU J EXP MED, V230, P103; Okita Y, 2012, INT J ONCOL, V41, P1325, DOI 10.3892/ijo.2012.1564; Ronaghi M., 1998, SCIENCE, V281, P365; Setty P, 2010, J MOL DIAGN, V12, P750, DOI 10.2353/jmoldx.2010.090237; Sun HR, 2013, J NEURO-ONCOL, V113, P277, DOI 10.1007/s11060-013-1107-5; Zhang CB, 2014, J CANCER RES CLIN, V140, P45, DOI 10.1007/s00432-013-1519-9	67	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	APR	2015	32	2					79	89		10.1007/s10014-014-0197-x		11	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CF8NT	WOS:000352819500001		
J	Sonoda, Y; Shibahara, I; Kawaguchi, T; Saito, R; Kanamori, M; Watanabe, M; Suzuki, H; Kumabe, T; Tominaga, T				Sonoda, Yukihiko; Shibahara, Ichiyoo; Kawaguchi, Tomohiro; Saito, Ryuta; Kanamori, Masayuki; Watanabe, Mika; Suzuki, Hiroyoshi; Kumabe, Toshihiro; Tominaga, Teiji			Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas	BRAIN TUMOR PATHOLOGY			English	Article						Anaplastic glioma; IDH mutation; 1p19q co-deletion; Location	PHASE-III TRIAL; IDH1; OLIGODENDROGLIOMAS; GLIOBLASTOMA; ENHANCEMENT; MUTATIONS; SURVIVAL; ORIGIN; CELL	The aim of this study was to determine if molecular alterations are associated with tumor location and radiological characteristics in anaplastic gliomas. We performed a retrospective analysis of 122 anaplastic gliomas for molecular alterations (IDH1/2 mutations, TP53 mutations, and 1p19q co-deletion) to compare MRI features (location and image characteristics). We observed that IDH mutation is strongly associated with frontal location (P = 0.001). However, 13 tumors not located in the cerebral cortex were IDH intact tumors (P < 0.0001). While IDH mutation and TP53 mutation are significantly associated with AA (p < 0.0001), IDH mutation and 1p19q co-deletion were significantly associated with AO/AOA (p < 0.0001). No tumors with IDH mutation and 1p19q co-deletion infiltrated the temporal lobe (P = 0.003). The tumors with 1p19q co-deletion and histologically diagnosed as AO/AOA were associated with contrast enhancement on MR images (p = 0.007, p = 0.002, respectively) and those with TP53 mutation had a weak association with sharp tumor borders (p = 0.043). MRI features might be useful to predict molecular profiles in anaplastic gliomas.	[Sonoda, Yukihiko; Shibahara, Ichiyoo; Kawaguchi, Tomohiro; Saito, Ryuta; Kanamori, Masayuki; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Watanabe, Mika] Tohoku Univ Hosp, Div Pathol, Sendai, Miyagi, Japan; [Suzuki, Hiroyoshi] Sendai Med Ctr, Dept Pathol, Sendai, Miyagi, Japan; [Tominaga, Teiji] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa 228, Japan	Sonoda, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	sono@nsg.med.tohoku.ac.jp		Sonoda, Yukihiko/0000-0001-7651-1374			Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Jenkinson MD, 2006, BRAIN, V129, P1884, DOI 10.1093/brain/awl108; Reyes-Botero G, 2014, NEURO-ONCOLOGY, V16, P662, DOI 10.1093/neuonc/not235; Shibahara I, 2012, INT J CLIN ONCOL, V17, P551, DOI 10.1007/s10147-011-0323-2; Sonoda Y, 2009, CANCER SCI, V100, P1996, DOI 10.1111/j.1349-7006.2009.01270.x; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Carrillo JA, 2012, AM J NEURORADIOL, V33, P1349, DOI 10.3174/ajnr.A2950; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; Qi ST, 2014, ONCOL LETT, V7, P1895, DOI 10.3892/ol.2014.2013; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Kim JW, 2010, J NEUROL NEUROSUR PS, V82, P224; Levin VA, 2003, CLIN CANCER RES, V9, P981; Louis DN, 2007, WHO CLASSIFICATION T; Shibahara I, 2015, NEURO-ONCOLOGY, V17, P136, DOI 10.1093/neuonc/nou112; The committee of Brain Tumor Registry of Japan, 2014, REP BRAIN TUM REG JA; Yan H, 2009, CANCER RES, V69, P9157, DOI 10.1158/0008-5472.CAN-09-2650	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	APR	2015	32	2					99	104		10.1007/s10014-014-0211-3		6	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CF8NT	WOS:000352819500003		
J	Kawakami, F; Nambu, J; Hirose, T; Sasayama, T; Itoh, T				Kawakami, Fumi; Nambu, Junichi; Hirose, Takanori; Sasayama, Takashi; Itoh, Tomoo			Central neurocytoma with ependymoma-like glial component	BRAIN TUMOR PATHOLOGY			English	Article						Glioneuronal tumor; Central neurocytoma; Ependymoma; Olig2	NEUROPIL-LIKE ISLANDS; GLIONEURONAL TUMOR; HISTOGENETIC IMPLICATIONS; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; MIGRATION; CELLS; 4TH-VENTRICLE; OLIG2	We present the first case of central neurocytoma with a component suggesting ependymal-like differentiation as an unclassified glioneuronal tumor. The patient was a 26-year-old Japanese man with a brain tumor extending from the frontal wall of the bilateral lateral ventricles to the corpus callosum. Histologically, the tumor's neuronal component consisted of small bland looking cells with fine, delicate, neuropil-like processes forming a rosette structure; its glial component consisted of tumor cells with thick processes arranged around the thinly walled vessels, resulting in a perivascular pseudo-rosette formation and indicating ependymal-like differentiation. Immunohistochemically, the cytoplasm of the tumor cells with ependymal-like features was positive for glial fibrillary acidic protein and negative for synaptophysin, while the tumor component with neuronal features showed the opposite immunohistochemical staining pattern. Most of the tumor cells were positive for Olig2, but EMA, D2-40, CD99, p53, and mutant IDH-1 (R132H) were totally negative. Its Ki-67 labeling index was less than 1 %. Histologically, this tumor was diagnosed as a central neurocytoma with an ependymoma-like glial component, and its tumor grade was estimated at grade II. The tumor location, infiltrating the corpus callosum, and histology were distinctive and might represent a peculiar subtype of glioneuronal tumor.	[Kawakami, Fumi; Nambu, Junichi; Itoh, Tomoo] Kobe Univ Hosp, Dept Diagnost Pathol, Chuou Ku, Kobe, Hyogo 6500017, Japan; [Hirose, Takanori] Kobe Univ, Grad Sch Med, Dept Community Med & Social Healthcare Sci, Div Pathol Reg Commun,Chuou Ku, Kobe, Hyogo 6500017, Japan; [Hirose, Takanori] Hyogo Canc Ctr, Dept Diagnost Pathol, Akashi, Hyogo 6730021, Japan; [Sasayama, Takashi] Kobe Univ Hosp, Dept Neurosurg, Chuou Ku, Kobe, Hyogo 6500017, Japan	Kawakami, F (reprint author), Kobe Univ Hosp, Dept Diagnost Pathol, Chuou Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	fkwkm@med.kobe-u.ac.jp					Ahn S, 2014, CLIN NEUROPATHOL, V33, P128, DOI 10.5414/NP300695; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Chiba K, 2014, CHILD NERV SYST, V30, P351, DOI 10.1007/s00381-013-2216-3; Ishizawa K, 2012, CLIN NEUROPATHOL, V31, P67, DOI 10.5414/NP300402; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Hirose T, 2013, HUM PATHOL, V44, P2353, DOI 10.1016/j.humpath.2013.02.013; Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Okada M, 2011, BRAIN TUMOR PATHOL, V28, P157, DOI 10.1007/s10014-011-0017-5; Preusser M, 2007, HISTOPATHOLOGY, V50, P365, DOI 10.1111/j.1365-2559.2007.02614.x; Perry A, 2010, ACTA NEUROPATHOL, V120, P237, DOI 10.1007/s00401-010-0695-9; Perry A, 2002, J NEUROPATH EXP NEUR, V61, P947; Matsumura N, 2013, NEUROPATHOLOGY, V33, P246, DOI 10.1111/j.1440-1789.2012.01355.x; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Garcia Cabezas S, 2014, BRAIN TUMOR PATHOL; Gessi M, 2005, ACTA NEUROPATHOL, V109, P231, DOI 10.1007/s00401-004-0927-y; Huse JT, 2011, ACTA NEUROPATHOL, V122, P367, DOI 10.1007/s00401-011-0855-6; Ishiuchi S, 1997, ACTA NEUROPATHOL, V94, P425; Jouvet A, 2005, ACTA NEUROPATHOL, V109, P346, DOI 10.1007/s00401-004-0963-7; Kleihues P, 2007, WHO CLASSIFICATION T, P30; Nakazato Y, 2007, WHO CLASSIFICATION T, P113; Quinones-Hinojosa A, 2007, EXP NEUROL, V205, P313, DOI 10.1016/j.expneurol.2007.03.016; Rodriguez FJ, 2007, ACTA NEUROPATHOL, V113, P313, DOI 10.1007/s00401-006-0153-x; Schlamann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101211; Teo JGC, 1999, AM J SURG PATHOL, V23, P502, DOI 10.1097/00000478-199905000-00002; VONDEIMLING A, 1990, ACTA NEUROPATHOL, V79, P473	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	APR	2015	32	2					119	123		10.1007/s10014-014-0204-2		5	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CF8NT	WOS:000352819500006		
J	Fukushima, S; Yoshida, A; Narita, Y; Arita, H; Ohno, M; Miyakita, Y; Ichimura, K; Shibui, S				Fukushima, Shintaro; Yoshida, Akihiko; Narita, Yoshitaka; Arita, Hideyuki; Ohno, Makoto; Miyakita, Yasuji; Ichimura, Koichi; Shibui, Soichiro			Multinodular and vacuolating neuronal tumor of the cerebrum	BRAIN TUMOR PATHOLOGY			English	Article						Tumor; Cerebrum; Adult; Seizure	GLIONEURONAL TUMOR	Multinodular and vacuolating neuronal tumors of the cerebrum (MVNT) are superficial neuronal tumors in adults that were first documented in 2013. Herein, we report a case of MNVT involving a 37-year-old man who presented with an epileptogenic, superficial solid lesion in the left parietal lobe. Histomorphology of the resected specimen was characterized by nodular lesions with vacuolation. Nodules comprised irregular proliferation of neuronal cells, which ranged from ganglion-like forms to those with indistinct lineage. Immunohistochemical analysis showed that the lesional cells stained positively for HuC/HuD, synaptophysin, and Olig2, and negatively for NeuN, neurofilament, chromogranin A, GFAP, CD34, IDH1(R132H), and BRAF(V600E). Eighteen months following surgery, the patient is well and without neurological deficits. MVNTs are distinctive tumors that should be differentiated from ganglion cell tumors, dysembryoplastic neuroepithelial tumors, and malformation of cortical development.	[Fukushima, Shintaro; Ichimura, Koichi] Natl Canc Ctr, Div Brain Tumor Translat Res, Chuo Ku, Tokyo 1040045, Japan; [Fukushima, Shintaro; Yoshida, Akihiko] Natl Canc Ctr, Dept Pathol & Clin Labs, Chuo Ku, Tokyo 1040045, Japan; [Narita, Yoshitaka; Arita, Hideyuki; Ohno, Makoto; Miyakita, Yasuji; Shibui, Soichiro] Natl Canc Ctr, Dept Neurosurg & Neurooncol, Chuo Ku, Tokyo 1040045, Japan	Yoshida, A (reprint author), Natl Canc Ctr, Dept Pathol & Clin Labs, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	akyoshid@ncc.go.jp			National Cancer Center Research and Development Fund [26-A-9]	We are grateful to Dr. Marc K. Rosenblum (New York, NY) for confirming the diagnosis. This work was supported in part by the National Cancer Center Research and Development Fund (26-A-9).	ZAGZAG D, 1993, AM J SURG PATHOL, V17, P537, DOI 10.1097/00000478-199306000-00001; Huse JT, 2013, BRAIN PATHOL, V23, P515, DOI 10.1111/bpa.12035; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Komori T, 1998, AM J SURG PATHOL, V22, P1171, DOI 10.1097/00000478-199810000-00002; Komori T, 2002, AM J SURG PATHOL, V26, P582, DOI 10.1097/00000478-200205000-00004; Perry A, 2002, J NEUROPATH EXP NEUR, V61, P947; Becker AJ, 2007, WHO CLASSIFICATION T, P103; Bodi Istvan, 2014, Acta Neuropathol Commun, V2, P7, DOI 10.1186/2051-5960-2-7; Daumas-Duport C, 2007, WHO CLASSIFICATION T, P99; Meroni A, 2009, EPILEPSIA, V50, P116, DOI 10.1111/j.1528-1167.2008.01717.x	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	APR	2015	32	2					131	136		10.1007/s10014-014-0198-9		6	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CF8NT	WOS:000352819500008		
J	Iwami, K; Momota, H; Fujii, M; Natsume, A; Yagi, S; Toriyama, K; Kamei, Y; Wakabayashi, T				Iwami, Kenichiro; Momota, Hiroyuki; Fujii, Masazumi; Natsume, Atsushi; Yagi, Shunjiro; Toriyama, Kazuhiro; Kamei, Yuzuru; Wakabayashi, Toshihiko			Anaplastic meningioma with rapid growth after omental flap transposition: a case report and experimental study	BRAIN TUMOR PATHOLOGY			English	Article						Meningioma; Omentum; Adipocyte; FABP4; Mouse model	CENTRAL-NERVOUS-SYSTEM; GREATER OMENTUM; CANCER-CELLS; BONE FLAPS; METASTASIS; SURGERY; TUMORS; RECONSTRUCTION; COLONIZATION; PRESERVATION	Meningiomas occasionally display aggressive behavior, but the mechanisms of malignant transformation remain unclear. We encountered the case of a 65-year-old man with a 10-year history of recurrent meningioma. The patient had undergone multiple tumor resections, radiotherapy treatments, and reconstructive surgeries due to wound infection. After the third resection of the tumor and reconstruction with an omental flap, the tumor demonstrated rapid growth and lung metastasis. The final pathological diagnosis was anaplastic meningioma. Because the drastic change of the tumor was observed after omental flap transposition, we investigated the effect of the omentum on tumor cells and performed histopathological analyses of meningiomas using a mouse model. We found that meningioma cells have a high affinity to the omentum and show a growth advantage when co-cultured with adipocytes. Immunohistochemical staining revealed that meningioma cells adjacent to the omentum strongly expressed fatty acid-binding protein 4, a lipid transfer protein, in both mouse and human. Our results suggest that tumor cells can receive lipid supply from omental adipocytes, and the surrounding tissues may induce tumor progression. We conclude that although omental tissue is an ideal material for reconstruction surgery, close follow-up is recommended in meningioma patients when used for cranioplasty.	[Iwami, Kenichiro; Momota, Hiroyuki; Fujii, Masazumi; Natsume, Atsushi; Wakabayashi, Toshihiko] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Yagi, Shunjiro; Toriyama, Kazuhiro; Kamei, Yuzuru] Nagoya Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Showa Ku, Nagoya, Aichi 4668550, Japan	Momota, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Neurosurg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	momota-nsu@umin.ac.jp			Japan Society for the Promotion of Science [21790398, 21390408, 21591867]	The authors would like to thank the members of the Division of Experimental Animals and the Department of Pathology (Nagoya University) and Akira Kato for histology assistance and mouse maintenance. This work was supported by Grant-in-Aid for Young Scientists (B) (21790398) to Hiroyuki Momota, by Grant-in-Aid for Scientific Research (B) (21390408) to Atsushi Natsume, and by Grant-in-Aid for Scientific Research (C) (21591867) to Masazumi Fujii from the Japan Society for the Promotion of Science.	Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Iwami K, 2012, J NEUROSURG, V116, P630, DOI 10.3171/2011.10.JNS11852; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Monleon D, 2010, CANCER RES, V70, P8426, DOI 10.1158/0008-5472.CAN-10-1498; Asai S, 2004, ANN PLAS SURG, V52, P144, DOI 10.1097/01.sap.0000100898.68014.6f; Delgado-Lopez PD, 2009, NEUROCIRUGIA, V20, P124; Jain D, 2007, J NEURO-ONCOL, V81, P315, DOI 10.1007/s11060-006-9237-7; Black PM, 2008, NEUROSURGERY, V62, P1115, DOI [10.1227/01.neu.0000333778.66316.38, 10.1227/01.NEU.0000318093.43855.2A]; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Wilkosz S, 2005, ANAT EMBRYOL, V209, P251, DOI 10.1007/s00429-004-0446-6; Sanai N, 2010, J NEUROSURG, V112, P913, DOI 10.3171/2009.6.JNS081490; RODBELL M, 1964, J BIOL CHEM, V239, P375; Harris AE, 2003, SURG NEUROL, V60, P298, DOI 10.1016/S0090-3019(03)00320-3; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Auguste KI, 2006, J NEUROSURG, V105, P640, DOI 10.3171/jns.2006.105.4.640; Baillie LD, 2011, J NEUROSCI METH, V198, P274, DOI 10.1016/j.jneumeth.2011.04.015; Black P, 1998, ACTA NEUROCHIR, V140, P1013, DOI 10.1007/s007010050209; Bruce JN, 2003, J NEUROSURG, V98, P1203, DOI 10.3171/jns.2003.98.6.1203; Cavallotti C, 2004, CLIN EXP PHARMACOL P, V31, P190, DOI 10.1111/j.1440-1681.2004.03972.x; Huffmann BC, 2005, J NEUROSURG, V102, P283; Ichikawa M, 2010, NEUROL MED-CHIR, V50, P70; Kamei Y, 2005, HEAD NECK CANC, V31, P498; Khan SM, 2010, CLIN EXP METASTAS, V27, P185, DOI 10.1007/s10585-010-9317-0; Okamura A, 2000, CLIN EXP METASTAS, V18, P37, DOI 10.1023/A:1026526829010; Stafford SL, 2001, NEUROSURGERY, V49, P1029, DOI 10.1097/00006123-200111000-00001; Yagi S, 2007, ANN PLAS SURG, V58, P531, DOI 10.1097/01.sap.0000244928.29667.fd	27	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	APR	2015	32	2					137	144		10.1007/s10014-014-0190-4		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CF8NT	WOS:000352819500009		
J	Tomono, A; Hara, S; Hirose, T; Itoh, T				Tomono, Ayako; Hara, Shigeo; Hirose, Takanori; Itoh, Tomoo			A case of cerebellar hemangioblastoma with rhabdoid features	BRAIN TUMOR PATHOLOGY			English	Article						Hemangioblastoma; Inhibin A; Rhabdoid cells	CENTRAL-NERVOUS-SYSTEM; RENAL-CELL CARCINOMA; ATYPICAL TERATOID/RHABDOID TUMOR; STROMAL CELLS; DIFFERENTIAL-DIAGNOSIS; EXPRESSION; GLIOBLASTOMA; MENINGIOMAS; BRACHYURY	We present an unusual case of cerebellar hemangioblastoma characterized by rhabdoid features. The patient was a 35-year-old Japanese man with occipital neuralgia and exacerbating blurred vision. Magnetic resonance imaging revealed a left posterior cranial fossa tumor, which was isointense on T1-weighted images and hyperintense on T2-weighted images with marked homogeneous enhancement. Histology of the surgically resected tumor showed cellular-type hemangioblastoma with extensive proliferation of rhabdoid cells Immunohistochemistry analysis showed tumor cells positive for inhibin A, CD56, vimentin, INI-1, and vascular endothelial growth factor; negative for PAX8, CD10, epithelial membrane antigen, cytokeratin, (AE1/3), alpha-smooth muscle actin and D2-40; and had focal positivity for glial fibrillary acidic protein and S100. The Ki-67 labeling index was < 1 %. Ultrastructural analysis revealed large lipid droplets and abundant intracellular accumulation of intermediate filaments. Based on these findings, the diagnosis was hemangioblastoma with focal rhabdoid features. After a 14-month follow-up, there was no evidence of recurrence. This is the first report of hemangioblastoma with rhabdoid features in the central nervous system. In addition, we discuss the possible pathogenesis.	[Tomono, Ayako; Hara, Shigeo; Itoh, Tomoo] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Tomono, Ayako] Kobe Univ, Grad Sch Med, Dept Gastrointestinal Surg, Kobe, Hyogo 6500017, Japan; [Hirose, Takanori] Hyogo Canc Ctr, Dept Pathol, Akashi, Hyogo, Japan	Hara, S (reprint author), Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	shara@med.kobe-u.ac.jp					Adams SA, 1999, NEUROPATHOL APPL NEU, V28, P142; Aldape KD, 2007, WHO CLASSIFICATION T, P184; Barresi V, 2012, AM J SURG PATHOL, V36, P1052, DOI 10.1097/PAS.0b013e31824f4ce3; Hoang MP, 2003, AM J SURG PATHOL, V27, P1152, DOI 10.1097/00000478-200308000-00014; Hilden JM, 2004, J CLIN ONCOL, V22, P2877, DOI 10.1200/jco.2004.07.073; Rivera AL, 2010, NEUROPATHOLOGY, V30, P580, DOI 10.1111/j.1440-1789.2010.01109.x; Carney EM, 2011, AM J SURG PATHOL, V35, P262, DOI 10.1097/PAS.0b013e3182064d11; Burger PC, 1998, AM J SURG PATHOL, V22, P1083, DOI 10.1097/00000478-199809000-00007; Tirabosco R, 2008, AM J SURG PATHOL, V32, P572, DOI 10.1097/PAS.0b013e31815b693a; Hasselblatt M, 2005, NEUROPATH APPL NEURO, V31, P618, DOI 10.1111/j.1365-2990.2005.00669.x; Nagai S, 2009, BRAIN TUMOR PATHOL, V26, P19, DOI 10.1007/s10014-008-0241-9; He MX, 2011, NEUROPATHOLOGY, V31, P421, DOI 10.1111/j.1440-1789.2010.01166.x; Ishizawa K, 2005, PATHOL INT, V55, P377, DOI 10.1111/j.1440-1827.2005.01841.x; Cooper WA, 2004, CLIN NEUROPATHOL, V23, P16; DECK JHN, 1981, ACTA NEUROPATHOL, V54, P173; JURCO S, 1982, HUM PATHOL, V13, P13, DOI 10.1016/S0046-8177(82)80133-0; Kepes JJ, 1998, AM J SURG PATHOL, V22, P231, DOI 10.1097/00000478-199802000-00012; Park DM, 2007, PLOS MED, V4, P333, DOI 10.1371/journal.pmed.0040060; Perry A, 1998, AM J SURG PATHOL, V22, P1482, DOI 10.1097/00000478-199812000-00005; Perry A, 2005, MODERN PATHOL, V18, P951, DOI 10.1038/modpathol.3800375; Tashiro Y, 1999, NEUROPATHOLOGY, V19, P294; Wyatt-Ashmead J, 2001, CLIN NEUROPATHOL, V20, P248; Yin WH, 2012, DIAGN PATHOL, V12, P39	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	APR	2015	32	2					145	150		10.1007/s10014-014-0193-1		6	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CF8NT	WOS:000352819500010		
J	Krishnan, SR; Nair, BC; Sareddy, GR; Roy, SS; Natarajan, M; Suzuki, T; Peng, Y; Raj, G; Vadlamudi, RK				Krishnan, Samaya R.; Nair, Binoj C.; Sareddy, Gangadhara R.; Roy, Sudipa Saha; Natarajan, Mohan; Suzuki, Takayoshi; Peng, Yan; Raj, Ganesh; Vadlamudi, Ratna K.			Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells	BREAST CANCER RESEARCH AND TREATMENT			English	Article						PELP1; p53; DNA damage response; Oncogene; Coregulator; E2F1; TNBC	DNA-DAMAGE; ONCOGENIC FUNCTIONS; P53; E2F1; APOPTOSIS; PHOSPHORYLATION; TRANSCRIPTION; EXPRESSION; IDENTIFICATION; METASTASIS	Triple-negative breast cancer (TNBC), the most aggressive breast cancer subtype, occurs in younger women and is associated with poor prognosis. Gain-of-function mutations in TP53 are a frequent occurrence in TNBC and have been demonstrated to repress apoptosis and up-regulate cell cycle progression. Even though TNBC responds to initial chemotherapy, resistance to chemotherapy develops and is a major clinical problem. Tumor recurrence eventually occurs and most patients die from their disease. An urgent need exists to identify molecular-targeted therapies that can enhance chemotherapy response. In the present study, we report that targeting PELP1, an oncogenic co-regulator molecule, could enhance the chemotherapeutic response of TNBC through the inhibition of cell cycle progression and activation of apoptosis. We demonstrate that PELP1 interacts with MTp53, regulates its recruitment, and alters epigenetic marks at the target gene promoters. PELP1 knockdown reduced MTp53 target gene expression, resulting in decreased cell survival and increased apoptosis upon genotoxic stress. Mechanistic studies revealed that PELP1 depletion contributes to increased stability of E2F1, a transcription factor that regulates both cell cycle and apoptosis in a context-dependent manner. Further, PELP1 regulates E2F1 stability in a KDM1A-dependent manner, and PELP1 phosphorylation at the S1033 residue plays an important role in mediating its oncogenic functions in TNBC cells. Accordingly, depletion of PELP1 increased the expression of E2F1 target genes and reduced TNBC cell survival in response to genotoxic agents. PELP1 phosphorylation was significantly greater in the TNBC tumors than in the other subtypes of breast cancer and in the normal tissues. These findings suggest that PELP1 is an important molecular target in TNBC, and that PELP1-targeted therapies may enhance response to chemotherapies.	[Krishnan, Samaya R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Krishnan, Samaya R.; Nair, Binoj C.; Sareddy, Gangadhara R.; Roy, Sudipa Saha; Vadlamudi, Ratna K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Natarajan, Mohan] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Suzuki, Takayoshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Sakyo Ku, Kyoto 6060823, Japan; [Peng, Yan] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Raj, Ganesh] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Vadlamudi, Ratna K.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	Vadlamudi, RK (reprint author), Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	vadlamudi@uthscsa.edu			NIH/NCI [CA095681]; CPRIT [DP150096, RP140105]; Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant [P30CA054174-17]	This study was supported by the NIH/NCI Grant CA095681 (RKV); CPRIT grant DP150096 (RKV; GR); CPRIT pre-doctoral fellow ship grant RP140105 (SK); CPRIT postdoctoral fellowship grant RP140105 (GRS); and the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant P30CA054174-17.	Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Roy S, 2012, MOL CANCER RES, V10, P25, DOI 10.1158/1541-7786.MCR-11-0456; Mann M, 2013, CARCINOGENESIS, V34, P1468, DOI 10.1093/carcin/bgt091; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Lin WC, 2001, GENE DEV, V15, P1833; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Sun MN, 2012, J MOL CELL BIOL, V4, P304, DOI 10.1093/jmcb/mjs048; Bertheau P, 2013, BREAST, V22, pS27, DOI 10.1016/j.breast.2013.07.005; Girard BJ, 2014, MOL CELL ENDOCRINOL, V382, P642, DOI 10.1016/j.mce.2013.07.031; BARTEK J, 1990, ONCOGENE, V5, P893; Xie Q, 2011, J RECEPT SIG TRANSD, V31, P139, DOI 10.3109/10799893.2011.552914; Habashy HO, 2010, BREAST CANCER RES TR, V120, P603, DOI 10.1007/s10549-009-0419-9; Wright JD, 2007, J BIOSCIENCES, V32, P827, DOI 10.1007/s12038-007-0083-3; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; DeGregori J, 2006, CURR MOL MED, V6, P739; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Nair BC, 2010, CANCER RES, V70, P7166, DOI 10.1158/0008-5472.CAN-10-0628; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Boohaker RJ, 2013, RADIOTHER ONCOL, V108, P403, DOI 10.1016/j.radonc.2013.06.017; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Ueda R, 2009, J AM CHEM SOC, V131, P17536, DOI 10.1021/ja907055q; Nair BC, 2014, CELL DEATH DIFFER, V21, P1409, DOI 10.1038/cdd.2014.55; Di AS, 2006, CANCER CELL, V10, P191; Dobes P, 2014, ONCOL REP, V32, P1695, DOI 10.3892/or.2014.3346; Gonugunta VK, 2014, ENDOCR-RELAT CANCER, V21, pT79, DOI 10.1530/ERC-13-0502; Mann Monica, 2011, Cancers (Basel), V3, P1691, DOI 10.3390/cancers3021691; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Tonsing-Carter E, 2013, CANCER RES, V279, P8627	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	APR	2015	150	3					487	499		10.1007/s10549-015-3339-x		13	Oncology	Oncology	CF1GW	WOS:000352293600004		
J	Minami, Y; Hosokawa, T; Nakaya, N; Sugawara, Y; Nishino, Y; Kakugawa, Y; Fukao, A; Tsuji, I				Minami, Yuko; Hosokawa, Toru; Nakaya, Naoki; Sugawara, Yumi; Nishino, Yoshikazu; Kakugawa, Yoichiro; Fukao, Akira; Tsuji, Ichiro			Personality and breast cancer risk and survival: the Miyagi Cohort Study	BREAST CANCER RESEARCH AND TREATMENT			English	Article						Breast cancer; Cohort study; Personality; Risk; Survival; Eysenck Personality Questionnaire-Revised	POPULATION-BASED COHORT; PSYCHOLOGICAL RESPONSE; PSYCHOSOCIAL FACTORS; SOCIAL SUPPORT; FOLLOW-UP; PROGNOSTIC-SIGNIFICANCE; WOMEN; PROGRESSION; DIAGNOSIS; VERSION	It has long been hypothesized that personality is associated with breast cancer risk and survival. The present population-based prospective cohort study in Japan tested this hypothesis. To investigate the association of personality with breast cancer risk, a total of 15,107 women aged 40-64 years who completed the Eysenck Personality Questionnaire-Revised (EPQ-R) Short Form were followed from 1990 to 2007. To assess the association of personality with survival after breast cancer, 250 identified cases were further followed up from the date of diagnosis to 2008, and 45 all-cause deaths were documented. Study subjects were categorized into four groups based on the quartile points of scores ranging between 0 and 12 on each EPQ-R subscale (extraversion, neuroticism, psychoticism, and lie), and the hazard ratio (HR) for each category was computed using the lowest category as reference. Multivariate analysis revealed no association between any of the four personality subscales and the risk of breast cancer. In the analysis on survival, no significant association was found between any of these subscales and the risk of death, although breast cancer cases with a higher score of extraversion tended to have a lower risk of death (P for trend = 0.07; HR for highest score level = 0.38). Exclusion of 32 cases diagnosed in the first 3 years of follow-up did not largely change the results with regard to either breast cancer risk or survival. The present findings suggest that personality does not impact significantly on the development and progression of breast cancer.	[Minami, Yuko] Tohoku Univ, Grad Sch Med, Div Community Hlth, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Hosokawa, Toru] Tohoku Univ, Grad Sch Med, Dept Human Dev & Disabil, Sendai, Miyagi 9808575, Japan; [Nakaya, Naoki] Tohoku Univ, Dept Prevent Med & Epidemiol, Tohoku Med Megabank Org, Sendai, Miyagi 9808575, Japan; [Sugawara, Yumi; Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 9808575, Japan; [Nishino, Yoshikazu] Miyagi Canc Ctr, Res Inst, Div Canc Epidemiol & Prevent, Natori, Miyagi 9811293, Japan; [Kakugawa, Yoichiro] Miyagi Canc Ctr Hosp, Dept Breast Oncol, Natori, Miyagi, Japan; [Fukao, Akira] Yamagata Univ, Grad Sch Med Sci, Dept Publ Hlth, Yamagata 990, Japan	Minami, Y (reprint author), Tohoku Univ, Grad Sch Med, Div Community Hlth, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	adym@med.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [23390169]	This work was supported by Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) for Scientific Research (B) (23390169).	Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; Watson M, 1999, LANCET, V354, P1331, DOI 10.1016/S0140-6736(98)11392-2; COX DR, 1972, J R STAT SOC B, V34, P187; Soler-Vila H, 2003, CANCER, V98, P1299, DOI 10.1002/cncr.11670; HISLOP TG, 1987, J CHRON DIS, V40, P729; HOSOKAWA T, 1993, PSYCHOL REP, V72, P823; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; Kawai M, 2010, BRIT J CANCER, V103, P1443, DOI 10.1038/sj.bjc.6605885; HAHN RC, 1988, CANCER, V61, P845, DOI 10.1002/1097-0142(19880215)61:4<845::AID-CNCR2820610434>3.0.CO;2-Q; Kawai M, 2011, BREAST CANCER RES TR, V128, P817, DOI 10.1007/s10549-011-1381-x; Jokela M, 2014, BRIT J CANCER, V110, P1820, DOI 10.1038/bjc.2014.58; Den Oudsten BL, 2010, SUPPORT CARE CANCER, V18, P499, DOI 10.1007/s00520-009-0714-3; Hussain SK, 2008, INT J CANCER, V122, P165, DOI 10.1002/ije.23007; VIKEN RJ, 1994, J PERS SOC PSYCHOL, V66, P722, DOI 10.1037/0022-3514.66.4.722; Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Nakaya N, 2010, AM J EPIDEMIOL, V172, P377, DOI 10.1093/aje/kwq046; Groenvold M, 2007, BREAST CANCER RES TR, V105, P209, DOI 10.1007/s10549-006-9447-x; Kawai M, 2010, CANCER CAUSE CONTROL, V21, P135, DOI 10.1007/s10552-009-9443-7; Bleiker EMA, 2008, J NATL CANCER I, V100, P213, DOI 10.1093/jnci/djm280; Cohen F, 1999, BRAIN BEHAV IMMUN, V13, P155, DOI 10.1006/brbi.1998.0531; DEAN C, 1989, J PSYCHOSOM RES, V33, P561, DOI 10.1016/0022-3999(89)90063-9; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; Eysenck Jr H, 1991, MANUAL EYSENCK PERSO; FARAGHER EB, 1990, PSYCHOL MED, V20, P663; Fukao A, 1995, J EPIDEMIOL, V5, P153; GREER S, 1979, LANCET, V2, P785; HILAKIVICLARKE L, 1994, BREAST CANCER RES TR, V29, P141, DOI 10.1007/BF00665676; Kenney JW, 2000, J ADV NURS, V32, P249, DOI 10.1046/j.1365-2648.2000.01464.x; Lemogne C, 2013, PSYCHOSOM MED, V75, P262, DOI 10.1097/PSY.0b013e31828b5366; Lillberg K, 2002, INT J CANCER, V100, P361, DOI 10.1002/ijc.10484; MAUNSELL E, 1995, CANCER, V76, P631, DOI 10.1002/1097-0142(19950815)76:4<631::AID-CNCR2820760414>3.0.CO;2-9; McManus IC, 1992, PSYCHOL MED, P65; MORRIS T, 1981, J PSYCHOSOM RES, V25, P111, DOI 10.1016/0022-3999(81)90098-2; Nakaya N, 2003, J NATL CANCER I, V95, P799, DOI 10.1093/jnci/95.11.799; Nakaya N, 2005, BRIT J CANCER, V92, P2089, DOI 10.1038/sj.bjc.6602610; Pervin LA, 1990, HDB PERSONALITY THEO, P244; Rhodes RE, 2001, PSYCHO-ONCOL, V10, P380, DOI 10.1002/pon.516; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; Spiegel D, 1996, HARVARD REV PSYCHIAT, V4, P10, DOI 10.3109/10673229609030518; Watson M, 2005, EUR J CANCER, V41, P1710, DOI 10.1016/j.ejca.2005.01.012; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P, P1	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	APR	2015	150	3					675	684		10.1007/s10549-015-3364-9		10	Oncology	Oncology	CF1GW	WOS:000352293600023		
J	Ohi, K				Ohi, Kazutaka			Influences of schizophrenia risk variant rs7914558 at CNNM2 on brain structure	BRITISH JOURNAL OF PSYCHIATRY			English	Letter									Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka, Japan	Ohi, K (reprint author), Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka, Japan.	ohi@psy.med.osaka-u.ac.jp					Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ohl K, 2013, BEHAV BRAIN FUNCT, V9, P40; Rose EJ, 2014, BRIT J PSYCHIAT, V204, P115, DOI 10.1192/bjp.bp.113.131359	5	0	0	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON SW1X 8PG, ENGLAND	0007-1250	1472-1465		BRIT J PSYCHIAT	Br. J. Psychiatry	APR	2015	206	4					343	344		10.1192/bjp.206.4.343b		2	Psychiatry	Psychiatry	CF6QE	WOS:000352680400019		
J	Terasawa, Y; Hotani, T; Katayama, Y; Tachibana, M; Mizuguchi, H; Sakurai, F				Terasawa, Y.; Hotani, T.; Katayama, Y.; Tachibana, M.; Mizuguchi, H.; Sakurai, F.			Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing	CANCER GENE THERAPY			English	Article							HUMAN-MELANOMA CELLS; ENDOPLASMIC RETICULAR STRESS; ACTIVATED RAS PATHWAY; MAMMALIAN REOVIRUS; CANCER-CELLS; RIG-I; INFECTION; EXPRESSION; APOPTOSIS; NOXA	Reovirus has gained much attention as an anticancer agent; however, the mechanism of the tumor cell-specific replication of reovirus is not fully understood. Although Ras activation is known to be crucial for tumor cell-specific replication of reovirus, it remains controversial which cellular factors are required for the reovirus-mediated tumor cell killing. In this study, we systematically investigated which cellular factors determined the efficiencies of reovirus-mediated tumor cell killing in various human cultured cell lines. The efficiency of reovirus-mediated cell killing varied widely among the cell lines. Junction adhesion molecule-A, a reovirus receptor, was highly expressed in almost all cell lines examined. Ras activation levels were largely different between the cell lines; however, there were no apparent correlations among the reovirus-mediated cell killing efficiencies and Ras activation status. On the other hand, activity levels of the cysteine proteases cathepsins B and L, which are crucial for proteolytic disassembly of the outer capsid proteins of reovirus, showed a tendency to be correlated with the efficiency of reovirus-mediated cell killing. These results indicate that the activity of cathepsins B and L is the most suitable as a bionnarker for the efficacy of reovirus-mediated oncolysis among the factors examined in this study.	[Terasawa, Y.; Hotani, T.; Katayama, Y.; Tachibana, M.; Mizuguchi, H.; Sakurai, F.] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Suita, Osaka 5650871, Japan; [Mizuguchi, H.] Natl Inst Biomed Innovat, Lab Hepat Differentiat Res, Osaka, Japan; [Mizuguchi, H.] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Mizuguchi, H.] Osaka Univ, Grad Sch Pharmaceut Sci, Lab iPS Res, Suita, Osaka 5650871, Japan; [Sakurai, F.] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Regulatory Sci Oligonucleotide Therapeut, Clin Drug Dev Unit, Suita, Osaka 5650871, Japan	Sakurai, F (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	sakurai@phs.osaka-u.ac.jp		Tachibana, Masashi/0000-0002-0376-508X	Ministry of Education, Culture, Sports, Sciences and Technology of Japan	We would like to thank Sayuri Okamoto and Eri Hosoyamada (Osaka University, Osaka, Japan) for their help. We also would like to thank Takeshi Kobayashi (Osaka University, Osaka, Japan) for his advice. This study was supported by Grant-in-Aid for Young Scientists (A) and a Grant-in-Aid for Scientific Research (B) from Ministry of Education, Culture, Sports, Sciences and Technology of Japan.	Alain T, 2010, LEUKEMIA RES, V34, P100, DOI 10.1016/j.leukres.2009.05.020; Galanis E, 2012, MOL THER, V20, P1998, DOI 10.1038/mt.2012.146; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Knowlton JJ, 2012, J VIROL, V86, P1650, DOI 10.1128/JVI.05924-11; Kicielinski KP, 2014, MOL THER, V22, P1056, DOI [10.1038/mt.2014.21, 10.1038/mt.2074.21]; HASHIRO G, 1977, ARCH VIROL, V54, P307, DOI 10.1007/BF01314776; Alain T, 2007, MOL THER, V15, P1512, DOI 10.1038/sj.mt.6300207; Campbell JA, 2005, J VIROL, V79, P7967, DOI 10.1128/JVI.79.13.7967-7978.2005; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Kelly KR, 2012, ONCOGENE, V31, P3023, DOI 10.1038/onc.2011.478; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Yin M, 2012, AM J PATHOL, V181, P2202, DOI 10.1016/j.ajpath.2012.08.027; Konopka-Anstadt JL, 2014, CELL HOST MICROBE, V15, P681, DOI 10.1016/j.chom.2014.05.010; Maitra R, 2012, MOL CANCER RES, V10, P1514, DOI 10.1158/1541-7786.MCR-12-0157; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Song L, 2009, CANCER GENE THER, V16, P382, DOI 10.1038/cgt.2008.84; Karapanagiotou EM, 2012, CLIN CANCER RES, V18, P2080, DOI 10.1158/1078-0432.CCR-11-2181; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Strong JE, 1996, J VIROL, V70, P612; BANERJEE AK, 1970, J VIROL, V6, P1; Norman KL, 2004, P NATL ACAD SCI USA, V101, P11099, DOI 10.1073/pnas.0404310101; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Lee S, 2009, INT J ONCOL, V34, P161, DOI 10.3892/ijo_00000138; Barbarin A, 2011, BIOCHEM J, V437, P97, DOI 10.1042/BJ20110361; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Baer GS, 1999, J VIROL, V73, P9532; Carew JS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.259; Collette J, 2004, INT J CANCER, V112, P190, DOI 10.1002/ijc.20398; Coulibaly S, 1999, INT J CANCER, V83, P526, DOI 10.1002/(SICI)1097-0215(19991112)83:4<526::AID-IJC15>3.3.CO;2-D; Donnelly OG, 2012, CURR PHARM BIOTECHNO, V13, P1834; Golden JW, 2004, J BIOL CHEM, V279, P8547, DOI 10.1074/jbc.M309758200; Golden JW, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-48; Golden JW, 2002, J VIROL, V76, P7430, DOI 10.1128/JVI.76.15.7430-7443.2002; Hwang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073555; Kim M, 2007, ONCOGENE, V26, P4124, DOI 10.1038/sj.onc.1210189; Koblinski JE, 2002, J BIOL CHEM, V277, P32220, DOI 10.1074/jbc.M204708200; Matsushima-Miyagi T, 2012, CLIN CANCER RES, V18, P6271, DOI 10.1158/1078-0432.CCR-12-1595; Rosebeck S, 2011, VIROLOGY, V417, P293, DOI 10.1016/j.virol.2011.06.010; Twigger K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-368; van Houdt WJ, 2008, CANCER GENE THER, V15, P284, DOI 10.1038/cgt.2008.2	41	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0929-1903	1476-5500		CANCER GENE THER	Cancer Gene Ther.	APR	2015	22	4					188	197		10.1038/cgt.2015.4		10	Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity; Research & Experimental Medicine	CG1ZJ	WOS:000353074400004		
J	Iimori, M; Kitao, H; Maehara, Y				Iimori, Makoto; Kitao, Hiroyuki; Maehara, Yoshihiko			Mad2 and BubR1: chemotherapeutic coordinators in gastric cancer	CELL CYCLE			English	Editorial Material							CHECKPOINT		[Iimori, Makoto; Kitao, Hiroyuki] Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka 812, Japan; [Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Iimori, M (reprint author), Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka 812, Japan.	iimori@surg2.med.kyushu-u.ac.jp					Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Sakamoto J, 2009, GASTRIC CANCER, V12, P69, DOI 10.1007/s10120-009-0505-z; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bargiela-Iparraguirre J, 2014, CELL CYCLE, V13, P3590, DOI 10.4161/15384101.2014.962952	7	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4101	1551-4005		CELL CYCLE	Cell Cycle	APR 1	2015	14	7					946	946		10.1080/15384101.2015.1018051		1	Cell Biology	Cell Biology	CF5OM	WOS:000352606600009		
J	Sanuki, Y; Kubota, Y; Kanemaki, MT; Takahashi, TS; Mimura, S; Takisawa, H				Sanuki, Yosuke; Kubota, Yumiko; Kanemaki, Masato T.; Takahashi, Tatsuro S.; Mimura, Satoru; Takisawa, Haruhiko			RecQ4 promotes the conversion of the pre-initiation complex at a site-specific origin for DNA unwinding in Xenopus egg extracts	CELL CYCLE			English	Article						DNA unwinding; eukaryotic DNA replication; pre-RC; pre-IC; RecQ4; site-specific origin; Xenopus egg extracts	REPLICATION IN-VITRO; CHROMOSOMAL DNA; RECOGNITION COMPLEX; BUDDING YEAST; POLYMERASE-ALPHA; MCM2-7 HELICASE; MCM10 PLAYS; PROTEINS; ASSOCIATION; ACTIVATION	Eukaryotic DNA replication is initiated through stepwise assembly of evolutionarily conserved replication proteins onto replication origins, but how the origin DNA is unwound during the assembly process remains elusive. Here, we established a site-specific origin on a plasmid DNA, using in vitro replication systems derived from Xenopus egg extracts. We found that the pre-replicative complex (pre-RC) was preferentially assembled in the vicinity of GAL4 DNA-binding sites of the plasmid, depending on the binding of Cdc6 fused with a GAL4 DNA-binding domain in Cdc6-depleted extracts. Subsequent addition of nucleoplasmic S-phase extracts to the GAL4-dependent pre-RC promoted initiation of DNA replication from the origin, and components of the pre-initiation complex (pre-IC) and the replisome were recruited to the origin concomitant with origin unwinding. In this replication system, RecQ4 is dispensable for both recruitment of Cdc45 onto the origin and stable binding of Cdc45 and GINS to the pre-RC assembled plasmid. However, both origin binding of DNA polymerase a and unwinding of DNA were diminished upon depletion of RecQ4 from the extracts. These results suggest that RecQ4 plays an important role in the conversion of pre-ICs into active replisomes requiring the unwinding of origin DNA in vertebrates.	[Sanuki, Yosuke; Kubota, Yumiko; Takahashi, Tatsuro S.; Mimura, Satoru; Takisawa, Haruhiko] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan; [Kanemaki, Masato T.] Res Org Informat & Syst, Natl Inst Genet, Ctr Frontier Res, Mishima, Shizuoka 4118540, Japan; [Kanemaki, Masato T.] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan	Takisawa, H (reprint author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan.	takisawa@bio.sci.osaka-u.ac.jp			Japan Society for the Promotion of Science for Young Scientists; NIG Collaborative Research Program [2012-B-15, 2013-A-24]	This work was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists, and by the NIG Collaborative Research Program (2012-B-15, 2013-A-24).	On KF, 2014, EMBO J, V33, P605, DOI 10.1002/embj.201387369; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; MECHALI M, 1984, CELL, V38, P55, DOI 10.1016/0092-8674(84)90526-9; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; Li Y, 2013, GENES CELLS, V18, P266, DOI 10.1111/gtc.12040; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Tanaka S, 2013, MOL CELL BIOL, V33, P2614, DOI 10.1128/MCB.00431-13; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Gros J, 2014, EMBO J, V33, P621, DOI 10.1002/embj.201387278; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Riera A, 2014, SEMIN CELL DEV BIOL, V30, P104, DOI 10.1016/j.semcdb.2014.03.008; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Danis E, 2004, NAT CELL BIOL, V6, P721, DOI 10.1038/ncb1149; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Araki H, 2011, GENES GENET SYST, V86, P141; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; COSTA A, 2013, ANNU REV BIOCHEM, V82, P25, DOI DOI 10.1146/ANNUREV-BI0CHEM-052610-094414; Coster G, 2014, MOL CELL, V55, P1; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Harvey KJ, 2003, MOL CELL BIOL, V23, P6769, DOI 10.1128/MCB.23.19.6769-6779.2003; Kang S, 2014, MOL CELL, V55, P1; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Leonard AC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010116; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; Makarova KS, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012963; Masai H, 2011, J BIOCHEM, V149, P629, DOI 10.1093/jb/mvr031; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Ode KL, 2011, GENES CELLS, V16, P380, DOI 10.1111/j.1365-2443.2011.01501.x; Ritzi M, 1998, J BIOL CHEM, V273, P24543, DOI 10.1074/jbc.273.38.24543; Rowles A, 1999, J CELL SCI, V112, P2011; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Waga S, 2006, J BIOL CHEM, V281, P10926, DOI 10.1074/jbc.M600299200; Wardlaw CP, 2014, DNA REPAIR, V22, P165, DOI 10.1016/j.dnarep.2014.06.004	60	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4101	1551-4005		CELL CYCLE	Cell Cycle	APR 1	2015	14	7					1010	1023		10.1080/15384101.2015.1007003		14	Cell Biology	Cell Biology	CF5OM	WOS:000352606600019		
J	Nojima, S; Kamata, K; Suzuki, K; Yamaguchi, K; Mizuno, N				Nojima, Susumu; Kamata, Keigo; Suzuki, Kosuke; Yamaguchi, Kazuya; Mizuno, Noritaka			Selective Oxidation with Aqueous Hydrogen Peroxide by [PO4{WO(O-2)(2)}(4)](3-) Supported on Zinc-Modified Tin Dioxide	CHEMCATCHEM			English	Article						epoxidation; heterogeneous catalysis; hydrogen peroxide; peroxotungstate; phosphorus	EFFICIENT HETEROGENEOUS EPOXIDATION; ALKENE EPOXIDATION; HETEROPOLY ACIDS; CETYLPYRIDINIUM CHLORIDE; ASYMMETRIC EPOXIDATION; CATALYZED EPOXIDATIONS; MOLECULAR-OXYGEN; TERMINAL ALKENES; CARBOXYLIC-ACIDS; ALLYLIC ALCOHOLS	We prepared supported phosphorus-containing tetranuclear peroxotungstate ([PO4{WO(O-2)(2)}(4)](3-), denoted by PW4) catalysts by using zinc-modified SnO2 supports with different zinc contents [PW4-Zn(x)/SnO2, in which x denotes the zinc content (wt%)]. The supported catalysts, in particular PW4-Zn(0.8)/SnO2, could act as efficient and reusable heterogeneous catalysts for selective oxidation with aqueous H2O2 as the terminal oxidant. The catalytic performance of PW4-Zn(0.8)/SnO2 was much superior to those of the corresponding homogeneous analogue THA(3)PW4 (THA=tetra-n-hexylammonium) and the previously reported tungstate-based heterogeneous catalysts such as our W-Zn/SnO2. In the presence of PW4-Zn(0.8)/SnO2, various types of organic substrates such as alkenes, amines, silanes, and sulfides could be converted into the corresponding oxygenated products in high to excellent yields by using near-stoichiometric amounts of H2O2 with respect to the substrates (typically 1.2equiv.). The PW4 species interacting with highly dispersed Zn2+ species on SnO2 likely plays an important role in the present oxidation.	[Nojima, Susumu; Kamata, Keigo; Suzuki, Kosuke; Yamaguchi, Kazuya; Mizuno, Noritaka] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Kamata, K (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	tmizuno@mail.ecc.u-tokyo.ac.jp	Kamata, Keigo/E-6997-2014	Kamata, Keigo/0000-0002-0624-8483	Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Ministry of Education, Culture, Science, Sports, and Technology of Japan; Sumitomo Foundation [130417]	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", Grants-in-Aid for JSPS Fellows and Scientific Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan, and Grant for Basic Science Research Projects from The Sumitomo Foundation(No. 130417).	Altmann P, 2012, EUR J INORG CHEM, P3235, DOI 10.1002/ejic.201200120; Hill CL, 1998, CHEM REV, V98, P1, DOI 10.1021/cr960395y; Rudolph J, 1997, J AM CHEM SOC, V119, P6189, DOI 10.1021/ja970623l; Maksimchuk NV, 2010, INORG CHEM, V49, P2920, DOI 10.1021/ic902459f; Talsi EP, 2012, COORDIN CHEM REV, V256, P1418, DOI 10.1016/j.ccr.2012.04.005; VENTURELLO C, 1983, J ORG CHEM, V48, P3831, DOI 10.1021/jo00169a052; Cavani F, 2009, CHEMSUSCHEM, V2, P508, DOI 10.1002/cssc.200900020; Crucianelli M, 2010, CHEMSUSCHEM, V3, P524, DOI 10.1002/cssc.201000022; Uyanik M, 2013, ACS CATAL, V3, P513, DOI 10.1021/cs300821u; BUTLER A, 1994, CHEM REV, V94, P625, DOI 10.1021/cr00027a004; Doherty S, 2012, GREEN CHEM, V14, P925, DOI 10.1039/c2gc16679h; Kholdeeva OA, 2014, CATAL SCI TECHNOL, V4, P1869, DOI 10.1039/c4cy00087k; Swalus C, 2013, CATAL COMMUN, V37, P80, DOI 10.1016/j.catcom.2013.03.036; Costas M, 2000, COORDIN CHEM REV, V200, P517, DOI 10.1016/S0010-8545(00)00320-9; Bassil BS, 2011, DALTON T, V40, P9649, DOI 10.1039/c1dt10845j; SALLES L, 1994, INORG CHEM, V33, P871, DOI 10.1021/ic00083a008; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Sato K, 1996, J ORG CHEM, V61, P8310, DOI 10.1021/jo961287e; Sato K, 1998, SCIENCE, V281, P1646, DOI 10.1126/science.281.5383.1646; Sawada Y, 2006, ANGEW CHEM INT EDIT, V45, P3478, DOI 10.1002/anie.200600636; Guo Z, 2014, CHEM SOC REV, V43, P3480, DOI 10.1039/c3cs60282f; ISHII Y, 1990, J ORG CHEM, V55, P5545, DOI 10.1021/jo00308a002; Neumann R, 1997, ANGEW CHEM INT EDIT, V36, P1738, DOI 10.1002/anie.199717381; Kamata K, 2011, ANGEW CHEM INT EDIT, V50, P12062, DOI 10.1002/anie.201106064; Lane BS, 2002, J AM CHEM SOC, V124, P11946, DOI 10.1021/ja025956j; Adolfsson H, 2000, J ORG CHEM, V65, P8651, DOI 10.1021/jo005623+; Wischang D, 2011, COORDIN CHEM REV, V255, P2204, DOI 10.1016/j.ccr.2011.04.003; Herrmann WA, 1998, J ORGANOMET CHEM, V555, P293, DOI 10.1016/S0022-328X(97)00784-5; Neumann R, 2010, INORG CHEM, V49, P3594, DOI 10.1021/ic9015383; De Vos DE, 1998, TETRAHEDRON LETT, V39, P3221, DOI 10.1016/S0040-4039(98)00396-7; Leng Y, 2011, GREEN CHEM, V13, P1636, DOI 10.1039/c1gc15302a; Antonelli E, 1998, J ORG CHEM, V63, P7190, DOI 10.1021/jo980481t; Kamata K, 2010, NAT CHEM, V2, P478, DOI [10.1038/nchem.648, 10.1038/NCHEM.648]; Sakamoto T, 2000, TETRAHEDRON LETT, V41, P10009, DOI 10.1016/S0040-4039(00)01787-1; Colladon M, 2006, J AM CHEM SOC, V128, P14006, DOI 10.1021/ja0647607; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Mizuno N, 2011, COORDIN CHEM REV, V255, P2358, DOI 10.1016/j.ccr.2011.01.041; White MC, 2001, J AM CHEM SOC, V123, P7194, DOI 10.1021/ja015884g; Mizuno N, 2005, COORDIN CHEM REV, V249, P1944, DOI 10.1016/j.ccr.2004.11.019; BATTIONI P, 1988, J AM CHEM SOC, V110, P8462, DOI 10.1021/ja00233a023; Ishimoto R, 2012, ANGEW CHEM INT EDIT, V51, P4662, DOI 10.1002/anie.201201049; Long DL, 2010, ANGEW CHEM INT EDIT, V49, P1736, DOI 10.1002/anie.200902483; Punniyamurthy T, 2005, CHEM REV, V105, P2329, DOI 10.1021/cr050523v; Okuhara T, 1996, ADV CATAL, V41, P113, DOI 10.1016/S0360-0564(08)60041-3; Lane BS, 2003, CHEM REV, V103, P2457, DOI 10.1021/cr020471z; Shul'pin GB, 2013, DALTON T, V42, P12794, DOI 10.1039/c3dt51004b; DUNCAN DC, 1995, J AM CHEM SOC, V117, P681, DOI 10.1021/ja00107a012; Saisaha P, 2013, CHEM SOC REV, V42, P2059, DOI 10.1039/c2cs35443h; Kamata K, 2012, ANGEW CHEM INT EDIT, V51, P7275, DOI 10.1002/anie.201201605; Kamata K, 2009, J AM CHEM SOC, V131, P6997, DOI 10.1021/ja901289r; AUBRY C, 1991, INORG CHEM, V30, P4409, DOI 10.1021/ic00023a024; Conte V, 2011, DALTON T, V40, P1419, DOI 10.1039/c0dt00706d; Colladon M, 2007, J AM CHEM SOC, V129, P7680, DOI 10.1021/ja071142x; Jia CG, 2001, ACCOUNTS CHEM RES, V34, P633, DOI 10.1021/ar000209h; Wu P, 2014, ACS CATAL, V4, P23, DOI 10.1021/cs4006056; Sheldon RA, 1998, ACCOUNTS CHEM RES, V31, P485, DOI 10.1021/ar9700163; ISHII Y, 1987, J ORG CHEM, V52, P1868, DOI 10.1021/jo00385a042; VENTURELLO C, 1985, J MOL CATAL, V32, P107, DOI 10.1016/0304-5102(85)85037-9; ISHII Y, 1988, J ORG CHEM, V53, P3587, DOI 10.1021/jo00250a032; Sofia LTA, 2009, J PHYS CHEM C, V113, P21114, DOI 10.1021/jp906108e; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Kamata K, 2003, SCIENCE, V300, P964, DOI 10.1126/science.1083176; Backvall J.-E., 2004, MODERN OXIDATION MET; CLERICI MG, 1993, J CATAL, V140, P71, DOI 10.1006/jcat.1993.1069; Clerici MG, 2013, LIQUID PHASE OXIDATION VIA HETEROGENEOUS CATALYSIS: ORGANIC SYNTHESIS AND INDUSTRIAL APPLICATIONS, P1, DOI 10.1002/9781118356760; Craven M, 2013, CHEM COMMUN, V49, P349, DOI 10.1039/c2cc36793a; DENGEL AC, 1993, J CHEM SOC DALTON, P2683, DOI 10.1039/dt9930002683; De Vos DE, 2001, ADV CATAL, V46, P1, DOI 10.1016/S0360-0564(02)46021-X; Gelbard G, 2002, J MOL CATAL A-CHEM, V182, P257, DOI 10.1016/S1381-1169(01)00485-X; Gelbard G, 2000, J MOL CATAL A-CHEM, V153, P7, DOI 10.1016/S1381-1169(99)00327-1; Hill C. L., 2004, COMPREHENSIVE COORDI, V4, P679, DOI 10.1016/B0-08-043748-6/03036-X; Hoegaerts D, 2000, CATAL TODAY, V60, P209, DOI 10.1016/S0920-5861(00)00337-0; Hutchings GJ, 2009, J MATER CHEM, V19, P1222, DOI 10.1039/b812300b; ISHII Y, 1994, CHEM LETT, P1, DOI 10.1246/cl.1994.1; ISHII Y, 1988, J ORG CHEM, V53, P5549, DOI 10.1021/jo00258a032; Ishimoto R., 2012, ANGEW CHEM, V124, P4740; IWAHAMA T, 1995, TETRAHEDRON LETT, V36, P1523, DOI 10.1016/0040-4039(95)00075-N; Kamata K., 2011, ANGEW CHEM, V123, P12268; Kamata K., 2012, ANGEW CHEM, V124, P7387; Kamata K, 2014, CHEMCATCHEM, V6, P2327, DOI 10.1002/cctc.201402268; Kholdeeva OA, 2013, EUR J INORG CHEM, P1595, DOI 10.1002/ejic.201201396; Kovalchuk T, 2007, J CATAL, V249, P1, DOI 10.1016/j.jcat.2007.03.018; Kozhevnikov I. V., 2002, CATALYSTS FINE CHEM, V2; Li J, 2006, ORG PROCESS RES DEV, V10, P876, DOI 10.1021/op060108k; Long D.-L., 2010, ANGEW CHEM, V122, P1780; Mizuno N., 2009, MODERN HETEROGENEOUS; Neumann R., 1997, ANGEW CHEM, V109, P1810, DOI 10.1002/ange.19971091619; NEUMANN R, 1995, J CHEM SOC CHEM COMM, P2277, DOI 10.1039/c39950002277; Nlate S, 2004, ADV SYNTH CATAL, V346, P1445, DOI 10.1002/adsc.200404185; Noyori R, 2003, CHEM COMMUN, P1977, DOI 10.1039/b303160h; OGUCHI T, 1989, CHEM LETT, P2053, DOI 10.1246/cl.1989.2053; Oyama S.T., 2008, MECH HOMOGENEOUS HET; Perrin D. D., 2003, PURIFICATION LAB CHE; Pope M.T., 2004, COMPREHENSIVE COORDI, P635; Proust A, 2008, CHEM COMMUN, P1837, DOI 10.1039/b715502f; SAKATA Y, 1991, J ORG CHEM, V56, P6233, DOI 10.1021/jo00021a051; SAKATA Y, 1992, CHEM LETT, P671, DOI 10.1246/cl.1992.671; SAKAUE S, 1992, CHEM LETT, P289, DOI 10.1246/cl.1992.289; Sawada Y., 2006, ANGEW CHEM, V118, P3558, DOI 10.1002/ange.200600636; Schroder D, 2008, P NATL ACAD SCI USA, V105, P18114, DOI 10.1073/pnas.0801849105; Sels BF, 2000, TOP CATAL, V13, P223, DOI 10.1023/A:1009046703320; Sheldon R. A., 2007, GREEN CHEM CATALYSIS; Vedernikov AN, 2012, ACCOUNTS CHEM RES, V45, P803, DOI 10.1021/ar200191k; Vogel A.I., 1978, TXB QUANTITATIVE INO; Zhang ZX, 2010, CATAL COMMUN, V12, P318, DOI 10.1016/j.catcom.2010.09.026; Zhao W., 2011, REAC KINET MECH CAT, V102, P459; Zuwei X, 2001, Science, V292, P1139, DOI 10.1126/science.292.5519.1139	107	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	APR	2015	7	7					1097	1104		10.1002/cctc.201402975		8	Chemistry, Physical	Chemistry	CF3ZR	WOS:000352488300009		
J	Hotta, N; Abe-Dohmae, S; Taguchi, R; Yokoyama, S				Hotta, Noriko; Abe-Dohmae, Sumiko; Taguchi, Ryo; Yokoyama, Shinji			Preferential incorporation of shorter and less unsaturated acyl phospholipids into high density lipoprotein-like particles in the ABCA1-and ABCA7-mediated biogenesis with apoA-I	CHEMISTRY AND PHYSICS OF LIPIDS			English	Article						HDL; Lipidomics; Global analysis; Phosphatidylcholine; Sphingomyelin; ABCA1; ABCA7	APOLIPOPROTEIN-A-I; CASSETTE TRANSPORTER A7; CELLULAR LIPID EFFLUX; CHOLESTEROL EFFLUX; TANGIER-DISEASE; PLASMA-MEMBRANE; HUMAN SERUM; BINDING; ABCA7; SPHINGOMYELIN	Molecular species of phosphatidylcholine (PC) and sphingomyelin (SPM) were globally analyzed for lipidomics in the nascent high-density lipoprotein (HDL)-like particles generated with human apolipoprotein A-I (apoA-I) form HEK293 cells where either human ATP binding cassette transporter (ABC) A1 or ABCA7 was transfected and overexpressed. SPM/PC ratio was higher in the ABCA1-mediated HDL than ABCA7-mediated HDL likely being related to their cholesterol content, while it was less than the ratio in the cell membrane in either case. Molecular species composition of hydrocarbon chain moiety in each phospholipid in the HDL largely reflected that in the cells the lipoprotein originated in, without remarkable difference between ABCA1 and ABCA7. Further analysis, however, revealed apparent preference for the molecules with shorter hydrocarbon chain length for both PC and SPM in their relative incorporation into HDL by ABCA1 and ABCA7. Likewise, it was in favor for less-unsaturated hydrocarbon chains of PC while this preference was not apparent for SPM. The results are consistent with the view that assembly of HDL particles with extracellular apoA-I is primarily with the cellular phospholipid molecules being regulated in part by their physicochemical nature. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Hotta, Noriko; Taguchi, Ryo] Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Hotta, Noriko; Abe-Dohmae, Sumiko] Nagoya City Univ, Med Sci, Nagoya, Aichi, Japan; [Taguchi, Ryo; Yokoyama, Shinji] Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 487, Japan	Yokoyama, S (reprint author), Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 487, Japan.	syokoyam@isc.chubu.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1201007]; MEXT Japan [24614018]	This work was supported in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1201007) and by Grant-in-aid from MEXT Japan (24614018).	Taguchi R, 2000, J MASS SPECTROM, V35, P953, DOI 10.1002/1096-9888(200008)35:8<953::AID-JMS23>3.3.CO;2-W; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092JLR200; TAKAYAMA M, 1977, CLIN CHIM ACTA, V79, P93; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Yokoyama S, 2005, CURR OPIN LIPIDOL, V16, P269, DOI 10.1097/01.mol.0000169346.15450.90; Brooks-Wilson A, 1999, NAT GENET, V22, P336; Wu CA, 2004, J BIOL CHEM, V279, P30168, DOI 10.1074/jbc.M403765200; Abe-Dohmae S, 2006, J LIPID RES, V47, P1542, DOI 10.1194/jlr.M600145-JLR200; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Tanaka N, 2011, J ATHEROSCLER THROMB, V18, P274; Tsujita M, 1996, BIOCHEMISTRY-US, V35, P13011, DOI 10.1021/bi960734h; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8; Bodzioch M, 1999, NAT GENET, V22, P347; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Tanaka N, 2010, J LIPID RES, V51, P2591, DOI 10.1194/jlr.M006049; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Ito J, 2000, J LIPID RES, V41, P894; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485; Jayaraman S, 2005, BIOPHYS J, V88, P2907, DOI 10.1529/biophysj.104.055921; Costet P, 2003, MOL CELL BIOL, V23, P7756, DOI 10.1128/MCB.23.21.7756-7766.2003; Fukuda M, 2010, J PHYS CHEM B, V114, P8228, DOI 10.1021/jp101071t; GUO LSS, 1980, J LIPID RES, V21, P993; Ha JS, 2003, BBA-MOL CELL RES, V1640, P119, DOI 10.1016/S0167-4889(03)00027-2; HARA H, 1991, J BIOL CHEM, V266, P3080; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; HOFF H F, 1973, Biochimica et Biophysica Acta, V296, P653, DOI 10.1016/0005-2760(73)90130-6; Ito J, 2002, J BIOL CHEM, V277, P44709, DOI 10.1074/jbc.M208379200; Jayaraman S, 2010, J LIPID RES, V51, P324, DOI 10.1194/jlr.M000117; Kishimoto T, 2002, CLIN BIOCHEM, V35, P411, DOI 10.1016/S0009-9120(02)00327-2; MCCALL MR, 1989, J LIPID RES, V30, P1579; MCCALL MR, 1993, J LIPID RES, V34, P37; Peng Liu, 2008, Protein Pept Lett, V15, P360, DOI 10.2174/092986608784246542; Schifferer R, 2007, BBA-MOL CELL BIOL L, V1771, P853, DOI 10.1016/j.bbalip.2007.04.011; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Yamauchi Y, 2002, BBA-MOL CELL BIOL L, V1585, P1, DOI 10.1016/S1388-1981(02)00304-9; YOKOYAMA S, 1982, J BIOCHEM-TOKYO, V91, P1267	44	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0009-3084	1873-2941		CHEM PHYS LIPIDS	Chem. Phys. Lipids	APR	2015	187						1	9		10.1016/j.chemphyslip.2015.01.005		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CG2HJ	WOS:000353095200001		
J	Liu, M; Zhong, M; Li, HM; Piao, LY; Wang, WJ				Liu, Min; Zhong, Miao; Li, Hongmei; Piao, Lingyu; Wang, Wenjing			Facile Synthesis of Hollow TiO2 Single Nanocrystals with Improved Photocatalytic and Photoelectrochemical Activities	CHEMPLUSCHEM			English	Article						electrochemistry; hollow structures; nanocrystals; photochemistry; titanium	DOMINANT 001 FACETS; DOPED TIO2; CRYSTALS; WATER; NANOSHEETS; FABRICATION; PERCENTAGE; EFFICIENCY; POWDERS; CELLS	Diverse titanium dioxide (TiO2) nanostructures have attracted considerable attention owing to their broad applications in photocatalytic and photoelectrochemical fields. Herein, TiO2 hollow single nanocrystals are reported for the first time by using TiO2 nanopowders as the raw material and hydrofluoric acid as a capping and etching agent through a simple hydrothermal treatment. The influence of experimental parameters such as the concentration of HF, the amount of TiO2 nanoparticles, the reaction time, and temperature was investigated systematically. The obtained hollow single nanocrystals exhibited enhanced photoelectrochemical and photocatalytic performances attributed to their good crystallinity, suppressed charge recombination, and increased active sites. The current study will provide new insights into the nanostructured engineering of anatase TiO2 as well as opportunities for the controllable synthesis of hollow single nanocrystals.	[Liu, Min; Wang, Wenjing] Chinese Acad Sci, Inst Elect Engn, Key Lab Solar Thermal Energy & Photovolta Syst, Beijing 100190, Peoples R China; [Li, Hongmei] Shaoyang Univ, Dept Informat Engn, Inst Laser & Informat, Shaoyang 42200, Hunan, Peoples R China; [Piao, Lingyu] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China; [Liu, Min; Zhong, Miao] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Li, HM (reprint author), Shaoyang Univ, Dept Informat Engn, Inst Laser & Informat, Shaoyang 42200, Hunan, Peoples R China.	hongmeili82@gmail.com; piaoly@nanoctr.cn; wjwangwj@126.com	Liu, Min/H-3699-2011; Liu, Min/D-6532-2013	Liu, Min/0000-0002-9007-4817	National Basic Research Program of China [2011CB932802]; National High-Technology Research and Development Programme of China [2007AA05Z437]; Scientific Research Fund of Hunan Provincial Education Department [14A129]	This study was supported by the National Basic Research Program of China under grant no. 2011CB932802, the National High-Technology Research and Development Programme of China under grant no. 2007AA05Z437, and the Scientific Research Fund of Hunan Provincial Education Department under grant no. 14A129.	Chen JS, 2010, J AM CHEM SOC, V132, P6124, DOI 10.1021/ja100102y; Wang P, 2013, APPL CATAL B-ENVIRON, V132, P452, DOI 10.1016/j.apcatb.2012.12.009; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Jiang HB, 2014, CATAL TODAY, V225, P18, DOI 10.1016/j.cattod.2013.08.027; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Wen CZ, 2011, J MATER CHEM, V21, P7052, DOI 10.1039/c1jm00068c; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Liu M, 2014, ACS NANO, V8, P7229, DOI 10.1021/nn502247x; Zheng ZK, 2009, CHEM-EUR J, V15, P12576, DOI 10.1002/chem.200902438; Wang WL, 2008, J AM CERAM SOC, V91, P628, DOI 10.1111/j.1551-2916.2007.02132.x; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Warren SC, 2013, NAT MATER, V12, P842, DOI [10.1038/nmat3684, 10.1038/NMAT3684]; Crossland EJW, 2013, NATURE, V495, P215, DOI 10.1038/nature11936; SEAGER CH, 1979, APPL PHYS LETT, V34, P337, DOI 10.1063/1.90779; Li FB, 2002, CHEMOSPHERE, V48, P1103, DOI 10.1016/S0045-6535(02)00201-1; Bikondoa O, 2006, NAT MATER, V5, P189, DOI 10.1038/nmat1592; Pan JH, 2008, J AM CHEM SOC, V130, P11256, DOI 10.1021/ja803582m; Liu G, 2011, CHEM COMMUN, V47, P6763, DOI 10.1039/c1cc10665a; Dulub O, 2007, SCIENCE, V317, P1052, DOI 10.1126/science.1144787; Liu B, 2005, SMALL, V1, P566, DOI 10.1002/smll.200500020; Li HM, 2012, CHEMPLUSCHEM, V77, P1017, DOI 10.1002/cplu.201200158; Qiu XQ, 2012, ACS NANO, V6, P1609, DOI 10.1021/nn2045888; Fang WQ, 2011, J PHYS CHEM LETT, V2, P725, DOI 10.1021/jz200117r; Liu M, 2010, CHEM COMMUN, V46, P1664, DOI 10.1039/b924172h; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Yang XH, 2011, CHEM-EUR J, V17, P6615, DOI 10.1002/chem.201100134; Yang HG, 2008, NATURE, V453, P638, DOI 10.1038/nature06964; Liu M, 2011, CHEM MATER, V23, P5282, DOI 10.1021/cm203025b; Liu SW, 2010, J AM CHEM SOC, V132, P11914, DOI 10.1021/ja105283s; Jiao W, 2013, CHEM COMMUN, V49, P11770, DOI 10.1039/c3cc46527f; Liu M, 2013, APPL SURF SCI, V274, P117, DOI 10.1016/j.apsusc.2013.02.125; Li HM, 2012, CHEM-EUR J, V18, P7525, DOI 10.1002/chem.201103087; Liu M, 2010, NANOSCALE, V2, P1115, DOI 10.1039/c0nr00050g; Yang HG, 2009, J AM CHEM SOC, V131, P4078, DOI 10.1021/ja808790p; Li YB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3566; Ostwald W., 1896, LEHRBUCH ALLGEMEINEN, V2; PIKE GE, 1979, J APPL PHYS, V50, P3414, DOI 10.1063/1.326334; Wu Q, 2012, J PHYS CHEM C, V116, P26800, DOI 10.1021/jp3087495; Wu Q, 2012, CHINESE J CATAL, V33, P1743, DOI 10.1016/S1872-2067(11)60448-8	39	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2192-6506			CHEMPLUSCHEM	ChemPlusChem	APR	2015	80	4					688	696		10.1002/cplu.201402368		9	Chemistry, Multidisciplinary	Chemistry	CF7AH	WOS:000352707900007		
J	Yuan, YS; Li, KW; Wang, N; Irie, Y; Wang, S				Yuan Yao-Shuo; Li Kai-Wei; Wang Na; Irie, Yoshiro; Wang Sheng			Study of the beam loading effect in the CSNS/RCS	CHINESE PHYSICS C			English	Article						beam loading effect; beam-induced voltage; beam simulation; CSNS/RCS	BOOSTER	The China Spallation Neutron Source/Rapid Cycling Synchrotron (CSNS/RCS) accelerates a high-intensity proton beam from 80 MeV to 1.6 GeV. Since the beam current and beam power is high, the beam loading is a severe problem for the stability of the circulating beam in the RCS. To study the beam loading effect in the CSNS/RCS theoretically, the RLC circuit model of the rf cavity, the method of Fast Fourier Transform and the method of Laplace transform have been employed to obtain the impedance of the rf system, the beam spectrum and the beam-induced voltage, respectively. Based on these physical models, the beam dynamics equations have been revised and a beam loading model has been constructed in the simulation code ORIENT. By using the code, the beam loading effect on the rf system of the CSNS/RCS has been investigated. Some simulation results have been obtained and conclusions have been drawn.	[Yuan Yao-Shuo; Li Kai-Wei; Wang Sheng] Chinese Acad Sci, Inst High Energy Phys, Dongguan 523803, Peoples R China; [Yuan Yao-Shuo; Li Kai-Wei; Wang Sheng] Dongguan Inst Neutron Sci, Dongguan 523808, Peoples R China; [Wang Na] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China; [Irie, Yoshiro] High Energy Accelerator Org, Tsukuba, Ibaraki 3050801, Japan	Yuan, YS (reprint author), Chinese Acad Sci, Inst High Energy Phys, Dongguan Campus, Dongguan 523803, Peoples R China.	wangs@ihep.ac.cn			National Natural Science Foundation of China [11175193]	Supported by National Natural Science Foundation of China (11175193)	Wang S, 2009, CHINESE PHYS C, V33, P1; Barratt P, 1990, P 2 EUR PART ACC C, P949; CSNS Project Team, 2009, CHIN SPALL NEUTR SOU; EZURA E, 1979, IEEE T NUCL SCI, V26, P3538, DOI 10.1109/TNS.1979.4330092; GAROBY R, 1989, PROCEEDINGS OF THE 1989 IEEE PARTICLE ACCELERATOR CONFERENCE, VOLS 1-3, P135, DOI 10.1109/PAC.1989.73037; PEDERSEN F, 1975, IEEE T NUCL SCI, VNS22, P1906, DOI 10.1109/TNS.1975.4328024; Yuan YS, 2013, NUCL INSTRUM METH A, V729, P864, DOI 10.1016/j.nima.2013.08.055	7	0	0	CHINESE PHYSICAL SOC	BEIJING	P O BOX 603, BEIJING 100080, PEOPLES R CHINA	1674-1137			CHINESE PHYS C	Chin. Phys. C	APR	2015	39	4							047003	10.1088/1674-1137/39/4/047003		6	Physics, Nuclear; Physics, Particles & Fields	Physics	CF8RE	WOS:000352828800015		
J	Ono, M; Sakao, Y; Tsuji, T; Ohashi, N; Yasuda, H; Nishiyama, A; Fujigaki, Y; Kato, A				Ono, Masafumi; Sakao, Yukitoshi; Tsuji, Takayuki; Ohashi, Naro; Yasuda, Hideo; Nishiyama, Akira; Fujigaki, Yoshihide; Kato, Akihiko			Role of intrarenal (pro)renin receptor in ischemic acute kidney injury in rats	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						(Pro)renin receptor; Angiotensin II; ERK 1/2; Ischemic AKI; Saline loading	ACUTE-RENAL-FAILURE; VACUOLAR H+-ATPASE; RENIN-ANGIOTENSIN SYSTEM; URINARY ANGIOTENSINOGEN; PRORENIN RECEPTOR; PROTEIN-KINASE; HANDLE-REGION; KAPPA-B; ACTIVATION; EXPRESSION	(Pro)renin receptor [(P)RR], a trans-membrane receptor for renin and prorenin, is involved in the local activation of renin-angiotensin system (RAS) in the kidney. However, it remains to be determined whether (P)RR plays a role in the development of ischemic acute kidney injury (AKI). We examined the abundance of (P)RR, renin/prorenin, angiotensinogen (AGT), AT(1) receptor (AT(1)R), phosphorylation of extracellular signal-regulated protein kinase 1/2 (ERK 1/2) and nuclear factor-kappa B (NF-kappa B) by Western blots at 6, 24 and 48 h, and at 7 days after 45-min ischemic injury in rats. Intrarenal angiotensin II (Ang II) levels were determined by radioimmunoassay. We then tested whether the beneficial effects of oral loading of saline solution (1.0 % NaCl) for 7 days prior to ischemic injury were associated with changes in RAS components and ERK 1/2 and NF-kappa B phosphorylation in the kidney. We also examined the effect of AT(1)R blocker, olmesartan, on ischemia-induced changes of (P)RR downstream such as AGT and phosphorylation of ERK 1/2. Renal ischemia increased the abundance of (P)RR protein at 24 h, and peaked at 48 h. (P)RR was mainly stained in the connecting tubules and collecting ducts in control rats, while ischemia increased its immunointensity in the damaged proximal tubules. Renal ischemia increased phosphorylation of ERK 1/2 and NF-kappa B proteins as early as at 6 h. There was a significant increase in AGT and Ang II levels at 24 and 48 h. Prior saline loading prevented the increase in serum creatinine at 48 h (5.36 +/- A 1.26 vs. 3.38 +/- A 1.74 mg/dL, p < 0.05), and suppressed the increases in renal (P)RR, AGT and Ang II contents. Saline drinking also significantly blocked the ischemia-induced increases in phosphorylation of ERK 1/2 and NF-kappa B. In contrast, although treatment with olmesartan (10 mg/kg/day) for 14 days suppressed an increase of intrarenal AGT, olmesartan did not alleviate ischemic AKI, along with no change of (P)RR and phosphorylated ERK 1/2. These findings suggest that increased (P)RR is associated with activation of RAS-independent downstream such as ERK 1/2 and NF-kappa B phosphorylation in the ischemic kidney.	[Ono, Masafumi; Tsuji, Takayuki; Ohashi, Naro; Yasuda, Hideo] Hamamatsu Univ Sch Med, Div Nephrol, Internal Med 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Sakao, Yukitoshi; Kato, Akihiko] Hamamatsu Univ Sch Med, Blood Purificat Unit, Hamamatsu, Shizuoka 4313192, Japan; [Nishiyama, Akira] Kagawa Univ, Sch Med, Dept Pharmacol, Takamatsu, Kagawa, Japan; [Fujigaki, Yoshihide] Teikyo Univ, Dept Internal Med, Sch Med, Itabashi Ku, Tokyo, Japan	Ono, M (reprint author), Hamamatsu Univ Sch Med, Div Nephrol, Internal Med 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	m-ono@hama-med.ac.jp					Alderliesten M, 2007, AM J PATHOL, V171, P452, DOI 10.2353/ajpath.2007.060805; Alge JL, 2013, CRIT CARE, V17, DOI 10.1186/cc12612; Allred AJ, 2000, AM J PHYSIOL-RENAL, V279, pF636; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCl200421398; Takahashi H, 2007, J AM SOC NEPHROL, V18, P2054, DOI 10.1681/ASN.2006080820; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Matavelli LC, 2012, AM J PHYSIOL-RENAL, V303, pF1652, DOI 10.1152/ajprenal.00204.2012; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Nishiyama A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026610.48842.CB; Rabb H, 2003, KIDNEY INT, V63, P600, DOI 10.1046/j.1523-1755.2003.00753.x; Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; da Silveira KD, 2010, CLIN SCI, V119, P385, DOI 10.1042/CS20090554; Ichihara A, 2006, J AM SOC NEPHROL, V17, P2495, DOI 10.1681/ASN.2005121278; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Alge JL, 2013, CLIN J AM SOC NEPHRO, V8, P184, DOI 10.2215/CJN.06280612; Kobori H, 2002, KIDNEY INT, V61, P579, DOI 10.1046/j.1523-1755.2002.00155.x; Ichihara A, 2006, J AM SOC NEPHROL, V17, P1950, DOI 10.1681/ASN.2006010029; Efrati S, 2012, NEPHROL DIAL TRANSPL, V27, P136, DOI 10.1093/ndt/gfr256; Feldt S, 2008, HYPERTENSION, V51, P682, DOI 10.1161/HYPERTENSIONAHA.107.101444; BIDANI A, 1979, KIDNEY INT, V16, P481, DOI 10.1038/ki.1979.153; DEROUGEMONT D, 1982, J LAB CLIN MED, V99, P646; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195; Fouad AA, 2010, PHARMACOLOGY, V85, P158, DOI 10.1159/000269779; HISHIDA A, 1988, KIDNEY INT, V33, P942, DOI 10.1038/ki.1988.91; Huang JQ, 2012, HYPERTENSION, V59, P317, DOI 10.1161/HYPERTENSIONAHA.111.186056; Huang JQ, 2010, ENDOCRINOLOGY, V151, P3317, DOI 10.1210/en.2009-1368; Huang YJ, 2012, AM J PHYSIOL-RENAL, V303, pF130, DOI 10.1152/ajprenal.00275.2011; Kato A, 1997, NEPHRON, V75, P72; KDIGO Working Group, 2012, KIDNEY INT S, V2, P37; Kontogiannis J, 1998, AM J PHYSIOL-RENAL, V274, pF79; MCDONALD FD, 1969, P SOC EXP BIOL MED, V131, P610; Prieto Minolfa C, 2013, Ochsner J, V13, P26; Rosivall L, 2009, MOL CELL ENDOCRINOL, V302, P185, DOI 10.1016/j.mce.2008.09.033; Song RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063835; Tsuji T, 2009, TOXICOL APPL PHARM, V234, P202, DOI 10.1016/j.taap.2008.09.031; Uraoka M, 2009, BIOCHEM BIOPH RES CO, V390, P1202, DOI 10.1016/j.bbrc.2009.10.121; ZAGER RA, 1986, J LAB CLIN MED, V108, P60; Zhu A, 2009, J HYPERTENS, V27, P800, DOI 10.1097/HJH.0b013e328325d861	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					185	196		10.1007/s10157-014-0979-9		12	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900004		
J	Yoshihara, F; Tokudome, T; Kishimoto, I; Otani, K; Kuwabara, A; Horio, T; Kawano, Y; Kangawa, K				Yoshihara, Fumiki; Tokudome, Takeshi; Kishimoto, Ichiro; Otani, Kentaro; Kuwabara, Atsunori; Horio, Takeshi; Kawano, Yuhei; Kangawa, Kenji			Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Guanylyl cyclase-A; Angiotensin II; Renal tubular atrophy; Interstitial fibrosis	MESANGIAL CELL-PROLIFERATION; ANGIOTENSIN-II; GENE-TRANSCRIPTION; GLOMERULAR INJURY; IN-VIVO; HYPERTENSION; EXPRESSION; HYPOXIA; KIDNEY; RATS	The infusion of chronic angiotensin II (Ang II) has been shown to promote renal interstitial fibrosis. To evaluate the pathophysiological significance of the natriuretic peptide-GC-A system, we infused Ang II (1.0 mg/kg/day) in GC-A-deficient mice (GC-A-KO). We used 5 groups (Wild-Saline n = 12, Wild-Ang II n = 14, GC-A-KO-Saline n = 11, GC-A-KO-Ang II n = 13, and GC-A-KO-Ang II-Hydralazine n = 10). Saline or Ang II was infused subcutaneously using an osmotic minipump for 3 weeks. Hydralazine was administered orally (0.05 g/L in drinking water). Systolic blood pressure was significantly higher in the GC-A-KO-Saline group (130 +/- A 12 mmHg) than in the Wild-Saline group (105 +/- A 30 mmHg), and was similar to that in the Wild-Ang II (141 +/- A 17 mmHg) and GC-A-KO-Ang II-Hydralazine (140 +/- A 20 mmHg) groups. Systolic blood pressure was significantly higher in the GC-A-KO-Ang II group (159 +/- A 21 mmHg) than in the 4 other groups. Renal tubular atrophy and interstitial fibrosis were significantly more severe in the GC-A-KO-Ang II group (atrophy 13.4 %, fibrosis 12.0 %) than in the Wild-Saline (0, 2.0 %), Wild-Ang II (2.9, 4.4 %), and GC-A-KO-Saline (0, 2.6 %) groups. Hydralazine could not inhibit this aggravation (GC-A-KO-Ang II-Hydralazine 13.5, 11.3 %). The expression of monocyte chemotactic protein-1 in tubular cells, and F4/80 and alpha-smooth muscle actin in the interstitium was clearly detected in the Ang II-infused wild and GC-A-KO groups and was associated with renal tubular atrophy and interstitial fibrosis. The expression of E-cadherin in tubular cells was absent in the Ang II-infused wild and GC-A-KO groups and was associated with renal tubular atrophy. The natriuretic peptide-GC-A system may play an inhibitory role in Ang II-induced renal tubular atrophy, interstitial fibrosis, and phenotypic transformation in renal tubular cells and fibroblasts.	[Yoshihara, Fumiki; Horio, Takeshi; Kawano, Yuhei] Natl Cerebral & Cardiovasc Ctr, Div Nephrol & Hypertens, Suita, Osaka 5658565, Japan; [Tokudome, Takeshi; Kangawa, Kenji] Natl Cerebral & Cardiovasc Res Inst, Dept Biochem, Suita, Osaka, Japan; [Kishimoto, Ichiro] Natl Cerebral & Cardiovasc Ctr, Div Atherosclerosis & Diabet, Suita, Osaka 5658565, Japan; [Otani, Kentaro] Natl Cerebral & Cardiovasc Res Inst, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan; [Kawano, Yuhei] Kawasaki Med Univ, Dept Internal Med, Div Nephrol & Hypertens, Kurashiki, Okayama, Japan	Yoshihara, F (reprint author), Natl Cerebral & Cardiovasc Ctr, Div Nephrol & Hypertens, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	fyoshi@hsp.ncvc.go.jp			Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan [22590906]	We thank the Howard Hughes Medical Institute for the GC-A knockout mice, Dr. Kyoko Shioya for her support, and Tamaki Mabuchi and Junko Nakamura for their excellent technical assistance. This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan (No. 22590906).	JOHNSON RJ, 1992, HYPERTENSION, V19, P464; Garg R, 2003, HYPERTENSION, V41, P730, DOI 10.1161/01.HYP.0000051890.68573.94; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Tokudome T, 2009, ARTERIOSCL THROM VAS, V29, P1516, DOI 10.1161/ATVBAHA.109.187526; Lombardi DM, 2001, NEPHRON, V87, P66, DOI 10.1159/000045886; Sabrane K, 2005, J CLIN INVEST, V115, P1666, DOI 10.1172/JCI23360; Tokudome T, 2005, CIRCULATION, V111, P3095, DOI 10.1161/CIRCULATIONAHA.104.510594; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; Arise KK, 2006, BIOCHEM BIOPH RES CO, V349, P131, DOI 10.1016/j.bbrc.2006.08.003; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Weber NC, 2003, J LEUKOCYTE BIOL, V74, P932, DOI 10.1189/jlb.0603254; Saito Y, 2010, J CARDIOL, V56, P262, DOI 10.1016/j.jjcc.2010.08.001; Chen W, 2012, CARDIOVASC RES, V93, P141, DOI 10.1093/cvr/cvr279; Kasahara M, 2000, J AM SOC NEPHROL, V11, P1691; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Li P, 2007, J APPL PHYSIOL, V102, P390, DOI 10.1152/japplphysiol.00468.2006; Baltatu O, 2000, HYPERTENSION, V35, P409; Canaan-Kuhl S, 1998, KIDNEY INT, V53, P1143, DOI 10.1046/j.1523-1755.1998.00895.x; CARGILL RI, 1994, BRIT J CLIN PHARMACO, V38, P139; Faulkner JL, 2005, AM J PATHOL, V167, P1193, DOI 10.1016/S0002-9440(10)61208-4; GIACHELLI CM, 1994, KIDNEY INT, V45, P515, DOI 10.1038/ki.1994.67; Hu P, 2013, MOL BIOL REP, V40, P1429, DOI 10.1007/s11033-012-2186-7; Kitayama H, 2006, AM J HYPERTENS, V19, P718, DOI 10.1016/j.amjhyper.2005.09.022; Long DA, 2006, AM J PHYSIOL-RENAL, V291, pF1248, DOI 10.1152/ajprenal.00096.2006; Makino H, 2006, DIABETOLOGIA, V49, P2514, DOI 10.1007/s00125-006-0352-y; Manotham K, 2004, KIDNEY INT, V65, P871, DOI 10.1111/j.1523-1755.2004.00461.x; MARINGREZ M, 1986, NATURE, V324, P473, DOI 10.1038/324473a0; Nath KA, 1995, AM J KIDNEY DIS, V20, P1; Ozawa Y, 2007, AM J PHYSIOL-RENAL, V292, pF330, DOI 10.1152/ajprenal.00059.2006; Parekh N, 1996, AM J PHYSIOL-RENAL, V271, pF653; Quesada A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040402; Segawa K, 1998, N-S ARCH PHARMACOL, V357, P70; SEXTON PM, 1992, TOHOKU J EXP MED, V166, P41, DOI 10.1620/tjem.166.41; Suganami T, 2001, J AM SOC NEPHROL, V12, P2652; Suzuki K, 2007, AM J PATHOL, V170, P1841, DOI 10.2353/ajpath.2007.060484; Zhu Q, 2011, HYPERTENSION, V58, P657, DOI 10.1161/HYPERTENSIONAHA.111.177626	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					197	207		10.1007/s10157-014-0982-1		11	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900005		
J	Iwatani, H; Nagasawa, Y; Yamamoto, R; Iio, K; Mizui, M; Horii, A; Kitahara, T; Inohara, H; Kumanogoh, A; Imai, E; Rakugi, H; Isaka, Y				Iwatani, Hirotsugu; Nagasawa, Yasuyuki; Yamamoto, Ryohei; Iio, Kenichiro; Mizui, Masayuki; Horii, Arata; Kitahara, Tadashi; Inohara, Hidenori; Kumanogoh, Atsushi; Imai, Enyu; Rakugi, Hiromi; Isaka, Yoshitaka			CD16(+)CD56(+) cells are a potential culprit for hematuria in IgA nephropathy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						CD16(+)CD56(+) cells; Hematuria; IgA nephropathy; NK cells; Tonsil; Tonsillectomy	NK CELLS; MOUSE STRAIN; DDY MICE; GLOMERULONEPHRITIS; DEPOSITION; SERUM	Hematuria is the first manifestation of urinary abnormality in immunoglobulin A nephropathy (IgAN). Hematuria has recently been reported as a risk factor for deterioration of renal function; however, its cause remains unknown. We analyzed the surface marker of peripheral blood mononuclear cells before and immediately after tonsillectomy in IgAN patients and controls (chronic tonsillitis or tonsillar hypertrophy) by flow cytometry and investigated the association with hematuria. To prove our hypothesis that NK cells induce hematuria, we administered IL-12, activator of NK cells, to HIGA mice. In addition, we transferred cultured NK cells to nude rats and transferred the CD16(+)CD56(+) cells, including NK cells, that are derived from the peripheral blood of IgAN patients immediately after tonsillectomy to nude rats to assess the hematuria level and renal histology of the recipients. We also performed cytotoxicity assays against glomerular endothelial cells by NK cells. We found that IgAN patients who showed rapid deterioration of hematuria after tonsillectomy also displayed a significant increase in CD16(+)CD56(+) cells in the peripheral blood immediately after tonsillectomy. Exogenous administration of IL-12 to HIGA mice induced hematuria. Adoptive transfer of either cells of an NK cell line, or of CD16(+)CD56(+) cells derived from IgAN patients, into nude rats induced hematuria in the recipients. In vitro analysis showed that NK cells exert cytotoxic activity toward human glomerular endothelial cells in a dose-dependent manner. CD16(+)CD56(+) cells seem to be responsible for hematuria in IgAN.	[Iwatani, Hirotsugu; Yamamoto, Ryohei; Iio, Kenichiro; Mizui, Masayuki; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Nagasawa, Yasuyuki] Hyogo Coll Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Horii, Arata; Kitahara, Tadashi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka 5650871, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [Imai, Enyu] Nakayamadera Imai Clin, Takarazuka, Hyogo, Japan	Isaka, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	isaka@kid.med.osaka-u.ac.jp			 [18790562]	This study was supported by a Grant-in-Aid for Young Scientists B (18790562).	Segawa C, 1997, KIDNEY INT, V52, P1054, DOI 10.1038/ki.1997.428; Erdbruegger U, 2008, RHEUMATOLOGY, V47, P1820, DOI 10.1093/rheumatology/ken373; Muso E, 1996, KIDNEY INT, V50, P1946, DOI 10.1038/ki.1996.517; Cox SN, 2012, KIDNEY INT, V82, P548, DOI 10.1038/ki.2012.147; Manno C, 2007, AM J KIDNEY DIS, V49, P763, DOI 10.1053/j.ajkd.2007.03.013; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Yildirim I, 2003, J LARYNGOL OTOL, V117, P619; Maintz L, 2011, J INNATE IMMUN, V3, P131, DOI 10.1159/000323963; Kobayashi I, 2002, NEPHROL DIAL TRANSPL, V17, P2108, DOI 10.1093/ndt/17.12.2108; Yoneda O, 2000, J IMMUNOL, V164, P4055; Espinosa M, 2009, NEPHROL DIAL TRANSPL, V24, P886, DOI 10.1093/ndt/gfn563; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Antonaci S, 1992, Cytobios, V69, P27; Ayalon O, 1998, P NATL ACAD SCI USA, V95, P2435, DOI 10.1073/pnas.95.5.2435; Gutieerrez E, 2007, CLIN J AM SOC NEPHRO, V2, P51, DOI 10.2215/CJN.02670706; Haas M, 1996, AM J KIDNEY DIS, V28, P365, DOI 10.1016/S0272-6386(96)90493-X; HOTTA O, 1991, NEPHRON, V57, P239, DOI 10.1159/000186261; Nogaki F, 2000, NEPHROL DIAL TRANSPL, V15, P1146, DOI 10.1093/ndt/15.8.1146; Pettersson E, 1997, J INTERN MED, V242, P349, DOI 10.1046/j.1365-2796.1997.00194.x; Yago T, 1998, J IMMUNOL, V161, P1140	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					216	224		10.1007/s10157-014-0968-z		9	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900007		
J	Watanabe, H; Goto, S; Miyashita, A; Maruyama, H; Wakasugi, M; Yokoseki, A; Kuwano, R; Narita, I				Watanabe, Hirofumi; Goto, Shin; Miyashita, Akinori; Maruyama, Hiroki; Wakasugi, Minako; Yokoseki, Akio; Kuwano, Ryozo; Narita, Ichiei			Role of the p.E66Q variant of GLA in the progression of chronic kidney disease	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						alpha-Galactosidase A; Fabry disease; Genetic association study; Hemodialysis; Polymorphism; SNP genotyping	JAPANESE DIALYSIS PATIENTS; FABRY-DISEASE; ALPHA-GALACTOSIDASE; HEMODIALYSIS-PATIENTS; GENE; IDENTIFICATION; PREVALENCE; MUTATION; FREQUENCY	The p.E66Q variant of the alpha-galactosidase A gene (GLA) is frequently found during screening for Fabry disease in dialysis patients in Japan. However, recent reports suggest that the p.E66Q variant is not a disease-causing mutation but is a risk factor for cerebral small-vessel occlusion. To evaluate the role of the p.E66Q in the progression of renal diseases, we performed a genetic association study in patients with chronic kidney disease (CKD). In this study, we enrolled 1651 chronic hemodialysis and 941 non-dialysis patients who attended medical institutions in the Niigata Prefecture, Japan. The frequency of the p.E66Q allele was compared between hemodialysis and non-dialysis patients, with data from a previously published study of Japanese male newborns. In addition, we compared estimated glomerular filtration rates (eGFR) in the presence or absence of the p.E66Q variant in non-dialysis patients. Of the 2233 alleles in hemodialysis and 1447 alleles in non-dialysis patients, 21 and nine harbored p.E66Q, respectively. However, p.E66Q allele frequencies did not differ between the two patient groups (0.90 versus 0.62 %, P = 0.35), and no significant difference in p.E66Q allele frequency was observed between male hemodialysis patients and the general Japanese population (0.52 versus 0.63 %, P = 0.67). Moreover, eGFR did not significantly differ between non-dialysis patients with the p.E66Q variant and patients with the wild-type allele (65.5 +/- A 10.7 versus 62.7 +/- A 16.6 mL/min/1.73 m(2), P = 0.69). This study indicated that the p.E66Q variant of GLA does not affect the progression of CKD.	[Watanabe, Hirofumi; Goto, Shin; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Chuo Ku, Niigata 9518510, Japan; [Miyashita, Akinori; Kuwano, Ryozo] Niigata Univ, Brain Res Inst, Dept Mol Genet, Niigata 9518510, Japan; [Maruyama, Hiroki] Niigata Univ, Dept Clin Nephrosci, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Wakasugi, Minako; Yokoseki, Akio] Niigata Univ, Ctr Interorgan Commun Res, Grad Sch Med & Dent Sci, Niigata 9518510, Japan	Narita, I (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Chuo Ku, 1-757 Asahimachi dori, Niigata 9518510, Japan.	naritai@med.niigata-u.ac.jp			Ministry of Education, Science and Culture of Japan [23390223]; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Ms. Hiroko Aita for technical assistance. We are indebted to the patients, nurses, medical staff, and physicians who supported this study. This work was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Science and Culture of Japan (23390223) (H.M.), and by a Grant-in-Aid for Project in Sado for Total Health (PROST) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; OKUMIYA T, 1995, BIOCHEM BIOPH RES CO, V214, P1219, DOI 10.1006/bbrc.1995.2416; Lee BH, 2010, J HUM GENET, V55, P512, DOI 10.1038/jhg.2010.58; Kikumoto Y, 2012, CLIN NEPHROL, V78, P224, DOI 10.5414/CN107097; Maruyama H, 2013, CLIN J AM SOC NEPHRO, V8, P629, DOI 10.2215/CJN.08780812; Togawa T, 2012, MOL GENET METAB, V105, P615, DOI 10.1016/j.ymgme.2012.01.010; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; ISHII S, 1992, HUM GENET, V89, P29, DOI 10.1007/BF00207037; Nakao S, 2003, KIDNEY INT, V64, P801, DOI 10.1046/j.1523-1755.2003.00160.x; Nakamura K, 2014, EUR J NEUROL, V21, P49, DOI 10.1111/ene.12214; Fujii H, 2009, AM J NEPHROL, V30, P527, DOI 10.1159/000250968; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Ichinose Mayuri, 2005, Clin Exp Nephrol, V9, P228, DOI 10.1007/s10157-005-0369-4; Inoue T, 2013, J HUM GENET, V58, P548, DOI 10.1038/jhg.2013.48; Kobayashi M, 2012, MOL GENET METAB, V107, P711, DOI 10.1016/j.ymgme.2012.10.018; Nishino T, 2012, RENAL FAILURE, V34, P566, DOI 10.3109/0886022X.2012.669300; Tanaka M, 2005, CLIN NEPHROL, V64, P281; Utsumi K, 2000, CLIN EXP NEPHROL, V4, P49, DOI 10.1007/s101570050061	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					225	230		10.1007/s10157-014-0969-y		6	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900008		
J	Isobe, S; Ohashi, N; Fujikura, T; Tsuji, T; Sakao, Y; Yasuda, H; Kato, A; Miyajima, H; Fujigaki, Y				Isobe, Shinsuke; Ohashi, Naro; Fujikura, Tomoyuki; Tsuji, Takayuki; Sakao, Yukitoshi; Yasuda, Hideo; Kato, Akihiko; Miyajima, Hiroaki; Fujigaki, Yoshihide			Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Circadian rhythm; Intrarenal RAS; Risers; Urinary angiotensinogen	AMBULATORY BLOOD-PRESSURE; CHRONIC KIDNEY-DISEASE; URINARY ANGIOTENSINOGEN; SALT SENSITIVITY; RECEPTOR; RATS; NEPHROPATHY; NATRIURESIS; ACTIVATION; EXPRESSION	The intrarenal renin-angiotensin system (RAS) plays an important role in the development of hypertension and renal damage. Disruption of diurnal blood pressure (BP) variation is an additional risk factor for renal damage. However, little is known regarding whether intrarenal RAS circadian rhythm exists or if it influences the disruption of diurnal BP and renal damage. We investigated the circadian rhythm of urinary angiotensinogen (U-AGT) that reflects intrarenal RAS activity in 14 individuals without chronic kidney disease (CKD) and 36 CKD patients classified according to circadian BP rhythms. BP values were higher during the daytime than during the nighttime in both individuals without CKD and CKD patients. U-AGT levels were not different between the daytime and nighttime in individuals without CKD, but were significantly higher in the daytime in CKD patients (log U-AGT/creatinine: daytime, 2.39 +/- A 0.99; nighttime, 2.24 +/- A 1.06; p = 0.001). Furthermore, in CKD patients showing a riser pattern of circadian BP, U-AGT levels did not decrease during the nighttime compared with those in the daytime (log U-AGT/creatinine: daytime, 2.51 +/- A 0.65; nighttime, 2.52 +/- A 0.71; p = 0.78). Circadian fluctuation of albuminuria and proteinuria occurred parallel to that of the U-AGT levels. U-AGT levels were significantly and positively correlated with the levels of BP and circadian fluctuation of U-AGT was correlated with diurnal BP changes. These data suggest that the circadian rhythm of intrarenal RAS activation may lead to renal damage and hypertension, which are associated with diurnal BP variation.	[Isobe, Shinsuke; Ohashi, Naro; Fujikura, Tomoyuki; Tsuji, Takayuki; Yasuda, Hideo; Miyajima, Hiroaki; Fujigaki, Yoshihide] Hamamatsu Univ Sch Med, Internal Med 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Sakao, Yukitoshi; Kato, Akihiko] Hamamatsu Univ Sch Med, Blood Purificat Unit, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Fujigaki, Yoshihide] Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 1738606, Japan	Ohashi, N (reprint author), Hamamatsu Univ Sch Med, Internal Med 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ohashi-n@hama-med.ac.jp			Salt Science Research Foundation [1230]; Hamamatsu University School of Medicine	This study was supported by grants from the Salt Science Research Foundation (Awarded to Naro OHASHI, no. 1230) and Young Investigator Research Projects of Hamamatsu University School of Medicine in 2011 (Awarded to Naro OHASHI) and in 2012 (Awarded to Naro OHASHI and Shinsuke ISOBE).	Agarwal R, 2006, KIDNEY INT, V69, P1175, DOI 10.1038/sj.ki.5000247; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Konishi Y, 2011, HYPERTENSION, V58, P205, DOI 10.1161/HYPERTENSIONAHA.110.166843; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Kobori H, 2001, J AM SOC NEPHROL, V12, P431; Kobori H, 2008, J AM SOC HYPERTENS, V2, P349, DOI 10.1016/j.jash.2008.04.008; Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410; Nakano D, 2012, J AM SOC NEPHROL, V23, P1847, DOI 10.1681/ASN.2012010078; Fukuda M, 2008, J HYPERTENS, V26, P583, DOI 10.1097/HJH.0b013e3282f2fded; Kamiyama M, 2012, J PHARMACOL SCI, V119, P314, DOI 10.1254/jphs.12076FP; Naito Y, 2002, HYPERTENSION, V40, P827, DOI 10.1161/01.HYP.0000039960.66987.89; Kario K, 2004, CLIN EXP HYPERTENS, V26, P177, DOI 10.1081/CEH-120028556; Mills KT, 2012, NEPHROL DIAL TRANSPL, V27, P3176, DOI 10.1093/ndt/gfs011; Fukuda M, 2004, KIDNEY INT, V65, P621, DOI 10.1111/j.1523-1755.2004.00419.x; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Navar LG, 2002, HYPERTENSION, V39, P316, DOI 10.1161/hy0202.103821; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; Kobori H, 2009, HYPERTENSION, V53, P344, DOI 10.1161/HYPERTENSIONAHA.108.123802; Uzu T, 1999, CIRCULATION, V100, P1635; Hermida RC, 2007, HYPERTENSION, V50, P715, DOI 10.1161/HYPERTENSIONAHA.107.094235; BEILIN LJ, 1983, CLIN EXP HYPERTENS B, V2, P271; Coffman TM, 2008, HYPERTENSION, V51, P811, DOI 10.1161/HYPERTENSIONAHA.105.063636; Farmer CKT, 1997, NEPHROL DIAL TRANSPL, V12, P2301, DOI 10.1093/ndt/12.11.2301; Fukuda M, 2012, J HYPERTENS, V30, P1453, DOI 10.1097/HJH.0b013e328353e807; Fukuda M, 2008, HYPERTENSION, V52, P1155, DOI 10.1161/HYPERTENSIONAHA.108.115329; Fukuda M, 2011, AM J PHYSIOL-RENAL, V301, P953; Huang YJ, 2012, AM J PHYSIOL-RENAL, V303, pF130, DOI 10.1152/ajprenal.00275.2011; Ingert C, 2002, AM J PHYSIOL-RENAL, V283, pF995, DOI 10.1152/ajprenal.00321.2001; KALA R, 1973, SCAND J CLIN LAB INV, V31, P363, DOI 10.3109/00365517309084318; Katsurada A, 2007, AM J PHYSIOL-RENAL, V293, P956; Kimura G, 2010, HYPERTENS RES, V33, P515, DOI 10.1038/hr.2010.47; Kobori H, 2007, AM J PHYSIOL-RENAL, V293, pF938, DOI 10.1152/ajprenal.00146.2007; Nishijima Y, 2012, TOHOKU J EXP MED, V228, P333, DOI 10.1620/tjem.228.333; Nishimura M, 2002, AM J NEPHROL, V22, P455, DOI 10.1159/000065274; Nishiyama A, 2004, KIDNEY INT, V65, P972, DOI 10.1111/j.1523-1755.2004.00476.x; Ramkumar N, 2013, AM J HYPERTENS, V26, P473, DOI 10.1093/ajh/hps078; Satou R, 2008, AM J PHYSIOL-RENAL, V295, pF283, DOI 10.1152/ajprenal.00047.2008; TERADA Y, 1993, KIDNEY INT, V43, P1251, DOI 10.1038/ki.1993.177	39	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					231	239		10.1007/s10157-014-0973-2		9	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900009		
J	Fujiwara, A; Hirawa, N; Kobayashi, Y; Yatsu, K; Katsumata, M; Ehara, Y; Okuyama, Y; Yutoh, J; Kaneda, T; Fujita, M; Yamamoto, Y; Saka, S; Toya, Y; Yasuda, G; Umemura, S				Fujiwara, Akira; Hirawa, Nobuhito; Kobayashi, Yusuke; Yatsu, Keisuke; Katsumata, Mari; Ehara, Yohsuke; Okuyama, Yuki; Yutoh, Jun; Kaneda, Tomoko; Fujita, Megumi; Yamamoto, Yuichiro; Saka, Sanae; Toya, Yoshiyuki; Yasuda, Gen; Umemura, Satoshi			Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Cyclosporine; Minimal change nephrotic syndrome; Prednisolone; Clinical efficacy; Drug nephrotoxicity	PULSE METHYLPREDNISOLONE; STEROID RESPONSIVENESS; CONTROLLED-TRIAL; RISK-FACTORS; CHILDREN; PREDNISONE; PATIENT; RELAPSE; DISEASE	Cyclosporine and prednisolone combination therapy has been used in the treatment of minimal change nephrotic syndrome (MCNS). However, few studies have evaluated the efficacy of cyclosporine combined with intravenous methylprednisolone pulse therapy (MPT) as a first-line treatment for new-onset MCNS. We conducted a retrospective clinical study to evaluate the efficacy and safety of cyclosporine combined with MPT and oral prednisolone for new-onset MCNS in adults. Forty-six adult patients with biopsy-proven MCNS were analyzed retrospectively. This study included three groups. Group 1 (n = 17) was treated with intravenous MPT (0.5 or 1.0 g/day for 3 days) followed by oral cyclosporine (2-3 mg/kg/day) and prednisolone (30 mg/day). Group 2 (n = 15) was treated with intravenous MPT followed by oral prednisolone (0.4-0.8 mg/kg/day). Group 3 (n = 14) was treated with oral prednisolone (0.6-1.0 mg/kg/day) alone. The length of hospital stay was the shortest in Group 1 (P < 0.001). The mean duration to achieve < 20 mg/day of prednisolone was also the shortest in Group 1 (P < 0.05). Complete remission rates were 100 % in Group 1, 85.7 % in Group 2, and 69.2 % in Group 3 during the 9-month follow-up (P = 0.073). The rate of adverse effects caused by prednisolone was less in Group 1 (P < 0.05). Multivariate analysis revealed that the independent determinants of durations of remission were the selectivity index (P = 0.004), eGFR (P = 0.001) and the use of cyclosporine (P = 0.045). Combination therapy with cyclosporine may be a beneficial treatment option for new-onset MCNS in adults because of its clinical efficacy and safety.	[Fujiwara, Akira; Kobayashi, Yusuke; Yatsu, Keisuke; Okuyama, Yuki; Fujita, Megumi; Toya, Yoshiyuki; Umemura, Satoshi] Yokohama City Univ, Dept Med Sci & Cardiorenal Med, Sch Med, Yokohama, Kanagawa 2320024, Japan; [Hirawa, Nobuhito; Katsumata, Mari; Ehara, Yohsuke; Yutoh, Jun; Kaneda, Tomoko; Yamamoto, Yuichiro; Saka, Sanae; Yasuda, Gen] Yokohama City Univ, Med Ctr, Dept Hypertens & Nephrol, Minami Ku, Yokohama, Kanagawa 2320024, Japan	Hirawa, N (reprint author), Yokohama City Univ, Med Ctr, Dept Hypertens & Nephrol, Minami Ku, 45-7 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	hirawa@yokohama-cu.ac.jp			Daiichi-Sankyou; Nippon Boehringer Ingelheim; Astellas; Novartis Pharma	Satoshi Umemura received Honoraria from MSD, Pfizer, Novartis Pharma, Dainippon-Sumitomo. S Umemura received research funding from Daiichi-Sankyou, Nippon Boehringer Ingelheim, Astellas, Novartis Pharma.	Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Radhakrishnan J, 2012, KIDNEY INT, V82, P840, DOI 10.1038/ki.2012.280; Nakayama M, 2002, AM J KIDNEY DIS, V39, P503, DOI 10.1053/ajkd.2002.31400; Iijima K, 2002, KIDNEY INT, V61, P1801, DOI 10.1046/j.1523-1755.2002.00303.x; Hamasaki Y, 2009, PEDIATR NEPHROL, V24, P2177, DOI 10.1007/s00467-009-1264-0; Waldman M, 2007, CLIN J AM SOC NEPHRO, V2, P445, DOI 10.2215/CJN.03531006; Ferrante M, 2009, INFLAMM BOWEL DIS, V15, P1062, DOI 10.1002/ibd.20863; Cattran DC, 2007, KIDNEY INT, V72, P1429, DOI 10.1038/sj.ki.5002553; Colquitt JL, 2007, HEALTH TECHNOL ASSES, V11, P1; DeOreo PB, 1997, AM J KIDNEY DIS, V30, P204, DOI 10.1016/S0272-6386(97)90053-6; Eguchi A, 2010, NEPHROL DIAL TRANSPL, V25, P124, DOI 10.1093/ndt/gfp422; Fukudome K, 2012, NEPHROLOGY, V17, P263, DOI 10.1111/j.1440-1797.2011.01544.x; IMBASCIATI E, 1985, BRIT MED J, V291, P1305; Kengne-Wafo S, 2009, CLIN J AM SOC NEPHRO, V4, P1409, DOI 10.2215/CJN.01520209; Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, 2009, AM J TRANSPLANT S3, V9, pS1; Matsumoto H, 2004, INTERNAL MED, V43, P668, DOI 10.2169/internalmedicine.43.668; Matsuo S, 2011, JPN J NEPHROL, V53, P136; MEYRIER A, 1994, KIDNEY INT, V45, P1446, DOI 10.1038/ki.1994.189; Mori D, 2012, JPN J NEPHROL, V54, P1023; Summey BT, 2006, ARCH DERMATOL, V142, P82, DOI 10.1001/archderm.142.1.82; Takei Takashi, 2007, Clin Exp Nephrol, V11, P214, DOI 10.1007/s10157-007-0484-5; TEJANI A, 1991, NEPHRON, V59, P96, DOI 10.1159/000186526; Tse KC, 2003, NEPHROL DIAL TRANSPL, V18, P1316, DOI 10.1093/ndt/gfg134; Yorgin PD, 2001, PEDIATR NEPHROL, V16, P245	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					240	246		10.1007/s10157-014-0975-0		7	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900010		
J	Hoshino, T; Ookawara, S; Miyazawa, H; Ito, K; Ueda, Y; Kaku, Y; Hirai, K; Mori, H; Yoshida, I; Tabei, K				Hoshino, Taro; Ookawara, Susumu; Miyazawa, Haruhisa; Ito, Kiyonori; Ueda, Yuichiro; Kaku, Yoshio; Hirai, Keiji; Mori, Honami; Yoshida, Izumi; Tabei, Kaoru			Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Type 2 diabetic kidney disease; Thiazides; Loop diuretics; Proteinuria; Hypertension; Chronic kidney disease	CHRONIC-RENAL-FAILURE; HYDROCHLOROTHIAZIDE; NEPHROPATHY; PROGRESSION; HYPERTENSION; PHARMACOKINETICS; ASSOCIATION; FUROSEMIDE; LOSARTAN; TRIAL	Type 2 diabetic kidney disease (DKD) is frequently accompanied by uncontrollable hypertension due to the sodium sensitivity inherent in DKD and to diuretic-resistant edema. In general, diuretics are effective in treating this condition, but thiazide diuretics are thought to be innocuous in advanced chronic kidney disease (CKD). We examined the renoprotective effects of combination therapy with thiazides and loop diuretics in type 2 DKD patients with CKD stage G4 or G5. This study included 11 patients with type 2 DKD and an estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m(2) who were suffering from severe edema even with loop diuretics. Each patient received additional hydrochlorothiazide (HCTZ) therapy, which was continued for more than 12 months. We examined clinical parameters including blood pressure (BP), proteinuria, and eGFR before and after the addition of HCTZ. Patients received a 13.6 +/- A 3.8 mg/day dose of HCTZ in addition to loop diuretics (azosemide: 120 mg/day in 6 cases, 60 mg/day in 3 cases and furosemide: 80 mg/day in 1 case, 120 mg/day in 1 case). Side effects of HCTZ were not observed in all patients. After the addition of HCTZ therapy, systolic and diastolic blood pressures (S-BP, D-BP) as well as proteinuria significantly decreased (S-BP: at 6 months, p < 0.05 and 12 months, p < 0.01 vs. 0 month, D-BP: at 12 months, p < 0.05 vs. 0 month, proteinuria: at 6 months, p < 0.05 and 12 months, p < 0.01 vs. 0 month). The annual decline in eGFR was not significantly different before and after HCTZ therapy (-7.7 +/- A 8.5 and -8.4 +/- A 4.8 mL/min/1.73 m(2)/year, respectively). Our findings suggest that the combination of HCTZ and loop diuretics improves BP levels, and decreases proteinuria even in advanced stage type 2 DKD patients with severe edema. The addition of HCTZ therapy was not found to negatively affect the change in eGFR in the present study.	[Hoshino, Taro; Ookawara, Susumu; Miyazawa, Haruhisa; Ito, Kiyonori; Ueda, Yuichiro; Kaku, Yoshio; Hirai, Keiji; Mori, Honami; Yoshida, Izumi; Tabei, Kaoru] Jichi Med Univ, Dept Integrated Med 1, Div Nephrol, Saitama Med Ctr,Omiya Ku, Saitama 3308503, Japan	Ookawara, S (reprint author), Jichi Med Univ, Dept Integrated Med 1, Div Nephrol, Saitama Med Ctr,Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	ookawaras@jichi.ac.jp					Abe M, 2010, INT J CLIN PHARM TH, V48, P206; American Diabetes Association, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011; Unsal A, 2012, EUR REV MED PHARMACO, V16, P878; Hayashi K, 2007, CIRC RES, V100, P342, DOI 10.1161/01.RES.0000256155.31133.49; Altemtam N, 2012, NEPHROL DIAL TRANSPL, V27, P1847, DOI 10.1093/ndt/gfr561; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711; Dussol B, 2012, J CLIN HYPERTENS, V14, P32, DOI 10.1111/j.1751-7176.2011.00564.x; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Kobori H, 2013, CURR PHARM DESIGN, V19, P3033; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; REUBI FC, 1961, CIRCULATION, V23, P200; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; NIEMEYER C, 1983, EUR J CLIN PHARMACOL, V24, P661, DOI 10.1007/BF00542218; Arias SCA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056215; Cases A, 2005, KIDNEY INT, V68, P87; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Dussol B, 2005, NEPHROL DIAL TRANSPL, V20, P349, DOI 10.1093/ndt/gfh650; Fanelli C, 2011, AM J PHYSIOL-RENAL, V301, pF580, DOI 10.1152/ajprenal.00042.2011; Farbakhsh K, 2005, MED CLIN N AM, V89, P689, DOI 10.1016/j.mena.2004.11.002; Fliser D, 1996, NEPHROL DIAL TRANSPL, V11, P408; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF1810, DOI 10.1152/ajprenal.00521.2006; HAABER AB, 1992, DIABETIC MED, V9, P557; Japan Nephrology Society, 2012, NIHON JINZO GAKKAI S, V54, P1034; O'Grady P, 1999, BRIT J CLIN PHARMACO, V48, P375, DOI 10.1046/j.1365-2125.1999.00013.x; SUCKLING RJ, 2010, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					247	253		10.1007/s10157-014-0981-2		7	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900011		
J	Tsutsui, H; Ojima, T; Ozaki, N; Kusunoki, M; Ishiguro, T; Oshida, Y				Tsutsui, Hideyo; Ojima, Toshiyuki; Ozaki, Nobuaki; Kusunoki, Masataka; Ishiguro, Tetsuya; Oshida, Yoshiharu			Validation of the Comprehensive International Classification of Functioning, Disability and Health (ICF) Core Set for Diabetes Mellitus in patients with diabetic nephropathy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						ICF core set for diabetes mellitus; Diabetic nephropathy; Hemodialysis; Validity evaluation	QUALITY-OF-LIFE; HEMODIALYSIS-PATIENTS; KIDNEY-DISEASE; PAIN	Diabetic nephropathy (DMN) is the most common cause of end-stage renal disease. Progression of DMN leads to impairment of physical activity, restriction of daily activities, and diminished social participation. Therefore, the precise assessment of the physical and psychosocial problems of DMN patients is important. The objective of this study was to validate the Comprehensive International Classification of Functioning, Disability and Health Core Set for Diabetes Mellitus (ICF-CS for DM) from the perspective of DMN patients. A total of 176 DMN outpatients were interviewed using the ICF-CS for DM. Content and construct validity were evaluated. Patients were divided into 2 groups: DMN patients without hemodialysis (HD) (non-HD group) and DMN patients undergoing HD (HD group). Content validity was evaluated based on the frequency of patients who had a problem in each category. For construct validity, the patients were divided into two groups based on DM duration and hemoglobin A1C levels. Content validity evaluation revealed 58 categories reported as problem categories: 39 categories in the non-HD group and 50 categories in the HD group. Construct validity evaluation showed that longer DM duration and poor glycemic control contributes to increased problems. Content and construct validity of the ICF-CS for DM was supported from the DMN patients' perspective. Some categories of the "Environmental factors" component need further studies to be appropriate.	[Tsutsui, Hideyo] Teikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Itabashi Ku, Tokyo 1738605, Japan; [Tsutsui, Hideyo; Ozaki, Nobuaki; Kusunoki, Masataka; Ishiguro, Tetsuya; Oshida, Yoshiharu] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ojima, Toshiyuki] Hamamatsu Univ Sch Med, Dept Community Hlth & Prevent Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kusunoki, Masataka] Aichi Med Univ, Med Clin, Higashi Ku, Nagoya, Aichi 4610005, Japan	Tsutsui, H (reprint author), Teikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	htsutsui@med.teikyo-u.ac.jp			Kidney Foundation, Japan [JKF10-5]; Aichi Kidney Foundation	This study was supported by a grant from the Kidney Foundation, Japan (JKF10-5), and a research grant from the Aichi Kidney Foundation. The authors thank the staff members of the following organizations for their clinical support: Ishiguro Internal Medical Clinic, Akishima Clinic, Tawada Hospital, Tawada Clinic, and Sakashita Clinic.	Afsar B, 2009, J RENAL NUTR, V19, P365, DOI 10.1053/j.jrn.2009.01.016; Akinci A, 2008, DIABETES RES CLIN PR, V79, P117; American Diabetes Association, 2009, DIABETES CARE S1, V32, pS13, DOI DOI 10.2337/DC09-S013; Mirrakhimov AE, 2012, SLEEP BREATH, V16, P1009, DOI 10.1007/s11325-011-0624-8; [Anonymous], 2004, J REHABIL MED S; Goreshi R, 2011, J AM ACAD DERMATOL, V65, P1107, DOI 10.1016/j.jaad.2010.10.016; Muehrer RJ, 2011, CLIN J AM SOC NEPHRO, V6, P489, DOI 10.2215/CJN.02550310; Min TZ, 2012, BRIT MED BULL, V104, P113, DOI 10.1093/bmb/lds030; Amatya B, 2008, J DERMATOL, V35, P140, DOI 10.1111/j.1346-8138.2008.00433.x; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Tsutsui H, 2009, THER APHER DIAL, V13, P186, DOI 10.1111/j.1744-9987.2009.00683.x; Van Buren PN, 2013, MED CLIN N AM, V97, P31, DOI 10.1016/j.mcna.2012.10.003; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; [Anonymous], 2001, J JPN DIABETES SOC, V44, P623; Covic A, 2004, NEPHROL DIAL TRANSPL, V19, P2078, DOI 10.1093/ndt.gfh254; Baden Megu Yamaguchi, 2011, Journal of the Japan Diabetes Society, V54, P493; Cieza Alarcos, 2006, BMC Med Res Methodol, V6, P36, DOI 10.1186/1471-2288-6-36; Macdonald JH, 2012, AM J KIDNEY DIS, V60, P930, DOI 10.1053/j.ajkd.2012.06.021; Nakahara R, 2006, PSYCHOSOMATICS, V47, P240, DOI 10.1176/appi.psy.47.3.240; Schwegler U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1088; Soman Manoj, 2013, Clin Ophthalmol, V7, P113; van Steenbergen-Weijenburg KM, 2011, DIABETIC MED, V28, P86, DOI 10.1111/j.1464-5491.2010.03125.x; VIBERTI GC, 1982, LANCET, V1, P1430; World Health Organization, 2001, INT CLASS FUNCT DIS	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					254	263		10.1007/s10157-014-0983-0		10	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900012		
J	Ueno, K; Shimizu, M; Yokoyama, T; Ishikawa, S; Tasaki, Y; Inoue, N; Sugimoto, N; Ohta, K; Yachie, A				Ueno, Kazuyuki; Shimizu, Masaki; Yokoyama, Tadafumi; Ishikawa, Sayaka; Tasaki, Yuko; Inoue, Natsumi; Sugimoto, Naotoshi; Ohta, Kazuhide; Yachie, Akihiro			Urinary neopterin: an immune activation marker in mesangial proliferative glomerulonephritis	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Neopterin; IgA nephropathy; Henoch-Schonlein purpura nephritis; Cell-mediated immunity; Urinary biomarker	CLINICAL-SIGNIFICANCE; INTERFERON-GAMMA; CELLS; SERUM; MACROPHAGE; RELEASE; INJURY	To clarify in vivo neopterin expression within the human kidney and its clinical role as a biomarker for immune complex-mediated mesangial proliferative glomerulonephritis (mesPGN) in children. We examined neopterin expression within the kidneys of 14 patients with mesPGN and five patients with minimal changes. We also measured the serum and urinary neopterin levels in fourteen patients with mesPGN and sixteen age-matched healthy controls and correlated the histological findings and clinical features. Neopterin expression was observed within the distal tubular epithelial cells. It was induced within the glomerular endothelial cells and infiltrated CD68-positive macrophages in the glomeruli and interstitial areas. Furthermore, urinary neopterin levels were significantly elevated and positively correlated with histopathological findings and the degree of proteinuria. These findings indicate that increased urinary neopterin may reflect macrophage activation and active inflammation within the kidney in immune complex-mediated glomerulonephritis. Neopterin may thus represent a useful biomarker of immune complex-mediated glomerulonephritis in the clinical setting.	[Ueno, Kazuyuki; Shimizu, Masaki; Yokoyama, Tadafumi; Ishikawa, Sayaka; Tasaki, Yuko; Inoue, Natsumi; Sugimoto, Naotoshi; Yachie, Akihiro] Kanazawa Univ, Sch Med, Dept Pediat, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208641, Japan; [Ohta, Kazuhide] Kanazawa Med Ctr, Dept Pediat, Kanazawa, Ishikawa, Japan	Shimizu, M (reprint author), Kanazawa Univ, Sch Med, Dept Pediat, Inst Med Pharmaceut & Hlth Sci, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	shimizum@staff.kanazawa-u.ac.jp					ANDERT SE, 1992, CLIN EXP IMMUNOL, V88, P555; ANDREOLI SP, 1986, AM J NEPHROL, V6, P28, DOI 10.1159/000167049; MOUTABARRIK A, 1994, SCAND J IMMUNOL, V39, P27, DOI 10.1111/j.1365-3083.1994.tb03335.x; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Lhee HY, 2006, J KOREAN MED SCI, V21, P678; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Coppo R, 2009, PEDIAT NEPHROLOGY, P1111, DOI 10.1007/978-3-540-76341-3_46; Erwig LP, 2003, NEPHROL DIAL TRANSPL, V18, P1962, DOI 10.1093/ndt/gfg313; GODAI K, 1991, CLIN NEPHROL, V36, P141; HOLDSWORTH SR, 1981, J CLIN INVEST, V68, P686, DOI 10.1172/JCI110304; Ikezumi Y, 2003, KIDNEY INT, V63, P83, DOI 10.1046/j.1523-1755.2003.00717.x; Lange-Sperandio B, 2003, PEDIATR NEPHROL, V18, P335, DOI 10.1007/s00467-003-1116-2; LEOHIRUN L, 1991, CLIN CHEM, V37, P47; Nagata M, 2009, PEDIAT NEPHROLOGY, P703, DOI 10.1007/978-3-540-76341-3_29; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; NATHAN CF, 1980, NEW ENGL J MED, V303, P622, DOI 10.1056/NEJM198009113031106; Oda K, 1999, AM J KIDNEY DIS, V34, P611, DOI 10.1016/S0272-6386(99)70383-5; Pluss C, 1996, BIOCHEM J, V318, P665; SHINTAKU H, 1982, J INHERIT METAB DIS, V5, P241, DOI 10.1007/BF02179155; STRIKER GE, 1979, J EXP MED, V149, P127, DOI 10.1084/jem.149.1.127	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					264	270		10.1007/s10157-014-0984-z		7	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900013		
J	Yamamoto, H; Hashimoto, H; Nakamura, M; Horiguchi, H; Yasunaga, H				Yamamoto, Hiroyuki; Hashimoto, Hideki; Nakamura, Mitsuhiro; Horiguchi, Hiromasa; Yasunaga, Hideo			Relationship between hospital volume and hemorrhagic complication after percutaneous renal biopsy: results from the Japanese diagnosis procedure combination database	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Hemorrhagic complications; Hospital volume; Renal biopsy; Risk factor; Volume-outcome relationship	NATIVE KIDNEY BIOPSY; POSTOPERATIVE COMPLICATIONS; BLEEDING COMPLICATIONS; MORTALITY; SURGERY; OUTCOMES; SAFETY	Although hemorrhagic complications are major complications of percutaneous renal biopsy (PRB), the relationship between procedure volume and morbidity remains unclear for PRB. The present study investigated the impact of hospital volume on the occurrence of hemorrhagic complications after PRB. Using large claims-based data in the diagnosis procedure combination database in Japan, we identified inpatients with renal disorders who underwent PRB within 4 days after admission during July to December 2007 to 2010. We assessed patient age, sex, clinical syndromes, hemorrhagic complications and diagnoses, and annual hospital volume of PRB divided into quintiles. Multivariate logistic regression analyses fitted with a generalized estimation equation were performed accounting for within-hospital clustering. A total of 15,191 patients were identified from 942 hospitals. The overall proportion of hemorrhagic complications was 2.1 %, including diagnoses of hemorrhagic events (1.6 %), red blood cell transfusion (0.5 %), and requiring angiography or endovascular procedure (0.1 %). In-hospital deaths attributable to the complications occurred in 0.06 % of the patients. Patients with rapidly progressive nephritic syndrome (odds ratio 3.41, 95 % confidence interval 2.22-5.25) had significantly higher incidence than those with chronic nephritic syndrome. No significant association was observed between hospital volume and hemorrhagic complications, with odds ratios for the low-intermediate, intermediate, intermediate-high, and high-volume groups relative to the low-volume group of 0.74 (0.43-1.26), 1.19 (0.74-1.92), 1.16 (0.67-2.00), and 1.35 (0.78-2.34), respectively. No significant relationship was observed between hemorrhagic complication incidence and hospital volume regarding PRB.	[Yamamoto, Hiroyuki; Hashimoto, Hideki] Univ Tokyo, Dept Hlth & Social Behav, Sch Publ Hlth, Tokyo 1130033, Japan; [Nakamura, Mitsuhiro] Univ Tokyo, Dept Mental Hlth, Grad Sch Med, Tokyo 1130033, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Dept Clin Data Management & Res, Clin Res Ctr, Tokyo, Japan; [Yasunaga, Hideo] Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Bunkyo Ku, Tokyo 1130033, Japan	Yasunaga, H (reprint author), Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasunagah-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H22-Policy-031, H22-Policy-033]; Ministry of Education, Culture, Sports, Science and Technology, Japan [22390131]; Council for Science and Technology Policy, Japan [0301002001001]	This work was accepted as a poster presentation at Kidney Week 2013, Annual Meeting of the American Society of Nephrology, November 5-10, 2013, Atlanta, GA. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare, Japan (H22-Policy-031 and, in part, H22-Policy-033); by a Grant-in-Aid for Scientific Research B (No. 22390131) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from the Council for Science and Technology Policy, Japan (No. 0301002001001).	Alsfasser G, 2012, SURGERY, V152, pS50, DOI 10.1016/j.surg.2012.05.011; ALWALL N, 1952, ACTA MED SCAND, V143, P430; Corapi KM, 2012, AM J KIDNEY DIS, V60, P62, DOI 10.1053/j.ajkd.2012.02.330; PARRISH AE, 1992, CLIN NEPHROL, V38, P135; Panageas KS, 2007, STAT MED, V26, P2017, DOI 10.1002/sim.2657; Shidham GB, 2005, NEPHROLOGY, V10, P305, DOI 10.1111/j.1440-1797.2005.00394.x; Whittier WL, 2004, J AM SOC NEPHROL, V15, P142, DOI 10.1097/01.ASN.0000102472.37947.14; Manno C, 2004, KIDNEY INT, V66, P1570, DOI 10.1111/j.1523-1755.2004.00922.x; Khajehdehi P, 1999, AM J KIDNEY DIS, V34, P92, DOI 10.1016/S0272-6386(99)70113-7; Tondel C, 2012, CLIN J AM SOC NEPHRO, V7, P1591, DOI 10.2215/CJN.02150212; Sugiyama H, 2011, CLIN EXP NEPHROL, V15, P493, DOI 10.1007/s10157-011-0430-4; Marwah DS, 1996, AM J KIDNEY DIS, V28, P47, DOI 10.1016/S0272-6386(96)90129-8; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Sugihara T, 2011, J UROLOGY, V185, P2248, DOI 10.1016/j.juro.2011.01.080; IVERSEN P, 1951, AM J MED, V11, P324, DOI 10.1016/0002-9343(51)90169-6; Barocas DA, 2010, UROL ONCOL-SEMIN ORI, V28, P243, DOI 10.1016/j.urolonc.2009.03.001; Fish R, 2010, CLIN J AM SOC NEPHRO, V5, P1977, DOI 10.2215/CJN.00650110; Hirakata Hideki, 2005, Nihon Jinzo Gakkai Shi, V47, P73; Hirakata Hideki, 2003, Nihon Jinzo Gakkai Shi, V45, P731; MADAIO MP, 1990, KIDNEY INT, V38, P529, DOI 10.1038/ki.1990.236; MENDELSSOHN DC, 1995, AM J KIDNEY DIS, V26, P580, DOI 10.1016/0272-6386(95)90592-8; Miyata H, 2009, EUR J CARDIO-THORAC, V36, P517, DOI 10.1016/j.ejcts.2009.03.020; Stratta P, 2007, EUR J CLIN INVEST, V37, P954, DOI 10.1111/j.1365-2362.2007.01885.x; Yasunaga H, 2012, HEPATOL RES, V42, P1073, DOI 10.1111/j.1872-034X.2012.01022.x; Yasunaga H, 2009, J ORTHOP SCI, V14, P3, DOI 10.1007/s00776-008-1289-4; Yasunaga H, 2009, SURG TODAY, V39, P955, DOI 10.1007/s00595-008-4052-8; Yasunaga H, 2010, UROLOGY, V76, P548, DOI 10.1016/j.urology.2010.03.021; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					271	277		10.1007/s10157-014-0986-x		7	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900014		
J	Kitajima, S; Furuichi, K; Sakai, N; Sagara, A; Shinozaki, Y; Toyama, T; Iwata, Y; Shimizu, M; Yokoyama, H; Kaneko, S; Wada, T				Kitajima, Shinji; Furuichi, Kengo; Sakai, Norihiko; Sagara, Akihiro; Shinozaki, Yasuyuki; Toyama, Tadashi; Iwata, Yasunori; Shimizu, Miho; Yokoyama, Hitoshi; Kaneko, Shuichi; Wada, Takashi			Relapse and its remission in Japanese patients with idiopathic membranous nephropathy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						MN; Relapse; Remission; Electron-dense deposit	LONG-TERM PROGNOSIS; GLOMERULONEPHRITIS; OUTCOMES; CYCLOPHOSPHAMIDE; THERAPY	The prognosis in patients with idiopathic membranous nephropathy (IMN) is diverse. However, the prognosis after relapse and factors affecting relapse remain unclear. A total of 146 Japanese patients with IMN who had been followed up for at least 3 years, or until end-stage renal failure or death were enrolled in this retrospective study. The initial clinicopathological factors were examined between the patients with and without relapse. The patients were assigned to two groups based on the electron microscopic findings: homogeneous type with synchronous electron-dense deposits and heterogeneous type with various phases of dense deposits. A total of 105 of the 146 patients (72 %) achieved complete remission (CR) or incomplete remission (ICR) I after initial treatment. Twenty-six of the 105 patients relapsed after CR or ICR I (25 %). There were no differences in initial clinical findings or data between the patients with and without relapse, except for the higher degree of proteinuria at onset in patients with relapse. The relapse rate of the heterogeneous group (43 %) was higher than that in the homogeneous group (20 %). There were no significant associations between relapse rate and immunosuppressive therapy at onset. Eleven of 26 patients showing relapse (42 %) achieved CR or ICR I, which was lower than the rate for patients with initial remission. Our results suggest that patients with relapse achieved CR or ICR I and that electron microscopic findings demonstrating heterogeneous type indicated susceptibility to relapse.	[Kitajima, Shinji; Furuichi, Kengo; Sakai, Norihiko; Sagara, Akihiro; Shinozaki, Yasuyuki; Toyama, Tadashi; Iwata, Yasunori; Shimizu, Miho; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Yokoyama, Hitoshi] Kanazawa Med Univ, Sch Med, Div Nephrol, Kanazawa, Ishikawa, Japan; [Kaneko, Shuichi] Kanazawa Univ, Dept Dis Control & Homeostasis, Fac Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208641, Japan; [Wada, Takashi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Med, Dept Lab Med, Kanazawa, Ishikawa 9208641, Japan	Wada, T (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Med, Dept Lab Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	twada@m-kanazawa.jp			Ministry of Health, Labour and Welfare of Japan	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan.	Yokoyama H, 1999, NEPHROL DIAL TRANSPL, V14, P2379, DOI 10.1093/ndt/14.10.2379; PONTICELLI C, 1992, NEPHROL DIAL TRANSPL, V7, P85; Yoshimoto K, 2004, KIDNEY INT, V65, P148, DOI 10.1111/j.1523-1755.2004.00403.x; EHRENREICH T, 1976, NEW ENGL J MED, V295, P741, DOI 10.1056/NEJM197609302951401; OGI M, 1994, AM J KIDNEY DIS, V24, P427; NOEL LH, 1979, AM J MED, V66, P82, DOI 10.1016/0002-9343(79)90486-8; Bohdan J, 1999, AM J KIDNEY DIS, V33, P1026; CAMERON JS, 1992, NEW ENGL J MED, V327, P638, DOI 10.1056/NEJM199208273270911; Ehrenreich T, 1968, PATHOL ANNU, V3, P145; Eriguchi M, 2009, NEPHROL DIAL TRANSPL, V24, P3082, DOI 10.1093/ndt/gfp251; KIDA H, 1986, CLIN NEPHROL, V25, P64; MANOS J, 1982, CLIN NEPHROL, V18, P286; Marx BE, 1997, KIDNEY INT, V51, P873, DOI 10.1038/ki.1997.123; Marx BE, 1999, KIDNEY INT, V56, P666, DOI 10.1046/j.1523-1755.1999.00598.x; Reichert LJM, 2001, AM J KIDNEY DIS, V31, P1; Rosen S, 1989, RENAL PATHOLOGY CLIN, P196; TORNROTH T, 1987, CLIN NEPHROL, V28, P107; Wadi N, 2001, AM J NEPHROL, V31, P1; WAKAI S, 1992, KIDNEY INT, V41, P428, DOI 10.1038/ki.1992.59; Wu Q, 2001, AM J KIDNEY DIS, V37, P380, DOI 10.1053/ajkd.2001.21319; Yuan JZ, 2011, NEPHROLOGY, V16, P440, DOI 10.1111/j.1440-1797.2010.01427.x	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					278	283		10.1007/s10157-014-0987-9		6	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900015		
J	Horio, M; Imai, E; Yasuda, Y; Watanabe, T; Yokoyama, H; Makino, H; Matsuo, S				Horio, Masaru; Imai, Enyu; Yasuda, Yoshinari; Watanabe, Tsuyoshi; Yokoyama, Hitoshi; Makino, Hirofumi; Matsuo, Seiichi			Serum albumin, but not glycated albumin was a potent factor affecting the performance of GFR equation based on serum creatinine	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						GFR equation; Creatinine; Glycated albumin; Albumin; Diabetes	GLOMERULAR-FILTRATION-RATE; DIABETIC-PATIENTS; SKELETAL-MUSCLE	Recently, Tsuda et al. reported that high HbA1C or high glycated albumin (GA) level is a major factor in overestimation of GFR by Japanese GFR equation based on serum creatinine (Eq-cr). They developed a modified equation of Eq-cr (M-Eq-cr) using GA or HbA1c. Therefore, effect of GA levels on the estimated GFR (eGFR) by Eq-cr was evaluated in Japanese subjects. We validated the accuracy of the modified equation using GA by Tsuda et al. (M-Eq-cr) and new equations that we developed in the present study. Seven hundred and fifteen Japanese subjects were included. GFR was measured by inulin renal clearance (Cin). The subjects were divided into two groups by upper limit of the GA reference range (GA-1: GA < 16.3 % and GA-2: GA > 16.4 %). Factors affecting the ratio of eGFR to Cin (eGFR/Cin) were evaluated using multivariate analysis. New equations based on creatinine and albumin (Eq-cr-alb) and based on creatinine, albumin and GA were developed from development dataset (382 subjects). Performances of the equations were validated in validation dataset (333 subjects). Correlation coefficients between eGFR by Eq-cr and Cin were 0.839 and 0.914 in GA-1 and GA-2, respectively. Slopes (95 % confidential interval) of the regression lines with zero intercepts were 1.013 (0.991 to 1.036) and 0.997 (0.951 to 1.043), respectively. Both slopes were not significantly different from 1.0. Biases were -2.3 +/- A 19.0 and 0.2 +/- A 11.7 ml/min/1.73 m(2), respectively. Accuracy (p30; percentage of subjects within 30 % of Cin) (95 % CI) were 78 % (75, 81) and 71 % (62, 78), respectively. There was no significant difference in bias and accuracy between the two groups, indicating a reasonable accuracy of Eq-cr in GA-1 and GA-2. Multiple regression analysis showed that lower serum albumin and higher GA were associated with higher eGFR/Cin. Albumin was a more potent factor affecting eGFR/Cin than GA. M-Eq-cr significantly underestimated GFR and had significantly larger bias compared with Eq-cr in subjects with GA > 20 %, suggesting that the modification of Eq-cr using GA by Tsuda et al. was too much compensation in our subjects. Precisions of Eq-cr-alb were significantly better compared with Eq-cr. Eq-cr has a reasonable accuracy in GA-1 and GA-2. Lower serum albumin and higher GA were significantly associated with higher eGFR/Cin. The former was a more potent factor affecting eGFR/Cin. Eq-cr-alb showed better performance compared with Eq-cr. M-Eq-cr using GA showed too much compensation and did not improve the accuracy of the equation in our subjects.	[Horio, Masaru] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka 5650871, Japan; [Imai, Enyu] Nakayamadera Imai Clin, Takarazuka, Hyogo, Japan; [Yasuda, Yoshinari] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Yasuda, Yoshinari; Matsuo, Seiichi] Nagoya Univ, Dept CKD Initiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Watanabe, Tsuyoshi] Fukushima Med Univ, Dept Med 3, Fukushima, Japan; [Yokoyama, Hitoshi] Kanazawa Med Univ, Sch Med, Div Nephrol, Uchinada, Ishikawa 92002, Japan; [Makino, Hirofumi] Okayama Univ, Grad Sch Med, Dept Med & Clin Sci, Okayama 7008530, Japan	Horio, M (reprint author), Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka 5650871, Japan.	horio@sahs.med.osaka-u.ac.jp			Japanese Society of Nephrology; JSPS KAKENHI, Japan [25305029]	This study was supported in part by the grant from the Japanese Society of Nephrology and JSPS KAKENHI Grant Number 25305029, Japan.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Baumgartner RN, 1996, AM J CLIN NUTR, V64, P552; Okada T, 2011, INTERNAL MED, V50, P23, DOI 10.2169/internalmedicine.50.4129; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; Tsuda A, 2014, DIABETES CARE, V37, P596, DOI 10.2337/dc13-1899; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Branten AJW, 2005, NEPHROL DIAL TRANSPL, V20, P707, DOI 10.1093/ndt/gfh719; Tajiri Y, 2010, METAB SYNDR RELAT D, V8, P137, DOI 10.1089/met.2009.0043; Levey AS, 1999, ANN INTERN MED, V130, P461; Horio M, 2014, CLIN EXP NEPHROL, V18, P469, DOI 10.1007/s10157-013-0841-5; Sarhill Nabeel, 2003, Am J Hosp Palliat Care, V20, P465, DOI 10.1177/104990910302000610; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Takei I, 2003, LAB CLIN PRACT, V21, P4; Walser M, 1998, AM J KIDNEY DIS, V32, P23, DOI 10.1053/ajkd.1998.v32.pm9669420	15	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					284	292		10.1007/s10157-014-0988-8		9	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900016		
J	Suzue, M; Urushihara, M; Nakagawa, R; Saijo, T; Kagami, S				Suzue, Masashi; Urushihara, Maki; Nakagawa, Ryuji; Saijo, Takahiko; Kagami, Shoji			Urinary angiotensinogen level is increased in preterm neonates	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Renin-angiotensin system; Neonates; Renal development; Gestational age; Preterm	RENIN; SYSTEM; HYPERTENSION; INHIBITOR; ONTOGENY	All components of the renin-angiotensin system (RAS) are abundantly synthesized in the developing kidney, suggesting that the RAS plays an important role in renal development. To examine this system in human neonates, we measured urinary angiotensinogen levels in preterm and full-term neonates and examined the relationship between urinary angiotensinogen levels and gestational age. Urine and plasma samples were collected from 20 preterm and 18 full-term neonates at birth. Angiotensinogen levels were measured using enzyme-linked immunosorbent assay. Plasma angiotensinogen concentrations were not increased in preterm neonates compared with that in full-term neonates (P = 0.7288). However, the urinary angiotensinogen-to-creatinine ratio was significantly higher in preterm neonates compared with that in full-term neonates (P = 0.0011). Importantly, the urinary angiotensinogen-to-creatinine ratio dropped significantly with increasing gestational age (P = 0.0010), whereas the plasma angiotensinogen concentration was not correlated with gestational age (P = 0.7814). These results suggest that urinary angiotensinogen levels may indicate the involvement of intrarenal RAS activation in prenatal renal development.	[Suzue, Masashi; Urushihara, Maki; Nakagawa, Ryuji; Saijo, Takahiko; Kagami, Shoji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pediat, Tokushima 7708503, Japan	Urushihara, M (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pediat, Kuramoto Cho 3-18-15, Tokushima 7708503, Japan.	urushihara@tokushima-u.ac.jp			JSPS KAKENHI [23591569, 23591570]	The authors acknowledge excellent technical assistance from Mrs. Naomi Okamoto. This study was supported by JSPS KAKENHI Grant Numbers 23591569 and 23591570.	Zoja C, 2002, KIDNEY INT, V61, P1635, DOI 10.1046/j.1523-1755.2002.00332.x; Rohrwasser A, 1999, HYPERTENSION, V34, P1265; Lantelme P, 2002, HYPERTENSION, V39, P1007, DOI 10.1161/01.HYP.0000016177.20565.A0; Nakano D, 2012, J AM SOC NEPHROL, V23, P1847, DOI 10.1681/ASN.2012010078; PRYDE PG, 1993, J AM SOC NEPHROL, V3, P1575; Mahieu-Caputo D, 2000, AM J PATHOL, V156, P629, DOI 10.1016/S0002-9440(10)64767-0; Gubler MC, 2010, KIDNEY INT, V77, P400, DOI 10.1038/ki.2009.423; Schutz S, 1996, AM J PATHOL, V149, P2067; Navar LG, 2002, HYPERTENSION, V39, P316, DOI 10.1161/hy0202.103821; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Saito T, 2009, AM J MED SCI, V338, P478, DOI 10.1097/MAJ.0b013e3181b90c25; Urushihara M, 2010, AM J NEPHROL, V31, P318, DOI 10.1159/000286037; GOMEZ RA, 1984, CIRC RES, V54, P301; Kobori H, 2013, PFLUG ARCH EUR J PHY, V465, P3, DOI 10.1007/s00424-012-1143-6; Madsen K, 2013, ACTA PHYSIOL, V208, P41, DOI 10.1111/apha.12088; Martinovic J, 2001, LANCET, V358, P241, DOI 10.1016/S0140-6736(01)05426-5; Navar LG, 1999, J AM SOC NEPHROL, V10, pS266; PELAYO JC, 1981, CLIN PERINATOL, V8, P347; TUFROMCREDDIE A, 1993, SEMIN NEPHROL, V13, P519; Urushihara M, 2011, INT J CLIN MED, V2, P378, DOI DOI 10.4236/IJCM.2011.24064); Urushihara M, 2011, INT J NEPHROL, V2011	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					293	297		10.1007/s10157-014-0977-y		5	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900017		
J	Inoue, N; Watanabe, H; Okamura, K; Kondo, S; Kagami, S				Inoue, Nami; Watanabe, Hiroyoshi; Okamura, Kazumi; Kondo, Shuji; Kagami, Shoji			Are the equations for the creatinine-based estimated glomerular filtration rate applicable to the evaluation of renal function in Japanese children and adult patients receiving chemotherapy?	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Estimated glomerular filtration rate; Creatinine; Cancer; Chemotherapy	CYSTATIN-C; SERUM CREATININE; CANCER-PATIENTS; MALIGNANCY	Equations for the creatinine-based estimated glomerular filtration rate (eGFR) were recently established for Japanese adults (> 18 years old) and children (2-11 years old), respectively, but it is unclear whether eGFR can be as useful as 24-h creatinine clearance (CCr) for assessing renal function in patients receiving chemotherapy. This study examined the degree of concordance between eGFR and CCr and the risk factors leading to the overestimation of renal function by eGFR. A total of 53 data points of 19 children and 56 data points of 16 adults who received chemotherapy were analyzed retrospectively. Body mass index, serum creatinine concentration, 24-h urinary creatinine excretion (UCr), and nephrectomy were considered as risk factors for overestimation by eGFR. In the pediatric part of the study, 7 data points from 3 patients who underwent nephrectomy were included. The eGFR in patients with bilateral kidneys overestimated renal function to a greater degree than in patients with a unilateral kidney. In 45.7 % of pediatric patients with bilateral kidneys and in 19.6 % of adult patients, eGFR overestimated renal function. The risk factor for overestimation was lower UCr in pediatric patients with bilateral kidneys and adult patients. Concordance between eGFR and CCr in pediatric patients with a unilateral kidney should be assessed separately from that in patients with bilateral kidneys. In restricting calculation of eGFR to pediatric patients with bilateral kidneys and adult patients without little muscle mass, eGFR may be useful regardless of whether patients are receiving chemotherapy.	[Inoue, Nami; Watanabe, Hiroyoshi; Okamura, Kazumi; Kondo, Shuji; Kagami, Shoji] Univ Tokushima, Grad Sch, Dept Pediat, Tokushima 7708503, Japan	Inoue, N (reprint author), Univ Tokushima, Grad Sch, Dept Pediat, Kuramoto Cho 3-18-15, Tokushima 7708503, Japan.	namii_7779@tokushima-u.ac.jp					Nakai K, 2008, CLIN EXP NEPHROL, V12, P132, DOI 10.1007/s10157-008-0043-8; Uemura O, 2011, CLIN EXP NEPHROL, V15, P694, DOI 10.1007/s10157-011-0452-y; Launay-Vacher V, 2007, CANCER, V110, P1376, DOI 10.1002/cncr.22904; Blum D, 2011, CRIT REV ONCOL HEMAT, V80, P114, DOI 10.1016/j.critrevonc.2010.10.004; Blufpand HN, 2011, PEDIATR BLOOD CANCER, V57, P262, DOI 10.1002/pbc.23119; Risch L, 2001, CLIN CHEM, V47, P2055; Barnum Douglas A., 2004, Studies in Avian Biology, P100; Hari P, 2007, PEDIATR NEPHROL, V22, P1757, DOI 10.1007/s00467-007-0535-x; Hartlev LB, 2012, EUR J NUCL MED MOL I, V39, P1478, DOI 10.1007/s00259-012-2158-0; Holweger K, 2005, J CANCER RES CLIN, V131, P559, DOI 10.1007/s00432-005-0679-7; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Kawasaki T, 1991, Nihon Koshu Eisei Zasshi, V38, P567; MORIYAMA M, 1987, J NUTR SCI VITAMINOL, V33, P185; Nagai T, 2013, CLIN EXP NEPHROL, V17, P877, DOI 10.1007/s10157-013-0799-3	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					298	308		10.1007/s10157-014-0976-z		11	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900018		
J	Tsujita, M; Inaguma, D; Goto, N; Yamamoto, T; Hiramitsu, T; Katayama, A; Takeda, A; Kobayashi, T; Morozumi, K; Uchida, K; Narumi, S; Watarai, Y; Tominaga, Y				Tsujita, Makoto; Inaguma, Daijo; Goto, Norihiko; Yamamoto, Takayuki; Hiramitsu, Takahisa; Katayama, Akio; Takeda, Asami; Kobayashi, Takaaki; Morozumi, Kunio; Uchida, Kazuharu; Narumi, Shunji; Watarai, Yoshihiko; Tominaga, Yoshihiro			Beneficial effects of preemptive kidney transplantation on calcium and phosphorus disorders in early post-transplant recipients	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Kidney transplant recipients; Preemptive kidney transplantation; Fibroblast growth factor 23; Intact parathyroid hormone	FGF-23 LEVELS; HYPOPHOSPHATEMIA; METABOLISM	Recently, preemptive kidney transplantation (PKT) has increased in Japan; however, the effects of PKT on calcium (Ca) and phosphorus (Pi) metabolism are poorly understood. Thirty-two consecutive patients were enrolled in this study at Nagoya Daini Red Cross Hospital. Fifteen patients were in the PKT group and 17 patients were in the non-PKT group. Parameters of Ca and Pi metabolism, including fibroblast growth factor (FGF) 23 and intact parathyroid hormone, were measured before transplantation and 1, 3, and 24 weeks after transplantation. FGF 23 decreased dramatically in both groups after transplantation; however, FGF 23 before transplantation and at 1 and 3 weeks after transplantation was significantly lower in the PKT group than in the non-PKT group (p < 0.05). Although iPTH levels were higher in the PKT group than in the non-PKT group before transplantation, these levels were lower in the PKT group at 24 weeks after transplantation (p < 0.05). Corrected Ca was lower at 24 weeks in the PKT group (p < 0.05), whereas Pi was lower in the non-PKT group at 1 and 3 weeks (p < 0.05), but not significantly different at 24 weeks. Multivariate linear regression analysis revealed that FGF 23 before transplantation was the strongest predictor of Ca and Pi disorders in early post-transplant recipients. This study suggests that PKT has beneficial effects on Ca and Pi metabolism and pre-transplant FGF 23 levels are a good marker of post-transplant Ca and Pi metabolism disorders.	[Tsujita, Makoto; Inaguma, Daijo; Goto, Norihiko; Yamamoto, Takayuki; Hiramitsu, Takahisa; Takeda, Asami; Morozumi, Kunio; Narumi, Shunji; Watarai, Yoshihiko; Tominaga, Yoshihiro] Nagoya Daini Red Cross Hosp, Dept Kidney Dis Ctr, Showa Ku, Nagoya, Aichi 4668650, Japan; [Katayama, Akio] Masuko Mem Hosp, Dept Transplant Surg, Nagakute, Aichi, Japan; [Kobayashi, Takaaki] Nagoya Univ, Sch Med, Dept Transplant Immunol, Nagoya, Aichi 466, Japan; [Uchida, Kazuharu] Aichi Med Univ, Dept Transplant Surg, Nagakute, Aichi 48011, Japan	Tsujita, M (reprint author), Nagoya Daini Red Cross Hosp, Dept Kidney Dis Ctr, Showa Ku, 2-9 Myoken Cho, Nagoya, Aichi 4668650, Japan.	tsujita4850@nagoya2.jrc.or.jp			Kidney Foundation, Japan [JKFB 12-62]	We sincerely thank all the staff of the Kidney Disease Center at Nagoya Daini Red Cross Hospital for their cooperation with this study. This work was partly supported by grants from The Kidney Foundation, Japan. (JKFB 12-62).	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Evenepoel P, 2004, NEPHROL DIAL TRANSPL, V19, P1281, DOI 10.1093/ndt/gfh128; Shigematsu T, 2004, AM J KIDNEY DIS, V44, P250, DOI 10.1053/j.ajkd.2004.04.029; Kazama JJ, 2005, KIDNEY INT, V67, P1120, DOI 10.1111/j.1523-1755.2005.00178.x; Trombetti A, 2011, EUR J ENDOCRINOL, V164, P839, DOI 10.1530/EJE-10-1150; Ghanekar H, 2006, CURR OPIN NEPHROL HY, V15, P97, DOI 10.1097/01.mnh.0000203187.49890.cc; Kawarazaki H, 2011, NEPHROL DIAL TRANSPL, V26, P2691, DOI 10.1093/ndt/gfq777; Evenepoel P, 2007, AM J TRANSPLANT, V7, P1193, DOI 10.1111/j.1600-6143.2007.01753.x; Bhan I, 2006, KIDNEY INT, V70, P1486, DOI 10.1038/sj.ki.5001788; Evenepoel P, 2009, CLIN J AM SOC NEPHRO, V4, P665, DOI 10.2215/CJN.03920808; Grams ME, 2011, J AM SOC NEPHROL, V22, P1615, DOI 10.1681/ASN.2011010023; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Sirilak S, 2012, CLIN J AM SOC NEPHRO, V7, P323, DOI 10.2215/CJN.06380611; Wetmore JB, 2011, J CLIN ENDOCR METAB, V96, pE57, DOI 10.1210/jc.2010-1277	14	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					319	324		10.1007/s10157-014-0967-0		6	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900020		
J	Ieiri, N; Osamu, H				Ieiri, Norio; Osamu, Hotta			Importance of the duration of nephropathy prior to tonsillectomy and steroid pulse therapy in IgA nephropathy patients	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Letter						IgA nephropathy; Duration of nephropathy; Tonsillectomy and steroid pulse therapy; Clinical remission; Lead time bias; Annual urinalysis screening system			[Ieiri, Norio; Osamu, Hotta] Hotta Osamu Clin, Wakabayashi Ku, Sendai, Miyagi 9840013, Japan	Ieiri, N (reprint author), Hotta Osamu Clin, Wakabayashi Ku, Rokuchounomeminamimachi 2-39, Sendai, Miyagi 9840013, Japan.	no-ieiri@pf6.so-net.ne.jp					Ieiri N, 2012, CLIN EXP NEPHROL, V16, P122, DOI 10.1007/s10157-011-0530-1; Geddes CC, 2003, NEPHROL DIAL TRANSPL, V18, P1541, DOI 10.1093/ndt.gfg207; Suzuki K, 2014, CLIN EXP NEPHROL, V18, P606, DOI 10.1007/s10157-013-0867-8	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					325	325		10.1007/s10157-014-1043-5		1	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900021		
J	Shimamura, Y; Sakurai, Y; Takizawa, H				Shimamura, Yoshinosuke; Sakurai, Yasuo; Takizawa, Hideki			Renal arteriovenous fistula	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Editorial Material						Flank bruit; Renal arteriovenous fistula; Angiographic embolization	MALFORMATIONS		[Shimamura, Yoshinosuke; Takizawa, Hideki] Teine Keijinkai Med Ctr, Dept Nephrol, Sapporo, Hokkaido, Japan; [Sakurai, Yasuo] Teine Keijinkai Med Ctr, Dept Intervent Radiol, Sapporo, Hokkaido, Japan	Shimamura, Y (reprint author), Teine Keijinkai Med Ctr, Dept Nephrol, Sapporo, Hokkaido, Japan.	yoshinosukeshimamura@gmail.com					Chimpiri A Rao, 2009, Semin Intervent Radiol, V26, P253, DOI 10.1055/s-0029-1225665; Cura M, 2010, ACTA RADIOL, V51, P144, DOI 10.3109/02841850903463646; Poh PG, 2013, ANN ACAD MED SINGAP, V42, P207	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	APR	2015	19	2					326	327		10.1007/s10157-014-1039-1		2	Urology & Nephrology	Urology & Nephrology	CF7EV	WOS:000352719900022		
J	Hashimoto, Y; Tanaka, M; Okada, H; Senmaru, T; Hamaguchi, M; Asano, M; Yamazaki, M; Oda, Y; Hasegawa, G; Toda, H; Nakamura, N; Fukui, M				Hashimoto, Yoshitaka; Tanaka, Muhei; Okada, Hiroshi; Senmaru, Takafumi; Hamaguchi, Masahide; Asano, Mai; Yamazaki, Masahiro; Oda, Yohei; Hasegawa, Goji; Toda, Hitoshi; Nakamura, Naoto; Fukui, Michiaki			Metabolically Healthy Obesity and Risk of Incident CKD	CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; RENAL-DISEASE; METAANALYSIS; ASSOCIATION; HYPERTENSION; OVERWEIGHT; PHENOTYPE	Background and objectives Metabolically healthy obesity (MHO) is a unique obesity phenotype that apparently protects people from the metabolic complications of obesity. The association between MHO phenotype and incident CKD is unclear. Thus, this study investigated the association between MHO phenotype and incident CKD. Design, setting, participants, & measurements A total of 3136 Japanese participants were enrolled in an 8-year follow-up cohort study in 2001. Metabolically healthy status was assessed by common clinical markers: BP, triglycerides, HDL cholesterol, and fasting plasma glucose concentrations. Body mass index >= 25.0 kg/m(2) was defined as obesity. CKD was defined by proteinuria or eGFR of <60 ml/min per 1.73 m(2). To calculate the odds ratio for incident CKD, logistic regression analyses were performed. Results The crude incidence proportions of CKD were 2.6% (56 of 2122 participants) in participants with the metabolically healthy nonobesity phenotype, 2.6% (8 of 302) in those with the MHO phenotype, 6.7% (30 of 445) in those with the metabolically abnormal nonobesity phenotype, and 10.9% (29 of 267) in those with the metabolically abnormal obesity phenotype. Compared with metabolically healthy nonobesity phenotype, the odds ratios for incident CKD were 0.83 (95% confidence interval [95% CI], 0.36 to 1.72; P=0.64) for MHO, 1.44 (95% CI, 0.80 to 2.57; P=0.22) for metabolically abnormal nonobesity, and 2.80 (95% CI, 1.45 to 5.35; P=0.02) for metabolically abnormal obesity phenotype after adjustment for confounders, including age, sex, smoking statues, alcohol use, creatinine, uric acid, systolic BP, HDL cholesterol, and impaired fasting glucose or diabetes. Conclusion MHO phenotype was not associated with higher risk of incident CKD.	[Hashimoto, Yoshitaka; Tanaka, Muhei; Senmaru, Takafumi; Hamaguchi, Masahide; Asano, Mai; Yamazaki, Masahiro; Oda, Yohei; Nakamura, Naoto; Fukui, Michiaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto 6028566, Japan; [Okada, Hiroshi; Hasegawa, Goji] Japanese Red Cross Kyoto Daini Hosp, Div Metab Nephrol & Rheumatol, Kyoto, Japan; [Toda, Hitoshi] Oike Clin, Dept Internal Med, Kyoto, Japan	Fukui, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	sayarinapm@hotmail.com		Hamaguchi, Masahide/0000-0002-8651-4445; Hashimoto, Yoshitaka/0000-0002-8794-0550			Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Aneja A, 2004, RECENT PROG HORM RES, V59, P169, DOI 10.1210/rp.59.1.169; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Kramer H, 2005, AM J KIDNEY DIS, V46, P587, DOI 10.1053/j.ajkd.2005.06007; Shen WW, 2010, CLIN J AM SOC NEPHRO, V5, P1401, DOI 10.2215/CJN.01370210; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Wen Chi Pang, 2009, Public Health Nutr, V12, P497, DOI 10.1017/S1368980008002802; Pataky Z, 2010, INT J OBESITY, V34, pS18, DOI 10.1038/ijo.2010.235; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Lee SK, 2013, J HYPERTENS, V31, P145, DOI 10.1097/HJH.0b013e32835a3637; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Bell JA, 2014, OBES REV, V15, P504, DOI 10.1111/obr.12157; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Adamczak M, 2013, SEMIN NEPHROL, V33, P2, DOI 10.1016/j.semnephrol.2012.12.008; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Griffin KA, 2006, CLIN J AM SOC NEPHRO, V1, P1054, DOI 10.2215/CJN.02231205; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Barba C, 2004, LANCET, V363, P157; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Griffin Karen A, 2008, Am J Physiol Renal Physiol, V294, pF685, DOI 10.1152/ajprenal.00324.2007; Grimm R H Jr, 1997, Kidney Int Suppl, V63, pS10; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; Heianza Y, 2014, J CLIN ENDOCR METAB, V99, P2952, DOI 10.1210/jc.2013-4427; [International Association for the Study of Obesity (GB) International Obesity Task Force (GB) World Health Organization Western Pacific Region (PH)], 2000, AS PAC PERSP RED OB; Konta Tsuneo, 2007, Clin Exp Nephrol, V11, P51, DOI 10.1007/s10157-006-0458-z; Meguid ENA, 2005, LANCET, V365, P331; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586	45	1	1	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1555-9041	1555-905X		CLIN J AM SOC NEPHRO	Clin. J. Am. Soc. Nephrol.	APR	2015	10	4					578	583		10.2215/CJN.08980914		6	Urology & Nephrology	Urology & Nephrology	CF3QK	WOS:000352463400008		
J	Himoto, T; Tanaka, N; Saito, A; Muro, Y; Sugiura, K; Tani, J; Miyoshi, H; Morishita, A; Yoneyama, H; Haba, R; Masaki, T				Himoto, Takashi; Tanaka, Noriyo; Saito, Akiko; Muro, Yoshinao; Sugiura, Kazumitsu; Tani, Joji; Miyoshi, Hisaaki; Morishita, Asahiro; Yoneyama, Hirohito; Haba, Reiji; Masaki, Tsutomu			Diversity of humoral responses to the centromere proteins among HCV-related chronic liver disease, PBC and AIH patients	CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY			English	Article							PRIMARY BILIARY-CIRRHOSIS; CENP-B; ANTICENTROMERE ANTIBODIES; CLINICAL CHARACTERISTICS; SYSTEMIC-SCLEROSIS; CREST SYNDROME; SCLERODERMA; HEPATITIS; SERA; AUTOANTIBODIES	Background: Anticentromere antibodies (ACAs) have been observed in patients with autoimmune hepatitis (AIH) and hepatitis C virus (HCV)-related chronic liver disease (CLD-C) as well as those with primary biliary cirrhosis (PBC). However, little is known about the differences in immune responses to the centromere proteins among these liver diseases. Objective: By synthesizing recombinant proteins consisting of the N- and C-termini of major centromere proteins, we investigated the humoral responses against them in each disease. Results: Eight of the 754 (1%) patients with CLD-C, 14 of the 57 (25%) patients with PBC and six of the 38 (16%) patients with AIH were seropositive for ACAs. There were no significant differences in ACA titers determined by an indirect immunofluorescent method among the groups of patients with CLD-C, PBC and AIH. However, the analysis of immunoreactivities against each recombinant protein revealed that the titers of IgG-subclass autoantibodies against the C-terminus of centromere protein (CENP)-B were significantly higher in the CLD-C patients than in the AIH patients. Likewise, the titers of IgM-subclass autoantibodies against the N-terminus of CENP-A were significantly higher in the PBC group than in the CLD-C group. The ACA-positive patients who developed liver cirrhosis had significantly higher titers of the IgA-subclass autoantibodies against the C-terminus of CENP-C than those who did not. Conclusion: These findings suggest that immunoreactivities against the fragments of centromere proteins show distinct patterns among CLD-C, PBC and AIH and that the determination of immunoreactivities against the centromere proteins may be useful for the prediction of disease progression. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Himoto, Takashi] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Takamatsu, Kagawa 7610123, Japan; [Tanaka, Noriyo; Saito, Akiko; Muro, Yoshinao; Sugiura, Kazumitsu] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan; [Tani, Joji; Miyoshi, Hisaaki; Morishita, Asahiro; Yoneyama, Hirohito; Masaki, Tsutomu] Kagawa Univ, Sch Med, Dept Gastroenterol & Neurol, Kagawa, Japan; [Haba, Reiji] Kagawa Univ, Sch Med, Dept Diag Pathol, Kagawa, Japan	Himoto, T (reprint author), Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, 281-1 Hara,Mure Cho, Takamatsu, Kagawa 7610123, Japan.	himoto@chs.pref.kanagawa.jp	Sugiura, Kazumitsu /M-8913-2014; MURO, Yoshinao/M-8883-2014; 	Sugiura, Kazumitsu /0000-0002-5207-4592; Muro, Yoshinao/0000-0003-2329-8375			Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Hayashi Y, 2000, INT IMMUNOL, V12, P1431, DOI 10.1093/intimm/12.10.1431; Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Bogdanos DP, 2001, LIVER, V21, P225, DOI 10.1034/j.1600-0676.2001.021004225.x; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; ROTHFIELD N, 1987, ARTHRITIS RHEUM, V30, P1416, DOI 10.1002/art.1780301214; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413; Degott C, 1999, HEPATOLOGY, V29, P1007, DOI 10.1002/hep.510290444; EARNSHAW WC, 1987, P NATL ACAD SCI USA, V84, P4979, DOI 10.1073/pnas.84.14.4979; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; FRITZLER MJ, 1980, AM J MED, V69, P520, DOI 10.1016/0002-9343(80)90462-3; Gelber AC, 2006, ANN RHEUM DIS, V65, P1028, DOI 10.1136/ard.2005.046003; Himoto T, 2010, HEPATOL RES, V40, P786, DOI 10.1111/j.1872-034X.2010.00684.x; Himoto T, 2009, DIGEST DIS SCI, V54, P360, DOI 10.1007/s10620-008-0359-y; Hoshino K, 2008, CLIN EXP RHEUMATOL, V26, P505; Kremer J, 1988, CLIN EXP IMMUNOL, V72, P465; MAKINEN D, 1983, ARTHRITIS RHEUM, V26, P914, DOI 10.1002/art.1780260714; Muro Y, 2000, CLIN EXP IMMUNOL, V120, P218, DOI 10.1046/j.1365-2249.2000.01189.x; Muro Yoshinao, 1992, Journal of Dermatology (Tokyo), V19, P584; Page SL, 1995, HUM MIL GENET, V4; Pillemer SR, 2004, J RHEUMATOL, V31, P1171; Russo K, 2000, J RHEUMATOL, V27, P142; Saito A, 2009, J RHEUMATOL, V36, P781, DOI 10.3899/jrheum.080726; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257; SHOJI I, 1992, INTERNAL MED, V31, P1348, DOI 10.2169/internalmedicine.31.1348; Sugimoto K, 1998, J RHEUMATOL, V25, P474; SUGIMOTO K, 1992, J BIOCHEM-TOKYO, V111, P478; Sun DX, 1996, ARTHRITIS RHEUM, V39, P863, DOI 10.1002/art.1780390520; Tojo J, 2002, HEPATOL RES, V22, P187, DOI 10.1016/S1386-6346(01)00138-3; Tomita K, 2011, DIGEST DIS SCI, V56, P3648, DOI 10.1007/s10620-011-1771-2; Watanabe A, 2004, ARTHRITIS RHEUM-US, V50, P892, DOI 10.1002/art.20096	33	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	2210-7401	2210-741X		CLIN RES HEPATOL GAS	Clin. Res. Hepatol. Gastroenterol.	APR	2015	39	2					222	229		10.1016/j.clinre.2014.08.004		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE9JL	WOS:000352160100016		
J	Ichino, A; Yamana, S				Ichino, Atsushi; Yamana, Shunsuke			Periods of automorphic forms: the case of (GL(n+1) x GL(n), GL(n))	COMPOSITIO MATHEMATICA			English	Article						tensor product L-functions; Whittaker functions; Gan-Gross-Prasad conjecture	TRACE FORMULA; RESIDUAL SPECTRUM; EISENSTEIN SERIES; REDUCTIVE GROUPS; REPRESENTATION	Following Jacquet, Lapid and Rogawski, we define a regularized period of an automorphic form on GL(n+1) x GL(n) along the diagonal subgroup G(n) and express it in terms of the Rankin-Selberg integral of Jacquet, Piatetski-Shapiro and Shalika. This extends the theory of Rankin-Selberg integrals to all automorphic forms on GL(n+1) x GL(n).	[Ichino, Atsushi] Kyoto Univ, Dept Math, Sakyo Ku, Kyoto 6068502, Japan; [Yamana, Shunsuke] Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan	Ichino, A (reprint author), Kyoto Univ, Dept Math, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	ichino@math.kyoto-u.ac.jp; yamana@math.kyushu-u.ac.jp			JSPS [22740021, 24840033]	A. Ichino was partially supported by JSPS Grant-in-Aid for Young Scientists (B) 22740021. S. Yamana was partially supported by JSPS Grant-in-Aid for Research Activity Start-up 24840033 and JSPS Institutional Program for Young Researcher Overseas Visits 'Promoting international young researchers in mathematics and mathematical sciences led by OCAMI'. This paper was partly written while the authors were visiting the Hebrew University of Jerusalem in September 2012. The authors thank Erez Lapid for his suggestion to use the work of Franke [Fra98] and Xiaoqing Li for pointing out an inaccuracy of the absolute convergence of the Fourier expansion in Lemma 4.2.	Jacquet H, 2009, CONTEMP MATH, V489, P57; GROSS BH, 1992, CAN J MATH, V44, P974, DOI 10.4153/CJM-1992-060-8; VOGAN DA, 1986, INVENT MATH, V83, P449, DOI 10.1007/BF01394418; JACQUET H, 1983, AM J MATH, V105, P367, DOI 10.2307/2374264; MOEGLIN C, 1989, ANN SCI ECOLE NORM S, V22, P605; Ichino A, 2010, GEOM FUNCT ANAL, V19, P1378, DOI 10.1007/s00039-009-0040-4; ARTHUR J, 1980, COMPOS MATH, V40, P87; Lapid EM, 2003, DUKE MATH J, V120, P153; Jacquet H, 1999, J AM MATH SOC, V12, P173, DOI 10.1090/S0894-0347-99-00279-9; Franke J, 1998, ANN SCI ECOLE NORM S, V31, P181, DOI 10.1016/S0012-9593(98)80015-3; SHALIKA JA, 1974, ANN MATH, V100, P171, DOI 10.2307/1971071; ARTHUR JG, 1978, DUKE MATH J, V45, P911, DOI 10.1215/S0012-7094-78-04542-8; ARTHUR J, 1982, DUKE MATH J, V49, P35, DOI 10.1215/S0012-7094-82-04904-3; ARTHUR J, 1985, CAN J MATH, V37, P1237, DOI 10.4153/CJM-1985-067-0; ARTHUR J, 1981, ANN MATH, V114, P1, DOI 10.2307/1971376; BERNSTEIN JN, 1984, LECT NOTES MATH, V1041, P50; CASSELMAN W, 1993, MATH ANN, V296, P755, DOI 10.1007/BF01445135; Cogdell J. W., 2004, CONTRIBUTIONS AUTOMO, P256; Dixmier J., 1978, B SCI MATH, V102, P307; Gan WT, 2012, ASTERISQUE, P1; HARISHCH, 1966, ACTA MATH-UPPSALA, V116, P1, DOI 10.1007/BF02392813; JACQUET H, 1979, ANN MATH, V109, P169, DOI 10.2307/1971270; Jacquet H, 2001, B SOC MATH FR, V129, P33; Jacquet H., 2011, CLAY MATH P, V13, P205; JACQUET H, 1984, LECT NOTES MATH, V1041, P185; Jacquet H, 2004, CONTRIBUTIONS TO AUTOMORPHIC FORMS, GEOMETRY, AND NUMBER THEORY, P373; Jacquet Herve, 1990, ISRAEL MATH C P, V2, P125; Lapid E., 2011, CLAY MATH P, V13, P309; Treves F., 2006, TOPOLOGICAL VECTOR S; Waldspurger JL, 1997, ASTERISQUE, P139; Waldspurger J.-L., 1995, CAMBRIDGE TRACTS MAT, V113; Wallach N., 1992, PURE APPL MATH, V132-11; Zhang W., 2014, MATH PROBL ENG, V2014, P7; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693	34	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0010-437X	1570-5846		COMPOS MATH	Compos. Math.	APR	2015	151	4					665	712		10.1112/S0010437X14007362		48	Mathematics	Mathematics	CF9VP	WOS:000352915600002		
J	Omotuyi, OI; Ueda, H				Omotuyi, Olaposi I.; Ueda, Hiroshi			Molecular dynamics study-based mechanism of nefiracetam-induced NMDA receptor potentiation	COMPUTATIONAL BIOLOGY AND CHEMISTRY			English	Article						NMDA receptor; Nefiracetam; Threonine-647; Gauche trap; Molecular dynamics	NOOTROPIC DRUG NEFIRACETAM; NICOTINIC ACETYLCHOLINE-RECEPTORS; COGNITION-ENHANCER NEFIRACETAM; LONG-TERM-POTENTIATION; RAT CORTICAL-NEURONS; LIGAND-BINDING CORE; CRYSTAL-STRUCTURES; SUBUNIT; SIMULATIONS; ACTIVATION	Plastic changes in the brain required for memory formation and long-term learning are dependent on N-methyl-D-aspartic acid (NMDA) receptor signaling. Nefiracetam reportedly boosts NMDA receptor functions as a basis for its nootropic properties. Previous studies suggest that nefiracetam potentiates the NMDA receptor activation, as a more potent co-agonist for glycine binding site than glycine, though the underlying mechanisms remain elusive. Here, using BSP-SLIM method, a novel binding site within the core of spiral beta-strands-1-5 of LBD-GLUN1 has been predicted in glycine-bound GLUN1 conformation in addition to the glycine pocket in Apo-GLUN1. Within the core of spiral beta-strands-1-5 of LBD-GLUN1 pocket, all-atom molecular dynamics simulation revealed that nefiracetam disrupts Arg523-glycine-Asp732 interaction resulting in open GLUN1 conformation and ultimate diffusion of glycine out of the clamshell cleft. Open GLUN1 conformation coerces other intra-chain domains and proximal inter-chain domains to sample inactivate conformations resulting in closure of the transmembrane gate via a novel gauche trap on threonine 647 (chi-1 dihedral (X1) = -45 degrees instead of +45 degrees). Docking of nefiracetam into the glycine pocket reversed the gauche trap and meditates partial opening of the TMD gate within a time-scale of 100 ns as observed in glycine-only state. All these results suggest that nefiracetam can favorably complete with glycine for GLUN1-LBD in a two-step process, first by binding to a novel site of GLUN1-LBD-NMDA receptor followed by disruption of glycine-binding dynamics then replacing glycine in the GLUN1-LBD cleft. (C) 2015 Elsevier Ltd. All rights reserved.	[Omotuyi, Olaposi I.; Ueda, Hiroshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmacol & Therapeut Innovat, Nagasaki, Japan; [Omotuyi, Olaposi I.; Ueda, Hiroshi] Nagasaki Univ, Ctr Drug Discovery & Therapeut Innovat, Nagasaki, Japan	Ueda, H (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmacol & Therapeut Innovat, Nagasaki, Japan.	ueda@nagasaki-u.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Nagasaki University Major Research Project "Therapeutic Innovation Center"	This work was supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and a grant from Nagasaki University Major Research Project "Therapeutic Innovation Center".	Aihara H, 2001, BRAIN RES, V922, P158, DOI 10.1016/S0006-8993(01)03165-1; Rashid MH, 2002, J PHARMACOL EXP THER, V303, P226, DOI 10.1124/jpet.102.037952; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jones KS, 2002, J NEUROSCI, V22, P2044; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Bennett WFD, 2013, BBA-BIOMEMBRANES, V1828, P1765, DOI 10.1016/j.bbamem.2013.03.004; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Talukder I, 2011, J GEN PHYSIOL, V138, P179, DOI 10.1085/jgp.201110623; Jones JE, 1924, P R SOC LOND A-CONTA, V106, P463, DOI 10.1098/rspa.1924.0082; Yao YN, 2013, STRUCTURE, V21, P1788, DOI 10.1016/j.str.2013.07.011; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Dyer KM, 2009, MOL PHYS, V107, P423, DOI 10.1080/00268970902845313; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P16719, DOI 10.1039/c4cp01388c; RISON RA, 1995, NEUROSCI BIOBEHAV R, V19, P533, DOI 10.1016/0149-7634(95)00017-8; Amico-Ruvio SA, 2011, BIOPHYS J, V100, P1910, DOI 10.1016/j.bpj.2011.02.042; Moriguchi S, 2007, MOL PHARMACOL, V71, P580, DOI 10.1124/mol.106.027607; [Anonymous], 2015, PYMOL MOL GRAPHICS S; Murphy KJ, 2006, NEUROPSYCHOPHARMACOL, V31, P90, DOI 10.1038/sj.npp.1300810; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Choi C, 2011, MAGN RESON MED, V66, P609, DOI 10.1002/mrm.22857; KEMP JA, 1988, P NATL ACAD SCI USA, V85, P6547, DOI 10.1073/pnas.85.17.6547; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Dai J, 2013, BIOPHYS J, V104, P2170, DOI 10.1016/j.bpj.2013.04.013; Fujita R, 2002, NEUROCHEM INT, V40, P139, DOI 10.1016/S0197-0186(01)00080-8; Hanndelmann G.E., 1989, PHARM BIOCH BEHAV, V34, P823; Huang CS, 1996, NEUROPHARMACOLOGY, V35, P1251, DOI 10.1016/S0028-3908(96)00074-3; Kazi R, 2014, BIOPHYS J, V106, p29A; Lee S., 2012, PROTEIN-STRUCT FUNCT, V80, P93; Moriguchi S, 2003, J PHARMACOL EXP THER, V307, P160, DOI 10.1124/jpet.103.050823; Newcomer J W, 2000, Dialogues Clin Neurosci, V2, P219; Nishizaki T, 1999, BRAIN RES, V826, P281, DOI 10.1016/S0006-8993(99)01312-8; Nishizaki T, 2000, ALZ DIS ASSOC DIS, V14, pS82, DOI 10.1097/00002093-200000001-00013; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; SKEEL RD, 1993, BIT, V33, P172, DOI 10.1007/BF01990352; Ueda M, 2004, J PHARMACOL EXP THER, V309, P200, DOI 10.1124/jpet.103.061127; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Zhao XL, 2001, MOL PHARMACOL, V59, P674	47	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1476-9271	1476-928X		COMPUT BIOL CHEM	Comput. Biol. Chem.	APR	2015	55						14	22		10.1016/j.compbiolchem.2015.01.004		9	Biology; Computer Science, Interdisciplinary Applications	Life Sciences & Biomedicine - Other Topics; Computer Science	CG1AE	WOS:000353004600002		
J	Yoshikawa, A; Kurosawa, S; Shoji, Y; Chani, VI; Kamada, K; Yokota, Y; Ohashi, Y				Yoshikawa, Akira; Kurosawa, Shunsuke; Shoji, Yasuhiro; Chani, Valery I.; Kamada, Kei; Yokota, Yuui; Ohashi, Yuji			Growth, Structural Considerations, and Characterization of Ce-Doped (La,Gd)(2)Si2O7 Scintillating Crystals	CRYSTAL GROWTH & DESIGN			English	Article							PULLING-DOWN METHOD; IMPROVEMENT	Ce-doped lantanium-gadolinium pyrosilicate (La,Ce,Gd)(2)Si2O7 (Ce:La-GPS), crystals with various content of rare-earth elements were produced from the melt, and their optimal La/Gd ratio was examined. It was found that Ce:La-GPS single crystals of acceptable optical quality can be produced from the melts ranging from La0.5Gd1.5Si2O7 to La1.0Gd1.0Si2O7 and containing about 1 atom % Ce with respect to the host rare-earths of La and Gd. The crystal growth was performed by the micro-pulling-down and Czochralski methods. The crystals were chemically uniform along the growth axis, and their composition was equal to that of the melt, thus corresponding to vicinity of congruent melting composition. Spatial distribution of Ce in La-GPS was also inspected, and no variation of Ce content was detected as a result of its similarity to one of the host cations (La) regarding the size. Basic optical and scintillation properties of the Ce:La-GPS crystals are also reported, and it is demonstrated that partial substitution of Gd with La has no negative impact on crystal growth and physical performance of the crystals.	[Yoshikawa, Akira; Kurosawa, Shunsuke; Shoji, Yasuhiro; Chani, Valery I.; Ohashi, Yuji] Tohoku Univ, IMR, Sendai, Miyagi 9808577, Japan; [Yoshikawa, Akira; Kurosawa, Shunsuke; Kamada, Kei; Yokota, Yuui] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan; [Yoshikawa, Akira; Shoji, Yasuhiro; Kamada, Kei] C&A Corp, Sendai, Miyagi 9808579, Japan	Yoshikawa, A (reprint author), Tohoku Univ, IMR, Sendai, Miyagi 9808577, Japan.	yoshikawa@imr.tohoku.ac.jp			Adaptable & Seamless Technology Transfer Program through Target-driven RD (A-STEP), JST; Japan Society for the Promotion of Science (JSPS); Development of Systems and Technology for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST); JSPS	This work is partially supported by (i) Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP), JST (ii) Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Exploratory Research (AY), (iii) Development of Systems and Technology for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST), (iv) the funding program for next generation world-leading researchers, JSPS. In addition, we would like to thank following for their support: Mr. Hiroshi Uemura, Ms. Keiko Toguchi, Ms. Megumi Sasaki, and Ms. Yuka Takeda in IMR. The authors thank Mr. Sugawara, Ms. Nomura at Crystal Growth & Design, Cooperative Research and Development Center for Advanced Materials, IMR, Tohoku University.	Nikl M, 2006, MEAS SCI TECHNOL, V17, pR37, DOI 10.1088/0957-0233/17/4/R01; Kawamura S, 2007, IEEE T NUCL SCI, V54, P1383, DOI 10.1109/TNS.2007.902372; Sidletskiy O, 2010, RADIAT MEAS, V45, P365, DOI 10.1016/j.radmeas.2009.12.022; BONDAR IA, 1967, MATER RES BULL, V2, P479, DOI 10.1016/0025-5408(67)90088-8; Gektin AV, 2014, IEEE T NUCL SCI, V61, P262, DOI 10.1109/TNS.2013.2277883; Weber MJ, 2002, J LUMIN, V100, P35, DOI 10.1016/S0022-2313(02)00423-4; Yoshikawa A, 2009, MRS BULL, V34, P266, DOI 10.1557/mrs2009.77; Gerasymov I, 2011, J CRYST GROWTH, V318, P805, DOI 10.1016/j.jcrysgro.2010.11.047; Yoshikawa A, 2007, OPT MATER, V30, P6, DOI 10.1016/j.optmat.2006.10.030; Sidletskiy O, 2014, PHYS STATUS SOLIDI A, V211, P2384, DOI 10.1002/pssa.201431137; Derenzo SE, 2003, NUCL INSTRUM METH A, V505, P111, DOI 10.1016/S0168-9002(03)01031-3; Chai BHT, 2000, P IEEE INT FREQ CONT, P163, DOI 10.1109/FREQ.2000.887346; Kurosawa S, 2014, NUCL INSTRUM METH A, V744, P30, DOI 10.1016/j.nima.2014.01.018; Yoshikawa A, 2013, ACTA PHYS POL A, V124, P250; Baumer V, 2011, J ALLOY COMPD, V509, P8478, DOI 10.1016/j.jallcom.2011.06.016; Bondar I. A., 1982, Ceramics International, V8, DOI 10.1016/0272-8842(82)90022-0; Boogerd G. M., 1980, U.S. Patent, Patent No. [4,215,289, 4215289]; Chain V. I., 1997, MAT SCI ENG R, V20, P281; Chani VI, 2000, J CRYST GROWTH, V212, P469, DOI 10.1016/S0022-0248(00)00021-X; FELSCHE J, 1970, J LESS-COMMON MET, V21, P1, DOI 10.1016/0022-5088(70)90159-1; Fernandez-Carrion AJ, 2012, J PHYS CHEM C, V116, P21523, DOI 10.1021/jp305777m; Fernandez-Carrion AJ, 2012, J EUR CERAM SOC, V32, P2477, DOI 10.1016/j.jeurceramsoc.2012.03.009; Fernandez-Carrion AJ, 2013, J PHYS CHEM C, V117, P20876, DOI 10.1021/jp407172z; Fleet ME, 2000, ACTA CRYSTALLOGR B, V56, P940, DOI 10.1107/S0108768100008545; Fukada T, 2007, ADV MATER RES-GER, V8, P1, DOI 10.1007/978-3-540-71295-4; Gerasymov Ia. V., 2013, FUNCT MAT, V20, P234; Hartenbach I, 2003, Z NATURFORSCH B, V58, P925; Kahlenberg V, 2008, Z ANORG ALLG CHEM, V634, P1166, DOI 10.1002/zaac.200700548; Kurtsev D, 2014, MATER RES BULL, V52, P25, DOI 10.1016/j.materresbull.2014.01.006; Lecog P., 2006, INORGANIC SCINTILLAT; Leskela M., 1986, HDB PHYSICS CHEM RAR, V8, P203, DOI 10.1016/S0168-1273(86)08006-6; Maria JP, 2002, J MATER RES, V17, P1571, DOI 10.1557/JMR.2002.0234; Martin J., 2006, MAT ENG; Saeld S., 2007, IEEE NUCL SCI S, V2, P1426; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Suzuki A., 2012, APPL PHYS EXPRESS, V5; Toropov N. A., 1961, B ACAD SCI USSR CH, V10, P497, DOI 10.1007/BF00909108; Toropov N. A., 1961, B ACAD SCI USSR CH, V10, P1278, DOI 10.1007/BF00910095; Toropov N. A., 1961, B ACAD SCI USSR CH, V10, P682, DOI 10.1007/BF00905927; TOROPOV NA, 1964, DOKL AKAD NAUK SSSR+, V156, P1127; Tsubota Y., 2011, PROG NUCL SCI TECHNO, V1, P288; Tsubota Y., 2012, PROG NUCL SCI TECHNO, V3, P97; van Eijk C. V. E, 2012, IEEE T NUCL SCI, V55, P2242	43	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	APR	2015	15	4					1642	1651		10.1021/cg501416u		10	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CF0PG	WOS:000352246100015		
J	Li, HC; Fan, WS; Peng, BN; Wang, W; Zhuang, YF; Guo, LS; Yao, X; Ikuta, H				Li, Hao-Chen; Fan, Wen-Shuo; Peng, Bo-nan; Wang, Wei; Zhuang, Yu-Feng; Guo, Lin-Shan; Yao, Xin; Ikuta, Hiroshi			Seed-Size Effect on the Growth and Superconducting Performance of YBCO Single-Grain Bulks	CRYSTAL GROWTH & DESIGN			English	Article							CRYSTALS	Exploiting their distinguished merits of commercial availability, large size, and extremely high thermal stability, a series of NdBCO film-seeds were employed to study their size effects on the YBCO bulks by melt-growth. First, our findings show that the nucleation range is almost the same with the variation of the seed size and that the effective contact area of the seed with the molten pellet is smaller than the seed area, which can be explained by the liquids wettability and its surface energy. Moreover, induced by the large-sized seed, the YBCO grain has the highest alpha-axis growth rate, R-a, because of a double mode of thermally driven plus seed-induced growth, leading to a larger c-GS (c-growth sector). Finally, the levitation force of bulks were proven to possess an ascending and subsequently descending tendency with increasing the seed size, which is clarified by the enlargement of c-GS in competition with enhancement of pore density of bulks. In short, the results from this work are helpful to understand the crystallization mechanism and to gain the optimal superconductivity property with a reasonable seed size.	[Li, Hao-Chen; Fan, Wen-Shuo; Peng, Bo-nan; Wang, Wei; Zhuang, Yu-Feng; Guo, Lin-Shan; Yao, Xin] Shanghai Jiao Tong Univ, Key Lab Artificial Struct & Quantum Control, State Key Lab Met Matrix Composites, Minist Educ,Dept Phys & Astron, Shanghai 200240, Peoples R China; [Yao, Xin] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Ikuta, Hiroshi] Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan	Yao, X (reprint author), Shanghai Jiao Tong Univ, Key Lab Artificial Struct & Quantum Control, State Key Lab Met Matrix Composites, Minist Educ,Dept Phys & Astron, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	xyao@sjtu.edu.cn	YAO, XIN/O-5678-2015		MOST of China [2012CB821404]; NSFC [51172143]; Minhang Government	The authors are grateful for financial support from the MOST of China (grant no 2012CB821404), NSFC (grant no. 51172143), and the Minhang Government.	Endo A, 1996, J MATER RES, V11, P795, DOI 10.1557/JMR.1996.0096; Oda M, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/7/075012; Wu XD, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/12/125003; Werfel FN, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/1/014007; Campbell AM, 1997, CRYOGENICS, V37, P567, DOI 10.1016/S0011-2275(97)00068-4; Cardwell DA, 1998, MAT SCI ENG B-SOLID, V53, P1, DOI 10.1016/S0921-5107(97)00293-6; Guo-Zheng L., 2013, CRYST GROWTH DES, V3, P1246; Headings NS, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104513; Reddy ES, 2005, SUPERCOND SCI TECH, V18, P64, DOI 10.1088/0953-2048/18/1/011; Lo W., 1998, MAT SCI ENG B, V1-2, P45; Nizhelskiy N. A., 2007, SUPERCOND SCI TECH, V81, P20; Scruggs S. J., 2006, SUPERCOND SCI TECH S, VS451, P19; Volochova D, 2012, J CRYST GROWTH, V353, P31, DOI 10.1016/j.jcrysgro.2012.04.029; Xu HH, 2013, J SUPERCOND NOV MAGN, V26, P919, DOI 10.1007/s10948-012-1981-7; Yao X, 2004, J PHYS-CONDENS MAT, V16, P3819, DOI 10.1088/0953-8984/16/23/002	15	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	APR	2015	15	4					1740	1744		10.1021/cg501754c		5	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CF0PG	WOS:000352246100026		
J	Ban, T; Nakagawa, T; Ohya, Y				Ban, Takayuki; Nakagawa, Takuya; Ohya, Yutaka			Bottom-Up Synthesis of Titanate Nanosheets in Aqueous Sols and Their Morphology Change by the Addition of Organic Ligands and Dialysis	CRYSTAL GROWTH & DESIGN			English	Article							ROOM-TEMPERATURE; SINGLE-CRYSTALS; SEED LAYER; THIN-FILMS; ZEOLITE-A; GROWTH; NANOCRYSTALS; SILICALITE-1; TRANSPARENT; TRANSITION	The size, shape, and stacking of titanate nanosheets synthesized by heating aqueous mixtures of titanium complexes and tetrabutylammonium hydroxide were dependent on the type and amount of organic ligands and the amount of tetrabutylammonium ion (TBA+). When titanium isopropoxide was used as the titanium source, most titanate crystals were smaller than 10 nm in lateral size. However, the use of titanium complexes provided a lateral size of about 100 nm. The titanate crystals were synthesized by the acid-base reaction of titanic acid and TBAOH. The decrease in titanic acid concentration by titanium complex formation led to larger titanate crystals by the inhibition of crystal nucleation. Moreover, the use of triethanolamine and lactic acid as an organic ligand provided round and hexagonal titanate crystals, respectively. However, when the concentration of organic ligands was decreased by the dialysis of the titanate sols, the form of titanate crystals was changed to a rhombic shape. Thus, the adsorption of organic ligands on the titanate crystals probably influenced the shape of the titanate crystals. Furthermore, the decrease in TBA+ concentration by the dialysis of the sols inhibited the stacking of the titanate nanosheets during the evaporation of the sols.	[Ban, Takayuki; Nakagawa, Takuya; Ohya, Yutaka] Gifu Univ, Dept Chem & Biomol Sci, Gifu 5011193, Japan	Ban, T (reprint author), Gifu Univ, Dept Chem & Biomol Sci, Yanagido 1-1, Gifu 5011193, Japan.	ban@gifu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26410237]	This study was supported by KAKENHI (Grant-in-Aid for Scientific Research (C) 26410237) from Japan Society for the Promotion of Science (JSPS).	Shao CL, 1999, MICROPOR MESOPOR MAT, V33, P215, DOI 10.1016/S1387-1811(99)00140-7; Osada M, 2012, ADV MATER, V24, P210, DOI 10.1002/adma.201103241; Osada M, 2006, ADV MATER, V18, P1023, DOI 10.1002/adma.200501224; Nakamura K, 2013, J AM CHEM SOC, V135, P4501, DOI 10.1021/ja400443a; Tanaka T, 2003, CHEM MATER, V15, P3564, DOI 10.1021/cm034307j; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; Ohya T, 2002, CHEM MATER, V14, P3082, DOI 10.1021/cm0200588; Tae EL, 2008, J AM CHEM SOC, V130, P6534, DOI 10.1021/ja711467g; Kai K, 2012, J MATER CHEM, V22, P14691, DOI 10.1039/c2jm31080e; Osada M, 2010, ACS NANO, V4, P5225, DOI 10.1021/nn101453v; Ban T, 2011, J COLLOID INTERF SCI, V364, P85, DOI 10.1016/j.jcis.2011.08.026; Huang X, 2014, ADV MATER, V26, P2185, DOI 10.1002/adma.201304964; Kai K, 2008, J AM CHEM SOC, V130, P15938, DOI 10.1021/ja804503f; Ohya T, 2003, J SOL-GEL SCI TECHN, V26, P799, DOI 10.1023/A:1020783113661; Ma RZ, 2010, ADV MATER, V22, P5082, DOI 10.1002/adma.201001722; Wang CX, 2014, ACS NANO, V8, P2658, DOI 10.1021/nn406367p; SCOTT G, 1990, ZEOLITES, V10, P44, DOI 10.1016/0144-2449(90)90093-7; Shibata T, 2008, ADV MATER, V20, P231, DOI 10.1002/adma.200701381; Nijland M, 2014, ACS APPL MATER INTER, V6, P2777, DOI 10.1021/am4052624; Ban T, 1999, ANGEW CHEM INT EDIT, V38, P3324, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3324::AID-ANIE3324>3.0.CO;2-J; Ban T, 2014, J POROUS MAT, V21, P337, DOI 10.1007/s10934-013-9779-y; Ban T, 2013, MATER CHEM PHYS, V137, P1067, DOI 10.1016/j.matchemphys.2012.11.035; Ban T, 2012, CRYSTENGCOMM, V14, P7709, DOI 10.1039/c2ce25531f; Ban T, 2013, INORG CHEM, V52, P10520, DOI 10.1021/ic4014587; Ban T, 2008, CRYST GROWTH DES, V8, P935, DOI 10.1021/cg7008072; Ban T, 1999, INT J INORG MATER, V1, P243, DOI 10.1016/S1466-6049(99)00037-9; CHARNELL JF, 1971, J CRYST GROWTH, V8, P291, DOI 10.1016/0022-0248(71)90074-1; Gunjakar J. L., 2014, J PHYS CHEM C, V118, P3848; Jung CH, 2013, ACS APPL MATER INTER, V5, P4592, DOI 10.1021/am400849z; MORRIS M, 1991, ZEOLITES, V11, P178, DOI 10.1016/0144-2449(91)80413-T; Ohya T, 2004, J SOL-GEL SCI TECHN, V30, P71, DOI 10.1023/B:JSST.0000034694.61859.78; Petranovskii V, 1997, STUD SURF SCI CATAL, V105, P149; SASAKI T, 1991, J CHEM SOC CHEM COMM, P817, DOI 10.1039/c39910000817; Shao CL, 2000, MICROPOR MESOPOR MAT, V39, P117, DOI 10.1016/S1387-1811(00)00183-9; Shibata T, 2014, J MATER CHEM C, V2, P441, DOI 10.1039/c3tc31787k	35	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	APR	2015	15	4					1801	1807		10.1021/cg501852a		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CF0PG	WOS:000352246100033		
J	Yamada, M; Hamada, F				Yamada, Manabu; Hamada, Fumio			Halogen Interactions in Macrocyclic Thiacalix[4]arene Systems	CRYSTAL GROWTH & DESIGN			English	Article							CHARGE-DENSITY ANALYSIS; ONE-POT SYNTHESIS; SUPRAMOLECULAR CHEMISTRY; INCLUSION COMPLEXES; CRYSTAL-STRUCTURE; PI INTERACTIONS; HYDROGEN; BONDS; IODO; BR	The crystalline supramolecular assemblies of brominated thiacalix[4]arene alkyl ethers were studied by single-crystal X-ray diffraction and computational analysis. Eight compounds were synthesized that exhibited linear alkyl groups of varying lengths projecting from the thiacalixarene lower rims (-CH3: 4, -CH2CH3: 5, -(CH2)(4)CH3) to -(CH2)(9)CH3): 6-11) in order to study the intermolecular halogen interactions between the macrocycles. These crystals displayed remarkably different assemblies, which was rationalized as an effect of varying alkyl chain length on the stabilization afforded by the halogen interactions. The two compounds with the shortest alkyl chains, 4 and 5, assembled primarily through the influence of halogen-pi interactions between distinct molecules. In contrast, the compounds with the longest chains, 8-11, assembled primarily through the influence of halogen-sulfur halogen bonding. Oddly, 6 and 7 did not follow this pattern in that they showed no major assembly motivated by halogen interactions. Finally, the supramolecular assemblies were found to be stabilized by additional intermolecular interactions, including hydrogen bonding, S-pi, CH-pi, and Br-H interactions.	[Yamada, Manabu] Akita Univ, Res Ctr Engn Sci, Grad Sch Engn & Resource Sci, Akita 0108502, Japan; [Hamada, Fumio] Akita Univ, Dept Appl Chem, Grad Sch Engn & Resource Sci, Akita 0108502, Japan	Yamada, M (reprint author), Akita Univ, Res Ctr Engn Sci, Grad Sch Engn & Resource Sci, 1-1 Tegatagakuen Machi, Akita 0108502, Japan.	myamada@gipc.akita-u.ac.jp; hamada@gipc.akita-u.ac.jp			"Program to Disseminate Tenure Tracking System" of Japan	This work was supported by "Program to Disseminate Tenure Tracking System" of Japan. We thank Dr. Hiroshi Katagiri (Graduate School of Science and Engineering, Yamagata University, Japan) and Mr. Noritaka Uchida (Wavefunction, Inc.; Japan Branch Office) for their valuable discussions and technical support on single-crystal X-ray diffraction studies and quantum chemical calculations.	Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Lamouchi M, 2014, INORG CHEM, V53, P63, DOI 10.1021/ic4012422; Pigge FC, 2008, CHEM COMMUN, P4726, DOI 10.1039/b809592b; Hathwar VR, 2011, CRYST GROWTH DES, V11, P1855, DOI 10.1021/cg2000415; Yamada M, 2014, CRYSTENGCOMM, V16, P2605, DOI 10.1039/c3ce42535e; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Hauchecorne D, 2011, PHYS CHEM CHEM PHYS, V13, P10204, DOI 10.1039/c0cp02960b; Yamada M, 2013, TETRAHEDRON LETT, V54, P1510, DOI 10.1016/j.tetlet.2012.12.102; Metrangolo P, 2001, CHEM-EUR J, V7, P2511, DOI 10.1002/1521-3765(20010618)7:12<2511::AID-CHEM25110>3.0.CO;2-T; Caronna T, 2004, J AM CHEM SOC, V126, P4500, DOI 10.1021/ja039884n; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; Siram RBK, 2013, CRYST GROWTH DES, V13, P1045, DOI 10.1021/cg3012298; Kida T, 2013, J AM CHEM SOC, V135, P3371, DOI 10.1021/ja312367k; Reinhoudt DN, 2002, SCIENCE, V295, P2403, DOI 10.1126/science.1069197; Wan CQ, 2009, NEW J CHEM, V33, P707, DOI 10.1039/b818344a; El-Sheshtawy HS, 2012, J AM CHEM SOC, V134, P19935, DOI 10.1021/ja3102902; [Anonymous], 2013, SPARTAN 14; Erdelyi M, 2012, CHEM SOC REV, V41, P3547, DOI 10.1039/c2cs15292d; Parisini E, 2011, CHEM SOC REV, V40, P2267, DOI 10.1039/c0cs00177e; Metrangolo P, 2008, SCIENCE, V321, P918, DOI 10.1126/science.1162215; Andrews MB, 2012, DALTON T, V41, P3911, DOI 10.1039/c2dt11985d; Rekharsky MV, 2006, ORG LETT, V8, P815, DOI 10.1021/ol0528742; Hamada F, 2011, CRYSTENGCOMM, V13, P6920, DOI 10.1039/c1ce05813d; Pigge FC, 2013, CRYSTENGCOMM, V15, P4386, DOI 10.1039/c3ce26732f; Morohashi N, 2006, CHEM REV, V106, P5291, DOI 10.1021/cr050565j; Awwadi FF, 2006, CHEM-EUR J, V12, P8952, DOI 10.1002/chem.200600523; Metrangolo P, 2009, SCIENCE, V323, P1461, DOI 10.1126/science.1168679; Schollmeyer D, 2008, CRYSTENGCOMM, V10, P715, DOI 10.1039/b716442d; Paton AS, 2011, CRYSTENGCOMM, V13, P3653, DOI 10.1039/c0ce00796j; Meyer F, 2013, CRYSTENGCOMM, V15, P3058, DOI 10.1039/c2ce26150b; Kumar R, 2014, CHEM SOC REV, V43, P4824, DOI 10.1039/c4cs00068d; Pang X, 2013, CRYSTENGCOMM, V15, P2722, DOI 10.1039/c3ce26661c; Saha BK, 2005, CRYST GROWTH DES, V5, P887, DOI 10.1021/cg049691r; Voth AR, 2007, P NATL ACAD SCI USA, V104, P6188, DOI 10.1073/pnas.0610531104; Bui TTT, 2009, ANGEW CHEM INT EDIT, V48, P3838, DOI 10.1002/anie.200805739; Nguyen HL, 2004, J AM CHEM SOC, V126, P16, DOI 10.1021/ja0369941; Legon AC, 2010, PHYS CHEM CHEM PHYS, V12, P7736, DOI 10.1039/c002129f; Atwood J. L., 2008, ORGANIC NANOSTRUCTUR; Caballero A, 2013, CRYSTENGCOMM, V15, P3076, DOI 10.1039/c2ce26020d; Higuchi Y, 2000, TETRAHEDRON, V56, P4659, DOI 10.1016/S0040-4020(00)00377-X; Iki N, 2012, INORG CHEM, V51, P1648, DOI 10.1021/ic2019583; Jentzsch A. V., 2012, NAT COMMUN, V3, P1; Jetti RKR, 2001, CHEM COMMUN, P919, DOI 10.1039/b102150h; Kasyan O, 2003, TETRAHEDRON LETT, V44, P7167, DOI 10.1016/S0040-4039(03)01809-4; Kimuro T, 2015, J INCL PHENOM MACRO, V81, P245, DOI 10.1007/s10847-014-0435-1; Kondo Y, 2005, J INCL PHENOM MACRO, V52, P45, DOI 10.1007/s10847-004-2384-6; Kondo Y, 2007, J INCL PHENOM MACRO, V58, P123, DOI 10.1007/s10847-006-9133-y; Lehn J. M., 1995, SUPRAMOLECULAR CHEMI; Lhota K. P., 2004, EUR J ORG CHEM, P1675; Ogoshi T., 2012, J INCL PHENOM MACRO, V72, P2470; PEDIREDDI VR, 1994, J CHEM SOC PERK T 2, P2353, DOI 10.1039/p29940002353; Raatikainen K, 2012, CHEM SCI, V3, P1235, DOI 10.1039/c2sc00997h; Sheldrick G M, 1997, SHELXS 97 PROGRAM FO; Sheldrick G. M., 1997, SHELXL 97 PROGRAM FO; Steed J. W., 2007, CORE CONCEPTS IN SUP; Wallnoefer HG, 2010, PHYS CHEM CHEM PHYS, V12, P14941, DOI 10.1039/c0cp00607f; Yamada M, 2011, CRYSTENGCOMM, V13, P2494, DOI 10.1039/c0ce00824a; Yamada M, 2013, CRYSTENGCOMM, V15, P5703, DOI 10.1039/c3ce40431e	58	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	APR	2015	15	4					1889	1897		10.1021/acs.cgd.5b00065		9	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CF0PG	WOS:000352246100043		
J	Iwaihara, C; Kitagawa, D; Kobatake, S				Iwaihara, Chika; Kitagawa, Daichi; Kobatake, Seiya			Polymorphic Crystallization and Thermodynamic Phase Transition between the Polymorphs of a Photochromic Diarylethene	CRYSTAL GROWTH & DESIGN			English	Article							CRYSTAL THICKNESS DEPENDENCE; MICROCRYSTALLINE SURFACE; SUPERHYDROPHOBIC SURFACE; LIGHT; WETTABILITY; PHOTOIRRADIATION; LUMINESCENCE; REACTIVITY; ACTUATORS; MEMORIES	We synthesized a photochromic diarylethene, 1,2-bis(2-methyl-5-(4-hexyloxyphenyl)-3-thienyl)perfluorocyclopentene (1a), and found that it has two types of crystals, a needle-like alpha-crystal and a plate-like beta-crystal. From X-ray crystallographic analysis, the space groups of the alpha- and beta-crystals were determined to be P1 and C2/c, respectively. The molecular conformation and packing of two crystal forms are quite different. The alpha- and beta-crystals can be obtained individually by recrystallization from acetone at different temperatures. The solvent-mediated phase transition from the a-crystal to the beta-crystal was found to occur in the acetone solution at room temperature. Moreover, the thermodynamic phase transition from alpha-form to beta-form was found to take place above 88 degrees C, as confirmed by differential scanning calorimetry measurement, optical microscopic observation under crossed Nicols, and powder X-ray diffraction measurement. The phase transition from alpha-form to beta-form was also observed at 78 degrees C by photochromic reaction of 1a, and the phase transition proceeded from the UV irradiated part to the nonirradiated part.	[Iwaihara, Chika; Kitagawa, Daichi; Kobatake, Seiya] Osaka City Univ, Grad Sch Engn, Dept Appl Chem, Sumiyoshi Ku, Osaka 5588585, Japan	Kobatake, S (reprint author), Osaka City Univ, Grad Sch Engn, Dept Appl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	kobatake@a-chem.eng.osaka-cu.ac.jp	Kitagawa, Daichi/F-7255-2014; Kobatake, Seiya/P-4989-2015	Kitagawa, Daichi/0000-0002-1994-3047; Kobatake, Seiya/0000-0002-1526-4629	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [26107013]; Japan Society for the Promotion of Science (JSPS) [24550161]	This work was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Photosynergetics" (No. 26107013) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and a Grant-in-Aid for Scientific Research (C) (No. 24550161) from the Japan Society for the Promotion of Science (JSPS). D.K. appreciates Research Fellowships of JSPS for Young Scientists. The authors also thank Nippon Zeon Co., Ltd. for providing octafluorocyclopentene.	Kobatake S, 2011, CRYST GROWTH DES, V11, P1223, DOI 10.1021/cg101448m; Zhang GQ, 2010, J AM CHEM SOC, V132, P2160, DOI 10.1021/ja9097719; Chen S, 2005, J AM CHEM SOC, V127, P9881, DOI 10.1021/ja052098t; CARDEW PT, 1985, P ROY SOC LOND A MAT, V398, P415, DOI 10.1098/rspa.1985.0043; Uchida K, 2010, ANGEW CHEM INT EDIT, V49, P5942, DOI 10.1002/anie.201000793; Kitagawa D, 2013, J PHYS CHEM C, V117, P20887, DOI 10.1021/jp4083079; Uchida K, 2006, ANGEW CHEM INT EDIT, V45, P6470, DOI 10.1002/anie.200602126; Kobatake S, 2009, NEW J CHEM, V33, P1362, DOI 10.1039/b822372f; Yu L, 2000, J AM CHEM SOC, V122, P585, DOI 10.1021/ja9930622; Kitagawa D, 2013, ANGEW CHEM INT EDIT, V52, P9320, DOI 10.1002/anie.201304670; Luo XL, 2011, ADV MATER, V23, P3261, DOI 10.1002/adma.201101059; Uchida K, 2008, CHEM COMMUN, P326, DOI 10.1039/b715251e; Kitagawa D, 2011, B CHEM SOC JPN, V84, P141, DOI 10.1246/bcsj.20100274; Kobayashi H, 2004, CHEM REV, V104, P5265, DOI 10.1021/cr030657d; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Kitagawa D, 2014, PHOTOCH PHOTOBIO SCI, V13, P764, DOI 10.1039/c3pp50417d; Mori T, 2004, CHEM REV, V104, P4947, DOI 10.1021/cr030660x; Terao F, 2012, ANGEW CHEM INT EDIT, V51, P901, DOI 10.1002/anie.201105585; Kuroki L, 2010, PHOTOCH PHOTOBIO SCI, V9, P221, DOI 10.1039/b9pp00093c; Kobatake S, 2007, NATURE, V446, P778, DOI 10.1038/nature05669; Irie M, 2014, CHEM REV, V114, P12174, DOI 10.1021/cr500249p; Shoji H, 2013, CHEM COMMUN, V49, P2362, DOI 10.1039/c3cc00053b; Harada N, 2013, CRYST GROWTH DES, V13, P4705, DOI 10.1021/cg401386b; Kitagawa D, 2010, CHEM COMMUN, V46, P3723, DOI 10.1039/c0cc00061b; Morimoto M, 2010, J AM CHEM SOC, V132, P14172, DOI 10.1021/ja105356w; Kitagawa D, 2011, CHEM-EUR J, V17, P9825, DOI 10.1002/chem.201100385; Mutai T, 2008, ANGEW CHEM INT EDIT, V47, P9522, DOI 10.1002/anie.200803975; Kitagawa D, 2012, CHEM SCI, V3, P1445, DOI 10.1039/c2sc20051a; Bernstein J., 2002, POLYMORPHISM MOL CRY; Feringa B. L., 2001, MOL SWITCHES, P37; Irie M., 2001, ELECT TRANSFER CHEM, P215; Izumi N, 2008, JPN J APPL PHYS, V47, P7298, DOI 10.1143/JJAP.47.7298; Izumi N, 2009, NEW J CHEM, V33, P1324, DOI 10.1039/b821329a; Kitagawa D, 2011, CHEM LETT, V40, P93, DOI 10.1246/cl.2011.93; Kitagawa D, 2014, CHEM-ASIAN J, V9, P289, DOI 10.1002/asia.201301020; Kobatake S, 2002, CHEM COMMUN, P2804, DOI 10.1039/b208419h; Kodama R, 2015, CHEM COMMUN, V51, P1736, DOI 10.1039/c4cc07790c; Morimoto M, 2003, CHEM-EUR J, V9, P621, DOI 10.1002/chem.200390066; Nakamura S, 2011, J PHOTOCH PHOTOBIO C, V12, P138, DOI 10.1016/j.jphotochemrev.2011.07.002; Nishikawa N, 2013, LANGMUIR, V29, P8164, DOI 10.1021/la4014834; Nishikawa N, 2012, LANGMUIR, V28, P17817, DOI 10.1021/la3043846; Shoji H, 2014, NEW J CHEM, V38, P933, DOI 10.1039/c3nj01246h; Uyama A, 2011, LANGMUIR, V27, P6395, DOI 10.1021/la2006524; Yamamoto S, 2003, ORG LETT, V5, P1769, DOI 10.1021/ol034440h	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	APR	2015	15	4					2017	2023		10.1021/acs.cgd.5b00196		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CF0PG	WOS:000352246100058		
J	Tsuda, I				Tsuda, Ichiro			Chaotic itinerancy and its roles in cognitive neurodynamics	CURRENT OPINION IN NEUROBIOLOGY			English	Article							NONEQUILIBRIUM NEURAL-NETWORKS; SELF-ORGANIZED CRITICALITY; MEMORY; BRAIN; COORDINATION; BEHAVIOR; MODEL	Chaotic itinerancy is an autonomously excited trajectory through high-dimensional state space of cortical neural activity that causes the appearance of a temporal sequence of quasi-attractors. A quasi-attractor is a local region of weakly convergent flows that represent ordered activity, yet connected to divergent flows representing disordered, chaotic activity between the regions. In a cognitive neurodynamic aspect, quasi-attractors represent perceptions, thoughts and memories, chaotic trajectories between them with intelligent searches, such as history-dependent trial-and-error via exploration, and itinerancy with history-dependent sequences in thinking, speaking and writing.	Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido 0600012, Japan	Tsuda, I (reprint author), Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Kita 12,Nishi 7, Sapporo, Hokkaido 0600012, Japan.	tsuda@math.sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [4103, 21120002]; HFSPO [HFSP.RGP0039]	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'The study on the neural dynamics for understanding communication in terms of complex hetero systems (No. 4103)' (21120002) of The Ministry of Education, Culture, Sports, Science, and Technology, Japan, and was partially supported by HFSPO (HFSP.RGP0039).	Amari S, 2011, ADV COGN NEURODYN 2, P3, DOI 10.1007/978-90-481-9695-1_1; Amari S, 2013, NEURAL NETWORKS, V37, P48, DOI 10.1016/j.neunet.2012.09.014; Amari S. I., 2000, METHODS INFORM GEOME; Matsuzawa T, 2013, CURR OPIN NEUROBIOL, V23, P443, DOI 10.1016/j.conb.2013.01.012; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793; TSUDA I, 1992, NEURAL NETWORKS, V5, P313, DOI 10.1016/S0893-6080(05)80029-2; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Kaneko K, 2003, CHAOS, V13, P926, DOI 10.1063/1.1607783; Pan XC, 2008, NAT NEUROSCI, V11, P703, DOI 10.1038/nn.2128; Wang XJ, 1996, J NEUROSCI, V16, P6402; MILNOR J, 1985, COMMUN MATH PHYS, V99, P177, DOI 10.1007/BF01212280; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Freeman WJ., 1999, BRAINS MAKE THEIR MI; Hatakeyamaa M, 2007, BIOSYSTEMS, V90, P273, DOI 10.1016/j.biosystems.2006.09.031; Kurikawa T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002943; Kawasaki M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01692; Kelso JAS, 2013, NEURAL NETWORKS, V37, P120, DOI 10.1016/j.neunet.2012.09.003; Kozma R, 2012, CRITICALITY IN NEURA, P1; Li YT, 2013, COGN NEURODYNAMICS, V7, P225, DOI 10.1007/s11571-012-9231-z; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Osawa M, 2014, HON, P54; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Searle John Rogers, 1979, EXPRESSION MEANING; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161; Tognoli E, 2014, NEURON, V81, P35, DOI 10.1016/j.neuron.2013.12.022; Tsuda Ichiro, 2004, Journal of Integrative Neuroscience, V3, P159, DOI 10.1142/S021963520400049X; Tsuda I, 2014, ADV COGN NE IN PRESS; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P810; Tsuda I., 2013, SCHOLARPEDIA, V8, P4459; Tsuda I, 2009, CHAOS, V19; Tsuda I., 1991, WORLD FUTURES, V32, P167; Tsukada H, 2013, COGN NEURODYNAMICS, V7, P409, DOI 10.1007/s11571-013-9244-2; Yamaguti Y, 2014, NEURAL NETW IN PRESS	33	3	3	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-4388	1873-6882		CURR OPIN NEUROBIOL	Curr. Opin. Neurobiol.	APR	2015	31						67	71		10.1016/j.conb.2014.08.011		5	Neurosciences	Neurosciences & Neurology	CF6QH	WOS:000352680700012		
J	Kawasaki, H				Kawasaki, Hiroshi			Spatio-temporal regulation of the formation of the somatosensory system	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						barrel; barrel nets; birth; serotonin; somatosensory system	LESION-INDUCED PLASTICITY; CRITICAL PERIOD PLASTICITY; MOUSE BARREL CORTEX; LAYER 2/3 NEURONS; MONOAMINE-OXIDASE; AXONAL PATTERNS; MICE; NEOCORTEX; RECEPTOR; BIRTH	The somatosensory system in the brain has been widely used for investigating the mechanisms underlying neural circuit formation and developmental neural plasticity. In the primary somatosensory cortex (S1) of rodents, there are discrete cytoarchitectonic units called barrels. Reverse genetic analyses using knockout mice have revealed molecules that control spatial pattern formation of barrels in S1. Glutamatergic receptors such as the NMDA receptor and mGluR5, and molecules related to serotonin such as serotonin transporter and monoamine oxidase A are essential for the formation of barrels. In addition to the mechanisms of spatial pattern formation, those regulating the timing of developmental processes were uncovered recently. Barrels are formed soon after the birth of newborn mouse pups from their mothers, and it was shown that the timing of barrel formation was determined by the timing of the birth of mouse pups. The mechanisms downstream of birth were also examined. It would be intriguing to examine if the mechanisms found using the somatosensory system are applicable to other brain regions.	[Kawasaki, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Biophys Genet, Kanazawa, Ishikawa 9208640, Japan; [Kawasaki, Hiroshi] Kanazawa Univ, Brain Liver Interface Med Res Ctr, Kanazawa, Ishikawa 9208640, Japan	Kawasaki, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Biophys Genet, Kanazawa, Ishikawa 9208640, Japan.	hiroshi-kawasaki@umin.ac.jp	Kawasaki, Hiroshi/C-4404-2015; 	Kawasaki, Hiroshi/0000-0002-2514-1497	Ministry of Education, Culture, Sports, Science and Technology-Japan	Apologies are due to the numerous authors whose valuable papers were not cited due to space limitations. We are grateful to Drs S. Tsuji, T. Kadowaki, H. Bito (The University of Tokyo), E. Nishida (Kyoto University), the late Y. Sasai (RIKEN CDB) and S. Nakanishi (Osaka Bioscience Institute) for their continuous support and warm encouragement. We thank Kawasaki lab members for their contributions. This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology-Japan.	Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; Sehara K, 2012, NEUROSCIENCE, V226, P289, DOI 10.1016/j.neuroscience.2012.09.010; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Persico AM, 2001, J NEUROSCI, V21, P6862; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Takasaki C, 2008, J NEUROSCI, V28, P4995, DOI 10.1523/JNEUROSCI.0861-08.2008; Toda T, 2013, DEV CELL, V27, P32, DOI 10.1016/j.devcel.2013.09.002; Matsui A, 2013, SCIENCE, V342, P1114, DOI 10.1126/science.1244505; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; Ince-Dunn G, 2006, NEURON, V49, P683, DOI 10.1016/j.neuron.2006.01.031; Mizuno H, 2014, NEURON, V82, P365, DOI 10.1016/j.neuron.2014.02.026; Sehara K, 2010, J NEUROSCI, V30, P3082, DOI 10.1523/JNEUROSCI.6096-09.2010; Toda T, 2008, MOL CELL NEUROSCI, V39, P40, DOI 10.1016/j.mcn.2008.05.014; Erzurumlu RS, 2001, TRENDS NEUROSCI, V24, P589, DOI 10.1016/S0166-2236(00)01958-5; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Datwani A, 2002, J NEUROSCI, V22, P9171; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Rebsam A, 2006, DEV PLASTICITY SENSO, P183, DOI 10.1007/978-0-387-38607-2_11; Rebsam A, 2005, J NEUROSCI, V25, P706, DOI 10.1523/JNEUROSCI.4191-04.2005; Salichon N, 2001, J NEUROSCI, V21, P884; Toda T, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-8; Wakimoto M., 2014, CEREB CORTE IN PRESS	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	APR	2015	57	3					193	199		10.1111/dgd.12208		7	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CF8EG	WOS:000352788000001		
J	Matsunaga, E; Nambu, S; Oka, M; Tanaka, M; Taoka, M; Iriki, A				Matsunaga, Eiji; Nambu, Sanae; Oka, Mariko; Tanaka, Michio; Taoka, Miki; Iriki, Atsushi			Periostin, a neurite outgrowth-promoting factor, is expressed at high levels in the primate cerebral cortex	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						electroporation; macaque; marmoset; mouse; primary culture	HUMAN BRAIN; TRANSCRIPTIONAL LANDSCAPE; CADHERIN EXPRESSION; OSVZ PROGENITORS; GENE-EXPRESSION; EVOLUTION; NEOCORTEX; SYSTEM; MOUSE; MALFORMATIONS	Periostin (POSTN or osteoblast specific factor) is an extracellular matrix protein originally identified as a protein highly expressed in osteoblasts. Recently, periostin has been reported to function in axon regeneration and neuroprotection. In the present study, we focused on periostin function in cortical evolution. We performed a comparative gene expression analysis of periostin between rodents (mice) and primates (marmosets and macaques). Periostin was expressed at higher levels in the primate cerebral cortex compared to the mouse cerebral cortex. Furthermore, we performed overexpression experiments of periostin invivo and invitro. Periostin exhibited neurite outgrowth activity in cortical neurons. These results suggested the possibility that prolonged and increased periostin expression in the primate cerebral cortex enhances the cortical plasticity of the mammalian cerebral cortex.	[Matsunaga, Eiji; Nambu, Sanae; Oka, Mariko; Tanaka, Michio; Taoka, Miki; Iriki, Atsushi] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan	Matsunaga, E (reprint author), RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan.	Eiji.Matsunaga@brain.riken.jp			NBRP "Japanese Monkeys" through the National Bio-Resource Project of the MEXT, Japan; JSPS KAKENHI [25750403]; Takeda Science Foundation; JSPS through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," - initiated by the Council for Science and Technology Policy (CSTP); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by the MEXT of Japan	We thank RIKEN RRC for DNA sequence analysis and the FANTOM Consortium Core Group for mouse cDNA clone and Dr Shigeyoshi Itohara for lab facility. The monkeys used in this study were provided by NBRP "Japanese Monkeys" through the National Bio-Resource Project of the MEXT, Japan. This work was supported by JSPS KAKENHI Grant number 25750403 and Takeda Science Foundation (to E.M.), the JSPS through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP) and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by the MEXT of Japan (to A.I.).	Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Zhu SM, 2008, J HISTOCHEM CYTOCHEM, V56, P329, DOI 10.1369/jhc.7A7321.2007; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Shih CH, 2014, J NEUROSCI, V34, P2438, DOI 10.1523/JNEUROSCI.2947-13.2014; Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Tabata H, 2008, DEV GROWTH DIFFER, V50, P507, DOI [10.1111/j.1440-169X.2008.01043.x, 10.1111/j.1440-169x.2008.01043.x]; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Hata K, 2013, J NEUROSCI, V33, P19704, DOI 10.1523/JNEUROSCI.2355-13.2013; Higo N, 2010, J COMP NEUROL, V518, P2633, DOI 10.1002/cne.22356; Kaas JH, 2012, PROG BRAIN RES, V195, P91, DOI 10.1016/B978-0-444-53860-4.00005-2; Krubitzer L, 2009, ANN NY ACAD SCI, V1156, P44, DOI 10.1111/j.1749-6632.2009.04421.x; LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006; Li J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002692; Mashiko H, 2012, J NEUROSCI, V32, P5039, DOI 10.1523/JNEUROSCI.4788-11.2012; Matsunaga E, 2013, J COMP NEUROL, V521, P4027, DOI 10.1002/cne.23389; Matsunaga E, 2015, NEUROSCIENCE, V284, P566, DOI 10.1016/j.neuroscience.2014.10.032; Matsunaga E, 2014, DEV GROWTH DIFFER, V56, P535, DOI 10.1111/dgd.12154; Matsunaga E, 2011, J COMP NEUROL, V519, P1736, DOI 10.1002/cne.22598; Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454; Shimamura M, 2012, STROKE, V43, P1108, DOI 10.1161/STROKEAHA.111.636662; Stenzel D, 2014, DEVELOPMENT, V141, P1419, DOI 10.1242/dev.108902; Takaji M, 2009, CEREB CORTEX, V19, P2865, DOI 10.1093/cercor/bhp062; Yamamori T, 2011, PROG NEUROBIOL, V94, P201, DOI 10.1016/j.pneurobio.2011.04.008	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	APR	2015	57	3					200	208		10.1111/dgd.12194		9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CF8EG	WOS:000352788000002		
J	Hwang, B; An, Y; Agata, K; Umesono, Y				Hwang, Byulnim; An, Yang; Agata, Kiyokazu; Umesono, Yoshihiko			Two distinct roles of the yorkie/yap gene during homeostasis in the planarian Dugesia japonica	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						homeostasis; osmoregulation; planarian; stem cells; Yorkie; Yap	HIPPO SIGNALING PATHWAY; CELL-PROLIFERATION; PROMOTES APOPTOSIS; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; EXCRETORY SYSTEM; TEAD/TEF FAMILY; SIZE-CONTROL; STEM-CELLS; REGENERATION	Adult planarians possess somatic pluripotent stem cells called neoblasts that give rise to all missing cell types during regeneration and homeostasis. Recent studies revealed that the Yorkie (Yki)/Yes-associated protein (YAP) transcriptional coactivator family plays an important role in the regulation of tissue growth during development and regeneration, and therefore we investigated the role of a planarian yki-related gene (termed Djyki) during regeneration and homeostasis of the freshwater planarian Dugesiajaponica. We found that knockdown of the function of Djyki by RNA interference (RNAi) downregulated neoblast proliferation and caused regeneration defects after amputation. In addition, DjykiRNAi caused edema during homeostasis. These seemingly distinct defects induced by DjykiRNAi were rescued by simultaneous RNAi of a planarian mats-related gene (termed Djmats), suggesting an important role of Djmats in the negative regulation of Djyki, in accordance with the conservation of the functional relationship of these two genes during the course of evolution. Interestingly, Djyki RNAi did not prevent normal protonephridial structure, suggesting that Djyki RNAi induced the edema phenotype without affecting the excretory system. Further analyses revealed that increased expression of the D.japonica gene DjaquaporinA (DjaqpA), which belongs to a large gene family that encodes a water channel protein for the regulation of transcellular water flow, promoted the induction of edema, but not defects in neoblast dynamics, in Djyki(RNAi) animals. Thus, we conclude that Djyki plays two distinct roles in the regulation of active proliferation of stem cells and in osmotic water transport across the body surface in D.japonica.	[Hwang, Byulnim; An, Yang; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan; [Umesono, Yoshihiko] Hyogo Univ, Grad Sch Life Sci, Kobe, Hyogo 6500044, Japan	Umesono, Y (reprint author), Hyogo Univ, Grad Sch Life Sci, Kobe, Hyogo 6500044, Japan.	yumesono@sci.u-hyogo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22124004, 22124001]	We thank Dr Elizabeth Nakajima for critical reading of the manuscript, and all other laboratory members for their help and encouragement. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas to Y.U. (22124004), a Grant-in-Aid for Scientific Research on Innovative Areas to K.A. (22124001), and a scholarship from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to B.H.	Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Umesono Y, 2009, DEV GROWTH DIFFER, V51, P185, DOI 10.1111/j.1440-169X.2009.01099.x; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Ogawa K, 2002, DEV BIOL, V250, P59, DOI 10.1006/dbio.2002.0790; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Scimone ML, 2011, DEVELOPMENT, V138, P4387, DOI 10.1242/dev.068098; Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Lin AYT, 2014, DEVELOPMENT, V141, P1197, DOI 10.1242/dev.101915; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025; Umesono Y, 1997, DEV GROWTH DIFFER, V39, P723; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997; Sakurai T, 2012, INT J DEV BIOL, V56, P173, DOI 10.1387/ijdb.113439ts; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Rink JC, 2011, DEVELOPMENT, V138, P3769, DOI 10.1242/dev.066852; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Agata K, 1999, SEMIN CELL DEV BIOL, V10, P377, DOI 10.1006/scdb.1999.0324; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Mineta K, 2003, P NATL ACAD SCI USA, V100, P7666, DOI 10.1073/pnas.1332513100; Carbrey JM, 2009, HDB EXP PHARM, V190, P3, DOI DOI 10.1007/978-3-540-79885-9_; Demircan T, 2013, STEM CELLS DEV, V22, P2174, DOI 10.1089/scd.2013.0006; Hayashi S, 2014, DEV BIOL, V388, P57, DOI 10.1016/j.ydbio.2014.01.018; Nishimura O, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-289; Rouhana L, 2013, DEV DYNAM, V242, P718, DOI 10.1002/dvdy.23950; Zador Z, 2009, HDB EXP PHARM, V190, P159	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	APR	2015	57	3					209	217		10.1111/dgd.12195		9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CF8EG	WOS:000352788000003		
J	Yanagi, T; Ito, K; Nishihara, A; Minamino, R; Mori, S; Sumida, M; Hashimoto, C				Yanagi, Takanori; Ito, Kenta; Nishihara, Akiha; Minamino, Reika; Mori, Shoko; Sumida, Masayuki; Hashimoto, Chikara			The Spemann organizer meets the anterior-most neuroectoderm at the equator of early gastrulae in amphibian species	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						amphibian; chordate; gastrulation; movement; Spemann organizer	IN-SITU HYBRIDIZATION; DORSAL MARGINAL ZONE; XENOPUS GASTRULATION; SUPERFICIAL LAYER; GENE-EXPRESSION; MESODERM; EMBRYOS; MORPHOGENESIS; FIBRONECTIN; INDUCTION	The dorsal blastopore lip (known as the Spemann organizer) is important for making the body plan in amphibian gastrulation. The organizer is believed to involute inward and migrate animally to make physical contact with the prospective head neuroectoderm at the blastocoel roof of mid- to late-gastrula. However, we found that this physical contact was already established at the equatorial region of very early gastrula in a wide variety of amphibian species. Here we propose a unified model of amphibian gastrulation movement. In the model, the organizer is present at the blastocoel roof of blastulae, moves vegetally to locate at the region that lies from the blastocoel floor to the dorsal lip at the onset of gastrulation. The organizer located at the blastocoel floor contributes to the anterior axial mesoderm including the prechordal plate, and the organizer at the dorsal lip ends up as the posterior axial mesoderm. During the early step of gastrulation, the anterior organizer moves to establish the physical contact with the prospective neuroectoderm through the subduction and zippering movements. Subduction makes a trench between the anterior organizer and the prospective neuroectoderm, and the tissues face each other via the trench. Zippering movement, with forming Brachet's cleft, gradually closes the gap to establish the contact between them. The contact is completed at the equator of early gastrulae and it continues throughout the gastrulation. After the contact is established, the dorsal axis is formed posteriorly, but not anteriorly. The model also implies the possibility of constructing a common model of gastrulation among chordate species.	[Yanagi, Takanori; Ito, Kenta; Nishihara, Akiha; Minamino, Reika; Mori, Shoko; Hashimoto, Chikara] JT Biohist Res Hall, Takatsuki, Osaka 5691125, Japan; [Yanagi, Takanori; Ito, Kenta; Minamino, Reika; Hashimoto, Chikara] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Sumida, Masayuki] Hiroshima Univ, Inst Amphibian Biol, Higashihiroshima, Hiroshima 7398526, Japan	Hashimoto, C (reprint author), JT Biohist Res Hall, 1-1 Murasaki Cho, Takatsuki, Osaka 5691125, Japan.	hashimoto@brh.co.jp					Moosmann J, 2013, NATURE, V497, P374, DOI 10.1038/nature12116; SHIH J, 1992, DEVELOPMENT, V116, P887; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Hara Y, 2013, DEV BIOL, V382, P482, DOI 10.1016/j.ydbio.2013.07.023; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472; Moya IM, 2007, DEV BIOL, V304, P467, DOI 10.1016/j.ydbio.2006.12.036; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; WINKLBAUER R, 1991, DEV BIOL, V148, P573, DOI 10.1016/0012-1606(91)90275-8; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Zhang SC, 1997, DEV GENES EVOL, V206, P532, DOI 10.1007/s004270050083; BLITZ IL, 1995, DEVELOPMENT, V121, P993; BOUCAUT JC, 1984, NATURE, V307, P364, DOI 10.1038/307364a0; Butler K, 2001, METHODS, V23, P303, DOI 10.1006/meth.2000.1142; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; delsPino E M., 2007, P NATL ACAD SCI USA, V104, P11882; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Jeffery W. R, 1992, DEVELOPMENT S, V116, P53; JOHNSON KE, 1993, J EXP ZOOL, V265, P40, DOI 10.1002/jez.1402650107; Kaneda T, 2012, DEV BIOL, V369, P1, DOI 10.1016/j.ydbio.2012.05.019; Kaneda T, 2009, DEV BIOL, V334, P84, DOI 10.1016/j.ydbio.2009.07.032; Keibfl F., 1925, NORMENTAFELN ENTWICK; KELLER RE, 1975, DEV BIOL, V42, P222, DOI 10.1016/0012-1606(75)90331-0; Koide T, 2002, INT J DEV BIOL, V46, P777; Kuroda H, 2004, PLOS BIOL, V2, P623, DOI 10.1371/journal.pbio.0020092; Munro E, 2006, CURR OPIN GENET DEV, V16, P399, DOI 10.1016/j.gde.2006.06.004; Nakamura Osamu, 1942, ANNOT ZOOL JAPONENSES, V21, P169; NAKATSUJI N, 1982, J CELL SCI, V56, P207; Nieuwkoop P.D., 1956, NORMAL TABLE XENOPUS; Okada YK, 1947, JPN J EXP MORPHOL, V3, P1; Papan C, 2007, DEV BIOL, V305, P161, DOI 10.1016/j.ydbio.2007.02.005; Poznanski A, 1997, DEV BIOL, V184, P351, DOI 10.1006/dbio.1996.8500; Shook DR, 2002, DEV BIOL, V248, P220, DOI 10.1006/dbio.2002.0718; SLACK JMW, 1994, DEV BIOL, V161, P313, DOI 10.1006/dbio.1994.1031; Vogt W, 1929, WILHELM ROUX ARCH EN, V120, P384, DOI 10.1007/BF02109667; Winklbauer R, 1999, DEVELOPMENT, V126, P3703; Yamaguti M, 2005, DEV DYNAM, V234, P102, DOI 10.1002/dvdy.20523; Yokota C, 1998, DEV GROWTH DIFFER, V40, P335	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	APR	2015	57	3					218	231		10.1111/dgd.12200		14	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CF8EG	WOS:000352788000004		
J	Murai, H; Tadokoro, R; Sakai, KI; Takahashi, Y				Murai, Hidetaka; Tadokoro, Ryosuke; Sakai, Ken-Ichiro; Takahashi, Yoshiko			In ovo gene manipulation of melanocytes and their adjacent keratinocytes during skin pigmentation of chicken embryos	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						dendrite; G418; in ovo electroporation; melanin; retrovirus	EPIDERMAL MELANOCYTES; MERKEL CELLS; DIFFERENTIATION; MICROFILAMENTS; PROLIFERATION; MICROTUBULES	During skin pigmentation in avians and mammalians, melanin is synthesized in the melanocytes, and subsequently transferred to adjacently located keratinocytes, leading to a wide coverage of the body surface by melanin-containing cells. The behavior of melanocytes is influenced by keratinocytes shown mostly by invitro studies. However, it has poorly been investigated how such intercellular cross-talk is regulated invivo because of a lack of suitable experimental models. Using chicken embryos, we developed a method that enables invivo gene manipulations of melanocytes and keratinocytes, where these cells are separately labeled by different genes. Two types of gene transfer techniques were combined: one was a retrovirus-mediated gene infection into the skin/keratinocytes, and the other was the in ovo DNA electroporation into neural crest cells, the origin of melanocytes. Since the Replication-Competent Avian sarcoma-leukosis virus long terminal repeat with Splice acceptor (RCAS) infection was available only for the White leghorn strain showing little pigmentation, melanocytes prepared from the Hypeco nera (pigmented) were back-transplanted into embryos of White leghorn. Prior to the transplantation, enhanced green fluorescent protein (EGFP)(+)Neo(r+)-electroporated melanocytes from Hypeco nera were selectively grown in G418-supplemented medium. In the skin of recipient White leghorn embryos infected with RCAS-mOrange, mOrange(+) keratinocytes and transplanted EGFP(+) melanocytes were frequently juxtaposed each other. High-resolution confocal microscopy also revealed that transplanted melanocytes exhibited normal behaviors regarding distribution patterns of melanocytes, dendrite morphology, and melanosome transfer. The method described in this study will serve as a useful tool to understand the mechanisms underlying intercellular regulations during skin pigmentation invivo.	[Murai, Hidetaka; Tadokoro, Ryosuke; Takahashi, Yoshiko] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; [Murai, Hidetaka; Sakai, Ken-Ichiro] NARA, Grad Sch Biol Sci, Nara Inst Sci & Technol, Takayama, Ikoma 6300192, Japan; [Takahashi, Yoshiko] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Takahashi, Y (reprint author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.	yotayota@develop.zool.kyoto-u.ac.jp			National BioResource Project Chicken/Quail from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cosmetology Research Foundation; Mitsubishi Foundation; Takeda Science Foundation	We thank Dr H. Kokubu (Kyoto Univ) for helpful suggestions concerning mathematical analyses. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, a Grant-in-Aid for Scientific Research (C), and the National BioResource Project Chicken/Quail from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, This study was also supported by The Cosmetology Research Foundation, The Mitsubishi Foundation, and Takeda Science Foundation.	ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Bertolotto C, 1998, MOL CELL BIOL, V18, P694; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; KIM DK, 1995, J INVEST DERMATOL, V104, P411, DOI 10.1111/1523-1747.ep12665903; HARA M, 1994, J CELL SCI, V107, P2739; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Aspengren S, 2009, INT REV CEL MOL BIO, V272, P245, DOI 10.1016/S1937-6448(08)01606-7; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Yokota Y, 2011, DEV BIOL, V353, P382, DOI 10.1016/j.ydbio.2011.02.001; Yoshida H, 1996, DEVELOPMENT, V122, P1207; HUGHES SH, 1987, J VIROL, V61, P3004; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; FUNASAKA Y, 1992, MOL BIOL CELL, V3, P197; JIMBOW K, 1973, YALE J BIOL MED, V46, P411; Kormos B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017197; Kotani T, 2006, METHODS, V39, P199, DOI 10.1016/j.ymeth.2005.12.006; MAYERSON PL, 1981, J CELL SCI, V51, P25; MORISITA M., 1962, RES POPUL ECOL, V4, P1, DOI 10.1007/BF02533903; NAFSTAD PHJ, 1986, J ANAT, V145, P25; Nordlund J. J., 2006, GENETIC HYPOMELANOSE, P551; Scott G, 2002, PIGM CELL RES, V15, P322, DOI 10.1034/j.1600-0749.2002.02056.x; TORRES AP, 1994, J ANAT, V184, P591; YADA Y, 1991, J BIOL CHEM, V266, P18352; Yoshida K, 2014, J ALLERGY CLIN IMMUN, V134, P856, DOI 10.1016/j.jaci.2014.08.001	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	APR	2015	57	3					232	241		10.1111/dgd.12201		10	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CF8EG	WOS:000352788000005		
J	Yaguchi, S; Yamazaki, A; Wada, W; Tsuchiya, Y; Sato, T; Shinagawa, H; Yamada, Y; Yaguchi, J				Yaguchi, Shunsuke; Yamazaki, Atsuko; Wada, Wakana; Tsuchiya, Yasutaka; Sato, Toshihiko; Shinagawa, Hideo; Yamada, Yutaro; Yaguchi, Junko			Early development and neurogenesis of Temnopleurus reevesii	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						serotonin; temperature tolerance	SEA-URCHIN EMBRYOS; LARVAL NERVOUS-SYSTEM; STRONGYLOCENTROTUS-PURPURATUS; NEURAL DEVELOPMENT; APICAL GANGLION; GENE; SPECIFICATION; TEMPERATURE; EXPRESSION; PATTERNS	Sea urchins are model non-chordate deuterostomes, and studying the nervous system of their embryos can aid in the understanding of the universal mechanisms of neurogenesis. However, despite the long history of sea urchin embryology research, the molecular mechanisms of their neurogenesis have not been well investigated, in part because neurons appear relatively late during embryogenesis. In this study, we used the species Temnopleurus reevesii as a new sea urchin model and investigated the detail of its development and neurogenesis during early embryogenesis. We found that the embryos of T.reevesii were tolerant of high temperatures and could be cultured successfully at 15-30 degrees C during early embryogenesis. At 30 degrees C, the embryos developed rapidly enough that the neurons appeared at just after 24h. This is faster than the development of other model urchins, such as Hemicentrotus pulcherrimus or Strongylocentrotus purpuratus. In addition, the body of the embryo was highly transparent, allowing the details of the neural network to be easily captured by ordinary epifluorescent and confocal microscopy without any additional treatments. Because of its rapid development and high transparency during embryogenesis, T.reevesii may be a suitable sea urchin model for studying neurogenesis. Moreover, the males and females are easily distinguishable, and the style of early cleavages is intriguingly unusual, suggesting that this sea urchin might be a good candidate for addressing not only neurology but also cell and developmental biology.	[Yaguchi, Shunsuke; Yamazaki, Atsuko; Wada, Wakana; Tsuchiya, Yasutaka; Sato, Toshihiko; Shinagawa, Hideo; Yamada, Yutaro; Yaguchi, Junko] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; [Yaguchi, Shunsuke] Japanese Assoc Marine Biol JAMBIO, Shizuoka 4150025, Japan; [Yaguchi, Junko] JSPS, Tokyo 1020083, Japan	Yaguchi, S (reprint author), Univ Tsukuba, Shimoda Marine Res Ctr, 5-10-1 Shimoda, Shizuoka 4150025, Japan.	yag@shimoda.tsukuba.ac.jp			Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MEXT); Takeda Science Foundation, and Pre-Strategic Initiatives of University of Tsukuba [25440101]; JSPS [23-3584]	This work was supported, in part, by Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MEXT), by Grant-in Aid for Scientific Research (C: No. 25440101), Takeda Science Foundation, and Pre-Strategic Initiatives of University of Tsukuba to S.Y. J.Y. was a Predoctoral Fellows of JSPS with research grant (23-3584). We thank Dr. Yoko Nakajima, for essential reagents.	Yaguchi S, 2008, DEV CELL, V14, P97, DOI 10.1016/j.devcel.2007.10.012; Yaguchi S, 2006, DEVELOPMENT, V133, P2337, DOI 10.1242/dev.02396; Wei Z, 2009, DEVELOPMENT, V136, P1179, DOI 10.1242/dev.032300; Bishop CD, 2013, DEV BIOL, V377, P236, DOI 10.1016/j.ydbio.2013.03.006; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Angerer LM, 2011, DEVELOPMENT, V138, P3613, DOI 10.1242/dev.058172; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; He X, 2008, NAT CELL BIOL, V10, P11, DOI 10.1038/ncb0108-11; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; Croce JC, 2010, DEVELOPMENT, V137, P83, DOI 10.1242/dev.044149; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; BISGROVE BW, 1986, DEV GROWTH DIFFER, V28, P569; BURKE RD, 1983, CELL TISSUE RES, V229, P145; Burke RD, 2006, J COMP NEUROL, V496, P244, DOI 10.1002/cne.20939; Cunningham AW, 2010, ECHINODERMS: DURHAM, P451; FUJISAWA H, 1989, BIOL BULL, V176, P96, DOI 10.2307/1541576; Kitazawa C, 2014, ZOOL STUD, V53, DOI 10.1186/1810-522X-53-3; Kitazawa C, 2010, INFORMATION-TOKYO, V13, P1075; Kiyomoto M, 2014, MAR ENVIRON RES, V93, P102, DOI 10.1016/j.marenvres.2013.08.014; Lapraz F, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000248; LOEB LA, 1969, J BIOL CHEM, V244, P1672; Matsunaga M, 2002, BIOL BULL, V202, P213, DOI 10.2307/1543471; Mizoguchi H, 1999, ZOOL SCI, V16, P341, DOI 10.2108/zsj.16.341; NAKAJIMA Y, 1993, DEV GROWTH DIFFER, V35, P531; Nakajima Y, 2004, EVOL DEV, V6, P95, DOI 10.1111/j.1525-142X.2004.04011.x; ROLLER RA, 1993, MAR BIOL, V116, P583, DOI 10.1007/BF00355477; RYBERG E, 1977, CELL TISSUE RES, V179, P157; Tahara Y., 1960, SETO MAR BIOL LAB, V8, P183; Yaguchi S, 2003, J COMP NEUROL, V466, P219, DOI 10.1002/cne.10865; Yaguchi S, 2007, DEV BIOL, V302, P494, DOI 10.1016/j.ydbio.2006.10.010; Yaguchi S, 2000, DEV GROWTH DIFFER, V42, P479; Yaguchi S, 2011, DEVELOPMENT, V138, P4233, DOI 10.1242/dev.069856	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	APR	2015	57	3					242	250		10.1111/dgd.12202		9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CF8EG	WOS:000352788000006		
J	Nakanoh, S; Fuse, N; Takahashi, Y; Agata, K				Nakanoh, Shota; Fuse, Naoyuki; Takahashi, Yoshiko; Agata, Kiyokazu			Verification of chicken Nanog as an epiblast marker and identification of chicken PouV as Pou5f3 by newly raised antibodies	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						chicken; class V POU transcription factor; epiblast; Nanog; pluripotent	EMBRYONIC STEM-CELLS; TROPHECTODERM DIFFERENTIATION; PLURIPOTENCY; NETWORK; OCT4; EVOLUTION; ENDODERM	Pluripotency is an important feature of early embryonic cells of multicellular organisms. Recent advances in stem cell research have shown that Nanog and Pou5f1 (Oct3/4) play important roles in mammalian pluripotency. However, whether these molecules exert conserved functions in other species remains unknown. Although the epiblast of the early chicken embryo would provide a useful experimental model, a lack of antibodies against chicken Nanog (cNanog) and chicken PouV/Pou5f3 (cPouV) proteins has hampered intensive investigation. Here we report newly raised polyclonal antibodies that specifically recognize cNanog and cPouV proteins. The specificity and sensitivity of the antibodies were validated by both western blotting and immunostaining with transfected 293T cells and chicken embryonic tissues. Immunohistochemistry using these antibodies revealed that cNanog protein was specifically localized in epiblastic cells and germ cells. In contrast, cPouV expression was seen almost ubiquitously. We also found that chicken epiblast-derived colony-forming cells that morphologically resemble mouse embryonic stem cells were cNanog-positive, implying that these colony-forming cells possess pluripotency. The anti-cPouV antibody further enabled us to identify a previously unknown region at the N-terminus of the cPouV protein containing a characteristic motif that is absent in mammalian Pou5f1. Thus, the antibodies raised in this study are useful tools for studying the functions of cNanog and cPouV at the protein level and the molecular mechanisms of chicken pluripotency.	[Nakanoh, Shota; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Fuse, Naoyuki] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Takahashi, Yoshiko] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; [Takahashi, Yoshiko] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Nakanoh, S (reprint author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	nakanoh@mdb.biophys.kyoto-u.ac.jp; agata@mdb.biophys.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22124001, 22124002]	We thank Dr Elizabeth Nakajima for careful reading of the manuscript, Dr Daisuke Saito for instructions for cryosectioning and genomic PCR and Mr Osamu Nishimura for kind advice. This work was supported by a Grant-in-Aid for JSPS Fellows to S. N., and a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan to K. A. (22124001, 22124002).	Frankenberg S, 2010, DEV BIOL, V337, P162, DOI 10.1016/j.ydbio.2009.10.017; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Stern CD, 2012, DEVELOPMENT, V139, P1059, DOI 10.1242/dev.070730; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Fernandez-Tresguerres B, 2010, P NATL ACAD SCI USA, V107, P19955, DOI 10.1073/pnas.1010708107; Frankenberg S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-56; Frankenberg SR, 2014, DEVELOPMENT, V141, P2921, DOI 10.1242/dev.108407; HATADA Y, 1994, DEVELOPMENT, V120, P2879; Nakanoh S, 2013, ZOOL SCI, V30, P543, DOI 10.2108/zsj.30.543; Nichols Jennifer, 2006, V329, P91; Niwa H, 2008, EVOL DEV, V10, P671, DOI 10.1111/j.1525-142X.2008.00280.x; Tapia N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2229; Theunissen TW, 2011, DEVELOPMENT, V138, P4853, DOI 10.1242/dev.068775; Xie Y., 2014, ONCOGENE, V33, P2040	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	APR	2015	57	3					251	263		10.1111/dgd.12205		13	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CF8EG	WOS:000352788000007		
J	Kumagai, Y; Kawada, K; Higashi, M; Ishiguro, T; Sobajima, J; Fukuchi, M; Ishibashi, K; Baba, H; Mochiki, E; Aida, J; Kawano, T; Ishida, H; Takubo, K				Kumagai, Y.; Kawada, K.; Higashi, M.; Ishiguro, T.; Sobajima, J.; Fukuchi, M.; Ishibashi, K.; Baba, H.; Mochiki, E.; Aida, J.; Kawano, T.; Ishida, H.; Takubo, K.			Endocytoscopic observation of various esophageal lesions at x600: can nuclear abnormality be recognized?	DISEASES OF THE ESOPHAGUS			English	Article						digital magnification; endocytoscopy system; esophagus; magnifying endoscopy; squamous cell carcinoma	SQUAMOUS-CELL CARCINOMA; NEWLY DEVELOPED ENDOCYTOSCOPE; MAGNIFYING CHROMOENDOSCOPY; ENDOSCOPY; TECHNOLOGY; MICROSCOPY; HISTOLOGY; GIF-Y0002; SYSTEM	Endocytoscopy (ECS) is a novel endoscopic technique that allows detailed diagnostic examination of the gastrointestinal tract at the cellular level. We previously reported that use of ECS at x380 magnification (GIF-Y0002) allowed a pathologist to diagnose esophageal squamous cell carcinoma (ESCC) with high sensitivity (94.9%) but considerably low specificity (46.7%) because this low magnification did not reveal information about nuclear abnormality. In the present study, we used the same magnifying endoscope to observe various esophageal lesions, but employed digital 1.6-fold magnification to achieve an effective magnification of x600, and evaluated whether this improved the diagnostic accuracy in distinguishing neoplastic from non-neoplastic lesions.We examined the morphology of surface cells using vital staining with toluidine blue and compared the histological features of 40 cases, including 19 case of ESCC and 21 non-neoplastic esophageal lesions (18 cases of esophagitis, 1 case of glycogenic acanthosis, 1 case of leiomyoma, and 1 case of normal squamous epithelium). One endoscopist classified the lesions using the type classification, and we consulted one pathologist for judgment of the ECS images as neoplastic', borderline', or non-neoplastic'. At x600 magnification, the pathologist confirmed that nuclear abnormality became evident, in addition to the information about nuclear density provided by observation at x380. The overall sensitivity and specificity with which the endoscopist was able to predict neoplastic lesions using the type classification was 100% (19/19) and 90.5% (19/21), respectively, in comparison with values of 94.7% (18/19 cases) and 76.2% (16/21), respectively, for the pathologist using a magnification of x600. The pathologist diagnosed two non-neoplastic lesions and one case of ESCC showing an apparent increase of nuclear density with weak nuclear abnormality as borderline'. Among the 21 non-cancerous lesions, two cases of esophagitis that were misdiagnosed by the endoscopist were also misinterpreted as neoplastic' by the pathologist. We have shown, by consultation with a pathologist, that an ECS magnification of x600 (on a 19-inch monitor) is adequate for recognition of nuclear abnormality. We consider that it is feasible to diagnose esophageal neoplasms on the basis of ECS images, and that biopsy histology can be omitted if a combination of increased nuclear density and nuclear abnormality is observed.	[Kumagai, Y.; Ishiguro, T.; Sobajima, J.; Fukuchi, M.; Ishibashi, K.; Baba, H.; Mochiki, E.; Ishida, H.] Saitama Med Univ, Dept Digest Tract & Gen Surg, Saitama Med Ctr, Kawagoe, Saitama 3508550, Japan; [Higashi, M.] Saitama Med Univ, Dept Pathol, Saitama Med Ctr, Kawagoe, Saitama 3508550, Japan; [Kawada, K.; Kawano, T.] Tokyo Med & Dent Univ, Dept Esophageal & Gen Surg, Tokyo, Japan; [Aida, J.; Takubo, K.] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan	Kumagai, Y (reprint author), Saitama Med Univ, Dept Digest Tract & Gen Surg, Saitama Med Ctr, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	kuma7srg1@gmail.com			Saitama Medical University	This study was supported by a grant from Saitama Medical University.	Kumagai Y, 2012, J DIGEST DIS, V13, P393, DOI 10.1111/j.1751-2980.2012.00612.x; Inoue H, 2006, ENDOSCOPY, V38, P891, DOI 10.1055/s-2006-944667; Neumann H, 2011, WORLD J GASTROENTERO, V17, P63, DOI 10.3748/wjg.v17.i1.63; Inoue H, 2005, NAT CLIN PRACT GASTR, V2, P31, DOI 10.1038/ncpgasthep0072; Kumagai Y, 2004, ENDOSCOPY, V36, P590, DOI 10.1055/s-2004-814533; Kudo S, 2014, J GASTROEN HEPATOL, V29, P83, DOI 10.1111/jgh.12374; Muto M, 2009, J GASTROEN HEPATOL, V24, P1333, DOI 10.1111/j.1440-1746.2009.05925.x; Kumagai Y, 2002, LANCET ONCOL, V3, P604, DOI 10.1016/S1470-2045(02)00874-4; Kumagai Y, 2010, DIGEST ENDOSC, V22, P10, DOI 10.1111/j.1443-1661.2009.00931.x; Arima M, 2005, ESOPHAGUS, V2, P191, DOI DOI 10.1007/S10388-005-0060-6; Eberl T, 2007, ENDOSCOPY, V39, P497, DOI 10.1055/s-2007-966446; Endo M, 1997, Dis Esophagus, V10, P155; Inoue Haruhiro, 2004, Gastrointest Endosc Clin N Am, V14, P589, DOI 10.1016/j.giec.2004.03.013; Inoue H, 1997, DIGEST ENDOSC, V9/1, P16, DOI 10.1111/j.1443-1661.1997.tb00453.x; Inoue H, 1996, DIGEST ENDOSC, V8, P134, DOI 10.1111/j.1443-1661.1996.tb00429.x; Kumagai Y, 2010, DIGEST ENDOSC, V22, P259, DOI 10.1111/j.1443-1661.2010.01010.x; Kumagai Y, 2004, DIGEST ENDOSC, V16, P277, DOI 10.1111/j.1443-1661.2004.00358.x; Kumagai Y, 2002, ENDOSCOPY, V34, P369, DOI 10.1055/s-2002-25285; Kumagai Y, 2010, DIS ESOPHAGUS, V23, P627, DOI 10.1111/j.1442-2050.2010.01074.x; Kumagai Y, 2009, DIS ESOPHAGUS, V22, P505, DOI 10.1111/j.1442-2050.2009.00952.x; Kumagai Y, 2007, ESOPHAGUS, V4, P173, DOI 10.1007/s10388-007-0127-7; Minami H, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-22; Newton RC, 2011, LUNG, V189, P111, DOI 10.1007/s00408-011-9282-7; Ohigashi T, 2006, J ENDOUROL, V20, P698, DOI 10.1089/end.2006.20.698; Thekkek N, 2011, WORLD J GASTROENTERO, V17, P53, DOI 10.3748/wjg.v17.i1.53	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1120-8694	1442-2050		DIS ESOPHAGUS	Dis. Esophagus	APR	2015	28	3					269	275		10.1111/dote.12183		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF4EN	WOS:000352501600012		
J	Matsumoto, J; Ariyoshi, N; Sakakibara, M; Nakanishi, T; Okubo, Y; Shiina, N; Fujisaki, K; Nagashima, T; Nakatani, Y; Tamai, I; Yamada, H; Takeda, H; Ishii, I				Matsumoto, Jun; Ariyoshi, Noritaka; Sakakibara, Masahiro; Nakanishi, Takeo; Okubo, Yoshiyuki; Shiina, Nobumitsu; Fujisaki, Kaoru; Nagashima, Takeshi; Nakatani, Yukio; Tamai, Ikumi; Yamada, Harumi; Takeda, Hiroshi; Ishii, Itsuko			Organic anion transporting polypeptide 2B1 expression correlates with uptake of estrone-3-sulfate and cell proliferation in estrogen receptor-positive breast cancer cells	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Organic anion-transporting polypeptide 2B1; Estrone-3-sulfate; Estrogen receptor; Breast cancer; Ki-67; Luminal A-like; Luminal B-Like	STEROID SULFATASE; FUNCTIONAL-ANALYSIS; PROGNOSTIC-FACTOR; CACO-2 CELLS; OATP2B1; CARCINOMA; IDENTIFICATION; PATHWAYS; THERAPY; TISSUES	Estrone-3-sulfate (E1S) is thought to be a major estrogen precursor in estrogen receptor (ER)-positive breast cancer. Since E1S is a hydrophilic compound, the uptake of E1S into cancer cells is probably mediated by transporters, such as organic anion-transporting polypeptide (OATP, SLCO) family. In this study, we investigated the relationship between expression of OATP2B1 and cell proliferation in ER-positive breast cancer. Cell-based assays were carried out in MCF-7 cells both with and without overexpression of OATP2B1. Normal breast and tumor tissues were collected and used in this study. Cell proliferation, ER-mediated transcriptional activities and estradiol secretion were stimulated by addition of E1S to the culture medium of MCF-7 cells. These stimulatory effects were significantly greater in MCF-7 cells overexpressing OATP2B1 than in control cells. The expression level of SLCO2B1 mRNA was significantly correlated with histological grade, Ki-67 labelling index and mRNA expression of steroid sulfatase. The expression level of SLCO2B1 mRNA in luminal B-like cancers was higher than that in luminal A-like cancers. Uptake of E1S resulted in down-regulation of ER alpha protein and induction of Ki-67 in MCF-7 cells. The present study suggests that OATP2B1 is involved in cell proliferation by increasing the amount of estrogen in ER-positive breast cancer cells. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Matsumoto, Jun; Ariyoshi, Noritaka; Ishii, Itsuko] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol, Chiba, Japan; [Matsumoto, Jun; Yamada, Harumi; Takeda, Hiroshi] Int Univ Hlth & Welf, Dept Pharmaceut Sci, Otawara, Tochigi, Japan; [Ariyoshi, Noritaka; Ishii, Itsuko] Chiba Univ Hosp, Div Pharm, Chiba, Japan; [Sakakibara, Masahiro; Okubo, Yoshiyuki; Shiina, Nobumitsu; Fujisaki, Kaoru; Nagashima, Takeshi] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan; [Nakanishi, Takeo; Tamai, Ikumi] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan; [Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba, Japan	Ariyoshi, N (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol, Chiba, Japan.	ariyoshi@ho.chiba-u.ac.jp	TAMAI, Ikumi/D-8412-2015				Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; PASQUALINI JR, 1989, J STEROID BIOCHEM, V34, P155, DOI 10.1016/0022-4731(89)90077-0; Banerjee N, 2012, J PHARMACOL EXP THER, V342, P510, DOI 10.1124/jpet.112.192344; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Suzuki T, 2003, J STEROID BIOCHEM, V86, P449, DOI 10.1016/S0960-0760(03)00356-X; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; Hanggi E, 2006, MOL PHARMACOL, V70, P806, DOI 10.1124/mol.105.019547; Allred DC, 2004, BREAST CANCER RES, V6, P240, DOI 10.1186/bcr938; Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Chetrite GS, 2000, J STEROID BIOCHEM, V72, P23, DOI 10.1016/S0960-0760(00)00040-6; Kis O, 2010, J PHARMACOL EXP THER, V334, P1009, DOI 10.1124/jpet.110.166314; Foster PA, 2008, ENDOCRINOLOGY, V149, P4035, DOI 10.1210/en.2008-0223; Jigorel E, 2006, DRUG METAB DISPOS, V34, P1756, DOI 10.1124/dmd.106.010033; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Muto M, 2007, CANCER SCI, V98, P1570, DOI 10.1111/j.1349-7006.2007.00570.x; Nozawa T, 2002, J PHARMACOL EXP THER, V302, P804, DOI 10.1124/jpet.302.2.804; Maeda T, 2010, J STEROID BIOCHEM, V122, P180, DOI 10.1016/j.jsbmb.2010.06.014; Osborne CK, 2011, CLIN CANCER RES, V17, P1147, DOI 10.1158/1078-0432.CCR-10-1869; Sai Y, 2006, DRUG METAB DISPOS, V34, P1423, DOI 10.1124/dmd.106.009530; Nozawa T, 2004, J PHARMACOL EXP THER, V311, P1032, DOI 10.1124/jpet.104.071522; Nozawa T, 2005, PHARM RES, V22, P1634, DOI 10.1007/s11095-005-7096-0; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Miyoshi Y, 2003, CLIN CANCER RES, V9, P2288; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Stanway SJ, 2007, ONCOLOGIST, V12, P370, DOI 10.1634/theoncologist.12-4-370; Miki Y, 2006, CANCER RES, V66, P535, DOI 10.1158/0008-5472.CAN-05-1070; Hagenbuch B, 2013, MOL ASPECTS MED, V34, P396, DOI 10.1016/j.mam.2012.10.009; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Pizzagalli F, 2003, J CLIN ENDOCR METAB, V88, P3902, DOI 10.1210/jc.2003-030174; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; Cheng XG, 2005, DRUG METAB DISPOS, V33, P1276, DOI 10.1124/dmd.105.003988; Kock K, 2010, J BIOL CHEM, V285, P11336, DOI 10.1074/jbc.M109.056457; Creighton Chad J, 2012, Biologics, V6, P289, DOI 10.2147/BTT.S29923; HENDERSON IC, 1980, NEW ENGL J MED, V302, P17, DOI 10.1056/NEJM198001033020104; HONJO H, 1987, HORM RES, V27, P61, DOI 10.1159/000180788; Kindla J, 2011, CANCER BIOL THER, V11, P584, DOI 10.4161/cbt.11.6.14533; Matsumoto J, 2012, J HUM GENET, V58, P267; Nakata T, 2003, J STEROID BIOCHEM, V86, P455, DOI 10.1016/S0960-0760(03)00357-1; Sakakibara M, 2012, CANCER-AM CANCER SOC, V118, P3899, DOI 10.1002/cncr.26725; Seo HS, 1998, INT J CANCER, V78, P760, DOI 10.1002/(SICI)1097-0215(19981209)78:6<760::AID-IJC14>3.0.CO;2-U; Stute P, 2012, MATURITAS, V71, P376, DOI 10.1016/j.maturitas.2011.12.020; Tirona RG, 2008, CANCER RES, V68, P9338; Wlcek Katrin, 2008, Cancer Biol Ther, V7, P1450, DOI 10.4161/cbt.7.9.6282	45	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	APR	2015	30	2					133	141		10.1016/j.dmpk.2014.10.005		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VR	WOS:000353286000001		
J	Matsunaga, N; Suzuki, K; Nakanishi, T; Ogawa, M; Imawaka, H; Tamai, I				Matsunaga, Norikazu; Suzuki, Kaori; Nakanishi, Takeo; Ogawa, Mikio; Imawaka, Haruo; Tamai, Ikumi			Modeling approach for multiple transporters-mediated drug-drug interactions in sandwich-cultured human hepatocytes: Effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Mathematical modeling; Sandwich-cultured human hepatocytes; Hepatic disposition; Drug transporter; Drug-drug interaction	RENAL-TRANSPLANT PATIENTS; CALCINEURIN INHIBITORS; ALLOGRAFT RECIPIENTS; PHARMACOKINETICS; TACROLIMUS; MOFETIL; IMPACT; METABOLITES; EXCRETION; THERAPY	A lower exposure of mycophenolic acid (MPA) in patients receiving MPA-mofetil in combination with cyclosporin A (CsA) is thought to be due to the inhibition of enterohepatic circulation of phenylglucuronide of MPA (MPAG). This study aimed to evaluate the interaction of CsA with hepatic disposition of MPA and MPAG in sandwich-cultured human hepatocytes (SCHH) by a mathematical modeling approach. In addition, the inhibition of CsA for glucuronidation of MPA to MPAG was examined in human liver microsomes. Inhibitory parameters of CsA for hepatic disposition of MPAG were estimated using a non-linear mixed effect model program, NONMEM. As a result, CsA did not influence the conversion of MPA to MPAG in either SCHH or human liver microsomes. In contrast, CsA inhibited the basolateral uptake of MPAG with an estimated maximum inhibitory effect (I-max) of 32.4%. CsA also inhibited basolateral efflux and biliary excretion of MPAG formed in SCHH, and the concentration producing 50% of I-max (IC50) for biliary excretion was lower than that for basolateral efflux. Our modeling approach suggests that CsA inhibits both basolateral uptake and biliary excretion of MPAG and leads to changes in systemic exposure of MPA and MPAG in humans. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Matsunaga, Norikazu; Nakanishi, Takeo; Tamai, Ikumi] Kanazawa Univ, Dept Membrane Transport & Biopharmaceut, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Matsunaga, Norikazu; Suzuki, Kaori; Ogawa, Mikio; Imawaka, Haruo] Ono Pharmaceut Co Ltd, Pharmacokinet Res Labs, Tsukuba, Ibaraki, Japan	Tamai, I (reprint author), Kanazawa Univ, Dept Membrane Transport & Biopharmaceut, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan.	tamai@p.kanazawa-u.ac.jp	TAMAI, Ikumi/D-8412-2015				Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881; Kobayashi M, 2004, J PHARMACOL EXP THER, V309, P1029, DOI 10.1124/jpet.103.063073; Matsunaga N, 2013, DRUG METAB DISPOS, V41, P735, DOI 10.1124/dmd.112.049817; Picard N, 2010, CLIN PHARMACOL THER, V87, P100, DOI 10.1038/clpt.2009.205; Matsunaga N, 2014, MOL PHARMACEUT, V11, P568, DOI 10.1021/mp400513k; Kotani N, 2011, DRUG METAB DISPOS, V39, P1503, DOI 10.1124/dmd.111.038968; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Michelon H, 2010, PHARMACOGENOMICS, V11, P1703, DOI [10.2217/pgs.10.132, 10.2217/PGS.10.132]; Hirano M, 2006, DRUG METAB DISPOS, V34, P1229, DOI 10.1124/dmd.106.009290; [Anonymous], 2013, LABEL INFORM NEORAL; Falck P, 2008, NEPHROL DIAL TRANSPL, V23, P1048, DOI 10.1093/ndt/gfm632; Brouwer KLR, 2013, CLIN PHARMACOL THER, V94, P95, DOI 10.1038/clpt.2013.81; Shugarts S, 2009, PHARM RES-DORDR, V26, P2039, DOI 10.1007/s11095-009-9924-0; [Anonymous], 2004, DRUG APPR PACK MYF U; Lee JK, 2010, J PHARMACOL EXP THER, V332, P26, DOI 10.1124/jpet.109.156653; Staatz CE, 2007, CLIN PHARMACOKINET, V46, P13, DOI 10.2165/00003088-200746010-00002; Nakanishi T, 2012, TOXICOL APPL PHARM, V263, P244, DOI 10.1016/j.taap.2012.06.016; Zucker K, 1997, TRANSPL IMMUNOL, V5, P225, DOI 10.1016/S0966-3274(97)80042-1; Westley IS, 2006, DRUG METAB DISPOS, V34, P261, DOI 10.1124/dmd.105.006122; Naesens M, 2006, CLIN PHARMACOL THER, V80, P509, DOI 10.1016/j.clpt.2006.08.002; Barraclough KA, 2010, PHARMACOGENOMICS, V11, P369, DOI [10.2217/pgs.10.9, 10.2217/PGS.10.9]; Cremers S, 2005, BRIT J CLIN PHARMACO, V60, P249, DOI 10.1111/j.1365-2125.2005.02398.x; European Medicines Agency, 2012, GUID INV DRUG INT; Fukuda H, 2014, DRUG METAB PHARMACOK, V29, P94, DOI 10.2133/dmpk.DMPK-13-NT-049; Gregoor PJHS, 1999, NEPHROL DIAL TRANSPL, V14, P706, DOI 10.1093/ndt/14.3.706; Hartman JC, 2010, CAN J PHYSIOL PHARM, V88, P682, DOI 10.1139/Y10-060; Horikawa Masato, 2003, Drug Metab Pharmacokinet, V18, P16, DOI 10.2133/dmpk.18.16; Hubner GI, 1999, THER DRUG MONIT, V21, P536, DOI 10.1097/00007691-199910000-00008; Naito T, 2009, J CLIN PHARMACOL, V49, P710, DOI 10.1177/0091270009335003; Picard N, 2006, BRIT J CLIN PHARMACO, V62, P477, DOI 10.1111/j.1365-2125.2006.02509.x; The United States Federal Drug Agency, 2012, GUID IND DRUG INT ST; Yau WP, 2009, J CLIN PHARMACOL, V49, P684, DOI 10.1177/0091270009332813	32	1	1	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	APR	2015	30	2					142	148		10.1016/j.dmpk.2014.10.006		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VR	WOS:000353286000002		
J	Ikeda, M; Tsuji, D; Yamamoto, K; Kim, YI; Daimon, T; Iwabe, Y; Hatori, M; Makuta, R; Hayashi, H; Inoue, K; Nakamichi, H; Shiokawa, M; Itoh, K				Ikeda, Midori; Tsuji, Daiki; Yamamoto, Keisuke; Kim, Yong-Il; Daimon, Takashi; Iwabe, Yutaro; Hatori, Masahiro; Makuta, Ryo; Hayashi, Hideki; Inoue, Kazuyuki; Nakamichi, Hidenori; Shiokawa, Mitsuru; Itoh, Kunihiko			Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Adenosine triphosphate-binding cassette; subfamily B member 1 polymorphism; Neutropenia; Breast neoplasms; Doxorubicin; Cyclophosphamide	P-GLYCOPROTEIN; PHASE-III; DOXORUBICIN DISPOSITION; ADJUVANT CHEMOTHERAPY; MDR1 GENOTYPE; PHARMACOGENETICS; CYCLOPHOSPHAMIDE; TRIAL; PHARMACOKINETICS; EXPRESSION	Chemotherapy-induced neutropenia is one of the major adverse events which results in the reduction of chemotherapy. Doxorubicin is a substrate of the adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) transporter; reportedly, ABCB1 polymorphisms influence doxorubicin pharmacokinetics. We evaluated the association between chemotherapy-induced neutropenia and ABCB1 polymorphisms in patients with breast cancer. We investigated 141 patients with breast cancer treated with doxorubicin and cyclophosphamide (AC) chemotherapy. Peripheral blood samples obtained from patients were genotyped for the ABCB1 2677G>T/A and 3435C>T polymorphisms. The genotypes were then investigated for their association with grade 3 or greater neutropenia, and further their risk factors were examined using a multivariate logistic regression. The proportion of patients with grade 3 or greater neutropenia was 85.7% in the homozygous variant group, and 80% and 58.6% in the heterozygous variant and GG genotype groups, respectively (p = 0.021). The multivariate logistic regression analysis revealed that the ABCB1 2677G>T/A polymorphism was a strong predictor of grade 3 or greater neutropenia (odds ratio: 3.76; 95% confidence interval: 1.44-9.81; p = 0.007). ABCB1 polymorphisms may influence the extent of chemotherapy-induced neutropenia in AC combination-treated patients with breast cancer. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Ikeda, Midori; Tsuji, Daiki; Iwabe, Yutaro; Hatori, Masahiro; Makuta, Ryo; Hayashi, Hideki; Inoue, Kazuyuki; Itoh, Kunihiko] Univ Shizuoka, Sch Pharmaceut Sci, Dept Clin Pharmacol & Genet, Shizuoka 4228526, Japan; [Yamamoto, Keisuke; Nakamichi, Hidenori; Shiokawa, Mitsuru] Seirei Hamamatsu Gen Hosp, Dept Pharm, Hamamatsu, Shizuoka, Japan; [Kim, Yong-Il] Seirei Hamamatsu Gen Hosp, Dept Med Oncol, Hamamatsu, Shizuoka, Japan; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo, Japan	Tsuji, D (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Clin Pharmacol & Genet, Shizuoka 4228526, Japan.	d-tsuji@u-shizuoka-ken.ac.jp					Kuderer NM, 2006, CANCER, V106, P2258, DOI 10.1002/cncr.21847; Sakaeda T, 2001, PHARMACEUT RES, V18, P1400, DOI 10.1023/A:1012244520615; Jones SE, 2006, J CLIN ONCOL, V24, P5381, DOI 10.1200/JCO.2006.06.5391; Lal S, 2010, CURR DRUG METAB, V11, P115; Milojkovic M, 2011, PHARMACOL REP, V63, P808; Siegmund W, 2002, CLIN PHARMACOL THER, V72, P572, DOI 10.1067/mcp.2002.127739; Eiermann W, 2011, J CLIN ONCOL, V29, P3877, DOI 10.1200/JCO.2010.28.5437; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Yano R, 2013, INT J CLIN ONCOL, V18, P96, DOI 10.1007/s10147-011-0349-5; Asano Takeshi, 2003, Pharmacogenetics, V13, P675, DOI 10.1097/00008571-200311000-00003; Barba C, 2004, LANCET, V363, P157; Bray J, 2010, BRIT J CANCER, V102, P1003, DOI 10.1038/sj.bjc.6605587; Chan A, 2012, SUPPORT CARE CANCER, V20, P1525, DOI 10.1007/s00520-011-1241-6; Chua S, 2005, ANN ONCOL, V16, P1435, DOI 10.1093/annonc/mdi276; Gianni L, 2009, J CLIN ONCOL, V27, P4798, DOI 10.1200/JCO.2008.21.4791; Horinouchi M, 2002, PHARMACEUT RES, V19, P1581, DOI 10.1023/A:1020433422259; Komoto C, 2006, DRUG METAB PHARMACOK, V21, P126, DOI 10.2133/dmpk.21.126; Lal S, 2008, CANCER SCI, V99, P816, DOI 10.1111/j.1349-7006.2008.00744.x; Lyman GH, 2005, ONCOLOGIST, V10, P427, DOI 10.1634/theoncologist.10-6-427; Ma B, 2002, RADIOTHER ONCOL, V62, P185, DOI 10.1016/S0167-8140(02)00003-8; Schwenkglenks M, 2011, SUPPORT CARE CANCER, V19, P483, DOI 10.1007/s00520-010-0840-y; Tang NLS, 2013, J CANCER RES CLIN, V139, P419, DOI 10.1007/s00432-012-1345-5; Tellingen O, 2003, BRIT J CANCER, V89, P1776	26	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	APR	2015	30	2					149	153		10.1016/j.dmpk.2014.09.009		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VR	WOS:000353286000003		
J	Furumiya, M; Yamashiro, T; Inoue, K; Nishijima, C; Ohta, K; Hayashi, Y; Yuasa, H				Furumiya, Mai; Yamashiro, Takahiro; Inoue, Katsuhisa; Nishijima, Chihiro; Ohta, Kinya; Hayashi, Yayoi; Yuasa, Hiroaki			Sustained inhibition of proton-coupled folate transporter by myricetin	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Proton-coupled folate transporter; Caco-2 cells; Folate; Methotrexate; Myricetin; Flavonoid; Sustained inhibition; Drug interaction	DRUG-INTERACTIONS; GRAPEFRUIT JUICE; FUNCTIONAL-CHARACTERIZATION; CACO-2 CELLS; CARRIER; MALABSORPTION; MODULATION; ABSORPTION; RAT	Myricetin is a flavonoid that has recently been suggested to interfere with the intestinal folate transport system. To examine that possibility, focusing on its sustained inhibitory effect on proton-coupled folate transporter (PCFT), the uptake of folate was examined in Caco-2 cells, in which PCFT is known to be in operation, in the absence of myricetin in the medium during uptake period after preincubation of the cells with the flavonoid (100 mu M) for 1 h. This pretreatment induced an extensive and sustained reduction in the carrier-mediated component of folate uptake, which was attributable to a reduction in the maximum transport rate (V-max). Although the affinity of the transporter for folate was increased at the same time as indicated by a reduction in the Michaelis constant (K-m), the change in K-m was overwhelmed in extent by that in V-max. Consistent with the finding, folate transport by human PCFT stably expressed in Madin-Darby canine kidney II cells was reduced in a similar manner with simultaneous reductions in V-max and K-m by myricetin pretreatment. Attention may need to be given for a possibility that such a sustained inhibition of PCFT could potentially be a cause of the malabsorption of folate and also antifolate drugs. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Furumiya, Mai; Yamashiro, Takahiro; Nishijima, Chihiro; Ohta, Kinya; Yuasa, Hiroaki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Nagoya, Aichi 4678603, Japan; [Furumiya, Mai; Hayashi, Yayoi] Kinjo Gakuin Univ, Coll Pharm, Dept Biopharmaceut, Nagoya, Aichi, Japan; [Inoue, Katsuhisa] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biopharmaceut, Tokyo, Japan	Yuasa, H (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	yuasa@phar.nagoya-cu.ac.jp					Grimm SW, 2009, DRUG METAB DISPOS, V37, P1355, DOI 10.1124/dmd.109.026716; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; Furumiya M, 2014, DRUG METAB PHARMACOK, V29, P312, DOI 10.2133/dmpk.DMPK-13-RG-107; Hamid A, 2007, FEBS J, V274, P6317, DOI 10.1111/j.1742-4658.2007.06150.x; Vuorinen H, 2000, J AGR FOOD CHEM, V48, P2675, DOI 10.1021/jf991388o; Alemdaroglu NC, 2007, PLANTA MED, V73, P27, DOI 10.1055/s-2006-951745; Huang SM, 2004, CLIN PHARMACOL THER, V75, P1, DOI 10.1016/j.clpt.2003.07.002; SchmiedlinRen P, 1997, DRUG METAB DISPOS, V25, P1228; Brantley SJ, 2014, DRUG METAB DISPOS, V42, P301, DOI 10.1124/dmd.113.055236; Lemos C, 2007, EUR J NUTR, V46, P329, DOI 10.1007/s00394-007-0670-y; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Yuasa H, 2009, J PHARM SCI-US, V98, P1608, DOI 10.1002/jps.21515; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Guo LQ, 2000, DRUG METAB DISPOS, V28, P766; Bailey DG, 2010, BRIT J CLIN PHARMACO, V70, P645, DOI 10.1111/j.1365-2125.2010.03722.x; Dolton MJ, 2012, CLIN PHARMACOL THER, V92, P622, DOI 10.1038/clpt.2012.159; Shitara Y, 2012, DRUG METAB PHARMACOK, V27, P368, DOI 10.2133/dmpk.DMPK-11-RG-096; Bailey DG, 1998, BRIT J CLIN PHARMACO, V46, P101, DOI 10.1046/j.1365-2125.1998.00764.x; Alvarez AI, 2010, J PHARM SCI-US, V99, P598, DOI 10.1002/jps.21851; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Lemos C, 2005, ALCOHOL CLIN EXP RES, V29, P664, DOI 10.1097/01.ALC.0000159114.86360.B5; Shirasaka Y, 2013, DRUG METAB DISPOS, V41, P615, DOI 10.1124/dmd.112.049635; Halsted CH, 2002, J NUTR, V132, p2367S; Shitara Y, 2013, J PHARM SCI-US, V102, P3427, DOI 10.1002/jps.23477	25	1	1	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	APR	2015	30	2					154	159		10.1016/j.dmpk.2014.11.001		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VR	WOS:000353286000004		
J	Sugiyama, I; Bouillon, T; Yamaguchi, M; Suzuki, H; Hirota, T; Fink, M				Sugiyama, Ikuo; Bouillon, Thomas; Yamaguchi, Masayuki; Suzuki, Hikoe; Hirota, Takashi; Fink, Martin			Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Population PK; Oxcarbazepine; Japanese population; Pediatrics; Epilepsy; Ethnic sensitivity assessment	ACTIVE METABOLITE; DOUBLE-BLIND; CARBAMAZEPINE; MECHANISMS; SEIZURES; CHILDREN	Oxcarbazepine is an anti-epileptic drug, which is almost completely metabolized by cytosolic enzymes in the liver to the active 10-monohyroxy metabolite (MHD) following oral administration. The pharmacokinetic (PK) profiles of MHD were evaluated in pediatric epileptic patients and a possible ethnic difference in PK of MHD between Japanese and non-Japanese pediatric patients was assessed. A non-linear mixed effect modeling approach was used to determine the PK of MHD. A one-compartment population model with first-order absorption appropriately described the PK of MHD. No clinically relevant differences were found for using body surface area or weight to explain between-patient variability, therefore the final model included the effects of body weight on apparent clearance (CL/F) and apparent volume of distribution (V/F) of MHD, and in addition, the effect of 3 concomitant anti-epileptic drugs (carbamazepine, phenobarbital and phenytoin) on CL/F of MHD. Inclusion of ethnicity as a covariate in the final model, concluded no ethnic difference with respect to CL/F of MHD between Japanese and non-Japanese patients. Hence, oxcarbazepine can be generally applied using the same dosage and administration for the treatment of partial onset seizures in pediatric patients, regardless of ethnicity. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Sugiyama, Ikuo; Yamaguchi, Masayuki; Suzuki, Hikoe] Novartis Pharma KK, Drug Metab & Pharmacokinet, Tokyo, Japan; [Bouillon, Thomas; Fink, Martin] Novartis Pharma AG, Integrated Quantitat Sci, Basel, Switzerland; [Hirota, Takashi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biopharmaceut, Chiba, Japan	Sugiyama, I (reprint author), Novartis Pharma KK, Drug Metab & Pharmacokinet, Tokyo, Japan.	ikuo.sugiyama@novartis.com					STEFANI A, 1995, EPILEPSIA, V36, P997, DOI 10.1111/j.1528-1157.1995.tb00958.x; BARUZZI A, 1994, EPILEPSIA, V35, pS14, DOI 10.1111/j.1528-1157.1994.tb05939.x; Bergstrand M, 2011, AAPS J, V13, P143, DOI 10.1208/s12248-011-9255-z; Glauser TA, 2000, NEUROLOGY, V54, P2237; DAM M, 1989, EPILEPSY RES, V3, P70; MCLEAN MJ, 1994, EPILEPSIA, V35, pS5, DOI 10.1111/j.1528-1157.1994.tb05949.x; FAIGLE JW, 1990, INT CLIN PSYCHOPHARM, V5, P73; Flesch G, 2004, CLIN DRUG INVEST, V24, P185, DOI 10.2165/00044011-200424040-00001; Harnisch L, 2013, CPT Pharmacometrics Syst Pharmacol, V2, pe28, DOI 10.1038/psp.2013.6; MCKEE PJW, 1994, BRIT J CLIN PHARMACO, V37, P27; Sallas WM, 2003, CLIN PHARMACOL THER, V74, P138, DOI 10.1016/S0009-9236(03)00124-3; SCHMUTZ M, 1994, EPILEPSIA, V35, pS47, DOI 10.1111/j.1528-1157.1994.tb05967.x; TARTARA A, 1993, BRIT J CLIN PHARMACO, V36, P366; WAMIL AW, 1994, EUR J PHARMACOL, V271, P301, DOI 10.1016/0014-2999(94)90787-0	14	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	APR	2015	30	2					160	167		10.1016/j.dmpk.2014.12.002		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VR	WOS:000353286000005		
J	Higuchi, K; Kitamura, A; Okura, T; Deguchi, Y				Higuchi, Kei; Kitamura, Atsushi; Okura, Takashi; Deguchi, Yoshiharu			Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Memantine; Blood-brain barrier; hCMEC/D3 cells; Proton-coupled organic cation antiporter; Active transport	NMDA RECEPTOR ANTAGONIST; ALZHEIMERS-DISEASE; RETINAL BARRIER; LINE HCMEC/D3; H+ ANTIPORTER; INVOLVEMENT; VIVO; AMANTADINE; OXYCODONE	Memantine is clinically used for the treatment of patients with Alzheimer's disease and is highly distributed to the brain. The aim of this study is to characterize memantine transport at the blood-brain barrier (BBB) using hCMEC/D3 cells, a human BBB model. The initial uptake velocity of memantine in hCMEC/D3 cells was concentration-dependent, and was reduced by metabolic inhibitors, but was independent of extracellular sodium ion and membrane potential. Intracellular alkalization and intracellular acidification markedly reduced and enhanced the uptake, respectively. The uptake was strongly inhibited by quinidine, pyrilamine and verapamil, and was moderately inhibited by TEA (substrate of OCTs and OCTNs) and L-carnitine (substrate of OCTN2), but was not inhibited by MPP+ (substrate of OCTs and PMAT) or ergothioneine (substrate of OCTN1). Although relatively abundant expression of OCTN2 gene has been observed in hCMEC/D3 cells, knockdown of OCTN2 with siRNA did not decrease memantine uptake. Memantine and diphenhydramine each showed inhibition of the other's uptake in a competitive manner. Thus, proton-coupled organic cation antiporter(s) appears to be involved in the transport of memantine in hCMEC/D3 cells, at least in part. Our results indicate that the in vivo BBB permeability of memantine in humans can be predicted from the in vitro uptake clearance in hCMEC/D3 cells. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Higuchi, Kei; Kitamura, Atsushi; Okura, Takashi; Deguchi, Yoshiharu] Teikyo Univ, Fac Pharmasci, Lab Drug Disposit & Pharmacokinet, Itabashi Ku, Tokyo 1738605, Japan	Deguchi, Y (reprint author), Teikyo Univ, Fac Pharmasci, Lab Drug Disposit & Pharmacokinet, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	deguchi@pharm.teikyo-u.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [2546019];  [24590213]	We thank Dr. Pierre-Olivier Couraud (Institut Cochin, Paris, France) for supplying hCMEC/D3 cells under license from INSERM. This work was supported in part by a "Grant-in-Aid for Scientific Research (2546019 and 24590213)" and by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2013-2016) provided by "the Ministry of Education, Culture, Sports, Science and Technology of Japan".	Ametamey SM, 2002, NUCL MED BIOL, V29, P227, DOI 10.1016/S0969-8051(01)00293-1; Busch AE, 1998, MOL PHARMACOL, V54, P342; Sonkusare SK, 2005, PHARMACOL RES, V51, P1, DOI 10.1016/j.phrs.2004.05.005; Jimenez-Jimenez FJ, 1998, J NEURAL TRANSM, V105, P269, DOI 10.1007/s007020050056; Andre P, 2009, J CEREBR BLOOD F MET, V29, P1293, DOI 10.1038/jcbfm.2009.54; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Tega Y, 2013, NEUROCHEM INT, V62, P173, DOI 10.1016/j.neuint.2012.11.014; Kubo Y, 2013, PHARM RES-DORDR, V30, P847, DOI 10.1007/s11095-012-0926-y; Okura T, 2007, LIFE SCI, V80, P1564, DOI 10.1016/j.lfs.2007.01.035; Kuwayama K, 2008, BBA-BIOMEMBRANES, V1778, P42, DOI 10.1016/j.bbamem.2007.08.023; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Ohta KY, 2006, DRUG METAB DISPOS, V34, P1868, DOI 10.1124/dmd.106.010876; Ohtsuki S, 2013, MOL PHARMACEUT, V10, P289, DOI 10.1021/mp3004308; Sadiq MW, 2011, J PHARM SCI-US, V100, P3912, DOI 10.1002/jps.22567; Okura T, 2008, DRUG METAB DISPOS, V36, P2005, DOI 10.1124/dmd.108.022087; Weksler BB, 2005, FASEB J, V19, P1872; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; Beconi M.G., 2011, PLOS CURR, V3, DOI DOI 10.1371/CURRENTS.RRN1291; Carl SM, 2010, MOL PHARM, V2, P1057; Deo AK, 2013, MOL PHARMACEUT, V10, P1581, DOI 10.1021/mp300570z; Hesselink MB, 1999, PHARMACEUT RES, V16, P637, DOI 10.1023/A:1018856020583; HONEGGER UE, 1993, PHARMACOL TOXICOL, V73, P202; Kitamura A, 2014, J PHARM SCI-US, V103, P3335, DOI 10.1002/jps.24129; KORNHUBER J, 1991, EUR J PHARM-MOLEC PH, V206, P297, DOI 10.1016/0922-4106(91)90113-V; Kubo Y, 2013, J PHARM SCI-US, V102, P3332, DOI 10.1002/jps.23535; Lin AP, 2003, MAGN RESON MATER PHY, V16, P29, DOI 10.1007/s10334-003-0004-x; Mehta DC, 2013, MOL PHARMACEUT, V10, P4491, DOI 10.1021/mp400316e; Moellentin D, 2008, ANN PHARMACOTHER, V42, P443, DOI 10.1345/aph.1K619; Moritoyo T, 2012, J PHARMACOL SCI, V119, P324, DOI 10.1254/jphs.12043FP; Okura T, 2014, DRUG METAB PHARMACOK, V29, P69, DOI 10.2133/dmpk.DMPK-13-RG-058; Shimomura K, 2013, FLUIDS BARRIERS CNS, V26, P8; Smith Quentin R, 2003, Methods Mol Med, V89, P193	32	1	1	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	APR	2015	30	2					182	187		10.1016/j.dmpk.2014.12.006		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VR	WOS:000353286000008		
J	Gamou, T; Habano, W; Terashima, J; Ozawa, S				Gamou, Toshie; Habano, Wataru; Terashima, Jun; Ozawa, Shogo			A CAR-responsive enhancer element locating approximately 31 kb upstream in the 5 '-flanking region of rat cytochrome P450 (CYP) 3A1 gene	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Nuclear receptor; Constitutive androstane receptor ( CAR); Cytochrome P450; CYP3A family; Enzyme induction	CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; LIVER-TUMOR PROMOTION; NUCLEAR RECEPTOR; ACTIVE/ANDROSTANE RECEPTOR; REGULATORY ELEMENT; HUMAN HEPATOCYTES; DRUG-METABOLISM; MOUSE-LIVER; EXPRESSION	Constitutive androstane receptor (CAR) is one of the principal regulators of hepatic cytochrome P450s (CYPs) 3A (CYP3A). cDNA-mediated expression of a mature rat CAR (rCAR) into rat hepatoma cells induced CYP3A1 and CYP2B mRNAs. Aberrant rCAR failed in these inductions. Three important human CYP3A4 regulatory elements (REs), proximal ER6 (proER6), xenobiotic responsive enhancer module (XREM) and constitutive liver enhancer module (CLEM), support constitutive and inducible expression of CYP3As mediated by CAR and pregnane X receptor (PXR). NHR-scan software predicted proER6, XREM and CLEM at -255 b, -8 kb and -11.5 kb, respectively of CYP3A4, but neither XREM nor CLEM was predicted in rat CYP3A. A luciferase reporter construct carrying a 5 '-flanking sequence of CYP3A1 (-31,739 to -31,585 from its transcription initiation site) revealed important for the rCAR-dependent transactivation of CYP3A1. This region includes two putative binding motifs of nuclear receptors (DR4 and DR2), a putative hepatocyte nuclear factor-1 binding motif (HNF1), nuclear factor-kappa B binding motif (NF kappa B), activator protein 1 binding motif (AP-1), and ecotropic viral integration site 1 binding motif (Evi1). We hereby conclude DR4 and/or DR2 motifs being primarily responsible and HNF1 being synergistically functioning elements for the rCAR-mediated transcription of CYP3A1. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Gamou, Toshie; Habano, Wataru; Terashima, Jun; Ozawa, Shogo] Iwate Med Univ, Sch Pharm, Dept Pharmacodynam & Mol Genet, Yahaba, Iwate 0283694, Japan	Ozawa, S (reprint author), Iwate Med Univ, Sch Pharm, Dept Pharmacodynam & Mol Genet, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	sozawa@iwate-med.ac.jp			Risk Assessment Study on Food Safety from the Food Safety Commission, Japan [1303]	This work was supported in part by a Grant-in-Aid for the Research Program for Risk Assessment Study on Food Safety from the Food Safety Commission, Japan (No. 1303).	Anakk S, 2004, PHARMACOGENOMICS J, V4, P91, DOI 10.1038/sj.tpj.6500222; Watanabe K, 2013, BIOCHEM PHARMACOL, V86, P428, DOI 10.1016/j.bcp.2013.05.016; Li Y, 2009, DRUG METAB DISPOS, V37, P1978, DOI 10.1124/dmd.109.027409; Benoki S, 2012, ARCH BIOCHEM BIOPHYS, V517, P123, DOI 10.1016/j.abb.2011.10.014; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Ozawa S, 2011, J TOXICOL SCI, V36, P613; Benet M, 2010, J BIOL CHEM, V285, P28457, DOI 10.1074/jbc.M110.118364; COOPER KO, 1993, ARCH BIOCHEM BIOPHYS, V301, P345, DOI 10.1006/abbi.1993.1154; Frank C, 2003, J BIOL CHEM, V278, P43299, DOI 10.1074/jbc.M305186200; Frank C, 2005, J MOL BIOL, V346, P505, DOI 10.1016/j.jmb.2004.12.003; Inoue K, 2009, FEBS LETT, V583, P2126, DOI 10.1016/j.febslet.2009.05.031; Inoue K, 2008, J BIOL CHEM, V283, P10425, DOI 10.1074/jbc.M800729200; Inoue SI, 2011, MOL PHARMACOL, V79, P148, DOI 10.1124/mol.110.068577; Kanno Y, 2007, BBA-MOL CELL RES, V1773, P934, DOI 10.1016/j.bbamcr.2007.03.020; Koracek TA, 2002, MOL PHARM, V62, P1177; Lewis DFV, 1997, CYTOCHROME P, V123; Mahnke Axel, 1997, Archives of Biochemistry and Biophysics, V337, P62, DOI 10.1006/abbi.1996.9752; Matsumura K, 2004, MOL PHARMACOL, V65, P326, DOI 10.1124/mol.65.2.326; Ni SQ, 2008, BIOPHARM DRUG DISPOS, V29, P501, DOI 10.1002/bdd.635; Qiu H, 2010, PHARMACOGENET GENOM, V20, P167, DOI 10.1097/FPC.0b013e328336bbeb; Takada Tomonari, 2004, Drug Metab Pharmacokinet, V19, P103, DOI 10.2133/dmpk.19.103; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	31	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	APR	2015	30	2					188	197		10.1016/j.dmpk.2014.12.008		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VR	WOS:000353286000009		
J	Watanabe, M; Watanabe, T; Yabuki, M; Tamai, I				Watanabe, Masaki; Watanabe, Takao; Yabuki, Masashi; Tamai, Ikumi			Dehydroepiandrosterone sulfate, a useful endogenous probe for evaluation of drug-drug interaction on hepatic organic anion transporting polypeptide (OATP) in cynomolgus monkeys	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Drug-drug interaction; Organic anion-transporting polypeptide (OATP); Dehydroepiandrosterone sulfate; Endogenous probe; Rifampicin; Cynomolgus monkey	BILE-SALT TRANSPORTERS; TRANSPLANT RECIPIENTS; CYCLOSPORINE-A; HUMAN LIVER; IN-VIVO; INHIBITION; PHARMACOKINETICS; IDENTIFICATION; ATORVASTATIN; PITAVASTATIN	Since drug-drug interaction (DDI) can affect organic anion-transporting polypeptide (OATP) and cause clinical events, prediction of such DDI is important in early clinical development. Although statins are useful probes for OATP-mediated DDI, endogenous probes would be more practical for predicting such DDI. In this study, we investigate the possible use of dehydroepiandrosterone sulfate (DHEAS), an endogenous OATP substrate, in predicting OATP-mediated DDI in cynomolgus monkeys as a first step toward in human assessment. In in vitro experiments, both human and cynomolgus monkey hepatocytes showed a time-and temperature-dependent DHEAS uptake. Rifampicin (RIF), a typical OATP inhibitor, inhibited this uptake, indicating the involvement of OATP in DHEAS uptake. In in vivo experiments, the area under the plasma concentration-time curve (AUC) and maximum plasma concentration (C-max) of DHEAS were significantly increased following administration of RIF 10 mg/kg, although the extent of this increase was lower than that observed with the test-statins used in this study. However, based on the results of in vitro hepatic DHEAS uptake, changes in DHEAS concentration are expected to be more prominent in human than in monkey. This shows for the first time that DHEAS may be used as endogenous probe for predicting OATP-mediated DDI. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Watanabe, Masaki; Watanabe, Takao; Yabuki, Masashi] Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, Japan; [Watanabe, Masaki; Tamai, Ikumi] Kanazawa Univ, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 920, Japan	Watanabe, M (reprint author), Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, Japan.	masaki-watanabe@ds-pharma.co.jp	TAMAI, Ikumi/D-8412-2015				Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615; Ito S, 2012, CLIN PHARMACOL THER, V92, P635, DOI 10.1038/clpt.2012.138; Koenen A, 2012, EUR J PHARM SCI, V47, P774, DOI 10.1016/j.ejps.2012.08.017; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Abe T, 1999, J BIOL CHEM, V274, P17159, DOI 10.1074/jbc.274.24.17159; Parker CR, 1999, STEROIDS, V64, P640, DOI 10.1016/S0039-128X(99)00046-X; Imamura Y, 2011, CLIN PHARMACOL THER, V89, P81, DOI 10.1038/clpt.2010.232; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Muck W, 1999, CLIN PHARMACOL THER, V65, P251, DOI 10.1016/S0009-9236(99)70104-9; Nakanishi T, 2012, DRUG METAB PHARMACOK, V27, P106, DOI 10.2133/dmpk.DMPK-11-RV-099; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Mita S, 2006, DRUG METAB DISPOS, V34, P1575, DOI 10.1124/dmd.105.008748; Niemi M, 2011, PHARMACOL REV, V63, P157, DOI 10.1124/pr.110.002857; Asberg A, 2001, AM J TRANSPLANT, V1, P382, DOI 10.1034/j.1600-6143.2001.10415.x; Ebeling M, 2011, GENOME RES, V21, P1746, DOI 10.1101/gr.123117.111; Kato K, 2014, PHARM RES-DORDR, V31, P136, DOI 10.1007/s11095-013-1144-y; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; He YJ, 2009, CLIN CHIM ACTA, V405, P49, DOI 10.1016/j.cca.2009.04.003; Simonson SG, 2004, CLIN PHARMACOL THER, V76, P167, DOI 10.1016/j.clpt.2004.03.010; Lau YY, 2007, CLIN PHARMACOL THER, V81, P194, DOI 10.1038/sj.clpt.6100038; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; Center for Drug Evaluation and Research (CDER), 2012, GUID IND DRUG INT ST; Chen CP, 2005, DRUG METAB DISPOS, V33, P537, DOI 10.1124/dmd.104.002477; Committee for Human Medicinal Products (CHMP), 2012, GUID INV DRUG INT FI; Deng JW, 2008, PHARMACOGENET GENOM, V18, P424, DOI 10.1097/FPC.0b013e3282fb02a3; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156; MONTANINI V, 1988, HORM RES, V29, P1, DOI 10.1159/000180956; Shen H, 2013, J PHARMACOL EXP THER, V344, P673, DOI 10.1124/jpet.112.200691; Takahashi T, 2013, DRUG METAB DISPOS, V41, P1875, DOI 10.1124/dmd.113.052753; Tran JQ, 1999, J CLIN PHARMACOL, V39, P487; White EP, 2006, INT SOC STUD XEN ISS	33	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	APR	2015	30	2					198	204		10.1016/j.dmpk.2014.12.009		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VR	WOS:000353286000010		
J	Uchida, Y; Ohtsuki, S; Kamiie, J; Ohmine, K; Iwase, R; Terasaki, T				Uchida, Yasuo; Ohtsuki, Sumio; Kamiie, Junichi; Ohmine, Ken; Iwase, Ryo; Terasaki, Tetsuya			Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						QTAP; Protein expression level; Caco-2; MDR1; BCRP; PEPT1; OST alpha/beta; Different culture period; LC-MS/MS; SRM/MRM analysis	ALPHA-OST-BETA; GENE-EXPRESSION; DRUG; PERMEABILITY; PROTEINS; PEPT1; LIVER; LINES	The purpose of the present study was to evaluate and compare the absolute protein expression levels of 28 drug-related transporters in Caco-2 cell monolayers cultured for 2, 3, and 4 weeks. Plasma membrane fractions of Caco-2 cells cultured on Transwell inserts for 2, 3 and 4 weeks were prepared and digested with trypsin, and then simultaneous absolute quantification of 28 transporters and Na+/K+-ATPase was conducted using our established quantitative targeted absolute proteomic technique. Nine transporters and Na+/K+-ATPase were detected. MDR1, BCRP, PEPT1, OST alpha and OST beta were highly expressed ( greater than 1 fmol/mu g protein), while MRP2, MRP4, OATP2B1 and MCT1 were moderately expressed (0.328 -0.871 fmol/mu g protein). No significant difference was observed in the protein expression levels of these transporters or Na+/K+-ATPase among the 2-, 3- and 4-week cultures. The other 19 transporters, including MRP1, MRP3, OATP1A2, OATP3A1, OATP4A1, and OATP1B3, were not detected. This information about the rank order of transporter protein expression will be useful to predict what transporter(s) are likely or unlikely to influence the permeability of various compounds across monolayers of Caco-2 cells, which are widely used in drug development studies. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Uchida, Yasuo; Ohmine, Ken; Iwase, Ryo; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ohtsuki, Sumio] Kumamoto Univ, Fac Life Sci, Dept Pharmaceut Microbiol, Kumamoto, Japan; [Kamiie, Junichi] Azabu Univ, Sch Vet Med, Lab Vet Pathol, Sagamihara, Kanagawa, Japan	Uchida, Y (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Aoba Ku, 6-3 Aoba Aramaki, Sendai, Miyagi 9808578, Japan.	yuchida@m.tohoku.ac.jp			Japanese Society for the Promotion of Science (JSPS) [KAKENHI: 18109002, KAKENHI: 24249011]	This study was supported in part by two Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS) for Scientific Research (S) [KAKENHI: 18109002] and for Scientific Research (A) [KAKENHI: 24249011].	Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164; Hayeshi R, 2008, EUR J PHARM SCI, V35, P383, DOI 10.1016/j.ejps.2008.08.004; Seithel A, 2006, EUR J PHARM SCI, V28, P291, DOI 10.1016/j.ejps.2006.03.003; Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Brandsch M, 2013, CURR OPIN PHARMACOL, V13, P881, DOI 10.1016/j.coph.2013.08.004; Kitamura Y, 2008, J PHARMACOL EXP THER, V327, P465, DOI 10.1124/jpet.108.140475; Xia CQ, 2005, DRUG METAB DISPOS, V33, P637, DOI 10.1124/dmd.104.003442; Hosoya K, 1996, PHARMACEUT RES, V13, P885, DOI 10.1023/A:1016005212640; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Kamiie J, 2008, PHARM RES, V25, P1469, DOI 10.1007/s11095-008-9532-4; Bretschneider B, 1999, PHARMACEUT RES, V16, P55, DOI 10.1023/A:1018814627484; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902; Posada MM, 2013, PHARM RES-DORDR, V30, P2931, DOI 10.1007/s11095-013-1168-3; Shirasaka Y, 2008, J PHARM SCI-US, V97, P553, DOI 10.1002/jps.21114; Ieiri I, 2012, J CLIN PHARMACOL, V52, P1078, DOI 10.1177/0091270011408612; Volpe DA, 2011, FUTURE MED CHEM, V3, P2063, DOI [10.4155/fmc.11.149, 10.4155/FMC.11.149]; Seward DJ, 2003, J BIOL CHEM, V278, P27473, DOI 10.1074/jbc.M301106200; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Ming X, 2010, BIOCHEM PHARMACOL, V79, P455, DOI 10.1016/j.bcp.2009.08.029; Kamiyama E, 2009, DRUG METAB DISPOS, V37, P1956, DOI 10.1124/dmd.109.027490; Ming X, 2011, MOL PHARMACEUT, V8, P1677, DOI 10.1021/mp200026v; Uchida Y, 2014, DRUG DELIVERY BRAIN, P63	23	2	2	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	APR	2015	30	2					205	208		10.1016/j.dmpk.2014.11.002		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VR	WOS:000353286000011		
J	Kawamoto, T; Nakajima, J; Reynard, B; Toh, H				Kawamoto, Tatsuhiko; Nakajima, Junichi; Reynard, Bruno; Toh, Hiroaki			Special issue 'Geofluid processes in subduction zones and mantle dynamics'	EARTH PLANETS AND SPACE			English	Editorial Material							MIYAGI NAIRIKU EARTHQUAKE; NE JAPAN ARC; ELECTRICAL-CONDUCTIVITY; NARUKO VOLCANO; KII PENINSULA; SALINE FLUIDS; WATER-CONTENT; SW JAPAN; SLAB; BENEATH		[Kawamoto, Tatsuhiko] Kyoto Univ, Grad Sch Sci, Inst Geothermal Sci, Beppu, Oita 8740903, Japan; [Nakajima, Junichi] Tohoku Univ, Grad Sch Sci, Res Ctr Predict Earthquakes & Volcan Erupt, Sendai, Miyagi 9808578, Japan; [Reynard, Bruno] Ecole Normale Super Lyon, F-69342 Lyon, France; [Reynard, Bruno] Univ Lyon 1, F-69622 Villeurbanne, France; [Toh, Hiroaki] Kyoto Univ, Grad Sch Sci, Data Anal Ctr Geomagnetism & Space Magnetism, Kyoto 6068502, Japan	Kawamoto, T (reprint author), Kyoto Univ, Grad Sch Sci, Inst Geothermal Sci, Beppu, Oita 8740903, Japan.	kawamoto@bep.vgs.kyoto-u.ac.jp	Reynard, Bruno/C-8301-2012; Kawamoto, Tatsuhiko/H-6088-2011	Reynard, Bruno/0000-0002-4782-6163; 			Yoshino T, 2013, ANNU REV EARTH PL SC, V41, P605, DOI 10.1146/annurev-earth-050212-124022; Hilairet N, 2007, SCIENCE, V318, P1910, DOI 10.1126/science.1148494; Nakajima J, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-12; Reynard B, 2013, LITHOS, V178, P171, DOI 10.1016/j.lithos.2012.10.012; Katayama I, 2004, GEOLOGY, V32, P1045, DOI 10.1130/G20805.1; Korenaga J, 2013, ANNU REV EARTH PL SC, V41, P117, DOI 10.1146/annurev-earth-050212-124208; Hu Y, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-106; Kawamoto T, 2012, P NATL ACAD SCI USA, V109, P18695, DOI 10.1073/pnas.1207687109; Kawamoto T, 2013, P NATL ACAD SCI USA, V110, P9663, DOI 10.1073/pnas.1302040110; Deschamps F, 2013, LITHOS, V178, P96, DOI 10.1016/j.lithos.2013.05.019; Ariyoshi K, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-55; Bowen NL, 1928, EVOLUTION IGNEOUS RO, P332; den Hartog SAM, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-78; Hamada M, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-15; Ichihara H, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-50; Ikemoto A, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-26; Ishikawa M, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-35; Jung S, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-46; Kanda W, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-39; Kato A, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-86; Kawamoto T, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-61; Kazahaya K, 2014, J JPN ASS HYDROL SCI, V44, P3; Kimura JI, 2014, GEOCHIM COSMOCHIM AC, V143, P165, DOI 10.1016/j.gca.2014.04.019; Kirby SH, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-67; Koga KT, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-60; Kosuga M, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-77; Kusuda C, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-119; Kuwatani T, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-5; Matsukage KN, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-29; Matsumoto T, 2003, EARTH PLANET SC LETT, V216, P221, DOI 10.1016/S0012-821X(03)00479-5; Mitsui Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006220; Mori Y, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-47; Ogawa Y, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/s40623-014-0158-y; Okada T, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-114; Okamoto A, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-33; Pommier A, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-38; Rose-Koga EF, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-81; Shiina T, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-69; Shiina T, 2013, GEOPHYS RES LETT, V40, P2006, DOI 10.1002/grl.50468; Shimizu I, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-73; Shimojuku A, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-2; Tatsumi Y., 2005, GSA TODAY, V15, P4, DOI DOI 10.1130/1052-5173; Togo YS, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-131; Ushioda M, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-127; Yoshida K, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-59; Zheng YF, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-93	46	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1880-5981			EARTH PLANETS SPACE	Earth Planets Space	APR 1	2015	67								46	10.1186/s40623-015-0209-z		4	Geosciences, Multidisciplinary	Geology	CF8UV	WOS:000352838300001		
J	Imaizumi, F; Sidle, RC; Togari-Ohta, A; Shimamura, M				Imaizumi, Fumitoshi; Sidle, Roy C.; Togari-Ohta, Asako; Shimamura, Makoto			Temporal and spatial variation of infilling processes in a landslide scar in a steep mountainous region, Japan	EARTH SURFACE PROCESSES AND LANDFORMS			English	Article						landslide; infilling; soil creep; dry ravel; sediment flux	OREGON COAST RANGE; SEDIMENT TRANSPORT; SOIL PRODUCTION; EROSION RATES; HILLSLOPES; MODEL; SOLIFLUCTION; CREEP; CHRONOSEQUENCE; EQUILIBRIUM	The duration of the soil-depth recovery needed for reoccurrence of shallow colluvial landslides at a given site in humid regions is much longer than the return period of rainfall needed to generate sufficient pore water pressure to initiate a landslide. Knowledge of the rate of change in soil depth in landslide scars is therefore necessary to evaluate return intervals of landslides. Spatial variation in sediment transport at the Kumanodaira landslide scar in central Japan was investigated by field observations. Spatial distribution of the rate of change in soil depth was estimated using sediment transport data and geographic information system (GIS) analysis. Observations revealed that the timing of sediment transport differed for shallow and deep soil layers. Near-surface sediment transport (mostly dry ravel and some shallow soil creep at depths 005 m) measured in sediment traps was active in winter and early spring and was affected by freezing-thawing; soil creep of subsoil (i.e. >005 m), monitored by strain probes, was active in summer and autumn when precipitation was abundant. Near-surface sediment flux was estimated by a power law function of slope gradient. Deeper soil creep was more affected by relative location to the landslide scar, which influences soil depth, than by slope gradient. Our study indicated that the rate of soil-depth recovery is high just below the head scarp of the landslide. Abrupt changes in the longitudinal slope topography immediately above, within and just below the head scarp became smoother with time due to degradation proximate to the landslide head scarp and flanks, as well as aggradation just below the head scarp. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Imaizumi, Fumitoshi] Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan; [Sidle, Roy C.] US EPA, Ecosyst Res Div, Athens, GA USA; [Togari-Ohta, Asako] East Japan Railway Co, Ctr Res & Dev, Disaster Prevent Res Lab, Saitama, Japan; [Shimamura, Makoto] Univ Tokyo, Sch Engn, Tokyo, Japan	Imaizumi, F (reprint author), Shizuoka Univ, Grad Sch Agr, 836 Ohya, Shizuoka 4228529, Japan.	imaizumi@cii.shizuoka.ac.jp			JSPS KAKENHI [24780141]	This work was supported by JSPS KAKENHI Grant Number 24780141. The authors are grateful to Dr Ryoko Nishii who provided useul comments on this paper. The authors thank Professor Mieko Sonoda for the advice on the use of strain probes, and members of the Geohazards Division of DPRI, Kyoto University, Takashi Saito, Mika Yamao, and Sohei Kobayashi, for help with the field study. This document has been reviewed in accordance with US Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute an endorsement or recommendation for use.	Anderson E. W., 1978, Catena, V5, P81, DOI 10.1016/0341-8162(78)90001-2; Bovis MJ, 1999, EARTH SURF PROC LAND, V24, P1039, DOI 10.1002/(SICI)1096-9837(199910)24:11<1039::AID-ESP29>3.0.CO;2-U; ROBERTS RG, 1986, CAN J FOREST RES, V16, P1092, DOI 10.1139/x86-189; BENDA L, 1990, EARTH SURF PROCESSES, V15, P457, DOI 10.1002/esp.3290150508; Matsuoka N, 2001, EARTH-SCI REV, V55, P107, DOI 10.1016/S0012-8252(01)00057-5; Braun J, 2001, GEOLOGY, V29, P683, DOI 10.1130/0091-7613(2001)029<0683:STMOSM>2.0.CO;2; Matsuoka N, 1998, PERMAFROST PERIGLAC, V9, P397, DOI 10.1002/(SICI)1099-1530(199810/12)9:4<397::AID-PPP302>3.0.CO;2-Q; Heimsath AM, 2001, EARTH SURF PROC LAND, V26, P531, DOI 10.1002/esp.209; MONTGOMERY DR, 1994, WATER RESOUR RES, V30, P1153, DOI 10.1029/93WR02979; Heimsath AM, 1997, NATURE, V388, P358, DOI 10.1038/41056; Pillans B, 1997, GEODERMA, V80, P117, DOI 10.1016/S0016-7061(97)00068-2; Imaizumi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026250; Gabet EJ, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001686; Inbar M, 1998, GEOMORPHOLOGY, V24, P17, DOI 10.1016/S0169-555X(97)00098-6; Roering JJ, 1999, WATER RESOUR RES, V35, P853, DOI 10.1029/1998WR900090; Harris C, 2008, PERMAFROST PERIGLAC, V19, P359, DOI 10.1002/ppp.630; DIETRICH WE, 1995, HYDROL PROCESS, V9, P383, DOI 10.1002/hyp.3360090311; Minasny B, 1999, GEODERMA, V90, P3, DOI 10.1016/S0016-7061(98)00115-3; RENEAU SL, 1986, GEOLOGY, V14, P655, DOI 10.1130/0091-7613(1986)14<655:GAPIOL>2.0.CO;2; Barr DJ, 1970, AM J SCI, V269, P467, DOI 10.2475/ajs.269.5.467; Dietrich W. E., 1978, Z GEOMORPHOLOGIE S, V29, P191; Gabet EJ, 2002, GEOL SOC AM BULL, V114, P983, DOI 10.1130/0016-7606(2002)114<0983:LOCSSA>2.0.CO;2; HIGASHI A, 1971, SCIENCE, V171, P480, DOI 10.1126/science.171.3970.480; Iida T, 1979, GEOGRAPH REV JAPAN, V52, P426; Iida T, 2004, HYDROL PROCESS, V18, P739, DOI 10.1002/hyp.1264; Imaizumi F, 2009, J JAPAN SOC EROSION, V62, P13; Imaizumi F, 2013, T JAPANESE GEOMORPHO, V34, P129; Imaizumi F, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000495; Koide H, 1951, STUDY DISASTERS MOUN; Maita H, 1985, J JPN SOC EROS CONTR, V38, P16; Matsubayashi T, 2005, J GEOGR, V114, P751; Nyberg R., 1993, Permafrost and Periglacial Processes, V4, P37, DOI 10.1002/ppp.3430040104; Okunishi K, 1981, T JAPANESE GEOMORPHO, V2, P291; Onda Y, 1992, J NATURAL DISASTER S, V14, P45; ONDA Y, 1994, EARTH SURF PROCESSES, V19, P627, DOI 10.1002/esp.3290190704; RENEAU SL, 1991, EARTH SURF PROCESSES, V16, P307, DOI 10.1002/esp.3290160405; Roering JJ, 2004, EARTH SURF PROC LAND, V29, P1597, DOI 10.1002/esp.1112; Romeo RW, 2006, ENVIRON GEOL, V51, P1, DOI 10.1007/s00254-006-0294-1; Sasaki Y, 2000, ENG GEOL, V56, P163, DOI 10.1016/S0013-7952(99)00141-6; Sawaguchi S, 1987, GEOGRAPHICAL REV J A, V12, P795; Shimokawa E, 1989, T JAPANESE GEOMORPHO, V10, P267; Shimokawas E, 1984, P S EFF FOR LAND US, P99; Sidle R.C., 1985, WATER RESOURCES MONO; Sidle R.C., 2006, WATER RESOURCES MONO, V18; Sidle RC, 1987, IAHS PUBLICATION, P101; Smale MC, 1997, NEW ZEAL J ECOL, V21, P31; Sonoda M, 2005, T JAPANESE GEOMORPHO, V26, P105; Trustrum N., 1988, GEOMORPHOLOGY, V1, P143, DOI 10.1016/0169-555X(88)90012-8; VANDENBYGAART AJ, 1995, CAN J SOIL SCI, V75, P63; Vieira GT, 2003, GEOMORPHOLOGY, V52, P57, DOI 10.1016/S0169-555X(02)00248-9; Yamada S, 1996, T JAPANESE GEOMORPHO, V17, P29; YOUNG A, 1960, NATURE, V188, P120, DOI 10.1038/188120b0	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-9337	1096-9837		EARTH SURF PROC LAND	Earth Surf. Process. Landf.	APR	2015	40	5					642	653		10.1002/esp.3659		12	Geography, Physical; Geosciences, Multidisciplinary	Physical Geography; Geology	CG1LG	WOS:000353033500006		
J	Handford, M; Matous, P				Handford, Michael; Matous, Petr			Problem-solving discourse on an international construction site: Patterns and practices	ENGLISH FOR SPECIFIC PURPOSES			English	Article						International construction industry; Problem solving; Professional discourse; Discursive practices; BELF	LINGUA-FRANCA; BUSINESS MEETINGS; REPORTED SPEECH; ENGLISH; NEGOTIATIONS; CONVERSATION; PERSPECTIVE; IDENTITIES; TALK	This paper analyses the discursive realisation of on-site problem-solving encounters in a large international construction project in Hong Kong. Specifically, the analyses focus on professional English as a lingua franca interactions between the engineers from Japan who are full-time employees of the company heading the joint venture, and contracted Hong-Kongese foremen and engineers. A combination of methods and several data sources are used to interpret the interlocutors' communications and relationships, and show how certain items, for instance problem, issue and if as well as evaluative items such as metaphors and idioms, index discursive practices and patterns during problem solving. These data sources include fully transcribed spoken interactions, interviews with the participants and expert informants, and researcher field notes. The results shed light on the key intertextual role the contract plays in the context of construction industry problem solving, the various bodies that are involved in addressing complex problems, and the importance of the foreman and on-site engineer relationship. (C) 2014 Elsevier Ltd. All rights reserved.	[Handford, Michael] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Matous, Petr] Univ Tokyo, Sch Engn, Construct Management Lab, Bunkyou Ku, Tokyo 1138656, Japan	Handford, M (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, Room 133a Bldg 8, Tokyo 1138656, Japan.	mjahandford@gmail.com			Japanese Society for Promotion of Science [24246076, 25370423]	We would like to thank Professor Ozawa Kazumasa for his essential support for this project, the Japanese Society for Promotion of Science for funding the research, Grant No. 24246076 (Project Director Ozawa Kazumasa) and Grant No. 25370423 (International Corpus of Spoken Engineering English, Project Director Michael Handford). We would also like to thank Ozawa Kazumasa, Tanaka Hiromasa, Yamakita Takeshi, Alex Gilmore and the two anonymous reviewers for their very helpful critical comments.	Angouri J, 2012, J PRAGMATICS, V44, P1565, DOI 10.1016/j.pragma.2012.06.010; Baxter J, 2009, DISCOURSE SOC, V20, P411, DOI 10.1177/0957926509104021; Reiter-Palmon R, 2004, LEADERSHIP QUART, V15, P55, DOI 10.1016/j.leaqua.2003.12.005; Rogerson-Revell P, 2008, ENGL SPECIF PURP, V27, P338, DOI 10.1016/j.esp.2008.02.003; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Nickerson C, 2005, ENGL SPECIF PURP, V24, P367, DOI 10.1016/j.esp.2005.02.001; Planken B, 2005, ENGL SPECIF PURP, V24, P381, DOI 10.1016/j.esp.2005.02.002; Rogerson-Revell P, 2007, ENGL SPECIF PURP, V26, P103, DOI 10.1016/j.esp.2005.12.004; Bhatia V. K., 2004, WORLDS WRITTEN DISCO; Boden D., 1994, BUSINESS TALK ORG AC; Bourdieu P., 1991, LANGUAGE SYMBOLIC PO; Carter R., 2004, LANGUAGE CREATIVITY; Carter R, 2006, CAMBRIDGE GRAMMAR EN; Dainty A., 2006, COMMUNICATION CONSTR; Emmitt S., 2003, CONSTRUCTION COMMUNI; Firth A, 1996, J PRAGMATICS, V26, P237, DOI 10.1016/0378-2166(96)00014-8; Flowerdew L., 2007, CORPUS BASED ANAL PR; Gee J. P., 2005, INTRO DISCOURSE ANAL; Gerritsen M., 2009, HDB BUSINESS DISCOUR, P180; Gluch P, 2009, BUILD RES INF, V37, P164, DOI 10.1080/09613210802632849; Handford M., 2014, DISCOURSE IN CONTEXT; Handford M, 2014, ROUT HANDB APPL, P363; Handford M, 2014, LANG INTERCULT COMM, V14, P41, DOI 10.1080/14708477.2013.866123; Handford M., 2010, LANGUAGE BUSINESS ME; Handford M., 2012, J JAPAN SOC CIVIL EN, V67, P73; Handford M, 2011, ENGL SPECIF PURP, V30, P87, DOI 10.1016/j.esp.2010.12.002; Handford M, 2010, TEXT TALK, V30, P27, DOI 10.1515/TEXT.2010.002; Henry J., 2001, CREATIVE MANAGEMENT; Hoey M., 1983, SURFACE DISCOURSE; Hofstede G., 1991, CULTURE ORG; Holmes J, 2013, DISCOURSE COMMUN, V7, P275, DOI 10.1177/1750481313494500; Kankaanranta A, 2010, ENGL SPECIF PURP, V29, P204, DOI 10.1016/j.esp.2009.06.004; Koester A, 2006, INVESTIGATING WORKPL; Koester Almut, 2010, WORKPLACE DISCOURSE; Koester A, 2014, ENGL SPECIF PURP, V36, P35, DOI 10.1016/j.esp.2014.03.005; Lewis R., 1999, CROSS CULTURAL COMMU; Lipshitz R, 1996, ORGAN BEHAV HUM DEC, V65, P48, DOI 10.1006/obhd.1996.0004; Loosemore M., 1999, INT J PROJ MANAG, V17, P95, DOI 10.1016/S0263-7863(98)00030-1; Loosemore M., 2008, CONSTRUCTION MANAGEM, V26, P125, DOI DOI 10.1080/01446190701798810; Louhiala-Salminen L, 2005, ENGL SPECIF PURP, V24, P401, DOI 10.1016/j.esp.2005.02.003; Myers G, 1999, APPL LINGUIST, V20, P376, DOI 10.1093/applin/20.3.376; Nakane I., 2007, SILENCE INTERCULTURA; Nelson M., 2000, THESIS U MANCHESTER; Nickerson C, 2005, ENGL SPECIF PURP, V24, P333, DOI 10.1016/j.esp.2005.01.003; Poncini Gina, 2004, DISCURSIVE STRATEGIE; POUNDS WF, 1969, IMR-IND MANAG REV, V11, P1; PricewaterhouseCoopers, 2010, ENG CONSTR REP; Sarangi S., 1999, TALK WORK I ORDER; Stubbe M., 2003, POWER POLITENESS WOR; Swales J. M., 2004, RES GENRES EXPLORATI; Tsuchiya K, 2014, J PRAGMATICS, V64, P117, DOI 10.1016/j.pragma.2014.02.004	51	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0889-4906	1873-1937		ENGL SPECIF PURP	Engl. Specif. Purp.	APR	2015	38						85	98		10.1016/j.esp.2014.12.002		14	Linguistics	Linguistics	CF6JY	WOS:000352664200008		
J	Wang, WM; Liu, LJ; Zhao, CQ; Han, LB				Wang, Wei-Min; Liu, Li-Juan; Zhao, Chang-Qiu; Han, Li-Biao			Diastereoselective Hydrolysis of Asymmetric P-Cl Species and Synthesis of Optically Pure (R-P)-(-)-Menthyl H-Phenylphosphinate	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						P Stereogenic; Phosphorus; Diastereoselectivity; Hydrolysis; Synthetic methods	SECONDARY PHOSPHINE OXIDES; HYDROGENATION; PHOSPHORUS; LIGANDS; BOND; STEREOCHEMISTRY; PHOSPHONATES; DERIVATIVES; SELECTIVITY; ALKYLATION	Phenyl dichlorophosphine reacted with (L)-(-)-menthol to afford two diastereomers of menthyl phenylphosphinate (R-P)-1a/(S-P)-1a in up to 89:11 dr. Compound (R-P)-1a was isolated in 58% yield (60 g) and > 99:1 dr. An HCl-promoted diastereoselective hydrolysis of the P-Cl species was found to be involved in the reaction. On the basis of this, a mixture of 1a/1a with 50:50 dr was converted to a mixture enriched in 1a with 88:12 dr by treatment with phosphorus trichloride.	[Wang, Wei-Min; Liu, Li-Juan; Zhao, Chang-Qiu] Liaocheng Univ, Coll Chem & Chem Engn, Liaocheng 252059, Shandong, Peoples R China; [Han, Li-Biao] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Zhao, CQ (reprint author), Liaocheng Univ, Coll Chem & Chem Engn, Liaocheng 252059, Shandong, Peoples R China.	literabc@hotmail.com; libiao-han@aist.go.jp			National Natural Science Foundation of China [20772055]	The authors acknowledge the financial support of the National Natural Science Foundation of China (grant no. 20772055).	Afarinkia K, 2003, TETRAHEDRON LETT, V44, P781, DOI 10.1016/S0040-4039(02)02647-3; Wang XB, 2014, CHEM-EUR J, V20, P3631, DOI 10.1002/chem.201304675; Jiang XB, 2003, ORG LETT, V5, P1503, DOI 10.1021/ol034282u; Han LB, 2002, J AM CHEM SOC, V124, P3842, DOI 10.1021/ja025816+; Chan EYY, 2004, INORG CHEM, V43, P4921, DOI 10.1021/ic049744u; Xu Q, 2008, J AM CHEM SOC, V130, P12648, DOI 10.1021/ja804412k; Zhou YB, 2010, J ORG CHEM, V75, P7924, DOI 10.1021/jo101540d; FARNHAM WB, 1970, J AM CHEM SOC, V92, P5809, DOI 10.1021/ja00722a083; Jiang XB, 2004, TETRAHEDRON-ASYMMETR, V15, P2223, DOI 10.1016/j.tetasy.2004.05.002; Wang G, 2010, J ORG CHEM, V75, P3890, DOI 10.1021/jo100473s; Han LB, 2005, J ORG CHEM, V70, P10121, DOI 10.1021/jo051582b; Jiang XB, 2004, J ORG CHEM, V69, P2327, DOI 10.1021/jo035487j; CASALNUOVO AL, 1994, J AM CHEM SOC, V116, P9869, DOI 10.1021/ja00101a007; Berger O, 2013, ANGEW CHEM INT EDIT, V52, P11377, DOI 10.1002/anie.201306628; Cai JX, 2003, HETEROATOM CHEM, V14, P312, DOI 10.1002/hc.10150; Dai WM, 2003, TETRAHEDRON-ASYMMETR, V14, P2821, DOI 10.1016/j.tetasy.2003.07.008; DEBRUIN KE, 1989, J AM CHEM SOC, V111, P5871, DOI 10.1021/ja00197a056; Dubrovina N. V., 2004, ANGEW CHEM, V116, P6007, DOI 10.1002/ange.200460848; Dubrovina NV, 2004, ANGEW CHEM INT EDIT, V43, P5883, DOI 10.1002/anie.200460848; Dzygiel P, 1999, TETRAHEDRON, V55, P9923, DOI 10.1016/S0040-4020(99)00531-1; EMMICK TL, 1968, J AM CHEM SOC, V90, P3459, DOI 10.1021/ja01015a030; FERNANDEZ MD, 1995, J ORG CHEM, V60, P7390, DOI 10.1021/jo00128a006; Gatineau G., 2011, J AM CHEM SOC, V133, P10728; Imamoto T, 1992, HDB ORGANOPHOSPHORUS; Kagan H. B., 1990, CHEM ORGANOPHOSPHORU, V1; LOPUSINSKI A, 1991, J CHEM SOC CHEM COMM, P889, DOI 10.1039/c39910000889; Luczak L, 1998, TETRAHEDRON, V54, P9731, DOI 10.1016/S0040-4020(98)00529-8; Nemoto T, 2006, TETRAHEDRON LETT, V47, P6577, DOI 10.1016/j.tetlet.2006.07.029; Nifantyev EE, 2005, PHOSPHORUS SULFUR, V180, P2733, DOI 10.1080/104265090968073; Quin L. D., 2000, GUIDE ORGANOPHOSPHOR; QUIN LD, 1966, J ORG CHEM, V31, P1206, DOI 10.1021/jo01342a053; Sasaki M., 1998, CHIRALITY AGROCHEMIC, P85; Sun YM, 2014, ORG BIOMOL CHEM, V12, P9457, DOI 10.1039/c4ob01574f; WADA T, 1991, J ORG CHEM, V56, P1243, DOI 10.1021/jo00003a056; Zhang H, 2014, CHEM-ASIAN J, V9, P1329, DOI 10.1002/asia.201301650	35	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	APR	2015		11					2342	2345		10.1002/ejoc.201500126		4	Chemistry, Organic	Chemistry	CF5YT	WOS:000352634000004		
J	Hattori, T; Ida, T; Tsubone, A; Sawama, Y; Monguchi, Y; Sajiki, H				Hattori, Tomohiro; Ida, Takashi; Tsubone, Aya; Sawama, Yoshinari; Monguchi, Yasunari; Sajiki, Hironao			Facile Arene Hydrogenation under Flow Conditions Catalyzed by Rhodium or Ruthenium on Carbon	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Flow reactions; Heterogeneous catalysis; Hydrogenation; Rhodium; Ruthenium; Arenes	PROTECTING GROUP REMOVAL; MILD CONDITIONS; ORGANIC-CHEMISTRY; IONIC LIQUIDS; NANOPARTICLES; REACTOR; EFFICIENT; OPTIMIZATION; PRESSURE; HYDROGENOLYSIS	An efficient and practical protocol for the flow hydrogenation of aromatic rings was developed. The hydrogenation of a variety of aromatic compounds, such as benzene, furan, and pyridine derivatives, could be completed within only 20 s during a single pass through a catalyst cartridge containing 10% rhodium on carbon (Rh/C) or 10% ruthenium on carbon (Ru/C) under neutral conditions. The protocol was successfully applied to a 10 mmol scale reaction. Furthermore, the 10% Rh/C and 10% Ru/C did not deteriorate during the entire study.	[Hattori, Tomohiro; Ida, Takashi; Tsubone, Aya; Sawama, Yoshinari; Monguchi, Yasunari; Sajiki, Hironao] Gifu Pharmaceut Univ, Organ Chem Lab, Gifu 5011196, Japan	Monguchi, Y (reprint author), Gifu Pharmaceut Univ, Organ Chem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	monguchi@gifu-pu.ac.jp; sajiki@gifu-pu.ac.jp			Japan Science Society for a Sasakawa Scientific Research Grant	The authors sincerely thank Dr. Zsolt Lepp and CEO Richard Jones of ThalesNano Nanotechnology, Inc., and Dr. Yuko Kawahashi and Mr. Satoshi Ohtsu of Ikeda Scientific Co., Ltd. (Tokyo, Japan) for their kind assistance and the use of the H-Cube (R) SS continuous-flow hydrogenator without charge. A kind gift of 10% Rh/C and 10% Ru/C and the ICP-AES measurements by the N. E. Chemcat Corporation are highly appreciated. The authors thank ThalesNano Nanotechnology, Inc. for packing the catalysts in the 30 mm long cartridges (CatCarts). Zeon Corporation (Tokyo, Japan) is thanked for a kind gift of cyclopentyl methyl ether (CPME). T. H. is grateful to the Japan Science Society for a Sasakawa Scientific Research Grant and for partial financial support of this study.	Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Leger B, 2008, CHEMSUSCHEM, V1, P984, DOI 10.1002/cssc.200800194; Linares N, 2012, ACS CATAL, V2, P2194, DOI 10.1021/cs3005902; O'Brien M, 2011, CHEM SCI, V2, P1250, DOI 10.1039/c1sc00055a; Liu J, 2012, SYNTHESIS-STUTTGART, V44, P2469, DOI 10.1055/s-0032-1316550; Yao KX, 2012, CHEMCATCHEM, V4, P1938, DOI 10.1002/cctc.201200354; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Jones RV, 2006, J COMB CHEM, V8, P110, DOI 10.1021/cc050107o; Oyamada H, 2011, BEILSTEIN J ORG CHEM, V7, P735, DOI 10.3762/bjoc.7.83; Glasnov TN, 2010, ADV SYNTH CATAL, V352, P3089, DOI 10.1002/adsc.201000646; Knudsen KR, 2007, ADV SYNTH CATAL, V349, P535, DOI 10.1002/adsc.200600558; Tarleton M, 2011, TETRAHEDRON LETT, V52, P1583, DOI 10.1016/j.tetlet.2011.01.096; Stratton SA, 2012, CATAL TODAY, V183, P96, DOI 10.1016/j.cattod.2011.09.016; Park KH, 2007, ANGEW CHEM INT EDIT, V46, P1152, DOI 10.1002/anie.200603961; Motoyama Y, 2009, ORG LETT, V11, P5042, DOI 10.1021/ol902018g; Irfan M, 2011, CHEMSUSCHEM, V4, P300, DOI 10.1002/cssc.201000354; Desai B, 2005, J COMB CHEM, V7, P641, DOI 10.1021/cc050076x; Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584; Bakker JJW, 2011, CHEMCATCHEM, V3, P1155, DOI 10.1002/cctc.201100044; Barthe L, 2009, CATAL COMMUN, V10, P1235, DOI 10.1016/j.catcom.2009.01.026; Baumann M, 2010, SYNLETT, P749, DOI 10.1055/s-0029-1219344; Baxendale IR, 2013, J CHEM TECHNOL BIOT, V88, P519, DOI 10.1002/jctb.4012; Bryan MC, 2011, BEILSTEIN J ORG CHEM, V7, P1141, DOI 10.3762/bjoc.7.132; Cieplik MK, 2004, EUR J ORG CHEM, P3011; Clapham B, 2008, J COMB CHEM, V10, P88, DOI 10.1021/cc700178a; Colombo E, 2011, J FLOW CHEM, V1, P68, DOI 10.1556/jfchem.2011.00009; Cooper CGF, 2012, ORG PROCESS RES DEV, V16, P1090, DOI 10.1021/op2001222; Ekholm FS, 2011, TETRAHEDRON LETT, V52, P1839, DOI 10.1016/j.tetlet.2010.12.109; Falini G, 2009, SYNTHESIS-STUTTGART, P2440, DOI 10.1055/s-0029-1216852; Franckevicius V, 2006, SYNLETT, P889, DOI 10.1055/s-2006.939036; Gutmann B, 2011, CHEM-EUR J, V17, P13146, DOI 10.1002/chem.201102772; Hattori T, 2015, CATALYSTS, V5, P18, DOI 10.3390/catal5010018; Hattori T, 2014, TETRAHEDRON, V70, P4790, DOI 10.1016/j.tet.2014.05.038; Horvath HH, 2007, CATAL COMMUN, V8, P442, DOI 10.1016/j.catcom.2006.07.016; Hubert C, 2010, GREEN CHEM, V12, P1167, DOI 10.1039/c004079g; Hubert C, 2011, GREEN CHEM, V13, P1766, DOI 10.1039/c0gc00931h; Irfan M, 2009, EUR J ORG CHEM, P1327, DOI 10.1002/ejoc.200801131; Kakade BA, 2008, J PHYS CHEM C, V112, P13317, DOI 10.1021/jp804843h; Kobayashi J, 2005, CHEM COMMUN, P2567, DOI 10.1039/b501169h; Garcia-Verdugo E, 2010, RSC GREEN CHEM SER, P44; Maegawa T, 2009, CHEM-EUR J, V15, P6953, DOI 10.1002/chem.200900361; Niembro S, 2013, NEW J CHEM, V37, P278, DOI 10.1039/c2nj40859g; Nishimura S., 2001, HDB HETEROGENEOUS CA, P414; Park IS, 2005, CHEM COMMUN, P5667, DOI 10.1039/b511577a; Park K. H., 2007, ANGEW CHEM, V119, P1170, DOI 10.1002/ange.200603961; Saaby S, 2005, CHEM COMMUN, P2909, DOI 10.1039/b504854k; Sachse A, 2013, DALTON T, V42, P1378, DOI 10.1039/c2dt31690k; Yoswathananont N, 2005, CHEM COMMUN, P40, DOI 10.1039/b410014j	48	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	APR	2015		11					2492	2497		10.1002/ejoc.201500050		6	Chemistry, Organic	Chemistry	CF5YT	WOS:000352634000021		
J	Leinsalu, M; Stickley, A; Kunst, AE				Leinsalu, Mall; Stickley, Andrew; Kunst, Anton E.			Reduced affordability of cigarettes and socio-economic inequalities in smoking continuation in Stakhanov, Ukraine, 2009	EUROPEAN JOURNAL OF PUBLIC HEALTH			English	Article							TOBACCO; COUNTRIES; CESSATION	The recent tobacco excise tax increase and economic crisis reduced cigarette affordability in Ukraine dramatically. Using survey data from Stakhanov (n = 1691), eastern Ukraine, we employed logistic regression analysis to examine whether socio-economic status was associated with the continuation of smoking in this environment in 2009. Low education (in women) and ownership of household assets (in men) were negatively associated with smoking continuation, whereas a positive association was found for personal monthly income. Our findings suggest that in a low-income setting where efficient cessation services are absent, reduced cigarette affordability may have only a limited effect in cutting down smoking.	[Leinsalu, Mall; Stickley, Andrew] Sodertorn Univ, Stockholm Ctr Hlth Soc Transit, S-14189 Huddinge, Sweden; [Leinsalu, Mall] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Tallinn, Estonia; [Stickley, Andrew] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo 1138654, Japan; [Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1012 WX Amsterdam, Netherlands	Leinsalu, M (reprint author), Sodertorn Univ, Stockholm Ctr Hlth Soc Transit, S-14189 Huddinge, Sweden.	mall.leinsalu@sh.se			European Commission, Directorate-General for Research and Innovation [278273]; Swedish Foundation for Baltic and East European Studies [A052-10]; Estonian Research Council [IUT5-1]	This study is part of the project 'Tackling socio-economic inequalities in smoking (SILNE)', which is funded by the European Commission, Directorate-General for Research and Innovation, under the FP7-Health-2011 program, with grant agreement number 278273. ML's and AS's work was partly funded by the Swedish Foundation for Baltic and East European Studies (grant number A052-10) and ML's work was additionally supported by the Estonian Research Council (IUT5-1).	Siahpush M, 2006, ADDICTION, V101, P121, DOI 10.1111/j.1360-0443.2005.01292.x; Tyas SL, 1998, TOB CONTROL, V7, P409; Schaap MM, 2008, NICOTINE TOB RES, V10, P359, DOI 10.1080/14622200701825098; Bobak M, 2000, TOB CONTROL, V9, P310, DOI 10.1136/tc.9.3.310; Flint A J, 1997, Tob Control, V6, P14; Footman K, 2013, NICOTINE TOB RES, V15, P1628, DOI 10.1093/ntr/ntt034; Gentile M, 2012, URBAN GEOGR, V33, P401, DOI 10.2747/0272-3638.33.3.401; Krasovsky K, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-21; Krasovsky K, WANT SAVE LIVES HIKE; Regidor E, 2007, EUR J CANCER PREV, V16, P380, DOI 10.1097/01.cej.0000228403.60729.76; The World Bank, 2014, WORLD BANK DAT; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; WHO/Europe, 2010, GLOB AD TOB SURV UKR	13	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1101-1262	1464-360X		EUR J PUBLIC HEALTH	Eur. J. Public Health	APR	2015	25	2					216	218		10.1093/eurpub/cku125		3	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE9ZE	WOS:000352201500010		
J	Fujii, S; Kido, A; Baba, T; Fujimoto, K; Daido, S; Matsumura, N; Konishi, I; Togashi, K				Fujii, Shinya; Kido, Aki; Baba, Tsukasa; Fujimoto, Koji; Daido, Sayaka; Matsumura, Noriomi; Konishi, Ikuo; Togashi, Kaori			Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						MR; Dynamic contrast enhanced imaging; Endometrial cancer; Uterine; Uterus	LYMPHVASCULAR SPACE INVOLVEMENT; APPARENT DIFFUSION-COEFFICIENT; MYOMETRIAL INVASION; PROGNOSTIC-SIGNIFICANCE; CARCINOMA; DEPTH; METAANALYSIS; TUMOR	Objectives: To evaluate the diagnostic accuracy of subendometrial enhancement (SEE) in assessing the myometrial invasion in endometrial cancer, the frequency and clinical significance of peritumoral enhancement (PTE) on dynamic contrast enhanced (DCE) imaging. Materials and methods: MR images of 147 patients with endometrial cancer were retrospectively analyzed for intact SEE and PTEs: Type 1, a focal early enhancement peritumorally, and Type 2, an irregular thinlayered early intense enhancement peritumorally. Two radiologists independently assessed intact SEE and PTEs on DCE imaging and compared the lesions by the presence and depth of myometrial invasion, grade, lymphovascular space involvement (LVSI), and lymph node metastasis. The relationship between SEE, PTEs, and each factor was analyzed using univariate and multivariate analyses. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were calculated for SEE. Results: The sensitivity, specificity, PPV, NPV and diagnostic accuracy for myometrial invasion based on SEE disruption on DCE were 96.6%, 32.1-46.4%, 85.8-88.5%, 69.2-76.5%, and 84.4-87.1%. According to multivariate analysis, SEE significantly predicted myometrial invasion (p < 0.0001). PTE Type 2 significantly predicted myometrial invasion presence (p < 0.05) and depth (p < 0.01). Conclusion: Diagnosis of myometrial invasion only by using SEE might be difficult on DCE-MRI due to the overestimation by strong focal enhancement of PTE Type 1. PTE Type 2 correlates both with the presence and depth of myometrial invasion and also may play an important role in the diagnosis of LVSI. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Fujii, Shinya] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, Yonago, Tottori 683, Japan; [Fujii, Shinya; Kido, Aki; Fujimoto, Koji; Daido, Sayaka; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Kyoto 6068507, Japan; [Baba, Tsukasa; Matsumura, Noriomi; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Gynecol, Kyoto, Kyoto 6068507, Japan; [Baba, Tsukasa; Matsumura, Noriomi; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Obstet, Kyoto, Kyoto 6068507, Japan	Kido, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 57 Shogoin Kawa Haracho, Kyoto, Kyoto 6068507, Japan.	akikido@kuhp.kyoto-u.ac.jp					O'Brien DJ, 2009, BJOG-INT J OBSTET GY, V116, P991, DOI 10.1111/j.1471-0528.2009.02162.x; Beddy P, 2012, RADIOLOGY, V262, P530, DOI 10.1148/radiol.11110984; Nakamura K, 2012, GYNECOL ONCOL, V124, P335, DOI 10.1016/j.ygyno.2011.10.014; YAMASHITA Y, 1993, RADIOLOGY, V186, P495; Frei KA, 2001, J MAGN RESON IMAGING, V13, P850, DOI 10.1002/jmri.1121; Lin G, 2009, RADIOLOGY, V250, P784, DOI 10.1148/radiol.2503080874; Abu-Rustum NR, 2011, INT J GYNECOL CANCER, V21, P511, DOI 10.1097/IGC.0b013e31820cc305; SVANHOLM H, 1989, APMIS, V97, P689; Frei KA, 2000, RADIOLOGY, V216, P444; Manfredi R, 2004, RADIOLOGY, V231, P372, DOI 10.1148/radiol.2312021184; Kinkel K, 1999, RADIOLOGY, V212, P711; TSURUCHI N, 1995, GYNECOL ONCOL, V57, P307, DOI 10.1006/gyno.1995.1148; Briet JM, 2005, GYNECOL ONCOL, V96, P799, DOI 10.1016/j.ygyno.2004.11.033; Tamai K, 2007, J MAGN RESON IMAGING, V26, P682, DOI 10.1002/jmri.20997; Rechichi G, 2011, AM J ROENTGENOL, V197, P256, DOI 10.2214/AJR.10.5584; Cohn DE, 2002, GYNECOL ONCOL, V87, P243, DOI 10.1006/gyno.2002.6825; Nakao Y, 2006, GYNECOL ONCOL, V102, P343, DOI 10.1016/j.ygyno.2005.12.028; Arora V, 2012, BEST PRACT RES CLIN, V26, P311; Boddy P, 2011, RADIOGRAPHICS, V32, P241; Creasman W, 2009, INT J GYNECOL OBSTET, V105, P109; Fujii S, 2014, J OBSTET GYNAECOL RE, V40, P1445, DOI 10.1111/jog.12318; HORI M, 2009, MAGN RESON IMAGING, V30, P621; Inoue Y, 1996, CANCER, V78, P1447, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1447::AID-CNCR11>3.0.CO;2-#; Kaneda S, 2011, ABDOM IMAGING, V36, P612, DOI 10.1007/s00261-011-9719-8; SIVRIDIS E, 1987, BRIT J OBSTET GYNAEC, V94, P991, DOI 10.1111/j.1471-0528.1987.tb02275.x; Sivridis E, 2002, J PATHOL, V196, P416, DOI 10.1002/path.1060; Torricelli P, 2008, AM J ROENTGENOL, V190, P489, DOI [10.2214/AJR.07.2380, 10.2214/AJR.07.2680]	27	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	APR	2015	84	4					581	589		10.1016/j.ejrad.2015.01.004		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6YZ	WOS:000352704200006		
J	Kawasumi, Y; Usui, A; Hosokai, Y; Igari, Y; Hosoya, T; Hayashizaki, Y; Saito, H; Ishibashi, T; Funayama, M				Kawasumi, Yusuke; Usui, Akihito; Hosokai, Yoshiyuki; Igari, Yui; Hosoya, Tadashi; Hayashizaki, Yoshie; Saito, Haruo; Ishibashi, Tadashi; Funayama, Masato			Post-mortem computed tomography findings of the lungs: Retrospective review and comparison with autopsy results of 30 infant cases	EUROPEAN JOURNAL OF RADIOLOGY			English	Review						Post-mortem computed tomography; Forensic medicine; Autopsy; Sudden infant death; Lung	UNEXPECTED DEATH; SUDDEN; CLASSIFICATION	Objectives: Infant cases frequently show a diffuse increase in the concentration of lung fields on postmortem computed tomography (PMCT). However, the lungs often show simply atelectasis at autopsy in the absence of any other abnormal changes. Thus, we retrospectively reviewed the PMCT findings of lungs following sudden infant death and correlated them with the autopsy results. Materials and methods: We retrospectively reviewed infant cases (0 year) who had undergone PMCT and a forensic autopsy at our institution between May 2009 and June 2013. Lung opacities were classified according to their type; consolidation, ground-glass opacity and mixed, as well as distribution; bilateral diffuse and areas of sparing. Statistical analysis was performed to assess the relationships among lung opacities, causes of death and resuscitation attempt. Results: Thirty infant cases were selected, which included 22 sudden and unexplained deaths and 8 other causes of death. Resuscitation was attempted in 22 of 30 cases. Bilateral diffuse opacities were observed in 21 of the 30 cases. Of the 21 cases, 18 were sudden and unexplained deaths. Areas of sparing were observed in 4 sudden and unexplained deaths and 5 other causes of death. Distribution of opacities was not significantly associated with causes of death or resuscitation attempt. The 21 cases with bilateral diffuse opacities included 6 consolidations (4 sudden and unexplained deaths, 2 other causes of death), 4 ground-glass opacities (3 sudden and unexplained deaths and 1 other) and 11 mixed (11 sudden and unexplained deaths). Types of opacities were not significantly associated with causes of death or resuscitation attempt. Conclusion: Atelectasis is very common in sudden and unexplained death of infants. Bilateral diffuse mixed opacity was observed only in sudden and unexplained deaths. Bilateral diffuse pure consolidation or ground-glass opacity was also observed in other causes of death. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kawasumi, Yusuke; Ishibashi, Tadashi] Tohoku Univ, Grad Sch Med, Dept Clin Imaging, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Usui, Akihito; Hosokai, Yoshiyuki; Saito, Haruo] Tohoku Univ, Grad Sch Med, Dept Diagnost Image Anal, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Igari, Yui; Hosoya, Tadashi; Hayashizaki, Yoshie; Funayama, Masato] Tohoku Univ, Grad Sch Med, Dept Forens Med, Aoba Ku, Sendai, Miyagi 9808575, Japan	Kawasumi, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Clin Imaging, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	ssu@rad.med.tohoku.ac.jp; t7402r0506@med.tohoku.ac.jp; hosokai@med.tohoku.ac.jp; igari@forensic.med.tohoku.ac.jp; yoshie@forensic.med.tohoku.ac.jp; hsait@med.tohoku.ac.jp; tisibasi@med.tohoku.ac.jp; funayama@forensic.med.tohoku.ac.jp					Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Weber MA, 2008, ARCH DIS CHILD, V93, P1048, DOI 10.1136/adc.2007.136739; Proisy M, 2013, EUR RADIOL, V23, P1711, DOI 10.1007/s00330-012-2738-1; Christe A, 2008, EUR RADIOL, V18, P283, DOI 10.1007/s00330-007-0745-4; Shapiro-Mendoza CK, 2014, PEDIATRICS, V134, pE210, DOI 10.1542/peds.2014-0180; Dirnhofer R, 2006, RADIOGRAPHICS, V26, P1305, DOI 10.1148/rg.265065001; Bolliger SA, 2007, EUR RADIOL, V18, P273; Dolinak D, 2005, FORENSIC PATHOLOGY P, P329; Hymel KP, 2006, PEDIATRICS, V118, P421, DOI 10.1542/peds.2006-1245; Lin Shaoying, 2006, J Clin Forensic Med, V13, P293, DOI 10.1016/j.jcfm.2006.06.002; Oyake Yuji, 2006, Radiat Med, V24, P493, DOI 10.1007/s11604-006-0061-y; Poulsen K, 2006, FORENSIC SCI INT, V171, P190; Saukko P, 2004, KNIGHTS FORENSIC PAT, P451; Shiotani S, 2004, FORENSIC SCI INT, V139, P39, DOI 10.1016/j.forsciint.2003.09.016; Thali MJ, 2011, BROGDONS FORENSIC RA, P409; Usui A, 2014, JPN J RADIOL, V32, P414, DOI 10.1007/s11604-014-0326-9	16	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	APR	2015	84	4					721	725		10.1016/j.ejrad.2014.12.002		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6YZ	WOS:000352704200025		
J	Kinoshita, T; Kawayama, T; Imamura, Y; Sakazaki, Y; Hirai, R; Ishii, H; Suetomo, M; Matsunaga, K; Azuma, K; Fujimoto, K; Hoshino, T				Kinoshita, Takashi; Kawayama, Tomotaka; Imamura, Youhei; Sakazaki, Yuki; Hirai, Ryo; Ishii, Hidenobu; Suetomo, Masashi; Matsunaga, Kazuko; Azuma, Koichi; Fujimoto, Kiminori; Hoshino, Tomoaki			Paired maximum inspiratory and expiratory plain chest radiographs for assessment of airflow limitation in chronic obstructive pulmonary disease	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Airway obstruction; Chronic obstructive pulmonary disease; Imaging	LOW ATTENUATION AREAS; COMPUTED-TOMOGRAPHY; FUNCTION TESTS; EMPHYSEMA; COPD; CT; PNEUMOTHORAX; SPIROMETRY; EFFICACY; DENSITY	Background: The usefulness of paired maximum inspiratory and expiratory (I/E) plain chest radiography (pCR) for diagnosis of chronic obstructive pulmonary disease (COPD) is still unclear. Objectives: We examined whether measurement of the IIE ratio using paired I/E pCR could be used for detection of airflow limitation in patients with COPD. Methods: Eighty patients with COPD (GOLD stage I = 23, stage II = 32, stage III = 15, stage IV = 10) and 34 control subjects were enrolled. The IIE ratios of frontal and lateral lung areas, and lung distance between the apex and base on pCR views were analyzed quantitatively. Pulmonary function parameters were measured at the same time. Results: The IIE ratios for the frontal lung area (1.25 +/- 0.01), the lateral lung area (1.29 +/- 0.01), and the lung distance (1.18 +/- 0.01) were significantly (p <0.05) reduced in COPD patients compared with controls (1.31 +/- 0.02 and 1.38 +/- 0.02, and 1.22 +/- 0.01, respectively). The I/E ratios in frontal and lateral areas, and lung distance were significantly (p <0.05) reduced in severe (GOLD stage III) and very severe (GOLD stage IV) COPD as compared to control subjects, although the I/E ratios did not differ significantly between severe and very severe COPD. Moreover, the I/E ratios were significantly correlated with pulmonary function parameters. Conclusions: Measurement of I/E ratios on paired I/E pCR is simple and reproducible, and can detect airflow limitation in patients with severe and very severe COPD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kinoshita, Takashi; Kawayama, Tomotaka; Imamura, Youhei; Sakazaki, Yuki; Hirai, Ryo; Ishii, Hidenobu; Suetomo, Masashi; Matsunaga, Kazuko; Azuma, Koichi; Hoshino, Tomoaki] Kurume Univ, Sch Med, Dept Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 8300011, Japan; [Fujimoto, Kiminori] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka 8300011, Japan	Kawayama, T (reprint author), Kurume Univ, Sch Med, Dept Med, Div Respirol Neurol & Rheumatol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	tkino@med.kurume-u.ac.jp; kawayama_tomotaka@med.kurume-u.ac.jp; mamura_youhei@med.kurume-u.ac.jp; sakazaki@med.kurume-u.ac.jp; hira_ryou@kurume-u.ac.jp; shii.hidenobu@med.kurume-u.ac.jp; jin_t_f_c@yahoo.co.jp; kmatsunaga@kouhoukai.or.jp; azuma@med.kunume-u.ac.jp; kimichan@med.kurume-u.ac.jp; hoshino@med.kurume-u.ac.jp					Akira M, 2009, AM J ROENTGENOL, V192, P267, DOI 10.2214/AJR.07.3953; KINSELLA M, 1990, CHEST, V97, P315, DOI 10.1378/chest.97.2.315; THURLBECK WM, 1978, AM J ROENTGENOL, V130, P429; Kim WJ, 2009, CHEST, V136, P396, DOI 10.1378/chest.08-2858; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; KNUDSON RJ, 1991, CHEST, V99, P1357, DOI 10.1378/chest.99.6.1357; Kubo K, 1999, EUR RESPIR J, V13, P252, DOI 10.1034/j.1399-3003.1999.13b06.x; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Hughes JMB, 2012, AM J RESP CRIT CARE, V186, P132, DOI 10.1164/rccm.201112-2160CI; Derom E, 2008, EUR RESPIR J, V31, P197, DOI 10.1183/09031936.00066607; Betsuyaku T, 1996, RESPIRATION, V63, P333; BLAND JM, 1986, LANCET, V1, P307; Clayton N, 2007, Chron Respir Dis, V4, P151, DOI 10.1177/1479972307081647; Dunnill MS, 1962, THORAX, V17, P103; ELAM EA, 1992, AM J ROENTGENOL, V158, P509; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2013, GLOB STRAT DIAGN MAN; Hayashi T, 2008, THROMB RES, V123, P274, DOI 10.1016/j.thromres.2008.03.027; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396; Miniati M, 2008, EUR RESPIR J, V31, P509, DOI 10.1183/09031936.00095607; Nakano Y, 1999, THORAX, V54, P384; Perez-Padilla R, 2008, RESP CARE, V53, P1019; Seow A, 1996, AM J ROENTGENOL, V166, P313; Sistrom CL, 1996, AM J ROENTGENOL, V166, P317; SUTINEN S, 1965, AM REV RESPIR DIS, V91, P69; Xu W, 2010, EUR RESPIR J, V35, P1022, DOI 10.1183/09031936.00079409; Yamashiro T, 2010, ACAD RADIOL, V17, P489; Zaporozhan J, 2005, CHEST, V128, P3212, DOI 10.1378/chest.128.5.3212	30	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	APR	2015	84	4					726	731		10.1016/j.ejrad.2014.12.021		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6YZ	WOS:000352704200026		
J	Ueda, N; Nishimura, K; Yoshida, Y; Hirai, T; Kishikawa, H; Ichikawa, Y				Ueda, Norichika; Nishimura, Kenji; Yoshida, Yasuyuki; Hirai, Toshiaki; Kishikawa, Hidefumi; Ichikawa, Yasuji			Living-Donor Kidney Transplant From a Type A Donor to a Type A Subgroup Recipient	EXPERIMENTAL AND CLINICAL TRANSPLANTATION			English	Article						Blood group; Chronic kidney disease; Immunosuppression		Type A subgroup is rare in Japan, and kidney transplant to a type A subgroup recipient is rare worldwide. A 65-year-old man presented for living-donor kidney transplant. Blood group testing showed that his wife (kidney donor) had blood group type A. The patient (recipient) had a type A subgroup because reverse blood grouping showed a weak reaction with A(1) antigen. Further testing showed that the recipient had type A subgroup between A(x) and A(ei) because adsorption elution experiments and flow cytometry showed a few A antigens that were not detected on forward grouping, and DNA analysis was not consistent with A(ei). The patient was given a milder protocol for immunosuppressive preoperative therapy than typically used for ABO-incompatible kidney transplant; mycophenolate mofetil and prednisolone were started 3 weeks and cyclosporine 2 weeks before transplant, rituximab (100 mg) was given once, and double filtration plasmapheresis and plasma exchange were not used. Follow-up at 9 months after transplant showed stable clinical status and no allograft rejection. In summary, the present case showed that when type A subgroup recipient has low level of anti-A(1) antibody and is receiving a kidney transplant from a blood type A donor, milder immunosuppressive preoperative therapy appears safe.	[Ueda, Norichika; Nishimura, Kenji; Yoshida, Yasuyuki; Hirai, Toshiaki; Kishikawa, Hidefumi; Ichikawa, Yasuji] Hyogo Prefectural Nishinomiya Hosp, Dept Kidney Transplantat Ctr, Nishinomiya, Hyogo 6620918, Japan	Ueda, N (reprint author), Hyogo Prefectural Nishinomiya Hosp, Dept Renal Transplantat Ctr, 13-9 Rokutanji Cho, Nishinomiya, Hyogo 6620918, Japan.	norichika_at_mie@live.jp					Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; Bryan CF, 2007, AM J TRANSPLANT, V7, P1181, DOI 10.1111/j.1600-6143.2007.01750.x; GORODZINSKY FP, 1981, CAN MED ASSOC J, V125, P871; Hosoi Eiji, 2008, J Med Invest, V55, P174, DOI 10.2152/jmi.55.174; Takahashi K, 2012, NEW STRATEGIES ABO I, P3; Toyama H, 2004, BLOOD TRANSFUSION ME, P164; Vengelen-Tyler V, 1996, TECHNICAL MANUAL, P234	7	0	0	BASKENT UNIV	ANKARA	TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY	1304-0855			EXP CLIN TRANSPLANT	Exp. Clin. Transplant.	APR	2015	13	2					193	195		10.6002/ect.2013.0247		3	Transplantation	Transplantation	CG1ZL	WOS:000353074600014		
J	Ishikawa, M; Sawada, Y; Yoshitomi, T				Ishikawa, Makoto; Sawada, Yu; Yoshitomi, Takeshi			Structure and function of the interphotoreceptor matrix, surrounding retinal photoreceptor cells	EXPERIMENTAL EYE RESEARCH			English	Article						Retina; Photoreceptor cell; Interphotoreceptor matrix; lnterphotoreceptor retinoid binding protein; Proteoglycans; Growth factors; Inherited retinal degenerative disorders; Age-related macular degeneration	EPITHELIUM-DERIVED FACTOR; BINDING PROTEIN IRBP; ENDOTHELIAL GROWTH-FACTOR; CHONDROITIN-SULFATE PROTEOGLYCAN; RECESSIVE RETINITIS-PIGMENTOSA; CONE OUTER SEGMENTS; NERVOUS MUTANT MICE; CHICK NEURAL RETINA; COMPLEMENT FACTOR-H; ADULT HUMAN RETINA	The interphotoreceptor matrix (IPM) is a highly organized structure with interconnected domains surrounding cone and rod photoreceptor cells and extends throughout the subretinal space. Based on known roles of the extracellular matrix in other tissues, the IPM is thought to have several prominent functions including serving as a receptor for growth factors, regulating retinoid transport, participating in cytoskeletal organization in surrounding cells, and regulation of oxygen and nutrient transport. In addition, a number of studies suggest that the IPM also may play a significant role in the etiology of retinal degenerative disorders. In this review, we describe the present knowledge concerning the structure and function of the IPM under physiological and pathological conditions. (C) 2015 The Authors. Published by Elsevier Ltd.	[Ishikawa, Makoto; Sawada, Yu; Yoshitomi, Takeshi] Akita Univ, Dept Ophthalmol, Sch Med, Akita 0108543, Japan	Ishikawa, M (reprint author), Akita Univ, Dept Ophthalmol, Sch Med, 1-1-1 Hondo, Akita 0108543, Japan.	mako@med.akita-u.ac.jp			JSPS KAKENHI [24592666]	This work was supported in part by JSPS KAKENHI Grant No. 24592666 to M.I.	Acharya S, 2000, J BIOL CHEM, V275, P6945, DOI 10.1074/jbc.275.10.6945; ADLER AJ, 1982, EXP EYE RES, V34, P423, DOI 10.1016/0014-4835(82)90088-4; ADLER AJ, 1989, EXP EYE RES, V49, P1067, DOI 10.1016/S0014-4835(89)80027-2; ADLER AJ, 1982, CURR EYE RES, V2, P359, DOI 10.3109/02713688209000781; ADLER AJ, 1988, OPHTHALMIC RES, V20, P275; ADLER AJ, 1981, EXP EYE RES, V32, P755, DOI 10.1016/0014-4835(81)90025-7; ADLER AJ, 1982, BIOCHEM BIOPH RES CO, V108, P1601, DOI 10.1016/S0006-291X(82)80091-0; AGUIRRE GD, 1988, EXP EYE RES, V46, P663, DOI 10.1016/S0014-4835(88)80055-1; Alberts B., 2007, MOL BIOL CELL; Al-Ubaidi MR, 2013, INVEST OPHTH VIS SCI, V54, P8119, DOI 10.1167/iovs.13-13536; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; ANDERSON DH, 1979, J ULTRA MOL STRUCT R, V67, P23, DOI 10.1016/S0022-5320(79)80014-3; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Lin H, 1998, INVEST OPHTH VIS SCI, V39, P1703; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; CHAITIN MH, 1994, EXP EYE RES, V58, P359, DOI 10.1006/exer.1994.1026; SAMESHIMA M, 1987, EXP EYE RES, V45, P845, DOI 10.1016/S0014-4835(87)80101-X; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Carafoli F, 2013, BBA-PROTEINS PROTEOM, V1834, P2187, DOI 10.1016/j.bbapap.2012.10.014; Edwards RB, 2000, EXP EYE RES, V70, P235, DOI 10.1006/exer.1999.0781; LAZARUS HS, 1993, EXP EYE RES, V56, P531, DOI 10.1006/exer.1993.1067; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Li SH, 2013, J BIOL CHEM, V288, P11395, DOI 10.1074/jbc.M112.418251; Margolis RK, 1996, PERSPECT DEV NEUROBI, V3, P273; Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013; Garlipp MA, 2012, J COMP NEUROL, V520, P756, DOI 10.1002/cne.22773; JOHNSON LV, 1986, INVEST OPHTH VIS SCI, V27, P129; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Adler AJ, 2000, EXP EYE RES, V70, P227, DOI 10.1006/exer.1999.0780; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; ROBERTS WG, 1995, J CELL SCI, V108, P2369; ADLER AJ, 1983, BIOCHIM BIOPHYS ACTA, V761, P217, DOI 10.1016/0304-4165(83)90068-5; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; YAMAGATA M, 1987, J BIOL CHEM, V262, P4146; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; Zako M, 1997, J NEUROCHEM, V69, P2155; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Clark SJ, 2011, INVEST OPHTH VIS SCI, V52, P6511, DOI 10.1167/iovs.11-7909; Kozhevnikova OS, 2013, CELL CYCLE, V12, P1745, DOI 10.4161/cc.24825; Miller CL, 2011, BASIC RES CARDIOL, V106, P1023, DOI 10.1007/s00395-011-0228-2; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Iozzo RV, 1996, FASEB J, V10, P598; Mochimaru H, 2009, INVEST OPHTH VIS SCI, V50, P4410, DOI 10.1167/iovs.08-3044; Becerra SP, 2008, J BIOL CHEM, V283, P33310, DOI 10.1074/jbc.M801287200; Steinle JJ, 2008, J GERONTOL A-BIOL, V63, P135; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Keenan TDL, 2012, INVEST OPHTH VIS SCI, V53, P7528, DOI 10.1167/iovs.12-10797; WU YQ, 1995, PROTEIN EXPRES PURIF, V6, P447, DOI 10.1006/prep.1995.1060; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004; Liutkeviciene R, 2012, MED LITH, V48, P404; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Chen Y, 1996, J BIOL CHEM, V271, P20507; Kay P, 2013, J CELL MOL MED, V17, P833, DOI 10.1111/jcmm.12070; Kolomeyer AM, 2011, INVEST OPHTH VIS SCI, V52, P5963, DOI 10.1167/iovs.10-6440; PEPPERBERG DR, 1993, MOL NEUROBIOL, V7, P61, DOI 10.1007/BF02780609; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Holekamp NM, 2002, AM J OPHTHALMOL, V134, P220, DOI 10.1016/S0002-9394(02)01549-0; Rhodes JM, 2007, J CELL MOL MED, V11, P176, DOI 10.1111/j.1582-4934.2007.00031.x; Sobel RA, 2001, J NEUROPATH EXP NEUR, V60, P1198; BLODI CF, 1990, OPHTHALMIC PAED GEN, V11, P49; Trebaul A, 2007, BIOCHEM SOC T, V35, P695; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Broadhead ML, 2010, GROWTH FACTORS, V28, P280, DOI 10.3109/08977191003604513; Tran KT, 2005, J DERMATOL SCI, V40, P11, DOI 10.1016/j.jdermsci.2005.05.001; FISHER SK, 1982, J COMP NEUROL, V206, P131, DOI 10.1002/cne.902060204; Cruz-Munoz W, 2008, CRIT REV CL LAB SCI, V45, P291, DOI 10.1080/10408360801973244 ; Acharya S, 1998, GLYCOBIOLOGY, V8, P997, DOI 10.1093/glycob/8.10.997; Semenova EM, 2003, VISION RES, V43, P3063, DOI 10.1016/j.visres.2003.09.008; Manes G, 2013, AM J HUM GENET, V93, P571, DOI 10.1016/j.ajhg.2013.07.018; Inatani M, 2002, PROG RETIN EYE RES, V21, P429, DOI 10.1016/S1350-9462(02)00009-5; Barbehenn E, 1985, Prog Clin Biol Res, V190, P129; BAZAN NG, 1985, J BIOL CHEM, V260, P3677; BERMAN ER, 1968, BIOCHEM J, V108, P75; Berman E R, 1969, Bibl Ophthalmol, V79, P5; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; BRAEKEVELT CR, 1983, GRAEF ARCH CLIN EXP, V220, P273, DOI 10.1007/BF00231355; Bridges C D, 1985, Prog Clin Biol Res, V190, P195; Campochiaro P.A., 2006, HUM GENE THER, V17, P16; CARTERDAWSON L, 1989, EXP EYE RES, V49, P829, DOI 10.1016/S0014-4835(89)80042-9; CHADER GJ, 1984, VISION RES, V24, P1605, DOI 10.1016/0042-6989(84)90318-3; COHEN D, 1984, INVEST OPHTH VIS SCI, V25, P1342; Dietrich K, 2002, BRIT J OPHTHALMOL, V86, P328, DOI 10.1136/bjo.86.3.328; du Plooy C.S., 2014, HEART LUNG CIRC; Duncan T, 2006, MOL VIS, V12, P1632; Fariss RN, 1997, AM J PATHOL, V150, P323; Feeney L., 1973, DEV BIOL, V32, P115; Fernandez-Moran H., 1961, STRUCTURE EYE, P521; Fiotti N, 2005, GENET MED, V7, P272, DOI 10.1097/01.GIM.0000159903.69597.73; Foletta VC, 2001, J COMP NEUROL, V435, P354, DOI 10.1002/cne.1035; FONG SL, 1984, J BIOL CHEM, V259, P6534; Ford KM, 2012, MOL VIS, V18, P519; Gardiner NJ, 2011, DEV NEUROBIOL, V71, P1054, DOI 10.1002/dneu.20950; Garlipp MA, 2013, EXP EYE RES, V113, P192, DOI 10.1016/j.exer.2013.02.003; Gonzalez-Fernandez F, 2009, INVEST OPHTH VIS SCI, V50, P5577, DOI 10.1167/iovs.08-1857; GONZALEZFERNANDEZ F, 1985, INVEST OPHTH VIS SCI, V26, P1381; GONZALEZFERNANDEZ F, 1984, J CELL BIOL, V99, P2092, DOI 10.1083/jcb.99.6.2092; GOSPODAROWICZ D, 1983, J CELL PHYSIOL, V114, P191, DOI 10.1002/jcp.1041140208; Guillonneau X, 1999, HUM MOL GENET, V8, P1541, DOI 10.1093/hmg/8.8.1541; HAGEMAN GS, 1991, PROGR RETINAL RES, V10, P207, DOI 10.1016/0278-4327(91)90014-S; HAGEMAN GS, 1991, P NATL ACAD SCI USA, V88, P6706, DOI 10.1073/pnas.88.15.6706; HAGEMAN GS, 1987, CURR EYE RES, V6, P639, DOI 10.3109/02713688709025225; HAGEMAN GS, 1995, ARCH OPHTHALMOL-CHIC, V113, P655; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Hauck SM, 2005, PROTEOMICS, V5, P3623, DOI 10.1002/pmic.200401223; HAYASAKA S, 1981, A GRAEF ARCH KLIN EX, V216, P269, DOI 10.1007/BF00455034; Henle J., 1855, HDB SYSTEMATISCHEN A, V2, P636; HERRON WL, 1969, INVEST OPHTH VISUAL, V8, P595; HEWITT AT, 1988, INVEST OPHTH VIS SCI, V29, P720; Hollyfield JG, 1999, EXP EYE RES, V69, P311, DOI 10.1006/exer.1999.0707; HOLLYFIELD JG, 1990, EXP EYE RES, V50, P335, DOI 10.1016/0014-4835(90)90220-O; HOLLYFIELD JG, 1990, EXP EYE RES, V51, P107, DOI 10.1016/0014-4835(90)90177-V; Hollyfield JG, 1998, EXP EYE RES, V66, P241, DOI 10.1006/exer.1997.0422; HOLLYFIELD JG, 1985, INVEST OPHTH VIS SCI, V26, P58; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Hubmacher D, 2014, INVEST OPHTH VIS SCI, V55, P7934, DOI 10.1167/iovs.14-15453; Ishikawa M, 2009, JPN J OPHTHALMOL, V53, P536, DOI 10.1007/s10384-009-0700-9; Ishikawa M, 1996, OPHTHALMIC RES, V28, P117; IWASAKI M, 1992, EXP EYE RES, V54, P415, DOI 10.1016/0014-4835(92)90054-V; Jacob S., 1973, HISTOCHEMISTRY, V35, P13; Jacob S., 1973, HISTOCHEMISTRY, V35, P39; Jacob S., 1973, HISTOCHEMISTRY, V35, pIV; Johnson L.V., 1989, INVEST OPHTHALM S490; JOHNSON LV, 1991, INVEST OPHTH VIS SCI, V32, P1951; JONES BE, 1994, EXP EYE RES, V59, P257, DOI 10.1006/exer.1994.1107; Kasuga DT, 2011, AGE-RELATED MACULAR DEGENERATION DIAGNOSIS AND TREATMENT, P1, DOI 10.1007/978-1-4614-0125-4_1; KOHNO T, 1983, JPN J OPHTHALMOL, V27, P496; Kuehn MH, 1999, MATRIX BIOL, V18, P509, DOI 10.1016/S0945-053X(99)00043-8; LANDERS RA, 1994, J NEUROCHEM, V63, P737; LANDERS RA, 1992, EXP EYE RES, V55, P345, DOI 10.1016/0014-4835(92)90199-3; LANDIS SC, 1973, J HERED, V64, P193; LANDIS SC, 1973, J CELL BIOL, V57, P782, DOI 10.1083/jcb.57.3.782; LAVAIL MM, 1993, J COMP NEUROL, V333, P168, DOI 10.1002/cne.903330204; LAVAIL MM, 1981, INVEST OPHTH VIS SCI, V21, P658; LaVail M M, 1985, Prog Clin Biol Res, V190, P179; LAZARUS HS, 1992, INVEST OPHTH VIS SCI, V33, P364; Lee JW, 2000, EXP EYE RES, V71, P341, DOI 10.1006/exer.2000.0888; LI AR, 1995, J NEUROSCI, V15, P385; Lin JM, 2008, AM J OPHTHALMOL, V145, P716, DOI 10.1016/j.ajo.2007.11.006; Machalińska Anna, 2012, Klin Oczna, V114, P115; MARMOR MF, 1994, RETINA-J RET VIT DIS, V14, P181, DOI 10.1097/00006982-199414020-00014; MCLAUGHLIN BJ, 1980, INVEST OPHTH VIS SCI, V19, P728; Mecham R.P., 2012, CURR PROTOC CELL BIO; MIEZIEWSKA K, 1993, INVEST OPHTH VIS SCI, V34, P3056; MIEZIEWSKA K, 1993, EXP EYE RES, V56, P429, DOI 10.1006/exer.1993.1056; Mieziewska K, 1996, MICROSC RES TECHNIQ, V35, P463; MORRIS JE, 1987, ARCH BIOCHEM BIOPHYS, V258, P206, DOI 10.1016/0003-9861(87)90337-7; MULLEN RJ, 1975, NATURE, V258, P528, DOI 10.1038/258528a0; Ogilvie JM, 2000, EXP NEUROL, V161, P676, DOI 10.1006/exnr.1999.7291; OOHIRA A, 1994, NEUROSCI RES, V20, P195, DOI 10.1016/0168-0102(94)90088-4; Padgett LC, 1997, EXP EYE RES, V64, P927, DOI 10.1006/exer.1997.0287; Patel DD, 2001, CLIN IMMUNOL, V99, P43, DOI 10.1006/clim.2000.4997; Petrs-Silva Hilda, 2014, Clin Ophthalmol, V8, P127, DOI 10.2147/OPTH.S38041; PFEFFER B, 1983, J CELL PHYSIOL, V117, P333, DOI 10.1002/jcp.1041170308; PFEFFER BA, 1981, J ULTRA MOL STRUCT R, V76, P158, DOI 10.1016/S0022-5320(81)80014-7; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Plantner JJ, 1998, EXP EYE RES, V67, P637, DOI 10.1006/exer.1998.0552; PLANTNER JJ, 1992, CURR EYE RES, V11, P91, DOI 10.3109/02713689209069171; Plantner JJ, 1998, CURR EYE RES, V17, P132, DOI 10.1076/ceyr.17.2.132.5610; PLANTNER JJ, 1992, EXP EYE RES, V54, P113, DOI 10.1016/0014-4835(92)90075-4; Plantner JJ, 1997, CURR EYE RES, V16, P51, DOI 10.1076/ceyr.16.1.51.5118; PORRELLO K, 1986, CURR EYE RES, V5, P981, DOI 10.3109/02713688608995180; PORRELLO K, 1989, Investigative Ophthalmology and Visual Science, V30, P638; ROHLICH P, 1970, EXP EYE RES, V10, P80, DOI 10.1016/S0014-4835(70)80013-6; Saari John C., 1994, P351; SANYAL S, 1988, CURR EYE RES, V7, P1183, DOI 10.3109/02713688809033222; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; SCHMIDT SY, 1988, INVEST OPHTH VIS SCI, V29, P1585; SCHUBERT D, 1985, J CELL BIOL, V101, P1071, DOI 10.1083/jcb.101.3.1071; Seddon JM, 2001, OPHTHALMOLOGY, V108, P2060, DOI 10.1016/S0161-6420(01)00777-1; Senanayake P.D., 2001, J CELL SCI, V114, P199; SENGER DR, 1990, CANCER RES, V50, P1774; SIDMAN RL, 1958, ANN NY ACAD SCI, V74, P182; SIDMAN RL, 1965, J HERED, V56, P23; Smith Michael L, 2007, PLoS Biol, V5, pe268, DOI 10.1371/journal.pbio.0050268; Sonoda S., 2009, AGING, V2, P28; Sprenger CC, 2010, INT J CANCER, V127, P2739, DOI 10.1002/ijc.25615; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Srramm L.E., 1989, INVEST OPHTH VIS SCI, V30, P2118; STEINBERG RH, 1977, PHILOS T ROY SOC B, V277, P459, DOI 10.1098/rstb.1977.0028; STEINBER.RH, 1974, PROC R SOC SER B-BIO, V187, P461, DOI 10.1098/rspb.1974.0088; Steiner C., 2006, MOL VIS, V12, P892; Tan J., 2009, CURR EYE RES, V35, P37; TAWARA A, 1989, EXP EYE RES, V48, P815, DOI 10.1016/0014-4835(89)90066-3; TAWARA A, 1988, EXP EYE RES, V46, P689, DOI 10.1016/S0014-4835(88)80056-3; TAWARA A, 1990, EXP EYE RES, V51, P301, DOI 10.1016/0014-4835(90)90027-R; TIEN LF, 1992, EXP EYE RES, V55, P297, DOI 10.1016/0014-4835(92)90194-W; TIMPL R, 1984, CIBA F SYMP, V108, P25; TOMBRANTINK J, 1992, J COMP NEUROL, V317, P175, DOI 10.1002/cne.903170206; UEHARA F, 1990, SCIENCE, V248, P1633, DOI 10.1126/science.2194288; van Veen T, 1989, Prog Clin Biol Res, V314, P275; VANVEEN T, 1986, FEBS LETT, V208, P133, DOI 10.1016/0014-5793(86)81547-2; VARNER HH, 1987, EXP EYE RES, V44, P633, DOI 10.1016/S0014-4835(87)80135-5; WALDBILLIG RJ, 1991, EXP EYE RES, V53, P13, DOI 10.1016/0014-4835(91)90139-6; Wang YJ, 2013, ASN NEURO, V5, DOI 10.1042/AN20130028; White M.P., 1993, J COMP NEUROL, V333, P192; Wilson CG, 2009, TISSUE ENG PT A, V15, P1513, DOI 10.1089/ten.tea.2008.0106; WOOD JG, 1984, J COMP NEUROL, V228, P299, DOI 10.1002/cne.902280214; WORTMAN B, 1962, FED PROC, V21, P170; WORTMAN B, 1959, AM J OPHTHALMOL, V47, P203; Yamada E, 1985, Prog Clin Biol Res, V190, P25; YAO XY, 1994, INVEST OPHTH VIS SCI, V35, P744; YING SY, 1995, EXP EYE RES, V60, P585, DOI 10.1016/S0014-4835(05)80073-9; Yokomori H, 2003, LIVER INT, V23, P467, DOI 10.1111/j.1478-3231.2003.00880.x; Zako M, 2002, J BIOL CHEM, V277, P25592, DOI 10.1074/jbc.M201279200; ZIMMERMANN DR, 1989, EMBO J, V8, P2975; Zipfel PF, 2001, SEMIN THROMB HEMOST, V27, P191, DOI 10.1055/s-2001-15248	225	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	APR	2015	133				SI		3	18		10.1016/j.exer.2015.02.017		16	Ophthalmology	Ophthalmology	CF8PO	WOS:000352824600002		
J	Togami, K; Kitaura, J; Uchida, T; Inoue, D; Nishimura, K; Kawabata, KC; Nagase, R; Horikawa, S; Izawa, K; Fukuyama, T; Nakahara, F; Oki, T; Harada, Y; Harada, H; Aburatani, H; Kitamura, T				Togami, Katsuhiro; Kitaura, Jiro; Uchida, Tomoyuki; Inoue, Daichi; Nishimura, Koutarou; Kawabata, Kimihito C.; Nagase, Reina; Horikawa, Sayuri; Izawa, Kumi; Fukuyama, Tomofusa; Nakahara, Fumio; Oki, Toshihiko; Harada, Yuka; Harada, Hironori; Aburatani, Hiroyuki; Kitamura, Toshio			A C-terminal mutant of CCAAT-enhancer-binding protein alpha (C/EBP alpha-C-m) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBP alpha-C-m	EXPERIMENTAL HEMATOLOGY			English	Article							ACUTE MYELOBLASTIC-LEUKEMIA; INITIATING CELLS; CEBPA MUTATIONS; UP-REGULATION; EXPRESSION; GENE; FMS; TRANSCRIPTION; IDENTIFICATION; ACTIVATION	Two types of CCAAT-enhancer-binding protein a (C/EBP alpha) mutants are found in acute myeloid leukemia (AML) patients: N-terminal frame-shift mutants (C/EBP alpha-N-m) generating p30 as a dominant form and C-terminal basic leucine zipper domain mutants (C/EBP alpha-C-m). We have previously shown that C/EBP alpha-K304_R323dup belonging to C/EBP alpha-C-m, but not C/EBP alpha-T6OfsX159 belonging to C/EBP alpha-N-m, alone induced AML in mouse bone marrow transplantation (BMT) models. Here we show that various C/EBP alpha-C-m mutations have a similar, but not identical, potential in myeloid leukemogenesis. Notably, like C/EBP alpha-K304_R323dup, any type of C/EBP alpha-C-m tested (C/EBP alpha-S299_K304dup, K313dup, or N321D) by itself induced AML, albeit with different latencies after BMT; C/EBP alpha-N321D induced AML with the shortest latency. By analyzing the gene expression profiles of C/EBP alpha-N321D- and mock-transduced c-kit(+)Sca-1(+)Lin(-) cells, we identified Csf1r as a gene downregulated by C/EBP alpha-N321D. In addition, leukemic cells expressing C/EBP alpha-C-m exhibited low levels of colony stimulating factor 1 receptor in mice. On the other hand, transduction with C/EBP alpha-N-m did not influence Csf1r expression in c-kit(+)Sca-1(+)Lin(-) cells, implying a unique role for C/EBP alpha-C-m in downregulating Csf1r. Importantly, Csf1r overexpression collaborated with C/EBP alpha-N321D to induce fulminant AML with leukocytosis in mouse BMT models to a greater extent than did C/EBP alpha-N321D alone. Collectively, these results suggest that C/EBP alpha-C-m-mediated downregulation of Csf1r has a negative, rather than a positive, impact on the progression of AML involving C/EBP alpha-C-m, which might possibly be accelerated by additional genetic and/or epigenetic alterations inducing Csf1r upregulation. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Togami, Katsuhiro; Kitaura, Jiro; Uchida, Tomoyuki; Inoue, Daichi; Nishimura, Koutarou; Kawabata, Kimihito C.; Nagase, Reina; Horikawa, Sayuri; Izawa, Kumi; Fukuyama, Tomofusa; Nakahara, Fumio; Oki, Toshihiko; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo 1088639, Japan; [Oki, Toshihiko; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Stem Cell Signaling, Tokyo 1088639, Japan; [Harada, Yuka; Harada, Hironori] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan; [Harada, Yuka] Hiroshima Univ, Res Inst Radiat Biol & Med, Div Radiat Informat Registry, Hiroshima, Japan; [Harada, Hironori] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo 1088639, Japan	Kitamura, T (reprint author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp			Ministry of Education, Science, Technology, Sports and Culture, Japan [23249051]	We thank Dr. I. Kitabayashi for providing the cDNA of Csf1r. We also thank R&D Systems for providing cytokines. We thank Dr. Dovie Wylie for her excellent language assistance. This work was supported by a grant (no. 23249051) from the Ministry of Education, Science, Technology, Sports and Culture, Japan.	Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Kato N, 2011, BLOOD, V117, P221, DOI 10.1182/blood-2010-02-270181; Tenen DG, 1997, BLOOD, V90, P489; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Aikawa Y, 2010, NAT MED, V16, P580, DOI 10.1038/nm.2122; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Renneville A, 2009, BLOOD, V113, P5090, DOI 10.1182/blood-2008-12-194704; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Ding Y, 2009, BLOOD, V114, P5201, DOI 10.1182/blood-2009-06-223982; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; GISSELBRECHT S, 1987, NATURE, V329, P259, DOI 10.1038/329259a0; HEARD JM, 1987, CELL, V51, P663, DOI 10.1016/0092-8674(87)90135-8; Kagiyama Y, 2012, INT J HEMATOL, V96, P638, DOI 10.1007/s12185-012-1207-6; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Lu Y, 2007, LEUKEMIA, V21, P2246, DOI 10.1038/sj.leu.2404883; lwama A, 2002, J EXP MED, V195, P547; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; Nerlov C, 2004, NAT REV CANCER, V4, P391; NERLOV C, 1995, EMBO J, V14, P4318; PREISLER HD, 1987, CANCER RES, V47, P874; RAMBALDI A, 1988, J CLIN INVEST, V81, P1030, DOI 10.1172/JCI113413; WANG C, 1988, J CELL PHYSIOL, V135, P133, DOI 10.1002/jcp.1041350119	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	APR	2015	43	4					300	308		10.1016/j.exphem.2014.11.011		9	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CF8QD	WOS:000352826100006		
J	Tani, H; Teramoto, S; Okamoto, K				Tani, Hiroumi; Teramoto, Susumu; Okamoto, Koji			High-speed observations of cryogenic single and coaxial jets under subcritical and transcritical conditions	EXPERIMENTS IN FLUIDS			English	Article							SUPERCRITICAL PRESSURE; LIQUID JET; INJECTION; ATOMIZATION; DYNAMICS; LAYERS; FLAMES	Cryogenic single round and coaxial jets were observed under subcritical and transcritical conditions using a high-speed camera to explore the effects of the single-phase-like and two-phase-like properties of transcritical fluids on the unsteady behavior and flow structures of the jets. Cryogenic nitrogen and gaseous nitrogen were used as injectants. Cryogenic nitrogen was clearly visualized in all cases as the dark core. In the cases of single round jets, the large-scale characteristics of the jet behavior observed, such as the width of the dark core and the length scale of wave development in the mixing layers, were similar to those observed under subcritical conditions. Furthermore, dense nitrogen in the mixing layer entrained into the ambient environment and stretched in a manner similar to that observed under subcritical conditions. However, in contrast to the droplet formation observed under subcritical conditions, the entrained dense nitrogen diffused in a manner similar to turbulent mixing in a variable-density single-phase mixing layer. This means that the microscale behaviors that occur under transcritical conditions, which are comparable to turbulent eddies, are similar to those that occur in variable-density single-phase jets. In the cases of coaxial jets, the turbulent-eddy-scale phenomena observed were also similar to those observed for variable-density single-phase jets. However, in contrast to the phenomena observed for single round jets, the larger-scale behavior of the dark core was different from that observed under subcritical conditions. Two significant features were observed only under transcritical conditions. The first feature was the formation of shear-layer instability waves near the injector exit. The second feature was the shedding of dense nitrogen lumps from the end of the dark core at nearly uniform intervals. Because similar behavior was not observed under subcritical conditions, the single-phase-like properties of transcritical fluids are considered to have induced these features. The present correlation between the dark core length and the outer-to-inner jet momentum flux ratio was found to be in good agreement with the empirical correlation for variable-density single-phase coaxial jets.	[Tani, Hiroumi] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki, Japan; [Teramoto, Susumu] Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo, Japan; [Okamoto, Koji] Univ Tokyo, Dept Adv Energy, Kashiwa, Chiba, Japan	Tani, H (reprint author), Japan Aerosp Explorat Agcy, 2-1-1 Sengen, Tsukuba, Ibaraki, Japan.	tani.hiroumi@jaxa.jp					Lasheras JC, 2000, ANNU REV FLUID MECH, V32, P275, DOI 10.1146/annurev.fluid.32.1.275; Oschwald M, 2006, COMBUST SCI TECHNOL, V178, P49, DOI 10.1080/00102200500292464; Branam R, 2003, J PROPUL POWER, V19, P342, DOI 10.2514/2.6138; Candel S, 2006, COMBUST SCI TECHNOL, V178, P161, DOI 10.1080/00102200500292530; Oschwald M, 1999, EXP FLUIDS, V27, P497, DOI 10.1007/s003480050374; Mayer W, 2000, J PROPUL POWER, V16, P823, DOI 10.2514/2.5647; BROWN GL, 1974, J FLUID MECH, V64, P775, DOI 10.1017/S002211207400190X; Rehab H, 1997, J FLUID MECH, V345, P357, DOI 10.1017/S002211209700637X; Balarac G, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1900786; Chehroudi B., 2012, INT J AEROSPACE ENG, V2012, P31; Chehroudi B, 2002, INT J HEAT FLUID FL, V23, P554, DOI 10.1016/S0142-727X(02)00151-0; DAHM WJA, 1992, J FLUID MECH, V241, P371, DOI 10.1017/S0022112092002088; Davis D. W., 2006, THESIS PENNSYLVANIA; Farago Z, 1992, INT J HEAT MASS TRAN, V44, P1913; Favre-Marinet M, 2001, AT SPRAYS, V2, P137; Graham JJ, 2009, 45 AIAA ASME SAE ASE; Hosangadi A, 2008, 44 AIAA ASME SAE ASE; Kafengauz NL, 1968, J ENG PHYS THERMOPH+, V14, P489, DOI 10.1007/BF00828077; Kim T, 2011, J SUPERCRIT FLUID, V58, P254, DOI 10.1016/j.supflu.2011.05.020; Lacaze G, 2013, 49 AIAA ASME SAE ASE; Leyva IA, 2007, 43 AIAA ASME SAE ASE; Locke JM, 2010, 46 AIAA ASME SAE ASE; Matsuyama S, 2010, 48 AIAA AER SCI M IN; Mayer WOH, 2004, EXP FLUIDS, V36, P528, DOI 10.1007/s00348-003-0675-0; Oschwald M, 1999, 35 AIAA ASME SAE ASE; Roy A, 2013, J FLUID MECH, V717, P193, DOI 10.1017/jfm.2012.566; Roy A, 2013, AIAA J, V51, P2009, DOI 10.2514/1.J052415; Schumaker SA, 2009, THESIS U MICHIGAN; TANG SK, 1994, EXP FLUIDS, V17, P147, DOI 10.1007/BF00190911; Terashima H, 2011, AIAA J, V49, P2658, DOI 10.2514/1.J051079; Terashima H, 2014, 52 AER SCI M NAT HAR; Woodward R., 2006, 42 AIAA ASME SAE ASE; Woodward Richard P, 2007, 45 AIAA AER SCI M EX	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0723-4864	1432-1114		EXP FLUIDS	Exp. Fluids	APR	2015	56	4							85	10.1007/s00348-015-1956-0		13	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CG1MU	WOS:000353037800010		
J	Tamura, K; Inoue, K; Takahashi, M; Matsuo, S; Irie, K; Kodama, Y; Garno, T; Ozawa, S; Yoshida, M				Tamura, Kei; Inoue, Kaoru; Takahashi, Miwa; Matsuo, Saori; Irie, Kaoru; Kodama, Yukio; Garno, Toshie; Ozawa, Shogo; Yoshida, Midori			Involvement of constitutive androstane receptor in liver hypertrophy and liver tumor development induced by triazole fungicides	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Triazoles; CAR; Liver hypertrophy; Liver tumorigenesis; Cyp2b; Mice	NUCLEAR RECEPTOR; ACTIVE/ANDROSTANE RECEPTOR; GENE-EXPRESSION; CAR; MICE; PROMOTION; MODE; CANCER; PXR; MKK7/JNKK2	We clarified the involvement of constitutive androstane receptor (CAR) in triazole-induced liver hypertrophy and tumorigenesis using CAR-knockout (CARKO) mice. Seven-week-old male CARKO and wild-type (WT) mice were treated with 200 ppm cyproconazole (Cypro), 1500 ppm tebuconazole (Teb), or 200 ppm fluconazole (Flu) in the diet for 27 weeks after initiation by diethylnitrosamine (DEN). At weeks 4 (without DEN) and 13 (with DEN), WT mice in all treatment groups and CARKO mice in Teb group revealed liver hypertrophy with mainly Cyp2b10 and following Cyp3al1 inductions in the liver. Teb also induced Cyp4a10 in both genotypes. Cypro induced slight and duration-dependent liver hypertrophy in CARKO mice. At week 27, Cypro and Teb significantly increased eosinophilic altered foci and/or adenomas in WT mice. These proliferating lesions were clearly reduced in CARKO mice administered both compounds. The eosinophilic adenomas caused by Flu decreased in CARKO mice. The present study indicates that CAR is the main mediator of liver hypertrophy induced by Cypro and Flu, but not Teb. In contrast CAR played a crucial role in liver tumor development induced by all three triazoles. (C) 2015 Elsevier Ltd. All rights reserved.	[Tamura, Kei; Inoue, Kaoru; Takahashi, Miwa; Matsuo, Saori; Irie, Kaoru; Yoshida, Midori] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan; [Kodama, Yukio] Natl Inst Hlth Sci, Div Toxicol, Setagaya Ku, Tokyo 1588501, Japan; [Garno, Toshie; Ozawa, Shogo] Iwate Med Univ, Sch Pharm, Dept Pharmacodynam Mol Genet, Morioka, Iwate 0208505, Japan	Yoshida, M (reprint author), Natl Inst Hlth Sci, Setagaya Ku, Kamiyoga I-18-1, Tokyo 1588501, Japan.	midoriy@nihs.go.jp			Cabinet Office Research for Assessment of the Effect of Food on Human Health, Japan [1303]	This research was commissioned under a grant for the 2013 Cabinet Office Research for Assessment of the Effect of Food on Human Health, Japan (Topic No. 1303). We thank Ms. Tomomi Morikawa, Ms. Yoshimi Komatsu, and Ms. Ayako Saikawa for expert technical assistance in performing the animal experiments and processing histological materials.	Braeuning A, 2014, TOXICOL SCI, V140, P259, DOI 10.1093/toxsci/kfu099; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Nesnow S, 2009, TOXICOL SCI, V110, P68, DOI 10.1093/toxsci/kfp076; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931.7940.2004; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501; Peffer RC, 2007, TOXICOL SCI, V99, P315, DOI 10.1093/toxsci/kfm154; Sakamoto Y, 2013, TOXICOL PATHOL, V41, P1078, DOI 10.1177/0192623313482055; Tamura K, 2013, TOXICOL LETT, V221, P47, DOI 10.1016/j.toxlet.2013.05.011; Luisier R, 2014, TOXICOL SCI, V139, P501, DOI 10.1093/toxsci/kfu038; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Ross J, 2010, TOXICOL SCI, V116, P452, DOI 10.1093/toxsci/kfq118; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Hall AP, 2012, TOXICOL PATHOL, V40, P971, DOI 10.1177/0192623312448935; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Yamamoto Y, 2008, DRUG METAB DISPOS, V36, P1189, DOI 10.1124/dmd.108.020628; Ozawa S, 2011, J TOXICOL SCI, V36, P613; Wei P, 2000, NATURE, V407, P920; Currie RA, 2014, TOXICOLOGY, V321, P80, DOI 10.1016/j.tox.2014.03.003; DIWAN BA, 1986, CARCINOGENESIS, V7, P215, DOI 10.1093/carcin/7.2.215; Elcombe CR, 2014, CRIT REV TOXICOL, V44, P64, DOI 10.3109/10408444.2013.835786; INCHEM, 1994, INCHEM MON 2, V884; INCHEM, 1987, INCHEM MON 2, V768; INCHEM, 1992, INCHEM MON 2, V847; INCHEM, 2001, JMPR MON 2001; INCHEM, 1997, INCHEM MON 2, V930; International Agency for Research on Cancer (IARC), 2001, IARC MONOGR EVAL CAR, V79; Kamino H, 2011, CANCER GENET-NY, V204, P382, DOI 10.1016/j.cancergen.2011.05.007; Klaunig J.E., 2013, CASARETT DOULLS TOXI, P393; Lamminpaa A, 2002, EUR J CLIN PHARMACOL, V58, P137, DOI 10.1007/s00228-002-0429-6; La Vecchia C, 2014, EUR J CANCER PREV, V23, P1, DOI 10.1097/CEJ.0b013e32836014c8; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; Phillips JM, 2009, TOXICOL SCI, V110, P319, DOI 10.1093/toxsci/kfp108; Regulatory Affairs Department SDS Biotech K.K., 1997, J PEST SCI, V22, P263; Sun GB, 2006, TOXICOL LETT, V164, P44, DOI 10.1016/j.toxlet.2005.11.015; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499	35	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	APR	2015	78						86	95		10.1016/j.fct.2015.01.021		10	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	CF6JQ	WOS:000352663400012		
J	Nagai, K; Oda, A; Konishi, H				Nagai, Katsuhito; Oda, Ayano; Konishi, Hiroki			Theanine prevents doxorubicin-induced acute hepatotoxicity by reducing intrinsic apoptotic response	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Doxorubicin; Theanine; Biochemical modulation; Hepatotoxicity; Apoptotic response	GREEN TEA; INDUCED CARDIOMYOPATHY; LIVER-INJURY; MICE; ADRIAMYCIN; MECHANISMS; TOXICITY; PATHWAY; MODEL; RATS	Doxorubicin (DOX) is widely used as an antitumor agent with topoisomerase II inhibiting activity; however, its dosage and duration of administration have been strictly limited due to dose-related organ damage. The present study investigated whether theanine, an amino acid found in green tea leaves, could reduce DOX-induced acute hepatotoxicity and the apoptotic response in mice. Activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in serum, biomarkers of hepatic impairment, were markedly increased after the administration of 20 mg/kg DOX, whereas the degree of these elevations was significantly attenuated by 10 mg/kg theanine, which was consistent with histological hepatic images assessed by microscopic examination. The hepatic expression of Bax and Fas, representative intrinsic and extrinsic apoptotic molecules, respectively, was significantly increased by dosing with DOX. However, the elevation in the hepatic expression of Bax, but not Fas, was suppressed to control levels by theanine. The formation of cleaved caspase-3 protein in the group given DOX with theanine was significantly lower than that in the group treated with DOX alone. These results suggest that theanine can protect against acute hepatic damage induced by DOX, which is attributed to the suppression of intrinsic caspase-3dependent apoptotic signaling. (C) 2015 Elsevier Ltd. All rights reserved.	[Nagai, Katsuhito; Oda, Ayano; Konishi, Hiroki] Osaka Ohtani Univ, Fac Pharm, Lab Clin Pharm & Therapeut, Tondabayashi 5840066, Japan	Nagai, K (reprint author), Osaka Ohtani Univ, Fac Pharm, Lab Clin Pharm & Therapeut, 3-11-1 Nishikiori Kita, Tondabayashi 5840066, Japan.	nagaika@osaka-ohtani.ac.jp					Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Wilting RH, 2012, DRUG RESIST UPDATE, V15, P21, DOI 10.1016/j.drup.2012.01.008; Desai MJ, 2005, CHIRALITY, V17, P154, DOI 10.1002/chir.20144; Sadzuka Y, 1996, CANCER LETT, V105, P203, DOI 10.1016/0304-3835(96)04282-6; Bardi E, 2007, PATHOL ONCOL RES, V13, P249; Hu QW, 2012, FOOD CHEM TOXICOL, V50, P1927, DOI 10.1016/j.fct.2012.03.059; Wang N, 2011, FOOD CHEM TOXICOL, V49, P2975, DOI 10.1016/j.fct.2011.06.080; Vuong QV, 2011, J SEP SCI, V34, P2468, DOI 10.1002/jssc.201100401; Muller I, 1998, INT J MOL MED, V1, P491; Arola OJ, 2000, CANCER RES, V60, P1789; Kalender Y, 2005, TOXICOLOGY, V209, P39, DOI 10.1016/j.tox.2004.12.003; Sugiyama T, 2004, CANCER LETT, V212, P177, DOI 10.1016/j.canlet.2004.03.040; Zheng BB, 2013, BIOL PHARM BULL, V36, P1118; Zhao XY, 2012, BIOL PHARM BULL, V35, P796, DOI 10.1248/bpb.35.796; Kassner N, 2008, DRUG METAB DISPOS, V36, P2113, DOI 10.1124/dmd.108.022251; Jiang W, 2012, BIOCHEM BIOPH RES CO, V422, P344, DOI 10.1016/j.bbrc.2012.05.022; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Beere HM, 2000, NAT CELL BIOL, V2, P469; Li GL, 2012, FOOD CHEM TOXICOL, V50, P363, DOI 10.1016/j.fct.2011.10.036; Kim YI, 2014, ANTICANCER RES, V34, P1715; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Damodar G, 2014, Ann Med Health Sci Res, V4, P74, DOI 10.4103/2141-9248.126619; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Henninger C, 2012, TOXICOL APPL PHARM, V261, P66, DOI 10.1016/j.taap.2012.03.012; Kim Tae Il, 2009, Free Radic Biol Med, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008; Nagai K., 2013, Biomedicine & Preventive Nutrition, V3, P197; Yu YN, 2009, BASIC CLIN PHARMACOL, V104, P300, DOI 10.1111/j.1742-7843.2008.00343.x; Zhong XG, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-115	29	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	APR	2015	78						147	152		10.1016/gct.2015.02.009		6	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	CF6JQ	WOS:000352663400019		
J	Chivero, P; Gohtani, S; Yoshii, H; Nakamura, A				Chivero, Peter; Gohtani, Shoichi; Yoshii, Hidefumi; Nakamura, Akihiro			Effect of xanthan and guar gums on the formation and stability of soy soluble polysaccharide oil-in-water emulsions	FOOD RESEARCH INTERNATIONAL			English	Article						Soy soluble polysaccharide (SSPS); Xanthan gum (XG); Guar gum (GG); Depletion flocculation; Rheology	LOCUST BEAN GUM; EMULSIFYING PROPERTIES; SODIUM CASEINATE; RHEOLOGICAL CHARACTERIZATION; O/W EMULSIONS; FLOCCULATION; INTERFACES; MIXTURES; PROTEINS; BEHAVIOR	The incorporation of relevant amounts of non-adsorbing hydrocolloids to oil-in-water (O/W) emulsions is a suitable alternative to reduce creaming. The effect of incorporating xanthan gum (XG) or guar gum (GG) in soy soluble polysaccharide (SSPS) stabilized oil-in-water (O/W) emulsions was studied. The emulsions contained 6 wt.% of SSPS, 20 wt.% Perilla seed oil (PSO), an omega-3 vegetable oil, and variable amounts of XG or GG ranging from 0.03 to 03 wt.%. The presence of minute amounts of XG or GG in fresh emulsions significantly decreased the emulsion droplet size (EDS) although such low concentrations did not provide enough continuous phase viscosity to arrest creaming. Emulsion microstructure indicated the presence of flocculation even at high concentrations of XG or GG caused by a depletion mechanism. All emulsions with XG or GG exhibited pseudoplastic behavior while the control emulsions showed an almost Newtonian behavior. Emulsion droplet polydispersion generally decreased with increase in the continuous phase viscosity indicating the importance of continuous phase viscosity in the dissipation of shear energy throughout the emulsion during homogenization. The characteristics of the emulsions were closely related to the rheological changes of the continuous phase. (C) 2015 Elsevier Ltd. All rights reserved.	[Chivero, Peter] Ehime Univ, United Grad Sch Agr Sci, Dept Food Sci, Miki, Ikenobe 7610795, Japan; [Gohtani, Shoichi; Yoshii, Hidefumi] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Ikenobe 7610795, Japan; [Nakamura, Akihiro] Fuji Oil Co Ltd, New Business Dev Div, Minato Ku, Tokyo 1086323, Japan	Gohtani, S (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, 2393 Kitagun, Miki, Ikenobe 7610795, Japan.	pchivero@yahoo.com; gohtani@ag.kagawa-u.ac.jp; foodeng.yoshii@ag.kagawa-u.ac.jp; nakamura.akihiro@so.fujioil.co.jp					Narchi I, 2009, FOOD HYDROCOLLOID, V23, P188, DOI 10.1016/j.foodhyd.2007.12.010; Makri EA, 2006, FOOD HYDROCOLLOID, V20, P1141, DOI 10.1016/j.foodhyd.2005.12.008; Palazolo GG, 2004, J AM OIL CHEM SOC, V81, P625, DOI 10.1007/s11746-004-953-0; Qian C, 2011, FOOD HYDROCOLLOID, V25, P1000, DOI 10.1016/j.foodhyd.2010.09.017; Dickinson E, 2008, SOFT MATTER, V4, P932, DOI 10.1039/b718319d; Nakauma M, 2008, FOOD HYDROCOLLOID, V22, P1254, DOI 10.1016/j.foodhyd.2007.09.004; Nakamura A, 2012, FOOD HYDROCOLLOID, V29, P75, DOI 10.1016/j.foodhyd.2012.01.018; Dickinson E, 2003, FOOD HYDROCOLLOID, V17, P25, DOI 10.1016/S0268-005X(01)00120-5; Hayati IN, 2007, FOOD RES INT, V40, P1051, DOI 10.1016/j.foodres.2007.05.008; Wang Q, 2005, CARBOHYD RES, V340, P2637, DOI 10.1016/j.carres.2005.08.012; Papalamprou EM, 2005, J SCI FOOD AGR, V85, P1967, DOI 10.1002/jsfa.2159; Depree JA, 2001, TRENDS FOOD SCI TECH, V12, P157, DOI 10.1016/S0924-2244(01)00079-6; Hakansson A, 2009, CHEM ENG SCI, V64, P2915, DOI 10.1016/j.ces.2009.03.034; Desplanques S, 2012, FOOD HYDROCOLLOID, V27, P401, DOI 10.1016/j.foodhyd.2011.10.015; Long Z, 2012, FOOD RES INT, V49, P545, DOI 10.1016/j.foodres.2012.07.032; Dickinson E, 2011, FOOD HYDROCOLLOID, V25, P1966, DOI 10.1016/j.foodhyd.2010.12.001; Torres MD, 2014, FOOD HYDROCOLLOID, V40, P85, DOI 10.1016/j.foodhyd.2014.02.011; Quintana JM, 2002, J TEXTURE STUD, V33, P215, DOI 10.1111/j.1745-4603.2002.tb01346.x; Pooja D, 2014, CARBOHYD POLYM, V110, P1, DOI 10.1016/j.carbpol.2014.03.041; Nakamura A, 2001, BIOSCI BIOTECH BIOCH, V65, P2249, DOI 10.1271/bbb.65.2249; Reiffers-Magnani CK, 2000, FOOD HYDROCOLLOID, V14, P521, DOI 10.1016/S0268-005X(00)00032-1; Cao Y, 1990, FOOD HYDROCOLLOID, V4, P185; Nakamura A, 2004, FOOD HYDROCOLLOID, V18, P795, DOI 10.1016/j.foodhyd.2003.12.005; Hemar Y, 2001, FOOD HYDROCOLLOID, V15, P513, DOI 10.1016/S0268-005X(01)00075-3; Nakamura A, 2006, FOOD HYDROCOLLOID, V20, P277, DOI 10.1016/j.foodhyd.2005.02.018; Garcia-Ochoa F, 2000, BIOTECHNOL ADV, V18, P549, DOI 10.1016/S0734-9750(00)00050-1; Chivero P, 2014, FOOD HYDROCOLLOID, V35, P279, DOI 10.1016/j.foodhyd.2013.06.006; Chivero P, 2014, FOOD HYDROCOLLOID, V39, P34, DOI 10.1016/j.foodhyd.2013.12.017; DICKINSON E, 1994, FOOD HYDROCOLLOID, V8, P481; Ganzevles RA, 2006, LANGMUIR, V22, P10089, DOI 10.1021/la061537e; Gordon C. M., 1990, GUMS STABILISERS FOO, V5, P351; Gunning PA, 1988, FOOD HYDROCOLLOID, V2, P119; Garakani AHK, 2011, IRAN J ENVIRON HEALT, V8, P255; Khouryieh H, 2015, FOOD CHEM, V167, P340, DOI 10.1016/j.foodchem.2014.07.009; Kobori T, 2009, CARBOHYD POLYM, V75, P719, DOI 10.1016/j.carbpol.2008.10.008; Kono H, 2014, CARBOHYD POLYM, V111, P830, DOI 10.1016/j.carbpol.2014.05.050; LUYTEN H, 1993, ROY SOC CH, V113, P224; McClements D. J., 1999, FOOD EMULSIONS PRINC; Monsanto G. S, 2001, HDB HYDROCOLLOIDS, P103; Sopade PA, 2008, J FOOD ENG, V86, P604, DOI 10.1016/j.jfoodeng.2007.11.013; Viebke C., 2014, Bioactive Carbohydrates and Dietary Fibre, V4, P101	41	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0963-9969	1873-7145		FOOD RES INT	Food Res. Int.	APR	2015	70						7	14		10.1016/j.foodres.2015.01.025		8	Food Science & Technology	Food Science & Technology	CG1AX	WOS:000353006500002		
J	Nakayama, S; Kimura, Y; Miki, S; Oshitani, J; Kobayashi, T; Adachi, S; Matsuura, T; Imanaka, H; Ishida, N; Tada, H; Nakanishi, K; Imamura, K				Nakayama, Shota; Kimura, Yoshifumi; Miki, Sayuri; Oshitani, Jun; Kobayashi, Takashi; Adachi, Shuji; Matsuura, Tsutashi; Imanaka, Hiroyuki; Ishida, Naoyuki; Tada, Hiroko; Nakanishi, Kazuhiro; Imamura, Koreyoshi			Influence of sugar surfactant structure on the encapsulation of oil droplets in an amorphous sugar matrix during freeze-drying	FOOD RESEARCH INTERNATIONAL			English	Article						O/W emulsion; Sugar ester; Encapsulation efficiency; Lyophilization; Mixed emulsifier	HYDROPHILE-LIPOPHILE BALANCE; OXIDATIVE STABILITY; PHYSICOCHEMICAL CHARACTERIZATION; VOLATILE COMPOUNDS; FOOD INGREDIENTS; D-LIMONENE; MICROENCAPSULATION; EMULSIONS; CARRIERS; ACID	The encapsulation of O/W emulsion droplets in a freeze-dried amorphous sugar matrix was investigated, focusing on the impact of the molecular structure of the emulsifying surfactant. O/W emulsions, containing various surfactants, were freeze-dried in the presence of a sugar. Thirty types of surfactants, including eighteen different sugar surfactants and ten types of commercially available sugar ester mixtures, were used. Linoleic acid methyl ester and trehalose were used as the oil phase and sugar. The amounts of oil droplets encapsulated in freeze-dried amorphous sugar matrix were analyzed by Fourier transform Infrared spectroscopy. Sugar surfactants were generally superior to the other classes of surfactants for oil droplet encapsulation during freeze-drying, and there was the optimum alkyl chain length of the sugar surfactant. Sugar esters generally exhibited greater oil encapsulation than sugar ethers. Larger sugar head group appeared to result in better encapsulation in the case of sugar esters, but the opposite tendency was found for sugar ethers. A limited combination of sugar surfactants (15% sucrose mono- and 85% di-stearate) resulted in the maximum oil droplet encapsulation efficiency although these surfactants are individually quite poor in the encapsulation and other tested combinations did not improve the encapsulation efficiency relative to their individual effectiveness. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakayama, Shota; Kimura, Yoshifumi; Miki, Sayuri; Oshitani, Jun; Imanaka, Hiroyuki; Ishida, Naoyuki; Imamura, Koreyoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biochem, Kita Ku, Okayama 7008530, Japan; [Kobayashi, Takashi; Adachi, Shuji] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan; [Matsuura, Tsutashi] Mitsubishi Kagaku Foods Co, Minato Ku, Tokyo 1050011, Japan; [Tada, Hiroko] Okayama Univ, Adv Sci Res Ctr, Dept Instrumental Anal & Cryogen, Kita Ku, Okayama 7008530, Japan; [Nakanishi, Kazuhiro] Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan	Imamura, K (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biochem, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	kore@cc.okayama-u.ac.jp	Imanaka, Hiroyuki/J-5579-2015	Imanaka, Hiroyuki/0000-0001-6830-9934	Ministry of Education, Science, Sport and Culture of Japan [23560908]; Japan Food Chemical Research Foundation; Iijima Foundation for Food Science; Information Center of Particle Technology, Japan	This work was supported by Grant-in-Aids for Science Research (C) (No. 23560908) from the Ministry of Education, Science, Sport and Culture of Japan, the Japan Food Chemical Research Foundation, the Information Center of Particle Technology, Japan, and lijima Foundation for Food Science.	MATSUNO R, 1993, TRENDS FOOD SCI TECH, V4, P256, DOI 10.1016/0924-2244(93)90141-V; Desai KGH, 2005, DRY TECHNOL, V23, P1361, DOI 10.1081/DRT-200063478; Soottitantawat A, 2005, INNOV FOOD SCI EMERG, V6, P107, DOI 10.1016/j.ifset.2004.09.003; Gibbs BF, 1999, INT J FOOD SCI NUTR, V50, P213, DOI 10.1080/096374899101256; DAVIS HT, 1994, COLLOID SURFACE A, V91, P9, DOI 10.1016/0927-7757(94)02929-6; Drusch S, 2006, FOOD RES INT, V39, P807, DOI 10.1016/j.foodres.2006.03.003; Desobry SA, 1997, J FOOD SCI, V62, P1158, DOI 10.1111/j.1365-2621.1997.tb12235.x; Anwar SH, 2011, J FOOD ENG, V105, P367, DOI 10.1016/j.jfoodeng.2011.02.047; Soottitantawat A, 2003, J FOOD SCI, V68, P2256, DOI 10.1111/j.1365-2621.2003.tb05756.x; Paramita V, 2010, FOOD SCI TECHNOL RES, V16, P365, DOI 10.3136/fstr.16.365; Gharsallaoui A, 2007, FOOD RES INT, V40, P1107, DOI 10.1016/j.foodres.2007.07.004; Porter CJH, 1996, INT J PHARM, V141, P227, DOI 10.1016/0378-5173(96)04641-8; Imamura K, 2008, J PHARM SCI-US, V97, P2789, DOI 10.1002/jps.21202; Moreau DL, 1996, J FOOD SCI, V61, P39, DOI 10.1111/j.1365-2621.1996.tb14721.x; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023; SHIMADA Y, 1991, J AGR FOOD CHEM, V39, P637, DOI 10.1021/jf00004a001; Hogan SA, 2003, J MICROENCAPSUL, V20, P675, DOI 10.1080/0265204031000151974; Imamura K, 2013, FOOD RES INT, V51, P201, DOI 10.1016/j.foodres.2012.12.010; Minemoto Y, 2002, J MICROENCAPSUL, V19, P181; Corveleyn S, 1999, DRUG DEV IND PHARM, V25, P1005, DOI 10.1081/DDC-100102263; Jonsdottir R, 2005, J FOOD SCI, V70, pC433, DOI 10.1111/j.1365-2621.2005.tb11465.x; Gouin S, 2004, TRENDS FOOD SCI TECH, V15, P330, DOI 10.1016/j.tifs.2003.10.005; Capek I, 2004, ADV COLLOID INTERFAC, V107, P125, DOI 10.1016/S0001-8686(03)00115-5; BENITA S, 1993, J PHARM SCI, V82, P1069, DOI 10.1002/jps.2600821102; Imamura K, 2001, J PHARM SCI, V90, P1955; Bayrarn OA, 2005, J FOOD ENG, V69, P253, DOI 10.1016/j.jfoodeng.2004.08.012; Hansen T, 2004, INT J PHARM, V287, P55, DOI 10.1016/j.ijpharm.2004.08.014; Koreishi M, 2005, J AM OIL CHEM SOC, V82, P631, DOI 10.1007/s11746-005-1121-2; Koreishi M, 2009, J BIOTECHNOL, V141, P160, DOI 10.1016/j.jbiotec.2009.03.008; KUNIEDA H, 1985, J COLLOID INTERF SCI, V107, P122, DOI 10.1016/0021-9797(85)90155-9; Longmore A. P., 1971, Food Processing Industry, V40, P46; Zhang XM, 2003, FOOD SCI TECHNOL RES, V9, P110, DOI 10.3136/fstr.9.110	32	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0963-9969	1873-7145		FOOD RES INT	Food Res. Int.	APR	2015	70						143	149		10.1016/j.foodres.2015.02.003		7	Food Science & Technology	Food Science & Technology	CG1AX	WOS:000353006500019		
J	Takahashi, YS; Matsushita, N; Hogetsu, T				Takahashi, Y. S.; Matsushita, N.; Hogetsu, T.			Genotype distribution of Raffaelea quercivora in the oak galleries and its composition in the mycangia of Platypus quercivorus	FOREST PATHOLOGY			English	Article							MICROSATELLITE MARKERS; GENETIC-STRUCTURE; FUNGUS; POPULATION; QUERCUS; PLATYPODIDAE; COLEOPTERA; DISPERSAL; FOREST; BEETLE	Raffaelea quercivora is the pathogenic fungus that causes Japanese oak wilt. The female monogynous ambrosia beetle, Platypus quercivorus, carries this fungus in mycangia on the pronotum. These beetles bore galleries in oak trees with their partners to produce offspring, and they deposit fungus on the gallery walls from their mycangia. The offspring mature in the gallery, before loading the fungal pathogen and flying from the gallery to other healthy trees. To investigate the unloading and loading modes of the fungus within the gallery, we developed four polymorphic microsatellite markers for R.quercivora and identified the fungal genotypes in the galleries and mycangia of the beetles. Small wood chips were sampled at 5-10-mm intervals from the walls of five galleries in a dead Quercus serrata tree. The pronota were also sampled from five female adult beetles. The genotypes of the R.quercivora isolates from the wood chips and pronota were identified using the microsatellite makers. The genotypic analysis showed that each gallery was inhabited patchily by 5-10 genotypes of R.quercivora, and the mycangia of each beetle contained 3-6 genotypes. These results indicate that diverse R.quercivora genotypes are unloaded repeatedly from the mycangia of female beetles onto the gallery wall, which results in their patchy distribution on the walls. When the offspring leave the host tree, the fungal clones that proliferate in the walls are also loaded repeatedly into the mycangia of the mature beetles.	[Takahashi, Y. S.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan; [Matsushita, N.; Hogetsu, T.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Takahashi, YS (reprint author), Univ Tokyo, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	ytakah@gmail.com			Japan Society for the Promotion of Science (JSPS) [07J04284, 11J06173, 22380082]	We thank Dr Takuo Sawahata for help in sampling of dead trees in Atema, and to the staff of the University Forest in Aichi, The University of Tokyo for help in sampling of the dead trees in Inuyama and Akazu Research Forests. This research was supported in part by Grant-in-Aid for JSPS Fellows (No. 07J04284, 11J06173) and Grant-in-Aid for Scientific Research (No. 22380082) from Japan Society for the Promotion of Science (JSPS).	[Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Andjic V, 2011, EUR J PLANT PATHOL, V131, P49, DOI 10.1007/s10658-011-9786-2; Kuroda K, 2001, J WOOD SCI, V47, P425, DOI 10.1007/BF00767893; Beiler KJ, 2010, NEW PHYTOL, V185, P543, DOI 10.1111/j.1469-8137.2009.03069.x; Prospero S, 2012, PHYTOPATHOLOGY, V102, P73, DOI 10.1094/PHYTO-02-11-0055; Lian CL, 2006, J PLANT RES, V119, P415, DOI 10.1007/s10265-006-0274-2; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Zhou ZH, 1999, NEW PHYTOL, V144, P55, DOI 10.1046/j.1469-8137.1999.00504.x; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; HOLM S, 1979, SCAND J STAT, V6, P65; Kinuura H, 2006, APPL ENTOMOL ZOOL, V41, P123, DOI 10.1303/aez.2006.123; Takahashi Y, 2010, PHYTOPATHOLOGY, V100, P747, DOI 10.1094/PHYTO-100-8-0747; Matsuda Y, 2010, MYCOSCIENCE, V51, P310, DOI 10.1007/s10267-010-0040-0; Travadon R, 2012, NEW PHYTOL, V193, P959, DOI 10.1111/j.1469-8137.2011.04015.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Prospero S, 2008, MOL ECOL, V17, P3366, DOI 10.1111/j.1365-294X.2007.03829.x; Lian C, 2002, MOL ECOL NOTES, V2, P211, DOI 10.1046/j.1471-8278.2002.00213.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Carriconde F, 2008, MOL ECOL, V17, P4433, DOI 10.1111/j.1365-294X.2008.03924.x; Forestry Agency, 2012, SHINR RING TOUK YOUR; Gonzalez-Varela G, 2011, EUR J PLANT PATHOL, V131, P67, DOI 10.1007/s10658-011-9788-0; Grobbelaar JW, 2009, MOL ECOL RESOUR, V9, P399, DOI 10.1111/j.1755-0998.2008.02239.x; Hijii N., 1991, Journal of the Japanese Forestry Society, V73, P471; Ito S., 1998, Journal of the Japanese Forestry Society, V80, P229; Ito S., 1998, Journal of the Japanese Forestry Society, V80, P170; Kinuura H, 2002, J FOR RES, V7, P7, DOI DOI 10.1007/BF02762592; Kobayashi M., 2005, Journal of the Japanese Forest Society, V87, P435; Kubono Takanori, 2002, Mycoscience, V43, P255, DOI 10.1007/s102670200037; Kuroda K., 1996, Journal of the Japanese Forestry Society, V78, P84; Nobuchi A., 1973, B GOVT FOREST EXPT S, V256, P1; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider S., 2000, ARLEQUIN SOFTWARE PO; Sone K, 1998, APPL ENTOMOL ZOOL, V33, P67; Tsui CKM, 2012, MOL ECOL, V21, P71, DOI 10.1111/j.1365-294X.2011.05366.x; Ueda A, 2001, J FOR RES, V6, P173, DOI 10.1007/BF02767089	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1437-4781	1439-0329		FOREST PATHOL	Forest Pathol.	APR	2015	45	2					149	154		10.1111/efp.12148		6	Forestry	Forestry	CF6BK	WOS:000352641200007		
J	Watanabe, T				Watanabe, Tomonari			Global Existence and Decay Estimates for Quasilinear Wave Equations with Nonuniform Dissipative Term	FUNKCIALAJ EKVACIOJ-SERIO INTERNACIA			English	Article						Dissipative quasilinear wave equations; Space variable coefficients; Time decay estimates	NONLINEAR ELASTIC-WAVES; EXTERIOR DOMAINS	In this paper, we study a Cauchy problem for quasilinear wave equations with dissipative term in Sobolev space H-L x HL-1 (L >= [d/2] + 3). The coefficients of the dissipative term depends on space variables and may vanish in some compact region. In order to control the derivatives of the dissipative coefficients, we introduce a resealing argument. Using the argument, we obtain a global existence theorem and decay estimates with additional assumptions for the initial data.	Hiroshima Univ, Grad Sch Sci, Dept Math, Higashihiroshima, Hiroshima 7398526, Japan	Watanabe, T (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan.						KAWASHIMA S, 1995, J MATH SOC JPN, V47, P617, DOI 10.2969/jmsj/04740617; Agemi R, 2000, INVENT MATH, V142, P225, DOI 10.1007/s002220000084; Nakao M, 2001, MATH Z, V238, P781, DOI 10.1007/s002090100275; Charao RC, 2007, NONLINEAR ANAL-THEOR, V67, P398, DOI 10.1016/j.na.2006.06.001; Dharmawardane PMN, 2011, KYOTO J MATH, V51, P467, DOI 10.1215/21562261-1214411; Gilbarg D., 1983, GRUNDLEHREN MATH WIS, V224; Ikehata R., 2003, J DIFFER EQUATIONS, V188, P390; JOHN F, 1981, COMMUN PUR APPL MATH, V34, P29, DOI 10.1002/cpa.3160340103; Klainerman S., 1986, LECTURES APPL MATH, V23, P293; Matsumura A., 1976, PUBL RIMS KYOTO U, V12, P169, DOI DOI 10.2977/PRIMS/1195190962; Matsumura A., 1977, PUBL RIMS KYOTO U, V13, P349, DOI 10.2977/prims/1195189813; Nakao M, 2003, J MATH SOC JPN, V55, P765, DOI 10.2969/jmsj/1191419002; RACKE R, 1990, MATH METHOD APPL SCI, V13, P481, DOI 10.1002/mma.1670130604; Sideris TC, 2000, ANN MATH, V151, P849, DOI 10.2307/121050; Tao T., 2006, CBMS REGIONAL C SERI, V106; Taylor ME, 2011, APPL MATH SCI, V117, P1, DOI 10.1007/978-1-4419-7049-7	16	0	0	KOBE UNIV, DEPT MATHEMATICS	KOBE	FACULTY SCIENCE, KOBE, 657-8501, JAPAN	0532-8721			FUNKC EKVACIOJ-SER I	Funkc. Ekvacioj-Ser. Int.	APR	2015	58	1					1	42				42	Mathematics, Applied; Mathematics	Mathematics	CG0ZE	WOS:000353002000001		
J	Makino, T				Makino, Tetu			On Spherically Symmetric Motions of the Atmosphere Surrounding a Planet Governed by the Compressible Euler Equations	FUNKCIALAJ EKVACIOJ-SERIO INTERNACIA			English	Article						Compressible Euler equations; Spherically symmetric solutions; Vacuum boundary; Nash-Moser theorem	PHYSICAL VACUUM; WELL-POSEDNESS	We consider spherically symmetric motions of inviscid compressible gas surrounding a solid ball under the gravity of the core. Equilibria touch the vacuum with finite radii, and the linearized equation around one of the equilibria has time-periodic solutions. To justify the linearization, we should construct true solutions for which this time-periodic solution plus the equilibrium is the first approximation. But this leads us to difficulty caused by singularities at the free boundary touching the vacuum. We solve this problem by the Nash-Moser theorem.	Yamaguchi Univ, Fac Engn, Dept Appl Math, Ube, Yamaguchi 7558611, Japan	Makino, T (reprint author), Yamaguchi Univ, Fac Engn, Dept Appl Math, Ube, Yamaguchi 7558611, Japan.	makino@yamaguchi-u.ac.jp					Adams R A, 1975, PURE APPL MATH, V65; Yang T, 2006, J COMPUT APPL MATH, V190, P211, DOI 10.1016/j.cam.2005.01.043; Coutand D, 2011, COMMUN PUR APPL MATH, V64, P328, DOI 10.1002/cpa.20344; Jang J, 2009, COMMUN PUR APPL MATH, V62, P1327; DING XX, 1989, COMMUN MATH PHYS, V121, P63; Coddington E. A., 1955, THEORY ORDINARY DIFF; HAMILTON RS, 1982, B AM MATH SOC, V7, P65, DOI 10.1090/S0273-0979-1982-15004-2; Ikawa M., 2000, TRANSLATIONS MATH MO, V189; Kato T., 1970, J FAC SCI U TOKYO  1, V25, P241; Kato T., 2011, CIME SUMMER SCH, V72, P125; LIU T.-P., 2000, METHODS APPL ANAL, V7, P495; LIU T.-P., 1996, JAPAN J APPL MATH, V13, P25, DOI DOI 10.1007/BF03167296; Makin T., 1989, JAPAN J APPL MATH, V6, P479; Makino T., 1994, JAPAN J IND APPL MAT, V11, P171; Makino T., 1986, STUD MATH APPL, V18, P459; Malcino T., 1986, JAPAN J APPL MATH, V3, P249; Mizohata S., 1973, THEORY PARTIAL DIFFE; Reed M., 1975, METHODS MODERN MATH, V2; Sneddon I. N., 1995, FOURIER TRANSFORM; Watson G.N., 1944, TREATISE THEORY BESS	20	0	0	KOBE UNIV, DEPT MATHEMATICS	KOBE	FACULTY SCIENCE, KOBE, 657-8501, JAPAN	0532-8721			FUNKC EKVACIOJ-SER I	Funkc. Ekvacioj-Ser. Int.	APR	2015	58	1					43	85				43	Mathematics, Applied; Mathematics	Mathematics	CG0ZE	WOS:000353002000002		
J	Matsunaga, H; Murakami, S; Nagabuchi, Y; Minh, NV				Matsunaga, Hideaki; Murakami, Satoru; Nagabuchi, Yutaka; Nguyen Van Minh			Center Manifold Theorem and Stability for Integral Equations with Infinite Delay	FUNKCIALAJ EKVACIOJ-SERIO INTERNACIA			English	Article						Integral equations with infinite delay; Center manifolds; Stability properties; Phase space; A variation-of-constants formula	FUNCTIONAL-DIFFERENTIAL EQUATIONS; OF-CONSTANTS FORMULA; INVARIANT-MANIFOLDS; BANACH-SPACES; ASYMPTOTIC FORMULA; PHASE-SPACE; MAPS	The present paper deals with autonomous integral equations with infinite delay via dynamical system approach. Existence, local exponential attractivity, and other properties of center manifold are established by means of the variation-of-constants formula in the phase space that is obtained in our previous paper [22] (Funkcial. Elcvac. 55 (2012), 479-520). Furthermore, we prove a stability reduction principle by which the stability of an autonomous integral equation is implied by that of an ordinary differential equation which we call the "central equation".	[Matsunaga, Hideaki] Osaka Prefecture Univ, Dept Math Sci, Sakai, Osaka 5998531, Japan; [Murakami, Satoru] Okayama Univ Sci, Dept Appl Math, Okayama 7000005, Japan; [Nagabuchi, Yutaka] Okayama Univ Sci, Dept Appl Sci, Okayama 7000005, Japan; [Nguyen Van Minh] Columbus State Univ, Dept Math & Philosophy, Columbus, GA 31907 USA	Matsunaga, H (reprint author), Osaka Prefecture Univ, Dept Math Sci, Sakai, Osaka 5998531, Japan.	hideaki@ms.osakafu-u.ac.jp; murakami@youhei.xmath.ous.ac.jp; nagabuti@das.ous.ac.jp; nguyen_minh2@columbusstate.edu			Japan Society for the Promotion of Science [22540211]	Partly supported by the Grant-in-Aid for Scientific Research (C), No. 22540211, Japan Society for the Promotion of Science.	Faria T, 2000, T AM MATH SOC, V352, P2217, DOI 10.1090/S0002-9947-00-02280-7; Chen XY, 1997, J DIFFER EQUATIONS, V139, P283, DOI 10.1006/jdeq.1997.3255; Van Minh N, 2004, J DIFFER EQUATIONS, V198, P381, DOI 10.1016/j.jde.2003.10.006; Aulbach B., 1996, ABSTR APPL ANAL, V1, P351, DOI 10.1155/S108533759600019X; CARR J., 1981, APPL MATH SCI, V35; Chicone C, 1997, J DIFFER EQUATIONS, V141, P356, DOI 10.1006/jdeq.1997.3343; Coddington E.A., 1984, THEORY ORDINARY DIFF; Diekmann O, 2012, J DIFFER EQUATIONS, V252, P819, DOI 10.1016/j.jde.2011.09.038; Diekmann O., 1995, APPL MATH SCI, V110; Faria T, 2002, SIAM J MATH ANAL, V34, P173, DOI 10.1137/S0036141001384971; Hale J., 1969, PURE APPL MATH, VXXI; Hale J. K., 1993, APPL MATH SCI, V99; Henry D, 1981, LECT NOTES MATH, V840; Hino Y., 2002, FUNKC EKVACIOJ-SER I, V45, P341; Hino Y., 1991, LECT NOTES MATH, V1473; Hino Y, 2002, J DIFFER EQUATIONS, V179, P336, DOI 10.1006/jdeq.2001.4020; Hirsh M., 1977, LECT NOTES MATH, V583; Krisztin T, 2004, SIAM J MATH ANAL, V36, P717, DOI 10.1137/S0036141003419170; Lang Serge, 1999, GRADUATE TEXTS MATH, V191; Magal P., 2009, MEM AM MATH SOC, V202; Mallet-Paret J., 1988, J AM MATH SOC, V1, P805, DOI 10.1090/S0894-0347-1988-0943276-7; Matsunaga H, 2004, J DIFFER EQU APPL, V10, P661, DOI 10.1080/10236190410001685021; Matsunaga H, 2012, J DIFFER EQU APPL, V18, P57, DOI 10.1080/10236198.2011.575070; Matsunaga H, 2014, J MATH ANAL APPL, V410, P807, DOI 10.1016/j.jmaa.2013.08.035; Matsunaga H, 2012, FUNKC EKVACIOJ-SER I, V55, P479; MEMORY MC, 1991, NONLINEAR ANAL-THEOR, V16, P131, DOI 10.1016/0362-546X(91)90164-V; Murakami S, 2007, FUNKC EKVACIOJ-SER I, V50, P133, DOI 10.1619/fesi.50.133; Murakami S., 2002, VIETNAM J MATH, V30, P437; Pliss V. A., 1964, IZV AKAD NAUK SSSR M, V28, P1297; Shub M., 1987, GLOBAL STABILITY DYN; VANDERBAUWHEDE A, 1987, J FUNCT ANAL, V72, P209, DOI 10.1016/0022-1236(87)90086-3; Wu J., 1996, APPL MATH SCI, V119; Yoshizawa T., 1966, PUBLICATIONS MATH SO	33	0	0	KOBE UNIV, DEPT MATHEMATICS	KOBE	FACULTY SCIENCE, KOBE, 657-8501, JAPAN	0532-8721			FUNKC EKVACIOJ-SER I	Funkc. Ekvacioj-Ser. Int.	APR	2015	58	1					87	134				48	Mathematics, Applied; Mathematics	Mathematics	CG0ZE	WOS:000353002000003		
J	Kirchmaier, S; Naruse, K; Wittbrodt, J; Loosli, F				Kirchmaier, Stephan; Naruse, Kiyoshi; Wittbrodt, Joachim; Loosli, Felix			The Genomic and Genetic Toolbox of the Teleost Medaka (Oryzias latipes)	GENETICS			English	Review						teleost; Oryzias latipes; medaka; genetics; genomics	TRANSPOSON-MEDIATED TRANSGENESIS; EFFICIENT TARGETED MUTAGENESIS; GERM-CELL MUTAGENESIS; SEX-DETERMINING GENE; ZEBRAFISH EMBRYOS; IN-VIVO; EFFECTOR NUCLEASES; WILD POPULATIONS; JAPANESE MEDAKA; SLEEPING-BEAUTY	The Japanese medaka, Oryzias latipes, is a vertebrate teleost model with a long history of genetic research. A number of unique features and established resources distinguish medaka from other vertebrate model systems. A large number of laboratory strains from different locations are available. Due to a high tolerance to inbreeding, many highly inbred strains have been established, thus providing a rich resource for genetic studies. Furthermore, closely related species native to different habitats in Southeast Asia permit comparative evolutionary studies. The transparency of embryos, larvae, and juveniles allows a detailed in vivo analysis of development. New tools to study diverse aspects of medaka biology are constantly being generated. Thus, medaka has become an important vertebrate model organism to study development, behavior, and physiology. In this review, we provide a comprehensive overview of established genetic and molecular-genetic tools that render medaka fish a full-fledged vertebrate system.	[Kirchmaier, Stephan; Wittbrodt, Joachim] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany; [Naruse, Kiyoshi] Natl Inst Basic Biol, Lab Bioresources, Okazaki, Aichi 4448585, Japan; [Loosli, Felix] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany	Wittbrodt, J (reprint author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.	Jochen.Wittbrodt@cos.uni-heidelberg.de; felix.loosli@kit.edu	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377	ERC Advanced Grant - Manipulating and Imaging Stem Cells at Work; NBRP (Core Facility Upgrading Program); NBRP (Genome Information Upgrading Program Project); NBRP (Fundamental Technologies Upgrading Program)	J.W. was supported by the ERC Advanced Grant - Manipulating and Imaging Stem Cells at Work. K.N. acknowledges NBRP (Core Facility Upgrading Program, Genome Information Upgrading Program Project, and Fundamental Technologies Upgrading Program).	Abe G, 2011, METHOD CELL BIOL, V104, P23, DOI 10.1016/B978-0-12-374814-0.00002-1; SHIMA A, 1991, P NATL ACAD SCI USA, V88, P2545, DOI 10.1073/pnas.88.6.2545; Inoue K, 2002, ZOOL SCI, V19, P727, DOI 10.2108/zsj.19.727; Shestopalov IA, 2007, NAT CHEM BIOL, V3, P650, DOI 10.1038/nchembio.2007.30; Spivakov M, 2014, G3-GENES GENOM GENET, V4, P433, DOI 10.1534/g3.113.008722; Loosli F, 2000, MECH DEVELOP, V97, P133, DOI 10.1016/S0925-4773(00)00406-8; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Wakamatsu Y, 2001, P NATL ACAD SCI USA, V98, P10046, DOI 10.1073/pnas.181204298; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5<487::AID-BIES11>3.3.CO;2-#; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Willems B, 2012, DEV BIOL, V364, P128, DOI 10.1016/j.ydbio.2012.01.023; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Kimura T, 2014, P NATL ACAD SCI USA, V111, P7343, DOI 10.1073/pnas.1311254111; Hockendorf B, 2012, DEV CELL, V23, P1111, DOI 10.1016/j.devcel.2012.10.008; Sebillot A, 2014, ENVIRON SCI TECHNOL, V48, P10919, DOI 10.1021/es5030977; Centanin L, 2011, CELL STEM CELL, V9, P553, DOI 10.1016/j.stem.2011.11.004; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Herder C, 2013, DEVELOPMENT, V140, P2787, DOI 10.1242/dev.096487; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Sato T, 2005, ZOOL SCI, V22, P985, DOI 10.2108/zsj.22.985; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Zeng ZQ, 2005, ENVIRON SCI TECHNOL, V39, P9001, DOI 10.1021/es050728l; Deguchi T, 2009, DEV GROWTH DIFFER, V51, P769, DOI 10.1111/j.1440-169X.2009.01135.x; Lee S, 2013, P NATL ACAD SCI USA, V110, P1640, DOI 10.1073/pnas.1218468110; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; Matsuda M, 2003, ZOOL SCI, V20, P159, DOI 10.2108/zsj.20.159; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Tanaka K, 2007, GENETICS, V177, P2075, DOI 10.1534/genetics.107.075598; Knapik EW, 2000, MAMM GENOME, V11, P511, DOI 10.1007/s003350010098; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Kelly A, 2011, BRIEF FUNCT GENOMICS, V10, P189, DOI 10.1093/bfgp/elr014; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Asai T, 2011, ICHTHYOL EXPLOR FRES, V22, P289; Kelsh RN, 2004, MECH DEVELOP, V121, P841, DOI 10.1016/j.mod.2004.01.004; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Yoshihara Y, 2002, NEUROSCI RES, V44, P133, DOI 10.1016/S0168-0102(02)00130-X; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Naruse K, 2004, MECH DEVELOP, V121, P619, DOI 10.1016/j.mod.2004.04.014; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; Hayashi Y, 2010, MOL REPROD DEV, V77, P679, DOI 10.1002/mrd.21203; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; Ando H, 2001, NAT GENET, V28, P317, DOI 10.1038/ng583; Shimada A, 2008, DEVELOPMENT, V135, P281, DOI 10.1242/dev.011494; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Ansai S, 2012, DEV GROWTH DIFFER, V54, P546, DOI 10.1111/j.1440-169X.2012.01357.x; Ansai S, 2014, DEV GROWTH DIFFER, V56, P98, DOI 10.1111/dgd.12104; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Boon Ng Grace Hwee, 2011, Biochimie, V93, P1858, DOI 10.1016/j.biochi.2011.07.006; Centanin L, 2014, DEVELOPMENT, V141, P3472, DOI 10.1242/dev.109892; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cheung CHY, 2014, ECOTOXICOLOGY, V23, P1260, DOI 10.1007/s10646-014-1269-8; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; De Rienzo G, 2012, ZEBRAFISH, V9, P97, DOI 10.1089/zeb.2012.0770; Dong M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006125; Dorn S, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-50; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI [10.1016/j.ydbio.2008.04.042, 10.1016/.i.ydbio.2008,.4.04]; Froschauer A, 2012, TRANSGENIC RES, V21, P149, DOI 10.1007/s11248-011-9514-x; Fukamachi S, 2009, GENE, V442, P81, DOI 10.1016/j.gene.2009.04.010; Grabher Clemens, 2008, V461, P521, DOI 10.1007/978-1-60327-483-8_36; Grabher C, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-26; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Grabher C, 2003, GENE, V322, P57, DOI 10.1016/j.gene.2003.09.009; Hardy ME, 2007, DEV DYNAM, V236, P3071, DOI 10.1002/dvdy.21318; Hasegawa S, 2009, P NATL ACAD SCI USA, V106, P13832, DOI 10.1073/pnas.0903999106; Henrich T, 2005, BIOINFORMATICS, V21, P3195, DOI 10.1093/bioinformatics/bti478; HYODO-TAGUCHI Y, 1980, Zoological Magazine (Tokyo), V89, P283; Ieki T, 2013, J COMP NEUROL, V521, P1781, DOI 10.1002/cne.23256; Inoue D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019713; INOUE K, 1990, CELL DIFFER DEV, V29, P123, DOI 10.1016/0922-3371(90)90030-Z; Ishikawa Y, 1999, BRAIN BEHAV EVOLUT, V53, P2, DOI 10.1159/000006577; Itou J, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-60; Kamei Y., 2008, NAT METHODS, V6, P79; Kawaguchi M., 2012, INTERDISCIPLINARY ST, V6, P49; Kimura T, 2007, GENETICS, V177, P2379, DOI 10.1534/genetics.106.068460; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kinoshita M, 2003, ZOOL SCI, V20, P869, DOI 10.2108/zsj.20.869; Kirchmaier S, 2013, DEVELOPMENT, V140, P4287, DOI 10.1242/dev.096081; Kishi K, 2006, GENOMICS, V88, P241, DOI 10.1016/j.ygeno.2006.03.023; Kobayashi K, 2013, GENESIS, V51, P59, DOI 10.1002/dvg.22348; Kobayashi T, 2007, MOL REPROD DEV, V74, P207, DOI 10.1002/mrd.20577; Koger CS, 1999, BIOL REPROD, V61, P1287, DOI 10.1095/biolreprod61.5.1287; Kok F. O, 2014, DEV CELL, V32, P97; Liu TM, 2011, INT J BIOL SCI, V7, P469; Ma AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065259; Martinez-Morales JR, 2009, DEVELOPMENT, V136, P2165, DOI 10.1242/dev.033563; Matsuzaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054424; Mongin E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019747; Myosho T, 2012, ICHTHYOL RES, V59, P384, DOI 10.1007/s10228-012-0295-x; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Ng GHB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064334; Nguyen Nhung, 2011, Am J Physiol Gastrointest Liver Physiol, V300, pG1, DOI 10.1152/ajpgi.00343.2010; Oda S, 2010, ZOOL SCI, V27, P410, DOI 10.2108/zsj.27.410; Okuyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066597; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; SAKAIZUMI M, 1992, J EXP ZOOL, V264, P85, DOI 10.1002/jez.1402640113; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sampetrean O, 2009, CELL CYCLE, V8, P620; Sano S, 2009, GENESIS, V47, P505, DOI 10.1002/dvg.20528; Sasado T, 2010, EXP ANIM TOKYO, V59, P13; Schartl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037880; Shima A, 2001, MAR BIOTECHNOL, V3, pS162, DOI 10.1007/s10126-001-0038-X; Shimada A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2643; Takehana Y, 2004, ZOOL SCI, V21, P977, DOI 10.2108/zsj.21.977; Takehana Y, 2004, ZOOL SCI, V21, P483, DOI 10.2108/zsj.21.483; Takehana Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5157; Tanaka M, 2001, ZOOL SCI, V18, P615, DOI 10.2108/zsj.18.615; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Tena JJ, 2014, GENOME RES, V24, P1075, DOI 10.1101/gr.163915.113; UWA H, 1981, P JPN ACAD B-PHYS, V57, P39, DOI 10.2183/pjab.57.39; Vopalensky P, 2010, BIOTECHNIQUES, V48, P235, DOI 10.2144/000113368; Wada H, 1998, ZOOL SCI, V15, P123, DOI 10.2108/zsj.15.123; Winkler S, 2000, DEVELOPMENT, V127, P1911; Yoshinari N, 2012, DEV GROWTH DIFFER, V54, P818, DOI 10.1111/dgd.12013	133	1	2	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2015	199	4					905	918		10.1534/genetics.114.173849		14	Genetics & Heredity	Genetics & Heredity	CF7KF	WOS:000352734400003		
J	Tasaki, S; Ben Sauerwine,; Hoff, B; Toyoshiba, H; Gaiteri, C; Neto, EC				Tasaki, Shinya; Ben Sauerwine; Hoff, Bruce; Toyoshiba, Hiroyoshi; Gaiteri, Chris; Chaibub Neto, Elias			Bayesian Network Reconstruction Using Systems Genetics Data: Comparison of MCMC Methods	GENETICS			English	Article						Bayesian networks; MCMC methods; causal inference; eSNPs; network reconstruction	ALZHEIMERS-DISEASE; GRAPHICAL MODELS; APOE EPSILON-4; GENOMICS; EXPRESSION; INFERENCE; PHENOTYPES; DEMENTIA; GENES; BRAIN	Reconstructing biological networks using high-throughput technologies has the potential to produce condition-specific interactomes. But are these reconstructed networks a reliable source of biological interactions? Do some network inference methods offer dramatically improved performance on certain types of networks? To facilitate the use of network inference methods in systems biology, we report a large-scale simulation study comparing the ability of Markov chain Monte Carlo (MCMC) samplers to reverse engineer Bayesian networks. The MCMC samplers we investigated included foundational and state-of-the-art Metropolis-Hastings and Gibbs sampling approaches, as well as novel samplers we have designed. To enable a comprehensive comparison, we simulated gene expression and genetics data from known network structures under a range of biologically plausible scenarios. We examine the overall quality of network inference via different methods, as well as how their performance is affected by network characteristics. Our simulations reveal that network size, edge density, and strength of gene-to-gene signaling are major parameters that differentiate the performance of various samplers. Specifically, more recent samplers including our novel methods outperform traditional samplers for highly interconnected large networks with strong gene-to-gene signaling. Our newly developed samplers show comparable or superior performance to the top existing methods. Moreover, this performance gain is strongest in networks with biologically oriented topology, which indicates that our novel samplers are suitable for inferring biological networks. The performance of MCMC samplers in this simulation framework can guide the choice of methods for network reconstruction using systems genetics data.	[Tasaki, Shinya; Toyoshiba, Hiroyoshi] Takeda Pharmaceut Co, Div Pharmaceut Res, Integrated Technol Res Lab, Fujisawa, Kanagawa 2518555, Japan; [Ben Sauerwine] Google, Seattle, WA 98103 USA; [Hoff, Bruce; Gaiteri, Chris; Chaibub Neto, Elias] Sage Bionetworks, Seattle, WA 98109 USA; [Gaiteri, Chris] Allen Inst Brain Sci, Modeling Anal & Theory Grp, Seattle, WA 98103 USA; [Gaiteri, Chris] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Tasaki, S (reprint author), Takeda Pharmaceut Co Ltd, 2-26-1 Muraoka Higashi, Fujisawa, Kanagawa 2518555, Japan.	stasaki@gmail.com; gaiteri@gmail.com; elias.chaibub.neto@sagebase.org					Ellis B, 2008, J AM STAT ASSOC, V103, P778, DOI 10.1198/016214508000000193; Pinna A, 2011, BIOINFORMATICS, V27, P2459, DOI 10.1093/bioinformatics/btr407; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Neto EC, 2008, GENETICS, V179, P1089, DOI 10.1534/genetics.107.085167; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Hageman RS, 2011, GENETICS, V187, P1163, DOI 10.1534/genetics.110.123273; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Neto EC, 2010, ANN APPL STAT, V4, P320, DOI 10.1214/09-AOAS288; Grzegorczyk M, 2008, MACH LEARN, V71, P265, DOI 10.1007/s10994-008-5057-7; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Zhang B, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1128; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; MADIGAN D, 1995, INT STAT REV, V63, P215, DOI 10.2307/1403615; Huang TL, 2005, NEUROLOGY, V65, P1409, DOI 10.1212/01.wnl.0000183148.34197.2e; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Rhinn H, 2013, NATURE, V500, P45, DOI 10.1038/nature12415; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Uhler C, 2013, ANN STAT, V41, P436, DOI 10.1214/12-AOS1080; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Beinlich I. A., 1989, 2ND P EUR C ART INT, P247; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Chen LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r219; Duarte CW, 2011, GENETICS, V187, P955, DOI 10.1534/genetics.110.124685; Eaton D, 2007, P 23 ANN C UNC ART I, P101; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Giudici P, 2003, MACH LEARN, V50, P127, DOI 10.1023/A:1020202028934; Goudie R. J. B., 2011, 1121 CTR RES STAT ME; King V, 2002, J COMPUT SYST SCI, V65, P150, DOI 10.1006/jcss.2002.1883; Liu B, 2008, GENETICS, V178, P1763, DOI 10.1534/genetics.107.080069; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Logsdon BA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001014; McKenzie M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-31; Moon J. Y., 2014, PROBABILISTIC GRAPHI, P165; Neto EC, 2013, GENETICS, V193, P1003, DOI [10.1534/genetics.112.147124, 10.1534/genetics.112.147124/-/DC1]; Pearl J., 1988, PROBABILISTIC INFERE; Spirtes P., 2000, CAUSATION PREDICTION; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Yang SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-13; Zhang LX, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003420; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	47	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2015	199	4					973	U128		10.1534/genetics.114.172619		22	Genetics & Heredity	Genetics & Heredity	CF7KF	WOS:000352734400007		
J	Leal-Bertioli, S; Shirasawa, K; Abernathy, B; Moretzsohn, M; Chavarro, C; Clevenger, J; Ozias-Akins, P; Jackson, S; Bertioli, D				Leal-Bertioli, Soraya; Shirasawa, Kenta; Abernathy, Brian; Moretzsohn, Marcio; Chavarro, Carolina; Clevenger, Josh; Ozias-Akins, Peggy; Jackson, Scott; Bertioli, David			Tetrasomic Recombination Is Surprisingly Frequent in Allotetraploid Arachis	GENETICS			English	Article						Arachis; peanut; groundnut; induced allotetraploid; tetrasomic genetics; segmental genetics	GENETIC-LINKAGE MAP; QUANTITATIVE TRAIT LOCI; CULTIVATED PEANUT; HYPOGAEA L.; WILD RELATIVES; GENOMES; MARKERS; POLYPLOIDY; PLANTS; INTROGRESSION	Arachis hypogaea L. (cultivated peanut) is an allotetraploid (2n = 4x = 40) with an AABB genome type. Based on cytogenetic studies it has been assumed that peanut and wild-derived induced AABB allotetraploids have classic allotetraploid genetic behavior with diploid-like disomic recombination only between homologous chromosomes, at the exclusion of recombination between homeologous chromosomes. Using this assumption, numerous linkage map and quantitative trait loci studies have been carried out. Here, with a systematic analysis of genotyping and gene expression data, we show that this assumption is not entirely valid. In fact, autotetraploid-like tetrasomic recombination is surprisingly frequent in recombinant inbred lines generated from a cross of cultivated peanut and an induced allotetraploid derived from peanut's most probable ancestral species. We suggest that a better, more predictive genetic model for peanut is that of a "segmental allotetraploid" with partly disomic, partly tetrasomic genetic behavior. This intermediate genetic behavior has probably had a previously overseen, but significant, impact on the genome and genetics of cultivated peanut.	[Leal-Bertioli, Soraya; Moretzsohn, Marcio] Embrapa Genet Resources & Biotechnol, BR-70770917 Brasilia, DF, Brazil; [Shirasawa, Kenta] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan; [Leal-Bertioli, Soraya; Abernathy, Brian; Chavarro, Carolina; Jackson, Scott; Bertioli, David] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Clevenger, Josh; Ozias-Akins, Peggy] Univ Georgia, Dept Hort, Tifton, GA 31973 USA; [Bertioli, David] Univ Brasilia, Inst Biol Sci, BR-70910900 Brasilia, DF, Brazil	Bertioli, D (reprint author), Ctr Appl Genet Technol, 111 Riverbend Rd, Athens, GA 30602 USA.	bertioli@uga.edu			Mars Inc.; Brazilian Agricultural Research Corporation (EMBRAPA); Peanut Foundation; U.S. Department of Agriculture National Institute of Food; Agriculture National Research Initiative Competitive Grants Program [2006-35604-17242]	This work was performed with the support of the University of Georgia Genomics Facility at the University of Georgia and funding from Mars Inc., Brazilian Agricultural Research Corporation (EMBRAPA), the Peanut Foundation, and the U.S. Department of Agriculture National Institute of Food and the Agriculture National Research Initiative Competitive Grants Program (#2006-35604-17242).	Burow MD, 2001, GENETICS, V159, P823; Zhou XJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-351; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Moretzsohn MC, 2013, ANN BOT-LONDON, V111, P113, DOI 10.1093/aob/mcs237; CHURCHILL GA, 1994, GENETICS, V138, P963; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Varshney RK, 2009, THEOR APPL GENET, V118, P729, DOI 10.1007/s00122-008-0933-x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; STEBBINS GL, 1947, ADV GENET, V1, P403, DOI 10.1016/S0065-2660(08)60490-3; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; KOCHERT G, 1991, THEOR APPL GENET, V81, P565, DOI 10.1007/BF00226719; Wang H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-10; ZENG ZB, 1994, GENETICS, V136, P1457; Bertioli DJ, 2013, ANN BOT-LONDON, V112, P545, DOI 10.1093/aob/mct128; Nagy ED, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-469; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; Shirasawa K, 2013, DNA RES, V20, P173, DOI 10.1093/dnares/dss042; Doerge RW, 1996, GENETICS, V142, P285; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P8089, DOI 10.1073/pnas.92.18.8089; Renny-Byfield S, 2014, AM J BOT, V101, P1711, DOI 10.3732/ajb.1400119; Robledo G, 2010, THEOR APPL GENET, V121, P1033, DOI 10.1007/s00122-010-1369-7; Bertioli DJ, 2014, G3-GENES GENOM GENET, V4, P89, DOI 10.1534/g3.113.007617; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Qin HD, 2012, THEOR APPL GENET, V124, P653, DOI 10.1007/s00122-011-1737-y; Mallikarjuna N, 2011, GENET RESOUR CROP EV, V58, P889, DOI 10.1007/s10722-010-9627-8; Fisher R. A., 1936, Ann Sci London, V1, P115, DOI 10.1080/00033793600200111; Fonceka D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-26; GARCIA GM, 1995, GENOME, V38, P166; Gautami B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041213; Grabiele M, 2012, PLANT SYST EVOL, V298, P1151, DOI 10.1007/s00606-012-0627-3; Hong Y. B., 2010, BMC PLANT BIOL, V10, P1; HUSTED L., 1936, Cytologia, V7, P396; Krapovickas A., 2007, BONPLANDIA S, V16, P1; Krapovickas A., 1994, Bonplandia, V8, P1; Leal-Bertioli SCM, 2015, ANN BOT-LONDON, V115, P237, DOI 10.1093/aob/mcu237; Robertson M., 2009, J BIOL-LONDON, V8, P79; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; SIMPSON CE, 1993, CROP SCI, V33, P1418; SINGH AK, 1982, THEOR APPL GENET, V61, P305, DOI 10.1007/BF00272846; SMARTT J, 1978, EUPHYTICA, V27, P665, DOI 10.1007/BF00023701; Stebbins GL, 1950, VARIATION EVOLUTION; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Wang S, 2006, WINDOWS QTL CARTOGRA; Wu RL, 2001, GENETICS, V159, P869; WYNNE JC, 1989, CRIT REV PLANT SCI, V8, P189, DOI 10.1080/07352688909382275	48	2	2	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2015	199	4					1093	U297		10.1534/genetics.115.174607		15	Genetics & Heredity	Genetics & Heredity	CF7KF	WOS:000352734400016		
J	Okumura, T; Sasamura, T; Inatomi, M; Hozumi, S; Nakamura, M; Hatori, R; Taniguchi, K; Nakazawa, N; Suzuki, E; Maeda, R; Yamakawa, T; Matsuno, K				Okumura, Takashi; Sasamura, Takeshi; Inatomi, Momoko; Hozumi, Shunya; Nakamura, Mitsutoshi; Hatori, Ryo; Taniguchi, Kiichiro; Nakazawa, Naotaka; Suzuki, Emiko; Maeda, Reo; Yamakawa, Tomoko; Matsuno, Kenji			Class I Myosins Have Overlapping and Specialized Functions in Left-Right Asymmetric Development in Drosophila	GENETICS			English	Article						myosin I; Myosin 31DF; Myosin 61F; Myosin 95E; left-right asymmetry	BRUSH-BORDER STRUCTURE; UNCONVENTIONAL MYOSIN; ACTIN CYTOSKELETON; GENOME SEQUENCE; GENE-EXPRESSION; FISSION YEAST; HEARING-LOSS; ABDOMINAL-B; MELANOGASTER; IDENTIFICATION	The class I myosin genes are conserved in diverse organisms, and their gene products are involved in actin dynamics, endocytosis, and signal transduction. Drosophila melanogaster has three class I myosin genes, Myosin 31DF (Myo31DF), Myosin 61F (Myo61F), and Myosin 95E (Myo95E). Myo31DF, Myo61F, and Myo95E belong to the Myosin ID, Myosin IC, and Myosin IB families, respectively. Previous loss-of-function analyses of Myo31DF and Myo61F revealed important roles in left-right (LR) asymmetric development and enterocyte maintenance, respectively. However, it was difficult to elucidate their roles in vivo, because of potential redundant activities. Here we generated class I myosin double and triple mutants to address this issue. We found that the triple mutant was viable and fertile, indicating that all three class I myosins were dispensable for survival. A loss-of-function analysis revealed further that Myo31DF and Myo61F, but not Myo95E, had redundant functions in promoting the dextral LR asymmetric development of the male genitalia. Myo61F overexpression is known to antagonize the dextral activity of Myo31DF in various Drosophila organs. Thus, the LR-reversing activity of overexpressed Myo61F may not reflect its physiological function. The endogenous activity of Myo61F in promoting dextral LR asymmetric development was observed in the male genitalia, but not the embryonic gut, another LR asymmetric organ. Thus, Myo61F and Myo31DF, but not Myo95E, play tissue-specific, redundant roles in LR asymmetric development. Our studies also revealed differential colocalization of the class I myosins with filamentous (F)-actin in the brush border of intestinal enterocytes.	[Okumura, Takashi; Sasamura, Takeshi; Hozumi, Shunya; Nakamura, Mitsutoshi; Hatori, Ryo; Taniguchi, Kiichiro; Nakazawa, Naotaka; Maeda, Reo; Yamakawa, Tomoko; Matsuno, Kenji] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 1251500, Japan; [Sasamura, Takeshi; Inatomi, Momoko; Nakamura, Mitsutoshi; Yamakawa, Tomoko; Matsuno, Kenji] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Suzuki, Emiko] Struct Biol Ctr, Natl Inst Genet, Gene Network Lab, Shizuoka 4118540, Japan; [Suzuki, Emiko] SOKENDAI, Dept Genet, Shizuoka 4118540, Japan	Matsuno, K (reprint author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	kmatsuno@bio.sci.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22127004]; National Institute of Genetics (NIG) Cooperative Research Program [2007-A51, 2009-A79]	We are grateful to S. Noselli for providing the Myo31DF<SUP>K2</SUP> and UAS-Myo31DF-GFP lines. We also thank the Drosophila Genetic Resource Center at the Kyoto Institute of Technology, the Bloomington Drosophila Stock Center at Indiana University, and the Development Studies Hybridoma Bank at the University of Iowa for providing flies and antibodies. We thank members of the Matsuno laboratory for critical comments and discussions. This work was supported by The Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants-in-Aid for Scientific Research (KAKENHI) grant 22127004 and the National Institute of Genetics (NIG) Cooperative Research Program (2007-A51 and 2009-A79).	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Donaudy F, 2003, AM J HUM GENET, V72, P1571, DOI 10.1086/375654; BRAND AH, 1993, DEVELOPMENT, V118, P401; Taniguchi K, 2011, SCIENCE, V333, P339, DOI 10.1126/science.1200940; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Foronda D, 2006, DEVELOPMENT, V133, P117, DOI 10.1242/dev.02173; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Ligoxygakis P, 2001, DEVELOPMENT, V128, P1171; Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Kuranaga E, 2011, DEVELOPMENT, V138, P1493, DOI 10.1242/dev.058958; Toya M, 2001, GENES CELLS, V6, P187, DOI 10.1046/j.1365-2443.2001.00414.x; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Coutelis JB, 2013, DEV CELL, V24, P89, DOI 10.1016/j.devcel.2012.11.013; Berg JS, 2001, MOL BIOL CELL, V12, P780; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Hayashi T, 2001, DEV GROWTH DIFFER, V43, P239; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Suzanne M, 2010, CURR BIOL, V20, P1773, DOI 10.1016/j.cub.2010.08.056; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Almeida CG, 2011, NAT CELL BIOL, V13, P779, DOI 10.1038/ncb2262; Krendel M, 2009, J AM SOC NEPHROL, V20, P86, DOI 10.1681/ASN.2007111172; Ashburner M., 1989, DROSOPHILA LAB HDB; Barylko B, 2000, BBA-MOL CELL RES, V1496, P23, DOI 10.1016/S0167-4889(00)00006-9; Chen AH, 2001, ARCH OTOLARYNGOL, V127, P921; Chen CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002446; Cherbas L., 2000, DROSOPHILA PROTOCOLS, P373; Coluccio LM, 1997, AM J PHYSIOL-CELL PH, V273, pC347; Fath K R, 1993, J Cell Sci Suppl, V17, P65; Fyrberg C, 1997, GENE, V197, P315, DOI 10.1016/S0378-1119(97)00278-3; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Gillespie PG, 2004, PHILOS T ROY SOC B, V359, P1945, DOI 10.1098/rstb.2004.1564; Goodson HV, 1996, J CELL BIOL, V133, P1277, DOI 10.1083/jcb.133.6.1277; Grigliatti T. A., 1998, DROSOPHILA PRACTICAL, P85; Hegan PS, 2007, MOL BIOL CELL, V18, P4625, DOI 10.1091/mbc.E07-02-0191; Hozumi S, 2008, DEV DYNAM, V237, P3528, DOI 10.1002/dvdy.21583; Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI 10.1016/j.ibmb.2008.11.004; Iwaki DD, 2002, MECH DEVELOP, V114, P71, DOI 10.1016/S0925-4773(02)00061-8; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Kim SV, 2006, SCIENCE, V314, P136, DOI 10.1126/science.1131920; MORGAN NS, 1995, DEV BIOL, V172, P51, DOI 10.1006/dbio.1995.0005; MORGAN NS, 1994, J MOL BIOL, V239, P347, DOI 10.1006/jmbi.1994.1376; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; O'Kane C. J., 1998, DROSOPHILA PRACTICAL, V2, P131; Osherov N, 2000, CELL MOTIL CYTOSKEL, V47, P163, DOI 10.1002/1097-0169(200011)47:3<163::AID-CM1>3.0.CO;2-U; Petzoldt AG, 2012, DEVELOPMENT, V139, P1874, DOI 10.1242/dev.047589; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Shyamala BV, 2002, DEVELOPMENT, V129, P1839; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Spradling A. C., 1986, DROSOPHILA PRACTICAL, P175; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taniguchi K, 2007, FLY, V1, P287; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Tzolovsky G, 2002, MOL BIOL EVOL, V19, P1041; Venit T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061406; Zadro C, 2009, BBA-MOL BASIS DIS, V1792, P27, DOI 10.1016/j.bbadis.2008.10.017	82	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2015	199	4					1183	U493		10.1534/genetics.115.174698		22	Genetics & Heredity	Genetics & Heredity	CF7KF	WOS:000352734400022		
J	Wakabayashi, H; Sashika, H; Matsushima, M				Wakabayashi, Hidetaka; Sashika, Hironobu; Matsushima, Masato			Head lifting strength is associated with dysphagia and malnutrition in frail older adults	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						deglutition disorders; frailty; malnutrition; presbyphagia; sarcopenia	NURSING-HOME RESIDENTS; OF-THE-LITERATURE; PREVALENCE; RELIABILITY; VALIDITY; SCALE; UNDERNUTRITION; DISORDERS; CONSENSUS; SWALLOW	AimThe purpose of the present study was to assess the association between head lifting strength, dysphagia and malnutrition in frail older adults. MethodsA cross-sectional study was carried out in 386 frail older adults aged 65years and older with dysphagia or suspected dysphagia. Head lifting strength was assessed by the Medical Research Council score. The severity of swallowing and nutritional status was evaluated using the Dysphagia Severity Scale and the Mini-Nutritional Assessment Short Form, respectively. Univariate and logistic regression analyses were applied to examine the associations between head lifting strength, dysphagia and malnutrition. ResultsThere were 129 men and 257 women. The mean age was 83years. The median Barthel Index score was 30 (interquartile range 5-65). A total of 189 (49%) older adults could independently lift their head. Based on the Dysphagia Severity Scale, 79 participants had no dysphagia, 138 had dysphagia without aspiration and 169 had dysphagia with aspiration. The Mini-Nutritional Assessment Short Form showed that 175 older adults were malnourished, 171 were at risk for malnutrition and 40 had a normal nutritional status. The Medical Research Council score in men was higher compared with women. Head lifting strength was significantly correlated with age (r=-0.256), the Barthel Index (r=0.540), the Dysphagia Severity Scale (r=0.458) and the Mini-Nutritional Assessment Short Form (r=0.331). In logistic regression analysis, the Medical Research Council score was independently associated with both dysphagia with aspiration and malnutrition. ConclusionsHead lifting strength is associated with dysphagia with aspiration and malnutrition in frail older adults. Geriatr Gerontol Int 2015; 15: 410-416.	[Wakabayashi, Hidetaka; Sashika, Hironobu] Yokohama City Univ, Med Ctr, Dept Rehabil Med, Yokohama, Kanagawa 2320024, Japan; [Wakabayashi, Hidetaka; Matsushima, Masato] Jikei Univ, Div Clin Epidemiol, Sch Med, Tokyo, Japan	Wakabayashi, H (reprint author), Yokohama City Univ, Med Ctr, Dept Rehabil Med, Minami Ward, 4-57 Urafune Chou, Yokohama, Kanagawa 2320024, Japan.	noventurenoglory@gmail.com		Wakabayashi, HIdetaka/0000-0002-0364-0818	Ministry of Health, Labor, and Welfare of Japan	This study was supported by a Grant-in-Aid for the Comprehensive Research on Aging and Health from the Ministry of Health, Labor, and Welfare of Japan.	Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; BLOEM BR, 1990, BRIT MED J, V300, P721; Bours GJ, 2009, J ADV NURS, V65, P477, DOI 10.1111/j.1365-2648.2008.04915.x; Roy N, 2007, ANN OTO RHINOL LARYN, V116, P858; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Nogueira D, 2013, CLIN INTERV AGING, V8, P221, DOI 10.2147/CIA.S39452; Holland G, 2011, DIS ESOPHAGUS, V24, P476, DOI 10.1111/j.1442-2050.2011.01182.x; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; Serra-Prat M, 2011, J AM GERIATR SOC, V59, P186, DOI 10.1111/j.1532-5415.2010.03227.x; Belafsky PC, 2008, ANN OTO RHINOL LARYN, V117, P919; Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; Vellas B, 2006, J NUTR HEALTH AGING, V10, P456; Ney DM, 2009, NUTR CLIN PRACT, V24, P395, DOI 10.1177/0884533609332005; Antunes EB, 2012, GERODONTOLOGY, V29, P247, DOI 10.1111/j.1741-2358.2012.00638.x; Tamura BK, 2013, J AM MED DIR ASSOC, V14, P649, DOI 10.1016/j.jamda.2013.02.022; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Kuroda Y, 2012, J AM GERIATR SOC, V60, P1785, DOI 10.1111/j.1532-5415.2012.04123.x; Kawashima K, 2004, DYSPHAGIA, V19, P266, DOI 10.1007/s00455-004-0013-6; Foley NC, 2009, J REHABIL MED, V41, P707, DOI 10.2340/16501977-0415; Steele CM, 1997, DYSPHAGIA, V12, P43, DOI 10.1007/PL00009517; Tamura F, 2012, DYSPHAGIA, V27, P556, DOI 10.1007/s00455-012-9407-z; Yoshida M, 2006, DYSPHAGIA, V21, P61, DOI 10.1007/s00455-005-9011-6; Feng X, 2013, J GERONTOL A-BIOL, V68, P853, DOI 10.1093/gerona/gls225; Hara K, 2014, ARCH PHYS MED REHAB, V95, P867, DOI 10.1016/j.apmr.2013.09.005; Ikeda K, 2007, JPN J REHABIL MED, V44, pS569; Kagaya H, 2011, AM J PHYS MED REHAB, V90, P901, DOI 10.1097/PHM.0b013e31822deb32; MAHONEY F I, 1965, Md State Med J, V14, P61; Medical Research Council, 1976, AIDS EX PERIPH NERV; Nakamura R, 2013, J NEUROL NEUROSUR PS, V84, P1365, DOI 10.1136/jnnp-2013-306020; Park YH, 2013, GERIATR NURS, V34, P212, DOI 10.1016/j.gerinurse.2013.02.014; Paternostro-Sluga T, 2008, J REHABIL MED, V40, P665, DOI 10.2340/16501977-0235; Rubenstein LZ, 2001, J GERONTOL A-BIOL, V56, pM366; Steele CM, 1997, DYSPHAGIA, V12, P51; Wakabayashi H, J JSPEN IN PRESS; Wakabayashi H, 2012, DYSPHAGIA SARCOPENIA; Wakabayashi H, 2013, J FRAILTY AGING; Yoshida Tsuyoshi, 2007, J Jpn Phys Ther Assoc, V10, P11, DOI 10.1298/jjpta.10.11	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	APR	2015	15	4					410	416		10.1111/ggi.12283		7	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AI	WOS:000352565900003		
J	Kikutani, T; Tamura, F; Tashiro, H; Yoshida, M; Konishi, K; Hamada, R				Kikutani, Takeshi; Tamura, Fumiyo; Tashiro, Haruki; Yoshida, Mitsuyoshi; Konishi, Kiyoshi; Hamada, Ryo			Relationship between oral bacteria count and pneumonia onset in elderly nursing home residents	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						aspiration pneumonia; oral bacteria count; oral health care	ASPIRATION PNEUMONIA; DETECTION APPARATUS; HEALTH-CARE; DYSPHAGIA; RISK; COLONIZATION; INFECTIONS; PREVALENCE; LUNG	AimOral bacteria, which are a source of infection for aspiration pneumonia, were examined in frail older adults with the aim of establishing a standard bacteria count that indicates the risk of pneumonia onset in this group. MethodsA survey of bacteria count in the saliva using a simple instrument for measurement of the number of oral bacteria, along with factors including swallowing function and nutritional status, was carried out in 691 elderly individuals requiring care (137 men; mean age 82.68.3years; 554 women; mean age 88.07.1years; total mean age 86.7 +/- 7.8years) at 16 nursing homes in Japan. All participants gave their consent for inclusion in the present study. During a 6-month follow-up period, participants who developed pneumonia were identified, and relationships between the factors measured at the start of the period and pneumonia onset were examined. ResultsDuring the 6-month follow-up period, 33 participants (4.8%; 5 men, 28 women; mean age 88.3 +/- 7.4years) developed pneumonia. Pneumonia onset was significantly associated with reduced activities of daily living, swallowing dysfunction and undernourishment. Logistic regression analysis identified a saliva bacteria count of 10(8.5)colony-forming units/mL as an independent explanatory factor for pneumonia onset (P=0.012, RR=3.759). ConclusionsOral bacteria count of 10(8.5)colony-forming units/mL saliva in an elderly person requiring care was identified as a risk factor for pneumonia onset. Geriatr Gerontol Int 2015; 15: 417-421.	[Kikutani, Takeshi; Tamura, Fumiyo] Nippon Dent Univ Grad Sch Life Dent, Div Clin Oral Rehabil, Tokyo, Japan; [Konishi, Kiyoshi] Nippon Dent Univ Sch Life Dent, Dept Microbiol, Tokyo, Japan; [Kikutani, Takeshi; Tashiro, Haruki] Nippon Dent Univ Tama Oral Rehabil Clin, Div Rehabil Speech & Swallowing Disorders, Koganei, Tokyo 1840011, Japan; [Yoshida, Mitsuyoshi] Hiroshima City Gen Rehabil Ctr, Dept Dent, Hiroshima, Japan; [Hamada, Ryo] Incubat Ctr Panason Healthcare Co Ltd, Tokyo, Japan	Kikutani, T (reprint author), Nippon Dent Univ Tama Oral Rehabil Clin, Div Rehabil Speech & Swallowing Disorders, 4-44-19 Higashi, Koganei, Tokyo 1840011, Japan.	kikutani@tky.ndu.ac.jp			Ministry of Health, Labor and Welfare, Japan	This study was supported in part by a Research Grant from of the Ministry of Health, Labor and Welfare, Japan.	Adachi M, 2002, ORAL SURG ORAL MED O, V94, P191, DOI 10.1067/moe.2002.123493; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; JOHANSON WG, 1972, ANN INTERN MED, V77, P701; Hamada R, 2011, IET NANOBIOTECHNOL, V5, P25, DOI 10.1049/iet-nbt.2010.0011; Abe S, 2008, ARCH GERONTOL GERIAT, V47, P267, DOI 10.1016/.j.archger.2007.08.005; Cabre M, 2010, AGE AGEING, V39, P39, DOI 10.1093/ageing/afp100; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Margetts BM, 2003, EUR J CLIN NUTR, V57, P69, DOI 10.1038/sj.ejcn.1601499; Abe S, 2006, ARCH GERONTOL GERIAT, V43, P157, DOI 10.1016/j.arcger.2005.10.004; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Yoneyama T, 1999, LANCET, V354, P515, DOI 10.1016/S0140-6736(05)75550-1; Terpenning M, 2002, J AM GERIATR SOC, V50, P584, DOI 10.1046/j.1532-5415.2002.50131.x; Teramoto S, 2000, ARCH PHYS MED REHAB, V81, P1517, DOI 10.1053/apmr.2000.9171; Akner G, 2001, AM J CLIN NUTR, V74, P6; Hirota K, 1997, Nihon Ronen Igakkai Zasshi, V34, P125; INGLIS TJJ, 1993, LANCET, V341, P911, DOI 10.1016/0140-6736(93)91208-4; Ishikawa A, 2008, J DENT RES, V87, P594; JOHANSON WG, 1980, MED CLIN N AM, V64, P385; Kakinoki Yasuaki, 2004, Gerodontology, V21, P229, DOI 10.1111/j.1741-2358.2004.00037.x; Kikutani T, 2012, GERODONTOLOGY, V29, pE560, DOI 10.1111/j.1741-2358.2011.00517.x; MAHONEY F I, 1965, Md State Med J, V14, P61; PIERCE AK, 1974, AM REV RESPIR DIS, V110, P647; Scannapieco F A, 1998, Ann Periodontol, V3, P251, DOI 10.1902/annals.1998.3.1.251; Sumi Y, 2006, Gerodontology, V23, P55, DOI 10.1111/j.1741-2358.2006.00093.x; Takahashi Koji, 1994, Dysphagia, V9, P54; van der Maarel-Wierink CD, 2011, J DENT RES, V90, P1398, DOI 10.1177/0022034511422909	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	APR	2015	15	4					417	421		10.1111/ggi.12286		5	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AI	WOS:000352565900004		
J	Doi, T; Shimada, H; Makizako, H; Tsutsumimoto, K; Uemura, K; Suzuki, T				Doi, Takehiko; Shimada, Hiroyuki; Makizako, Hyuma; Tsutsumimoto, Kota; Uemura, Kazuki; Suzuki, Takao			Apolipoprotein E genotype and physical function among older people with mild cognitive impairment	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						apolipoproteinE; dementia; mild cognitive impairment; physical function; walking	ALZHEIMER-DISEASE; E EPSILON-4; GAIT SPEED; RISK; DEMENTIA; DECLINE; ASSOCIATION; ADULTS; MOTOR; DYSFUNCTION	AimMild cognitive impairment (MCI) is conceptualized as prodromal of Alzheimer's disease (AD). Declined physical function is one of the risk factors for progression to AD, whereas genetic factors, especially the apolipoproteinE epsilon 4 allele (APOE4), also contribute to the risk of AD and affect the risk factors. However, the association between APOE4 and physical function in MCI is still unclear. To elucidate the association, we carried out the present study to compare physical function between APOE4 carriers and non-carriers in MCI. MethodsThe study included 386 MCI patients (mean age 71.6 years) who were classified into APOE4 carrier and non-carrier groups. The participants' characteristics were assessed by face-to-face interviews. Grip strength, five chair stand test, walking speed and 6-min walking test were measured as physical functions. ResultsIn univariate analysis, the APOE4 carrier group had decreased walking speed compared with the non-carrier group (P<0.05), but other measures of physical function were not significantly different between the groups. The linear regression model showed a significant association between walking speed and APOE4 after adjusting for covariates (P<0.05). ConclusionsThe present study showed that APOE4 carrier participants with MCI had decreased walking speed compared with non-carrier participants. Thus, APOE4 genotypes should be considered as a potential mediator when the measure of walking speed is used as a risk factor of dementia in older adults with MCI. Further studies using prospective data are required to clarify the relationship between physical function and genetic factors in MCI. Geriatr Gerontol Int 2015; 15: 422-427.	[Doi, Takehiko; Shimada, Hiroyuki; Makizako, Hyuma; Tsutsumimoto, Kota; Uemura, Kazuki] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Res & Dev Support Independent Life Elderly, Sect Hlth Promot, Obu, Aichi 4748511, Japan; [Doi, Takehiko; Makizako, Hyuma; Uemura, Kazuki] Japan Soc Promot Sci, Tokyo, Japan; [Doi, Takehiko; Makizako, Hyuma; Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi 4748511, Japan	Doi, T (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Res & Dev Support Independent Life Elderly, Sect Hlth Promot, 35 Gengo, Obu, Aichi 4748511, Japan.	take-d@ncgg.go.jp			Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health); National Center for Geriatrics and Gerontology, Japan [22-16];  [24700585]	This work was supported by Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health); a Grant-in-Aid for for Young Scientists (B) (grant number 24700585); and Research Funding for Longevity Sciences (22-16) from the National Center for Geriatrics and Gerontology, Japan.	Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Okonkwo OC, 2010, ALZHEIMERS DEMENT, V6, P404, DOI 10.1016/j.jalz.2010.02.003; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Hausdorff JM, 2013, J GERONTOL A-BIOL, V68, P409, DOI 10.1093/gerona/glt002; Aggarwal NT, 2006, ARCH NEUROL-CHICAGO, V63, P1763, DOI 10.1001/archneur.63.12.1763; Buchman AS, 2009, ALZ DIS ASSOC DIS, V23, P63; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Allan LM, 2005, J AM GERIATR SOC, V53, P1681, DOI 10.1111/j.1532-5415.2005.53552.x; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Rosano C, 2010, NEUROBIOL AGING, V31, P1197, DOI 10.1016/j.neurobiolaging.2008.08.004; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Farlow MR, 2004, NEUROLOGY, V63, P1898; GURALNIK JM, 1994, J GERONTOL, V49, pM85; Irie F, 2008, ARCH GEN PSYCHIAT, V65, P906, DOI 10.1001/archpsyc.65.8.906; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; BUTLAND RJA, 1982, BRIT MED J, V284, P1607; Choi P, 2012, STROKE, V43, P1505, DOI 10.1161/STROKEAHA.111.647271; desLaat KF, 2012, NEUROIMAGE, V59, P1478; Doi T, 2012, J GERONTOL A-BIOL, V67, P790, DOI 10.1093/gerona/glr214; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Melzer D, 2005, J GERONTOL A-BIOL, V60, P1319; Shimada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002424; Whitehair DC, 2010, ALZHEIMERS DEMENT, V6, P412, DOI 10.1016/j.jalz.2009.12.003	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	APR	2015	15	4					422	427		10.1111/ggi.12291		6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AI	WOS:000352565900005		
J	Osone, A; Arai, R; Hakamada, R; Shimoda, K				Osone, Akira; Arai, Reiko; Hakamada, Rina; Shimoda, Kazutaka			Impact of cognitive reserve on the progression of mild cognitive impairment to Alzheimer's disease in Japan	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						Alzheimer's disease; cognitive reserve; education; mild cognitive impairment; premorbid IQ	PREMORBID IQ; DEMENTIA; PREVALENCE; EDUCATION; DIAGNOSIS; COHORT; WORDS	AimThe present study aimed to investigate whether cognitive reserve (CR), referring here to education and premorbid intelligence (IQ), is associated with the risk for progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD). MethodsA total of 51 patients with MCI and 59 patients with AD were prospectively enrolled for assessment with the Mini-Mental State Examination, the Japanese version of the cognitive subscale of the Alzheimer's Disease Assessment Scale, the Japanese version of the Nelson Adult Reading Test (JART), magnetic resonance imaging (MRI) and single-photon emission computed tomography (SPECT), adjusting for sex, age at diagnosis, age at onset and duration of illness. ResultsSPECT findings showed hypoperfusion in the posterior cingulate gyri and precunei, suggesting that the participants were in the early or mild stage of AD or MCI. Voxel-based morphometry MRI showed no statistical differences between the two groups in gray matter loss in the entorhinal and hippocampal areas; however, multiple logistic regression analysis showed a significant difference in premorbid IQ measured with JART. ConclusionDespite the limitations of the cross-sectional design, the findings suggest that premorbid intellectual function might explain the discrepancy in clinical status between MCI and AD patients with a similar magnitude of brain pathology and comorbid medical disorders. Geriatr Gerontol Int 2015; 15: 428-434.	Dokkyo Med Univ, Sch Med, Dept Psychiat, Shimotsuga, Tochigi, Japan; Dokkyo Med Univ, Sch Med, Ctr Dementia Related Dis, Shimotsuga, Tochigi, Japan	Osone, A (reprint author), Dokkyo Med Univ, Sch Med, Dept Psychiat, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	osone@dokkyomed.ac.jp					Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Cano SJ, 2010, J NEUROL NEUROSUR PS, V81, P1363, DOI 10.1136/jnnp.2009.204008; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; Matsuda H, 2007, J NUCL MED, V48, P1289, DOI 10.2967/jnumed.106.037218; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Albert MS, 1995, PSYCHOL AGING, V10, P578, DOI 10.1037/0882-7974.10.4.578; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Ott A, 1999, NEUROLOGY, V53, P1937; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Matsuda H, 2007, NEUROPATHOLOGY, V27, P570, DOI 10.1111/j.1440-1789.2007.00794.x; Sharp ES, 2011, ALZ DIS ASSOC DIS, V25, P289, DOI 10.1097/WAD.0b013e318211c83c; Richards M, 2005, ANN NEUROL, V58, P617, DOI 10.1002/ana.20637; Doraiswamy PM, 2002, J GERONTOL A-BIOL, V57, pM173; McGurn B, 2004, NEUROLOGY, V62, P1184; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Ishii K, 2005, AM J NEURORADIOL, V26, P333; KATZMAN R, 1993, NEUROLOGY, V43, P13; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Boksay I, 2005, J AM GERIATR SOC, V53, P2235, DOI 10.1111/j.1532-5415.2005.00512_4.x; Braak H., 1996, ACTA NEUROL SCAND, V94, P3, DOI [10.1111/j.1600-0404.1996.tb05866.x, DOI 10.1111/J.1600-0404.1996.TB05866.X]; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; MCKHANN G, 1984, NEUROLOGY, V34, P939; Mori E, 1985, SHINKEI SHINRI, V1, P2; Nelson H. E., 1991, NATL ADULT READING T; Nelson HE, 1982, NATL ADULT READING T; Pavlik VN, 2006, DEMENT GERIATR COGN, V22, P367, DOI 10.1159/000095640; Sakurai H, 2010, GERIATR GERONTOL INT, V10, P216, DOI 10.1111/j.1447-0594.2010.00609.x; Starr JM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-27; Sugishita M, 2009, JPN J COGN NEUROSCI, V11, P87; Yamashita M, 1998, JPN J GERIATR, V9, P187	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	APR	2015	15	4					428	434		10.1111/ggi.12292		7	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AI	WOS:000352565900006		
J	Sato, T; Yamauchi, H; Kanno, Y; Suzuki, S; Yoshihisa, A; Yamaki, T; Sugimoto, K; Kunii, H; Nakazato, K; Suzuki, H; Saitoh, S; Takeishi, Y				Sato, Takamasa; Yamauchi, Hiroyuki; Kanno, Yuki; Suzuki, Satoshi; Yoshihisa, Akiomi; Yamaki, Takayoshi; Sugimoto, Koichi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika			Comparisons of prognostic factors between young and elderly patients with chronic heart failure	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						B-type natriuretic peptide; clinical outcome; age; chronic heart failure	JAPANESE CARDIAC REGISTRY; CARDIOLOGY JCARE-CARD; BRAIN NATRIURETIC PEPTIDE; TERM ADVERSE OUTCOMES; HOSPITALIZED-PATIENTS; VENTILATORY RESPONSE; ATRIAL-FIBRILLATION; EXERCISE; ANEMIA; METAANALYSIS	AimThe purpose in the present study was to compare prognostic risk factors between older and younger chronic heart failure (CHF) patients. MethodsWe examined 598 consecutive CHF patients (476 men and 122 women, mean age 61.414.3 years) who underwent cardiopulmonary exercise testing, echocardiography and blood examination. We divided the 598 patients into two groups: the elderly group (age 75 years, n=123) and the young group (age <75, n=475). We compared blood testing data, exercise capacity, cardiac function and prognosis between the two groups. Patients were followed up (median 782 days) to register cardiac deaths or rehospitalization as a result of worsening heart failure. ResultsPatients in the elderly group were associated with higher frequencies of atrial fibrillation and diuretic use than those in the young group. Patients in the elderly group had lower hemoglobin concentration, more impaired renal function, higher plasma B-type natriuretic peptide (BNP) levels, smaller left ventricular volume, longer deceleration time of early mitral wave and lower exercise capacity than those in the young group. There were 199 cardiac events during follow-up periods. As expected, Kaplan-Meier analysis showed that patients in the elderly group had higher cardiac event rates than those in the young group. In the young group, multivariable Cox hazard analysis showed that hemoglobin concentration, log BNP and peak VO2 were independent predictors related to cardiac events. In contrast, in the elderly group, estimated glomerular filtration rate, atrial fibrillation and peak VO2 were independent factors to predict adverse clinical outcomes. ConclusionsPrognostic factors were different between the elderly and young patients in CHF. Geriatr Gerontol Int 2015; 15: 435-442.	[Sato, Takamasa; Yamauchi, Hiroyuki; Kanno, Yuki; Suzuki, Satoshi; Yoshihisa, Akiomi; Yamaki, Takayoshi; Sugimoto, Koichi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima 9601295, Japan	Sato, T (reprint author), Fukushima Med Univ, Dept Cardiol & Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.	takamasa@fmu.ac.jp			Japan Society for the Promotion of Science [23700613]; Japanese Ministry of Health, Labor and Welfare, Tokyo, Japan	This study was supported in part by grants-in-aid for Scientific Research (No. 23700613) from the Japan Society for the Promotion of Science and grants-in-aid from the Japanese Ministry of Health, Labor and Welfare, Tokyo, Japan.	Ponikowski P, 2001, CIRCULATION, V103, P967; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Tsutsui H, 2006, CIRC J, V70, P1617, DOI 10.1253/circj.70.1617; Hamaguchi S, 2009, CIRC J, V73, P1901; Manzano L, 2012, EUR J HEART FAIL, V14, P1097, DOI 10.1093/eurjhf/hfs109; Komajda M, 2009, EUR HEART J, V30, P478, DOI 10.1093/eurheartj/ehn539; Hamaguchi S, 2011, CIRC J, V75, P2403, DOI 10.1253/circj.CJ-11-0267; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Chua TP, 1997, J AM COLL CARDIOL, V29, P1585; Neder JA, 1999, EUR RESPIR J, V14, P1304, DOI 10.1183/09031936.99.14613049; Piepoli MF, 2004, BRIT MED J, V328, P189, DOI 10.1136/bmj.37938.645220.EE; Silverberg D, 2003, NEPHROL DIAL TRANSPL, V18, P7, DOI [10.1093/ndt//gfg1084, 10.1093/ndt/gfg1056]; Rodriguez F, 2013, J CARD FAIL, V19, P542, DOI 10.1016/j.cardfail.2013.05.016; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Osada N, 1998, J AM COLL CARDIOL, V31, P577, DOI 10.1016/S0735-1097(97)00533-0; Mamas MA, 2009, EUR J HEART FAIL, V11, P676, DOI 10.1093/eurjhf/hfp085; Ostir GV, 2002, J CLIN EPIDEMIOL, V55, P916, DOI 10.1016/S0895-4356(02)00436-5; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rrcm.2202033; Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Dumurgier J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4460; Garhard-Herman M, 2006, J AM SOC ECHOCARDIOG, V19, P955; Greenberg B, 2011, PROGNOSIS BRAUNWALDS, P505; Kannel W B, 2000, Heart Fail Rev, V5, P167; Mabuchi N, 2000, JPN CIRC J, V64, P765, DOI 10.1253/jcj.64.765; Mosterd A, 2001, EUR HEART J, V22, P1318, DOI 10.1053/euhj.2000.2533; Rohrig G, 2012, Z GERONTOL GERIATR, V45, P191, DOI 10.1007/s00391-012-0320-8; Tsuchihashi-Makaya M, 2009, CIRC J, V73, P1893; Tsutamoto T, 2006, J AM COLL CARDIOL, V47, P582, DOI 10.1016/j.jacc.2005.10.038; Yamagata K, 2008, CLIN EXP NEPHROL, V12, P1, DOI 10.1007/s10157-007-0010-9	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	APR	2015	15	4					435	442		10.1111/ggi.12293		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AI	WOS:000352565900007		
J	Kimura, T; Imanaga, T; Matsuzaki, M; Akahoshi, T				Kimura, Takuma; Imanaga, Teruhiko; Matsuzaki, Makoto; Akahoshi, Tohru			Home death is associated with frequency of physician home medical care visits: A questionnaire survey on communications in home medical care settings	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						communication; doctor; family; home death; home medical care	NATIONWIDE SURVEY; PALLIATIVE CARE; COMPANIONS; CANCER; ENCOUNTERS; PREDICTORS; HEALTH	AimTo investigate the factors related to communications in home medical care settings, and the association between such factors and a patient's place of death. MethodsA questionnaire survey of 295 families of patients who had previously received home medical care was carried out in June and July 2011. The response rate was 83.8% (n=227). Following the exclusion of families where the patient was still alive, or where the place of death was unknown, 143 questionnaires were available for analysis. Logistic regression was used to identify significant associations between possible factors related to communication and occurrence of home death. ResultsHome death was observed in 66.4% (n=95) of the families analyzed. Home death was significantly associated with the frequency of doctor home-visits per week (OR 2.835, 95% CI 1.436-5.597, P=0.003). There was no statistically significant association between home death and any of the other variables included: malignant tumors as primary disease, independence in daily activity, duration of home medical care, duration of doctor's visits, experience of doctor-patient communication without family, doctor-family communication without the patient or explanation from the doctor on the phone, existence of home-visit nursing services, existence of family's anxieties and/or questions, age of primary caregiver(s) and sex of primary caregiver(s). ConclusionThe frequency of doctor home-visits was the only factor identified that was positively associated with the occurrence of home death in home medical care settings. Geriatr Gerontol Int 2015; 15: 465-471.	[Kimura, Takuma; Akahoshi, Tohru] Kitasato Univ, Sch Med, Dept Gen Med, Sagamihara, Kanagawa 2520374, Japan; [Kimura, Takuma; Imanaga, Teruhiko] Higashisaitama Hosp, Natl Hosp Org, Dept Gen Med, Hasuda, Saitama, Japan; [Matsuzaki, Makoto] Toho Univ, Ctr Clin Training & Educ, Sch Med, Tokyo, Japan	Kimura, T (reprint author), Kitasato Univ, Sch Med, Dept Gen Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	takumak@med.kitasato-u.ac.jp			Department of General Medicine, School of Medicine, Kitasato University; Center for Clinical Training and Education Research, Faculty of Medicine, Toho University	This study was supported by a research fund from the Department of General Medicine, School of Medicine, Kitasato University, and the Center for Clinical Training and Education Research, Faculty of Medicine, Toho University.	Akiyama Akiko, 2007, Nihon Ronen Igakkai Zasshi, V44, P740, DOI 10.3143/geriatrics.44.740; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863; Ishikawa H, 2006, PATIENT EDUC COUNS, V61, P80, DOI 10.1016/j.pec.2005.02.010; Gomes B, 2006, BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Schilling LM, 2002, J FAM PRACTICE, V51, P685; Ishikawa H, 2005, SOC SCI MED, V60, P2307, DOI 10.1016/j.socscimed.2004.08.071; Cole S. A., 2000, MED INTERVIEW 3 FUNC; Elfrink EJ, 2002, J PALLIATIVE CARE, V18, P105; Fukui S, 2011, ANN ONCOL, V22, P2113, DOI 10.1093/annonc/mdq719; Fukui S, 2011, INT J NURS STUD, V48, P1393, DOI 10.1016/j.ijnurstu.2011.05.001; Goodman C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-337; Japan Medical Association, 2000, INT UT HOM DOCT OP B; Kawagoe S, 2013, GERIATR GERONTOL INT, V13, P874, DOI 10.1111/ggi.12018; Kimura T, 2013, JPN J PRIM CARE, V36, P166; Kimura T, 2013, JAPANESE J HOME CARE, V15, P7; MacAdam M, 2004, HOME HLTH CARE MANAG, V16, P393, DOI 10.1177/1084822304264615; Maguire P, 2000, COMMUNICATION SKILLS; Morishima Y, 2009, HLTH RES FORUM, V15, P16; Neergaard Mette Asbjoern, 2009, BMC Palliat Care, V8, P18, DOI 10.1186/1472-684X-8-18; Ozawa Martha N, 2005, J Aging Soc Policy, V17, P61, DOI 10.1300/J031v17n03_04; Sasaki Megumi, 2008, Nihon Ronen Igakkai Zasshi, V45, P622; Suzuki H, 2005, JPN J PRIM CARE, V28, P251; Tanaka T, 2008, TXB GERIATRIC MED, P44; Wolff JL, 2008, ARCH INTERN MED, V168, P1409, DOI 10.1001/archinte.168.13.1409	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	APR	2015	15	4					465	471		10.1111/ggi.12297		7	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AI	WOS:000352565900011		
J	Ohara, Y; Yoshida, N; Kono, Y; Hirano, H; Yoshida, H; Mataki, S; Sugimoto, K				Ohara, Yuki; Yoshida, Naomi; Kono, Yoko; Hirano, Hirohiko; Yoshida, Hideyo; Mataki, Shiro; Sugimoto, Kumiko			Effectiveness of an oral health educational program on community-dwelling older people with xerostomia	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						exercise; oral function; salivary secretion; xerostomia	DRY MOUTH; ELDERLY JAPANESE; NURSING-HOMES; CARE; HYPOSALIVATION; INTERVENTION; PREVALENCE; PNEUMONIA; ADULTS; SALIVA	AimThe purpose of the present study was to evaluate the changes in oral health and function through an oral health educational program for the independent older people with xerostomia. MethodsCommunity-dwelling older people with xerostomia aged over 65 years who participated in a preliminary comprehensive health survey in 2011 were recruited for the educational program. A total of 47 participants were randomly assigned into two groups, the intervention group (n=26) and the control group (n=21). The intervention group attended a 90-min oral health education program every 2 weeks for 3 months. The program consisted of oral hygiene instruction, facial and tongue muscle exercise, and salivary gland massage. The control group was provided only general information about oral health. The assessments of oral function, such as oral diadochokinesis of articulation, swallowing, taste threshold and salivary flow rate, were carried out before and after 3 months with or without intervention. ResultsA total of 38 participants (21 of intervention group and 17 of control group) completed the study protocol. In the intervention group, resting salivation significantly improved after the program. The second and third cumulated Repetitive Saliva Swallowing Test times significantly improved in the intervention group. The threshold for bitterness significantly lowered in the intervention group, whereas the sour threshold significantly heightened in the control group after 3 months (P<0.05). ConclusionsThe present study suggests that the educational program targeting oral function improvement is effective among the independent older population. Geriatr Gerontol Int 2015; 15: 481-489.	[Ohara, Yuki; Mataki, Shiro] Tokyo Med & Dent Univ, Fac Dent, Grad Sch Med & Dent Sci, Behav Dent, Tokyo 1138549, Japan; [Kono, Yoko] Tokyo Med & Dent Univ, Fac Dent, Grad Sch Med & Dent Sci, Cognit Neurobiol, Tokyo 1138549, Japan; [Sugimoto, Kumiko] Tokyo Med & Dent Univ, Fac Dent, Sch Oral Hlth Care Sci, Basic Oral Hlth Sci, Tokyo 1138549, Japan; [Hirano, Hirohiko; Yoshida, Hideyo] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan; [Yoshida, Naomi] Chiba Prefectural Univ Hlth Sci, Fac Hlth Care Sci, Dept Dent Hyg, Chiba, Japan	Sugimoto, K (reprint author), Tokyo Med & Dent Univ, Fac Dent, Sch Oral Hlth Care Sci, Basic Oral Hlth Sci,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	ksugimoto.bohs@tmd.ac.jp			Ministry of Education, Science, Sports, Science and Technology [22592329]	This study was partly supported by the Ministry of Education, Science, Sports, Science and Technology Grant-in-Aid for Science Research (C) No. 22592329.	Adachi M, 2002, ORAL SURG ORAL MED O, V94, P191, DOI 10.1067/moe.2002.123493; Ship JA, 2002, ORAL DIS, V8, P77, DOI 10.1034/j.1601-0825.2002.2o837.x; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Holland G, 2011, DIS ESOPHAGUS, V24, P476, DOI 10.1111/j.1442-2050.2011.01182.x; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216; Flink H, 2008, COMMUNITY DENT ORAL, V36, P523, DOI [10.1111/j.1600-0528.2008.00432.x, 10.1111/j.1600-0528.2008.00440.x]; Tamura F, 2002, DYSPHAGIA, V17, P235, DOI 10.1007/s00455-002-0063-6; Ohara Y, 2011, GERIATR GERONTOL INT, V11, P83, DOI 10.1111/j.1447-0594.2010.00647.x; Villa A, 2011, AUST DENT J, V56, P290, DOI 10.1111/j.1834-7819.2011.01347.x; Fukunaga A, 2005, J GERONTOL A-BIOL, V60, P109; Dangore-Khasbage SB, 2010, ORAL DIS, V16, P469, DOI 10.1111/j.1601-0825.2010.01658.x; Naito M, 2006, J PUBLIC HEALTH DENT, V66, P273; El-Solh AA, 2011, LUNG, V189, P173, DOI 10.1007/s00408-011-9297-0; Ziegler W, 2002, BRAIN LANG, V80, P556, DOI 10.1006/brln.2001.2614; Atchison K A, 1990, J Dent Educ, V54, P680; Cho MA, 2010, J ORAL REHABIL, V37, P185, DOI 10.1111/j.1365-2842.2009.02037.x; Endo S., 1990, J NIHON U MED ASS, V49, P590; Fitzpatrick Sara E., 2008, Journal of Nutrition for the Elderly, V27, P135, DOI 10.1080/01639360802060223; Forner L, 2011, ORAL ONCOL, V47, P546, DOI 10.1016/j.oraloncology.2011.03.021; Gerdin Elisabeth Wärnberg, 2005, Gerodontology, V22, P219, DOI 10.1111/j.1741-2358.2005.00087.x; Hakuta C, 2009, GERODONTOLOGY, V26, P250, DOI 10.1111/j.1741-2358.2008.00269.x; Ibayashi H, 2008, TOHOKU J EXP MED, V215, P237, DOI 10.1620/tjem.215.237; Ichikawa K, 2011, GERODONTOLOGY, V28, P116, DOI 10.1111/j.1741-2358.2009.00358.x; Ikebe K, 2001, Spec Care Dentist, V21, P52, DOI 10.1111/j.1754-4505.2001.tb00225.x; Ikebe K, 2007, ORAL SURG ORAL MED O, V103, P216, DOI 10.1016/j.tripleo.2005.12.001; Kikutani Takeshi, 2006, Gerodontology, V23, P93, DOI 10.1111/j.1741-2358.2006.00104.x; Kimura M, 2013, BMC GERIATR, V23, P13, DOI DOI 10.1186/1471-2318-13-8; Koshino H, 2008, PROSTHODONT RES PRAC, V7, P12, DOI 10.2186/prp.7.12; Mavi A, 1999, Gerodontology, V16, P119, DOI 10.1111/j.1741-2358.1999.00119.x; Mavi A, 1999, AGING-CLIN EXP RES, V11, P61; Ministry of Health Labour and Welfare, REV VERS OR FUNCT IM; Motegi Etsuko, 2009, Bull Tokyo Dent Coll, V50, P135; NARHI TO, 1994, J DENT RES, V73, P20, DOI 10.1177/00220345940730010301; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Nittayananta Wipawee, 2013, J Investig Clin Dent, V4, P164, DOI 10.1111/jicd.12052; Ohno Tomohisa, 2003, Journal of Medical and Dental Sciences, V50, P101; Peltola P, 2007, GERODONTOLOGY, V24, P14, DOI 10.1111/j.1741-2358.2007.00147.x; Sakayori T, 2013, GERIATR GERONTOL INT, V13, P451, DOI 10.1111/j.1447-0594.2012.00930.x; Sekiguchi Haruko, 2010, Nihon Ronen Igakkai Zasshi, V47, P226; Sugano Keiko, 2012, Dement Geriatr Cogn Dis Extra, V2, P69, DOI 10.1159/000337224; Turner MD, 2007, J AM DENT ASSOC, V138, p15S; Yamauchi Y, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P119	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	APR	2015	15	4					481	489		10.1111/ggi.12301		9	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AI	WOS:000352565900013		
J	Arai, H; Satake, S				Arai, Hidenori; Satake, Shosuke			English translation of the Kihon Checklist	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter							OLDER-ADULTS; JAPANESE; FRAILTY; CARE		[Arai, Hidenori] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Satake, Shosuke] Natl Ctr Geriatr & Gerontol, Obu, Japan	Arai, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan.						Fukutomi E, 2013, GERIATR GERONTOL INT, V13, P654, DOI 10.1111/j.1447-0594.2012.00959.x; Koizumi Y, 2013, HYPERTENS RES, V36, P639, DOI 10.1038/hr.2013.7; Nemoto M, 2012, ARCH GERONTOL GERIAT, V55, P385, DOI 10.1016/j.archger.2011.10.004; Sampaio PYS, 2014, GERIATR GERONTOL INT, V14, P561, DOI 10.1111/ggi.12134; Tomata Yasutake, 2011, Nihon Koshu Eisei Zasshi, V58, P3; Umegaki H, 2012, GERIATR GERONTOL INT, V12, DOI 10.1111/j.1447-0594.2011.00762.x	6	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	APR	2015	15	4					518	519		10.1111/ggi.12397		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5AI	WOS:000352565900020		
J	Fukumoto, A; Sean, WY; Sato, T; Yamasaki, A; Kiyono, F				Fukumoto, Ayako; Sean, Wu-Yang; Sato, Toru; Yamasaki, Akihiro; Kiyono, Fumio			Estimation of dissociation rate constant of CO2 hydrate in water flow	GREENHOUSE GASES-SCIENCE AND TECHNOLOGY			English	Article						CO2 hydrate; carbon capture and storage; hydrate dissociation; dissociation rate constant; Gibbs free energy; CFD	CARBON-DIOXIDE; GAS HYDRATE; METHANE; DISSOLUTION; PREDICTION; SOLUBILITY; ENTHALPY; NUMBER; CFD	Dissociation processes of CO2 hydrate under water flow conditions were investigated by experimental measurements and numerical calculation. Dissociation experiments were carried out with a CO2 hydrate ball (diameter 10 mm) mounted in a flow cell, and the overall dissociation rate of CO2 hydrate without bubble formation was measured under various conditions of temperature, pressure, and water flow rate. A linear phenomenological rate equation in the form of the product of the dissociation rate constant and the molar Gibbs free energy difference, between the hydrate phase and the ambient aqueous phase, was derived by considering the Gibbs free energy difference as the driving force for the dissociation. The molar Gibbs free energy difference was expressed by the logarithm of the ratio of the concentration of CO2 dissolved in water at the hydrate surface to the solubility of CO2 in the aqueous solution in equilibrium with the hydrate. The dissociation rate constant was determined from the experimental results of the overall dissociation rate combined with the numerical simulation results of the concentration profile of CO2 constructed by the computational fluid dynamics (CFD) method. The obtained dissociation rate constant at the same pressure was found to be dependent on the temperature with the apparent activation energy of 97.51 kJ/mol. A general form with product of the dissociation rate constant times driving force is proposed to calculate the dissociation rate of CO2 hydrate in the water. (c) 2014 Society of Chemical Industry and John Wiley & Sons, Ltd	[Fukumoto, Ayako; Sato, Toru] Univ Tokyo, Kashiwa, Chiba, Japan; [Sean, Wu-Yang] Chung Yuan Christian Univ, Chungli 32023, Taiwan; [Yamasaki, Akihiro] Seikei Univ, Dept Mat & Life Sci, Musashino, Tokyo 1808633, Japan; [Kiyono, Fumio] Natl Inst Adv Ind Sci & Technol, Environm Fluid Engn Res Grp, Tsukuba, Ibaraki, Japan	Sean, WY (reprint author), Chung Yuan Christian Univ, Dept Bioenvironm Engn, Chungli 32023, Taiwan.	wysean@cycu.org.tw; akihiro@st.seike.ac.jp					Andersson V, 2005, GREENHOUSE GAS CONTR, VII, P1487; Anderson GK, 2003, J CHEM THERMODYN, V35, P1171, DOI 10.1016/S0021-9614(03)00093-4; Yang SO, 2000, FLUID PHASE EQUILIBR, V175, P75, DOI 10.1016/S0378-3812(00)00467-2; Li Q, 2009, ENERG CONVERS MANAGE, V50, P503, DOI 10.1016/j.enconman.2008.11.011; HANDA YP, 1986, J CHEM THERMODYN, V18, P915, DOI 10.1016/0021-9614(86)90149-7; Clarke MA, 2004, CHEM ENG SCI, V59, P2983, DOI 10.1016/j.ces.2004.04.030; Aya I, 1997, ENERGY, V22, P263, DOI 10.1016/S0360-5442(96)00093-X; Chemical Society of Japan, 1985, KAG BINR; Inui M, 2006, P 26 INT C OFFSH MEC, P1; Jung RT, 2005, J COMPUT PHYS, V203, P221, DOI 10.1016/j.jcp.2004.08.016; Kawamura T, 2002, J CRYST GROWTH, V234, P220, DOI 10.1016/S0022-0248(01)01639-6; Kohl AL., 1997, GAS PURIFICATION; Nihous GC, 2006, CHEM ENG SCI, V61, P7827, DOI 10.1016/j.ces.2005.09.010; North WJ, 1998, ENVIRON SCI TECHNOL, V32, P676, DOI 10.1021/es970483f; Pryde A, 1979, APPL HIGH PERFORMANC; Riestenberg DE, 2005, ABSTR PAP AM CHEM S, V229; Sean WY, 2007, AICHE J, V53, P262, DOI 10.1002/aic.11060; Sean WY, 2007, AICHE J, V53, P2148, DOI 10.1002/aic.11217; Servio P, 2001, FLUID PHASE EQUILIBR, V190, P127, DOI 10.1016/S0378-3812(01)00598-2; Sloan E. D., 1998, CLATHRATE HYDRATE NA; Sloan ED, 2008, CHEM IND-SER, V119, pXIX	21	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	2152-3878			GREENH GASES	Greenh. Gases	APR	2015	5	2					169	179		10.1002/ghg.1469		11	Energy & Fuels; Engineering, Environmental; Environmental Sciences	Energy & Fuels; Engineering; Environmental Sciences & Ecology	CF8LQ	WOS:000352811900006		
J	Sakata, Y				Sakata, Yoshitaka			Heat as a Tracer for Examining Depth-Decaying Permeability in Gravel Deposits	GROUNDWATER			English	Article							HYDRAULIC CONDUCTIVITY; ALLUVIAL-FAN; GEOSTATISTICAL SIMULATION; CAPE-COD; HETEROGENEITY; AQUIFERS; SCALE; TRANSPORT; SAND; IDENTIFICATION	Depth dependence of permeability can appear in any geologic setting; however, vertical trends in alluvial gravel deposits are poorly understood because of the high variability of hydraulic conductivity K in monotonic sequences. This paper examines the sensitivity of depth-decaying permeability through heat transport simulation around a river's losing reach in the Toyohira River alluvial fan, Japan. Observed variations in groundwater temperature indicate that heat fluxes are dominant in the shallow zone, despite a vertical hydraulic gradient. In eight cases with different conditions (presence or absence of exponential decay trend, large or small variogram range, and cell isotropy or anisotropy) 1000 K realizations are stochastically generated throughout a cross-sectional model. The groundwater flow and heat transport are transiently calculated, and the averaged root mean square error RMSE?</mml:mover> is used for sensitivity comparison. The variance of RMSE?</mml:mover> shows that small RMSE<mml:mo stretchy="true">?</mml:mover> realizations are effectively reproduced with vertical trend assumed. Plausible realizations of <mml:mover>RMSE<mml:mo stretchy="true">?</mml:mover> below a given threshold were obtained only when a vertical trend was assumed. The most plausible realization almost completely matched the observations. However, the number of plausible realizations per case was 10 and the median <mml:mover>RMSE<mml:mo stretchy="true">?</mml:mover> were insensitive to all the conditions. Statistical testing suggested that these plausible realizations may be statistically significant, aiding in generating a connected K zone for high heat flows. The cell anisotropy condition had the smallest effect on the simulation. Thus, effective modeling of the vertical trend contributes to heat transport; however, the model's efficiency is low without detailed information about the sedimentary structure.	[Sakata, Yoshitaka] Hokkaido Univ, Div Earth & Planetary Dynam, Fac Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Sakata, Yoshitaka] Docon Co Ltd, Dept Geotech, Div Environm Engn, Atsubetsu ku, Sapporo, Hokkaido 0048585, Japan	Sakata, Y (reprint author), Hokkaido Univ, Div Earth & Planetary Dynam, Fac Sci, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan.	yoshitaka_sakata@mail.sci.hokudai.ac.jp					American Society of Civil Engineers (ASCE), 2008, 5008 ASCEEWRI; Anderson M. P., 1992, APPL GROUNDWATER MOD; Eggleston J, 1998, WATER RESOUR RES, V34, P2155, DOI 10.1029/98WR01475; Zlotnik VA, 2011, GROUND WATER, V49, P576, DOI 10.1111/j.1745-6584.2010.00775.x; Woessner WW, 2000, GROUND WATER, V38, P423, DOI 10.1111/j.1745-6584.2000.tb00228.x; Sakata Y, 2013, HYDROGEOL J, V21, P773, DOI 10.1007/s10040-013-0961-8; Jang CS, 2004, HYDROL PROCESS, V18, P1333, DOI 10.1002/hyp.1397; Burger RL, 1997, WATER RESOUR RES, V33, P1515, DOI 10.1029/97WR00570; HESS KM, 1992, WATER RESOUR RES, V28, P2011, DOI 10.1029/92WR00668; Koltermann CE, 1996, WATER RESOUR RES, V32, P2617, DOI 10.1029/96WR00025; Thorne D, 2006, COMPUT GEOSCI-UK, V32, P1758, DOI 10.1016/j.cageo.2006.04.005; Constantz J, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006996; Berg SJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010616; Regli C, 2002, J HYDROL, V255, P234, DOI 10.1016/S0022-1694(01)00531-5; Cardenas MB, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009370; Koltermann CE, 1995, WATER RESOUR RES, V31, P3283, DOI 10.1029/95WR02020; BUTLER JJ, 1994, J HYDROL, V156, P137, DOI 10.1016/0022-1694(94)90075-2; JUSSEL P, 1994, WATER RESOUR RES, V30, P1803, DOI 10.1029/94WR00162; Bravo HR, 2002, WATER RESOUR RES, V38, DOI 10.1029/2000WR000172; Zappa G, 2006, J HYDROL, V325, P134, DOI 10.1016/j.jhydrol.2005.10.016; Ramanathan R, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008111; Chen XH, 2011, HYDROL PROCESS, V25, P278, DOI 10.1002/hyp.7844; Anderson MP, 2005, GROUND WATER, V43, P951, DOI 10.1111/j.1745-6584.2005.00052.x; Lee SY, 2007, ADV WATER RESOUR, V30, P1914, DOI 10.1016/j.advwatres.2007.03.005; Weissmann GS, 1999, WATER RESOUR RES, V35, P1761, DOI 10.1029/1999WR900048; Bennett GL, 2006, GEOL SOC AM BULL, V118, P724, DOI 10.1130/B25774.1; Deutsch C. V., 1998, GSLIB GEOSTATISTICAL; Deutsch CV, 2007, GEOPHYS MONOGR SER, V171, P7, DOI 10.1029/171GM03; Eggleston JR, 1996, WATER RESOUR RES, V32, P1209, DOI 10.1029/96WR00272; Felletti F, 2006, J SEDIMENT RES, V76, P1215, DOI 10.2110/jsr.2006.091; Freeze R. A., 1979, GROUNDWATER; Gelhar L.W., 1993, STOCHASTIC SUBSURFAC; Guin A, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008112; Hu SungGi, 2010, Groundwater response to changing climate, P141; Ingebritsen S, 2006, GROUNDWATER GEOLOGIC; Jiang XW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041251; Jiang XW, 2010, HYDROGEOL J, V18, P839, DOI 10.1007/s10040-010-0575-3; Jiang XW, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042387; Langevin C. D., 2008, TECHNIQUES METHODS, V6, pA22; Major J. J., 1997, ASCE P 1 INT C DEBR, P249; Marion A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006079; NETON MJ, 1994, J SEDIMENT RES B, V64, P245; Nowak M., 2004, GEOSTATISTICS BANFF, P387, DOI [10.1007/978-1-4020-3610-1_39, DOI 10.1007/978-1-4020-3610-1_39]; Rubin Y., 2003, APPL STOCHASTIC HYDR; Rust B. R., 1979, FACIES MODELS, P11; Saar MO, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002855; Sakata Y., 2013, THESIS HOKKAIDO U SA, P112; Sakata Y., 2013, Journal of Water Resource and Protection, V5, P823, DOI 10.4236/jwarp.2013.58083; Sakata Y., 2012, Journal of Japan Society of Hydrology and Water Resources, V25, P89, DOI 10.3178/jjshwr.25.89; Schwartz F.W., 1998, PHYS CHEM HYDROGEOLO; Voss C. L., 1984, 844369 USGS; WANG KL, 1989, GEOPH MONOG SERIES, V47, P7; WOODBURY AD, 1988, WATER RESOUR RES, V24, P356, DOI 10.1029/WR024i003p00356; Yamaguchi Y., 1994, J GROUNDWATER HYDROL, V36, P423	54	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-467X	1745-6584		GROUNDWATER	Groundwater	APR	2015	53			1			21	32		10.1111/gwat.12236		12	Geosciences, Multidisciplinary; Water Resources	Geology; Water Resources	CF7DE	WOS:000352715600004		
J	Kudo, M				Kudo, Masatoshi			Value of dynamic contrast enhanced MRI in predicting outcomes of HCC receiving radiotherapy	HEPATOLOGY INTERNATIONAL			English	Editorial Material							HEPATOCELLULAR-CARCINOMA; GUIDELINES		Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan	Kudo, M (reprint author), Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan.	m-kudo@med.kindai.ac.jp					Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Llovet JM, 2012, J HEPATOL, V56, P908; Kudo Masatoshi, 2014, Liver Cancer, V3, P458, DOI 10.1159/000343875; Lee Dong Soo, 2014, Liver Cancer, V3, P18, DOI 10.1159/000343855; Liang PC, 2014, HEPATOL INT, DOI [10.1007/s12072-014-9557-1, DOI 10.1007/S12072-014-9557-1]	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	APR	2015	9	2					155	156		10.1007/s12072-015-9618-0		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3WQ	WOS:000352480100001		
J	Kawamura, Y; Ikeda, K; Arase, Y; Sorin, Y; Fukushima, T; Kunimoto, H; Hosaka, T; Kobayashi, M; Saitoh, S; Sezaki, H; Akuta, N; Suzuki, F; Suzuki, Y; Kumada, H				Kawamura, Yusuke; Ikeda, Kenji; Arase, Yasuji; Sorin, Yushi; Fukushima, Taito; Kunimoto, Hideo; Hosaka, Tetsuya; Kobayashi, Masahiro; Saitoh, Satoshi; Sezaki, Hitomi; Akuta, Norio; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Kumada, Hiromitsu			New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan	HEPATOLOGY INTERNATIONAL			English	Article						Non-alcoholic fatty liver disease; Discriminant score; Fibrosis	FATTY LIVER-DISEASE; SIMPLE NONINVASIVE INDEX; HEPATOCELLULAR-CARCINOMA; SIGNIFICANT FIBROSIS; METABOLIC SYNDROME; CHRONIC HEPATITIS; BIOPSY; SYSTEM; VALIDATION; MANAGEMENT	Currently, non-alcoholic steatohepatitis (NASH) can only be diagnosed histopathologically. Our objective was to establish a new scoring system for the fibrotic stage of NASH. We enrolled 139 patients with histologically proven NASH and divided them into two groups to construct (n = 90) and validate (n = 49) a fibrotic score for NASH (FSN). We used 17 variables and their natural logarithmic transformations in the multivariate analysis. To assess the accuracy of the FSN in determining NASH advanced fibrosis (stages 3-4), we compared various fibrotic scores for NASH. In the construct group, multivariate regression analysis ultimately obtained the following function: z = 1.022 x ln (type IV collagen 7S) (ng/mL) - 0.00680 x (platelet count) (x10(9)/L) + 1.925 x ln (AST) (IU/L) - 1.239 x ln (ALT) (IU/L) + 0.249. Median values of the FSN for stages 1, 2, 3 and 4 were 1.87, 2.14, 3.26 and 3.89, respectively. The multiple regression coefficient and coefficient of determination were 0.70 and 0.46, respectively. In the validation group, the median value was 2.00, 2.83, 3.08 and 4.37 in each stage. With regard to the utility of the FSN for predicting advanced fibrosis of NASH (stage a parts per thousand yen3), the area under the receiver operating characteristic curves (AUROC), 0.909 (95 % CI 0.847-0.970, p < 0.001), was higher than that for the other fibrotic scores (APRI, NAFLD fibrosis score, FIB-4 index, BARD score, NIKEI) in the construct group. This simple scoring system accurately predicts fibrotic stage and discriminates patients with advanced fibrosis of NASH.	[Kawamura, Yusuke; Ikeda, Kenji; Arase, Yasuji; Sorin, Yushi; Fukushima, Taito; Kunimoto, Hideo; Hosaka, Tetsuya; Kobayashi, Masahiro; Saitoh, Satoshi; Sezaki, Hitomi; Akuta, Norio; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Minato Ku, Tokyo 1058470, Japan; [Kawamura, Yusuke; Ikeda, Kenji; Arase, Yasuji; Sorin, Yushi; Fukushima, Taito; Kunimoto, Hideo; Hosaka, Tetsuya; Kobayashi, Masahiro; Saitoh, Satoshi; Sezaki, Hitomi; Akuta, Norio; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Kumada, Hiromitsu] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo 1058470, Japan	Kawamura, Y (reprint author), Toranomon Gen Hosp, Dept Hepatol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	k-yusuke@toranomon.gr.jp					American Diabetes Association, 2010, DIABETES CARE S1, V33, pS62, DOI DOI 10.2337/DC10-S062; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Kruger FC, 2011, SAMJ S AFR MED J, V101, P477; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Kawamura Y, 2012, AM J GASTROENTEROL, V107, P253, DOI 10.1038/ajg.2011.327; Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6; Ratziu V, 2002, HEPATOLOGY, V35, P1485, DOI 10.1053/jhep.2002.33324; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Demir M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058360	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	APR	2015	9	2					269	277		10.1007/s12072-014-9605-x		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3WQ	WOS:000352480100015		
J	Sato, T; Kondo, F; Ebara, M; Sugiura, N; Okabe, S; Sunaga, M; Yoshikawa, M; Suzuki, E; Ogasawara, S; Shinozaki, Y; Ooka, Y; Chiba, T; Kanai, F; Kishimoto, T; Nakatani, Y; Fukusato, T; Yokosuka, O				Sato, Tsunenobu; Kondo, Fukuo; Ebara, Masaaki; Sugiura, Nobuyuki; Okabe, Shinichiro; Sunaga, Masahiko; Yoshikawa, Masaharu; Suzuki, Eiichiro; Ogasawara, Sadayuki; Shinozaki, Yusuke; Ooka, Yoshihiko; Chiba, Tetsuhiro; Kanai, Fumihiko; Kishimoto, Takashi; Nakatani, Yukio; Fukusato, Toshio; Yokosuka, Osamu			Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study	HEPATOLOGY INTERNATIONAL			English	Article						Large regenerative nodule; Dysplastic nodule; Natural history; Malignant transformation	EARLY HEPATOCELLULAR-CARCINOMA; ADENOMATOUS HYPERPLASIA; HISTOLOGICAL FEATURES; MALIGNANT-TRANSFORMATION; LESIONS	Some follow-up studies of large regenerative nodules (LRNs) and dysplastic nodules (DNs) were reported previously. However, the pre-malignant potentiality of LRNs has remained controversial up to now. No LRNs showed malignant transformation in our previous study. We aimed to evaluate the pre-malignant potentiality of LRNs and DNs with a greater number of cases and longer follow-up periods. From 1982 to 2005, 1,500 consecutive nodular lesions up to 2 cm in diameter were subjected to US guided thin-needle biopsy in cirrhotic patients at Chiba University Hospital. Of these lesions, 68 LRNs in 60 cases and 20 DNs in 22 cases were followed up for more than 6 months without any anti-cancer therapy. The last US examination was in 2010. The total study period was 28 years. We analyzed the histological findings and the clinical data of all cases retrospectively. The outcome of the lesions was examined. The mean follow-up period was 38.9 (16-119) months in LRNs and 31.9 (6-101 months) in DNs. Rate of nodule enlargement was higher in DNs (8/24 nodules, 33 %) than LRNs (11/68 nodules, 16 %), (p = 0.0743, not significant). Rate of malignant transformation was also higher in DNs (10/24 nodules, 42 %) than LRNs (9/68 nodules, 13 %), (p = 0.0040, significant). The rate of disappearance in images was similar between LRNs and DNs. We should recognize LRN as low risk pre-malignant lesions whereas DNs as high risk lesions.	[Sato, Tsunenobu; Yoshikawa, Masaharu; Suzuki, Eiichiro; Ogasawara, Sadayuki; Ooka, Yoshihiko; Chiba, Tetsuhiro; Kanai, Fumihiko; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba, Chiba 2608670, Japan; [Sato, Tsunenobu; Sunaga, Masahiko] Chiba Cent Med Ctr, Dept Gastroenterol, Wakaba Ku, Chiba, Chiba 2640017, Japan; [Kondo, Fukuo] Teikyo Univ Hosp, Dept Pathol, Itabashi Ku, Tokyo 1738606, Japan; [Ebara, Masaaki; Okabe, Shinichiro] Matsudo City Hosp, Dept Gastroenterol, Matsudo, Chiba 2718511, Japan; [Sugiura, Nobuyuki; Shinozaki, Yusuke] Natl Hosp Org Chiba Med Ctr, Dept Internal Med, Chuo Ku, Chiba, Chiba 2608606, Japan; [Kishimoto, Takashi] Chiba Univ, Grad Sch Med, Dept Mol Pathol, Chuo Ku, Chiba, Chiba 2608670, Japan; [Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chuo Ku, Chiba, Chiba 2608670, Japan; [Fukusato, Toshio] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan	Kondo, F (reprint author), Teikyo Univ Hosp, Dept Pathol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738606, Japan.	tsune-sato@cnc.jp; fkondo55@med.teikyo-u.ac.jp; masaaki-ebara@nifty.com; sugiura@nho-chiba.hosp.go.jp; okabeshin1966@yahoo.co.jp; sunaga-m@umin.ac.jp; yoshikawa@faculty.chiba-u.jp; eiichiro0709@hotmail.com; sadahisa@me.com; y-shino@alpha.ocn.ne.jp; ooka-y@umin.ac.jp; techiba@faculty.chiba-u.jp; kanaif@faculty.chiba-u.jp; tkishi@faculty.chiba-u.jp; nakatani@faculty.chiba-u.jp; fukusato@med.teikyo-u.ac.jp; yokosukao@faculty.chiba-u.jp			Vehicle Racing Commemorative Foundation	This study (Fukuo Kondo) was supported in part by the grants from The Vehicle Racing Commemorative Foundation.	TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; Kobayashi M, 2006, CANCER, V106, P636, DOI 10.1002/cncr.21607; Kondo F, 2009, HEPATOL INT, V3, P283, DOI 10.1007/s12072-008-9107-9; Borzio M, 2003, J HEPATOL, V39, P208, DOI 10.1016/S0168-8278(03)00190-9; EBARA M, 1986, GASTROENTEROLOGY, V90, P289; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; WANLESS IR, 1995, HEPATOLOGY, V22, P983, DOI 10.1002/hep.1840220341; KONDO F, 1990, HEPATOLOGY, V12, P592, DOI 10.1002/hep.1840120324; LENCIONI R, 1994, ITAL J GASTROENTEROL, V26, P163; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST; RAPACCINI GL, 1990, DIGEST DIS SCI, V35, P422, DOI 10.1007/BF01536913; Sakamoto M, 1998, JPN J CLIN ONCOL, V28, P604, DOI 10.1093/jjco/28.10.604; Seki S, 2000, CLIN CANCER RES, V6, P3469; Terasaki S, 1998, GASTROENTEROLOGY, V115, P1216, DOI 10.1016/S0016-5085(98)70093-9; Theise ND, 2010, WHO CLASSIFICATION T, P205	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	APR	2015	9	2					330	336		10.1007/s12072-015-9620-6		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3WQ	WOS:000352480100022		
J	Watanabe, S; Hashimoto, E; Ikejima, K; Uto, H; Ono, M; Sumida, Y; Seike, M; Takei, Y; Takehara, T; Tokushige, K; Nakajima, A; Yoneda, M; Saibara, T; Shiota, G; Sakaida, I; Nakamuta, M; Mizuta, T; Tsubouchi, H; Sugano, K; Shimosegawa, T				Watanabe, Sumio; Hashimoto, Etsuko; Ikejima, Kenichi; Uto, Hirofumi; Ono, Masafumi; Sumida, Yoshio; Seike, Masataka; Takei, Yoshiyuki; Takehara, Tetsuo; Tokushige, Katsutoshi; Nakajima, Atsushi; Yoneda, Masashi; Saibara, Toshiji; Shiota, Goshi; Sakaida, Isao; Nakamuta, Makoto; Mizuta, Toshihiko; Tsubouchi, Hirohito; Sugano, Kentaro; Shimosegawa, Tooru			Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis	HEPATOLOGY RESEARCH			English	Article						NAFLD; NASH Guideline; treatment	PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; II RECEPTOR ANTAGONIST; TERM-FOLLOW-UP; JAPANESE PATIENTS; HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; NATURAL-HISTORY; RISK-FACTORS; LONG-TERM	Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a serious public health issue not only in Western countries but also in many Asian countries including Japan. Within the wide spectrum of NAFLD, non-alcoholic steatohepatitis (NASH) is a progressive form of disease, which often develops into liver cirrhosis and increases the risk of hepatocellular carcinoma. In turn, a large proportion of NAFLD/NASH is the liver manifestation of metabolic syndrome, suggesting that NAFLD/NASH plays a key role in the pathogenesis of systemic atherosclerotic diseases. Currently, a definite diagnosis of NASH requires liver biopsy, though various non-invasive measures are under development. The mainstays of prevention and treatment of NAFLD/NASH include dietary restriction and exercise; however, pharmacological approaches are often necessary. Currently, vitamin E and thiazolidinedione derivatives are the most evidence-based therapeutic options, although the clinical evidence for long-term efficacy and safety is limited. This practice guideline for NAFLD/NASH, established by the Japanese Society of Gastroenterology in cooperation with The Japan Society of Hepatology, covers lines of clinical evidence reported internationally in the period starting from 1983 through January 2012, and each clinical question was evaluated using the GRADE system. Based on the primary release of the full version in Japanese, this English summary provides the core essentials of this clinical practice guideline comprising the definition, diagnosis, and current therapeutic recommendations for NAFLD/NASH in Japan.	[Watanabe, Sumio] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan; [Hashimoto, Etsuko] Tokyo Womens Med Univ, Dept Med & Gastroenterol, Tokyo, Japan; [Saibara, Toshiji] Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan; [Shiota, Goshi] Tottori Univ, Fac Med, Dept Genet Med & Regenerat Therapeut, Tottori, Japan; [Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan; [Sugano, Kentaro] Jichi Med Univ, Shimotsuke, Tochigi, Japan	Watanabe, S (reprint author), Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan.	sumio@juntendo.ac.jp			JSGE	THIS ARTICLE WAS supported by a Grant-in-Aid from the JSGE. The authors thank R. F. Whittier (Mitsui Plant Biotechnology Research Institute) for critical reading of the manuscript and thoughtful discussions and Kazuyoshi Kon (Juntendo University) for great assistance with manuscript preparation. The authors also express special appreciation to Shunhei Yamashina, Reiko Yaginuma, Kyoko Fukuhara, Akira Uchiyama, Tomonori Aoyama (Juntendo University), Seiichi Mawatari, Kohei Oda, Kazuaki Tabu (Kagoshima University), Takeshi Okanoue (Saiseikai Suita Hospital), Naoki Fujita, Motoo Iwasa, Kazushi Sugimoto (Mie University), Takuya Miyagi, Yoshihiro Kamada (Osaka University), Takaomi Kessoku, Wataru Tomeno, Kento Imajo, Masato Yoneda, Yuji Ogawa (Yokohama City University), Haruhisa Nakao, Kiyoaki Ito, Ken Sato and Yukiomi Nakade (Aichi Medical University).	Amarapurkar Deepak N, 2004, Trop Gastroenterol, V25, P130; Angelicos F, 2007, COCHRANE DB SYST REV, V24, P31; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Nobili V, 2007, DIABETES CARE, V30, P2638, DOI 10.2337/dc07-0281; Fujita N, 2009, CANCER EPIDEM BIOMAR, V18, P424, DOI 10.1158/1055-9965.EPI-08-0725; Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Zein CO, 2011, HEPATOLOGY, V54, P1610, DOI 10.1002/hep.24544; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Kaneda H, 2006, J GASTROEN HEPATOL, V21, P1459, DOI 10.1111/j.1440-1746.2006.04447.x; Lavine JE, 2000, J PEDIATR-US, V136, P734, DOI 10.1067/mpd.2000.106566; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; Farrell GC, 2002, SEMIN LIVER DIS, V22, P185, DOI 10.1055/s-2002-30106; Mencin AA, 2011, CURR OPIN CLIN NUTR, V14, P151, DOI 10.1097/MCO.0b013e328342baec; Roldan-Valadez E, 2008, ANN HEPATOL, V7, P212; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Bellentani S, 2000, ANN INTERN MED, V132, P112; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Georgescu EF, 2009, WORLD J GASTROENTERO, V15, P942, DOI 10.3748/wjg.15.942; Ekstedt M, 2007, J HEPATOL, V47, P135, DOI 10.1016/j.jhep.2007.02.013; Boettcher E, 2012, ALIMENT PHARM THER, V35, P66, DOI 10.1111/j.1365-2036.2011.04912.x; Wang RT, 2003, AM J MED, V115, P554, DOI 10.1016/S0002-9343(03)00449-2; Baranova A, 2011, ALIMENT PHARM THER, V33, P801, DOI 10.1111/j.1365-2036.2011.04579.x; Angulo P, 2007, ALIMENT PHARM THERAP, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6; Yokohama S, 2006, WORLD J GASTROENTERO, V12, P322; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Facchini FS, 2002, GASTROENTEROLOGY, V122, P931, DOI 10.1053/gast.2002.32403; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Evans CDJ, 2002, J CLIN PATHOL, V55, P689, DOI 10.1136/jcp.55.9.689; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Foster T, 2011, AM J GASTROENTEROL, V106, P71, DOI 10.1038/ajg.2010.299; Tokushige K, 2007, J HEPATOL, V46, P1104, DOI 10.1016/j.jhep.2007.01.028; Yatsuji S, 2007, HEPATOL RES, V37, P1034, DOI 10.1111/j.1872-034X.2007.00156.x; Targher G, 2008, CLIN ENDOCRINOL, V68, P481, DOI 10.1111/j.1365-2265.2007.03068.x; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1016/0270-9139(95)90196-5; Michitaka K, 2010, J GASTROENTEROL, V45, P86, DOI 10.1007/s00535-009-0128-5; Yokohama S, 2004, HEPATOLOGY, V40, P1222, DOI 10.1002/hep.20420; Haukeland JW, 2009, SCAND J GASTROENTERO, V44, P853, DOI 10.1080/00365520902845268; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Dam-Larsen S, 2009, SCAND J GASTROENTERO, V44, P1236, DOI 10.1080/00365520903171284; Abdelmalek MF, 2009, HEPATOLOGY, V50, P1818, DOI 10.1002/hep.23239; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Yalamanchili K, 2010, LIVER TRANSPLANT, V16, P431, DOI 10.1002/lt.22004; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Tokushige K, 2008, INTERNAL MED, V47, P405, DOI 10.2169/internalmedicine.47.0476; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Hashimoto E, 2011, J GASTROENTEROL, V46, P63, DOI 10.1007/s00535-010-0311-8; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Hyogo H, 2008, METABOLISM, V57, P1711, DOI 10.1016/j.metabol.2008.07.030; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Socha P, 2009, J PEDIATR GASTR NUTR, V48, P587, DOI 10.1097/MPG.0b013e31818e04d1; Loomba R, 2009, HEPATOLOGY, V50, P1282, DOI 10.1002/hep.23119; Shyangdan D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15380; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579; Mummadi RR, 2008, CLIN GASTROENTEROL H, V6, P1396, DOI 10.1016/j.cgh.2008.08.012; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Adams LA, 2004, HEPATOLOGY, V39, P909, DOI 10.1002/hep.20140; Yoneda M, 2008, DIGEST LIVER DIS, V40, P371, DOI 10.1016/j.dld.2007.10.019; Malik SM, 2009, AM J TRANSPLANT, V9, P782, DOI 10.1111/j.1600-6143.2009.02590.x; Chan HLY, 2007, J GASTROEN HEPATOL, V22, P801, DOI 10.1111/j.1440-1746.2007.04977.x; Harrison SA, 2002, AM J GASTROENTEROL, V97, P2714; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Leuschner UFH, 2010, HEPATOLOGY, V52, P472, DOI 10.1002/hep.23727; Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024; Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Athyros VG, 2006, CURR MED RES OPIN, V22, P873, DOI 10.1185/030079906X104696; Radu C, 2008, J GASTROINTEST LIVER, V17, P255; Tokushige K, 2010, J GASTROENTEROL, V45, P960, DOI 10.1007/s00535-010-0237-1; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Ratziu V, 2011, J HEPATOL, V54, P1011, DOI 10.1016/j.jhep.2010.08.030; Bellentani S, 1997, GUT, V41, P845; Bhagat V, 2009, LIVER TRANSPLANT, V15, P1814, DOI 10.1002/lt.21927; Bhatt SP, 2012, DIABETES TECHNOL THE, V14, P828, DOI 10.1089/dia.2011.0277; Days CP, 1998, GASTROENTEROLOGY, V114, P842; Dureja P, 2011, TRANSPLANTATION, V91, P684, DOI 10.1097/TP.0b013e31820b6b84; Eguchis Y, 2012, J GASTROENTEROL, V47, P586; Enjoji M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-29; Fargion S, 2005, ALIMENT PHARM THERAP, V22, P61, DOI 10.1111/j.1365-2036.2005.02599.x; Guha IN, 2006, GUT, V55, P1650, DOI 10.1136/gut.2006.091454; Hasegawa T, 2001, ALIMENT PHARM THERAP, V15, P1667, DOI 10.1046/j.1365-2036.2001.01083.x; Hashizume H, 2007, EUR J GASTROEN HEPAT, V19, P827; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; Hous XH, 2011, J GASTROEN HEPATOL, V26, P722; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Komeda T, 2005, HEPATOL RES, V33, P83, DOI 10.1016/j.hepres.2005.09.009; Lis W, 2011, LIPIDS HLTH DIS, V10, P49; Loria P, 2009, NAT REV GASTRO HEPAT, V6, P236, DOI 10.1038/nrgastro.2009.33; Mahadys SE, 2011, HEPATOLOGY, V55, P1383; Mostafa SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050931; Nars A, 2009, ACTA DIABETOL, V46, P113; Nobili Valerio, 2008, Pediatr Endocrinol Rev, V6, P241; Obara N, 2008, J GASTROENTEROL, V43, P720, DOI 10.1007/s00535-008-2225-2; Okanoues T, 2009, KANZO, V50, P741; Park H, 2010, CLIN CHIM ACTA, V411, P1735, DOI 10.1016/j.cca.2010.07.012; Rakoski MO, 2010, ALIMENT PHARM THER, V32, P1211, DOI 10.1111/j.1365-2036.2010.04467.x; Riquelme A, 2004, DIGEST DIS SCI, V49, P1012, DOI 10.1023/B:DDAS.0000034564.68307.39; Samy Waleed, 2011, Arab J Gastroenterol, V12, P80, DOI 10.1016/j.ajg.2011.04.008; Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sofer E, 2011, METABOLISM, V60, P1278, DOI 10.1016/j.metabol.2011.01.011; Sorensen HT, 2003, J CLIN GASTROENTEROL, V36, P356; Sumida Y, 2006, HEPATOL RES, V36, P315, DOI 10.1016/j.hepres.2006.08.003; Tanaka N, 2011, J GASTROENTEROL, V46, P758, DOI 10.1007/s00535-011-0370-5; Thameem F, 2012, DIABETES, V61, P2385, DOI 10.2337/db11-1078; Tokushige K, 2011, J GASTROENTEROL, V46, P1230, DOI 10.1007/s00535-011-0431-9; van ders Heijdens GJ, 2010, HISPANIC ADOLESCENTS, V18, P384; Van Wagner LB, 2011, ANN HEPATOL, V10, P277; Yoneda M, 2010, HEPATOL RES, V40, P566, DOI 10.1111/j.1872-034X.2010.00644.x; Yoshioka Y, 2004, J GASTROENTEROL, V39, P1215, DOI 10.1007/s00535-004-1475-x	132	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					363	377		10.1111/hepr.12511		15	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900001		
J	Kimura, T; Aikata, H; Takahashi, S; Takahashi, I; Nishibuchi, I; Doi, Y; Kenjo, M; Murakami, Y; Honda, Y; Kakizawa, H; Awai, K; Chayama, K; Nagata, Y				Kimura, Tomoki; Aikata, Hiroshi; Takahashi, Shigeo; Takahashi, Ippei; Nishibuchi, Ikuno; Doi, Yoshiko; Kenjo, Masahiro; Murakami, Yuji; Honda, Yohji; Kakizawa, Hideaki; Awai, Kazuo; Chayama, Kazuaki; Nagata, Yasushi			Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies	HEPATOLOGY RESEARCH			English	Article						hepatocellular carcinoma; stereotactic body radiotherapy; transarterial chemoembolization	RADIATION-THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-CANCER; GUIDELINES; TRIALS	AimTo evaluate the efficacy and safety of stereotactic body radiotherapy (SBRT) in patients with small hepatocellular carcinoma (HCC) who were ineligible for resection or ablation therapies. MethodsOverall, 65 patients with 74 HCC (median tumor size, 16mm) were enrolled. They were treated at the prescribed dose of 48Gy in four fractions at the isocenter. Child-Turcotte-Pugh (CTP) scoring was used to classify 56 and nine patients into classes A and B, respectively. Local progression was defined as irradiated tumor growth on a dynamic computed tomography follow up. The median follow-up period was 26 months. Tumor responses were assessed according to the modified Response Evaluation Criteria in Solid Tumors. Treatment-related toxicities were evaluated according to the Common Terminology Criteria for Adverse Events version 4.0. ResultsThe 2-year overall survival, progression-free survival and local control rates were 76.0% (95% confidence interval [CI], 65.4-86.7%), 40.0% (95% CI, 27.6-52.3%) and 100% (95% CI, 100%), respectively. At 6-12 months after SBRT, grade 3 or higher toxicities was observed in 15 (23.1%) patients. The incidence of grade 3 or higher toxicities was higher in CTP class B than in class A (P=0.0127). ConclusionSBRT was effective and relatively safe for patients with small HCC who were ineligible for resection or ablation therapies.	[Aikata, Hiroshi; Honda, Yohji; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Div Frontier Med Sci,Programs Biomed Res, Hiroshima 7348551, Japan; [Kimura, Tomoki; Takahashi, Shigeo; Takahashi, Ippei; Nishibuchi, Ikuno; Doi, Yoshiko; Kenjo, Masahiro; Murakami, Yuji; Nagata, Yasushi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Radiat Oncol, Hiroshima 7348551, Japan; [Kakizawa, Hideaki; Awai, Kazuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima 7348551, Japan; [Takahashi, Shigeo] Kagawa Univ Hosp, Dept Radiat Oncol, Kita, Kagawa, Japan	Kimura, T (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Radiat Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	tkkimura@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22591385]	THIS WORK WAS supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant no. 22591385).	Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Tateishi R, 2005, CANCER, V103, P1201, DOI 10.1002/cncr.20892; Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Kang JK, 2012, CANCER-AM CANCER SOC, V118, P5424, DOI 10.1002/cncr.27533; [Anonymous], 2012, J HEPATOL, V56, P908; Miyayama S, 2007, J VASC INTERV RADIOL, V18, P365, DOI 10.1016/j.jvir.2006.12.004; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Andolino DL, 2011, INT J RADIAT ONCOL, V81, pE447, DOI 10.1016/j.ijrobp.2011.04.011; Bujold A, 2013, J CLIN ONCOL, V31, P1631, DOI 10.1200/JCO.2012.44.1659; Dawson LA, 2011, SEMIN RADIAT ONCOL, V21, P241, DOI 10.1016/j.semradonc.2011.05.009; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Bensons AB, NCCN CLIN PRACTICE G; Kudos M, 2010, KANZO, V51, P460; Kwon JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-475; Lees IJ, 2009, INT J RADIAT ONCOL, V73, P154; National Cancer Center Center for Cancer Control and Information Services, 2009, LAT CANC STAT; Pans CC, 2010, INT J RADIAT ONCOL, V76, pS94; Sanukis N, 2014, ACTA ONCOL, V58, P399; Takayasu K, 2012, J HEPATOL, V56, P886, DOI 10.1016/j.jhep.2011.10.021	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					378	386		10.1111/hepr.12359		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900002		
J	Abe, H; Tsubota, A; Shimada, N; Atsukawa, M; Kato, K; Takaguchi, K; Asano, T; Chuganji, Y; Sakamoto, C; Toyoda, H; Kumada, T; Ide, T; Sata, M; Aizawa, Y				Abe, Hiroshi; Tsubota, Akihito; Shimada, Noritomo; Atsukawa, Masanori; Kato, Keizo; Takaguchi, Koichi; Asano, Toru; Chuganji, Yoshimichi; Sakamoto, Choitsu; Toyoda, Hidenori; Kumada, Takashi; Ide, Tatsuya; Sata, Michio; Aizawa, Yoshio			Factors associated with sustained virological response in 24-week telaprevir-based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype	HEPATOLOGY RESEARCH			English	Article						fasting low-density lipoprotein cholesterol; hepatitis C virus; IL28B minor genotype; peginterferon; ribavirin; telaprevir	DENSITY-LIPOPROTEIN CHOLESTEROL; CHRONIC HCV INFECTION; COMBINATION THERAPY; PEGINTERFERON ALPHA-2B; PEGYLATED INTERFERON; RIBAVIRIN THERAPY; VIRUS; POLYMORPHISMS; RETREATMENT; VARIANTS	AimSingle nucleotide polymorphisms (SNP) near the interleukin-28B (IL28B) gene affect the outcome of 24-week telaprevir-based triple therapy with telaprevir, pegylated interferon- and ribavirin for chronic hepatitis C virus (HCV) genotype 1b patients. We aimed to identify factors associated with treatment outcomes in patients with the unfavorable minor IL28B SNP genotype, who have poor response to combination therapy. MethodsPretreatment and on-treatment factors associated with sustained virological response (SVR) for 24-week telaprevir-based triple therapy were analyzed using multiple logistic regression analysis in 106 HCV genotype 1b patients with the minor IL28B SNP rs8099917 genotype (non-TT). ResultsOf the 106 non-TT patients, 62 (58.5%) achieved SVR. Of the 44 remaining patients, 22 experienced relapse, 13 experienced viral breakthrough and nine were non-responders. Pretreatment factors such as treatment-naive/prior treatment response (P=0.0041), high fasting serum low-density lipoprotein cholesterol (LDL-C) concentration (P=0.0068) and low serum HCV RNA levels (P=0.0088) were significantly and independently associated with SVR. On-treatment factors such as achievement of rapid virological response (RVR) were significantly and independently associated with SVR (P=0.0001). For both pre- and on-treatment factors, treatment-naive/prior treatment response (P=0.0018), low pretreatment serum fasting LDL-C (P=0.0062) and achieving RVR (P=0.0021) were significantly and independently associated with SVR. ConclusionIn HCV genotype 1b patients with the minor IL28B SNP rs8099917 genotype, evaluating prior treatment response and achieving RVR and pretreatment serum fasting LDL-C concentrations were useful for predicting SVR achievement after 24-week telaprevir-based triple therapy.	[Abe, Hiroshi; Aizawa, Yoshio] Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Katsushika Med Ctr, Tokyo 1258506, Japan; [Asano, Toru; Chuganji, Yoshimichi] Tokyo Metropolitan Bokutoh Hosp, Dept Gastroenterol, Tokyo, Japan; [Sakamoto, Choitsu] Nippon Med Sch, Grad Sch Med, Dept Gastroenterol, Tokyo 113, Japan; [Tsubota, Akihito] Jikei Univ, Sch Med, Inst Clin Med & Res, Kashiwa, Chiba, Japan; [Shimada, Noritomo; Kato, Keizo] Shinmatsudo Cent Gen Hosp, Dept Gastroenterol & Hepatol, Matsudo, Chiba, Japan; [Atsukawa, Masanori] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Inzai City, Japan; [Takaguchi, Koichi] Kagawa Prefectural Cent Hosp, Dept Hepatol, Takamatsu, Kagawa, Japan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan; [Ide, Tatsuya; Sata, Michio] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka 830, Japan	Abe, H (reprint author), Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Katsushika Med Ctr,Katsushika Ku, 6-41-2 Aoto, Tokyo 1258506, Japan.	hiroshiabe222@aol.com			Merck Sharp & Dohme (MSD), Tokyo, Japan; Tanabe Mitsubishi Pharma, Osaka, Japan	Yoshio Aizawa received grants from Merck Sharp & Dohme (MSD), Tokyo, Japan, and Tanabe Mitsubishi Pharma, Osaka, Japan. Masanori Atsukawa received grants from Merck Sharp & Dohme (MSD), Tokyo, Japan, and Tanabe Mitsubishi Pharma, Osaka, Japan.	Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Clark PJ, 2012, J VIRAL HEPATITIS, V19, P332, DOI 10.1111/j.1365-2893.2011.01553.x; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Ramcharran D, 2010, HEPATOLOGY, V52, P854, DOI 10.1002/hep.23796; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Simmonds P, 1996, J GEN VIROL, V77, P3013, DOI 10.1099/0022-1317-77-12-3013; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Tsubota A, 2014, J GASTROEN HEPATOL, V29, P144, DOI 10.1111/jgh.12402; OKAMOTO H, 1992, J GEN VIROL, V73, P673, DOI 10.1099/0022-1317-73-3-673; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Ges D, 2009, NATURE, V461, P399; Harrison SA, 2010, HEPATOLOGY, V52, P864, DOI 10.1002/hep.23787; Muir AJ, 2011, HEPATOLOGY, V54, P1538, DOI 10.1002/hep.24549; Pols S, 2013, J HEPATOL, V58, P883; Suzuki F, 2013, HEPATOL RES, V43, P691, DOI 10.1111/hepr.12009; TELAVIC. Health Labour and Welfare Ministry, 2011, PROP US GUID TEL PRO; Tsubota A, 2012, LIVER INT, V32, P826, DOI 10.1111/j.1478-3231.2011.02727.x; Wais CT, 2003, HEPATOLOGY, V38, P518; World Health Organization, 2013, HEP C	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					387	396		10.1111/hepr.12360		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900003		
J	Sato, M; Hikita, H; Hagiwara, S; Sato, M; Soroida, Y; Suzuki, A; Gotoh, H; Iwai, T; Kojima, S; Matsuura, T; Yotsuyanagi, H; Koike, K; Yatomi, Y; Ikeda, H				Sato, Masaya; Hikita, Hiromi; Hagiwara, Shu; Sato, Mamiko; Soroida, Yoko; Suzuki, Atsushi; Gotoh, Hiroaki; Iwai, Tomomi; Kojima, Soichi; Matsuura, Tomokazu; Yotsuyanagi, Hiroshi; Koike, Kazuhiko; Yatomi, Yutaka; Ikeda, Hitoshi			Potential associations between perihepatic lymph node enlargement and liver fibrosis, hepatocellular injury or hepatocarcinogenesis in chronic hepatitis B virus infection	HEPATOLOGY RESEARCH			English	Article						fibrosis; hepatitis B; immune response; inflammatory activity; perihepatic lymph node enlargement	ABDOMINAL LYMPHADENOPATHY; EXTRAHEPATIC MANIFESTATIONS; ULTRASOUND DETECTION; C PATIENTS; INTERFERON; DISEASE; CANCER; CRYOGLOBULINEMIA; PREVALENCE; CARCINOMA	AimAlthough perihepatic lymph node enlargement (PLNE) is frequently observed in chronic liver disease, little is known about PLNE in chronic hepatitis B virus (HBV) infection. We aimed to evaluate this issue. MethodsWe originally enrolled a consecutive 502 patients with chronic HBV infection. Among them, 288 patients without history of interferon-based or nucleoside analog treatment and hepatocellular carcinoma (HCC) were primarily analyzed. ResultsPLNE was detected in 27 of 288 (9.4%) patients, which was fewer than that in chronic hepatitis C patients but more than that in subjects undertaking a general health examination as previously reported. The presence of PLNE was significantly associated with a higher probability of having an aspartate aminotransferase (AST) platelet ratio index of more than 1.5 (11.1% vs 1.5%, P=0.01), a higher AST level (38.0 vs 26.8U/L, P=0.001), a higher alanine aminotransferase level (50.1 vs 28.0U/L, P<0.0001), and a lower platelet count (18.6 vs 20.6x10(4)/L, P=0.048) after adjustment for sex and age. However, in our original sample (n=502), PLNE was observed in 1.4% of the patients with HCC and/or its history whereas 9.2% of the patients without HCC, and the proportion was significantly lower in patients with HCC and/or its history (P=0.03). ConclusionPLNE was associated with liver fibrosis and hepatocellular injury, but was negatively associated with HCC in chronic HBV infection.	[Sato, Masaya; Hikita, Hiromi; Hagiwara, Shu; Sato, Mamiko; Soroida, Yoko; Suzuki, Atsushi; Gotoh, Hiroaki; Iwai, Tomomi; Yatomi, Yutaka; Ikeda, Hitoshi] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo 1138655, Japan; [Sato, Masaya; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Yotsuyanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Infect Dis, Tokyo 1138655, Japan; [Matsuura, Tomokazu] Jikei Univ, Sch Med, Dept Lab Med, Tokyo, Japan; [Kojima, Soichi] RIKEN Ctr Life Sci Technol, Regulat Technol Unit, Wako, Saitama, Japan	Ikeda, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ikeda-1im@h.u-tokyo.ac.jp					Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gast.2004.09.014; AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Muller P, 2003, J HEPATOL, V39, P807, DOI 10.1016/S0168-8278(03)00357-X; Watanabe T, 2005, EUR J GASTROEN HEPAT, V17, P185, DOI 10.1097/00042737-200502000-00009; Trepo C, 2001, J AUTOIMMUN, V16, P269, DOI 10.1006/jaut.2000.0502; Cassani F, 1997, J HEPATOL, V26, P479, DOI 10.1016/S0168-8278(97)80410-2; CASSANI F, 1990, J CLIN GASTROENTEROL, V12, P42, DOI 10.1097/00004836-199002000-00012; Marazuela M, 1996, CLIN ENDOCRINOL, V44, P635, DOI 10.1046/j.1365-2265.1996.751768.x; Soresi M, 2003, CLIN RADIOL, V58, P372, DOI 10.1016/S0009-9260(03)00055-2; MISIANI R, 1992, ANN INTERN MED, V117, P573; Soresi M, 1998, J HEPATOL, V28, P544, DOI 10.1016/S0168-8278(98)80276-6; TRAN A, 1993, HEPATOLOGY, V18, P253, DOI 10.1016/0270-9139(93)90004-7; Stibbe KJM, 2011, SCAND J GASTROENTERO, V46, P962, DOI 10.3109/00365521.2011.574725; Soresi M, 1999, AM J GASTROENTEROL, V94, P497; Bertoletti A, 2003, HEPATOLOGY, V38, P4, DOI 10.1053/jhep.2003.50310; Gotoh H, 2013, HEPATOL RES, V43, P906, DOI 10.1111/hepr.12029; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Hikita H, 2013, J GASTROENTEROL, V48, P366, DOI 10.1007/s00535-012-0635-7; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Zhang XM, 2002, AM J ROENTGENOL, V179, P417; Cacoub P, 2000, MEDICINE, V79, P47, DOI 10.1097/00005792-200001000-00005; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Hikita H, 2013, HEPATOL RES, V43, P1005, DOI 10.1111/hepr.12061; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; dels Olmos JA, 2002, ULTRASOUND MED BIOL, V28, P297; Dienstag J L, 1981, Semin Liver Dis, V1, P45, DOI 10.1055/s-2008-1063929; Dietrich Christoph Frank, 1997, Hepatology, V26, P467, DOI 10.1002/hep.510260230; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; HADDAD J, 1992, LANCET, V339, P321, DOI 10.1016/0140-6736(92)91645-O; JOHNSON RJ, 1993, NEW ENGL J MED, V328, P465, DOI 10.1056/NEJM199302183280703; Khan Dilshad Ahmad, 2008, J Ayub Med Coll Abbottabad, V20, P122; Moonka D, 2008, J VIROL, V82, P11742, DOI 10.1128/JVI.01130-08; Tavakoli-Tabasi S, 2011, DIGEST DIS SCI, V56, P2137, DOI 10.1007/s10620-010-1555-0; Wais CT, 2003, HEPATOLOGY, V38, P518	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					397	404		10.1111/hepr.12361		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900004		
J	Mikami, S; Tateishi, R; Hagiwara, S; Sato, M; Minami, T; Uchino, K; Enooku, K; Sato, T; Nakagawa, H; Masuzaki, R; Asaoka, Y; Kondo, Y; Shiina, S; Ikeda, H; Omata, M; Yoshida, H; Koike, K				Mikami, Shintaro; Tateishi, Ryosuke; Hagiwara, Shu; Sato, Masaya; Minami, Tatsuya; Uchino, Koji; Enooku, Kenichiro; Sato, Takahisa; Nakagawa, Hayato; Masuzaki, Ryota; Asaoka, Yoshinari; Kondo, Yuji; Shiina, Shuichiro; Ikeda, Hitoshi; Omata, Masao; Yoshida, Haruhiko; Koike, Kazuhiko			Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography	HEPATOLOGY RESEARCH			English	Article						hepatocellular carcinoma; surveillance; tumor marker; ultrasonography	VIRUS-RELATED CIRRHOSIS; FATTY LIVER-DISEASE; RISK-FACTORS; HEPATITIS; METAANALYSIS; RECURRENCE; ULTRASOUND; RESECTION; ABLATION; OUTCOMES	AimThe objectives of this study was to evaluate the utility of tumor markers in hepatocellular carcinoma (HCC) surveillance based on the reliability of ultrasonography. MethodsWe analyzed 313 patients with HCC detected through a surveillance program using ultrasonography combined with three tumor markers from February 2000 to December 2010. The patients were categorized into two groups based on the triggering event: the US group (n=281) in which a tumor was first detected using ultrasonography and the TM group (n=32) in which elevated tumor markers led to the diagnosis of a tumor that was undetected using ultrasonography. The reliability of ultrasonography was scored on a 4-point scale based on three items (coarseness of liver parenchyma, patient obesity and liver atrophy). Additionally, patient survival was assessed using the Kaplan-Meier method and log-rank test. ResultsThe median tumor size was 20mm (interquartile range, 15-24). The reliability of ultrasonography was evaluated as good in 208 (66.5%), satisfactory in 80 (8.0%), poor in 21 (6.7%) and unsatisfactory in four (1.2%) patients. The proportion of patients in the TM group increased significantly according to the score, from 7.2% to 25.0% (P=0.01). The survival rates of patients at 3 and 5years were 83.7% and 57.2% in the US group, and 79.3% and 59.4% in the TM group, respectively (P=0.98). ConclusionTumor markers may play a diagnostic role in patients with unreliable ultrasonography results. The survival of patients diagnosed by elevated tumor markers was not significantly different from those diagnosed by ultrasonography.	[Mikami, Shintaro; Tateishi, Ryosuke; Minami, Tatsuya; Uchino, Koji; Enooku, Kenichiro; Nakagawa, Hayato; Masuzaki, Ryota; Asaoka, Yoshinari; Kondo, Yuji; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Hagiwara, Shu; Sato, Masaya; Ikeda, Hitoshi] Tokyo Univ Hosp, Dept Clin Lab Med, Tokyo 113, Japan; [Sato, Takahisa; Shiina, Shuichiro] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan; [Omata, Masao] Yamanashi Prefectural Hosp Org, Kofu, Yamanashi, Japan	Tateishi, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tateishi-tky@umin.ac.jp	Nakagawa, Hayato/I-2837-2012		Health Sciences Research Grants of the Ministry of Health, Labor and Welfare of Japan (Research on Hepatitis)	This work was supported partly by Health Sciences Research Grants of the Ministry of Health, Labor and Welfare of Japan (Research on Hepatitis).	Toshikuni N, 2009, J GASTROEN HEPATOL, V24, P1276, DOI 10.1111/j.1440-1746.2009.05851.x; BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Nishiura T, 2005, BRIT J RADIOL, V78, P189, DOI 10.1259/bjr/75208448; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gast.2004.09.014; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Wong JSW, 2011, ALIMENT PHARM THER, V33, P1104, DOI 10.1111/j.1365-2036.2011.04634.x; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Singal AK, 2010, ALIMENT PHARM THER, V32, P851, DOI 10.1111/j.1365-2036.2010.04414.x; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x; Sato T, 2009, HEPATOL INT, V3, P544, DOI 10.1007/s12072-009-9145-y; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; Torzilli G, 1999, HEPATOLOGY, V30, P889, DOI 10.1002/hep.510300411; Tateishi R, 2006, HEPATOLOGY, V44, P1518, DOI 10.1002/hep.21408; Hashimoto E, 2005, HEPATOL RES, V33, P72, DOI 10.1016/j.hepres.2005.09.007; BEASLEY RP, 1981, LANCET, V2, P1129; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Montano-Loza AJ, 2008, AM J GASTROENTEROL, V103, P1944, DOI 10.1111/j.1572-0241.2008.01922.x; Caballeria L, 2001, AM J GASTROENTEROL, V96, P1160; Llovet JM, 2012, J HEPATOL, V56, P908; Giannini EG, 2012, HEPATOLOGY, V56, P1371, DOI 10.1002/hep.25814; Ikedas K, 1993, CANCER, V1, P19; Loks AS, 2010, GASTROENTEROLOGY, V138, P493; The committee for revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, 2010, HEPATOL RES, V40, P16; Yoshizawa Hiroshi, 2006, Intervirology, V49, P7, DOI 10.1159/000087257	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					415	422		10.1111/hepr.12365		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900006		
J	Nishigaki, Y; Hayashi, H; Tomita, E; Suzuki, Y; Watanabe, N; Watanabe, S; Watanabe, C; Takagi, Y; Kato, T; Naiki, T				Nishigaki, Yoichi; Hayashi, Hideki; Tomita, Eiichi; Suzuki, Yusuke; Watanabe, Naoki; Watanabe, Satoshi; Watanabe, Chiaki; Takagi, Yui; Kato, Tomohiro; Naiki, Takafumi			Usefulness of contrast-enhanced ultrasonography using Sonazoid for the assessment of therapeutic response to percutaneous radiofrequency ablation for hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Article						contrast-enhanced ultrasonography; hepatocellular carcinoma; radiofrequency ablation; Sonazoid; treatment assessment	FOCAL LIVER-LESIONS; B-MODE SONOGRAPHY; PROGNOSTIC-FACTORS; HARMONIC SONOGRAPHY; LOCAL RECURRENCE; ULTRASOUND; CIRRHOSIS; CANCER; PHASE; TRIAL	AimAccurate assessment of the coagulated area is imperative to achieve an excellent outcome from percutaneous radiofrequency ablation (PRFA) for the treatment of hepatocellular carcinoma (HCC). We evaluated the efficacy of contrast-enhanced ultrasonography (CEUS) with the contrast-enhancing agent Sonazoid for precisely assessing the therapeutic effect of PRFA for HCC. MethodsWe enrolled 87 consecutive patients with solitary naive HCC of less than 3cm in diameter. PRFA treatment was performed with a 17-G cool-tip needle, and CEUS was performed to assess the ablative margin 3h after the procedure, when the coagulated tumor outline was easiest to discern. The treatment was repeated until an ablative margin greater than 5mm was confirmed. After CEUS assessment of the therapeutic response, the patients were followed to investigate local tumor recurrence. ResultsIn 78 patients (89.7%), the outline of the coagulated tumors could be recognized by ultrasonography, and CEUS assessment of the ablative margin was successful. The remaining nine patients were assessed by computed tomography. The 5-year cumulative survival rate after the assessment of the treatment response with CEUS was 58.4%, and the 4-year cumulative total recurrence rate was 72.3%. The 5-year cumulative local tumor recurrence rate was very low (2.3%). ConclusionThe assessment with CEUS at 3h after the PRFA procedure was successful in the majority of the patients, and it yielded a very low rate of local recurrence.	[Nishigaki, Yoichi; Hayashi, Hideki; Tomita, Eiichi; Suzuki, Yusuke; Watanabe, Naoki; Watanabe, Satoshi; Watanabe, Chiaki; Takagi, Yui; Kato, Tomohiro] Gifu Municipal Hosp, Dept Gastroenterol & Hepatol, Gifu 5008513, Japan; [Naiki, Takafumi] Gifu Municipal Hosp, Lab Ctr, Gifu 5008513, Japan	Nishigaki, Y (reprint author), Gifu Municipal Hosp, Dept Gastroenterol & Hepatol, 7-1 Kashima Cho, Gifu 5008513, Japan.	nishigak@he.mirai.ne.jp					Andreana L, 2010, ONCOLOGY-BASEL, V78, P68, DOI 10.1159/000315233; Song I, 2009, EUR RADIOL, V19, P2630, DOI 10.1007/s00330-009-1463-x; Livraghi T, 2003, RADIOLOGY, V226, P441, DOI 10.1148/radiol.2262012198; Hatanaka K, 2010, ONCOLOGY-BASEL, V78, P53, DOI 10.1159/000315231; Mita K, 2010, WORLD J GASTROENTERO, V16, P4187, DOI 10.3748/wjg.v16.i33.4187; Sugimoto K, 2012, J ULTRAS MED, V31, P529; Ohnishi T, 2008, J GASTROEN HEPATOL, V23, pE410, DOI 10.1111/j.1440-1746.2007.05091.x; Nishikawa H, 2011, J GASTROENTEROL, V46, P1418, DOI 10.1007/s00535-011-0452-4; Kawada N, 2010, HEPATOL RES, V40, P930, DOI 10.1111/j.1872-034X.2010.00697.x; Nakazawa T, 2007, AM J ROENTGENOL, V188, P480, DOI 10.2214/AJR.05.2079; Shiozawa K, 2010, J CLIN ULTRASOUND, V38, P182, DOI 10.1002/jcu.20685; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Sparchez Z, 2009, J GASTROINTEST LIVER, V18, P243; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Sirli R, 2010, MED ULTRASON, V12, P280; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Salvaggio G, 2010, ABDOM IMAGING, V35, P447, DOI 10.1007/s00261-009-9551-6; Miyamoto N, 2010, J CLIN ULTRASOUND, V38, P339, DOI 10.1002/jcu.20720; Inoue T, 2010, ONCOLOGY-BASEL, V78, P94, DOI 10.1159/000315236; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Tanaka H, 2012, HEPATOL RES, V42, P376, DOI 10.1111/j.1872-034X.2011.00936.x; Bartolotta TV, 2008, ABDOM IMAGING, V33, P501, DOI 10.1007/s00261-007-9294-1; Catalano O, 2001, ABDOM IMAGING, V26, P375, DOI 10.1007/s002610000199; Celli N, 2007, EUR J GASTROEN HEPAT, V19, P3, DOI 10.1097/01.meg.0000250585.53608.3c; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; Dill-Macky MJ, 2006, AM J ROENTGENOL, V186, pS287, DOI 10.2214/AJR.04.1916; Faccioli N, 2007, RADIOL MED, V112, P810, DOI 10.1007/s11547-007-0185-x; Luos W, 2010, EUR J RADIOL, V75, P91; Mandai M, 2011, BRIT J RADIOL, V84, P499, DOI 10.1259/bjr/38682601; Maruyama H, 2010, EUR J RADIOL, V75, pE102, DOI 10.1016/j.ejrad.2009.08.017; Minami Y, 2007, AM J ROENTGENOL, V188, P489, DOI 10.2214/AJR.05.1286; Minami Y, 2004, AM J ROENTGENOL, V182, P1224; Piscaglia F, 2010, DIGEST LIVER DIS, V42, P729, DOI 10.1016/j.dld.2010.03.003; Romanini Laura, 2007, Eur Radiol, V17 Suppl 6, pF99; Salmi Andrea, 2008, Int J Med Sci, V5, P327; Waki K, 2010, J GASTROEN HEPATOL, V25, P597, DOI 10.1111/j.1440-1746.2009.06125.x; Wens YL, 2003, AM J ROENTGENOL, V181, P57; Wens YL, 2004, AM J ROENTGENOL, V182, P1019	40	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					432	440		10.1111/hepr.12370		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900008		
J	Tokushige, K; Hashimoto, E; Horie, Y; Taniai, M; Higuchi, S				Tokushige, Katsutoshi; Hashimoto, Etsuko; Horie, Yoshinori; Taniai, Makiko; Higuchi, Susumu			Hepatocellular carcinoma based on cryptogenic liver disease: The most common non-viral hepatocellular carcinoma in patients aged over 80 years	HEPATOLOGY RESEARCH			English	Article						cryptogenic liver disease; diabetes mellitus; hepatocellular carcinoma; liver cirrhosis; old age	NONALCOHOLIC STEATOHEPATITIS; NATIONWIDE SURVEY; CANCER; JAPAN; RISK; ETIOLOGY; US	AimTo clarify the clinical features of patients with hepatocellular carcinoma (HCC) with cryptogenic liver diseases, we analyzed the data from a nationwide survey in Japan. MethodsThe survey was conducted in 2009. The factors examined included age and underlying liver diseases: alcoholic liver disease (ALD; n=991), non-alcoholic fatty liver disease (n=292), modest alcohol intake (intake between 20 and 70g/day, n=214) and cryptogenic liver diseases (n=316). We compared the clinical features of cryptogenic HCC among patient-age subgroups. ResultsHCC with ALD etiology was most common among the non-viral HCC patients under 80 years old; for those aged 80 years or older, cryptogenic HCC was the most common etiology. Among the cryptogenic HCC patients, the body mass index values and the prevalences of liver cirrhosis (LC) and diabetes mellitus (DM) were significantly lower in the 80 years or older group versus the 50-79 years group. In the 80 years or older group, 28% of the patients developed HCC without cirrhosis, obesity and DM. ConclusionIn the HCC patients aged 80 years and over, the etiology of most of the non-viral HCC cases was classified as cryptogenic. In light of our finding that the prevalences of obesity, DM and LC in the 80 years or older group of cryptogenic HCC patients were significantly lower those in the younger patients, it is apparent that analyses of HCC cases must take age differences into account.	[Tokushige, Katsutoshi; Hashimoto, Etsuko; Taniai, Makiko] Tokyo Womens Med Univ, Dept Internal Med & Gastroenterol, Tokyo 1628666, Japan; [Horie, Yoshinori] Int Univ Hlth & Welf, Sanno Hosp, Dept Internal Med, Tokyo, Japan; [Higuchi, Susumu] Natl Hosp Org Kurihama Alcoholism Ctr, Yokohama, Kanagawa, Japan	Hashimoto, E (reprint author), Tokyo Womens Med Univ, Dept Internal Med & Gastroenterol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	drs-hashimoto@mti.biglobe.ne.jp			Ministry of Health, Labor and Welfare of Japan	THIS WORK WAS supported in part by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan.	Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Bellentani S, 2000, ANN INTERN MED, V132, P112; Afdhal NH, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-832922; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Michitaka K, 2010, J GASTROENTEROL, V45, P86, DOI 10.1007/s00535-009-0128-5; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Hashimoto E, 2009, J GASTROENTEROL, V44, P89, DOI 10.1007/s00535-008-2262-x; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; [Anonymous], 2013, J HLTH WELFARE STAT, V60, P51; Bonafe M, 2002, EXP GERONTOL, V37, P1263, DOI 10.1016/S0531-5565(02)00137-7; Brunts EM, 2004, SEMIN LIVER DIS, V2, P3; Katos JH, 2000, GASTROENTEROLOGY, V118, P554; Mannucci E, 1999, DIABETIC MED, V16, P579, DOI 10.1046/j.1464-5491.1999.00116.x; Matsuzawa Y, 2000, J JAPAN SOC STUDY OB, V6, P18; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Suzuki Y, 2013, HEPATOL RES, V43, P1020, DOI 10.1111/hepr.12056; TAKADA A, 1995, J GASTROEN HEPATOL, V10, P509, DOI 10.1111/j.1440-1746.1995.tb01339.x; Tokushige K, 2011, J GASTROENTEROL, V46, P1230, DOI 10.1007/s00535-011-0431-9	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					441	447		10.1111/hepr.12372		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900009		
J	Ichimura, M; Kawase, M; Masuzumi, M; Sakaki, M; Nagata, Y; Tanaka, K; Suruga, K; Tamaru, S; Kato, S; Tsuneyama, K; Omagari, K				Ichimura, Mayuko; Kawase, Miku; Masuzumi, Miki; Sakaki, Mika; Nagata, Yasuo; Tanaka, Kazunari; Suruga, Kazuhito; Tamaru, Shizuka; Kato, Shigeko; Tsuneyama, Koichi; Omagari, Katsuhisa			High-fat and high-cholesterol diet rapidly induces non-alcoholic steatohepatitis with advanced fibrosis in Sprague-Dawley rats	HEPATOLOGY RESEARCH			English	Article						animal model; enzyme activity; high-fat and high-cholesterol diet; liver cirrhosis; liver fibrosis; non-alcoholic steatohepatitis	LIVER-DISEASE; ATHEROGENIC DIET; MICE; STEATOSIS; INFLAMMATION; METABOLISM; MODELS; CELLS; OBESE; NASH	AimThe development of fibrosis is considered an important phase in the progress of non-alcoholic steatohepatitis (NASH) towards the end stage of liver disease, including cirrhosis. However, few small animal models can display NASH-associated fibrosis. We aimed to establish a dietary model of NASH with rapid progression to fibrosis using genetically normal rats. MethodsNine-week-old male Sprague-Dawley rats were fed with normal, high-fat (HF), or two types of high-fat and high-cholesterol (HFC) diets for 9 weeks (n=5 each). All HFC diets contained 1.25% or 2.5% cholesterol. ResultsThe rats fed with the HF diet developed mild steatosis and inflammation without fibrosis at 18 weeks of age, whereas all rats given the HFC diet developed obvious steatosis and inflammation with hepatocyte ballooning and fibrosis. Two of five (40%) rats given the HFC diet containing 2.5% cholesterol progressed to liver cirrhosis. Hepatic total cholesterol levels were significantly higher in rats given the HFC, than the normal or HF diets. The HFC diet significantly and dose-dependently decreased microsomal triglyceride transfer protein expression. Cholesterol tended to suppress carnitine palmitoyltransferase activity and adenosine triphosphate-binding cassette transporter G5 expression. Adding cholesterol to the HF diet modified hepatic lipid metabolism at the molecular level. ConclusionThe HFC diet induced hepatic features of NASH and eventually progressed cirrhosis in Sprague-Dawley rats within 9 weeks.	[Ichimura, Mayuko; Nagata, Yasuo; Tanaka, Kazunari; Suruga, Kazuhito; Tamaru, Shizuka; Kato, Shigeko; Omagari, Katsuhisa] Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutr Sci, Nagasaki 8512195, Japan; [Kawase, Miku; Masuzumi, Miki; Sakaki, Mika; Tanaka, Kazunari; Suruga, Kazuhito; Tamaru, Shizuka; Kato, Shigeko; Omagari, Katsuhisa] Nagasaki Univ, Fac Nursing & Nutr, Dept Nutr, Nagasaki 8512195, Japan; [Tsuneyama, Koichi] Toyama Univ, Dept Diagnost Pathol, Toyama 930, Japan	Omagari, K (reprint author), Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutr Sci, 1-1-1 Manabino,Nagayo Cho, Nagasaki 8512195, Japan.	omagari@sun.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [24614011]	THIS STUDY WAS supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology to K. Omagari (no. 24614011).	Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Choudhary NS, 2012, ANN HEPATOL, V11, P478; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Montero J, 2008, CANCER RES, V68, P5246, DOI 10.1158/0008-5472.CAN-07-6161; Yasutake K, 2009, SCAND J GASTROENTERO, V44, P471, DOI 10.1080/00365520802588133; Jeong W, 2005, J VET MED SCI, V67, P235, DOI 10.1292/jvms.67.235; Nakamuta M, 2009, INT J MOL MED, V23, P603, DOI 10.3892/ijmm_00000170; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Lieber CS, 2004, AM J CLIN NUTR, V79, P502; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Teratani T, 2012, GASTROENTEROLOGY, V142, P152, DOI 10.1053/j.gastro.2011.09.049; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Ioannou GN, 2009, HEPATOLOGY, V50, P175, DOI 10.1002/hep.22941; Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378; De Hewavisenthi S J S, 2005, Ceylon Med J, V50, P113; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hoekstra M, 2005, J HEPATOL, V42, P400, DOI 10.1016/j.jhep.2004.11.032; Ichimura M, 2013, NUTR RES, V33, P397, DOI 10.1016/j.nutres.2013.03.006; Itos M, 2007, HEPATOL RES, V37, P50; Kumada T, 2004, MODERN PATHOL, V17, P1141, DOI 10.1038/modpathol.3800165; Lius Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449; Omagari K, 2010, PATHOLOGY, V42, P66, DOI 10.3109/00313020903434389; Spolding B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092656	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					458	469		10.1111/hepr.12358		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900011		
J	Fudaba, Y; Oshita, A; Tashiro, H; Ohdan, H				Fudaba, Yasuhiro; Oshita, Akihiko; Tashiro, Hirotaka; Ohdan, Hideki			Intrahepatic triglyceride measurement and estimation of viability in rat fatty livers by near-infrared spectroscopy	HEPATOLOGY RESEARCH			English	Article						fatty liver; ischemia-reperfusion injury; liver transplantation; near-infrared spectroscopy; primary graft dysfunction	MAGNETIC-RESONANCE-SPECTROSCOPY; MICROVESICULAR STEATOSIS; PRIMARY NONFUNCTION; TISSUE OXYGENATION; IN-VIVO; TRANSPLANTATION; INJURY; GRAFT; MICROCIRCULATION; QUANTIFICATION	AimThis study investigated the features of fatty livers using near-infrared (NIR) spectroscopy and validated the usefulness of NIR spectroscopy for the measurement of intrahepatic triglyceride (TG) contents and evaluation of viability in fatty livers. MethodsIn vitro, we examined specific spectra for each purified TG fraction by NIR. In vivo, the differences between the spectra obtained from normal and fatty livers before warm ischemia and the differences between the spectra obtained from each rat liver before and after warm ischemia were subjected to multicomponent analysis. ResultsIn vitro experiments revealed a specific peak at 925nm in major TG fractions, and NIR spectroscopy precisely detected changes in TG volume. In vivo experiments revealed that NIR spectroscopy detected TG content changes in rat fatty livers induced by a choline-deficient diet following the addition of purified TG spectrum for NIR spectroscopic analysis in least square curve fitting. The TG level in the fatty livers measured by NIR spectroscopy significantly correlated with the morphometric measurement of lipid content in the livers. NIR spectroscopy also revealed decreased levels of total hemoglobin (Hb) and oxidized Hb and maintenance of homeostasis in cytochrome redox states in fatty livers under normal condition. However, NIR spectroscopy showed irreversible deterioration of hepatic microcirculation, Hb oxygenation and homeostasis of the cytochrome redox states in fatty livers after 60-min warm ischemia reperfusion. ConclusionThese studies demonstrated that NIR spectroscopy can quantitatively measure the intrahepatic TG content in addition to simultaneously evaluating microcirculation and Hb oxygenation.	[Fudaba, Yasuhiro; Oshita, Akihiko; Tashiro, Hirotaka; Ohdan, Hideki] Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Surg, Hiroshima 7348551, Japan	Ohdan, H (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Surg,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	hohdan@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [21791289]	THIS RESEARCH WAS supported in part by a Grant-in-Aid for Scientific Research (no. 21791289) of the Japan Society for the Promotion of Science.	ADAM R, 1991, TRANSPLANT P, V23, P1538; Albanell E, 1999, J AOAC INT, V82, P753; Ijaz S, 2003, MICROCIRCULATION, V10, P447, DOI 10.1038/sj.mn.7800206; WYATT JS, 1986, LANCET, V2, P1063; Fishbein TM, 1997, TRANSPLANTATION, V64, P248, DOI 10.1097/00007890-199707270-00012; QUIGLEY EMM, 1993, GASTROENTEROLOGY, V104, P286; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; Leff DR, 2010, ANN SURG, V252, P1082, DOI 10.1097/SLA.0b013e3181ff449c; THOMSEN C, 1994, MAGN RESON IMAGING, V12, P487, DOI 10.1016/0730-725X(94)92543-7; HILDEN M, 1977, SCAND J GASTROENTERO, V12, P593; DALESSANDRO AM, 1991, TRANSPLANTATION, V51, P157, DOI 10.1097/00007890-199101000-00024; CLAIN DJ, 1987, GASTROENTEROL CLIN N, V16, P239; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; McCormack L, 2007, ANN SURG, V246, P940, DOI 10.1097/SLA.0b013e31815c2a3f; TERAMOTO K, 1993, TRANSPLANTATION, V56, P1076, DOI 10.1097/00007890-199311000-00005; GROUND KEU, 1982, AVIAT SPACE ENVIR MD, V53, P14; Asahara Toshimasa, 1998, Hiroshima Journal of Medical Sciences, V47, P31; Burt AD, 1998, SEMIN DIAGN PATHOL, V15, P246; Franzen LE, 2005, MODERN PATHOL, V18, P912, DOI 10.1038/modpathol.3800370; Fromenty Bernard, 1997, Journal of Hepatology, V26, P13, DOI 10.1016/S0168-8278(97)82328-8; Fukumori T, 1999, TRANSPLANTATION, V67, P195, DOI 10.1097/00007890-199901270-00002; HAMPSON NB, 1990, BRAIN RES, V519, P249, DOI 10.1016/0006-8993(90)90085-P; HAUTEKEETE ML, 1990, ACTA CLIN BELG, V45, P311; Huis AM, 1994, HEPATOLOGY, V20, P1287; Kital T, 1996, TRANSPLANTATION, V62, P642, DOI 10.1097/00007890-199609150-00018; MARKIN RS, 1993, TRANSPLANTATION, V56, P1403, DOI 10.1097/00007890-199312000-00025; McCormack L, 2007, ANN SURG, V246, P6; Neumeister V, 1997, J PEDIATR GASTR NUTR, V25, P388, DOI 10.1097/00005176-199710000-00005; Noriyuki T, 1997, AM J RESP CRIT CARE, V156, P1656; OHDAN H, 1995, TRANSPLANTATION, V60, P530, DOI 10.1097/00007890-199509270-00002; Petersen KF, 1996, HEPATOLOGY, V24, P114, DOI 10.1002/hep.510240119; Seifalian AM, 1999, TRANSPLANTATION, V68, P780, DOI 10.1097/00007890-199909270-00009; Shibata S, 1999, AM J RESP CRIT CARE, V160, P317; Simonson SG, 1996, CRIT CARE CLIN, V12, P1019, DOI 10.1016/S0749-0704(05)70290-6; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977; Takahashi K, 2000, TRANSPLANTATION, V69, P2028, DOI 10.1097/00007890-200005270-00009; TASHIRO H, 1993, TRANSPLANTATION, V56, P1261; TERAMOTO K, 1993, TRANSPLANTATION, V55, P737, DOI 10.1097/00007890-199304000-00010; TODO S, 1989, TRANSPLANTATION, V47, P903, DOI 10.1097/00007890-198905000-00034; GROUND KEU, 1984, AVIAT SPACE ENVIR MD, V55, P59; VANSTEENBERGEN W, 1995, INT J OBESITY, V19, pS27	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					470	479		10.1111/hepr.12364		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900012		
J	Yamada, H; Fujimoto, M; Svay, S; Lim, O; Hok, S; Goto, N; Ohisa, M; Akita, T; Matsuo, J; Do, SH; Katayama, K; Miyakawa, Y; Tanaka, J				Yamada, Hiroko; Fujimoto, Mayumi; Svay, Somana; Lim, Olline; Hok, Sirany; Goto, Noboru; Ohisa, Masayuki; Akita, Tomoyuki; Matsuo, Junko; Do, Son Huy; Katayama, Keiko; Miyakawa, Yuzo; Tanaka, Junko			Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia	HEPATOLOGY RESEARCH			English	Article						adults; Cambodia; hepatitis B virus; hepatitis C virus; seroepidemiology	BLOOD-DONORS; PREVALENCE; EPIDEMIOLOGY; THAILAND; MYANMAR; WORKERS; REGION; JAPAN	AimWe investigated hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among adults in Siem Reap, Cambodia, to consider the prevention strategy in cooperation with the Ministry of Health in Cambodia. MethodsSerological tests for determining HBV and HCV infections and questionnaires were performed from 2010 to 2012 among the general population in the province of Siem Reap. Multivariate logistic regression analysis was conducted to clarify the factors related to HBV and HCV infections. ResultsThere were 483 participants, comprising 194 men and 289 women (age range, 18-89years). The prevalence of hepatitis B surface antigen was not very high at 4.6%, while anti-hepatitis B core (anti-HBc) was high at 38.5%. All HBV DNA samples were classified as genotype C. Anti-HBc showed the trend that the older the age, the higher the positive rate (P=0.0002). The prevalence of HCV RNA and anti-HCV were 2.3% and 5.8%, respectively. HCV RNA was detected in 39.3% of anti-HCV positive samples and most of them were classified as genotype 6 (54.5%) and 1 (27.3%). Remarkably, in multivariate logistic regression analysis, history of operation and blood transfusion were significantly associated with the positivity for HBV infection and HCV RNA, respectively. ConclusionOur results showed that operation and blood transfusion were potential risk factors for HBV and HCV infection, respectively, and supposed that horizontal HBV transmission may be frequent in adults in Cambodia. Hence, for reducing HBV and HCV infections, it is necessary to improve the safety of blood and medical treatment.	[Yamada, Hiroko; Fujimoto, Mayumi; Ohisa, Masayuki; Akita, Tomoyuki; Matsuo, Junko; Do, Son Huy; Katayama, Keiko; Tanaka, Junko] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima 7348551, Japan; [Goto, Noboru] Hiroshima Univ, Grad Sch Social Sci, Dept Management Studies, Hiroshima 7348551, Japan; [Miyakawa, Yuzo] Miyakawa Mem Res Fdn, Tokyo, Japan; [Svay, Somana; Lim, Olline; Hok, Sirany] Minist Hlth, Phnom Penh, Cambodia	Tanaka, J (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	jun-tanaka@hiroshima-u.ac.jp			JSPS KAKENHI in Japan [24590793]	WE THANK MS Yuko Go for laboratory analysis, and assistance in processing and testing serum samples. This work was supported in part by a grant from JSPS KAKENHI (no.) 24590793) in Japan.	Akkarathamrongsin S, 2011, INTERVIROLOGY, V54, P10, DOI 10.1159/000318884; Caruana SR, 2005, AUST NZ J PUBL HEAL, V29, P64, DOI 10.1111/j.1467-842X.2005.tb00751.x; Fung J, 2008, J INFECT DIS, V198, P808, DOI 10.1086/591252; Reekie J, 2013, J GASTROEN HEPATOL, V28, P1539, DOI 10.1111/jgh.12245; Clements CJ, 2006, VACCINE, V24, P1975, DOI 10.1016/j.vaccine.2005.11.035; Ol HS, 2009, SE ASIAN J TROP MED, V40, P963; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; [Anonymous], GEN POP CENS CAMB 20; Tanaka J, 2004, INTERVIROLOGY, V47, P32, DOI 10.1159/000076640; Chen DS, 2013, J HEPATOL, V59, P1073, DOI 10.1016/j.jhep.2013.06.029; Huy TTT, 2008, VIRUS GENES, V36, P299, DOI 10.1007/s11262-008-0205-5; Moriya T, 1999, INTERVIROLOGY, V42, P153, DOI 10.1159/000024974; Nguyen Mindie H, 2005, Clin Gastroenterol Hepatol, V3, pS97, DOI 10.1016/S1542-3565(05)00711-1; Sa-Nguanmoo P, 2010, J MED VIROL, V82, P1341, DOI 10.1002/jmv.21828; Sato T, 2014, HEPATOL RES; Thuring E. Ghioldi, 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P239; World Health Organization, 2013, PREV CONTR VIR HEP I; World Health Organization, 2012, INT AG RES CANC GLOB	18	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					480	487		10.1111/hepr.12367		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900013		
J	Tomimaru, Y; Kobayashi, S; Wada, H; Hama, N; Kawamoto, K; Eguchi, H; Kira, T; Morii, E; Doki, Y; Mori, M; Nagano, H				Tomimaru, Yoshito; Kobayashi, Shogo; Wada, Hiroshi; Hama, Naoki; Kawamoto, Koichi; Eguchi, Hidetoshi; Kira, Toshihiko; Morii, Eiichi; Doki, Yuichiro; Mori, Masaki; Nagano, Hiroaki			Intrahepatic cholangiocarcinoma in a worker at an offset color proof-printing company: An autopsy case report	HEPATOLOGY RESEARCH			English	Article						1; 2-dichloropropane; bile duct cancer; cholangiocarcinoma; dichloromethane; printing company; printing plant	FIBER PRODUCTION WORKERS; DICHLOROMETHANE; EPIDEMIOLOGY; MORTALITY; THETA; MOUSE	A 40-year-old Japanese man visited our hospital after test results indicated elevated hepatobiliary enzymes. He had worked at a printing plant for 8 years and been exposed to organic solvents, including 1,2-dichloropropane (1,2-DCP) and dichloromethane (DCM). Abdominal computed tomography (CT) showed an intrahepatic tumor with dilation of the intrahepatic bile duct. He was diagnosed with intrahepatic cholangiocarcinoma. He had no known risk factors for cholangiocarcinoma. Extended left hepatectomy with lymph node dissection was performed and the tumor was histologically diagnosed as well-differentiated adenocarcinoma. A histological examination also showed biliary intraepithelial preneoplastic lesions in non-cancerous liver areas. Two years after surgery, the patient developed jaundice, esophageal varices and ascites. A CT examination showed liver cirrhosis without recurrence of the cholangiocarcinoma. Although a liver transplantation was planned as a therapeutic option for his liver cirrhosis, his liver failure progressed rapidly and he died before transplantation could be performed. At autopsy, fibrosis was found in the whole liver, especially in the wall of the bile duct and periductal area suggesting chronic bile duct injury due to exposure to organic solvents. Taken together, the current case may suggest that exposure to organic solvents, including 1,2-DCP and DCM, is a risk factor for cholangiocarcinoma. Identifying risk factors for cholangiocarcinoma will help identify the mechanism and help prevent development of the disease.	[Tomimaru, Yoshito; Kobayashi, Shogo; Wada, Hiroshi; Hama, Naoki; Kawamoto, Koichi; Eguchi, Hidetoshi; Doki, Yuichiro; Mori, Masaki; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Kira, Toshihiko] Nissay Hosp, Dept Surg, Osaka, Japan	Nagano, H (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, 2-2 Yamadaoka E-2, Suita, Osaka 5650871, Japan.	hnagano@gesurg.med.osaka-u.ac.jp					Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; PARKIN DM, 1993, CANCER EPIDEM BIOMAR, V2, P537; LANES SF, 1993, SCAND J WORK ENV HEA, V19, P426; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Sherratt PJ, 2002, TOXICOL APPL PHARM, V179, P89, DOI 10.1006/taap.2002.9348; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; des Groens PC, 1999, NEW ENGL J MED, V28, P1368; GUENGERICH FP, 1992, ENVIRON HEALTH PERSP, V98, P75, DOI 10.2307/3431250; International Agency for Research on Cancer, 2012, AG CLASS IARC MON; Japan Liver Cancer Study Group of Japan, 2008, GEN RUL CLIN PATH ST; Kubos S, 2014, J HEPATOBIL IN PRESS; LANES SF, 1990, SCAND J WORK ENV HEA, V16, P247; MEYER DJ, 1991, BIOCHEM J, V274, P409; Minister of Health La, 2013, REP PAN M WORK REL B; Nakanuma Y, 1992, PRIMARY LIVER CANC J, P39; Nakanuma Y, 2010, WHO CLASSIFICATION T, P217; Program NT, 1986, NATL TOXICOL PROGRAM, V263, P1; Program NT, 1986, NATL TOXICOL PROGRAM, V306, P1; Sherratt PJ, 1997, BIOCHEM J, V326, P837; UNECE, 2003, HARM SYST CLASS LAB; Vlaanderen J, 2013, OCCUP ENVIRON MED, V70, P828, DOI 10.1136/oemed-2013-101500	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					488	493		10.1111/hepr.12363		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900014		
J	Kanamori, H; Nakade, Y; Yamamoto, T; Kobayashi, Y; Sato, K; Ito, K; Ohashi, T; Nakao, N; Ishii, N; Takahashi, E; Yokoi, T; Nakao, H; Kurokawa, T; Yamaguchi, C; Yoneda, M				Kanamori, Hiroyuki; Nakade, Yukiomi; Yamamoto, Takaya; Kobayashi, Yuji; Sato, Ken; Ito, Kiyoaki; Ohashi, Tomohiko; Nakao, Noiku; Ishii, Norimitsu; Takahashi, Emiko; Yokoi, Toyoharu; Nakao, Haruhisa; Kurokawa, Tsuyoshi; Yamaguchi, Chikara; Yoneda, Masashi			Case of cholangiocellular carcinoma in a patient with glycogen storage disease type Ia	HEPATOLOGY RESEARCH			English	Article						cholangiocellular carcinoma; glycogen storage disease; hepatocellular adenoma	COMPARATIVE GENOMIC HYBRIDIZATION; HEPATOCELLULAR-CARCINOMA; CONTRAST-MEDIUM; ADENOMAS; LIVER; DIFFERENTIATION; GADOLINIUM; TUMORS	Glycogen storage disease (GSD) type Ia is caused by a deficiency in glucose-6-phosphatase. Long-term complications, including renal disease, gout, osteoporosis and pulmonary hypertension, develop in patients with GSD type Ia. In the second or third decade, 22-75% of GSD type Ia patients develop hepatocellular adenoma (HCA). In some of these patients, the HCA evolves into hepatocellular carcinoma. However, little is known about GSD type Ia patients with HCA who develop cholangiocellular carcinoma (CCC). Here, we report for the first time, a patient with GSD type Ia with HCA, in whom intrahepatic CCC was developed.	[Kanamori, Hiroyuki; Nakade, Yukiomi; Yamamoto, Takaya; Kobayashi, Yuji; Sato, Ken; Ito, Kiyoaki; Ohashi, Tomohiko; Ishii, Norimitsu; Nakao, Haruhisa; Yoneda, Masashi] Aichi Med Univ, Dept Internal Med, Div Gastroenterol, Nagakute, Aichi 4801195, Japan; [Nakao, Noiku] Aichi Med Univ, Dept Surg, Div Gastroenterol, Nagakute, Aichi 4801195, Japan; [Takahashi, Emiko; Yokoi, Toyoharu] Aichi Med Univ, Dept Pathol, Nagakute, Aichi 4801195, Japan; [Kurokawa, Tsuyoshi] Masuko Hosp, Nagoya, Aichi, Japan; [Yamaguchi, Chikara] Setoguchi Psychosomat Clin, Seto, Japan	Nakade, Y (reprint author), Aichi Med Univ, Dept Internal Med, Div Gastroenterol, 1-1 Karimata Yazako, Nagakute, Aichi 4801195, Japan.	ynakade@aichi-med-u.ac.jp					Rake JP, 2002, EUR J PEDIATR, V161, pS20, DOI 10.1007/s00431-002-0999-4; Reimer P, 1996, RADIOLOGY, V199, P177; COIRE CI, 1987, ARCH PATHOL LAB MED, V111, P166; Hayashi M, 1999, AM J ROENTGENOL, V172, P969; WEINMANN HJ, 1991, MAGNET RESON MED, V22, P233, DOI 10.1002/mrm.1910220214; BIANCHI L, 1993, EUR J PEDIATR, V152, pS63; Cassiman D, 2010, J HEPATOL, V53, P213, DOI 10.1016/j.jhep.2010.03.002; Earls JP, 1996, RADIOLOGY, V201, P207; KHARSA G, 1990, GASTROEN CLIN BIOL, V14, P84; Kishnani PS, 2009, HUM MOL GENET, V18, P4781, DOI 10.1093/hmg/ddp441; Ochi H, 2011, INTERNAL MED, V50, P2317, DOI 10.2169/internalmedicine.50.5491; PARKER P, 1981, GASTROENTEROLOGY, V81, P534; Pauleit D, 2002, RADIOLOGY, V222, P73; Steinemann D, 2006, CLIN GASTROENTEROL H, V4, P1283, DOI 10.1016/j.cgh.2006.07.010; Weinmann HJ, 1991, MAGN RESON MED, V22, P42; Wilkens L, 2001, J PATHOL, V193, P476, DOI 10.1002/path.825; Yius WH, 2008, KIDNEY INT, V73, P716	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	APR	2015	45	4					494	499		10.1111/hepr.12366		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF5XF	WOS:000352629900015		
J	Nakagomi, T; Nakano-Doi, A; Matsuyama, T				Nakagomi, Takayuki; Nakano-Doi, Akiko; Matsuyama, Tomoiro			Leptomeninges: a novel stem cell niche harboring ischemia-induced neural progenitors	HISTOLOGY AND HISTOPATHOLOGY			English	Review						Ischemic stroke; Neural stem cells; Pericyte; Leptomeninges; CNS	MARROW MONONUCLEAR-CELLS; CEREBRAL-ARTERY OCCLUSION; ADULT SUBVENTRICULAR ZONE; CENTRAL-NERVOUS-SYSTEM; STEM/PROGENITOR CELLS; NEURONAL DIFFERENTIATION; MYOCARDIAL-INFARCTION; INDUCED NEUROGENESIS; FUNCTIONAL RECOVERY; VASCULAR NICHE	It is well known that neural stem cells (NSCs) are present in many parts of the central nervous system (CNS), including the subventricular zone (SVZ) of the lateral ventricle, subgranular zone (SGZ) of the hippocampal dentate gyrus, cortex, and spinal cord. Using a mouse model of cortical infarction, we demonstrated for the first time that NSCs, which can differentiate into neural lineage cells, could be induced in the meninges (leptomeninges) of ischemic brain areas as well. However, such ischemia-induced NSCs (iNSCs) were not observed in the leptomeninges of non-ischemic areas. This suggests the leptomeninges, which surround the CNS, might be a novel stem cell niche harboring endogenous iNSCs following brain injury. In this review, we introduce the characterization and possible origin of leptomeningeal iNSCs based on our reports and recent findings. We also refer to the potential of leptomeningeal iNSCs for cortical neurogenesis.	[Nakagomi, Takayuki; Nakano-Doi, Akiko; Matsuyama, Tomoiro] Hyogo Coll Med, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan	Nakagomi, T (reprint author), Hyogo Coll Med, Inst Adv Med Sci, 1-1 Mukogawacho, Nishinomiya, Hyogo 6638501, Japan.	nakagomi@hyo-med.ac.jp					Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Shimada IS, 2010, STROKE, V41, pE552, DOI 10.1161/STROKEAHA.110.589010; Jiang W, 2001, STROKE, V32, P1201; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Li WY, 2008, CELL TRANSPLANT, V17, P1045; Yoo SW, 2013, NEUROBIOL DIS, V58, P249, DOI 10.1016/j.nbd.2013.06.001; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Ribeiro-Resende VT, 2009, NEUROSCIENCE, V159, P540, DOI 10.1016/j.neuroscience.2008.12.059; Salewski RP, 2013, STEM CELLS DEV, V22, P383, DOI 10.1089/scd.2012.0218; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; MORSE DE, 1984, ANAT REC, V210, P125, DOI 10.1002/ar.1092100115; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Nakagomi T, 2012, STEM CELLS DEV, V21, P2350, DOI 10.1089/scd.2011.0657; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Bifari F, 2009, J CELL MOL MED, V13, P3195, DOI 10.1111/j.1582-4934.2009.00706.x; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Darsalia V, 2007, EUR J NEUROSCI, V26, P605, DOI 10.1111/j.1460-9568.2007.05702.x; Nakano-Doi A, 2010, STEM CELLS, V28, P1292, DOI 10.1002/stem.454; Magavi SS, 2000, NATURE, V405, P951; Halfter W, 2002, J NEUROSCI, V22, P6029; Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161; Takata M, 2012, CELL DEATH DIFFER, V19, P756, DOI 10.1038/cdd.2011.145; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakagomi T, 2011, STEM CELLS DEV, V20, P2037, DOI 10.1089/scd.2011.0279; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Decimo I, 2011, STEM CELLS, V29, P2062, DOI 10.1002/stem.766; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Nakagomi T, 2009, EUR J NEUROSCI, V29, P1842, DOI 10.1111/j.1460-9568.2009.06732.x; Hayase M, 2009, J CEREBR BLOOD F MET, V29, P1409, DOI 10.1038/jcbfm.2009.62; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Birbrair A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00245; Derval N, 2008, EUR J CARDIO-THORAC, V34, P248, DOI 10.1016/j.ejcts.2008.03.058; HUTCHINGS M, 1986, J NEUROSURG, V65, P316, DOI 10.3171/jns.1986.65.3.0316; Jordan PM, 2009, J NEUROSCI RES, V87, P318, DOI 10.1002/jnr.21856; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kim H, 2009, STEM CELLS, V27, P1686, DOI 10.1002/stem.87; Li TS, 2006, AM J PHYSIOL-HEART C, V290, pH1362, DOI 10.1152/ajpheart.00766.2005; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Nagoshi N, 2009, J CELL BIOCHEM, V107, P1046, DOI 10.1002/jcb.22213; Nakayama D, 2010, EUR J NEUROSCI, V31, P90, DOI 10.1111/j.1460-9568.2009.07043.x; Rowland JW, 2011, STEM CELLS DEV, V20, P1829, DOI 10.1089/scd.2011.0214; Saino O, 2010, J NEUROSCI RES, V88, P2385, DOI 10.1002/jnr.22410; Sockanathan S, 2009, CELL STEM CELL, V5, P455, DOI 10.1016/j.stem.2009.10.010; Song Hongjun, 2002, Nature (London), V417, P39, DOI 10.1038/417039a; Teng L, 2006, ADV EXP MED BIOL, V589, P206; Xue JH, 2009, STROKE, V40, pE606, DOI 10.1161/STROKEAHA.109.560334	75	3	3	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	APR	2015	30	4					391	399		10.14670/HH-30.391		9	Cell Biology; Pathology	Cell Biology; Pathology	CF4DW	WOS:000352499900001		
J	Kitamura, H; Terunuma, N; Kurosaki, S; Hata, K; Masuda, M; Kochi, T; Yanagi, N; Murase, T; Ogami, A; Higashi, T				Kitamura, H.; Terunuma, N.; Kurosaki, S.; Hata, K.; Masuda, M.; Kochi, T.; Yanagi, N.; Murase, T.; Ogami, A.; Higashi, T.			A cohort study of toner-handling workers on inflammatory, allergic, and oxidative stress markers: Cross-sectional and longitudinal analyses from 2003 to 2008	HUMAN & EXPERIMENTAL TOXICOLOGY			English	Article						Inhalation toxicology/pulmonary toxicology; epidemiology; biomarkers/exposure assessment	DUST	Objectives: This study examines the relationship between toner exposure and its health effects in terms of biomarkers which are known to assess the damages to humans caused by toxic material exposure. Methods: The subjects were 1504 male workers aged below 50 in 2003 in a Japanese toner and photocopier manufacturing company. Personal exposure measurements, pulmonary function tests, chest X-ray examinations, biomarker measurement, and a questionnaire about respiratory symptoms were conducted. We will report about bionnarker measurement in this study. Cross-sectional survey studies and a longitudinal study from 2003 to 2008 were conducted. Results: Few significant findings were associated with the toner exposure in both the cross-sectional and the longitudinal studies. The higher toner exposure concentrations did not induce effects on increasing biomarkers. Conclusion: There was no evidence of excessive inflammatory, allergic, or oxidative stress reaction in toner-handling workers as compared to non-handling workers, despite some sporadically significant findings. There are no other reports of a longitudinal epidemiological study with regard to toner exposure; this report significantly contributes to toner exposure literature. Although in the current well-controlled working environment, the toner exposure concentrations are quite low; further studies are needed to completely understand the health effects toner may have, however small they may be.	[Kitamura, H.; Terunuma, N.; Kurosaki, S.; Hata, K.; Masuda, M.; Kochi, T.; Yanagi, N.; Ogami, A.; Higashi, T.] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Work Syst & Hlth, Kitakyushu, Fukuoka 8078555, Japan; [Murase, T.] Tokai Univ, Sch Med, Dept Haematol, Hachioji, Tokyo, Japan	Kitamura, H (reprint author), Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Work Syst & Hlth, 1-1 Iseigaoka Yahatanishi Ward, Kitakyushu, Fukuoka 8078555, Japan.	h-kita@med.uoeh-u.ac.jp			Fuji Xerox Co Ltd	Fuji Xerox Co Ltd provided the funds for the present study to University of Occupational and Environmental Health, Japan, according to the research contract.	American Conference of Governmental Industrial Hygienists (ACGIH), 2001, DOC THRESH LIM VAL B; LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241; Lee CW, 2007, ATMOS ENVIRON, V41, P6598, DOI 10.1016/j.atmosenv.2007.04.016; GALLARDO M, 1994, LANCET, V344, P412, DOI 10.1016/S0140-6736(94)91441-9; Morawska L, 2009, ENVIRON SCI TECHNOL, V43, P1015, DOI 10.1021/es802193n; Armbruster C, 1996, LANCET, V348, P690, DOI 10.1016/S0140-6736(05)65119-7; Wittczak T, 2003, ALLERGY, V58, P957, DOI 10.1034/j.1398-9995.2003.00241.x; Chun-Yuh Y, 2008, J TOXICOL ENV HEAL A, V71, P1314; Congrong H, 2007, ENVIRON SCI TECHNOL, V41, P6039; Federal Institute for Risk Assessment, 2008, AFR ANN REP, P21; Francesca A, 2006, J ALLERGY CLIN IMMUN, V117, P824; Higashi T, 2006, 28 ICOH MIL IT 16 JU; IARC, 2006, IARC MON EV CARC RIS, V93; Kung-Yee L, 1986, BIOMETRIKA, V73, P13, DOI DOI 10.1093/BI0MET/73.1.13; Mathias B, 2011, ENVIRON SCI TECHNOL, V45, P7819; Ministry of Health Labour and Welfare, 2009, GUID EV EXP HARMF SU; Morillas RJ, 2005, EUR J APPL PHYSL, V95, P543; Naoki K, 2008, EAROZORU KENKYU, V23, P252; Norikazu N, 2006, J AEROSOL RES, V21, P59; Peter MG, 2011, ENVIRON SCI TECHNOL, V45, P6444; Ru B, 2010, TOXICOL LETT, V199, P288; Suzuki Akitake, 2005, Nihon Rinsho, V63 Suppl 7, P28; Tao T, 2012, ENVIRON MOL MUTAGEN, V53, P125; Umezawa M, 2011, J TOXICOL SCI, V36, P461; Wieriks J, 1996, LANCET, V348, P1518, DOI 10.1016/S0140-6736(05)65937-5	25	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0960-3271	1477-0903		HUM EXP TOXICOL	Hum. Exp. Toxicol.	APR	2015	34	4					337	344		10.1177/0960327113512339		8	Toxicology	Toxicology	CG1ZE	WOS:000353073900001		
J	Kitamura, H; Terunuma, N; Kurosaki, S; Hata, K; Masuda, M; Kochi, T; Yanagi, N; Murase, T; Ogami, A; Higashi, T				Kitamura, H.; Terunuma, N.; Kurosaki, S.; Hata, K.; Masuda, M.; Kochi, T.; Yanagi, N.; Murase, T.; Ogami, A.; Higashi, T.			A cohort study using pulmonary function tests and x-ray examination in toner-handling workers: Cross-sectional and longitudinal analyses from 2003 to 2008	HUMAN & EXPERIMENTAL TOXICOLOGY			English	Article						Inhalation toxicology/pulmonary toxicology; epidemiology; occupational toxicology; toner; printer; photocopier	A549 LUNG-CELLS; RESPIRATORY HEALTH; PARTICLES; EXPOSURE; DUST; INHALATION; PRINTERS; SYMPTOMS; TAIWAN; FINE	Objectives: This study uses pulmonary function tests and chest x-ray examinations to examine the relationship between toner-handling work and its health effects. Methods: The subjects were 1504 male workers in a Japanese toner and photocopier manufacturing company, in the age range from 19 to 50 years in 2003. Personal exposure measurements, pulmonary function tests, chest x-ray examinations, biomarker measurements, and a questionnaire about respiratory symptoms were conducted. The present study reports the results of pulmonary function tests and chest x-ray examinations conducted in the subjects, which includes a cross-sectional study on the toner handling and non-handling workers and a longitudinal study from 2003 to 2008. Results: Few significant findings were suspected to be caused by toner exposure found in pulmonary function indices in both the cross-sectional and longitudinal studies. Any obvious fibrotic findings in chest x-ray findings related to the toner exposure could not be found out. Conclusion: No evidence of adverse effects on pulmonary function indices and chest x-rays was present in the toner-handling workers as compared to the nonspecifically exposed workers. Although the toner exposure concentration is quite low in the current well-controlled working environment, even among the toner-handling workers, we would like to continue this study in the future to verify the toner exposure health effects.	[Kitamura, H.; Terunuma, N.; Kurosaki, S.; Hata, K.; Masuda, M.; Kochi, T.; Yanagi, N.; Ogami, A.; Higashi, T.] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Work Syst & Hlth, Kitakyushu, Fukuoka 8078555, Japan; [Murase, T.] Tokai Univ, Sch Med, Dept Haematol, Hachioji, Tokyo, Japan	Kitamura, H (reprint author), Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Work Syst & Hlth, 1-1 Iseigaoka Yahatanishi Ward, Kitakyushu, Fukuoka 8078555, Japan.	h-kita@med.uoeh-u.ac.jp			Fuji Xerox Co. Ltd	Fuji Xerox Co. Ltd provided the funds for the present study to University of Occupational and Environmental Health (UOEH), Kitakyushu, Japan, according to the research contract.	American Conference of Governmental Industrial Hygienists (ACGIH), 2001, DOC THRESH LIM VAL B; Alessandrini F, 2006, J ALLERGY CLIN IMMUN, V117, P824, DOI 10.1016/j.jaci.2005.11.046; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McGarry P, 2011, ENVIRON SCI TECHNOL, V45, P6444, DOI 10.1021/es200249n; Tang T, 2012, ENVIRON MOL MUTAGEN, V53, P125, DOI 10.1002/em.20695; Konczol M, 2013, TOXICOL LETT, V216, P171, DOI 10.1016/j.toxlet.2012.11.018; Barthel M, 2011, ENVIRON SCI TECHNOL, V45, P7819, DOI 10.1021/es201590q; Strak M, 2012, ENVIRON HEALTH PERSP, V120, P1183, DOI 10.1289/ehp.1104389; Yang CY, 2008, J TOXICOL ENV HEAL A, V71, P1314, DOI 10.1080/15287390802240785; Kitamura H, 2009, HUM EXP TOXICOL, V28, P331, DOI 10.1177/0960327109105152; Lee CW, 2007, ATMOS ENVIRON, V41, P6598, DOI 10.1016/j.atmosenv.2007.04.016; Morimoto Y, 2009, INHAL TOXICOL, V21, P898, DOI 10.1080/08958370802641938; Terunuma N, 2009, HUM EXP TOXICOL, V28, P325, DOI 10.1177/0960327109105160; GALLARDO M, 1994, LANCET, V344, P412, DOI 10.1016/S0140-6736(94)91441-9; He C, 2007, ENVIRON SCI TECHNOL, V41, P6039, DOI 10.1021/es063049z; Bai R, 2010, TOXICOL LETT, V199, P288, DOI 10.1016/j.toxlet.2010.09.011; Morawska L, 2009, ENVIRON SCI TECHNOL, V43, P1015, DOI 10.1021/es802193n; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Armbruster C, 1996, LANCET, V348, P690, DOI 10.1016/S0140-6736(05)65119-7; Nakadate T, 2006, OCCUP ENVIRON MED, V63, P244, DOI 10.1136/oem.2005.020644; Wittczak T, 2003, ALLERGY, V58, P957, DOI 10.1034/j.1398-9995.2003.00241.x; ATS, 1995, AM J RESP CRIT CARE, V152, P1107; BfR-Pressestelle, 2008, GEF DRUCK ERG BFR TO, P21; Department of Health and Safety Ministry of Labour Japan, 1978, JINP SHINS HDB; Higashi T, 2006, 28 ICOH MIL IT 16 JU; HIGENBOTTAM T, 1980, LANCET, V1, P409; IARC, 2006, IARC MON EV CARC RIS, V93; ILO, 2002, GUID US ILO INT CLAS; Japanese Respiratory Society, 2001, J JPN RESP SOC, V39, P1; Kagi N, 2008, J AEROSOL RES, V23, P252; Klepczynska-Nystrom A, 2012, INHAL TOXICOL, V24, P645, DOI 10.3109/08958378.2012.708065; Ministry of Health Labour and Welfare, 1972, WORK ENV MEAS STAND; Ministry of Health Labour and Welfare, 2003, INV BAS PEOPL LIF 20; Ministry of Health Labour and Welfare, 2009, GUID EV EXP HARMF SU; Ministry of Labour Japan, 1982, JINP HYOJ XRAY FILMS; Namiki N, 2006, J AEROSOL RES, V21, P59; Umezawa M, 2011, J TOXICOL SCI, V36, P461; Wieriks J, 1996, LANCET, V348, P1518, DOI 10.1016/S0140-6736(05)65937-5; World Health Organization, 2000, WHO TECHN REP SER	39	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0960-3271	1477-0903		HUM EXP TOXICOL	Hum. Exp. Toxicol.	APR	2015	34	4					345	356		10.1177/0960327113520018		12	Toxicology	Toxicology	CG1ZE	WOS:000353073900002		
J	Puppo, F; Dionnet, E; Gaillard, MC; Gaildrat, P; Castro, C; Vovan, C; Bertaux, K; Bernard, R; Attarian, S; Goto, K; Nishino, I; Hayashi, Y; Magdinier, F; Krahn, M; Helmbacher, F; Bartoli, M; Levy, N				Puppo, Francesca; Dionnet, Eugenie; Gaillard, Marie-Cecile; Gaildrat, Pascaline; Castro, Christel; Vovan, Catherine; Bertaux, Karine; Bernard, Rafaelle; Attarian, Shahram; Goto, Kanako; Nishino, Ichizo; Hayashi, Yukiko; Magdinier, Frederique; Krahn, Martin; Helmbacher, Francoise; Bartoli, Marc; Levy, Nicolas			Identification of Variants in the 4q35 Gene FAT1 in Patients with a Facioscapulohumeral Dystrophy-Like Phenotype	HUMAN MUTATION			English	Article						neuromuscular pathology; facioscapulohumeral dystrophy; FAT1-protocadherin	FASCIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; DNA METHYLATION; FSHD; MUTATIONS; DELETION; CANCER; ALLELE; SMCHD1; ABNORMALITIES; ASSOCIATION	Facioscapulohumeralmuscular dystrophy (FSHD) is linked to copy-number reduction (N<10) of the 4q D4Z4 subtelomeric array, in association with DUX4-permissive haplotypes. This main form is indicated as FSHD1. FSHD-like phenotypes may also appear in the absence of D4Z4 copy-number reduction. Variants of the SMCHD1 gene have been reported to associate with D4Z4 hypomethylation in DUX4-compatible haplotypes, thus defining FSHD2. Recently, mice carrying a muscle-specific knock-out of the protocadherin gene Fat1 or its constitutive hypomorphic allele were shown to develop muscular and nonmuscular defects mimicking human FSHD. Here, we report FAT1 variants in a group of patients presenting with neuromuscular symptoms reminiscent of FSHD. The patients do not carry D4Z4 copy-number reduction, 4q hypomethylation, or SMCHD1 variants. However, abnormal splicing of the FAT1 transcript is predicted for all identified variants. To determine their pathogenicity, we elaborated a minigene approach coupled to an antisense oligonucleotide (AON) assay. In vitro, four out of five selected variants induced partial or complete alteration of splicing by creating new splice sites or modifying splicing regulators. AONs confirmed these effects. Altered transcripts may affect FAT1 protein interactions or stability. Altogether, our data suggest that defective FAT1 is associated with an FSHD-like phenotype.	[Puppo, Francesca; Dionnet, Eugenie; Gaillard, Marie-Cecile; Castro, Christel; Attarian, Shahram; Magdinier, Frederique; Krahn, Martin; Bartoli, Marc; Levy, Nicolas] Aix Marseille Univ, GMGF, F-13385 Marseille, France; [Puppo, Francesca; Dionnet, Eugenie; Gaillard, Marie-Cecile; Castro, Christel; Attarian, Shahram; Magdinier, Frederique; Krahn, Martin; Bartoli, Marc; Levy, Nicolas] INSERM, UMR, F-13258 Marseille, France; [Gaildrat, Pascaline] Univ Rouen, INSERM, IRIB, UMR 1079, Rouen, France; [Vovan, Catherine; Bertaux, Karine; Bernard, Rafaelle; Krahn, Martin; Bartoli, Marc; Levy, Nicolas] Hop Enfants La Timone, AP HM, Dept Genet Med & Biol Cellulaire, Marseille, France; [Attarian, Shahram] CHU La Timone, Dept Neurol & Neuromuscular Dis, Marseille, France; [Goto, Kanako; Nishino, Ichizo] Natl Inst Neurosci, NCNP, Tokyo, Japan; [Hayashi, Yukiko] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan; [Helmbacher, Francoise] Aix Marseille Univ, CNRS, IBDM, UMR 7288, F-13385 Marseille, France	Bartoli, M (reprint author), Aix Marseille Univ, GMGF, Fac Med 27, UMR S 910, Bd Jean Moulin, F-13385 Marseille, France.	marc.bartoli@univ-amu.fr		Bartoli, Marc/0000-0003-3339-9858; HELMBACHER, Francoise/0000-0001-6822-1246	Association Francaise contre les Myopathies (AFM)-Telethon (strategical pole MNH Decrypt); Fondation Maladies Rares	Contract grant sponsors: Association Francaise contre les Myopathies (AFM)-Telethon (strategical pole MNH Decrypt); Fondation Maladies Rares.	Abou Jamra R, 2008, MOL PSYCHIATR, V13, P277, DOI 10.1038/sj.mp.4002111; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Richards M, 2012, HUM GENET, V131, P325, DOI 10.1007/s00439-011-1100-z; Gaillard MC, 2014, NEUROLOGY, V83, P733, DOI 10.1212/WNL.0000000000000708; Gaildrat P, 2010, METHODS MOL BIOL, V653, P249, DOI 10.1007/978-1-60761-759-4_15; Wallefeld W, 2006, NEUROMUSCULAR DISORD, V16, P541, DOI 10.1016/j.nmd.2006.07.018; Scionti I, 2012, AM J HUM GENET, V90, P628, DOI 10.1016/j.ajhg.2012.02.019; Gendrel AV, 2012, DEV CELL, V23, P265, DOI 10.1016/j.devcel.2012.06.011; Broucqsault N, 2013, HUM MOL GENET, V22, P4206, DOI 10.1093/hmg/ddt272; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Lee S, 2012, CANCER RES, V72, P4574, DOI 10.1158/0008-5472.CAN-12-0636; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Blair IP, 2006, MOL PSYCHIATR, V11, P372, DOI 10.1038/sj.mp.4001784; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Morris LGT, 2013, CELL CYCLE, V12, P1011, DOI 10.4161/cc.24305; Balatsouras DG, 2007, OTOL NEUROTOL, V28, P7, DOI 10.1097/01.mao.0000244362.39696.c8; Bendavid C, 2007, EUR J MED GENET, V50, P66, DOI 10.1016/j.ejmg.2006.09.003; Caruso N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003550; desBock CE, 2012, LEUKEMIA, V26, P918; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Hou R, 2009, J BIOL CHEM, V284, P6955, DOI 10.1074/jbc.M809333200; Jung YE, 2013, CLIN PSYCHOPHARM NEU, V11, P67, DOI 10.9758/cpn.2013.11.2.67; Justin Besancon L, 1964, SEMIN HOP, V40, P2990; Kergourlay V, 2014, HUM MUTAT, V35, P1532, DOI 10.1002/humu.22710; Kitsiou-Tzeli S, 2008, EUR J MED GENET, V51, P61, DOI 10.1016/j.ejmg.2007.09.004; Larsen M, 2014, EUR J HUM GENET, DOI [10.1038/ejhg.2014.191, DOI 10.1038/EJHG.2014.191]; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; OCKEY CH, 1967, ARCH DIS CHILD, V42, P428; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; Sacconi S, 2013, AM J HUM GENET, V93, P744, DOI 10.1016/j.ajhg.2013.08.004; Saito Y, 2007, BRAIN DEV-JPN, V29, P231, DOI 10.1016/j.braindev.2006.08.012; Scionti I, 2012, J MED GENET, V49, P171, DOI 10.1136/jmedgenet-2011-100454; Spurlock G, 2010, MUSCLE NERVE, V42, P820, DOI 10.1002/mus.21766; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; vansDeutekom JC, 1993, HUM MOL GENET, V2, P2037; vansOverveld P G, 2000, HUM MOL GENET, V9, P2879; VANSOVERVELD PGM, 2003, NAT GENET, V35, P315; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wein N, 2010, HUM MUTAT, V31, P136, DOI 10.1002/humu.21160; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; Wohlgemuth M, 2004, NEUROLOGY, V63, P176; Yamanaka G, 2004, J NEUROL SCI, V219, P89, DOI 10.1016/j.jns.2003.12.010	54	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	APR	2015	36	4					443	453		10.1002/humu.22760		11	Genetics & Heredity	Genetics & Heredity	CF1KO	WOS:000352304200009		
J	Park, JB; Kario, K; Wang, JG				Park, Jeong Bae; Kario, Kazuomi; Wang, Ji-Guang			Systolic hypertension: an increasing clinical challenge in Asia	HYPERTENSION RESEARCH			English	Review						aging; antihypertensive agents; Asians; cardiovascular diseases; vascular stiffness	BLOOD-PRESSURE CONTROL; CORONARY-HEART-DISEASE; JAPANESE GENERAL-POPULATION; CARDIOVASCULAR RISK-FACTORS; CHRONIC KIDNEY-DISEASE; MEDICAL-SCHOOL COHORT; TO-VISIT VARIABILITY; PULSE-WAVE VELOCITY; DIETARY SALT INTAKE; MIDDLE-AGED MEN	Systolic hypertension, the predominant form of hypertension in patients aged over 50-60 years, is a growing health issue as the Asian population ages. Elevated systolic blood pressure is mainly caused by arterial stiffening, resulting from age-related vascular changes. Elevated systolic pressure increases the risk of cardiovascular disease, mortality and renal function decline, and this risk may increase at lower systolic pressure levels in Asian than Western subjects. Hence, effective systolic pressure lowering is particularly important in Asians yet blood pressure control remains inadequate despite the availability of numerous antihypertensive medications. Reasons for poor blood pressure control include low awareness of hypertension among health-care professionals and patients, under-treatment, and tolerability problems with antihypertensive drugs. Current antihypertensive treatments also lack effects on the underlying vascular pathology of systolic hypertension, so novel drugs that address the pathophysiology of arterial stiffening are needed for optimal management of systolic hypertension and its cardiovascular complications.	[Park, Jeong Bae] Kwandong Univ, Coll Med, Cheil Gen Hosp, Dept Med Cardiol, Seoul 100380, South Korea; [Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Wang, Ji-Guang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Hypertens,Ctr Epidemiol Studies & C, Shanghai 200030, Peoples R China	Park, JB (reprint author), Kwandong Univ, Coll Med, Cheil Gen Hosp, Dept Med Cardiol, Seoul 100380, South Korea.	mdparkjb@gmail.com			Novartis Pharma AG, Basel, Switzerland	The authors thank Gregor Fyfe and Chris Cammack of CircleScience, part of KnowledgePoint360, an Ashfield Company, and Tamsin Williamson (a freelance medical writer contracted to CircleScience) for providing writing assistance, which was funded by Novartis Pharma AG, Basel, Switzerland.	Almas Aysha, 2012, BMC Res Notes, V5, P579, DOI 10.1186/1756-0500-5-579; Tomiyama H, 2010, ATHEROSCLEROSIS, V212, P345, DOI 10.1016/j.atherosclerosis.2010.05.033; Miura K, 2010, J EPIDEMIOL, V20, pS524, DOI 10.2188/jea.JE20090220; Kim BG, 2005, J HUM HYPERTENS, V19, P877, DOI 10.1038/sj.jhh.1001904; Briet M, 2013, CURR HYPERTENS REP, V15, P3, DOI 10.1007/s11906-012-0325-0; Jablonski KL, 2013, J AM COLL CARDIOL, V61, P335, DOI 10.1016/j.jacc.2012.09.010; Sun ZQ, 2010, ANN FAM MED, V8, P19, DOI 10.1370/afm.1018; Huang LY, 2013, EUR REV MED PHARMACO, V17, P410; Greenlund KJ, 2004, ARCH INTERN MED, V164, P2113, DOI 10.1001/archinte.164.19.2113; Kagiyama S, 2008, HYPERTENS RES, V31, P265, DOI 10.1291/hypres.31.265; HU HH, 1992, STROKE, V23, P1237; Wang J, 2014, J HUM HYPERTENS, V28, P25, DOI 10.1038/jhh.2013.44; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; Ogihara T, 2008, HYPERTENS RES, V31, P1595, DOI 10.1291/hypres.31.1595; Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278; Segura J, 2013, EXPERT OPIN INV DRUG, V22, P915, DOI 10.1517/13543784.2013.797962; Umesawa M, 2008, AM J CLIN NUTR, V88, P195; [Anonymous], 2008, WHO PREVALENCE RAISE; Wang JG, 2012, DIABETES-METAB RES, V28, P67, DOI 10.1002/dmrr.2356; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Mori H, 2006, HYPERTENS RES, V29, P143, DOI 10.1291/hypres.29.143; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594; Wang JG, 2013, ADV THER, V30, P771, DOI 10.1007/s12325-013-0048-x; Tian S, 2011, HYPERTENS RES, V34, P1087, DOI 10.1038/hr.2011.99; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; Mendis S, 2010, B WORLD HEALTH ORGAN, V88, P412, DOI 10.2471/BLT.08.062364; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/01.hjh.0000098149.7095679; Oparil S, 2003, ANN INTERN MED, V139, P761; He FJ, 2009, HYPERTENSION, V54, P482, DOI 10.1161/HYPERTENSIONAHA.109.133223; He J, 2009, J HYPERTENS, V27, P48, DOI 10.1097/HJH.0b013e328316bb87; Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Ogihara T, 2000, AM J HYPERTENS, V13, P461, DOI 10.1016/S0895-7061(99)00215-0; Gardner DG, 2007, HYPERTENSION, V49, P419, DOI 10.1161/01.HYP.0000258532.07418.fa; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Guerin AP, 2001, CIRCULATION, V103, P987; Arima H, 2012, HYPERTENSION, V59, P1118, DOI 10.1161/HYPERTENSIONAHA.111.187252; Paulis L, 2012, NAT REV CARDIOL, V9, P276, DOI 10.1038/nrcardio.2012.33; Tomiyama H, 2005, CIRC J, V69, P815, DOI 10.1253/circj.69.815; Laurent S, 2012, LANCET, V380, P591, DOI 10.1016/S0140-6736(12)60825-3; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; Shoji T, 2001, J AM SOC NEPHROL, V12, P2117; Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; Radhika G, 2007, J Assoc Physicians India, V55, P405; Chung N, 2008, INT J CLIN PRACT, V62, P1306, DOI 10.1111/j.1742-1241.2008.01838.x; Kagiyama S, 2009, CLIN EXP HYPERTENS, V31, P639, DOI 10.3109/10641960903407009; Aronow WS, 2011, J AM COLL CARDIOL, V57, P2037, DOI 10.1016/j.jacc.2011.01.008; Zheng LQ, 2010, EUR J CARDIOV PREV R, V17, P217, DOI 10.1097/HJR.0b013e328334f417; O'Seaghdha CM, 2009, HYPERTENSION, V54, P509, DOI 10.1161/HYPERTENSIONAHA.108.128413; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; Yui Y, 2004, HYPERTENS RES, V27, P181, DOI 10.1291/hypres.27.181; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; Ishikawa Y, 2008, HYPERTENS RES, V31, P1323, DOI 10.1291/hypres.31.1323; Park S, 2012, YONSEI MED J, V53, P258, DOI 10.3349/ymj.2012.53.2.258; Pandey KN, 2008, J AM SOC HYPERTENS, V2, P210, DOI 10.1016/j.jash.2008.02.001; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Kim JA, 2007, J HUM HYPERTENS, V21, P107, DOI 10.1038/sj.jhh.1002119; Kubo M, 2008, CIRCULATION, V118, P2672, DOI 10.1161/CIRCULATIONAHA.107.743211; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; Wang KL, 2010, HYPERTENSION, V55, P799, DOI 10.1161/HYPERTENSIONAHA.109.139964; Zhou B, 2013, J HUM HYPERTENS, V27, P427, DOI 10.1038/jhh.2012.63; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Franklin SS, 2001, HYPERTENSION, V37, P869; Ohishi M, 2011, HYPERTENS RES, V34, P1209, DOI 10.1038/hr.2011.117; Okada H, 2013, HYPERTENS RES, V36, P996, DOI 10.1038/hr.2013.66; Nakamura K, 2008, STROKE, V39, P1694, DOI 10.1161/STROKEAHA.107.496752; Aung Myo Nyein, 2012, Int J Gen Med, V5, P553, DOI 10.2147/IJGM.S29406; Cheng H, 2011, INT J CLIN PHARM-NET, V33, P215, DOI 10.1007/s11096-010-9476-8; Huxley R, 2006, INT J EPIDEMIOL, V35, P1025, DOI 10.1093/ije/dyl058; Davarian S, 2013, GERONTOLOGY, V59, P392, DOI 10.1159/000350531; Dong GH, 2008, INDIAN J MED RES, V128, P122; Duprez DA, 2008, AM J MED, V121, P179, DOI 10.1016/j.amjmed.2007.10.027; Feigin V, 2005, STROKE, V36, P1360, DOI 10.1161/01.STR.0000170710.95689.41; Franklin SS, 2012, J CLIN HYPERTENS, V14, P779, DOI 10.1111/j.1751-7176.2012.00703.x; Fujita T, 2006, INT J CLIN PRACT, V60, P3, DOI 10.1111/j.1742-1241.2006.01115.x; Gupta Rajeev, 2012, J Assoc Physicians India, V60, P11; Hatori N, 2012, J NIPPON MED SCH, V79, P69; He Sen, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P494; Chongsuvivatwong V, 2011, LANCET, V377, P429, DOI 10.1016/S0140-6736(10)61507-3; Huxley R, 2005, J WOMENS HEALTH, V14, P820; Ishikawa Shizukiyo, 2007, J Clin Hypertens (Greenwich), V9, P677, DOI 10.1111/j.1524-6175.2007.07102.x; Ishikawa Y, 2010, J HYPERTENS, V28, P1630, DOI 10.1097/HJH.0b013e32833a8b9f; JATOS Study Group, 2008, HYPERTENS RES, V31, P2115; Jonas JB, 2010, AM J HYPERTENS, V23, P347, DOI 10.1038/ajh.2009.276; Kang Dong Goo, 2009, J Korean Med Sci, V24, P800, DOI 10.3346/jkms.2009.24.5.800; Kario Kazuomi, 2013, Vasc Health Risk Manag, V9, P695, DOI 10.2147/VHRM.S50077; Kario K., 2013, HYPERTENS RES, V36, P564; Kawamoto R, 2008, TOHOKU J EXP MED, V216, P353, DOI 10.1620/tjem.216.353; Kawano Y, 2007, HYPERTENS RES, V30, P879, DOI 10.1291/hypres.30.879; Kengne AP, 2007, J HYPERTENS, V25, P1205; Law MR, 2009, BMJ-BRIT MED J, V338, pb1665; Lee HS, 2010, BLOOD PRESSURE, V19, P31, DOI 10.3109/08037050903424117; Lee JH, 2011, J KOREAN MED SCI, V26, P1286, DOI 10.3346/jkms.2011.26.10.1286; Li JJ, 2008, ACTA CARDIOL, V63, P389, DOI 10.2143/AC.63.3.1020317; Li Yi-chong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P409; Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579; Liu PH, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-133; Matsumura K, 2013, QJM-INT J MED, V106, P909, DOI 10.1093/qjmed/hct121; Matsuoka O, 2005, BIOMED PHARMACOTHER, V59, pS40, DOI 10.1016/S0753-3322(05)80008-3; Matsuzaki M, 2011, J HYPERTENS, V29, P1649, DOI 10.1097/HJH.0b013e328348345d; Meenakshisundaram R, 2009, ANN NY ACAD SCI, V1173, pE68, DOI 10.1111/j.1749-6632.2009.04958.x; Midha Tanu, 2010, Indian J Community Med, V35, P89, DOI 10.4103/0970-0218.62579; Morgan T, HYPERTENSION ASIAN P; National Heart Lung and Blood Institute US Department of Health and Human Services, 7 US DEP HLTH HUM SE; Ogihara T, 2004, HYPERTENS RES, V27, P657, DOI 10.1291/hypres.27.657; Park JB, 2006, KOREAN CIRC J, V36, P405; Park S, 2011, J HYPERTENS, V29, P1502, DOI 10.1097/HJH.0b013e3283486311; Park YH, 2013, EUR J CARDIOVASC NUR, V12, P17, DOI 10.1016/j.ejcnurse.2011.05.006; Pongwecharak J, 2011, J AM PHARM ASSOC, V51, P719, DOI 10.1331/JAPhA.2011.10129; Prisant LM, 2005, HYPERTENSION ELDERLY; Ratnasabapathy Y, 2003, DRUG AGING, V20, P241, DOI 10.2165/00002512-200320040-00001; Ruixing Yin, 2009, Public Health Nutr, V12, P553, DOI 10.1017/S1368980008002437; Sauvaget C, 2010, J EPIDEMIOL COMMUN H, V64, P366, DOI 10.1136/jech.2008.086777; Sheng CS, 2013, HYPERTENS RES, V36, P824, DOI 10.1038/hr.2013.57; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Shimamoto K, 2008, HYPERTENS RES, V31, P469, DOI 10.1291/hypres.31.469; Stamler Jeremiah, 1997, American Journal of Clinical Nutrition, V65, p626S; Starmans-Kool MJ, 2011, J APPL PHYSIOL, V110, P468, DOI 10.1152/japplphysiol.00917.2010; Strazzullo P, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4567; Sung SK, 2009, CLIN THER, V31, P1309, DOI 10.1016/j.clinthera.2009.06.011; Taylor EN, 2006, DIABETES CARE, V29, P1063; Uzu T, 2006, J HYPERTENS, V24, P1627, DOI 10.1097/01.hjh.0000239299.71001.77; Wang JG, 2000, ARCH INTERN MED, V160, P211, DOI 10.1001/archinte.160.2.211; Wang JG, 2011, HYPERTENS RES, V34, P423, DOI 10.1038/hr.2010.259; Wang LX, 2004, MED PRIN PRACT, V13, P282, DOI 10.1159/000079528; WHO Global Health Observatory, PREV RAIS BLOOD PRES; Williams B, 2006, LANCET, V368, P6, DOI 10.1016/S0140-6736(06)68943-5; Woodward M, 2005, EUR J CARDIOV PREV R, V12, P484; Woodward Mark, 2011, Womens Health (Lond Engl), V7, P305, DOI 10.2217/whe.11.25; Xu TY, 2011, CLIN EXP HYPERTENS, V33, P304, DOI 10.3109/10641963.2010.549261; Yang XM, 2007, J VASC SURG, V46, P296, DOI 10.1016/j.jvs.2007.03.034; Zhang XG, 2012, NUTRITION, V28, P46, DOI 10.1016/j.nut.2011.02.004; Zhao XS, 2012, AM J HYPERTENS, V25, P583, DOI 10.1038/ajh.2012.9	135	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	APR	2015	38	4					227	236		10.1038/hr.2014.169		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF3PJ	WOS:000352460700001		
J	Sufiun, A; Rafiq, K; Fujisawa, Y; Rahman, A; Mori, H; Nakano, D; Kobori, H; Ohmori, K; Masaki, T; Kohno, M; Nishiyama, A				Sufiun, Abu; Rafiq, Kazi; Fujisawa, Yoshihide; Rahman, Asadur; Mori, Hirohito; Nakano, Daisuke; Kobori, Hiroyuki; Ohmori, Koji; Masaki, Tsutomu; Kohno, Masakazu; Nishiyama, Akira			Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats	HYPERTENSION RESEARCH			English	Article						blood pressure; Dahl salt-sensitive rats; dipeptidyl peptidase-4 (DPP-4) inhibitors; dipping pattern	GLUCAGON-LIKE PEPTIDE-1; SENSITIVE RATS; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEART-RATE; DAHL RATS; VILDAGLIPTIN; NERVE; SITAGLIPTIN; METFORMIN	A growing body of evidence has indicated that dipeptidyl peptidase-4 (DPP-4) inhibitors have antihypertensive effects. Here, we aim to examine the effect of vildagliptin, a DPP-4-specific inhibitor, on blood pressure and its circadian-dipping pattern during the development of salt-dependent hypertension in Dahl salt-sensitive (DSS) rats. DSS rats were treated with a high-salt diet (8% NaCl) plus vehicle or vildagliptin (3 or 10 mg kg(-1) twice daily by oral gavage) for 7 days. Blood pressure was measured by the telemetry system. High-salt diet for 7 days significantly increased the mean arterial pressure (MAP), systolic blood pressure (SBP) and were also associated with an extreme dipping pattern of blood pressure in DSS rats. Treatment with vildagliptin dose-dependently decreased plasma DPP-4 activity, increased plasma glucagon-like peptide 1 (GLP-1) levels and attenuated the development of salt-induced hypertension. Furthermore, vildagliptin significantly increased urine sodium excretion and normalized the dipping pattern of blood pressure. In contrast, intracerebroventricular infusion of vildagliptin (50, 500 or 2500 mu g) did not alter MAP and heart rate in DSS rats. These data suggest that salt-dependent hypertension initially develops with an extreme blood pressure dipping pattern. The DPP-4 inhibitor, vildagliptin, may elicit beneficial antihypertensive effects, including the improvement of abnormal circadian blood pressure pattern, by enhancing urinary sodium excretion.	[Sufiun, Abu; Rafiq, Kazi; Rahman, Asadur; Nakano, Daisuke; Kobori, Hiroyuki; Nishiyama, Akira] Kagawa Univ, Fac Med, Dept Pharmacol, Miki, Kagawa 7610793, Japan; [Fujisawa, Yoshihide] Kagawa Univ, Fac Med, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Mori, Hirohito; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol, Miki, Kagawa 7610793, Japan; [Ohmori, Koji; Kohno, Masakazu] Kagawa Univ, Fac Med, Cardiorenal & Cerebrovasc Med, Miki, Kagawa 7610793, Japan	Rafiq, K (reprint author), Kagawa Univ, Fac Med, Dept Pharmacol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	kazir73@med.kagawa-u.ac.jp			Japan Society for the Promotion of Science (JSPS) (KAKENHI) [26460343]; JSPS Postdoctoral Fellowship for Foreign Researchers [P12420]	This study was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI; 26460343 to Akira Nishiyama). Kazi Rafiq is a recipient of a JSPS Postdoctoral Fellowship for Foreign Researchers (P12420).	Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Nakagami H, 2014, HYPERTENS RES, V37, P629, DOI 10.1038/hr.2014.53; Kamezaki F, 2013, HYPERTENS RES, V36, P398, DOI 10.1038/hr.2012.197; Bosi E, 2007, DIABETES CARE, V30, P890, DOI 10.2337/dc06-1732; STERZEL RB, 1988, KIDNEY INT, V33, P1119, DOI 10.1038/ki.1988.120; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Ingelsson E, 2006, JAMA-J AM MED ASSOC, V295, P2859, DOI 10.1001/jama.295.24.2859; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Yamamoto H, 2002, J CLIN INVEST, V110, P43, DOI 10.1172/JCI200215595; Mistry GC, 2008, J CLIN PHARMACOL, V48, P592, DOI 10.1177/0091270008316885; Pacheco BPM, 2011, J HYPERTENS, V29, P520, DOI 10.1097/HJH.0b013e328341939d; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Burkey BF, 2005, J PHARMACOL EXP THER, V315, P688, DOI 10.1124/jpet.105.087064; Yu M, 2003, J HYPERTENS, V21, P1125, DOI 10.1097/01.hjh.0000059046.65882.49; Fukuda M, 2004, KIDNEY INT, V65, P621, DOI 10.1111/j.1523-1755.2004.00419.x; Ogawa S, 2011, TOHOKU J EXP MED, V223, P133, DOI 10.1620/tjem.223.133; Okamoto LE, 2009, HYPERTENSION, V53, P363, DOI 10.1161/HYPERTENSIONAHA.108.124552; Ito O, 1999, HYPERTENSION, V33, P419; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Fukuda M, 2011, AM J PHYSIOL-RENAL, V301, pF953, DOI 10.1152/ajprenal.00167.2011; Pelisch N, 2011, AM J HYPERTENS, V24, P362, DOI 10.1038/ajh.2010.241; Shannon RP, 2013, DIABETES, V62, P1029, DOI 10.2337/db12-1794; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Mason RP, 2012, J CARDIOVASC PHARM, V60, P467, DOI 10.1097/FJC.0b013e31826be204; Kothny W, 2013, DIABETES OBES METAB, V15, P252, DOI 10.1111/dom.12020; Hirata K, 2009, BIOCHEM BIOPH RES CO, V380, P44, DOI 10.1016/j.bbrc.2009.01.003; BARRAGAN JM, 1994, AM J PHYSIOL, V266, pE459; BROWN DR, 1989, AM J PHYSIOL, V257, pR1225; CALHOUN DA, 1994, HYPERTENSION, V24, P1; Fujisawa Y, 2011, HYPERTENS RES, V34, P1228, DOI 10.1038/hr.2011.115; Fukuda M, 2006, MED HYPOTHESES, V67, P802, DOI 10.1016/j.mehy.2006.04.024; Jin Heung Yong, 2009, Arch Med Res, V40, P536, DOI 10.1016/j.arcmed.2009.09.005; Johansson ME, 2008, AM J PHYSIOL-REG I, V294, pR1240, DOI 10.1152/ajpregu.00493.2007; Moreno C, 2002, EUR J PHARMACOL, V434, P163, DOI 10.1016/S0014-2999(01)01542-4; Nagasu H, 2012, HYPERTENS RES, V35, P348, DOI 10.1038/hr.2011.184; Nishiyama A, 2004, J AM SOC NEPHROL, V15, P306, DOI 10.1097/01.ASN.0000108523.02100.E0; Shokoji T, 2003, HYPERTENSION, V41, P266, DOI 10.1161/01.HYP.0000049621.85474.CF; Sueta D, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000035; White WB, 2000, BLOOD PRESS MONIT, V5, pS17; White William B, 2007, J Manag Care Pharm, V13, P34	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	APR	2015	38	4					237	243		10.1038/hr.2014.173		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF3PJ	WOS:000352460700002		
J	Kurita, S; Takeuchi, K; Hayashi, Y; Ueyama, H; Zankov, DP; Pang, XL; Otsuka, T; Ohkubo, I; Ogikubo, O; Ogita, H				Kurita, Souichi; Takeuchi, Keisuke; Hayashi, Yoshimi; Ueyama, Hisao; Zankov, Dimitar P.; Pang, Xiaoling; Otsuka, Takanobu; Ohkubo, Iwao; Ogikubo, Osamu; Ogita, Hisakazu			Significance of serum Zn-alpha 2-glycoprotein for the regulation of blood pressure	HYPERTENSION RESEARCH			English	Article						blood pressure; serum protein; small G protein; transcription factor	LIPID-MOBILIZING FACTOR; CANCER CACHEXIA; WEIGHT-LOSS; ZINC-ALPHA(2)-GLYCOPROTEIN; MICE; ZINC-ALPHA-2-GLYCOPROTEIN; ACTIVATION; ZAG; RHO; ZN-ALPHA2-GLYCOPROTEIN	Zn-alpha 2-glycoprotein (ZAG) (molecular weight = 41 kDa) is one component in the alpha 2 fraction of human plasma, and is reported to be associated with several diseases, such as cancers and metabolic syndromes. ZAG is also considered to be an important modulator of lipid metabolism. However, little is known about the correlation of serum ZAG levels with indicators of metabolic syndrome. Serum ZAG concentrations analyzed by enzyme-linked immunoassay were positively correlated with systolic and diastolic blood pressure in 326 subjects (236 males and 90 females) aged 17-79 years who had an annual health examination. By luciferase reporter and electrophoretic mobility shift assays, the core promoter region to regulate the ZAG gene expression was found to exist between - 110 and - 101. The transcription factor Sp1 interacted with this region, and Sp1 knockdown experiments showed that Sp1 critically regulated ZAG expression. Furthermore, ZAG increased the active form of RhoA, which was determined by pull-down assay. Increased serum ZAG concentrations induced, at least partly, by Sp1 may cause an increase in vascular tone through the activation of RhoA and contribute to elevated blood pressure.	[Kurita, Souichi; Takeuchi, Keisuke; Ueyama, Hisao; Zankov, Dimitar P.; Pang, Xiaoling; Ohkubo, Iwao; Ogita, Hisakazu] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Otsu, Shiga 5202192, Japan; [Hayashi, Yoshimi; Otsuka, Takanobu; Ogikubo, Osamu] Nagoya City Univ, Dept Orthoped Surg, Nagoya, Aichi, Japan; [Ohkubo, Iwao] Tenshi Coll, Dept Nutr, Sapporo, Hokkaido, Japan; [Ogikubo, Osamu] Nagoya City Rehabil Hosp, Dept Orthoped, Nagoya, Aichi, Japan	Ogita, H (reprint author), Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	hogita@belle.shiga-med.ac.jp			Japan Society for the Promotion of Science; Takeda Science Foundation; Naito Foundation	We thank the members at the Central Research Laboratory, Shiga University of Medical Science, for their excellent technical assistance in this study. This study was supported by Grants-in-aid for Scientific Research from Japan Society for the Promotion of Science; Takeda Science Foundation; The Naito Foundation.	Mracek T, 2011, BRIT J CANCER, V104, P441, DOI 10.1038/sj.bjc.6606083; Pelham CJ, 2012, CELL METAB, V16, P462, DOI 10.1016/j.cmet.2012.08.011; Selva DM, 2009, J CLIN ENDOCR METAB, V94, P4499, DOI 10.1210/jc.2009-0758; Felix K, 2011, LIFE SCI, V88, P218, DOI 10.1016/j.lfs.2010.11.011; Hirai K, 1998, CANCER RES, V58, P2359; Rolli V, 2007, FEBS LETT, V581, P394, DOI 10.1016/j.febslet.2006.12.047; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Shimoyama S, 2014, BBA-GENE REGUL MECH, V1839, P107, DOI 10.1016/j.bbagrm.2013.12.004; Choi JW, 2012, CELL PHYSIOL BIOCHEM, V30, P295, DOI 10.1159/000339065; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Brysk MM, 1999, CANCER LETT, V137, P117, DOI 10.1016/S0304-3835(98)00347-4; Watanabe S, 2010, MOL BIOL CELL, V21, P3193, DOI 10.1091/mbc.E10-04-0324; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj/bjc/6600086; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345; Cao X, 2014, HYPERTENS RES, V37, P803, DOI 10.1038/hr.2014.90; Behuliak M, 2013, J HYPERTENS, V31, P2025, DOI 10.1097/HJH.0b013e328362adb3; Russell ST, 2010, ENDOCRINOLOGY, V151, P948, DOI 10.1210/en.2009-0827; BAGCHI MK, 1990, NATURE, V345, P547, DOI 10.1038/345547a0; BURGI W., 1961, JOUR BIOL CHEM, V236, P1066; Ceperuelo-Mallafre V, 2009, J CLIN ENDOCR METAB, V94, P5062, DOI 10.1210/jc.2009-0764; DIEZITZA I, 1993, EUR J CANCER, V29A, P1256, DOI 10.1016/0959-8049(93)90068-Q; Majima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068134; Marrades MP, 2008, J PHYSIOL BIOCHEM, V64, P61; Mracek T, 2010, CLIN ENDOCRINOL, V72, P334, DOI 10.1111/j.1365-2265.2009.03658.x; Mustafa S, 2010, MOL CELL BIOCHEM, V333, P203, DOI 10.1007/s11010-009-0220-4; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; OHKUBO I, 1990, BIOCHIM BIOPHYS ACTA, V1034, P152, DOI 10.1016/0304-4165(90)90069-9; Olofsson LE, 2010, METABOLISM, V59, P1316, DOI 10.1016/j.metabol.2009.12.006; Pietri P, 2014, HYPERTENS RES, V37, P452, DOI 10.1038/hr.2013.148; POORTMAN.JR, 1968, J LAB CLIN MED, V71, P807; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221; UEYAMA H, 1993, BIOCHEMISTRY-US, V32, P12968, DOI 10.1021/bi00211a004; Ueyama H, 1998, BIOCHEM BIOPH RES CO, V248, P852, DOI 10.1006/bbrc.1998.9064; Yang ML, 2013, DIABETES CARE, V36, P1074, DOI 10.2337/dc12-0940; Zhu HJ, 2014, ISRN ENDOCRINOL, V2014	37	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	APR	2015	38	4					244	251		10.1038/hr.2014.165		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF3PJ	WOS:000352460700003		
J	Furuhashi, M; Mita, T; Moniwa, N; Hoshina, K; Ishimura, S; Fuseya, T; Watanabe, Y; Yoshida, H; Shimamoto, K; Miura, T				Furuhashi, Masato; Mita, Tomohiro; Moniwa, Norihito; Hoshina, Kyoko; Ishimura, Shutaro; Fuseya, Takahiro; Watanabe, Yuki; Yoshida, Hideaki; Shimamoto, Kazuaki; Miura, Tetsuji			Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension	HYPERTENSION RESEARCH			English	Article						adipocyte; adipokine; insulin resistance; lipolysis	INSULIN SENSITIVITY; METABOLIC SYNDROME; TYPE-1 RECEPTOR; HEART-DISEASE; OBESITY; AP2; ATHEROSCLEROSIS; TELMISARTAN; ADIPOCYTES; BLOCKADE	Elevated circulating fatty acid-binding protein 4 (FABP4/A-FABP/aP2), an adipokine, is associated with obesity, insulin resistance, hypertension and cardiovascular events. However, how circulating FABP4 level is modified by pharmacological agents remains unclear. We here examined the effects of angiotensin II receptor blockers (ARBs) on serum FABP4 level. First, essential hypertensives were treated with ARBs: candesartan (8 mg day-1; n= 7) for 2 weeks, olmesartan (20 mg day-1; n= 9) for 12 weeks, and valsartan (80 mg day-1; n= 94) or telmisartan (40 mg day-1; n= 91) for 8 weeks added to amlodipine (5 mg day-1). Treatment with ARBs significantly decreased blood pressure and serum FABP4 concentrations by 8-20% without significant changes in adiposity or lipid variables, though the M value determined by hyperinsulinemic-euglycemic glucose clamp, a sensitive index of insulin sensitivity, was significantly increased by candesartan. Next, alterations in FABP4 secretion from 3T3-L1 adipocytes were examined under several agents. Lipolytic stimulation of the beta-adrenoceptor in 3T3-L1 adipocytes by isoproterenol increased FABP4 secretion, and conversely, insulin suppressed FABP4 secretion. However, treatment of 3T3-L1 adipocytes with angiotensin II or ARBs for 2 h had no effect on gene expression or secretion of FABP4 regardless of beta-adrenoceptor stimulation. In conclusion, treatment with structurally different ARBs similarly decreases circulating FABP4 concentrations in hypertensive patients as a class effect of ARBs, which is not attributable to blockade of the angiotensin II receptor in adipocytes. Reduction of FABP4 levels by ARBs might be involved in suppression of cardiovascular events.	[Furuhashi, Masato; Mita, Tomohiro; Hoshina, Kyoko; Ishimura, Shutaro; Fuseya, Takahiro; Watanabe, Yuki; Yoshida, Hideaki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido 0608543, Japan; [Moniwa, Norihito] Teine Keijinkai Hosp, Dept Nephrol, Sapporo, Hokkaido, Japan; [Shimamoto, Kazuaki] Sapporo Med Univ, Sapporo, Hokkaido, Japan	Furuhashi, M (reprint author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, S-1,W-16, Sapporo, Hokkaido 0608543, Japan.	furuhasi@sapmed.ac.jp			JSPS KAKENHI; Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Japan Diabetes Foundation; Takeda Medical Research Foundation; Ono Medical Research Foundation; Takeda Science Foundation; Akiyama Life Science Foundation; Yamaguchi Endocrine Research Foundation	We thank the members of SPEED investigators group for their cooperation in collection of data. MF has been supported by grants from JSPS KAKENHI, Uehara Memorial Foundation, SENSHIN Medical Research Foundation, Japan Diabetes Foundation, Takeda Medical Research Foundation, Ono Medical Research Foundation, Takeda Science Foundation, Akiyama Life Science Foundation and Yamaguchi Endocrine Research Foundation.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Fogari R, 2009, HORM METAB RES, V41, P893, DOI 10.1055/s-0029-1237359; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Shimoda S, 2012, INTERNAL MED, V51, P2091, DOI 10.2169/internalmedicine.51.7408; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Miyoshi T, 2011, HEART VESSELS, V26, P408, DOI 10.1007/s00380-010-0060-x; Takagi H, 2013, HYPERTENS RES, V36, P368, DOI 10.1038/hr.2012.196; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; van der Zijl NJ, 2011, DIABETES CARE, V34, P845, DOI 10.2337/dc10-2224; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Cabré A, 2007, Atherosclerosis, V195, pe150, DOI 10.1016/j.atherosclerosis.2007.04.045; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Furuhashi M., 2011, INT J INFLAM, V2011, DOI DOI 10.4061/2011/642612; Furuhashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027356; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Fuseya T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0126-7; Hasan AU, 2014, HYPERTENS RES, V37, P621, DOI 10.1038/hr.2014.51; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Krum H, 2001, Curr Hypertens Rep, V3 Suppl 1, pS17, DOI 10.1007/s11906-001-0067-x; Mita T, 2015, OBESITY, V23, P359, DOI 10.1002/oby.20954; Sharma AM, 2002, HYPERTENSION, V40, P609, DOI 10.1161/01.HYP.0000036448.44066.53; Yoshida H, 2014, HYPERTENS RES, V37, P225, DOI 10.1038/hr.2013.141	35	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	APR	2015	38	4					252	259		10.1038/hr.2015.2		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF3PJ	WOS:000352460700004		
J	Ito, S; Satoh, M; Tamaki, Y; Gotou, H; Charney, A; Okino, N; Akahori, M; Zhang, J				Ito, Sadayoshi; Satoh, Minoru; Tamaki, Yuko; Gotou, Hiromi; Charney, Alan; Okino, Naoko; Akahori, Mizuki; Zhang, Jack			Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction	HYPERTENSION RESEARCH			English	Article						angiotensin receptor neprilysin inhibitor; Japanese; LCZ696; renal dysfunction	CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE CONTROL; ATRIAL-NATRIURETIC-PEPTIDE; CONVERTING ENZYME-INHIBITORS; HEART-FAILURE; DOUBLE-BLIND; PROGRESSION; RISK; PROTEINURIA; SYSTEM	This 8-week, multi-center, open-label study assessed the safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction. Patients (n= 32) with mean sitting systolic blood pressure (msSBP) >= 140mmHg (after a 2-5-week washout of previous antihypertensive medications) and estimated glomerular filtration rate (eGFR) >= 15 and <60 ml min(-1) 1.73m(-2) received LCZ696 100 mg with an optional titration to 200 and 400 mg in a sequential manner starting from Week 2 in patients with inadequate BP control (msSBP >= 130 mm Hg and mean sitting diastolic blood pressure (msDBP) >= 80 mm Hg) and without safety concerns. Safety was assessed by monitoring and recording all adverse events (AEs) and change in potassium and creatinine. Efficacy was assessed as change from baseline in msSBP/msDBP. The mean baseline BP was 151.6/86.9mmHg, urinary albumin/creatinine ratio (UACR) geometric mean was 7.3 mg mmol(-1) and eGFR was >= 30 and <60 in 25 (78.1%) patients and was >= 15 and <30 in 7 (21.9%) patients. Fourteen (43.8%) patients reported at least one AE, which were mild in severity. No severe AEs or deaths were reported. There were no clinically meaningful changes in creatinine, potassium, blood urea nitrogen and eGFR. The geometric mean reduction in UACR was 15.1%, and the mean reduction in msSBP and msDBP was 20.5 +/- 11.3 and 8.3 +/- 6.3 mm Hg, respectively, from baseline to Week 8 end point. LCZ696 was generally safe and well tolerated and showed effective BP reduction in Japanese patients with hypertension and renal dysfunction without a decline in renal function.	[Ito, Sadayoshi] Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan; [Satoh, Minoru] Kawasaki Med Sch Hosp, Okayama, Japan; [Tamaki, Yuko; Gotou, Hiromi; Okino, Naoko; Akahori, Mizuki] Novartis Pharma KK, Tokyo, Japan; [Charney, Alan; Zhang, Jack] Novartis Pharmaceut, E Hanover, NJ USA	Ito, S (reprint author), Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	db554@mail.tains.tohoku.ac.jp			Novartis	Novartis is the sponsor of this study and prepared the study protocol. This study was supported by Novartis. All authors participated in the development and writing of the paper and approved the final manuscript for publication. The authors take full responsibility for the content of the paper and thank Hyosung Kim for statistical analysis (who was an employee of Novartis at the time of study completion and statistical analysis), Sandra Thompson for statistical review (who was an employee of Novartis at the time of statistical analysis) and Dr Madhavi Dokku (Novartis Healthcare) for assisting in the writing of this manuscript, collating comments from all authors and editing the final manuscript. We also thank all the clinical investigators and study coordinators at the participating centers (Shinagawa East one Medical Clinic, Miho Clinic, Minamino Heart Clinic, Koukan Clinic, Motomachi Takatsuka Naika Clinic, Anbe Heart Clinic, Ikeoka Clinic, Sapporo Century Hospital, Yoshida Memorial Hospital, Kotoni Medical Support Clinic, Kawahara Nephro-urological Clinic, Tohoku University Hospital, Kawasaki Medical School Hospital) and especially all the patients who participated in the study.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Boerrigter G, 2004, EXPERT OPIN INV DRUG, V13, P643, DOI 10.1517/13543784.13.6.643; Weber MA, 2014, J HYPERTENS, V32, P3, DOI 10.1097/HJH.0000000000000065; Klein IHHT, 2003, J AM SOC NEPHROL, V14, P3239, DOI 10.1097/01.ASN.0000098687.01005.A5; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932; Palmer BF, 2003, NEPHROL DIAL TRANSPL, V18, P1973, DOI 10.1093/ndt/gfg282; Vanderheyden M, 2004, EUR J HEART FAIL, V6, P261, DOI 10.1016/j.ejheart.2004.01.004; Kario K, 2014, HYPERTENSION, V63, P698, DOI 10.1161/HYPERTENSIONAHA.113.02002; Potter Lincoln R., 2009, V191, P341; Fliser D, 2005, J AM SOC NEPHROL, V16, P2456, DOI 10.1681/ASN.2005020179; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; BRENNER BM, 1990, PHYSIOL REV, V70, P665; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; Gardner DG, 2007, HYPERTENSION, V49, P419, DOI 10.1161/01.HYP.0000258532.07418.fa; Plantinga LC, 2009, HYPERTENSION, V54, P47, DOI 10.1161/HYPERTENSIONAHA.109.129841; Yano Y, 2012, KIDNEY INT, V81, P293, DOI 10.1038/ki.2011.346; Mangiafico S, 2013, EUR HEART J, V34, P886, DOI 10.1093/eurheartj/ehs262; O'Seaghdha CM, 2009, HYPERTENSION, V54, P509, DOI 10.1161/HYPERTENSIONAHA.108.128413; PETERSON JC, 1995, ANN INTERN MED, V123, P754; Agarwal R, 2009, CLIN J AM SOC NEPHRO, V4, P830, DOI 10.2215/CJN.06201208; Jafar TH, 2003, ANN INTERN MED, V139, P244; Baxter GF, 2004, BASIC RES CARDIOL, V99, P71, DOI 10.1007/s00395-004-0457-8; Charra Bernard, 2007, Hemodial Int, V11, P21, DOI 10.1111/j.1542-4758.2007.00148.x; Chopra Sandeep, 2011, Indian J Endocrinol Metab, V15 Suppl 4, pS281, DOI 10.4103/2230-8210.86860; Drawz PE, 2013, KIDNEY INT SUPPL, V3, P372, DOI 10.1038/kisup.2013.80; Japan nephrology society, 2013, NIHON JINZO GAKKAI S, V55, P585; Kalra PR, 2001, CARDIOVASC RES, V51, P495, DOI 10.1016/S0008-6363(01)00297-8; KIBERD BA, 1987, AM J PHYSIOL, V252, pF1112; Kidney Disease Outcomes Quality Initiative (K/DOQI), 2004, AM J KIDNEY DIS S, V43, pS65; Kobalava Z, 2010, CIRCULATION, V122; Konta T, 2012, AM J HYPERTENS, V25, P342, DOI 10.1038/ajh.2011.217; Mangrum AJ, 2004, SEMIN NEPHROL, V24, P168, DOI 10.1016/j.semnephrol.2003.11.001; Martinez-Castelao A, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-53; Peralta CA, 2005, HYPERTENSION, V45, P1119, DOI 10.1161/01.HYP.0000164577.81087.70; Plum J, 1998, J AM SOC NEPHROL, V9, P2223; Prosch LK, 2005, SCAND J UROL NEPHROL, V39, P242, DOI 10.1080/00365590510007810; Renkin EM, 1996, NEWS PHYSIOL SCI, V11, P138; RICHARDS AM, 1993, J HYPERTENS, V11, P407, DOI 10.1097/00004872-199304000-00011; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; Sarafidis PA, 2012, NEPHRON CLIN PRACT, V120, pC147, DOI 10.1159/000337571; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20	44	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	APR	2015	38	4					269	275		10.1038/hr.2015.1		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF3PJ	WOS:000352460700007		
J	Nezu, T; Hosomi, N; Aoki, S; Kubo, S; Araki, M; Mukai, T; Takahashi, T; Maruyama, H; Higashi, Y; Matsumoto, M				Nezu, Tomohisa; Hosomi, Naohisa; Aoki, Shiro; Kubo, Satoshi; Araki, Mutsuko; Mukai, Tomoya; Takahashi, Tetsuya; Maruyama, Hirofumi; Higashi, Yukihito; Matsumoto, Masayasu			Endothelial dysfunction is associated with the severity of cerebral small vessel disease	HYPERTENSION RESEARCH			English	Article						cerebral microbleeds; cerebral small vessel disease; endothelial dysfunction; white matter lesions	WHITE-MATTER LESIONS; POSITRON-EMISSION-TOMOGRAPHY; FLOW-MEDIATED VASODILATION; ARTERY OCCLUSIVE DISEASE; ISCHEMIC-STROKE; VASOMOTOR REACTIVITY; INTRACEREBRAL HEMORRHAGE; ACETAZOLAMIDE REACTIVITY; CEREBROVASCULAR-DISEASE; OXYGEN-METABOLISM	The pathogenesis of cerebral small vessel disease, a disease that involves white matter lesions (WMLs) and cerebral microbleeds (CMBs), is thought to be associated with endothelial dysfunction. Flow-mediated dilation (FMD) has been used to measure endothelium-dependent vasodilation. The aim of this study was to investigate the association between endothelial function (as measured by FMD) and cerebral small vessel disease. Patients with a history of cerebrovascular disease and comorbidities were enrolled in this study (n= 102; 69 males, 70.1 +/- 9.2 years). The patients were divided into two groups according to the severity of WMLs, which were assessed by Fazekas classification; grades 0 to 1 as mild WMLs group and grades 2 to 3 as severe WMLs group. A gradient-echo MRI was performed in 96 patients (94.1%) to evaluate whether CMBs were present. The patients in the severe WMLs group (n= 40) were older (P = 0.001), more frequently exhibited hypertension (P = 0.045) and diabetes mellitus (P = 0.026) and possessed lower FMD values (P<0.001) than the patients in the mild WMLs group (n= 62). CMBs were observed in 30 patients (31.3%). Using receiver operating characteristic curves, the optimal FMD cutoff values for predicting the presence of severe WMLs and CMBs were 3.9% and 3.7%, respectively. On multivariate logistic analysis, FMD <4.0% (odds ratio 9.50; 95% confidence interval 3.55-28.83) was independently associated with severe WMLs. Additionally, FMD <3.8% (5.82; 2.23-16.50) was also associated with the presence of CMBs. Endothelial dysfunction as evaluated by FMD may be predictive of the severity of cerebral small vessel disease.	[Nezu, Tomohisa; Hosomi, Naohisa; Aoki, Shiro; Kubo, Satoshi; Araki, Mutsuko; Mukai, Tomoya; Takahashi, Tetsuya; Maruyama, Hirofumi; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima 7348551, Japan; [Higashi, Yukihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Res Ctr Radiat Genome Med, Dept Cardiovasc Regenerat & Med, Hiroshima 7348551, Japan	Nezu, T (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	tomonezu@hiroshima-u.ac.jp	Maruyama, Hirofumi/B-9333-2011		Smoking Research Foundation; Tsuchiya Foundation; Japan Science and Technology Agency; Japan Heart Foundation	We express our gratitude to Takamichi Sugimoto, Shigeru Tanaka, Tomokazu Nishikawa, Hiroki Fujii, Hayato Matsushima, Yasuko Furuno, Miwako Sasanishi and Akemi Hironaka for their clinical research advice, ultrasonographic and technical assistance. This study was supported in part by research grants from the Smoking Research Foundation, the Tsuchiya Foundation, the Japan Science and Technology Agency and the Japan Heart Foundation.	Hoth KF, 2007, STROKE, V38, P308, DOI 10.1161/01.STR.0000254517.04275.3f; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kozera GM, 2010, AM J HYPERTENS, V23, P1198, DOI 10.1038/ajh.2010.152; Iwamoto Y, 2012, ARTERIOSCL THROM VAS, V32, P2295, DOI 10.1161/ATVBAHA.112.249680; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Lammie GA, 2002, BRAIN PATHOL, V12, P358; Maruhashi T, 2012, CIRCULATION, V126, P598, DOI 10.1161/CIRCULATIONAHA.112.105775; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; YAO H, 1992, STROKE, V23, P1673; Maruhashi T, 2013, ARTERIOSCL THROM VAS, V33, P1401, DOI 10.1161/ATVBAHA.112.300934; Birns J, 2009, J NEUROL NEUROSUR PS, V80, P1093, DOI 10.1136/jnnp.2009.174607; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351; Ras RT, 2013, INT J CARDIOL, V168, P344, DOI 10.1016/j.ijcard.2012.09.047; Ostlund E, 2013, HYPERTENS RES, V36, P1081, DOI 10.1038/hr.2013.81; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Stevenson SF, 2010, STROKE, V41, pE434, DOI 10.1161/STROKEAHA.109.569855; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Fornage M, 2008, STROKE, V39, P1952, DOI 10.1161/STROKEAHA.107.508135; Kalaria RN, 2012, STROKE, V43, P2526, DOI 10.1161/STROKEAHA.112.655803; Hosomi N, 2012, CEREBROVASC DIS, V34, P385, DOI 10.1159/000343659; MEGURO K, 1990, ANN NEUROL, V28, P378, DOI 10.1002/ana.410280313; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; HANDA N, 1995, STROKE, V26, P1781; YAO H, 1990, STROKE, V21, P1694; Neumann-Haefelin T, 2006, STROKE, V37, P2463, DOI 10.1161/01.STR.0000239321.53203.ea; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Bakker SLM, 1999, NEUROLOGY, V52, P578; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Schachinger V, 2000, CIRCULATION, V101, P1899; Palumbo V, 2007, NEUROLOGY, V68, P1020, DOI 10.1212/01.wnl.0000257817.29883.48; Pantoni L, 1997, STROKE, V28, P652; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Chen PL, 2006, NEUROLOGY, V67, P1056, DOI 10.1212/01.wnl.0000237526.32692.67; Fu JH, 2006, J NEUROIMAGING, V16, P120, DOI 10.1111/j.1552-6569.2006.00030.x; HIRANO T, 1994, J CEREBR BLOOD F MET, V14, P763; Isa K, 2013, HYPERTENS RES, V36, P980, DOI 10.1038/hr.2013.72; MAEDA H, 1993, STROKE, V24, P670; Nezu T, 2012, J CEREBR BLOOD F MET, V32, P844, DOI 10.1038/jcbfm.2011.190; Prettlar-Oblak J, 2006, STROKE, V37, P2540, DOI 10.1161/01.STR.0000239659.99112.fb; Suwaidi J A, 2000, Circulation, V101, P948	42	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	APR	2015	38	4					291	297		10.1038/hr.2015.4		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF3PJ	WOS:000352460700010		
J	Mohammad, AMA; Uchiyama, N; Sano, S				Mohammad, Abd El Khalick A. M.; Uchiyama, Naoki; Sano, Shigenori			Energy Saving in Feed Drive Systems Using Sliding-Mode-Based Contouring Control With a Nonlinear Sliding Surface	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article						Contouring control; energy saving; machine tool	GENERALIZED PREDICTIVE CONTROL; CROSS-COUPLED CONTROL; ERROR; TRACKING; DESIGN; ALGORITHM	Reduction of contour error, which is defined as the shortest distance between the actual position of the cutting tool and the reference trajectory, is an essential requirement in machining by multiaxis feed drive systems. In addition, because these machines operate all the time in industrial applications all over the world, reduction of the consumed energy in these machines contributes to environmental, natural resources, and energy problems. This paper presents a novel sliding mode contouring controller with a nonlinear sliding surface to improve the machining accuracy of the biaxial feed drive systems. Because the contour error is more important than the tracking error with respect to each feed drive axis, the contour error component is included in the proposed sliding surface. The advantage of including the contour error in the proposed sliding surface is that the damping ratio of the system changes from its initial low value to final high value as the contour error changes from high value to small value and vice versa. Hence, the proposed algorithm allows a closed-loop system to simultaneously achieve low energy consumption and small settling time, resulting in a smaller error. By using the proposed method, experimental results for a biaxial feed drive system show a significant performance improvement in terms of the contour error. In addition, the proposed approach reduces the control input variance by about 41.2% and 14.9% for x- and y-axis, respectively, and consumed energy by about 23.7% and 5.5% for the respective axis from the conventional method with a linear sliding surface.	[Mohammad, Abd El Khalick A. M.; Uchiyama, Naoki; Sano, Shigenori] Toyohashi Univ Technol, Dept Mech Engn, Toyohashi, Aichi 4418580, Japan	Mohammad, AMA (reprint author), Toyohashi Univ Technol, Dept Mech Engn, Toyohashi, Aichi 4418580, Japan.	abdelkhalick_m@rm.me.tut.ac.jp; uchiyama@tut.jp; sano@me.tut.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24560131]; Hori Sciences & Arts Foundation, Nagoya, Japan	Manuscript received January 25, 2013; revised June 21, 2013 and October 26, 2013; accepted November 16, 2013. Date of publication January 12, 2014; date of current version October 24, 2014. This work was supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grants-in-Aid for Scientific Research) Grant 24560131 and the Hori Sciences & Arts Foundation, Nagoya, Japan. Recommended by Technical Editor J. M. Berg.	Altintas Y, 2000, CIRP ANN-MANUF TECHN, V49, P265, DOI 10.1016/S0007-8506(07)62943-6; Su YX, 2005, MECHATRONICS, V15, P1005, DOI 10.1016/j.mechatronics.2005.03.003; Yang JZ, 2011, IEEE-ASME T MECH, V16, P643, DOI 10.1109/TMECH.2010.2048718; Hu CX, 2010, IEEE-ASME T MECH, V15, P728, DOI 10.1109/TMECH.2009.2032292; Ho HC, 1999, INT J MACH TOOL MANU, V39, P1619, DOI 10.1016/S0890-6955(98)00095-9; Zolgharni M, 2008, DIAM RELAT MATER, V17, P1733, DOI 10.1016/j.diamond.2007.11.012; Ho TH, 2012, IEEE-ASME T MECH, V17, P976, DOI 10.1109/TMECH.2011.2153866; Yao B, 2012, IEEE-ASME T MECH, V17, P622, DOI 10.1109/TMECH.2011.2111377; TOMIZUKA M, 1987, J DYN SYST-T ASME, V109, P65; Chiu GTC, 1997, P AMER CONTR CONF, P2731, DOI 10.1109/ACC.1997.611952; Li YM, 2010, IEEE-ASME T MECH, V15, P125, DOI 10.1109/TMECH.2009.2019956; Uchiyama N, 2009, INT J MACH TOOL MANU, V49, P876, DOI 10.1016/j.ijmachtools.2009.05.004; Vijayaraghavan A, 2010, CIRP ANN-MANUF TECHN, V59, P21, DOI 10.1016/j.cirp.2010.03.042; Yeh SS, 2002, IEEE-ASME T MECH, V7, P44; Hu CX, 2011, IEEE T IND ELECTRON, V58, P5195, DOI 10.1109/TIE.2011.2123859; Lin ZL, 1998, INT J CONTROL, V70, P1, DOI 10.1080/002071798222433; Mondal S, 2011, COMMUN NONLINEAR SCI, V16, P3760, DOI 10.1016/j.cnsns.2010.12.020; Boucher P., 1990, ANN CIRP, V39, P357; Chen SL, 2002, IEEE-ASME T MECH, V7, P329, DOI 10.1109/TMECH.2002.802723; Cheng M. Y., 2005, P IEEE ASME INT C AD, P1047; CLARKE DW, 1987, AUTOMATICA, V23, P149, DOI 10.1016/0005-1098(87)90088-4; CLARKE DW, 1987, AUTOMATICA, V23, P137, DOI 10.1016/0005-1098(87)90087-2; Dahmus J. B., 2004, P ASME INT MECH ENG; Dietmair A., 2009, MODERN MACH SCI J; El Khalick A., 2013, P IEEE INT C MECH VI, P822; El Khalick A., IEEE T IND IN PRESS; Fazeli A, 2012, IEEE-ASME T MECH, V17, P745, DOI 10.1109/TMECH.2011.2129525; Hu C., 2010, P IEEE ASME INT C AD, P750; Hu CX, 2010, IEEE T IND ELECTRON, V57, P1746, DOI 10.1109/TIE.2009.2030769; Koren Y, 1980, ASME, V102, P265; Lo C.-C., 1999, T ASME J DYN SYST ME, V121, P126; Newman S, 2012, CIRP J MANUF SCI TEC, V5, P127, DOI DOI 10.1016/J.CIRPJ.2012.03.007; Peng CC, 2007, INT J MACH TOOL MANU, V47, P1542, DOI 10.1016/j.ijmachtools.2006.11.008; Ramesh R, 2005, INT J MACH TOOL MANU, V45, P301, DOI 10.1016/j.ijmachtools.2004.08.008; Sencer B., 2009, T ASME J MANUF SCI E, V131; Tan Y. K., 2003, POWER ELECT DRIVE SY, V2, P1653; TORFS D, 1992, J DYN SYST-T ASME, V114, P347, DOI 10.1115/1.2897354; Weck M., 1990, ANN CIRP, V39, P437	38	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1083-4435	1941-014X		IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	APR	2015	20	2					572	579		10.1109/TMECH.2013.2296698		8	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	CF2GO	WOS:000352365800008		
J	Sariyildiz, E; Ohnishi, K				Sariyildiz, Emre; Ohnishi, Kouhei			An Adaptive Reaction Force Observer Design	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article						Adaptive control; disturbance observer (DOB); force control systems; reaction force observer (RFOB); robust control	MOTION CONTROL; DISTURBANCE OBSERVER; VALIDATION	In this paper, a new adaptive design method is proposed for reaction force observer (RFOB)-based robust force control systems. It is a well-known fact that an RFOB has several superiorities over a force sensor such as higher force control bandwidth, stability improvement, force-sensorless force control, and so on. However, there are insufficient analysis and designmethods for an RFOB-based robust force control system; therefore, its stability and performance highly depend on designers own experiences. To overcome this issue, a new stability analysis and a novel adaptive design method are proposed for RFOB-based robust force control systems. In the proposed adaptive design method, the design parameters of the robust force control system, i.e., the bandwidths of disturbance observer (DOB) and RFOB, the nominal and identified inertias in the design of DOB and RFOB, respectively, and the force control gain, are adjusted automatically by using an adaptive control algorithm which is derived by estimating the plant parameters and environmental impedance. The proposed adaptive design method provides good stability and performance by considering the design constraints of a DOB. The validity of the proposals is verified by simulation and experimental results.	[Sariyildiz, Emre; Ohnishi, Kouhei] Keio Univ, Dept Syst Design Engn, Ohnishi Lab, Yokohama, Kanagawa 2238522, Japan	Sariyildiz, E (reprint author), Keio Univ, Dept Syst Design Engn, Ohnishi Lab, Yokohama, Kanagawa 2238522, Japan.	emre@sum.sd.keio.ac.jp; ohnishi@sd.keio.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25220903]	Manuscript received September 20, 2013; revised January 12, 2014 and February 21, 2014; accepted April 7, 2014. Date of publication May 15, 2014; date of current version October 24, 2014. Recommended by Technical Editor R. Oboe. This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan under Grant-in-Aid for Scientific Research (S), 25220903, 2013.	Kobayashi H, 2007, IEEE T IND ELECTRON, V54, P3413, DOI 10.1109/TIE.2007.905948; DEWIT CC, 1995, IEEE T AUTOMAT CONTR, V40, P419; Ohnishi K, 1996, IEEE-ASME T MECH, V1, P56, DOI 10.1109/3516.491410; Boudaoud M, 2013, IEEE-ASME T MECH, V18, P1130, DOI 10.1109/TMECH.2012.2197216; Katsura S, 2007, IEEE T IND ELECTRON, V54, P530, DOI 10.1109/TIE.2006.885459; Tian DP, 2012, IEEE-ASME T MECH, V17, P488, DOI 10.1109/TMECH.2012.2187459; Bode H. W., 1949, NETWORK ANAL FEEDBAC; Hongbing Li, 2013, IEEE/ASME Transactions on Mechatronics, V18, DOI 10.1109/TMECH.2011.2163415; Katsura S, 2006, IEEE T IND ELECTRON, V53, P922, DOI 10.1109/TIE.2006.874262; Kim KY, 2013, IEEE-ASME T MECH, V18, P200, DOI 10.1109/TMECH.2011.2164929; Lu Q, 2013, IEEE-ASME T MECH, V18, P11, DOI 10.1109/TMECH.2011.2160555; Mortl A, 2012, INT J ROBOT RES, V31, P1656, DOI 10.1177/0278364912455366; MURAKAMI T, 1993, IEEE T IND ELECTRON, V40, P259, DOI 10.1109/41.222648; Sabanovic A., 2011, ADV MOTION CONTROL 2; Sariyildiz E, 2013, INT J CONTROL, V86, P1733, DOI 10.1080/00207179.2013.795663; Sariyildiz E, 2013, EUR J CONTROL, V19, P199, DOI 10.1016/j.ejcon.2013.03.009; Sariyildiz E., 2014, ASME T J DYN SYST ME, V136; Sariyildiz E., IEEE T IND IN PRESS; Tsuji T, 2009, IEEE T IND ELECTRON, V56, P510, DOI 10.1109/TIE.2008.2003208; Vasilyev Nikolay V, 2012, Future Cardiol, V8, P285, DOI 10.2217/fca.12.20; Yao B., 2010, P 11 IEEE INT WORKSH, P815; Zi-Jiang Y., IEEE T CONTROL SYSTE, V20, P1357	22	4	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1083-4435	1941-014X		IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	APR	2015	20	2					750	760		10.1109/TMECH.2014.2321014		11	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	CF2GO	WOS:000352365800025		
J	Zhu, HZ; Fujimoto, H				Zhu, Hongzhong; Fujimoto, Hiroshi			Mechanical Deformation Analysis and High-Precision Control for Ball-Screw-Driven Stages	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article						Ball-screw-driven stages; elastic deformation; friction compensation; zero-speed region	FRICTION MODEL; TRACKING CONTROL; SPEED CONTROL; COMPENSATION; BEHAVIOR; SIMULATION; SYSTEMS; DESIGN	Ball-screw-driven stages are widely used in industry for long-range and high-precision fabrication. One of the main difficulties in dealing with high-precision motion control is the nonlinear friction, which originates at elastic deformation of the mechanical components. In this paper, first, a novel mechanical model of a ball-screw-driven stage is proposed to analyze the elastic deformation dynamics under various motion conditions. It is achieved that the mechanical deformation characteristic of fast motions differs from the case of slow motions in the zero-speed region, and therefore, performing friction compensation should take the motion conditions into account. Then, based on this observation, a sinc-function-based friction compensation method for slow motions including both reverse motions and nonreverse motions and a Sigmoid-function-based friction compensation method for fast reverse motions are proposed to improve the control performance. Thanks to the very few parameters, the proposed methods can save much trouble in design and maintenance and are particularly suitable for control purposes. Finally, the advantages of the proposed methods are evaluated by experiments.	[Zhu, Hongzhong; Fujimoto, Hiroshi] Univ Tokyo, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan	Zhu, HZ (reprint author), Univ Tokyo, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan.	zhu@hflab.k.u-tokyo.ac.jp; fujimoto@k.u-tokyo.ac.jp			DMG Mori Seiki Co., Ltd.	Recommended by Technical Editor G. Liu. This work was supported in part by the DMG Mori Seiki Co., Ltd.	Amthor A, 2010, IEEE T AUTOMAT CONTR, V55, P274, DOI 10.1109/TAC.2009.2036307; UMENO T, 1991, IEEE T IND ELECTRON, V38, P363, DOI 10.1109/41.97556; Jamaludin Z, 2009, IEEE T IND ELECTRON, V56, P3848, DOI 10.1109/TIE.2009.2017560; Huang WS, 2010, IEEE T IND ELECTRON, V57, P420, DOI 10.1109/TIE.2009.2034178; Swevers J, 2000, IEEE T AUTOMAT CONTR, V45, P675, DOI 10.1109/9.847103; Iwasaki M, 2012, IEEE IND ELECTRON M, V6, P32, DOI 10.1109/MIE.2012.2182859; DEWIT CC, 1995, IEEE T AUTOMAT CONTR, V40, P419; Fujimoto H, 2001, IEEE T IND ELECTRON, V48, P636, DOI 10.1109/41.925591; Al-Bender F, 2005, IEEE T AUTOMAT CONTR, V50, P1883, DOI 10.1109/TAC.2005.858676; Altintas Y, 2011, CIRP ANN-MANUF TECHN, V60, P779, DOI 10.1016/j.cirp.2011.05.010; Lin CJ, 2013, IEEE-ASME T MECH, V18, P1385, DOI 10.1109/TMECH.2012.2202679; Lee HS, 1996, IEEE T IND ELECTRON, V43, P48; Boegli M, 2014, IEEE-ASME T MECH, V19, P1593, DOI 10.1109/TMECH.2013.2288944; Chen CL, 2004, PRECIS ENG, V28, P483, DOI 10.1016/j.precisioneng.2004.03.001; Dahl P. R., 1968, TOR0158310718 AER CO; Dietrich F, 2013, IEEE-ASME T MECH, V18, P1377, DOI 10.1109/TMECH.2012.2201495; Fukada S, 2011, PRECIS ENG, V35, P650, DOI 10.1016/j.precisioneng.2011.05.006; Ghaffari A, 2013, IEEE-ASME T MECH, V18, P922, DOI 10.1109/TMECH.2012.2195670; Hsieh C, 2000, WEAR, V242, P1, DOI 10.1016/S0043-1648(00)00399-9; Huo F, 2013, INT J ADV MANUF TECH, V64, P319, DOI 10.1007/s00170-012-4015-5; Jamaludin Z, 2008, AMC '08: 10TH INTERNATIONAL WORKSHOP ON ADVANCED MOTION CONTROL, VOLS 1 AND 2, PROCEEDINGS, P212; Lee TH, 2011, IEEE-ASME T MECH, V16, P133, DOI 10.1109/TMECH.2009.2036994; Maeda Y, 2014, IEEE T IND ELECTRON, V61, P1123, DOI 10.1109/TIE.2013.2242420; Maeda Y, 2013, IEEE T IND ELECTRON, V60, P3865, DOI 10.1109/TIE.2012.2205350; Ruderman M., 2013, IEEE T IND ELECTRON, V61, P3727; Ruderman M, 2013, MECH SYST SIGNAL PR, V39, P316, DOI 10.1016/j.ymssp.2013.03.010; Sakai S, 1995, IEEE IND ELEC, P615, DOI 10.1109/IECON.1995.483479; Shen JC, 2014, IEEE-ASME T MECH, V19, P788, DOI 10.1109/TMECH.2013.2260762; Varanasi KK, 2004, J DYN SYST-T ASME, V126, P388, DOI 10.1115/1.1771690; Zhu H., 2013, P IEEE 39 ANN C IND, P6537; Zhu HZ, 2013, J DYN SYST-T ASME, V135, DOI 10.1115/1.4007065	31	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1083-4435	1941-014X		IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	APR	2015	20	2					956	966		10.1109/TMECH.2014.2337933		11	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	CF2GO	WOS:000352365800044		
J	Matsuda, T; Maki, T; Sakamaki, T; Ura, T				Matsuda, Takumi; Maki, Toshihiro; Sakamaki, Takashi; Ura, Tamaki			State Estimation and Compression Method for the Navigation of Multiple Autonomous Underwater Vehicles With Limited Communication Traffic	IEEE JOURNAL OF OCEANIC ENGINEERING			English	Article						Autonomous underwater vehicle (AUV); clustering; multiple AUVs; particle filter		This study proposes a state estimation and compression method for navigating multiple autonomous underwater vehicles (AUVs) toward wide area surveys near seafloors. In the proposed method, a moving AUV navigates by referencing a stationary landmark AUV on the seafloor. By alternating the landmark role, all AUVs can cover a wide area while maintaining low positioning errors. The moving AUV estimates the states (positions and headings) of both moving and landmark AUVs by a stochastic approach called a particle filter. When AUVs exchange their landmark roles, they must share their estimated states. However, state sharing is precluded by the low data rate of acoustical communications in underwater environments. To overcome the problem, this paper proposes a state compression method in which AUVs approximate their states by "particle clustering" based on a clustering method (k-means) and a model evaluation method (Akaike information criterion). The compression method enables AUVs to share their states by communicating small amounts of data. The proposed method was evaluated in simulations of two AUVs navigating over a 300 x 300-m(2) seafloor area. Throughout the simulation, the proposed method maintained stable positioning and successful state sharing with small communication data size.	[Matsuda, Takumi; Maki, Toshihiro; Sakamaki, Takashi] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Ura, Tamaki] Kyushu Inst Technol, Fukuoka 8080196, Japan	Matsuda, T (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan.	matsuda@iis.u-tokyo.ac.jp; maki@iis.u-tokyo.ac.jp; sakamaki@iis.u-tokyo.ac.jp; ura@iis.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [12J06829]	This work was supported by the Japan Society for the Promotion of Science (JSPS) under Grant 12J06829.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Bingham B, 2010, J FIELD ROBOT, V27, P702, DOI 10.1002/rob.20350; Marsh L, 2013, DEEP-SEA RES PT II, V92, P124, DOI 10.1016/j.dsr2.2013.02.007; Caiti A, 2005, IEEE J OCEANIC ENG, V30, P140, DOI 10.1109/JOE.2004.841432; Kurazume R, 2000, AUTON ROBOT, V8, P43, DOI 10.1023/A:1008988801987; Techy L, 2010, J FIELD ROBOT, V27, P335, DOI 10.1002/rob.20335; Burgard W, 2005, IEEE T ROBOT, V21, P376, DOI 10.1109/TRO.2004.839232; Arthur D., 2007, P 18 ANN ACMSIAM S D, V8, P1027; Bahr A., 2009, P IEEE INT C ROB AUT, DOI [10.1109/ROBOT.2009.5152859, DOI 10.1109/ROBOT.2009.5152859]; Dunbabin M., 2005, P IEEE INT C ROB AUT, DOI [10.1109/ROBOT.2005.1570424, DOI 10.1109/ROBOT.2005.1570424]; Jung YS, 2009, INT J CONTROL AUTOM, V7, P615, DOI 10.1007/s12555-009-0412-4; Kunz C., 2008, P INT ROB SYST SEP, DOI [10.1109/IROS.2008.4651097, DOI 10.1109/IROS.2008.4651097]; MacQueen J., 1967, P 5 BERK S MATH STAT, P281, DOI DOI 10.1234/12345678; Maki T, 2013, IEEE J OCEANIC ENG, V38, P167, DOI 10.1109/JOE.2012.2210799; Maki T., 2007, P OCEANS EUR C JUN, DOI [10.1109/OCEANSE.2007.4302374, DOI 10.1109/OCEANSE.2007.4302374]; Matsuda T., 2012, P MTS IEEE OCEANS C, DOI [10.1109/OCEANS.2012.6405084, DOI 10.1109/OCEANS.2012.6405084]; Matsuda T, 2012, MAR TECHNOL SOC J, V46, P45; Nakatani T., 2009, P OCEANS EUR C MAY, DOI [10.1109/OCEANSE.2009.5278194, DOI 10.1109/0OCEANSE.2009.5278194]; Papadopoulos G., 2010, P INT ROB SYST OCT, DOI [10.1109/IROS.2010.5650250, DOI 10.1109/IROS.2010.5650250]; Rekleitis I. M., 2002, P INT ROB SYST, DOI [10.1109/IRDS.2002.1041676, DOI 10.1109/IRDS.2002.1041676]; Rui G., 2010, P OCEANS SYDN C MAY, DOI [10.1109/OCEANSSYD.2010.5603615, DOI 10.1109/OCEANSSYD.2010.5603615]; Thrun S., 2005, PROBABILISTIC ROBOTI, P96; Zaki M. J., 2014, DATA MINING ANAL FUN, P335	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0364-9059	1558-1691		IEEE J OCEANIC ENG	IEEE J. Ocean. Eng.	APR	2015	40	2					337	348		10.1109/JOE.2014.2323492		12	Engineering, Civil; Engineering, Ocean; Engineering, Electrical & Electronic; Oceanography	Engineering; Oceanography	CF9NH	WOS:000352891100009		
J	Okano, Y; Takatsuka, M; Mizutani, T; Fujisawa, S				Okano, Yoshinobu; Takatsuka, Masahiro; Mizutani, Terukazu; Fujisawa, Shingo			Novel Hybrid Antenna for Broadcasting Satellite and Terrestrial HD-TV	IEEE TRANSACTIONS ON ANTENNAS AND PROPAGATION			English	Article						Broadcasting Satellite (BS) service; field test; hybrid antenna; metal parabolic reflector; omnidirectional; terrestrial HD-TV	PARABOLIC-REFLECTOR ANTENNAS	High-definition television (HD-TV) is available via satellite broadcast and terrestrial HD-TV services. However, antennas that can receive HD-TV signals using different carrier waves (i.e., X band and UHF band) have not yet been designed. Therefore, in an effort to realize such an antenna, we created a slot aperture in the reflector of a typical Broadcasting Satellite (BS) antenna, and investigated its possible use as a UHF-band antenna element. Furthermore, a practical hybrid antenna for BS and terrestrial HD-TV was developed by implementing omnidirectional radiation in a parabolic reflector with a slot. This hybrid antenna exhibited excellent practical performance in a field test.	[Okano, Yoshinobu] Musashi Inst Technol, Setagaya Ku, Tokyo 1588557, Japan; [Takatsuka, Masahiro] NHK Japan Broadcasting Corp, Shibuya Ku, Tokyo 1508001, Japan; [Mizutani, Terukazu] NHK Japan Broadcasting Corp, Nagoya, Aichi 4618725, Japan; [Fujisawa, Shingo] DX Antenna Corp, Kobe, Hyogo 6512241, Japan	Okano, Y (reprint author), Musashi Inst Technol, Setagaya Ku, Tokyo 1588557, Japan.	y-okano@tcu.ac.jp; takatsuka.m-ic@nhk.or.jp; mizutani.t-gk@nhk.or.jp; s_fujisawa@dxantenna.co.jp					[Anonymous], 2003, STDB21 ARIB; TAFLOVE A, 1975, IEEE T MICROW THEORY, V23, P623, DOI 10.1109/TMTT.1975.1128640; Encinar JA, 2011, IEEE T ANTENN PROPAG, V59, P3255, DOI 10.1109/TAP.2011.2161449; [Anonymous], 2013, IND REV ELECT INFORM; RUDGE AW, 1978, P IEEE, V66, P1592, DOI 10.1109/PROC.1978.11170; Kawakami H, 2010, IEEE ANTENN PROPAG M, V52, P78, DOI 10.1109/MAP.2010.5723226; Chamberlain N., 2010, PHAS ARR SYST ECHN A, P381; Collin R., 1969, ANTENNA THEORY 2; Geterud EG, 2013, IEEE T ANTENN PROPAG, V61, P125, DOI 10.1109/TAP.2012.2220113; HASSELMANN FJV, 1982, IEEE T ANTENN PROPAG, V30, P677, DOI 10.1109/TAP.1982.1142868; KILDAL PS, 1980, IEEE T ANTENN PROPAG, V28, P210, DOI 10.1109/TAP.1980.1142300; Kunz K. S., 1993, FINITE DIFFERENCE TI; Luo YL, 2002, IEEE T ANTENN PROPAG, V50, P266; Morabito DD, 1999, IEEE ANTENNAS PROPAG, V41, P23, DOI 10.1109/74.789734; MRSTIK AV, 1981, IEEE T ANTENN PROPAG, V29, P455, DOI 10.1109/TAP.1981.1142617; Okano Y., 2010, IEEE INT C WIR INF T; Sanad M., 2010, P LOUGHB ANT PROP C, P285; Stutzman W. L., 1981, ANTENNA THEORY DESIG	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-926X	1558-2221		IEEE T ANTENN PROPAG	IEEE Trans. Antennas Propag.	APR	2015	63	4	1		SI		1425	1435		10.1109/TAP.2014.2382686		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CF6YI	WOS:000352702400026		
J	Iwai, D; Kodama, K; Sato, K				Iwai, Daisuke; Kodama, Kei; Sato, Kosuke			Reducing Motion Blur Artifact of Foveal Projection for a Dynamic Focus-Plus-Context Display	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS FOR VIDEO TECHNOLOGY			English	Article						Focus-plus-context (F plus C) display; projection display	SYSTEM	This paper presents a novel technique to reduce the motion blur artifacts of foveal projection in a dynamic focus-plus-context (DF+C) display. The DF+C display is generally configured with multiple projectors and provides a nonuniform spatial resolution that consists of high-resolution (hi-res) regions (foveal projection) and low-resolution regions (peripheral projection). A serious problem of the DF+C display is motion blur, which inevitably occurs when a foveal projection is moved by a pan-tilt mirror or gantry. We propose a solution that reduces the motion blur artifacts, and evaluate how this solution improves the image quality using both qualitative and quantitative experiments. Our proposed method defines an error function to assess the displayed image quality as the difference between an original hi-res image and the displayed image by considering the nonuniform spatial property of human visual acuity. Then, it decides the set of positions and moving techniques of foveal projections so that the sum of errors during a video sequence is minimized. Through experiment, we confirmed that the proposed method can provide a better image quality and significantly improve the motion blur artifacts when compared with a conventional DF+C display.	[Iwai, Daisuke; Kodama, Kei; Sato, Kosuke] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan	Iwai, D (reprint author), Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan.	daisuke.iwai@sys.es.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [22135003]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas Shitsukan under Grant 22135003, through the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This paper was recommended by Associate Editor A. Kaup.	Cao X, 2007, UIST 2007: PROCEEDINGS OF THE 20TH ANNUAL ACM SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P43; Raskar R, 2001, SPRING EUROGRAP, P89; Brady DJ, 2012, NATURE, V486, P386, DOI 10.1038/nature11150; Ashdown M., 2005, P 2005 IEEE COMP SOC, P1; Ashdown M, 2005, IEEE MULTIMEDIA, V12, P34, DOI 10.1109/MMUL.2005.18; Baudisch P., 2001, P 14 ANN ACM S US IN, P31; Chan LW, 2006, LECT NOTES COMPUT SC, V4159, P21; Chen KW, 2011, IEEE T MULTIMEDIA, V13, P1256, DOI 10.1109/TMM.2011.2165055; Cotting D, 2007, COMPUT GRAPH FORUM, V26, P685, DOI 10.1111/j.1467-8659.2007.01092.x; Feng YL, 2013, IEEE T MULTIMEDIA, V15, P1865, DOI 10.1109/TMM.2013.2272918; Godin G., 2004, P 10 EUR S VIRT ENV, P7; Hsiao CH, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P153; Hu T.-T., 2008, P IEEE TABL 08, P177; Iwamoto K., 2004, THESIS U TOKYO TOKYO; Kopf J, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1276377.1276494, 10.1145/1239451.1239544]; MAJUMDER A., 2007, PRACTICAL MULTIPROJE; Mitsugami I., 2005, P IAPR C MACH VIS AP, P492; Pirk S., 2012, P ACM SIGGRAPH AS TE; Staadt O. G., 2006, P 2006 ACM INT C VIR, P281, DOI 10.1145/1128923.1128971; Strasburger H., 2011, J VISION, V11, P1, DOI DOI 10.1167/11.5.13.[; Tsai Y.-P., 2003, P IEEE PROCAMS OCT; Wertheim T., 1894, Z PSYCHOL PHYSL SINN, V7, P172; Yamaguchi H., 1990, T I ELECT INF COMMUN, VJ73-C-II, P721; Yang RG, 2001, IEEE VISUAL, P167	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1051-8215	1558-2205		IEEE T CIRC SYST VID	IEEE Trans. Circuits Syst. Video Technol.	APR	2015	25	4					547	556		10.1109/TCSVT.2014.2352500		10	Engineering, Electrical & Electronic	Engineering	CF4DC	WOS:000352497800002		
J	Kamiya, T; Matsuoka, S; Kumada, A; Hidaka, K				Kamiya, Tomoki; Matsuoka, Shigeyasu; Kumada, Akiko; Hidaka, Kunihiko			High Voltage Measuring Apparatus Based on Kerr Effect in Gas	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Kerr effect; electric field measurement; optical phase modulation; lightning impulse; laser	ELECTRIC-FIELD; DIELECTRICS; CHARGE	In testing and monitoring electric power systems, a high voltage measuring system which covers wide frequency range is required. In this study, high voltage measuring apparatus based on Kerr effect in gas is developed. Parallel plate electrodes are placed in a chamber filled with gaseous material up to 0.5 MPa and the electric field between the electrodes is optically measured by Kerr effect in gas. Since the Kerr constant of gas is very small, a White cell structure is utilized to multiply the optical path length and an optical phase modulation technique is also introduced to improve the sensitivity of the measuring system. With the prototype system whose modulation frequency is 50 kHz, ac power-frequency voltage up to 130 kV is measured by using SF6, N-2, CO2, and CF3I as the Kerr material. With the modified system whose modulation frequency is raised above 200 MHz, lightning impulses up to 160 kV are measured by using CF3I whose Kerr constant is relatively high.	[Kamiya, Tomoki; Matsuoka, Shigeyasu; Kumada, Akiko; Hidaka, Kunihiko] Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo, Japan	Kamiya, T (reprint author), Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.						Kumada A, 2013, IEEE T POWER DELIVER, V28, P1306, DOI 10.1109/TPWRD.2013.2250315; Bottcher C. J. F., 1973, THEORY ELECT POLARIZ, VI; Breazeale WM, 1935, PHYS REV, V48, P237, DOI 10.1103/PhysRev.48.237; Bruce CW, 1933, PHYS REV, V44, P0682, DOI 10.1103/PhysRev.44.682; BUCKINGH.AD, 1968, T FARADAY SOC, V64, P1776, DOI 10.1039/tf9686401776; Hikita M, 1996, IEEE T DIELECT EL IN, V3, P80, DOI 10.1109/94.485518; Hippel R. V., 1995, DIELECTRIC MAT APPL; Kuffel E., 2000, HIGH VOLTAGE ENG FUN; Kumada A, 2002, J APPL PHYS, V92, P2875, DOI 10.1063/1.1499216; Kumada A., 2007, 15 INT S HIGH VOLT E; MAENO T, 1987, IEEE T ELECTR INSUL, V22, P503, DOI 10.1109/TEI.1987.298916; Shindo T., 1997, T96032 CRIEPI, P1; Torne A., 1985, IEEE INT C PROP APPL, V85, P61; Toyota H., 2005, IEEJ T FM, V125, P409, DOI 10.1541/ieejfms.125.409; Zahn M, 1998, IEEE T DIELECT EL IN, V5, P627, DOI 10.1109/94.729687	15	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	APR	2015	22	2					760	765		10.1109/TDEI.2014.004710		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF8GD	WOS:000352793300016		
J	Takami, J; Tsuboi, T; Yamamoto, K; Okabe, S; Baba, Y				Takami, Jun; Tsuboi, Toshihiro; Yamamoto, Keisuke; Okabe, Shigemitsu; Baba, Yoshihiro			FDTD Simulation Considering an AC Operating Voltage for Air-insulation Substation in Terms of Lightning Protective Level	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Transmission line; substation; incoming line; lightning surge; back-flashover; FDTD simulation; lightning impulse withstand voltage	BREAKDOWN CHARACTERISTICS; TRANSMISSION-LINES; SURGE; STROKES; IMPULSE; WIRE	The accuracy of lightning overvoltage evaluation of electrical equipment has been improved based on circuit analysis such as the Electro-magnetic Transients Program, but analyzing phenomena whose plane wave propagation (TEM) mode cannot be assumed remains unsolved. Since numerical analysis of electromagnetic fields such as the finite-difference time-domain (FDTD) method directly solves Maxwell's equations, it is an appropriate means for solving this issue. In this paper, the lightning surge waveform due to the back-flashover is analyzed using the FDTD method; bearing detailed modeling of transmission towers and incoming substation lines in mind. An open end of a circuit breaker of a 500 kV air-insulated substation was selected as the subject of analysis, and ac operation voltage was considered as an analysis condition. Following FDTD analysis, a 150 kA lightning stroke to the first tower, which is the standard lightning stroke of the lightning protection design, does not cause back-flashover, but a 200 kA lightning stroke to the first tower and a 150 kA lightning stroke to the second did do so. The flashover occurred in the later timing than the result of conventional circuit analysis, and the rise of the lightning surge was also slower. The voltage waveform of the open end of the circuit breaker reached its peak after repeating reflections, and the overvoltage value became lower than the circuit analysis. According to the FDTD analysis, the required withstand voltage value after the waveform evaluation with a 200 kA lightning stroke is 1,337 kV, which is lower than the present lightning impulse withstand voltage (LIWV) 1,550 kV. The lightning stroke current 200 kA is the value adopted in the lightning protection design of the UHV system. Therefore, the existing air-insulated substation equipment is considered highly capable of withstanding overvoltage at the time of a back-flashover.	[Takami, Jun; Tsuboi, Toshihiro; Yamamoto, Keisuke; Okabe, Shigemitsu] Tokyo Elect Power Co Ltd, Tsurumi Ku, Yokohama, Kanagawa 2308510, Japan; [Baba, Yoshihiro] Doshisha Univ, Kyoto 6100321, Japan	Takami, J (reprint author), Tokyo Elect Power Co Ltd, Tsurumi Ku, 4-1 Egasaki Cho, Yokohama, Kanagawa 2308510, Japan.						Ametani A, 2005, IEEE T POWER DELIVER, V20, P867, DOI 10.1109/TPWRD.2004.839183; Noda T, 2002, IEEE T POWER DELIVER, V17, P840, DOI 10.1109/TPWRD.2002.1022813; Takami J, 2007, IEEE T POWER DELIVER, V22, P537, DOI 10.1109/TPWRD.2006.887102; Takami J, 2013, IEEE T DIELECT EL IN, V20, P739, DOI 10.1109/TDEI.2013.6518943; [Anonymous], 2004, 600714 IEC TR; Baba Y., IEEE T ELEC IN PRESS; CIGRE Study Committee 33 - Working Group 01, 1991, GUID PROC EST LIGHT, V63; CIGRE Working Group C4.306, 2013, C4306 CIGRE WORK GRO; CIGRE Working Group C4.501, 2013, C4501 CIGRE WORK GRO; LIAO ZP, 1984, SCI SIN A-MATH P A T, V27, P1063; Motoyama H, 1996, IEEE T POWER DELIVER, V11, P972, DOI 10.1109/61.489359; Noda T., 2005, INT C POW SYST TRANS; Okabe S, 2009, IEEE T DIELECT EL IN, V16, P42, DOI 10.1109/TDEI.2009.4784550; Okabe S, 2011, IEEE T DIELECT EL IN, V18, P182, DOI 10.1109/TDEI.2011.5704509; Scott-Meyer W., 1984, EMTP RULE BOOK; Takami J, 2014, IEEE T DIELECT EL IN, V21, P1044, DOI [10.1109/TDEI.2014.6832247, 10.1109/TDEI.2014.004497]; Takami J, 2014, IEEE T DIELECT EL IN, V21, P96, DOI [10.1109/TDEI.2014.6740730, 10.1109/TDEI.2013.004059]; Tatematsu A., 2007, H06006 CRIEPI; Tatematsu A., 2013, H13009 CRIEPI; Tatematsu A., 2010, IEEJ TRANS PE, V130, P373; Tatematsu A, 2014, IEEE T ELECTROMAGN C, V56, P159, DOI 10.1109/TEMC.2013.2272652; The Fast Front Task Force of the IEEE Modeling and Analysis of System Transients Working Group, 1999, IEEE RES SPEC PUBL, VTP-133-0; Working Group of IEE Japan, 2002, 872 WORK GROUP IEE J	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	APR	2015	22	2					806	814		10.1109/TDEI.2014.004944		9	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF8GD	WOS:000352793300022		
J	Tsuboi, T; Takami, J; Okabe, S; Kido, T; Maekawa, T				Tsuboi, Toshihiro; Takami, Jun; Okabe, Shigemitsu; Kido, Takayuki; Maekawa, Toshihiro			Energy Absorption Capacity of a 500 kV Surge Arrester for Direct and Multiple Lightning Strokes	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						500 kV surge arrester; energy duty; direct lightning; multiple lightning	SIZED TRANSMISSION-LINES	Damage to 500 kV surge arresters occurred due to direct and multiple lightning strokes. The present paper initially analyzes the mechanism of how the surge arresters were damaged based on the accident investigative results and evaluates the energy absorption capacity of existing surge arresters by analyzing the energy absorbed when the surge arresters were damaged. Consequently, the damage was confirmed as attributable by the crack of ZnO elements due to the thermal stress sustained when absorbing the energy of direct and multiple lightning strokes. The damage energy was estimated at about 5.4 MJ. Subsequently, based on the lightning observation data according to the lightning location system and the lightning outage rate of transmission lines, the standard lightning-stroke conditions were determined, the required energy absorption capacity of the surge arresters was analyzed and determined to be less than 5.3 MJ. Although the energy absorbed in the above damage cases exceeds this required energy absorption capacity, it is still considered within the variable range of lightning events. Consequently, existing surge arresters have the required energy absorption capacity and the cases involving damage to surge arresters are considered extremely rare.	[Tsuboi, Toshihiro; Takami, Jun; Okabe, Shigemitsu] Tokyo Elect Power Co Ltd, R&D Ctr, High Voltage & Insulat Grp, Tsurumi Ku, Yokohama, Kanagawa 2308510, Japan; [Kido, Takayuki; Maekawa, Toshihiro] Tokyo Elect Power Co Ltd, Chiyoda Ku, Tokyo 1008560, Japan	Tsuboi, T (reprint author), Tokyo Elect Power Co Ltd, R&D Ctr, High Voltage & Insulat Grp, Tsurumi Ku, 4-1 Egasaki Cho, Yokohama, Kanagawa 2308510, Japan.						[Anonymous], 1999, C6211 IEEE; Taniguchi S, 2010, IEEE T DIELECT EL IN, V17, P53, DOI 10.1109/TDEI.2010.5412002; [Anonymous], 2003, JEC23712003; [Anonymous], 2009, 600994 IEC; Taniguchi S, 2009, IEEE T DIELECT EL IN, V16, P552, DOI 10.1109/TDEI.2009.4815191; Berger K., 1975, ELECTRA, V41, P23; Dommel H. W., 1992, EMTP THEORY BOOK; IEEJ Surge Arresters Investigation R & D Committee, 2009, 1173 IEEEJ; Kingery W. D., 1976, INTRO CERAMICS; Nagaoka N., 1991, T IEE JAPAN B, V111-B, P529; Subcommittee for Power stations and Substations Study Committee on Lightning Risk, 2012, H06 EL POW ENG RES L, P37; Suda T., 2002, INT C LIGHTN PROT IC, P111; Tsuboi T, 2013, IEEE T DIELECT EL IN, V20, P2277, DOI 10.1109/TDEI.2013.6678880; Xu ZY, 2008, IEEE T POWER DELIVER, V23, P1795, DOI 10.1109/TPWRD.2008.919038	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	APR	2015	22	2					916	924		10.1109/TDEI.2014.004864		9	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF8GD	WOS:000352793300035		
J	Kikuchi, Y; Yamashita, K; Matsuoka, S; Kumada, A; Hidaka, K; Tatamidani, K; Masuda, T				Kikuchi, Yuto; Yamashita, Kenji; Matsuoka, Shigeyasu; Kumada, Akiko; Hidaka, Kunihiko; Tatamidani, Kazuaki; Masuda, Takato			Partial Discharge Characteristics in Composite Insulation Systems with PPLP (R) for HTS Cable	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						high-temperature superconducting cable; partial discharge; polypropylene laminated paper	PROGRAM	The electrical insulation system of high-temperature superconducting (HTS) cable consists of liquid nitrogen (N-2(l)) and polypropylene laminated paper (PPLP (R)). Partial discharge (PD) may occur in butt gaps of the insulation layers and its characteristics imply the insulation performance of HTS cables. N-2(l) cooling system is installed in the power system and N-2(l) will flow through the cables during the system operation. Filling the HTS cable with N-2(l) in order to perform pre-shipment inspection is time-consuming and costly for cable manufacturers. Therefore, the authors are trying to find a cost effective method for pre-shipment inspections. One alternative is to use high pressure gaseous nitrogen (N2(g)) instead of N-2(l). This article investigates PD characteristics such as PD inception electric field (PDIE) and PD extinction electric field (PDEE) in butt gaps of HTS cables in 0.1-MPa to 0.3-MPa N-2(l) and 0.1-MPa to 1.0-MPa N-2(g) environments. For assessing the surface/volume effects, PD characteristics are measured with changing the size of butt gaps. It turns out that PDIE and PDEE in N-2(g) are linearly correlated with those in N-2(l) at any gas pressure in our testing, and PDIE in 1.0-MPa N-2(g) is almost 30% of that in 0.2-MPa N-2(l). It suggests that PD characteristics in N-2(l) can be extrapolated from those in N-2(g).	[Kikuchi, Yuto; Yamashita, Kenji; Matsuoka, Shigeyasu; Kumada, Akiko; Hidaka, Kunihiko] Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo, Japan; [Tatamidani, Kazuaki; Masuda, Takato] Sumitomo Elect Ind Ltd, Osaka 5540024, Japan	Kikuchi, Y (reprint author), Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo, Japan.						Honjo S, 2011, IEEE T APPL SUPERCON, V21, P967, DOI 10.1109/TASC.2010.2092744; Weber CS, 2005, IEEE T APPL SUPERCON, V15, P1793, DOI 10.1109/TASC.2005.849290; Hayakawa N., 2008, IEEE INT C DIEL LIQ, P1; Kwag DS, 2006, IEEE T APPL SUPERCON, V16, P1618, DOI 10.1109/TASC.2006.870519; Kwag DS, 2005, IEEE T APPL SUPERCON, V15, P1731, DOI 10.1109/TASC.2005.849268; Rezaeifar F, 2010, IEEE T DIELECT EL IN, V17, P1747, DOI 10.1109/TDEI.2010.5658225; Ryu KS, 2006, SUPERCOND SCI TECH, V19, pS102, DOI 10.1088/0953-2048/19/3/014; Ueda K, 2003, IEEE T APPL SUPERCON, V13, P1946, DOI 10.1109/TASC.2003.812973	8	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	APR	2015	22	2					1025	1030		10.1109/TDEI.2014.004657		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF8GD	WOS:000352793300047		
J	Tanaka, K; Kojima, H; Onoda, M; Suzuki, K				Tanaka, Kiyoteru; Kojima, Hiroaki; Onoda, Mitsuru; Suzuki, Keiji			Prediction of Residual Breakdown Electrical Field Strength of Epoxy-Mica Paper Insulation Systems for the Stator Winding of Large Generators	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Large generator; stator winding; diagnosis of epoxy-mica paper insulation system; prediction of residual breakdown strength; tip-up; voltage-charge pattern; mechanical aging; thermal and mechanical aging; thermal aging		A method of predicting the residual breakdown electrical field strength of an epoxy-mica paper insulation system is described. This method was developed by using data on service-aged stator bars from generators as well as accelerated aging model bars. Thermal aging, mechanical aging, and combined thermal and mechanical aging were done individually as accelerated aging. The partial discharge characteristics, dissipation factor, and breakdown voltage were measured on the model bars and service-aged bars from generators. From these results, the residual breakdown electrical field strength was predicted based on the partial discharge characteristics and dissipation factor. First, the dominant type of deterioration (thermal or mechanical aging) on a bar's insulation was determined by the pattern of voltage-partial discharge magnitude characteristics. Then the residual breakdown electrical field strength was predicted by using a predicting equation for both thermal and mechanical aging. Each predicting equation uses dissipation factor tip-up (i.e. difference in dissipation factor values between 2 kV and rated voltage) and partial discharge inception electrical field strength. The accuracy of this method was confirmed using data measured on 112 service-aged stator bars from generators and 10 accelerated aged model bars. The 95% confidence interval level included 94% of the measured residual breakdown electrical field strength values. This result shows that the method enables precise predictions of the residual breakdown electrical field strength of an epoxy-mica paper insulation system.	[Tanaka, Kiyoteru] Mitsubishi Hitachi Power Syst Ltd, Ctr Res & Dev, Hitachi, Ibaraki 3170073, Japan; [Kojima, Hiroaki] Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3191292, Japan; [Onoda, Mitsuru; Suzuki, Keiji] Mitsubishi Hitachi Power Syst Ltd, Hitachi Works, Hitachi, Ibaraki 3178511, Japan	Tanaka, K (reprint author), Mitsubishi Hitachi Power Syst Ltd, Ctr Res & Dev, 3-1-1 Saiwai Cho, Hitachi, Ibaraki 3170073, Japan.						Frahani M., 2005, IEEE T DIELECT EL IN, V21, P5; Ikeda Y., 1996, REPORT CENTRAL RES I, VW95517; Kadotani K., 1981, IEEE T PAS SEPT, P4136; KAKO Y, 1987, IEEE T ELECTR INSUL, V22, P69, DOI 10.1109/TEI.1987.298967; Montanari GC, 2006, ICPASM 2005: Proceedings of the 8th International Conference on Properties and Applications of Dielectric Materials, Vols 1 and 2, P1; Stone G. C., 2010, IEEE INT S EL INS, P1; Stone G. C., 2003, ELECT INSULATION ROT	7	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	APR	2015	22	2					1118	1123		10.1109/TDEI.2014.004409		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF8GD	WOS:000352793300056		
J	Wu, J; Miyahara, A; Khan, A; Iwata, M; Toyoda, K; Cho, MG; Zheng, XQ				Wu, Jiang; Miyahara, Akira; Khan, Arifur; Iwata, Minoru; Toyoda, Kazuhiro; Cho, Mengu; Zheng, Xiaoquan			Effects of Space Environmental Exposure on Photoemission Yield of Polyimide	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Photoemission yield; electron and proton radiation effects; ultraviolet radiation effects; atomic oxygen; degradation; polyimide films	IRRADIATED POLYIMIDE; DEGRADATION; RADIATION	As photoemission plays a key role in surface potential of spacecraft materials in sunlight, the photoemission yield of spacecraft used polyimide film is required for surface potential analysis. To reveal the space environmental effects on the photoemission, the ground based degradations of polyimide film due to 500 keV electrons and 50 keV protons irradiation with 4 different fluences respectively, ultraviolet irradiation with 5 different doses, and atomic oxygen beam erosion with 2 different fluences were conducted separately. By using a developed measuring system, we measured the photoemission yield of the virgin and the 4 kinds of degraded polyimide films respectively and compared the results. It is inferred that, the variation of photoemission yield was obvious after electrons, protons and ultraviolet irradiation but slight for atomic oxygen erosion. The variation of photoemission yield has been explained from the viewpoint of surface reflectance, roughness, and the free radical concentration of the exposed samples. Besides, the Monte-Carlo analysis software Casino and SRIM were used to analysis the distribution and stopping power of electron and proton respectively. It is considered that, the degradation mechanism is the multiple effects of reflectance, free radicals and so forth.	[Wu, Jiang; Zheng, Xiaoquan] Xi An Jiao Tong Univ, Dept Elect Engn, Xian 710049, Shaanxi, Peoples R China; [Wu, Jiang; Miyahara, Akira; Khan, Arifur; Iwata, Minoru; Toyoda, Kazuhiro; Cho, Mengu] Kyushu Inst Technol, Dept Elect Engn, Kitakyushu, Fukuoka 8040015, Japan	Wu, J (reprint author), Xi An Jiao Tong Univ, Dept Elect Engn, 28 Xianning West Rd, Xian 710049, Shaanxi, Peoples R China.						GRARD RJL, 1973, J GEOPHYS RES, V78, P2885, DOI 10.1029/JA078i016p02885; Artiaga R, 2005, NUCL INSTRUM METH B, V236, P432, DOI 10.1016/j.nimb.2005.04.013; Chen Y., 2012, 12 SPAC CHARG TECHN; Cho M, 2012, IEEE T PLASMA SCI, V40, P1248, DOI 10.1109/TPS.2012.2187074; Dever J. A., 1994, P FLIGHT VEH MAT STR, P422; Dever J. A., 2001, HIGH PERFORM POLYM, V13, P391; Dressler R. A., 2001, CHEM DYNAMICS EXTREM; Feuerbacher B., 1972, J APPL PHYS, V43; Glicklin M. J., 2012, THESIS CALIFORNIA PO; Hastings D., 1996, SPACE ENV INTERACTIO; HILL DJT, 1995, J APPL POLYM SCI, V58, P1847, DOI 10.1002/app.1995.070581023; Lai S. T., 2011, FUNDAMENTALS SPACECR, P60; Nitta K, 2010, INT SYM DISCH ELECTR, P551; Nomura K., 2012, 12 SPAC CHARG TECHN; Peng GR, 2004, J APPL POLYM SCI, V94, P1370, DOI 10.1002/app.20920; Rasmussen K., 2012, ACS APPL MATH INT, V2, P1879; Sun CY, 2012, NUCL INSTRUM METH B, V271, P61, DOI 10.1016/j.nimb.2011.10.007; Wu J., IEEE T PLASMA UNPUB; Wu YY, 2010, POLYM DEGRAD STABIL, V95, P1219, DOI 10.1016/j.polymdegradstab.2010.03.033; Yue L, 2012, NUCL INSTRUM METH B, V291, P17, DOI 10.1016/j.nimb.2012.09.008	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	APR	2015	22	2					1204	1212		10.1109/TDEI.2014.004442		9	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF8GD	WOS:000352793300066		
J	Takada, T; Kikuchi, H; Miyake, H; Tanaka, Y; Yoshida, M; Hayase, Y				Takada, T.; Kikuchi, H.; Miyake, H.; Tanaka, Y.; Yoshida, M.; Hayase, Y.			Determination of Charge-trapping Sites in Saturated and Aromatic Polymers by Quantum Chemical Calculation	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Quantum chemical calculation; DFT; space charge; charge-trapping site; saturated polymer; aromatic polymer	POLYETHYLENE	We studied the trapping of positive and negative charges in the chemical structures of polymers under a high electric field using a space charge measurement system. Positive charges accumulated in low-density polyethylene (LDPE), whereas positive and negative charges accumulated in polyimide (Kapton (R)) and also in ethylene tetrafluoroethylene (ETFE) subjected to electron beam irradiation. To determine the charge-trapping sites in the chemical structures, a quantum chemical calculation was carried out using Density Function Theory (DFT) with Gaussian 09. The relationship between the energy band and the isosurface of orbital electrons at various energy levels was obtained. A three-dimensional (3D) electrostatic potential distribution map was obtained for positively and negatively charged polymers to determine the relationship between a trapping site and the charge accumulation center in the 3D potential distribution map. Positive and negative charges in Kapton and ETFE films are trapped in trapping sites in chemical structures and the positive charges in an LDPE film are trapped in physical defects.	[Takada, T.; Kikuchi, H.; Miyake, H.; Tanaka, Y.; Yoshida, M.] Tokyo City Univ, Setagaya Ku, Tokyo 1588557, Japan; [Hayase, Y.] Fuji Elect Co Ltd, Hino, Tokyo 1918502, Japan	Takada, T (reprint author), Tokyo City Univ, Setagaya Ku, 1-28-1 Tamazutsumi, Tokyo 1588557, Japan.						Serra S, 2000, PHYS REV B, V62, P4389, DOI 10.1103/PhysRevB.62.4389; Fairley P., 2013, IEEE SPECTRUM, P32; Frisch A., 2009, GAUSSIAN 09 USERS RE; IEC Technical Specification, 2012, 62758 IEC TS; Inuishi Y., 1974, IEEJ, V94, P779; Kumagai J., 2013, IEEE SPECTRUM, P38; Meunier M, 2000, J CHEM PHYS, V113, P369, DOI 10.1063/1.481802; Meunier M., 2001, J CHEM PHYS, V115, P2867; Nagasawa K., 2010, IEEJ T IEE, V5, P412; Qin S, 2012, IEEE ELECTR INSUL M, V28, P36, DOI 10.1109/MEI.2012.6340523; Takada T, 1999, IEEE T DIELECT EL IN, V6, P519, DOI 10.1109/94.798112; Takada T., 2012, IEEJ TECHN M; Wang Y, 2013, IEEE INT C SOL DIEL, P19	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	APR	2015	22	2					1240	1249		10.1109/TDEI.2014.004460		10	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF8GD	WOS:000352793300070		
J	Wada, J; Ueta, G; Okabe, S; Amimoto, T				Wada, Junichi; Ueta, Genyo; Okabe, Shigemitsu; Amimoto, Tsuyoshi			Method to Evaluate the Degradation Condition of Transformer Insulating Oil - Establishment of the Evaluation Method and Application to Field Transformer Oil	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Insulating oil; aging; dissociation property; breakdown voltage; dissipation factor; volume resistivity; evaluation method	COMPONENTS	To operate power transformers long-term, as well as ensuring their insulating reliability, it is important to study age-related decline in various insulating oil characteristics and the method used to evaluate the same adequately. Previous studies showed that age-related decline in insulating oil characteristics was caused by trace components in oil produced during oxidation degradation. To maintain and manage aged insulating oil rationally, a specific diagnostic method must be studied, based on measurement of the trace components in oil that cause degradation in these insulating oil characteristics. The present study evaluated the sensitivity to detect various components based on the amount of trace components produced in oil during oxidation degradation for field-aged insulating oil for 34 transformers in various degradation conditions. A study was also conducted to evaluate the degradation condition based on the ratio of trace components produced in oil. Consequently, the detection sensitivity levels were in the order of carbonyl value, saponification value, peroxide value, and total acid value. As the ratio of the saponification value - the so-called final product increased, the degradation of insulating oil developed further. With the above study results, methods of evaluating the dissociation property in the preceding study and the breakdown voltage with the degree of water saturation taken into consideration were combined to establish a comprehensive method of evaluating aged oil. This was then applied to field-aged insulating oil as an example, whereupon the need to replace insulating oil could be evaluated.	[Wada, Junichi; Ueta, Genyo; Okabe, Shigemitsu] Tokyo Elect Power Co Ltd, Tsurumi Ku, Yokohama, Kanagawa 2308510, Japan; [Amimoto, Tsuyoshi] Mitsubishi Electr Corp, Ako City, Hyogo 6780256, Japan	Wada, J (reprint author), Tokyo Elect Power Co Ltd, Tsurumi Ku, 4-1 Egasaki Cho, Yokohama, Kanagawa 2308510, Japan.						[Anonymous], 1992, 61125 IEC; [Anonymous], 2012, 60296 IEC; [Anonymous], 2004, 60247 IEC, VThird; Okabe S, 2013, IEEE T DIELECT EL IN, V20, P346, DOI 10.1109/TDEI.2013.6451376; [Anonymous], 2013, 60422 IEC; [Anonymous], 2003, 620211 IEC; BARTNIKA.R, 1967, IEEE T ELECTR INSUL, VEI 2, P33, DOI 10.1109/TEI.1967.298847; Goto K., 1990, CIGRE P INT C LARG H, V33, P1; IEC, 1986, IEC SC 10A BRUSS M; Ishii T., 1972, IEEJ T FUNDAMENTALS, V92, P154; JIS, 1992, K0070 JIS; JIS, 1999, C2101 JIS; JIS, 2011, K0050 JIS; JIS, 2012, K6241 JIS; JIS, 2003, K2276 JIS; Okabe S, 2010, IEEE T DIELECT EL IN, V17, P302, DOI 10.1109/TDEI.2010.5412031; O'Sullivan F., 2006, IEEE C EL INS DIEL P, P756; Sroff D. H., 1985, IEEE P C, V132, P312; The Institute of Electrical and Electronics Engr. Inc, 1997, C57106 ANSIIEEE; Ueta G, 2012, IEEE T DIELECT EL IN, V19, P2216, DOI 10.1109/TDEI.2012.6396983; Wada J, 2014, IEEE T DIELECT EL IN, V21, P873, DOI 10.1109/TDEI.2013.004204; Wada J, 2013, IEEE T DIELECT EL IN, V20, P1388, DOI 10.1109/TDEI.2013.6571460; Yanari T., 1981, IEEJ T POWER ENERGY, V101, P719	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	APR	2015	22	2					1266	1274		10.1109/TDEI.2014.004633		9	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF8GD	WOS:000352793300073		
J	Umemoto, T; Shimizu, Y; Naruse, H; Yamamoto, O				Umemoto, Takahiro; Shimizu, Yusuke; Naruse, Hiroki; Yamamoto, Osamu			3-D SEEA Charge Analyses on Surface of Insulators in Vacuum	IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION			English	Article						Vacuum; insulator; SEEA; charge distribution; 3-D; surface charge method; electrostatic probe; cathode electric field		In the bridged vacuum gaps, the secondary electron emission avalanche (SEEA) occurring along the surface of solid insulator and the resultant surface charging play a crucial role in the progress of surface discharge. In order to sophisticate the insulation design of high voltage vacuum devices, analysis and control of SEEA charging are of importance. Boersh et al. have proposed a boundary condition on the surface of an insulator to solve the charge distribution at an equilibrium state of SEEA charging. The boundary condition can be easily adopted for analyzing two dimensional SEEA charge distributions. However, the above condition by Boersh et al. cannot be applied in the case of three dimensional distributions. In this paper, the authors newly developed the boundary condition for three dimensional applications and created a numerical simulation code for analyzing three dimensional SEEA charge distributions. Two types of insulator were examined in this study; one was a solid cylinder and the other a hollow cylinder. In the case of the solid cylinder, electric field strength on the cathode was calculated and compared with the measurement. On the other hand, in the case of the hollow cylinder, the calculated result was compared with the charge distribution experimentally obtained by a movable electrostatic probe system. These calculation and measurement results have shown reasonable agreement and we have validated the newly developed numerical simulation method for three dimensional SEEA charge distributions.	[Umemoto, Takahiro; Shimizu, Yusuke; Naruse, Hiroki] Kyoto Univ, Kyoto 6158510, Japan; [Yamamoto, Osamu] Res Inst Appl Sci, Kyoto 6068202, Japan	Umemoto, T (reprint author), Kyoto Univ, Kyoto 6158510, Japan.				JSPS KAKENHI [22560272]	This study was supported by JSPS KAKENHI Grant Number 22560272.	Greenwood J, 2002, VACUUM, V67, P217, DOI 10.1016/S0042-207X(02)00173-2; PILLAI AS, 1982, J APPL PHYS, V53, P2983, DOI 10.1063/1.331037; Boersch H., 1963, Zeitschrift fur Angewandte Physik, V15; DETOURRE.CH, 1973, IEEE T ELECTR INSUL, VEI 8, P17, DOI 10.1109/TEI.1973.299238; Shimizu Y, 2014, IEEE T DIELECT EL IN, V21, P1312, DOI [10.1109/TDEI.2014.6832279, 10.1109/TDEI.2014.003796]; Shimizu Y, 2012, INT SYM DISCH ELECTR, P141, DOI 10.1109/DEIV.2012.6412471; Shimizu Y., 2010, 24 INT S DISCH EL IN, P100; Tatematsu A., 2009, H09014 CRIEPI; Umemoto T., 2013, 21 INT S HIGH VOLT E; Yamamoto O, 2008, P INT SYMP DISCH EL, P70; Yamamoto O., 2005, 14 INT S HIGH VOLT E; YAMAMOTO O, 1993, IEEE T ELECTR INSUL, V28, P706, DOI 10.1109/14.231554; Yamamoto O., 2007, 15 INT S HIGH VOLT E	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9878	1558-4135		IEEE T DIELECT EL IN	IEEE Trns. Dielectr. Electr. Insul.	APR	2015	22	2					1298	1305		10.1109/TDEI.2014.004578		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF8GD	WOS:000352793300077		
J	Nguyen, NMK; Iizuka, T; Sasaki, A; Yamada, M; Morita, O; Asada, K				Nguyen Ngoc Mai-Khanh; Iizuka, Tetsuya; Sasaki, Akihiko; Yamada, Makoto; Morita, Osamu; Asada, Kunihiro			A Near-Field Magnetic Sensing System With High-Spatial Resolution and Application for Security of Cryptographic LSIs	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						CMOS; coil; cryptography; high-spatial resolution; integrated circuit; magnetic; probe; sensing	ELECTROMAGNETIC ANALYSIS; POWER ANALYSIS; PROBE; ATTACKS; LEAKAGE; MODEL	This paper presents a high-resolution inductive near-field magnetic sensing system to detect sensitive and suspicious areas of cryptographic large-scale integration (LSI) chips for nondestructive inspection. The proposed system includes a probe chip based on a 0.18-mu m five-metal-layer CMOS process technology and a microposition calibration mechanism. The probe chip includes a magnetic pick-up coil followed by a three-stage low-noise amplifier (LNA) to amplify the induced voltage on the coil. The Si-substrate area under the coil is removed by applying a focused-ion-beam (FIB) technique to enhance the quality factor of the coil. A mechanical scanning system with an ability of microposition calibration is proposed to allow high-precision calibration and microscanning operation. High-spatial resolution magnetic scanning experiment is conducted on a microstrip line and on the surface of a cryptographic field programmable gate array (FPGA) running 128-b advanced encryption standard (AES) algorithm. By making a comparison in the scanning performance of a commercial probe, this sensing measurement holds the advantage of higher resolution magnetic maps in multiple frequency bands. Moreover, the proposed system can be used to identify vulnerable areas of cryptographic LSI chips that can cause location-dependent side-channel leakage.	[Nguyen Ngoc Mai-Khanh; Asada, Kunihiro] Univ Tokyo, VLSI Design & Educ Ctr, Tokyo 1138654, Japan; [Iizuka, Tetsuya] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan; [Sasaki, Akihiko; Yamada, Makoto] Morita Tech Co Ltd, Kawasaki, Kanagawa 2150032, Japan; [Morita, Osamu] Aoyama Gakuin Univ, Dept Elect & Elect Engn, Tokyo 1508366, Japan	Nguyen, NMK (reprint author), Univ Tokyo, VLSI Design & Educ Ctr, Tokyo 1138654, Japan.	khanh@silicon.u-tokyo.ac.jp			Japan Society for the Promotion of Science [24700042]	This work was supported by the Japan Society for the Promotion of Science through the Grants-in-Aid for Scientific Research under Grant 24700042. The Associate Editor coordinating the review process was Dr. Deniz Gurkan.	Agrawal D., 2002, CRYPTOGRAPHIC HARDWA; Peeters E, 2007, INTEGRATION, V40, P52, DOI 10.1016/j.vlsi.2005.12.013; Standaert FX, 2008, LECT NOTES COMPUT SC, V5154, P411; Dubois T, 2008, IEEE T INSTRUM MEAS, V57, P2398, DOI 10.1109/TIM.2008.926371; Brier E, 2004, LECT NOTES COMPUT SC, V3156, P16; Yue CP, 1998, IEEE J SOLID-ST CIRC, V33, P743, DOI 10.1109/4.668989; Lenz J, 2006, IEEE SENS J, V6, P631, DOI 10.1109/JSEN.2006.874493; Wei HY, 2011, IEEE T INSTRUM MEAS, V60, P3853, DOI 10.1109/TIM.2011.2147590; Chen KY, 2008, 2008 INTERNATIONAL CONFERENCE ON EMBEDDED SOFTWARE AND SYSTEMS SYMPOSIA, PROCEEDINGS, P197, DOI 10.1109/ICESS.Symposia.2008.75; Gandol Karine, 2001, LNCS, P251; Homma N, 2010, IEEE INT SYMP ELEC, P97, DOI 10.1109/ISEMC.2010.5711254; Kocher P., 1999, LECT NOTES COMPUTER, V1666, P388, DOI DOI 10.1007/3-540-48405-1; Kocher P. C., 1996, ADV CRYPTOLOGY CRYPT, V1109, P104, DOI [10.1007/3-540-68697-5_9, DOI 10.1007/3-540-68697-5_]; Mai-Khanh N. N., 2014, P IEEE SENS APPL S F, P111; Mai-Khanh N. N., 2013, IEEE SENS J, V13, P2675; Mai-Khanh NN, 2012, IEEE SENSOR, P2074; Mangard S., 2003, P AUSTR 2003, p13 ; Mangard S, 2007, POWER ANAL ATTACKS R; Muroga S, 2013, IEEE T MAGN, V49, P3886, DOI 10.1109/TMAG.2013.2250264; Nishikawa K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.106502; Real D, 2009, DES AUT TEST EUROPE, P628; Sauvage L, 2009, DES AUT TEST EUROPE, P640; Sugawara T, 2009, LECT NOTES COMPUT SC, V5932, P66; Wu J, 2012, IEEE T INSTRUM MEAS, V61, P2765, DOI 10.1109/TIM.2012.2200399; Yamaguchi M, 2007, IEEE T MAGN, V43, P2370, DOI 10.1109/TMAG.2007.892998; Zhang J, 2013, IEEE T INSTRUM MEAS, V62, P648, DOI 10.1109/TIM.2012.2218678	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	APR	2015	64	4					840	848		10.1109/TIM.2014.2373472		9	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CF4BC	WOS:000352492400001		
J	Siriteanu, C; Takemura, A; Kuriki, S; Richards, DS; Shin, H				Siriteanu, Constantin; Takemura, Akimichi; Kuriki, Satoshi; Richards, Donald St P.; Shin, Hyundong			Schur Complement Based Analysis of MIMO Zero-Forcing for Rician Fading	IEEE TRANSACTIONS ON WIRELESS COMMUNICATIONS			English	Article						MIMO; non/central-Wishart matrix distribution; Rayleigh and Rician ( Ricean) fading; schur complement; zeroforcing.	SYSTEMS; DISTRIBUTIONS; CAPACITY	For multiple-input/multiple-output (MIMO) spatial multiplexing with zero-forcing detection (ZF), signal-to-noise ratio (SNR) analysis for Rician fading involves the cumbersome noncentral-Wishart distribution (NCWD) of the transmit sample-correlation (Gramian) matrix. An approximation with a virtual CWD previously yielded for the ZF SNR an approximate (virtual) Gamma distribution. However, analytical conditions qualifying the accuracy of the SNR-distribution approximation were unknown. Therefore, we have been attempting to exactly characterize ZF SNR for Rician fading. Our previous attempts succeeded only for the sole Rician-fading stream under Rician-Rayleigh fading, by writing the ZF SNR as scalar Schur complement (SC) in the Gramian. Herein, we pursue a more general matrix-SC-based analysis to characterize SNRs when several streams may undergo Rician fading. On one hand, for full-Rician fading, the SC distribution is found to be exactly a CWD if and only if a channel-mean-correlation condition holds. Interestingly, this CWD then coincides with the virtual CWD ensuing from the approximation. Thus, under the condition, the actual and virtual SNR-distributions coincide. On the other hand, for Rician-Rayleigh fading, the matrix-SC distribution is characterized in terms of the determinant of a matrix with elementary-function entries, which also yields a new characterization of the ZF SNR. Average error probability results validate our analysis vs. simulation.	[Siriteanu, Constantin] Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan; [Takemura, Akimichi] Univ Tokyo, Dept Math Informat, Stat, Tokyo, Japan; [Kuriki, Satoshi] Inst Stat Math, Tachikawa, Tokyo, Japan; [Richards, Donald St P.] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Shin, Hyundong] Kyung Hee Univ, Dept Elect & Radio Engn, Gyeonggi Do 446701, South Korea	Siriteanu, C (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan.	constantin.siriteanu@ist.osaka-u.ac.jp; hshin@khu.ac.kr			Japan Society for the Promotion of Science [25220001]; Japan Science and Technology Agency; U.S. National Science Foundation [DMS-1309808]; Institute of Statistical Mathematics of Japan; Romberg Guest Professorship at Heidelberg University Graduate School of Mathematical and Computational Methods in the Sciences under German Universities Excellence Initiative [GSC 220/2]; National Research Foundation of Korea [2009-0083495, 2013-R1A1A2-019963]; Ministry of Science, ICT and Future Planning	The work of A. Takemura was supported in part by the Japan Society for the Promotion of Science under Grant-in-Aid for Scientific Research 25220001 and in part by the Japan Science and Technology Agency. The work of D. St. P. Richards was supported in part by the U.S. National Science Foundation under Grant DMS-1309808, by the Institute of Statistical Mathematics of Japan, and by a Romberg Guest Professorship at Heidelberg University Graduate School of Mathematical and Computational Methods in the Sciences under German Universities Excellence Initiative Grant GSC 220/2. The work of H. Shin was supported by the National Research Foundation of Korea under Grants 2009-0083495 and 2013-R1A1A2-019963, funded by the Ministry of Science, ICT and Future Planning. The associate editor coordinating the review of this paper and approving it for publication was X. Dong.	Matthaiou M, 2013, IEEE J SEL AREA COMM, V31, P180, DOI 10.1109/JSAC.2013.130207; Mckay MR, 2009, IEEE T COMMUN, V57, P676, DOI 10.1109/TCOMM.2009.03.060521; Li QH, 2010, IEEE COMMUN MAG, V48, P86, DOI 10.1109/MCOM.2010.5458368; GROSS KI, 1989, J APPROX THEORY, V59, P224, DOI 10.1016/0021-9045(89)90153-6; Siriteanu C, 2012, IEEE T VEH TECHNOL, V61, P3087, DOI 10.1109/TVT.2012.2202133; McKay MR, 2005, IEEE T INFORM THEORY, V51, P3121, DOI 10.1109/TIT.2005.853325; Marzetta TL, 1999, IEEE T INFORM THEORY, V45, P139, DOI 10.1109/18.746779; Gore DA, 2002, IEEE COMMUN LETT, V6, P491, DOI 10.1109/LCOMM.2002.805517; Gesbert D, 2007, IEEE SIGNAL PROC MAG, V24, P36, DOI 10.1109/MSP.2007.904815; Chiani M, 2010, IEEE T INFORM THEORY, V56, P336, DOI 10.1109/TIT.2009.2034810; Boyd S, 2004, CONVEX OPTIMIZATION; Chen XM, 2010, IEEE T SIGNAL PROCES, V58, P5791, DOI 10.1109/TSP.2010.2062508; Gallager R. G., 2008, PREPRINT; Gentle J. E., 2007, MATRIX ALGEBRA THEOR; Gupta A., 2000, MATRIX VARIATE DISTR; JAMES AT, 1964, ANN MATH STAT, V35, P475, DOI 10.1214/aoms/1177703550; Jung M, 2013, J COMMUN NETW-S KOR, V15, P362, DOI 10.1109/JCN.2013.000067; Kiessling M., 2003, P 4 IEEE WORKSH SIGN, P383; Kuriki S, 2010, ANN I STAT MATH, V62, P645, DOI 10.1007/s10463-010-0279-4; Kyosti P., 2008, IST4027756 CEC; Lee J, 2009, EURASIP J WIREL COMM, DOI 10.1155/2009/302092; Loyka S, 2009, IEEE T WIREL COMMUN, V8, P1107, DOI 10.1109/TWC.2008.080188; Muirhead R. J., 2005, ASPECTS MULTIVARIATE; Olver F. W. J., 2010, NIST HDB MATH FUNCTI; OUELLETTE DV, 1981, LINEAR ALGEBRA APPL, V36, P187, DOI 10.1016/0024-3795(81)90232-9; Paulraj A. J., 2003, INTRO SPACE TIME WIR, P139; SIMON M. K, 2005, DIGITAL COMMUNICATIO; Siriteanu C, 2014, IEEE T WIREL COMMUN, V13, P1514, DOI 10.1109/TWC.2014.011614.130882; Steyn H. S., 1972, S AFR STAT J, V6, P164; Zhang F., 2005, SCHUR COMPLEMENT ITS	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1276	1558-2248		IEEE T WIREL COMMUN	IEEE Trans. Wirel. Commun.	APR	2015	14	4					1757	1771		10.1109/TWC.2014.2371467		15	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CF7LY	WOS:000352739200001		
J	Lu, PS; Zhou, XB; Matsumoto, T				Lu, Pen-Shun; Zhou, Xiaobo; Matsumoto, Tad			Outage Probabilities of Orthogonal Multiple-Access Relaying Techniques With Imperfect Source-Relay Links	IEEE TRANSACTIONS ON WIRELESS COMMUNICATIONS			English	Article						Multiple access relay channel; outage probability; decode-and-forward; Slepian-Wolf theorem; source-channel separation theorem	CORRELATED SOURCES; NETWORK; CHANNEL; PERFORMANCE; CODES; TRANSMISSION; DESIGN	An outage probability that is independent of signaling schemes is theoretically derived in this paper for an orthogonal multiple-access relay channel (MARC) system, where the estimates of the information sequences sent from source nodes, regardless of whether or not they are correctly decoded at the relay, are exclusive-OR (XOR)-network-coded and forwarded by the relay to the destination. The MARC system described above is referred to as estimates-exploiting MARC (e-MARC) in this paper for convenience. Following the probability derivation of e-MARC, comparisons are then made with the outage probability of the orthogonal MARC with the Select Decode-and-Forward relaying strategy (MARC-SDF). It is found through simulations that when one of the source nodes is far away from both the relay and the destination, the e-MARC system is superior to MARC-SDF in terms of outage performance. We further numerically calculate the outage probabilities for two special cases, and compare them with the probability of e-MARC. Furthermore, the impact of the source correlation on the outage probability of the e-MARC system is also investigated.	[Lu, Pen-Shun; Zhou, Xiaobo; Matsumoto, Tad] Univ Oulu, Ctr Wireless Commun, Oulu 90014, Finland; [Lu, Pen-Shun; Matsumoto, Tad] Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi, Ishikawa 9231292, Japan	Lu, PS (reprint author), Univ Oulu, Ctr Wireless Commun, Oulu 90014, Finland.	penshun@ee.oulu.fi; zhouxiaobo07@gmail.com; tadashi.matsumoto@ee.oulu.fi			European Union [ICT-619555 RESCUE]; Japanese government [23360170]	This work was supported in part by the European Union's FP7 project, ICT-619555 RESCUE (Links-on-the-fly Technology for Robust, Efficient and Smart Communication in Unpredictable Environments), and also in part by the Japanese government funding program, Grant-in-Aid for Scientific Research(B), No. 23360170. The associate editor coordinating the review of this paper and approving it for publication was W. Choi.	ROBERTSON P, 1995, ICC '95 - 1995 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, CONFERENCE RECORD, VOLS 1-3, P1009; Hagenauer J, 1996, IEEE T INFORM THEORY, V42, P429, DOI 10.1109/18.485714; Tian C, 2014, IEEE T INFORM THEORY, V60, P904, DOI 10.1109/TIT.2013.2291787; Li YH, 2006, IEEE J SEL AREA COMM, V24, P2040, DOI 10.1109/JSAC.2006.881630; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; ten Brink S, 2003, IEEE T SIGNAL PROCES, V51, P2764, DOI 10.1109/TSP.2003.818250; Zhang Y, 2013, IEEE T WIREL COMMUN, V12, P320, DOI 10.1109/TWC.2012.120312.120633; Shampine LF, 2008, APPL MATH COMPUT, V202, P266, DOI 10.1016/j.amc.2008.02.012; Yang S, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-7, P801, DOI 10.1109/ISIT.2007.4557108; Yune TW, 2011, IEEE T COMMUN, V59, P1791, DOI 10.1109/TCOMM.2011.050911.090660; Cheng M., 2013, EURASIP J ADV SIG PR, V34, P34; Cover T. M., 2006, ELEMENTS INFORM THEO; Gamal A. E., 2011, NETWORK INFORM THEOR; Garcia-Frias J, 2005, IEEE T COMMUN, V53, P555, DOI 10.1109/TCOMM.2005.844959; Hausl C., 2006, P 3 ANN IEEE COMM SO, V3, P817; Hernaez M, 2013, IEEE J SEL AREA COMM, V31, P1368, DOI 10.1109/JSAC.2013.130802; Huynh K. Q., 2012, P IEEE VEH TECHN C, P1; Iscan O., 2011, P 2011 IEEE VEH TECH, P1; Kramer G., 2000, P IEEE INT S INF THE, P40; Lee K, 2009, IEEE T WIREL COMMUN, V8, P376, DOI 10.1109/T-WC.2009.080048; Li Y, 2009, IEEE COMMUN LETT, V13, P600, DOI 10.1109/LCOMM.2009.090201; Lu PS, 2014, IEEE T VEH TECHNOL, V63, P2298, DOI 10.1109/TVT.2013.2292508; Lu PS, 2011, 2011 IEEE 22ND INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P1687; Maral G., 2009, SATELLITE COMMUNICAT; McEliece R. J., 2002, THEORY INFORM CODING; Meng Q., 2013, J INF COMPUT SCI, V10, P829; Mohamad A., 2013, P IEEE 24 INT S PERS, P1321; Mohamad A, 2013, 2013 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE WORKSHOPS (WCNCW), P160, DOI 10.1109/WCNCW.2013.6533333; Murin Y, 2013, IEEE T INFORM THEORY, V59, P5446, DOI 10.1109/TIT.2013.2260592; Sankaranarayanan L, 2004, P 1 ANN IEEE COMM SO, P191; Sneesens H. H., 2005, P IEEE INT WORKSH CO, P157; Sneessens HH, 2008, INT CONF ACOUST SPEE, P3213, DOI 10.1109/ICASSP.2008.4518334; Tang SH, 2009, IEICE T COMMUN, VE92B, P3470, DOI 10.1587/transcom.E92.B.3470; Vu XT, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P2901; Woldegebreal D., 2007, P IEEE INT S WIR COM, P732; Xiao M, 2009, IEEE T COMMUN, V57, P1402, DOI 10.1109/TCOMM.2009.05.070201; Xu Xiaoka, 2008, P IEEE C NEW TECHN M, P1; Yin YZ, 2012, IEEE INT WORK SIGN P, P419; Zeitler G, 2012, IEEE T COMMUN, V60, P1148, DOI 10.1109/TCOMM.2012.020612.100096; Zhou XB, 2014, IEEE T WIREL COMMUN, V13, P1424, DOI 10.1109/TW.2014.011614.130598	40	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1276	1558-2248		IEEE T WIREL COMMUN	IEEE Trans. Wirel. Commun.	APR	2015	14	4					2269	2280		10.1109/TWC.2014.2384046		12	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CF7LY	WOS:000352739200041		
J	Siriteanu, C; Takemura, A; Kuriki, S; Shin, H; Koutschan, C				Siriteanu, Constantin; Takemura, Akimichi; Kuriki, Satoshi; Shin, Hyundong; Koutschan, Christoph			MIMO Zero-Forcing Performance Evaluation Using the Holonomic Gradient Method	IEEE TRANSACTIONS ON WIRELESS COMMUNICATIONS			English	Article						Holonomic gradient method; hypergeometric function; MIMO; Rayleigh-Rician fading; zero-forcing	HYPERGEOMETRIC FUNCTION; MATRIX ARGUMENT; SYSTEMS; DIVERSITY; COMPLEXITY; RECEIVERS; WIRELESS; EQUALIZERS; CAPACITY; CHANNELS	For multiple-input-multiple-output (MIMO) spatial-multiplexing transmission, zero-forcing (ZF) detection is appealing because of its low complexity. Our recent MIMO ZF performance analysis for Rician-Rayleigh fading, which is relevant in heterogeneous networks, has yielded for the ZF outage probability and ergodic capacity infinite-series expressions. Because they arose from expanding the confluent hypergeometric function 1F1(center dot, center dot, sigma) around 0, they do not converge numerically at realistically high Rician K-factor values. Therefore, herein, we seek to take advantage of the fact that 1F1(center dot, center dot, sigma) satisfies a differential equation, i.e., it is a holonomic function. Holonomic functions can be computed by the holonomic gradient method (HGM), i.e., by numerically solving the satisfied differential equation. Thus, we first reveal that the moment generating function (m.g.f.) and probability density function (p.d.f.) of the ZF signal-to-noise ratio (SNR) are holonomic. Then, from the differential equation for 1F1(center dot, center dot, sigma), we deduce those satisfied by the SNR m.g.f. and p.d.f. and demonstrate that the HGM helps compute the p.d.f. accurately at practically relevant values of K. Finally, numerical integration of the SNR p.d.f. produced by HGM yields accurate ZF outage probability and ergodic capacity results.	[Siriteanu, Constantin] Osaka Univ, Dept Informat Syst Engn, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Takemura, Akimichi] Univ Tokyo, Dept Math Informat, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan; [Takemura, Akimichi] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Kuriki, Satoshi] Inst Stat Math, Tokyo 1908562, Japan; [Shin, Hyundong] Kyung Hee Univ, Dept Elect & Radio Engn, Yongin 446701, South Korea; [Koutschan, Christoph] Austrian Acad Sci, Johann Radon Inst Computat & Appl Math, A-4040 Linz, Austria	Siriteanu, C (reprint author), Osaka Univ, Dept Informat Syst Engn, Grad Sch Informat Sci & Technol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	constantin.siriteanu@ist.osaka-u.ac.jp; hshin@khu.ac.kr			Japan Science and Technology Agency	The first version of this paper was prepared when the first author was with the Graduate School of Information Science and Technology, University of Tokyo, supported by Japan Science and Technology Agency. These institutions also supported the publication of this paper. The second (accepted) version was prepared after he joined the Graduate School of Information Science and Technology, Osaka University.	Matthaiou M, 2013, IEEE J SEL AREA COMM, V31, P180, DOI 10.1109/JSAC.2013.130207; Mckay MR, 2009, IEEE T COMMUN, V57, P676, DOI 10.1109/TCOMM.2009.03.060521; Ropokis GA, 2010, IEEE T COMMUN, V58, P2486, DOI 10.1109/TCOMM.2010.09.090282; WINTERS JH, 1994, IEEE T COMMUN, V42, P1740, DOI 10.1109/TCOMM.1994.582882; Ngo HQ, 2013, IEEE T COMMUN, V61, P2350, DOI 10.1109/TCOMM.2013.032713.120408; Li QH, 2010, IEEE COMMUN MAG, V48, P86, DOI 10.1109/MCOM.2010.5458368; Ma XL, 2008, IEEE T INFORM THEORY, V54, P3442, DOI 10.1109/TIT.2008.926433; Basnayaka DA, 2013, IEEE T WIREL COMMUN, V12, P2240, DOI 10.1109/TWC.2013.032113.120798; Li P, 2006, IEEE T INFORM THEORY, V52, P271, DOI 10.1109/TIT.2005.860466; Siriteanu C, 2012, IEEE T VEH TECHNOL, V61, P3087, DOI 10.1109/TVT.2012.2202133; Grant AJ, 2005, IEEE T COMMUN, V53, P738, DOI 10.1109/TCOMM.2005.844968; Louie RHY, 2009, IEEE T COMMUN, V57, P2348, DOI 10.1109/TCOMM.2009.08.070412; Jiang Y, 2011, IEEE T INFORM THEORY, V57, P2008, DOI 10.1109/TIT.2011.2112070; Artes H, 2003, IEEE T SIGNAL PROCES, V51, P2808, DOI 10.1109/TSP.2003.818210; Muller KE, 2001, NUMER MATH, V90, P179, DOI 10.1007/s002110100285; Paulraj AJ, 2004, P IEEE, V92, P198, DOI 10.1109/JPROC.2003.821915; Gore DA, 2002, IEEE COMMUN LETT, V6, P491, DOI 10.1109/LCOMM.2002.805517; Mehana AH, 2012, IEEE T INFORM THEORY, V58, P6788, DOI 10.1109/TIT.2012.2204954; Gesbert D, 2007, IEEE SIGNAL PROC MAG, V24, P36, DOI 10.1109/MSP.2007.904815; Hoydis J, 2013, IEEE J SEL AREA COMM, V31, P160, DOI 10.1109/JSAC.2013.130205; Gesbert D, 2003, IEEE T SIGNAL PROCES, V51, P2863, DOI 10.1109/TSP.2003.818160; Bai L., 2012, LOW COMPLEXITY MIMO; Chikuse Y., 1976, ANN I STAT MATH, V28, P187, DOI 10.1007/BF02504739; Hashiguchi H, 2013, J MULTIVARIATE ANAL, V117, P296, DOI 10.1016/j.jmva.2013.03.011; Hibi T., 2013, GROBNER BASES STAT S; Ilie S, 2008, J COMPLEXITY, V24, P341, DOI 10.1016/j.jco.2007.11.004; Jung M, 2013, J COMMUN NETW-S KOR, V15, P362, DOI 10.1109/JCN.2013.000067; Kauers M, 2011, TEXT MG SYMB COMPUT, P1, DOI 10.1007/978-3-7091-0445-3; Kiessling M., 2003, P 4 IEEE WORKSH SIGN, P383; Kim KJ, 2012, IEEE T VEH TECHNOL, V61, P584, DOI 10.1109/TVT.2011.2181548; Koev P, 2006, MATH COMPUT, V75, P833, DOI 10.1090/S0025-5718-06-01824-2; Koutschan C., 2010, RISC REP SER; Koutschan C., 2009, THESIS J KEPLER U LI; Kyosti P., 2008, IST4027756 CEC I MAT; Loyka S, 2009, IEEE T WIREL COMMUN, V8, P1107, DOI 10.1109/TWC.2008.080188; Mallinger C., 1996, THESIS J KEPLER U LI; Maurer J, 2009, IEEE J-STSP, V3, P986, DOI 10.1109/JSTSP.2009.2038210; MUIRHEAD RJ, 1970, ANN MATH STAT, V41, P991, DOI 10.1214/aoms/1177696975; Olver F. W. J., 2010, NIST HDB MATH FUNCTI; Saito M., 2011, ALGORITHMS COMPUTATI; Sei T, 2015, STAT COMPUT, V25, P321, DOI 10.1007/s11222-013-9434-0; Simon M. K., 2000, DIGITAL COMMUNICATIO; Siriteanu C, 2014, IEEE T WIREL COMMUN, V13, P1514, DOI 10.1109/TWC.2014.011614.130882; Siriteanu C., 2015, IEEE T WIR UNPUB APR; Siriteanu C., 2014, P AUSCTW SYDN NS W A, P114; Siriteanu C., 2015, P IEEE ICC; ZEILBERGER D, 1990, J COMPUT APPL MATH, V32, P321, DOI 10.1016/0377-0427(90)90042-X	47	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1276	1558-2248		IEEE T WIREL COMMUN	IEEE Trans. Wirel. Commun.	APR	2015	14	4					2322	2335		10.1109/TWC.2014.2385075		14	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CF7LY	WOS:000352739200045		
J	Ogi, C; Aruga, A				Ogi, Chizuru; Aruga, Atsushi			Approaches to improve development methods for therapeutic cancer vaccines	IMMUNOLOGY LETTERS			English	Article						Therapeutic vaccine; Immunotherapy; Cancer; Regulatory science	RESISTANT PROSTATE-CANCER; RENAL-CELL CARCINOMA; ACTIVE-SPECIFIC IMMUNOTHERAPY; RANDOMIZED PHASE-III; METASTATIC MELANOMA; CLINICAL-TRIALS; SIPULEUCEL-T; FOLLICULAR LYMPHOMA; DOUBLE-BLIND; TUMOR	Therapeutic cancer vaccines are an immunotherapy that amplify or induce an active immune response against tumors. Notably, limitations in the methodology for existing anti-cancer drugs may subsist while applying them to cancer vaccine therapy. A retrospective analysis was performed using information obtained from ClinicalTrials.gov, PubMed, and published articles. Our research evaluated the optimal methodologies for therapeutic cancer vaccines based on (1) patient populations, (2) immune monitoring, (3) tumor response evaluation, and (4) supplementary therapies. Failure to optimize these methodologies at an early phase may impact development at later stages; thus, we have proposed some points to be considered during the early phase. Moreover, we compared our proposal with the guidance for industry issued by the US Food and Drug Administration in October 2011 entitled "Clinical Considerations for Therapeutic Cancer Vaccines". Consequently, while our research was aligned with the guidance, we hope it provides further insights in order to predict the risks and benefits and facilitate decisions for a new technology. We identified the following points for consideration: (1) include in the selection criteria the immunological stage with a prognostic value, which is as important as the tumor stage; (2) select immunological assays such as phenotype analysis of lymphocytes, based on their features and standardize assay methods; (3) utilize optimal response criteria for immunotherapy in therapeutic cancer vaccine trials; and (4) consider supplementary therapies, including immune checkpoint inhibitors, for future therapeutic cancer vaccines. (C) 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.	[Ogi, Chizuru; Aruga, Atsushi] Joint Grad Sch Tokyo Womens Med Univ & Waseda Uni, TWIns, Adv Biomed Sci, Shinjuku Ku, Tokyo 1628666, Japan	Aruga, A (reprint author), Joint Grad Sch Tokyo Womens Med Univ & Waseda Uni, TWIns, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	aruga.atsushi@twmu.ac.jp					Gulley JL, 2011, CURR ONCOL, V18, pE150; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Uyl-de Groot CA, 2005, VACCINE, V23, P2379, DOI 10.1016/j.vaccine.2005.01.015; Higano CS, 2009, CANCER, V115, P3670, DOI 10.1002/cncr.24429; Tjin EPM, 2011, CLIN CANCER RES, V17, P5736, DOI 10.1158/1078-0432.CCR-11-0230; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Giaccone G, 2005, J CLIN ONCOL, V23, P6854, DOI 10.1200/JCO.2005.17.186; Le DT, 2013, J IMMUNOTHER, V36, P382, DOI 10.1097/CJI.0b013e31829fb7a2; Sheikh NA, 2013, CANCER IMMUNOL IMMUN, V62, P137, DOI 10.1007/s00262-012-1317-2; Freedman A, 2009, J CLIN ONCOL, V27, P3036, DOI 10.1200/JCO.2008.19.8903; Amin A, 2008, CANCER IMMUNOL IMMUN, V57, P1817, DOI 10.1007/s00262-008-0509-2; Hoos A, 2010, J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Hoos A, 2011, NAT BIOTECHNOL, V29, P867, DOI 10.1038/nbt.2000; Lee ST, 2007, EXPERT OPIN BIOL TH, V7, P113, DOI 10.1517/14712598.7.1.113; Hsueh EC, 2003, SEMIN CANCER BIOL, V13, P401, DOI 10.1016/j.semcancer.2003.09.003; Gulley JL, 2010, CANCER IMMUNOL IMMUN, V59, P663, DOI 10.1007/s00262-009-0782-8; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; [Anonymous], 2011, GUIDANCE IND CLIN CO; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Wood C, 2008, LANCET, V372, P145, DOI 10.1016/S0140-6736(08)60697-2; Butts C, 2014, LANCET ONCOL, V15, P59, DOI 10.1016/S1470-2045(13)70510-2; Aarntzen EHJG, 2012, CANCER RES, V72, P6102, DOI 10.1158/0008-5472.CAN-12-2479; [Anonymous], 2008, PHARM STOPS ON 2 PHA; Fernandez LE, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/814397; [Anonymous], 2007, GEN CORP REP; Bedikian AY, 2008, EXPERT OPIN BIOL TH, V8, P839, DOI [10.1517/14712598.8.6.839 , 10.1517/14712590802133059]; Devaud C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25961; Emens LA, 2008, EXPERT OPIN EMERG DR, V13, P295, DOI [10.1517/14728214.13.2.295 , 10.1517/14728210802166890]; Finke LH, 2007, VACCINE, V25, pB97, DOI 10.1016/j.vaccine.2007.06.067; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-1; Gilliam AD, 2007, EXPERT OPIN BIOL TH, V7, P397, DOI 10.1517/14712598.7.3.397; Jonasch E, 2008, BRIT J CANCER, V98, P1336, DOI 10.1038/sj.bjc.6604266; MORTON DL, 1992, ANN SURG, V216, P463, DOI 10.1097/00000658-199210000-00010; Ogi C, 2013, HUM VACC IMMUNOTHER, V9, P1049, DOI 10.4161/hv.23917; Ogi C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26012; Ogi C, 2014, IMMUNOTHERAPY-UK, V6, P1025, DOI [10.2217/imt.14.74, 10.2217/IMT.14.74]; Randazzo M, 2012, INT J CANCER, V130, P2219, DOI 10.1002/ijc.27332; Ruiz R, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0400-6; Schuster SJ, 2009, J CLIN ONCOL, V27, p18s; Sondak VK, 2006, CLIN CANCER RES, V12, p2337S, DOI 10.1158/1078-0432.CCR-05-2555; Weng WK, 2004, J CLIN ONCOL, V22, P4717, DOI 10.1200/JCO.2004.06.003	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	APR	2015	164	2					100	108		10.1016/j.imlet.2015.02.010		9	Immunology	Immunology	CG2HG	WOS:000353094900008		
J	Kawakami, H; Yokoyama, M; Takagi, K; Ogawa, S; Hara, K; Komine, M; Yamamoto, Y				Kawakami, Hiroko; Yokoyama, Mineyuki; Takagi, Kazuteru; Ogawa, Shigeyuki; Hara, Kojiro; Komine, Masashi; Yamamoto, Yoshikazu			9-hydroxy-10-oxo-12(Z),15(Z)-octadecadienoic acid (KODA) enhances adventitious root redifferentiation from Swertia japonica callus	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT			English	Article						KODA; Redifferentiation; Adventitious root; Swertia japonica; Xanthone production	LINOLENIC ACID; MAKINO; LEMNA	The stress-induced alpha-ketol derivative of linolenic acid, identified in Lemna paucicostata as 9-hydroxy-10-oxo-12(Z),15(Z)-octadecadienoic acid (KODA), is involved in the enhancement of flower formation and the breaking of dormancy. Swertia japonica is an important bitter stomachic, and its adventitious roots contain xanthones, which are antioxidant compounds. Here, we demonstrate that KODA enhanced redifferentiation of adventitious roots from calli of S. japonica. Moreover, the effect of KODA was confirmed in liquid culture and the redifferentiation of adventitious roots was increased more than in solid culture. Conversely, KODA suppressed the biosynthesis of xanthone diglycoside, which suggests that KODA maintained the roots in an immature state under our culture conditions.	[Kawakami, Hiroko; Hara, Kojiro; Komine, Masashi; Yamamoto, Yoshikazu] Akita Prefectural Univ, Grad Sch, Akita, Akita 0100195, Japan; [Yokoyama, Mineyuki] Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Takagi, Kazuteru; Ogawa, Shigeyuki] Shiseido Co Ltd, Technol & Engn Ctr, Kakegawa, Shizuoka 4360047, Japan	Kawakami, H (reprint author), Akita Prefectural Univ, Grad Sch, Kaidobata Nishi 241-438, Akita, Akita 0100195, Japan.	D14G001@akita-pu.ac.jp					Niiho Y, 2006, J NAT MED, V60, P82, DOI 10.1007/s11418-005-0014-2; Kikuchi M, 2004, CHEM PHARM BULL, V52, P1210, DOI 10.1248/cpb.52.1210; ASHIDA S, 1994, J AM OIL CHEM SOC, V71, P1095, DOI 10.1007/BF02675902; Jamwal A., 2012, INT J PHARM CHEM SCI, V1, P1115; Kittikorn M, 2011, PLANT GROWTH REGUL, V64, P75, DOI 10.1007/s10725-010-9538-x; Kondo S, 2012, POSTHARVEST BIOL TEC, V72, P20, DOI 10.1016/j.postharvbio.2012.04.012; Lloyd G, 1981, INT PLANT PROP SOC P, V30, P421; Nakajima Naoko, 2011, Horticultural Research (Japan), V10, P407; Ono M, 2013, PLANT BIOTECHNOL-NAR, V30, P17, DOI 10.5511/plantbiotechnology.12.1105a; Sakamoto D, 2010, HORTSCIENCE, V45, P1470; Yamaguchi S, 2001, PLANT CELL PHYSIOL, V42, P1201, DOI 10.1093/pcp/pce152; Yokoyama M, 2000, PLANT CELL PHYSIOL, V41, P110; Yokoyama M., 2005, Regulation of Plant Growth & Development, V40, P90	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1054-5476	1475-2689		IN VITRO CELL DEV-PL	In Vitro Cell. Dev. Biol.-Plant	APR	2015	51	2					201	204		10.1007/s11627-015-9676-y		4	Plant Sciences; Cell Biology; Developmental Biology	Plant Sciences; Cell Biology; Developmental Biology	CF9XI	WOS:000352920100010		
J	Hatano, S; Hirose, Y; Yamamoto, Y; Murosaki, S; Yoshikai, Y				Hatano, Shinya; Hirose, Yoshitaka; Yamamoto, Yoshihiro; Murosaki, Shinji; Yoshikai, Yasunobu			Scavenger receptor for lipoteichoic acid is involved in the potent ability of Lactobacillus plantarum strain L-137 to stimulate production of interleukin-12p40	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Bacteria; Interleukin-12; Phagocytosis; Scavenger receptor; Immunotherapy	STAPHYLOCOCCUS-AUREUS; PATTERN-RECOGNITION; CELL-WALL; CD36; ACIDOPHILUS; MACROPHAGES; INDUCTION; BACTERIA; IMMUNITY; MICE	Heat-killed Lactobacillus plantarum strain L-137 (HK L-137) is a more potent inducer of interleukin (IL)-12 than other heat-killed Lactobacillus strains. To elucidate the mechanism involved in this IL-12p40 induction, we compared HK L-137 with heat-killed L. plantarum strain JCM1149 (HK JCM1149) by nuclear magnetic resonance and mass spectrometry. Results showed that HK L-137 contained lipoteichoic acid (LTA) with a chemical structure similar to that of JCM1149, except for a lower degree of glucosyl substitution in the poly(glycerol phosphate) backbone. Lysozyme sensitivity and electrophoretic moiety analysis revealed that HK L-137 exposed more LTA on its cell surface than HK JCM1149. Phagocytosis of HK L-137 by splenic adherent cells was significantly greater than that of HK JCM1149. Anti-LTA antibody and anti-scavenger receptor-A (SR-A) antibody selectively inhibited phagocytosis of HK L-137, as well as IL-12p40 production, by splenic adherent cells. Thus, a higher efficiency of phagocytosis of HK L-137 via SR-A for LTA is responsible for the potent IL-12p40 induction. (C) 2015 Elsevier B.V. All rights reserved.	[Hatano, Shinya; Yoshikai, Yasunobu] Kyushu Univ, Div Host Def, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Hirose, Yoshitaka; Yamamoto, Yoshihiro; Murosaki, Shinji] House Wellness Foods Corp, Inst Res & Dev, Itami, Hyogo 6640011, Japan	Yoshikai, Y (reprint author), Kyushu Univ, Div Host Def, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yoshikai@bioreg.kyushu-u.ac.jp			Japan Society for the Promotion of Science; Japanese Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation	This work was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science, and grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Y.Y.), and the Takeda Science Foundation (Y.Y.).	Hirose Y, 2006, J NUTR, V136, P3069; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Schar-Zammaretti P, 2005, APPL ENVIRON MICROB, V71, P8165, DOI 10.1128/AEM.71.12.8165-8173.2005; Shida K, 2006, J DAIRY SCI, V89, P3306; Fischer K, 2011, GLYCOBIOLOGY, V21, P1588, DOI 10.1093/glycob/cwr071; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Hirose Y, 2010, MICROBIOL IMMUNOL, V54, P143, DOI 10.1111/j.1348-0421.2009.00189.x; Murosaki S, 1998, J ALLERGY CLIN IMMUN, V102, P57, DOI 10.1016/S0091-6749(98)70055-7; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Morath S, 2002, INFECT IMMUN, V70, P938, DOI 10.1128/IAI.70.2.938-944.2002; Lotz S, 2004, J LEUKOCYTE BIOL, V75, P467, DOI 10.1189/jlb.0803360; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; JOHNSSON T, 1995, APPL ENVIRON MICROB, V61, P4497; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Baranova IN, 2008, J IMMUNOL, V181, P7147; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Andre G, 2011, ACS CHEM BIOL, V6, P366, DOI 10.1021/cb1003509; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Sever-Chroneos Z, 2011, J BIOL CHEM, V286, P4854, DOI 10.1074/jbc.M110.125567; Carballo PMS, 2010, CARBOHYD RES, V345, P538, DOI 10.1016/j.carres.2009.12.007; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259.266.2003; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Murosaki S, 2000, CANCER IMMUNOL IMMUN, V49, P157, DOI 10.1007/s002620050615; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Areschoug T, 2008, EUR J IMMUNOL, V38, P3068, DOI 10.1002/eji.200838457; Draing C, 2008, EUR J IMMUNOL, V38, P797, DOI 10.1002/eji.200737466; Evans D.F., 1994, COLLOIDAL DOMAIN PHY; FISCHER W, 1980, J BIOL CHEM, V255, P4550; Fujiki T, 2012, BIOSCI BIOTECH BIOCH, V76, P918, DOI 10.1271/bbb.110919; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Jang KS, 2011, BIOCHEM BIOPH RES CO, V407, P823, DOI 10.1016/j.bbrc.2011.03.107; OLYMPIA M, 1992, J FERMENT BIOENG, V73, P193, DOI 10.1016/0922-338X(92)90159-R; Sanchez B, 2012, CURR MICROBIOL, V64, P592, DOI 10.1007/s00284-012-0115-6; Schar-Zammaretti P, 2003, BIOPHYS J, V85, P4076, DOI 10.1016/S0006-3495(03)74820-6	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	APR	2015	25	2					321	331		10.1016/j.intimp.2015.02.011		11	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CF6MA	WOS:000352669600011		
J	Tabata, C; Tabata, R; Takahashi, Y; Nakamura, K; Nakano, T				Tabata, Chiharu; Tabata, Rie; Takahashi, Yuta; Nakamura, Kazuki; Nakano, Takashi			Thalidomide prevents cigarette smoke extract-induced lung damage in mice	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						COPD; Cytokine; Inflammation; Apoptosis	OBSTRUCTIVE PULMONARY-DISEASE; NECROSIS-FACTOR-ALPHA; INDUCED EMPHYSEMA; FIBROSIS; SENESCENCE; THERAPY; MOUSE	Chronic obstructive pulmonary disease (COPD) is characterized by a progressive airway obstruction that is not completely reversible and is mainly caused by smoking tobacco. COPD is a major cause of morbidity and mortality worldwide and there are currently no proven effective treatments. The pathogenesis of COPD involves several factors such as chronic inflammation, oxidative stress, and apoptosis. Cytokines play important roles in chronic inflammation. Thalidomide (Thal) has been used to treat multiple myeloma due to its inhibitory effects on IL-6-induced cell growth. We recently demonstrated that thalidomide (Thal) played important roles in cytokine-induced lung damage in a bleomycin-induced pulmonary fibrosis model in mice. We herein examined the preventative effects of Thal on cigarette smoke extract (CSE)-induced emphysematous changes in mice. We performed histological examinations and quantitative measurements of the expression of IL-1 beta and IL-6 mRNA, as well as apoptosis in CSE-induced mouse lung tissues treated with or without Thal. The results of the histological examination showed that Thal ameliorated CSE-induced emphysema in mice. It also inhibited the expression of IL-1 beta and IL-6 mRNA in mouse lung tissues. Thal decreased apoptosis in the mouse lung. In vitro studies revealed that Thal decreased 1) the expression of IL-1 beta and IL-6 in human lung epithelial cells, and 2) CSE-induced apoptosis and the inhibition of cell growth, which may be the underlying mechanisms for the preventative effects of Thal on emphysema. These results provide a rationale for exploring the clinical use of Thal for COPD. (C) 2015 Elsevier B.V. All rights reserved.	[Tabata, Chiharu; Nakano, Takashi] Hyogo Coll Med, Ctr Canc, Nishinomiya, Hyogo 6638501, Japan; [Tabata, Rie] Hyogo Prefectural Tsukaguchi Hosp, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Takahashi, Yuta; Nakamura, Kazuki] Mukogawa Womens Univ, Fac Pharmaceut Sci, Dept Pharmacol 1, Nishinomiya, Hyogo, Japan	Tabata, C (reprint author), Hyogo Coll Med, Ctr Canc, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ctabata@hyo-med.ac.jp			KAKENHI [23591167]; Health Labour Sciences Research Grant [201314008A]	This study was supported by grants from KAKENHI, a Grant-in-Aid for Scientific Research (C) (23591167) and Health Labour Sciences Research Grant (201314008A). No competing interests are declared. We thank Ms. Hidemi Kitai (Department of Thoracic Oncology, Hyogo College of Medicine) for her technical assistance.	Tasaka S, 2010, EXP LUNG RES, V36, P362, DOI 10.3109/01902141003678590; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Soler RA, 1996, CLIN INFECT DIS, V23, P501; Haslett PAJ, 1998, J EXP MED, V187, P1885, DOI 10.1084/jem.187.11.1885; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-5110C; Tabata C, 2007, J IMMUNOL, V179, P708; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Kasagi S, 2006, AM J PHYSIOL-LUNG C, V290, pL396, DOI 10.1152/ajplung.00483.2004; Zhang Y, 2013, EXP LUNG RES, V39, P18, DOI 10.3109/01902148.2012.745910; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Bauditz J, 2002, GUT, V50, P196, DOI 10.1136/gut.50.2.196; Tabata C, 2006, AM J RESP CRIT CARE, V174, P1352, DOI 10.1164/rccm.200606-862OC; Corral LG, 1999, J IMMUNOL, V163, P380; Aoshiba K, 2003, AM J RESP CELL MOL, V28, P555, DOI 10.1165/rcmb.2002.0090OC; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Tsuji T, 2004, AM J RESP CELL MOL, V31, P643, DOI 10.1165/rcmb.2003-0290OC; Chen Y, 2010, EUR RESPIR J, V35, P904, DOI 10.1183/09031936.00003909; Herfs M, 2012, AM J RESP CELL MOL, V47, P67, DOI 10.1165/rcmb.2011-0353OC; Jacobson JM, 1997, NEW ENGL J MED, V336, P1487, DOI 10.1056/NEJM199705223362103; Koch H P, 1985, Prog Med Chem, V22, P165, DOI 10.1016/S0079-6468(08)70231-5; Lee FC, 2003, AM J HEMATOL, V73, P48, DOI 10.1002/ajh.10310; Oliver SJ, 1999, CLIN EXP IMMUNOL, V118, P315; Ruwanpura SM, 2011, AM J RESP CELL MOL, V45, P720, DOI 10.1165/rcmb.2010-0462OC; SCHULER U, 1995, DRUG SAFETY, V12, P364, DOI 10.2165/00002018-199512060-00002; SHESKIN J, 1980, INT J DERMATOL, V19, P318, DOI 10.1111/j.1365-4362.1980.tb00342.x; Stebbing J, 2001, BRIT J CANCER, V85, P953, DOI 10.1054/bjoc.2001.2025; Tabata C, 2006, AM J PHYSIOL-LUNG C, V290, P597; Takahashi Y, 2013, CHEM PHARM BULL, V61, P85, DOI 10.1248/cpb.c12-00539; Taraseviciene-Stewart I, 2005, AM J RESP CRIT CARE, V171, P734; Zeldis JB, 2003, SEMIN ONCOL, V30, P275, DOI 10.1053/sonc.2003.50078; Zorat F, 2001, BRIT J HAEMATOL, V115, P881, DOI 10.1046/j.1365-2141.2001.03204.x	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	APR	2015	25	2					511	517		10.1016/j.intimp.2015.02.036		7	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CF6MA	WOS:000352669600033		
J	Gromiha, MM; Anoosha, P; Velmurugan, D; Fukui, K				Gromiha, M. Michael; Anoosha, P.; Velmurugan, D.; Fukui, Kazuhiko			Mutational studies to understand the structure-function relationship in multidrug efflux transporters: Applications for distinguishing mutants with high specificity	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						Membrane protein; Multidrug efflux transporter; Multiple regression technique; Amino acid properties	AMINO-ACID-RESIDUES; RESISTANCE PROTEIN-1 MRP1/ABCC1; BASIS FUNCTION NETWORKS; P-GLYCOPROTEIN; MEMBRANE-PROTEINS; BIOCHEMICAL-PROPERTIES; SUBSTRATE-SPECIFICITY; SCORING MATRICES; IDENTIFICATION; PREDICTION	Multidrug transporters play key roles for drug resistance, mediating the transport of organic compounds and substrate recognition. The specificity of substrates and functions of multidrug transporters are affected with amino acid substitutions. Hence, it is important to understand the effect of mutations in multidrug resistance proteins on transport function and substrate specificity. In this work, we have analyzed the relationship between amino acid properties and activity of multidrug resistance proteins upon mutations and substrates. We found that the properties for drug activity and kinetic factors depend on amino acid substitutions and specific to substrates. The inclusion of information from neighboring residues from the mutants enhanced our understanding to the activity of multidrug resistant proteins. Further, we have combined amino acid properties using multiple regression technique, which showed a correlation of up to 0.99 between amino acid properties and activity. In addition, we have utilized Naive Bayes classifier for distinguishing between decrease and increase in IC50 upon mutations using wild type, mutant and neighboring residues, which showed a 10-fold cross-validation accuracy of 86%. Further, we have developed multiple regression models for predicting IC50 upon mutations with a maximum correlation of 0.92. The present method could be used for identifying the mutants in multidrug resistant proteins with enhanced specificity. (C) 2015 Elsevier B.V. All rights reserved.	[Gromiha, M. Michael; Anoosha, P.] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Velmurugan, D.] Univ Madras, Ctr Adv Study Crystallog & Biophys, Madras 600025, Tamil Nadu, India; [Velmurugan, D.] Univ Madras, Bioinformat Infrastruct Facil, Madras 600025, Tamil Nadu, India; [Fukui, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo 1350064, Japan	Gromiha, MM (reprint author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	gromiha@iitm.ac.in			Indian Institute of Technology Madras research grant [BIO/10-11/540/NFSC/MICH]; Indo-Japan Grant of Department of Biotechnology, India; National Institute of Advanced Industrial Science and Technology, Japan	We thank the reviewer for constructive comments. This research was partially supported by Indian Institute of Technology Madras research grant (BIO/10-11/540/NFSC/MICH), Indo-Japan Grant of Department of Biotechnology, India and National Institute of Advanced Industrial Science and Technology, Japan.	Gromiha MM, 1999, PROTEIN ENG, V12, P549, DOI 10.1093/protein/12.7.549; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/bse0500161, 10.1042/BSE0500161]; Martinez L, 2014, FEBS J, V281, P673, DOI 10.1111/febs.12613; Storm J, 2007, BIOCHEMISTRY-US, V46, P9899, DOI 10.1021/bi700447p; Gromiha MM, 2005, J CHEM INF MODEL, V45, P494, DOI 10.1021/ci049757q; Gromiha MM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S1; Ma J, 2013, PROTEINS, V81, P1653, DOI 10.1002/prot.24324; Adler J, 2004, J BIOL CHEM, V279, P8957, DOI 10.1074/jbc.M313422200; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Chen SA, 2011, BIOINFORMATICS, V27, P2062, DOI 10.1093/bioinformatics/btr340; Baker J, 2012, PROTEINS, V80, P1620, DOI 10.1002/prot.24056; Bhardwaj Ashima K, 2012, Recent Pat Antiinfect Drug Discov, V7, P73; Bikadi Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025815; Dolghih E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002083; Grewal P.S., 1987, NUMERICAL METHODS ST; Gromiha MM, 2006, PROTEINS, V63, P1031, DOI 10.1002/prot.20929; Gromiha MM, 2010, PROTEIN BIOINFORMATICS: FROM SEQUENCE TO FUNCTION, P1; Gromiha MM, 2014, BRIEF BIOINFORM, V15, P155, DOI 10.1093/bib/bbt015; Gromiha MM, 2009, NUCLEIC ACIDS RES, V37, pD201, DOI 10.1093/nar/gkn672; Gromiha MM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-135; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Li HQ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-418; Li HQ, 2008, BIOINFORMATICS, V24, P1129, DOI 10.1093/bioinformatics/btn099; Liu M, 2013, J BIOMOL STRUCT DYN, V31, P612, DOI 10.1080/07391102.2012.706079; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/jb.187.1552-1558.2005; Ou YY, 2013, PROTEINS, V81, P1634, DOI 10.1002/prot.24322; Ou YY, 2010, PROTEINS, V78, P1789, DOI 10.1002/prot.22694; Storm J, 2008, BIOCHEMISTRY-US, V47, P3615, DOI 10.1021/bi7023089; Witten IH, 2005, DATA MINING PRACTICA; Yang RY, 2008, BIOCHEMISTRY-US, V47, P8456, DOI 10.1021/bi8007643; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Zhang DW, 2003, J BIOL CHEM, V278, P46052, DOI 10.1074/jbc.M308403200; Zhang DW, 2002, J BIOL CHEM, V277, P20934, DOI 10.1074/jbc.M201311200	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	APR	2015	75						218	224		10.1016/j.ijbiomac.2015.01.028		7	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CF1UF	WOS:000352332700030		
J	Watanabe, T; Itabashi, M; Shimada, Y; Tanaka, S; Ito, Y; Ajioka, Y; Hamaguchi, T; Hyodo, I; Igarashi, M; Ishida, H; Ishihara, S; Ishiguro, M; Kanemitsu, Y; Kokudo, N; Muro, K; Ochiai, A; Oguchi, M; Ohkura, Y; Saito, Y; Sakai, Y; Ueno, H; Yoshino, T; Boku, N; Fujimori, T; Koinuma, N; Morita, T; Nishimura, G; Sakata, Y; Takahashi, K; Tsuruta, O; Yamaguchi, T; Yoshida, M; Yamaguchi, N; Kotake, K; Sugihara, K				Watanabe, Toshiaki; Itabashi, Michio; Shimada, Yasuhiro; Tanaka, Shinji; Ito, Yoshinori; Ajioka, Yoichi; Hamaguchi, Tetsuya; Hyodo, Ichinosuke; Igarashi, Masahiro; Ishida, Hideyuki; Ishihara, Soichiro; Ishiguro, Megumi; Kanemitsu, Yukihide; Kokudo, Norihiro; Muro, Kei; Ochiai, Atsushi; Oguchi, Masahiko; Ohkura, Yasuo; Saito, Yutaka; Sakai, Yoshiharu; Ueno, Hideki; Yoshino, Takayuki; Boku, Narikazu; Fujimori, Takahiro; Koinuma, Nobuo; Morita, Takayuki; Nishimura, Genichi; Sakata, Yuh; Takahashi, Keiichi; Tsuruta, Osamu; Yamaguchi, Toshiharu; Yoshida, Masahiro; Yamaguchi, Naohiko; Kotake, Kenjiro; Sugihara, Kenichi		Japanese Soc Canc Colon Rectum	Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Colorectal cancer; Guideline; Surgery; Chemotherapy; Endoscopy; Radiotherapy	RANDOMIZED PHASE-III; TOTAL MESORECTAL EXCISION; FLUOROURACIL PLUS LEUCOVORIN; ENDOSCOPIC MUCOSAL RESECTION; SHORT-COURSE RADIOTHERAPY; LYMPH-NODE METASTASIS; HIGH-DOSE LEUCOVORIN; INTENSIVE FOLLOW-UP; PREOPERATIVE RADIOTHERAPY; 1ST-LINE TREATMENT	Colorectal cancer is a major cause of death in Japan, where it accounts for the largest number of deaths from malignant neoplasms among women and the third largest number among men. Many new methods of treatment have been developed during recent decades. The Japanese Society for Cancer of the Colon and Rectum Guidelines 2014 for treatment of colorectal cancer (JSCCR Guidelines 2014) have been prepared as standard treatment strategies for colorectal cancer, to eliminate treatment disparities among institutions, to eliminate unnecessary treatment and insufficient treatment, and to deepen mutual understanding among health-care professionals and patients by making these guidelines available to the general public. These guidelines have been prepared as a result of consensuses reached by the JSCCR Guideline Committee on the basis of careful review of evidence retrieved by literature searches and taking into consideration the medical health insurance system and actual clinical practice in Japan. They can, therefore, be used as a guide for treating colorectal cancer in clinical practice. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. As a result of the discussions of the Guideline Committee, controversial issues were selected as clinical questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories, on the basis of consensus reached by Guideline Committee members. Here we present the English version of the JSCCR Guidelines 2014.	[Watanabe, Toshiaki; Ishihara, Soichiro] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138655, Japan; [Itabashi, Michio] Tokyo Womens Med Univ, Dept Surg 2, Tokyo, Japan; [Shimada, Yasuhiro; Hamaguchi, Tetsuya] Natl Canc Ctr, Div Gastrointestinal Med Oncol, Tokyo, Japan; [Tanaka, Shinji] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Ito, Yoshinori] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan; [Ajioka, Yoichi] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Diagnost Pathol, Niigata, Japan; [Hyodo, Ichinosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Gastroenterol, Ibaraki, Japan; [Igarashi, Masahiro] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Endoscopy, Tokyo, Japan; [Ishida, Hideyuki] Saitama Med Univ, Dept Digest Tract & Gen Surg, Saitama Med Ctr, Saitama, Japan; [Ishiguro, Megumi; Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Grad Sch, Tokyo, Japan; [Kanemitsu, Yukihide] Natl Canc Ctr, Colorectal Surg Div, Tokyo, Japan; [Kokudo, Norihiro] Univ Tokyo, Hepatobiliary Pancreat Surg Div, Artificial Organ & Transplantat Div, Dept Surg,Grad Sch Med, Tokyo, Japan; [Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan; [Ochiai, Atsushi] Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Chiba, Japan; [Oguchi, Masahiko] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan; [Ohkura, Yasuo] Kyorin Univ, Dept Pathol, Sch Med, Tokyo, Japan; [Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Kyoto, Japan; [Ueno, Hideki] Natl Def Med Coll, Dept Surg, Saitama, Japan; [Yoshino, Takayuki] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan; [Boku, Narikazu] St Marianna Univ, Dept Clin Oncol, Kawasaki, Kanagawa, Japan; [Fujimori, Takahiro] Dokkyo Med Univ, Sch Med, Dept Surg & Mol Pathol, Mibu, Tochigi, Japan; [Koinuma, Nobuo] Tohoku Pharmaceut Univ, Dept Hlth Adm & Policy, Sendai, Miyagi, Japan; [Morita, Takayuki] Aomori Prefectural Cent Hosp, Dept Surg, Ctr Canc, Aomori, Japan; [Nishimura, Genichi] Japanese Red Cross Kanazawa Hosp, Dept Surg, Kanazawa, Ishikawa, Japan; [Sakata, Yuh] Misawa City Hosp, Aomori, Japan; [Takahashi, Keiichi] Komagome Hosp, Dept Surg, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Tsuruta, Osamu] Kurume Univ, Div GI Endoscopy, Sch Med, Fukuoka, Japan; [Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan; [Yoshida, Masahiro] Int Univ Hlth & Welf, Chemotherapy Res Inst, Dept Hemodialysis & Surg, Chiba, Japan; [Yamaguchi, Naohiko] Toho Univ, Med Ctr, Sakura Hosp, Chiba 2748510, Japan; [Kotake, Kenjiro] Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan	Watanabe, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	toshwatanabe@yahoo.co.jp			Chugai; Taiho; Yakult; Takeda; Merck Serono; Bristol-Myers Squibb; Yakult Takeda; Bayel; Bayer; Nippon Kayaku; Dainippon Sumitomo; Chigai; Daiich Sankyo; Eli Lilly; Pfizer; Ono; Otsuka Pharmaceutical; Synergy International	Toshiaki Watanabe received research grants from Chugai, Taiho, Yakult, Takeda, Merck Serono, and Bristol-Myers Squibb, and received lecture fees from Chugai, Taiho, Yakult Takeda, Merck Serono, Bristol-Myers Squibb, and Bayel; Michio Itabashi has received lecture fees from Chugai; Yasuhiro Shimada received research grants from Taiho, Chugai, Yakult, and Bayer, and received lecture fees from Taiho, Chugai, Yakult, and Bayer; Shinji Tanaka has no conflict of interest; Yoshinori Ito has no conflict of interest; Yoichi Ajioka has no conflict of interest; Tetsuya Hamaguchi serves as a consultant to Takeda; Ichinosuke Hyodo received research grants from Taiho, Chugai, and Yakult, and received lecture fees from Taiho, Chugai, and Yakult; Masahiro Igarashi has no conflict of interest; Hideyuki Ishida has no conflict of interest; Soichiro Ishihara has no conflict of interest; Megumi Ishiguro serves as a consultant to Taiho, and received a research grant from Taiho, and received lecture fees from Taiho, Chugai, Yakult, and Nippon Kayaku, and received writing fees from Taiho; Yukihide Kanemitsu has no conflict of interest; Norihiro Kokudo received research grants from Dainippon Sumitomo, Bayer, Merk-Serono, Bristol-Mayers, Chigai, and Taiho; Kei Muro received lecture fees from Merk Serono, Taiho, Chugai, and Takeda; Atsushi Ochiai has no conflict of interest; Masahiko Oguchi has no conflict of interest; Yasuo Ohkura has no conflict of interest; Yutaka Saito has no conflict of interest; Yoshiharu Sakai has no conflict of interest; Hideki Ueno has no conflict of interest; Takayuki Yoshino received research grants from Daiich Sankyo, Taiho, Eli Lilly, Pfizer, Yakult, and Dainippon Sumitomo, and received lecture fees from Chugai and Takeda; Narikazu Boku received research grants from Taiho and Chugai, and received lecture fees from Taiho and Ono; Takahiro Fujimori has no conflict of interest; Nobuo Koinuma has no conflict of interest; Takayuki Morita has no conflict of interest; Genichi Nishimura has no conflict of interest; Yuh Sakata received lecture fees from Taiho, Daiich Sankyo, Yakult, Otsuka Pharmaceutical, Merck Serono, and Bristol-Myers Squibb, and received manuscript fees from Synergy International; Keiichi Takahashi has no conflict of interest; Osamu Tsuruta has no conflict of interest; Toshiharu Yamaguchi has no conflict of interest; Masahiro Yoshida has no conflict of interest; Naohiko Yamaguchi has no conflict of interest; Kenjiro Kotake has no conflict of interest; Kenichi Sugihara received research grants from Chugai, Taiho, Yakult, Takeda, Merck Serono, Bristol-Myers Squibb, and Bayel, and received lecture fees from Chugai, Taiho, Yakult, Takeda, Merck Serono, Bristol-Myers Squibb, and Bayel, and received manuscript fees from Chugai, Taiho, Merck Serono, Bristol-Myers Squibb, and Bayel.	Adam R, 2007, SEMIN ONCOL, V34, pS7, DOI 10.1053/j.seminoncol.2007.01.003; Aihara M, 2010, GRADE SYSTEM CLIN PR; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Atkins D, 2004, BRIT MED J, V328, P1490; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Mitry E, 2008, J CLIN ONCOL, V26, P4906, DOI 10.1200/JCO.2008.17.3781; Brunetti M, 2013, J CLIN EPIDEMIOL, V66, P140, DOI 10.1016/j.jclinepi.2012.04.012; BRUINVELS DJ, 1994, ANN SURG, V219, P174, DOI 10.1097/00000658-199402000-00009; Lowry AC, 2001, DIS COLON RECTUM, V44, P915, DOI 10.1007/BF02235475; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Murata S, 1998, CANCER-AM CANCER SOC, V83, P1086, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1086::AID-CNCR6>3.0.CO;2-6; Green RJ, 2002, ANN INTERN MED, V136, P261; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI 10.1016/j.jclinepi.2011.06.004; Ikematsu H, 2013, GASTROENTEROLOGY, V144, P551, DOI 10.1053/j.gastro.2012.12.003; Matsuda T, 2011, CANCER SCI, V102, P1693, DOI 10.1111/j.1349-7006.2011.01997.x; Rothenberg ML, 2003, J CLIN ONCOL, V21, P2059, DOI 10.1200/JCO.2003.11.126; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Lam VWT, 2012, ANN SURG ONCOL, V19, P1292, DOI 10.1245/s10434-011-2061-0; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Tree AC, 2013, LANCET ONCOL, V14, pE28, DOI 10.1016/S1470-2045(12)70510-7; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Figueredo A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-26; Kohne CH, 2012, J CANCER RES CLIN, V138, P65, DOI 10.1007/s00432-011-1061-6; Falcone A, 2007, J CLIN ONCOL, V25, P1670, DOI 10.1200/JCO.2006.09.0928; Shirao K, 2004, J CLIN ONCOL, V22, P3466, DOI 10.1200/JCO.2004.05.017; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Renehan AG, 2005, BRIT J CANCER, V92, P430, DOI 10.1038/sj.bjc.6602369; Cunningham D, 1998, LANCET, V352, P1413, DOI 10.1016/S0140-6736(98)02309-5; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P173, DOI 10.1016/j.jclinepi.2012.08.001; Fuchs CS, 2008, J CLIN ONCOL, V26, P689, DOI 10.1200/JCO.2007.15.5390; Tanaka S, 2008, J GASTROENTEROL, V43, P641, DOI 10.1007/s00535-008-2223-4; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; ENKER WE, 1995, J AM COLL SURGEONS, V181, P335; Van Cutsem E, 2001, J CLIN ONCOL, V19, P4097; Portier G, 2006, J CLIN ONCOL, V24, P4976, DOI 10.1200/JCO.2006.06.8353; Wong SL, 2010, J CLIN ONCOL, V28, P493, DOI 10.1200/JCO.2009.23.4450; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Gerard JP, 2010, J CLIN ONCOL, V28, P1638, DOI 10.1200/JCO.2009.25.8376; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Park IJ, 2008, ANN SURG ONCOL, V15, P227, DOI 10.1245/s10434-007-9625-z; Muro K, 2010, LANCET ONCOL, V11, P853, DOI 10.1016/S1470-2045(10)70181-9; SCHEITHAUER W, 1993, BRIT MED J, V306, P752; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Aschele C, 2011, J CLIN ONCOL, V29, P2773, DOI 10.1200/JCO.2010.34.4911; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Lambert LA, 2000, ARCH SURG-CHICAGO, V135, P473, DOI 10.1001/archsurg.135.4.473; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Camma C, 2000, JAMA-J AM MED ASSOC, V284, P1008, DOI 10.1001/jama.284.8.1008; Haller DG, 2005, J CLIN ONCOL, V23, P8671, DOI 10.1200/JCO.2004.00.5686; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Fuchs CS, 2007, J CLIN ONCOL, V25, P4779, DOI 10.1200/JCO.2007.11.3357; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006; Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1783, DOI 10.1007/s10350-007-9030-5; deGramont A, 1997, J CLIN ONCOL, V15, P808; Hoff PM, 2001, J CLIN ONCOL, V19, P2282; PETRELLI N, 1987, J CLIN ONCOL, V5, P1559; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Douillard JY, 2002, J CLIN ONCOL, V20, P3605, DOI 10.1200/JCO.2002.04.123; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; PATCHELL RA, 1990, NEW ENGL J MED, V322, P494, DOI 10.1056/NEJM199002223220802; Shibata T, 2000, CANCER, V89, P276, DOI 10.1002/1097-0142(20000715)89:2<276::AID-CNCR11>3.0.CO;2-0; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Renehan AG, 2002, BRIT MED J, V324, P813, DOI 10.1136/bmj.324.7341.813; Francois Y, 1999, J CLIN ONCOL, V17, P2396; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Ngan SY, 2012, J CLIN ONCOL, V30, P3827, DOI 10.1200/JCO.2012.42.9597; MACFARLANE JK, 1993, LANCET, V341, P457; Carmichael J, 2002, J CLIN ONCOL, V20, P3617, DOI 10.1200/JCO.2002.10.129; Rothenberg ML, 2008, ANN ONCOL, V19, P1720, DOI 10.1093/annonc/mdn370; Tebbutt NC, 2010, J CLIN ONCOL, V28, P3191, DOI 10.1200/JCO.2009.27.7723; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Gerard JP, 2012, J CLIN ONCOL, V30, P4558, DOI 10.1200/JCO.2012.42.8771; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Beppu T, 2000, SURG THERAPY, V83, P237; Berman JM, 2000, LANCET, V355, P395, DOI 10.1016/S0140-6736(99)06552-6; Cancer pain relief and palliative care, 1990, WHO TECHN REP SER, V804, P21; Gray R, 2001, LANCET, V358, P1291; FLEISCHER DE, 1989, JAMA-J AM MED ASSOC, V261, P580, DOI 10.1001/jama.261.4.580; Fukui T, 2014, MINDS HDB CLIN PRACT; Guyatt GH, 2008, BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Hofheinz RD, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70116-X; Jaeschke R, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a744; Japanese Society for Cancer of the Colon and Rectum, 2011, MULT REG LARG BOW CA, V29; Japanese Society for Cancer of the Colon and Rectum, 2014, JSCCR GUID 2014 TREA; Japanese Society for Cancer of the Colon and Rectum, 2012, JSCCR GUID 2012 CLIN; Japanese Society for Cancer of the Colon and Rectum, 1994, GEN RUL CLIN PATH ST; Japanese Society for Cancer of the Colon and Rectum, 1980, GEN RUL CLIN PATH ST; Japanese Society for Cancer of the Colon and Rectum, 2005, JSCCR GUID 2005 TREA; Jeffery M, 2007, COCHRANE DB SYST REV, V24; Kobayashi K, 1999, J THORAC CARDIOV SUR, V118, P1090, DOI 10.1016/S0022-5223(99)70106-6; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Oka S, 2011, DIGEST ENDOSC, V23, P190, DOI 10.1111/j.1443-1661.2010.01072.x; Peeters M, 2010, 2010 ASCO GASTR CANC; Piedbois P, 1996, J NATL CANCER I, V88, P252; Regnard JF, 1998, ANN THORAC SURG, V66, P214, DOI 10.1016/S0003-4975(98)00269-0; Robinson BJ, 1999, J THORAC CARDIOV SUR, V117, P66, DOI 10.1016/S0022-5223(99)70470-8; Roh MS, 2011, J CLIN ONCOL, V29; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Simmonds P C, 2000, BMJ, V321, P531; Skibber JM, 2001, CANC PRINCIPLES PRAC, P1271; Tanaka S, 2000, ONCOL REP, V7, P783	132	8	8	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					207	239		10.1007/s10147-015-0801-z		33	Oncology	Oncology	CF5SI	WOS:000352616900001		
J	Ebina, Y; Yaegashi, N; Katabuchi, H; Nagase, S; Udagawa, Y; Hachisuga, T; Saito, T; Mikami, M; Aoki, Y; Yoshikawa, H				Ebina, Yasuhiko; Yaegashi, Nobuo; Katabuchi, Hidetaka; Nagase, Satoru; Udagawa, Yasuhiro; Hachisuga, Toru; Saito, Tsuyoshi; Mikami, Mikio; Aoki, Yoichi; Yoshikawa, Hiroyuki			Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Uterine cervical cancer; Clinical practice guidelines; Surgery; Chemotherapy; Irradiation; Recurrence		The second edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of uterine cervical cancer was published in 2011. The guidelines comprise eight chapters and five algorithms. They were prepared by consensus among the members of the Japan Society of Gynecologic Oncology Guidelines Formulation Committee and Evaluation Committee and are based on a careful review of the evidence obtained from the literature, health insurance system, and actual clinical settings in Japan. The highlights of the 2011 revision are (1) the recommended grades have been changed to five stages-A, B, C1, C2, and D; (2) the revisions are consistent with the new International Federation of Gynecology and Obstetrics staging system; (3) the roles are shared between the 'Japanese classification of cervical cancer' and the new guidelines; (4) clinical questions related to adenocarcinoma have been revised; and (5) a clinical question regarding cervical cancer in pregnant patients has been added. Each chapter includes a clinical question, recommendations, background, objectives, explanations, and references. Each recommendation is accompanied by a classification of recommendation categories. The objective of these guidelines is to update the standard treatment strategies for cervical cancer, thus eliminating unnecessary and insufficient treatment.	[Ebina, Yasuhiko] Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Katabuchi, Hidetaka] Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Kumamoto, Japan; [Nagase, Satoru] Yamagata Univ, Fac Med, Dept Obstet & Gynecol, Yamagata 990, Japan; [Udagawa, Yasuhiro] Fujita Hlth Univ, Sch Med, Dept Obstet & Gynecol, Toyoake, Aichi 47011, Japan; [Hachisuga, Toru] Univ Occupat & Environm Hlth, Sch Med, Dept Obstet & Gynecol, Kitakyushu, Japan; [Saito, Tsuyoshi] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Mikami, Mikio] Tokai Univ, Sch Med, Dept Obstet & Gynecol, Isehara, Kanagawa 25911, Japan; [Aoki, Yoichi] Univ Ryukyus, Grad Sch Med Sci, Dept Obstet & Gynecol, Nishihara, Okinawa 90301, Japan; [Yoshikawa, Hiroyuki] Univ Tsukuba, Fac Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki, Japan	Ebina, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ebiyas@med.kobe-u.ac.jp			Ministry of Health, Labour and Welfare [H24-Clinical Cancer Research-001]	We thank the Japan Society of Obstetrics and Gynecology, the Japan Association of Obstetricians and Gynecologists, the Japanese Gynecologic Oncology Group, the Japan Society of Clinical Oncology, and the Japanese Society for Therapeutic Radiology and Oncology for their comments and contributions throughout the project. We also acknowledge support by grants from the Ministry of Health, Labour and Welfare; H24-Clinical Cancer Research-001 (chief researcher, Koichi Hirata).	Ariyoshi Hiroshi, 2002, Gan To Kagaku Ryoho, V29, P970; Fukui T, 2007, MINDS GUIDANCE PRACT; Gynecologic cancer committee, 2012, ACTA OBSTET GYENCOL, V64, P2340; Nagase S, 2010, INT J CLIN ONCOL, V15, P117, DOI 10.1007/s10147-010-0061-x; Ochiai Kazunori, 2002, Gan To Kagaku Ryoho, V29, P1047	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					240	248		10.1007/s10147-015-0806-7		9	Oncology	Oncology	CF5SI	WOS:000352616900002		
J	Iwase, H				Iwase, Hirotaka			Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material							PROGRESSION-FREE SURVIVAL; TERM-FOLLOW-UP; POSTMENOPAUSAL PATIENTS; ENDOCRINE THERAPY; RANDOMIZED-TRIAL; FULVESTRANT; TAMOXIFEN; WOMEN; CHEMOTHERAPY		Kumamoto Univ, Dept Breast & Endocrine Surg, Chuo Ku, Kumamoto 8608556, Japan	Iwase, H (reprint author), Kumamoto Univ, Dept Breast & Endocrine Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hiwase@kumamoto-u.ac.jp					Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Rocca A, 2014, EXPERT OPIN PHARMACO, V15, P407, DOI 10.1517/14656566.2014.870555; Burzykowski T, 2008, J CLIN ONCOL, V26, P1987, DOI 10.1200/JCO.2007.10.8407; Giordano SH, 2004, CANCER, V100, P44, DOI 10.1002/cncr.11859; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Lianidou ES, 2013, BRIT J CANCER, V108, P2426, DOI 10.1038/bjc.2013.265; Fossati R, 1998, J CLIN ONCOL, V16, P3439; Iwase H, 2013, BRIT J CANCER, V109, P1537, DOI 10.1038/bjc.2013.520; Haddow A, 1944, Br Med J, V2, P393; Yamamoto N, 1998, J CLIN ONCOL, V16, P2401; Iwase H, 2008, BREAST CANCER-TOKYO, V15, P278, DOI 10.1007/s12282-008-0071-y; Greenberg PAC, 1996, J CLIN ONCOL, V14, P2197; Rahman ZU, 1999, CANCER, V85, P104, DOI 10.1002/(SICI)1097-0142(19990101)85:1<104::AID-CNCR15>3.0.CO;2-R; Yardley DA, 2013, ADV THER, V30, P870, DOI 10.1007/s12325-013-0060-1; Robertson JFR, 2005, BREAST CANCER RES TR, V92, P169, DOI 10.1007/s10549-004-4776-0; Gennari A, 2005, CANCER, V104, P1742, DOI 10.1002/cncr.21359; Howell A, 2004, J CLIN ONCOL, V22, P1605, DOI 10.1200/JCO.2004.02.112; Byrne MJ, 1997, J CLIN ONCOL, V15, P3141; Gralow JR, 2005, BREAST CANCER RES TR, V89, pS9, DOI 10.1007/s10549-005-0143-z; Osborne CK, 1998, NEW ENGL J MED, V339, P1609; Rothe F, 2014, ANN ONCOL, V25, P1959, DOI 10.1093/annonc/mdu288; Tot T, 2011, VIRCHOWS ARCH, V458, P125, DOI 10.1007/s00428-010-1005-6	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					249	252		10.1007/s10147-015-0795-6		4	Oncology	Oncology	CF5SI	WOS:000352616900003		
J	Iwase, H; Yamamoto, Y				Iwase, Hirotaka; Yamamoto, Yutaka			Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review						Metastatic breast cancer; Sequential endocrine therapy; Estrogen additive therapy	NONSTEROIDAL AROMATASE INHIBITOR; PHASE-II TRIAL; GOSERELIN PLUS ANASTROZOLE; HIGH-DOSE ESTROGEN; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; MEGESTROL-ACETATE; DOUBLE-BLIND; PREMENOPAUSAL WOMEN; HORMONAL-THERAPY	Sequential use of endocrine agents is common in estrogen receptor (ER)-positive metastatic breast cancer (MBC). In premenopausal women with MBC, tamoxifen and/or a luteinizing hormone-releasing hormone (LH-RH) agonist are options for endocrine treatment. Meta-analysis showed that the combination of the two agents is superior to either monotherapy. Under ovarian ablation or function-suppression, an agent used to treat postmenopausal women, such as the aromatase inhibitor (AI), fulvestrant, becomes possible as a subsequent therapy. In postmenopausal women, endocrine treatment options are widely available and an optimal sequence has not yet to be determined. Options for first-line therapy of metastatic disease include an AI for women who have received adjuvant tamoxifen, or tamoxifen for patients who have received adjuvant AI. In addition, data suggest that fulvestrant is a promising therapeutic option that has proven efficacy in the treatment of postmenopausal women with MBC. Other agents that may be used in the sequence include a steroidal AI or a progestin. Furthermore, estrogen additive therapy by with diethylstilbestrol or ethinylestradiol has recently been revived and showed a high response rate as a salvage endocrine therapy, although its mechanism of action is still unclear. Thus, sequential use of endocrine therapies, especially the use of a subsequent therapy with a different mechanism of action to the prior therapy, has a beneficial effect in maintaining a good quality of life and extending survival for MBC with hormone responsiveness.	[Iwase, Hirotaka; Yamamoto, Yutaka] Kumamoto Univ, Dept Breast & Endocrine Therapy, Chuo Ku, Kumamoto 8608556, Japan	Iwase, H (reprint author), Kumamoto Univ, Dept Breast & Endocrine Therapy, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hiwase@kumamoto-u.ac.jp			Chugai-Roche; AstraZeneca; Novartis; Taiho; Takeda	The author and his immediate family members declare their conflicts of interest as follows: employment, not applicable (N/A); leadership, N/A; consultant, N/A; stock, N/A; honoraria, AstraZeneca; research funds, Chugai-Roche, AstraZeneca, Novartis, Taiho, Takeda; testimony, N/A; other, N/A.	Agrawal Amit, 2006, World J Surg Oncol, V4, P44, DOI 10.1186/1477-7819-4-44; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Bergh J, 2012, J CLIN ONCOL, V30, P1919, DOI 10.1200/JCO.2011.38.1095; Kaufmann M, 2000, J CLIN ONCOL, V18, P1399; WILLEMSE PHB, 1990, EUR J CANCER, V26, P337, DOI 10.1016/0277-5379(90)90231-H; Mehta RS, 2012, NEW ENGL J MED, V367, P435, DOI 10.1056/NEJMoa1201622; Paridaens RJ, 2008, J CLIN ONCOL, V26, P4883, DOI 10.1200/JCO.2007.14.4659; Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Iwase H, 2013, BRIT J CANCER, V109, P1537, DOI 10.1038/bjc.2013.520; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Haddow A, 1944, Br Med J, V2, P393; Robertson JFR, 2009, J CLIN ONCOL, V27, P4530, DOI 10.1200/JCO.2008.21.1136; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758; Lonning PE, 2001, BREAST CANCER RES TR, V67, P111, DOI 10.1023/A:1010619225209; Buzdar AU, 1998, CANCER-AM CANCER SOC, V83, P1142, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.3.CO;2-7; Carlson RW, 2010, J CLIN ONCOL, V28, P3917, DOI 10.1200/JCO.2009.24.9565; Thurlimann B, 2003, EUR J CANCER, V39, P2310, DOI 10.1016/S0959-8049(03)00602-6; Peethambaram PP, 1999, BREAST CANCER RES TR, V54, P117, DOI 10.1023/A:1006185805079; Yardley DA, 2013, ADV THER, V30, P870, DOI 10.1007/s12325-013-0060-1; Nishimura R, 2013, ONCOL REP, V29, P1707, DOI 10.3892/or.2013.2312; MANNI A, 1981, CANCER, V48, P2507, DOI 10.1002/1097-0142(19811201)48:11<2507::AID-CNCR2820481127>3.0.CO;2-E; Iwase H, 2010, BREAST CANCER-TOKYO, V17, P118, DOI 10.1007/s12282-009-0113-0; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; BOCCARDO F, 1994, ANN ONCOL, V5, P337; Klijn JGM, 2001, J CLIN ONCOL, V19, P343; Buzdar A, 2001, J CLIN ONCOL, V19, P3357; Klijn JGM, 2000, J NATL CANCER I, V92, P903, DOI 10.1093/jnci/92.11.903; Robertson JFR, 2003, CANCER, V98, P229, DOI 10.1002/cncr.11468; Dombernowsky P, 1998, J CLIN ONCOL, V16, P453; Chia S, 2008, J CLIN ONCOL, V26, P1664, DOI 10.1200/JCO.2007.13.5822; Mauri D, 2006, J NATL CANCER I, V98, P1285, DOI 10.1093/jnci/djj357; Howell A, 2004, J CLIN ONCOL, V22, P1605, DOI 10.1200/JCO.2004.02.112; Lonning PE, 2000, J CLIN ONCOL, V18, P2234; Steele N, 2006, BREAST, V15, P430, DOI 10.1016/j.breast.2005.08.032; Bartsch R, 2012, EUR J CANCER, V48, P1932, DOI 10.1016/j.ejca.2012.03.002; Byrne MJ, 1997, J CLIN ONCOL, V15, P3141; Crump M, 1997, BREAST CANCER RES TR, V44, P201, DOI 10.1023/A:1005833811584; Forward DP, 2004, BRIT J CANCER, V90, P590, DOI 10.1038/sj.bjc.6601557; Iaffaioli R, 2005, BRIT J CANCER, V92, P1621, DOI 10.1038/sj.bjc.6602579; Johnston SRD, 2013, LANCET ONCOL, V14, P989, DOI 10.1016/S1470-2045(13)70322-X; Jordan VC, 2009, BREAST, V18, pS10, DOI 10.1016/S0960-9776(09)70266-8; Mahtani RL, 2009, CLIN THER, V31, P2371, DOI 10.1016/j.clinthera.2009.11.002; PATERSON AHG, 1990, SEMIN ONCOL, V17, P52; Rose C, 2003, EUR J CANCER, V39, P2318, DOI 10.1016/S0959-8049(03)00630-0; Taylor CW, 1998, J CLIN ONCOL, V16, P994; Yamamoto Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-239	47	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					253	261		10.1007/s10147-015-0793-8		9	Oncology	Oncology	CF5SI	WOS:000352616900004		
J	Hayashi, S; Kimura, M				Hayashi, Shin-ichi; Kimura, Mariko			Mechanisms of hormonal therapy resistance in breast cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review						Estrogen receptor; Aromatase inhibitor; Hormonal therapy; Androgen; mTOR	TERM-ESTROGEN-DEPRIVATION; STROMAL INTERACTION; RECEPTOR; PATHWAYS; GROWTH; SURVIVAL; CELLS; HYPERSENSITIVITY; PHOSPHORYLATION; SERINE-167	Whilst estrogen receptor (ER)-positive breast cancers are preferentially treated with hormone therapy, approximately one-third of them relapse. The mechanisms of refractoriness have been investigated by numerous studies but have not been fully clarified. Hormonal therapy resistance, particularly aromatase inhibitor (AI) resistance, may be related to the acquisition of alternative intracellular ER signaling. We have been investing the mechanisms using cancer specimens and cell lines by monitoring the transcription activity of ERs. AI refractory specimens showed diverse ER activity in the adenovirus estrogen receptor element-green fluorescent protein (ERE-GFP) assay and varied sensitivity to anti-estrogens, indicating the existence of multiple resistant mechanisms. We established six different types of cell lines mimicking AI resistance from ERE-GFP-introduced ER-positive cell lines. They revealed that multiple and alternative ER activating pathways were involved in the resistance, such as phosphorylation-dependent or androgen metabolite-dependent mechanisms. The response to fulvestrant and mammalian target of rapamycin inhibitor also varied among individual resistant cell lines. These results indicate that further subclassification of ER-positive breast cancer is extremely important to decide the therapeutic management of not only hormonal therapy but also new molecular target therapy.	[Hayashi, Shin-ichi; Kimura, Mariko] Tohoku Univ, Grad Sch Med, Dept Mol & Funct Dynam, Aoba Ku, Sendai, Miyagi 980, Japan; [Hayashi, Shin-ichi; Kimura, Mariko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigen & Dis, Aoba Ku, Sendai, Miyagi 980, Japan; [Kimura, Mariko] Yokohama City Univ, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan	Hayashi, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Mol & Funct Dynam, Aoba Ku, Sendai, Miyagi 980, Japan.	shin@med.tohoku.ac.jp					Castano E, 1997, BIOCHEM J, V326, P149; Matsumoto M, 2008, ENDOCR-RELAT CANCER, V15, P451, DOI 10.1677/ERC-07-0227; Hanamura T, 2014, BREAST CANCER RES TR, V143, P69, DOI 10.1007/s10549-013-2788-3; Fujii R, 2014, J STEROID BIOCHEM, V144, P513, DOI 10.1016/j.jsbmb.2014.08.019; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Santen RJ, 2008, ADV EXP MED BIOL, V630, P19; Hanamura T, 2013, BREAST CANCER RES TR, V139, P731, DOI 10.1007/s10549-013-2595-x; Martin LA, 2005, ENDOCR-RELAT CANCER, V12, pS75, DOI 10.1677/erc.1.0123; Zardavas D, 2013, NAT REV CLIN ONCOL, V10, P191, DOI 10.1038/nrclinonc.2013.29; Yamaguchi Y, 2005, CANCER RES, V65, P4653, DOI 10.1158/0008-5472.CAN-04-3236; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Yamashita H, 2005, BREAST CANCER RES, V7, pR753, DOI 10.1186/bcr1285; Sabnis GJ, 2005, CANCER RES, V65, P3903, DOI 10.1158/0008-5472.CAN-04-4092; Baum M, 2003, Cancer, V98, P1802; Cadoo Karen A, 2014, Breast Cancer (Dove Med Press), V6, P123, DOI 10.2147/BCTT.S46725; Cambell RA, 2001, J BIOL CHEM, V276, P9817; Diaby V, 2014, BREAST CANCER RES TR, V146, P669, DOI 10.1007/s10549-014-3047-y; Fujiki N, 2014, J STEROID BIOCHEM, V139, P61, DOI 10.1016/j.jsbmb.2013.08.012; Gohno T, 2012, CANCER MED-US, V1, P328, DOI 10.1002/cam4.41; Di Leo A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt337; Johnston SR, 2013, AM SOC CLIN ONCOL ED, DOI [10.1200/EdBook_AM.2013.33.e28, DOI 10.1200/EDBOOK_AM.2013.33.E28]; Miller TW, 2013, AM SOC CLIN ONCOL ED, DOI [10.1200/EdBook_AM.2013.33.e37, DOI 10.1200/EDBOOK_AM.2013.33.E37]; Piccart M, 2014, ANN ONCOL, V25, P2357, DOI 10.1093/annonc/mdu456; Strasser-Weippl K, 2005, J CLIN ONCOL, V23, P1751, DOI 10.1200/JCO.2005.11.038; Yue W, 2003, J STEROID BIOCHEM, V86, P265, DOI 10.1016/S0960-0760(03)00366-2; Zardavas D, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3605	27	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					262	267		10.1007/s10147-015-0788-5		6	Oncology	Oncology	CF5SI	WOS:000352616900005		
J	Saji, S; Kimura-Tsuchiya, R				Saji, Shigehira; Kimura-Tsuchiya, Reiko			Combination of molecular-targeted drugs with endocrine therapy for hormone-resistant breast cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review						Estrogen receptor; Molecular-targeted drugs; Breast cancer; Resistant	POSTMENOPAUSAL WOMEN; BRAIN METASTASES; CONTROLLED-TRIAL; PHASE-II; INHIBITOR; SURVIVAL; RECURRENT	Overcoming resistance to endocrine therapy is the most intensive research area in estrogen receptor (ER)-positive breast cancer. A strategy to restore endocrine sensitivity using molecular-targeted drugs such as mammalian target of rapamycin inhibitor everolimus along with endocrine therapy has already been used as a treatment option after the progression of previous aromatase inhibitor therapy. Phase II/III clinical trials of several signal pathway inhibitors and cyclin-dependent kinase 4/6 inhibitors are underway. In addition, a randomized phase II trial of the histone deacetylase inhibitor entinostat showed interesting findings. In this review, we summarize the mechanistic principles of combination therapy of molecular-targeted drugs with endocrine therapy by using a hybrid car model.	[Saji, Shigehira; Kimura-Tsuchiya, Reiko] Fukushima Med Univ, Sch Med, Dept Med Oncol, Fukushima, Fukushima 9601295, Japan	Saji, S (reprint author), Fukushima Med Univ, Sch Med, Dept Med Oncol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	ss-saji@wa2.so-net.ne.jp			Princess Takamatsu Cancer Research Fund	This article was supported by a Research Grant from the Princess Takamatsu Cancer Research Fund.	Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Shien T, 2012, JPN J CLIN ONCOL, V42, P970, DOI 10.1093/jjco/hys120; Giordano SH, 2004, CANCER, V100, P44, DOI 10.1002/cncr.11859; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251; Saad ED, 2010, J CLIN ONCOL, V28, P1958, DOI 10.1200/JCO.2009.25.5414; Wolff AC, 2013, J CLIN ONCOL, V31, P195, DOI 10.1200/JCO.2011.38.3331; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Niikura N, 2014, BREAST CANCER RES TR, V147, P103, DOI 10.1007/s10549-014-3090-8; Finn RS, 2014, LANCET ONCOL S, VS1470-2045, P71159; Niikura N, 2014, JPN J CLIN ONCOL, V44, P1133, DOI 10.1093/jjco/hyu156; Saji S, 2012, NAT REV CLIN ONCOL, V9, DOI 10.1038/nrclinonc.2012.9-c1; Saji S, 2013, BIODRUGS, V27, P469, DOI 10.1007/s40259-013-0038-1; Thomas S, 2009, CANCER LETT, V280, P184, DOI 10.1016/j.canlet.2008.12.026	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					268	272		10.1007/s10147-015-0799-2		5	Oncology	Oncology	CF5SI	WOS:000352616900006		
J	Omura, G; Ando, M; Saito, Y; Kobayashi, K; Yamasoba, T; Asakage, T				Omura, Go; Ando, Mizuo; Saito, Yuki; Kobayashi, Kenya; Yamasoba, Tatsuya; Asakage, Takahiro			Disease control and clinicopathological prognostic factors of total pharyngolaryngectomy for hypopharyngeal cancer: a single-center study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Hypopharyngeal cancer; Total pharyngolaryngectomy; >= 4 metastatic lymph nodes; Distant metastases; Comorbidity	SQUAMOUS-CELL CARCINOMA; NECK-CANCER; HEAD; COMORBIDITY; CHEMOTHERAPY; PATTERNS; SURVIVAL; THERAPY; FAILURE; SURGERY	Total pharyngolaryngectomy (TPL) is a conventional and standard surgical method for locoregional control of advanced hypopharyngeal cancer (HPC). This study aimed to define the clinicopathological prognostic factors of TPL by evaluating our surgical experience of TPL in the treatment of HPCs. We retrospectively reviewed the clinical charts of patients with HPC who were treated between 1995 and 2011 at the University of Tokyo Hospital and enrolled 119 patients who underwent TPL as an initial curative treatment. The mean follow-up period was 46 months (range, 2-164 months). The 5-year overall survival (OS), disease-specific survival (DSS), locoregional control rates, and relapse-free survival for all patients were 44, 53, 76, and 50 %, respectively. In multivariate analysis, the number of a parts per thousand yen4 metastatic lymph nodes (LNs) was a significant poor prognostic factor for both OS and DSS (p = 0.03 and p = 0.01). Patients with moderate to severe comorbidities had poor prognoses for OS (p = 0.002). In addition, patients with the number of a parts per thousand yen4 metastatic LNs had a higher incidence of distant metastases (p < 0.0001). The locoregional control rate following TPL was acceptable and the number of metastatic LNs was associated with the incidence of distant metastases.	[Omura, Go; Ando, Mizuo; Saito, Yuki; Kobayashi, Kenya; Yamasoba, Tatsuya; Asakage, Takahiro] Univ Tokyo, Fac Med, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, Tokyo 1138655, Japan	Omura, G (reprint author), Univ Tokyo, Fac Med, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	goomura@msn.com			JSPS KAKENHI [24791750]	This study was supported by JSPS KAKENHI Grant Number 24791750.	Posner MR, 2009, ANN ONCOL, V20, P921, DOI 10.1093/annonc/mdn752; Paleri V, 2002, J LARYNGOL OTOL, V116, P200; Sanabria A, 2007, ANN SURG ONCOL, V14, P1449, DOI 10.1245/s10434-006-9296-1; Piccirillo JF, 2000, LARYNGOSCOPE, V110, P593, DOI 10.1097/00005537-200004000-00011; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; JACOBS JR, 1993, LARYNGOSCOPE, V103, P64; Ferrier MB, 2005, ARCH OTOLARYNGOL, V131, P27, DOI 10.1001/archotol.131.1.27; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Alvi A, 1997, HEAD NECK-J SCI SPEC, V19, P500, DOI 10.1002/(SICI)1097-0347(199709)19:6<500::AID-HED7>3.0.CO;2-2; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Triboulet JP, 2001, ARCH SURG-CHICAGO, V136, P1164, DOI 10.1001/archsurg.136.10.1164; Cooper JS, 2012, INT J RADIAT ONCOL, V84, P1198, DOI 10.1016/j.ijrobp.2012.05.008; Hilgers FJM, 1997, ACTA OTO-LARYNGOL, V117, P889, DOI 10.3109/00016489709114220; Cooper JS, 1998, HEAD NECK-J SCI SPEC, V20, P588, DOI 10.1002/(SICI)1097-0347(199810)20:7<588::AID-HED2>3.0.CO;2-F; Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Baghi M, 2007, CLIN OTOLARYNGOL, V32, P372; Bova R, 2005, LARYNGOSCOPE, V115, P864, DOI 10.1097/01.MLG.0000158348.38763.5D; Chu PY, 2004, J LARYNGOL OTOL, V118, P443; Hamajima N, 2002, ASIAN PAC J CANCER P, V3, P197; Homma A, 2010, HEAD NECK-J SCI SPEC, V32, P148, DOI 10.1002/hed.21158; LEEMANS CR, 1993, CANCER, V71, P452, DOI 10.1002/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B; Rapoport A, 1993, Rev Paul Med, V111, P337; Rogers SN, 2005, BR J ORAL MAXILLOFAC, V43, P511; Terada T, 2007, AURIS NASUS LARYNX, V34, P65, DOI 10.1016/j.anl.2006.09.017; THEILE DR, 1995, HEAD NECK-J SCI SPEC, V17, P83, DOI 10.1002/hed.2880170202; Wang WL, 2011, HEAD NECK-J SCI SPEC, V33, P77, DOI 10.1002/hed.21397	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					290	297		10.1007/s10147-014-0709-z		8	Oncology	Oncology	CF5SI	WOS:000352616900009		
J	Kamikawa, Y; Kanmura, Y; Hamada, T; Yamada, N; Macha, MA; Batra, SK; Higashi, M; Yonezawa, S; Sugihara, K				Kamikawa, Yoshiaki; Kanmura, Yuji; Hamada, Tomofumi; Yamada, Norishige; Macha, Muzafar A.; Batra, Surinder K.; Higashi, Michiyo; Yonezawa, Suguru; Sugihara, Kazumasa			Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Oral squamous cell carcinoma; MUC1; MUC4; Immunohistochemistry; Prognosis	BILE-DUCT CARCINOMA; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; NODE METASTASIS; DNA METHYLATION; SPLICE VARIANTS; HUMAN NEOPLASMS; CANCER-CELLS; MUCINS; TUMORS	Both MUC1 and MUC4 are high molecular weight glycoproteins and are independent indicators of worse prognosis in many human epithelial cancers including oral squamous cell carcinoma (OSCC). However, there has been no investigation of the clinical importance of the co-expression of MUC1 and MUC4 in OSCC. The aim of this study was to evaluate the co-expression profile of MUC1/MUC4 and analyze the prognostic significance in OSCC. We examined the expression profile of MUC1 and MUC4 in OSCC tissues from 206 patients using immunohistochemistry. The co-expression profile of MUC1/MUC4 and its prognostic significance in OSCC was statistically analyzed. MUC1 and MUC4 overexpression were strongly correlated with each other (p < 0.0001) and a combination of both MUC1 and MUC4 expression was a powerful indicator for tumor aggressiveness such as tumor size (p = 0.014), lymph node metastasis (0.0001), tumor stage (p = 0.006), diffuse invasion (p = 0.028), and vascular invasion (p = 0.014). The MUC1/MUC4 double-positive patients showed the poorest overall and disease-free survival. Multivariate analysis revealed that MUC1/MUC4 double-positivity was the strong independent prognostic factor for overall and disease-free survival (p = 0.007 and (p = 0.0019), in addition to regional recurrence (p = 0.0025). Taken together, these observations indicate that the use of a combination of MUC1/MUC4 can predict outcomes for patients with OSCC. This combination is also a useful marker for predicting regional recurrence. MUC1 and MUC4 may be attractive targets for the selection of treatment methods in OSCC.	[Kamikawa, Yoshiaki; Hamada, Tomofumi; Sugihara, Kazumasa] Kagoshima Univ Hosp, Dept Oral Surg, Kagoshima 8908544, Japan; [Kanmura, Yuji; Sugihara, Kazumasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Diagnost & Surg Sci, Field Oral & Maxillofacial Rehabil, Kagoshima 8908544, Japan; [Yamada, Norishige] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Cincinnati, OH 45229 USA; [Macha, Muzafar A.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Buffett Canc Ctr, Eppley Canc Inst, Omaha, NE 68198 USA; [Higashi, Michiyo; Yonezawa, Suguru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Field Oncol, Kagoshima 8908544, Japan	Hamada, T (reprint author), Kagoshima Univ Hosp, Dept Oral Surg, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	thamada@dent.kagoshima-u.ac.jp			Ministry of Education, Science, Sports, Culture and Technology, Japan [23390085, 24590447, 23390466, 24792239]	The authors thank Mr. Yoshiharu Atsuji and Ms. Yukari Nishimura for their excellent technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research (B) 23390085 to S. Yonezawa; Scientific Research (C) 24590447 to M. Higashi; Scientific Research (B) 23390466 to K. Sugihara and Young Scientists (B) 24792239 to T. Hamada from the Ministry of Education, Science, Sports, Culture and Technology, Japan.	Yamada N, 2008, CANCER RES, V68, P2708, DOI 10.1158/0008-5472.CAN-07-6844; Nakamura A, 2002, J PATHOL, V197, P201, DOI 10.1002/path.1109; Schmid BC, 2003, ONCOL REP, V10, P1981; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Kitazono I, 2013, PANCREAS, V42, P1120, DOI 10.1097/MPA.0b013e3182965915; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Nagy P, 2005, CANCER RES, V65, P473; Sagara M, 1999, INT J CANCER, V84, P251, DOI 10.1002/(SICI)1097-0215(19990621)84:3<251::AID-IJC9>3.0.CO;2-7; Shibahara H, 2004, HEPATOLOGY, V39, P220, DOI 10.1002/hep.20031; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; OSAKO M, 1993, CANCER, V71, P2191, DOI 10.1002/1097-0142(19930401)71:7<2191::AID-CNCR2820710705>3.0.CO;2-X; Yonezawa S, 2010, J HEPATO-BIL-PAN SCI, V17, P108, DOI 10.1007/s00534-009-0174-7; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Zhang LX, 2013, CANCER IMMUNOL IMMUN, V62, P423, DOI 10.1007/s00262-012-1325-2; Kowalski LP, 2000, HEAD NECK-J SCI SPEC, V22, P207, DOI 10.1002/(SICI)1097-0347(200005)22:3<207::AID-HED1>3.0.CO;2-9; Obermair A, 2002, INT J CANCER, V100, P166, DOI 10.1002/ijc.10456; Moniaux N, 2000, EUR J BIOCHEM, V267, P4536, DOI 10.1046/j.1432-1327.2000.01504.x; Tsutsumida H, 2007, LUNG CANCER, V55, P195, DOI 10.1016/j.lungcan.2006.10.013; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Capote A, 2007, HEAD NECK-J SCI SPEC, V29, P3, DOI 10.1002/hed.20482; Yonezawa S, 1997, PATHOL INT, V47, P813, DOI 10.1111/j.1440-1827.1997.tb03713.x; Tamada S, 2002, PATHOL INT, V52, P713, DOI 10.1046/j.1440-1827.2002.01414.x; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Choudhury A, 2000, J BIOCHEM-TOKYO, V128, P233; Hamada T, 2012, INT J CANCER, V130, P1768, DOI 10.1002/ijc.26187; Vincent A, 2008, FASEB J, V22, P3035, DOI 10.1096/fj.07-103390; HAYES DF, 1985, J CLIN INVEST, V75, P1671, DOI 10.1172/JCI111875; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M; Cheng Allen, 2008, Oral Maxillofac Surg Clin North Am, V20, P477, DOI 10.1016/j.coms.2008.02.002; Choudhury A, 2001, TERATOGEN CARCIN MUT, V21, P83, DOI 10.1002/1520-6866(2001)21:1<83::AID-TCM8>3.0.CO;2-3; Hamada T, 2012, CANCER-AM CANCER SOC, V118, P5251, DOI 10.1002/cncr.27542; Higashi M, 1999, HEPATOLOGY, V30, P1347, DOI 10.1002/hep.510300609; Lee HK, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-224; Mahfouz ME, 2010, EUR ARCH OTO-RHINO-L, V267, P851, DOI 10.1007/s00405-009-1177-3; Moniaux N, 2001, FRONT BIOSCI, V6, P1192; Shibahara H, 2004, AM J SURG PATHOL, V28, P327, DOI 10.1097/00000478-200403000-00005; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Sobin LH, 2009, TNM CLASSIFICATION M; Takao S, 1999, CANCER, V86, P1966, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1966::AID-CNCR13>3.0.CO;2-M; Tamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049251; Yamada N, 2009, BRIT J CANCER, V100, P344, DOI 10.1038/sj.bjc.6604845; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Yonezawa Suguru, 2002, J Hepatobiliary Pancreat Surg, V9, P328, DOI 10.1007/s005340200037; Yonezawa S, 1998, PATHOL INT, V48, P319, DOI 10.1111/j.1440-1827.1998.tb03913.x; Yonezawa S, 2008, GUT LIVER, V2, P137, DOI 10.5009/gnl.2008.2.3.137	46	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					298	307		10.1007/s10147-014-0710-6		10	Oncology	Oncology	CF5SI	WOS:000352616900010		
J	Shimomura, H; Sasahira, T; Yamanaka, Y; Kurihara, M; Imai, Y; Tamaki, S; Yamakawa, N; Shirone, N; Hasegawa, M; Kuniyasu, H; Kirita, T				Shimomura, Hiroyuki; Sasahira, Tomonori; Yamanaka, Yasutsugu; Kurihara, Miyako; Imai, Yuichiro; Tamaki, Shigehiro; Yamakawa, Nobuhiro; Shirone, Norihisa; Hasegawa, Masatoshi; Kuniyasu, Hiroki; Kirita, Tadaaki			[F-18]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Oral squamous cell carcinoma; FDG-PET; Standardized uptake value; Ki-67; HIF-1 alpha; Chemoradiotherapy	STANDARDIZED UPTAKE VALUE; LUNG-CANCER; FDG-PET; CONCURRENT CHEMORADIOTHERAPY; ESOPHAGEAL CANCER; BREAST-CANCER; NECK-CANCER; HEAD; PREDICTION; INDEX	[F-18]fluoro-2-deoxyglucose-positron emission tomography (FDG-PET) is widely used to evaluate tumor metabolic activity. The aim of this study was to evaluate the usefulness of FDG-PET in assessing the histopathological response to preoperative concurrent chemoradiotherapy (CRT) in patients with oral squamous cell carcinoma (OSCC). Forty-five patients with resectable advanced OSCC who had received preoperative CRT followed by tumor ablative surgery between January 2004 and December 2011 were included in the study. All patients underwent FDG-PET before and after preoperative CRT. The maximum standardized uptake value (SUVmax) before (pre-SUV) and after preoperative CRT (post-SUV) and the SUVmax reduction rate (Delta SUV %) were used to evaluate the response to preoperative CRT. Correlations among SUVmax, histopathological response, and expression of cancer antigen Ki-67 and hypoxia-inducible factor-1 alpha (HIF-1 alpha) were analyzed. Preoperative CRT significantly reduced intratumoral FDG uptake (P < 0.001). The pre-SUV and post-SUV were significantly lower in patients with a pathological complete response (pCR) than in those with a non-pCR (pre-SUV P = 0.037; post-SUV P = 0.001). Delta SUV % was higher in patients with pCR than in those with non-pCR (P = 0.029). The pre-SUV was significantly correlated with Ki-67 and HIF-1 alpha expression in pretreatment biopsy specimens (Ki-67 P = 0.046, R = 0.292; HIF-1 alpha P = 0.007, R = 0.385). The expression of both Ki-67 and HIF-1 alpha was significantly lower in patients with pCR than in those with non-pCR (Ki-67 P < 0.001; HIF-1 alpha P < 0.001). Low pre-SUV and post-SUV and high Delta SUV % may predict a good histopathological response to preoperative CRT. Ki-67 and HIF-1 alpha expression in pretreatment biopsy specimens were predictors of histopathological response to preoperative CRT.	[Shimomura, Hiroyuki; Imai, Yuichiro; Yamakawa, Nobuhiro; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara 6348522, Japan; [Sasahira, Tomonori; Kurihara, Miyako; Kuniyasu, Hiroki] Nara Med Univ, Dept Mol Pathol, Kashihara, Nara 6348522, Japan; [Yamanaka, Yasutsugu; Tamaki, Shigehiro] Takai Hosp, Dept Dent & Oral Surg, Tenri, Nara 6320006, Japan; [Shirone, Norihisa] Takai Hosp, Dept Radiol, Tenri, Nara, Japan; [Hasegawa, Masatoshi] Nara Med Univ, Dept Radiat Oncol, Kashihara, Nara 6348522, Japan	Shimomura, H (reprint author), Nara Med Univ, Dept Oral & Maxillofacial Surg, 804 Shijo Cho, Kashihara, Nara 6348522, Japan.	hiroz@naramed-u.ac.jp					Nguyen XC, 2007, EUR J RADIOL, V62, P214, DOI 10.1016/j.ejrad.2006.12.008; Yamada T, 2012, OR SURG OR MED OR PA, V113, P464, DOI 10.1016/j.tripleo.2011.04.006; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201; Vallbohmer D, 2009, ANN SURG, V250, P888, DOI 10.1097/SLA.0b013e3181bc9c0d; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Higashi K, 2002, J NUCL MED, V43, P39; Jalava P, 2006, HISTOPATHOLOGY, V48, P674, DOI 10.1111/j.1365-2559.2006.02402.x; Vicente AMG, 2012, CLIN NUCL MED, V37, P460, DOI 10.1097/RLU.0b013e31823926c9; Brun E, 2002, HEAD NECK-J SCI SPEC, V24, P127, DOI 10.1002/hed.10037; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Kitagawa Y, 2003, EUR J NUCL MED MOL I, V30, P63, DOI 10.1007/s00259-002-0978-z; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Kim MK, 2007, EUR J CANCER, V43, P1385, DOI 10.1016/j.ejca.2007.04.001; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Kresnik E, 2001, EUR J NUCL MED, V28, P816, DOI 10.1007/s002590100554; Oshida M, 1998, CANCER, V82, P2227, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W; Eckardt A, 2007, ONCOLOGY-BASEL, V73, P198, DOI 10.1159/000127420; Ishihara R, 2012, INT J CLIN ONCOL, V17, P225, DOI 10.1007/s10147-011-0278-3; Izumo T, 2012, JPN J CLIN ONCOL, V42, P1099, DOI 10.1093/jjco/hys141; Japan Society for Head and Neck Cancer Cancer Registry Committee, 2006, JPN J HEAD NECK CA S, V32, P1; Jingu K, 2010, INT J CLIN ONCOL, V15, P184, DOI 10.1007/s10147-010-0044-y; Kim SY, 2011, ORAL ONCOL, V47, P376, DOI 10.1016/j.oraloncology.2011.03.018; Kirita T, 1999, ORAL ONCOL, V35, P597, DOI 10.1016/S1368-8375(99)00044-5; Kirita T, 2012, INT J ORAL MAX SURG, V41, P421, DOI 10.1016/j.ijom.2011.12.003; Klug C, 2008, J CRANIO MAXILL SURG, V36, P75, DOI 10.1016/j.jcms.2007.06.007; Lee SW, 2008, RADIOTHER ONCOL, V87, P211, DOI 10.1016/j.radonc.2008.01.009; Miyawaki A, 2010, ONCOL REP, V23, P1205, DOI 10.3892/or_00000751; Pugsley JM, 2002, CANCER J, V8, P222, DOI 10.1097/00130404-200205000-00003; Sasahira T, 2013, CLIN EXP METASTAS, V30, P165, DOI 10.1007/s10585-012-9525-x; Shimosato Y, 1971, JPN J CLIN ONCOL, V1, P19; Yamanaka Yasutsugu, 2011, Gan To Kagaku Ryoho, V38, P89	32	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					308	316		10.1007/s10147-014-0711-5		9	Oncology	Oncology	CF5SI	WOS:000352616900011		
J	Nozawa, K; Ichimura, M; Oshima, A; Tokunaga, E; Masuda, N; Kitano, A; Fukuuchi, A; Shinji, O				Nozawa, Keiko; Ichimura, Miho; Oshima, Akira; Tokunaga, Eriko; Masuda, Norikazu; Kitano, Atsuko; Fukuuchi, Atsushi; Shinji, Ono			The present state and perception of young women with breast cancer towards breast reconstructive surgery	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Breast reconstruction (BR); Physical appearance; Patients' decision-making; Psychological well-being	SELF-CONSCIOUSNESS; MASTECTOMY	This study was conducted to identify factors influencing patients' decisions to undergo breast reconstruction, and to identify the influences of breast reconstruction on patient behavior and psychological well-being. Data were collected from January to June 2011, using a questionnaire distributed to women a parts per thousand currency sign45 years old with breast cancer, at five medical institutes across Japan. Completed questionnaires were collected from 316 women (mean age: 39.46 +/- A 4.4 years, range: 27-45 years). Overall, 174 patients received breast-conserving surgery, 101 received mastectomy, 31 received subcutaneous mastectomy, 3 patients received none, and 49 were unreported). The data indicated a reconstruction rate of 36.7 % in women who underwent mastectomy. The most prevalent reason for not undergoing breast reconstruction was the fear of cancer relapse. Other factors mentioned were to avoid additional distress on the body from surgery, financial reasons, and a belief that breast reconstruction is unnecessary. The main factor that influenced the decision not to undergo delayed breast reconstruction, specifically, was the expense. Women who had completed breast reconstruction showed higher self-evaluations of physical attractiveness and were more active in comparison to those who did not. However, regardless of having undergone breast reconstruction or not, women who reported higher levels of self-consciousness over the treated areas showed more restrictions on activity and higher chances of a decline in psychological well-being. Regardless of deciding to undergo breast reconstruction or not, the results of this study suggested the need for cognitive interventions to avoid patients fixating on self-consciousness over treated areas.	[Nozawa, Keiko] Natl Canc Ctr, Appearance Support Ctr, Chuo Ku, Tokyo 1040045, Japan; [Ichimura, Miho] Mejiro Univ, Shinjuku Ku, Tokyo 1618539, Japan; [Oshima, Akira] Kyushu Natl Canc Ctr, Dept Psychooncol, Minami Ku, Fukuoka 8111395, Japan; [Tokunaga, Eriko] Kyusyu Univ Hosp, Dept Comprehens Clin Oncol, Higashi Ku, Fukuoka 8128582, Japan; [Masuda, Norikazu] Osaka Natl Hosp, Dept Surg, Breast Oncol, Chuo Ku, Osaka 5400006, Japan; [Kitano, Atsuko] St Lukes Int Hosp, Dept Breast Surg, Chuo Ku, Tokyo, Japan; [Fukuuchi, Atsushi] Mitsui Mem Hosp, Chiyoda Ku, Tokyo 1018642, Japan; [Shinji, Ono] Kyushu Natl Canc Ctr, Clin Res Ctr, Minami Ku, Fukuoka 8111395, Japan	Nozawa, K (reprint author), Natl Canc Ctr, Appearance Support Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	knozawa@ncc.go.jp					Reaby LL, 1998, PLAST RECONSTR SURG, V101, P1810, DOI 10.1097/00006534-199806000-00006; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Lemieux J, 2008, PSYCHO-ONCOL, V17, P317, DOI 10.1002/pon.1245; Ananian P, 2004, ANN SURG ONCOL, V11, P762, DOI 10.1245/ASO.2004.11.027; Lee C, 2009, J AM COLL SURGEONS, V209, P123, DOI 10.1016/j.jamcollsurg.2009.02.061; Levine SM, 2012, ANN PLAS SURG, V69, P376, DOI 10.1097/SAP.0b013e31824b26d2; Rowland JH, 2000, J NATL CANCER I, V92, P1422, DOI 10.1093/jnci/92.17.1422; Fallbjork U, 2010, ACTA ONCOL, V49, P174, DOI 10.3109/02841860903490069; Goldberg DP, 1972, MAUDSLEY MONOGRAPH, P21; Metcalfe K, 2011, ANN SURG ONCOL, V19, P233; Nakagawa D, 1985, MENTAL HLTH RES JAPA; Nikkei BP, 2003, 520 MED I NATL RES B; Nozawa K, 2008, J JPN SOC PLAST RECO, V28, P440; SUGAWARA K, 1984, JPN J PSYCHOL, V55, P184; Takahashi M, 2006, PLAST RECONSTR SURG, V118, P1508; Yano K, 2008, JPN J BREAST CANC, V22, P509; Yano K, 2008, J JPN SOC PLAST RECO, V28, P68	17	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					324	331		10.1007/s10147-014-0716-0		8	Oncology	Oncology	CF5SI	WOS:000352616900013		
J	Yoshida, Y; Hoshino, S; Aisu, N; Naito, M; Tanimura, S; Mogi, A; Tanaka, T; Hirata, K; Tamura, K; Yamashita, Y				Yoshida, Yoichiro; Hoshino, Seiichiro; Aisu, Naoya; Naito, Masayasu; Tanimura, Syu; Mogi, Ai; Tanaka, Toshihiro; Hirata, Keiji; Tamura, Kazuo; Yamashita, Yuichi			Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Chemotherapy; Colorectal cancer; Central venous port; Median cubital vein	COMPLICATIONS; OXALIPLATIN; DEVICES; EXPERIENCE; SYSTEMS; NEUROTOXICITY; CAPECITABINE; MANAGEMENT; REDUCTION; CATHETERS	Repeated venous punctures are usually required during chemotherapy administration for cancer patients. Central venous catheters and implantable port systems have substantially facilitated vascular access, and safe, easy-to-handle port systems have become an integral part of daily clinical routines in oncology. However, several serious complications are associated with central venous ports (CV-ports), and recent developments of combined oral capecitabine and oxaliplatin (XELOX) therapies allow CV-port-free administration. In this study, the safety and efficacy of CV-port-free chemotherapy administration via the median cubital vein was assessed in metastatic colorectal cancer patients. This study included 144 patients who received XELOX + bevacizumab (BV) or XELOX therapy for metastatic colorectal cancer without CV-port implantation. Eighty-five patients experienced transient vascular pain. The drip infusion route was switched to the opposite side following vascular pain in only 1 patient. No patients required CV-port implantation or delayed treatment due to adverse events associated with drug administration via the peripheral vein. Grade 3 or higher hemotoxicity and grade 3 or higher non-hematological toxicity was noted in 12.5 and 17.4 % of patients, respectively. Port-free-chemotherapy administration via the median cubital vein is appropriate for patients with colorectal cancer, thereby avoiding complications associated with CV-ports.	[Yoshida, Yoichiro; Hoshino, Seiichiro; Aisu, Naoya; Naito, Masayasu; Tanimura, Syu; Yamashita, Yuichi] Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Jonan Ku, Fukuoka 8140180, Japan; [Mogi, Ai; Tanaka, Toshihiro; Tamura, Kazuo] Fukuoka Univ, Fac Med, Dept Internal Med, Div Oncol Hematol & Infect Dis, Fukuoka 8140180, Japan; [Hirata, Keiji] Fukuoka Sanno Hosp, Dept Surg, Fukuoka, Japan	Yoshida, Y (reprint author), Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	yy4160@yahoo.co.jp					Walshe LJ, 2002, J CLIN ONCOL, V20, P3276, DOI 10.1200/JCO.2002.11.135; Schwarz RE, 1997, CANCER, V79, P1635, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1635::AID-CNCR30>3.0.CO;2-X; Biffi R, 1998, ANN ONCOL, V9, P767, DOI 10.1023/A:1008392423469; Vardy J, 2004, BRIT J CANCER, V91, P1045, DOI 10.1038/sj.bjc.6602082; Kock HJ, 1998, WORLD J SURG, V22, P12; Petrioli R, 2008, CANCER CHEMOTH PHARM, V61, P105, DOI 10.1007/s00280-007-0454-3; Kiernan MC, 2006, CURR MED CHEM, V13, P2901, DOI 10.2174/092986706778521904; Jordan K, 2008, ONKOLOGIE, V31, P404, DOI 10.1159/000140451; NIEDERHUBER JE, 1982, SURGERY, V92, P706; Kuwahara T, 1998, NUTRITION, V14, P496, DOI 10.1016/S0899-9007(98)00037-9; Jerremalm E, 2003, J PHARM SCI, V92, P436, DOI 10.1002/jps.10306; Teichgraber UKM, 2004, ROFO-FORTSCHR RONTG, V176, P944, DOI 10.1055/s-2004-813258; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898; TORRAMADE JR, 1993, EUR J SURG, V159, P323; Curran C F, 1990, Oncol Nurs Forum, V17, P387; deGregorio MA, 1996, EUR RADIOL, V6, P748; DRISCOLL DF, 1994, AM J HOSP PHARM, V51, P2834; EASTRIDGE BJ, 1995, J CLIN ONCOL, V13, P233; EREMIN O, 1977, MED J AUSTRALIA, V2, P528; FONKALSR.EW, 1968, SURGERY, V63, P280; Hill Steven E., 1996, Journal of Parenteral and Enteral Nutrition, V20, P81, DOI 10.1177/014860719602000181; Inaba Y, 2007, JPN J CLIN ONCOL, V37, P951, DOI 10.1093/jjco/hym118; Ishida H, 2009, JPN J CLIN ONCOL, V39, P601, DOI 10.1093/jjco/hyp067; Kameyama Hitoshi, 2010, Gan To Kagaku Ryoho, V37, P453; Kuwahara Takashi, 1999, Journal of Toxicological Sciences, V24, P113; Lorch H, 2001, CARDIOVASC INTER RAD, V24, P180, DOI 10.1007/s002700001721; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602; Matsuyama Kazuyo, 2011, Gan To Kagaku Ryoho, V38, P411; Nakayama Shoichi, 2002, Gan To Kagaku Ryoho, V29, P633; Nobili Elisabetta, 2010, Pathophysiol Haemost Thromb, V37, P30, DOI 10.1159/000319552; Saif MW, 2008, ANTI-CANCER DRUG, V19, P447, DOI 10.1097/CAD.0b013e3282f945aa; Silberzweig JE, 2000, J VASC INTERV RADIOL, V11, P391, DOI 10.1016/S1051-0443(07)61435-3; Tsunoda A, 2009, ONCOLOGY-BASEL, V77, P192, DOI 10.1159/000236017; Yoshida Y, 2013, WORLD J SURG ONCOL, V7, P39; Yoshida Y, 2012, J CANC SCI THER, V4, piv, DOI [10.4172/1948-5956.1000e105, DOI 10.4172/1948-5956.1000E105]; Yoshida Y., 2012, British Journal of Medicine and Medical Research, V2, P132; Yoshida Yoichiro, 2012, Case Rep Oncol, V5, P290, DOI 10.1159/000339614; Yoshida Yoichiro, 2014, Case Rep Oncol, V7, P117, DOI 10.1159/000360132; Yoshida Yoichiro, 2011, Case Rep Oncol, V4, P250, DOI 10.1159/000328805; Yukisawa S, 2010, BRIT J RADIOL, V83, P850, DOI 10.1259/bjr/41019720	40	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					332	337		10.1007/s10147-014-0703-5		6	Oncology	Oncology	CF5SI	WOS:000352616900014		
J	Ohue, M; Hamaguchi, T; Ito, Y; Sakai, D; Noura, S; Kinugasa, Y; Fujita, S; Shimada, Y; Saito, N; Moriya, Y				Ohue, Masayuki; Hamaguchi, Tetsuya; Ito, Yoshinori; Sakai, Daisuke; Noura, Shingo; Kinugasa, Yusuke; Fujita, Shin; Shimada, Yasuhiro; Saito, Norio; Moriya, Yoshihiro			A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Lower rectal cancer; T4; Lateral pelvic lymph node metastasis; S-1; Oxaliplatin; Preoperative chemoradiation	COLORECTAL-CANCER; NEOADJUVANT CHEMORADIOTHERAPY; MESORECTAL EXCISION; PLUS OXALIPLATIN; III TRIAL; DISSECTION; CHEMORADIATION; FLUOROURACIL; CHEMOTHERAPY; RADIOTHERAPY	The purpose of this phase I study of the dose escalation of oxaliplatin in combination with oral S-1 and pelvic radiation preoperatively for poor-risk lower rectal cancer was to determine the dose-limiting toxicity (DLT) and recommended dose of oxaliplatin. Patients with cT4 and lateral pelvic lymph node metastasis, and without distant metastasis (cM0), were treated with weekly oxaliplatin, oral S-1 40 mg/m(2) twice daily for 5 days a week, and radiation. A total of 5 weekly doses of oxaliplatin were planned. RT was administered to a total dose of 50.4 Gy in 28 fractions. We enrolled 11 patients between December 2009 and January 2012. DLTs were observed at dose level 1 (50 mg/m(2)) in two patients, one of whom experienced grade 3 aspartate aminotransferase elevation and a grade 3 alanine aminotransferase increase, and the other developed grade 4 hypokalemia and a grade 3 alanine aminotransferase increase. Five patients at dose level 2 (60 mg/m(2)) showed no DLTs. The hematological toxicities in all patients were mild and reversible. One patient showed distant metastasis after chemoradiation. Ten of the 11 patients achieved R0 resection by mesorectal resection and lateral lymph node dissection; three of the 10 underwent combined resection of the other organs. This phase I trial of preoperative S-1 in combination with oxaliplatin and radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis revealed that the recommended dose of oxaliplatin was 60 mg/m(2) weekly.	[Ohue, Masayuki; Noura, Shingo] Osaka Med Ctr Canc & Cardiovasc Dis, Div Colon & Rectal Surg, Higashinari Ku, Osaka 5378511, Japan; [Hamaguchi, Tetsuya; Shimada, Yasuhiro] Natl Canc Ctr, Div Gastrointestinal Oncol, Tokyo, Japan; [Ito, Yoshinori] Natl Canc Ctr, Div Radiat Oncol, Tokyo, Japan; [Sakai, Daisuke] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan; [Kinugasa, Yusuke] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan; [Fujita, Shin] Tochigi Canc Ctr Hosp, Dept Surg, Utsunomiya, Tochigi, Japan; [Saito, Norio] Natl Canc Ctr Hosp East, Colorectal & Pelv Surg Div, Kashiwa, Chiba, Japan; [Moriya, Yoshihiro] Japanese Red Cross Med Ctr, Colorectal Surg Div, Tokyo, Japan	Ohue, M (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Div Colon & Rectal Surg, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	ohue-ma@mc.pref.osaka.jp			Ministry of Health, Labour and Welfare of Japan [23-A-14]	We thank Drs. Tatsuya Ioka and Hiroshi Nokihara for their critical advice. Oxaliplatin was provided for the first three patients by Yakult Co., Ltd. before its acceptance by the health insurance system in Japan. This study was supported by Grants-in-Aids for the National Cancer Center Research and Development Fund [23-A-14] from the Ministry of Health, Labour and Welfare of Japan.	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020; Fujita S, 2012, LANCET ONCOL, V13, P616, DOI 10.1016/S1470-2045(12)70158-4; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; An X, 2013, EUR J CANCER, V49, P843, DOI 10.1016/j.ejca.2012.09.026; Kusters M, 2009, ANN SURG, V249, P229, DOI 10.1097/SLA.0b013e318190a664; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Gerard JP, 2010, J CLIN ONCOL, V28, P1638, DOI 10.1200/JCO.2009.25.8376; Yamada Y, 2008, BRIT J CANCER, V98, P1034, DOI 10.1038/sj.bjc.6604271; Aschele C, 2011, J CLIN ONCOL, V29, P2773, DOI 10.1200/JCO.2010.34.4911; Rodel C, 2007, J CLIN ONCOL, V25, P110, DOI 10.1200/JCO.2006.08.3675; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; MORIYA Y, 1995, EUR J CANCER, V31A, P1229, DOI 10.1016/0959-8049(95)00164-E; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; Kim JC, 2007, ANN SURG, V246, P754, DOI 10.1097/SLA.0b013e318070d587; MACFARLANE JK, 1993, LANCET, V341, P457; Hong YS, 2012, LANCET ONCOL, V13, P1125, DOI 10.1016/S1470-2045(12)70363-7; Hecht JR, 1998, ONCOLOGY-NY, V12, P72; Hong YS, 2011, INT J RADIAT ONCOL, V79, P684, DOI 10.1016/j.ijrobp.2009.11.037; Japanese Society for Cancer of the Colon and Rectum, 2006, GEN RUL CLIN PATH ST; Lee EM, 2013, CANCER SCI, V104, P111, DOI 10.1111/cas.12041; Mori T, 1998, LANGENBECK ARCH SURG, V383, P409, DOI 10.1007/s004230050153; Sobin LH, 2009, TNM CLASSIFICATION M; Takechi T, 1997, CANCER CHEMOTH PHARM, V39, P205; Zeng LH, 2008, CANCER SCI, V99, P2327, DOI 10.1111/j.1349-7006.2008.00943.x	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					338	344		10.1007/s10147-014-0705-3		7	Oncology	Oncology	CF5SI	WOS:000352616900015		
J	Takatori, E; Shoji, T; Omi, H; Kagabu, M; Miura, F; Takeuchi, S; Kumagai, S; Yoshizaki, A; Sato, A; Sugiyama, T				Takatori, Eriko; Shoji, Tadahiro; Omi, Hideo; Kagabu, Masahiro; Miura, Fumiharu; Takeuchi, Satoshi; Kumagai, Seisuke; Yoshizaki, Akira; Sato, Akira; Sugiyama, Toru			Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Prognostic analysis; Cervical cancer; Bulky tumor; Squamous cell carcinoma; Neoadjuvant chemotherapy	GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-II; CONCURRENT CHEMOTHERAPY; CISPLATIN CHEMOTHERAPY; RADIATION-THERAPY; PELVIC RADIATION; STAGE IB2; CANCER; RADIOTHERAPY; IRINOTECAN	Neoadjuvant chemotherapy (NAC) is not yet widely recommended for the treatment of stage I/II cervical cancer. However, it may be possible to achieve a favorable outcome by selecting appropriate patients. In the present study, prognostic factors were retrospectively investigated to obtain data for devising individualized NAC. The subjects were 33 patients with bulky stage Ib2-IIb squamous cell carcinoma (SCC) of the uterine cervix who gave consent and were scheduled to undergo radical hysterectomy. The patients intravenously received irinotecan 70 mg/m(2) on days 1 and 8 and cisplatin 70 mg/m(2) on day 1 of a 21-day course, and two courses were performed in principle. The potential prognostic factors investigated were age, performance status (PS), clinical stage, lymph node metastasis and tumor size before NAC, SCC antigen value, anti-tumor response, histological effect of NAC, lymph node metastasis in resected specimens, and postoperative adjuvant therapy after NAC. The impacts of these factors on overall survival (OS) were calculated with the Cox regression model. According to the univariate analysis, lymph node metastasis before NAC, SCC antigen value after NAC, anti-tumor response, and histological effect of NAC significantly influenced OS. These factors were tested in a multivariate model, and significant prognostic factors were lymph node metastasis before NAC (hazard ratio 0.116, P = 0.027) and anti-tumor response (hazard ratio 0.025, P = 0.003). The presence or absence of lymph node metastasis by computed tomography imaging was the only significant prognostic factor identified during the pre-NAC period.	[Takatori, Eriko; Shoji, Tadahiro; Omi, Hideo; Kagabu, Masahiro; Miura, Fumiharu; Takeuchi, Satoshi; Sugiyama, Toru] Iwate Med Univ, Sch Med, Dept Obstet & Gynecol, Morioka, Iwate 0208505, Japan; [Kumagai, Seisuke] Natl Hosp Org, Kokura Med Ctr, Dept Obstet & Gynecol, Kokura, Japan; [Yoshizaki, Akira] Miyama Hosp, Dept Gynecol, Oshu, Japan; [Sato, Akira] Med Coat Hachinohe West Hosp, Dept Gynecol, Hachinohe, Aomori, Japan	Shoji, T (reprint author), Iwate Med Univ, Sch Med, Dept Obstet & Gynecol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	tshoji@iwate-med.ac.jp					Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; Sugiyama T, 2000, ONCOLOGY-BASEL, V58, P31, DOI 10.1159/000012076; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Ryu HS, 2007, INT J GYNECOL CANCER, V17, P132, DOI 10.1111/j.1525-1438.2007.00803.x; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; Duenas-Gonzalez A, 2002, ANN ONCOL, V13, P1212, DOI 10.1093/annonc/mdf196; Katsumata N, 2013, BRIT J CANCER, V108, P1957, DOI 10.1038/bjc.2013.179; Pearcey R, 2002, J CLIN ONCOL, V20, P966, DOI 10.1200/JCO.20.4.966; Yamaguchi S, 2012, ONCOL REP, V28, P487, DOI 10.3892/or.2012.1814; Whitney CW, 1999, J CLIN ONCOL, V17, P1339; Sugiyama T, 1999, BRIT J CANCER, V81, P95, DOI 10.1038/sj.bjc.6690656; Benedetti-Panici P, 2003, EUR J CANCER, V39, P2470, DOI 10.1016/S0959-8049(03)00425-8; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Li R, 2013, GYNECOL ONCOL, V128, P524, DOI 10.1016/j.ygyno.2012.11.006; Lukka H, 2002, CLIN ONCOL-UK, V14, P203, DOI 10.1053/clon.2002.0076; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; NCCN, 2006, CLIN PRACT GUID ONC; Shoji T, 2010, ONCOL LETT, V1, P515, DOI 10.3892/ol_00000091; Shoji T, 2012, SQUAMOUS CELL CARCIN, P79; Shoji Tadahiro, 2010, Gan To Kagaku Ryoho, V37, P643; Sugiyama T, 1996, ACTA OBSTET GYNECOL, V48, P827; Takeuchi S, 1991, JPN J CANC CHEMOTHER, V18, P1681; TATTERSALL MHN, 1995, J CLIN ONCOL, V13, P444	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					345	350		10.1007/s10147-014-0702-6		6	Oncology	Oncology	CF5SI	WOS:000352616900016		
J	Furukawa, J; Miyake, H; Kusuda, Y; Fujisawa, M				Furukawa, Junya; Miyake, Hideaki; Kusuda, Yuji; Fujisawa, Masato			Hyponatremia as a powerful prognostic predictor for Japanese patients with clear cell renal cell carcinoma treated with a tyrosine kinase inhibitor	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Renal cell carcinoma; Hyponatremia; Sorafenib; Sunitinib	SERUM SODIUM-LEVEL; CANCER-PATIENTS; SURVIVAL; INTERLEUKIN-6; THERAPIES; ALPHA	We aimed to evaluate the prognostic significance of hyponatremia in patients with metastatic clear cell renal cell carcinoma (RCC) treated with a tyrosine kinase inhibitor (TKI). This study included a total of 209 consecutive Japanese patients undergoing radical nephrectomy who were subsequently treated with either sunitinib or sorafenib as a first-line therapy for metastatic clear cell RCC. In this series, normal natremia and hyponatremia prior to the introduction of TKI was defined as a serum sodium level > 136 and a parts per thousand currency sign136 mEq/L, respectively. Patients were classified into 165 (78.9 %) with normal natremia and 44 (21.1 %) with hyponatremia. Progression-free survival (PFS) in the hyponatremia group (median 10.0 months) was significantly poorer than that in the normal natremia group (median 28.4 months). Overall survival (OS) in the hyponatremia group (median 20.9 months) was significantly poorer than that in the normal natremia group (median 38.5 months). Multivariate analyses identified hyponatremia, in addition to the existence of sarcomatoid components in radical nephrectomy specimens, high serum C-reactive protein levels, and low serum albumin levels, as poor prognostic factors for both PFS and OS. There were significant differences in both PFS and OS according to the number of these 4 independent risk factors that were positive (negative for any risk factors vs positive for 1 or 2 risk factors vs positive for 3 or 4 risk factors). Hyponatremia appears to be one of the most powerful prognostic predictors in Japanese patients treated with a TKI as a first-line agent against metastatic clear cell RCC.	[Furukawa, Junya; Miyake, Hideaki; Kusuda, Yuji; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Miyake, H (reprint author), Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hideakimiyake@hotmail.com					Akaza H, 2011, JPN J CLIN ONCOL, V41, P1023, DOI 10.1093/jjco/hyr067; Jeppesen AN, 2010, BRIT J CANCER, V102, P867, DOI 10.1038/sj.bjc.6605563; Rini BI, 2008, CURR OPIN ONCOL, V20, P300, DOI 10.1097/CCO.0b013e3282f9782b; Berghmans T, 2000, SUPPORT CARE CANCER, V8, P192, DOI 10.1007/s005200050284; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Nair V, 2007, AM J NEPHROL, V27, P184, DOI 10.1159/000100866; Jacob S, 2006, ANN PHARMACOTHER, V40, P1618, DOI 10.1345/aph.1G293; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kim HS, 2007, ONCOLOGY-BASEL, V73, P192, DOI 10.1159/000127386; Benrick A, 2009, J NEUROENDOCRINOL, V21, P620, DOI 10.1111/j.1365-2826.2009.01879.x; FYFE G, 1995, J CLIN ONCOL, V13, P688; Vasudev NS, 2008, CLIN CANCER RES, V14, P1775, DOI 10.1158/1078-0432.CCR-07-1721; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; MASTORAKOS G, 1994, J CLIN ENDOCR METAB, V79, P934, DOI 10.1210/jc.79.4.934; Spital A, 1999, AM J NEPHROL, V19, P447, DOI 10.1159/000013496; Patel GP, 2007, CLIN THER, V29, P211, DOI 10.1016/j.clinthera.2007.02.004; Bellmunt J, 2007, BJU INT, V99, P274, DOI 10.1111/j.1464-410X.2006.06589.x; Chowdhury S, 2008, EUR J CANCER, V44, P2152, DOI 10.1016/j.ejca.2008.06.028; Hashizume M, 2011, CYTOKINE, V54, P92, DOI 10.1016/j.cyto.2011.01.007; Huo T, 2008, DIGEST LIVER DIS, V40, P882, DOI 10.1016/j.dld.2008.01.015; Kacprowicz RF, 2009, EMERG MED CLIN N AM, V27, P257, DOI 10.1016/j.emc.2009.01.007; Kawashima A, 2012, INT J UROL, V19, P1050, DOI 10.1111/j.1442-2042.2012.03115.x; Murakami T, 1998, INTERNAL MED, V37, P792, DOI 10.2169/internalmedicine.37.792; Rusinaru D, 2009, AM J CARDIOL, V103, P405, DOI 10.1016/j.amjcard.2008.09.091; Yokoyama H, 2005, BJU INT, V95, P526, DOI 10.1111/j.1464-410X.2005.05332.x	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					351	357		10.1007/s10147-014-0713-3		7	Oncology	Oncology	CF5SI	WOS:000352616900017		
J	Naya, Y; Kawauchi, A; Oishi, M; Ueda, T; Fujihara, A; Naito, Y; Nakamura, T; Hongo, F; Kamoi, K; Okihara, K; Miki, T				Naya, Yoshio; Kawauchi, Akihiro; Oishi, Masakatu; Ueda, Takashi; Fujihara, Atsuko; Naito, Yasuyuki; Nakamura, Terukazu; Hongo, Fumiya; Kamoi, Kazumi; Okihara, Koji; Miki, Tsuneharu			Comparison of diameter-axial-polar nephrometry and RENAL nephrometry score for treatment decision-making in patients with small renal mass	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						DAP nephrometry; RENAL nephrometry score; Laparoscopic partial nephrectomy; Small renal cell carcinoma	PARTIAL NEPHRECTOMY; MORTALITY; OUTCOMES	The aim of this study was to evaluate our institution's experience in performing laparoscopic radical nephrectomy (LRN) and partial nephrectomy (PN) in patients with small renal masses. 142 patients with cT1aN0M0 lesions were identified. 68 of these subjects were treated with LRN and 74 were treated with laparoscopic PN (LPN). The clinicopathological characteristics of the two groups of patients, including diameter-axial-polar (DAP) nephrometry and RENAL nephrometry score (RENAL-NS), operative results, and outcomes, were retrospectively analyzed. A multivariate logistic regression analysis for the selection of PN as the treatment showed that tumor size, DAP nephrometry, RENAL-NS and imperative condition were all independent factors. The area under the curve receiver operating characteristics (ROC-AUC) of DAP and RENAL-NS for performing LPN were 0.897 and 0.825, respectively. Although LRN was performed in patients with a high nephrometry score in this study, open partial nephrectomy (OPN) should be considered for patients with a high nephrometry score in T1a renal cell carcinoma (RCC) because of better functional and similar oncological outcomes. Based on ROC analysis, when DAP is 6 or less, LPN should be considered and when DAP is 7 or more, OPN should be considered.	[Naya, Yoshio; Kawauchi, Akihiro; Oishi, Masakatu; Ueda, Takashi; Fujihara, Atsuko; Naito, Yasuyuki; Nakamura, Terukazu; Hongo, Fumiya; Kamoi, Kazumi; Okihara, Koji; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kyoto, Japan	Naya, Y (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kyoto, Japan.	ynaya@koto.kpu-m.ac.jp					Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Zini L, 2009, CANCER, V115, P1465, DOI 10.1002/cncr.24035; Heuer R, 2010, EUR UROL, V57, P223, DOI 10.1016/j.eururo.2009.10.023; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Simmons MN, 2012, J UROLOGY, V188, P384, DOI 10.1016/j.juro.2012.03.123; Huang WC, 2009, J UROLOGY, V181, P55, DOI 10.1016/j.juro.2008.09.017; Kunkle DA, 2008, J UROLOGY, V179, P1227, DOI 10.1016/j.juro.2007.11.047; Marszalek M, 2009, EUR UROL, V55, P1171, DOI 10.1016/j.eururo.2009.01.042; Berger A, 2008, CURR OPIN UROL, V18, P462, DOI 10.1097/MOU.0b013e32830a4f10; Broughton GJ, 2012, BJU INT, V109, P1607, DOI 10.1111/j.1464-410X.2011.10607.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; European Association of Urology, 2014, EAU GUID REN CELL CA; Japanese Society of Nephrology, 2009, CLIN EXP NEPHROL, V13, P537, DOI 10.1007/s10157-009-0237-8; Lai FC, 2007, J ENDOUROL, V21, P1309, DOI 10.1089/end.2007.9885; National Comprehensive Cancer Network, 2014, NCCN GUID VERS 2 201	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					358	361		10.1007/s10147-014-0714-2		4	Oncology	Oncology	CF5SI	WOS:000352616900018		
J	Sakano, S; Matsuyama, H; Kamiryo, Y; Hayashida, S; Yamamoto, N; Kaneda, Y; Nasu, T; Baba, Y; Shimabukuro, T; Suga, A; Yamamoto, M; Aoki, A; Takai, K; Yoshihiro, S; Oba, K				Sakano, Shigeru; Matsuyama, Hideyasu; Kamiryo, Yoriaki; Hayashida, Shigeaki; Yamamoto, Norio; Kaneda, Yoshitaka; Nasu, Takahito; Baba, Yoshikazu; Shimabukuro, Tomoyuki; Suga, Akinobu; Yamamoto, Mitsutaka; Aoki, Akihiko; Takai, Kimio; Yoshihiro, Satoru; Oba, Kazuo		Yamaguchi Uro-Oncology Grp	Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Histology; Kidney pelvis; Survival; Transitional cell carcinoma; Ureteral neoplasms	UPPER URINARY-TRACT; RENAL PELVIS; RADICAL NEPHROURETERECTOMY; BLADDER-CANCER; CELL CARCINOMA; CYSTECTOMY; SURVIVAL; URETER	Patients with urinary bladder urothelial carcinoma (UC) with variant histology have features of more advanced disease and a likelihood of poorer survival than those with pure UC. We investigated the impact of variant histology on disease aggressiveness and clinical outcome after radical nephroureterectomy (RNU) in Japanese patients with upper tract UC (UTUC). Information on variant histology might guide appropriate patient selection for adjuvant therapy after RNU. We enrolled 502 UTUC patients treated with RNU in this retrospective cohort study, and analyzed associations of variant histology with clinicopathological variables and disease-specific survival. The median follow-up was 41.4 months. A total of 60 (12.0 %) UTUC patients had variant histology. UTUC with variant histology was significantly associated with advanced pathological T stage (pT a parts per thousand yen 3), higher tumor grade (G3), and more lymphovascular invasion (P < 0.0001). Variant histology in all patients was significantly associated with worse disease-specific survival after RNU on univariate analysis (P = 0.0004), but this effect did not remain significant on multivariate analysis. However, variant histology was a significantly independent predictor for disease-specific survival in patients with pT a parts per thousand yen 3 tumors (P = 0.0095). UTUC with variant histology might be a phenotype of high-grade, locally aggressive advanced tumors rather than of systemic disease. Variant histology may be useful for selection of patients with pT a parts per thousand yen 3 UTUC for adjuvant therapy. Prospective studies in a larger number of patients with a centralized pathological review are needed to confirm our results.	[Sakano, Shigeru; Matsuyama, Hideyasu] Yamaguchi Univ, Grad Sch Med, Dept Urol, Ube, Yamaguchi 7558505, Japan; [Sakano, Shigeru] Kokura Mem Hosp, Dept Urol, Kokurakita Ku, Kitakyushu, Fukuoka 8028555, Japan; [Kamiryo, Yoriaki] Shimonoseki Municipal Saiseikai Toyoura Hosp, Dept Urol, Yamaguchi 7596302, Japan; [Hayashida, Shigeaki; Nasu, Takahito] Tokuyama Cent Hosp, Dept Urol & Nephrol, Yamaguchi 7458522, Japan; [Yamamoto, Norio] Tokuyama Med Assoc Hosp, Dept Urol, Yamaguchi 7450846, Japan; [Kaneda, Yoshitaka] Konan St Hill Hosp, Dept Urol, Ube, Yamaguchi 7590204, Japan; [Baba, Yoshikazu] Shuto Gen Hosp, Dept Urol, Yamaguchi 7420032, Japan; [Shimabukuro, Tomoyuki] Ube Ind Cent Hosp, Dept Urol, Ube, Yamaguchi 7550151, Japan; [Suga, Akinobu] Yamaguchi Red Cross Hosp, Dept Urol, Yamaguchi 7538519, Japan; [Yamamoto, Mitsutaka] Yamaguchi Grand Med Ctr, Dept Urol, Yamaguchi 7478511, Japan; [Aoki, Akihiko] Masuda Red Cross Hosp, Dept Urol, Masuda, Shimane 6988501, Japan; [Takai, Kimio] Saiseikai Shimonoseki Gen Hosp, Dept Urol, Yamaguchi 7596603, Japan; [Yoshihiro, Satoru] Shimonoseki City Hosp, Dept Urol, Yamaguchi 7508520, Japan; [Oba, Kazuo] Saiseikai Yamaguchi Gen Hosp, Dept Urol, Yamaguchi, Yamaguchi 7530078, Japan	Sakano, S (reprint author), Kokura Mem Hosp, Dept Urol, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8028555, Japan.	shigerus@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [24592393]	This study was supported, in part, by a Grant-in-Aid for Scientific Research (C) (24592393) from the Japan Society for the Promotion of Science. The authors wish to thank the members of the Yamaguchi Uro-Oncology Group for important contributions to this study.	Kikuchi E, 2009, J CLIN ONCOL, V27, P612, DOI 10.1200/JCO.2008.17.2361; Sakano S, 2013, ANN SURG ONCOL, V20, P4389, DOI 10.1245/s10434-013-3259-0; Rink M, 2012, J UROLOGY, V188, P398, DOI 10.1016/j.juro.2012.04.009; Kim SP, 2012, J UROLOGY, V188, P405, DOI 10.1016/j.juro.2012.04.020; Chromecki TF, 2012, EUR UROL, V61, P245, DOI 10.1016/j.eururo.2011.09.017; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Pons F, 2011, CURR ONCOL REP, V13, P216, DOI 10.1007/s11912-011-0161-4; Perez-Montiel D, 2006, MODERN PATHOL, V19, P494, DOI 10.1038/modpathol.3800559; Matsumoto K, 2011, BJU INT, V108, pE304, DOI 10.1111/j.1464-410X.2011.10188.x; Akao J, 2008, BJU INT, V102, P572, DOI 10.1111/j.1464-410X.2008.07749.x; Honma I, 2004, UROLOGY, V64, P744, DOI 10.1016/j.urology.2004.05.003; Zigeuner R, 2008, EUR UROL, V53, P720, DOI 10.1016/j.eururo.2008.01.006; Margulis V, 2009, CANCER, V115, P1224, DOI 10.1002/cncr.24135; Blacks PC, 2009, UROL ONCOL-SEMIN ORI, V27, P3, DOI 10.1016/j.urolonc.2007.07.010; Czito B, 2004, J UROLOGY, V172, P1271, DOI 10.1097/01.ju.0000137910.38441.8a; Holmang S, 2007, J UROLOGY, V178, P51, DOI 10.1016/j.juro.2007.03.033; Jenkins P, 2009, INT J RADIAT ONCOL, V75, P1379, DOI 10.1016/j.ijrobp.2009.01.063; Mostofi FK, 1973, INT CLASSIFICATION T, V19	18	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					362	368		10.1007/s10147-014-0721-3		7	Oncology	Oncology	CF5SI	WOS:000352616900019		
J	Yoneyama, T; Tobisawa, Y; Yoneyama, T; Yamamoto, H; Imai, A; Hatakeyama, S; Hashimoto, Y; Koie, T; Ohyama, C				Yoneyama, Takahiro; Tobisawa, Yuki; Yoneyama, Tohru; Yamamoto, Hayato; Imai, Atsushi; Hatakeyama, Shingo; Hashimoto, Yasuhiro; Koie, Takuya; Ohyama, Chikara			Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Advanced bladder cancer; Elderly patients; Carboplatin-based combination chemotherapy	CISPLATIN-BASED CHEMOTHERAPY; TRANSITIONAL-CELL CARCINOMA; ADVANCED UROTHELIAL CARCINOMA; GEMCITABINE PLUS CARBOPLATIN; COOPERATIVE-ONCOLOGY-GROUP; PHASE-II TRIAL; 1ST-LINE TREATMENT; URINARY-TRACT; UNFIT; GEMCITABINE/CARBOPLATIN	We evaluated retrospectively the feasibility and effectiveness of carboplatin-based combination chemotherapy in elderly patients with advanced bladder cancer. Forty-seven patients with advanced bladder cancer (33 men and 14 women) and treated at our hospital between August 2004 and December 2011 were enrolled. The average age was 77.1 years (range 70-86 years), the average creatinine clearance was 37.0 ml/min (range 14.5-113.0 ml/min), and the average follow-up period was 17.4 months (range 10-55 months). Twenty-nine patients (61.7 %) were unfit for cisplatin-based chemotherapy. There were 15 recurrent cases after radical surgery and 32 inoperable cases. In this study, the first-line therapy was gemcitabine and carboplatin (GCarbo), with two courses as a set. The second-line therapy was GCarbo and docetaxel (GCarboD) if there was an insufficient response to the first-line therapy. Of the 47 patients who underwent GCarbo therapy, the response rate was 38.3 % (complete response plus partial response), with 5 and 13 patients exhibiting a complete response and a partial response, respectively. The average response duration was 15.7 months (range 2-42 months). The response rate of the nine patients who received GCarboD was 11.1 %, and the overall median survival was 15.0 months. Adverse events occurred in 30 patients (63.8 %) who underwent GCarbo therapy. Bone marrow suppression was observed in 30 patients (61.7 %), and digestive symptoms were observed in three patients (9.0 %). Our study demonstrates that GCarbo is a safe and effective combination chemotherapy in elderly patients with advanced bladder cancer. However, the GCarboD regimen appears to have limited effectiveness for nonresponders to GCarbo therapy.	[Yoneyama, Takahiro; Tobisawa, Yuki; Yoneyama, Tohru; Yamamoto, Hayato; Imai, Atsushi; Hatakeyama, Shingo; Hashimoto, Yasuhiro; Koie, Takuya; Ohyama, Chikara] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan	Hashimoto, Y (reprint author), Hirosaki Univ, Grad Sch Med, Dept Urol, 5 Zaifucho, Hirosaki, Aomori 0368562, Japan.	bikkuri@opal.plala.or.jp	Tobisawa, Yuki/G-3802-2014	Tobisawa, Yuki/0000-0001-8026-9541			Bellmunt J, 1997, CANCER, V80, P1966, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1966::AID-CNCR14>3.0.CO;2-W; Nogue-Aliguer M, 2003, CANCER, V97, P2180, DOI 10.1002/cncr.10990; Linardou H, 2004, UROLOGY, V64, P479, DOI 10.1016/j.urology.2004.04.024; McCaffrey JA, 1997, J CLIN ONCOL, V15, P1853; De Santis M, 2012, J CLIN ONCOL, V30, P191, DOI 10.1200/JCO.2011.37.3571; Park JH, 2013, CANCER CHEMOTH PHARM, V71, P1033, DOI 10.1007/s00280-013-2098-9; Tsuruta H, 2011, INT J CLIN ONCOL, V16, P533, DOI 10.1007/s10147-011-0224-4; Bamias A, 2006, CANCER, V106, P297, DOI 10.1002/cncr.21604; Galsky MD, 2011, J CLIN ONCOL, V29, P2432, DOI 10.1200/JCO.2011.34.8433; Koie T, 2013, INT J CLIN ONCOL, V18, P724, DOI 10.1007/s10147-012-0447-z; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748; Hoschke B, 2004, INT J UROL, V11, P461, DOI 10.1111/j.0919-8172.2004.00846.x; Stenzl A, 2009, EUR UROL, V55, P815, DOI 10.1016/j.eururo.2009.01.002; Hoshi Senji, 2004, Int J Clin Oncol, V9, P125, DOI 10.1007/s10147-003-0379-8; Sella A, 2012, INT BRAZ J UROL, V38, P49, DOI 10.1590/S1677-55382012000100007; Xu N, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-98	16	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					369	374		10.1007/s10147-014-0706-2		6	Oncology	Oncology	CF5SI	WOS:000352616900020		
J	Saito, S; Ito, K; Yorozu, A; Aoki, M; Koga, H; Satoh, T; Ohashi, T; Shigematsu, N; Maruo, S; Kikuchi, T; Kojima, S; Dokiya, T; Fukushima, M; Yamanaka, H				Saito, Shiro; Ito, Kazuto; Yorozu, Atsunori; Aoki, Manabu; Koga, Hirofumi; Satoh, Takefumi; Ohashi, Toshio; Shigematsu, Naoyuki; Maruo, Shinichiro; Kikuchi, Takashi; Kojima, Shinsuke; Dokiya, Takushi; Fukushima, Masanori; Yamanaka, Hidetoshi			Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS)	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Brachytherapy; Iodine-125; Multi-institutional prospective cohort study; Prostate cancer	RADICAL PROSTATECTOMY; RECTAL MORBIDITY; BRACHYTHERAPY; RECOMMENDATIONS; RADIOTHERAPY	To evaluate the safety and efficacy of brachytherapy with permanent iodine-125 seed implantation (PI) for prostate cancer. The nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS) has continued since July 2005. This manuscript presents the rationale, J-POPS study design, and the characteristics of initial participants enrolled in this study from July 2005 to June 2007. All participants were treated with PI in accordance with the American Brachytherapy Society recommendations. The primary outcome measure was biochemical progression-free survival. Progression-free survival, overall survival, cause-specific survival, longitudinal changes in health-related quality of life, disease-specific quality of life, the International Prostate Symptom Score, and the incidence of adverse events were also investigated as secondary outcome measurements. Overall, 6,927 patients were enrolled by the end of 2010, that is approximately 40 % of all cases treated around the country. During the first 2 years, 2,354 participants were enrolled and 2,339 were actually treated with PI. The age range of participants was 45 to 89 years (median 69 years) and their risk classifications were 1,037 (44.3 %) at low risk, 1,126 (48.1 %) at intermediate risk, and 134 (5.7 %) at high risk, in addition to 16 participants whose classification was unknown. Of all patients, 76.6 % were treated with PI without external beam radiation therapy and 49.3 % received neoadjuvant hormone therapy. The J-POPS, a nationwide prospective cohort study that enrolled approximately 40 % of all PI cases in Japan, will provide highly reliable evidence, including outcomes and quality of life, after long-term follow-up.	[Saito, Shiro] Natl Hosp Org, Tokyo Med Ctr, Dept Urol, Meguro Ku, Tokyo 1528902, Japan; [Ito, Kazuto] Gunma Univ, Dept Urol, Gunma, Japan; [Yorozu, Atsunori] Natl Hosp Org, Tokyo Med Ctr, Dept Radiat Oncol, Tokyo 1528902, Japan; [Aoki, Manabu] Jikei Univ, Sch Med, Dept Radiat Oncol, Tokyo, Japan; [Koga, Hirofumi] Hara Sanshin Hosp, Dept Urol, Fukuoka, Japan; [Satoh, Takefumi] Kitasato Univ, Sch Med, Dept Urol, Sagamihara, Kanagawa, Japan; [Ohashi, Toshio; Shigematsu, Naoyuki] Keio Univ, Sch Med, Dept Radiat Oncol, Tokyo, Japan; [Maruo, Shinichiro; Kikuchi, Takashi; Kojima, Shinsuke; Fukushima, Masanori] Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Dokiya, Takushi] Saitama Med Coll, Dept Radiat Oncol, Saitama, Japan; [Yamanaka, Hidetoshi] Kurosawa Hosp, Inst Prevent Med, Gunma, Japan	Saito, S (reprint author), Natl Hosp Org, Tokyo Med Ctr, Dept Urol, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan.	saitoshr@netjoy.ne.jp	Ohashi, Toshio/J-2964-2014	Ohashi, Toshio/0000-0002-2011-3016			GLEASON DF, 1974, J UROLOGY, V111, P58; Waterman FM, 2003, INT J RADIAT ONCOL, V55, P342, DOI 10.1016/S0360-3016(02)03934-2; Nag S, 2000, INT J RADIAT ONCOL, V46, P221, DOI 10.1016/S0360-3016(99)00351-X; Dearnaley DP, 2007, LANCET ONCOL, V8, P475, DOI 10.1016/S1470204S(07)70143-2; CATALONA WJ, 1990, J UROLOGY, V143, P538; Rivard MJ, 2007, BRACHYTHERAPY, V6, P34, DOI 10.1016/j.brachy.2006.11.001; Peinemann F, 2011, EUR UROL, V60, P881, DOI 10.1016/j.eururo.2011.06.044; Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3; Rosenthal SA, 2011, INT J RADIAT ONCOL, V79, P335, DOI 10.1016/j.ijrobp.2010.08.045; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Porter CR, 2006, J UROLOGY, V176, P569, DOI 10.1016/j.juro.2006.03.094; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Bittner N, 2010, INT J RADIAT ONCOL, V76, P1078, DOI 10.1016/j.ijrobp.2009.02.069; Harada M, 1999, JPN J UROL SURG, V12, P1033; Nag S, 2000, Semin Urol Oncol, V18, P133; NCCN, 2013, CLIN PRACT GUID ONC; Sobin LH, 2002, TNM CLASSIFICATION M; Stock Richard G, 2002, Brachytherapy, V1, P83, DOI 10.1016/S1538-4721(02)00017-X; WALLNER K, 1995, INT J RADIAT ONCOL, V32, P465, DOI 10.1016/0360-3016(94)00599-G	19	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					375	385		10.1007/s10147-014-0704-4		11	Oncology	Oncology	CF5SI	WOS:000352616900021		
J	Yamamura, Y; Tsuchikawa, T; Miyauchi, K; Takeuchi, S; Wada, M; Kuwatani, T; Kyogoku, N; Kuroda, A; Maki, T; Shichinohe, T; Hirano, S				Yamamura, Yoshiyuki; Tsuchikawa, Takahiro; Miyauchi, Kengo; Takeuchi, Shintaro; Wada, Masataka; Kuwatani, Toshihiko; Kyogoku, Noriaki; Kuroda, Aki; Maki, Takehiro; Shichinohe, Toshiaki; Hirano, Satoshi			The key role of calreticulin in immunomodulation induced by chemotherapeutic agents	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Immunogenic cell death; Chemotherapy; Immunotherapy; Calreticulin; HLA class I	SQUAMOUS-CELL CARCINOMA; CD8(+) T-CELLS; TUMOR MICROENVIRONMENT; CANCER; ESOPHAGEAL; STRATEGIES; PROGNOSIS; PATHWAY; CD4(+)	It has recently been shown that certain chemotherapeutic agents can improve host immune responses. The present study aimed to demonstrate the mechanism by which chemotherapeutic agents modify the tumor microenvironment and induce tumor-specific immune responses. Three mouse cancer cell lines [CT26 mouse colon cancer cells, B16 melanoma cells and Lewis lung carcinoma (LLC)], 5 human carcinoma cell lines (human esophageal squamous cell carcinoma cell lines TE8 and HEC46 and the human pancreatic carcinoma cell lines PK-9, AsPC-1 and SUIT-2) and 5 chemotherapeutic agents [mitoxantrone (MIT), mitomycin C(MMC), 5-fluorouracil (5FU), camptothecin (CPT-11) and cisplatin (CDDP)] that are frequently used in a clinical setting for cancer treatment were utilized to investigate the surface expression level of calreticulin and HLA class I after exposure to chemotherapeutic agents. Increased calreticulin (CRT) expression on the surface of mouse cell lines and, moreover, increased surface expression levels of both CRT and HLA class I in all human cell lines were observed in cells treated by the chemotherapeutic agents as compared with non-treated cells. The surface expression level of CRT was significantly correlated with the HLA class I expression level in all human cell lines. In conclusion, chemotherapeutic drugs can improve the immunogenicity of cancer cells in a cell-specific manner through the mechanism of translocation of CRT.	[Yamamura, Yoshiyuki; Tsuchikawa, Takahiro; Miyauchi, Kengo; Takeuchi, Shintaro; Wada, Masataka; Kuwatani, Toshihiko; Kyogoku, Noriaki; Kuroda, Aki; Maki, Takehiro; Shichinohe, Toshiaki; Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido 0600815, Japan	Tsuchikawa, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, N-15 W-17, Sapporo, Hokkaido 0600815, Japan.	tsuchi-t@med.hokudai.ac.jp					Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Cho Y, 2003, CANCER RES, V63, P1555; Tanaka K, 2012, INT J ONCOL, V40, P965, DOI 10.3892/ijo.2011.1274; Kageyama S, 2008, CANCER SCI, V99, P601, DOI 10.1111/j.1349-7006.2007.00705.x; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Brode S, 2008, CRIT REV IMMUNOL, V28, P109; Tsuchikawa T, 2013, CANCER SCI, V104, P531, DOI 10.1111/cas.12119; Rizvi SM, 2011, J IMMUNOL, V186, P2309, DOI 10.4049/jimmunol.1002959; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Ma YT, 2011, CANCER METAST REV, V30, P71, DOI 10.1007/s10555-011-9283-2; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Mimura K, 2013, J IMMUNOL, V191, P6261, DOI 10.4049/jimmunol.1301597; Tsuchikawa T, 2012, ANN SURG ONCOL, V19, P1713, DOI 10.1245/s10434-011-1906-x; Berraondo P, 2012, CANCER RES, V72, P5159, DOI 10.1158/0008-5472.CAN-12-1952; Fukunaga A, 2004, PANCREAS, V28, P26; Karbach J, 2012, CLIN CANCER RES, V18, P5449, DOI 10.1158/1078-0432.CCR-12-1116; Marsh RD, 2012, J SURG ONCOL, V106, P339, DOI 10.1002/jso.23027; Tsuboi A, 2012, LEUKEMIA, V26, P1410, DOI 10.1038/leu.2011.343; Weber GF, 2012, EXPERT REV ANTICANC, V12, P481, DOI [10.1586/era.12.3, 10.1586/ERA.12.3]	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					386	394		10.1007/s10147-014-0719-x		9	Oncology	Oncology	CF5SI	WOS:000352616900022		
J	Utsumi, F; Kajiyama, H; Sakata, J; Higashi, M; Niimi, K; Sekiya, R; Mitsui, H; Suzuki, S; Umezu, T; Mizuno, M; Yamamoto, E; Shibata, K; Kikkawa, F				Utsumi, Fumi; Kajiyama, Hiroaki; Sakata, Jun; Higashi, Makiko; Niimi, Kaoru; Sekiya, Ryuichiro; Mitsui, Hiroko; Suzuki, Shiro; Umezu, Tomokazu; Mizuno, Mika; Yamamoto, Eiko; Shibata, Kiyosumi; Kikkawa, Fumitaka			Opioid needs of terminally ill patients with gynecologic malignancies	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Cancer-related pain; Gynecologic malignancy; Opioid intake; Age; Pelvic invasion	CANCER-RELATED PAIN; MORPHINE; PREVALENCE; RECOMMENDATIONS; SENSITIVITY; SYMPTOMS; GENDER; AGE	Little is known about patterns and predictive factors regarding opioid use for terminally ill patients with gynecologic malignancies. The aim of this study was to elucidate predictors affecting opioid requirements of end-of-life patients with gynecologic malignancies. A retrospective study was carried out on patients with gynecological malignancies admitted to our institute and died during the years 2002 to 2012. The association between maximum opioid dose and factors affecting opioid requirements were examined. Data extracted from medical records included age, site of primary cancer, maximum total dose of opioids prescribed over 24 h, the site of recurrence and metastasis, procedures performed during the hospital stay, total number of chemotherapy courses and overall survival. The study identified 189 patients. Most patients had ovarian cancer (42.3 %) followed by cervical cancer (28.0 %) and then corpus malignancy (27.0 %). Opioid requirements decreased with increasing age, especially from the 50s onward. This was particularly marked in cervical cancer patients. In addition, pelvic metastasis was associated with the maximum dose of opioids and the average opioid use was highest in patients with cervical cancer. Young age and pelvic invasion were significant predictive factors regarding opioid requirements. Additionally, cervical cancer patients may require more opioids among those with gynecologic malignancies.	[Utsumi, Fumi; Kajiyama, Hiroaki; Sakata, Jun; Higashi, Makiko; Niimi, Kaoru; Sekiya, Ryuichiro; Mitsui, Hiroko; Suzuki, Shiro; Umezu, Tomokazu; Mizuno, Mika; Yamamoto, Eiko; Shibata, Kiyosumi; Kikkawa, Fumitaka] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, Nagoya, Aichi 4668550, Japan	Kajiyama, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, Tsuruma Cho 65, Nagoya, Aichi 4668550, Japan.	kajiyama@med.nagoya-u.ac.jp	NIIMI, Kaoru/I-7509-2014				Quigley C, 2003, PALLIATIVE MED, V17, P185, DOI 10.1191/0269216303pm658oa; Breivik H, 2009, ANN ONCOL, V20, P1420, DOI 10.1093/annonc/mdp001; Strohbuecker B, 2005, J PAIN SYMPTOM MANAG, V29, P498, DOI 10.1016/j.japinsymman.2004.08.012; Hanks GW, 2001, BRIT J CANCER, V84, P587, DOI 10.1054/bjoc.2001.1680; Goncalves F, 2013, SUPPORT CARE CANCER, V21, P2033, DOI 10.1007/s00520-013-1746-2; Klepstad P, 2003, ACTA ANAESTH SCAND, V47, P725, DOI 10.1034/j.1399-6576.2003.00138.x; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Cherny N, 2001, J CLIN ONCOL, V19, P2542; Hall S, 2003, PAIN MED, V4, P125, DOI 10.1046/j.1526-4637.2003.03020.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Vainio A, 1996, J PAIN SYMPTOM MANAG, V12, P3, DOI 10.1016/0885-3924(96)00042-5; Fisch MJ, 2012, J CLIN ONCOL, V30, P1980, DOI 10.1200/JCO.2011.39.2381; Mercadante S, 2002, CANCER, V94, P832, DOI 10.1002/cncr.10249; Zoega S, 2013, QUAL LIFE RES, V22, P1273, DOI 10.1007/s11136-012-0264-x; Brun JL, 2000, GYNECOL ONCOL, V78, P21, DOI 10.1006/gyno.2000.5805; Dalacorte Roberta Rigo, 2011, N Am J Med Sci, V3, P348, DOI 10.4297/najms.2011.3348; Ikeda K, 2005, TRENDS PHARMACOL SCI, V26, P311, DOI 10.1016/j.tips.2005.04.001; Ikeda K, 2001, J NEUROSCI, V21, P1334; Jost L, 2007, ANN ONCOL, V18, P92, DOI 10.1093/annonc/mdm053; Mercadante S, 2000, SUPPORT CARE CANCER, V8, P123, DOI 10.1007/s005200050026; Mercadante S, 1997, J PAIN SYMPTOM MANAG, V13, P204, DOI 10.1016/S0885-3924(96)00302-8; Rees W D, 1990, Clin Oncol (R Coll Radiol), V2, P79, DOI 10.1016/S0936-6555(05)80792-7; van den Beuken-van Everdingen M H J, 2007, Ann Oncol, V18, P1437, DOI 10.1093/annonc/mdm056; Zerzan J, 2010, J PALLIAT MED, V13, P501, DOI 10.1089/jpm.2009.0406	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	APR	2015	20	2					405	410		10.1007/s10147-014-0708-0		6	Oncology	Oncology	CF5SI	WOS:000352616900024		
J	Rungamornrat, J; Phongtinnaboot, W; Wijeyewickrema, AC				Rungamornrat, J.; Phongtinnaboot, W.; Wijeyewickrema, A. C.			Analysis of cracks in 3D piezoelectric media with various electrical boundary conditions	INTERNATIONAL JOURNAL OF FRACTURE			English	Article						Cracks; Electrical boundary conditions; Piezoelectric media; SGBEM; Stress intensity factor; Electric intensity factor; Weakly singular	PENNY-SHAPED CRACK; HYPERSINGULAR INTEGRAL-EQUATION; 3-DIMENSIONAL FRACTURE PROBLEMS; WEAKLY-SINGULAR SGBEM; FINITE-PART INTEGRALS; DIELECTRIC CRACK; INTENSITY FACTORS; MECHANICS; SOLIDS; BEM	A weakly singular, symmetric Galerkin boundary element method capable of solving problems of isolated cracks in three-dimensional, linear anisotropic piezoelectric, infinite media with various types of crack-face boundary conditions including impermeable, permeable, semi-permeable, and the energetically consistent boundary condition introduced by Landis (Int J Solids Struct 41:6291-6315, 2004) is established. The key governing boundary integral equation used in the formulation possesses several crucial features including its desirable symmetric weak-form, weakly singular nature, and ability to treat general material anisotropy, arbitrary crack configurations and any type of boundary condition on the crack surface. The positive consequence of utilizing the singularity-reduced integral equations in the modeling, is that all involved singular integrals can be interpreted in the sense of Riemann and their validity requires only continuous crack-face data allowing -interpolation functions to be employed everywhere in the numerical discretization. Special crack-tip elements with appropriate square-root functions are adopted in a local region along the crack front to accurately approximate the relative crack-face displacement and electric potential. With use of these crack-tip elements, the stress and electric intensity factors can be extracted directly in terms of crack-front nodal data. A system of nonlinear algebraic equations resulting from semi-permeable and energetically consistent boundary conditions is solved by standard Newton-Raphson iterative scheme. Various numerical examples of both planar and non-planar cracks under different types of electrical boundary conditions are considered and the proposed technique is found promising and computationally robust. In addition, it was determined that using crack-tip elements along the crack front significantly enhances the computational performance and that the stress and electric intensity factors can be obtained accurately using relatively coarse meshes.	[Rungamornrat, J.] Chulalongkorn Univ, Dept Civil Engn, Fac Engn, Bangkok 10330, Thailand; [Phongtinnaboot, W.] Burapha Univ, Dept Civil Engn, Fac Engn, Chon Buri 20131, Thailand; [Wijeyewickrema, A. C.] Tokyo Inst Technol, Dept Civil & Environm Engn, Tokyo 1528552, Japan	Rungamornrat, J (reprint author), Chulalongkorn Univ, Dept Civil Engn, Fac Engn, Bangkok 10330, Thailand.	Jaroon.r@chula.ac.th			Thailand Research Fund [MRG5380159]; Research and Development Fund of the Faculty of Engineering, Burapha University [1/2557]	The first author gratefully acknowledges financial support provided by Thailand Research Fund (Grant No. MRG5380159) and the second author gratefully acknowledges the Research and Development Fund of the Faculty of Engineering, Burapha University (Grant No. 1/2557). Some of the work presented in this paper was completed while the second author was visiting Tokyo Institute of Technology.	Nam BG, 2008, ENG FRACT MECH, V75, P207, DOI 10.1016/j.engfracmech.2007.03.022; SUO Z, 1992, J MECH PHYS SOLIDS, V40, P739, DOI 10.1016/0022-5096(92)90002-J; McMeeking RM, 2004, ENG FRACT MECH, V71, P1149, DOI 10.1016/S0013-7944(03)00135-8; Chen MC, 2003, INT J FRACTURE, V121, P133, DOI 10.1023/B:FRAC.0000005344.23327.f6; Schneider GA, 2003, ACTA MATER, V51, P2235, DOI 10.1016/S1359-6454(03)00027-2; DUNN ML, 1994, ENG FRACT MECH, V48, P25, DOI 10.1016/0013-7944(94)90140-6; Chen MC, 2003, INT J FRACTURE, V121, P149, DOI 10.1023/B:FRAC.0000005327.72708.32; PARTON VZ, 1976, ACTA ASTRONAUT, V3, P671, DOI 10.1016/0094-5765(76)90105-3; Landis CM, 2004, INT J SOLIDS STRUCT, V41, P6291, DOI 10.1016/j.ijsolstr.2004.05.062; Chen WQ, 2005, INT J FRACTURE, V131, P231, DOI [10.1007/s10704-004-4195-6, 10.1007/s10740-004-4195-6]; Sosa H, 1996, INT J SOLIDS STRUCT, V33, P3399, DOI 10.1016/0020-7683(95)00187-5; Qin TY, 2007, INT J SOLIDS STRUCT, V44, P4770, DOI 10.1016/j.ijsolstr.2006.12.002; Li Q, 2008, ARCH APPL MECH, V78, P559, DOI 10.1007/s00419-007-0180-7; Qin TY, 2004, JSME INT J A-SOLID M, V47, P173, DOI 10.1299/jsmea.47.173; Pan E, 1999, ENG ANAL BOUND ELEM, V23, P67, DOI 10.1016/S0955-7997(98)00062-9; Denda M, 2005, ENG ANAL BOUND ELEM, V29, P533, DOI 10.1016/j.enganabound.2005.01.009; Zhao MH, 1997, THEOR APPL FRACT MEC, V26, P141, DOI 10.1016/S0167-8442(96)00042-0; Martin PA, 1996, INT J NUMER METH ENG, V39, P687, DOI 10.1002/(SICI)1097-0207(19960229)39:4<687::AID-NME876>3.0.CO;2-S; Chen WQ, 2000, INT J SOLIDS STRUCT, V37, P2603, DOI 10.1016/S0020-7683(99)00113-4; Chen WQ, 2000, INT J FRACTURE, V105, P49, DOI 10.1023/A:1007656411540; Chiang CR, 2007, J APPL MECH-T ASME, V74, P852, DOI 10.1115/1.2712227; Davi G, 2001, INT J SOLIDS STRUCT, V38, P7065, DOI 10.1016/S0020-7683(00)00416-9; Deeg W. F., 1980, THESIS STANFORD U; Gao CF, 1999, INT J SOLIDS STRUCT, V36, P2527, DOI 10.1016/S0020-7683(98)00120-6; HAO TH, 1994, ENG FRACT MECH, V47, P793; Jiang LZ, 2001, INT J SOLIDS STRUCT, V38, P1903, DOI 10.1016/S0020-7683(00)00142-6; Li XF, 2004, J APPL MECH-T ASME, V71, P866, DOI 10.1115/1.1795219; McMeeking RM, 2001, INT J FRACTURE, V108, P25, DOI 10.1023/A:1007652001977; Motola Y, 2009, J APPL MECH-T ASME, V76, DOI 10.1115/1.2998485; Ou ZC, 2007, EUR J MECH A-SOLID, V26, P659, DOI 10.1016/j.euromechsol.2006.09.007; Ou ZC, 2003, INT J FRACTURE, V123, pL151, DOI 10.1023/B:FRAC.0000005808.89187.97; Park SB, 1995, INT J FRACTURE, V70, P302; Phongtinnaboot W, 2011, ENG ANAL BOUND ELEM, V35, P319, DOI 10.1016/j.enganabound.2010.10.002; Rungamornrat J, 2008, COMPUT METHOD APPL M, V197, P4319, DOI 10.1016/j.cma.2008.05.009; Rungamornrat J, 2008, INT J FRACTURE, V151, P1, DOI 10.1007/s10704-008-9242-2; Sanz JA, 2005, ENG ANAL BOUND ELEM, V29, P586, DOI 10.1016/j.enganabound.2004.12.014; Solis M, 2009, ENG ANAL BOUND ELEM, V33, P271, DOI 10.1016/j.enganabound.2008.08.002; Wang BL, 2004, J APPL MECH-T ASME, V71, P575, DOI 10.1115/1.1748294; Wang XD, 2004, ACTA MECH, V172, P195, DOI 10.1007/s00707-004-0151-9; Wang XD, 2002, P ROY SOC A-MATH PHY, V458, P2545, DOI 10.1098/rspa.2002.0976; Wippler K, 2007, COMP MATER SCI, V39, P261, DOI 10.1016/j.commatsci.2006.03.023; Xiao L, 1998, THESIS U TEXAS AUSTI; Xu XL, 2001, INT J SOLIDS STRUCT, V38, P7643, DOI 10.1016/S0020-7683(01)00029-4	43	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0376-9429	1573-2673		INT J FRACTURE	Int. J. Fract.	APR	2015	192	2					133	153		10.1007/s10704-015-9991-7		21	Materials Science, Multidisciplinary; Mechanics	Materials Science; Mechanics	CF7BT	WOS:000352711800001		
J	Shoji, H; Ohata, M; Minami, F				Shoji, Hiroto; Ohata, Mitsuru; Minami, Fumiyoshi			Simulation-based method for hierarchal material design to improve ductile crack growth resistance of structural component	INTERNATIONAL JOURNAL OF FRACTURE			English	Article						3D-simulation; Ductile crack; Heterogeneous microstructure; Damage model; Stress triaxiality	MULTIPHASE STEEL; DAMAGE MECHANICS; VOID NUCLEATION; FRACTURE; MODEL	The purpose of this study is to propose a method to correlate micro-structural characteristics of two-phase steel with structural performance in terms of ductile crack growth resistance (R-curve). For this purpose, a meso-scopic simulation method is proposed to predict two types of ductile properties of two-phase steel that control the R-curve from micro-structural characteristics. The R-curve of three-point bend specimen with fatigue pre-crack predicted by a macro-scopic simulation method that we have proposed, in which these two types of ductile properties obtained by the proposed meso-scopic methods are implemented, is in good agreement with experimental result.	[Shoji, Hiroto; Ohata, Mitsuru; Minami, Fumiyoshi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Shoji, H (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamada OKa, Suita, Osaka 5650871, Japan.	shoji@mapse.eng.osaka-u.ac.jp					XIA L, 1995, J MECH PHYS SOLIDS, V43, P389, DOI 10.1016/0022-5096(94)00069-H; ROUSSELIER G, 1987, NUCL ENG DES, V105, P97, DOI 10.1016/0029-5493(87)90234-2; LEBLOND JB, 1994, INT J PLASTICITY, V10, P213, DOI 10.1016/0749-6419(94)90001-9; Ohata M, 2010, ENG FRACT MECH, V77, P277, DOI 10.1016/j.engfracmech.2009.08.011; Uthaisangsuk V, 2009, COMP MATER SCI, V45, P617, DOI 10.1016/j.commatsci.2008.06.024; Uthaisangsuk V, 2009, INT J FRACTURE, V157, P55, DOI 10.1007/s10704-009-9329-4; XIA L, 1995, J MECH PHYS SOLIDS, V43, P233, DOI 10.1016/0022-5096(94)00064-C; CHABOCHE JL, 1988, J APPL MECH-T ASME, V55, P59; Ohata M, 2010, INT J DAMAGE MECH, V19, P441, DOI 10.1177/1056789509103704; GURSON AL, 1977, J ENG MATER-T ASME, V99, P2; Konda N, 2001, J SOC NAVAL ARCHITEC, V190, P507; LEMAITRE J, 1985, J ENG MATER-T ASME, V107, P83; XIA L, 1995, J MECH PHYS SOLIDS, V43, P1953, DOI 10.1016/0022-5096(95)00063-O; Nakashima K, 2009, Q J JPN WELD SOC, V27, P13; Ohata M, 2007, MATER SCI FORUM, V539-543, P2168; Ohata M, 2013, TETSU TO HAGANE, V99, P573, DOI 10.2355/tetsutohagane.99.573; TVERGAARD V, 1984, ACTA METALL MATER, V32, P157, DOI 10.1016/0001-6160(84)90213-X; TVERGAARD V, 1981, INT J FRACTURE, V17, P389, DOI 10.1007/BF00036191; Ueda K, 2007, JFE TECHNICAL REPORT, V18, P23	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0376-9429	1573-2673		INT J FRACTURE	Int. J. Fract.	APR	2015	192	2					167	178		10.1007/s10704-015-9993-5		12	Materials Science, Multidisciplinary; Mechanics	Materials Science; Mechanics	CF7BT	WOS:000352711800003		
J	Hirakata, H; Takeda, Y; Kondo, T; Minoshima, K				Hirakata, Hiroyuki; Takeda, Yuki; Kondo, Toshiyuki; Minoshima, Kohji			Direct observation of the thickness effect on critical crack tip opening displacement in freestanding copper submicron-films by in situ electron microscopy fracture toughness testing	INTERNATIONAL JOURNAL OF FRACTURE			English	Article						Thin-films; Fracture toughness; Crack tip opening displacement; Size effects; Elastic-plastic fracture mechanics; Copper	NANO-FILMS; MECHANICS; PLASTICITY	We evaluated the thickness effect on fracture toughness in freestanding Cu films with thicknesses of approximately 100, 500, and 2600 nm, on the basis of crack tip opening displacement (CTOD) concept by means of in situ (field emission scanning electron microscopy) FESEM and (transmission electron microscopy) TEM fracture toughness testing. During testing, an acute pre-crack tip blunted gradually and necking deformation in the out-of-plane direction occurred in the region ahead of the crack tip in all the specimens. A crack then initiated from the pre-crack tip and propagated along the necking region resulting in chisel point fracture. Since the small scale yielding condition was not satisfied in the 500 and 2600 nm specimens, the critical CTOD, , at the onset of crack extension was directly evaluated from the in situ images. The results indicate a clear thickness effect on (i.e. decreases as the thickness decreases). Normalized critical CTOD, defined as (where is the thickness), of 100 and 500 nm specimens are similar, . This suggests the presence of a fracture criterion, , in the submicron scale regardless of the film thickness. On the other hand, of the 2600 nm specimen was roughly half of those of the 100 and 500 nm specimens.	[Hirakata, Hiroyuki; Takeda, Yuki; Kondo, Toshiyuki; Minoshima, Kohji] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan	Hirakata, H (reprint author), Osaka Univ, Dept Mech Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hirakata@mech.eng.osaka-u.ac.jp			JSPS KAKENHI [26220901, 23246026]	This work was supported by JSPS KAKENHI Grant Number 26220901 and 23246026. The TEM observation was supported by Prof. Yasuda H., Director and the Research Center for Ultrahigh Voltage Electron Microscopy, Osaka University.	Anderson TL, 2005, FRACTURE MECH FUNDAM; DUGDALE DS, 1960, J MECH PHYS SOLIDS, V8, P100, DOI 10.1016/0022-5096(60)90013-2; [Anonymous], ASTME182001; Greer JR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245410; Haque MA, 2004, P NATL ACAD SCI USA, V101, P6335, DOI 10.1073/pnas.0400066101; Hirakata H, 2012, ACTA MATER, V60, P4438, DOI 10.1016/j.actamat.2012.04.036; [Anonymous], ESISP292; Schwalbe KH, 2005, ENG FRACT MECH, V72, P557, DOI 10.1016/j.engfrachmech.2004.04.006; [Anonymous], ASTME39990; Armstrong DEJ, 2009, J MATER RES, V24, P3268, DOI 10.1557/JMR.2009.0396; BROBERG KB, 1971, J MECH PHYS SOLIDS, V19, P407, DOI 10.1016/0022-5096(71)90008-1; Kondo T, 2013, ACTA MATER, V61, P6310, DOI 10.1016/j.actamat.2013.07.017; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; Hirakata H, 2011, MAT SCI ENG A-STRUCT, V528, P8120, DOI 10.1016/j.msea.2011.07.071; Espinosa HD, 2004, J MECH PHYS SOLIDS, V52, P667, DOI 10.1016/j.jmps.2003.07.001; Burdekin F.M., 1966, J STRAIN ANAL, V1, P145, DOI DOI 10.1243/03093247V012145; Knott JF, 1973, FUNDAMENTALS FRACTUR; KNOTT JF, 1971, MATER SCI ENG, V7, P1, DOI 10.1016/0025-5416(71)90058-9; Kondo T, 2014, FATIGUE CRACK UNPUB; Murakami Y, 1986, STRESS INTENSITY FAC, V1; Wang HW, 2003, INT J FRACTURE, V123, P177, DOI 10.1023/B:FRAC.0000007376.06477.e8	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0376-9429	1573-2673		INT J FRACTURE	Int. J. Fract.	APR	2015	192	2					203	216		10.1007/s10704-015-0003-8		14	Materials Science, Multidisciplinary; Mechanics	Materials Science; Mechanics	CF7BT	WOS:000352711800006		
J	Imamura, S; Muramoto, H; Murata, Y; Shimada, Y; Kayamori, Y; Tagawa, T				Imamura, Shungo; Muramoto, Hirokazu; Murata, Yoshinori; Shimada, Yusuke; Kayamori, Yoichi; Tagawa, Tetsuya			Crystallographic orientation analysis of cleavage facets adjacent to a fracture trigger in low carbon steel	INTERNATIONAL JOURNAL OF FRACTURE			English	Article						Ferritic steel; Ferrite-pearlite; Cleavage fracture; Grain boundaries; Crystal structure	EFFECTIVE GRAIN-SIZE; TOUGHNESS; MICROSTRUCTURE	The microstructure and crystallographic orientation under a cleavage crack trigger point, which was detected on a fracture toughness specimen of low carbon steel, were investigated. SEM fractographs of an etched cleavage facet reveal that a flat cleavage facet between facet ridges spreading from the trigger point is divided by a grain boundary between ferrite and pearlite. Even a different phase boundary does not occasionally create any steps and ridges on the cleavage facet: it suggests this phase boundary is not an obstacle to cleavage cracking. Electron diffraction analysis for the thin foil sample milled out from this phase boundary demonstrates that the crystallographic orientation of the ferrite grain is consistent with that of the ferrite in the adjacent pearlite block. It is strictly examined that the ferrite/pearlite boundary does not act as a local resistance to cleavage crack growth when the crystallographic orientation of the ferrite in the pearlite block is aligned with an adjacent ferrite grain.	[Imamura, Shungo; Murata, Yoshinori; Tagawa, Tetsuya] Nagoya Univ, Dept Mat Sci & Engn, Nagoya, Aichi 4648603, Japan; [Muramoto, Hirokazu] Toyohashi Univ Technol, Cooperat Res Facil Ctr, Toyohashi, Aichi 4418580, Japan; [Shimada, Yusuke; Kayamori, Yoichi] Nippon Steel & Sumitomo Met Corp, Steel Res Labs, Amagasaki, Hyogo 6600891, Japan	Tagawa, T (reprint author), Nagoya Univ, Dept Mat Sci & Engn, Nagoya, Aichi 4648603, Japan.	tagawa@numse.nagoya-u.ac.jp					ALEXANDER DJ, 1982, METALL TRANS A, V13, P1865, DOI 10.1007/BF02647843; Kim MC, 2000, SCRIPTA MATER, V43, P205, DOI 10.1016/S1359-6462(00)00392-4; Chakrabarti D, 2009, METALL MATER TRANS A, V40A, P780, DOI 10.1007/s11661-009-9794-4; Bhattacharjee D, 2002, SCRIPTA MATER, V47, P825, DOI 10.1016/S1359-6462(02)00324-X; Ghosh A, 2014, SCRIPTA MATER, V81, P8, DOI 10.1016/j.scriptamat.2014.02.007; Hanamura T, 2004, ISIJ INT, V44, P610, DOI 10.2355/isijinternational.44.610; LIN T, 1987, METALL TRANS A, V18, P641, DOI 10.1007/BF02649480; HAHN GT, 1984, METALL TRANS A, V15, P947, DOI 10.1007/BF02644685; Wallin K, 2006, FATIGUE FRACT ENG M, V29, P788, DOI 10.1111/j.1460-2695.2006.01005.x; Zhao MC, 2011, MAT SCI ENG A-STRUCT, V528, P8157, DOI 10.1016/j.msea.2011.07.067	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0376-9429	1573-2673		INT J FRACTURE	Int. J. Fract.	APR	2015	192	2					253	257		10.1007/s10704-015-0014-5		5	Materials Science, Multidisciplinary; Mechanics	Materials Science; Mechanics	CF7BT	WOS:000352711800011		
J	Watanabe, R; Gono, T; Yamagata, T; Fujisawa, N				Watanabe, R.; Gono, T.; Yamagata, T.; Fujisawa, N.			Three-dimensional flow structure in highly buoyant jet by scanning stereo PIV combined with POD analysis	INTERNATIONAL JOURNAL OF HEAT AND FLUID FLOW			English	Article						Highly buoyant jet; Scanning stereo PIV; Proper orthogonal decomposition; Three-dimensional flow; Inflow	PARTICLE IMAGE VELOCIMETRY; PROPER ORTHOGONAL DECOMPOSITION; LIQUID-CRYSTAL THERMOMETRY; VELOCITY-FIELD; EXCHANGE FLOW; TURBULENT; PLUME; TEMPERATURE; SECTION	The flow characteristics and the structure of highly buoyant jet of low density fluid issuing into a stagnant surrounding of high density fluid is studied by scanning stereo My combined with proper orthogonal decomposition (POD) analysis. The experiment is carried out at Froude number of 0.3 and Reynolds number of 200, which satisfies the inflow condition due to the unstable density gradient near the nozzle exit. An increase in the maximum mean velocity occurs and the vertical velocity fluctuation is highly amplified near the nozzle exit, which suggests the influence of inflow due to the unstable density gradient. The POD analysis indicates that the vertical velocity fluctuation is the major source of fluctuating energy contributing to the development of the highly buoyant jet. The examination of the POD modes show that the longitudinal structure of the vertical velocity fluctuation is generated along the jet axis having the opposite sign of velocity fluctuation on both sides of the jet axis. The vertical scale of the POD mode decreases with increasing the mode number and results in the frequent appearance of cross-flow across the buoyant jet. The reconstruction flow from the POD modes indicates that the vortex structure is caused by the highly sheared layer between the upward and downward velocity and the inflow is induced by the vortex structure. The magnitude of the vortex structure seems to be weakened with an increase in the distance from the nozzle and the buoyant jet approaches to an asymptotic state in the further downstream. (C) 2014 Elsevier Inc. All rights reserved.	[Watanabe, R.; Gono, T.] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Yamagata, T.; Fujisawa, N.] Niigata Univ, Visualizat Res Ctr, Nishi Ku, Niigata 9502181, Japan	Yamagata, T (reprint author), Niigata Univ, Visualizat Res Ctr, Nishi Ku, 8050 Nino Cho, Niigata 9502181, Japan.	yamagata@eng.niigata-u.ac.jp; fujisawa@eng.niigata-u.ac.jp					LIST EJ, 1982, ANNU REV FLUID MECH, V14, P189, DOI 10.1146/annurev.fl.14.010182.001201; Aranyi P, 2013, INT J HEAT FLUID FL, V43, P204, DOI 10.1016/j.ijheatfluidflow.2013.07.001; PAPANICOLAOU PN, 1988, J FLUID MECH, V195, P341, DOI 10.1017/S0022112088002447; Zhou J, 1999, J FLUID MECH, V387, P353, DOI 10.1017/S002211209900467X; BERKOOZ G, 1993, ANNU REV FLUID MECH, V25, P539, DOI 10.1146/annurev.fl.25.010193.002543; Funatani S, 2004, MEAS SCI TECHNOL, V15, P983, DOI 10.1088/0957-0233/15/5/030; Soloff SM, 1997, MEAS SCI TECHNOL, V8, P1441, DOI 10.1088/0957-0233/8/12/008; SHABBIR A, 1994, J FLUID MECH, V275, P1, DOI 10.1017/S0022112094002260; Hori T, 2004, MEAS SCI TECHNOL, V15, P1067, DOI 10.1088/0957-0233/15/6/005; Fujisawa N, 2005, EXP FLUIDS, V38, P291, DOI 10.1007/s00348-004-0891-2; Graftieaux L, 2001, MEAS SCI TECHNOL, V12, P1422, DOI 10.1088/0957-0233/12/9/307; Chakraborty P, 2005, J FLUID MECH, V535, P189, DOI 10.1017/S0022112005004726; Shim YM, 2013, EXP THERM FLUID SCI, V51, P37, DOI 10.1016/j.expthermflusci.2013.06.014; Cholemari MR, 2005, INT J HEAT MASS TRAN, V48, P4467, DOI 10.1016/j.ijheatmasstransfer.2005.04.025; Funatani S, 2002, MEAS SCI TECHNOL, V13, P1197, DOI 10.1088/0957-0233/13/8/306; Fujisawa N, 2008, J VISUAL-JAPAN, V11, P247; SIROVICH L, 1987, Q APPL MATH, V45, P561; van Oudheusden BW, 2005, EXP FLUIDS, V39, P86, DOI 10.1007/s00348-005-0985-5; Bernero S, 2000, EXP FLUIDS, V29, pS274, DOI 10.1007/s003480070029; Burgmann S, 2008, EXP FLUIDS, V44, P609, DOI 10.1007/s00348-007-0421-0; Chen CJ, 1980, VERTICAL TURBULENT B; Dehmani L, 1996, INT J HEAT FLUID FL, V17, P452, DOI 10.1016/0142-727X(96)00050-1; EPSTEIN M, 1988, J HEAT TRANS-T ASME, V110, P885; Gono T, 2012, J VISUAL-JAPAN, V15, P231, DOI 10.1007/s12650-012-0129-y; Maeda A., 2012, J VIS, V15, P67; Murota A., 1989, J JAPAN SOC CIVIL EN, V405, P79; Pham MW, 2005, J HEAT TRANS-T ASME, V127, P624, DOI 10.1115/1.186375; Prourde F., 2008, J FLUID MECH, V604, P99; Raffel M., 1998, PARTICLE IMAGE VELOC, P174; Syuto T, 2010, J VISUAL-JAPAN, V13, P203, DOI 10.1007/s12650-010-0027-0; Ungate CD, 1975, 75014 MITEL; Watanabe Y, 2005, J VISUAL-JAPAN, V8, P293; Zhou X., 2004, J TURBUL, V5, P1, DOI 10.1088/1468-5248/5/1/028	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0142-727X	1879-2278		INT J HEAT FLUID FL	Int. J. Heat Fluid Flow	APR	2015	52						98	110		10.1016/j.ijheatfluidflow.2014.12.003		13	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CF6IZ	WOS:000352661700010		
J	Shen, XZ; Hibiki, T; Nakamura, H				Shen, Xiuzhong; Hibiki, Takashi; Nakamura, Hideo			Bubbly-to-cap bubbly flow transition in a long-26 m vertical large diameter pipe at low liquid flow rate	INTERNATIONAL JOURNAL OF HEAT AND FLUID FLOW			English	Article						Long vertical large diameter pipe; Low liquid flow rate; Local void fraction measurement; N-shaped axial void fraction change; Flow regime transition from bubbly to cap bubbly flow; Evaluation of drift flux correlations	MULTIDIMENSIONAL 2-PHASE FLOW; DRIFT-FLUX MODEL; 4-SENSOR PROBE; PHASE DISTRIBUTION; HOLDUP; PATTERN; TUBES	The concurrent upward two-phase flow of air and water in a long vertical large diameter pipe with an inner diameter (D) of 200 mm and a height (z) of 26 m (z/D = 130) was investigated experimentally at low superficial liquid velocities from 0.05009 to 0.3121 m/s and the superficial gas velocities from 0.01779 to 0.5069 m/s. The resultant void fractions range from 0.03579 to 0.4059. According to the observations using a high speed video camera, the flow regimes of bubbly, developing cap bubbly and fully-developed cap bubbly flows prevailed in the flows. The developing cap bubbly flow appeared as a flow regime transition from bubbly to fully-developed cap bubble flow in the vertical large diameter pipe. The developing cap bubbly flow changes gradually and lasts for a long time period and a wide axial region in the flow direction, in contrast to a sudden transition from bubbly to slug flows in a small diameter pipe. The analysis in this study showed that the flow regime transition depends not only on the void fraction but also on the axial distance in the flow and the pipe diameter. The axial flow development brings about the transition to happen in a lower void fraction flow and the increase of pipe diameter causes the transition to happen in a higher void fraction flow. The measured void fraction showed an N-shaped axial changing manner that the void fraction increases monotonously with axial position in the bubbly flow, decreases non-monotonously with axial position in the developing cap bubbly flow, and increases monotonously again with axial position in the fully-developed cap bubbly flow. The temporary void fraction decrease phenomenon in the transition region from bubbly to cap bubbly flow can be attributed to the formation of medium to large cap bubbles and their gradual growth into the maximum size of cap bubble and/or cluster of large cap bubbles in the developing cap bubbly flow. In order to predict the N-shaped axial void fraction changing behaviors in the flow regime transition from bubbly to cap bubbly flow, the existing 12 drift flux correlation sets for large diameter pipes are reviewed and their predictabilities are studied against the present experimental data. Although some drift flux correlation sets, such as those of Clark and Flemmer (1986) and Hibiki and Ishii (2003), can predict the present experimental data with reasonable average relative deviations, no drift flux correlation set for distribution parameter and drift velocity can give a reliable prediction for the observed N-shaped axial void fraction changing behaviors in the region from bubbly to cap bubbly flow in a vertical large diameter pipe. (C) 2015 Elsevier Inc. All rights reserved.	[Shen, Xiuzhong] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Hibiki, Takashi] Purdue Univ, Sch Nucl Engn, W Lafayette, IN 47907 USA; [Nakamura, Hideo] Japan Atom Energy Agcy, Nucl Safety Res Ctr, Tokai, Ibaraki 3191195, Japan	Shen, XZ (reprint author), Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan.	xzshen@rri.kyoto-u.ac.jp			Kansai Atomic Society (Kangenkon) of Japan	The authors would like to express their sincere appreciation to Kansai Atomic Society (Kangenkon) of Japan for the financial support in this study.	Ohnuki A, 2000, INT J MULTIPHAS FLOW, V26, P367, DOI 10.1016/S0301-9322(99)00024-5; Shen XZ, 2005, INT J HEAT MASS TRAN, V48, P211, DOI 10.1016/j.ijheatmasstransfer.2004.06.034; Shen XZ, 2012, INT J HEAT FLUID FL, V34, P70, DOI 10.1016/j.ijheatfluidflow.2012.02.004; Prasser HM, 2007, NUCL ENG DES, V237, P1848, DOI 10.1016/j.nucengdes.2007.02.018; Shawkat ME, 2008, INT J MULTIPHAS FLOW, V34, P767, DOI 10.1016/j.ijmultiphaseflow.2008.01.007; CHISHOLM D, 1967, INT J HEAT MASS TRAN, V10, P1767, DOI 10.1016/0017-9310(67)90047-6; Omebere-Iyari NK, 2008, INT J MULTIPHAS FLOW, V34, P461, DOI 10.1016/j.ijmultiphaseflow.2007.11.001; Shen X, 2008, INT J HEAT MASS TRAN, V51, P882, DOI 10.1016/j.ijheatmasstransfer.2006.01.054; TAITEL Y, 1980, AICHE J, V26, P345, DOI 10.1002/aic.690260304; Bruun H.H., 1995, HOT WIRE ANEMOMETRY, P1; Chen K., 2001, BOILER TECHNOL, V32, P1; Chexal B., 1991, NSAC139 EL POW RES I; CLARK N, 1986, INT J MULTIPHAS FLOW, V12, P299, DOI 10.1016/0301-9322(86)90032-7; CLARK NN, 1985, AICHE J, V31, P500, DOI 10.1002/aic.690310323; CUNNINGH.JP, 1973, T AM NUCL SOC, V17, P369; Dukler A.E., 1977, NUREG0163; Hibiki T, 2000, NUCL ENG DES, V195, P69, DOI 10.1016/S0029-5493(99)00176-4; Hibiki T, 2003, INT J HEAT MASS TRAN, V46, P1773, DOI 10.1016/S0017-9310(02)00473-8; Hills J.H, 1976, CHEM ENG J, V12, P89, DOI 10.1016/0300-9467(76)87002-5; Hirao Y., 1986, P 2 INT TOP M NUCL P, p[1, 1]; Ishii M., 1977, ANL7747; Ishii M., 1975, THERMOFLUID DYNAMIC; Ishii M., 1985, P ASME WINT ANN M FE, P99; KATAOKA I, 1987, INT J HEAT MASS TRAN, V30, P1927; MISHIMA K, 1984, INT J HEAT MASS TRAN, V27, P723; MURASE M, 1986, J NUCL SCI TECHNOL, V23, P487, DOI 10.3327/jnst.23.487; Prasser HM, 2005, NUCL TECHNOL, V152, P3; Schlegel JP, 2009, NUCL ENG DES, V239, P2864, DOI 10.1016/j.nucengdes.2009.08.004; Shen X., 2014, FRONTIERS PROGR MULT, P55; Shen X., 2010, JPN J MULTIPHASE FLO, V23, P605; Shen X., 2011, JPN J MULTIPHASE FLO, V24, P595; Shen XZ, 2005, INT J MULTIPHAS FLOW, V31, P593, DOI 10.1016/j.ijmultiphaseflow.2005.02.003; Shen XZ, 2013, INT J HEAT MASS TRAN, V67, P843, DOI 10.1016/j.ijheatmasstransfer.2013.08.064; Shen XZ, 2002, NUCL ENG DES, V217, P103, DOI 10.1016/S0029-5493(02)00154-1; Shen XZ, 2008, INT J MULTIPHAS FLOW, V34, P502, DOI 10.1016/j.ijmultiphaseflow.2007.11.006; Shen XZ, 2012, INT J HEAT FLUID FL, V36, P72, DOI 10.1016/j.ijheatfluidflow.2012.04.007; SHIPLEY DG, 1984, CHEM ENG SCI, V39, P163, DOI 10.1016/0009-2509(84)80143-8; Sun XD, 2002, EXP THERM FLUID SCI, V27, P97, DOI 10.1016/S0894-1777(02)00220-0; YU Pingan, 2002, NUCL REACTOR THERMAL; ZUBER N, 1965, J HEAT TRANSF, V87, P453	40	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0142-727X	1879-2278		INT J HEAT FLUID FL	Int. J. Heat Fluid Flow	APR	2015	52						140	155		10.1016/j.ijheatfluidflow.2015.01.001		16	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CF6IZ	WOS:000352661700013		
J	Tamura, T				Tamura, Tomohiko			Guest editorial: Transcriptional control in myeloid cell development and related diseases	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Editorial Material									Yokohama City Univ, Grad Sch Med, Dept Immunol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Tamura, T (reprint author), Yokohama City Univ, Grad Sch Med, Dept Immunol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	tamurat@yokohama-cu.ac.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					317	318		10.1007/s12185-015-1770-8		2	Hematology	Hematology	CF3WR	WOS:000352480200002		
J	Tamura, T; Kurotaki, D; Koizumi, S				Tamura, Tomohiko; Kurotaki, Daisuke; Koizumi, Shin-ichi			Regulation of myelopoiesis by the transcription factor IRF8	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Myeloid cell development; Transcription factor; IRF8; Chromatin; Leukemia	SEQUENCE-BINDING-PROTEIN; DENDRITIC CELL-DEVELOPMENT; CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; TUMOR-SUPPRESSOR GENE; PROGENITOR CELLS; BCR-ABL; HEMATOPOIETIC PROGENITORS; MONOCYTE DIFFERENTIATION; LINEAGE COMMITMENT	Interferon regulatory factor-8 (IRF8) is a transcription factor expressed in hematopoietic cells, particularly in mononuclear phagocytes [monocytes/macrophages and dendritic cells (DCs)] and their progenitors. Various studies have demonstrated that IRF8 is essential for the development of monocytes, DCs, eosinophils, and basophils. Conversely, IRF8 suppresses the generation of neutrophils. Accordingly, Irf8 (-/-) mice develop immunodeficiency and a chronic myeloid leukemia (CML)-like disease. Mutations and loss of expression of the human IRF8 gene are also associated with immunodeficiency and CML, respectively. Recent findings have begun to reveal the transcription factor network and epigenetic changes governed by IRF8. For example, in mononuclear phagocyte progenitors, IRF8 cooperates with PU.1 to promote the formation of promoter-distal enhancers to induce monocyte-related genes including the critical downstream transcription factor gene Klf4. On the other hand, IRF8 blocks C/EBP alpha activity to suppress the neutrophil differentiation program. Indeed, Irf8 (-/-) mononuclear phagocyte progenitors fail to efficiently generate monocytes and DCs and, instead, aberrantly give rise to neutrophils. This article provides an overview of recent advances in our understanding of the role of IRF8 in myelopoiesis and related diseases.	[Tamura, Tomohiko; Kurotaki, Daisuke; Koizumi, Shin-ichi] Yokohama City Univ, Grad Sch Med, Dept Immunol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Tamura, T (reprint author), Yokohama City Univ, Grad Sch Med, Dept Immunol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	tamurat@yokohama-cu.ac.jp			Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT)	We thank Dr. Keiko Ozato for invaluable discussions and suggestions. This work was supported by Grants-in-Aids (KAKENHI) from the Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT). S. K. is a JSPS postdoctoral fellow.	Franco CB, 2010, CELL STEM CELL, V6, P361, DOI 10.1016/j.stem.2010.02.013; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Deng M, 2001, BLOOD, V97, P3491, DOI 10.1182/blood.V97.11.3491; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Chopin M, 2013, J EXP MED, V210, P2967, DOI 10.1084/jem.20130930; Mohty M, 2002, BRIT J HAEMATOL, V119, P115, DOI 10.1046/j.1365-2141.2002.03831.x; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Scheller M, 2013, J EXP MED, V210, P2239, DOI 10.1084/jem.20130706; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Masuda T, 2012, CELL REPORTS, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tamura T, 2003, BLOOD, V102, P4547, DOI 10.1182/blood-2003-01-0291; Alder JK, 2008, J IMMUNOL, V180, P5645; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Vidovic K, 2010, LEUKEMIA, V24, P992, DOI 10.1038/leu.2010.33; Waight JD, 2014, J BIOL CHEM, V289, P15642, DOI 10.1074/jbc.M113.544320; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Tsujimura H, 2003, J IMMUNOL, V170, P1131; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schmidt M, 2004, BLOOD, V103, P4142, DOI 10.1182/blood-2003-01-0285; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Tamura T, 2005, J IMMUNOL, V174, P2573; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Boissel N, 2004, LEUKEMIA, V18, P1656, DOI 10.1038/sj.leu.2403474; Bornstein C, 2014, MOL CELL, V56, P749, DOI 10.1016/j.molcel.2014.10.014; Cohen SB, 2015, J IMMUNOL, V194, P210, DOI 10.4049/jimmunol.1402453; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Gurevich RM, 2006, EXP HEMATOL, V34, P1192, DOI 10.1016/j.exphem.2006.04.020; Hara T, 2008, ONCOGENE, V27, P3865, DOI 10.1038/sj.onc.1211043; Jaiswal H, 2013, J IMMUNOL, V191, P5993, DOI 10.4049/jimmunol.1203541; KANNO Y, 1993, MOL CELL BIOL, V13, P3951; Kurotaki D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5978; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Milanovic M, 2008, J IMMUNOL, V181, P5045; Nardi V, 2009, BLOOD, V113, P3813, DOI 10.1182/blood-2008-07-167189; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Qi XP, 2013, IMMUNITY, V39, P97, DOI 10.1016/j.immuni.2013.06.012; Sasaki H, 2015, BLOOD, V125, P358, DOI 10.1182/blood-2014-02-557983; Scheller M, 1999, BLOOD, V94, P3764; Schmidt M, 1998, BLOOD, V91, P22; Shimokawa N, 2010, IMMUNOGENETICS, V62, P421, DOI 10.1007/s00251-010-0444-1; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tsujimura H, 2002, J IMMUNOL, V169, P1261; Watanabe T, 2013, CANCER RES, V73, P6642, DOI 10.1158/0008-5472.CAN-13-0802; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812	76	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					342	351		10.1007/s12185-015-1761-9		10	Hematology	Hematology	CF3WR	WOS:000352480200005		
J	Yokoyama, A				Yokoyama, Akihiko			Molecular mechanisms of MLL-associated leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						MLL; Leukemia; Cellular memory; Transcription; Epigenetics	PROTO-ONCOPROTEIN MLL; HISTONE METHYLTRANSFERASE COMPLEX; HOX GENE-EXPRESSION; FUSION PROTEINS; H3K79 METHYLATION; PWWP DOMAIN; MLL-AF9-INDUCED LEUKEMOGENESIS; TRANSCRIPTION ELONGATION; DROSOPHILA-TRITHORAX; MYELOID PROGENITORS	Gene rearrangements of the mixed lineage leukemia (MLL) gene cause aggressive leukemia. The fusion of MLL and its partner genes generates various MLL fusion genes, and their gene products trigger aberrant self-renewal of hematopoietic progenitors leading to leukemia. Since the identification of the MLL gene two decades ago, a substantial amount of information has been obtained regarding the mechanisms by which MLL mutations cause leukemia. Wild-type MLL maintains the expression of Homeobox (HOX) genes during development. MLL activates the expression of posterior HOX-A genes in the hematopoietic lineage to stimulate the expansion of immature progenitors. MLL fusion proteins constitutively activate the HOX genes, causing aberrant self-renewal. The modes of transcriptional activation vary depending on the fusion partners and can be categorized into at least four groups. Here I review the recent progress in research related to the molecular mechanisms of MLL fusion-dependent leukemogenesis.	Kyoto Univ, Grad Sch Med, Lab Malignancy Control Res, Kyoto 6068501, Japan	Yokoyama, A (reprint author), Kyoto Univ, Grad Sch Med, Lab Malignancy Control Res, Kyoto 6068501, Japan.	yokoyama@dsk.med.kyoto-u.ac.jp			JSPS KAKENNHI [25670450]	I thank lab members Hiroshi Okuda and Boban Stanojevic for commenting on the manuscript. This work was supported by a JSPS KAKENNHI grant to A.Y. (25670450).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Yokoyama A, 2011, J CELL SCI, V124, P2208, DOI 10.1242/jcs.080523; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Deshpande AJ, 2013, BLOOD, V121, P2533, DOI 10.1182/blood-2012-11-465120; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Okuda H, 2014, NUCLEIC ACIDS RES, V42, P4241, DOI 10.1093/nar/gkt1394; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Chen L, 2013, LEUKEMIA, V27, P813, DOI 10.1038/leu.2012.327; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Wang KC, 2009, TRENDS CELL BIOL, V19, P268, DOI 10.1016/j.tcb.2009.03.007; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Lukasik SM, 2006, PROTEIN SCI, V15, P314, DOI 10.1110/ps.051751706; Slany RK, 1998, MOL CELL BIOL, V18, P122; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yagi H, 1998, BLOOD, V92, P108; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Martin ME, 2003, CANCER CELL, V4, P197, DOI 10.1016/S1535-6108(03)00214-9; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Lavau C, 2000, EMBO J, V19, P4655, DOI 10.1093/emboj/19.17.4655; Grembecka J, 2012, NAT CHEM BIOL, V8, P277, DOI [10.1038/nchembio.773, 10.1038/NCHEMBIO.773]; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Artinger EL, 2013, CELL CYCLE, V12, P2969, DOI 10.4161/cc.26032; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; BREEN TR, 1993, DEVELOPMENT, V117, P119; Deshpande AJ, 2014, CANCER CELL, V26, P896, DOI 10.1016/j.ccell.2014.10.009; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Dobson CL, 1999, EMBO J, V18, P3564, DOI 10.1093/emboj/18.13.3564; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Eguchi M, 2004, BLOOD, V103, P3876, DOI 10.1182/blood-2003-11-3817; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; La P, 2004, J BIOL CHEM, V279, P49045, DOI 10.1074/jbc.M409358200; Li BE, 2014, EXP HEMATOL, V42, P995, DOI 10.1016/j.exphem.2014.09.006; Liedtke M, 2010, BLOOD, V116, P63, DOI 10.1182/blood-2009-09-243386; Maethner E, 2013, CELL REP, V3, P1553, DOI 10.1016/j.celrep.2013.03.038; Metzler M, 2006, ONCOGENE, V25, P3093, DOI 10.1038/sj.onc.1209636; Mishra BP, 2014, CELL REP, V7, P1239, DOI 10.1016/j.celrep.2014.04.015; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Ono R, 2005, J CLIN INVEST, V115, P919, DOI 10.1172/JCI200522725; SEDKOV Y, 1994, DEVELOPMENT, V120, P1907; So CW, 2002, MOL CELL BIOL, V22, P6542, DOI 10.1128/MCB.22.18.6542-6552.2002; So CW, 2004, BLOOD, V104, P919, DOI 10.1182/blood-2004-03-0992; Tan JY, 2011, CANCER CELL, V20, P563, DOI 10.1016/j.ccr.2011.09.008; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; Yokoyama A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073649	95	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					352	361		10.1007/s12185-015-1774-4		10	Hematology	Hematology	CF3WR	WOS:000352480200006		
J	Yoshioka, A; Ishii, E; Ueno, T; Usami, I; Kobayashi, M; Kobayashi, R; Sotomatsu, M; Shirahata, A; Suzuki, T; Taki, M; Ishida, Y; Matsushita, T; Shima, M; Nogami, K; Sakai, M; Kigasawa, H; Fukutake, K				Yoshioka, Akira; Ishii, Eizaburo; Ueno, Tamaki; Usami, Ikuya; Kobayashi, Masao; Kobayashi, Ryoji; Sotomatsu, Manabu; Shirahata, Akira; Suzuki, Takashi; Taki, Masashi; Ishida, Yasushi; Matsushita, Tadashi; Shima, Midori; Nogami, Keiji; Sakai, Michio; Kigasawa, Hisato; Fukutake, Katsuyuki			The International Immune Tolerance Induction Study and its follow-up study on Japanese hemophilia A patients with inhibitors	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Hemophilia A; Inhibitor; Immune tolerance induction (ITI); International Immune Tolerance Induction (I-ITI) Study; Follow-up study		The International Immune Tolerance Induction (I-ITI) Study in hemophilia A patients with inhibitors included 16 Japanese patients among a total of 115 test subjects. The results within this group of Japanese patients were 11 cases of I-ITI off-study, three cases of I-ITI on-study, and two cases of tolerance on prophylaxis. There was no significant difference in success rate between the low-dose and high-dose groups (Study I). Successively, independent follow-up survey in Japan was conducted in 14 cases, with consent (Study II). Ten cases were off-study at the end of the I-ITI Study. Of these 10 cases, seven of seven successful cases remained clinical successes at the end of the follow-up study, one partial success became a full success while a second relapsed, and one failure was subsequently evaluated as a partial success. Four cases that were on-study at the end of I-ITI Study were classified as three successes and one failure at the end of the follow-up study. As a result, the status at the end of follow-up study was: 11 ITI successes (78.6 %); one partial success; one failure; and one relapse. Thus, the ITI follow-up study was helpful in providing a long-term prognostic determination of inhibitors.	[Yoshioka, Akira] Nara Med Univ, Kashihara, Nara 6348521, Japan; [Ishii, Eizaburo] Nagano Prefectural Suzaka Hosp, Div Hematol Oncol, Nagano, Japan; [Ueno, Tamaki] Ayabe City Hosp, Div Pediat, Ayabe, Kyoto, Japan; [Usami, Ikuya] Hyogo Prefectural Tsukaguchi Hosp, Div Pediat, Amagasaki, Hyogo, Japan; [Kobayashi, Masao] Hiroshima Univ, Sch Med, Dept Pediat, Hiroshima, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Div Pediat, Sapporo, Hokkaido, Japan; [Sotomatsu, Manabu] Gunma Childrens Med Ctr, Div Hematol Oncol, Gunma, Japan; [Shirahata, Akira] Kitakyushu Yahata Higashi Hosp, Kitakyushu, Fukuoka, Japan; [Suzuki, Takashi; Fukutake, Katsuyuki] Tokyo Med Univ, Dept Clin Lab Med, Tokyo 1608402, Japan; [Taki, Masashi] St Marianna Univ, Sch Med, Yokohama City Seibu Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Ishida, Yasushi] Ehime Prefectural Cent Hosp, Div Pediat, Matsuyama, Ehime, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Div Blood Transfus, Nagoya, Aichi, Japan; [Shima, Midori; Nogami, Keiji] Nara Med Univ, Dept Pediat, Kashihara, Nara 634, Japan; [Sakai, Michio] Univ Occupat & Environm Hlth, Dept Pediat, Kitakyushu, Fukuoka 807, Japan; [Kigasawa, Hisato] Kanagawa Childrens Med Ctr, Div Hematol Oncol, Yokohama, Kanagawa, Japan	Yoshioka, A (reprint author), Nara Med Univ, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	ks840@naramed-u.ac.jp			Blood Products Research Organization, Japan	The authors thank the Blood Products Research Organization, Japan, for its financial support of the domestic follow-up study and Mrs. Michiyo Goto (NICP) and Miss Nari Hashimoto (Nara Medical University) for their assistance in preparing the manuscript.	Hay CRM, 2012, BLOOD, V119, P1335, DOI 10.1182/blood-2011-08-369132; Astermark J, 2006, HAEMOPHILIA, V12, P363, DOI 10.1111/j.1365-2516.2006.01296.x; Astermark J, 2010, TXB HEMOPHILIA, P57, DOI 10.1002/9781444318555.ch8; DiMichele D., 2000, Haematologica, V85, P40; DiMichele DM, 2006, J THROMB HAEMOST, V4, P2271, DOI 10.1111/j.1538-7836.2006.02127.x	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					362	368		10.1007/s12185-015-1734-z		7	Hematology	Hematology	CF3WR	WOS:000352480200007		
J	Sakuragi, M; Hayashi, S; Maruyama, M; Kabutomori, O; Kiyokawa, T; Nagamine, K; Kato, H; Kashiwagi, H; Kanakura, Y; Tomiyama, Y				Sakuragi, Mikiko; Hayashi, Satoru; Maruyama, Miho; Kabutomori, Osamu; Kiyokawa, Tomoko; Nagamine, Keisuke; Kato, Hisashi; Kashiwagi, Hirokazu; Kanakura, Yuzuru; Tomiyama, Yoshiaki			Clinical significance of IPF% or RP% measurement in distinguishing primary immune thrombocytopenia from aplastic thrombocytopenic disorders	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Immune thrombocytopenia; Reticulated platelets; Differential diagnosis; Paroxysmal nocturnal hemoglobinuria; Thrombopoietin	RETICULATED PLATELETS; THROMBOPOIETIN LEVELS; DIAGNOSTIC-CRITERIA; PURPURA; ASSAY	The diagnosis of primary immune thrombocytopenia (ITP) is based on differential diagnosis. Although the measurement of percentages of reticulated platelets (RP%) by flow cytometry is useful as a supportive diagnostic test, this method is nonetheless a time-consuming, laboratory-based assay. To identify alternative assays that are useful in daily practice, we compared three methods in parallel, IPF% measured by XE-2100 [IPF% (XE), Sysmex Corp.], IPF% measured by new XN-1000 [IPF% (XN)], and RP%. We examined 47 patients with primary ITP, 28 patients with aplastic thrombocytopenia (18 aplastic anemia and 10 chemotherapy-induced thrombocytopenia) and 80 healthy controls. In a selected experiment, we examined 16 patients with paroxysmal nocturnal hemoglobinuria (PNH) to examine the effect of hemolysis. As compared with IPF% (XE), IPF% (XN) showed better within-run reproducibility. The sensitivity and specificity for the diagnosis of ITP were 83.0 and 75.0 % for IPF% (XE), 85.1 and 89.3 % for IPF% (XN), and 93.6 and 89.3 % for RP%, respectively. Examination of PNH patients revealed that hemolysis and/or red blood cell fragments interfered with IPF% (XE) values, but not with IFP % (XN) values. Our results suggest that IPF% measured by XN-1000 may be of comparable value with RP% as a supportive diagnostic test for ITP.	[Sakuragi, Mikiko; Hayashi, Satoru; Kiyokawa, Tomoko; Nagamine, Keisuke; Kato, Hisashi; Tomiyama, Yoshiaki] Osaka Univ Hosp, Dept Blood Transfus, Suita, Osaka 5650871, Japan; [Maruyama, Miho; Kabutomori, Osamu] Osaka Univ Hosp, Lab Clin Invest, Suita, Osaka, Japan; [Kato, Hisashi; Kashiwagi, Hirokazu; Kanakura, Yuzuru; Tomiyama, Yoshiaki] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka, Japan	Tomiyama, Y (reprint author), Osaka Univ Hosp, Dept Blood Transfus, Suita, Osaka 5650871, Japan.	yoshi@hp-blood.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan; Ministry of Health, Labor and Welfare in Japan	This work was supported by Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan and the Ministry of Health, Labor and Welfare in Japan.	Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Brighton TA, 1996, BLOOD, V88, P194; McMillan R, 2007, SEMIN HEMATOL, V44, pS3, DOI 10.1053/j.seminhematol.2007.11.002; Tanaka Y, 2014, J CLIN LAB ANAL, V28, P341, DOI 10.1002/jcla.21691; KIENAST J, 1990, BLOOD, V75, P116; Barsam SJ, 2011, BLOOD, V117, P5723, DOI 10.1182/blood-2010-11-321398; Emmons RVB, 1996, BLOOD, V87, P4068; Zhang L, 2012, J EXP MED, V209, P2165, DOI 10.1084/jem.20121090; Kurata Y, 2001, AM J CLIN PATHOL, V115, P656; Kashiwagi H, 2013, INT J HEMATOL, V98, P24, DOI 10.1007/s12185-013-1370-4; Kosugi S, 1996, BRIT J HAEMATOL, V93, P704, DOI 10.1046/j.1365-2141.1996.d01-1702.x; Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; Hayashi Satoru, 2009, Rinsho Byori, V57, P1039; HEIMPEL H, 1987, BLOOD, V70, P1718; Kuwana M, 2006, J THROMB HAEMOST, V4, P1936, DOI 10.1111/j.1538-7836.2006.02091.x; McMillan R, 2003, J THROMB HAEMOST, V1, P485, DOI 10.1046/j.1538-7836.2003.00091.x; RICHARDS EM, 1995, BRIT J HAEMATOL, V91, P445, DOI 10.1111/j.1365-2141.1995.tb05320.x; Tomiyama Y, 2005, INT J HEMATOL, V81, P100, DOI 10.1532/IJH97.04193; van der Linden N, 2014, EUR J HAEMATOL, V93, P150, DOI 10.1111/ejh.12319	20	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					369	375		10.1007/s12185-015-1741-0		7	Hematology	Hematology	CF3WR	WOS:000352480200008		
J	Nasu, R; Nannya, Y; Kurokawa, M				Nasu, R.; Nannya, Y.; Kurokawa, M.			A randomized controlled study evaluating the efficacy of aprepitant for highly/moderately emetogenic chemotherapies in hematological malignancies	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Anti-emetics; Chemotherapy; CINV; Hematological oncology; NK1 receptor antagonist; Supportive therapy	ORAL NEUROKININ-1 ANTAGONIST; STEM-CELL TRANSPLANTATION; HIGH-DOSE MELPHALAN; INDUCED NAUSEA; DOUBLE-BLIND; RECEPTOR-ANTAGONIST; PLUS DEXAMETHASONE; CLINICAL-TRIALS; DELAYED EMESIS; OVARIAN-CANCER	Chemotherapy-induced nausea and vomiting (CINV) is a serious complication of treatments of hematological malignancies. Although aprepitant, an NK1 receptor antagonist, has been shown to control CINV in highly emetogenic therapies for solid tumors, the antiemetic effect of this agent in hematological chemotherapies is not well established. In this randomized controlled trial, we examined the additional effect of aprepitant in combination with conventional 5HT3 blocker-based prophylaxis for CINV in highly or moderately emetic chemotherapies for hematological malignancies (n = 41). The complete response rate, defined as no emetic episodes and no salvage treatments, was significantly higher in the aprepitant arm than the control arm (82 versus 47 %, p = 0.026), with no increase in severe adverse effects. However, the difference of nausea, measured with visual analog scale, and of oral intake impairment was moderate, which suggests insufficiency of blocking NK receptor for these events. Furthermore, sub-group analysis revealed that merit of aprepitant addition depends on treatment regimens. Our results indicate the overall advantage of applying aprepitant in the control of CINV in hematological malignancies and the need for further refinement of anti-CINV strategies, including stratification according to regimen.	[Nasu, R.; Nannya, Y.; Kurokawa, M.] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan; [Kurokawa, M.] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat Med, Tokyo 113, Japan	Kurokawa, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; SIMON R, 1985, CANCER TREAT REP, V69, P1375; Campos D, 2001, J CLIN ONCOL, V19, P1759; Shults J, 2009, STAT MED, V28, P2338, DOI 10.1002/sim.3622; Herrstedt J, 2008, NAT CLIN PRACT ONCOL, V5, P32, DOI 10.1038/ncponc1021; Mizukami N, 2014, J PAIN SYMPTOM MANAG, V47, P542, DOI 10.1016/j.jpainsymman.2013.05.003; Gralla RJ, 2005, CANCER, V104, P864, DOI 10.1002/cncr.21222; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Sun CC, 2005, SUPPORT CARE CANCER, V13, P219, DOI 10.1007/s00520-004-0710-6; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Aapro M, 2010, ANN ONCOL, V21, P1083, DOI 10.1093/annonc/mdp584; Roila F, 2010, ANN ONCOL, V21, pv232, DOI 10.1093/annonc/mdq194; Albany C, 2012, J CLIN ONCOL, V30, P3998, DOI 10.1200/JCO.2011.39.5558; dos Santos LV, 2012, JNCI-J NATL CANCER I, V104, P1280, DOI 10.1093/jnci/djs335; Warr DG, 2005, EUR J CANCER, V41, P1278, DOI 10.1016/j.ejca.2005.01.024; Sakurai M, 2014, INT J HEMATOL, V99, P457, DOI 10.1007/s12185-014-1538-6; Warr DG, 2005, J CLIN ONCOL, V23, P2822; Bubalo JS, 2012, J CLIN PHARMACOL, V52, P586, DOI 10.1177/0091270011398243; Choi CH, 2014, SUPPORT CARE CANCER, V22, P1181, DOI 10.1007/s00520-013-2070-6; Egerer G, 2010, BRIT J CLIN PHARMACO, V70, P903, DOI 10.1111/j.1365-2125.2010.03792.x; Gralla RJ, 1996, ONCOLOGY, V53, P86; Hargreaves R, 2011, ANN NY ACAD SCI, V1222, P40, DOI 10.1111/j.1749-6632.2011.05961.x; Hesketh PJ, 2008, NEW ENGL J MED, V358, P2482, DOI 10.1056/NEJMra0706547; Jordan K, 2011, BONE MARROW TRANSPL, V46, P784, DOI 10.1038/bmt.2010.205; Massaro AM, 2005, ANN PHARMACOTHER, V39, P77, DOI 10.1345/aph.1E242; MOHER D, 1984, CANCER TREAT REV, V11, P257, DOI 10.1016/0305-7372(84)90011-2; National comprehensive cancer network (NCCN), 2013, NCCN CLIN PRACT GUID, pAE7; Navari Rudolph M, 2011, J Support Oncol, V9, P188, DOI 10.1016/j.suponc.2011.05.002; Olver I, 1996, ANN ONCOL, V7, P945; Rubinsky Melissa D, 2012, Dimens Crit Care Nurs, V31, P267, DOI 10.1097/DCC.0b013e3182619944; Stiff PJ, 2013, BIOL BLOOD MARROW TR, V19, pe1; Uchida M, 2013, PHARMACOTHERAPY, V33, P893, DOI 10.1002/phar.1294; Ueda K, 2010, J CHEMOTHERAPY, V22, P54; Vig S, 2014, J CANCER RES CLIN, V140, P77, DOI 10.1007/s00432-013-1540-z	34	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					376	385		10.1007/s12185-015-1735-y		10	Hematology	Hematology	CF3WR	WOS:000352480200009		
J	Amakishi, E; Irie, Y; Nishizawa, K; Kamada, H; Nakajima, F; Matsuyama, N; Ishii, H; Matsukura, H; Yasui, K; Hirayama, F				Amakishi, Etsuko; Irie, Yoriko; Nishizawa, Kanae; Kamada, Hiromi; Nakajima, Fumiaki; Matsuyama, Nobuki; Ishii, Hiroyuki; Matsukura, Harumichi; Yasui, Kazuta; Hirayama, Fumiya			Evaluation of HNA-expressing cell line-based antigen capture systems and a solid-phase system for detecting HNA-1a antibodies	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						HNA-1a antibody; Panel cell line; MAIGA	FLOW-CYTOMETRIC ANALYSIS; NEUTROPHIL; ASSAY; ESTABLISHMENT; PANEL	Granulocyte immunofluorescence and granulocyte agglutination tests are standard methods for detecting human neutrophil antigen (HNA) antibodies (Abs); however, these require a typed panel of neutrophils, which can be time-consuming to develop, and it remains difficult to determine antibody specificity in some cases. We established and evaluated four detection systems for HNA-1a Abs based on an HNA-1a-expressing cell line (KY cells) and antigen capture. We additionally evaluated a commercial solid-phase system. Eleven HNA-1a antibody-positive samples, including the World Health Organization Reference Reagent, and 40 serum samples derived from male blood donors were used as positive and negative control samples, respectively. Although specificity was > 0.90 in all systems evaluated, the sensitivity varied among the systems. The KY cell-based monoclonal antibody specific immobilisation of granulocyte antigens (KY-MAIGA) system using certain, but not all, monoclonal Abs, and the solid-phase system revealed higher sensitivity than other systems. In conclusion, the KY-MAIGA and commercial solid-phase systems were superior in terms of specific and sensitive detection of HNA-1a Abs.	[Amakishi, Etsuko; Irie, Yoriko; Nishizawa, Kanae; Matsuyama, Nobuki; Ishii, Hiroyuki; Matsukura, Harumichi; Yasui, Kazuta; Hirayama, Fumiya] Japanese Red Cross Kinki Block Blood Ctr, Osaka 5670085, Japan; [Kamada, Hiromi; Nakajima, Fumiaki] Japanese Red Cross Soc, Cent Blood Inst, Tokyo, Japan	Hirayama, F (reprint author), Japanese Red Cross Kinki Block Blood Ctr, 7-5-17 Saitoasagi, Osaka 5670085, Japan.	f-hirayama@kk.bbc.jrc.or.jp					Allen D, 2005, VOX SANG, V89, P100, DOI 10.1111/j.1423-0410.2005.00669.x; Amakishi E, 2014, VOX SANG, V106, P368, DOI 10.1111/vox.12118; Moritz E, 2009, AN ACAD BRAS CIENC, V81, P559, DOI 10.1590/S0001-37652009000300019; Hayashi T, 2011, TRANSFUSION MED, V21, P199, DOI 10.1111/j.1365-3148.2010.01064.x; Bierling P, 2009, VOX SANG, V96, P266, DOI 10.1111/j.1423-0410.2008.01144.x; BUX J, 1993, TRANSFUSION MED, V3, P157, DOI 10.1111/j.1365-3148.1993.tb00055.x; Muschter S, 2011, CURR OPIN HEMATOL, V18, P452, DOI 10.1097/MOH.0b013e32834babdd; Bayat B, 2012, TRANSFUSION, V52, P613, DOI 10.1111/j.1537-2995.2011.03303.x; Bayat B, 2009, TRANSFUSION, V49, P1819, DOI 10.1111/j.1537-2995.2009.02229.x; Bruin MCA, 1999, BLOOD, V94, P1797; Bux J, 2002, INT J HEMATOL, V76, P399; Fromont P, 2010, TRANSFUSION, V50, P2643, DOI 10.1111/j.1537-2995.2010.02762.x; Fung YL, 2011, VOX SANG, V101, P282, DOI 10.1111/j.1423-0410.2011.01511.x; Hirayama F, 2013, VOX SANG, V105, P183, DOI 10.1111/vox.12057; Kanack AJ, 2012, TRANSFUSION, V52, P1112, DOI 10.1111/j.1537-2995.2011.03411.x; Lopez GH, 2012, VOX SANG, V102, P171, DOI 10.1111/j.1423-0410.2011.01532.x; Matsuyama N, 2006, TRANSFUSION MED, V16, P111, DOI 10.1111/j.1365-3148.2006.00642.x; Metcalfe P, 2013, VOX SANG, V104, P153, DOI 10.1111/j.1423-0410.2012.01647.x; Stroncek DF, 1996, TRANSFUSION, V36, P168, DOI 10.1046/j.1537-2995.1996.36296181931.x; Werth S, 2012, TRANSFUSION, V53, P193; Wozniak MJ, 2012, TRANSFUSION, V52, P1458, DOI 10.1111/j.1537-2995.2011.03490.x; Yasui K, 2008, TRANSFUSION, V48, P1037, DOI 10.1111/j.1537-2995.2008.01705.x; Yasui K, 2007, TRANSFUSION, V47, P478, DOI 10.1111/j.1537-2995.2006.01139.x	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					386	391		10.1007/s12185-015-1751-y		6	Hematology	Hematology	CF3WR	WOS:000352480200010		
J	Konuma, T; Kato, S; Ooi, J; Ebihara, Y; Mochizuki, S; Oiwa-Monna, M; Tojo, A; Takahashi, S				Konuma, Takaaki; Kato, Seiko; Ooi, Jun; Ebihara, Yasuhiro; Mochizuki, Shinji; Oiwa-Monna, Maki; Tojo, Arinobu; Takahashi, Satoshi			Third allogeneic stem cell transplantation (SCT) using unrelated cord blood for relapsed acute leukemia after second allogeneic SCT	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Third allogeneic stem cell transplantation; Cord blood transplantation; Acute myeloid leukemia; Acute lymphoblastic leukemia; Myelodysplastic syndrome	BONE-MARROW-TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; ADULT PATIENTS; DONOR	We analyzed the results of third allogeneic stem cell transplantation (SCT3) using single-unit unrelated cord blood (CB) in seven adult patients with relapsed acute leukemia after second allogeneic stem cell transplantation (SCT2). The median age at SCT 3 was 44 years (range 20-58 years). The patients had de novo acute myeloid leukemia (AML) (n = 4), secondary AML following myelodysplastic syndrome (n = 2), and acute lymphoblastic leukemia (n = 1). Four patients received myeloablative conditioning, and three received reduced-intensity conditioning. All but one patient had myeloid reconstitution with remission, but five patients relapsed even after SCT3. However, one patient is alive and disease-free 6 years after SCT3, which is the longest remission duration among three allogeneic SCTs she received. Furthermore, actual survival after relapse of SCT 2 was significantly better for patients who received SCT3 compared with institutional control patients who never received SCT3 (P < 0.001). These results suggest that the use of CB may allow the opportunity to perform SCT3 in patients who have experienced relapsed leukemia without donors, and SCT3 with CB may offer the chance of durable remission for selected patients with relapsed acute leukemia.	[Konuma, Takaaki; Kato, Seiko; Ebihara, Yasuhiro; Mochizuki, Shinji; Oiwa-Monna, Maki; Tojo, Arinobu; Takahashi, Satoshi] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, Tokyo 1088639, Japan; [Ooi, Jun] Teikyo Univ, Sch Med, Dept Hematol Oncol, Tokyo 173, Japan	Konuma, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tkonuma@ims.u-tokyo.ac.jp			Kobayashi Foundation	The authors thank all of the physicians and staff at the hospital in this study. This work was supported in part by grants from the Kobayashi Foundation.	Ooi J, 2009, BONE MARROW TRANSPL, V44, P661, DOI 10.1038/bmt.2009.282; Sumi M, 2012, INTERNAL MED, V51, P2943, DOI 10.2169/internalmedicine.51.7837; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Bosi A, 2001, J CLIN ONCOL, V19, P3675; Christopeit M, 2013, J CLIN ONCOL, V31, P3259, DOI 10.1200/JCO.2012.44.7961; Duus JE, 2005, BONE MARROW TRANSPL, V35, P261, DOI 10.1038/sj.bmt.1704761; Eapen M, 2004, BONE MARROW TRANSPL, V34, P721, DOI 10.1038/sj.bmt.1704645; Hartwig M, 2009, ACTA HAEMATOL-BASEL, V122, P185, DOI 10.1159/000253025; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kedmi M, 2009, BIOL BLOOD MARROW TR, V15, P483, DOI [10.1016/j.bbmt.2009.01.009, 10.1010/j.bbmt.2009.01.009]; Kishi K, 1997, BONE MARROW TRANSPL, V19, P461, DOI 10.1038/sj.bmt.1700680; Konuma T, 2009, LEUKEMIA RES, V33, P840, DOI 10.1016/j.leukres.2008.10.003; Konuma T, 2014, BIOL BLOOD MARROW TR, V20, P1150, DOI 10.1016/j.bbmt.2014.04.005; Lee SY, 2014, CASE REP HEMATOL, V2014; Oda M, 2009, INT J HEMATOL, V89, P374, DOI 10.1007/s12185-009-0266-9; Pawson R, 2001, BRIT J HAEMATOL, V115, P622, DOI 10.1046/j.1365-2141.2001.03150.x; RADICH JP, 1993, J CLIN ONCOL, V11, P304; Schechter T, 2013, LEUKEMIA LYMPHOMA, V54, P105, DOI 10.3109/10428194.2012.704998; Thakar MS, 2009, HEMATOL-AM SOC HEMAT, V2009, P414	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					392	397		10.1007/s12185-015-1755-7		6	Hematology	Hematology	CF3WR	WOS:000352480200011		
J	Totani, H; Kusumoto, S; Ishida, T; Masuda, A; Yoshida, T; Ito, A; Ri, M; Komatsu, H; Murakami, S; Mizokami, M; Ueda, R; Niimi, A; Inagaki, H; Tanaka, Y; Iida, S				Totani, Haruhito; Kusumoto, Shigeru; Ishida, Takashi; Masuda, Arisa; Yoshida, Takashi; Ito, Asahi; Ri, Masaki; Komatsu, Hirokazu; Murakami, Shuko; Mizokami, Masashi; Ueda, Ryuzo; Niimi, Akio; Inagaki, Hiroshi; Tanaka, Yasuhito; Iida, Shinsuke			Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Reactivation; HBV; CCR4; Mogamulizumab; ATL	MONOCLONAL-ANTIBODY KW-0761; LEUKEMIA/LYMPHOMA; THERAPY; MOGAMULIZUMAB; RITUXIMAB; RISK; CCR4	Reactivation of hepatitis B virus (HBV) infection may occur in adult T-cell leukemia-lymphoma (ATL) patients with resolved HBV infection who receive monotherapy with the anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab. However, there is little evidence regarding the incidence and characteristics of HBV reactivation in ATL patients receiving systemic chemotherapy, including the use of this antibody. We conducted a retrospective study for 24 ATL patients with resolved HBV infection underwent regular HBV DNA monitoring to assess HBV reactivation in Nagoya City University Hospital between January 2005 and June 2013. With median HBV DNA follow-up of 238 days (range 57-1420), HBV reactivation (defined as the detection of HBV DNA) was observed in three (12.5 %) of 24 patients with resolved HBV infection. No hepatitis due to HBV reactivation occurred in those patients who were diagnosed with HBV DNA levels below 2.1 log copies/mL and who received antiviral drugs. Mogamulizumab was administered prior to HBV reactivation in two of three HBV-reactivated patients. In the mogamulizumab era, further well-designed prospective studies are warranted to estimate the incidence of HBV reactivation and to establish regular HBV DNA monitoring-guided preemptive antiviral therapy for such patients.	[Totani, Haruhito; Kusumoto, Shigeru; Ishida, Takashi; Masuda, Arisa; Yoshida, Takashi; Ito, Asahi; Ri, Masaki; Komatsu, Hirokazu; Iida, Shinsuke] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Murakami, Shuko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi 4678601, Japan; [Murakami, Shuko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi 4678601, Japan; [Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan; [Ueda, Ryuzo] Aichi Med Univ, Sch Med, Dept Tumor Immunol, Nagakute, Aichi, Japan; [Niimi, Akio] Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Rheumatol, Nagoya, Aichi 4678601, Japan; [Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Dept Anat Pathol & Mol Diagnost, Nagoya, Aichi 4678601, Japan	Kusumoto, S (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	kusshan@rb3.so-net.ne.jp			Ministry of Health, Labour and Welfare of Japan [H24-kanen-004]; Ministry of Education, Culture, Sports Science and Technology of Japan [24591428, 26-A-4]	We would like to thank staff as follows: Ms. Chiori Fukuyama and Dr. Shintaro Ogawa (Nagoya City University Graduate School of Medical Sciences, Nagoya) for keeping and measurement of specimens on this study. We also thank Dr. Shiro Akinaga (Kyowa Hakko Kirin Co., Ltd., Tokyo) for his enlightening advice on this article. This study was supported in part by the Ministry of Health, Labour and Welfare of Japan (grant-in-aid H24-kanen-004 to M.M.) and the Ministry of Education, Culture, Sports Science and Technology of Japan (grant-in-aid for Scientific Research (C) No. 24591428 to S.K.) and grant-in-aid for National Cancer Center Research and Development Fund (No. 26-A-4 to T.I.).	Ishida T, 2003, CLIN CANCER RES, V9, P3625; Ishida T, 2011, CANCER SCI, V102, P44, DOI 10.1111/j.1349-7006.2010.01767.x; Kusumoto S, 2011, J GASTROENTEROL, V46, P9, DOI 10.1007/s00535-010-0331-4; Oketani M, 2012, HEPATOL RES, V42, P627, DOI 10.1111/j.1872-034X.2012.00998.x; Hsu C, 2014, HEPATOLOGY, V59, P2092, DOI 10.1002/hep.26718; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P1664, DOI 10.1001/jama.2013.281115; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Kusumoto S, 2009, INT J HEMATOL, V90, P13, DOI 10.1007/s12185-009-0359-5; Hui CK, 2006, GASTROENTEROLOGY, V131, P59, DOI 10.1053/j.gastro.2006.04.015; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; Ishida T, 2011, INT J HEMATOL, V94, P443, DOI 10.1007/s12185-011-0941-5; European Association For The Study Of The Liver, 2012, J HEPATOL, V57, P167; Jo T, 2013, J CLIN ONCOL S, V31; Kusumoto S, 2012, BLOOD, V120; Motohashi K, 2013, INT J HEMATOL, V98, P258, DOI 10.1007/s12185-013-1387-8; Nakano N, 2014, HEPATOL RES, V44, P354, DOI 10.1111/hepr.12117; Shin IT, 2008, HEPATOL RES, V38, P234, DOI DOI 10.1111/J.1872-034X.2007.00262.X	21	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					398	404		10.1007/s12185-015-1750-z		7	Hematology	Hematology	CF3WR	WOS:000352480200012		
J	Kawashima-Goto, S; Imamura, T; Seki, M; Kato, M; Yoshida, K; Sugimoto, A; Kaneda, D; Fujiki, A; Miyachi, M; Nakatani, T; Osone, S; Ishida, H; Taki, T; Takita, J; Shiraishi, Y; Chiba, K; Tanaka, H; Miyano, S; Ogawa, S; Hosoi, H				Kawashima-Goto, Sachiko; Imamura, Toshihiko; Seki, Masafumi; Kato, Motohiro; Yoshida, Kenichi; Sugimoto, Atsuya; Kaneda, Daisuke; Fujiki, Atsushi; Miyachi, Mitsuru; Nakatani, Takuya; Osone, Shinya; Ishida, Hiroyuki; Taki, Tomohiko; Takita, Junko; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru; Ogawa, Seishi; Hosoi, Hajime			Identification of a homozygous JAK3 V674A mutation caused by acquired uniparental disomy in a relapsed early T-cell precursor ALL patient	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						ETP-ALL; JAK3; Acquired UPD; SNP array; Whole-exome sequencing	ACUTE LYMPHOBLASTIC-LEUKEMIA	Investigation of genetic alterations associated with relapse in acute lymphoblastic leukemia (ALL) may help to identify druggable targets for specific therapies. Early T-cell precursor ALL (ETP-ALL) is a subtype of T-ALL with poor prognosis. Although the genetic landscape of ETP-ALL has been determined, genetic alterations related to the relapse of ETP-ALL have not been fully investigated. Here, we report the first patient with relapsed pediatric ETP-ALL to exhibit a homozygous JAK3 activating mutation, V674A, caused by acquired uniparental disomy (UPD). Single nucleotide polymorphism array analysis revealed acquired UPD (aUPD) at the 19p13.3-p12 locus only in leukemic cells at relapse. Sanger sequence of the JAK3 gene, which was located at 19p13.1 and frequently mutated in ETP-ALL, was performed in paired leukemic samples to determine homozygous JAK3 V674A mutation only in relapsed leukemic cells. In contrast, leukemic cells at initial diagnosis harbored hemizygous JAK3 V674A mutation. Further, whole-exome sequencing revealed mutations in 18 genes only in relapsed samples, although none of these was recurrent in T-ALL. These findings suggest that aUPD at 19p13.1 is partly associated with relapse in this patient. Pharmacological inhibition of JAK3 may be therapeutic in such cases.	[Kawashima-Goto, Sachiko; Imamura, Toshihiko; Sugimoto, Atsuya; Kaneda, Daisuke; Miyachi, Mitsuru; Osone, Shinya; Ishida, Hiroyuki; Hosoi, Hajime] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kamigyo Ku, Kyoto 6028566, Japan; [Seki, Masafumi; Kato, Motohiro; Takita, Junko] Univ Tokyo, Dept Pediat, Tokyo, Japan; [Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan; [Fujiki, Atsushi; Nakatani, Takuya] Natl Hosp Org Maizuru Med Ctr, Dept Pediat, Maizuru, Japan; [Nakatani, Takuya; Ishida, Hiroyuki] Matsushita Mem Hosp, Dept Pediat, Moriguchi, Osaka, Japan; [Taki, Tomohiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Diagnost & Therapeut, Kyoto, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Lab Sequence Anal, Ctr Human Genome, Tokyo, Japan	Imamura, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kamigyo Ku, Kajii Cho Hirokoji, Kyoto 6028566, Japan.	timamura@sa3.so-net.ne.jp		Seki, Masafumi/0000-0003-4671-7026			Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Raghavan M, 2008, BLOOD, V112, P814, DOI 10.1182/blood-2008-01-132431; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Bergmann AK, 2014, GENE CHROMOSOME CANC, V53, P309, DOI 10.1002/gcc.22141; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Choi YL, 2007, LEUKEMIA RES, V31, P203, DOI 10.1016/j.leukres.2006.05.006; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Suzuki N, 2010, PEDIATR BLOOD CANCER, V54, P71, DOI 10.1002/pbc.22217; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					411	416		10.1007/s12185-014-1711-y		6	Hematology	Hematology	CF3WR	WOS:000352480200014		
J	Nakajima, Y; Kuwabara, H; Kishimoto, K; Numata, A; Motohashi, K; Tachibana, T; Tanaka, M; Yamashita, N; Ishigatsubo, Y; Fujisawa, S				Nakajima, Yuki; Kuwabara, Hideyuki; Kishimoto, Kumiko; Numata, Ayumi; Motohashi, Kenji; Tachibana, Takayoshi; Tanaka, Masatsugu; Yamashita, Naoki; Ishigatsubo, Yoshiaki; Fujisawa, Shin			Successful pregnancy and delivery via in vitro fertilization with cryopreserved and thawed embryo transfer in an acute myeloid leukemia patient after allogeneic bone marrow transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Acute myeloid leukemia; In vitro fertilization; Embryo cryopreservation; Pregnancy; Hematopoietic stem cell transplantation	STEM-CELL TRANSPLANTATION; TOTAL-BODY IRRADIATION; FERTILITY PRESERVATION; OVARIAN-FUNCTION; CYCLOPHOSPHAMIDE; BUSULFAN	As the number of young long-term survivors of hematopoietic stem cell transplantation (HSCT) for acute leukemia continues to increase, post-transplant infertility is becoming a significant concern. HSCT, particularly with cyclophosphamide and total body irradiation conditioning, is known to cause secondary premature ovarian failure, resulting in infertility. To preserve post-transplant fertility, several methods have been proposed, including in vitro fertilization (IVF) with embryo cryopreservation. Due to the aggressiveness of acute leukemia, however, patients have little chance to undergo egg harvesting and IVF before they must begin receiving chemotherapy. To the best of our knowledge, there have been no detailed reports of successful pregnancy after HSCT using IVF with embryo cryopreservation and transfer in a patient with acute myeloid leukemia. Here, we report the case of a 42-year-old woman with acute myeloid leukemia who became pregnant 2 years and 2 months after allogeneic bone marrow transplantation via IVF-embryo transfer with an egg collected after induction therapy and delivered a full-term healthy infant.	[Nakajima, Yuki; Kuwabara, Hideyuki; Kishimoto, Kumiko; Numata, Ayumi; Motohashi, Kenji; Tachibana, Takayoshi; Tanaka, Masatsugu; Fujisawa, Shin] Yokohama City Univ, Med Ctr, Dept Hematol, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Yamashita, Naoki] Yamashita Shonan Yume Clin, Fujisawa, Kanagawa, Japan; [Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 2320024, Japan	Nakajima, Y (reprint author), Yokohama City Univ, Med Ctr, Dept Hematol, Minami Ku, Urafune Cho 4-57, Yokohama, Kanagawa 2320024, Japan.	yuki1234@yokohama-cu.ac.jp					Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Jadoul P, 2012, J ASSIST REPROD GEN, V29, P479, DOI 10.1007/s10815-012-9792-0; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Borgmann-Staudt A, 2012, BONE MARROW TRANSPL, V47, P271, DOI 10.1038/bmt.2011.78; Meirow D, 2001, HUM REPROD, V16, P632, DOI 10.1093/humrep/16.4.632; Sanders JE, 1996, BLOOD, V87, P3045; Salooja N, 2001, LANCET, V358, P271, DOI 10.1016/S0140-6736(01)05482-4; Joshi S, 2014, BONE MARROW TRANSPL, V49, P477, DOI 10.1038/bmt.2013.211; Courbiere B, 2010, BONE MARROW TRANSPL, V45, P1247, DOI 10.1038/bmt.2009.313; Kanda Y, 2014, ANN HEMATOL, V93, P287, DOI 10.1007/s00277-013-1852-8; Lipton JH, 1997, J CLIN ONCOL, V15, P3347; Matias K, 2008, BIOL BLOOD MARROW TR, V14, P944, DOI 10.1016/j.bbmt.2008.06.003; Meirow D, 2005, J NATL CANC I MONOGR, P21; National Comprehensive Cancer Network<SUP>&REG;</SUP>, NCCN GUID VERS 1 201; Royal College of Physicians, 2007, EFF CANC TREATM REPR; SANDERS JE, 1986, BLOOD, V68, P1129; SANDERS JE, 1988, J CLIN ONCOL, V6, P813; Wu KN, 2012, J INT MED RES, V40, P2409	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	APR	2015	101	4					417	420		10.1007/s12185-014-1709-5		4	Hematology	Hematology	CF3WR	WOS:000352480200015		
J	Nada, H; Hara, H; Tadano, Y; Shizawa, K				Nada, H.; Hara, H.; Tadano, Y.; Shizawa, K.			Molecular chain plasticity model similar to crystal plasticity theory based on change in local free volume and FE simulation of glassy polymer	INTERNATIONAL JOURNAL OF MECHANICAL SCIENCES			English	Article						Crystal plasticity; Finite strain; Glassy polymer; Finite elements; Molecular chain	DEFORMATION-BEHAVIOR; CONSTITUTIVE MODEL; NECK PROPAGATION; YIELD; FLOW	In this paper, the new concept of a "molecular chain slip system" is analogically proposed on the basis of crystal plasticity theory for metals, and a molecular chain plasticity model that can reproduce the large deformation behaviors of glassy polymers is presented. In this model, the independent rotation of slip systems is allowed, which is a major difference from conventional crystal plasticity theory. Moreover, an inelastic response law based on probabilistic theory considering the change in the local free volume is adopted as a hardening law so as to express the nonlinear viscoelastic response. It is shown that the present model has many advantages over those in previous works. For example, the molecular chain network model based on J(2)-flow theory and Argon's hardening law cannot directly express the deformation-induced orientation of molecular chains, the propagation of a high-strain-rate shear band and the nonlinear viscoelastic response before the initial yielding, which is an inelastic behavior peculiar to polymers. A finite element (FE) simulation based on the present model is carried out for polymethyl methacrylate (PMMA) under plane-strain tension. The large deformation and nonlinear viscoelastic behaviors of glassy polymers, e.g., the neck propagation with a shear band and the orientation of molecular chains, are represented. (c) 2015 Elsevier Ltd. All rights reserved.	[Nada, H.; Hara, H.] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Tadano, Y.] Saga Univ, Dept Mech Engn, Saga 8408502, Japan; [Shizawa, K.] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Hara, H (reprint author), Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	hideyuki@shizawa.mech.keio.ac.jp					Adachi T, 1998, T JSME, V64, P758; HASAN OA, 1995, POLYM ENG SCI, V35, P331, DOI 10.1002/pen.760350407; TOMITA Y, 1995, INT J SOLIDS STRUCT, V32, P3423, DOI 10.1016/0020-7683(94)00315-N; BOYCE MC, 1988, MECH MATER, V7, P15, DOI 10.1016/0167-6636(88)90003-8; TOMITA Y, 1993, INT J SOLIDS STRUCT, V30, P225; CHATER E, 1984, J APPL MECH-T ASME, V51, P269; ARGON AS, 1973, PHILOS MAG, V28, P839, DOI 10.1080/14786437308220987; HUTCHINSON JW, 1983, J MECH PHYS SOLIDS, V31, P405, DOI 10.1016/0022-5096(83)90007-8; WU PD, 1993, J MECH PHYS SOLIDS, V41, P427, DOI 10.1016/0022-5096(93)90043-F; TUGCU P, 1990, INT J MECH SCI, V32, P405, DOI 10.1016/0020-7403(90)90169-J; ASARO RJ, 1985, ACTA METALL MATER, V33, P923, DOI 10.1016/0001-6160(85)90188-9; Tomita Y, 2005, INT J MECH SCI, V47, P687, DOI 10.1016/j.ijmecsci.2004.10.011; TVERGAARD V, 1981, J MECH PHYS SOLIDS, V29, P115, DOI 10.1016/0022-5096(81)90019-3; ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6; HASAN OA, 1993, J POLYM SCI POL PHYS, V31, P185, DOI 10.1002/polb.1993.090310207; Inoue T, 1982, T JPN SOC MECH EN A, V48, P221; PAN J, 1983, INT J SOLIDS STRUCT, V19, P973, DOI 10.1016/0020-7683(83)90023-9; PEIRCE D, 1984, COMPUT STRUCT, V18, P875, DOI 10.1016/0045-7949(84)90033-6; Shizawa K, 1999, INT J PLASTICITY, V15, P899, DOI 10.1016/S0749-6419(99)00018-2; Tomita Y, 2003, INT J MECH SCI, V45, P1703, DOI 10.1016/j.ijmecsci.2003.09.023; Tomita Y, 2000, INT J MECH SCI, V42, P1455, DOI 10.1016/S0020-7403(99)00085-5; Tomita Y, 1997, EUR J MECH A-SOLID, V16, P745; TUGCU P, 1987, INT J MECH SCI, V29, P793, DOI 10.1016/0020-7403(87)90065-8; TUGCU P, 1988, J ENG MATER-T ASME, V110, P395	24	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7403	1879-2162		INT J MECH SCI	Int. J. Mech. Sci.	APR	2015	93						120	135		10.1016/j.ijmecsci.2014.12.018		16	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CF6IQ	WOS:000352660800012		
J	Murakami, K; Livingstone, MBE				Murakami, K.; Livingstone, M. B. E.			Variability in eating frequency in relation to adiposity measures and blood lipid profiles in British children and adolescents: findings from the National Diet and Nutrition Survey	INTERNATIONAL JOURNAL OF OBESITY			English	Article							REGULAR MEAL FREQUENCY; HEALTHY LEAN WOMEN; BODY-MASS INDEX; INSULIN SENSITIVITY; METABOLIC SYNDROME; ENERGY-INTAKE; CHILDHOOD; ASSOCIATION; CHOLESTEROL; ADULTHOOD	BACKGROUND: A very limited number of intervention trials and observational studies in adults have suggested that irregular eating frequency is associated with adverse profiles of metabolic risk factors, but evidence in younger populations is lacking. OBJECTIVE: This cross-sectional study examined the association of variability in eating frequency with adiposity measures (n = 1636) and blood lipid profiles (n = 843) in British children aged 4-10 years (n = 818 for adiposity measures and 324 for blood lipids) and adolescents aged 11-18 years (n = 818 for adiposity measures and 519 for blood lipids). DESIGN: Data from the UK National Diet and Nutrition Survey were analyzed. Dietary intake was assessed using a 7-day weighed dietary record. Eating frequency was calculated based on all eating occasions, except for those providing <210 kJ of energy. Variability in eating frequency was calculated by adding the absolute difference between the 7-day mean eating frequency and that in each day divided by the number of days (7 days), with a higher value indicating a large weekly variability in eating frequency. RESULTS: After adjustment for age, sex, social class, physical activity, ratio of reported energy intake to estimated energy requirement, body mass index z-score, eating frequency, and intakes of protein, saturated fat, total sugar and dietary fiber, variability in eating frequency was positively associated with total and low-density lipoprotein (LDL) cholesterol in children aged 4-10 years (P = 0.04 and 0.03, respectively), but not in adolescents aged 11-18 years. There were no associations between eating frequency variability and other metabolic risk factors examined, including body mass index z-score, waist-to-height ratio, high-density lipoprotein cholesterol and triacylglycerol concentrations. CONCLUSIONS: Larger variability in eating frequency was associated with higher total and LDL cholesterol concentrations in children aged 4-10 years.	[Murakami, K.] Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, Shiga 5228533, Japan; [Livingstone, M. B. E.] Univ Ulster, Northern Ireland Ctr Food & Hlth, Coleraine BT52 1SA, Londonderry, North Ireland	Murakami, K (reprint author), Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, Shiga 5228533, Japan.	kenmrkm@m.u-tokyo.ac.jp			JSPS Postdoctoral Fellowships for Research Abroad, Japan Society for the Promotion of Science, Japan	This work was supported in part by the JSPS Postdoctoral Fellowships for Research Abroad, Japan Society for the Promotion of Science, Japan (to KM).	Farshchi HR, 2005, AM J CLIN NUTR, V81, P16; Cecil JE, 2005, AM J CLIN NUTR, V82, P302; Farshchi HR, 2004, EUR J CLIN NUTR, V58, P1071, DOI 10.1038/sj.ejcn.1601935; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884; Murakami K, 2013, BRIT J NUTR, V110, P1512, DOI 10.1017/S000711451300072X; Yannakoulia M, 2007, OBESITY, V15, P100, DOI 10.1038/oby.2007.503; Sierra-Johnson J, 2008, OBESITY, V16, P1302, DOI 10.1038/oby.2008.203; Murakami K, 2014, BRIT J NUTR, V111, P2176, DOI 10.1017/S0007114514000452; COLE TJ, 1995, ARCH DIS CHILD, V73, P25; Hartline-Grafton HL, 2010, OBESITY, V18, P736, DOI 10.1038/oby.2009.249; Farshchi HR, 2004, INT J OBESITY, V28, P653, DOI 10.1038/sj.ijo.0802616; Juonala M, 2005, CIRCULATION, V112, P1486, DOI 10.1161/CIRCULATIONAHA.104.502161; Mills JP, 2011, OBESITY, V19, P552, DOI 10.1038/oby.2010.265; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117; Rennie KL, 2005, BRIT J NUTR, V93, P241, DOI 10.1079/BJN20041307; Shin A, 2009, J AM DIET ASSOC, V109, P633, DOI 10.1016/j.jada.2008.12.015; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Food Standards Agency, 2002, MCCANCE WIDD COMP FO; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Gregory J, 2000, NATL DIET NUTR SURVE, V1; Institute of Medicine, 2002, DIET REF INT EN CARB; LAUER RM, 1990, JAMA-J AM MED ASSOC, V264, P3034, DOI 10.1001/jama.264.23.3034; Murakami K, 2014, INT J OBESITY, V38, P1200, DOI 10.1038/ijo.2014.1; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; Scientific Advisory Committee on Nutrition, 2011, DIET REF VAL EN; Smithers G, 1993, NUTR FOOD SCI, V93, P16, DOI 10.1108/eb059385	27	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0307-0565	1476-5497		INT J OBESITY	Int. J. Obes.	APR	2015	39	4					608	613		10.1038/ijo.2015.7		6	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CF4XO	WOS:000352557500009		
J	Bai, Y; Yang, M				Bai, Yang; Yang, Ming			Deformation Analysis of Brass in Micro Compression Test with Presence of Ultrasonic Vibration	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Ultrasonic; Softening effect; Compression test; FEM	ALUMINUM-ALLOY; FRICTION; BEHAVIOR; METALS	The application of ultrasonic vibration in metal forming is attracting more attention due to the better performance of ultrasonic-assisted process. By adding small vibration amplitude on tools, the plastic deformation behavior of metal material would differ from the static process. In this study, ultrasonic-assisted compression test was carried out to investigate the influences induced by ultrasonic systematically Ultrasonic influences on material flow stress, friction and temperature were analyzed Acoustic softening effect was found size dependent and a new model on basis of surface grain model was proposed to explain it. Numerical simulations were carried out to validate and compare with experimental results.	[Bai, Yang] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, Inst Forming Technol & Equipment, Shanghai 200030, Peoples R China; [Yang, Ming] Tokyo Metropolitan Univ, Grad Sch Syst Design, Tokyo 1910065, Japan	Bai, Y (reprint author), Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, Inst Forming Technol & Equipment, 1954 Huashan Rd, Shanghai 200030, Peoples R China.	baiyangsky@sjtu.edu.cn			National Natural Science Foundation of China [51405296]	The authors acknowledge the financial support by National Natural Science Foundation of China through grant no. 51405296.	Abdul Aziz S., 2010, APPL MECH MAT, V24-25, P311; Zhang KF, 2009, J MATER PROCESS TECH, V209, P4949, DOI 10.1016/j.jmatprotec.2008.11.018; Hung JC, 2005, ULTRASONICS, V43, P692, DOI 10.1016/j.ultras.2005.03.001; Gau JT, 2007, J MATER PROCESS TECH, V184, P42, DOI 10.1016/j.jmatprotec.2006.11.003; Engel U, 2002, J MATER PROCESS TECH, V125, P35, DOI 10.1016/S0924-0136(02)00415-6; Peng LF, 2009, MAT SCI ENG A-STRUCT, V526, P93, DOI 10.1016/j.msea.2009.06.061; Ebrahimi R, 2004, J MATER PROCESS TECH, V152, P136, DOI 10.1016/j.jmatprotec.2004.03.029; Kals TA, 2000, J MATER PROCESS TECH, V103, P95, DOI 10.1016/S0924-0136(00)00391-5; Hirao M, 2000, ACTA MATER, V48, P517, DOI 10.1016/S1359-6454(99)00346-8; Yao ZH, 2012, J MATER PROCESS TECH, V212, P640, DOI 10.1016/j.jmatprotec.2011.10.017; Siddiq A, 2011, MATER LETT, V65, P356, DOI 10.1016/j.matlet.2010.10.031; Michel JF, 2003, J MATER PROCESS TECH, V141, P439, DOI 10.1016/S0924-0136(03)00570-3; Siddiq A, 2008, MECH MATER, V40, P982, DOI 10.1016/j.mechmat.2008.06.004; Huang H, 2009, J APPL PHYS, V106, DOI 10.1063/1.3266170; Huang B. Y., 2005, CHINA MAT ENG CANON, P264; Hung JC, 2013, MATER DESIGN, V45, P412, DOI 10.1016/j.matdes.2012.07.021; Kosuge S., 2013, THESIS TOKYO METROPO; LANGENEC.B, 1966, IEEE T SON ULTRASON, VSU13, P1; Min XH, 2004, MAT SCI ENG A-STRUCT, V372, P269, DOI 10.1016/j.msea.2004.01.033; Savkina R. K., 2005, INFRARED PHYS TECHN, V46, P388; Shimizu T, 2010, KEY ENG MAT, V443, P110, DOI 10.4028/www.scientific.net/KEM.443.110; Wang JP, 2001, INT J MACH TOOL MANU, V41, P311, DOI 10.1016/S0890-6955(00)00088-2; Wang Ting, 2008, Applied Surface Science, V255, DOI 10.1016/j.apsusc.2008.06.034	23	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	APR	2015	16	4					685	691		10.1007/s12541-015-0091-4		7	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CF6JP	WOS:000352663300009		
J	Lee, KJ; Park, SJ; Lee, SJ; Naito, M; Kwon, SY				Lee, Kyung-Jin; Park, Sung-Jae; Lee, Sung-Jae; Naito, Masatoshi; Kwon, Soon-Yong			Biomechanical Study on the Efficacy of the Periacetabular Osteotomy using Patient-specific Finite Element Analysis	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Periacetabular Ostoetomy (PAO); Developmental Dysplasia of the Hip (DDH); Biomechanical study; Patient-specific; Finite Element Analysis (FEA)	JOINT CONTACT PRESSURE; DEVELOPMENTAL DYSPLASIA; FOLLOW-UP; ACETABULAR DYSPLASIA; HIP; REPLACEMENT; STABILITY; FIXATION	Periacetabular osteotomy (PAO) is a joint-preserving surgical procedure and it has been introduced as a surgical alternative to the total hip arthroplasty (THA) for young person. However, its clinical and biomechanical efficacies remain unknown. In this study, we constructed patient-specific finite element (FE) models of the hip joint before and after surgery to evaluate the efficacies in more quantitative fashion. 3-D FE models were constructed based on patient's computed tomography (CT) images. Post-operative geometrical changes in joint contact areas, center-edge (CE) angle and distance between the symphysis pubis and the femoral head (DBSPFH) were assessed in three dimensions. In addition, changes in peak contact pressures and peak von Mises stress (PVMS) at the hip joint were predicted After PAO, CE angle was increased by 126.2% and DBSPFH was decreased by 3.7%. The contact area was increased by 32% while peak contact pressure was decreased by 53.8%. More even distribution of stresses at the femur were observed Our results suggested that for this given patient FAQ was an effective reconstructive surgical choice in terms of reconstructing joint congruency Therefore, FAQ can be considered a good alternative to THA especially for young patients who need to be treated with joint-preserving techniques.	[Lee, Kyung-Jin; Kwon, Soon-Yong] Catholic Univ, St Marys Hosp, Dept Orthopaed Surg, Seoul 150713, South Korea; [Park, Sung-Jae; Lee, Sung-Jae] Inje Univ, Dept Biomed Engn, Gimhae Si 621749, Gyeongsangnam D, South Korea; [Naito, Masatoshi] Fukuoka Univ, Sch Med, Dept Orthopaed Surg, Fukuoka 8140180, Japan	Kwon, SY (reprint author), Catholic Univ, St Marys Hosp, Dept Orthopaed Surg, 10,63 Ro, Seoul 150713, South Korea.	sykwon@catholic.or.kr					ANDA S, 1991, J COMPUT ASSIST TOMO, V15, P115, DOI 10.1097/00004728-199101000-00018; Anderson Lucas A, 2011, Orthopedics, V34, P86, DOI 10.3928/01477447-20101221-17; Harris MD, 2012, J ORTHOP RES, V30, P1133, DOI 10.1002/jor.22040; Clohisy JC, 2009, CLIN ORTHOP RELAT R, V467, P2041, DOI 10.1007/s11999-009-0842-6; Siebenrock KA, 1999, CLIN ORTHOP RELAT R, P9; Armiger RS, 2009, ACTA ORTHOP, V80, P155, DOI 10.3109/17453670902947390; Hsieh PH, 2003, J BONE JOINT SURG AM, V85A, P244; Anderson AE, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2953472; DALSTRA M, 1995, J BIOMECH, V28, P715, DOI 10.1016/0021-9290(94)00125-N; Chegini S, 2009, J ORTHOP RES, V27, P195, DOI 10.1002/jor.20747; Naito M, 2005, CLIN ORTHOP RELAT R, P129, DOI 10.1097/01.blo.0000153281.75265.1d; Clohisy JC, 2005, J BONE JOINT SURG AM, V87A, P254, DOI 10.2106/JBJS.D.02093; Lane NE, 2000, ARTHRITIS RHEUM, V43, P400, DOI 10.1002/1529-0131(200002)43:2<400::AID-ANR21>3.0.CO;2-D; Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P1633, DOI 10.1007/s11999-008-0242-3; Fujii M, 2010, J BONE JOINT SURG AM, V92A, P895, DOI 10.2106/JBJS.I.00046; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Nishii T, 2004, OSTEOARTHR CARTILAGE, V12, P650, DOI 10.1016/j.joca.2004.04.009; Troelsen A, 2009, J BONE JOINT SURG AM, V91A, P2169, DOI 10.2106/JBJS.H.00994; HODGE WA, 1989, J BONE JOINT SURG AM, V71A, P1378; Armand M, 2005, ACTA ORTHOP, V76, P303, DOI 10.1080/00016470510030742; Babis GC, 2002, CLIN ORTHOP RELAT R, P221; Brand Richard A, 2005, Iowa Orthop J, V25, P82; Chang J. S., 2008, J KOREAN ORTHOPAEDIC, V43, P718; Chen W. M., 2009, SPINE, V34, P716; Clohisy John C, 2004, Iowa Orthop J, V24, P43; Fu M, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-47; GANZ R, 1988, CLIN ORTHOP RELAT R, P26; Johnson J. E., 2014, J BIOMECHANICAL ENG, V136; Jung TG, 2013, INT J PRECIS ENG MAN, V14, P819, DOI 10.1007/s12541-013-0107-x; Kim H., 2012, J BIOMECHANICAL SCI, V7, P358; Li Ziqing, 2014, Eur J Orthop Surg Traumatol, V24, P179, DOI 10.1007/s00590-012-1163-0; Omeroglu H, 2002, SKELETAL RADIOL, V31, P25, DOI 10.1007/s002560100402; Tai C. L., 2010, J MED BIOL ENG, V31, P53; Trumble SJ, 1999, CLIN ORTHOP RELAT R, P54; Widmer BJ, 2010, J PEDIATR ORTHOPED, V30, P443, DOI 10.1097/BPO.0b013e3181e00c24; Yassir W, 2005, J PEDIATR ORTHOPED, V25, P14, DOI 10.1097/00004694-200501000-00005; Zou ZM, 2013, J ORTHOP RES, V31, P472, DOI 10.1002/jor.22245	37	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	APR	2015	16	4					823	829		10.1007/s12541-015-0108-z		7	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CF6JP	WOS:000352663300026		
J	Ban, M				Ban, Masashi			Cumulant Expansion for a System with Pre- and Post-Selection and a Weak Value of a Gaussian System	INTERNATIONAL JOURNAL OF THEORETICAL PHYSICS			English	Article						Weak value; Quantum measurement; Cumulant expansion; Gaussian state	COMPONENT; SPIN	The generalized cumulant expansion is a suitable method for investigating a quantum system with pre- and post-selection. When pre- and post-selected states of a system to be measured and an initial state of a measurement device are Gaussian with respect to relevant observables, weak values can be obtained from measurement outcomes without any other restrictions such as weakness of a system-device coupling and large uncertainty of a pointer observable in the initial state since all the cumulants higher than the second order vanish. A Gaussian weak value is investigated for a single mode optical system prepared in a coherent-squeezed state, where the post-selection is done by a homodyne detection.	Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan	Ban, M (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Ohtsuka, Tokyo 1128610, Japan.	ban.masashi@ocha.ac.jp					Zhu XM, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052111; AHARONOV Y, 1990, PHYS REV A, V41, P11, DOI 10.1103/PhysRevA.41.11; Wu SJ, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.052106; Wiseman HM, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.032111; DUCK IM, 1989, PHYS REV D, V40, P2112, DOI 10.1103/PhysRevD.40.2112; KUBO R, 1962, J PHYS SOC JPN, V17, P1100; AHARONOV Y, 1988, PHYS REV LETT, V60, P1351, DOI 10.1103/PhysRevLett.60.1351; Kofman AG, 2012, PHYS REP, V520, P43, DOI 10.1016/j.physrep.2012.07.001; Barnett S. M., 1997, METHODS THEORETICAL; Geszti T, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.044102; Johansen LM, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052115; Johansen LM, 2004, PHYS LETT A, V322, P298, DOI 10.1016/j.physleta.2004.01.041; Johansen LM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.120402; Jozsa R, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.044103; Kubo R., 1963, J MATH PHYS, V4, P2270; Lobo AC, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.012112; Nakamura K., 2011, PHYS REV A, V85; Peres A., 1993, QUANTUM THEORY CONCE; von Neumann J., 1932, MATH FDN QUANTUM MEC	19	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0020-7748	1572-9575		INT J THEOR PHYS	Int. J. Theor. Phys.	APR	2015	54	4					1342	1351		10.1007/s10773-014-2332-1		10	Physics, Multidisciplinary	Physics	CF0FK	WOS:000352218300030		
J	Jarukasemratana, S; Murata, T				Jarukasemratana, Sorn; Murata, Tsuyoshi			Edge Weight Method for Community Detection on Mixed Scale-Free Networks	INTERNATIONAL JOURNAL ON ARTIFICIAL INTELLIGENCE TOOLS			English	Article						Community detection; scale-free; weighting scheme	DYNAMICS; MODEL	In this paper, we proposed an edge weight method for performing a community detection on mixed scale-free networks. We use the phrase "mixed scale-free networks" for networks where some communities have node degree that follows a power law similar to scale-free networks, while some have node degree that follows normal distribution. In this type of network, community detection algorithms that are designed for scale-free networks will have reduced accuracy because some communities do not have scale-free properties. On the other hand, algorithms that are not designed for scale-free networks will also have reduced accuracy because some communities have scale-free properties. To solve this problem, our algorithm consists of two community detection steps; one is aimed at extracting communities whose node degree follows power law distribution (scale-free), while the other one is aimed at extracting communities whose node degree follows normal distribution (non scale-free). To evaluate our method, we use NMI - Normalized Mutual Information - to measure our results on both synthetic and real-world datasets comparing with both scale-free and non scale-free community detection methods. The results show that our method outperforms all other based line methods on mixed scale-free networks.	[Jarukasemratana, Sorn; Murata, Tsuyoshi] Tokyo Inst Technol, Meguro Ku, Tokyo 152, Japan	Jarukasemratana, S (reprint author), Tokyo Inst Technol, Meguro Ku, W8-59 2-12-1 Ookayama, Tokyo 152, Japan.	sorn.jaru@ai.cs.litech.ac.jp; murata@cs.titech.ac.jp					Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xu XW, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P824; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; DORSO C, 1993, PHYS LETT B, V301, P328, DOI 10.1016/0370-2693(93)91158-J; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Barabasi AL, 2003, SCI AM, V288, P60; [Anonymous], 1953, PSYCHOMETRIKA; Blondel V. D., 2008, J STAT MECH THEORY E; Boguna M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056122; Foster K. C., 2001, Computational & Mathematical Organization Theory, V7, DOI 10.1023/A:1013470632383; Jarukasemratana S., 2013, P 24 ACM C HYP SOC M, P258; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2009, NEW J PHYS, V11; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Leskovec J., 2005, P 11 ACM SIGKDD INT, P117; McAuley J., 2012, DISCOVERING SOCIAL C; Newman M, 2003, PHYS REV E, V69, P1, DOI DOI 10.1103/PHYSREVE.69.026113; Qian R, 2007, LECT NOTES COMPUT SC, V4430, P226; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Ripeanu M., 2002, IEEE INTERNET COMPUT, V6; Yang J., 2012, ARXIV E PRINTS; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452	23	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-2130	1793-6349		INT J ARTIF INTELL T	Int. J. Artif. Intell. Tools	APR	2015	24	2			SI				1540007	10.1142/S0218213015400072		24	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Computer Science	CF9TJ	WOS:000352909400004		
J	Honda, T				Honda, Toshio			Untitled	INTERNATIONAL STATISTICAL REVIEW			English	Editorial Material							MODELS		Hitotsubashi Univ, Grad Sch Econ, Kunitachi, Tokyo 1868601, Japan	Honda, T (reprint author), Hitotsubashi Univ, Grad Sch Econ, Kunitachi, Tokyo 1868601, Japan.	honda@econ.hit-u.ac.jp					Lian H, 2012, STAT SINICA, V22, P1563, DOI 10.5705/ss.2010.308; Zhang HH, 2011, J AM STAT ASSOC, V106, P1099, DOI 10.1198/jasa.2011.tm10281; Chengs M. -Y., 2014, ANN STAT IN PRESS; Fans J., 2014, J AM STAT ASSOC, DOI [10.1080/01621459.2013.879828, DOI 10.1080/01621459.2013.879828]; Tang YL, 2013, J MULTIVARIATE ANAL, V122, P115, DOI 10.1016/j.jmva.2013.07.015; Weis F., 2011, STAT SINICA, V21, P1515	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-7734	1751-5823		INT STAT REV	Int. Stat. Rev.	APR	2015	83	1					68	70		10.1111/insr.12080		3	Statistics & Probability	Mathematics	CF8LX	WOS:000352812800006		
J	Kenyon, M				Kenyon, Michiko (Nakakita)			Randomized controlled trial on the relaxation effects of back massages for puerperants on the first post-partum day	JAPAN JOURNAL OF NURSING SCIENCE			English	Article						autonomic nervous system; massage; post-partum period; randomized controlled trial; relaxation		AimThe purpose of this study was to investigate relaxation effects of back massage for puerperants on the first post-partum day using physiological and subjective indicators. MethodsThis randomized controlled trial included both primiparous and multiparous groups, each of which was divided into intervention and control groups. The intervention group was given a back massage for 20min, while the control group maintained a sitting position for 20min. Physiological measurements included heart rate variability, parasympathetic nerve activity (high frequency, HF), sympathetic nerve activity (low frequency, LF/HF), and blood pressure. The subjective indicator was an assessment of the feeling of relaxation. ResultsThe intervention group included 27 primiparous and 26 multiparous women, and the control group included 23 primiparous and 25 multiparous women. In both primiparous and multiparous women, there were significant differences in heart rate variability and sense of relaxation between the intervention and control groups, and a partial reduction of physical symptoms was found in the intervention groups. In the multiparous women, a significant difference in HF was also observed, and beneficial effects were found in the intervention group. ConclusionA back massage is considered to be one of the effective nursing care methods with which psychological relaxation can be given to puerperants in the early part of the puerperium. The multiparous group demonstrated the relaxation effects because a significant effect was observed in heart rate, HF, and diastolic blood pressure. However, no significant difference was seen in LF/HF; therefore, further investigation of this relaxation effect using physiological indicators is warranted.	[Kenyon, Michiko (Nakakita)] Toho Univ, Fac Nursing, Tokyo 1430015, Japan	Kenyon, M (reprint author), Toho Univ, Fac Nursing, Ota Ku, 4-16-20 Omori Nishi, Tokyo 1430015, Japan.	michiko.nakakita@med.toho-u.ac.jp			Keio University	The author wishes to thank the participating mothers, the facility director, and all staff members who cooperated with this study. The author is also grateful to Professor Hiroe Tsubaki of The Institute of Statistical Mathematics and Professor Takenori Takahashi of Mejiro University for the kind coaching on statistical analysis. The author also thanks Professor Keiko Takenoue of Graduate School, Keio University for the dedicated leadership. This study was conducted with a grant from the Keio University Doctorate Student Grant-in-Aid Program. This paper was prepared by partially amending the doctoral thesis at Graduate School of Heath Management, Keio University in 2011.	Abe Y., 2001, J JAPANESE ASS MANUA, V12, P34; Benson H., 2000, RELAXATION RESPONSE; Hasegawa M., 2000, NURS HLTH SCI, V2, P231, DOI 10.1046/j.1442-2018.2000.00064.x; Igusa R., 2008, JAPAN SOC NURSING RE, V31, P21; Imura M., 2005, JAPANESE J AROMATHER, V15, P17; Imura M, 2006, J MIDWIFERY WOM HEAL, V51, P21; Koitabashi K, 2006, EVIDENCE CARE TECHNI, P402; Koitabashi K., 1994, NURSING, V14, P128; Nakakita M., 2009, J JAPAN ACAD MIDWIFE, V23, P230; Nakakita M., 2010, KEIO SFC J, V10, P57; Nakakita M., 2011, J JAPAN ACAD MIDWIFE, V25, P191; Nakakita M., 2012, JAPAN J MAT HLTH, V53, P98; Nedate K., 1984, JAPAN J THERAPY RES, V9, P33; Okamura A., 2005, HYOGO J MAT HLTH, V14, P40; Ono K., 2010, KOKUSHIKAN SOC SPORT, V10, P21; Takahashi M., 1999, JAPAN J MAT HLTH, V40, P522; Tani A., 1999, CLIN APPL HEAT RATE, P28; Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 1996, EUROPEAN HEART J, V17, P354, DOI DOI 10.1161/01.CIR.93.5.1043; Wada S, 1990, PSYCHOSOCIAL ASPECT, P9; Yanagi N, 2006, JAPAN J NURSING RES, V39, P457	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7932	1742-7924		JPN J NURS SCI	Jpn. J. Nurs. Sci.	APR	2015	12	2					87	98		10.1111/jjns.12053		12	Nursing	Nursing	CF4NG	WOS:000352525300001		
J	Oztekin, SD; Larson, EE; Altun Ugras, G; Yuksel, S; Savaser, S				Oztekin, Seher Deniz; Larson, Eric Edwin; Altun Ugras, Gulay; Yuksel, Serpil; Savaser, Sevim			Nursing educators' perceptions about disaster preparedness and response in Istanbul and Miyazaki	JAPAN JOURNAL OF NURSING SCIENCE			English	Article						disasters; emergency preparedness; nursing faculty; perception; response	PUBLIC-HEALTH NURSES; EMERGENCY PREPAREDNESS; COMPETENCES; PREFECTURE; SCHOOL; JAPAN; NEEDS	AimAs healthcare professionals, nursing educators need to be prepared to manage and deliver care in what are often dangerous conditions. This research aims to determine and compare nursing educators' perceptions of disaster preparedness and response (DP&R) in Istanbul and Miyazaki. MethodsAn 18 question descriptive questionnaire was used. ResultsOne hundred and forty-four nursing educators representing two state university nursing schools in Istanbul, Turkey, and one state and two private universities in Miyazaki, Japan were enrolled. Educators had an average age of 40 years and had been educators for 1-15 years. Just over half of the participants had basic knowledge regarding DP&R with most of them considering taking special courses in the future. The majority considered caregiver as a role they could undertake in a disaster situation. The existence of major concerns and conflicts in disaster responses were low. The top ranked item was in the area of conflict between family and job responsibilities. Age and academic levels showed significant differences in basic knowledge on DP&R. Regardless of knowledge in this subject area, no statistical significance on personal preparedness or being a volunteer to disaster events was found. ConclusionNursing educators were not thinking about what kinds of disasters occur in the areas where they currently teach and were underprepared to deal with disaster situations. To improve the perceptions of the nursing educators on DP&R, mass casualty care and disaster management skills need to be incorporated into formal education and training on disaster preparedness and workplace preparedness.	[Oztekin, Seher Deniz] Istanbul Univ, Florence Nightingale Fac Nursing, Div Surg Nursing, Istanbul, Turkey; [Altun Ugras, Gulay] Mersin Univ, Sch Hlth, Div Surg Nursing, Mersin, Turkey; [Yuksel, Serpil] Abant Izzet Baysal Univ, Bolu Hlth Sch, Div Surg Nursing, Bolu, Turkey; [Savaser, Sevim] Istanbul Senate, Hlth Family Labor & Social Affairs Commiss, Ankara, Turkey; [Larson, Eric Edwin] Miyazaki Prefectural Nursing Univ, Miyazaki, Japan	Oztekin, SD (reprint author), Istanbul Univ, Florence Nightingale Hemsirelik Fak, Cerrahi Hastaliklari Hemsireligi Anabilim Dali, Ogretim Uyesi, Abide I Hurriyer Cdbi, TR-34381 Sisli, Turkey.	doztekin@istanbul.edu.tr					Jakeway CC, 2008, PUBLIC HEALTH NURS, V25, P353, DOI 10.1111/j.1525-1446.2008.00716.x; Fung OWM, 2008, J ADV NURS, V62, P698, DOI 10.1111/j.1365-2648.2008.04655.x; Arbon Paul, 2013, Australas Emerg Nurs J, V16, P52, DOI 10.1016/j.aenj.2013.05.003; Arbon P, 2006, AUSTRALASIAN EMERGEN, V9, P171, DOI 10.1016/j.aenj.2006.05.003; Arbon Paul, 2013, Australas Emerg Nurs J, V16, P103, DOI 10.1016/j.aenj.2013.05.004; Auf der Heide E., 2002, DISASTER MED, P57; Auf der Heide E, 2006, ANN EMERG MED, V47, P34, DOI 10.1016/j.annemergmed.2005.05.009; Bergin A., 2007, AUSTR STRATEGIC POLI, V4, P1; Caudill K., 2011, THESIS WRIGHT STATE; Center for Research on the Epidemiology of Disasters (CRED), 2009, EM EV DAT EM DAT INT; Chan SSS, 2010, J NURS SCHOLARSHIP, V42, P405, DOI 10.1111/j.1547-5069.2010.01363.x; Chapman K., 2008, AUSTRALASIAN EMERGEN, V11, P135, DOI DOI 10.1016/J.AENJ.2008.04.002; Corrigan Ellen, 2012, Prehosp Disaster Med, V27, P432, DOI 10.1017/S1049023X12001045; Culley JM, 2010, J NURS EDUC, V49, P708, DOI 10.3928/01484834-20100930-04; Edwards Nicholas A, 2006, Emerg Med Australas, V18, P185, DOI 10.1111/j.1742-6723.2006.00827.x; Elgin K. G., 2006, ISTANBUL PROJECT COO; Erickson D., 2001, AM ASS COLL NURSING; Fitzgerald G. J., 2010, INT DISASTER NURSING, P495; Fung W M Olivia, 2009, J Clin Nurs, V18, P3165, DOI 10.1111/j.1365-2702.2008.02777.x; Fuse A, 2011, J NIPPON MED SCH, V78, P401; Gebbie K, 2002, AM J NURS, V102, P46; Gebbie KM, 2010, COLLEGIAN, V17, P209, DOI 10.1016/j.colegn.2010.10.001; Gebbie KM, 2012, ANNU REV NURS RES, V30, P169, DOI 10.1891/0739-6686.30.169; Hilton Carla, 2004, J Contin Educ Nurs, V35, P59; Hsu Edbert B, 2004, Prehosp Disaster Med, V19, P191; International Affairs Division Miyagi Prefectural Government, 2011, INT POL MIYAG OUTL B; Ireland Mary, 2006, Disaster Manag Response, V4, P72, DOI 10.1016/j.dmr.2006.03.001; James D., 2006, CLIN SIMUL NURS, V2, pe59; Jennings-Sanders Andrea, 2004, Nurse Educ Pract, V4, P69, DOI 10.1016/S1471-5953(03)00007-6; Jirojwong S., 2011, RES METHODS NURSING; Littleton-Kearney Marguerite T, 2008, Crit Care Nurs Clin North Am, V20, P103, DOI 10.1016/j.ccell.2007.10.008; Modaressi H., 2011, WP5 APPL INTEGRATED; Morrison AM, 2010, PUBLIC HEALTH NURS, V27, P164, DOI 10.1111/j.1525-1446.2010.00838.x; Mosca NW, 2005, J PUBLIC HEALTH MAN, pS38; Nasrabadi AN, 2007, INT NURS REV, V54, P13, DOI 10.1111/j.1466-7657.2007.00495.x; Nozawa M, 2008, INT NURS REV, V55, P20, DOI 10.1111/j.1466-7657.2007.00589.x; Ohara M., 2012, PRESENT SITUATION DI; O'Neill PA, 2005, SCAND J SURG, V94, P259, DOI 10.1177/145749690509400403; Perron A, 2010, ADV NURS SCI, V33, P184, DOI 10.1097/ANS.0b013e3181e093bc; Polit D. F., 2008, NURSING RES GENERATI, P248; Rains A. B., 2013, DISASTER NURSING EME, P655; Ranse Jamie, 2013, Australas Emerg Nurs J, V16, P58, DOI 10.1016/j.aenj.2013.04.002; Romig L., 2013, DISASTER NURSING EME, P202; Schmidt Cheryl K, 2011, Nurs Educ Perspect, V32, P380; Slepski L. A., 2010, INT DISASTER NURSING, P549; Smith E., 2007, AUSTRAL J EMERG MANA, V22, P21; French Emily D, 2002, J Emerg Nurs, V28, P111, DOI 10.1067/men.2002.123076; Speraw S., 2013, DISASTER NURSING EME, P669; Stanley SAR, 2008, PUBLIC HEALTH NURS, V25, P166, DOI 10.1111/j.1525-1446.2008.00693.x; Thomas J., MASS CASUALTY INCIDE; UNISDR, 2004, TERM BAS TERMS DIS R; Unlu A, 2010, DISASTER PREV MANAG, V19, P155, DOI 10.1108/09653561011037977; Urbano M. T., 2002, AM NURSE, V34, P8; Usher K., 2011, AUSTRALASIAN EMERGEN, V14, P75; Veenema Tener Goodwin, 2006, Nurs Educ Perspect, V27, P93; Veenema T. G., 2013, DISASTER NURSING EME, P9; Weiner Elizabeth, 2005, Nurs Educ Perspect, V26, P334; Weiner Elizabeth, 2006, Online J Issues Nurs, V11, P4; Wetta-Hall Ruth, 2006, J Contin Educ Nurs, V37, P106; Wetter DC, 2001, AM J PUBLIC HEALTH, V91, P710, DOI 10.2105/AJPH.91.5.710; Whitty K. K., 2006, THESIS; Whitty KK, 2009, J NURS EDUC, V48, P291, DOI 10.9999/01484834-20090416-10; Wise Gail Insko, 2007, Disaster Manag Response, V5, P14, DOI 10.1016/j.dmr.2006.10.004; Wisniewski R, 2004, J NURS ADMIN, V34, P475, DOI 10.1097/00005110-200410000-00009; World Health Organization (WHO) & International Council for Nurses (ICN), 2009, INCR ACC HLTH WORK R; Yamamoto Aiko, 2008, Prehosp Disaster Med, V23, ps6; Yamamoto A., 2004, JAPAN J NURSING SCI, V1, P57, DOI 10.1111/j.1742-7924.2004.00010.x	67	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7932	1742-7924		JPN J NURS SCI	Jpn. J. Nurs. Sci.	APR	2015	12	2					99	112		10.1111/jjns.12054		14	Nursing	Nursing	CF4NG	WOS:000352525300002		
J	Oztekin, SD; Larson, EE; Yuksel, S; Altun Ugras, G				Oztekin, Seher Deniz; Larson, Eric Edwin; Yuksel, Serpil; Altun Ugras, Gulay			Undergraduate nursing students' perceptions about disaster preparedness and response in Istanbul, Turkey, and Miyazaki, Japan: A cross-sectional study	JAPAN JOURNAL OF NURSING SCIENCE			English	Article						disaster; emergency preparedness; nursing students; perception; response	TRAINING-PROGRAM; NURSES; COMPETENCES	AimAlthough the awareness of disasters has increased among nurses, the concept of disaster preparedness and response has not been sufficiently explored with undergraduate nursing students. The aim of this study was to assess and compare the perceptions of students regarding disaster preparedness and response that live in different earthquake-prone cities; Istanbul, Turkey and Miyazaki, Japan. MethodsA cross-sectional study employing seven questions was conducted in a final group of 1053 nursing students from Istanbul, Turkey, and Miyazaki, Japan. ResultsMost study respondents were female, aged 18-22years, with a high proportion of second year students in both cities. Istanbul's students had more knowledge about disaster preparedness and response in relation to age and year of university, showing statistically significant differences. Istanbul's highest rated responses to disaster characteristics were on structural elements and injuries/deaths, while Miyazaki's was unpredictable/sudden/disorganized. Respondents in Istanbul identified earthquakes as the disaster most likely to occur, while respondents in Miyazaki identified typhoon/hurricane. Study participants responded that they could provide caregiver roles during a disaster event rather than triage or managerial roles as disaster responders. ConclusionDisaster characteristics were not described by one third of the students. Of the two-thirds that were described, most were of events that were highly predictable because of their frequencies in the given areas. Universities need to target and then focus on high-risk factors in their areas and have disaster plans for students who can provide triage and managerial nursing roles as disaster responders.	[Oztekin, Seher Deniz] Istanbul Univ, Florence Nightingale Fac Nursing, Div Surg Nursing, Istanbul, Turkey; [Yuksel, Serpil] Abant Izzet Baysal Univ, Bolu Hlth Sch, Div Surg Nursing, Bolu, Turkey; [Altun Ugras, Gulay] Mersin Univ, Sch Hlth, Div Surg Nursing, Mersin, Turkey; [Larson, Eric Edwin] Miyazaki Prefectural Nursing Univ, Miyazaki, Japan	Oztekin, SD (reprint author), Istanbul Univ, Univ Istanbul, Florence Nightingale Fac Nursing, Div Surg Nursing, Abide I Hurriyer Cd, TR-34360 Sisli, Turkey.	doztekin@istanbul.edu.tr					Ahayalimudin N., 2012, BIOMED CENTRAL PUBLI, V12, pA3; Al Khalaileh MAA, 2010, J ADV NURS, V66, P664, DOI 10.1111/j.1365-2648.2009.05208.x; Pang SMC, 2009, NURS HEALTH SCI, V11, P367, DOI 10.1111/j.1442-2018.2009.00499.x; Subbarao I, 2008, DISASTER MED PUBLIC, V2, P57, DOI 10.1097/DMP.0b013e31816564af; [Anonymous], 2005, WORLD C DIS RED 18 2; Pattillo MM, 2009, NURS HEALTH SCI, V11, P378, DOI 10.1111/j.1442-2018.2009.00500.x; Fung OWM, 2008, J ADV NURS, V62, P698, DOI 10.1111/j.1365-2648.2008.04655.x; Culley JM, 2010, J NURS EDUC, V49, P708, DOI 10.3928/01484834-20100930-04; Cusack L, 2010, COLLEGIAN, V17, P193, DOI 10.1016/j.colegn.2010.09.006; Fung W M Olivia, 2009, J Clin Nurs, V18, P3165, DOI 10.1111/j.1365-2702.2008.02777.x; Hermawati D., 2010, 2 INT C HUM SOC SCI; International Affairs Division Miyagi Prefectural Government, 2011, INT POL MIYAG OUTL B; Ireland Mary, 2006, Disaster Manag Response, V4, P72, DOI 10.1016/j.dmr.2006.03.001; Istanbul Seismic Risk Mitigation and Emergency Preparedness Project (ISMEP), 2010, IST SEISM RISK MIT E; Jennings-Sanders Andrea, 2005, Disaster Manag Response, V3, P80, DOI 10.1016/j.dmr.2005.04.001; Jennings-Sanders Andrea, 2004, Nurse Educ Pract, V4, P69, DOI 10.1016/S1471-5953(03)00007-6; Katz Alan R, 2006, Prehosp Disaster Med, V21, P404; Landry LG, 2008, NURS EDUC, V33, P254, DOI 10.1097/01.NNE.0000334786.15052.d9; Littleton-Kearney Marguerite T, 2008, Crit Care Nurs Clin North Am, V20, P103, DOI 10.1016/j.ccell.2007.10.008; Markenson D., 2011, PREHOSPITAL DISA SS1, V26, pS31; Minami H, 2007, INT NURS REV, V54, P1, DOI 10.1111/j.1466-7657.2007.00551.x; Qureshi KA, 2004, FAM COMMUNITY HEALTH, V27, P242; ReliefWeb Geneva, 2008, REC NAT DIS TURK OV; Robinson JJA, 2010, INT NURS REV, V57, P148, DOI 10.1111/j.1466-7657.2010.00822.x; Rodriguez J., 2008, ANN DISASTER STAT RE; Schmidt Cheryl K, 2011, Nurs Educ Perspect, V32, P380; Shishani K., 2009, DISASTER NURSING GOL; Tichy M., 2009, AM J NURSE PRACTITIO, V13, P10; Tillman P, 2011, J CONTIN EDUC NURS, V42, P404, DOI 10.3928/00220124-20110502-02; Unlu A, 2010, DISASTER PREV MANAG, V19, P155, DOI 10.1108/09653561011037977; Usher K., 2011, AUSTRALASIAN EMERGEN, V14, P75; Wisniewski R, 2004, J NURS ADMIN, V34, P475, DOI 10.1097/00005110-200410000-00009; World Health Organization [WHO]/ Europe, 2013, TURK HLTH SYST WELL; World Health Organization [WHO] Regional Offices for the Western Pacific and South-East Asia, 2012, AS PAC EM DIS NURS N	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7932	1742-7924		JPN J NURS SCI	Jpn. J. Nurs. Sci.	APR	2015	12	2					145	153		10.1111/jjns.12058		9	Nursing	Nursing	CF4NG	WOS:000352525300006		
J	Nagata, S; Matsunaga, A; Teramoto, C				Nagata, Satoko; Matsunaga, Atsushi; Teramoto, Chie			Follow-up study of the general and mental health of people living in temporary housing at 10 and 20 months after the Great East Japan Earthquake	JAPAN JOURNAL OF NURSING SCIENCE			English	Article						disaster nursing; mental health; sense of isolation; social network; temporary housing	PSYCHOLOGICAL DISTRESS; NATURAL DISASTERS	AimAn earthquake of magnitude 9.0 and accompanying tsunami struck the Tohoku region in northeast Japan on 11 March 2011. The purpose of this study was to observe evacuees' health status such as general health, psychological distress, and feeling of isolation over time. MethodsThe authors distributed a questionnaire survey to residents of temporary housing in January to March (time 1) and again in October to December of 2012 (time 2). ResultsTwo hundred respondents who filled out the questionnaire at both times were the subjects of this study. The self-reported general health in 39% and mental health status in 43.5% of the participants were poor at time 2. In addition, a higher percentage of participants felt a sense of isolation at time 2 even though more of the participants participated in community activities at that time. ConclusionThis result shows the evacuees' prolonged psychological distress and strengthening sense of isolation. It will be necessary to monitor them carefully and provide support continuously over the long term.	[Nagata, Satoko; Matsunaga, Atsushi; Teramoto, Chie] Univ Tokyo, Grad Sch Med, Dept Community Hlth Nursing, Tokyo 1130033, Japan	Nagata, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Community Hlth Nursing, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	satoko-tky@umin.ac.jp			Research Institute of Science and Technology for Society of the Japan Science and Technology Agency	The authors are grateful to all of the participants for their considerable cooperation. This study was conducted as a part of the project named "Community design for temporary housing sites in the tsunami-stricken area", which is funded by a research grant from the Research Institute of Science and Technology for Society of the Japan Science and Technology Agency.	Matsubayashi T, 2013, SOC SCI MED, V82, P126, DOI 10.1016/j.socscimed.2012.12.021; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Chen CH, 2007, COMPR PSYCHIAT, V48, P269, DOI 10.1016/j.comppsych.2006.12.003; Oyama Mari, 2012, Environmental Health and Preventive Medicine, V17, P118, DOI 10.1007/s12199-011-0225-y; Kolves K, 2013, J AFFECT DISORDERS, V146, P1, DOI 10.1016/j.jad.2012.07.037; Kawada T, 2009, GENDER MED, V6, P329, DOI 10.1016/j.genm.2009.04.001; Kawakami N, 2007, RES REGARDING STAT I, P13; Many M., 2012, J HUMAN BEHAV SOCIAL, V22, P436; National Police Agency, 2013, DAM SIT POL COUNT AS; Rao K, 2006, INT REV PSYCHIATR, V18, P501, DOI 10.1080/09540260601038472	11	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7932	1742-7924		JPN J NURS SCI	Jpn. J. Nurs. Sci.	APR	2015	12	2					162	165		10.1111/jjns.12051		4	Nursing	Nursing	CF4NG	WOS:000352525300008		
J	Hamamoto, Y; Inata, H; Sodeoka, N; Nakayama, S; Tsuruoka, S; Takeda, H; Manabe, T; Mochizuki, T; Umeda, M				Hamamoto, Yasushi; Inata, Hiroki; Sodeoka, Noritaka; Nakayama, Shigeki; Tsuruoka, Shintaro; Takeda, Hideki; Manabe, Toshiharu; Mochizuki, Teruhito; Umeda, Masakichi			Observation of intrafraction prostate displacement through the course of conventionally fractionated radiotherapy for prostate cancer	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Planning target volume; Prostate cancer; Intrafraction motion; Image-guided radiotherapy; CyberKnife	MOTION; MARGINS; IMPACT	Intrafraction prostate displacement (IFPD) through the course of conventionally fractionated radiotherapy was observed by real-time tracking. IFPD was observed by using a CyberKnife real-time tracking system over 39 serial fractions in two patients. Stereoscopic X-ray images tracking the implanted fiducial markers were obtained with mean intervals of 58 s. In preparation for treatment, urination was performed routinely 1 h before treatment and rectal gas was evacuated if necessary. Patients were immobilized by a thermoplastic body shell. The maximal absolute values of IFPD in all 78 fractions were 7.9, 2.1, and 11.5 mm in cranio-caudal (CC), left-right (LR), and antero-posterior (AP) direction, respectively. Only in 5 % of fractions (4/78 fractions), the maximal absolute values of IFPD were 5.0 mm or larger. In these fractions, large IFPD was temporary or persistent. IFPD of a parts per thousand yen3 mm was detected in only 2-3 % of all obtained tracking images. Daily maximal IFPD changed day by day. Although maximal IFPD was more than 10 mm, IFPD of a parts per thousand yen3 mm was observed in a comparatively small proportion of treatment time. Through the course of conventionally fractionated radiotherapy, fractions with IFPD of a parts per thousand yen5 mm were infrequent.	[Hamamoto, Yasushi; Inata, Hiroki; Sodeoka, Noritaka; Nakayama, Shigeki; Tsuruoka, Shintaro; Takeda, Hideki; Manabe, Toshiharu] Saiseikai Imabari Hosp, Dept Radiol, Imabari, Ehime 7991592, Japan; [Mochizuki, Teruhito] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime 7910295, Japan; [Umeda, Masakichi] Saiseikai Imabari Hosp, Dept Internal Med, Imabari, Ehime 7991592, Japan	Hamamoto, Y (reprint author), Saiseikai Imabari Hosp, Dept Radiol, 7-1-6 Kitamura, Imabari, Ehime 7991592, Japan.	yahamamot@gmail.com					Langsenlehner T, 2013, STRAHLENTHER ONKOL, V189, P321, DOI 10.1007/s00066-012-0303-0; Steiner E, 2013, INT J RADIAT ONCOL, V86, P755, DOI 10.1016/j.ijrobp.2013.02.035; Langen KM, 2008, INT J RADIAT ONCOL, V71, P1084, DOI 10.1016/j.ijrobp.2007.11.054; Bittner N, 2010, INT J RADIAT ONCOL, V77, P490, DOI 10.1016/j.ijrobp.2009.05.033; Xie YQ, 2008, INT J RADIAT ONCOL, V72, P236, DOI 10.1016/j.ijrobp.2008.04.051; Cramer Avilash K, 2013, BMC Med Phys, V13, P4, DOI 10.1186/1756-6649-13-4; Curtis W, 2013, INT J RADIAT ONCOL, V85, P700, DOI 10.1016/j.ijrobp.2012.05.044; Litzenberg DW, 2006, INT J RADIAT ONCOL, V65, P548, DOI 10.1016/j.ijrobp.2005.12.033; Mutanga TF, 2012, INT J RADIAT ONCOL, V83, P400, DOI 10.1016/j.ijrobp.2011.05.049; Shelton Jay, 2011, Pract Radiat Oncol, V1, P243, DOI 10.1016/j.prro.2011.02.008; Tanyi JA, 2010, INT J RADIAT ONCOL, V78, P1579, DOI 10.1016/j.ijrobp.2010.02.001; Yu Cheng, 2004, Neurosurgery (Hagerstown), V55, P1138, DOI 10.1227/01.NEU.0000141080.54647.11	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	APR	2015	33	4					187	193		10.1007/s11604-015-0396-3		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF9XK	WOS:000352920400002		
J	Koiwahara, G; Tsuda, T; Matsuda, M; Hirata, M; Tanaka, H; Hyodo, T; Kido, T; Mochizuki, T				Koiwahara, Gen; Tsuda, Takaharu; Matsuda, Megumi; Hirata, Masaaki; Tanaka, Hiroaki; Hyodo, Tomoko; Kido, Teruhito; Mochizuki, Teruhito			Different enhancement of the hepatic parenchyma in dynamic CT for patients with normal liver and chronic liver diseases and with the dose of contrast medium based on body surface area	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Contrast material; Body surface area (BSA); Computed tomography (CT); Cirrhosis; Contrast enhancement	MULTIDETECTOR-ROW CT; HYPERVASCULAR HEPATOCELLULAR-CARCINOMA; MATERIAL INJECTION PROTOCOL; PHASE HELICAL CT; WEIGHT; SEVERITY; MDCT; METASTASES; DURATION; IODINE	The purpose of this study was to characterize hepatic parenchymal enhancement for normal and diseased liver in dynamic computed tomography (CT) with the dose of contrast medium calculated on the basis of body surface area (BSA). The records of 328 consecutive patients who underwent triple-phase contrast-enhanced CT were retrospectively reviewed. The patients were divided into four groups: normal liver (n = 125), chronic hepatitis (CH) (n = 92), Child-Pugh grade A liver cirrhosis (LC-A) (n = 78), and Child-Pugh grade B liver cirrhosis (LC-B) (n = 33). All patients received 22 g I m(-2) as contrast material, calculated on the basis of BSA. CT values were measured in the region of interest during the pre-contrast, arterial, and portal phases, and the change in the CT value (Delta HU, where HU is Hounsfield units) compared with pre-contrast images was calculated. Mean Delta HU for the hepatic parenchyma for the normal liver, CH, LC-A, and LC-B groups during the portal phase was 55.5 +/- A 11.8 HU, 55.2 +/- A 12.5 HU, 50.0 +/- A 13.0 HU, and 43.0 +/- A 12.7 HU, respectively; generalized estimating equation analysis showed the differences were significant (p < 0.01). Hepatic parenchymal enhancement during the portal phase decreased as the severity of chronic liver damage increased.	[Koiwahara, Gen; Tsuda, Takaharu; Matsuda, Megumi; Hirata, Masaaki; Tanaka, Hiroaki; Kido, Teruhito; Mochizuki, Teruhito] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime 7910925, Japan; [Hyodo, Tomoko] Kinki Univ, Fac Med, Dept Radiol, Osaka 5898511, Japan	Koiwahara, G (reprint author), Ehime Univ, Grad Sch Med, Dept Radiol, 454 Shitukawa, Toon, Ehime 7910925, Japan.	gkoiwa@m.ehime-u.ac.jp					Hashimoto K, 2006, ONCOL REP, V16, P677; Kondo H, 2010, RADIOLOGY, V254, P163, DOI 10.1148/radiol.09090369; Bae KT, 2008, AM J ROENTGENOL, V190, P777, DOI 10.2214/AJR.07.2765; Kanematsu M, 2005, J COMPUT ASSIST TOMO, V29, P195, DOI 10.1097/01.rct.0000155062.50236.59; Foley WD, 2000, AM J ROENTGENOL, V175, P679; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Van Beers BE, 2001, AM J ROENTGENOL, V176, P667; Yamashita Y, 2000, RADIOLOGY, V216, P718; Bae KT, 1998, RADIOLOGY, V207, P647; HEIKEN JP, 1995, RADIOLOGY, V195, P353; Kondo H, 2013, EUR RADIOL, V23, P1855, DOI 10.1007/s00330-013-2808-z; Soyer P, 2004, RADIOLOGY, V231, P413, DOI 10.1148/radiol.2312021639; Yanaga Y, 2008, AM J ROENTGENOL, V190, P1003, DOI 10.2214/AJR.07.3129; Awai K, 2004, RADIOLOGY, V233, P682, DOI 10.1148/radiol.2333031617; Awai K, 2003, JPN J DIAGNOSTIC IMA, V23, P1017; FOLEY WD, 1989, RADIOLOGY, V170, P617; Furuta A, 2004, AM J ROENTGENOL, V183, P157; Haider MA, 2002, RADIOLOGY, V225, P137, DOI 10.1148/radiol.2251011225; Ho LM, 2007, RADIOLOGY, V243, P431, DOI 10.1148/radiol.2432060390; Ichikawa T, 2006, EUR J RADIOL, V58, P165, DOI 10.1016/j.ejrad.2005.11.037; Onishi H, 2011, EUR J RADIOL, V80, P643, DOI 10.1016/j.ejrad.2010.08.037; PARTANEN KPL, 1984, INVEST RADIOL, V19, P303, DOI 10.1097/00004424-198407000-00012; Shindera ST, 2011, RADIOLOGY, V260, P454; Tsushima Y, 1999, DIGEST DIS SCI, V44, P1632, DOI 10.1023/A:1026679430553; Vignaux O, 1999, AM J ROENTGENOL, V173, P1193; Yanaga Y, 2007, RADIOLOGY, V245, P475, DOI 10.1148/radiol.2452061749; Yanaga Y, 2010, AM J ROENTGENOL, V194, P903, DOI 10.2214/AJR.09.3460; Zissen MH, 2013, AM J ROENTGENOL, V201, P1204, DOI 10.2214/AJR.12.10039	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	APR	2015	33	4					194	200		10.1007/s11604-015-0398-1		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF9XK	WOS:000352920400003		
J	Ochi, T; Taoka, T; Miyasaka, T; Wada, T; Sakamoto, M; Hori, S; Kichikawa, K				Ochi, Tomoko; Taoka, Toshiaki; Miyasaka, Toshiteru; Wada, Takeshi; Sakamoto, Masahiko; Hori, Saeka; Kichikawa, Kimihiko			"Cerebellar peduncle quarter notes" formed by the superior and middle cerebellar peduncles: comparison with a diffusion tensor study of spinocerebellar degeneration	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Spinocerebellar degeneration; Superior cerebellar peduncle; Middle cerebellar peduncle; MRI; Diffusion tensor imaging	MULTIPLE SYSTEM ATROPHY; RESONANCE-IMAGING FINDINGS; CORTICOSPINAL TRACT; ANISOTROPY; MATTER; DISEASE; TRACTOGRAPHY	To investigate morphological changes of the superior and middle cerebellar peduncles (SCP, MCP) in spinocerebellar degeneration (SCD) by observing "cerebellar peduncle quarter notes". We examined 21 patients with SCD, including nine patients with multiple system atrophy cerebellar type (MSA-C), and 24 controls. We measured SCP angle and performed diffusion tensor analysis to quantify the apparent diffusion coefficient (ADC) and fractional anisotropy (FA) of the MCP. We quantified the relationship between SCP angle and the ADC and FA of the MCP, and compared these variables between MSA-C patients and controls. There was statistically significant negative correlation between SCP angle and FA of the MCP, and a positive correlation between SCP angle and the ADC of the MCP. Mean SCP angle was larger among MSA-C patients than among normal controls. SCP angle tended to be larger among patients with severe degeneration of the MCP. The SCP angle, quantified by observing "cerebellar peduncle quarter notes", may be a simple index for evaluation of degeneration of the MCP.	[Ochi, Tomoko; Taoka, Toshiaki; Miyasaka, Toshiteru; Wada, Takeshi; Sakamoto, Masahiko; Hori, Saeka; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Kashihara, Nara 6348522, Japan	Taoka, T (reprint author), Nara Med Univ, Dept Radiol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	ttaoka@naramed-u.ac.jp					Kim J, 2005, AM J NEURORADIOL, V26, P2224; Kin T, 2006, AM J NEURORADIOL, V27, P1463; Kunimatsu A, 2003, NEURORADIOLOGY, V45, P532, DOI 10.1007/s00234-003-0974-4; Molko N, 2001, STROKE, V32, P2049, DOI 10.1161/hs0901.094255; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Taoka T, 2007, NEUROIMAGE, V37, P387, DOI 10.1016/j.neuroimage.2007.05.028; Taoka T, 2009, AM J NEURORADIOL, V30, P1700, DOI 10.3174/ajnr.A1698; Wiegell MR, 2000, RADIOLOGY, V217, P897; Burk K, 1996, BRAIN, V119, P1497, DOI 10.1093/brain/119.5.1497; Deverdun J, 2014, EUR J RADIOL, V83, P2074, DOI 10.1016/j.ejrad.2014.07.012; KONAGAYA M, 1994, J NEUROL NEUROSUR PS, V57, P1528, DOI 10.1136/jnnp.57.12.1528; Murata Y, 1998, ARCH NEUROL-CHICAGO, V55, P1348, DOI 10.1001/archneur.55.10.1348; Shiga K, 2005, J NEUROL, V252, P589, DOI 10.1007/s00415-005-0708-0; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Tokumaru AM, 2003, J COMPUT ASSIST TOMO, V27, P241, DOI 10.1097/00004728-200303000-00023; Trivedi R, 2006, AM J NEURORADIOL, V27, P1712; Wang S, 2006, AM J NEURORADIOL, V27, P1234	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	APR	2015	33	4					210	215		10.1007/s11604-015-0409-2		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF9XK	WOS:000352920400005		
J	Sone, M; Nakajima, Y; Woodhams, R; Shioyama, Y; Tsurusaki, M; Hiraki, T; Yoshimatsu, M; Hyodoh, H; Kubo, T; Takeda, S; Minakami, H				Sone, Miyuki; Nakajima, Yasuo; Woodhams, Reiko; Shioyama, Yasukazu; Tsurusaki, Masakatsu; Hiraki, Takao; Yoshimatsu, Misako; Hyodoh, Hideki; Kubo, Takahiko; Takeda, Satoru; Minakami, Hisanori			Interventional radiology for critical hemorrhage in obstetrics: Japanese Society of Interventional Radiology (JSIR) procedural guidelines	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Postpartum hemorrhage; Placental abnormality; Arterial embolization; Guideline; Interventional radiology	UTERINE ARTERY EMBOLIZATION; PRIMARY POSTPARTUM HEMORRHAGE; TEMPORARY BALLOON OCCLUSION; INTERNAL ILIAC ARTERIES; ANGIOGRAPHIC EMBOLIZATION; CONSERVATIVE MANAGEMENT; CESAREAN HYSTERECTOMY; PLACENTA PERCRETA; SELECTIVE EMBOLIZATION; FERTILITY	There has been an increasing demand for interventional radiology (IR) procedures for the treatment of severe postpartum hemorrhage (PPH) (also called critical hemorrhage in obstetrics). The Japanese Society of Interventional Radiology Guideline Committee developed the practical guidelines for IR procedures for severe PPH using evidence-based methodology. This article aimed to describe the rationale for developing these guidelines and to provide the answers for clinical questions about IR procedures consisting of current available evidence and the consensus among experts.	[Sone, Miyuki] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo 1040045, Japan; [Nakajima, Yasuo; Yoshimatsu, Misako] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan; [Woodhams, Reiko] Kitasato Univ, Sch Med, Dept Diagnost Radiol, Sagamihara, Kanagawa 228, Japan; [Shioyama, Yasukazu] Dokkyo Med Univ, Sch Med, Dept Radiol, Soka, Japan; [Tsurusaki, Masakatsu] Kinki Univ, Sch Med, Dept Radiol, Higashiosaka, Osaka 577, Japan; [Hiraki, Takao] Okayama Univ, Dept Radiol, Okayama 7008530, Japan; [Hyodoh, Hideki] Sapporo Med Univ, Dept Radiol, Sapporo, Hokkaido, Japan; [Kubo, Takahiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fatal Neonatal & Reprod Med, Div Obstet, Tokyo, Japan; [Takeda, Satoru] Juntendo Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Minakami, Hisanori] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan	Sone, M (reprint author), Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	msone@athena.ocn.ne.jp					HEASTON DK, 1979, AM J ROENTGENOL, V133, P152; Winograd RH, 2008, BEST PRACT RES CL OB, V22, P1119, DOI 10.1016/j.bpobgyn.2008.08.009; Katsumori T, 2006, CARDIOVASC INTER RAD, V29, P1077, DOI 10.1007/s00270-006-0059-y; Ratnam LA, 2008, J OBSTET GYNAECOL, V28, P573, DOI 10.1080/01443610802273374; Gaia G, 2009, EUR RADIOL, V19, P481, DOI 10.1007/s00330-008-1140-5; Hansch E, 1999, AM J OBSTET GYNECOL, V180, P1454, DOI 10.1016/S0002-9378(99)70036-0; Boulleret C, 2004, CARDIOVASC INTER RAD, V27, P344, DOI 10.1007/s00270-303-2698-6; Ojala K, 2005, ACTA OBSTET GYN SCAN, V84, P1075, DOI 10.1111/j.0001-6349.2005.00727.x; Salomon LJ, 2003, HUM REPROD, V18, P849, DOI 10.1093/humrep/deg168; Sewell MF, 2006, OBSTET GYNECOL, V108, P746, DOI 10.1097/01.AOG.0000201992.80130.2c; Weeks SM, 2000, J VASC INTERV RADIOL, V11, P622, DOI 10.1016/S1051-0443(07)61615-7; BROWN BJ, 1979, OBSTET GYNECOL, V54, P361; Pelage JP, 1998, RADIOLOGY, V208, P359; Kirby JM, 2009, J VASC INTERV RADIOL, V20, P1036, DOI 10.1016/j.jvir.2009.04.070; Eriksson LG, 2007, ACTA RADIOL, V48, P635, DOI 10.1080/02841850701370683; Clement D, 2004, EUR J OBSTET GYN R B, V114, P108, DOI 10.1016/j.ejogrb.2003.06.008; Porcu G, 2005, BJOG-INT J OBSTET GY, V112, P122, DOI 10.1111/j.1471-0528.2005.00306.x; Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Berkane N, 2010, CURR OPIN OBSTET GYN, V22, P242, DOI 10.1097/GCO.0b013e328338c179; Glomset O, 2006, ACTA RADIOL, V47, P179, DOI 10.1080/02841850500447211; Maassen MS, 2009, BJOG-INT J OBSTET GY, V116, P55, DOI 10.1111/j.1471-0528.2008.01939.x; Dubois J, 1997, AM J OBSTET GYNECOL, V176, P723, DOI 10.1016/S0002-9378(97)70582-9; Chauleur C, 2008, HUM REPROD, V23, P1553, DOI 10.1093/humrep/den122; Shih JC, 2005, AM J OBSTET GYNECOL, V193, P1756, DOI 10.1016/j.ajog.2005.08.033; Breathnach F, 2007, J OBSTET GYNAECOL, V27, P195, DOI 10.1080/01443610601137879; Cheng Yung-Yi, 2003, J Chin Med Assoc, V66, P727; Cheong Ji Yoon, 2014, Obstet Gynecol Sci, V57, P17, DOI 10.5468/ogs.2014.57.1.17; Chitrit Y, 2006, EUR J OBSTET GYN R B, V127, P140, DOI 10.1016/j.ejogrb.2004.01.047; Chung JW, 2003, J REPROD MED, V48, P268; Cordonnier C, 2002, EUR J OBSTET GYN R B, V103, P183, DOI 10.1016/S0301-2115(02)00029-5; Courbiere B, 2008, EUR J OBSTET GYN R B, V140, P291, DOI 10.1016/j.ejogrb.2008.03.012; Delotte J, 2009, EUR J OBSTET GYN R B, V145, P129, DOI 10.1016/j.ejogrb.2009.03.013; Deux JF, 2001, AM J ROENTGENOL, V177, P145; Fiori O, 2009, AM J OBSTET GYNECOL, V200, P384; GILBERT WM, 1992, AM J OBSTET GYNECOL, V166, P493; Goldberg J, 2002, OBSTET GYNECOL, V100, P869, DOI 10.1016/S0029-7844(02)02347-5; GREENWOOD LH, 1987, RADIOLOGY, V164, P155; Mathe ML, 2007, J PERINAT MED, V35, P532, DOI 10.1515/JPM.2007.113; Murakami R, 2000, CLIN IMAG, V24, P368, DOI 10.1016/S0899-7071(01)00235-2; Mushtaq S, 2007, J OBSTET GYNAECOL, V27, P853, DOI 10.1080/01443610701748658; Pelage JP, 1999, RADIOLOGY, V212, P385; RCOG, 2007, ROL EM EL INT RAD PO; Shim JY, 2006, ACTA OBSTET GYN SCAN, V85, P815, DOI 10.1080/00016340500438652; Timmermans S, 2007, OBSTET GYNECOL SURV, V62, P529, DOI 10.1097/01.ogx.0000271133.27011.05; Toda J, 2009, RADIOLOGY, V24, P134; Touboul C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003819; Tse Gary, 2010, Tech Vasc Interv Radiol, V13, P148, DOI 10.1053/j.tvir.2010.03.002; Tseng Shih-Hui, 2006, Taiwan J Obstet Gynecol, V45, P150; van Nieuwkoop C, 2008, AM J OBSTET GYNECOL, V199, pe1; Vegas G, 2006, EUR J OBSTET GYN R B, V127, P68, DOI 10.1016/j.ejogrb.2005.09.008; YAMASHITA Y, 1994, BRIT J RADIOL, V67, P530	51	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	APR	2015	33	4					233	240		10.1007/s11604-015-0399-0		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF9XK	WOS:000352920400010		
J	Nakajima, I				Nakajima, Ikuyo			Characterization of PSPA Cell Differentiation, an Established Pig Preadipocyte Cell Line as an In Vitro Model for Pig Fat Development	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Review						3T3-L1; extracellular matrix; fatty acid; pig backfat; subcutaneous adipose tissue	STROMAL-VASCULAR CELLS; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; CLONAL LINE; PRIMARY CULTURE; MEAT QUALITY; INSULIN; MOUSE; WHITE; OCTANOATE	We have established a clonal porcine subcutaneous preadipocyte cell line for the first time. This cell line, named PSPA, shows a fibroblast-like phenotype and keeps on growing under growth medium even after reaching confluence. Adipose conversion occurs only when confluent cultures are stimulated with insulin, dexamethasone, biotin, pantothenate, and octanoate. Following exposure to this differentiation medium, growth was arrested immediately without mitotic expansion and PSPA cells exhibited a marked increase in intracellular lipid accumulation accompanied by changes in gene expressions directly related to fat metabolism and also in extracellular environments. Since PSPA cells were established, it has become possible to end the discussion over whether there is species specificity in the adipose conversion between pig and mouse by comparing PSPA cells and 3T3-L1 cells, the most widely studied preadipocyte cell line. Consequently, we demonstrated that responsiveness to inducers and fatty acid composition was unequal, despite being treated with the same media. Thus, species-specific differences indeed exist in adipogenesis between these two, meaning that PSPA cells would be an in vitro model specialized to improve understanding of pig adipocyte growth and differentiation in controlling the carcass fat content of pigs.	NARO, Natl Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki 3050901, Japan	Nakajima, I (reprint author), NARO, Natl Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki 3050901, Japan.	ikuyon@affrc.go.jp					Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Kubo Y, 2000, IN VITRO CELL DEV-AN, V36, P38; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Nakajima I, 2002, BIOL CELL, V94, P197, DOI 10.1016/S0248-4900(02)01189-9; Nakajima I, 2003, BIOCHEM BIOPH RES CO, V309, P702, DOI 10.1016/j.bbrc.2003.08.057; AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nutr.12.1.207; Bonneau M, 2010, MEAT SCI, V84, P293, DOI 10.1016/j.meatsci.2009.03.013; GLENN KC, 1992, ENDOCRINOLOGY, V131, P1115, DOI 10.1210/en.131.3.1115; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Wood JD, 1999, P NUTR SOC, V58, P363, DOI 10.1017/S0029665199000488; Gregoire FM, 2001, EXP BIOL MED, V226, P997; CHRISTIE WW, 1991, J AM OIL CHEM SOC, V68, P695, DOI 10.1007/BF02662155; de Vries AG, 2000, FOOD CHEM, V69, P397, DOI 10.1016/S0308-8146(00)00049-2; FOREST C, 1987, EXP CELL RES, V168, P218, DOI 10.1016/0014-4827(87)90430-7; Gerfault V, 1999, GEN COMP ENDOCR, V114, P396, DOI 10.1006/gcen.1999.7271; HENTGES EJ, 1989, DOMEST ANIM ENDOCRIN, V6, P275, DOI 10.1016/0739-7240(89)90021-0; Ibrahimi Y., 1992, BIOCHEM BIOPH RES CO, V187, P1314; Irie Seiichi, 2012, Japanese Journal of Swine Science, V49, P150; KURIHARCUCH W, 1984, DIFFERENTIATION, V28, P173, DOI 10.1111/j.1432-0436.1984.tb00280.x; Martien, 2012, NATURE, V491, P393; Matsumoto T, 2012, ANIM GENET, V43, P535, DOI 10.1111/j.1365-2052.2011.02310.x; Nakajima I, 2002, DIFFERENTIATION, V70, P84, DOI 10.1046/j.1432-0436.2002.700203.x; NAPOLITANO L, 1963, J CELL BIOL, V18, P663, DOI 10.1083/jcb.18.3.663; NEGREL R, 1978, P NATL ACAD SCI USA, V75, P6054, DOI 10.1073/pnas.75.12.6054; SMAS CM, 1995, BIOCHEM J, V309, P697; SURYAWAN A, 1993, COMP BIOCHEM PHYS A, V105, P485, DOI 10.1016/0300-9629(93)90424-3; Suzuki S, 2008, BIOSCI BIOTECH BIOCH, V72, P1212, DOI 10.1271/bbb.706741; Taniguchi M, 2014, MOL BIOL REP, V41, P1081, DOI 10.1007/s11033-013-2954-z	28	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					85	90				6	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200001		
J	Hayama, H				Hayama, Hiroko			Water-Soaked Brown Flesh Disorders in Peach Fruit (Prunus persica (L.) Batsch)	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Review						browning; fruit quality; physiological disorder; watercore	POLYPHENOLOXIDASE ACTIVITY	Water-soaked brown flesh disorder of peach (Prunus persica (L.) Batsch) fruit, which occurs in unpicked fruit near harvest time, has been a problem in Japan since the 1990s. The affected fruit share the characteristics of more mature fruit in that the fruit are large, sweet, and soft. It has also transpired that high-quality; high-value fruit are more sensitive to the disorder, which exacerbates economic losses. The most susceptible regions of the fruit are those with high sugar content, although the symptoms are not clearly linked to specific cultivars. Investigations into the cause(s) of water-soaked brown flesh disorder of peach fruit have just started, and reports are limited to Japan. In this review, published information about the disorder is reviewed, and a hypothesis for the occurrence of water-soaked brown flesh disorder in peaches is presented.	NARO, Inst Fruit Tree Sci, Plant Physiol & Fruit Chem Div, Tsukuba, Ibaraki 3058605, Japan	Hayama, H (reprint author), NARO, Inst Fruit Tree Sci, Plant Physiol & Fruit Chem Div, Tsukuba, Ibaraki 3058605, Japan.	hhiroko@affrc.go.jp					VAUGHN KC, 1988, PHYSIOL PLANTARUM, V72, P659, DOI 10.1111/j.1399-3054.1988.tb09180.x; [Anonymous], 2011, HORT RES JAPAN S2; LEE CY, 1990, J AGR FOOD CHEM, V38, P99, DOI 10.1021/jf00091a019; CHENG GWW, 1995, J AM SOC HORTIC SCI, V120, P835; Fujii Y., 2012, HORT RES JAPAN S2, V11, P138; Fujii Y., 2011, HORT RES JAPAN S2, V10, P385; Fujimaru O., 2005, RES KUMAMOTO PREF AG, V13, P93; Furuya S., 2011, B YAMANASHI FRUIT TR, V13, P57; Hagihara E., 2009, HORT RES JAPAN S2, V8, P424; Hagihara E., 2014, B YAMANASHI FRUIT TR, V13, P57; Hayama H., 2007, HORT RES JAPAN S2, V6, P468; Hayama H., 2006, HORT RES JAPAN, V6, P201; Higashi M., 2001, KYUSYU NOGYO KENKYU, V63, P228; Iwatani A., 2009, RES B KUMAMOTO AGR R, V17, P35; Marlow G. C., 1984, Horticultural Reviews, V6, P189; Mathew A. G., 1971, Advances in Food Research, V19, P75, DOI 10.1016/S0065-2628(08)60031-2; MAYER AM, 1987, PHYTOCHEMISTRY, V26, P11; Ooura A., 2011, HORT RES JAPAN S2, V10, P387; Saito N., 2002, HORT RES JAPAN S1, V71, P210; Takata Daisuke, 2005, Horticultural Research (Japan), V4, P429, DOI 10.2503/hrj.4.429; Takata D., 2006, THESIS OKAYAMA U; Tezuka T., 2012, HORT RES JAPAN S2, V11, P354; Tsutani K., 2009, HORT RES JAPAN S2, V8, P159; Yamane T., 2010, HORT RES JAPAN S1, V9, P75; Yamane T., 2013, HORT RES JAPAN S1, V12, P74; Yasukawa H., 2006, KINKI CHUGOKU AGR RE, V8, P103	26	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					91	95				5	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200002		
J	Shoda, D; Kawamoto, O; Yoshisako, H; Inoue, K				Shoda, Daisuke; Kawamoto, Osamu; Yoshisako, Hiroshi; Inoue, Keisuke			Prediction of Inundation Areas Due to Failure in Small Earthfill Dam Using Numerical Analysis	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						analysis of inundation; dam for irrigation; heavy rain; outflow		This study aimed to verify the accuracy of inundation analysis by comparison with field-survey results for a small agricultural earthfill dam that failed due to heavy rain. In Japan, dam failures are caused by concentrated heavy rain or large earthquakes. Potential inundation areas are displayed on municipal "Hazard Maps" to reduce the risk of damage to downstream sites. However, the accuracy of inundation analysis for small earthfill dams has never been verified through comparison with field surveys. The following work was completed; i) the effect on the downstream gradient was verified by a simplified (one-dimensional unsteady flow) analysis for a case of dam failure; ii) the water depth and width of flow path in inundation areas were compared based on differences in peak outflow; and iii) the effect of the culvert structure blocked by flood debris downstream was also verified by comparing the result of analysis and the field survey. The following results were obtained: i) From the simplified analysis, the downstream water depth was sensitive to changes in outflow distribution from the dam breach section: ii) In the inundation analysis, using the peak outflow prediction equation proposed by Costa (1988), the water depth was deeper at the center of the flow path and the flow path was wider: iii) The water depth around the blocked culvert structure matched the field-survey results (the elevation data of the meshes around the culvert structure were raised to simulate the blocked structure).	[Shoda, Daisuke; Kawamoto, Osamu; Yoshisako, Hiroshi; Inoue, Keisuke] Natl Agr & Food Res Org NARO, Natl Inst Rural Engn, Fac & Geotech Engn Res Div, Tsukuba, Ibaraki 3058609, Japan	Shoda, D (reprint author), Natl Agr & Food Res Org NARO, Natl Inst Rural Engn, Fac & Geotech Engn Res Div, Tsukuba, Ibaraki 3058609, Japan.	dshoda@affrc.go.jp					Costa J., 1988, FLOOD GEOMORPHOLOGY, P436; FROEHLICH DC, 1995, J WATER RES PL-ASCE, V121, P90, DOI 10.1061/(ASCE)0733-9496(1995)121:1(90); Greg H., 2007, NATL DAM SAFETY PROG; Hughes A., 2000, RISK MANAGEMENT UK R; Inoue K., 2009, NOUGYONOUSONKOUGAKKA, V77, P7; Japan Society of Civil Engineers, 1999, HYDR FORM JSCE1999, P131; Kuriki M., 1997, MANUAL INUNDATION AN; Satofuka Y., 2007, SUIK RONB, P901; Tani S., 2009, NOUSONKOUGAKU KENKYU, V210, P137; Uno K., 2010, SUIK RONB, P865; Yasuda H., 2003, DOBOKUGAKKAI RONBUNS, V740/II-64, P1	11	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					97	102				6	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200003		
J	Matsukawa, M; Ito, K; Kawakita, K; Tanaka, T				Matsukawa, Mizuki; Ito, Kasumi; Kawakita, Kazuhito; Tanaka, Toshiharu			Farmer Perceptions and Management of Rice Planthoppers in Cambodia	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						brown planthopper; control; flow of information	DIFFUSION	Solving big problems requires accurate information. Rice in the area of Cambodia near Vietnam was extensively damaged by the brown planthopper (BPH) from 2007 to 2009, with all districts in Takeo province in the area of Cambodia near Vietnam severely affected. How did farmers learn of methods to protect rice plants? This study seeks to reveal how methods to control the BPH were diffused in Cambodia through interviews with farmers, local governmental officials, and village chiefs in the target province. The farmers stated that they controlled the BPH with nets and beating as physical controls and spraying mixed oil & ash and chemical pesticides as chemical controls. They tended to source their own information and experiences of neighbors, government officials, and pesticide sellers, while farmers in three communes very severely affected by the BPH infestation followed the advice of sellers in employing pesticides. Further, most local government officials and village chiefs recommended using nets and spraying oil mixtures and chemical pesticides. The flow of information from the resource to individual farmers seemed to be linked to the level of BPH infestation.	[Matsukawa, Mizuki; Kawakita, Kazuhito; Tanaka, Toshiharu] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ito, Kasumi] Nagoya Univ, Int Cooperat Ctr Agr Educ, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Matsukawa, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	matsukawa.mizuki@c.mbox.nagoya-u.ac.jp					Morone P, 2004, J EVOL ECON, V14, P327, DOI 10.1007/s00191-004-0211-2; Yorobe JM, 2011, AGR SYST, V104, P580, DOI 10.1016/j.agsy.2011.05.001; Ryan B, 1943, RURAL SOCIOL, V8, P15; Matsukawa M, 2014, JARQ-JPN AGR RES Q, V48, P167; DENNO RF, 1990, ANNU REV ENTOMOL, V35, P489; Gurr GM, 2011, ANN APPL BIOL, V158, P149, DOI 10.1111/j.1744-7348.2010.00455.x; Dyck V.A., 1979, BROWN PLANTHOPPER TH, P3; Heong K. L, 2013, ADB SUSTAINABLE DEV; Heong KL, 1998, INT J PEST MANAGE, V44, P191, DOI 10.1080/096708798228095; Huis Van, 1997, INT J PEST MANAGE, V43, P313; IRRI, 1983, FIELD PROBL TROP RIC; JICA-Cambodia, 2012, FIN REP CAP BUILD QU; Jintana C., 2012, INSECTICIDE APPL FAR; Matsumura M, 2010, JARQ-JPN AGR RES Q, V44, P225; Nathaniels NQR, 2003, INT J PEST MANAGE, V49, P25, DOI 10.1080/09670870210154109; Nootjarin J., 2012, ECOLOGICAL ENG RICE; Okamoto D., 1992, ORIGINAL SCENERY INS, P348; Paul V. M, 2001, INT J PEST MANAGE, V47, P7; Stephanie D. G, 2008, INT J PEST MANAGE, V54, P95; Sukanya A, 2013, STATE INSECTICIDE RE; Sylviane N. V, 2002, DEATH SMALL DOSES CA; HIBINO H, 1985, PHYTOPATHOLOGY, V75, P894, DOI 10.1094/Phyto-75-894; Williamson S, 2003, INT J PEST MANAGE, V49, P187, DOI 10.1080/0967087031000085015; World Bank, 1998, WORLD DEV REP 1998 1	24	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					103	109				7	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200004		
J	Mostafa, H; Fujimoto, N				Mostafa, Harby; Fujimoto, Naoya			Monitoring and Evaluation of Irrigation Management Projects in Egypt	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						canal; drainage; Nile; water resource		The fewer the water resources, the greater the demand and the more important water becomes. This applies in Egypt, where rainfall is rare and most of the country is desert, except for a narrow strip of cultivated land and urban areas along the Nile river course. Like other large rivers, the Nile Delta region is characterized by large tracts of rich fertile agricultural land, overpopulation and unique and delicate environmental conditions caused by mixing drainage and freshwater. Managing these unique natural resource areas has become increasing critical, given the threat to the ecological balance in these areas due to an increase in water exploitation to boost population and the development of resources. Accordingly, the performance of water-delivery systems, particularly irrigation systems, must be clearly defined and assessed under these current or expected stressed conditions. This paper highlights irrigation, drainage and water-management projects in Egypt and presents the positive and negative effects as well as the role of government and users in operating and maintaining the system. The objective is to identify significant research programs and projects carried out over the last three decades that have impacted on irrigated agricultural practices in Egypt. The study documents both successful and failed cases of direct and indirect research uptake. Specific recommendations for increasing the research uptake, improving the penetration of research results and taking corrective measures to strengthen and encourage research uptake to irrigation and drainage practices are highlighted.	[Mostafa, Harby] Benha Univ, Fac Agr, Dept Agr Engn, Moshtohor 13736, Kalyobia, Egypt; [Fujimoto, Naoya] JIRCAS, Tsukuba, Ibaraki 3058686, Japan	Fujimoto, N (reprint author), JIRCAS, Tsukuba, Ibaraki 3058686, Japan.	NaoyaFujimoto@gakushikai.jp			Japan International Research Center for Agricultural Sciences (JIRCAS); Benha university	The authors would like to extend sincere gratitude and appreciation to the Japan International Research Center for Agricultural Sciences (JIRCAS) and Benha university (http://www.bu.edu.eg) for the financial support and opportunity to fulfill this study through the JIRCAS Visiting Research Fellowship Program.	Molden D, 2010, AGR WATER MANAGE, V97, P528, DOI 10.1016/j.agwat.2009.03.023; Bos M. G., 2005, PRACTICAL GUIDELINES; Drainage Research Institute (DRI), 2007, SAL GROUNDW DRAIN WA; El Kashef A., 2012, FIN DOC PROD DISC VA; El-Agha D. E., 2011, Irrigation and Drainage Systems, V25, P215, DOI 10.1007/s10795-011-9116-z; El-Gendy A. M., 2011, SUSTAINABLE USE AGR; FAO, 2007, WORLD WATER DAY 0322, V22; International Fund for Agricultural Development (IFAD), 2012, NEW RES BAS COUNTR S; International Programme for Technology and Research in Irrigation and Drainage (IPTRID), 2007, EG EXP IRR DRAIN RES; Japan International Cooperation Agency (JICA), 2011, PART IRR MAN SYST JA, P125; Jensen M. E., 1990, AGRONOMY MONOGRAPH, V30, P31; Ministry of Agriculture and Land Reclamation (MALR), 2009, SUST AGR DEV STRAT; Ministry of Water Resources and Irrigation, 2005, NAT WAT RES PLAN NWR; Molden D. J., 2007, RES REPORT; World Bank, 2007, ICR0000442 WORLD BAN	15	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					111	118				8	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200005		
J	Furuya, J; Tokunaga, S; Okiyama, M; Akune, Y; Kunimitsu, Y; Aizaki, H; Kobayashi, S				Furuya, Jun; Tokunaga, Suminori; Okiyama, Mitsuru; Akune, Yuko; Kunimitsu, Yoji; Aizaki, Hideo; Kobayashi, Shintaro			Economic Evaluation of Agricultural Mitigation and Adaptation Technologies for Climate Change: Model Development for Impact Analysis and Technological Assessment	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Review						Choice experiment; Dynamic computable general-equilibrium model; Regional production model; World-food model	TEMPERATURE; YIELD	Agricultural mitigation and adaptation technologies developed and assessed in a project organized by the Agriculture, Forestry, and Fisheries Research Council were evaluated on an economic basis using a regional-production model, an applied general-equilibrium model, a discrete choice experiment, and a world-food model. Climate-change effects on food production were also evaluated using these models. This paper presents: (1) an overview of the sub-project structure and goals, (2) the six results of the sub-project, and (3) the future direction of the sub-project. Results of these models were subsequently integrated into a single regional model, whereupon selected technologies were economically evaluated using the models developed in the sub-project. The main results are as follows: (1) delaying the introduction of high-temperature-tolerant rice by one year will result in an average economic welfare losses of 429 million yen per year in Japan; (2) higher temperatures under RCP4.5 scenario will cause an increase in 0.2 t ha(-1) rice yield in Japan in 2040s compared to a constant climate variables case; (3) the target reduction rate of GHG, which is 25% of the 1990 figure, will imply benefit-cost ratios greater than one for most CH4-suppression technologies developed in the project.	[Furuya, Jun; Kobayashi, Shintaro] Japan Int Res Ctr Agr Sci, Social Sci Div, Tsukuba, Ibaraki 3058686, Japan; [Tokunaga, Suminori; Akune, Yuko] Reitaku Univ, Fac Econ & Business Adm, Kashiwa, Chiba 2778686, Japan; [Okiyama, Mitsuru] Reitaku Univ, Reitaku Inst Polit Econ & Social Studies, Kashiwa, Chiba 2778686, Japan; [Kunimitsu, Yoji] Natl Agr & Food Res Org, Natl Inst Rural Engn, Rural Dev & Planning Div, Tsukuba, Ibaraki 3058609, Japan; [Aizaki, Hideo] Hokkaido Univ, Grad Sch Agr, Res Fac Agr, Chair Agr & Resource Econ,Div Biosyst Sustainabil, Sapporo, Hokkaido 0608589, Japan	Furuya, J (reprint author), Japan Int Res Ctr Agr Sci, Social Sci Div, Tsukuba, Ibaraki 3058686, Japan.	furuya@affrc.go.jp					Aizaki H, 2015, JARQ-JPN AGR RES Q, V49, P143, DOI 10.6090/jarq.49.143; Aizaki H., 2014, TECHNICAL DATA SUBJE, V215, P219; Akune Y, 2015, JARQ-JPN AGR RES Q, V49, P127, DOI 10.6090/jarq.49.127; Iizumi T, 2011, CLIMATIC CHANGE, V107, P391, DOI 10.1007/s10584-010-9990-7; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Tran TA, 2008, TECHNOL FORECAST SOC, V75, P1396, DOI 10.1016/j.techfore.2008.04.004; West JW, 2003, J DAIRY SCI, V86, P232, DOI 10.3168/jds.S0022-0302(03)73602-9; Furuya J, 2005, JARQ-JPN AGR RES Q, V39, P121; Furuya J, 2015, JARQ-JPN AGR RES Q, V49, P187, DOI 10.6090/jarq.49.187; Intergovernmental Panel on Climate Change, 2013, WORK GROUP 1 CONTR I, P36; Kassam AH, 1979, 33 FAO, P193; Kawatsu S., 2007, Japanese Journal of Crop Science, V76, P423, DOI 10.1626/jcs.76.423; Kobayashi S., 2012, PAPERS ENV INFORM SC, V24, P19; Kobayashi S, 2015, JARQ-JPN AGR RES Q, V49, P135, DOI 10.6090/jarq.49.135; Kunimitsu Y, 2015, JARQ-JPN AGR RES Q, V49, P173, DOI 10.6090/jarq.49.173; Yagi K, 2013, SOIL SCI PLANT NUTR, V59, P1, DOI 10.1080/00380768.2013.766086	16	1	1	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					119	125				7	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200006		
J	Akune, Y; Okiyama, M; Tokunaga, S				Akune, Yuko; Okiyama, Mitsuru; Tokunaga, Suminori			Economic Evaluation of Dissemination of High Temperature-Tolerant Rice in Japan Using a Dynamic Computable General Equilibrium Model	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						economic welfare loss; farm size; multi-types of household; rice quality		This paper uses the dynamic computable general equilibrium (DCGE) model to evaluate the economic impact of technologies developed to foster adaptation to climate change in domestic rice production, related food industries, and economic welfare in Japan, where high temperatures in 2010 led to rice quality deteriorating and other serious problems over and above a mere decline in output. Three scenarios were simulated: one without temperature change, one with temperature change but rice cultivars unchanged, and one with both an increase in temperature and the adoption of high temperature-tolerant rice varieties. Our simulations indicate that new rice cultivars with high temperature tolerance would reduce economic welfare losses from 264 to 118 billion yen during the simulation period. Paddy-rice farming production increased because product prices increased. Farming inputs also rose correspondingly, triggering an increase in agricultural land rents. Non-agricultural household and small-scale paddy rice-growing household suffered welfare loss. Conversely, medium- and large-scale paddy rice-growing and other farming households saw their welfare boosted. These differences were attributable to the impact of changes in agricultural land rents to their total income. All impacts, not only on economic welfare but also production in the case with new cultivars of high temperature-tolerant rice were smaller than in the those without such cultivars, which indicates that adopting new adaptive technologies eases the economic impact of a warmer climate.	[Akune, Yuko; Okiyama, Mitsuru; Tokunaga, Suminori] Reitaku Univ, Fac Econ & Business Adm, Kashiwa, Chiba 2778686, Japan	Akune, Y (reprint author), Reitaku Univ, Fac Econ & Business Adm, Kashiwa, Chiba 2778686, Japan.	yakune@reitaku-u.ac.jp					Adi B., 2006, STUD REGION SCI, V35, P1021, DOI 10.2457/srs.35.1021; Iizumi T, 2011, CLIMATIC CHANGE, V107, P391, DOI 10.1007/s10584-010-9990-7; Tanaka T, 2011, FOOD POLICY, V36, P368, DOI 10.1016/j.foodpol.2011.01.002; ARMINGTON PS, 1969, INT MONET FUND S PAP, V16, P159; Dixon P.B., 2002, CONTRIBUTIONS EC ANA, V256; Fukuda Y., 2012, NOUGYOU KEIZAI KENKY, V84, P1; Hosoe N, 2010, TEXTBOOK OF COMPUTABLE GENERAL EQUILIBRIUM MODELLING: PROGRAMMING AND SIMULATIONS, P1, DOI 10.1057/9780230281653; Kawatsu S., 2007, Japanese Journal of Crop Science, V76, P423, DOI 10.1626/jcs.76.423; Kunimitsu Y., 2009, J RURAL EC, P59; Lofgren Hans, 2002, MODEL GAMS MICROCOMP, V5; Ministry of Agriculture Forestry and Fisheries of Japan, 2001, EFF RIC HIGH TEMP TE	11	1	1	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					127	133				7	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200007		
J	Kobayashi, S; Furuya, J				Kobayashi, Shintaro; Furuya, Jun			Development of a Tool for Socio-Economic Evaluation of Agricultural Technologies Directed toward Adaptation to Climate Change	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						CGE model; initial evaluation; input-output model; spreadsheet		In the present world affected by climate change, developing agricultural technologies to adapt to climate change is one of the most important challenges to mitigate the impacts of climate change on food security. In fact, many researchers and engineers are also working to develop adaptation technologies. If there is a low-cost, easy-to-use tool to evaluate such technologies, it will facilitate initial evaluation to consider the appropriate technical development perspective. Accordingly, this paper tries to develop a simple model structure for the tool and consider how best to use the evaluation tool, based on the achievements of a previous study. To enable simple calculations in a spreadsheet, an input-output model is applied to the model structure, assuming minimal impact of shocks on national nominal income. Comparisons of projection results by two alternative candidate models with those by a comprehensive but complex simulation model including flexible and realistic assumptions show that the developed simple models result in realistic and robust projections of real consumption and social welfare index. Accordingly, an evaluation tool based on simple model structures will enable a low-cost initial evaluation with social welfare as a criterion.	[Kobayashi, Shintaro; Furuya, Jun] Japan Int Res Ctr Agr Sci, Social Sci Div, Tsukuba, Ibaraki 3058686, Japan	Kobayashi, S (reprint author), Japan Int Res Ctr Agr Sci, Social Sci Div, Tsukuba, Ibaraki 3058686, Japan.	shinkoba@affrc.go.jp			research project "Economic Evaluation of Agricultural Mitigation and Adaptation Technologies for Climate Change" - the Agriculture, Forestry, and Fisheries Research Council (AFFRC) of Japan; research project "Development of Agricultural Technologies based on Sustainable Management of Environment and Natural Resources in Developing Regions" - Japan International Research Center for Agricultural Sciences (JIRCAS); AFFRC; JIRCAS	This study is part of both research project "Economic Evaluation of Agricultural Mitigation and Adaptation Technologies for Climate Change" funded by the Agriculture, Forestry, and Fisheries Research Council (AFFRC) of Japan and research project "Development of Agricultural Technologies based on Sustainable Management of Environment and Natural Resources in Developing Regions" funded by Japan International Research Center for Agricultural Sciences (JIRCAS). The financial supports provided by AFFRC and JIRCAS are gratefully acknowledged.	Trenberth KE, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Easterling W. E, 2007, CLIMATE CHANGE 2007, V4, P273; Kim H. B., 2001, REG STUD, V35, P103; Kobayashi S., 2012, KANKYO JYOHO KAGAKU, V26, P19; Kobayashi S., 2008, STUDIES REGIONAL SCI, V38, P137, DOI 10.2457/srs.38.137; Leontief W., 1941, STRUCTURE AM EC 1919, P181; Mas-Colell A., 1995, MICROECONOMIC THEORY, P80; Miller R. E., 2009, INPUT OUTPUT ANAL FD, P679; Statistics Bureau, 2012, INP OUTP TABL JAP	9	1	1	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					135	141				7	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200008		
J	Aizaki, H				Aizaki, Hideo			Examining Substitution Patterns Between Domestic and Imported Agricultural Products for Broccoli, Kiwifruit, Rice and Apples in Japan	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						discrete choice experiment; Japanese consumer; price elasticity of choice probability; stated preference method	CONSUMERS; CHOICE	Economic simulation systems such as computable general equilibrium modeling have been used to predict the impacts of climate change on the economy and evaluate countermeasures to mitigate its effects. In this regard, forming an assumption about international trade in agricultural products becomes problematic if limited information is available on substitution between domestic and imported agricultural products. This study examined the substitution patterns of Japanese consumers between domestically produced and imported agricultural products such as broccoli, kiwifruit, rice and apples using discrete choice experiments. Three web surveys were conducted in January 2011, February 2012 and January 2013 to gather responses to the discrete choice experiment questions for each of the four products. The responses were analyzed using the error components multinomial logit model. The results showed that the substitution of imported products for domestic sources was relatively large in the case of broccoli and kiwifruit and relatively low in the case of rice and apples. Although economic simulation systems sometimes assume that substitution patterns between domestic and imported products are fixed for different kinds of agricultural products, our results indicate that this assumption does not necessarily apply in all cases.	Natl Agr & Food Res Org, Inst Rural Engn, Rural Dev & Planning Div, Tsukuba, Ibaraki 3058609, Japan	Aizaki, H (reprint author), Natl Agr & Food Res Org, Inst Rural Engn, Rural Dev & Planning Div, Tsukuba, Ibaraki 3058609, Japan.	azk-r@ec.hokudai.ac.jp			Ministry of Agriculture, Forestry and Fisheries, Japan through research project "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries"	This study was financially supported by the Ministry of Agriculture, Forestry and Fisheries, Japan, through a research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries."	Aizaki H., 2012, AGRIBIOSCIENCE MONOG, V2, P1; Aizaki H, 2012, APPL ECON LETT, V19, P439, DOI 10.1080/13504851.2011.583207; Saito H, 2013, AGRIBUSINESS, V29, P147, DOI 10.1002/agr.21315; LOUVIERE JJ, 1983, J MARKETING RES, V20, P350, DOI 10.2307/3151440; Aomori Prefecture, 2012, DAT APPL EXP IMP; Furuya J, 2015, JARQ-JPN AGR RES Q, V49, P119, DOI 10.6090/jarq.49.119; Kunimitsu Y., 2011, SUSTAINABLE DEV PLAN, P533; Louviere J. J, 2000, STATED CHOICE METHOD, P402; Ministry of Agriculture Forestry and Fisheries of Japan, 2013, MAT REG RIC, P74; Nakamura T, 2007, NOUGYOU KEIEI KENKYU, V45, P73; Oura Y, 2002, NOUGYOU KEIEI KENKYU, V40, P106; Peterson H. H., 2004, Journal of Agricultural and Applied Economics, V36, P123; Saito Y., 2009, NOUGYOU JYOUHOU KENK, V18, P152; Sato K., 2001, NOURINGYOU MONDAI KE, V37, P37; Sugiura T, 2004, J JPN SOC HORTIC SCI, V73, P72; Ujiie K., 2012, FOOD SYSTEM KENKYUU, V19, P142; Yoshida K., 2013, 2013 NENDO NIHON NOU, V2013, P258	17	1	1	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					143	148				6	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200009		
J	Tokunaga, S; Okiyama, M; Ikegawa, M				Tokunaga, Suminori; Okiyama, Mitsuru; Ikegawa, Maria			Dynamic Panel Data Analysis of the Impacts of Climate Change on Agricultural Production in Japan	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						panel data analysis; precipitation; rice; solar radiation; vegetables and potatoes productions		This study empirically identifies the impact of global-warming-induced climate change on Japan's agricultural production using panel data. First, we constructed panel data; combining time-series data from 1995 to 2006 for a cross-section of eight regions in Japan. Next, we conducted a static panel data analysis, using a function for agricultural products incorporating labor and three weather variables (temperature, solar radiation, and precipitation.) From the estimation results of the production function, we selected the production function with the aforementioned labor and weather variables and found that the rising temperatures and precipitation and falling solar radiation caused by climate change have reduced the rice production, while rising temperatures and precipitation have reduced the vegetable and potato production in Japan. Second, we conducted dynamic panel data analysis, using a production function for agricultural products incorporating labor, a one-period lagged output, and the same three weather variables. Based on the estimation results of the dynamic panel data model, we selected the production function for agricultural products using only the labor and three weather variables and found the same results for both the rice production and vegetable and potato production in Japan. Based on the estimated results of the static and dynamic-panel data models for variable mean annual temperature, which serves as a proxy for climate change, we concluded that an increase of 1 degrees C in mean annual temperature would reduce rice production by 5.8% in the short term and 3.9% in the long term, and vegetables and potatoes productions by 5.0% and 8.6% in the short term and long term, respectively.	[Tokunaga, Suminori] Reitaku Univ, Fac Econ & Business Adm, Kashiwa, Chiba 2778686, Japan; [Tokunaga, Suminori] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Okiyama, Mitsuru] Reitaku Univ, Reitaku Inst Polit Econ & Social Studies, Kashiwa, Chiba 2778686, Japan; [Ikegawa, Maria] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Tokunaga, S (reprint author), Reitaku Univ, Fac Econ & Business Adm, Kashiwa, Chiba 2778686, Japan.	tokunaga@reitaku-u.ac.jp			Japanese Ministry of Agriculture, Forestry and Fisheries	This paper reports on the results obtained for the joint project "Economic Evaluation of Agriculture Mitigation and Adaptation Technologies for Climate Change" funded by the Japanese Ministry of Agriculture, Forestry and Fisheries.	Egaitsu F., 1983, J RURAL ECON, V54, P167; Fukuchi T, 1983, AJIA KEIZAI, V24, P24; Fukuchi T, 1983, AJIA KEIZAI, V24, P33; Godo Y., 1991, J RURAL EC, V63, P100; Greene W. H, 2011, ECONOMETRIC ANAL; Kako T, 1984, J RURAL EC, V56, P151; Kawatsu S., 2007, NIPPON SAKUMOTSU GAK, V76, P423; Kondo T., 1991, J RURAL EC, V63, P79; Kuroda Y., 1988, J RURAL EC, V60, P14; Kuroda Y., 1979, EC STUDIES Q, V30, P107; Kusakari H., 1985, EC PROGR AGR DEV, P193; Nakashima Y, 1989, J RURAL EC, V61, P19; Nishimori M., 2001, GLOBAL ENV RES J, V6, P149; Okiyama M., 2013, RURAL EC SOCIOLOGY I, V29, P1; Saito K., 2008, RIETI DISCUSSION PAP, P33; Sakamoto R., 2009, J RURAL PROBLEMS, V174, P33; Shimono H., 2008, NIPPON SAKUMOTSU GAK, V77, P489; Stern N., 2007, EC CLIMATE CHANGE ST, P692; Takahashi K., 1991, Q J AGR EC, V45, P83; Tokunaga S., 2008, MODEL ANAL ENV POLIC, P351; Tokunaga S., 2007, J RURAL EC, P83; Yokozawa M, 2009, GLOBE ENV, V14, P199	22	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					149	157				9	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200010		
J	Kunimitsu, Y; Kudo, R				Kunimitsu, Yoji; Kudo, Ryoji			Fluctuations in Rice Productivity Caused by Long and Heavy Rain Under Climate Change in Japan: Evidence from Panel Data Regression Analysis	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						global climate model; hydrological model; Malmquist index; total factor productivity; Tonqvist-Theil index	RESEARCH-AND-DEVELOPMENT; AGRICULTURAL PRODUCTIVITY; GROWTH; SECTOR; IMPACT; CHINA	The incidence of extreme rain is expected to increase with climate change and affect rice productivity in Japan. This study aims to evaluate the impacts of long and heavy rain on Japanese rice total-factor productivity (TFP) by estimating causality functions. We measured rice TFP by using the Tornqvist-Theil and Malmquist indexes for dependent variables and predicted, the influences of future temperature and rain on rice TFP by the causality function associated with crop models and a hydrological model based on climate projections from the global-climate model (GCM). The results initially showed no significant differences between Tornqvist-Theil and Malmquist indices in the effects of climate factors, although some differences emerged in the causality of socioeconomic factors. Second, the effects of rain were always negative, and absolute TFP elasticity against rain was lower than temperature via yield and quality, but poorly drained surface water as well as flooding reduced rice TFP by 2.5 to 4.5%. Third, changes in predicted rainfall under future climate change caused annual rice TFP to fluctuate, and an impact of rain on TFP fluctuations exceeded that of temperature via yield and quality. This is due to significant variations in annual rainfall, even though the measured elasticity against rain was low. Based on these findings, the implications for research and policy-making are discussed.	[Kunimitsu, Yoji] Natl Inst Rural Engn, Rural Dev Planning Div, Tsukuba, Ibaraki 3058609, Japan; [Kudo, Ryoji] Natl Inst Rural Engn, Hydraul Engn Res Div, Tsukuba, Ibaraki 3058609, Japan	Kunimitsu, Y (reprint author), Natl Inst Rural Engn, Rural Dev Planning Div, Tsukuba, Ibaraki 3058609, Japan.	ykuni@affrc.go.jp			Ministry of Agriculture, Forestry and Fishery; Ministry of Education, Culture, Sports, Science, and Technology; JSPS KAKENHI [24330073]	This study was supported by the research project "Economic evaluation of Agricultural Mitigation and Adaptation Technologies for Climate Change" (Ministry of Agriculture, Forestry and Fishery), SOUSEI Program "Precise Impact Assessments on Climate Change" (Ministry of Education, Culture, Sports, Science, and Technology) and JSPS KAKENHI Grant Number (24330073). Climate data used here were provided by Dr. Motoki Nishimori (National Institute for Agro-Environmental Sciences). The authors sincerely express our gratitude for their support.	Alene AD, 2010, AGR ECON-BLACKWELL, V41, P223, DOI 10.1111/j.1574-0862.2010.00450.x; Chen PC, 2008, CHINA ECON REV, V19, P580, DOI 10.1016/j.chieco.2008.07.001; Iizumi T, 2009, AGR FOREST METEOROL, V149, P333, DOI 10.1016/j.agrformet.2008.08.015; Astorga P, 2011, REV INCOME WEALTH, V57, P203, DOI 10.1111/j.1475-4991.2011.00447.x; Cabinet Office of Japan, 2010, Q J NATL ACCOUNTS, V144, P61; Coelli T., 2008, 9608 CTR EFF PROD AN; Denison E. F., 1979, ACCOUNTING SLOWER EC; Diewert W. E., 1976, J ECONOMETRICS, V4, P115, DOI 10.1016/0304-4076(76)90009-9; Fare R., 1994, PRODUCTION FRONTIERS; Hasumi H., 2004, 1 U TOK CTR CLIM SYS, P1; Jayasuriya RT, 2003, AGR SYST, V78, P405, DOI 10.1016/S0308-521X(03)00068-4; Kawatsu S., 2007, Japanese Journal of Crop Science, V76, P423, DOI 10.1626/jcs.76.423; Kitamura Y, 2005, PANEL DATA ANAL, P3; Kudo R., 2013, P 2013 M JAP SOC IRR, P56; Kunimitsu Y., 2014, PADDY WATER ENVIRON, DOI [10.1007/s10333-013-0368-0, DOI 10.1007/S10333-013-0368-0]; Kunimitsu Y., 2013, Journal of Rural Economics, P107; Kuroda Y, 1989, J JAPANESE INT EC, V3, P145, DOI 10.1016/0889-1583(89)90002-6; KURODA Y, 1995, AGR ECON, V12, P55, DOI 10.1016/0169-5150(94)00032-W; Masumoto T., 2009, HEADWATERS OCEAN; Nakakita E., 2011, ANN DISASTER PREVIEW, V54, P411; Nakicenovic N., 2000, SPECIAL REPORT EMISS, P612; Nin-Pratt A, 2010, AGR ECON-BLACKWELL, V41, P349, DOI 10.1111/j.1574-0862.2010.00446.x; Okada Masashi, 2009, Journal of Agricultural Meteorology, V65, P97; Pratt AN, 2009, CHINA AGRIC ECON REV, V1, P9, DOI 10.1108/17561370910915339; Salim RA, 2010, AUST J AGR RESOUR EC, V54, P561, DOI 10.1111/j.1467-8489.2010.00514.x; Suphannachart W, 2010, AUSTR J AGR RESOURCE, V55, P35; Thirtle C, 2008, AGR ECON-BLACKWELL, V39, P73, DOI 10.1111/j.1574-0862.2008.00316.x; Umetsu C, 2003, AM J AGR ECON, V85, P943, DOI 10.1111/1467-8276.00499; Yamamoto Y., 2007, Journal of Rural Economics, V79, P154; Yokozawa M, 2009, GLOBE ENV, V14, P199; Yoshida T., 2012, IRRIG DRAIN, V80, P9	31	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					159	172				14	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200011		
J	Kunimitsu, Y				Kunimitsu, Yoji			Regional Impacts of Long-term Climate Change on Rice Production and Agricultural Income: Evidence from Computable General Equilibrium Analysis	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						crop-growth model; crop-quality model; recursive-dynamic regional CGE model; total factor productivity (TFP)	MODEL	Future climate change will affect rice production, but whether these changes will be beneficial or detrimental is unclear. The present study evaluates the effect of climate change on Japanese rice production, rice price, agricultural income, and regional economies by using a recursive-dynamic regional computable general equilibrium (CGE) model, which is associated with crop-growth and crop-quality models. Simulation results demonstrate that future climate change will increase overall Japanese rice production nationwide, but that the price of rice will decrease. As a result, agricultural income will decrease, despite increased production in northern and eastern Japan, such as Hokkaido, Tohoku, and Kanto (including Niigata prefecture). Climate change will not benefit rice farmers in these regions. However, the western region will benefit, despite the decrease in production, and the consumer surplus in most regions will increase. This happens because rice demand is inelastic and an increase in production results in a serious decline in price, which more than offsets the effects of climate change on production. As such, the impacts of climate change are complicated and differ by region, so a CGE model can provide useful information to consider policy countermeasures.	Natl Inst Rural Engn NARO, Rural Dev Planning Div, Tsukuba, Ibaraki 3058609, Japan	Kunimitsu, Y (reprint author), Natl Inst Rural Engn NARO, Rural Dev Planning Div, Tsukuba, Ibaraki 3058609, Japan.	ykuni@affrc.go.jp			Ministry of Agriculture, Forestry and Fishery; Ministry of Education, Culture, Sports, Science, and Technology; JSPS KAKENHI [24330073]	This study was supported by the research project "Economic Evaluation of Agricultural Mitigation and Adaptation Technologies for Climate Change" (Ministry of Agriculture, Forestry and Fishery), SOUSEI Program "Precise Impact Assessments on Climate Change" (Ministry of Education, Culture, Sports, Science, and Technology) and JSPS KAKENHI Grant Number (24330073). Climate data used here were provided by Dr. Motoki Nishimori (National Institute for Agro-Environmental Sciences). The authors sincerely express gratitude for their support.	Palatnik RR, 2012, CLIMATIC CHANGE, V112, P1085, DOI 10.1007/s10584-011-0356-6; Calzadilla A, 2011, AGR ECON-BLACKWELL, V42, P305, DOI 10.1111/j.1574-0862.2010.00516.x; Iizumi T, 2009, AGR FOREST METEOROL, V149, P333, DOI 10.1016/j.agrformet.2008.08.015; Bann K., 2007, RIETI DISCUSSION PAP; Egaitsu N., 1985, EC ANAL JAPANESE AGR; Furuya J, 2005, JARQ-JPN AGR RES Q, V39, P121; Hasumi H., 2004, 1 U TOK CTR CLIM SYS, P1; Kunimitsu, 2009, J RURAL EC, P59; Kunimitsu Y., 2014, PADDY WATER ENVIRON, DOI [10.1007/s10333-013-0368-0, DOI 10.1007/S10333-013-0368-0]; Lee HL, 2009, PADDY WATER ENVIRON, V7, P321, DOI 10.1007/s10333-009-0181-y; Masui T, 2005, EUR J OPER RES, V166, P843, DOI 10.1016/j.ejor.2004.07.002; Nakicenovic N., 2000, SPECIAL REPORT EMISS, P612; Rutherford T. F., 1999, Computational Economics, V14, DOI 10.1023/A:1008655831209; Saito K., 2002, P INT C POL MOD 2002; Stern N., 2006, EC CLIMATE CHANGE ST; Yokozawa M, 2009, GLOBE ENV, V14, P199	16	1	1	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					173	185				13	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200012		
J	Furuya, J; Kobayashi, S; Yamamoto, Y; Nishimori, M				Furuya, Jun; Kobayashi, Shintaro; Yamamoto, Yukiyo; Nishimori, Motoki			Climate Change Effects on Long-term World-crop Production: Incorporating a Crop Model into Long-term Yield Estimates	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						CMIP5; CO2 exchange rate; Cubic-spline; Logistic function; RCP	MARKETS; IMPACTS	Annual crop yield forecasts are necessary for analysis because evaluating climate-change impacts on world food markets requires supply-response functions, including output prices of the prior year. This research was undertaken to develop yield-response functions of the world food model to evaluate climate- change effects by incorporating a crop model into the yield-trend function. Yield-trend functions of rice, wheat, maize, and soybeans were obtained by estimating logistic functions or linear functions with a logarithmic time-trend term and climate variables. Furthermore, temperature and solar-radiation elasticities of yields were calculated using a crop model of the FAO and IIASA. The functions of the maximum rate of gross biomass production and the maximum net rate of CO2 exchange of leaves in the crop model were modified by introducing cubic spline interpolation and logistic functions. Smoothing these two functions alleviates drastic changes, but reveals small changes in the elasticities of crop yields compared to the kinked functions and these more realistic elasticities can improve the evaluation accuracy of climate-change impacts on crop supply and demand. These variable elasticities of temperature and solar-radiation were inserted into the yield-trend functions, whereupon the global effects of changes in climate variables, including rainfall, were analyzed. The changes in yields obtained using climate variables of two of the four RCP scenarios were compared with the baseline, for which climate variables were fixed. Results of trend analyses show that yields of rice, wheat, maize, and soybeans under RCP8.5 are lower than those under RCP2.6, except for wheat in China. Results of geographical analysis show that climate change can be expected to affect wheat and maize productions in low-latitude countries. Furthermore, results suggest that climate change will depress rice production in sub-Saharan African countries in the 2040s.	[Furuya, Jun; Kobayashi, Shintaro] Japan Int Res Ctr Agr Sci, Social Sci Div, Tsukuba, Ibaraki 3058686, Japan; [Yamamoto, Yukiyo] Japan Int Res Ctr Agr Sci, Res Planning & Coordinat Div, Tsukuba, Ibaraki 3058686, Japan; [Nishimori, Motoki] Natl Inst Agroenvironm Sci, Agrometeorol Div, Tsukuba, Ibaraki 3058604, Japan	Furuya, J (reprint author), Japan Int Res Ctr Agr Sci, Social Sci Div, Tsukuba, Ibaraki 3058686, Japan.	furuya@affrc.go.jp			Office of Science at the U.S. Department of Energy	We acknowledge the international modeling groups for providing their data for analyses, the Program for Climate Model Diagnosis and Intercomparison (PCMDI) for collecting and archiving the model data, the JSC/CLIVAR Working Group on Coupled Modeling (WGCM) and their Coupled Model Intercomparison Project (CMIP), and the Climate Simulation Panel for organizing the model data analysis activity. We appreciate technical support from the IPCC WG1 TSU. The IPCC Data Archive at the Lawrence Livermore National Laboratory is supported by the Office of Science at the U.S. Department of Energy.	Jones PG, 2003, GLOBAL ENVIRON CHANG, V13, P51, DOI 10.1016/S0959-3780(02)00090-0; Hatch MD, 2002, PHOTOSYNTH RES, V73, P251, DOI 10.1023/A:1020471718805; Parry M, 1999, GLOBAL ENVIRON CHANG, V9, pS51, DOI 10.1016/S0959-3780(99)00018-7; Rosenzweig C, 2013, AGR FOREST METEOROL, V170, P166, DOI 10.1016/j.agrformet.2012.09.011; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI 10.1007/s10584-011-0148-z; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035; Fischer G., 2002, GLOBAL AGROECOLOGICA, P119; Fischer G., 2012, GLOBAL AGROECOLOGICA, P179; Furuya J, 2005, JARQ-JPN AGR RES Q, V39, P121; Furuya J, 2009, SUSTAIN SCI, V4, P71, DOI 10.1007/s11625-008-0062-0; Harris D., 1989, ED MEASUREMENT ISSUE, V8, P35, DOI 10.1111/j.1745-3992.1989.tb00313.x; Horie T, 1995, CLIMATE CHANGE AND RICE, P291; Kassam AH, 1979, 33 FAO, P193; Narayanan B. G., 2012, GUIDE GTAP DATABASE, P20; Ray D. K., 2012, NAT COMMUN, V3, P1; Rotter R, 1999, CLIMATIC CHANGE, V43, P651, DOI 10.1023/A:1005541132734; Sen A., 1981, POVERTY FAMINES ESSA, P272; Shimoda Y., 1990, HDB NUMERICAL CALCUL, P701; Vedenov D, 2008, J ANIM SCI, V86, P500, DOI 10.2527/jas.2007-0536; World Agricultural Outlook Board, 1994, AGR HDB, V664, P279; Yokozawa Masayuki, 2003, Journal of Agricultural Meteorology, V59, P117, DOI 10.2480/agrmet.59.117	23	1	1	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	APR	2015	49	2					187	202				16	Agriculture, Multidisciplinary	Agriculture	CG1XG	WOS:000353068200013		
J	Shimizu, F; Suzuki, M				Shimizu, Fumie; Suzuki, Machiko			Role development of nurses for technology-dependent children attending mainstream schools in Japan	JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING			English	Article						Mainstream school; modified grounded theory approach; nurse; role development; technology-dependent children	MEDICAL TECHNOLOGY; META-SYNTHESIS; TRANSITION; SPECIALIST; PATIENT	PurposeTo describe the role development of nurses caring for medical technology-dependent children attending Japanese mainstream schools. Design and MethodsSemi-structured interviews with 21 nurses caring for technology-dependent children were conducted and analyzed using the modified grounded theory approach. ResultsNurses developed roles centered on maintaining technology-dependent children's physical health to support children's learning with each other, through building relationships, learning how to interact with children, understanding the children and the school community, and realizing the meaning of supporting technology-dependent children. Practice ImplicationsThese findings support nurses to build relationships of mutual trust with teachers and children, and learn on the job in mainstream schools.	[Shimizu, Fumie; Suzuki, Machiko] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan	Shimizu, F (reprint author), Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan.	shimizu.fumie.52v@st.kyoto-u.ac.jp			Yuumi Memorial Foundation for Home Health Care	We would like to thank the participants, the staff of the boards of education, and school administrators. We are grateful to Professor Chikage Tsuzuki of Kobe City College of Nursing, Professor Yasuhito Kinoshita of Rikkyo University, and Professor Hitomi Katsuda of the Gifu College of Nursing for supervising this study. This study was supported by a grant from the Yuumi Memorial Foundation for Home Health Care.	All-Party Parliamentary Group on Global Health and the Africa All-Party Parliamentary Group, 2012, ALL TAL GLOB HLTH WO; Kirk S, 2010, SOC SCI MED, V71, P1796, DOI 10.1016/j.socscimed.2010.07.044; Heaton J, 2005, HEALTH SOC CARE COMM, V13, P441, DOI 10.1111/j.1365-2524.2005.00571.x; Kramer JM, 2012, CHILD CARE HLTH DEV, V38, P763, DOI 10.1111/j.1365-2214.2012.01365.x; Heitz LJ, 2004, J NURS EDUC, V43, P416; Dinc L, 2013, NURS ETHICS, V20, P501, DOI 10.1177/0969733012468463; Miller K, 2000, J APPL COMMUN RES, V28, P193; Benner P., 2009, EXPERTISE NURSING PR; Bostrom E, 2013, PRIM CARE DIABETES, V7, P207, DOI 10.1016/j.pcd.2013.04.013; Clancy C, 2007, J ADV NURS, V57, P161, DOI 10.1111/j.1365-2648.2006.04088.x; Ellis I, 2012, CONTEMP NURSE, V42, P90, DOI 10.5172/conu.2012.42.1.90; Glaser B., 1967, DISCOVERY GROUNDED T; Japan Ministry of Education Culture Sports Science and Technology, 2014, HEIS 25 NEND TOK TOU; Japan Ministry of Education Culture Sports Science and Technology, 2009, HEIS 20 NEND TOK NI; Jones ML, 2005, J ADV NURS, V49, P191, DOI 10.1111/j.1365-2648.2004.03279.x; Kinoshita Y, 2003, GROUNDED THEORY APPR; Matsumura K., 2009, B NATL I SPECIAL NEE, V36, P3; Rasmussen P, 2014, INT J MENT HEALTH NU, V23, P265, DOI 10.1111/inm.12039; Raymond JA, 2009, J SCH NURS, V25, P186, DOI 10.1177/1059840509335407; Shimizu F, 2015, JPN J NURS SCI, V12, P35, DOI 10.1111/jjns.12046; Shimizu F., 2014, J CHILD HEALTH CARE, V73, P360; Simmons D. R., 2002, J SCH NURS, V18, P87; Skar R, 2010, VOCAT LEARN, V3, P1, DOI 10.1007/s12186-009-9026-5; United Nations Educational Scientific and Cultural Organization, 2009, POL GUID INCL ED; United States Congress Office of Technology Assessment, 1987, OTATMH38 US C OFF TE; Zolnierek CD, 2014, J NURS SCHOLARSHIP, V46, P3, DOI 10.1111/jnu.12049	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1539-0136	1744-6155		J SPEC PEDIATR NURS	J. Spec. Pediatr. Nurs.	APR	2015	20	2					87	97		10.1111/jspn.12105		11	Nursing; Pediatrics	Nursing; Pediatrics	CF5AP	WOS:000352567000001		
J	Hirota, K				Hirota, Kazuyoshi			Launch of JA Clinical Reports Anesthesia research crisis in Japan	JOURNAL OF ANESTHESIA			English	Editorial Material									Hirosaki Univ, Grad Sch Med, Dept Anesthesiol, Hirosaki, Aomori 0368562, Japan	Hirota, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Anesthesiol, Hirosaki, Aomori 0368562, Japan.	hirotak@cc.hirosaki-u.ac.jp					[Anonymous], 2005, PROPOSAL LACK MAN PO; Hirota K, 2013, J ANESTH, V27, P323, DOI 10.1007/s00540-012-1554-8; Hirota K, 2014, MASUI IN PRESS; Reves JG, 2007, ANESTHESIOLOGY, V106, P826, DOI 10.1097/01.anes.0000264772.71791.58; The Royal College of Anaesthetists, 2005, NAT STRAT AC AN	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					161	163		10.1007/s00540-014-1959-7		3	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100001		
J	Yoshimura, K; Hayashi, H; Tanaka, Y; Nomura, Y; Kawaguchi, M				Yoshimura, Kie; Hayashi, Hironobu; Tanaka, Yuu; Nomura, Yasumitsu; Kawaguchi, Masahiko			Evaluation of predictive factors associated with increased intraocular pressure during prone position spine surgery	JOURNAL OF ANESTHESIA			English	Article						Intraocular pressure; Spine surgery; Prone position; Anesthesia	POSTOPERATIVE VISUAL-LOSS; AUTOREGULATION; CIRCULATION	Intraocular pressure(IOP) has been shown to increase during prone position spine surgery. The present study was conducted to evaluate IOP changes and predictive factors associated with increased IOP during prone position spine surgery. After institutional approval and written informed consent, 56 patients undergoing prone position spine surgery were studied. Anesthesia was maintained with propofol or sevoflurane, remifentanil, and fentanyl. IOP was measured using a Tono-Pen XL hand-held tonometer 10 min after induction of anesthesia, every 60 min after prone positioning, and 10 min after returning to the supine position. According to maximum IOP, patients were divided into group H with a maximum IOP value of a parts per thousand yen30 mmHg or group L with a maximum IOP value of < 30 mmHg. Logistic regression analyses were performed to identify predictive factors associated with increased IOP. Maximum IOP values ranged from 19-40 mmHg and 20 patients were included in group H. There were no statistically significant differences in demographic and intraoperative variables between the two groups. IOP 1 h after prone positioning (IOP1H) was significantly higher in group H than in group L. Logistic regression analysis revealed that IOP1H of a parts per thousand yen23 mmHg was a significant predictor (odds ratio 19.0, 95 % C.I 3.7-97.6). IOP1H values may be used as a predictive factor associated with increased IOP during prone position spine surgery.	[Yoshimura, Kie; Hayashi, Hironobu; Tanaka, Yuu; Nomura, Yasumitsu; Kawaguchi, Masahiko] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara 6348522, Japan	Kawaguchi, M (reprint author), Nara Med Univ, Dept Anesthesiol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	drjkawa@naramed-u.ac.jp					Agah M, 2011, UROL J, V8, P191; RIVA CE, 1981, INVEST OPHTH VIS SCI, V21, P34; Hunt K, 2004, J NEUROSURG ANESTH, V16, P287, DOI 10.1097/00008506-200410000-00005; RIVA CE, 1986, INVEST OPHTH VIS SCI, V27, P1706; Cheng MA, 2001, ANESTHESIOLOGY, V95, P1351, DOI 10.1097/00000542-200112000-00012; Pillunat LE, 1997, EXP EYE RES, V64, P737, DOI 10.1006/exer.1996.0263; Kim Tae-Woo, 2007, Korean J Ophthalmol, V21, P151; Lee LA, 2006, ANESTHESIOLOGY, V105, P652, DOI 10.1097/00000542-200610000-00007; Roth S, 2009, BR J ANAESTH S1, V103, pi31; Setogawa A, 1998, JPN J PHYSIOL, V48, P25, DOI 10.2170/jjphysiol.48.25; Sugata A, 2012, J NEUROSURG ANESTH, V24, P152, DOI 10.1097/ANA.0b013e31823fe822; Szmuk P, 2013, ANESTH ANALG, V116, P1309, DOI 10.1213/ANE.0b013e31828d3730	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					170	174		10.1007/s00540-014-1921-8		5	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100003		
J	Amaya, F; Shimamoto, S; Matsuda, M; Kageyama, K; Sawa, T				Amaya, Fumimasa; Shimamoto, Saki; Matsuda, Megumi; Kageyama, Kyoko; Sawa, Teiji			Preoperative anesthesia clinic in Japan: a nationwide survey of the current practice of preoperative anesthesia assessment	JOURNAL OF ANESTHESIA			English	Article						Preoperative assessment; Preoperative anesthesia clinic; Japan; National survey	OPERATING-ROOM CANCELLATIONS; IMPLEMENTATION; SMOKING; TRIAL	In order to investigate the current practice of preoperative anesthesia assessment in Japan, we conducted a nationwide survey of the preoperative anesthesia clinic (PAC). A written questionnaire was sent to anesthesia teaching hospitals certified by the Japanese Society of Anesthesiologists. Completed questionnaires were received from 789 hospitals (response rate 62.5 %). PACs were conducted in 52.0 % of these hospitals and were more frequently implemented in large hospitals. Services covered by the PAC included medical history taking, physical examination, review of laboratory data, and obtaining informed consent. Majority of the anesthesiologists at hospitals that did not have a PAC responded that although they acknowledged that a PAC is necessary, they were unable to set one up. The main obstacle preventing establishment of the PAC was shortage of human resources. Half the anesthesia teaching hospitals in Japan use a PAC for preoperative assessment. At such hospitals, all the procedures required before anesthesia are performed in the clinic. Lack of human resources is the major obstacle preventing establishment of PACs in all hospitals.	[Amaya, Fumimasa; Shimamoto, Saki; Matsuda, Megumi; Sawa, Teiji] Kyoto Prefectural Univ Med, Dept Anesthesiol, Kamigyo Ku, Kyoto 6028566, Japan; [Kageyama, Kyoko] Social Med Corp Otokoyama Hosp, Dept Anesthesiol, Kyoto, Japan	Amaya, F (reprint author), Kyoto Prefectural Univ Med, Dept Anesthesiol, Kamigyo Ku, 465 Kajiicho, Kyoto 6028566, Japan.	ama@koto.kpu-m.ac.jp					White SM, 2004, J MED ETHICS, V30, P286, DOI 10.1136/jme.2002.001610; Sachs R, 2012, CAN J ANESTH, V59, P662, DOI 10.1007/s12630-012-9716-6; Fischer SP, 1996, ANESTHESIOLOGY, V85, P196, DOI 10.1097/00000542-199607000-00025; Ferschl MB, 2005, ANESTHESIOLOGY, V103, P855, DOI 10.1097/00000542-200510000-00025; Lee SM, 2013, ANESTH ANALG, V117, P605, DOI 10.1213/ANE.0b013e318298a6b0; Emanuel A, 2013, ANAESTH INTENS CARE, V41, P90; Lemmens LC, 2008, BRIT J ANAESTH, V100, P645, DOI 10.1093/bja/aen068; Warner DO, 2005, ANESTH ANALG, V101, P481, DOI 10.1213/01.ANE.0000159152.31129.84; Lemmens LC, 2006, EUR J ANAESTH, V23, P962, DOI 10.1017/S0265021506000895; Pollard JB, 1999, ANESTH ANALG, V89, P502, DOI 10.1097/00000539-199908000-00048; Sakaguchi Misa, 2005, J Anesth, V19, P315, DOI 10.1007/s00540-005-0332-2; Schiff JH, 2010, MINERVA ANESTESIOL, V76, P491; Starsnic MA, 1997, J CLIN ANESTH, V9, P299, DOI 10.1016/S0952-8180(97)00007-X; van Klei WA, 2002, ANESTH ANALG, V94, P644; VANKLEI WA, 2006, ANESTHESIOLOGY, V105, P224	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					175	179		10.1007/s00540-014-1918-3		5	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100004		
J	Kotoda, M; Ishiyama, T; Shintani, N; Matsukawa, T				Kotoda, Masakazu; Ishiyama, Tadahiko; Shintani, Noriyuki; Matsukawa, Takashi			Direct effects of Rho-kinase inhibitor on pial microvessels in rabbits	JOURNAL OF ANESTHESIA			English	Article						Rho-kinase; Y-27632; Pial microvessels	BINDING PROTEIN RHO; PULMONARY-HYPERTENSION; SMOOTH-MUSCLE; IN-VIVO; FASUDIL; Y-27632; MYOSIN; ARTERY; PIGS; PHOSPHORYLATION	Rho-kinase inhibitor is widely used for prevention of cerebral vascular spasm. However, the cerebral pial vascular action of Rho-kinase inhibitor has not been investigated. We therefore evaluated the direct effects of Y-27632, a Rho-kinase inhibitor, on pial microvessels. Experiments were performed on anesthetized rabbits. A closed cranial window was used to visualize the pial microcirculation. After baseline hemodynamic and pial vascular measurements, the cranial window was superfused with four increasing concentrations of Y-27632 (10(-9), 10(-7), 10(-6), 10(-5) mol l(-1); n = 7) dissolved in artificial cerebrospinal fluid for 7 min each. We measured the diameters of pial vessels, mean arterial pressure (MAP), heart rate (HR), and rectal temperature at 7 min after application of each Y-27632 concentration. MAP, HR, rectal temperature, arterial pH, PaCO2, PaO2, and plasma Na+, K+ and glucose concentrations did not change significantly during the experimental period. Y-27632 at 10(-9) to 10(-7) mol l(-1) did not produce any significant change in pial arterioles. Topical application of Y-27632 at 10(-6) and 10(-5) mol l(-1) produced pial large (8.4 +/- A 5.7 and 19.8 +/- A 12.7 %) and small (10.1 +/- A 8.5 and 18.1 +/- A 12.3 %) arterioles dilation. However, Y-27632 did not produce any change in pial large and small venules. We evaluated the direct effects of Y-27632 on pial microvessels. Y-27632 dilates only pial arterioles in a concentration-dependent manner, and most at a concentration of 10(-5) mol l(-1). Y-27632 is a potent cerebral pial arteriolar dilator but is not a venular dilator.	[Kotoda, Masakazu; Matsukawa, Takashi] Univ Yamanashi, Dept Anesthesiol, Fac Med, Chuo Ku, Kofu, Yamanashi 4093898, Japan; [Ishiyama, Tadahiko; Shintani, Noriyuki] Univ Yamanashi, Univ Yamanashi Hosp, Surg Ctr, Chuo Ku, Kofu, Yamanashi 4093898, Japan	Kotoda, M (reprint author), Univ Yamanashi, Dept Anesthesiol, Fac Med, Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan.	mkotodaanes@yahoo.co.jp			JSPS KAKENHI [19591784, 23592246]	This work was supported by JSPS KAKENHI Grant Numbers 19591784 and 23592246.	Gupta V, 2013, J CONTROL RELEASE, V167, P189, DOI 10.1016/j.jconrel.2013.01.011; Toshima Y, 2000, STROKE, V31, P2245; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597; Ishizaki T, 1996, EMBO J, V15, P1885; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI 10.1007/s12015-009-9107-8; Honjo M, 2001, ARCH OPHTHALMOL-CHIC, V119, P1171; Abe K, 2004, CIRC RES, V94, P385, DOI 10.1161/01.RES.0000111804.34509.94; Matsui T, 1996, EMBO J, V15, P2208; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; LEUNG T, 1995, J BIOL CHEM, V270, P29051; Inokuchi K, 2004, J CARDIOVASC PHARM, V44, P275, DOI 10.1097/01.fjc.0000134775.76636.3f; Amano M, 1996, J BIOL CHEM, V271, P20246; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Nagaoka T, 2005, AM J RESP CRIT CARE, V171, P494, DOI 10.1164/rccm.200405-637OC; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1302.105938; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Fukumoto Y, 2005, HEART, V91, P391, DOI 10.1136/hrt.2003.029470; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Bagi Z, 2011, BRIT J PHARMACOL, V163, P1059, DOI 10.1111/j.1476-5381.2011.01307.x; BEVAN JA, 1987, FASEB J, V1, P193; Eto Y, 2000, AM J PHYSIOL-HEART C, V278, pH1744; Hartl R, 2005, ANESTH ANALG, V100, P1140, DOI 10.1213/01.ANE.0000147510.25610.9C; Iizuka K, 2000, EUR J PHARMACOL, V406, P273, DOI 10.1016/S0014-2999(00)00504-5; Ishiyama T, 2010, J NEUROSURG ANESTH, V22, P207, DOI 10.1097/ANA.0b013e3181cd318b; Ito I, 2007, AM J PHYSIOL-HEART C, V292, pH360, DOI 10.1152/ajpheart.00630.2006; Ito K, 1999, NAT MED, V5, P221; James SE, 2010, NEUROTOXICOLOGY, V31, P188, DOI 10.1016/j.neuro.2009.12.010; Kanda Takeshi, 2006, FASEB J, V20, P169; Kun Xia, 2009, J Card Surg, V24, P766, DOI 10.1111/j.1540-8191.2009.00888.x; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Morishige K, 2001, ARTERIOSCL THROM VAS, V21, P548; Shimokawa H, 2001, CARDIOVASC RES, V51, P169, DOI 10.1016/S0008-6363(01)00291-7; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0	36	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					186	190		10.1007/s00540-014-1903-x		5	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100006		
J	Kunisawa, T; Yamagishi, A; Suno, M; Nakade, S; Higashi, R; Kurosawa, A; Sugawara, A; Matsubara, K; Iwasaki, H				Kunisawa, Takayuki; Yamagishi, Akio; Suno, Manabu; Nakade, Susumu; Higashi, Ryunosuke; Kurosawa, Atsushi; Sugawara, Ami; Matsubara, Kazuo; Iwasaki, Hiroshi			Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in gynecologic patients	JOURNAL OF ANESTHESIA			English	Article						Landiolol hydrochloride; Pharmacokinetics; Target-controlled infusion	COMPUTER-CONTROLLED INFUSION; BETA-BLOCKER; PROPOFOL; MODEL	We previously determined the pharmacokinetic (PK) parameters of landiolol in healthy male volunteers. In this study, we evaluated the usefulness of target-controlled infusion (TCI) of landiolol hydrochloride and determined PK parameters of landiolol in gynecologic patients. Nine patients who were scheduled to undergo gynecologic surgery were enrolled. After inducing anesthesia, landiolol hydrochloride was administered at the target plasma concentrations of 500 and 1,000 ng/mL for each 30 min. A total of 126 data points of plasma concentration were collected from the patients and used for the population PK analysis. Furthermore, a population PK model was developed using the nonlinear mixed-effect modeling software. The patients had markedly decreased heart rates (HRs) at 2 min after the initiation of landiolol hydrochloride administration; however, their blood pressures did not markedly change from the baseline value. The concentration time course of landiolol was best described by a 2-compartment model with lag time. The estimate of PK parameters were total body clearance (CL) 34.0 mL/min/kg, distribution volume of the central compartment (V (1)) 74.9 mL/kg, inter-compartmental clearance (Q) 70.9 mL/min/kg, distribution volume of the peripheral compartment (V (2)) 38.9 mL/kg, and lag time (ALAG) 0.634 min. The predictive performance of this model was better than that of the previous model. TCI of landiolol hydrochloride is useful for controlling HR, and the PK parameters of landiolol in gynecologic patients were similar to those in healthy male volunteers and best described by a 2-compartment model with lag time.	[Kunisawa, Takayuki] Asahikawa Med Univ Hosp, Surg Operat Dept, Asahikawa, Hokkaido 0788510, Japan; [Kunisawa, Takayuki] Asahikawa Med Univ Hosp, Dept Anesthesiol & Crit Care Med, Asahikawa, Hokkaido 0788510, Japan; [Yamagishi, Akio; Kurosawa, Atsushi; Sugawara, Ami; Iwasaki, Hiroshi] Asahikawa Med Univ, Dept Anesthesiol & Crit Care Med, Asahikawa, Hokkaido, Japan; [Suno, Manabu] Okayama Univ, Dept Oncol Pharmaceut Care & Sci, Okayama 7008530, Japan; [Nakade, Susumu; Higashi, Ryunosuke] Ono Pharmaceut Co Ltd, Pharmacokinet Res Labs, Ibaraki, Japan; [Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 606, Japan	Kunisawa, T (reprint author), Asahikawa Med Univ Hosp, Dept Anesthesiol & Crit Care Med, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	taka.kunisawa@nifty.ne.jp			AstraZeneca K.K. (Osaka, Japan)	Takayuki Kunisawa received a speaker's honorarium from Ono Pharmaceutical Co., Ltd., (Osaka, Japan) for delivering a lecture on landiolol; the contents of the present study were not included in the lecture. Takayuki Kunisawa received a speaker's honorarium from AstraZeneca K.K. (Osaka, Japan) for delivering a lecture on propofol; the contents of the present study were not included in the lecture. Takayuki Kunisawa received research grants from AstraZeneca K.K. (Osaka, Japan) for scientific research on PK simulation; however, these grants were not used for this study. Susumu Nakade and Ryunosuke Higashi, who conducted population PK analysis using fixed data supplied by Asahikawa Medical University, are employees of Ono Pharmaceutical Co., Ltd., (Osaka, Japan), which sells landiolol hydrochloride in Japan.	Passot S, 2002, ANESTH ANALG, V94, P1212, DOI 10.1097/00000539-200205000-00030; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Lehtonen LA, 2004, CLIN PHARMACOKINET, V43, P187, DOI 10.2165/00003088-200443030-00003; SHAFER SL, 1990, ANESTHESIOLOGY, V73, P1091, DOI 10.1097/00000542-199012000-00005; Vermeyen KM, 2003, BRIT J ANAESTH, V90, P183, DOI 10.1093/bja/aeg043; Hooker AC, 2007, PHARM RES, V24, P2187, DOI 10.1007/s11095-007-9361-x; DYCK JB, 1993, ANESTHESIOLOGY, V78, P821, DOI 10.1097/00000542-199305000-00003; IGUCHI S, 1992, CHEM PHARM BULL, V40, P1462; De Castro V, 2003, ANESTH ANALG, V96, P33, DOI 10.1213/01.ANE.0000041461.10615.9F; DEBRUIJN NP, 1987, ANESTHESIOLOGY, V66, P323, DOI 10.1097/00000542-198703000-00010; Glass PS, 2005, MILLERS ANESTHESIA, P439; Honda N, 2008, DRUG METAB PHARMACOK, V23, P447; Nakashima M, 2000, RINSHO IYAKU, V16, P1531; Sepulveda P, 2011, BRIT J ANAESTH, V107, P593, DOI 10.1093/bja/aer198; Suno M, 2009, J CHROMATOGR B, V877, P1705, DOI 10.1016/j.jchromb.2009.04.017; Takahata Takenori, 2005, Drugs R D, V6, P385, DOI 10.2165/00126839-200506060-00006; Yoshida Y, 2008, J ANESTH, V22, P64, DOI 10.1007/s00540-007-0573-3	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					198	205		10.1007/s00540-014-1908-5		8	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100008		
J	Fujita, Y; Nakatsuka, H; Namba, Y; Mitani, S; Yoshitake, N; Sugimoto, E; Hazama, K				Fujita, Yoshihisa; Nakatsuka, Hideki; Namba, Yoshifumi; Mitani, Shigeru; Yoshitake, Nami; Sugimoto, Etsuko; Hazama, Keita			The incidence of pulmonary embolism and deep vein thrombosis and their predictive risk factors after lower extremity arthroplasty: a retrospective analysis based on diagnosis using multidetector CT	JOURNAL OF ANESTHESIA			English	Article						Pulmonary embolism; Total hip arthroplasty; Total knee arthroplasty; Multislice computed tomography	KNEE ARTHROPLASTY; VENOUS THROMBOEMBOLISM; COMPUTED-TOMOGRAPHY; TOTAL HIP; DOPPLER SONOGRAPHY; DOUBLE-BLIND; METAANALYSIS; PREVENTION; ENOXAPARIN; REPLACEMENT	The true incidence of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE) events, and the predictive risk factors are not well-defined in patients who undergo major lower extremity arthroplasty such as total hip arthroplasty (THA) or total or partial knee arthroplasty (TPKA). Using multidetector computed tomography (MDCT), pulmonary angiography (CTA), and MDCT venography (CTV), we investigated the prevalence of VTE and its predictive risk factors in patients for whom the guideline recommends prophylaxis. The electronic records of patients who underwent elective THA or TPKA at our institution from April 2010 through July 2013 were surveyed. We examined a total of 1,163 patient records for 986 patients who had undergone MDCT seven days after THA or TPKA. No PE-related deaths occurred in this study, though arterial embolization was needed for major bleeding in two cases. CTA-CTV revealed VTE in 51 (4.4 %) patients, PE in 20 (1.7 %), and DVT in 43 (3.3 %). Five of 51 patients had symptoms suggestive of DVT. In the logistic regression model, the type of surgery (TPKA > THA), patient age, and body mass index (BMI) were identified as predictive risk factors for VTE. This observational study showed that the overall incidence of VTE after THA and TPKA is 4.4 % in patients receiving recommended antithrombotic prophylaxis. TPKA is associated with a higher incidence of VTE than of THA, and greater BMI and older patient age are also independent risk factors.	[Fujita, Yoshihisa; Nakatsuka, Hideki; Yoshitake, Nami; Sugimoto, Etsuko; Hazama, Keita] Kawasaki Med Univ, Dept Anesthesiol, Kurashiki, Okayama 7010192, Japan; [Fujita, Yoshihisa; Nakatsuka, Hideki; Yoshitake, Nami; Sugimoto, Etsuko; Hazama, Keita] Kawasaki Med Univ, Dept ICM, Kurashiki, Okayama 7010192, Japan; [Namba, Yoshifumi; Mitani, Shigeru] Kawasaki Med Univ, Dept Orthoped, Kurashiki, Okayama 7010192, Japan	Fujita, Y (reprint author), Kawasaki Med Univ, Dept Anesthesiol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	fujitay@med.kawasaki-m.ac.jp					Lassen MR, 2010, NEW ENGL J MED, V363, P2487, DOI 10.1056/NEJMoa1006885; Lieberman JR, 2013, J BONE JOINT SURG AM, V95A, P1801, DOI 10.2106/JBJS.L.01328; Thomas SM, 2008, CLIN RADIOL, V63, P299, DOI 10.1016/j.crad.2007.09.010; Mantilla CB, 2003, ANESTHESIOLOGY, V99, P552, DOI 10.1097/00000542-200309000-00009; Fuji T, 2008, J ORTHOP SCI, V13, P442, DOI 10.1007/s00776-008-1264-0; Watanabe H, 2011, J ARTHROPLASTY, V26, P1488, DOI 10.1016/j.arth.2011.01.001; Turpie AGG, 2002, ARCH INTERN MED, V162, P1833, DOI 10.1001/archinte.162.16.1833; Xing KH, 2008, THROMB RES, V123, P24, DOI 10.1016/j.thromres.2008.05.005; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Begemann PGC, 2003, J COMPUT ASSIST TOMO, V27, P399, DOI 10.1097/00004728-200305000-00017; Byun SS, 2008, KOREAN J RADIOL, V9, P59, DOI 10.3348/kjr.2008.9.1.59; Elias A, 2004, EUR J VASC ENDOVASC, V27, P438, DOI 10.1016/j.ejvs.2003.12.021; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Jaffer AK, 2005, MAYO CLIN PROC, V80, P732; Januel JM, 2012, JAMA-J AM MED ASSOC, V307, P294, DOI 10.1001/jama.2011.2029; Krishan S, 2011, AM J ROENTGENOL, V196, P1065, DOI 10.2214/AJR.10.4745	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					235	241		10.1007/s00540-014-1891-x		7	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100014		
J	Kimura, Y; Kimura, S; Sumita, S; Yamakage, M				Kimura, Yoshinobu; Kimura, Saori; Sumita, Shinzou; Yamakage, Michiaki			Predictors of hypofibrinogenemia in blunt trauma patients on admission	JOURNAL OF ANESTHESIA			English	Article						Fibrinogen; Mortality; Revised Trauma Score	CARDIOPULMONARY BYPASS-SURGERY; FACTOR-XIII ACTIVITY; FIBRINOGEN CONCENTRATE; HEMORRHAGIC-SHOCK; BLOOD-LOSS; COAGULOPATHY; SCORE; REPLACEMENT; MANAGEMENT; SEVERITY	Massive bleeding usually leads to critically low levels of clotting factors, including fibrinogen. Although reduced fibrinogen levels correlate with increased mortality, predictors of hypofibrinogenemia have remained poorly understood. We investigated whether findings available on admission can be used as predictors of hypofibrinogenemia. We retrospectively reviewed serum fibrinogen levels tested on arrival in 290 blunt trauma patients transported to a level I trauma center during a 3-year period. The primary outcome was prehospital predictors for hypofibrinogenemia. Covariates included age, sex, prehospital fluid therapy, prehospital anatomical and physiological scores, time from injury, base excess, and lactate on arrival. All variables with values of p < 0.10 in univariate analysis were included in a multivariate logistic regression model. The relationships between the variables and the 7-day mortality rate were evaluated in a Cox proportional hazards model. Patient's age [odds ratio (OR): 0.97, p < 0.001], Triage Revised Trauma Score (T-RTS) (OR: 0.81, p = 0.003), and prehospital fluid therapy (OR: 2.54, p = 0.01) were detected as independent predictors for hypofibrinogenemia in multivariate logistic regression analysis. Serum fibrinogen level [hazard ratio (HR): 0.99, p = 0.01] and T-RTS (HR: 0.77, p < 0.01) were associated with the 7-day mortality rate. T-RTS is considered to play an important role in predicting hypofibrinogenemia and 7-day mortality in blunt trauma patients.	[Kimura, Yoshinobu; Kimura, Saori; Yamakage, Michiaki] Sapporo Med Univ, Sch Med, Dept Anesthesiol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Sumita, Shinzou] Asahikawa Red Cross Hosp, Div Anesthesia, Asahikawa, Hokkaido 0708530, Japan	Kimura, Y (reprint author), Sapporo Med Univ, Sch Med, Dept Anesthesiol, Chuo Ku, S1 W16, Sapporo, Hokkaido 0608556, Japan.	chiro1123@gmail.com; chiro828@gf6.so-net.ne.jp; ssumita@asahikawa-rch.gr.jp; yamakage@sapmed.ac.jp					Hess JR, 2008, J TRAUMA, V65, P748, DOI [10.1097/TA.0b013e3181877a9c, 10.1097/TA.0b013e181877a9c]; Charbit B, 2007, J THROMB HAEMOST, V5, P266, DOI 10.1111/j.1538-7836.2007.02297.x; Moore L, 2006, J TRAUMA, V61, P718, DOI 10.1097/01.ta.0000197906.28846.87; Moganasundram S, 2010, ANESTH ANALG, V110, P995, DOI 10.1213/ANE.0b013e3181cd6d20; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; Velik-Salchner C, 2007, J THROMB HAEMOST, V5, P1019, DOI 10.1111/j.1538-7836.2007.02481.x; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Stainsby D, 2006, BRIT J HAEMATOL, V135, P634; Raux M, 2011, J TRAUMA, V71, P754, DOI 10.1097/TA.0b013e3181fd0dae; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Pfister G, 2008, NEUROIMMUNOMODULAT, V15, P351, DOI 10.1159/000156477; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; Tieu BH, 2007, WORLD J SURG, V31, P1055, DOI 10.1007/s00268-006-0653-9; Shaz BH, 2010, TRANSFUSION, V50, P493, DOI 10.1111/j.1537-2995.2009.02414.x; Karlsson M, 2009, THROMB HAEMOSTASIS, V102, P137, DOI 10.1160/TH08-09-0587; Mari D, 2008, EXP GERONTOL, V43, P66, DOI 10.1016/j.exger.2007.06.014; Fries D, 2010, BRIT J ANAESTH, V105, P116, DOI 10.1093/bja/aeq161; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; Fenger-Eriksen C, 2008, BRIT J ANAESTH, V101, P769, DOI 10.1093/bja/aen270; Bell SF, 2010, INT J OBSTET ANESTH, V19, P218, DOI 10.1016/j.ijoa.2009.08.004; Blome M, 2005, THROMB HAEMOSTASIS, V93, P1101, DOI 10.1160/TH04-12-0799; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Committee on Medical Aspects of Automotive Safety, 1971, JAMA-J AM MED ASSOC, V2152, P277; Gerlach R, 2002, STROKE, V33, P1618, DOI 10.1161/01.STR.0000017219.83330.FF; Jansen JO, 2011, J TRAUMA, V71, pS435, DOI 10.1097/TA.0b013e318232e5cb; Kowalenko T, 1992, J TRAUMA, V33, P49; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Ucar HI, 2007, HEART SURG FORUM, V10, pE392, DOI 10.1532/HSF98.20071065	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					242	248		10.1007/s00540-014-1895-6		7	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100015		
J	Iguchi, N; Uchiyama, A; Ueta, K; Sawa, Y; Fujino, Y				Iguchi, Naoya; Uchiyama, Akinori; Ueta, Kazuyoshi; Sawa, Yoshiki; Fujino, Yuji			Neutrophil gelatinase-associated lipocalin and liver-type fatty acid-binding protein as biomarkers for acute kidney injury after organ transplantation	JOURNAL OF ANESTHESIA			English	Article						Neutrophil gelatinase-associated lipocalin; Liver-type fatty acid-binding protein; Organ transplantation; Acute kidney injury	CARDIAC-SURGERY; DIAGNOSIS; PREDICTS; MARKER; DAMAGE; NGAL	Neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty acid-binding protein (L-FABP) are promising early biomarkers for acute kidney injury (AKI). In organ transplant recipients, AKI predictability based on NGAL and L-FABP remains to be elucidated. Furthermore, the association between serial NGAL and L-FABP measurements and AKI outcome is unknown. Therefore, we conducted a study to evaluate the ability of NGAL and L-FABP to predict AKI after organ transplantation and investigate the association between NGAL, L-FABP and AKI outcome. Twenty-five organ transplant recipients admitted to the intensive care unit (ICU) immediately after transplant surgery were studied prospectively. Plasma NGAL (P-NGAL), urinary NGAL (U-NGAL) and L-FABP were measured from ICU admission to ICU discharge. U-NGAL and L-FABP were corrected for dilution/concentration by calculating U-NGAL/urine creatinine ratios (U-NGAL/Cr) and L-FABP/urine creatinine ratios (L-FABP/Cr). AKI was defined according to the Kidney Disease: Improving Global Outcomes criteria. AKI occurred in 11 patients. P-NGAL, U-NGAL/Cr and L-FABP/Cr upon ICU admission were unrelated to AKI development (p = 0.24, 0.22, and 0.53, respectively). There were no differences in P-NGAL, U-NGAL/Cr, and L-FABP/Cr levels from day 1 to day 6 between patients who did not recover from AKI and patients who recovered from AKI (p = 0.82, 0.26, and 0.61, respectively). Our findings suggest that NGAL and L-FABP upon ICU admission are not predictive of AKI and serial NGAL and L-FABP measurements may be ineffective for monitoring the status and treatment of post-transplantation AKI.	[Iguchi, Naoya] Osaka Univ Hosp, Intens Care Unit, Suita, Osaka 5650871, Japan; [Uchiyama, Akinori; Ueta, Kazuyoshi; Fujino, Yuji] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, Osaka, Japan; [Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan	Iguchi, N (reprint author), Osaka Univ Hosp, Intens Care Unit, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	iguchi@hp-icu.med.osaka-u.ac.jp			JSPS KAKENHI [24791592]	This work was supported by JSPS KAKENHI Grant, Grant-in-Aid for Young Scientists (B), number 24791592.	Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Niemann CU, 2009, LIVER TRANSPLANT, V15, P1852, DOI 10.1002/lt.21938; Martensson J, 2010, INTENS CARE MED, V36, P1333, DOI 10.1007/s00134-010-1887-4; [Anonymous], 2012, KIDNEY INT S, V2, P1; Portal AJ, 2010, LIVER TRANSPLANT, V16, P1257, DOI 10.1002/lt.22158; Glassford NJ, 2013, INTENS CARE MED, V39, P1714, DOI 10.1007/s00134-013-3040-7; McIlroy DR, 2010, CLIN J AM SOC NEPHRO, V5, P211, DOI 10.2215/CJN.04240609; Kamijo A, 2005, J LAB CLIN MED, V145, P125, DOI 10.1016/j.lab.2004.12.003; de Geus HRH, 2011, AM J RESP CRIT CARE, V183, P907, DOI 10.1164/rccm.200908-1214OC; Nickolas TL, 2008, ANN INTERN MED, V148, P810; McCullough PA, 2013, CONTRIB NEPHROL, V182, P13, DOI 10.1159/000349963; Wheeler DS, 2008, CRIT CARE MED, V36, P1297, DOI 10.1097/CCM.0b013e318169245a; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Barri YM, 2009, LIVER TRANSPLANT, V15, P475, DOI 10.1002/lt.21682; Valette X, 2013, INTENS CARE MED, V39, P857, DOI 10.1007/s00134-013-2826-y; Doi K, 2011, CRIT CARE MED, V39, P2464, DOI 10.1097/CCM.0b013e318225761a; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Iguchi N, 2012, CLIN EXP NEPHROL, V16, P356, DOI 10.1007/s10157-012-0604-8; Wgener G, 2011, NEPHROL DIAL TRANSPL, V26, P1717; Yalavarthy Rajesh, 2007, Hemodial Int, V11 Suppl 3, pS7, DOI 10.1111/j.1542-4758.2007.00223.x	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					249	255		10.1007/s00540-014-1909-4		7	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100016		
J	Morimoto, Y; Tanaka, E; Shimamoto, Y; Tokumine, J				Morimoto, Yasuhiro; Tanaka, Eriko; Shimamoto, Yoko; Tokumine, Joho			Dissection of the posterior wall by guide-wire during internal jugular vein catheterization	JOURNAL OF ANESTHESIA			English	Article						Central venous catheter; Hematoma; Ultrasound	CENTRAL VENOUS CATHETERS; ULTRASOUND GUIDANCE; CANNULATION	We report a case of posterior wall hematoma formation in the internal jugular vein after the puncture of central vein. An 82-year-old woman was scheduled for laparotomy for an abdominal incisional hernia. After induction of general anesthesia, we performed central venous catheterization via the right internal jugular vein under ultrasound guidance in the short-axis view and out-of plane technique. The ultrasound view after insertion of a guide-wire revealed a hematoma-like space on the posterior wall of the vein. We removed and reinserted the guide-wire. This time, insertion of the wire and catheter was uneventful. Seven days after the surgery, no hematoma-like space was found in the vein. The malposition of the guide-wire was detected before dilation, which enabled us to avoid complications in this case. We should note that the confirmation of guide-wire placement in the vein is important during ultrasound-guided central venous catheterization.	[Morimoto, Yasuhiro; Tanaka, Eriko; Shimamoto, Yoko] Ube Ind Cent Hosp, Dept Anesthesia, Yamaguchi 7550151, Japan; [Tokumine, Joho] Seikei Kai Chiba Med Ctr, Dept Anesthesia, Chiba, Japan	Morimoto, Y (reprint author), Ube Ind Cent Hosp, Dept Anesthesia, 750 Nishikiwa Ube, Yamaguchi 7550151, Japan.	yamorimo@nifty.com					Stone MB, 2010, AM J EMERG MED, V28, P343, DOI 10.1016/j.ajem.2008.11.022; Blaivas M, 2009, CRIT CARE MED, V37, P2345, DOI 10.1097/CCM.0b013e3181a067d4; Parsons AJ, 2009, ANESTH ANALG, V109, P135, DOI 10.1213/ane.0b013e3181a7f5a4; Miller AH, 2002, ACAD EMERG MED, V9, P800, DOI 10.1111/j.1553-2712.2002.tb02168.x; Troianos CA, 2012, ANESTH ANALG, V114, P46, DOI 10.1213/ANE.0b013e3182407cd8; Blaivas M, 2003, ACAD EMERG MED, V10, P1307, DOI 10.1197/S1069-6563(03)00534-7; Gibson F, 2013, BRIT J ANAESTH, V110, P333, DOI 10.1093/bja/aes497; Thompson C, 2009, CAN J ANAESTH, V56, P471, DOI 10.1007/s12630-009-9082-1	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					289	291		10.1007/s00540-014-1900-0		3	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100021		
J	Tagawa, T; Sakuraba, S; Mizoguchi, A				Tagawa, Tsuyoshi; Sakuraba, Shigeki; Mizoguchi, Akira			In reply: Is propofol more neurotoxic in the developing brain?	JOURNAL OF ANESTHESIA			English	Letter						Propofol; Neuroapoptosis; Pediatric anesthesia			[Tagawa, Tsuyoshi; Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, Tsu, Mie 5148507, Japan; [Sakuraba, Shigeki] Kanagawa Dent Coll, Dept Anesthesiol, Clin Care Med, Yokosuka, Kanagawa 238, Japan	Tagawa, T (reprint author), Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	tsuyoshitagawa@gmail.com					Tagawa T, J ANESTH, DOI [10.1007//s00540-014-1822-x., DOI 10.1007//S00540-014-1822-X]	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					314	314		10.1007/s00540-014-1927-2		1	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100028		
J	Ishihara, M; Aoi, R; Takahashi, K				Ishihara, Mariko; Aoi, Ryota; Takahashi, Kan			Anisocoria after anesthesia induction caused by Adie syndrome	JOURNAL OF ANESTHESIA			English	Letter									[Ishihara, Mariko] Sakai City Hosp, Dept Anesthesia, Sakai Ku, Sakai, Osaka, Japan; [Aoi, Ryota] Sakai City Hosp, Dept Anesthesia, Osaka, Japan; [Takahashi, Kan] Shiga Univ Med Sci, Dept Crit Care & Intens Care Med, Otsu, Shiga 52021, Japan	Ishihara, M (reprint author), Sakai City Hosp, Dept Anesthesia, Sakai Ku, 1-1-1 Minamiyasui Cho, Sakai, Osaka, Japan.	mariko_i@muc.biglobe.ne.jp					Aceto P, 2011, EUR REV MED PHARMACO, V15, P211; Kobayashi M, 2008, CAN J ANAESTH, V55, P130, DOI 10.1007/BF03016329	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					315	315		10.1007/s00540-014-1902-y		1	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100029		
J	Tanabe, K; Takahashi, H; Iida, H				Tanabe, Kumiko; Takahashi, Harumi; Iida, Hiroki			Safe use of rocuronium for a post-polio syndrome patient	JOURNAL OF ANESTHESIA			English	Letter									[Tanabe, Kumiko; Iida, Hiroki] Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu 5011194, Japan; [Takahashi, Harumi] Gihoku Kousei Hosp, Dept Surg, Takatomi, Japan	Tanabe, K (reprint author), Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu 5011194, Japan.	kumiko-t@m2.gyao.ne.jp					Lambert DA, 2005, ANESTHESIOLOGY, V103, P638, DOI 10.1097/00000542-200509000-00029	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					316	316		10.1007/s00540-014-1906-7		1	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100030		
J	Miyoshi, H; Nakamura, R; Hamada, H				Miyoshi, Hirotsugu; Nakamura, Ryuji; Hamada, Hiroshi			Asystole following skull clamp to Chiari malformation	JOURNAL OF ANESTHESIA			English	Letter						Arnold-Chiari type I malformation; Skull clamp; Asystole; Vagal reflex			[Miyoshi, Hirotsugu; Nakamura, Ryuji; Hamada, Hiroshi] Hiroshima Univ Hosp, Dept Anesthesiol & Crit Care, Minami Ku, Hiroshima 7348551, Japan	Miyoshi, H (reprint author), Hiroshima Univ Hosp, Dept Anesthesiol & Crit Care, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	h-miyoshi@hiroshima-u.ac.jp					ALEGRE S, 1994, INT J CARDIOL, V46, P286, DOI 10.1016/0167-5273(94)90253-4; Schaller B, 2004, J NEUROL, V251, P658, DOI 10.1007/s00415-004-0458-4	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					317	317		10.1007/s00540-014-1890-y		1	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100031		
J	Ono, Y; Abe, Y; Shinohara, K				Ono, Yuko; Abe, Yoshinobu; Shinohara, Kazuaki			Identification of a displaced glottis using vocalization	JOURNAL OF ANESTHESIA			English	Letter									[Ono, Yuko; Abe, Yoshinobu] Fukushima Med Univ Hosp, Emergency & Crit Care Med Ctr, Fukushima 9601295, Japan; [Shinohara, Kazuaki] Ohta Nishinouch Hosp, Ohta Gen Hosp Fdn, Dept Anesthesiol & Crit Care Med, Koriyama, Fukushima, Japan	Ono, Y (reprint author), Fukushima Med Univ Hosp, Emergency & Crit Care Med Ctr, 1 Hikarigaoka, Fukushima 9601295, Japan.	windmill@fmu.ac.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					320	320		10.1007/s00540-014-1917-4		1	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100034		
J	Uchida, T; Nakao, S; Morimoto, M; Iwamoto, T				Uchida, Tomohisa; Nakao, Shinichi; Morimoto, Masahiro; Iwamoto, Tatsushige			Serious cervical hematoma after stellate ganglion block	JOURNAL OF ANESTHESIA			English	Letter						Stellate ganglion block (SGB); Cervical hematoma; Venous bleeding			[Uchida, Tomohisa; Nakao, Shinichi; Morimoto, Masahiro; Iwamoto, Tatsushige] Kinki Univ, Fac Med, Dept Anesthesiol, Osaka 5898511, Japan	Uchida, T (reprint author), Kinki Univ, Fac Med, Dept Anesthesiol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	anesth@med.kindai.ac.jp					Higa K, 2006, ANESTHESIOLOGY, V105, P1238, DOI 10.1097/00000542-200612000-00024	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2015	29	2					321	321		10.1007/s00540-014-1914-7		1	Anesthesiology	Anesthesiology	CF9CL	WOS:000352859100035		
J	Fukushima, A; Kinugawa, S; Homma, T; Masaki, Y; Furihata, T; Yokota, T; Matsushima, S; Takada, S; Kadoguchi, T; Oba, K; Okita, K; Tsutsui, H				Fukushima, Arata; Kinugawa, Shintaro; Homma, Tsuneaki; Masaki, Yoshihiro; Furihata, Takaaki; Yokota, Takashi; Matsushima, Shouji; Takada, Shingo; Kadoguchi, Tomoyasu; Oba, Koji; Okita, Koichi; Tsutsui, Hiroyuki			Serum Brain-Derived Neurotropic Factor Level Predicts Adverse Clinical Outcomes in Patients With Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Article						Heart failure; brain-derived neurotrophic factor; exercise capacity; prognosis	OPERATING CHARACTERISTIC CURVES; SKELETAL-MUSCLE; COGNITIVE IMPAIRMENT; EXERCISE INTOLERANCE; RISK; BDNF; ASSOCIATION; DYSFUNCTION; BIOMARKERS; PROGNOSIS	Background: Brain-derived neurotropic factor (BDNF) is involved in cardiovascular diseases as well as skeletal muscle energy metabolism and depression. We investigated whether serum BDNF level was associated with prognosis in patients with heart failure (HF). Methods and Results: We measured the serum BDNF level in 58 patients with HF (59.2 +/- 13.7 years old, New York Heart Association functional class I III) at baseline, and adverse events, including all cardiac deaths and HF rehospitalizations, were recorded during the median follow-up of 20.3 months. In a univariate analysis, serum BDNF levels were significantly associated with peak oxygen capacity (beta = 0.547; P = .003), anaerobic threshold (beta = 0.929; P = .004), and log minute ventilation/carbon dioxide production slope (beta = 10.15; P = .005), but not Patient Health Questionnaire scores (beta = 0.099; P = .586). A multivariate analysis demonstrated that serum BDNF level was an independent prognostic factor of adverse events (hazard ratio 0.41, 95% confidence interval 0.20-0.84; P = .003). The receiver operating characteristic curve demonstrated that low levels of BDNF (<17.4 ng/mL) were associated with higher rates of adverse events compared with high levels of BDNF (>= 17.4 ng/mL; log rank test: P < .001). Conclusions: Decreased serum BDNF levels were significantly associated with adverse outcomes in HF patients, suggesting that these levels can be a useful prognostic biomarker.	[Fukushima, Arata; Kinugawa, Shintaro; Homma, Tsuneaki; Masaki, Yoshihiro; Furihata, Takaaki; Yokota, Takashi; Matsushima, Shouji; Takada, Shingo; Kadoguchi, Tomoyasu; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 0608638, Japan; [Oba, Koji] Hokkaido Univ Hosp, Translat Res & Clin Trial Ctr, Sapporo, Hokkaido 060, Japan; [Okita, Koichi] Hokusho Univ, Grad Sch, Program Lifelong Learning Studies, Ebetsu, Hokkaido, Japan	Kinugawa, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	tuckahoe@med.hokudai.ac.jp			Ministry of Education, Science, and Culture [20117004, 21390236, 24659379]	Grants from the Ministry of Education, Science, and Culture (20117004, 21390236, 24659379).	Aisen PS, 2014, JAMA-J AM MED ASSOC, V311, P1684, DOI [10.1001/jama.2014.3120, 10.1001/jamaneurol.2013.4781]; Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Suwa M, 2006, METABOLISM, V55, P852, DOI 10.1016/j.metabol.2006.02.012; Mongia SK, 2008, CLIN CHIM ACTA, V391, P102, DOI [10.1016/j.cca.2008.01.026, 10.1016/j.cea.2008.01.026]; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pedersen BK, 2009, EXP PHYSIOL, V94, P1153, DOI 10.1113/expphysiol.2009.048561; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Hirabayashi K, 2014, INT J CARDIOL, V176, P1110, DOI 10.1016/j.ijcard.2014.07.113; MANCINI DM, 1991, CIRCULATION, V83, P778; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Wang TJ, 2011, CIRCULATION, V123, P551, DOI 10.1161/CIRCULATIONAHA.109.912568; Hawkins LA, 2012, HEART LUNG, V41, P572, DOI 10.1016/j.hrtlng.2012.06.001; Yokota T, 2013, DIABETES CARE, V36, P1341, DOI 10.2337/dc12-1161; Zuccala G, 2003, AM J MED, V115, P97, DOI 10.1016/S0002-9343(03)00264-X; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; SCHILLER NB, 1979, CIRCULATION, V60, P547; Clark AL, 1996, J AM COLL CARDIOL, V28, P1092, DOI 10.1016/S0735-1097(96)00323-3; Jiang H, 2011, BIOCHEM BIOPH RES CO, V415, P99, DOI 10.1016/j.bbrc.2011.10.020; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; Okita K, 2013, CIRC J, V77, P293, DOI 10.1253/circj.CJ-12-1235; Rumsfeld JS, 2003, J AM COLL CARDIOL, V42, P1811, DOI 10.1016/j.jacc.2003.07.013; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Arena R, 2004, AM HEART J, V147, P354, DOI 10.1016/j.ahj.2003.07.014; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Bayes-Genis A, 2014, J AM COLL CARDIOL, V63, P158, DOI 10.1016/j.jacc.2013.07.087; Fukushima A, 2013, INT J CARDIOL, V168, pE142, DOI 10.1016/j.ijcard.2013.08.073; HANLEY JA, 1983, RADIOLOGY, V148, P839; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Park YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091061	37	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	APR	2015	21	4					300	306		10.1016/j.cardfail.2015.01.003		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CF3RU	WOS:000352467000003		
J	Tezuka, D; Terashima, M; Kato, Y; Toriihara, A; Hirasawa, K; Sasaoka, T; Yoshikawa, S; Maejima, Y; Ashikaga, T; Suzuki, J; Hirao, K; Isobe, M				Tezuka, Daisuke; Terashima, Masahiro; Kato, Yoko; Toriihara, Akira; Hirasawa, Kensuke; Sasaoka, Taro; Yoshikawa, Shunji; Maejima, Yasuhiro; Ashikaga, Takashi; Suzuki, Jun-ichi; Hirao, Kenzo; Isobe, Mitsuaki			Clinical Characteristics of Definite or Suspected Isolated Cardiac Sarcoidosis: Application of Cardiac Magnetic Resonance Imaging and F-18-Fluoro-2-deoxyglucose Positron-Emission Tomography/Computerized Tomography	JOURNAL OF CARDIAC FAILURE			English	Article						Isolated cardiac sarcoidosis; left ventricular dysfunction	HYPERTROPHIC CARDIOMYOPATHY; APICAL ANEURYSM; HEART; MYOCARDITIS; CARDIOLOGY; DIAGNOSIS	Background: Isolated cardiac sarcoidosis (iCS) is difficult to diagnose in patients without histologic evidence of sarcoidosis. We aimed to clarify the clinical characteristics of iCS, including imaging features on cardiac magnetic resonance imaging (MRI) and F-18-fluoro-2-deoxyglucose positron-emission tomography/computerized tomography (FDG-PET/CT) scans. We also reviewed the therapeutic effect of cordcosteroids and determined the long-term prognosis. Methods and Results: We retrospectively reviewed 83 consecutive patients with suspicious CS from 1997 to 2013. Systemic sarcoidosis with CS (sCS, n = 30) and iCS (n = 11) were diagnosed according to clinical criteria. In iCS cases, sarcoidosis was not detected in any other organs. The clinical features did not significantly differ between sCS and iCS cases, except for ejection fraction, which was lower in iCS (P = .025). Nine sCS and 4 iCS cases showed late gadolinium enhancement, and the lesions tended to be on the epicardial side (76.9% P = .011) and septal wall (52.9% P < .001). The coefficient of variance for the myocardial standardized uptake value of FDG-PET/CT was higher in sCS (0.32 +/- 0.13; n = 19) and iCS (0.32 +/- 0.09; n = 7) than in control cases (n = 31; P < .001). B-Type natriuretic peptide level was improved after prednisolone treatment in both groups. Kaplan-Meier curve indicated that prognosis was not different between sCS and iCS cases. Conclusions: The clinical cardiac characteristics of iCS cases were similar to those of sCS. Cardiac MRI and FDG-PET, noninvasive imaging modalities, could be useful modalities to detect myocardial involvement in the cases with definite or suspected iCS.	[Tezuka, Daisuke; Kato, Yoko; Hirasawa, Kensuke; Sasaoka, Taro; Yoshikawa, Shunji; Maejima, Yasuhiro; Ashikaga, Takashi; Hirao, Kenzo; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo 1138519, Japan; [Tezuka, Daisuke; Terashima, Masahiro] Cardiovasc Imaging Clin, Tokyo, Japan; [Tezuka, Daisuke; Suzuki, Jun-ichi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan; [Toriihara, Akira] Tokyo Med & Dent Univ, Dept Diagnost Radiol & Nucl Med, Tokyo 1138519, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo 1138519, Japan	Isobe, M (reprint author), Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	isobemi.cvm@tmd.ac.jp					ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; Maron MS, 2008, CIRCULATION, V118, P1541, DOI 10.1161/CIRCULATIONAHA.108.781401; Tahara N, 2010, JACC-CARDIOVASC IMAG, V3, P1219, DOI 10.1016/j.jcmg.2010.09.015; Kandolin R, 2011, J INTERN MED, V270, P461, DOI 10.1111/j.1365-2796.2011.02396.x; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204; Sekiguchi M, 1996, CARDIOVASC DRUG THER, V10, P495, DOI 10.1007/BF00050989; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; Yazaki Y, 2001, AM J CARDIOL, V88, P1006, DOI 10.1016/S0002-9149(01)01978-6; [Anonymous], 2007, JPN J SARCOIDOSIS GR, V27, P89; SEKIGUCHI M, 1980, JPN CIRC J, V44, P249; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; Yang YS, 2014, J MAGN RESON IMAGING, V39, P609, DOI 10.1002/jmri.24196; Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258; Tezuka D, 2012, JACC-CARDIOVASC IMAG, V5, P422, DOI 10.1016/j.jcmg.2012.01.013; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; Kosuge H, 2001, JPN HEART J, V42, P265, DOI 10.1536/jhj.42.265; Matsubara K, 2003, J AM COLL CARDIOL, V42, P288, DOI 10.1016/S0735-1097(03)00576-X; Kandolin R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P303, DOI 10.1161/CIRCEP.110.959254; Baba Y, 2012, INT HEART J, V53, P287; Ishida Y, 2014, ANN NUCL MED, V28, P393, DOI 10.1007/s12149-014-0806-0; Haraki T, 2002, CIRC J, V66, P519, DOI 10.1253/circj.66.519; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI [10.1056/NEJMra071714, DOI 10.1056/NEJMRA071714]; Isobe M, 2015, INT J CARDIOL, V182, P132, DOI 10.1016/j.ijcard.2014.12.056; Ohira Hiroshi, 2011, Eur J Nucl Med Mol Imaging, V38, P1773, DOI 10.1007/s00259-011-1832-y; Yasutake H, 2005, INT J CARDIOL, V102, P259, DOI 10.1016/j.ijcard.2004.05.028	27	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	APR	2015	21	4					313	322		10.1016/j.cardfail.2014.12.004		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CF3RU	WOS:000352467000005		
J	Kaneko, Y; Nakajima, T; Kurabayashi, M				Kaneko, Yoshiaki; Nakajima, Tadashi; Kurabayashi, Masahiko			Does the Prepotential Truly Reflect the Activation Preceding the Development of Ventricular Arrhythmias?	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Letter									[Kaneko, Yoshiaki; Nakajima, Tadashi; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 3718511, Japan	Kaneko, Y (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	kanekoy@gunma-u.ac.jp					ANDERSON RH, 1974, EUR J CARDIOL, V2, P219; Hai JJ, 2015, J CARDIOVASC ELECTR, V26, P158, DOI 10.1111/jce.12587; Saito A, 2010, INT HEART J, V51, P394, DOI 10.1536/ihj.51.394	3	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	APR	2015	26	4					E4	E4		10.1111/jce.12615		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CF8MH	WOS:000352814300003		
J	Wang, MF; Shibamoto, T; Shinomiya, S; Yamamoto, Y; Kurata, Y; Kuda, Y; Tanida, M; Toga, H				Wang, Mofei; Shibamoto, Toshishige; Shinomiya, Shohei; Yamamoto, Yuki; Kurata, Yasutaka; Kuda, Yuhichi; Tanida, Mamoru; Toga, Hirohisa			Pulmonary Vascular and Airway Responses to Systemic Vasoconstrictors in Anesthetized BALB/c Mice	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						total peripheral resistance; pulmonary arterial pressure; left atrial pressure; left heart overload; vasopressin; U46619	ANAPHYLACTIC HYPOTENSION; ARTERIAL-HYPERTENSION; ARGININE-VASOPRESSIN; ANGIOTENSIN-II; MOUSE MODELS; NITRIC-OXIDE; INFARCTION; PRESSURE; ISCHEMIA; VOLUME	There is no systematic study in which the effects of vasoactive substances were investigated on pulmonary vascular resistance (PVR) in in vivo mouse by directly measuring cardiac output and the inflow and outflow pressures in the pulmonary circulation. We determined the responses of PVR, total peripheral resistance (TPR), and airway pressure (AWP) to angiotensin II, endothelin-1, vasopressin, phenylephrine, and thromboxane A2 analog U46619 in anesthetized BALB/c mice. Pulmonary arterial pressure, left atrial pressure (LAP), and aortic blood flow were measured. TPR increased dose-dependently in response to consecutive administration of all vasoconstrictors except vasopressin which reduced TPR at the highest dose of 100 nmol/kg. At high doses of vasoconstrictors, pulmonary arterial pressure and AWP increased due to increased LAP, as demonstrated by the separate LAP elevation experiments. When LAP transiently increased at high doses, PVR did not increase but decreased. Nonetheless, enodothelin-1, angiotensin II, and U46619 increased PVR. Vasopressin at 100 nmol/kg increased AWP without LAP elevation. In conclusion, the high doses of the vasoconstrictors studied here exert indirectly a transient pulmonary vasodilatory and AWP increasing actions due to pulmonary congestion evoked by strong systemic vasoconstriction. Nevertheless, enodothelin-1, angiotensin II, and U46619 cause pulmonary vasoconstriction, and vasopressin constricts airway in anesthetized BALB/c mice.	[Wang, Mofei; Shibamoto, Toshishige; Yamamoto, Yuki; Kurata, Yasutaka; Kuda, Yuhichi; Tanida, Mamoru] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 9200293, Japan; [Wang, Mofei] China Med Univ, Affiliated Hosp 4, Dept Colorectal Surg, Shenyang 110001, Peoples R China; [Shinomiya, Shohei; Toga, Hirohisa] Kanazawa Med Univ, Dept Resp Med, Uchinada, Ishikawa 9200293, Japan	Shibamoto, T (reprint author), Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 9200293, Japan.	shibamo@kanazawa-med.ac.jp			Kanazawa Medical University [SR2012-04, S2013-1, PR2012-14]	Supported by a Grant from Kanazawa Medical University (SR2012-04, S2013-1, and PR2012-14).	Koshimizu T, 2006, P NATL ACAD SCI USA, V103, P7807, DOI 10.1073/pnas.0600875103; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Wagner EM, 1996, J APPL PHYSIOL, V81, P293; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; EVORA PRB, 1993, CHEST, V103, P1241, DOI 10.1378/chest.103.4.1241; EICHINGER MR, 1994, AM J PHYSIOL-HEART C, V267, pH2413; Cingolani OH, 2011, AM J PHYSIOL-HEART C, V301, pH2198, DOI 10.1152/ajpheart.00781.2011; Gomez-Arroyo J, 2012, AM J PHYSIOL-LUNG C, V302, pL977, DOI 10.1152/ajplung.00362.2011; Baron RM, 2012, AM J PHYSIOL-LUNG C, V302, pL485, DOI 10.1152/ajplung.00085.2011; Doggrell SA, 2004, EXPERT OPIN THER TAR, V8, P191, DOI 10.1517/14728222.8.3.191; EICHINGER MR, 1994, AM J PHYSIOL, V267, pH494; Hermo-Weiler CI, 1998, J APPL PHYSIOL, V85, P1655; Ikram H, 1996, HEART, V76, P60, DOI 10.1136/hrt.76.3_Suppl_3.60; Liu W, 2007, AM J PHYSIOL-REG I, V293, pR1947, DOI 10.1152/ajpregu.00904.2006; Lujan HL, 2013, AM J PHYSIOL-REG I, V304, pR286, DOI 10.1152/ajpregu.00517.2012; Mori T, 2006, LIFE SCI, V79, P637, DOI 10.1016/j.lfs.2006.02.005; ROOS A, 1961, J APPL PHYSIOL, V16, P77; SAI Y, 1995, EUR J PHARMACOL, V282, P235, DOI 10.1016/0014-2999(95)00343-J; Schmidt DT, 2001, N-S ARCH PHARMACOL, V364, P314; Shinomiya S, 2013, EXP LUNG RES, V39, P119, DOI 10.3109/01902148.2013.768720; Witzenrath M, 2006, EUR RESPIR J, V28, P370, DOI 10.1183/09031936.06.00080105; Xu ML, 2008, AM J PHYSIOL-HEART C, V294, pH220, DOI 10.1152/ajpheart.00968.2007	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0160-2446	1533-4023		J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	APR	2015	65	4					325	334				10	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CF4BL	WOS:000352493300005		
J	Sugimoto, A; Suzuki, Y; Endo, T; Matsumoto, K; Sugiyama, T; Someya, T				Sugimoto, Atsunori; Suzuki, Yutaro; Endo, Taro; Matsumoto, Keita; Sugiyama, Toshiro; Someya, Toshiyuki			Efficacy of Atomoxetine for Symptoms of Attention-Deficit/Hyperactivity Disorder in Children with a History of Child Abuse	JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY			English	Article							DISSOCIATION	Objective: Recent studies suggest that the severity and drug response of depression and anxiety are correlated with childhood abuse. However, whether a history of child abuse can predict the severity and/or drug response of attention-deficit/hyperactivity disorder (ADHD) is unclear. Therefore, we conducted a retrospective study to assess the efficacy of atomoxetine in children with a history of child abuse. Methods: We reviewed 41 cases of children treated with atomoxetine. Specifically, we compared dissociation associating symptoms (DAS) and other symptoms (OS) measured via the ADHD Rating Scale (ADHD-RS) in abused and nonabused children at baseline and at 8 weeks after atomoxetine administration. Results: At baseline, abused children had higher total scores (38.7 +/- 9.3 vs. 30.5 +/- 9.4, p=0.011), and greater levels of hyperactivity/impulsivity (17.3 +/- 5.8 vs. 11.3 +/- 6.0, p=0.004) on the ADHD-RS than did nonabused children, whereas the inattention scores were similar between the two groups (21.4 +/- 4.8 vs. 19.2 +/- 4.6). Additionally, the total score and the two subscores decreased at week 8 for both groups. In the nonabused group, DAS (5.5 +/- 2.3 vs. 3.9 +/- 1.7, p<0.001) and OS (25.0 +/- 8.1 vs. 17.4 +/- 6.7, p<0.001) significantly decreased after atomoxetine treatment. However, DAS in the abused group did not change after atomoxetine treatment (5.9 +/- 2.3 vs. 5.1 +/- 1.8), whereas OS significantly decreased (32.8 +/- 7.6 vs. 25.7 +/- 7.2, p=0.002). Conclusions: If DAS were caused by traumatic experiences in abused children, trauma treatment tools other than pharmacotherapy might be useful to treat DAS. These tools may include eye movement desensitization and reprocessing and trauma-focused cognitive behavioral therapy.	[Sugimoto, Atsunori; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata 9518510, Japan; [Sugimoto, Atsunori; Matsumoto, Keita; Sugiyama, Toshiro] Aichi Childrens Hlth & Med Ctr, Dept Psychiat, Nagoya, Aichi, Japan; [Suzuki, Yutaro; Endo, Taro] Niigata Univ, Med & Dent Hosp, Dept Psychiat, Niigata 9518510, Japan; [Sugiyama, Toshiro] Hamamatsu Univ Sch Med, Dept Pediat Psychiat, Hamamatsu, Shizuoka 4313192, Japan	Suzuki, Y (reprint author), Niigata Univ, Med & Dent Hosp, Dept Psychiat, Chuo Ku, 757 Asahimachidori Ichibancho, Niigata 9518510, Japan.	yutaro@med.niigata-u.ac.jp			Asahi Kasei Pharma; Astellas Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Eisai; Eli Lilly Japan; GlaxoSmithKline; Janssen Pharmaceutical; Meiji Seika Pharma; Mitsubishi Tanabe Pharma; Mochida Pharmaceutical; MSD; Otsuka Pharmaceutical; Pfizer Japan; Shionogi; Tsumura; Yoshitomiyakuhin; Mitsubishi Tanabe Pharma Corporation	Dr. Someya has received research support and honoraria from Asahi Kasei Pharma, Astellas Pharma, Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Eli Lilly Japan, GlaxoSmithKline, Janssen Pharmaceutical, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, MSD, Otsuka Pharmaceutical, Pfizer Japan, Shionogi, Tsumura, and Yoshitomiyakuhin. Dr. Sugiyama has received research support and honoraria from Eli Lilly Japan and Otsuka Pharmaceutical. Dr. Suzuki has received research support and honoraria from Janssen Pharmaceutical, Otsuka Pharmaceutical, and Mitsubishi Tanabe Pharma Corporation. The other authors have no conflicts of interest to disclose.	Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Tomoda A, 2009, BIOL PSYCHIAT, V66, P642, DOI 10.1016/j.biopsych.2009.04.021; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Olsen SA, 2012, J ANXIETY DISORD, V26, P225, DOI 10.1016/j.janxdis.2011.11.003; Pliszka SR, 2006, J AM ACAD CHILD PSY, V45, P642, DOI 10.1097/01.chi.0000215326.51175.eb; Endo T, 2006, PSYCHIAT CLIN NEUROS, V60, P434, DOI 10.1111/j.1440-1819.2006.01528.x; Brewin CR, 2013, CONSCIOUS COGN, V22, P315, DOI 10.1016/j.concog.2012.08.005; Bruce Laura C, 2012, Depress Anxiety, V29, P131, DOI 10.1002/da.20909; Weiss M, 2011, CANADIAN ADHD PRACTI	11	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1044-5463	1557-8992		J CHILD ADOL PSYCHOP	J. Child Adolesc. Psychopharmacol.	APR 1	2015	25	3					269	271		10.1089/cap.2014.0119		3	Pediatrics; Pharmacology & Pharmacy; Psychiatry	Pediatrics; Pharmacology & Pharmacy; Psychiatry	CG1DX	WOS:000353014300011		
J	Shimura, T; Mori, N; Mase, H				Shimura, Tomoya; Mori, Nobuhito; Mase, Hajime			Future Projection of Ocean Wave Climate: Analysis of SST Impacts on Wave Climate Changes in the Western North Pacific	JOURNAL OF CLIMATE			English	Article							WIND-WAVES; SEA-ICE; HEMISPHERE; PERFORMANCE; HEIGHTS; TRENDS; MODEL; ERA	Changes in ocean surface waves elicit a variety of impacts on coastal environments. To assess the future changes in the ocean surface wave climate, several future projections of global wave climate have been simulated in previous studies. However, previously there has been little discussion about the causes behind changes in the future wave climate and the differences between projections. The objective of this study is to estimate the future changes in mean wave climate and the sensitivity of the wave climate to sea surface temperature (SST) conditions in an effort to understand the mechanism behind the wave climate changes by specifically looking at spatial SST variation. Aseries of wave climate projections forced by surface winds from the MRI-AGCM3.2 were conducted based on SST ensemble experiments. The results yield future changes in annual mean wave height that are within about +/- 0.3 m. The future changes in summertime wave height in the western North Pacific (WNP), which are influenced by tropical cyclone changes, are highly sensitive to SST conditions. To generalize the result, the wave climate change and SST relation found by this study was compared with multimodel wave ensemble products from the Coordinated Ocean Wave Climate Project (COWCLIP). The spatial variation of SST in the tropical Pacific Ocean is a major factor in the wave climate changes for the WNP during summer.	[Shimura, Tomoya] Kyoto Univ, Grad Sch Engn, Kyoto 6158530, Japan; [Mori, Nobuhito; Mase, Hajime] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6158530, Japan	Shimura, T (reprint author), Kyoto Univ, Grad Sch Engn, Kyoto 6158530, Japan.	shimura.tomoya.36w@st.kyoto-u.ac.jp	Mori, Nobuhito/B-8627-2008	Mori, Nobuhito/0000-0001-9082-3235	Japan Society for the Promotion of Science (JSPS); SOSEI Program by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	The authors acknowledge COWCLIP, which is an international collaborative working group endorsed by the World Climate Research Programme and the Joint Commission on Oceanography and Marine Meteorology of the World Meteorological Organization (JCOMM/WCRP), and the WCRP's Working Group on Coupled Modelling for the CMIP3 and CMIP5 datasets. TS was supported by the Japan Society for the Promotion of Science (JSPS) Fellowships for Young Scientists and Grant-in-Aid for JSPS Fellows. This research was supported under the SOSEI Program by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and a Kakenhi Grant-in-Aid for Scientific Research.	Wang XLL, 2001, J CLIMATE, V14, P2204, DOI 10.1175/1520-0442(2001)014<2204:COEWHI>2.0.CO;2; Semedo A, 2011, J CLIMATE, V24, P1461, DOI 10.1175/2010JCLI3718.1; Menendez M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035394; Ardhuin F, 2011, OCEAN MODEL, V39, P405, DOI 10.1016/j.ocemod.2011.03.004; Charles E, 2012, OCEAN DYNAM, V62, P831, DOI 10.1007/s10236-012-0534-8; Gulev SK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021040; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Hemer MA, 2012, B AM METEOROL SOC, V93, P791, DOI 10.1175/BAMS-D-11-00184.1; Eisenman I, 2014, CRYOSPHERE, V8, P1289, DOI 10.5194/tc-8-1289-2014; Fan YL, 2013, J CLIMATE, V26, P6046, DOI 10.1175/JCLI-D-12-00410.1; Suh KD, 2012, J WATERW PORT C-ASCE, V138, P215, DOI 10.1061/(ASCE)WW.1943-5460.0000126; Hemer MA, 2013, OCEAN MODEL, V70, P221, DOI 10.1016/j.ocemod.2012.09.008; Mori N, 2013, OCEAN ENG, V71, P122, DOI 10.1016/j.oceaneng.2013.02.016; Mizuta R, 2012, J METEOROL SOC JPN, V90A, P233, DOI 10.2151/jmsj.2012-A12; Knutti R, 2013, GEOPHYS RES LETT, V40, P1194, DOI 10.1002/grl.50256; Ardhuin F, 2010, J PHYS OCEANOGR, V40, P1917, DOI 10.1175/2010JPO4324.1; Tolman HL, 1996, J PHYS OCEANOGR, V26, P2497, DOI 10.1175/1520-0485(1996)026<2497:STIATG>2.0.CO;2; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Murakami H, 2012, CLIM DYNAM, V39, P2569, DOI 10.1007/s00382-011-1223-x; Hemer MA, 2010, INT J CLIMATOL, V30, P475, DOI 10.1002/joc.1900; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219; Wang XLL, 2006, CLIM DYNAM, V26, P109, DOI 10.1007/s00382-005-0080-x; Zhan RF, 2013, J CLIMATE, V26, P2408, DOI 10.1175/JCLI-D-12-00798.1; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Delcambre SC, 2013, J CLIMATE, V26, P4930, DOI 10.1175/JCLI-D-12-00359.1; Hoeke RK, 2013, GLOBAL PLANET CHANGE, V108, P128, DOI 10.1016/j.gloplacha.2013.06.006; Hemer MA, 2013, NAT CLIM CHANGE, V3, P471, DOI [10.1038/nclimate1791, 10.1038/NCLIMATE1791]; Bidlot J.R., 2012, P ECMWF WORKSH OC WA; Cruz J, 2008, GREEN ENERGY TECHNOL, P1, DOI 10.1007/978-3-540-74895-3; Dobrynin M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052843; Kuriyama Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050704; Mori Nobuhito, 2010, Hydrological Research Letters, V4, DOI 10.3178/HRL.4.15; Sasaki W, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053845; Semedo A, 2013, J CLIMATE, V26, P8269, DOI 10.1175/JCLI-D-12-00658.1; Short AD, 1999, HDB BEACH SHOREFACE; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258; Stocker T. F., 2013, CLIMATE CHANGE 2013; Tolman H.L., 2009, 276 NOAANWSNCEPMMAB	39	2	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	APR	2015	28	8					3171	3190		10.1175/JCLI-D-14-00187.1		20	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CF3ZI	WOS:000352487300015		
J	Ouchi, M; Oba, K; Saigusa, T; Watanabe, K; Ohara, M; Matsumura, N; Suzuki, T; Anzai, N; Tsuruoka, S; Yasutake, M				Ouchi, Motoshi; Oba, Kenzo; Saigusa, Taro; Watanabe, Kentaro; Ohara, Makoto; Matsumura, Noriaki; Suzuki, Tatsuya; Anzai, Naohiko; Tsuruoka, Shuichi; Yasutake, Masahiro			Association Between Pulse Wave Velocity and a Marker of Renal Tubular Damage (N-Acetyl-beta-D-Glucosaminidase) in Patients Without Diabetes	JOURNAL OF CLINICAL HYPERTENSION			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; GLYCEMIC CONTROL CONDITIONS; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; CLINICAL-APPLICATIONS; HEART-FAILURE; MORTALITY; SERUM; PROGRESSION	The authors assessed the association between the ratio of urinary activity of N-acetyl--D-glucosaminidase (NAG) to creatinine and the brachial-ankle pulse wave velocity (baPWV) in patients without overt diabetes mellitus (DM). This was a cross-sectional study of 233 patients who had an estimated glomerular filtration rate (eGFR) 30mL/min/1.73m(2) and no history of kidney disease. Patients were divided into two groups: high NAG group (>5.8U/gcreatinine) and low NAG group (5.8U/gcreatinine). Mean baPWVs of the high NAG group were significantly higher than those of the low NAG group in both the eGFR 30 and <60tertiles and the eGFR 60 and <90tertiles. The baPWV was positively correlated with NAG in all patients (r=0.341, P<.001). Stepwise multivariate regression analysis showed that the baPWV was significantly related with NAG, age, and systolic blood pressure. Elevated NAG is related to elevated arterial stiffness in patients without DM. (C) 2015 Wiley Periodicals, Inc.	[Ouchi, Motoshi; Anzai, Naohiko] Dokkyo Med Univ, Sch Med, Dept Pharmacol & Toxicol, Shimotsuga, Tochigi 3210293, Japan; [Oba, Kenzo] Oarai Coast Core Clin, Dept Internal Med, Ibaraki, Japan; [Saigusa, Taro; Matsumura, Noriaki; Suzuki, Tatsuya; Yasutake, Masahiro] Nippon Med Sch, Div Geriatr Med, Tokyo 113, Japan; [Watanabe, Kentaro] Yamagata Univ, Fac Med, Dept Neurol Hematol Metab Endocrinol & Diabetol D, Yamagata 990, Japan; [Ohara, Makoto] Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol, Tokyo 142, Japan; [Tsuruoka, Shuichi] Nippon Med Sch, Grad Sch Med, Dept Internal Med, Div Nephrol, Tokyo 113, Japan; [Yasutake, Masahiro] Nippon Med Sch, Grad Sch Med, Dept Comprehens Med Care & Hlth Sci, Tokyo 113, Japan	Ouchi, M (reprint author), Dokkyo Med Univ, Sch Med, Dept Pharmacol & Toxicol, 880 Kitakobayashi, Shimotsuga, Tochigi 3210293, Japan.	ouchi@dokkyomed.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ishikawa T, 2008, AM J HYPERTENS, V21, P413, DOI 10.1038/ajh.2007.77; Lantelme P, 2002, HYPERTENSION, V39, P1083, DOI 10.1161/01.HYP.0000019132.41066.95; Yoon HE, 2013, INT J MED SCI, V10, P1430, DOI 10.7150/ijms.6645; Taal MW, 2014, CURR OPIN NEPHROL HY, V23, P169, DOI 10.1097/01.mnh.0000441153.40072.e0; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2964, DOI 10.1681/ASN.2006070704; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Metcalfe W, 2007, NEPHROL DIAL TRANSPL, V22, P26, DOI 10.1093/ndt/gfm446; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Hung CS, 2009, NUTR METAB CARDIOVAS, V19, P241, DOI 10.1016/j.numecd.2008.07.006; Damman K, 2010, EUR J HEART FAIL, V12, P974, DOI 10.1093/eurjhf/hfq118; [Anonymous], 2013, L TYP NAG PACK INS; Tomiyama H, 2011, ATHEROSCLEROSIS, V217, P130, DOI 10.1016/j.atherosclerosis.2011.03.028; Damman K, 2011, EUR HEART J, V32, P2705, DOI 10.1093/eurheartj/ehr190; Tomiyama H, 2005, HYPERTENSION, V45, P997, DOI 10.1161/01.HYP.0000165018.63523.8a; Tomiyama H, 2004, HYPERTENS RES, V27, P465, DOI 10.1291/hypres.27.465; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yambe M, 2007, J HYPERTENS, V25, P87, DOI 10.1097/01.hjh.0000254375.73241.e2; Yamanouchi T, 1998, DIABETES CARE, V21, P619, DOI 10.2337/diacare.21.4.619; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Jovanovic D, 2003, RENAL FAILURE, V25, P123, DOI 10.1081/JDI-120017475; Capodicasa E, 2011, RENAL FAILURE, V33, P650, DOI 10.3109/0886022X.2011.585262; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P724, DOI 10.2215/CJN.07700910; ELLIS BG, 1975, CLIN CHIM ACTA, V64, P195, DOI 10.1016/0009-8981(75)90201-6; GIBEY R, 1986, PATHOL BIOL, V34, P342; Helmersson-Karlqvist J, 2013, ATHEROSCLEROSIS, V227, P408, DOI 10.1016/j.atherosclerosis.2013.01.009; Hong Jeong Deok, 2012, Korean J Pediatr, V55, P136, DOI 10.3345/kjp.2012.55.4.136; Inoue T, 2000, ATHEROSCLEROSIS, V149, P117, DOI 10.1016/S0021-9150(99)00293-2; John M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-31; Kawamoto R, 2008, INTERNAL MED, V47, P593, DOI 10.2169/internalmedicine.47.0825; Kohara K, 2004, HYPERTENS RES, V27, P471, DOI 10.1291/hypres.27.471; Lee YJ, 2009, NUTR METAB CARDIOVAS, V19, P3, DOI 10.1016/j.numecd.2008.02.003; LesHir M, 1979, HISTOCHEMISTRY, V63, P245; Liu CS, 2010, ATHEROSCLEROSIS, V211, P315, DOI 10.1016/j.atherosclerosis.2010.02.015; Liu IT, 2013, J AM GERIATR SOC, V61, P1758, DOI 10.1111/jgs.12445; Morita A, 1998, CLIN CHIM ACTA, V278, P35, DOI 10.1016/S0009-8981(98)00157-0; Oba Kenzo, 1999, Journal of Nippon Medical School, V66, P33; Ouchi M, 2012, J CLIN LAB ANAL, V26, P473, DOI 10.1002/jcla.21549; Ouchi M, 2014, DIABETES TECHNOL THE, V16, P41, DOI 10.1089/dia.2013.0155; Ouchi M, 2014, CLIN CHIM ACTA, V433, P88, DOI 10.1016/j.cca.2013.11.035; PAIGEN K, 1978, J CLIN INVEST, V61, P751, DOI 10.1172/JCI108989; Saijo Y, 2005, HYPERTENS RES, V28, P505, DOI 10.1291/hypres.28.505; Weitgasser R, 1999, DIABETES CARE, V22, P1882, DOI 10.2337/diacare.22.11.1882; YAMANOUCHI T, 1995, CLIN SCI, V88, P203; Yoshikawa R, 2007, DIABETES RES CLIN PR, V76, P358, DOI 10.1016/j.diabres.2006.09.004; Yuzawa Y, 2008, NIPPON NAIKA GAKKAI, V97, P971	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1524-6175	1751-7176		J CLIN HYPERTENS	J. Clin. Hypertens.	APR	2015	17	4					290	297		10.1111/jch.12492		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF5BY	WOS:000352571400008		
J	Higashi, M; Yamaura, K; Matsubara, Y; Fukudome, T; Hoka, S				Higashi, Midoriko; Yamaura, Ken; Matsubara, Yukie; Fukudome, Takuya; Hoka, Sumio			In-line pressure within a HOTLINEA (R) Fluid Warmer, under various flow conditions	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						In-line pressure; Rapid infusion; Roller pump; Fluid warmer	NORMOTHERMIA; INFUSION	Roller pump infusion devices are widely used for rapid infusion, and may be combined with separate warming devices. There may be instances however, where the pressures generated by the roller pump may not be compatible with the warming device. We assessed a commonly used roller pump in combination with a HOTLINEA (R) Fluid Warmer, and found that it could generate pressures exceeding the HOTLINEA (R) manufacturers specifications. This was of concern because the HOTLINEA (R) manufacturer guideline states that not for use with pressure devices generating over 300 mmHg. Pressure greater than 300 mmHg may compromise the integrity of the HOTLINEA (R) Fluid Warming Set. The aim of this study was to compare in-line pressure within a HOTLINEA (R) Fluid Warmer at different infusion rates of a roller pump using various sizes of intravenous cannulae. The rapid infusion system comprised a 500 mL-normal saline bag, roller pump type infusion device, HOTLINEA (R) Fluid Warmer (blood and fluid warmer system), and six different sizes of intravenous cannulae. In-line pressure was measured proximal to the HOTLINEA (R) (pre-warmer) and proximal to the cannula (post-warmer), at flow rate of 50-160 mL/min. The in-line pressures increased significantly with increasing flow rate. The pre-warmer pressures exceeded 300 mmHg when the flow rate was a parts per thousand yen120 mL/min with 20-gauge, 48 mm length cannula, 130 with 20-gauge, 25 mm cannula, and 160 mL/min with 18-gauge, 48 mm cannula. However, they were < 300 mmHg at any flow rates with 18-gauge, 30 mm cannula and 16-gauge cannulae. The post-warmer pressures exceeded 300 mmHg at the flow rate of 140 mL/min with 20-gauge, 48 mm cannula, and 160 mL/min with 20-gauge, 25 mm cannula, while they were < 300 mmHg at any flow rates with 18 and 16-gauge cannulae. The in-line pressure within a HOTLINEA (R) could exceed 300 mmHg, depending on the flow rate and size and length of cannula. It is important to pay attention to the size and length of cannulae and flow rate to keep the maximum in-line pressure < 300 mmHg when a roller pump type infusion device is used.	[Higashi, Midoriko; Yamaura, Ken] Kyushu Univ Hosp, Higashi Ku, Fukuoka 8128582, Japan; [Matsubara, Yukie; Fukudome, Takuya; Hoka, Sumio] Kyushu Univ Hosp, Dept Anesthesiol & Crit Care Med, Fukuoka 8128582, Japan	Higashi, M (reprint author), Kyushu Univ Hosp, Higashi Ku, Operating Rooms,3-1-1 Maidashi, Fukuoka 8128582, Japan.	midoriko@kuaccm.med.kyushu-u.ac.jp					[Anonymous], HOTL FLUID WARM SET; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Buggy D, 2000, LANCET, V356, P355, DOI 10.1016/S0140-6736(00)02523-X; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; GOODIE DB, 1995, ANESTH ANALG, V80, P552, DOI 10.1097/00000539-199503000-00021; Horowitz PE, 2004, ANESTH ANALG, V99, P788, DOI 10.1213/01.ANE.0000129995.42008.A4; MATEER JR, 1985, ANN EMERG MED, V14, P966, DOI 10.1016/S0196-0644(85)80238-9; Patel N, 1996, ANESTH ANALG, V82, P517, DOI 10.1097/00000539-199603000-00016; Smart CM, 2014, ANAESTHESIA, V69, P110	10	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	APR	2015	29	2					301	305		10.1007/s10877-014-9605-3		5	Anesthesiology	Anesthesiology	CF7NE	WOS:000352742400014		
J	Tong, DC; Winter, TJ; Jin, J; Bennett, AC; Waddell, JN				Tong, D. C.; Winter, T. J.; Jin, J.; Bennett, A. C.; Waddell, J. N.			Quantification of subconcussive impact forces to the head using a forensic model	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Concussion; Forensic head model; Impact forces; Kendo; Subconcussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL FOOTBALL; SKULL-BRAIN MODEL; CONCUSSION; INJURY; SPORT; BIOMECHANICS; TAEKWONDO	Concussive and subconcussive head injury is a global phenomenon that affects millions of people each year. Concussive injury has been extensively studied in sport, which has led to a greater understanding of the biomechanical forces involved and guidelines aimed at preventing athletes from playing while concussed. Subconcussive forces by definition do not meet the threshold for concussion but nonetheless may have significant long term consequences due to the repetitive pattern of injury to the head. Quantifying these impact forces using a forensic head model provides the groundwork for future studies by establishing a range or threshold of subconcussive impact forces that could be correlated with clinical assessments. The use of a forensic head model has distinct advantages in terms of ethics and safety. (C) 2015 Elsevier Ltd. All rights reserved.	[Tong, D. C.; Winter, T. J.; Jin, J.; Waddell, J. N.] Univ Otago, Sir John Walsh Res Inst, Dunedin 9010, New Zealand; [Bennett, A. C.] Kansai Univ, Div Int Affairs, Suita, Osaka, Japan	Tong, DC (reprint author), Univ Otago, Sir John Walsh Res Inst, 310 Great King St, Dunedin 9010, New Zealand.	darryl.tong@otago.ac.nz			ANZAOMS Research and Education Trust	The authors gratefully acknowledge the support provided by the ANZAOMS Research and Education Trust in funding this study.	Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI [10.1227/01.neu.0000318162.67472.ad, 10.1227/01.NEU.0000311244.05104.96]; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.NEU.0000280146.37163.79; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375; Parmar K, 2012, INT J LEGAL MED, V126, P43, DOI 10.1007/s00414-011-0562-9; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Thali MJ, 2002, FORENSIC SCI INT, V125, P195; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Aotsuka A, 1990, Rinsho Shinkeigaku, V30, P1243; Bailes JE, 2001, NEUROSURGERY, V48, p[26, 45]; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Deibert E, 2012, NEUROLOGY, V78, P1712, DOI 10.1212/WNL.0b013e31825875f7; Feehan M, 1995, BRIT J SPORT MED, V29, P258; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1252; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; Nakiri F, 2005, BUDO ACAD J, V37, P1; Nakiri F, RES DEV SAFE KENDO T; Pellman EJ, 2003, NEUROSURGERY, V53, P1340; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Siana J E, 1986, Br J Sports Med, V20, P165; Whittle Kelly, 2008, Forensic Sci Med Pathol, V4, P33, DOI 10.1007/s12024-007-0029-y; Zetaruk MN, 2005, BRIT J SPORT MED, V39, P29, DOI 10.1136/bjsm.2003.010322	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	APR	2015	22	4					747	751		10.1016/j.jocn.2014.11.018		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CF6OT	WOS:000352676700027		
J	Minakuchi, S				Minakuchi, Shu			In situ characterization of direction-dependent cure-induced shrinkage in thermoset composite laminates with fiber-optic sensors embedded in through-thickness and in-plane directions	JOURNAL OF COMPOSITE MATERIALS			English	Article						Thermoset composite; chemical cure shrinkage; optical fiber sensor; process monitoring	BRAGG GRATING SENSORS; RESIDUAL-STRESSES; OPTIC SENSORS; STRAIN DEVELOPMENT; SHAPE DISTORTIONS; FBG SENSOR; SPRING-IN; RESIN; TEMPERATURE; MODEL	This study develops a fiber-optic-based technique for in situ characterization of direction-dependent cure-induced shrinkage in thermoset fiber-reinforced composites. A procedure is established to embed fiber Bragg grating (FBG) sensors in composite out-of-plane directions and to measure key through-thickness chemical cure shrinkage directly under practical curing conditions. First, sensitivity of the proposed method is evaluated through comparison with a standard technique (i.e. thermo-mechanical analysis (TMA)), and the effect of sensor tail length on measurement sensitivity is discussed considering shear-lag effect. Next, combined with double-sided vacuum bagging and demolding during curing, FBG sensors embedded in through-thickness and in-plane directions clarify direction-dependent cure-induced shrinkage in autoclaved unidirectional carbon/epoxy. Finally, the feasibility of characterizing through-thickness shear strain, which is important in complex-shaped parts but cannot be measured using conventional techniques, is confirmed. The developed technique will be a powerful tool for evaluating cure shrinkage in complex-shaped parts and for validating process-simulation tools based on internal strain.	Univ Tokyo, Dept Adv Energy, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan	Minakuchi, S (reprint author), Univ Tokyo, Dept Adv Energy, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	minakuchi@smart.k.u-tokyo.ac.jp			Aviation Program Group of Japan Aerospace Exploration Agency [JX-PSPC-335719]	This study was partially supported by the Aviation Program Group of Japan Aerospace Exploration Agency (JX-PSPC-335719).	Wisnom MR, 2006, COMPOS PART A-APPL S, V37, P522, DOI 10.1016/j.compositesa.2005.05.019; Johnston A, 2001, J COMPOS MATER, V35, P1435, DOI 10.1106/YXEA-5MH9-76J5-BACK; Murukeshan VM, 2000, SENSOR ACTUAT A-PHYS, V79, P153, DOI 10.1016/S0924-4247(99)00266-6; Antonucci V, 2006, COMPOS PART A-APPL S, V37, P592, DOI 10.1016/j.compositesa.2005.05.016; Minakuchi S, 2011, COMPOS PART A-APPL S, V42, P669, DOI 10.1016/j.compositesa.2011.02.006; Leng JS, 2002, SMART MATER STRUCT, V11, P249, DOI 10.1088/0964-1726/11/2/308; Kang HK, 2003, SMART MATER STRUCT, V12, P29, DOI 10.1088/0964-1726/12/1/304; Svanberg JM, 2004, COMPOS PART A-APPL S, V35, P711, DOI 10.1016/j.compositesa.2004.02.005; Chehura E, 2005, SMART MATER STRUCT, V14, P354, DOI 10.1088/0964-1726/14/2/009; Colpo F, 2007, COMPOS SCI TECHNOL, V67, P1830, DOI 10.1016/j.compscitech.2006.10.024; Svanberg JM, 2001, COMPOS PART A-APPL S, V32, P827, DOI 10.1016/S1359-835X(00)00173-1; Nielsen MW, 2013, WIND ENERGY, V16, P1241, DOI 10.1002/we.1550; Jinno M, 2003, ADV COMPOS MATER, V12, P57, DOI 10.1163/156855103322320374; de Oliveira R, 2008, COMPOS PART A-APPL S, V39, P1083, DOI 10.1016/j.compositesa.2008.04.011; Nawab Y, 2013, J MATER SCI, V48, P5387, DOI 10.1007/s10853-013-7333-6; Ersoy N, 2010, COMPOS PART A-APPL S, V41, P410, DOI 10.1016/j.compositesa.2009.11.008; Eum SH, 2007, SMART MATER STRUCT, V16, P2627, DOI 10.1088/0964-1726/16/6/067; Gafsi R, 2000, OPT FIBER TECHNOL, V6, P299, DOI 10.1006/ofte.2000.0333; Minakuchi S, 2013, COMPOS PART A-APPL S, V48, P153, DOI 10.1016/j.compositesa.2013.01.009; Khoun L, 2011, COMPOS PART A-APPL S, V42, P274, DOI 10.1016/j.compositesa.2010.11.013; Kang HK, 2002, SMART MATER STRUCT, V11, P279, DOI 10.1088/0964-1726/11/2/311; Mulle M, 2009, COMPOS PART A-APPL S, V40, P94, DOI 10.1016/j.compositesa.2008.10.008; Montanini R, 2007, SMART MATER STRUCT, V16, P1718, DOI 10.1088/0964-1726/16/5/026; Bao XY, 2002, OPT ENG, V41, P1496, DOI 10.1117/1.1482100; Colpo F, 2006, COMPOS PART A-APPL S, V37, P652, DOI 10.1016/j.compositesa.2005.05.009; Dewynter-Marty V, 1998, J INTEL MAT SYST STR, V9, P785; Garstka T, 2007, COMPOS PART A-APPL S, V38, P2517, DOI 10.1016/j.compositesa.2007.07.018; Giordano M, 2004, SENSOR ACTUAT A-PHYS, V113, P166, DOI 10.1016/j.sna.2004.02.033; Hernandez-Moreno H, 2009, APPL COMPOS MATER, V16, P197, DOI 10.1007/s10443-009-9088-4; Hull D, 1996, INTRO COMPOSITE MAT; Jung K, 2007, J COMPOS MATER, V41, P1499, DOI 10.1177/0021998306068088; Kalamkarov AL, 1999, COMPOS PART B-ENG, V30, P167, DOI 10.1016/S1359-8368(98)00052-3; Kim YK, 2002, J COMPOS MATER, V36, P1725, DOI 10.1106/002199802023598; Kominar V, 1996, J COMPOS MATER, V30, P406; Lammens N, 2013, COMPOS PART A-APPL S, V52, P38, DOI 10.1016/j.compositesa.2013.05.005; Lawrence CM, 1996, P SOC PHOTO-OPT INS, V2718, P60, DOI 10.1117/12.240892; Lawrence CM, 1998, J INTEL MAT SYST STR, V9, P788; Luyckx G, 2011, SENSORS-BASEL, V11, P384, DOI 10.3390/s110100384; Mulle M, 2009, COMPOS PART A-APPL S, V40, P1534, DOI 10.1016/j.compositesa.2009.06.013; O'Dwyer MJ, 1998, MEAS SCI TECHNOL, V9, P1153, DOI 10.1088/0957-0233/9/8/002; Othonos A, 1999, FIBER BRAGG GRATINGS; Parlevliet PP, 2007, COMPOS PART A-APPL S, V38, P651, DOI 10.1016/j.composites.2006.07.002; Satori K, 2000, P SOC PHOTO-OPT INS, V3986, P104, DOI 10.1117/12.388097; Takagaki K, 2014, ADV COMPOS MATER, V23, P195, DOI 10.1080/09243046.2013.844901; Tsai S.W., 1980, INTRO COMPOSITE MAT; Wisnom MR, 2007, J COMPOS MATER, V41, P1311, DOI 10.1177/0021998306068072; Zhou G, 2004, COMPOS PART A-APPL S, V35, P797, DOI 10.1016/j.compositesa.2004.01.018	47	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	APR	2015	49	9					1021	1034		10.1177/0021998314528735		14	Materials Science, Composites	Materials Science	CF8XQ	WOS:000352845800001		
J	Takeuchi, H; Omoto, K; Okura, K; Tajima, T; Suzuki, Y; Hosoki, M; Koori, M; Shigemoto, S; Ueda, M; Nishigawa, K; Rodis, OMM; Matsuka, Y				Takeuchi, Hisahiro; Omoto, Katsuhiro; Okura, Kazuo; Tajima, Toyoko; Suzuki, Yoshitaka; Hosoki, Maki; Koori, Motoharu; Shigemoto, Shuji; Ueda, Mayu; Nishigawa, Keisuke; Rodis, Omar Marianito Maningo; Matsuka, Yoshizo			Effects of Team-Based Learning on Fixed Prosthodontic Education in a Japanese School of Dentistry	JOURNAL OF DENTAL EDUCATION			English	Article						dental education; prosthodontics; team-based learning; educational methodology; Japan	DENTAL STUDENTS	The aims of this study were to evaluate the quality of team-based learning (TBL) in prosthodontics education for fourth-year dental students at Tokushima University School of Dentistry and to compare this teaching method with traditional lecture-based delivery. Participants in the study were 36 students (22 males and 14 females) who attended the TBL-style fixed prosthodontics course. Ten 60-minute classes were held. The first three were traditional lecture-style classes and were followed by one class introducing the TBL style. The remaining six classes constituted the TBL-format fixed prosthodontics course. The effectiveness of TBL was evaluated through student questionnaires at the end of each class and the results of the term-end examination. The questionnaire revealed high student approval for TBL-style learning, and active group discussion among students during TBL was a key factor in these ratings. In the results of the term-end examination, there were significantly higher scores on the questions that covered TBL-taught material than those covering traditional lecture-taught topics. The results of this study suggest that TBL-style lecture was more effective than traditional-style lecture for teaching fixed prosthodontics and that TBL was a more efficient mode of delivering dental education than traditional lecture-based teaching.	[Takeuchi, Hisahiro; Omoto, Katsuhiro; Okura, Kazuo; Tajima, Toyoko; Suzuki, Yoshitaka; Hosoki, Maki; Koori, Motoharu; Shigemoto, Shuji; Ueda, Mayu; Nishigawa, Keisuke; Matsuka, Yoshizo] Univ Tokushima, Grad Sch, Dept Stomatognath Funct & Occlusal Reconstruct, Inst Hlth Biosci, Tokushima 7708504, Japan; [Rodis, Omar Marianito Maningo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 7708504, Japan	Matsuka, Y (reprint author), Univ Tokushima, Grad Sch, Dept Stomatognath Funct & Occlusal Reconstruct, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	matsuka@tokushima-u.ac.jp					Pileggi R, 2008, J DENT EDUC, V72, P1182; Haj-Ali R, 2013, J DENT EDUC, V77, P351; Kumar V, 2012, J DENT EDUC, V76, P330; Matsuka Y, 2012, J DENT EDUC, V76, P1580; Michaelsen L., 2004, TEAM BASED LEARNING; Michaelsen LK, 2007, TEAM BASED LEARNING; Parmelee S, 2012, MED TEACH, V34, pe275	7	0	0	AMER DENTAL EDUCATION ASSOC-ADEA	WASHINGTON	655 K STREET NW, SUITE 800, WASHINGTON, DC 20001 USA	0022-0337	1930-7837		J DENT EDUC	J. Dent. Educ.	APR	2015	79	4					417	423				7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CF7RK	WOS:000352753800010		
J	Nomura, T; Katoh, M; Yamamoto, Y; Kabashima, K; Miyachi, Y				Nomura, Takashi; Katoh, Mayumi; Yamamoto, Yosuke; Kabashima, Kenji; Miyachi, Yoshiki			Eosinophilic pustular folliculitis: The transition in sex differences and interracial characteristics between 1965 and 2013	JOURNAL OF DERMATOLOGY			English	Article						chronology; eosinophilic pustular folliculitis; Ofuji's disease	ACQUIRED-IMMUNODEFICIENCY-SYNDROME; OFUJIS-DISEASE; INFANCY; INDOMETHACIN; SERIES	Eosinophilic pustular folliculitis (EPF) is characterized by a non-infectious infiltration of eosinophils in the hair follicles. It has three variants: (i) classic EPF; (ii) immunosuppression-associated EPF, which herein is subdivided into HIV-associated (IS/HIV) and non-HIV-associated (IS/non-HIV); and (iii) infancy-associated EPF (I-EPF). The rarity of EPF has hindered our understanding of this entity. To examine the characteristics of EPF, with respect to age, sex, race, and chronology, published in case reports to date, we queried PubMed using the following terms: (eosinophilic pustular folliculitis [All Fields] OR eosinophilic folliculitis [All Fields]) AND (1965/1/1 [PDAT]: 2013/12/31 [PDAT]). Additional Japanese cases were collected from Igaku Chuo Zasshi through Ichushi-Web, JDream III, and secondhand quotations from domestic periodicals published in Japan. Proceedings were excluded. The PubMed search produced 275 citations containing 358 cases of EPF (224 men, 132 women, and two of unspecified sex); these cases involved classic EPF (101 Japanese and 81 non-Japanese), IS/HIV (4 Japanese and 85 non-Japanese), IS/non-HIV (4 Japanese and 20 non-Japanese), and I-EPF (4 Japanese and 59 non-Japanese). Ichushi generated an additional 148 citations containing 207 cases of Japanese (148 men and 59 women), which included cases of classic EPF (181 cases), IS/HIV (14 cases), IS/non-HIV (9 cases), and I-EPF (3 cases). There was no sex difference in the classic EPF cases reported between 2003 and 2013, whereas IS/HIV, IS/non-HIV, and I-EPF were predominated by men. There is room for reconsideration of sex differences, particularly with regard to classic EPF. The rarity and specificity of I-EPF in Japan may reflect a state of uncertainty about this entity.	[Nomura, Takashi; Katoh, Mayumi; Yamamoto, Yosuke; Kabashima, Kenji; Miyachi, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Nomura, Takashi] Ijinkai Takeda Gen Hosp, Dept Dermatol, Kyoto, Japan; [Yamamoto, Yosuke] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto 6068507, Japan	Nomura, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	tnomura@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan	We dedicate this research to Dr. Shigeo Ofuji, our mentor and a highly cultured versatile dermatologist who passed away in 2012 at the age of 95. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare of Japan.	BLAUVELT A, 1995, ARCH DERMATOL, V131, P360, DOI 10.1001/archderm.131.3.360; DEKIO S, 1989, Journal of Dermatology (Tokyo), V16, P388; DesDulanto F, 1977, MED CUTAN IBERO LAT, V5, P323; DINEHART SM, 1986, J AM ACAD DERMATOL, V14, P475, DOI 10.1016/S0190-9622(86)70060-1; FERRER S, 1995, REV CLIN ESP, V195, P92; Fukamachi S, 2009, ACTA DERM-VENEREOL, V89, P155, DOI 10.2340/00015555-0578; Hernandez-Martin A, 2013, J AM ACAD DERMATOL, V68, P150, DOI 10.1016/j.jaad.2012.05.025; HOLST R, 1976, BRIT J DERMATOL, V95, P661, DOI 10.1111/j.1365-2133.1976.tb07043.x; Imai M, 2011, RINSHO HIFUKA, V65, P227; ISE S, 1965, ARCH DERMATOL, V92, P169, DOI 10.1001/archderm.92.2.169; ISHIBASHI A, 1974, DERMATOLOGICA, V149, P240; Ishiguro N, 2002, J AM ACAD DERMATOL, V46, P827, DOI 10.1067/mjd.2002.120533; Kasai Y, 1981, JPN J DERMATOL, V91, P1029; Katoh M, 2013, J DERMATOL, V40, P15, DOI 10.1111/1346-8138.12008; Katoh T, 1984, NISHINIHON J DERMATO, V46, P295; Lee JYY, 2003, J CUTAN PATHOL, V30, P307, DOI 10.1034/j.1600-0560.2003.00076.x; Lucky A W, 1984, Pediatr Dermatol, V1, P202, DOI 10.1111/j.1525-1470.1984.tb01116.x; Matsumura Y, 2012, EUR J DERMATOL, V22, P658, DOI 10.1684/ejd.2012.1825; Matsunaga M, 2010, ALLERGY PRACT, V30, P272; Miura H, 2004, PEDIATR DERMATOL, V21, P615, DOI 10.1111/j.0736-8046.2004.21525.x; MORITZ DL, 1991, J AM ACAD DERMATOL, V24, P903, DOI 10.1016/0190-9622(91)70144-Q; Nakazato S, 2014, HIFUKA NO RINSHO, V56, P341; Nervi SJ, 2006, J AM ACAD DERMATOL, V55, P285, DOI 10.1016/j.jaad.2006.02.034; Niiyama S, 1996, NISHI NIHON HIHUKA, V58, P207; OFUJI S, 1987, DERMATOLOGICA, V174, P53; OFUJI S, 1970, ACTA DERM-VENEREOL, V50, P195; Ofuji S, 1973, ACTA DERMATOL KYOTO, V68, P1; Ota T, 2001, CLIN EXP DERMATOL, V26, P179, DOI 10.1046/j.1365-2230.2001.00790.x; OTLEY CC, 1995, ARCH DERMATOL, V131, P1047, DOI 10.1001/archderm.131.9.1047; Parker SRS, 2006, AM J CLIN DERMATOL, V7, P193, DOI 10.2165/00128071-200607030-00006; SMITH KJ, 1995, ARCH DERMATOL, V131, P1089, DOI 10.1001/archderm.131.9.1089; SOEPRONO FF, 1986, J AM ACAD DERMATOL, V14, P1020, DOI 10.1016/S0190-9622(86)70126-6; Takayasu S, 1975, HIFU, V17, P223; TAKEMATSU H, 1985, ARCH DERMATOL, V121, P917, DOI 10.1001/archderm.121.7.917; Tang Mark B Y, 2003, Australas J Dermatol, V44, P44, DOI 10.1046/j.1440-0960.2003.00636.x; Toutous-Trellu L, 2005, ARCH DERMATOL, V141, P1203, DOI 10.1001/archderm.141.10.1203; Toyonaga E, 2013, JAMA DERMATOL, V149, P367, DOI 10.1001/2013.jamadermatol.591; Tsuboi H, 2004, CUTIS, V74, P107; Yamamoto Y, 2014, DERMATOLOGY, DOI [10.1159/000368774, DOI 10.1159/000368774.]; Yoshifuku A, 2013, J DERMATOL, V40, P711, DOI 10.1111/1346-8138.12211; Ziemer M, 2005, AM J DERMATOPATH, V27, P443, DOI 10.1097/01.dad.0000178003.96465.63	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					343	352		10.1111/1346-8138.12783		10	Dermatology	Dermatology	CF5VA	WOS:000352624100001		
J	Takai, T; Misago, N; Murata, Y				Takai, Toshihiro; Misago, Noriyuki; Murata, Yozo			Natural course of keratoacanthoma and related lesions after partial biopsy: Clinical analysis of 66 lesions	JOURNAL OF DERMATOLOGY			English	Article						clinical course; crateriform squamous cell carcinoma; infundibular squamous cell carcinoma; keratoacanthoma; regression	SQUAMOUS-CELL CARCINOMA; SOLITARY KERATOACANTHOMA; NEOPLASM; DEPEND; STAGE	There is some confusion regarding the classification of keratoacanthoma (KA) and related lesions that have crateriform architecture. We examined the clinical courses of 66 KA lesions and related lesions after a partial biopsy to clarify the nosological concept of KA. We histopathologically classified these lesions into five types: (i) KA at various stages (53 lesions); (ii) KA-like squamous cell carcinoma (SCC) (3 lesions); (iii) KA with malignant transformation (3 lesions); (iv) infundibular SCC (5 lesions); and (v) crateriform SCC arising from solar keratosis (2 lesions). We analyzed the clinical course in each group. The regression rate of KA was 98.1% and that of KA-like SCC/KA with malignant transformation was 33.3%. No regression was observed in either infundibular SCC or crateriform SCC arising from solar keratosis. Thus, KA is a distinct entity that should be distinguished from other types of SCC with crateriform architecture based on the high frequency of regression. The regression rate of 33.3% in KA-like SCC/KA with malignant transformation indicated that KA lesions with an SCC component still have the potential for regression. However, this result also indicated that KA is biologically unstable, and some KA tend to evolve into conventional SCC with a gradual loss of the capacity for the spontaneous regression. Infundibular SCC and crateriform SCC arising from solar keratosis are fundamentally different from KA, not only according to the histopathological findings but also based on the biological properties.	[Takai, Toshihiro; Murata, Yozo] Hyogo Canc Ctr, Dept Dermatol, Akashi, Hyogo 6738558, Japan; [Misago, Noriyuki] Saga Univ, Dept Internal Med, Div Dermatol, Saga 840, Japan	Takai, T (reprint author), Hyogo Canc Ctr, Dept Dermatol, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	to-takai@hp.pref.hyogo.jp					Weedon DD, 2010, AM J DERMATOPATH, V32, P423, DOI 10.1097/DAD.0b013e3181c4340a; BLESSING K, 1994, HISTOPATHOLOGY, V24, P381, DOI 10.1111/j.1365-2559.1994.tb00541.x; Ko CJ, 2010, CLIN DERMATOL, V28, P254, DOI 10.1016/j.clindermatol.2009.06.010; Savage JA, 2014, AM J DERMATOPATH, V36, P422, DOI 10.1097/DAD.0000000000000031; Beham A, 1998, Adv Anat Pathol, V5, P269, DOI 10.1097/00125480-199809000-00001; Diaz-Cascajo C, 2004, J CUTAN PATHOL, V31, P19, DOI 10.1046/j.0303-6987.2004.0134.x; Griffiths RW, 2004, BRIT J PLAST SURG, V57, P485, DOI 10.1016/j.bjps.2004.05.007; HODAK E, 1993, AM J DERMATOPATH, V15, P332, DOI 10.1097/00000372-199308000-00007; Kane CL, 2004, SEMIN CUTAN MED SURG, V23, P54, DOI 10.1016/S1085-5629(03)00088-9; Kossard S, 2008, AM J DERMATOPATH, V30, P127, DOI 10.1097/DAD.0b013e318161310c; Mandrell JC, 2009, SEMIN DIAGN PATHOL, V26, P150, DOI 10.1053/j.semdp.2009.09.003; Misago N, 2014, J CUTAN PATHOL, V41, P617, DOI 10.1111/cup.12350; Misago N, 2014, J DERMATOL, V41, P430, DOI 10.1111/1346-8138.12454; Misago N, 2011, AM J DERMATOPATH, V33, P687, DOI 10.1097/DAD.0b013e318205b2c5; Misago N, 2013, J DERMATOL, V40, P443, DOI 10.1111/1346-8138.12104; Misago N, 2014, J CUTAN PATHOL, V41, P437, DOI 10.1111/cup.12317; Weedon D., 2010, WEEDONS SKIN PATHOLO, P667, DOI 10.1016/B978-0-7020-3485-5.00032-2; Weedon D, 2006, WHO CLASSIFICATION T, P44; Yus ES, 2000, AM J DERMATOPATH, V22, P305, DOI 10.1097/00000372-200008000-00002	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					353	362		10.1111/1346-8138.12784		10	Dermatology	Dermatology	CF5VA	WOS:000352624100002		
J	Saeki, H; Imafuku, S; Abe, M; Shintani, Y; Onozuka, D; Hagihara, A; Katoh, N; Murota, H; Takeuchi, S; Sugaya, M; Tanioka, M; Kaneko, S; Masuda, K; Hiragun, T; Inomata, N; Kitami, Y; Tsunemi, Y; Abe, S; Kobayashi, M; Morisky, DE; Furue, M				Saeki, Hidehisa; Imafuku, Shinichi; Abe, Masatoshi; Shintani, Yoichi; Onozuka, Daisuke; Hagihara, Akihito; Katoh, Norito; Murota, Hiroyuki; Takeuchi, Satoshi; Sugaya, Makoto; Tanioka, Miki; Kaneko, Sakae; Masuda, Koji; Hiragun, Takaaki; Inomata, Naoko; Kitami, Yuki; Tsunemi, Yuichiro; Abe, Shinya; Kobayashi, Miwa; Morisky, Donald E.; Furue, Masutaka			Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients	JOURNAL OF DERMATOLOGY			English	Article						adherence; Morisky Medication Adherence Scale-8; psoriasis; sociomedical factor; treatment satisfaction	TOPICAL MEDICATION; NONADHERENCE; THERAPY	Previously we assessed the medication adherence for oral and topical remedies by a translated Japanese version of the Morisky Medication Adherence Scale-8 (MMAS-8) together with socioeconomic backgrounds in 3096 Japanese dermatological patients, and found the medication adherence, especially to topical drugs, was poor in these patients. In order to elucidate the disease-specific sociomedical factors, we further sub-analyzed the medication adherence in 237 psoriasis patients and compared it with that in other dermatological diseases such as atopic dermatitis, urticaria or tinea. This study was conducted among patients registered in monitoring system and 3096 eligible patients were enrolled. Our web-based questionnaire included the following items such as age, sex, annual income, main health-care institution, experience of effectiveness by oral or topical medication, overall satisfaction with treatment, and MMAS-8 for oral or topical medication. Mean adherence score by MMAS-8 was 5.2 for oral and 4.3 for topical medication. More patients with psoriasis used a university hospital and fewer used a private clinic compared with those with the other skin disease patients. Experience of drug effectiveness by oral medication and overall satisfaction with treatment was lower in psoriasis patients than in other patients. In oral medication, significantly better adherence was observed in those of higher age and with higher annual income. The adherence to medication, especially to topical drugs, was poor in 237 psoriasis patients. We speculated that some severe psoriasis patients were not sufficiently treated systemically and were resistant to topical therapy, leading to poor adherence.	[Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Tokyo 1138603, Japan; [Imafuku, Shinichi] Fukuoka Univ, Fac Med, Dept Dermatol, Fukuoka 81401, Japan; [Abe, Masatoshi] Kojinkai Sapporo Skin Clin, Sapporo, Hokkaido, Japan; [Shintani, Yoichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan; [Onozuka, Daisuke; Hagihara, Akihito] Kyushu Univ, Dept Hlth Serv Management & Policy, Fukuoka 812, Japan; [Katoh, Norito; Masuda, Koji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto, Japan; [Murota, Hiroyuki] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Takeuchi, Satoshi] Hamanomachi Hosp, Dept Dermatol, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Fukuoka, Japan; [Sugaya, Makoto] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan; [Tanioka, Miki] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Kaneko, Sakae] Shimane Univ, Fac Med, Dept Dermatol, Matsue, Shimane, Japan; [Hiragun, Takaaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Integrated Hlth Sci, Dept Dermatol, Hiroshima, Japan; [Inomata, Naoko] Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Yokohama, Kanagawa, Japan; [Kitami, Yuki] Showa Univ, Sch Med, Dept Dermatol, Tokyo 142, Japan; [Tsunemi, Yuichiro] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan; [Abe, Shinya] Kanazawa Med Univ, Dept Dermatol, Kanazawa, Ishikawa, Japan; [Kobayashi, Miwa] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka 807, Japan; [Morisky, Donald E.] UCLA Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA; [Furue, Masutaka] Kyushu Univ, Dept Dermatol, Fukuoka 812, Japan	Saeki, H (reprint author), Nippon Med Sch, Dept Dermatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	h-saeki@nms.ac.jp	Onozuka, Daisuke/F-5067-2014	Onozuka, Daisuke/0000-0001-9596-9188	Mitsubishi Tanabe Pharma; MPR	The web questionnaire was supported by Mitsubishi Tanabe Pharma and MPR.	Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Trindade AJ, 2011, INFLAMM BOWEL DIS, V17, P599, DOI 10.1002/ibd.21310; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Brown KK, 2006, J AM ACAD DERMATOL, V55, P607, DOI 10.1016/j.jaad.2005.12.021; Kawada A, 2003, J DERMATOL SCI, V31, P59, DOI 10.1016/S0923-1811(02)00142-1; Conlon NP, 2014, EUR J DERMATOL, V24, P385, DOI 10.1684/ejd.2014.2323; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Reynolds K, 2014, QUAL LIFE RES, V23, P2109, DOI 10.1007/s11136-014-0662-3; Gokdemir G, 2008, J EUR ACAD DERMATOL, V22, P330, DOI 10.1111/j.1468-3083.2007.02425.x; Dreno B, 2010, INT J DERMATOL, V49, P448, DOI 10.1111/j.1365-4632.2010.04416.x; Wilke T, 2011, VALUE HEALTH, V14, P1092, DOI 10.1016/j.jval.2011.06.002; Krejci-Manwaring J, 2007, J AM ACAD DERMATOL, V56, P211, DOI 10.1016/j.jaad.2006.05.073; Aso K, 1984, HIFU RINSHO, V26, P585; Furue Masutaka, 2011, J Dermatol, V38, P310, DOI 10.1111/j.1346-8138.2011.01209.x; Furue M, 2015, BRIT J DERMATOL, V172, P272, DOI 10.1111/bjd.13377; Koehler A M, 2001, Am J Clin Dermatol, V2, P7, DOI 10.2165/00128071-200102010-00002; Torrelo A, 2013, Actas Dermosifiliogr, V104, P409, DOI 10.1016/j.adengl.2013.04.004; Zschocke I, 2014, J EUR ACAD DERMATOL, V28, P4, DOI 10.1111/jdv.12445	19	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					367	372		10.1111/1346-8138.12804		6	Dermatology	Dermatology	CF5VA	WOS:000352624100004		
J	Okazaki, S; Funasaka, Y; Wakamatsu, K; Kawana, S; Saeki, H				Okazaki, Shizuka; Funasaka, Yoko; Wakamatsu, Kazumasa; Kawana, Seiji; Saeki, Hidehisa			Effect of infrared radiation A on photoaged hairless mice harboring eumelanin and pheomelanin in the epidermis	JOURNAL OF DERMATOLOGY			English	Article						hairless mice; infrared radiation; melanin; photocarcinogenesis; UV	STEM-CELL FACTOR; HUMAN-SKIN; DNA-DAMAGE; IRRADIATION; MECHANISMS; APOPTOSIS; MELANINS	Infrared radiation A (IRA) is absorbed by melanin and generates heat. Therefore, the effect of IRA could be well analyzed using skin, which contains melanin in the epidermis. Hairless mice harboring epidermal melanocytes that produce eumelanin, pheomelanin, or non-melanin were generated by backcrossing K14-stem cell factor mice, recessive yellow mice, and then albino hairless mice. High-dose IRA was irradiated over 18weeks after the establishment of photoaged mice by irradiation with ultraviolet B (UVB) three times a week for 14weeks. Tumor formation was assessed every week. The formation of cyclobutane pyrimidine dimer and apoptotic cells by the irradiation of IRA and UVB was evaluated. Repetitive irradiation of IRA did not promote tumor formation in all types of mice. Pre-irradiation of IRA to UVB, but not post-irradiation, accelerated the elimination of cyclobutane pyrimidine dimers and enhanced apoptosis; these effects were most obvious in eumelanin-producing mice. Real-time polymerase chain reaction analysis showed downregulation of FLICE (cellular caspase 8)-like inhibitory protein and B-cell lymphoma-extra large and upregulation of Bcl-2-associated X protein by UVB, but further enhancement of these molecules by pre-irradiation of IRA was not observed. These results indicate that IRA does not confer the promotion of UVB-induced carcinogenesis in photoaged mice harboring epidermal melanocytes and that photochemical reaction between IRA and melanin might be involved in the induction of apoptosis and the elimination of cyclobutane pyrimidine dimers by UVB. The enhancement of apoptosis by pre-irradiation of IRA to UVB might be induced by mechanisms other than the modification of the mRNA expression of FLICE (cellular caspase 8)-like inhibitory protein, B-cell lymphoma-extra large, and Bcl-2-associated X.	[Okazaki, Shizuka; Funasaka, Yoko; Kawana, Seiji; Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Tokyo 1138602, Japan; [Wakamatsu, Kazumasa] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi, Japan	Funasaka, Y (reprint author), Nippon Med Sch, Dept Dermatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	funasaka@nms.ac.jp					Panzella L, 2010, PHOTOCHEM PHOTOBIOL, V86, P757, DOI 10.1111/j.1751-1097.2010.00726.x; Tanaka Y, 2009, DERMATOL SURG, V35, P1099, DOI 10.1111/j.1524-4725.2009.01194.x; Calles C, 2010, J INVEST DERMATOL, V130, P1524, DOI 10.1038/jid.2010.9; Frank S, 2006, EXP DERMATOL, V15, P130, DOI 10.1111/j.1600-0625.2005.00397.x; OZEKI H, 1995, J INVEST DERMATOL, V105, P361, DOI 10.1111/1523-1747.ep12320792; ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2; Schroeder P, 2008, J INVEST DERMATOL, V128, P2491, DOI 10.1038/jid.2008.116; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191; Chan HH, 2008, LASER SURG MED, V40, P146, DOI 10.1002/lsm.20586; Darvin ME, 2007, LASER PHYS LETT, V4, P318, DOI 10.1002/lapl.200610113; Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Abdel-Daim M, 2010, J DERMATOL SCI, V60, P21, DOI 10.1016/j.jdermsci.2010.08.002; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; Zheng D, 2008, CANCER RES, V68, P3992, DOI 10.1158/0008-5472.CAN-07-6594; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Ezzati A, 2009, J REHABIL RES DEV, V46, P543, DOI 10.1682/JRRD.2008.09.0121; Dang YY, 2010, LASER MED SCI, V25, P719, DOI 10.1007/s10103-009-0657-4; Danno K, 2001, PHOTODERMATOL PHOTO, V17, P261, DOI 10.1034/j.1600-0781.2001.170603.x; Horwitz L R, 1999, Adv Wound Care, V12, P35; Jantschitsch C, 2009, J INVEST DERMATOL, V129, P1271, DOI 10.1038/jid.2008.362; Kim HH, 2005, MECH AGEING DEV, V126, P1170, DOI 10.1016/j.mad.2005.06.003; Scherer D, 2010, MUTAT RES-REV MUTAT, V705, P141, DOI 10.1016/j.mrrev.2010.06.002; Yamazaki F, 2005, J INVEST DERMATOL, V125, P521, DOI 10.1111/j.0022-202X.2005.23753.x	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					382	390		10.1111/1346-8138.12790		9	Dermatology	Dermatology	CF5VA	WOS:000352624100007		
J	Ishida, S; Takahashi, K; Kanaoka, M; Okawa, T; Tateishi, C; Yasukochi, A; Ishii, N; Li, XG; Hashimoto, T; Aihara, M				Ishida, Syuichi; Takahashi, Kazuo; Kanaoka, Miwa; Okawa, Tomoko; Tateishi, Chiharu; Yasukochi, Atsushi; Ishii, Norito; Li, Xiaoguang; Hashimoto, Takashi; Aihara, Michiko			Case of subepidermal autoimmune bullous disease with psoriasis vulgaris reacting to both BP180 C-terminal domain and laminin gamma-1	JOURNAL OF DERMATOLOGY			English	Article						BP180 C-terminal domain; immunoblotting; laminin-1; psoriasis vulgaris; subepidermal autoimmune bullous disease	ASSOCIATION; ANTI-P200	A number of cases of psoriasis vulgaris developing bullous skin lesions have been diagnosed as either bullous pemphigoid with antibodies to the 180-kDa bullous pemphigoid antigen (BP180) non-collagenous 16a (NC16a) domain or anti-laminin-1 (p200) pemphigoid. We report a case of subepidermal bullous disease with psoriasis vulgaris, showing antibodies to both BP180 C-terminal domain and laminin-1. A 64-year-old Japanese man with psoriasis vulgaris developed exudative erythemas and tense bullae on the whole body but he did not have mucosal involvement. The blistering lesion showed subepidermal blisters histopathologically. In indirect immunofluorescence of 1mol/L NaCl-split skin, immunoglobulin (Ig)G antibodies reacted with both the epidermal and dermal side. Immunoblotting showed positive IgG with recombinant protein of BP180 C-terminal domain and 200-kDa laminin-1 in normal human dermal extract.	[Ishida, Syuichi; Takahashi, Kazuo; Kanaoka, Miwa; Okawa, Tomoko; Aihara, Michiko] Yokohama City Univ, Sch Med, Dept Dermatol, Yokohama, Kanagawa 2360004, Japan; [Tateishi, Chiharu] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Yasukochi, Atsushi; Ishii, Norito; Li, Xiaoguang; Hashimoto, Takashi] Kurume Univ, Sch Med, Inst Cutaneous Cell Biol, Dept Dermatol, Fukuoka, Japan	Ishida, S (reprint author), Yokohama City Univ, Sch Med, Dept Dermatol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	syu_s_ishida@yahoo.co.jp					Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Dainichi T, 2010, J DERMATOL, V37, P231, DOI 10.1111/j.1346-8138.2009.00793.x; Cusano F, 2010, EUR J DERMATOL, V20, P520, DOI 10.1684/ejd.2010.0970; GRATTAN CEH, 1985, BRIT J DERMATOL, V113, P281, DOI 10.1111/j.1365-2133.1985.tb02079.x; Hirako Y, 2014, EXP CELL RES, V324, P172, DOI 10.1016/j.yexcr.2014.04.002; Kirtschig G, 1996, BRIT J DERMATOL, V135, P738; Lee JB, 2003, J DERMATOL SCI, V32, P59, DOI 10.1016/S0923-1811(03)00035-5; Nakatani C, 1998, BRIT J DERMATOL, V139, P365; Ohata C, 2013, EUR J DERMATOL, V23, P715, DOI 10.1684/ejd.2013.2138; Shin-ichi A, 2014, J DERMATOL, V41, P1031; Sugita K, 2007, J EUR ACAD DERMATOL, V21, P569, DOI 10.1111/j.1468-3083.2006.01966.x; Wilczek A, 2006, INT J DERMATOL, V45, P1353, DOI 10.1111/j.1365-4632.2006.02861.x; Yasuda H, 2004, DERMATOLOGY, V209, P149, DOI 10.1159/000079602	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					391	393		10.1111/1346-8138.12801		3	Dermatology	Dermatology	CF5VA	WOS:000352624100008		
J	Imanishi, A; Tateishi, C; Imanishi, H; Sowa-Osako, J; Koga, H; Tsuruta, D; Hashimoto, T				Imanishi, Akiko; Tateishi, Chiharu; Imanishi, Hisayoshi; Sowa-Osako, Junko; Koga, Hiroshi; Tsuruta, Daisuke; Hashimoto, Takashi			Pemphigoid with antibodies to laminin gamma 1, BP180 and BP230, associated with psoriasis vulgaris: Successful disease control with cyclosporin	JOURNAL OF DERMATOLOGY			English	Article						BP180; cyclosporin; laminin 1; pemphigoid; psoriasis		Both anti-laminin 1 pemphigoid and bullous pemphigoid are autoimmune subepidermal blistering diseases. The former is rare and characterized by autoantibodies to laminin 1, a 200-kDa dermal protein, while the latter is common among the elderly and characterized by autoantibodies to BP180 and BP230, both of which are hemidesmosomal proteins. We experienced a 69-year-old Japanese male patient with blister formation secondary to erythrodermic psoriasis, which was successfully treated with cyclosporin. The histopathology of erythema corresponded with psoriasis and that of a blistering lesion showed infiltration of neutrophils and eosinophils in and around the subepidermal blisters. Patient immunoglobulin G antibodies labeled both the epidermal and dermal sides of 1mol/L NaCl-split human skin by indirect immunofluorescent microscopy and recognized laminin 1, BP180 and BP230 by immunoblotting. To the best of our knowledge, this is the first report of coexistence of psoriasis and atypical pemphigoid with these three autoantibodies.	[Imanishi, Akiko; Tateishi, Chiharu; Imanishi, Hisayoshi; Sowa-Osako, Junko; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 5458585, Japan; [Koga, Hiroshi; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Sch Med, Dept Dermatol, Fukuoka, Japan	Tateishi, C (reprint author), Osaka City Univ, Grad Sch Med, Dept Dermatol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	m6274073@msic.med.osaka-cu.ac.jp					Chen YJ, 2011, BRIT J DERMATOL, V165, P593, DOI 10.1111/j.1365-2133.2011.10386.x; Goletz S, 2014, J AM ACAD DERMATOL, V71, P185, DOI 10.1016/j.jaad.2014.02.036; Dainichi T, 2010, J DERMATOL, V37, P231, DOI 10.1111/j.1346-8138.2009.00793.x; BIANCHI L, 1992, J AM ACAD DERMATOL, V27, P278, DOI 10.1016/S0190-9622(08)80749-9; BOIXEDA JP, 1991, J AM ACAD DERMATOL, V24, P152, DOI 10.1016/S0190-9622(08)80058-8; Chen KR, 1996, BRIT J DERMATOL, V134, P340; Goto-Ohguchi Y, 2009, DERMATOLOGY, V218, P265, DOI 10.1159/000182268; GRATTAN CEH, 1985, BRIT J DERMATOL, V113, P281, DOI 10.1111/j.1365-2133.1985.tb02079.x; Hashimoto T, 2011, J INVEST DERMATOL, V131, P2175, DOI 10.1038/jid.2011.276; Kaminaka C, 2010, J DERMATOL, V37, P272, DOI 10.1111/j.1346-8138.2009.00790.x; Kasperkiewicz M, 2010, CLIN EXP DERMATOL, V35, P614, DOI 10.1111/j.1365-2230.2009.03731.x; Salmhofer W, 1997, BRIT J DERMATOL, V137, P599, DOI 10.1111/j.1365-2133.1997.tb03794.x; Tsuruta Daisuke, 2009, Recent Pat Inflamm Allergy Drug Discov, V3, P40; Ujiie H, 2010, J DERMATOL, V37, P194, DOI 10.1111/j.1346-8138.2009.00792.x	14	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					394	397		10.1111/1346-8138.12798		4	Dermatology	Dermatology	CF5VA	WOS:000352624100009		
J	Nomura, H; Honda, H; Egami, S; Yokoyama, T; Fujimoto, A; Ishikawa, M; Sugiura, M				Nomura, Hisashi; Honda, Haruki; Egami, Shohei; Yokoyama, Tomoaki; Fujimoto, Atsushi; Ishikawa, Makiko; Sugiura, Makoto			False-positive serology following intravenous immunoglobulin and plasma exchange through transfusion of fresh frozen plasma in a patient with pemphigus vulgaris	JOURNAL OF DERMATOLOGY			English	Article						false serology; fresh frozen plasma; intravenous immunoglobulin; pemphigus vulgaris; plasma exchange	THERAPY; CHEMOTHERAPY; INFECTION; ANTIBODY; RISK	Intravenous immunoglobulin therapy and plasma exchange through transfusion of fresh frozen plasma are therapeutic options for patients with refractory pemphigus vulgaris. Passive acquisition of various clinically important antibodies through these therapies can occur, leading to false serology and negatively affecting patients' clinical care. It is recommended that dermatologists recognize the possibility of these phenomena and interpret them appropriately. Here, we report false-positive serology following intravenous immunoglobulin therapy and plasma exchange through transfusion of fresh frozen plasma in a patient with refractory pemphigus vulgaris. We also discuss the measure for misinterpretation and unnecessary clinical intervention.	[Nomura, Hisashi; Honda, Haruki; Egami, Shohei; Yokoyama, Tomoaki; Fujimoto, Atsushi; Sugiura, Makoto] Shizuoka Municipal Shimizu Hosp, Dept Dermatol, Shizuoka 4240911, Japan; [Ishikawa, Makiko] Shizuoka Municipal Shimizu Hosp, Dept Lab Med, Shizuoka 4240911, Japan	Nomura, H (reprint author), Shizuoka Municipal Shimizu Hosp, Dept Dermatol, Shimizu Ku, 1231 Miyakami, Shizuoka 4240911, Japan.	nomurahisashi@a3.keio.jp					Harman KE, 2003, BRIT J DERMATOL, V149, P926, DOI 10.1111/j.1365-2133.2003.05665.x; Taira R, 2013, TRANSFUSION, V53, P1393, DOI 10.1111/j.1537-2995.2012.03909.x; Kusumoto S, 2009, INT J HEMATOL, V90, P13, DOI 10.1007/s12185-009-0359-5; Hui CK, 2006, GASTROENTEROLOGY, V131, P59, DOI 10.1053/j.gastro.2006.04.015; Benton E, 2012, J AM ACAD DERMATOL, V66, pE123, DOI 10.1016/j.jaad.2011.03.032; DEVINE P, 1989, ARCH PATHOL LAB MED, V113, P529; IKEMURA K, 1989, J CLIN MICROBIOL, V27, P1965; Parker S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-99; Pelloux H, 1999, J CLIN MICROBIOL, V37, P3423; Rossi KQ, 2002, ARCH PATHOL LAB MED, V126, P1237	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					398	400		10.1111/1346-8138.12785		3	Dermatology	Dermatology	CF5VA	WOS:000352624100010		
J	Nakai, N; Okuzawa, Y; Katoh, N				Nakai, Noriaki; Okuzawa, Yasutaro; Katoh, Norito			Clinical usefulness of Mohs' chemosurgery for palliative purposes in patients with cutaneous squamous cell carcinoma with risk factors or without indication for surgery: Three case reports	JOURNAL OF DERMATOLOGY			English	Article						cutaneous squamous cell carcinoma; Mohs' chemosurgery; Mohs' paste; palliative treatment; quality of life		Mohs' chemosurgery is a technique of chemical fixation of a cutaneous tumor using 20% zinc chloride, and the surgeon performs a sequential series of excisions until no residual tumor can be found in the bottom layer of the specimen by microscopic examination. This technique has also been gradually accepted as one of the palliative treatment options in patients with cutaneous tumors with risk factors for surgery. We report three cases of cutaneous squamous cell carcinoma that were treated with Mohs' chemosurgery for palliative purposes. In case 1, Mohs' chemosurgery could prevent rapid tumor growth and control the bleeding, exudation and offensive odor from ulcerated tumors. The patient was able to live enjoyably at home with her family before she was transferred to a palliative care hospital. In case 2, Mohs' chemosurgery followed by debridement of residual tumor and a full-thickness skin graft contributed to an early hospital discharge, which prevented the progression of cognitive decline. In case 3, remission of the tumor was achieved by concurrent treatment with local radiotherapy and Mohs' chemosurgery. Mohs' chemosurgery for palliative purposes is not a radical treatment, but contributes to the patient's quality of life. It has the possibility of becoming a radical treatment if eligible patients and concurrent treatment are carefully selected. An increase in the number of skin cancer patients with risk factors for surgery has been predicted because of the progression of the aging society. Mohs' chemosurgery may become one of the treatment options for such patients.	[Nakai, Noriaki; Okuzawa, Yasutaro; Katoh, Norito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto 6028566, Japan	Nakai, N (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	nnakai@koto.kpu-m.ac.jp					Kakimoto M, 2010, J PALLIAT MED, V13, P11, DOI 10.1089/jpm.2009.0238; Mohs FE, 1941, ANN SURG, V114, P274; MOHS FE, 1980, CLIN PLAST SURG, V7, P349; PHELAN JT, 1968, ANN SURG, V168, P1023, DOI 10.1097/00000658-196812000-00012; ROBINSON JK, 1985, J AM ACAD DERMATOL, V12, P1093, DOI 10.1016/S0190-9622(85)80193-6; Snow SN, 1997, DERMATOL SURG, V23, P1055; Turner RJ, 2000, BRIT J DERMATOL, V142, P752, DOI 10.1046/j.1365-2133.2000.03422.x; Uno H, 2010, J DERMATOL, V37, P852, DOI 10.1111/j.1346-8138.2010.00898.x; Yanazume Shintaro, 2013, Gynecol Oncol Case Rep, V4, P47, DOI 10.1016/j.gynor.2013.01.001	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					405	407		10.1111/1346-8138.12767		3	Dermatology	Dermatology	CF5VA	WOS:000352624100012		
J	Oiso, N; Sugawara, K; Yonamine, A; Tsuruta, D; Kawada, A				Oiso, Naoki; Sugawara, Koji; Yonamine, Ayano; Tsuruta, Daisuke; Kawada, Akira			Epidermal nevi with aberrant epidermal structure in keratinocytes and melanocytes	JOURNAL OF DERMATOLOGY			English	Article						cutaneous hamartoma; electron microscopy; epidermal nevus; keratinocytes; melanocytes	WELL-DEFINED PHENOTYPES	Epidermal nevi are congenital cutaneous hamartomas caused by embryonic somatic mutations. Ultrastructural features of adult epidermal nevi have rarely been investigated. Herein, we report a case involving a Japanese adult who had epidermal nevi with right congenital blindness and a right accessory nipple. The histopathologic and ultrastructural studies showed divergent abnormal epidermal structures in both melanocytes and keratinocytes. Our case indicates the need to further investigate histopathologic, ultrastructural, and genetic associations in adult epidermal nevi.	[Oiso, Naoki; Kawada, Akira] Kinki Univ, Fac Med, Dept Dermatol, Osaka, Osaka 5898511, Japan; [Sugawara, Koji; Yonamine, Ayano; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan	Oiso, N (reprint author), Kinki Univ, Fac Med, Dept Dermatol, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.	naoiso@med.kindai.ac.jp					BHAWAN J, 1976, J CUTAN PATHOL, V3, P207, DOI 10.1111/j.1600-0560.1976.tb00865.x; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Oiso N, 2013, J DERMATOL, V40, P330, DOI 10.1111/j.1346-8138.2012.01583.x; SU WPD, 1982, AM J DERMATOPATH, V4, P161; Harmon RM, 2013, J CLIN INVEST, V123, P1556, DOI 10.1172/JCI65220; Cizmarova M, 2013, Endocr Regul, V47, P217; Hafner C, 2012, J MED GENET, V49, P249, DOI 10.1136/jmedgenet-2011-100637; Happle R, 2010, J AM ACAD DERMATOL, V63, P1, DOI 10.1016/j.jaad.2010.01.017; Happle R, 2010, J AM ACAD DERMATOL, V63, P25, DOI 10.1016/j.jaad.2010.01.016; Levinsohn JL, 2014, J INVEST DERMATOL, V134, P1149, DOI 10.1038/jid.2013.430; OBASI OE, 1987, CLIN EXP DERMATOL, V12, P132, DOI 10.1111/j.1365-2230.1987.tb01882.x; Oiso N, 2014, EUR J DERMATOL, DOI [10.1684/ejd.2014.2486, DOI 10.1684/EJD.2014.2486]	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					408	410		10.1111/1346-8138.12787		3	Dermatology	Dermatology	CF5VA	WOS:000352624100013		
J	Ozaki, S; Funasaka, Y; Takubo, M; Matayoshi, T; Ueno, T; Asayama, T; Saeki, H				Ozaki, Saeko; Funasaka, Yoko; Takubo, Masaya; Matayoshi, Takemitsu; Ueno, Takashi; Asayama, Toshio; Saeki, Hidehisa			Granulocyte colony-stimulating factor-induced granulomatous dermatitis with enlarged histiocytes clinically manifesting as painful edematous nodules with high fever similar to Sweet's syndrome	JOURNAL OF DERMATOLOGY			English	Article						edematous nodule; enlarged histiocyte; granulocyte colony-stimulating factor (G-CSF); granulomatous dermatitis; Sweet's syndrome	OF-THE-LITERATURE; CUTANEOUS REACTION; MACROPHAGES; ERUPTION	A 72-year-old woman with a history of diffuse large B cell lymphoma and recent recurrence visited our department complaining of several painful edematous nodules with blisters on her face. She had iteratively developed cutaneous eruptions after every treatment with granulocyte colony-stimulating factor (G-CSF) for neutropenia, and each time the eruption improved after the cessation of the G-CSF treatment. The blisters became crusty and the skin lesions slightly improved, but on the 24th hospital day, the eruption formed painful erythematous nodules with erosion, and the patient also developed a high fever of up to 38 degrees C. A biopsy specimen showed a dermal infiltrate of increased and enlarged plump histiocytes, some of which indicated karyomitosis with a small number of lymphocytes. No increase in the number of eosinophils or neutrophils was noted. These eruptions lasted for 15days and disappeared with the recovery of the peripheral blood count and attendant cessation of G-CSF. We diagnosed this case as G-CSF-induced granulomatous dermatitis with enlarged histiocytes. Several cases with maculopapular rash and dermal inflammatory infiltrate composed of interstitially arranged large histiocytes have been reported. However, to the best of our knowledge, this is the first case report of G-CSF-induced granulomatous dermatitis with enlarged histiocytes clinically manifesting as painful edematous nodules with a high fever, similar to Sweet's syndrome. We speculated that the infiltrating cells were not neutrophils but histiocytes, presumably because of agranulocytosis.	[Ozaki, Saeko; Funasaka, Yoko; Takubo, Masaya; Matayoshi, Takemitsu; Ueno, Takashi; Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Tokyo 1138603, Japan; [Asayama, Toshio] Nippon Med Sch, Dept Hematol, Tokyo 1138603, Japan	Ozaki, S (reprint author), Nippon Med Sch, Dept Dermatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	sae777@nms.ac.jp					Alvarez-Ruiz S, 2004, J EUR ACAD DERMATOL, V18, P310, DOI 10.1111/j.1468-3083.2004.00872.x; Requena L, 2005, ARCH DERMATOL, V141, P834, DOI 10.1001/archderm.141.7.834; Walker DC, 1996, J AM ACAD DERMATOL, V34, P918, DOI 10.1016/S0190-9622(96)90080-8; Chavan RN, 2014, J AM ACAD DERMATOL, V70, P1021, DOI 10.1016/j.jaad.2014.01.874; Azuma J, 1989, J CLIN THER MED, V8, P1579; Calixto R, 2014, J CLIN ONCOL, V32, pE1, DOI 10.1200/JCO.2011.40.3212; Farina MC, 1998, J CUTAN PATHOL, V25, P559, DOI 10.1111/j.1600-0560.1998.tb01741.x; Ferran M, 2006, DERMATOLOGY, V212, P188, DOI 10.1159/000090660; Glass LF, 1996, J AM ACAD DERMATOL, V34, P455, DOI 10.1016/S0190-9622(96)90439-9; HORN TD, 1991, ARCH DERMATOL, V127, P49, DOI 10.1001/archderm.127.1.49; Kawahara M, 1993, Kansenshogaku Zasshi, V67, P1094; Paul C, 1998, ARCH DERMATOL, V134, P111, DOI 10.1001/archderm.134.1.111; SCOTT GA, 1995, AM J DERMATOPATH, V17, P107, DOI 10.1097/00000372-199504000-00001; Valks R, 1998, J CUTAN PATHOL, V25, P259, DOI 10.1111/j.1600-0560.1998.tb01730.x	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					414	417		10.1111/1346-8138.12772		4	Dermatology	Dermatology	CF5VA	WOS:000352624100015		
J	Nishimoto, J; Amano, M; Setoyama, M				Nishimoto, Junko; Amano, Masahiro; Setoyama, Mitsuru			The detection of Propionibacterium acnes signatures in granulomas of lupus miliaris disseminatus faciei	JOURNAL OF DERMATOLOGY			English	Article						epithelioid cell granuloma; laser capture microdissection; lupus miliaris disseminatus faciei; Propionibacterium acnes; sarcoid-like reaction	SARCOIDOSIS; ROSACEA; DNA	Lupus miliaris disseminatus faciei (LMDF) is a papular eruption that occurs on adults' faces, predominantly on the lower eyelids. Histologically, the granulomatous lesions are primarily situated around the hair follicles, particularly the superficial region/infundibula. Its etiology remains to be elucidated. Recently, Propionibacterium acnes (P.acnes) has been suspected as a cause of sarcoidosis. In light of the sarcoid-like reactions that are present in LMDF, we hypothesized that P.acnes may also be implicated in granulomas associated with the disease. We evaluated nine DNA samples from granulomatous lesions from the skin of patients with LMDF. We used laser capture microdissection to extract DNA from these regions. Polymerase chain reaction was performed to amplify segments of the 16S ribosomal RNA of P.acnes, and the P.acnes gene was clearly detectable in all nine DNA samples. The gene was also detected in samples from normal-appearing skin, but these bands were faint in all samples. The results of the present study suggest that P.acnes plays a pathogenetic roles in LMDF.	[Nishimoto, Junko; Amano, Masahiro; Setoyama, Mitsuru] Miyazaki Univ, Fac Med, Dept Dermatol, Kiyotake, Miyazaki 8891692, Japan	Setoyama, M (reprint author), Miyazaki Univ, Fac Med, Dept Dermatol, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	mtsetoyama@med.miyazaki-u.ac.jp					Yamasaki K, 2011, J INVEST DERM SYMP P, V15, P12, DOI 10.1038/jidsymp.2011.4; Furukawa A, 2009, MICROB PATHOGENESIS, V46, P80, DOI 10.1016/j.micpath.2008.10.013; Berth-Jones J, 2010, ROOKS TXB DERMATOLOG, V43, P12; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Ebe Y, 2000, SARCOIDOSIS VASC DIF, V17, P256; Eishi Y, 2013, BIOMED RES INT, V2013, P1; elsDarouti M, 1993, INT J DERMATOL, V32, P508; Gerber PA, 2011, J INVEST DERM SYMP P, V15, P40, DOI 10.1038/jidsymp.2011.9; Ichiyasu H, 1999, J LEUKOCYTE BIOL, V65, P482; Iio K, 2010, ACTA MED OKAYAMA, V64, P75; Ioffreda MD, 2009, LEVERS HISTOPATHOLOG, P465; Lever WF, 1975, HISTOPATHOLOGY SKIN, P181; Sehgal Virendra N, 2005, Skinmed, V4, P151; SHITARA A, 1984, INT J DERMATOL, V23, P542, DOI 10.1111/j.1365-4362.1984.tb04206.x; Yamada T, 2002, J PATHOL, V198, P541, DOI 10.1002/path.1243	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					418	421		10.1111/1346-8138.12773		4	Dermatology	Dermatology	CF5VA	WOS:000352624100016		
J	Ise, M; Funakoshi, T; Furuichi, Y; Honda, H; Fujio, Y; Amagai, M; Ohyama, M				Ise, Misaki; Funakoshi, Takeru; Furuichi, Yuki; Honda, Haruki; Fujio, Yumi; Amagai, Masayuki; Ohyama, Manabu			Case of angiosarcoma on the abdominal wall, an extremely rare variant, putatively shared the pathogenesis with Stewart-Treves syndrome	JOURNAL OF DERMATOLOGY			English	Letter									[Ise, Misaki; Funakoshi, Takeru; Furuichi, Yuki; Honda, Haruki; Fujio, Yumi; Amagai, Masayuki; Ohyama, Manabu] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan	Ohyama, M (reprint author), Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	manabuohy@z8.keio.jp	Amagai, Masayuki/K-5325-2013				Albores-Saavedra J, 2011, ANN DIAGN PATHOL, V15, P93, DOI 10.1016/j.anndiagpath.2010.07.012; Reynolds HM, 2010, J ANAT, V216, P344, DOI 10.1111/j.1469-7580.2009.01183.x; Masuzawa M., 2009, SKIN CANC, V24, P377; Mizukami A, 2009, SKIN CANC, V24, P350; Yamazaki N, 2009, SKIN CANC, V24, P385	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					426	427		10.1111/1346-8138.12809		2	Dermatology	Dermatology	CF5VA	WOS:000352624100019		
J	Nagashima, K; Demitsu, T; Nakamura, T; Nakamura, S; Yamada, T; Kakurai, M; Umemoto, N; Dohmoto, T; Imagawa, I; Yoneda, K				Nagashima, Kazutaka; Demitsu, Toshio; Nakamura, Toshinobu; Nakamura, Satoshi; Yamada, Tomoko; Kakurai, Maki; Umemoto, Naoka; Dohmoto, Takashi; Imagawa, Ichiro; Yoneda, Kozo			Keloidal basal cell carcinoma possibly developed from classical nodulo-ulcerative type of basal cell carcinoma: Report of a case	JOURNAL OF DERMATOLOGY			English	Letter									[Nagashima, Kazutaka; Demitsu, Toshio; Nakamura, Toshinobu; Nakamura, Satoshi; Yamada, Tomoko; Kakurai, Maki; Umemoto, Naoka; Dohmoto, Takashi] Jichi Med Univ, Saitama Med Ctr, Dept Dermatol, Saitama 3308503, Japan; [Imagawa, Ichiro] Imagawa Clin Dermatol, Saitama, Japan; [Yoneda, Kozo] Kagawa Univ, Dept Dermatol, Fac Med, Takmatsu, Japan	Demitsu, T (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Dermatol, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	demitsu@omiya.jichi.ac.jp					Misago N, 2004, EUR J DERMATOL, V14, P182; Menzies SW, 2000, ARCH DERMATOL, V136, P1012, DOI 10.1001/archderm.136.8.1012; Jones M, 2009, BRIT J DERMATOL, V160, P127, DOI 10.1111/j.1365-2133.2008.08828.x; Requena L, 1996, BRIT J DERMATOL, V134, P953; Lewis JE, 2007, AM J DERMATOPATH, V29, P485	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					427	429		10.1111/1346-8138.12796		3	Dermatology	Dermatology	CF5VA	WOS:000352624100020		
J	Ishii, T; Takata, A; Hatta, N				Ishii, Takayuki; Takata, Akiko; Hatta, Naohito			Case of syringotropic malignant melanoma with formation of a tumor nest directly below the primary tumor	JOURNAL OF DERMATOLOGY			English	Letter							ECCRINE APPARATUS		[Ishii, Takayuki; Takata, Akiko; Hatta, Naohito] Toyama Prefectural Cent Hosp, Dept Dermatol, Toyama 9308550, Japan	Ishii, T (reprint author), Toyama Prefectural Cent Hosp, Dept Dermatol, 2-2-78 Nishinagae, Toyama 9308550, Japan.	t-i@tch.pref.toyama.jp					Balch CM, 2000, CANCER, V88, P1484, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D; Kiryu H, 2001, J DERMATOL, V28, P91; Massi G, 2009, AM J DERMATOPATH, V31, P117, DOI 10.1097/DAD.0b013e318194c904; Zembowicz A, 2012, AM J DERMATOPATH, V34, P151, DOI 10.1097/DAD.0b013e318227c90d	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					429	430		10.1111/1346-8138.12791		2	Dermatology	Dermatology	CF5VA	WOS:000352624100021		
J	Takahashi, C; Nishi, K; Minami-Hori, M; Kishibe, M; Ishida-Yamamoto, A; Iizuka, H				Takahashi, Chiaki; Nishi, Kaoru; Minami-Hori, Masako; Kishibe, Mari; Ishida-Yamamoto, Akemi; Iizuka, Hajime			Multiple poromas following combination chemotherapy and autologous peripheral blood stem cell transplantation	JOURNAL OF DERMATOLOGY			English	Letter							ECCRINE POROMATOSIS		[Takahashi, Chiaki; Nishi, Kaoru; Minami-Hori, Masako; Kishibe, Mari; Ishida-Yamamoto, Akemi; Iizuka, Hajime] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Takahashi, C (reprint author), Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	chiaki06@asahikawa-med.ac.jp					Fujii K, 2012, ACTA DERM-VENEREOL, V92, P687, DOI 10.2340/00015555-1279; Hashizume S, 2014, J DERMATOL, V41, P174, DOI 10.1111/1346-8138.12375; Mahlberg MJ, 2006, J AM ACAD DERMATOL, V55, pS46, DOI 10.1016/j.jaad.2006.02.052; Nguyen Bichchau T, 2012, Dermatol Online J, V18, P9; WILKINSON RD, 1977, ARCH DERMATOL, V113, P472, DOI 10.1001/archderm.113.4.472	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					430	432		10.1111/1346-8138.12794		3	Dermatology	Dermatology	CF5VA	WOS:000352624100022		
J	Itoh, E; Nakahara, T; Furue, M				Itoh, Eriko; Nakahara, Takeshi; Furue, Masutaka			Injury-induced acquired dermal melanocytosis arising on an operation scar	JOURNAL OF DERMATOLOGY			English	Letter							NEVUS		[Itoh, Eriko; Nakahara, Takeshi] Kyushu Univ, Grad Sch Med Sci, Div Skin Surface Sensing, Fukuoka 8128582, Japan; [Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 8128582, Japan	Itoh, E (reprint author), Kyushu Univ, Grad Sch Med Sci, Div Skin Surface Sensing, Dept Dermatol,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	itou@dermatol.med.kyushu-u.ac.jp					HORI Y, 1984, J AM ACAD DERMATOL, V10, P961, DOI 10.1016/S0190-9622(84)80313-8; JIMENEZ E, 1994, J AM ACAD DERMATOL, V30, P277; Mizushima J, 1998, BRIT J DERMATOL, V139, P349; Murakami F, 2005, BRIT J DERMATOL, V152, P903, DOI 10.1111/j.1365-2133.2005.06381.x; PARISER RJ, 1982, ARCH DERMATOL, V118, P125, DOI 10.1001/archderm.118.2.125	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					434	435		10.1111/1346-8138.12800		2	Dermatology	Dermatology	CF5VA	WOS:000352624100025		
J	Hanami, Y; Yamamoto, T				Hanami, Yuka; Yamamoto, Toshiyuki			Bullous prurigo pigmentosa in a pregnant woman with hyperemesis gravidarum	JOURNAL OF DERMATOLOGY			English	Letter									[Hanami, Yuka; Yamamoto, Toshiyuki] Fukushima Med Univ, Dept Dermatol, Fukushima, Fukushima 9601295, Japan	Hanami, Y (reprint author), Fukushima Med Univ, Sch Med, Dept Dermatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	yuka-66@fmu.ac.jp					Jang MS, 2011, EUR J DERMATOL, V21, P634, DOI 10.1684/ejd.2011.1409; Kim SK, 2007, INT J DERMATOL, V46, P888, DOI 10.1111/j.1365-4632.2007.03241.x; Leone L, 2007, INT J GYNECOL OBSTET, V98, P261, DOI 10.1016/j.ijgo.2007.03.044; DesFrancesco V, 2006, EUR J DERMATOL, V16, P184; Kubota Y, 1998, EUR J DERMATOL, V8, P439	5	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					436	437		10.1111/1346-8138.12795		2	Dermatology	Dermatology	CF5VA	WOS:000352624100026		
J	Arimura, A; Hatanaka, M; Katsue, H; Matsushita, S; Kanekura, T				Arimura, Akiko; Hatanaka, Miho; Katsue, Hiromi; Matsushita, Shigeto; Kanekura, Takuro			Granulocyte and monocyte adsorption apheresis for paradoxical reaction to infliximab	JOURNAL OF DERMATOLOGY			English	Letter							PSORIASIFORM; DISEASE; ALPHA		[Arimura, Akiko; Hatanaka, Miho; Katsue, Hiromi; Matsushita, Shigeto; Kanekura, Takuro] Kagoshima Univ, Grad Sch Med Sci, Dept Dermatol, Kagoshima 8908520, Japan	Arimura, A (reprint author), Kagoshima Univ, Grad Sch Med Sci, Dept Dermatol, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	aco75460414@gmail.com					Takahashi H, 2007, J DERMATOL, V34, P468, DOI 10.1111/j.1346-8138.2007.00312.x; Andrisani G, 2012, EUR REV MED PHARMACO, V16, P890; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Seneschal J, 2009, BRIT J DERMATOL, V161, P1081, DOI 10.1111/j.1365-2133.2009.09329.x; Zippi Maddalena, 2013, World J Clin Cases, V1, P74, DOI 10.12998/wjcc.v1.i2.74	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					438	439		10.1111/1346-8138.12789		2	Dermatology	Dermatology	CF5VA	WOS:000352624100028		
J	Nozaki, Y; Fujita, H; Okada, R; Kou, K; Aihara, M				Nozaki, Yuu; Fujita, Hiroyuki; Okada, Rika; Kou, Kenzen; Aihara, Michiko			Non-drug-induced Stevens-Johnson syndrome successfully treated with high-dose i.v. immunoglobulin	JOURNAL OF DERMATOLOGY			English	Letter							TOXIC EPIDERMAL NECROLYSIS; INTRAVENOUS IMMUNOGLOBULIN		[Nozaki, Yuu; Fujita, Hiroyuki; Okada, Rika; Kou, Kenzen; Aihara, Michiko] Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Yokohama, Kanagawa 2360004, Japan	Aihara, M (reprint author), Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	maihara1@med.yokohama-cu.ac.jp					Chen JB, 2010, EUR J DERMATOL, V20, P743, DOI 10.1684/ejd.2010.1077; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; Barron SJ, 2015, INT J DERMATOL, V54, P108, DOI 10.1111/ijd.12423; Feldmeyer L, 2011, ARCH DERMATOL, V147, P1440, DOI 10.1001/archdermatol.2011.1610; Lee HY, 2013, BRIT J DERMATOL, V169, P1304	5	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					439	440		10.1111/1346-8138.12819		2	Dermatology	Dermatology	CF5VA	WOS:000352624100029		
J	Kuwatsuka, S; Kuwatsuka, Y; Tomimura, S; Utani, A				Kuwatsuka, Sayaka; Kuwatsuka, Yutaka; Tomimura, Saori; Utani, Atsushi			Proposal of the new name "eruptive papular collageno-elastopathy" to unify the two indistinguishable entities, eruptive collagenoma and papular elastorrhexis	JOURNAL OF DERMATOLOGY			English	Letter							NEVUS ANELASTICUS		[Kuwatsuka, Sayaka; Kuwatsuka, Yutaka; Tomimura, Saori; Utani, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki 8528501, Japan	Utani, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	utani@nagasaki-u.ac.jp					UITTO J, 1980, J AM ACAD DERMATOL, V3, P441; BORDAS X, 1987, ARCH DERMATOL, V123, P433, DOI 10.1001/archderm.123.4.433; DUVERNE J, 1955, Ann Dermatol Syphiligr (Paris), V82, P160; Lee MW, 2002, PEDIATR DERMATOL, V19, P565, DOI 10.1046/j.1525-1470.2002.00236_2.x; Ryder HF, 2005, PEDIATR DERMATOL, V22, P153, DOI 10.1111/j.1525-1470.2005.22214.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					440	441		10.1111/1346-8138.12807		2	Dermatology	Dermatology	CF5VA	WOS:000352624100030		
J	Miyauchi, T; Nishie, W; Sakata, M; Osawa, R; Noguchi, A; Shimizu, H				Miyauchi, Toshinari; Nishie, Wataru; Sakata, Mayuko; Osawa, Rinko; Noguchi, Atsushi; Shimizu, Hiroshi			Sweet syndrome-like eruption with prominent dermal leukocytoclasis associated with systemic lupus erythematosus	JOURNAL OF DERMATOLOGY			English	Letter							NONBULLOUS NEUTROPHILIC DERMATOSIS		[Miyauchi, Toshinari; Nishie, Wataru; Sakata, Mayuko; Osawa, Rinko; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan; [Noguchi, Atsushi] Hokkaido Univ, Grad Sch Med, Dept Internal Med 2, Sapporo, Hokkaido 0608638, Japan	Nishie, W (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	nishie@med.hokudai.ac.jp					Larson AR, 2014, HUM PATHOL, V45, P598, DOI 10.1016/j.humpath.2013.10.029; Gleason BC, 2006, J CUTAN PATHOL, V33, P721, DOI 10.1111/j.1600-0560.2006.00559.x; GOETTE DK, 1985, ARCH DERMATOL, V121, P789, DOI 10.1001/archderm.121.6.789; Satter EK, 2007, J CUTAN PATHOL, V34, P958, DOI 10.1111/j.1600-0560.2007.00758.x; Tsuji H, 2013, J DERMATOL, V40, P641, DOI 10.1111/1346-8138.12184	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	APR	2015	42	4					442	443		10.1111/1346-8138.12802		2	Dermatology	Dermatology	CF5VA	WOS:000352624100031		
J	Oikawa, S; Watabe, T; Takata, H				Oikawa, Shinji; Watabe, Teruhisa; Takata, Hyoe			Distributions of Pu isotopes in seawater and bottom sediments in the coast of the Japanese archipelago before and soon after the Fukushima Dai-ichi Nuclear Power Station accident	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Pu-240/Pu-239; Global fallout; Ignition loss; Biogenic opal	PU-240/PU-239 ATOM RATIOS; NORTH PACIFIC-OCEAN; PLANT ACCIDENT; PLUTONIUM ISOTOPES; MARINE-ENVIRONMENT; ICP-MS; SEA; RADIONUCLIDES; SEPARATION; EXCHANGE	A radioactivity measurement survey was carried out from 24 April 2008 to 3 June 2011 to determine the levels of plutonium isotopes and Pu-240/Pu-239 atom ratios in the marine environments off the sites of commercial nuclear power stations around the Japanese islands; the sampling period extended to two months after the Fukushima Dai-ichi Nuclear Power Station accident. In our previous study (Oikawa et al., 2015), data on Pu isotopes and Am-241 in sediments have already been reported. In this study, we report those on Pu isotopes in seawater as well as sediments, and the characteristics of sediments in addition (e.g., ignition loss and biogenic opals). Concentrations of Pu239+240 in seawater and bottom sediments remained nearly constant at all sampling locations during the survey period. In addition, no regional differences were observed in the Pu239+240 concentrations in surface waters. Higher Pu239+240 concentrations were found in bottom waters at deeper sampling locations, but the Pu-240/Pu-239 atom ratios were nearly constant regardless of the water depth. Higher 239+240PU concentrations were also found in bottom sediments at deeper sampling locations, but vice versa for Pu-240/Pu-239 atom ratios as reported in the previous report. The sediments samples from deeper locations showed the higher percentage of ignition loss as well as the higher content of biogenic opal. There was likely to be some driving force participating in the transfer of Pu isotopes associated with biogenic substances to the deeper seabed. The present survey showed that the accident at the Fukushima Dai-ichi Nuclear Power Station did not contribute much to the inventory of Pu isotopes in the adjacent sea area. (C) 2015 Published by Elsevier Ltd.	[Oikawa, Shinji; Takata, Hyoe] Marine Ecol Res Inst, Cent Lab, Onjuku, Chiba 2995105, Japan; [Watabe, Teruhisa] Marine Ecol Res Inst, Head Off, Shinjuku Ku, Tokyo 1620801, Japan	Takata, H (reprint author), Marine Ecol Res Inst, Cent Lab, 300 Iwawada, Onjuku, Chiba 2995105, Japan.	takata@kaiseiken.or.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	We thank Dr. Masashi Kusakabe for helpful discussions. We sincerely thank our colleagues at the Marine Ecology Research Institute for their help with sampling and for logistical support for the survey. We also acknowledge the crews of the R/Vs and technicians who assisted greatly with onboard fieldwork. Thanks are extended to the associate editor and anonymous reviewers for many critical and helpful comments. This work was carried out as part of a research project contract with the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Yamada M, 2006, SCI TOTAL ENVIRON, V366, P242, DOI 10.1016/j.scitotenv.2005.08.014; Kim CS, 2007, J ANAL ATOM SPECTROM, V22, P827, DOI 10.1039/b617568f; Zheng J, 2012, GEOCHEM J, V46, P361; Kelley JM, 1999, SCI TOTAL ENVIRON, V238, P483; Muramatsu Y, 1999, J ANAL ATOM SPECTROM, V14, P859, DOI 10.1039/a900071b; Oikawa S, 2013, BUNSEKI KAGAKU, V62, P455, DOI 10.2116/bunsekikagaku.62.455; Shinonaga T, 2014, ENVIRON SCI TECHNOL, V48, P3808, DOI 10.1021/es404961w; Lindahl P, 2010, MAR ENVIRON RES, V69, P73, DOI 10.1016/j.marenvres.2009.08.002; Oikawa S, 2013, BIOGEOSCIENCES, V10, P5031, DOI 10.5194/bg-10-5031-2013; Kusakabe M, 2013, BIOGEOSCIENCES, V10, P5019, DOI 10.5194/bg-10-5019-2013; Bu WT, 2014, ENVIRON SCI TECHNOL, V48, P534, DOI 10.1021/es403500e; Bu WT, 2014, ENVIRON SCI TECHNOL, V48, P9070, DOI 10.1021/es502480y; Bu WT, 2013, BIOGEOSCIENCES, V10, P2497, DOI 10.5194/bg-10-2497-2013; DEMASTER DJ, 1981, GEOCHIM COSMOCHIM AC, V45, P1715, DOI 10.1016/0016-7037(81)90006-5; Hanawa K., 1987, J OCEANOGR SOC JAPAN, V42, P435; HIROSE K, 1981, PAP METEOROL GEOPHYS, V32, P301, DOI 10.2467/mripapers.32.301; Hirose K., 2009, J NUCL RADIOCHEM SCI, V10, pR7; Krey P. W., 1976, TRANSURANIUM NUCLIDE, P671; Livingston HD, 2001, RADIOACTIV ENVIRONM, V1, P267; Miura T, 2001, J RADIOANAL NUCL CH, V250, P449, DOI 10.1023/A:1017936703216; NERH (Nuclear Emergency Response Headquarters) Government of Japan, 2011, JAP GOV IAEA MIN C N; Oikawa S., 2015, J RADIOANAL NUCL CHE; Oikawa S, 2011, J ENVIRON RADIOACTIV, V102, P302, DOI 10.1016/j.jenvrad.2010.12.007; OtsujiHatori M, 1996, J ENVIRON RADIOACTIV, V31, P143, DOI 10.1016/0265-931X(95)00048-F; Pointurier F, 2008, J ANAL ATOM SPECTROM, V23, P94, DOI 10.1039/b708568k; Yamada M, 2011, RADIAT PROT DOSIM, V146, P311, DOI 10.1093/rpd/ncr178; Yamada M, 2007, J ENVIRON RADIOACTIV, V98, P274, DOI 10.1016/j.jenvrad.2007.05.005; Yamada M, 2010, SCI TOTAL ENVIRON, V408, P5951, DOI 10.1016/j.scitotenv.2010.08.054; Yamada M, 2008, APPL RADIAT ISOTOPES, V66, P103, DOI 10.1016/j.apradiso.2007.08.003; Yamamoto M, 2002, J RADIOANAL NUCL CH, V252, P373, DOI 10.1023/A:1015738911028; Zheng J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00304	31	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	APR	2015	142						113	123		10.1016/j.jenvrad.2015.01.003		11	Environmental Sciences	Environmental Sciences & Ecology	CG1AP	WOS:000353005700015		
J	Kubota, Y; Takahashi, H; Watanabe, Y; Fuma, S; Kawaguchi, I; Aoki, M; Kubota, M; Furuhata, Y; Shigemura, Y; Yamada, F; Ishikawa, T; Obara, S; Yoshida, S				Kubota, Yoshihisa; Takahashi, Hiroyuki; Watanabe, Yoshito; Fuma, Shoichi; Kawaguchi, Isao; Aoki, Masanari; Kubota, Masahide; Furuhata, Yoshiaki; Shigemura, Yusaku; Yamada, Fumio; Ishikawa, Takahiro; Obara, Satoshi; Yoshida, Satoshi			Estimation of absorbed radiation dose rates in wild rodents inhabiting a site severely contaminated by the Fukushima Dai-ichi nuclear power plant accident	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Small mammal; ERICA; Dosimeter; Radiocesium; Exposure; Half-life	CHERNOBYL EXCLUSION ZONE; MARINE BIOTA; ERICA TOOL; EXPOSURE; RADIONUCLIDES; CS-137; JAPAN; LIFE	The dose rates of radiation absorbed by wild rodents inhabiting a site severely contaminated by the Fukushima Dai-ichi Nuclear Power Plant accident were estimated. The large Japanese field mouse (Apodemus speciosus), also called the wood mouse, was the major rodent species captured in the sampling area, although other species of rodents, such as small field mice (Apodemus argenteus) and Japanese grass voles (Microtus montebelli), were also collected. The external exposure of rodents calculated from the activity concentrations of radiocesium (Cs-134 and Cs-137) in litter and soil samples using the ERICA (Environmental Risk from Ionizing Contaminants: Assessment and Management) tool under the assumption that radionuclides existed as the infinite plane isotropic source was almost the same as those measured directly with glass dosimeters embedded in rodent abdomens. Our findings suggest that the ERICA tool is useful for estimating external dose rates to small animals inhabiting forest floors; however, the estimated dose rates showed large standard deviations. This could be an indication of the inhomogeneous distribution of radionuclides in the sampled litter and soil. There was a 50-fold difference between minimum and maximum whole-body activity concentrations measured in rodents at the time of capture. The radionuclides retained in rodents after capture decreased exponentially over time. Regression equations indicated that the biological half-life of radiocesium after capture was 3.31 d. At the time of capture, the lowest activity concentration was measured in the lung and was approximately half of the highest concentration measured in the mixture of muscle and bone. The average internal absorbed dose rate was markedly smaller than the average external dose rate (<10% of the total absorbed dose rate). The average total absorbed dose rate to wild rodents inhabiting the sampling area was estimated to be approximately 52 mu Gy h(-1) (1.2 mGy d(-1)), even 3 years after the accident. This dose rate exceeds 0.1 -1 mGy d(-1) derived consideration reference level for Reference rat proposed by the International Commission on Radiological Protection (ICRP). (C) 2015 Elsevier Ltd. All rights reserved.	[Kubota, Yoshihisa; Watanabe, Yoshito; Fuma, Shoichi; Kawaguchi, Isao; Yoshida, Satoshi] Natl Inst Radiol Sci, Fukushima Project Headquarters, Project Environm Dynam & Radiat Effects, Inage Ku, Chiba 2638555, Japan; [Takahashi, Hiroyuki] Tokyo Nucl Serv Co Ltd, Taito Ku, Tokyo 1100016, Japan; [Aoki, Masanari; Kubota, Masahide; Furuhata, Yoshiaki] Japan Wildlife Res Ctr, Sumida Ku, Tokyo 1308606, Japan; [Shigemura, Yusaku] Japan NUS Co Ltd, Shinjyuku Ku, Tokyo 1600023, Japan; [Yamada, Fumio] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Ishikawa, Takahiro] Natl Inst Radiol Sci, Res Dev & Support Ctr, Dept Tech Support & Dev, Inage Ku, Chiba 2638555, Japan; [Obara, Satoshi] Natl Inst Radiol Sci, Med Radiat Exposure Project, Inage Ku, Chiba 2638555, Japan	Kubota, Y (reprint author), Natl Inst Radiol Sci, Fukushima Project Headquarters, Project Environm Dynam & Radiat Effects, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	y_kubota@nirs.go.jp			Ministry of Environment of Japan	This work was partially supported by a fund from the Ministry of Environment of Japan.	Ann ICRP, 2008, ANN ICRP, V38, P1, DOI DOI 10.1016/J.ICRP.2008.08.003; Beresford NA, 2008, J ENVIRON RADIOACTIV, V99, P1496, DOI 10.1016/j.jenvrad.2008.03.002; Garnier-Laplace J, 2011, ENVIRON SCI TECHNOL, V45, P5077, DOI 10.1021/es201637c; Yamashiro H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02850; Kryshev II, 2012, J ENVIRON RADIOACTIV, V114, P157, DOI 10.1016/j.jenvrad.2012.04.015; Fisher NS, 2013, P NATL ACAD SCI USA, V110, P10670, DOI 10.1073/pnas.1221834110; [Anonymous], 2014, ANN ICRP, V43, P1; Brown JE, 2008, J ENVIRON RADIOACTIV, V99, P1371, DOI 10.1016/j.jenvrad.2008.01.008; Evangeliou N, 2013, ENVIRON SCI TECHNOL, V47, P5803, DOI 10.1021/es400372u; Beresford NA, 2013, RADIAT ENVIRON BIOPH, V52, P505, DOI 10.1007/s00411-013-0481-x; Beresford NA, 2010, J RADIOL PROT, V30, P341, DOI 10.1088/0952-4746/30/2/S07; Batlle JVI, 2011, RADIAT ENVIRON BIOPH, V50, P231, DOI 10.1007/s00411-010-0346-5; Callaway E, 2013, NATURE, V499, P265, DOI 10.1038/499265a; Chesser RK, 2001, ENVIRON TOXICOL CHEM, V20, P1927, DOI 10.1897/1551-5028(2001)020<1927:AOCASF>2.0.CO;2; Fukuda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054312; ICRP, 2007, ANN ICRP, V37, P133; ICRP, 2003, ANN ICRP, V33, P201; Inaba J, 1967, J Radiat Res, V8, P132, DOI 10.1269/jrr.8.132; MAFF (Ministry of Agriculture Forestry and Fisheries), 2013, RES SURV RAD FOR; METI (Ministry of Economy Trade and Industry), 2011, RESTR AR DEL EV AR R; MEXT (Ministry of Education Culture Sports Science and Technology), 1982, MEXT DET RAD SER, V13, P20; MEXT (Ministry of Education Culture Sports Science and Technology), 2011, RES 2 AIRB MON MIN E; MILLER CE, 1968, P SOC EXP BIOL MED, V128, P563; Ministry of Economy Trade and Industry (METI) Government of Japan, 2013, AR WHICH EV ORD HAV; REICHLE DE, 1970, NUCL SAFETY, V11, P43; Schiermeier Q., 2011, NAT NEWS; Schiermeier Q, 2011, NATURE, V472, P145, DOI 10.1038/472145a; Strand P, 2014, ENVIRON SCI TECH LET, V1, P198, DOI 10.1021/ez500019j; Takahashi J, 2015, J ENVIRON RADIOACTIV, V139, P351, DOI 10.1016/j.jenvrad.2014.07.004; Wood MD, 2009, SCI TOTAL ENVIRON, V407, P4062, DOI 10.1016/j.scitotenv.2009.03.011	30	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	APR	2015	142						124	131		10.1016/j.jenvrad.2015.01.014		8	Environmental Sciences	Environmental Sciences & Ecology	CG1AP	WOS:000353005700016		
J	Wu, YH; Liu, KF				Wu, Ying-Hsin; Liu, Ko-Fei			Formulas for Calibration of Rheological Parameters of Bingham Fluid in Couette Rheometer	JOURNAL OF FLUIDS ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						Bingham fluid; rheological parameters; calibration formula; concentric cylinders	CONCENTRIC CYLINDER VISCOMETERS; YIELD-STRESS FLUIDS; INVERSE PROBLEM; FLOW; MUDFLOWS	We propose simple formulas for calibration of rheological parameters of Bingham fluid using a co-axial cylinder rheometer, in which the inner cylinder rotates at a constant speed, and the outer cylinder is stationary. A critical rotational speed exists due to existence of yield stress. If rotation speed exceeds the critical value, all fluid is fully sheared between the concentric cylinders. Plug flow exists only when rotation speed is less than the critical value. The effects of radius ratio and Bingham number are discussed. The rheometer with radius ratio very close to unity is discussed as a limiting case, and the result confirms previous research. Formulas for calibration are derived using Least Squares and perturbation methods for all values of radius ratio, based on measured rotation speed and torque. Two sets of experimental data are used for verification. The validation shows that the formulas derived here yield reasonable and accurate estimates of rheological parameters.	[Wu, Ying-Hsin] Shimane Univ, Project Ctr Nat Disaster Reduct, Matsue, Shimane 6908504, Japan; [Liu, Ko-Fei] Natl Taiwan Univ, Dept Civil Engn, Taipei 10617, Taiwan; [Liu, Ko-Fei] Natl Taiwan Univ, Hydrotech Res Inst, Taipei 10617, Taiwan	Wu, YH (reprint author), Shimane Univ, Project Ctr Nat Disaster Reduct, Matsue, Shimane 6908504, Japan.	yhwu@riko.shimane-u.ac.jp	Wu, Ying-Hsin/G-5628-2012	Wu, Ying-Hsin/0000-0002-1385-4035	Ministry of Science and Technology in Taiwan [NSC 96-2625-Z-002-006-MY3]	We thank the Ministry of Science and Technology in Taiwan for financially supporting this research through Grant No. NSC 96-2625-Z-002-006-MY3. The study was completed after YHW moved to Shimane University. Valuable comments from the reviewers and Professor Barry Roser were also appreciated.	Estelle P, 2008, J NON-NEWTON FLUID, V154, P31, DOI 10.1016/j.jnnfm.2008.01.006; DARBY R, 1985, J RHEOL, V29, P369, DOI 10.1122/1.549818; LIU KF, 1989, J FLUID MECH, V207, P505, DOI 10.1017/S0022112089002685; NGUYEN QD, 1987, RHEOL ACTA, V26, P508, DOI 10.1007/BF01333734; NGUYEN QD, 1992, ANNU REV FLUID MECH, V24, P47; Ancey C, 2005, J RHEOL, V49, P441, DOI 10.1122/1.1849181; Dontula P, 2005, J RHEOL, V49, P807, DOI 10.1122/1.1940640; Feys D, 2013, MATER STRUCT, V46, P289, DOI 10.1617/s11527-012-9902-6; Muravleva L, 2010, RHEOL ACTA, V49, P1197, DOI 10.1007/s00397-010-0497-y; Yeow YL, 2000, J RHEOL, V44, P1335, DOI 10.1122/1.1308520; Barnes HA, 1989, INTRO RHEOLOGY; Bingham E.C., 1922, FLUIDITY PLASTICITY; Bird RB, 1987, DYNAMIC POLYM LIQUID, V1; Brookfield Engineering Labs. Inc, 2005, MOR SOL STICK PROBL; Cantelli A, 2009, J HYDRAUL ENG-ASCE, V135, P640, DOI 10.1061/(ASCE)HY.1943-7900.0000092; Chatzimina M, 2009, APPL RHEOL, V19; Chhabra R. P., 2008, NONNEWTONIAN FLOW AP; Ferguson J., 1991, APPL FLUID RHEOLOGY; FINK JH, 1981, GEOPHYS RES LETT, V8, P43, DOI 10.1029/GL008i001p00043; Hammad KJ, 2014, J FLUID ENG-T ASME, V136, DOI 10.1115/1.4025990; Huang X, 1997, J HYDRAUL ENG-ASCE, V123, P986, DOI 10.1061/(ASCE)0733-9429(1997)123:11(986); Jan C. D., 2009, J CHIN SOIL WATER CO, V40, P95; Kalombo JJN, 2014, J FLUID ENG-T ASME, V136, DOI 10.1115/1.4025989; Loeng Y. K., 2003, RHEOL ACTA, V42, P365; Middleman S., 1968, FLOW HIGH POLYM; Prager W., 2004, INTRO MECH CONTINUA; Steffe J. F., 1996, RHEOLOGICAL METHODS; TOORMAN EA, 1994, RHEOL ACTA, V33, P193, DOI 10.1007/BF00437304; Whipple KX, 1997, J GEOL, V105, P243; Yih C. S., 1979, FLUID MECH CONCISE I	30	2	2	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0098-2202	1528-901X		J FLUID ENG-T ASME	J. Fluids Eng.-Trans. ASME	APR	2015	137	4							041202	10.1115/1.4028813		11	Engineering, Mechanical	Engineering	CF4YU	WOS:000352561300010		
J	Ikeda, A; Ichino, H; Kiguchiya, S; Chigwechokha, P; Komatsu, M; Shiozaki, K				Ikeda, Asami; Ichino, Hayato; Kiguchiya, Saori; Chigwechokha, Petros; Komatsu, Masaharu; Shiozaki, Kazuhiro			EVALUATION AND IDENTIFICATION OF POTENT ANGIOTENSIN-I CONVERTING ENZYME INHIBITORY PEPTIDE DERIVED FROM DWARF GULPER SHARK (CENTROPHORUS ATROMARGINATUS)	JOURNAL OF FOOD PROCESSING AND PRESERVATION			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; WAKAME UNDARIA-PINNATIFIDA; ANTIOXIDANT PROPERTIES; FUNCTIONAL-PROPERTIES; PROTEIN; HYDROLYSATE; DIGESTION; WATERS; PAPAIN	Dwarf gulper shark (Centrophorus atromarginatus) lives in tropical to temperate waters and has a plenty of squalene in the liver. On the other hand, its muscle is an unused resource in Japan because of high urea content. Here, we tried to find the new procedure for the preparation of angiotensin-I converting enzyme (ACE) inhibitory hydrolysate from this shark. Nine hydrolysates were prepared using food-processing proteases. Among them, three hydrolysates produced by Protease P, Papain and Thermoase showed the potent ACE inhibitory activity (The IC50 values: 172.2, 144.2 and 84.2g/mL, respectively). From Thermoase hydrolysate, Val-Trp was found as the most potent inhibitory peptide (IC50 value: 3.3g/mL). The mechanism of inhibition of Val-Trp for ACE was competitive. Val-Trp also exhibited antioxidant activities, suggesting the efficacy as bifunctional peptide against hypertension. This study showed the new possibility of the usage of dwarf gulper shark as material for healthy food. Practical ApplicationsThis study introduces processing techniques for potent ACE inhibitory hydrolysate from dwarf gulper shark muscle by using food-processing proteases. This hydrolysate shows low bitterness, which is suitable for the usage as functional food. The strongest ACE inhibitory peptide in this hydrolysate also possessed antioxidant activity, suggesting that the hydrolysate would be useful for hypertension acting as bifunctional (ACE inhibitory and antioxidative). Results of this study will contribute to utilize dwarf gulper shark muscle, a nonutilized resource in Japan.	[Ikeda, Asami; Ichino, Hayato; Kiguchiya, Saori; Chigwechokha, Petros; Komatsu, Masaharu; Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan	Shiozaki, K (reprint author), Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan.	shiozaki@fish.kagoshima-u.ac.jp			Sankei Science Foundation	We thank Tsugunori Maekawa, Yoshinari Nakamura, Yohei Abe and Momo Shiozaki for the experimental assistances. The financial support from Sankei Science Foundation is gratefully acknowledged.	Jung EY, 2012, ANN NUTR METAB, V61, P89, DOI 10.1159/000338441; Brodin B, 2002, PHARMACOL TOXICOL, V90, P285, DOI 10.1034/j.1600-0773.2002.900601.x; Tsopmo A, 2009, PEDIATR RES, V66, P614, DOI 10.1203/PDR.0b013e3181be9e7e; WALTER WM, 1973, APPL MICROBIOL, V26, P773; Chen C, 2012, AMINO ACIDS, V43, P457, DOI 10.1007/s00726-011-1102-0; SEKUL AA, 1978, J AGR FOOD CHEM, V26, P855, DOI 10.1021/jf60218a035; Lee DH, 2004, PEPTIDES, V25, P621, DOI 10.1016/j.peptides.2004.01.015; Sato M, 2002, ANN NUTR METAB, V46, P259, DOI 10.1159/000066495; Sato M, 2002, J AGR FOOD CHEM, V50, P6245, DOI 10.1021/jf020482t; Picot L, 2006, PROCESS BIOCHEM, V41, P1217, DOI 10.1016/j.procbio.2005.11.024; He HL, 2007, BIORESOURCE TECHNOL, V98, P3499, DOI 10.1016/j.biortech.2006.11.036; Girgih AT, 2013, FOOD RES INT, V52, P315, DOI 10.1016/j.foodres.2013.03.034; Otani L, 2009, BIOSCI BIOTECH BIOCH, V73, P2203, DOI 10.1271/bbb.90311; Berker KI, 2007, TALANTA, V72, P1157, DOI 10.1016/j.talanta.2007.01.019; Rizkalla SW, 2002, DIABETES METAB, V28, P385; AMBLER RP, 1968, BIOCHEM J, V108, P893; Fan J, 2012, MOLECULES, V17, P12836, DOI 10.3390/molecules171112836; Cho SM, 2004, FOOD HYDROCOLLOID, V18, P573, DOI 10.1016/j.foodhyd.2003.10.001; CLEGG KM, 1974, J DAIRY RES, V41, P283; DEPREZ PP, 1990, AUST J MAR FRESH RES, V41, P375; FitzGerald R.J., 2000, BRIT J NUTR, V84, P33, DOI DOI 10.1017/50007114500002221; Gouda KGM, 2006, J AGR FOOD CHEM, V54, P4568, DOI 10.1021/jf060264q; HARWOOD JE, 1970, WATER RES, V4, P805, DOI 10.1016/0043-1354(70)90037-0; Matsumoto H, 2004, J JPN SOC FOOD SCI, V51, P546; Ruiz JAG, 2004, INT DAIRY J, V14, P1075, DOI 10.1016/j.idairyj.2004.04.007; Shen HY, 2005, J MOL CATAL B-ENZYM, V37, P26, DOI 10.1016/j.molcatb.2005.09.002; Shiozaki K, 2010, FISHERIES SCI, V76, P865, DOI 10.1007/s12562-010-0264-0; Szostak Wiktor B, 2006, Przegl Lek, V63, P223; Tang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037863; Velayutham P. K., 2012, J SURG RES, V179, P125	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-8892	1745-4549		J FOOD PROCESS PRES	J. Food Process Preserv.	APR	2015	39	2					107	115		10.1111/jfpp.12210		9	Food Science & Technology	Food Science & Technology	CF4QA	WOS:000352534000001		
J	Asari, M; Okuda, K; Yajima, D; Maseda, C; Hoshina, C; Omura, T; Shiono, H; Matsubara, K; Shimizu, K				Asari, Masaru; Okuda, Katsuhiro; Yajima, Daisuke; Maseda, Chikatoshi; Hoshina, Chisato; Omura, Tomohiro; Shiono, Hiroshi; Matsubara, Kazuo; Shimizu, Keiko			Rapid genotyping of 25 autosomal STRs in a Japanese population using fluorescent universal primers containing locked nucleic acids	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						STR; Genotyping; Universal primer; Fast PCR; Locked nucleic acid (LNA); Forensic DNA	DEVELOPMENTAL VALIDATION; ALLELE FREQUENCIES; LOCI; KIT	Amplification of fluorescently labeled products is one of the most popular methods for genotyping genetic variations. Two-step amplification using fluorescent universal primers simultaneously produces multiple targeted fragments labeled with fluorescent dyes, and this strategy is applicable to large-scale, cost-effective genotyping. In this study, we developed a fast PCR-based, multiple short tandem repeat (STR) genotyping method using fluorescent universal primers containing locked nucleic acids (LNAs). Four amplification reactions, each assaying six or seven markers and using 0.5-1.0 ng of genomic DNA, produced obvious Fam-labeled peaks in all 26 loci tested (25 autosomal STRs and amelogenin). The overall amplification time was 37 min. Moreover, fluorescent signals for the 25 STRs obtained from LNA-containing primers were 1.5-9.0 fold higher compared to those from non-LNA primers. Using genomic DNA from 120 Japanese individuals, 16 out of the 25 STRs had observed heterozygosity greater than 0.7. Some of these 25 STRs also had high discriminatory power, similar to that of the 13 core STRs in the Combined DNA Index System dataset. The probability of incorrectly assigning a match based on the accumulated matching probability for these 25 STRs is 1.2 x 10(-22), and their combined use can provide robust information for Japanese forensics. (C) 2015 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Asari, Masaru; Okuda, Katsuhiro; Yajima, Daisuke; Maseda, Chikatoshi; Hoshina, Chisato; Shiono, Hiroshi; Shimizu, Keiko] Asahikawa Med Univ, Dept Legal Med, Asahikawa, Hokkaido 0788510, Japan; [Omura, Tomohiro; Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 6068507, Japan	Asari, M (reprint author), Asahikawa Med Univ, Dept Legal Med, Asahikawa, Hokkaido 0788510, Japan.	asari@asahikawa-med.ac.jp			Japan Society for the Promotion of Science [24590847]	This work was supported in part by a Grant-in-Aid for Scientific Research (24590847 to M. A.) from the Japan Society for the Promotion of Science.	Laurin N, 2012, FORENSIC SCI INT-GEN, V6, P47, DOI 10.1016/j.fsigen.2011.01.011; Westen AA, 2014, FORENSIC SCI INT-GEN, V10, P55, DOI 10.1016/j.fsigen.2014.01.008; Hares DR, 2012, FORENSIC SCI INT-GEN, V6, pE52, DOI 10.1016/j.fsigen.2011.04.012; Yoshida K, 2005, J FORENSIC SCI, V50, P718; Asari M, 2013, ELECTROPHORESIS, V34, P448, DOI 10.1002/elps.201200215; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Ozeki M, 2013, LEGAL MED-TOKYO, V15, P342, DOI 10.1016/j.legalmed.2013.08.006; Hill CR, 2009, J FORENSIC SCI, V54, P1008, DOI 10.1111/j.1556-4029.2009.01110.x; Zhou HG, 2014, FORENSIC SCI INT-GEN, V11, P31, DOI 10.1016/j.fsigen.2014.02.008; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Foster Amanda, 2012, Investig Genet, V3, P6, DOI 10.1186/2041-2223-3-6; Ge C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092826; Jin HJ, 2013, J FORENSIC LEG MED, V20, P1093, DOI 10.1016/j.jflm.2013.09.027; Li SL, 2014, FORENSIC SCI INT-GEN, V11, P207, DOI 10.1016/j.fsigen.2014.03.001; Rocchi A, 2012, FORENSIC SCI INT-GEN, V6, pE157, DOI 10.1016/j.fsigen.2012.04.002; Yuan L, 2014, LEGAL MED-TOKYO, V16, P314, DOI 10.1016/j.legalmed.2014.05.008; Zhang MX, 2014, GENET MOL RES, V13, P1179, DOI 10.4238/2014.February.27.2; Zhang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057471	18	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	APR	2015	31						36	41		10.1016/j.jflm.2015.01.004		6	Medicine, Legal	Legal Medicine	CG3AU	WOS:000353149600007		
J	Sakae, T; Nakada, H; LeGeros, JP				Sakae, Toshiro; Nakada, Hiroshi; LeGeros, John P.			Historical Review of Biological Apatite Crystallography	JOURNAL OF HARD TISSUE BIOLOGY			English	Review						Calcium phosphate; Precursor; Tooth enamel; Dentin; Bone		Biological apatites composing the inorganic part of many hard tissues have many characteristics differing from mineral and/or synthetic apatites. Before the modern precise analytical technique and methods were introduced to the hard tissue study, the non-stoichiometry of biological apatites was a problem, and the carbonated apatite in bone and tooth was sometimes mistaken for a mixture of calcium carbonates, calcium phosphates, and calcium oxides. Apatite is a mineral group which makes wide ranged solid-solution systems. Although hydroxyapatite is the most stable phase in the mimetic conditions to body system among the calcium phosphates, it can not be successfully precipitated under laboratory conditions. Therefore, some mechanisms have been proposed to crystallize biological apatite in the body conditions. In this review, the history of unveiling the nature of biological apatites is described from a crystallographic viewpoint, and bio-medical applications of calcium phosphates are introduced.	[Sakae, Toshiro] Nihon Univ, Sch Dent Matsudo, Dept Histol, Matsudo, Chiba 2718587, Japan; [Nakada, Hiroshi] Nihon Univ, Sch Dent Matsudo, Dept Removable Prosthodont, Matsudo, Chiba 2718587, Japan; [LeGeros, John P.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA	Sakae, T (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Histol, 28701 SakaechoNishi, Matsudo, Chiba 2718587, Japan.	sakae.toshiro@gmail.com					Palazzo B, 2009, ACTA BIOMATER, V5, P1241, DOI 10.1016/j.actbio.2008.10.024; BROWN WE, 1962, NATURE, V196, P1048, DOI 10.1038/1961048b0; Averbuch-Pouchot M. T., 1996, TOPICS PHOSPHATE CHE; Bale WF, 1934, AM J ROENTGENOL RADI, V32; Bazin D, 2009, OSTEOPOROSIS INT, V20; Beran A, 2004, NOTE MINERALOGY, V6; Bonucci E, 2007, BIOL CALCIFICATION; Bonucci E., 2013, ADV TOPICS CRYSTAL G; Boskey A, 1997, JDR, V76; Boskey AL, 2007, ELEMENTS, V3; Boudreau AE, 1995, SHORT COURSE SERIES, V23, P2545; Brown WE, 1962, NATURE, V196; Brudevold F, 1976, STRUCTURAL CHEM ORG; Carlson D., 1955, ACTA RADIOL S121, V121; Carrodeguas RG, 2011, ACTA BIOMATER, V7; Cheng PT, 1988, MAGNESIUM, V7; Chou AH, 2007, IMPLANT DENT, V16; Chow L. C., 2001, OCTACALCIUM PHOSPHAT; Christ C, 2010, ACTA BIOMATER, V6; Colfen H, 2010, NAT MATER, V9; Corbridge DEC, 1985, PHOSPHORUS OUTLINE I; Daculsi G, 1998, BIOCERAMICS, V11; Daculsi G, 2008, BIOCERAMICS THEIR CL; Dallemagne MJ, 1973, BIOL MINERALIZATION, P2342; Dana JD, 1868, SYSTEMS MINERALOGY D, V5th; De Jong WF, 1926, TEC TRAV CHIM, V45; Dickson GR, 1984, METHODS CALCIFIED TI; DiMasi E, 2014, BIOMINERALIZATION SO; Dorozhkin S, 2012, CALCIUM ORTHOPHOSPHATES: APPLICATIONS IN NATURE, BIOLOGY, AND MEDICINE, P1, DOI 10.1201/b12312; Dorozhkin SV, 2012, INT J MAT CHEM, V2, P1946; Dorozhkin S.V., 2011, BIO, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1; Driessense FCM, 1990, BIOMINERALS; Eanes ED, 1967, CLIN ORTHOP RELAT R, V53; Eanes ED, 2001, MONOGR ORAL SCI, V18; Eanes ED, 1970, MAT RES B, V5; Eanes ED, 1965, NATURE, V208; Elliott JC, 1973, SCIENCE, V180; Elliott JC, 1990, STRUCTURE CHEM APATI; Elliott JC, 2002, REV MINERAL GEOCHEM, V48; Elliott JC, 2002, ADV XRAY ANAL, V45; Elliott JC, 1973, CLIN ORTHOP RELAT R, V93; Elliott JC., 1984, METHODS CALCIFIED TI; Elliott JC, 1985, CALCIFIED TISSUE INT, V37; Epple M, 2004, BIOMINERALIZATION PR, V2nd; Feki H El, 1991, CALCIFIED TISSUE INT, V49; Fleet ME, 2013, FRONT BIOSCI E, V5; Garrido C. A., 2011, INT J BIOMATER, V2011; Gleadow AJW, 2002, REV MINERAL GEOCHEM, V48; Glimcher MJ, 2006, REV MINERAL GEOCHEM, V64; Grynpas MD, 1984, CALCIFIED TISSUE INT, V36; Holcomb DW, 1980, CALCIFIED TISSUE INT, V31; Hughes JM, 2014, AM MINERAL, V99, P369, DOI 10.2138/am.2014.4644; Hughes JM, 2002, REV MINERAL GEOCHEM, V48, P112; Iafisco M, 2014, APATITE SYNTHESIS ST; Ito A, 2006, BIOMED MATER, V1; Jean A, 1988, J ENDODONT, V14, P8387; Julien M, 2006, BIOMATERIALS, V28, P95665; Kaim W., 2013, BIOINORGANIC CHEM IN; Kay MI, 1964, NATURE, V204; Landis WJ, 1999, GRAVIT SPACE BIOL B, V12, P1526; Lasch P., 2008, BIOMEDICAL VIBRATION; LeGeros JP, 1994, CHARACTERIZATION PER, P3342; LeGeros RZ, 1991, MECH PHYLOGENY MINER; LeGeros RZ, 1968, B SOC CHIM FR; LeGeros RZ, 1993, INTRO BIOCERAMICS; LeGeros RZ., 2008, CHEM REV, V108; LeGeros RZ, 1994, HYDROXYAPATITE RELAT, P328; LeGeros RZ, 2003, J MATER SCI-MATER M, V14; LeGeros RZ, 1996, AM DENT RES, V10; LeGeros RZ., 2002, CLIN ORTHOP RELAT R, P8198; LeGeros R.Z., 1991, CALCIUM PHOSPHATES O; LeGeros RZ, 1995, CONNECT TISSUE RES, V33, P2039; LeGeros RZ, 1999, AM J DENT, V12, P6570; LeGeros RZ, 1995, ENCY HDB BIOMATRIALS, V2; LeGeros RZ, 1993, CLIN MAT, V14, P6588; LeGeros RZ, 2007, KEY ENG MATER, V361363, P4346; LeGeros RZ, 1970, DEV APPL SPECTROSC B, V7B, P312; LeGeros RZ, 1985, CALCIFIED TISSUE INT, V37, P98100; LeGeros RZ, 1984, PHOSPHATE MINERALS; LeGeros RZ, 2014, ADV CALCIUM PHOSPHAT, P119; LeGeros RZ, 1969, EXPERIENTIA, V25, P57; LeGeros RZ, 2001, Z KARDIOL, V90; LeGeros RZ, 1982, J DENT RES, V61, P343; LeGeros RZ, 1967, SCIENCE, V155; Li X, 2009, MAT SCI ENG C, V29; Lin S, 2003, J BIOMED MATER RES A, V66A; Lowenstam H. A., 1989, BIOMINERALIZATION; MacMillan AK, 2014, INT J NANOMED, V9; Mahamid J, 2011, CELLS TISSUES ORGANS, V194, P9297; Mann S, 1983, INORGANIC ELEMENTS B, V54; McConnell D, 1973, APATITE; McConnell D, 1967, SCIENCE, V155; Mehmel M., 1930, IZ KRISTALLOGR, V75; Mijares D, 2012, ARCH ORAL BIOL, V57; Moseke C, 2010, ACTA BIOMATER, V6; Mueller WEG., 2011, MOL BIOMINERALIZATIO; Nagatsuka H, 1998, BIOCERAMICS, V11; Nakada H, 2013, BIOCERAM DEV APPL S, VS1; Nakada H, 2012, INT J BIOMATER, V2012, P1; Nancollas GH, 1984, PHOSPHATE MINERALS; NaraySzabo S., 1930, Z KRISTALLOGR, V75; Nasdala L, 2004, EUROPEAN MINERALOGIC, V6, P4391; Newman WD, 1953, CHEM REV, V53, P145; Newman WF, 1973, BIOL MINERALIZATION, P319; Nriagu JO, 1984, PHOSPHATE MINERALS, P1136; Numata Y, 2008, J HARD TISSUE BIOL, V17; Okazaki M, 1996, ADV DENT RES, V10; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Pan Y, 2002, REV MINERAL GEOCHEM, V48, P1349; Pasero M, 2010, EUR J MINERAL, V22; Pasteris JD, 2008, ELEMENTS, V4, P97104; Penel G, 1998, CALCIFIED TISSUE INT, V63; Posner AS, 1985, CLIN ORTHOP RELAT R, V200, P8799; Posner AS, 1954, EXPERIENTIA, V10; Posner AS, 1960, NATURE, V188; Rey C, 1989, CALCIFIED TISSUE INT, V45; Rey C, 2009, OSTEOPOROSIS INT, V20; Rohanizadeh R, 2007, LETHAIA, V40, P6168; Rohanizadeh R, 2005, J BIOMED MATER RES A, V72A; Rowles SL, 1976, STRUCTURAL CHEM ORG; Sakae T, 1988, ARCH ORAL BIOL, V33; Sakae T, 2012, KEY ENG MATER, V529530; Sakae T, 1991, MECH PHYLOGENY MINER; Schmidt WJ, 1971, POLARIZING MICROSCOP; Simkiss K., 1991, MECH PHYLOGENY MINER; Sudarsanan K, 1969, ACTA CRYSTALLOGR B, V25; Suwa T, 1922, KEY ENG MATER, V309311, P2006; Suzuki K, 1998, CONNECT TISSUE RES, V38; Trautz OR., 1955, ANN NY ACAD SCI, V60; Trueman CN, 2002, REV MINERAL GEOCHEM, V48; Urlich L, 1987, ARCHAEOMETRY; Veis A, 2013, CALCIFIED TISSUE INT, V93; Very JM, 1984, METHODS CALCIFIED TI; Wakae H, 2008, J BIOMED MATER RES A, V87A; Watabe N, 1996, BIOMINERALIZATION HA, P925; Weiner S, 1986, CRC CRITICAL REV BIO, V20; Williams RAD, 1979, BASIC APPL DENTAL BI; Wilson RM, 1999, AM MINERAL, V84; Wopenka B, 2005, MAT SCI ENG C, V25; Wu WJ, 1998, BIOCERAMICS, V11; Wuthier RE, 1985, CALCIFIED TISSUE INT, V37; Wyckoff RWG, 1973, BIOL MINERALIZATION; Yamada Y, 2008, J BIOMED MATER RES A, V84A; Yoreo JD, 2013, RES MRTHODS BIOMINER; Young RA, 1980, MAT RES B, V15, P1729; Young RA, 1974, J DENT RES, V53; Zapanta-LeGeros R, 1965, NATURE, V206; Zavgorodniy AV, 2012, SURFACE COAT TECHNOL, V206	148	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					111	121				11	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600001		
J	Kobayashi, F; Yamamoto, M; Kitamura, K; Asuka, K; Kinoshita, H; Matsunaga, S; Abe, S				Kobayashi, Fumiaki; Yamamoto, Masahito; Kitamura, Kei; Asuka, Kishi; Kinoshita, Hideaki; Matsunaga, Satoru; Abe, Shin-ichi			Desmin and Vimentin Expression during Embryonic Development of Tensor Veli Palatini Muscle in Mice	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Secondary palate; Desmin; Vimentin; Embryo; Mouse	MEDIAL EDGE EPITHELIUM; HUMAN FETAL HEART; INTERMEDIATE-FILAMENTS; SECONDARY PALATE; SKELETAL-MUSCLE; RAT; GROWTH; PERIOSTIN; CELLS; PALATOGENESIS	During embryonic palatogenesis, development of the secondary palate represents a particularly complex process involving the formation, elevation and midline fusion of the palatal shelves. In recent years, it has been shown that the specific expression of type I collagen and periostin in the palatal aponeurosis results in formation of the soft palate. However, few reports have examined soft palate development in relation to the skeletal muscles connected to the palatal aponeurosis. Thus, in the present study, focusing on the tensor veli palatine muscle and surrounding tissues in embryonic mice, we performed immunohistochemical examination and real-time PCR (RT-PCR) in order to investigate the expression of desmin and vimentin. Low levels of desmin expression were observed in the tensor veli palatine muscle on embryonic day (ED) 12.5, with the levels of expression increasing from ED 13.5 to 15.5. In addition at ED 12.5, desmin was observed to accumulate in the area of the myotendinous junction, and this accumulation remained unchanged up to ED 15.5. Meanwhile, vimentin expression was observed in the tensor veli palatine muscle and surrounding tissue at ED 12.5, and this level of expression did not change up to ED 15.5. Strong expression of vimentin was observed at ED 14.5 only in the medial edge epithelium (MEE). Both immunohistochemical examination and RT-PCR yielded consistent results. In the present study, we found that desmin accumulates in the vicinity of the myotendinous junction at ED 12.5, which is prior to initiation of swallowing movement. From this, we are able to conclude that this accumulation of desmin is caused by factors other than mechanical stress resulting from initial muscle contraction. Furthermore, the elevated expression of vimentin during embryogenesis, and that of desmin after differentiation, suggest that there may be some interaction between the two intermediate filaments in determining muscle cell differentiation.	[Kobayashi, Fumiaki; Yamamoto, Masahito; Kitamura, Kei; Kinoshita, Hideaki; Matsunaga, Satoru; Abe, Shin-ichi] Tokyo Dent Coll, Dept Anat, Tokyo 1010061, Japan; [Asuka, Kishi] Ohu Univ, Sch Dent, Dept Morphol Biol, Div Oral Anat, Koriyama, Fukushima, Japan	Yamamoto, M (reprint author), Tokyo Dent Coll, Dept Anat, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo 1010061, Japan.	yamamotomasahito@tdc.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24593061]	This study was supported by grants-in-aid for scientific research (24593061: Shinichi Abe) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, 2012-2015.	Abe S, 2010, J ANAT, V217, P167, DOI 10.1111/j.1469-7580.2010.01246.x; Oka K, 2012, J HISTOCHEM CYTOCHEM, V60, P57, DOI 10.1369/0022155411427059; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; COLEMAN RD, 1965, ANAT REC, V151, P107, DOI 10.1002/ar.1091510202; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Hilliard SA, 2005, J ANAT, V207, P655; Zhou HM, 2010, J CELL COMMUN SIGNAL, V4, P99, DOI 10.1007/s12079-010-0090-2; Iwata J, 2011, ORAL DIS, V17, P733, DOI 10.1111/j.1601-0825.2011.01806.x; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; COHEN SR, 1993, CLEFT PALATE-CRAN J, V30, P441, DOI 10.1597/1545-1569(1993)030<0441:SPMADF>2.3.CO;2; Fuchs A, 2010, DEV DYNAM, V239, P2860, DOI 10.1002/dvdy.22421; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; Li P, 2007, J APPL PHYSIOL, V102, P390, DOI 10.1152/japplphysiol.00468.2006; BABAI F, 1990, DIFFERENTIATION, V44, P132, DOI 10.1111/j.1432-0436.1990.tb00546.x; Blanco CD, 2012, CELLS TISSUES ORGANS, V195, P392, DOI 10.1159/000329253; Chou MJ, 2004, ANAT EMBRYOL, V208, P19, DOI 10.1007/s00429-004-0379-0; DOMENECHRATTO G, 1977, ACTA ANAT, V97, P4; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Gibbins JR, 1999, INT J DEV BIOL, V43, P237; Jahan E, 2010, ARCH ORAL BIOL, V55, P919, DOI 10.1016/j.archoralbio.2010.07.010; JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P25; Kim HD, 1996, ANAT RECORD, V246, P271, DOI 10.1002/(SICI)1097-0185(199610)246:2<271::AID-AR13>3.0.CO;2-L; Kishi A, 2012, ANAT SCI INT, V87, P126, DOI 10.1007/s12565-012-0132-3; Montenegro MA, 2000, J CRAN GENET DEV BIO, V20, P137; Schonmeyr B, 2013, J PLAST SURG HAND SU, V48, P5; SHAPIRO F, 1995, ANAT REC, V241, P39, DOI 10.1002/ar.1092410107; TIDBALL JG, 1992, EXP CELL RES, V199, P206, DOI 10.1016/0014-4827(92)90425-8; WATANABE H, 1993, ACTA ANAT, V147, P14; Welsh IC, 2009, DEV BIOL, V336, P53, DOI 10.1016/j.ydbio.2009.09.028; Xian CJ, 2004, J ORTHOPAED RES, V22, P417, DOI 10.1016/j.orthres.2003.08.003; Xu X, 2006, DEV BIOL, V297, P238, DOI 10.1016/j.ydbio.2006.05.014; Yamamoto M, 2011, J ANAT, V219, P253, DOI 10.1111/j.1469-7580.2011.01382.x; Yang YG, 1996, ANAT REC, V246, P64, DOI 10.1002/(SICI)1097-0185(199609)246:1<64::AID-AR7>3.0.CO;2-F; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013	39	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					134	142				9	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600003		
J	Ohira, T; Tanabe, K; Sasaki, H; Yoshinari, M; Yajima, Y				Ohira, Takashi; Tanabe, Koji; Sasaki, Hodaka; Yoshinari, Masao; Yajima, Yasutomo			Effect of Locally Applied Fluvastatin in Low-turnover Osteoporosis Model Mouse with Femur Bone Defect	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Fluvastatin-gelatin complex; Low-turnover osteoporosis; Local-administration; Bone formation; Micro-CT	SENILE OSTEOPOROSIS; SIMVASTATIN ACID; IN-VITRO; STATIN; PHARMACOLOGY; ENHANCEMENT; RATS	The aim of this study was to investigate the effects of local administration of fluvastatin-gelatin complex on the healing of bone defects in low-turnover osteoporosis mice. Gelatin was used as a carrier of the fluvastatin. A fluvastatin-gelatin complex solution was created by dissolving each concentration of fluvastatin in a 75mg/mL gelatin solution. The gelatin solution was mixed with air, then lyophilized for 1 day and crosslinked by dry heating to make a fluvastatin-gelatin complex sponge. After crosslinking, the complex sponge was cut into pieces 1 mm diameter x 1 mm high to fit the bone defect area. The amount of fluvastatin in the sponge was adjusted to control (0 nmol), 0.1 nmol, 0.2 nmol, and 0.4 nmol. Using 20-week-old low-turnover osteoporosis model mice (SAMP6) and normal model mice (SAMR1), cylindrical and bone defects were made in sites 1.0 mm in diameter and depth, 1 mm of 3 mm from both sides of the distal end of the femur. The complex sponge was then inserted into each site, and the wound was closed. Radiographic analysis and histologic examinations were then performed. In SAMP6, the bone volumes of the bone defect areas in the 0.1nmol and 0.2nmol groups were significantly higher compared with those of the control and 0.4nmol groups at 14 and 21 days. Histological observation showed that the volume of newly formed bone increased in the 0.1nmol and 0.2nmol groups compared to those in the control and 0.4nmol groups at 14 and 21 days. The bone volumes of newly formed bone in SAMR1 were higher than were those in SAMP6, and the optimum concentration of fluvastatin was different between SAMP6 and SAMR1. The present study suggests that local administration of a fluvastatin-gelatin complex sponge provides improvement in bone healing in low-turnover osteoporosis.	[Ohira, Takashi; Sasaki, Hodaka; Yajima, Yasutomo] Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Tokyo 1010061, Japan; [Ohira, Takashi; Tanabe, Koji; Sasaki, Hodaka; Yoshinari, Masao; Yajima, Yasutomo] Tokyo Dent Coll, Oral Hlth Sci Ctr, Div Oral Implants Res, Tokyo 1010061, Japan; [Tanabe, Koji] Tokyo Dent Coll, Dept Pharmacol, Tokyo 1010061, Japan	Ohira, T (reprint author), Tokyo Dent Coll, Dept Oral Maxillofacial & Implantol, Chiyoda Ku, 2-9-18 Misakicho, Tokyo 1010061, Japan.	oohiratakashi@tdc.ac.jp			Japan Society for the Promotion of Science [18390524, 258618971]	This research was supported by a Grant-in-Aid for Scientific Research (B:18390524 and Young Scientists (B) 258618971) from the Japan Society for the Promotion of Science.	FREUND J, 1947, ANNU REV MICROBIOL, V1, P291, DOI 10.1146/annurev.mi.01.100147.001451; Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040; Stein D, 2005, J PERIODONTOL, V76, P1861, DOI 10.1902/jop.2005.76.11.1861; [Anonymous], 2007, J CLIN PERIODONTOL, V34, P610; Nyan M, 2009, CLIN ORAL IMPLAN RES, V20, P280, DOI 10.1111/j.1600-0501.2008.01639.x; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Yoshinari M, 2007, DENT MATER J, V26, P451; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Ayukawa Y, 2009, ORAL SURG ORAL MED O, V107, P336, DOI 10.1016/j.tripleo.2008.07.013; Tanabe K, 2012, DENT MATER J, V31, P489, DOI 10.4012/dmj.2012-008; Tsartsalis AN, 2012, HORM-INT J ENDOCRINO, V11, P126; MATSUSHITA M, 1986, AM J PATHOL, V125, P276; Shao HW, 2008, STEM CELLS, V26, P1376, DOI 10.1634/stemcells.2007-0785; Hodel C, 2002, TOXICOL LETT, V128, P159, DOI 10.1016/S0378-4274(02)00010-3; Moriyama Y, 2008, CLIN ORAL IMPLAN RES, V19, P600, DOI 10.1111/j.1600-0501.2007.01508.x; Ogasawara R, 2013, J HARD TISSUE BIOL, V22, P461; Plosker GL, 1996, DRUGS, V51, P433; Silva MJ, 2004, J BIOMECH, V37, P1639, DOI 10.1016/j.jbiomech.2004.02.018; Tanabe K, 2013, J HARD TISSUE BIOL, V22, P451; Tanabe K, 2011, J ORAL TISSUE ENG, V8, P181; Yasuda H, 2014, J HARD TISSUE BIOL, V23, P389; Yoshida A, 2013, J HARD TISSUE BIOL, V22, P301; Yoshinari M, 2006, BIOMED RES-TOKYO, V27, P29, DOI 10.2220/biomedres.27.29	23	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					147	154				8	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600005		
J	Shahid, F; Alam, MK; Khamis, MF; Honda, Y; Sugita, Y; Maeda, H				Shahid, Fazal; Alam, Mohammad Khursheed; Khamis, Mohd Fadhli; Honda, Yuma; Sugita, Yoshihiko; Maeda, Hatsuhiko			Geomorphometrics of Tooth Size and Arch Dimension Analysis by Conventional Digital Caliper and Digital Stereomicroscope to Establish Standard Norms for the Pakistani Population	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Mesiodistal; Buccolingual; Diagonal; Geomorphometric tooth size; Dental arch dimensions; Pakistani; Digital dental models	FLUCTUATING ODONTOMETRIC ASYMMETRY; DIFFERENT MALOCCLUSION GROUPS; PLANAR PROCRUSTES ANALYSIS; SEXUAL DIMORPHISM; TURKISH DENTITION; SOUTHERN CHINESE; MIXED DENTITION; DISCREPANCIES; SHAPE; RELIABILITY	In order to establish standard norms for the Pakistani population, we investigated the geomorphometrics of tooth size and arch dimension using a conventional digital caliper (DC) and a digital stereomicroscope (SM). The sample consisted of 128 subjects ranging in age from 18 to 24 years. A total of 44,155 variables were measured. Dental models of each subject for maxillary and mandibular arches were scanned via Hirox digital stereomicroscope for the fabrication of the digital models, and the geomorphometrics of tooth size and arch dimensions were measured via SM scanned digital models. All the measurements were also carried out via DC on plaster dental models. Sex differences and changes associated with methods were assessed, and interrelationships between different variables were explored within the study group. For the data obtained by DC and SM techniques, the men had significantly larger arch dimensions and geomorphometrics of tooth size than the women did. There were no significant disparities observed between the techniques. The developed norms for the mesiodistal, buccolingual, diagonal tooth sizes and arch dimension had significantly greater values for males in relation to females (*pd '' 0.05 to *** pd '' 0.001). This study has established a new reference database of tooth size and arch dimensions via both DC and digital SM for first time on Pakistani population. These norms will be helpful for clinical treatment planning in dentistry. Contemporaneously, the norms will be of great value to forensic dentists and dental anthropologists for making comparisons within and between different populations.	[Shahid, Fazal; Alam, Mohammad Khursheed] Univ Sains Malaysia, Orthodont Unit, Sch Dent Sci, Kelantan, Malaysia; [Khamis, Mohd Fadhli] Univ Sains Malaysia, Sch Dent Sci, Forens Dent Unit, Kelantan, Malaysia; [Honda, Yuma; Sugita, Yoshihiko; Maeda, Hatsuhiko] Aichi Gakuin Univ, Sch Dent, Dept Oral Pathol, Nagoya, Aichi 464, Japan	Alam, MK (reprint author), Univ Sains Malaysia, Orthodont Unit, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia.	dralam@gmail.com			Universiti Sains Malaysia [304/PPSG/61313104]	Universiti Sains Malaysia, short-term grant 304/PPSG/61313104.	Acharya AB, 2008, J FORENSIC SCI, V53, P790, DOI 10.1111/j.1556-4029.2008.00778.x; Adnani IQ, 2011, PAK ORTHOD J, V3, P16; Akyalcin S, 2006, ANGLE ORTHOD, V76, P637; Alam MK, 2014, RES J REC SCI, V3, P85; Alam MK, 2013, INT MED J, V20, P462; Al-Khatib AR, 2011, ORTHOD CRANIOFAC RES, V14, P243, DOI 10.1111/j.1601-6343.2011.01529.x; ANDERSON DL, 1973, J DENT RES, V52, P431, DOI 10.1177/00220345730520030701; Acharya AB, 2007, FORENSIC SCI INT, V173, P47, DOI 10.1016/j.forseiint.2007.01.024; Alam MK, 2013, ACTA ODONTOL SCAND, V71, P1520, DOI 10.3109/00016357.2013.775336; Smith SS, 2000, AM J ORTHOD DENTOFAC, V117, P169, DOI 10.1016/S0889-5406(00)70228-9; Bherwani AK, 2011, AM J ORTHOD DENTOFAC, V140, P626, DOI 10.1016/j.ajodo.2011.02.024; Karaman F, 2006, J FORENSIC SCI, V51, P630, DOI 10.1111/j.1556-4029.2006.00133.x; Alam MK, 2014, ACTA ODONTOL SCAND, V72, P1047, DOI 10.3109/00016357.2014.946967; Ates Muzaffer, 2006, Legal Medicine, V8, P288, DOI 10.1016/j.legalmed.2006.06.003; CROSBY DR, 1989, AM J ORTHOD DENTOFAC, V95, P457, DOI 10.1016/0889-5406(89)90408-3; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Batool Iffat, 2008, J Ayub Med Coll Abbottabad, V20, P51; Bernal V, 2007, HOMO, V58, P279, DOI 10.1016/j.jchb.2006.11.003; Bishara SE, 1995, AM J ORTHOD DENTOFAC, V108, P607, DOI 10.1016/S0889-5406(95)70006-4; Bolton WA, 1958, ANGLE ORTHOD, V28, P113; BOLTON WA, 1962, AM J ORTHOD DENTOFAC, V48, P504, DOI 10.1016/0002-9416(62)90129-X; Doodamani Geeta Maruti, 2011, Contemp Clin Dent, V2, P176, DOI 10.4103/0976-237X.86449; DORIS JM, 1981, AM J ORTHOD DENTOFAC, V79, P326, DOI 10.1016/0002-9416(81)90080-4; Fattahi HR, 2006, EUR J ORTHODONT, V28, P491, DOI 10.1093/ejo/cjl012; GARN SM, 1967, J DENT RES, V46, P963, DOI 10.1177/00220345670460055801; GARN SM, 1966, J DENT RES, V45, P1819, DOI 10.1177/00220345660450064301; Hamid MW, 2005, PAK ORAL DENT J, V25, P47; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Iscan MY, 2003, FORENSIC SCI INT, V137, P160, DOI 10.1016/S0379-0738(03)00349-9; Kaur S, 2003, LEGAL MED, V5, P261; Khamis MF, 2014, FORENSIC SCI INT, V234; KIESER JA, 1986, ANN HUM BIOL, V13, P489, DOI 10.1080/03014468600008651; KIESER JA, 1988, J DENT RES, V67, P1200, DOI 10.1177/00220345880670091001; Lakhanpal M GN, 2013, JSM DENT, V2, P1; Lavelle C L, 1970, Dent Pract Dent Rec, V21, P121; Ling JYK, 2007, HOMO, V58, P67, DOI 10.1016/j.jchb.2006.08.003; Lund H, 1999, J Forensic Odontostomatol, V17, P30; Memon S, 2010, JCPSP-J COLL PHYSICI, V20, P533, DOI 04.2010/JCPSP.533537; Munjal S, 2010, IND J DENT SCI, V2, P15; Peluso MJ, 2004, SEMIN ORTHOD, V10, P226, DOI DOI 10.1053/J.S0D0.2004.05.007; Prabhu S, 2009, FORENSIC SCI INT, V192; Quraishi BA, 2012, J PAK DENT ASS, V21, P5; Redmond WR, 2000, AM J ORTHOD DENTOFAC, V117, P240, DOI 10.1016/S0889-5406(00)70049-7; Rehmani SN, 2012, PAK ORTHOD J, V4, P39; Robinson DL, 2002, ARCH ORAL BIOL, V47, P545, DOI 10.1016/S0003-9969(02)00038-9; Robinson DL, 2001, ARCH ORAL BIOL, V46, P191, DOI 10.1016/S0003-9969(00)00120-5; Shahid F, 2014, J HARD TISSUE BIOL, V23, P439; Sharma Rekha, 2011, Contemp Clin Dent, V2, P170, DOI 10.4103/0976-237X.86445; Singh G D, 2003, Orthod Craniofac Res, V6, P88, DOI 10.1034/j.1600-0854.2003. c245.x; Singh G D, 2002, Orthod Craniofac Res, V5, P38, DOI 10.1034/j.1600-0544.2002.01121.x; Tajik I, 2011, PAK ORAL DEN J, V31, P92; Townsend GC, 1979, OCCAS PAP HUM BIOL, V1, P17; Vandenbroucke JP, 2007, ANN INTERN MED, V47, P163; Yuen KKW, 1997, EUR J ORTHODONT, V19, P721, DOI 10.1093/ejo/19.6.721; Zelditch ML, 2012, GEOMETRIC MORPHOMETR, P437	55	3	3	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					155	168				14	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600006		
J	Kato, S; Kawai, R; Isomura, M; Sato, N; Yoshida, W; Kamiya, K; Nagaya, Y; Hattori, T; Sato, E; Sugita, Y; Kubo, K; Maeda, H				Kato, Seeta; Kawai, Ryoko; Isomura, Madoka; Sato, Nobuaki; Yoshida, Waka; Kamiya, Kei; Nagaya, Yoshitaka; Hattori, Tomofumi; Sato, Emiko; Sugita, Yoshihiko; Kubo, Katsutoshi; Maeda, Hatsuhiko			Human Papillomavirus in Oral Lichen Planus of Japanese Patients	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Oral lichen planus; Human papillomavirus; Oral potentially malignant disorder; Japanese	POTENTIALLY MALIGNANT DISORDERS; MUCOSAL LESIONS; PATHOGENESIS; LEUKOPLAKIA; POPULATION; CLASSIFICATION; EXPRESSION; CARCINOMA; GENOTYPES; RESERVOIR	Oral lichen planus (OLP) can undergo malignant transformation and become squamous cell carcinoma (SCC). Oral infection with human papillomavirus (HPV) is associated with a significant risk of developing oral cancer. Although HPV DNA is detected more often in OLP tissue than in normal oral mucosa, there is as yet no firm evidence that HPV is a causative factor of malignant transformation in OLP. The objective of the present investigation was to assess HPV-genotype distribution in OLPs of Japanese patients and additionally to clarify the relationship between malignant transformation in OLP and HPV infection using PCR, in situ hybridization, and immunohistochemistry. DNA of 200 formalin-fixed, paraffin-embedded biopsy and surgical specimens of OLP was extracted. HPV infection was first detected by PCR using consensus HPV primers. Positive PCR samples were then further analyzed by PCR using HPV type-specific primers (HPV-6, -11, -16, -18 and -33). Eighty-three samples (41.5 %) out of the total 200 OLP specimens analyzed were HPV positive. In the HPV type-specific PCR assay, the most frequent type of HPV was HPV-16 (25.5 %), which is a high-risk type of HPV that is associated with malignant disorders and is often detected in SCC. The highest HPV-16 positive rate was obtained for the erosive type of OLP (28.3 %). Positive staining for HPV DNA by in situ hybridization was observed in the nuclei of cells in all layers of the epithelium in all HPV PCR positive samples. Immunohistochemically, nuclei of cells in the upper layer of the epithelium in all HPV PCR positive samples stained positive for the anti-HPV antibody. These results indicated that HPV-16 was often present in OLP of Japanese patients, especially in the erosive type of OLP, and suggested that HPV infection is a risk factor for malignant transformation in OLP lesions.	[Kato, Seeta; Kawai, Ryoko; Isomura, Madoka; Sato, Nobuaki; Yoshida, Waka; Kamiya, Kei; Nagaya, Yoshitaka; Hattori, Tomofumi; Sato, Emiko; Sugita, Yoshihiko; Kubo, Katsutoshi; Maeda, Hatsuhiko] Aichi Gakuin Univ, Dept Oral Pathol, Sch Dent, Nagoya, Aichi 4648650, Japan; [Yoshida, Waka; Sato, Emiko; Sugita, Yoshihiko; Kubo, Katsutoshi; Maeda, Hatsuhiko] Aichi Gakuin Univ, Grad Sch Dent, Res Inst Adv Oral Sci, Nagoya, Aichi 4648650, Japan	Maeda, H (reprint author), Aichi Gakuin Univ, Dept Oral Pathol, Sch Dent, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	hatsu@dpc.agu.ac.jp					IKEDA N, 1991, COMMUNITY DENT ORAL, V19, P160, DOI 10.1111/j.1600-0528.1991.tb00133.x; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Rad M, 2009, ORAL SURG ORAL MED O, V107, P796, DOI 10.1016/j.tripleo.2009.02.020; Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x; Fitzpatrick SG, 2014, J AM DENT ASSOC, V145, P45, DOI 10.14219/jada.2013.10; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; SNIJDERS PJF, 1990, J GEN VIROL, V71, P173, DOI 10.1099/0022-1317-71-1-173; AXELL T, 1987, COMMUNITY DENT ORAL, V15, P52, DOI 10.1111/j.1600-0528.1987.tb00480.x; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Szarka K, 2009, ORAL MICROBIOL IMMUN, V24, P314, DOI 10.1111/j.1399-302X.2009.00516.x; KRUTCHKOFF DJ, 1985, ORAL SURG ORAL MED O, V60, P308, DOI 10.1016/0030-4220(85)90315-9; Roopashree MR, 2010, J ORAL PATHOL MED, V39, P729, DOI 10.1111/j.1600-0714.2010.00946.x; Mattila R, 2012, ORAL ONCOL, V48, P980, DOI 10.1016/j.oraloncology.2012.04.009; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Gorsky M, 2011, ORAL SURG ORAL MED O, V111, P461, DOI 10.1016/j.tripleo.2010.11.007; MURTI PR, 1986, J ORAL PATHOL MED, V15, P71, DOI 10.1111/j.1600-0714.1986.tb00580.x; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Acay RR, 2006, ORAL ONCOL, V42, P475, DOI 10.1016/j.oraloncology.2005.09.012; Arirachakaran P, 2013, ISRN DENT, V2013, P1; Campisi G, 2004, ORAL SURG ORAL MED O, V98, P705, DOI 10.1016/j.tripleo.2004.04.012; de Villeirs EM, 2009, J GEN VIROL, V90, P1994; Egawa K, 2003, DERMATOLOGY, V207, P251, DOI 10.1159/000073085; Eisenberg E, 2000, J ORAL MAXIL SURG, V58, P1278, DOI 10.1053/joms.2000.16629; Epstein JB, 2003, ORAL SURG ORAL MED O, V96, P32, DOI 10.1016/S1079-2104(03)00161-6; Erkhembaatar A, 2014, J HARD TISSUE BIOL, V23, P149; Giovannelli L, 2006, MOL DIAGN THER, V10, P49; Hormia M, 2005, J PERIODONTOL, V76, P358, DOI 10.1902/jop.2005.76.3.358; Howley PM, 2007, FIELDS VIROLOGY, V2, P2299; Ikeda N, 1995, Community Dent Health, V12, P133; Ismail Sumairi B, 2007, J Oral Sci, V49, P89, DOI 10.2334/josnusd.49.89; JACOBS MV, 1995, J CLIN MICROBIOL, V33, P901; Kajitani N, 2012, FRONT MICROBIOL, V3, P1; Miller CS, 1996, ORAL SURG ORAL MED O, V82, P57, DOI 10.1016/S1079-2104(96)80378-7; Nagao T, 2005, J ORAL PATHOL MED, V34, P532, DOI 10.1111/j.1600-0714.2005.00349.x; Nagao T, 2000, ORAL ONCOL, V36, P340, DOI 10.1016/S1368-8375(00)00011-7; Nagashima M, 2006, ANN REP TOKYO METR I, V57, P65; Nishimura Y, 2004, J JPN PROSTHODONT SO, V48, P713; OFlatharta Cathal, 2003, Mol Diagn, V7, P73; Ostwald C, 2003, MED MICROBIOL IMMUN, V192, P145, DOI 10.1007/s00430-002-0161-y; Pol CA, 2015, INT DENT J, V65, P11, DOI 10.1111/idj.12125; Sand L, 2000, ANTICANCER RES, V20, P183; Tomita Y., 2000, TUMOR CAUSED HUMAN P, P7; van der Meij EH, 2007, ORAL ONCOL, V43, P742, DOI 10.1016/j.oraloncology.2006.09.006; Viguier M, 2015, J INVEST DERMATOL, V135, P418, DOI 10.1038/jid.2014.397; von Krogh G, 2002, J EUR ACAD DERMATOL, V16, P130, DOI 10.1046/j.1468-3083.2002.00420.x; World Health Organization, 2007, IARC MONOGR EVAL CAR, V90, P47; World Health Organization collaborating centre for oral precancerous lesions, 1987, ORAL SURG ORAL MED O, V46, P518; Zain RB, 1997, COMMUNITY DENT ORAL, V25, P377, DOI 10.1111/j.1600-0528.1997.tb00959.x	48	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					181	188				8	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600008		
J	Monden, K; Sasaki, H; Yoshinari, M; Yajima, Y				Monden, Kazuya; Sasaki, Hodaka; Yoshinari, Masao; Yajima, Yasutomo			Effect of Low-intensity Pulsed Ultrasound (LIPUS) with Different Frequency on Bone Defect Healing	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Low-intensity pulsed ultrasound; Frequency; Bone healing; Dental implant	DISTRACTION OSTEOGENESIS; THERAPEUTIC ULTRASOUND; TOOTH EXTRACTION; FRACTURE MODEL; DELAYED UNION; IN-VITRO; CELLS; EXPRESSION; INCREASES; IMPLANTS	Low-intensity pulsed ultrasound (LIPUS) is known to promote bone defect healing. The frequency of the LIPUS is known to influence directivity and depth of penetration, but the differences on bone healing remains unknown. This study was to investigate the effect of LIPUS with different frequencies on bone defect healing. Bone defects of 1.6 mm in diameter were created in femurs of ten-week-old male Long-Evans rats (n=36). Experimetal groups were exposed LIPUS (intensity: 30 mW/cm2, burst width: 200 mu s, time: 15 min/day) and divided into a low frequency (LF, 1.5 MHz) group and a high frequency (HF, 3.0 MHz) group. Non-exposed LIPUS group were used as control. After 3, 5, 7, and 10 days, femurs were removed and radiological, histomorphological and molecular biological evaluations were conducted. Micro-CT images showed that the depression in cortical bone was reduced in LF and HF groups. 3D bone morphological analysis at 10 days revealed that LIPUS increased cortical bone volume / tissue volume (BV/TV) and decreased BV/TV in the lower layer of cancellous bone (P < 0.05). Histomorphologically, clot retraction was seen in the both LIPUS groups but not in the control group at 3 days. These effects were observed at a deeper layer in the LF group than in the HF group. No significant difference in osteopontin (OPN) gene expression was observed. However, osteocalcin (OCN) gene expression was significantly elevated in the HF group relative to the control group at 10 days (P < 0.05). Immunohistochemical staining revealed that newly formed bone exhibited a positive reaction to OPN and OCN in both LIPUS groups. Healing of the bone defect area was noted in both LIPUS groups, but there was no clear difference in histomorphology between the LF and HF groups. LIPUS frequencies of 1.5 MHz and 3.0 MHz promote increased cortical bone mass and remodeling of cancellous bone in rat femurs with bone defects.	[Monden, Kazuya; Sasaki, Hodaka; Yajima, Yasutomo] Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Chiba, Japan; [Monden, Kazuya; Sasaki, Hodaka; Yoshinari, Masao; Yajima, Yasutomo] Tokyo Dent Coll, Oral Hlth Sci Ctr, Div Oral Implants Res, Chiba, Japan	Sasaki, H (reprint author), Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo 1010061, Japan.	hosasaki@tdc.ac.jp					Jiang T, 2012, J HUAZHONG U SCI-MED, V32, P75, DOI 10.1007/s11596-012-0013-y; Sena K, 2005, ULTRASOUND MED BIOL, V31, P703, DOI 10.1016/j.ultrasmedbio.2005.01.013; Fischer K, 2012, CLIN IMPLANT DENT R, V14, P808, DOI 10.1111/j.1708-8208.2011.00389.x; Speed CA, 2001, RHEUMATOLOGY, V40, P1331, DOI 10.1093/rheumatology/40.12.1331; Wu Z, 2008, INT J ORAL MAX SURG, V37, P170, DOI 10.1016/j.ijom.2007.06.018; Rutten S, 2008, BONE, V43, P348, DOI 10.1016/j.bone.2008.04.010; Kristiansen TK, 1997, J BONE JOINT SURG AM, V79A, P961; Cook SD, 1997, CLIN ORTHOP RELAT R, P198; Renno ACM, 2012, ULTRASONICS, V52, P111, DOI 10.1016/j.ultras.2011.07.002; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26; WANG SJ, 1994, J ORTHOPAED RES, V12, P40, DOI 10.1002/jor.1100120106; Shimazaki A, 2000, J BONE JOINT SURG BR, V82B, P1077, DOI 10.1302/0301-620X.82B7.9948; El-Mowafi H, 2005, INT ORTHOP, V29, P121, DOI 10.1007/s00264-004-0625-3; Lerner A, 2004, ULTRASONICS, V42, P915, DOI 10.1016/j.ultras.2003.11.014; Fiorellini JP, 2005, J PERIODONTOL, V76, P605, DOI 10.1902/jop.2005.76.4.605; Suzuki A, 2009, ACTA BIOCH BIOPH SIN, V41, P108, DOI 10.1093/abbs/gmn012; Chan CW, 2006, J ORTHOP RES, V24, P2072, DOI 10.1002/jor.20258; Cheung WH, 2012, J ORTHOP RES, V30, P129, DOI 10.1002/jor.21487; Warden SJ, 2006, PHYS THER, V86, P1118; Angle SR, 2011, ULTRASONICS, V51, P281, DOI 10.1016/j.ultras.2010.09.004; Liu Q, 2012, BRIT J ORAL MAX SURG, V50, P244, DOI 10.1016/j.bjoms.2011.03.001; Leung KS, 2004, CLIN ORTHOP RELAT R, P253; Reher P, 1999, CYTOKINE, V11, P416, DOI 10.1006/cyto.1998.0444; Gebauer GP, 2002, J ORTHOPAED RES, V20, P587, DOI 10.1016/S0736-0266(01)00136-X; Omar OM, 2011, BIOMATERIALS, V32, P374, DOI 10.1016/j.biomaterials.2010.09.011; Dierens M, 2012, CLIN ORAL IMPLAN RES, V23, P197, DOI 10.1111/j.1600-0501.2011.02212.x; Buser D A, 1988, Int J Oral Maxillofac Implants, V3, P173; Gleizal A, 2006, ULTRASOUND MED BIOL, V32, P1569, DOI 10.1016/j.ultasmedbio.2006.05.014; Hasuike A, 2011, ORAL SURG ORAL MED O, V111, P12; Ito M, 2000, ULTRASOUND MED BIOL, V26, P161, DOI 10.1016/S0301-5629(99)00110-6; Katano M, 2011, EXP ANIM TOKYO, V60, P385; Lalani Z, 2005, J ORAL MAXIL SURG, V63, P1500, DOI 10.1016/j.joms.2005.03.032; Lavandier B, 2009, ULTRASOUND MED BIOL, V35, P585, DOI 10.1016/j.ultrasmedbio.2008.10.002; Naruse K, 2009, CONNECT TISSUE RES, V50, P55, DOI 10.1080/03008200802419855; Takebe H, 2014, CLIN ORAL IMPLAN RES, V25, P735, DOI 10.1111/clr.12136; Yoshida A, 2013, J HARD TISSUE BIOL, V22, P301	36	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					189	197				9	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600009		
J	Uryu, T; Matsumoto, N; Namaki, S; Mashimo, T; Tamagawa, T; Yasumitsu, T; Okudera, M; Komiyama, K; Chung, U; Honda, K; Arai, Y; Yonehara, Y				Uryu, Takeshi; Matsumoto, Naoyuki; Namaki, Shunsuke; Mashimo, Takayuki; Tamagawa, Takaaki; Yasumitsu, Tomohiro; Okudera, Michisato; Komiyama, Kazuo; Chung, Ung-il; Honda, Kazuya; Arai, Yoshinori; Yonehara, Yoshiyuki			Histochemical and Radiological Study of Bone Regeneration by the Combinatorial Use of Tetrapod-Shaped Artificial Bone and Collagen	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						alpha-TCP; Artificial bones; Collagen; Osteogenesis; micro-CT	MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; OCTACALCIUM PHOSPHATE; TGF-BETA; SUBSTITUTES; DEFECTS	The purpose of this study was to examine the potential application of a tetrapod-shaped artificial bone, Tetrabone (TB), along with collagen, in bone regeneration. Nine-week-old male Wistar rats (n = 60) were used. An 8 mm-diameter defect was filled with TB, collagen, or a combination mixture of TB and collagen, and left untreated in the control group. The results showed higher volumes of the newly formed bones in the combination group than in the TB group or control group at each time point by micro-CT analysis (P < 0.05). The TB group showed bone formation that extended from the existing bone. In contrast, the collagen group showed disseminated bone formation in the defect. Runx2- and TGF beta-positive cells were identified at collagen and TB surfaces. The bone formation of the combination group had characteristics of both TB and collagen groups. The combination group showed bone formation from the existing bone edge and in the entire part of the defect. Thus, the combinatorial use of TB and collagen would be an effective strategy for the treatment of bone defect.	[Uryu, Takeshi; Namaki, Shunsuke; Mashimo, Takayuki; Tamagawa, Takaaki; Yasumitsu, Tomohiro; Yonehara, Yoshiyuki] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Tokyo 1018310, Japan; [Matsumoto, Naoyuki; Okudera, Michisato; Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Pathol, Tokyo 1018310, Japan; [Chung, Ung-il] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Chung, Ung-il] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Honda, Kazuya] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Tokyo 1018310, Japan; [Arai, Yoshinori] Nihon Univ, Sch Dent, Tokyo 1018310, Japan	Uryu, T (reprint author), Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Chiyoda Ku, 1-8-1 Kanda Surugadai, Tokyo 1018310, Japan.	ddh.mirai1824@gmail.com			Dental Research Center at the Nihon University School of Dentistry; Sato Fund of Nihon University School of Dentistry; Uemura Fund of the Nihon University School of Dentistry; Dental Research Center at the Nihon University School of Dentistry for Uryu; JSPS KAKENHI [24593063]	This study was supported by a grant from the Dental Research Center at the Nihon University School of Dentistry, the Sato Fund of Nihon University School of Dentistry, the Uemura Fund of the Nihon University School of Dentistry, and by a grant from the Dental Research Center at the Nihon University School of Dentistry for Uryu. This study was also supported in part by JSPS KAKENHI Grant Number 24593063.	Elgali I, 2014, BIOMATERIALS, V35, P3229, DOI 10.1016/j.biomaterials.2013.12.084; Ueda H, 2002, BIOMATERIALS, V23, P1003, DOI 10.1016/S0142-9612(01)00211-3; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Itonaga I, 2004, BONE, V34, P57, DOI 10.1016/j.bone.2003.08.008; KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Masuda H, 1998, CELL STRESS CHAPERON, V3, P256, DOI 10.1379/1466-1268(1998)003<0256:EALOCB>2.3.CO;2; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Maeda Y, 2013, BIOMATERIALS, V34, P5530, DOI 10.1016/j.biomaterials.2013.03.089; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0180; Saijo H, 2009, J ARTIF ORGANS, V12, P200, DOI 10.1007/s10047-009-0462-7; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Choi S, 2012, ACTA BIOMATER, V8, P2340, DOI 10.1016/j.actbio.2012.02.019; Giannoudis Peter V, 2005, Injury, V36 Suppl 3, pS20, DOI 10.1016/j.injury.2005.07.029; Kamakura S, 2007, J TISSUE ENG REGEN M, V1, P450, DOI 10.1002/term.58; KATZ EP, 1973, J MOL BIOL, V80, P1, DOI 10.1016/0022-2836(73)90230-1; Kawai T, 2011, EUR CELLS MATER, V22, P124; Rodriguez RM, 2011, REVIEW, P98; Teraoka K, 2008, KEY ENG MAT, V361-363, P163; Vigier S, 2011, TISSUE ENG PT A, V17, P889, DOI [10.1089/ten.TEA.2010.0336, 10.1089/ten.tea.2010.0336]	27	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					199	209				11	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600010		
J	Kobayashi, E; Nakahara, T; Inoue, M; Shigeno, K; Tanaka, A; Nakamura, T				Kobayashi, Eizaburo; Nakahara, Taka; Inoue, Masatoshi; Shigeno, Keiji; Tanaka, Akira; Nakamura, Tatsuo			Experimental Study on In Situ Tissue Engineering of the Temporomandibular Joint Disc using Autologous Bone Marrow and Collagen Sponge Scaffold	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Temporomandibular joint disc; Regeneration; Bone marrow; Collagen sponge scaffold; Rabbits	PERIODONTAL TISSUES; STEM-CELLS; PERFORATION; RABBIT; KNEE	The temporomandibular joint (TMJ) disc plays an important role in mandibular motion. Once the TMJ disc perforates, spontaneous recovery does not occur. The aim of this study was to induce regeneration of the TMJ disc through an in situ tissue engineering method. Japanese white rabbits weighing 2.5-3.0 kg were used in this study. The TMJ was surgically exposed and a round full-thickness perforation of diameter 1.6 mm was made in the center of the disc. Animals were divided into A and B groups. In group A, a collagen sponge scaffold (1.6 mm in diameter with a height of 1.0 mm) was placed in the perforation. In group B, a collagen sponge scaffold mixed with autologous bone marrow was placed in the perforation. In both groups, a control perforation was made on the opposite side and left unfilled. The TMJ discs with surrounding tissues were collected 2, 4 and 8 weeks after surgery and were subjected to histological evaluation. In group A, after 4 weeks the size of perforation was reduced, but after 8 weeks, the perforation had still not completely closed. In group B, after 2 weeks, regeneration of the disc was seen and the site of the perforation was completely filled by new connective tissue. In the controls, after 8 weeks, the size of perforation was reduced, but it had not completely closed. The results indicate that collagen sponge scaffold with autologous bone marrow may have the potential to induce regeneration of a damaged TMJ disc.	[Kobayashi, Eizaburo; Tanaka, Akira] Nippon Dent Univ, Dept Oral & Maxillofacial Surg, Sch Life Dent Niigata, Niigata 9518580, Japan; [Kobayashi, Eizaburo; Nakahara, Taka; Inoue, Masatoshi; Shigeno, Keiji; Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto, Japan; [Nakahara, Taka] Nippon Dent Univ, Dept Dev & Regenerat Dent, Sch Life Dent Tokyo, Niigata 9518580, Japan	Kobayashi, E (reprint author), Nippon Dent Univ, Dept Oral & Maxillofacial Surg, Sch Life Dent Niigata, Chuuo Ku, 1-8 Hamaura Cho, Niigata 9518580, Japan.	eizabu@ngt.ndu.ac.jp			Japan Society for the Promotion of Science [JSPS-13358016]	The authors would like to thank the members of the Department of Bioartificial Organs, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan for their valuable help. This study was supported in part by a Grant-in-Aid for Scientific Research (A-2) from the Japan Society for the Promotion of Science (JSPS-13358016).	Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Nakahara T, 2004, TISSUE ENG, V10, P537, DOI 10.1089/107632704323061898; Muraoka R, 2011, J HARD TISSUE BIOL, V20, P301; Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634; Bakhtina A, 2014, IN VITRO CELL DEV-AN, V50, P251, DOI 10.1007/s11626-013-9702-5; BOSANQUET A, 1991, INT J ORAL MAX SURG, V20, P177, DOI 10.1016/S0901-5027(05)80012-8; HANSSON T, 1977, ACTA ODONTOL SCAND, V35, P167, DOI 10.3109/00016357709056006; HELMY E, 1988, J ORAL MAXIL SURG, V46, P979, DOI 10.1016/0278-2391(88)90335-7; LANG TC, 1993, J ORAL MAXIL SURG, V51, P1115; Liu N, 2014, CURR STEM CELL RES T, V9, P174; Mabuchi Y, 2012, INFLAMM REGEN, V32, P146; Miyamoto H, 2003, JPN J ORAL DIAG ORAL, V16, P349; Nakahara T, 2003, TISSUE ENG, V9, P153, DOI 10.1089/107632703762687636; Quarch VMA, 2014, ARCH ORTHOP TRAUM SU, V134, P657, DOI 10.1007/s00402-014-1930-y; WALLACE DW, 1986, J ORAL MAXIL SURG, V44, P965	16	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					211	217				7	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600011		
J	Sukegawa, S; Kanno, T; Kawai, H; Shibata, A; Takahashi, Y; Nagatsuka, H; Furuki, Y				Sukegawa, Shintaro; Kanno, Takahiro; Kawai, Hotaka; Shibata, Akane; Takahashi, Yuka; Nagatsuka, Hitoshi; Furuki, Yoshihiko			Long-Term Bioresorption of Bone Fixation Devices Made from Composites of Unsintered Hydroxyapatite Particles and Poly-L-Lactide	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Resorbable plate; Unsintered hydroxyapatite/poly-L-lactide composite plate; Resorption process	FORGED COMPOSITES; BIORESORBABLE DEVICES; INTERNAL-FIXATION; HA PARTICLES; FRACTURES; SCREWS; PLLA; RODS	Osteosynthetic bone fixation devices made from composites of uncalcined and unsintered hydroxyapatite (u-HA) particles and poly-L-lactide (PLLA) are widely adopted for clinical use because of their bioresorbability and osteoconductive properties. However, how the plate systems constituting these devices change during long-term use in vivo is unknown. In this study, we present cases of two patients fitted with u-HA/PLLA devices for >5 years after surgery and evaluate the resorption process on the basis of the residual versus the resorbed material. In both cases, the majority of the degraded plates and screws had been replaced by bone. In post-operative three-dimensional (3D) CT imaging, plate and screws were maintained until two years after surgery, and then they were degraded and replaced to bone in 4-6 years after surgery. Examination of the aggregation of hydroxyapatite and decrease in molecular weight suggested that the residual material was in the final stages of resorption. The plate system examined demonstrated stable degradation without foreign body reactions in vivo. Although complete resorption is a lengthy process, it is possible to follow its progress using CT.	[Sukegawa, Shintaro; Shibata, Akane; Takahashi, Yuka; Furuki, Yoshihiko] Kagawa Prefectural Cent Hosp, Div Oral & Maxillofacial Surg, Takamatsu, Kagawa 7608557, Japan; [Kanno, Takahiro] Shimane Univ, Dept Oral & Maxillofacial Surg, Fac Med, Matsue, Shimane, Japan; [Kawai, Hotaka; Nagatsuka, Hitoshi] Okayama Univ, Dept Oral Med & Pathol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Sukegawa, S (reprint author), Kagawa Prefectural Cent Hosp, Div Oral & Maxillofacial Surg, 1-2-1 Asahi Cho, Takamatsu, Kagawa 7608557, Japan.	gouwan19@gmail.com					BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D; Bostman OM, 2000, CLIN ORTHOP RELAT R, P216; Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X; Pohjonen T, 1997, J MATER SCI-MATER M, V8, P311, DOI 10.1023/A:1018516529591; Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2; Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016; Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003; Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5; Chang YS, 1996, J BIOMED MATER RES, V30, P117, DOI 10.1002/(SICI)1097-4636(199601)30:1<117::AID-JBM15>3.0.CO;2-L; Hayashi M, 2013, J CRANIO MAXILL SURG, V41, P783, DOI 10.1016/j.jcms.2013.01.026; MATSUSUE Y, 1991, J APPL BIOMATER, V2, P1, DOI 10.1002/jab.770020102; Matsusue Y, 1999, JPN J ORTHOP SURG, V50, P1405; Matsusue Y, 1997, J LONG-TERM EFF MED, V7, P119; Turvey TA, 2011, INT J ORAL MAX SURG, V40, P244, DOI 10.1016/j.ijom.2010.11.024	14	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					219	224				6	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600012		
J	Purmal, K; Alam, MK; Pohchi, A; Razak, NHA; Muraoka, R; Shoumura, M; Osuga, N				Purmal, Kathiravan; Alam, Mohammad Khursheed; Pohchi, Abdullah; Razak, Noor Hayati Abdul; Muraoka, Rina; Shoumura, Masahito; Osuga, Naoto			3D Measurement of Maxillary Sinus Height for Multidisciplinary Benefit	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						3D; CBCT; Maxillary sinus; Malay	FLOOR	The normal position of maxillary sinus is imperative in the field of oral surgery, endodontics and orthodontics. In oral surgery, intermaxillary fixation (IMF) screws need to be positioned away from the maxillary sinus. The apices of the posterior maxillary teeth lie in close proximity to the sinus. This study aimed to correlate the position of the maxillary sinus to the alveolar crest as imaged by Cone Beam Computerized Tomography (CBCT) in a relatively larger sample of a particular race (Malaysian Malay). The CBCT volumetric data of 98 patients was used. Malay patients who had a complete set of dentition except third molars were selected for this study. A straight line was drawn from the alveolar crest to the sinus floor. The relationship between the maxillary sinus and the alveolar crest was evaluated by using the images from the sagittal view. The paired t test was used to compare the differences in the right and left quadrants. Sinus height between 2nd and 1st molar and 1st molar and 2nd molar shows significant difference (P<0.05) when compared between right and left quadrants. The 3D sinus height knowledge is imperative for multidiscipline purpose.	[Purmal, Kathiravan; Pohchi, Abdullah; Razak, Noor Hayati Abdul] Univ Sains Malaysia, Sch Dent Sci, Dept Oral & Maxillofacial Surg, Kelantan, Malaysia; [Alam, Mohammad Khursheed] Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kelantan, Malaysia; [Muraoka, Rina] Matsumoto Dent Univ, Sch Dent, Dept Orthodont, Shiojiri, Japan; [Shoumura, Masahito; Osuga, Naoto] Matsumoto Dent Univ, Sch Dent, Dept Pediat Denristry, Shiojiri, Japan	Alam, MK (reprint author), Univ Sains Malaysia, Orthodont Unit, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia.	dralam@gmail.com					EBERHARDT JA, 1992, ORAL SURG ORAL MED O, V73, P345, DOI 10.1016/0030-4220(92)90133-B; ARIJI Y, 1994, DENTOMAXILLOFAC RAD, V23, P163; Kwak HH, 2004, INT J ORAL MAX SURG, V33, P382, DOI 10.1016/j.ijom.2003.10.012; Uchida Y, 1998, J ORAL MAXIL SURG, V56, P1158, DOI 10.1016/S0278-2391(98)90761-3; Cohen S, 1987, PATHWAYS PULP; Purmal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084202; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297	7	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	APR	2015	24	2					225	227				3	Engineering, Biomedical	Engineering	CG2ZV	WOS:000353146600013		
J	Olsson, J; Berg, P; Kawamura, A				Olsson, Jonas; Berg, Peter; Kawamura, Akira			Impact of RCM Spatial Resolution on the Reproduction of Local, Subdaily Precipitation	JOURNAL OF HYDROMETEOROLOGY			English	Article						Precipitation; Climate models	CLIMATE MODEL SIMULATIONS; HYDROLOGICAL IMPACT; PART I; PERFORMANCE; EUROPE; SWEDEN	Many hydrological hazards are closely connected to local precipitation (extremes), especially in small and urban catchments. The use of regional climate model (RCM) data for small-scale hydrological climate change impact assessment has long been nearly unfeasible because of the low spatial resolution. The RCM resolution is, however, rapidly increasing, approaching the size of small catchments and thus potentially increasing the applicability of RCM data for this purpose. The objective of this study is to explore to what degree subhourly temporal precipitation statistics in an RCM converge to observed point statistics when gradually increasing the resolution from 50 to 6 km. This study uses precipitation simulated by RCA3 at seven locations in southern Sweden during 1995-2008. A positive impact of higher resolution was most clearly manifested in 10-yr intensity-duration-frequency (IDF) curves. At 50 km the intensities are underestimated by 50%-90%, but at 6 km they are nearly unbiased, when averaged over all locations and durations. Thus, at 6 km, RCA3 apparently generates low-frequency subdaily extremes that resemble the values found in point observations. Also, the reproduction of short-term variability and less extreme maxima were overall improved with increasing resolution. For monthly totals, a slightly increased overestimation with increasing resolution was found. The bias in terms of wet fraction and wet spell characteristics was overall not strongly dependent on resolution. These metrics are, however, influenced by the cutoff threshold used to separate between wet and dry time steps as well as the wet spell definition.	[Olsson, Jonas; Berg, Peter] Swedish Meteorol & Hydrol Inst, Res & Dev Hydrol, S-60176 Norrkoping, Sweden; [Kawamura, Akira] Tokyo Metropolitan Univ, Dept Civil & Environm Engn, Tokyo 158, Japan	Olsson, J (reprint author), Swedish Meteorol & Hydrol Inst, Res & Dev Hydrol, Folkborgsvagen 17, S-60176 Norrkoping, Sweden.	jonas.olsson@smhi.se			Swedish Research Council Formas, through the HYDROIMPACTS2.0 project; Foundation for Strategic Environmental Research (MISTRA), through the Mistra-SWECIA project; Tokyo Metropolitan University (TMU); Japan Society for the Promotion of Science (JSPS); Scandinavia-Japan Sasakawa Foundation	The study was mainly funded by the Swedish Research Council Formas, through the HYDROIMPACTS2.0 project, and the Foundation for Strategic Environmental Research (MISTRA), through the Mistra-SWECIA project. Additional funding from Tokyo Metropolitan University (TMU), Japan Society for the Promotion of Science (JSPS), and the Scandinavia-Japan Sasakawa Foundation allowed Jonas Olsson to perform complementary work during visits at TMU. Warm thanks are extended to Grigory Nikulin, Kean Foster, and Lennart Simonsson for help with data extraction and processing. Comments from three anonymous reviewers helped improve the original manuscript.	Allen RJ, 2005, J HYDROL ENG, V10, P327, DOI 10.1061/(ASCE)1084-0699(2005)10:4(327); Willems P, 2011, J HYDROL, V402, P193, DOI 10.1016/j.jhydrol.2011.02.030; Berg P, 2013, NAT GEOSCI, V6, P181, DOI 10.1038/ngeo1731; Mishra V, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050658; Haerter JO, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013384; Johansson B, 2003, INT J CLIMATOL, V23, P1523, DOI 10.1002/joc.951; Haylock MR, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010201; Samuelsson P, 2011, TELLUS A, V63, P4, DOI 10.1111/j.1600-0870.2010.00478.x; Chan SC, 2013, CLIM DYNAM, V41, P1475, DOI 10.1007/s00382-012-1568-9; Hofstra N, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011799; Trenberth KE, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; RESTREPOPOSADA PJ, 1982, J HYDROL, V55, P303, DOI 10.1016/0022-1694(82)90136-6; Kjellstrom E, 2011, TELLUS A, V63, P24, DOI 10.1111/j.1600-0870.2010.00475.x; Prein AF, 2013, CLIM DYNAM, V41, P2655, DOI 10.1007/s00382-013-1744-6; Dai A, 2001, J CLIMATE, V14, P1092, DOI 10.1175/1520-0442(2001)014<1092:GPATFP>2.0.CO;2; Kendon EJ, 2012, J CLIMATE, V25, P5791, DOI 10.1175/JCLI-D-11-00562.1; Berg P, 2013, CLIM DYNAM, V40, P401, DOI 10.1007/s00382-012-1508-8; Olsson J, 2009, ATMOS RES, V92, P364, DOI 10.1016/j.atmosres.2009.01.015; Barring L, 2006, CLIMATE RES, V31, P35, DOI 10.3354/cr031035; Heinrich G, 2012, INT J CLIMATOL, V32, P1951, DOI 10.1002/joc.2421; Hernebring C, 2006, DESIGN STORMS SWEDEN; Johannessen T. W, 1970, WORLD SURV CLIMATOL, V5, P23; Johansson B, 2000, NORD HYDROL, V31, P207; Jones CG, 2004, AMBIO, V33, P199, DOI 10.1639/0044-7447(2004)033[0199:TRCRAC]2.0.CO;2; Kain JS, 1993, METEOROL MONOGR, V46, P165; Kjellstrom E., 2005, REPORTS METEOROLOGY, P54; Maidment D. R., 1993, HDB HYDROLOGY; Olsson J., 2013, 6 SMHI; Olsson J, 2014, URBAN WATER J, V11, P605, DOI 10.1080/1573062X.2013.847465; Tripathi OP, 2013, J GEOPHYS RES-ATMOS, V118, P7591, DOI 10.1002/jgrd.50590; van Roosmalen L, 2010, J HYDROL, V380, P406, DOI 10.1016/j.jhydrol.2009.11.014; Walther A, 2013, ATMOS RES, V119, P131, DOI 10.1016/j.atmosres.2011.10.012; Wern L., 2009, 1392009 SMHI; Willems P, 2012, IMPACTS OF CLIMATE CHANGE ON RAINFALL EXTREMES AND URBAN DRAINAGE SYSTEMS, P1; WMO, 1981, WMO PUBL, V560	35	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	1525-755X	1525-7541		J HYDROMETEOROL	J. Hydrometeorol.	APR	2015	16	2					534	547		10.1175/JHM-D-14-0007.1		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CF7KM	WOS:000352735100005		
J	Ohba, M; Kadokura, S; Yoshida, Y; Nohara, D; Toyoda, Y				Ohba, Masamichi; Kadokura, Shinji; Yoshida, Yoshikatsu; Nohara, Daisuke; Toyoda, Yasushi			Anomalous Weather Patterns in Relation to Heavy Precipitation Events in Japan during the Baiu Season	JOURNAL OF HYDROMETEOROLOGY			English	Article						ENSO; Rainfall; Classification; Neural networks; Pattern detection	SELF-ORGANIZING MAPS; ASIAN SUMMER MONSOON; WESTERN NORTH PACIFIC; INDIAN-OCEAN; EL-NINO; EXTREME PRECIPITATION; INCREASING TREND; ENSO; RAINFALL; CLIMATE	Anomalous weather patterns (WPs) in relation to heavy precipitation events during the baiu season in Japan are investigated using a nonlinear classification technique known as the self-organizing map (SOM). The analysis is performed on daily time scales using the Japanese 55-year Reanalysis Project (JRA-55) to determine the role of circulation and atmospheric moisture on extreme events and to investigate interannual and interdecadal variations for possible linkages with global-scale climate variability. SOM is simultaneously employed on four atmospheric variables over East Asia that are related to baiu front variability, whereby anomalous WPs that dominated during the 1958-2011 period are obtained. Our analysis extracts seven typical WPs, which are linked to frequent occurrences of heavy precipitation events. Each WP is associated with regional variations in the probability of extreme precipitation events. On interannual time scales, El Nino-Southern Oscillation (ENSO) affects the frequency of the WPs in relation to the heavy rainfall events. The warm phase of ENSO results in an increased frequency of a WP that provides a southwesterly intrusion of high equivalent potential temperature at low levels, while the cold phase provides southeastern intrusion. In addition, the results of this analysis suggest that interdecadal variability of frequency for heavy rainfall events corresponds to changes in frequency distributions of WPs and are not due to one particular WP.	[Ohba, Masamichi; Kadokura, Shinji; Yoshida, Yoshikatsu; Nohara, Daisuke; Toyoda, Yasushi] Cent Res Inst Elect Power Ind, Abiko, Chiba 2701194, Japan	Ohba, M (reprint author), Cent Res Inst Elect Power Ind, Environm Sci Res Lab, 1646 Abiko, Abiko, Chiba 2701194, Japan.	oba-m@criepi.denken.or.jp					Hewitson BC, 2002, CLIMATE RES, V22, P13, DOI 10.3354/cr022013; Nishiyama K, 2007, ATMOS RES, V83, P185, DOI 10.1016/j.atmosres.2005.10.015; Johnson NC, 2008, J CLIMATE, V21, P6354, DOI 10.1175/2008JCLI2380.1; CHEN TJG, 1980, MON WEATHER REV, V108, P942, DOI 10.1175/1520-0493(1980)108<0942:TSAVBO>2.0.CO;2; Richardson AJ, 2003, PROG OCEANOGR, V59, P223, DOI 10.1016/j.pocean.2003.07.006; Polo I, 2011, J CLIMATE, V24, P3423, DOI 10.1175/2011JCLI3622.1; Ninomiya K, 2000, J METEOROL SOC JPN, V78, P141; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; Liu YG, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003117; Wu RG, 2003, J CLIMATE, V16, P3742, DOI 10.1175/1520-0442(2003)016<3742:EOERAI>2.0.CO;2; Wang B, 2000, J CLIMATE, V13, P1517, DOI 10.1175/1520-0442(2000)013<1517:PEATHD>2.0.CO;2; Cassano JJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000332; NINOMIYA K, 1984, J METEOROL SOC JPN, V62, P880; Garavaglia F, 2010, HYDROL EARTH SYST SC, V14, P951, DOI 10.5194/hess-14-951-2010; Klein SA, 1999, J CLIMATE, V12, P917, DOI 10.1175/1520-0442(1999)012<0917:RSSTVD>2.0.CO;2; Du Y, 2011, J CLIMATE, V24, P315, DOI 10.1175/2010JCLI3890.1; KIMOTO M, 1993, J ATMOS SCI, V50, P2645, DOI 10.1175/1520-0469(1993)050<2645:MFRITN>2.0.CO;2; Johnson NC, 2013, J CLIMATE, V26, P4816, DOI 10.1175/JCLI-D-12-00649.1; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Goswami BN, 2006, SCIENCE, V314, P1442, DOI 10.1126/science.1132027; Xie SP, 2009, J CLIMATE, V22, P730, DOI 10.1175/2008JCLI2544.1; Gong DY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014523; Chattopadhyay R, 2008, J ATMOS SCI, V65, P1549, DOI 10.1175/2007JAS2474.1; Reusch DB, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007460; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Sampe T, 2010, J CLIMATE, V23, P113, DOI 10.1175/2009JCLI3128.1; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Kosaka Y, 2013, P NATL ACAD SCI USA, V110, P7574, DOI 10.1073/pnas.1215582110; Fujibe F, 2005, SOLA, V1, P41, DOI 10.2151/sola.2005.012; Ohba M, 2009, J CLIMATE, V22, P177, DOI 10.1175/2008JCLI2334.1; Leloup JA, 2007, CLIM DYNAM, V28, P147, DOI 10.1007/s00382-006-0173-1; Chu JE, 2012, J CLIMATE, V25, P6975, DOI 10.1175/JCLI-D-11-00512.1; Casola JH, 2007, J APPL METEOROL CLIM, V46, P1619, DOI 10.1175/JAM2564.1; Johnson NC, 2010, J CLIMATE, V23, P851, DOI 10.1175/2009JCLI3099.1; Chang CP, 2000, J CLIMATE, V13, P4310, DOI 10.1175/1520-0442(2000)013<4310:IAIVOT>2.0.CO;2; Ohba M, 2006, SOLA, V2, P176, DOI 10.2151/sola.2006-045; Cavazos T, 1999, J CLIMATE, V12, P1506, DOI 10.1175/1520-0442(1999)012<1506:LSCACT>2.0.CO;2; KODAMA Y, 1992, J METEOROL SOC JPN, V70, P813; Emori S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023272; Brigode P, 2013, HYDROL EARTH SYST SC, V17, P1455, DOI 10.5194/hess-17-1455-2013; Cavazos T, 2002, J CLIMATE, V15, P2477, DOI 10.1175/1520-0442(2002)015<2477:IVAWWM>2.0.CO;2; Fujibe F, 2006, J METEOROL SOC JPN, V84, P311, DOI 10.2151/jmsj.84.311; Garavaglia F, 2011, HYDROL EARTH SYST SC, V15, P519, DOI 10.5194/hess-15-519-2011; Iseri Y., 2009, MEM FAC ENG KYUSHU U, V69, P37; Kamiguchi Kenji, 2010, Hydrological Research Letters, V4, DOI 10.3178/HRL.4.60; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kolczynski WC, 2014, MON WEATHER REV, V142, P1688, DOI 10.1175/MWR-D-13-00189.1; Nakazawa T, 2007, J METEOROL SOC JPN, V85, P101, DOI 10.2151/jmsj.85.101; Ninomiya K, 2007, J METEOROL SOC JPN, V85B, P103, DOI 10.2151/jmsj.85B.103; Ohba M, 2005, SOLA, V1, P89, DOI 10.2151/sola.2005.024; Ohba M, 2013, INT J CLIMATOL, V33, P1495, DOI 10.1002/joc.3529; Radic V, 2011, J CLIMATE, V24, P5257, DOI 10.1175/JCLI-D-11-00011.1; Singh D, 2014, B AM METEOROL SOC, V95, pS58; Sugimoto N, 2008, SOLA, V4, P41, DOI 10.2151/sola.2008-011; Tozuka T, 2008, CLIM DYNAM, V31, P333, DOI 10.1007/s00382-007-0356-4; WANG B, 1992, J ATMOS SCI, V49, P698, DOI 10.1175/1520-0469(1992)049<0698:TVSADO>2.0.CO;2; Wang B, 2001, J CLIMATE, V14, P4073, DOI 10.1175/1520-0442(2001)014<4073:IVOTAS>2.0.CO;2; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yamaura T, 2012, J METEOROL SOC JPN, V90, P449, DOI 10.2151/jmsj.2012-402; Yonekura E, 2014, J APPL METEOROL CLIM, V53, P406, DOI 10.1175/JAMC-D-12-0240.1; Yoshikane T, 2001, J METEOROL SOC JPN, V79, P671, DOI 10.2151/jmsj.79.671	62	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	1525-755X	1525-7541		J HYDROMETEOROL	J. Hydrometeorol.	APR	2015	16	2					688	701		10.1175/JHM-D-14-0124.1		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CF7KM	WOS:000352735100014		
J	Nijibayashi, K				Nijibayashi, Kei			Dorothea Brooke's Political Economy: Romanticism and the Influence of John Ruskin on George Eliot's Middlemarch	JOURNAL OF LANGUAGE LITERATURE AND CULTURE			English	Article						John Ruskin; George Eliot; Middlemarch; Unto This Last; Munera Pulveris; Romanticism; political economy		John Ruskin's influence on George Eliot, especially on her ideas about political economy, has attracted relatively little critical attention. This article offers a reading of Middlemarch which seeks to demonstrate that the thoughts of the novel's heroine, Dorothea Brooke, echo various ideas Ruskin put forward in his socio-political writings, including Unto This Last and Munera Pulveris. It goes on to suggest that, as characters, Dorothea Brooke and Will Ladislaw can be viewed as representatives of Eliot's idealism. Stressing the similarity between their ideas and Ruskin's, it further explores how Dorothea endeavours to put her idealist concepts into practice. The article argues that Eliot, who is often described as a realist, drew on the ideas of Ruskin and a larger tradition of Romantic idealism, with Ruskin's influence helping to account for the distinctiveness of George Eliot's work and the unique position she came to occupy among Victorian novelists.	Kyushu Inst Technol, English, Kitakyushu, Fukuoka, Japan	Nijibayashi, K (reprint author), Kyushu Inst Technol, English, Kitakyushu, Fukuoka, Japan.						[Anonymous], 1961, NINETEENTH CENTURY F, V16, P17; [Anonymous], 1870, COMMUNICATION; [Anonymous], 1998, VICTORIAN LITERATURE, V26, P273; [Anonymous], 1835, JOURNAL OF A TOUR TH; Bodenheimer Rosemarie, 1994, THE REAL LIFE OF MAR, P67; Bradley J. L., 1984, THE CRITICAL HERITAG, P274; Carroll David, 1986, MIDDLEMARCH; Cook E. T., 1903, THEWORKS OF JOHN RUS; Dorothea Ladislaw, 1980, THE ROMANTIC IMPULSE; Eliot George, 1990, SELECTED ESSAYS POEM, P368; Eliot George, 1954, THE GEORGE ELIOT LET, V2, P422; Hardy Barbara, 1959, THE NOVELS OF GEORGE; Harvey W. J., 1963, THE ART OF GEORGE EL, P147; Langland Elizabeth, 1994, NARRATIVE, VNarrative 2, P87; Leavis F, 1948, GREAT TRADITION; Leavis F. R., 1972, GEORGE ELIOT; Newton K. M., 1981, GEORGE ELIOT ROMANTI; Shelley Percy Bysshe, 1977, SHELLEYS POETRY PROS, P487; Swinden Patrick, 1972, GEORGE ELIOT; Swinden Patrick, 1972, GEORGE ELIOT MIDDLEM, P82	20	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	2051-2856	2051-2864		J LANG LIT CULT	J. Lang. Lit. Cult.	APR	2015	62	1					19	31		10.1179/2051285615Z.00000000047		13	Language & Linguistics; Literature	Linguistics; Literature	CF9LT	WOS:000352886900002		
J	Toyoda, M; Kogiso, N				Toyoda, Masahiro; Kogiso, Nozomu			Robust multiobjective optimization method using satisficing trade-off method	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Multiobjective optimization; Robust design; Satisficing trade-off method; Uncertainty	DESIGN	This study proposes a robust multiobjective optimization approach using the satisficing tradeoff method (STOM). STOM is a multiobjective optimization method that obtains a highly accurate single Pareto solution. Conventionally, a robust design is formulated as a single-objective optimization problem, where the objective function is defined as the weighted sum of the mean and standard deviation of the performance index. In this study, the mean and standard deviation are formulated as individual objective function. The effect of uncertainty can be investigated through Pareto surface. In STOM, the multiobjective optimization problem is transformed into the equivalent single objective problem by introducing an aspiration level. As the obtained single Pareto solution corresponds to the aspiration level that implies the ratio of the designer's desired objective function, the designer can investigate only the desired space in detail through setting the aspiration without obtaining full Pareto surfaces. The validity of using STOM for a robust multiobjective optimization problem is discussed using numerical examples.	[Toyoda, Masahiro; Kogiso, Nozomu] Osaka Prefecture Univ, Dept Aerosp Engn, Sakai, Osaka 5998531, Japan	Kogiso, N (reprint author), Osaka Prefecture Univ, Dept Aerosp Engn, Sakai, Osaka 5998531, Japan.	kogiso@aero.osakafu-u.ac.jp			JSPS KAKENHI [26249131]	Part of this research was supported by JSPS KAKENHI 26249131. The authors wish to express their appreciation to Prof. S. Kitayama at Kanazawa University for his valuable comments on this research.	Ang A. H-S, 1975, PROBABILISTIC CONCEP, V1; Park GJ, 2006, AIAA J, V44, P181, DOI 10.2514/1.13639; Beyer HG, 2007, COMPUT METHOD APPL M, V196, P3190, DOI 10.1016/j.cma.2007.03.003; Chen W, 1999, J MECH DESIGN, V121, P179, DOI 10.1115/1.2829440; Haftka RT, 1992, ELEMENTS STRUCTURAL; Kitayama S, 2012, APPL SOFT COMPUT, V12, P1959, DOI 10.1016/j.asoc.2012.03.024; Mittinen K. M., 2004, NONLINEAR MULTIOBJEC; NAKAYAMA H, 1992, EUR J OPER RES, V60, P87, DOI 10.1016/0377-2217(92)90336-8; NAKAYAMA H, 1984, LECT NOTES ECON MATH, V229, P113; Nakayama H, 1995, EUR J OPER RES, V87, P731, DOI 10.1016/0377-2217(95)00241-3	10	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	APR	2015	29	4					1361	1367		10.1007/s12206-015-0305-9		7	Engineering, Mechanical	Engineering	CF6SD	WOS:000352685600005		
J	Liu, Y; Shimoda, M; Shibutani, Y				Liu, Yang; Shimoda, Masatoshi; Shibutani, Yoji			Parameter-free method for the shape optimization of stiffeners on thin-walled structures to minimize stress concentration	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						H-1 gradient method; Kreisselmeier-Steinhauser function; Min-max problem; Parameter-free method; Shape optimization; Stiffener; Stress concentration; Thin-walled structure; von Mises stress	DESIGN	This paper presents a parameter-free shape optimization method for the strength design of stiffeners on thin-walled structures. The maximum von Mises stress is minimized and subjected to the volume constraint. The optimum design problem is formulated as a distributed- parameter shape optimization problem under the assumptions that a stiffener is varied in the in-plane direction and that the thickness is constant. The issue of nondifferentiability, which is inherent in this min-max problem, is avoided by transforming the local measure to a smooth differentiable integral functional by using the Kreisselmeier-Steinhauser function. The shape gradient functions are derived by using the material derivative method and adjoint variable method and are applied to the H-1 gradient method for shells to determine the optimal free-boundary shapes. By using this method, the smooth optimal stiffener shape can be obtained without any shape design parameterization while minimizing the maximum stress. The validity of this method is verified through two practical design examples.	[Liu, Yang; Shibutani, Yoji] Osaka Univ, Dept Mech Engn, Suita, Osaka 5670047, Japan; [Shimoda, Masatoshi] Toyota Technol Inst, Dept Adv Sci & Technol, Toyota 4688511, Japan	Liu, Y (reprint author), Osaka Univ, Dept Mech Engn, Suita, Osaka 5670047, Japan.	liuyang60212@gmail.com					Shimoda M, 2014, STRUCT MULTIDISCIP O, V50, P409, DOI 10.1007/s00158-014-1059-1; BRAIBANT V, 1984, COMPUT METHOD APPL M, V44, P247, DOI 10.1016/0045-7825(84)90132-4; Ding X, 2004, STRUCT MULTIDISCIP O, V26, P99, DOI 10.1007/s00158-003-0309-4; Azegami H, 1994, T JPN SOC MECH ENG A, V60, P1479; AZEGAMI H, 1997, COMPUTER AIDED OPTIM, V5, P309; Bletzinger K.-U., 2014, STRUCT MULTIDISCIP O, P1; Chen BS, 2008, STRUCT MULTIDISCIP O, V36, P83, DOI 10.1007/s00158-007-0174-7; Kreisselmeier G., 1979, P IFAC S COMP AID DE, P113; Liu Y., 2013, T JSME A, V79, P1340; Liu Y, 2014, STRUCT MULTIDISCIP O, V49, P39, DOI 10.1007/s00158-013-0954-1; Liu Y, 2015, INVERSE PROBL SCI EN, V23, P1, DOI 10.1080/17415977.2013.793322; Shimoda M., 2007, SAE J PASSENGER CARS, P483; Uysal M., 2007, ENG STRUCT, V29, P80	13	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	APR	2015	29	4					1383	1390		10.1007/s12206-015-0308-6		8	Engineering, Mechanical	Engineering	CF6SD	WOS:000352685600008		
J	Wan, XL; Urakubo, T; Tada, Y				Wan, Xianglong; Urakubo, Takateru; Tada, Yukio			Optimization of jumping motion of a legged robot for different take-off postures	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Singular configuration; Motion planning; Numerical optimization; Take-off posture		This paper deals with an optimal jumping motion of a four-link legged robot that minimizes the necessary joint torques during the motion. A fixed amount of translational energy is supplied to the robot from joint torques by the take-off time when the foot leaves the ground, and the rotations of joints are stopped in the air by the time when the robot reaches the maximum height with the joints fully extended. Numerical optimization results for different take-off postures show that the take-off posture that is close to a singular configuration has an advantage in supplying translational energy efficiently in ground phase, and is also useful for reducing the rotational energy that has to be eliminated in aerial phase.	[Wan, Xianglong; Urakubo, Takateru; Tada, Yukio] Kobe Univ, Grad Sch Syst Informat, Dept Syst Sci, Kobe, Hyogo 6578501, Japan	Wan, XL (reprint author), Kobe Univ, Grad Sch Syst Informat, Dept Syst Sci, Kobe, Hyogo 6578501, Japan.	man@opt.cs.kobe-u.ac.jp			KAKENHI [23760230]	This work was supported by KAKENHI (23760230, Grant-in-Aid for Young Scientists (B)).	Xu ZH, 2008, J BRAZ SOC MECH SCI, V30, P327, DOI 10.1590/S1678-58782008000400009; Arikawa K, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P3992; HUDSON JL, 1986, MED SCI SPORT EXER, V18, P242; KUMAR V, 1990, IEEE T ROBOTIC AUTOM, V6, P269, DOI 10.1109/70.54745; Park JH, 2011, J MECH SCI TECHNOL, V25, P3231, DOI 10.1007/s12206-011-0918-6; Urakubo T, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P1446, DOI 10.1109/IROS.2009.5354076; Urakubo T, 2010, IEEE INT C INT ROBOT, P1372; Wan X., 2013, P RVSP, P259; Wan X., 2012, P CJK OSM7, V7, pC097	9	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	APR	2015	29	4					1391	1397		10.1007/s12206-015-0309-5		7	Engineering, Mechanical	Engineering	CF6SD	WOS:000352685600009		
J	Ariyarit, A; Kanazaki, M				Ariyarit, Atthaphon; Kanazaki, Masahiro			Multi-modal distribution crossover method based on two crossing segments bounded by selected parents applied to multi-objective design optimization	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Multi-objective optimization; Real-coded genetic algorithm; Crossover method; Airfoil design		This paper discusses airfoil design optimization using a genetic algorithm (GA) with multi-modal distribution crossover (MMDX). The proposed crossover method creates four segments from four parents, of which two segments are bounded by selected parents and two segments are bounded by one parent and another segment. After these segments are defined, four offsprings are generated. This study applied the proposed optimization to a real-world, multi-objective airfoil design problem using class-shape function transformation parameterization, which is an airfoil representation that uses polynomial function, to investigate the effectiveness of this algorithm. The results are compared with the results of the blend crossover (BLX) and unimodal normal distribution crossover (UNDX) algorithms. The objective of these airfoil design problems is to successfully find the optimal design. The outcome of using this algorithm is superior to that of the BLX and UNDX crossover methods because the proposed method can maintain higher diversity than the BLX and UNDX methods. This advantage is desirable for real-world problems.	[Ariyarit, Atthaphon; Kanazaki, Masahiro] Tokyo Metropolitan Univ, Grad Sch Syst Design, Dept Aerosp Engn, Hino, Tokyo 1910065, Japan	Ariyarit, A (reprint author), Tokyo Metropolitan Univ, Grad Sch Syst Design, Dept Aerosp Engn, 6-6 Asahigaoka, Hino, Tokyo 1910065, Japan.	ariyarit-atthaphon@ed.tmu.ac.jp			Asian Human Resources Fund of the Tokyo Metropolitan Government	This work is supported by the Asian Human Resources Fund of the Tokyo Metropolitan Government, which supports Tokyo Metropolitan University.	Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; DRELA M, 1987, AIAA J, V25, P1347, DOI 10.2514/3.9789; [Anonymous], 1993, FDN GENETIC ALGORITH; Ariyairt A., 2014, 6 DOM M JAP SOC EV C, P126; Drela M., 2001, XFOIL 6 9 USER PRIME; Hijime K., 2002, T SOC INSTRUMENT CON, V2, P187; Kobayashi K., 2007, FRONTIERS SCI SERIES, V49, P401; Kulfan B.M., 2006, 11 AIAA ISSMO MULT A; Shigeyoshi T., 1999, P 1999 GEN EV COMP C, P657; Zitzler E., 1999, THESIS SWISS FEDERAL	10	1	1	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	APR	2015	29	4					1443	1448		10.1007/s12206-015-0316-6		6	Engineering, Mechanical	Engineering	CF6SD	WOS:000352685600016		
J	Tanaka, N; Honma, T; Yokosuka, Y				Tanaka, Natsuki; Honma, Toshio; Yokosuka, Yohei			Structural shape optimization of free-form surface shell and property of solution search using firefly algorithm	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Computational parameters; Firefly algorithm; Local search; Global optimal solution and local optimal solutions; Single-objective optimization		The computation procedure for structural shape optimization is based on the heuristic optimization procedures, such as swarm intelligence (SI), that use patterns found in self-organizing phenomena observed in nature. Most SI techniques including particle swarm optimization (PSO) and artificial bee colony (ABC), attain a global optimal solution. The firefly algorithm (FA) can attain both a global optimal and local optimal solutions by setting suitable computational parameters. However, the method for setting these parameters is comparatively difficult. In order to simplify the setting of these parameters, we implement a computational scheme where the distance between two fireflies in the design variable space is dimensionless. The effectiveness and the validity of this FA are clarified by showing the diversified solution for a global optimal solution and local optimal solutions using a local search in the structural shape optimization of a free-form surface shell.	[Tanaka, Natsuki; Honma, Toshio; Yokosuka, Yohei] Kagoshima Univ, Dept Architecture & Architectural Engn, Kagoshima 8900065, Japan	Honma, T (reprint author), Kagoshima Univ, Dept Architecture & Architectural Engn, Kagoshima 8900065, Japan.	honma@aae.kagoshima-u.ac.jp					Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Russell S. J., 2002, ARTIF INTELL, P111; Tanaka N., 2013, P INT ASS SHELL SPAT, P1; Zienkiewicz O.C., 2000, FINITE ELEMENT METHO, V2	7	1	1	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	APR	2015	29	4					1449	1455		10.1007/s12206-015-0317-5		7	Engineering, Mechanical	Engineering	CF6SD	WOS:000352685600017		
J	Yamakawa, M; Nihei, M; Tatibana, M; Hukazawa, K; Ohsaki, M; Nakamura, T; Yamanouchi, H				Yamakawa, Makoto; Nihei, Mitsuki; Tatibana, Masahiko; Hukazawa, Kyouzou; Ohsaki, Makoto; Nakamura, Takuzo; Yamanouchi, Hiroyuki			Modeling and simulation of spring steel damper based on parameter identification with a heuristic optimization approach	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Elasto-plastic damper; Hysteresis model; Non-smooth optimization; Parameter identification; Seismic design	LIQUID COLUMN DAMPER	In seismic design of building frames, dampers are designed to absorb an earthquake's energy. Conventional steel tension braces have disadvantages, such as pinching or deterioration of stiffness and strength under cyclic loading. A new type of elasto-plastic damper can potentially avoid such disadvantages at a relatively low cost. Main characteristics of the damper are twofold: i) hardening effect caused by geometric nonlinearity, and ii) asymmetric hysteretic restoring force in tensile and compressive loading conditions. The objective of the study is to present a constitutive model and identify the corresponding parameters. The process of parameter identification of the model is formulated as a non-smooth optimization problem and derivative-free optimization methods are suited for the problem. Through numerical examples, we investigate the seismic response reduction property of the damper. The results demonstrate the effectiveness of the optimization approach.	[Yamakawa, Makoto; Tatibana, Masahiko; Yamanouchi, Hiroyuki] Tokyo Denki Univ, Dept Architecture, Tokyo 1208551, Japan; [Nihei, Mitsuki] TDU Architects, Tokyo 1200026, Japan; [Hukazawa, Kyouzou] JARGC Cent Res Construct Technol, Tokyo 1030026, Japan; [Ohsaki, Makoto] Hiroshima Univ, Dept Architecture, Higashihiroshima 7398527, Japan; [Nakamura, Takuzo] NAKAMURA BUSSANN Ltd, Sendai, Miyagi 9820024, Japan	Yamakawa, M (reprint author), Tokyo Denki Univ, Dept Architecture, Tokyo 1208551, Japan.	myamakawa@mail.dendai.ac.jp	Ohsaki, Makoto/E-2021-2011		JSPS KAKENHI [25420576]	We appreciate the provision of data by Mr. Takayuki Matsutsuka, a graduate of Tokyo Denki University. Part of this work was supported by JSPS KAKENHI Grant Number 25420576. We gratefully acknowledge the support.	[Anonymous], 2013, ANSYS MECH APDL PROG; Talatahari S, 2012, J MECH SCI TECHNOL, V26, P2523, DOI 10.1007/s12206-012-0625-y; Sivaselvan MV, 2000, J ENG MECH-ASCE, V126, P633, DOI 10.1061/(ASCE)0733-9399(2000)126:6(633); Chaboche JL, 2008, INT J PLASTICITY, V24, P1642, DOI 10.1016/j.ijplas.2008.03.009; Araki Y, 2014, STRUCT CONTROL HLTH, V21, P1304, DOI 10.1002/stc.1644; Audet C, 2006, SIAM J OPTIMIZ, V17, P188, DOI 10.1137/040603371; Choi KM, 2007, J MECH SCI TECHNOL, V21, P870; Conn A. R., 2009, INTRO DERIVATRIVE FR; Kim YM, 2006, J MECH SCI TECHNOL, V20, P795, DOI 10.1007/BF02915943; Kurashima S., 2012, ANN M ARCH I JAP, P887; Lee DH, 2007, J MECH SCI TECHNOL, V21, P2011; Lee SK, 2007, J MECH SCI TECHNOL, V21, P885; Matsutsuka T., 2012, ANN M ARCH I JAP, P889; Ohsaki M., 2012, P 7 CHIN JAP KOR S O; Ozdemir H., 1976, THESIS U CALIFORNIA; Yamakawa M., 2011, P 9 WORLD C STRUCT M	16	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	APR	2015	29	4					1465	1472		10.1007/s12206-015-0319-3		8	Engineering, Mechanical	Engineering	CF6SD	WOS:000352685600019		
J	Yoden, A				Yoden, Atsushi			The pediatric gastrointestinal tract and ultrasonography	JOURNAL OF MEDICAL ULTRASONICS			English	Editorial Material									Osaka Med Coll, Dept Pediat, Osaka, Japan	Yoden, A (reprint author), Osaka Med Coll, Dept Pediat, Osaka, Japan.	ped018@poh.osaka-med.ac.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					135	135		10.1007/s10396-015-0613-9		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100001		
J	Hirooka, Y; Kuwahara, T; Irisawa, A; Itokawa, F; Uchida, H; Sasahira, N; Kawada, N; Itoh, Y; Shiina, T				Hirooka, Yoshiki; Kuwahara, Takamichi; Irisawa, Atsushi; Itokawa, Fumihide; Uchida, Hiroki; Sasahira, Naoki; Kawada, Natsuko; Itoh, Yuya; Shiina, Tsuyoshi			JSUM ultrasound elastography practice guidelines: pancreas	JOURNAL OF MEDICAL ULTRASONICS			English	Review						Pancreas; Strain; Shear wave; Elasticity imaging; Elastography	FORCE IMPULSE ELASTOGRAPHY; ENDOSCOPIC ULTRASOUND; EUS-ELASTOGRAPHY; DIFFERENTIAL-DIAGNOSIS; TISSUE ELASTOGRAPHY; US ELASTOGRAPHY; CONTRAST AGENTS; ELASTIC-MODULI; SINGLE-CENTER; MASSES	Ultrasound elastography is a relatively new diagnostic technique for measuring the elasticity (hardness) of tissue. Eleven years have passed since the debut of elastography. Various elastography devices are currently being marketed by manufacturers under different names. Pancreatic elastography can be used not only with transabdominal ultrasonography but also with endoscopic ultrasonography, but some types of elastography are difficult to perform for the pancreas. These guidelines aim to classify the various types of elastography into two major categories depending on the differences in the physical quantity (strain, shear wave), and to present the evidence for pancreatic elastography and how to use pancreatic elastography in the present day. But the number of reports on ultrasound elastography for the pancreas is still small, and there are no reports on some elastography devices for the pancreas. Therefore, these guidelines do not recommend methods of imaging and analysis by elastography device.	[Hirooka, Yoshiki] Nagoya Univ Hosp, Dept Endoscopy, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kuwahara, Takamichi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Irisawa, Atsushi] Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Japan; [Itokawa, Fumihide] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Uchida, Hiroki] Okazaki City Hosp, Dept Gastroenterol, Okazaki, Aichi, Japan; [Sasahira, Naoki] Tokyo Takanawa Hosp, Japan Community Hlth Care Org, Dept Gastroenterol, Tokyo, Japan; [Kawada, Natsuko] Kanazawa Med Univ, Dept Hepatopancreatobiliary, Kanazawa, Ishikawa, Japan; [Itoh, Yuya] Toyota Kosei Hosp, Dept Gastroenterol, Toyota, Japan; [Shiina, Tsuyoshi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan	Hirooka, Y (reprint author), Nagoya Univ Hosp, Dept Endoscopy, Showa Ku, Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	hirooka@med.nagoya-u.ac.jp					Abe Y, 2013, GASTROINTEST ENDOSC, V77, pAB424; Giovannini M, 2006, ENDOSCOPY, V38, P344, DOI 10.1055/s-2006-925158; Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Yashima Y, 2012, J GASTROENTEROL, V47, P427, DOI 10.1007/s00535-011-0491-x; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Lyshchik A, 2005, RADIOLOGY, V237, P202, DOI 10.1148/radiol.2363041248; Giovannini M, 2009, WORLD J GASTROENTERO, V15, P1587, DOI 10.3748/wjg.15.1587; UENO E, 1988, ULTRASOUND MED BIOL, V14, P53, DOI 10.1016/0301-5629(88)90047-6; Shimosegawa T, 2010, J GASTROENTEROL, V45, P584, DOI 10.1007/s00535-010-0242-4; Xu W, 2013, EUR J GASTROEN HEPAT, V25, P218, DOI 10.1097/MEG.0b013e32835a7f7c; Sporea I, 2012, EUR J RADIOL, V81, P4112, DOI 10.1016/j.ejrad.2012.08.018; Saftoiu A, 2008, GASTROINTEST ENDOSC, V68, P1086, DOI 10.1016/j.gie.2008.04.031; Kudo M, 2013, J MED ULTRASON, V40, P325, DOI 10.1007/s10396-013-0460-5; Kawada N, 2014, EUR J RADIOL, V83, P620, DOI 10.1016/j.ejrad.2013.11.029; Tsutsumi M, 2007, INT J CLIN ONCOL, V12, P250, DOI 10.1007/s10147-007-0669-7; Varadarajulu S, 2007, GASTROINTEST ENDOSC, V66, P501, DOI 10.1016/j.gie.2006.12.043; Janssen J, 2014, ULTRASCHALL MED, V35, P253, DOI 10.1055/s-0033-1355767; Goertz RS, 2011, EUR J RADIOL, V80, pE226, DOI 10.1016/j.ejrad.2010.09.025; Saftoiu A, 2010, GASTROINTEST ENDOSC, V72, P739, DOI 10.1016/j.gie.2010.02.056; Giovannini M, 2011, PANCREATOLOGY, V11, P34, DOI 10.1159/000323496; Samani A, 2007, PHYS MED BIOL, V52, P1565, DOI 10.1088/0031-9155/52/6/002; Saftoiu A, 2011, ENDOSCOPY, V43, P596, DOI 10.1055/s-0030-1256314; Dietrich CF, 2014, EUR J RADIOL, V83, P405, DOI 10.1016/j.ejrad.2013.03.023; Nakashima K, 2013, J MED ULTRASON, V40, P359, DOI 10.1007/s10396-013-0457-0; Dietrich CF, 2009, ENDOSCOPY, V41, P718, DOI 10.1055/s-0029-1214866; Mei M, 2013, GASTROINTEST ENDOSC, V77, P578, DOI 10.1016/j.gie.2012.09.035; Iglesias-Garcia J, 2013, ENDOSCOPY, V45, P781, DOI 10.1055/s-0033-1344614; Friedrich-Rust M, 2013, J CYST FIBROS, V12, P431, DOI 10.1016/j.jcf.2012.12.013; Herman BA, 2002, ULTRASOUND MED BIOL, V28, P1217, DOI 10.1016/S0301-5629(02)00558-6; Itoh Y, 2014, J GASTROENTEROL, V49, P1183, DOI 10.1007/s00535-013-0880-4; Itokawa F, 2011, J GASTROENTEROL, V46, P843, DOI 10.1007/s00535-011-0399-5; Dalecki D, 1997, ULTRASOUND MED BIOL, V23, P1435, DOI 10.1016/S0301-5629(97)00151-8; Dawwas MF, 2012, GASTROINTEST ENDOSC, V76, P953, DOI 10.1016/j.gie.2012.05.034; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260; Shiina T, 2013, J MED ULTRASON, V40, P309, DOI 10.1007/s10396-013-0490-z; Deprez PH, 2013, GASTROINTEST ENDOSC, V77, P590, DOI 10.1016/j.gie.2012.11.040; DeWitt J, 2005, GASTROINTEST ENDOSC, V62, P76, DOI 10.1016/S0016-5107(05)00504-3; Li X, 2013, WORLD J GASTROENTERO, V19, P6284, DOI 10.3748/wjg.v19.i37.6284; Catalano MF, 2009, GASTROINTEST ENDOSC, V69, P1251, DOI 10.1016/j.gie.2008.07.043; Iglesias-Garcia J, 2010, GASTROENTEROLOGY, V139, P1172, DOI 10.1053/j.gastro.2010.06.059; Barnett SB, 2007, ULTRASOUND MED BIOL, V33, P173, DOI 10.1016/j.ultrasmedbio.2006.07.002; Iglesias-Garcia J, 2009, GASTROINTEST ENDOSC, V70, P1101, DOI 10.1016/j.gie.2009.05.011; Hirche TO, 2008, ENDOSCOPY, V40, P910, DOI 10.1055/s-2008-1077726; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Dalecki D, 1997, ULTRASOUND MED BIOL, V23, P1405, DOI 10.1016/S0301-5629(97)00142-7; D'Onofrio M, 2013, J ULTRAS MED, V32, P647; Hirooka Y, 2005, GASTROINTEST ENDOSC, V61, pAB282, DOI 10.1016/S0016-5107(05)01447-1; Janssen C, 2009, BEST PRACT RES CLIN, V23, P743; Kawada N, 2014, HEPATO-GASTROENTEROL, V61, P478; Kawada N, 2012, PANCREAS, V41, P978, DOI 10.1097/MPA.0b013e3182499b84; Mateen Mohammad Abdul, 2012, JOP, V13, P36; Mayerle J, 2010, PANCREAS, V39, P1334; Pei QS, 2012, PANCREATOLOGY, V12, P402, DOI 10.1016/j.pan.2012.07.013; Shiina T, 1996, P IEEE INT ULTR S SA, V4, P1331; Shiina T, 2004, INT CONGR SER, V1274, P59, DOI 10.1016/j.ics.2004.07.054; Shiina T, 2002, J MED ULTRASON, V29, P119, DOI 10.1007/BF02481234; Tomita Y, 2014, PANCREAS; Uchida H, 2009, PANCREAS, V38, P17, DOI 10.1097/MPA.0b013e318184db78; Uchida H, 2005, GASTROENTEROLOGY, V128, pA536; Ueno E, 2007, P RAD SOC N AM SCI A; Wellman P. S., 1999, TECHNICAL REPORT; Yamakawa M, 2003, JPN J APPL PHYS 1, V42, P3265, DOI 10.1143/JJAP.42.3265; Yamakawa M, 2001, JPN J APPL PHYS 1, V40, P3872, DOI 10.1143/JJAP.40.3872; Ying L, 2013, J GASTROEN HEPATOL, V28, P1434, DOI 10.1111/jgh.12292	64	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					151	174		10.1007/s10396-014-0571-7		24	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100003		
J	Hirooka, Y; Kuwahara, T; Irisawa, A; Itokawa, F; Uchida, H; Sasahira, N; Kawada, N; Itoh, Y; Shiina, T				Hirooka, Yoshiki; Kuwahara, Takamichi; Irisawa, Atsushi; Itokawa, Fumihide; Uchida, Hiroki; Sasahira, Naoki; Kawada, Natsuko; Itoh, Yuya; Shiina, Tsuyoshi			JSUM ultrasound elastography practice guidelines: pancreas (vol 42, pg 151, 2015)	JOURNAL OF MEDICAL ULTRASONICS			English	Correction									[Hirooka, Yoshiki] Nagoya Univ Hosp, Dept Endoscopy, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kuwahara, Takamichi] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Irisawa, Atsushi] Fukushima Med Univ, Dept Gastroenterol, Aizu Med Ctr, Aizu Wakamatsu, Japan; [Itokawa, Fumihide] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Uchida, Hiroki] Okazaki City Hosp, Dept Gastroenterol, Okazaki, Aichi, Japan; [Sasahira, Naoki] Tokyo Takanawa Hosp, Japan Community Hlth Care Org, Dept Gastroenterol, Tokyo, Japan; [Kawada, Natsuko] Kanazawa Med Univ, Dept Hepatopancreatobiliary, Kanazawa, Ishikawa, Japan; [Itoh, Yuya] Toyota Kosei Hosp, Dept Gastroenterol, Toyota, Japan; [Shiina, Tsuyoshi] Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Kyoto, Japan	Hirooka, Y (reprint author), Nagoya Univ Hosp, Dept Endoscopy, Showa Ku, Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	hirooka@med.nagoya-u.ac.jp					Hirooka Y, 2015, J MED ULTRASON, V42, P151, DOI 10.1007/s10396-014-0571-7	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					175	175		10.1007/s10396-014-0595-z		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100004		
J	Chantarojanasiri, T; Hirooka, Y; Ratanachu-ek, T; Kawashima, H; Ohno, E; Goto, H				Chantarojanasiri, Tanyaporn; Hirooka, Yoshiki; Ratanachu-ek, Thawee; Kawashima, Hiroki; Ohno, Eizaburo; Goto, Hidemi			Evolution of pancreas in aging: degenerative variation or early changes of disease?	JOURNAL OF MEDICAL ULTRASONICS			English	Review						Pancreas; Age-related change	NORMAL ENDOSCOPIC PANCREATOGRAM; AGE-RELATED-CHANGES; COMPUTED-TOMOGRAPHY; RETROGRADE PANCREATOGRAPHY; DIAGNOSTIC-SIGNIFICANCE; SECRETIN STIMULATION; MR PANCREATOGRAPHY; ADULT PANCREAS; DUCT; FAT	Pancreatic changes in aging have been described for many decades. They involve not only pancreatic parenchyma but also pancreatic ductal, microscopic, and exocrine functional changes. There have been many studies of these changes based on pathology and various imaging modalities, as well as functional studies. The pancreatic volume was found to decrease with advancing age, with a higher incidence of pancreatic steatosis, as demonstrated in autopsy and imaging studies. The pancreatic ductal structure has been described with wide ranges of normal variation, but many studies have shown a tendency toward enlargement with advancing age. By endoscopic ultrasound imaging, the aging pancreas may exhibit abnormal findings similar to chronic pancreatitis. Microscopically, there has been evidence of patchy lobular fibrosis and papillary hyperplasia and demonstrable k-ras mutation in both normal and dysplastic ductal mucosa. The evidence of pancreatic exocrine insufficiency has yielded conflicting results, but most studies have shown a tendency toward decreased pancreatic exocrine function in the elderly. Differentiating pancreatic change in the elderly from early chronic pancreatitis may be difficult as there are limited studies to compare these two conditions in terms of structural and functional changes.	[Chantarojanasiri, Tanyaporn; Kawashima, Hiroki; Goto, Hidemi] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Hirooka, Yoshiki; Ohno, Eizaburo; Goto, Hidemi] Nagoya Univ Hosp, Dept Endoscopy, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ratanachu-ek, Thawee] Rajavithi Hosp, Dept Surg, Bangkok, Thailand	Hirooka, Y (reprint author), Nagoya Univ Hosp, Dept Endoscopy, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	hirooka@med.nagoya-u.ac.jp	KAWASHIMA, Hiroki/I-7285-2014				OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; LAUGIER R, 1991, DIGESTION, V50, P202; IKEDA M, 1994, PANCREAS, V9, P508, DOI 10.1097/00006676-199407000-00014; Caglar V, 2012, SURG RADIOL ANAT, V34, P935, DOI 10.1007/s00276-012-0988-x; Petrone MC, 2010, PANCREATOLOGY, V10, P597, DOI 10.1159/000314599; Torigoe T, 2014, AM J ROENTGENOL, V202, P1022, DOI 10.2214/AJR.13.10852; Cappeliez O, 2000, RADIOLOGY, V215, P358; Tsushima Y, 1998, PANCREAS, V17, P148, DOI 10.1097/00006676-199808000-00006; D'Onofrio M, 2014, EUR J RADIOL, V83, P415, DOI 10.1016/j.ejrad.2013.04.020; Smits MM, 2011, NAT REV GASTRO HEPAT, V8, P169, DOI 10.1038/nrgastro.2011.4; Matos C, 1997, RADIOLOGY, V203, P435; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; TISCORNIA OM, 1986, INT J PANCREATOL, V1, P95; Luttges J, 1999, VIRCHOWS ARCH, V435, P461, DOI 10.1007/s004280050428; NAGAI H, 1984, GASTROENTEROLOGY, V86, P331; MARKS WM, 1980, RADIOLOGY, V137, P475; SCHMITZMOORMANN P, 1985, GUT, V26, P406, DOI 10.1136/gut.26.4.406; Detlefsen S, 2005, VIRCHOWS ARCH, V447, P800, DOI 10.1007/s00428-005-0032-1; Kim SY, 2014, RADIOLOGY, V271, P104, DOI 10.1148/radiol.13122883; Kloppel G, 2004, VIRCHOWS ARCH, V445, P1, DOI 10.1007/s00428-004-1021-5; Catalano MF, 2009, GASTROINTEST ENDOSC, V69, P1251, DOI 10.1016/j.gie.2008.07.043; Munoz JED, 2010, BEST PRACT RES CL GA, V24, P233, DOI 10.1016/j.bpg.2010.03.008; Hastier P, 1998, GASTROINTEST ENDOSC, V48, P53, DOI 10.1016/S0016-5107(98)70129-4; VELLAS B, 1988, INT J PANCREATOL, V3, P497; STAMM BH, 1984, HUM PATHOL, V15, P677, DOI 10.1016/S0046-8177(84)80294-4; HADIDI A, 1983, J CLIN ULTRASOUND, V11, P17, DOI 10.1002/jcu.1870110105; BIRNSTINGL M, 1959, BRIT J SURG, V47, P128, DOI 10.1002/bjs.18004720203; BUSCAIL L, 1995, PANCREAS, V10, P251, DOI 10.1097/00006676-199504000-00006; Choi CW, 2010, WORLD J GASTROENTERO, V16, P4329, DOI 10.3748/wjg.v16.i34.4329; CLASSEN M, 1973, ENDOSCOPY, V5, P14; COTTON PB, 1974, ENDOSCOPY, V6, P65; Djuric-Stefanovic A, 2012, SURG RADIOL ANAT, V34, P811, DOI 10.1007/s00276-012-0962-7; Glaser J, 2000, GERONTOLOGY, V46, P93, DOI 10.1159/000022141; Gloor B, 2002, BEST PRACT RES CL GA, V16, P159, DOI 10.1053/bega.2002.0272; GULLO L, 1983, GERONTOLOGY, V29, P407; Gullo L, 2009, PANCREATOLOGY, V9, P240, DOI 10.1159/000212090; GULLO L, 1986, J AM GERIATR SOC, V34, P790; HAND BH, 1963, BRIT J SURG, V50, P486, DOI 10.1002/bjs.18005022303; Hernandez LV, 2010, BEST PRACT RES CL GA, V24, P243, DOI 10.1016/j.bpg.2010.03.004; Hirooka YIA, 2007, GASTROENTEROLOGY, V132, P1; Ishibashi T, 1991, Nihon Ronen Igakkai Zasshi, V28, P599; Itoh Y, 2013, J GASTROENTEROL; KARAK PK, 1991, INDIAN J MED RES-B, V94, P426; KASUGAI T, 1972, GASTROENTEROLOGY, V63, P217; KLOPPEL G, 1993, PANCREAS, V8, P659; Kochhar R, 1996, Trop Gastroenterol, V17, P223; KREEL L, 1973, GUT, V14, P962, DOI 10.1136/gut.14.12.962; LADAS SD, 1993, HEPATO-GASTROENTEROL, V40, P52; Li J, 2011, PANCREAS, V40, P295, DOI 10.1097/MPA.0b013e318201669f; MILLBOURN E, 1960, Acta Chir Scand, V118, P286; OGOSHI K, 1973, GASTROENTEROLOGY, V64, P210; OKUDA K, 1973, AM J ROENTGENOL, V117, P437; OLSEN TS, 1978, ACTA PATH MICRO IM A, V86, P367; Raimondo Massimo, 2004, JOP, V5, P1; Rajan E, 2005, GASTROINTEST ENDOSC, V61, P401, DOI 10.1016/S0016-5107(04)02758-0; ROBERTSTHOMSON IC, 1977, MED J AUSTRALIA, V2, P793; Sato T, 2012, EUR J RADIOL, V81, P2093, DOI 10.1016/j.ejrad.2011.07.014; SCHMITZMOORMANN P, 1981, PATHOL RES PRACT, V173, P45; Sepe PS, 2011, GASTROINTEST ENDOSC, V73, P987, DOI 10.1016/j.gie.2011.01.015; SIVAK MV, 1976, AM J DIG DIS, V21, P263, DOI 10.1007/BF01095900; TRAPNELL JE, 1966, SURGERY, V60, P1112; VARLEY PF, 1976, RADIOLOGY, V118, P295; WORTHEN NJ, 1982, AM J ROENTGENOL, V139, P1095; ZIMMERMANN W, 1981, FORTSCHR MED, V99, P1178	65	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					177	183		10.1007/s10396-014-0576-2		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100005		
J	Koizumi, Y; Hirooka, M; Ochi, H; Tokumoto, Y; Takechi, M; Hiraoka, A; Ikeda, Y; Kumagi, T; Matsuura, B; Abe, M; Hiasa, Y				Koizumi, Yohei; Hirooka, Masashi; Ochi, Hironori; Tokumoto, Yoshio; Takechi, Megumi; Hiraoka, Atsushi; Ikeda, Yoshio; Kumagi, Teru; Matsuura, Bunzo; Abe, Masanori; Hiasa, Yoichi			Characterization of the biliary tract by virtual ultrasonography constructed by gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Hepatocellular carcinoma; Radiofrequency ablation; Virtual ultrasonography; Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid; Bile duct	PERCUTANEOUS RADIOFREQUENCY ABLATION; SMALL HEPATOCELLULAR-CARCINOMA; INTERSTITIAL THERMAL ABLATION; GD-EOB-DTPA; HEPATIC-TUMORS; CLINICAL-EVALUATION; CONTRAST AGENT; LIVER-TUMORS; SAFETY; COMPLICATIONS	This study aimed at prospectively evaluating bile duct anatomy on ultrasonography and evaluating the safety and utility of radiofrequency ablation (RFA) assisted by virtual ultrasonography from gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI). The institutional review board approved this study, and patients provided written informed consent prior to entry into the study. Bile duct anatomy was assessed in 201 patients who underwent Gd-EOB-DTPA-enhanced MRI for the evaluation of hepatic tumor. Eighty-one of these patients subsequently underwent RFA assisted by ultrasound imaging. In 23 patients, the tumor was located within 5 mm of the central bile duct, as demonstrated by MRI. Virtual ultrasonography constructed by Gd-EOB-enhanced MRI was able to visualize the common bile duct, left hepatic duct, and right hepatic duct in 96.5, 94.0, and 89.6 % of cases, respectively. The target hepatic tumor nodule and biliary duct could be detected with virtual ultrasonography in all patients, and no severe complications occurred. The running pattern of the bile ducts could be recognized on conventional ultrasound by referencing virtual ultrasonography constructed by Gd-EOB-DTPA-enhanced MRI. RFA assisted by this imaging strategy did not result in bile duct injury.	[Koizumi, Yohei; Hirooka, Masashi; Ochi, Hironori; Tokumoto, Yoshio; Ikeda, Yoshio; Kumagi, Teru; Matsuura, Bunzo; Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan; [Takechi, Megumi] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime 7910295, Japan; [Hiraoka, Atsushi] Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Matsuyama, Ehime, Japan	Hiasa, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan.	hiasa@m.ehime-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [JSPS KAKENHI 24590980]; Japanese Ministry of Health, Labor and Welfare [JSPS KAKENHI 2586054]	This work was supported in part by a Grant-in-Aid for Scientific Research (JSPS KAKENHI 24590980 to Y.H.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, as well as a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor and Welfare to Y.H., and research (JSPS KAKENHI 2586054 to Y.K.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, as well as a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor and Welfare to Y.K.	Allgaier HP, 1999, LANCET, V353, P1676, DOI 10.1016/S0140-6736(99)00368-2; Kitami M, 2006, RADIOLOGY, V238, P156, DOI 10.1148/radiol.2381041783; Livraghi T, 2003, RADIOLOGY, V226, P441, DOI 10.1148/radiol.2262012198; HAMM B, 1995, RADIOLOGY, V195, P785; Reimer P, 1996, RADIOLOGY, V199, P177; Curley SA, 1999, ANN SURG, V230, P1, DOI 10.1097/00000658-199907000-00001; Pearson AS, 1999, AM J SURG, V178, P592, DOI 10.1016/S0002-9610(99)00234-2; Tateishi R, 2005, CANCER, V103, P1201, DOI 10.1002/cncr.20892; Dodd GD, 2000, RADIOGRAPHICS, V20, P9; Minami Y, 2008, AM J ROENTGENOL, V190, pW335, DOI 10.2214/AJR.07.3092; Mulier S, 2002, BRIT J SURG, V89, P1206, DOI 10.1046/j.1365-2168.2002.02168.x; de Baere T, 2000, AM J ROENTGENOL, V175, P1619; de Baere T, 2003, AM J ROENTGENOL, V181, P695; Saba L, 2011, SURG RADIOL ANAT, V33, P559, DOI 10.1007/s00276-011-0778-x; Wood TF, 2000, ANN SURG ONCOL, V7, P593; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Livraghi T, 1999, RADIOLOGY, V210, P655; Bilchik AJ, 1999, CANCER J SCI AM, V5, P356; Chopra S, 2003, AM J ROENTGENOL, V180, P697; Elias D, 1998, J SURG ONCOL, V67, P190, DOI 10.1002/(SICI)1096-9098(199803)67:3<190::AID-JSO9>3.0.CO;2-4; Kudo M, 2007, HEPATOL RES, V37, pS193, DOI 10.1111/j.1872-034X.2007.00184.x; McGhana J P, 2001, AJR Am J Roentgenol, V176, P3; Nordlinger B, 2002, CURR OPIN ONCOL, V14, P420, DOI 10.1097/01.CCO.0000020620.28068.4D; Ohnishi T, 2008, J GASTROENTEROL HE 2, V23, P410; Rossi S, 1996, AM J ROENTGENOL, V167, P759; Stippel DL, 2003, SURG ENDOSC, V17, P1965, DOI 10.1007/s00464-002-9273-0; Uehara T, 2009, HEPATOL RES, V39, P954, DOI 10.1111/j.1872-034X.2009.00537.x	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					185	193		10.1007/s10396-014-0598-9		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100006		
J	Hasegawa, J; Nakamura, M; Sekizawa, A				Hasegawa, Junichi; Nakamura, Masamitsu; Sekizawa, Akihiko			How do the trends in the prenatal diagnosis of aneuploidy change after a non-invasive prenatal test becomes available? A Japanese single center study	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Amniocentesis; Chorionic villous sampling; Chromosomal abnormality; Down syndrome; First trimester; Nuchal translucency; Ultrasound	FETAL NUCHAL-TRANSLUCENCY; DOWNS-SYNDROME; 1ST-TRIMESTER; ULTRASOUND; PREGNANCY	To clarify the trends in the use of the prenatal diagnosis of and screening for aneuploidy after a non-invasive prenatal test (NIPT) was made available at a single Japanese hospital. The subjects included consecutive pregnant females who visited our hospital for maternal checkups and delivery between January 2012 and April 2014. After the subjects were divided into those who desired a prenatal diagnosis or screening before the availability of NIPT and those who did after the availability of NIPT, the frequencies of various prenatal diagnosis and screening procedures were compared between the two groups. A total of 544 patients who visited the hospital before NIPT was available and 703 who visited the hospital after NIPT became available were analyzed. While only 16.2 % of pregnant females received a prenatal diagnosis or screening before the NIPT was available, 27.5 % of them considered undergoing a prenatal diagnosis or screening after the NIPT was available before genetic counseling, and 24.0 % ultimately received a prenatal diagnosis or screening following genetic counseling. Of these patients, 7.7 % underwent NIPT. First trimester ultrasound screening for chromosomal abnormalities was unlikely to be selected (from 12.9 to 10.5 %, p = 0.212), although the rate of amniocentesis significantly increased after genetic counseling (from 1.5 to 3.7 %, p = 0.021). Since NIPT became available in 2013, pregnant females have demonstrated a deep interest in obtaining a prenatal diagnosis and screening. Whereas some patients choose to forgo a screening after receiving genetic counseling, others prefer invasive diagnostic tests in contrast to screening.	[Hasegawa, Junichi; Nakamura, Masamitsu; Sekizawa, Akihiko] Showa Univ, Dept Obstet & Gynecol, Sch Med, Shinagawa Ku, Tokyo 1428666, Japan	Hasegawa, J (reprint author), Showa Univ, Dept Obstet & Gynecol, Sch Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	hasejun@oak.dti.ne.jp					Nicolaides KH, 2004, AM J OBSTET GYNECOL, V191, P45, DOI 10.1016/j.ajog.2004.03.090; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Nicolaides KH, 2007, ULTRASOUND OBST GYN, V30, P671, DOI 10.1002/uog.5156; Snijders RJM, 1998, LANCET, V352, P343, DOI 10.1016/S0140-6736(97)11280-6; Wald NJ, 1996, BRIT J OBSTET GYNAEC, V103, P407, DOI 10.1111/j.1471-0528.1996.tb09765.x; Yotsumoto J, 2012, PRENATAL DIAG, V32, P674, DOI 10.1002/pd.3886; Chiu RW, 2011, BMJ-BRIT MED J, V11, pc7401, DOI DOI 10.1136/BMJ.C7401; NICOLAIDES KH, 1994, BRIT J OBSTET GYNAEC, V101, P782, DOI 10.1111/j.1471-0528.1994.tb11946.x	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					195	198		10.1007/s10396-014-0589-x		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100007		
J	Misumi, I; Honda, T; Kusuhara, K; Yasuda, H; Kaikita, K; Hokimoto, S; Ogawa, H				Misumi, Ikuo; Honda, Tsuyoshi; Kusuhara, Kenichi; Yasuda, Hisayo; Kaikita, Koichi; Hokimoto, Seiji; Ogawa, Hisao			Paradoxical increase in E/e' ratio after treatment of heart failure in two patients with preserved ejection fraction	JOURNAL OF MEDICAL ULTRASONICS			English	Article						E/e ' ratio; Heart failure with preserved ejection fraction	DOPPLER; PRELOAD	We report an increase in E/e' ratio after treatment of heart failure (HF) in two patients. In case 1, the E/e' ratio increased from 15 to 18 after treatment of HF. In case 2, the E/e' ratio also increased from 24 to 35. Although a high E/e' ratio suggests high pulmonary artery wedge pressure and worsening HF, the ratio may increase after improvement of HF. In the present cases of diastolic dysfunction, the high E wave did not change, but the e' wave decreased relatively. This report may suggest difficulty in evaluating hemodynamic status based on the E/e' ratio in patients with diastolic dysfunction.	[Misumi, Ikuo; Honda, Tsuyoshi; Kusuhara, Kenichi] Kumamoto Saisyunsou Hosp, Dept Cardiol, Kumamoto 8611196, Japan; [Yasuda, Hisayo; Kaikita, Koichi; Hokimoto, Seiji; Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Sch Med, Kumamoto 8608556, Japan	Misumi, I (reprint author), Kumamoto Saisyunsou Hosp, Dept Cardiol, 2659 Suya, Kumamoto 8611196, Japan.	misumi@saisyunsou1.hosp.go.jp					Drighil A, 2008, EUR J ECHOCARDIOGR, V9, P530, DOI 10.1093/ejechocard/jen125; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Mullens W, 2009, CIRCULATION, V119, P62, DOI 10.1161/CIRCULATIONAHA.108.779223; Misumi I, 2011, INTERNAL MED, V50, P581, DOI 10.2169/internalmedicine.50.4791; Yalcin F, 2002, HEART, V87, P336, DOI 10.1136/heart.87.4.336	5	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					239	241		10.1007/s10396-014-0577-1		3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100013		
J	Tsugu, T; Murata, M; Iwanaga, S; Kitamura, Y; Inoue, S; Fukuda, K				Tsugu, Toshimitsu; Murata, Mitsushige; Iwanaga, Shiro; Kitamura, Yohei; Inoue, Soushin; Fukuda, Keiichi			A rare case of fungal endocarditis caused by Candida glabrata after completion of antibiotic therapy for Streptococcus endocarditis	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Echocardiography; Fungal endocarditis; Mitral valve replacement; Candida glabrata; Micafungin	INFECTIVE ENDOCARDITIS; CRITERIA; SOCIETY	We present the rare case of a 76-year-old female with infective endocarditis (IE) caused by Candida glabrata. Immediately before developing the present infection, she developed IE with vegetation on the mitral annular calcification, which was caused by Streptococcus mitis and successfully treated with penicillin-G and gentamicin. However, her fever recurred, and she developed disseminated intravascular coagulation. Blood culture revealed C. glabrata, and echocardiography revealed new vegetation on the mitral valve. After 4 weeks of treatment with micafungin, prosthetic valve replacement was performed, followed by additional administration of micafungin for 4 weeks (total of 8 weeks). No relapse at 9 months after surgery has been observed. C. glabrata endocarditis is extremely rare and difficult to manage. Our case and review of past reported cases suggest that early diagnosis and initiation of treatment contribute to good prognosis of C. glabrata endocarditis.	[Tsugu, Toshimitsu; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Tsugu, Toshimitsu; Inoue, Soushin] Hino Municipal Hosp, Dept Cardiol, Hino, Tokyo 1910062, Japan; [Murata, Mitsushige] Keio Univ, Sch Med, Dept Lab Med, Tokyo, Japan; [Iwanaga, Shiro] Saitama Int Med Ctr, Dept Cardiol, Saitama, Japan; [Kitamura, Yohei] Hino Municipal Hosp, Dept Neurosurg, Tokyo, Japan	Tsugu, T (reprint author), Hino Municipal Hosp, Dept Cardiol, 4-3-1 Tamadaira, Hino, Tokyo 1910062, Japan.	tsugu917@gmail.com					Ellis ME, 2001, CLIN INFECT DIS, V32, P50, DOI 10.1086/317550; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pierrotti LC, 2002, CHEST, V122, P302, DOI 10.1378/chest.122.1.302; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					243	246		10.1007/s10396-014-0580-6		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100014		
J	Toyoda, S; Inami, S; Masawa, T; Shibasaki, I; Yamada, Y; Fukuda, H; Kubo, T; Nakajima, M; Kato, H; Inoue, T				Toyoda, Shigeru; Inami, Shu; Masawa, Taito; Shibasaki, Ikuko; Yamada, Yasuyuki; Fukuda, Hirotsugu; Kubo, Tsukasa; Nakajima, Masanobu; Kato, Hiroyuki; Inoue, Teruo			Hypopharyngeal perforation caused by intraoperative transesophageal echocardiography	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Hypopharyngeal perforation; Intraoperative transesophageal echocardiography; Anesthesia complication	CASE SERIES; SAFETY	Intraoperative transesophageal echocardiography (TEE) is an invaluable tool for cardiac surgical decision-making. TEE is considered reasonably noninvasive and safe, but insertion and manipulation of the TEE probe can lead to complications. Here, we report a patient with aortic stenosis who experienced TEE-associated hypopharyngeal perforation at the pyriform sinus complicated by esophageal trauma, pneumomediastinum and pneumoretroperitoneum. Based on this case, we suggest that rare complications be kept in mind when using TEE intraoperatively.	[Toyoda, Shigeru; Inami, Shu; Masawa, Taito; Inoue, Teruo] Dokkyo Med Univ, Dept Cardiovasc Med, Mibu, Tochigi 3210293, Japan; [Shibasaki, Ikuko; Yamada, Yasuyuki; Fukuda, Hirotsugu] Dokkyo Med Univ, Dept Cardiac & Vasc Surg, Mibu, Tochigi 3210293, Japan; [Kubo, Tsukasa; Nakajima, Masanobu; Kato, Hiroyuki] Dokkyo Med Univ, Dept Surg 1, Mibu, Tochigi 3210293, Japan	Toyoda, S (reprint author), Dokkyo Med Univ, Dept Cardiovasc Med, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	s-toyoda@dokkyomed.ac.jp					Na SW, 2009, ANESTHESIOLOGY, V110, P38, DOI 10.1097/ALN.0b013e318190b56e; Kallmeyer IJ, 2001, ANESTH ANALG, V92, P1126; Brinkman WT, 2001, ANN THORAC SURG, V72, P1725, DOI 10.1016/S0003-4975(00)02704-1; DANIEL WG, 1991, CIRCULATION, V83, P817; Min JK, 2005, J AM SOC ECHOCARDIOG, V18, P925, DOI 10.1016/j.echo.2005.01.034; Mishra M, 1998, J CARDIOTHOR VASC AN, V12, P625, DOI 10.1016/S1053-0770(98)90232-4; Sainathan S, 2013, ECHOCARDIOGR-J CARD, V30, P977, DOI 10.1111/echo.12290; Savage RM, 1997, ANN THORAC SURG, V64, P368, DOI 10.1016/S0003-4975(97)00612-7	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					247	250		10.1007/s10396-014-0594-0		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100015		
J	Ishikawa, T; Haruta, J; Yamaguchi, T; Doisaki, M; Yama, T; Murate, K; Hattori, S; Hayakawa, F; Yamada, K; Yashika, J				Ishikawa, Takuya; Haruta, Jun-ichi; Yamaguchi, Takeo; Doisaki, Masao; Yama, Tsuyoki; Murate, Kentarou; Hattori, Shun; Hayakawa, Fumihiro; Yamada, Kenta; Yashika, Jun			A case of mucinous cystic neoplasm of the pancreas misdiagnosed as a pancreatic pseudocyst at the initial exam and resected after a 2-year follow-up	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Mucinous cystic neoplasm; Pseudocyst; Pancreatic neuroendocrine tumor	MANAGEMENT; TUMORS	A 44-year-old woman was referred to our hospital because of a cystic lesion in the pancreatic body that was found by computed tomography (CT) as a result of a screening for impaired liver function after the patient presented with a high fever in 2011. Trans-abdominal ultrasonography (US) revealed a 33-mm unilocular cyst within the pancreatic body and a 5-mm hypoechoic mass in the pancreatic neck. Contrast-enhanced CT showed a slight enhancement around the cyst and a mild dilation of the main pancreatic duct, but neither septum nor nodule was detected inside. Contrast-enhanced endoscopic ultrasonography (CE-EUS) revealed a hyperechoic elevated lesion inside the cystic lesion without enhancement in the pancreatic body; CE-EUS also revealed a 5-mm homogeneous hypoechoic mass with a remarkable enhancement in the pancreatic neck with the use of Sonazoid(A (R)) as a contrast medium. These lesions were diagnosed as a pancreatic pseudocyst and a neuroendocrine tumor (NET), respectively, and were followed up with periodic examinations. The cystic lesion showed contraction 6 months after the initial exam. However, US revealed an enlargement of the cystic lesion to 40 mm in diameter 2 years after the initial exam, and EUS showed irregular thickening of the wall with a cyst-in-cyst appearance. The diagnoses of a mucinous cystic neoplasm (MCN) and a concomitant small NET were made after a distal pancreatectomy. We herein report a rare case of MCN that showed various morphological changes over 2 years of observation.	[Ishikawa, Takuya; Haruta, Jun-ichi; Yamaguchi, Takeo; Doisaki, Masao; Yama, Tsuyoki; Murate, Kentarou; Hattori, Shun; Hayakawa, Fumihiro; Yamada, Kenta; Yashika, Jun] Japanese Red Cross Nagoya Daiichi Hosp, Dept Gastroenterol, Nakamura Ku, Nagoya, Aichi 4538511, Japan	Ishikawa, T (reprint author), Japanese Red Cross Nagoya Daiichi Hosp, Dept Gastroenterol, Nakamura Ku, 3-35 Michishita Cho, Nagoya, Aichi 4538511, Japan.	takuya2602@gmail.com					Suzuki Y, 2004, PANCREAS, V28, P241, DOI 10.1097/00006676-200404000-00005; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Bosman FT, 2010, WHO CLASSIFICATION T; Fukuda J, 2011, JPN J MED ULTRASON, V38, P19; Ishikawa T, 2010, GASTROINTEST ENDOSC, V71, P951, DOI 10.1016/j.gie.2009.12.023; Nomura N, 2007, JPN J GASTROENTEROL, V40, P319; Ooi LLPJ, 1998, AUST NZ J SURG, V68, P844, DOI 10.1111/j.1445-2197.1998.tb04699.x; Reddy RP, 2004, CLIN GASTROENTEROL H, V2, P1026, DOI 10.1053/S1542-3565(04)00450-1; Testini M, 2010, WORLD J GASTROENTERO, V16, P5682, DOI 10.3748/wjg.v16.i45.5682; Yamao Kenji, 2003, J Hepatobiliary Pancreat Surg, V10, P142, DOI 10.1007/s00534-002-0802-y; Yamashita Yasunobu, 2011, Nihon Shokakibyo Gakkai Zasshi, V108, P1280	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					257	265		10.1007/s10396-014-0581-5		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100017		
J	Watanabe, T; Aoyagi, K; Tomioka, Y; Ishibashi, H; Nimura, S; Sakisaka, S				Watanabe, Takashi; Aoyagi, Kunihiko; Tomioka, Yoshitaka; Ishibashi, Hideki; Nimura, Satoshi; Sakisaka, Shotaro			Endoscopic ultrasonography of duodenal aberrant pancreas: comparison with histology after endoscopic resection	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Aberrant pancreas; Duodenum; Endoscopic ultrasonography; Endoscopic resection	SINGLE-CENTER EXPERIENCE; GASTROINTESTINAL-TRACT; HETEROTOPIC PANCREAS; TUMORS; EUS	We present the case of a 45-year-old man with an aberrant pancreas in the duodenum. He was referred to our hospital for gastric cancer screening. On upper gastrointestinal endoscopy, a submucosal tumor was noted in the second portion of the duodenum; it was 10 mm in diameter, with a smooth surface and bridging fold. Endoscopic ultrasonography (EUS) showed a hypoechoic lesion with small anechoic areas located in the third sonographic layer of the duodenum wall. To confirm the exact diagnosis, endoscopic resection was performed. The histological diagnosis was aberrant pancreas, Heinrich type II. The hypoechoic lesion and anechoic areas on EUS findings clearly corresponded with pancreatic acinus cells and duct dilation on histological findings, respectively. EUS findings are useful to diagnosis a duodenal aberrant pancreas that has ductal structures.	[Watanabe, Takashi; Aoyagi, Kunihiko; Tomioka, Yoshitaka; Ishibashi, Hideki; Sakisaka, Shotaro] Fukuoka Univ, Sch Med, Dept Gastroenterol & Med, Jonan Ku, Fukuoka 8140180, Japan; [Nimura, Satoshi] Fukuoka Univ, Dept Pathol, Sch Med, Fukuoka 8140180, Japan	Watanabe, T (reprint author), Fukuoka Univ, Sch Med, Dept Gastroenterol & Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	takashii@minf.med.fukuoka-u.ac.jp					YOSHIKANE H, 1993, GASTROINTEST ENDOSC, V39, P375, DOI 10.1016/S0016-5107(93)70109-1; LAI ECS, 1986, AM J SURG, V151, P697, DOI 10.1016/0002-9610(86)90045-0; Palazzo L, 2000, GUT, V46, P88, DOI 10.1136/gut.46.1.88; Matsumoto S, 2013, ENDOSCOPY, V45, P136, DOI 10.1055/s-0032-1310123; Kojima T, 1999, GASTROINTEST ENDOSC, V50, P516, DOI 10.1016/S0016-5107(99)70075-1; BARBOSA JJD, 1946, SURG GYNECOL OBSTET, V82, P527; Mekky MA, 2010, GASTROINTEST ENDOSC, V71, P913, DOI 10.1016/j.gie.2009.11.044; Wei R, 2011, CLIN IMAG, V35, P353, DOI 10.1016/j.clinimag.2010.10.001; Hunt GC, 2003, GASTROINTEST ENDOSC, V57, P68, DOI 10.1067/mge.2003.34; Matsushita M, 1999, GASTROINTEST ENDOSC, V49, P493, DOI 10.1016/S0016-5107(99)70049-0; Park SH, 2011, J GASTROEN HEPATOL, V26, P1441, DOI 10.1111/j.1440-1746.2011.06764.x; Rosai JR, 1989, ACKERMANS SURG PATHO, P757; Shim CS, 1997, ULTRASOUND MED BIOL, V23, P42; von Heinrich H, 1909, VIRCHOWS ARCH A, V198, P392	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					277	280		10.1007/s10396-014-0592-2		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100020		
J	Inubashiri, E; Kuroki, K; Maeda, N; Kawai, K; Akutagawa, N; Sugawara, M; Imai, S; Minami, K; Nomura, Y				Inubashiri, Eisuke; Kuroki, Katumaru; Maeda, Nobuhiko; Kawai, Kiichirou; Akutagawa, Noriyuki; Sugawara, Masaki; Imai, Shosuke; Minami, Kunihiro; Nomura, Yasuhiro			Three-dimensional and four-dimensional HDlive-rendered images of thanatophoric dysplasia	JOURNAL OF MEDICAL ULTRASONICS			English	Article						HDlive ultrasonography; Thanatophoric dysplasia; Skeletal dysplasia; Short limbs	SKELETAL DYSPLASIAS; DIAGNOSIS; ULTRASOUND	We present herein our first experience with a case of thanatophoric dysplasia (type I) that was diagnosed during the second trimester using three- and four-dimensional HDlive ultrasonography. The HDlive rendering mode clearly showed the anatomical features of thanatophoric dysplasia: external malformations and skeletal abnormalities, including extremely short limbs, flattened vertebral bodies, and short horizontal ribs, among others. HDlive can provide valuable, highly realistic images for the differential diagnosis of skeletal dysplasia. It may also play an important complementary role when conventional two- and three-dimensional ultrasonography does not provide sufficient definition.	[Inubashiri, Eisuke; Kuroki, Katumaru; Maeda, Nobuhiko; Kawai, Kiichirou; Akutagawa, Noriyuki; Sugawara, Masaki; Imai, Shosuke; Minami, Kunihiro; Nomura, Yasuhiro] Sapporo Toho Hosp, Higashi Ku, Sapporo, Hokkaido 0650017, Japan	Inubashiri, E (reprint author), Sapporo Toho Hosp, Higashi Ku, Kita 17,Higashi 15, Sapporo, Hokkaido 0650017, Japan.	reduzierung@yahoo.co.jp					Schramm T, 2009, ULTRASOUND OBST GYN, V34, P160, DOI 10.1002/uog.6359; HADLOCK FP, 1982, AM J ROENTGENOL, V138, P875; Hata T, 2013, J MED ULTRASON, V40, P179, DOI 10.1007/s10396-012-0393-4; Kagan KO, 2011, ULTRASOUND OBST GYN, V38, P607, DOI 10.1002/uog.10112; Hata T, 2012, ARCH GYNECOL OBSTET, V286, P1431, DOI 10.1007/s00404-012-2505-1; Yeh P, 2011, PRENATAL DIAG, V31, P515, DOI 10.1002/pd.2729; Goncalves LF, 2004, ULTRASOUND OBST GYN, V24, P115, DOI 10.1002/uog.1712; Hata T, 2013, J MED ULTRASON, V40, P271, DOI 10.1007/s10396-012-0420-5; Hata T, 2013, J MED ULTRASON, V40, P437, DOI 10.1007/s10396-013-0441-8; Krakow D, 2008, AM J MED GENET A, V146A, P1917, DOI 10.1002/ajmg.a.32269; Vasilj O, 2012, J MATERN-FETAL NEO M, V25, P2786, DOI 10.3109/14767058.2012.704451; Wong HS, 2008, FETAL DIAGN THER, V24, P71, DOI 10.1159/000132411	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					281	285		10.1007/s10396-014-0597-x		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100021		
J	Numaguchi, K; Hatake, S; Ueda, T; Tomita, Y				Numaguchi, Kotaro; Hatake, Shinsaku; Ueda, Tomohiro; Tomita, Yukihiro			A kinked aortic tube graft after aortic root replacement causes heart failure: usefulness of the right parasternal approach on echocardiography	JOURNAL OF MEDICAL ULTRASONICS			English	Editorial Material						Echocardiography; Graft-related complication; Systolic murmur			[Numaguchi, Kotaro] Natl Hosp Org Kyushu Med Ctr, Dept Cardiol, Clin Res Inst, Chuo Ku, Fukuoka 8108563, Japan; [Hatake, Shinsaku] Natl Hosp Org Kyushu Med Ctr, Dept Clin Lab, Clin Res Inst, Fukuoka 8108563, Japan; [Ueda, Tomohiro; Tomita, Yukihiro] Natl Hosp Org Kyushu Med Ctr, Dept Cardiovasc Surg, Clin Res Inst, Fukuoka 8108563, Japan	Numaguchi, K (reprint author), Natl Hosp Org Kyushu Med Ctr, Dept Cardiol, Clin Res Inst, Chuo Ku, 1-8-1 Jigyohama, Fukuoka 8108563, Japan.	numaguchi@kyumed.jp					Al-Mohaissen MA, 2012, J THORAC IMAG, V27, pW88, DOI 10.1097/RTI.0b013e31821424de; Evangelista A, 2010, EUR J ECHOCARDIOGR, V11, P645, DOI 10.1093/ejechocard/jeq056	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					291	292		10.1007/s10396-014-0596-y		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100023		
J	Hasegawa, J; Takita, H; Arakaki, T; Sekizawa, A				Hasegawa, Junichi; Takita, Hiroko; Arakaki, Tatsuya; Sekizawa, Akihiko			Descendent migration in vasa previa	JOURNAL OF MEDICAL ULTRASONICS			English	Editorial Material						Vasa previa; Migration; Velamentous cord insertion; Placenta previa; Amniotic membrane			[Hasegawa, Junichi; Takita, Hiroko; Arakaki, Tatsuya; Sekizawa, Akihiko] Showa Univ, Dept Obstet & Gynecol, Sch Med, Shinagawa Ku, Tokyo 1428666, Japan	Hasegawa, J (reprint author), Showa Univ, Dept Obstet & Gynecol, Sch Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	hasejun@oak.dti.ne.jp					Oppenheimer L, 2001, ULTRASOUND OBST GYN, V18, P100, DOI 10.1046/j.1469-0705.2001.00450.x	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	APR	2015	42	2					295	296		10.1007/s10396-014-0590-4		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF6TL	WOS:000352689100025		
J	Karasawa, T; Takahashi, M				Karasawa, Tadayoshi; Takahashi, Masafumi			RIP140 as a novel therapeutic target in the treatment of atherosclerosis	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Editorial Material							TRANSCRIPTIONAL COREPRESSOR RIP140; RECEPTOR-INTERACTING PROTEIN-140; LIVER X RECEPTOR; NUCLEAR RECEPTOR; ACCELERATES ATHEROSCLEROSIS; OXIDATIVE-METABOLISM; MICE; ACCUMULATION; ACETYLATION; METHYLATION		[Karasawa, Tadayoshi; Takahashi, Masafumi] Jichi Med Univ, Div Inflammat Res, Ctr Mol Med, Shimotsuke, Tochigi 3290498, Japan	Takahashi, M (reprint author), Jichi Med Univ, Div Inflammat Res, Ctr Mol Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	masafumi2@jichi.ac.jp					Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Diaz MB, 2008, HEPATOLOGY, V48, P782, DOI 10.1002/hep.22383; Huq MDM, 2008, CURR MED CHEM, V15, P386; Karasawa T, 2011, ARTERIOSCL THROM VAS, V31, P1788, DOI 10.1161/ATVBAHA.110.219659; CAVAILLES V, 1995, EMBO J, V14, P3741; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Ho PC, 2012, NAT IMMUNOL, V13, P379, DOI 10.1038/ni.2238; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Herzog B, 2007, MOL ENDOCRINOL, V21, P2687, DOI 10.1210/me.2007-0213; Ho PC, 2008, CELL SIGNAL, V20, P1911, DOI 10.1016/j.cellsig.2008.07.001; Ho PC, 2011, FASEB J, V25, P1758, DOI 10.1096/fj.10-179267; Huq MDM, 2005, MOL CELL PROTEOMICS, V4, P975, DOI 10.1074/mcp.M500015-MCP200; Huq MDM, 2009, J PROTEOME RES, V8, P1156, DOI 10.1021/pr800569c; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Lee CH, 1998, MOL CELL BIOL, V18, P6745; Lin Y, 2014, J MOL CELL CARDIOL C, V79C, P287; Nautiyal J, 2013, TRENDS ENDOCRIN MET, V24, P451, DOI 10.1016/j.tem.2013.05.001; Tontonoz P, 2011, Cold Spring Harb Symp Quant Biol, V76, P129, DOI 10.1101/sqb.2011.76.010702; Zschiedrich I, 2008, BLOOD, V112, P264, DOI 10.1182/blood-2007-11-121699	22	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	APR	2015	81						136	138		10.1016/j.yjmcc.2015.02.009		3	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CG2BF	WOS:000353079200019		
J	Gautam, M; Fujita, D; Kimura, K; Ichikawa, H; Izawa, A; Hirose, M; Kashihara, T; Yamada, M; Takahashi, M; Ikeda, U; Shiba, Y				Gautam, Milan; Fujita, Daiki; Kimura, Kazuhiro; Ichikawa, Hinako; Izawa, Atsushi; Hirose, Masamichi; Kashihara, Toshihide; Yamada, Mitsuhiko; Takahashi, Masafumi; Ikeda, Uichi; Shiba, Yuji			Transplantation of adipose tissue-derived stem cells improves cardiac contractile function and electrical stability in a rat myocardial infarction model	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Adipose-derived stem cells; Echocardiography; Myocardial infarction; Pro-survival cocktail; Programmed electrical stimulation; Ventricular tachyarrhythmia	SMOOTH MUSCLE ACTIN; CARDIOMYOCYTES; THERAPY; CONDUCTION; EXPRESSION; HEARTS; MYOFIBROBLASTS; REFRACTORINESS; ARRHYTHMIAS; DISPERSION	The transplantation of adipose tissue-derived stem cells (ADSCs) improves cardiac contractility after myocardial infarction (MI); however, little is known about the electrophysiological consequences of transplantation. The purpose of this study was to clarify whether the transplantation of ADSCs increases or decreases the incidence of ventricular tachyarrhythmias (VT) in a rat model of MI. MI was induced experimentally by permanent occlusion of the left anterior descending artery of Lewis rats. ADSCs were harvested from GFP-transgenic rats, and were cultured until passage four. ADSCs (10 x 10(6)) resuspended in 100 mu L saline or pro-survival cocktail (PSC), which enhances cardiac graft survival, were injected directly into syngeneic rat hearts 1 week after MI. The recipients of ADSCs suspended in PSC had a larger graft area compared with those receiving ASDCs suspended in saline at 1 week post-transplantation (number of graft cells/section: 148.7 +/- 10.6 vs. 22.4 +/- 3.4, p < 0.05, n = 5/group). Thereafter, all ADSC recipients were transplanted with ASDCs in PSC. ADSCs were transplanted into infarcted hearts, and the mechanical and electrophysiological functions were assessed. Echocardiography revealed that ADSC recipients had improved contractile function compared with those receiving PSC vehicle (fractional shortening: 21.1 +/- 0.9 vs. 14.1 +/- 1.2, p <0.05, n >= 12/group). Four weeks post-transplantation, VT was induced via in vivo programmed electrical stimulation. The recipients of ADSCs showed a significantly lower incidence of induced VT compared with the control (31.3% vs. 83.3%, p < 0.05, n >= 12/group). To understand the electrical activity following transplantation, we performed ex vivo optical mapping using a voltage sensitive dye, and found that ADSC transplantation decreased conduction velocity and its dispersion in the pen-infarct area. These results suggest that ADSC transplantation improved cardiac mechanical and electrophysiological functions in subacute MI. (C) 2015 Elsevier Ltd. All rights reserved.	[Gautam, Milan; Kimura, Kazuhiro; Ichikawa, Hinako; Izawa, Atsushi; Ikeda, Uichi; Shiba, Yuji] Shinshu Univ, Dept Cardiovasc Med, Matsumoto, Nagano 3908621, Japan; [Fujita, Daiki] Shinshu Univ, Dept Anat & Organ Technol, Matsumoto, Nagano 3908621, Japan; [Fujita, Daiki; Shiba, Yuji] Shinshu Univ, Inst Biomed Sci, Dept Biotechnol & Biomed Engn, Matsumoto, Nagano 3908621, Japan; [Kashihara, Toshihide; Yamada, Mitsuhiko] Shinshu Univ, Mol Pharmacol, Matsumoto, Nagano 3908621, Japan; [Hirose, Masamichi] Iwate Med Univ, Dept Mol & Cellular Pharmacol, Morioka, Iwate, Japan; [Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan	Shiba, Y (reprint author), Shinshu Univ, Inst Biomed Sci, Dept Cardiovasc Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	yshiba@shinshu-u.ac.jp					Hwang HJ, 2012, J AM COLL CARDIOL, V60, P1698, DOI 10.1016/j.jacc.2012.04.056; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Windmolders S, 2014, J MOL CELL CARDIOL, V66, P177, DOI 10.1016/j.yjmcc.2013.11.016; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; van Dijk A, 2011, STEM CELL RES, V7, P219, DOI 10.1016/j.scr.2011.06.003; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Rosker C, 2011, CIRC RES, V109, P1120, DOI 10.1161/CIRCRESAHA.111.244798; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Ishii M, 2014, INT J CARDIOL, V175, P545, DOI 10.1016/j.ijcard.2014.06.034; Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132; Xu CH, 2011, REGEN MED, V6, P53, DOI [10.2217/rme.10.91, 10.2217/RME.10.91]; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122; Moss AJ, 2000, CIRCULATION, V101, P1638; Pak HN, 2003, J CARDIOVASC ELECTR, V14, P841, DOI 10.1046/j.1540-8167.2003.03124.x; Thompson SA, 2011, CIRCULATION, V123, P2083, DOI 10.1161/CIRCULATIONAHA.110.015057; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Tongers J, 2014, J MOL CELL CARDIOL, V74, P231, DOI 10.1016/j.yjmcc.2014.05.017; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Wiegerinck RF, 2008, HEART RHYTHM, V5, P1178, DOI 10.1016/j.hrthm.2008.04.026; Rigol M, 2010, J CARD FAIL, V16, P357, DOI 10.1016/j.cardfail.2009.12.006; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Baker LC, 2000, CIRC RES, V86, P396; CAPASSO JM, 1992, AM J PHYSIOL, V262, pH486; Chang MC, 2014, J MOL CELL CARDIOL, V72, P339, DOI 10.1016/j.yjmcc.2014.04.012; Huang J, 2002, J AM COLL CARDIOL, V40, P375, DOI 10.1016/S0735-1097(02)01942-3; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Mills WR, 2007, J MOL CELL CARDIOL, V42, P304, DOI 10.1016/j.yjmcc.2006.09.011; Nguyen T, 1998, CIRCULATION, V98, P2074; Richardson JD, 2013, J CARD FAIL, V19, P342, DOI 10.1016/j.cardfail.2013.03.011; Shiba Y, 2014, J CARDIOVASC PHARM T, V19, P368, DOI 10.1177/1074248413520344; Thompson SA, 2014, J MOL CELL CARDIOL, V68, P29, DOI 10.1016/j.yjmcc.2013.12.025	39	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	APR	2015	81						139	149		10.1016/j.yjmcc.2015.02.012		11	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CG2BF	WOS:000353079200020		
J	Wu, L; Tan, JL; Wang, ZH; Chen, YX; Gao, L; Liu, JL; Shi, YH; Endoh, M; Yang, HT				Wu, Lan; Tan, Ji-Liang; Wang, Zhi-Hua; Chen, Yi-Xiong; Gao, Ling; Liu, Jin-Long; Shi, Yun-Hua; Endoh, Masao; Yang, Huang-Tian			ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca2+ overload and contractile dysfunction via the JAK2/STAT3 pathway	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Reactive oxygen species; Intracellular Ca2+ concentration; STAT3; Bcl-2; SR Ca2+-ATPase 2; Intermittent hypobaric hypoxia	JAK-STAT PATHWAY; INDUCED CARDIAC DYSFUNCTION; ISCHEMIA-REPERFUSION; ISCHEMIA/REPERFUSION INJURY; SARCOPLASMIC-RETICULUM; SIGNALING PATHWAYS; RAT CARDIOMYOCYTES; MITOCHONDRIAL CA2+; HYDROGEN-PEROXIDE; NA+/CA2+ EXCHANGE	Moderate enhanced reactive oxygen species (ROS) during early reperfusion trigger the cardioprotection against ischemia/reperfusion (I/R) injury, while the mechanism is largely unknown. Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) contributes to the cardioprotection but whether it is activated by ROS and how it regulates Ca2+ homeostasis remain unclear. Here we investigated whether the ROS generated during early reperfusion protect the heart/cardiomyocyte against I/R-induced Ca2+ overload and contractile dysfunction via the activation of JAK2/STAT3 signaling pathway by using a cardioprotective model of intermittent hypobaric hypoxia (IHH) preconditioning. IHH improved the postischemic recovery of myocardial contractile performance in isolated rat I/R hearts as well as Ca2+ homeostasis and cell contraction in simulated I/R cardiomyocytes. Meanwhile, IHH enhanced I/R-increased STAT3 phosphorylation at tyrosine 705 in the nucleus and reversed I/R-suppressed STAT3 phosphorylation at serine 727 in the nucleus and mitochondria during reperfusion. Moreover, IHH improved I/R-suppressed sarcoplasmic reticulum (SR) Ca2+-ATPase 2 (SERCA2) activity, enhanced I/R-increased Bcl-2 expression, and promoted the co-localization and interaction of Bcl-2 with SERCA2 during reperfusion. These effects were abolished by scavenging ROS with N-(2-mercaptopropionyI)-glycine (2-MPG) and/or by inhibiting JAK2 with AG490 during the early reperfusion. Furthermore, IHH-improved postischemic SERCA2 activity and Ca2+ homeostasis as well as cell contraction were reversed after Bcl-2 knockdown by short hairpin RNA. In addition, the reversal of the I/R-suppressed mitochondrial membrane potential by IHH was abolished by 2-MPG and AG490. These results indicate that during early reperfusion the ROS/JAK2/STAT3 pathways play a crucial role in (i) the IHH-maintained intracellular Ca2+ homeostasis via the improvement of postischemic SERCA2 activity through the increase of SR Bcl-2 and its interaction with SERCA2; and (ii) the IHH-improved mitochondrial function. (C) 2015 Elsevier Ltd. All rights reserved.	[Wu, Lan; Tan, Ji-Liang; Wang, Zhi-Hua; Chen, Yi-Xiong; Gao, Ling; Liu, Jin-Long; Shi, Yun-Hua; Yang, Huang-Tian] Chinese Acad Sci, SIBS, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200031, Peoples R China; [Wu, Lan; Tan, Ji-Liang; Wang, Zhi-Hua; Chen, Yi-Xiong; Gao, Ling; Liu, Jin-Long; Shi, Yun-Hua; Yang, Huang-Tian] Chinese Acad Sci, SIBS, Inst Hlth Sci, Mol Cardiol Lab, Shanghai 200031, Peoples R China; [Wu, Lan; Tan, Ji-Liang; Wang, Zhi-Hua; Chen, Yi-Xiong; Gao, Ling; Liu, Jin-Long; Shi, Yun-Hua; Yang, Huang-Tian] Shanghai Jiao Tong Univ, Sch Med SJTUSM, Shanghai 200030, Peoples R China; [Wang, Zhi-Hua] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Endoh, Masao] Yamagata Univ, Sch Med, Dept Pharmacol, Yamagata 99023, Japan	Yang, HT (reprint author), Chinese Acad Sci, SIBS, Inst Hlth Sci, Room 1232,Biol Res Bldg A,320 Yue Yang Rd, Shanghai 200031, Peoples R China.	htyang@sibs.ac.cn			National Natural Sciences Foundation of China [81170119]; Major State Basic Research Development Program of China [2012CB518203]; National Science and Technology Major Project of China [2012ZX09501001]	This work was supported by National Natural Sciences Foundation of China (81170119), the Major State Basic Research Development Program of China (2012CB518203), and the National Science and Technology Major Project of China (2012ZX09501001).	Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Neckar J, 2004, PHYSIOL RES, V53, P621; Alreja G, 2012, J INVASIVE CARDIOL, V24, P42; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Wang ZH, 2011, AM J PHYSIOL-HEART C, V301, pH1695, DOI 10.1152/ajpheart.00276.2011; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; Tomai F, 1999, CIRCULATION, V100, P559; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; Barry SP, 2007, TRENDS MOL MED, V13, P82, DOI 10.1016/j.molmed.2006.12.002; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Chen L, 2006, AM J PHYSIOL-CELL PH, V290, pC1221, DOI 10.1152/ajpcell.00526.2005.; Ng FS, 2013, J MOL CELL CARDIOL, V59, P67, DOI 10.1016/j.yjmcc.2013.02.001; Boengler K, 2008, CIRC RES, V102, P131, DOI 10.1161/CIRCRESAHA.107.164699; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Sucher R, 2009, TRANSPL INT, V22, P922, DOI 10.1111/j.1432-2277.2009.00883.x; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Lu XY, 2008, CARDIOVASC RES, V79, P500, DOI 10.1093/cvr/cvn091; Asemu G, 1999, J MOL CELL CARDIOL, V31, P1821, DOI 10.1006/jmcc.1999.1013; Choi SY, 2012, INFLAMM RES, V61, P493, DOI 10.1007/s00011-012-0437-7; CORDEIRO JM, 1994, CARDIOVASC RES, V28, P1794, DOI 10.1093/cvr/28.12.1794; Del Pilar V, 2006, J CUCL CARDIOL, V13, P69, DOI DOI 10.1016/J.NUCLCARD.2005.11.008; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Gao H, 2007, CARDIOVASC RES, V75, P584, DOI 10.1016/j.cardiores.2007.04.008; Gao L, 2014, AM J PHYSIOL-HEART C, V306, pH1569, DOI 10.1152/ajpheart.00772.2013; Hausenloy DJ, 2007, PHARMACOL THERAPEUT, V116, P173, DOI 10.1016/j.pharmthera.2007.06.005; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; Li JY, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0271-7; Li YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048115; Luan HF, 2013, BRAZ J MED BIOL RES, V45, P898; Ma J, 2010, EXP CELL RES, V316, P2340, DOI 10.1016/j.yexcr.2010.05.013; McCormick J, 2006, FASEB J, V20, P2115, DOI 10.1096/fj.06-6188fje; Piper HM, 2006, CARDIOVASC RES, V70, P170, DOI 10.1016/j.cardiores.2006.03.010; Przyklenk K, 2011, BASIC RES CARDIOL, V106, P325, DOI 10.1007/s00395-011-0169-9; Sharikabad MN, 2004, FREE RADICAL BIO MED, V37, P531, DOI 10.1016/j.freeradbiomed.2004.05.002; Temsah RM, 2002, AM J PHYSIOL-HEART C, V282, pH1461, DOI 10.1152/ajpheart.00447.2001; Tian YK, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-53; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070587; Wang ZH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.267; Xie Y, 2005, AM J PHYSIOL-HEART C, V288, pH2594, DOI 10.1152/ajpheart.00926.2004; Xu WQ, 2011, BASIC RES CARDIOL, V106, P329, DOI 10.1007/s00395-011-0159-y; Yamaura G, 2003, AM J PHYSIOL-HEART C, V285, pH476, DOI 10.1152/ajpheart.00079.2003; Yang HT, 2012, INTERMITTENT HYPOXIA, P47; Yeung HM, 2007, AM J PHYSIOL-CELL PH, V292, pC2046, DOI 10.1152/ajpcell.00458.2006; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu HM, 2006, APOPTOSIS, V11, P931, DOI 10.1007/s10495-006-6578-9; Yu Z, 2009, AM J PHYSIOL-HEART C, V297, pH735, DOI 10.1152/ajpheart.01164.2008; Zhu WZ, 2006, J MOL CELL CARDIOL, V40, P96, DOI 10.1016/j.yjmcc.2005.09.016	50	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	APR	2015	81						150	161		10.1016/j.yjmcc.2015.02.015		12	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CG2BF	WOS:000353079200021		
J	Eum, S; Shoji, Y; Murata, M; Nishinaga, N				Eum, S.; Shoji, Y.; Murata, M.; Nishinaga, N.			Design and implementation of ICN-enabled IEEE 802.11 access points as nano data centers	JOURNAL OF NETWORK AND COMPUTER APPLICATIONS			English	Article						ICN; Nano data center	NETWORK	Network operators have suffered from explosive increase in mobile users, especially who are eager to watch all forms of video. At the same time, the mobile users tend to experience unexpected delay and disruption due to content retrieval from inappropriate location and frequent handover. To address the problems, this paper introduces an application scenario of Information Centric Networking (ICN) named CATT (Cache Aware Target idenTification), more specifically ICN-enabled IEEE 802.11 wireless access points as nano data centers. We describe its design tenet and implementation, and current deployment over the virtualization platform of JGN-X in Japan. The synergy between ICN supporting mobility as the norm and widely deployed broadband IEEE 802.11 wireless access points makes this proposal attractive as a potential application scenario for ICN. (C) 2014 Elsevier Ltd. All rights reserved.	[Eum, S.; Shoji, Y.; Nishinaga, N.] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan; [Murata, M.] Osaka Univ, Suita, Osaka 5650871, Japan	Eum, S (reprint author), Natl Inst Informat & Commun Technol, 4-2-1 Nukui Kitamachi, Koganei, Tokyo 1848795, Japan.	suyong@nict.go.jp; shoji@nict.go.jp; murata@osaka-u.ac.jp; nisinaga@nict.go.jp					Ain M, 2009, PSIRP 7 FP EU FUND P; Laoutaris N, 2008, ACM SIGCOMM COMP COM, V38, P51, DOI 10.1145/1341431.1341442; Zink M, 2009, COMPUT NETW, V53, P501, DOI 10.1016/j.comnet.2008.09.022; [Anonymous], IEEE80211AC; Anand A, 2009, PERF E R SI, V37, P37; [Anonymous], GLOBAL MOBILE DATA B; Lee U, 2011, IEEE NETWORK, V25, P14; Bonomi F., 2012, P 1 ED MCC WORKSH MO; Dannewitz C., 2009, P 3 GI ITG KUVS WORK; Duan Z, 2005, P SRUTI 05 STEPS RED; Eum S., 2012, P SIGCOMM 2012 ICN W; Eum S, 2013, COMPUT NETW, V57, P3154, DOI 10.1016/j.comnet.2013.08.010; Eum S, 2012, IEEE COMMUN MAG, V50, P60; Eum S, 2013, P 4 INT C ICT CONV 2; Jacobson V., 2009, P 5 INT C EM NETW EX; Ko B, 2012, P 2 ED ICN WORKSH IN; Koponen T., 2007, P 2007 C APPL TECHN; Lo SC, 2004, IEEE J SEL AREA COMM, V22, P691, DOI 10.1109/JSAC.2004.825964; Valancius V., 2009, P 5 INT C EM NETW EX; Varvello M, 2012, P SIGCOMM 2012 ICN W	20	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1084-8045			J NETW COMPUT APPL	J. Netw. Comput. Appl.	APR	2015	50						159	167		10.1016/j.jnca.2014.07.031		9	Computer Science, Hardware & Architecture; Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering	Computer Science	CF9ZJ	WOS:000352926100016		
J	Nagata, C; Wada, K; Tamura, T; Kawachi, T; Konishi, K; Tsuji, M; Nakamura, K				Nagata, Chisato; Wada, Keiko; Tamura, Takashi; Kawachi, Toshiaki; Konishi, Kie; Tsuji, Michiko; Nakamura, Kozue			Dietary Intakes of Glutamic Acid and Glycine Are Associated with Stroke Mortality in Japanese Adults	JOURNAL OF NUTRITION			English	Article						hypertension; dietary protein; amino acids; prospective studies; risk factors	BLOOD-PRESSURE; INTRAPARENCHYMAL HEMORRHAGE; ENDOTHELIAL DYSFUNCTION; PROSPECTIVE COHORT; PROTEIN-INTAKE; AMINO-ACIDS; WOMEN; RISK; FAT; HEALTH	Background: Dietary intakes of glutamic acid and glycine have been reported to be associated with blood pressure. However, the link between intakes of these amino acids and stroke has not been studied. Objective: We aimed to examine the association between glutamic acid and glycine intakes and the risk of mortality from stroke in a population-based cohort study in Japan. Methods: The analyses included 29,079 residents (13,355 men and 15,724 women) of Takayama City, Japan, who were aged 35-101 y and enrolled in 1992. Their body mass index ranged from 9.9 to 57.4 kg/m(2) Their diets were assessed by a validated food frequency questionnaire. Deaths from stroke were ascertained over 16 y. Results: During follow-up, 677 deaths from stroke (328 men and 349 women) were identified. A high intake of glutamic acid in terms of a percentage of total protein was significantly associated with a decreased risk of mortality from total stroke in women after controlling for covariates; the HR (95% CI) for the highest vs. lowest quartile was 0.72 (0.53, 0.98; P-trend: 0.03). Glycine intake was significantly associated with an increased risk of mortality from total and ischemic stroke in men without history of hypertension at baseline; the HRs (95% Cls) for the highest vs. lowest tertile were 1.60 (0.97, 2.51; P-trend: 0.03) and 1.88 (1.01, 3.52; P-trend: 0.02), respectively. There was no association between animal or vegetable protein intake and mortality from total and any subtype of stroke. Conclusion: The data suggest that glutamic acid and glycine intakes may be associated with risk of stroke mortality. Given that this is an initial observation, our results need to be confirmed.	[Nagata, Chisato; Wada, Keiko; Tamura, Takashi; Kawachi, Toshiaki; Konishi, Kie; Tsuji, Michiko; Nakamura, Kozue] Gifu Univ, Dept Epidemiol & Prevent Med, Grad Sch Med, Gifu, Japan; [Tsuji, Michiko] Japan Womens Univ, Dept Food & Nutr, Tokyo 112, Japan; [Nakamura, Kozue] Gifu City Womens Coll, Dept Food & Nutr, Gifu, Japan	Nagata, C (reprint author), Gifu Univ, Dept Epidemiol & Prevent Med, Grad Sch Med, Gifu, Japan.	chisato@gifu-u.ac.jp			National Cancer Center Research and Development Fund; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Supported by grants from the National Cancer Center Research and Development Fund and the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Sauvaget C, 2004, STROKE, V35, P1531, DOI 10.1161/01.STR.0000130426.52064.09; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Stamler J, 2009, CIRCULATION, V120, P221, DOI 10.1161/CIRCULATIONAHA.108.839241; Iso H, 2003, AM J EPIDEMIOL, V157, P32, DOI 10.1093/aje/kwf166; Qin LQ, 2011, J NUTR, V141, P249, DOI 10.3945/jn.110.128520; Stamler J, 2013, AM J CLIN NUTR, V98, P136, DOI 10.3945/ajcn.112.043000; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P446, DOI 10.1016/S0753-3322(02)00285-8; Wang WW, 2013, AMINO ACIDS, V45, P463, DOI 10.1007/s00726-013-1493-1; Wu GY, 2013, AMINO ACIDS, V44, P1107, DOI 10.1007/s00726-012-1444-2; Bernstein AM, 2012, STROKE, V43, P637, DOI 10.1161/STROKEAHA.111.633404; Preis SR, 2010, AM J CLIN NUTR, V91, P39, DOI 10.3945/ajcn.2009.28060; Iso H, 2001, CIRCULATION, V103, P856; Davis CM, 2013, TRANSL STROKE RES, V4, P381, DOI 10.1007/s12975-012-0227-0; El Hafidi M, 2006, CURR OPIN CLIN NUTR, V9, P26, DOI 10.1097/01.mco.0000196143.72985.9a; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Krajcovicova-Kudlackova M, 2005, Bratisl Lek Listy, V106, P231; Lagiou P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4026; Larsson SC, 2012, ATHEROSCLEROSIS, V224, P247, DOI 10.1016/j.atherosclerosis.2012.07.009; Nagata C, 2012, J NUTR, V142, P1713, DOI 10.3945/jn.112.161661; Nishioka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062929; Prasad A, 1999, J AM COLL CARDIOL, V34, P507, DOI 10.1016/S0735-1097(99)00216-8; Roth E, 2008, J NUTR, V138, P2025; Roth E, 2002, NUTRITION, V18, P217, DOI 10.1016/S0899-9007(01)00797-3; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Sasaki S, 1999, J Epidemiol, V9, P190; Shimizu H, 1999, JPN J CLIN ONCOL, V29, P38, DOI 10.1093/jjco/29.1.38; Shimizu H, 1996, BASIC REPORT TAKAYAM; Shimizu Hiroyuki, 2002, J Epidemiol, V12, P54; Young VR, 2001, J NUTR, V131, p2449S	29	2	2	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3166	1541-6100		J NUTR	J. Nutr.	APR	2015	145	4					720	728		10.3945/jn.114.201293		9	Nutrition & Dietetics	Nutrition & Dietetics	CE9RG	WOS:000352180500008		
J	Tsubota-Utsugi, M; Kikuya, M; Satoh, M; Inoue, R; Hosaka, M; Metoki, H; Hirose, T; Asayama, K; Imai, Y; Ohkubo, T				Tsubota-Utsugi, M.; Kikuya, M.; Satoh, M.; Inoue, R.; Hosaka, M.; Metoki, H.; Hirose, T.; Asayama, K.; Imai, Y.; Ohkubo, T.			Living situations associated with poor dietary intake among healthy japanese elderly: The ohasama study	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Living alone; living with family other than a spouse (nonspouse family); gender difference; dietary; intake; elderly; Japanese	OLDER-ADULTS; UNITED-STATES; FOLLOW-UP; COGNITIVE IMPAIRMENT; MARITAL-STATUS; RISK-FACTORS; ARRANGEMENTS; SURVIVAL; MEN; POPULATION	Background: Rapid increases in life expectancy have led to concurrent increases in the number of elderly people living alone or those forced to change living situations. Previous studies have found that poor dietary intake was common in elderly people living alone. However, there have been few studies about the dietary intake in elderly people living in other situations, particularly those living with family other than a spouse (nonspouse family), which is common in Japan. Objective: To examine the differences in dietary intake by different living situations in elderly Japanese people. We analyzed the data of 1542 healthy residents in the town of Ohasama aged 60 years and over who had completed self-administered questionnaires. Methods: The dietary intake was measured using a validated 141-item food frequency questionnaire. Multiple regression models with robust (White-corrected) standard errors were individually fitted for nutrients and foods by living situation. Results: In men, although the presence of other family was correlated with significantly lower intake of protein-related foods, e.g., legumes, fish and shellfish, and dairy products, these declines were more serious in men living with nonspouse family. Conversely, in men living alone the intake of fruits and vegetables was significantly lower. In women, lower intakes of fruit and protein-related foods were significantly more common in participants living with nonspouse family than those living with only a spouse. Conclusion: These findings revealed that elderly people living alone as well as those living with family other than a spouse had poor dietary intake, suggesting that strategies to improve food choices and skills for food preparation could promote of healthy eating in elderly Japanese people.	[Tsubota-Utsugi, M.] Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo 1628636, Japan; [Tsubota-Utsugi, M.] Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Tokyo 1628636, Japan; [Kikuya, M.; Metoki, H.] Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Satoh, M.] Tohoku Univ Hosp, Dept Pharm, Sendai, Miyagi, Japan; [Inoue, R.] Tohoku Univ, Dept Med Informat, Grad Sch Med, Sendai, Miyagi 980, Japan; [Hosaka, M.; Asayama, K.; Imai, Y.] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Hirose, T.] Coll France, Ctr Interdisciplinary Res Biol, F-75231 Paris, France; [Asayama, K.; Ohkubo, T.] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan	Tsubota-Utsugi, M (reprint author), Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Dept Nutr Epidemiol, Shinjyuku Ku, Toyama 1-23-1, Tokyo 1628636, Japan.	mutsugky@nih.go.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23249036, 23390171, 24591060, 24390084, 25253059, 26860093, 24790654, 25461205, 25461083, 25860156]; Ministry of Health, Labor, and Welfare, Japan [H23-Junkankitou [Seishuu]-Ippan-005]; Japan Arteriosclerosis Prevention Fund; Daiwa Securities Health Foundation	Funding sources and related paper presentations: This work was supported by the Grants for Scientific Research (23249036, 23390171, 24591060, 24390084, 25253059, 26860093, 24790654, 25461205, 25461083 and 25860156) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and a Health Labor Sciences Research Grant (H23-Junkankitou [Seishuu]-Ippan-005) from the Ministry of Health, Labor, and Welfare, Japan; the Japan Arteriosclerosis Prevention Fund; and the Grant from the Daiwa Securities Health Foundation.	Davis MA, 1997, AM J PUBLIC HEALTH, V87, P371, DOI 10.2105/AJPH.87.3.371; Michael YL, 2001, AM J EPIDEMIOL, V153, P123, DOI 10.1093/aje/153.2.123; Kimura Y, 2012, J NUTR HEALTH AGING, V16, P728, DOI 10.1007/s12603-012-0067-3; Tsuji I, 1997, AM J HYPERTENS, V10, P409; Hsiao PY, 2013, J NUTR HEALTH AGING, V17, P19, DOI 10.1007/s12603-012-0082-4; Sharkey JR, 2002, AM J CLIN NUTR, V76, P1435; Pearson JM, 1998, INT J FOOD SCI NUTR, V49, P131, DOI 10.1080/096374080410001666504; DAVIS MA, 1992, AM J PUBLIC HEALTH, V82, P401, DOI 10.2105/AJPH.82.3.401; Thompson JL, 2011, PUBLIC HEALTH NUTR, V14, P1640, DOI 10.1017/S1368980011000747; Chen RCY, 2012, PUBLIC HEALTH NUTR, V15, P1142, DOI 10.1017/S136898001200136X; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Hughes G, 2004, APPETITE, V43, P269, DOI 10.1016/j.appet.2004.06.002; Winkler S, 1999, J AM DENT ASSOC, V130, P1759; Kwon J, 2006, EUR J CLIN NUTR, V60, P305, DOI 10.1038/sj.ejcn.1602314; BarbergerGateau P, 1997, DISABIL REHABIL, V19, P175; Kaneda H, 2000, CHEM SENSES, V25, P331, DOI 10.1093/chemse/25.3.331; GOLDMAN N, 1995, SOC SCI MED, V40, P1717, DOI 10.1016/0277-9536(94)00281-W; Mehta KM, 2002, J AM GERIATR SOC, V50, P1045, DOI 10.1046/j.1532-5415.2002.50259.x; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Engel JH, 2011, J AM GERIATR SOC, V59, P482, DOI 10.1111/j.1532-5415.2010.03274.x; Bailey RL, 2004, J AM DIET ASSOC, V104, P1273, DOI 10.1016/j.jada.2004.05.210; Caroline C. H., 1989, J HUMAN NUTR DIETETI, V2, P185; Chang YH, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.126698; DAVIS MA, 1990, J AM DIET ASSOC, V90, P1667; DAVIS MA, 1985, J GERONTOL, V40, P434; DAVIS MA, 1988, J GERONTOL, V43, pS96; Flagg LA, 2013, PUBLIC HEALTH NUTR, P1; Fujiwara Yoshinori, 2003, Nihon Koshu Eisei Zasshi, V50, P360; Ikeda A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-73; Koyano, 1991, ARCH GERONTOL GERIAT, V13, P103; Linardakis M, 2013, PREVENTIVE MED; Ministry of Health Labour and Welfare, 2008, STAT ABSTR HLTH WELF; Ministry of Health Labour and Welfare, 2011, COMPR SURV LIV COND; Ministry of Health Labour and Welfare, 2009, ANN REP NAT HLTH NUT; Ministry of Health Labour and Welfare, 2010, ANN REP NAT HLTH NUT; Ohkubo Takayoshi, 2006, Expert Rev Neurother, V6, P163, DOI 10.1586/14737175.6.2.163; Scafato E, 2008, SOC SCI MED, V67, P1456, DOI 10.1016/j.socscimed.2008.06.026; Stone J, 2013, AGE AGEING, V42, P366, DOI 10.1093/ageing/aft006; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; Tsubono Y, 2001, NUTR CANCER, V39, P78, DOI 10.1207/S15327914nc391_11	40	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	APR	2015	19	4					375	382		10.1007/s12603-015-0456-5		8	Geriatrics & Gerontology; Nutrition & Dietetics	Geriatrics & Gerontology; Nutrition & Dietetics	CF6ZO	WOS:000352705800001		
J	Tanaka, H; Katsuragi, S; Tanaka, K; Miyoshi, T; Kamiya, C; Iwanaga, N; Neki, R; Takahashi, JC; Ikeda, T; Yoshimatsu, J				Tanaka, Hiroaki; Katsuragi, Shinji; Tanaka, Kayo; Miyoshi, Takekazu; Kamiya, Chizuko; Iwanaga, Naoko; Neki, Reiko; Takahashi, Jun C.; Ikeda, Tomoaki; Yoshimatsu, Jun			Vaginal delivery in pregnancy with Moyamoya disease: Experience at a single institute	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						delivery mode; Moyamoya disease; pregnancy	OUTCOMES; DOPPLER; TRIAL; JAPAN; WOMEN	AimCesarean section is commonly selected in pregnancy with Moyamoya disease. We consider vaginal delivery with epidural anesthesia a viable alternative in such cases. MethodsMode of delivery and outcomes were examined in 27 pregnancies in 19 women with Moyamoya disease treated at the Department of Perinatology, National Cardiovascular Center, Japan, from 1983 to 2013. Of these 27 pregnancies, 20 were delivered vaginally with epidural anesthesia. The cerebral circulation, mode of delivery, maternal outcome (presence of symptoms due to Moyamoya disease intrapartum) and neonatal outcome (gestational week, birthweight, Apgar score at 5min and pH of umbilical artery) were investigated. ResultsThe cerebral circulation was judged to be good in all pregnancies. No symptoms due to Moyamoya disease intrapartum were seen in the vaginal delivery cases. ConclusionOur findings indicate that vaginal delivery is viable in pregnancy with Moyamoya disease and that unnecessary cesarean section may be avoided. These findings are limited by the retrospective nature of the study.	[Tanaka, Hiroaki; Katsuragi, Shinji; Tanaka, Kayo; Miyoshi, Takekazu; Kamiya, Chizuko; Iwanaga, Naoko; Neki, Reiko; Yoshimatsu, Jun] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol, Suita, Osaka 5658565, Japan; [Takahashi, Jun C.] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka 5658565, Japan; [Ikeda, Tomoaki] Mie Univ, Fac Med, Dept Obstet & Gynecol, Tsu, Mie 514, Japan	Tanaka, H (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Perinatol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	tanaka.hiroaki.hp@ncvc.go.jp					SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Hannah ME, 2004, AM J OBSTET GYNECOL, V191, P917, DOI 10.1016/j.ajog.2004.08.004; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Miyamoto S, 2014, STROKE, V45, P1415, DOI 10.1161/STROKEAHA.113.004386; Fujimura M, 2013, NEUROL MED-CHIR, V53, P561; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Fukushima K, 2012, J CLIN NEUROSCI, V19, P1358, DOI 10.1016/j.jocn.2011.12.021; Goto Yasunobu, 1992, Neurologia Medico-Chirurgica, V32, P883, DOI 10.2176/nmc.32.883; Ikeda T, 2002, GYNECOL OBSTET INVES, V53, P65, DOI 10.1159/000049414; IKEDA T, 1991, J CARDIOVASC TECHNOL, V10, P65; Lis H, 2011, STROKE, V42, P1138; Mallory GW, 2013, NEUROSURGERY, V73, P984, DOI 10.1227/NEU.0000000000000162; Matsuda Ryosuke, 2011, No Shinkei Geka, V39, P1159; NISHIMOT.A, 1968, J NEUROSURG, V29, P255, DOI 10.3171/jns.1968.29.3.0255; Takahashi JC, 2012, NEUROL MED-CHIR, V52, P304; Takeuchi K, 1957, NO TO SHINKEI, V9, P37; vansHam MAPC, 1997, EUR J OBSTET GYN R B, V74, P1	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	APR	2015	41	4					517	522		10.1111/jog.12557		6	Obstetrics & Gynecology	Obstetrics & Gynecology	CF8DV	WOS:000352786800004		
J	Mochimaru, A; Aoki, S; Oba, MS; Kurasawa, K; Takahashi, T; Hirahara, F				Mochimaru, Aya; Aoki, Shigeru; Oba, Mari S.; Kurasawa, Kentaro; Takahashi, Tsuneo; Hirahara, Fumiki			Adverse pregnancy outcomes associated with adenomyosis with uterine enlargement	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						adenomyosis; fetal growth restriction; fetal malpresentation; pregnancy outcome; preterm delivery	BIRTH-WEIGHT; WOMEN; PREVALENCE; OXYTOCIN; PRETERM; DYSMENORRHEA; FERTILITY; LABOR; RISK	AimThe aim of this study was to elucidate the risk of poor pregnancy outcomes in women with adenomyosis by comparing their outcomes to those of women without uterine abnormalities. Material and MethodsThe subjects were 36 women diagnosed with adenomyosis before pregnancy who were managed at a tertiary care center between January 2002 and December 2012. Our hospital database was retrospectively reviewed to identify pregnancy outcomes associated with adenomyosis. The control group consisted of 144 women without uterine abnormalities who gave birth during the same period and whose age at delivery was adjusted by applying propensity scores. Pregnancy outcomes were compared between the adenomyosis and control groups. The main outcomes were gestational age at delivery, preterm delivery, preterm premature rupture of membranes, fetal malpresentation, cesarean delivery, small-for-gestational age, 5-min Apgar score<7, umbilical arterial pH<7.1, and neonatal intensive care unit admission. The data are presented as medians (range) or frequencies (percentage). ResultsThe adenomyosis group had significantly higher rates of preterm delivery (41.7% vs 12.5%), preterm premature rupture of membranes (19.4% vs 4.2%), small-for-gestational age (33.3% vs 10.4%), fetal malpresentation (27.8% vs 8.3%), and cesarean delivery (58.3% vs 24.3%), as compared with the control group. No significant differences were observed in 5-min Apgar score<7 or umbilical arterial pH<7.1 between the two groups. ConclusionsPregnancies in women with adenomyosis were associated with a higher preterm delivery rate and more frequent occurrences of fetal growth restriction and fetal malpresentation, such that both pregnancy and delivery outcomes were poor.	[Mochimaru, Aya; Aoki, Shigeru; Kurasawa, Kentaro; Takahashi, Tsuneo] Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonates, Yokohama, Kanagawa 2320024, Japan; [Oba, Mari S.] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 2320024, Japan; [Oba, Mari S.] Univ Med Ctr, Yokohama, Kanagawa, Japan; [Hirahara, Fumiki] Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan	Aoki, S (reprint author), Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonates, Minami Ku, 4-57 Urafunecyou, Yokohama, Kanagawa 2320024, Japan.	smyyaoki@yahoo.co.jp		Aoki, Shigeru/0000-0001-5307-575X			Al Jama Fathia E, 2011, Oman Med J, V26, P178, DOI 10.5001/omj.2011.43; Kissler S, 2008, EUR J OBSTET GYN R B, V137, P204, DOI 10.1016/j.ejogrb.2007.01.015; RICE JP, 1989, AM J OBSTET GYNECOL, V160, P1212; Salafia CM, 2008, PAEDIATR PERINAT EP, V22, P229, DOI 10.1111/j.1365-3016.2008.00935.x; Norwitz ER, 1999, NEW ENGL J MED, V341, P660, DOI 10.1056/NEJM199908263410906; Naftalin J, 2012, HUM REPROD, V27, P3432, DOI 10.1093/humrep/des332; Guo SW, 2013, FERTIL STERIL, V99, P231, DOI 10.1016/j.fertnstert.2012.08.038; Kunz G, 2005, HUM REPROD, V20, P2309, DOI 10.1093/humrep/dei021; Juang CM, 2007, BJOG-INT J OBSTET GY, V114, P165, DOI 10.1111/j.1471-0528.2006.01186.x; Ferenczy A, 1998, HUM REPROD UPDATE, V4, P312, DOI 10.1093/humupd/4.4.312; Maheshwari A, 2012, HUM REPROD UPDATE, V18, P374, DOI 10.1093/humupd/dms006; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; AZZIZ R, 1989, OBSTET GYN CLIN N AM, V16, P221; Devlieger R, 2003, HUM REPROD UPDATE, V9, P139, DOI 10.1093/humupd/dmg010; Dyson DC, 1998, NEW ENGL J MED, V338, P15, DOI 10.1056/NEJM199801013380103; HEINONEN PK, 1982, ACTA OBSTET GYN SCAN, V61, P157; LevGur M, 1996, J REPROD MED, V41, P166; Pierzynski P, 2004, J SOC GYNECOL INVEST, V11, P384, DOI 10.1016/j.jsgi.2004.02.008; REITER RC, 1992, OBSTET GYNECOL, V79, P481; TJUGUM J, 1985, EUR J OBSTET GYN R B, V19, P137, DOI 10.1016/0028-2243(85)90147-9; WORTHEN N J, 1984, Obstetrics and Gynecology, V64, p34S; Yorifuji T, 2013, J OBSTET GYNAECOL RE, V39, P1480, DOI 10.1111/jog.12088	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	APR	2015	41	4					529	533		10.1111/jog.12604		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CF8DV	WOS:000352786800006		
J	Takushima, S; Nishi, Y; Nonoshita, A; Mifune, H; Hirata, R; Tanaka, E; Doi, R; Hori, D; Kamura, T; Ushijima, K				Takushima, Sachiyo; Nishi, Yoshihiro; Nonoshita, Akiko; Mifune, Hiroharu; Hirata, Rumiko; Tanaka, Eiichiro; Doi, Ryosuke; Hori, Daizo; Kamura, Toshiharu; Ushijima, Kimio			Changes in the nitric oxide-soluble guanylate cyclase system and natriuretic peptide receptor system in placentas of pregnant Dahl salt-sensitive rats	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						cyclic guanosine monophosphate; Dahl-S rat; NOS-NO-sGC system; NP-NPR system; superimposed pre-eclampsia	DECIDUAL SPIRAL ARTERIAL; FETAL-DEVELOPMENT; BLOOD-PRESSURE; L-ARGININE; PREECLAMPSIA; PATHOGENESIS; EXPRESSION; HYPERTENSION; MECHANISMS; DISPARITY	s AimDiminished vasodilator activity during pregnancy, which augments vascular responses to vasoconstrictors, is one reason for the onset of pre-eclampsia and superimposed pre-eclampsia. It is known that Dahl salt-sensitive (Dahl-S) rats develop salt-sensitive hypertension like African-Americans. The present study attempted to assess the changes and the interactions of the NOS-NO-sGC-cGMP and NP-NPR-cGMP systems in the hypertensive placenta using Dahl-S rats as an animal model of superimposed pre-eclampsia. Material and MethodsPregnant Dahl-S rats were fed a high-salt diet to induce the development of hypertension and fetal growth restriction. Using these rats, we investigated the regulation of these two vasodilatation systems, including the kinetics of cyclic guanosine monophosphate (cGMP), soluble guanylate cyclase (sGC), endothelial nitric oxide synthase (NOS), cytokine-inducible NOS, natriuretic peptides (NP) (atrial NP, brain NP and C-type NP), and NP receptors (NPR) (NPR-A, NPR-B, NPR-C). ResultsDahl-S rats fed a high-salt diet exhibited hypertension, fetal growth restriction and thickening of the walls in decidual vessels. The placental cGMP level in the rats fed the high-salt diet was significantly decreased compared with that in controls. The expression levels of endothelial NOS and cytokine-inducible NOS mRNA increased significantly, while that of sGC2-sunbnit declined significantly. Messenger RNA levels of NPR-C, a clearance-type receptor of NP, declined significantly, whereas those of NP and their functional receptors NPR-A and NPR-B were unchanged. ConclusionsAs Dahl-S rats with excess salt-loading during pregnancy exhibited pathological changes similar to those observed in female humans with pre-eclampsia/superimposed pre-eclampsia, this rat could be useful as an animal model of superimposed pre-eclampsia. In the placentas of hypertensive Dahl-S rats, vasodilatation seemed to be disturbed by the deregulation of both the NO-sGC-cGMP and NP-NPR-cGMP systems.	[Takushima, Sachiyo; Nonoshita, Akiko; Hori, Daizo; Ushijima, Kimio] Kurume Univ, Dept Obstet & Gynecol, Sch Med, Kurume, Fukuoka 8300011, Japan; [Nishi, Yoshihiro; Hirata, Rumiko; Tanaka, Eiichiro] Kurume Univ, Dept Physiol, Sch Med, Kurume, Fukuoka 8300011, Japan; [Mifune, Hiroharu] Kurume Univ, Inst Anim Expt, Sch Med, Kurume, Fukuoka 8300011, Japan; [Doi, Ryosuke] Kurume Univ, Radioisotope Inst Basic & Clin Med, Sch Med, Kurume, Fukuoka 8300011, Japan; [Kamura, Toshiharu] Yanagawa Hosp, Dept Obstet & Gynecol, Yanagawa, Japan	Nishi, Y (reprint author), Kurume Univ, Dept Physiol, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	nishiynishi@gmail.com		Nishi, Yoshihiro/0000-0001-7529-1103	Japanese Grants-in-Aid for Scientific Research (KAKENHI) [16790979, 25461570]; Ishibashi Foundation for the Promotion of Science; Foundation for the Promotion of Science of Department of Obstetrics and Gynecology of Kyushu University	The authors of this manuscript would like to thank Dr Masae Oshima (Department of Obstetrics and Gynecology, Kurume University School of Medicine) and Mr Kazuyuki Oba (Institute of Animal Experimentation, Kurume University School of Medicine) for their valuable technical support. This work was supported in part by Japanese Grants-in-Aid for Scientific Research (KAKENHI 16790979 and 25461570) and also by a grant from the Ishibashi Foundation for the Promotion of Science and the Foundation for the Promotion of Science of Department of Obstetrics and Gynecology of Kyushu University.	Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; KNOWLES RG, 1994, BIOCHEM J, V298, P249; Jung JS, 2009, J CLIN ENDOCR METAB, V94, P1042, DOI 10.1210/jc.2008-1861; Cameron VA, 1996, ENDOCRINOLOGY, V137, P817, DOI 10.1210/en.137.3.817; Gewaltig MT, 2002, CARDIOVASC RES, V55, P250, DOI 10.1016/S0008-6363(02)00327-9; Tanaka M, 2007, AM J PUBLIC HEALTH, V97, P163, DOI 10.2105/AJPH.2005.068577; Sandrim VC, 2011, CLIN BIOCHEM, V44, P1012, DOI 10.1016/j.clinbiochem.2011.05.026; Schulz S, 2005, PEPTIDES, V26, P1024, DOI 10.1016/j.peptides.2004.08.027; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Anand-Srivastava MB, 2005, PEPTIDES, V26, P1044, DOI 10.1016/j.peptides.2004.09.023; Sarzani R, 1996, J ENDOCRINOL INVEST, V19, P581; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Vatish M, 2006, TRENDS MOL MED, V12, P223, DOI 10.1016/j.molmed.2006.03.003; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Tucker MJ, 2007, AM J PUBLIC HEALTH, V97, P247, DOI 10.2105/AJPH.2005.072975; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; Aviv A, 2004, HYPERTENSION, V43, P707, DOI 10.1161/01.HYP.0000120155.48024.6f; Kemp-Harper Barbara, 2009, V191, P447; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Wareing M, 2005, J CLIN ENDOCR METAB, V90, P2550, DOI 10.1210/jc.2004-1831; Alexander BT, 2004, HYPERTENSION, V43, P832, DOI 10.1161/01.HYP.0000119192.32360.a9; Russwurm M, 2002, MOL CELL BIOCHEM, V230, P159, DOI 10.1023/A:1014252309493; Bamberger AM, 2001, J CLIN ENDOCR METAB, V86, P909, DOI 10.1210/jc.86.2.909; Bryant AS, 2005, HYPERTENS PREGNANCY, V24, P281, DOI 10.1080/10641950500281134; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Hussain MB, 2001, AM J PHYSIOL-HEART C, V280, pH1151; Khalil RA, 2002, AM J PHYSIOL-REG I, V283, pR29, DOI 10.1152/ajpregu.00762.2001; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Kopincova J, 2008, NEUROENDOCRINOL LETT, V29, P784; LIM AT, 1995, J CLIN ENDOCR METAB, V80, P3091, DOI 10.1210/jc.80.10.3091; Madhani M, 2003, BRIT J PHARMACOL, V139, P1289, DOI 10.1038/sj.bjp.0705365; MARAIS WD, 1962, J OBSTET GYN BR COMM, V69, P213; MARAIS WD, 1962, J OBSTET GYN BR COMM, V69, P225; Miller SL, 2009, AM J OBSTET GYNECOL, V200, p102 e1; NISHI Y, 1994, INT J ONCOL, V5, P33; Nonoshita A, 2010, PLACENTA, V31, P358, DOI 10.1016/j.placenta.2010.02.013; Rytlewski K, 2005, EUR J CLIN INVEST, V35, P32, DOI 10.1111/j.1365-2362.2005.01445.x; Santos-Silva AJ, 2008, EUR J PHARMACOL, V582, P102, DOI 10.1016/j.ejphar.2007.12.017; Takemoto M, 1997, J CLIN INVEST, V99, P278, DOI 10.1172/JCI119156; TODA N, 1989, AM J PHYSIOL, V257, pH988; Turgut NH, 2013, CAN J PHYSIOL PHARM, V91, P797, DOI 10.1139/cjpp-2013-0086; Walther T, 2004, J ENDOCRINOL, V180, P17, DOI 10.1677/joe.0.1800017; Zuckerbraun BS, 2005, J SURG RES, V124, P256, DOI 10.1016/j.jss.2004.10.022	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	APR	2015	41	4					540	550		10.1111/jog.12602		11	Obstetrics & Gynecology	Obstetrics & Gynecology	CF8DV	WOS:000352786800008		
J	Tadakawa, M; Sugawara, J; Saito, M; Nishigori, H; Utsunomiya, H; Nagase, S; Tokunaga, H; Kurakata-Nakamura, M; Sugiyama, T; Yaegashi, N				Tadakawa, Mari; Sugawara, Junichi; Saito, Masatoshi; Nishigori, Hidekazu; Utsunomiya, Hiroki; Nagase, Satoru; Tokunaga, Hideki; Kurakata-Nakamura, Michiyo; Sugiyama, Takashi; Yaegashi, Nobuo			Fertility and pregnancy outcomes following B-Lynch sutures for post-partum hemorrhage	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						B-Lynch sutures; fertility; post-partum hemorrhage	UTERINE COMPRESSION SUTURES; SUBSEQUENT FERTILITY; CESAREAN-SECTION; MANAGEMENT; DELIVERY	AimThe aim of this study was to investigate the long-term fertility prognosis after B-Lynch sutures for post-partum hemorrhage (PPH). MethodsA retrospective observational study was conducted on patients who underwent B-Lynch sutures in our hospital between 2005 and 2010. Patient data was collected from hospital records. Information regarding subsequent pregnancies and menstrual complications were obtained by posted questionnaires and telephone interviews with patients who avoided hysterectomy. ResultsA total of 28 B-Lynch sutures were performed in 3976 deliveries, all in patients that underwent cesarean section. Twenty-two of the 26 patients who avoided hysterectomy answered our questionnaire or took part in an interview. All patients recovered regular menstruation with no severe complications. Of the 19 patients who wanted another child, 12 patients (63.2%) had 14 subsequent pregnancies in a mean follow-up period of 52.1 months. The results of pregnancies were nine uncomplicated term pregnancies, all delivered by elective cesarean section, two artificial abortions and three miscarriages. A significant difference was observed in the age of patients with subsequent pregnancies and those without pregnancies (30.8 vs 34.6 years, P=0.04). ConclusionB-Lynch sutures for PPH do not appear to jeopardize fecundity. An older age was a risk factor for achieving subsequent pregnancies.	[Tadakawa, Mari; Sugawara, Junichi; Saito, Masatoshi; Nishigori, Hidekazu; Utsunomiya, Hiroki; Nagase, Satoru; Tokunaga, Hideki; Kurakata-Nakamura, Michiyo; Sugiyama, Takashi; Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi 9808573, Japan; [Sugawara, Junichi; Yaegashi, Nobuo] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 9808573, Japan	Sugawara, J (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Div Fetomaternal Med Sci, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808573, Japan.	jsugawara@med.tohoku.ac.jp					An GH, 2013, OBSTET GYNECOL, V122, P565, DOI 10.1097/AOG.0b013e31829e3b1d; Fuglsang J, 2014, FERTIL STERIL, V101, P1194, DOI 10.1016/j.fertnstert.2014.01.015; Cho JH, 2000, OBSTET GYNECOL, V96, P129, DOI 10.1016/S0029-7844(00)00852-8; LASALA AP, 1987, AM J OBSTET GYNECOL, V157, P379; Doumouchtsis SK, 2014, BJOG-INT J OBSTET GY, V121, P382, DOI 10.1111/1471-0528.12546; Gurol-Urganci I, 2013, HUM REPROD, V28, P1943, DOI 10.1093/humrep/det130; BLynch C, 1997, BRIT J OBSTET GYNAEC, V104, P372, DOI 10.1111/j.1471-0528.1997.tb11471.x; Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P378, DOI 10.1111/aogs.12077; Kjerulff KH, 2013, HUM REPROD, V28, P3349, DOI 10.1093/humrep/det343; Baskett TF, 2007, OBSTET GYNECOL, V110, P68, DOI 10.1097/01.AOG.0000267499.40531.a4; Enriquez M, 2012, J OBSTET GYNAECOL, V32, P338, DOI 10.3109/01443615.2012.673035; Goojha CA, 2010, FERTIL STERIL, V94; Habek D, 2006, FETAL DIAGN THER, V21, P475, DOI 10.1159/000093892; Khan SK, 2006, LANCET, V376, P1066; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Nather A, 2002, FERTIL STERIL, V78, P424, DOI 10.1016/S0015-0282(02)03215-6; Sentilhes L, 2009, FERTIL STERIL, V91, p934 e5; Treloar EJ, 2006, BJOG-INT J OBSTET GY, V113, P486, DOI 10.1111/j.1471-0528.2006.00890.x	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	APR	2015	41	4					559	564		10.1111/jog.12590		6	Obstetrics & Gynecology	Obstetrics & Gynecology	CF8DV	WOS:000352786800010		
J	Sakaguchi, I; Ohba, T; Ikeda, O; Yamashita, Y; Katabuchi, H				Sakaguchi, Isao; Ohba, Takashi; Ikeda, Osamu; Yamashita, Yasuyuki; Katabuchi, Hidetaka			Embolization for post-partum rupture of ovarian artery aneurysm: Case report and review	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						angiography; early post-partum period; fertility; ovarian artery aneurysm; transcatheter arterial embolization	ENDOVASCULAR TREATMENT; HEMORRHAGE; PREGNANCY; DELIVERY; FERTILITY; HYSTERECTOMY; MENSES	Spontaneous rupture of an ovarian artery aneurysm most commonly presents with abdominal pain in a multiparous woman in the early post-partum period. Aneurysms of the ovarian artery have been reported in the published work very infrequently. In our case, a 31-year-old multiparous woman experienced sudden left lower quadrant abdominal pain on the second post-partum day. Angiography showed rupture of a left ovarian artery aneurysm, which was successfully embolized using gelatin sponge particles. The patient resumed menstruation 3 months after the embolization and concurrently conceived, ultimately giving birth at term without complications. Interventional radiology appears to be a highly safe and effective technique for diagnosis and management of a ruptured ovarian artery aneurysm with minimal risk of impairing subsequent fertility.	[Sakaguchi, Isao; Ohba, Takashi; Katabuchi, Hidetaka] Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Kumamoto, Kumamoto 8608556, Japan; [Ikeda, Osamu; Yamashita, Yasuyuki] Kumamoto Univ, Fac Life Sci, Dept Diagnost Radiol, Kumamoto, Kumamoto 8608556, Japan	Sakaguchi, I (reprint author), Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Chuo Ku, Honjo 1-1-1, Kumamoto, Kumamoto 8608556, Japan.	isakakuh@gmail.com					Hardeman S, 2010, FERTIL STERIL, V94, P2574, DOI 10.1016/j.fertnstert.2010.02.052; Descargues G, 2004, HUM REPROD, V19, P339, DOI 10.1093/humrep/deh082; Ornan D, 2003, OBSTET GYNECOL, V102, P904, DOI 10.1016/S0029-7844(03)00769-5; Salomon LJ, 2003, HUM REPROD, V18, P849, DOI 10.1093/humrep/deg168; BROWN BJ, 1979, OBSTET GYNECOL, V54, P361; StancatoPasik A, 1997, RADIOLOGY, V204, P791; Hong TM, 2004, CLIN RADIOL, V59, P96, DOI 10.1016/j.crad.2003.08.007; Barrett J M, 1982, Obstet Gynecol Surv, V37, P557, DOI 10.1097/00006254-198209000-00001; BELFORT MA, 1993, SOUTHERN MED J, V86, P1073; Blachar A, 2000, CLIN RADIOL, V55, P718, DOI 10.1053/crad.2000.0113; BURNETT RA, 1976, BRIT J OBSTET GYNAEC, V83, P744, DOI 10.1111/j.1471-0528.1976.tb00926.x; CAILLOUETTE JC, 1963, OBSTET GYNECOL, V21, P510; Chao LW, 2009, GYNECOL OBSTET INVES, V68, P104, DOI 10.1159/000220603; Deux JF, 2001, AM J ROENTGENOL, V177, P145; Guillem P, 1999, ANN VASC SURG, V13, P445, DOI 10.1007/s100169900281; HOGDALL CK, 1989, ACTA OBSTET GYN SCAN, V68, P651, DOI 10.3109/00016348909013287; JAFARI K, 1977, OBSTET GYNECOL, V49, P493; Kale A, 2005, SAUDI MED J, V26, P1826; King WL, 1990, J VASC SURG, V12, P190; Kirk JS, 2009, J VASC SURG, V49, P208, DOI 10.1016/j.jvs.2008.07.008; Manabe Yasushi, 2002, Journal of Medical Investigation, V49, P182; MOJAB K, 1977, AM J ROENTGENOL, V128, P695; Nakajo M, 2005, ACTA RADIOL, V46, P887, DOI 10.1080/02841850500270332; Panoskaltsis T, 2000, ACTA OBSTET GYN SCAN, V79, P718, DOI 10.1034/j.1600-0412.2000.079008718.x; Poilblanc M, 2008, AM J OBSTET GYNECOL, V199, pE7, DOI 10.1016/j.ajog.2008.04.053; Rathod KR, 2005, CARDIOVASC INTER RAD, V28, P113, DOI 10.1007/s00270-004-0259-2; RILEY PM, 1975, S AFR MED J, V49, P729; Ryu RK, 2003, AM J ROENTGENOL, V181, P89; Siu KF, 1986, J R COLL SURG EDINB, V31, P237; Tsai MT, 2009, AM J OBSTET GYNECOL, V200, P7; TSOUTSOPLEDES GEORGE C., 1967, SCOT MED J, V12, P289	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	APR	2015	41	4					623	627		10.1111/jog.12561		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CF8DV	WOS:000352786800019		
J	Kawata, E; Kondoh, E; Kawasaki, K; Baba, T; Ueda, A; Kido, A; Konishi, I				Kawata, Etsuko; Kondoh, Eiji; Kawasaki, Kaoru; Baba, Tsukasa; Ueda, Akihiko; Kido, Aki; Konishi, Ikuo			Utero-ovarian varices and absent inferior vena cava in pregnancy	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						absent inferior vena cava; magnetic resonance imaging; mode of delivery; pregnancy; utero-ovarian varices	VEIN THROMBOSIS; PATIENT	Extensively distended and tortuous vessels on both sides of the uterus are rare incidental findings on transvaginal sonography in early pregnancy. A 31-year-old woman with a history of surgical repair for congenital intestinal stenosis was noted to have utero-ovarian varices on a transvaginal ultrasound examination during her first prenatal visit at 6 weeks' gestation. Magnetic resonance imaging revealed dilated ovarian veins along with infrarenal absence of inferior vena cava as well as the absence of external and common iliac veins. Despite concerns regarding spontaneous utero-ovarian vessels rupture, her antenatal course was uneventful. A vaginal delivery was successfully achieved without any postpartum complication. We also demonstrated an intraoperative view of the utero-ovarian vessels during cesarean section in her subsequent pregnancy. Absence of inferior vena cava and pelvic varices can occur in women with a history of neonatal surgery. Although the risk of utero-ovarian varices rupture remains unclear, vaginal delivery may be safely achieved.	[Kawata, Etsuko; Kondoh, Eiji; Kawasaki, Kaoru; Baba, Tsukasa; Ueda, Akihiko; Konishi, Ikuo] Kyoto Univ, Dept Gynecol & Obstet, Kyoto 6068507, Japan; [Kido, Aki] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan	Kondoh, E (reprint author), Kyoto Univ, Dept Gynecol & Obstet, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kondo@kuhp.kyoto-u.ac.jp					MCDONALD P, 1974, AM J ROENTGENOL, V120, P368; Alicioglu B, 2009, BRATISL MED J, V110, P304; Ramanathan T, 2001, J VASC SURG, V33, P1097, DOI 10.1067/mva.2001.114205; Ruggeri M, 2001, LANCET, V357, P441, DOI 10.1016/S0140-6736(00)04010-1; Beebe-Dimmer JL, 2005, ANN EPIDEMIOL, V15, P175, DOI 10.1016/j.annepidem.2004.05.015; Bakhshi T, 2007, OBSTET GYNECOL, V110, P495, DOI 10.1097/01.AOG.0000262899.72849.91; Balzer KM, 2002, J VASC SURG, V36, P1053, DOI 10.1067/mva.2002.128939; Bili H, 2010, EUR J OBSTET GYN R B, V153, P108, DOI 10.1016/j.ejogrb.2010.06.013; Gils RJ, 2006, J VASC SURG, V44, P1114; Hausler M, 2001, ARCH DIS CHILD, V85, P228, DOI 10.1136/adc.85.3.228; Raposo Rodriguezs L, 2012, RADIOLOGIA, V54, P457; Rogers A, 2010, J VASC INTERV RADIOL, V21, P754, DOI 10.1016/j.jvir.2010.01.031; Waxs JR, 2007, J ULTRAS MED, V26, P699; Ziereisen V, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, P51	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	APR	2015	41	4					631	634		10.1111/jog.12599		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CF8DV	WOS:000352786800021		
J	Himoto, Y; Kido, A; Togashi, K				Himoto, Yuki; Kido, Aki; Togashi, Kaori			Response to 'Diagnosis of placental mesenchymal dysplasia: Magnetic resonance imaging or color Doppler?'	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Letter									[Himoto, Yuki; Kido, Aki; Togashi, Kaori] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Japan	Himoto, Y (reprint author), Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Japan.						Kuwata T, 2014, ULTRASOUND OBST GYN, V43, P355, DOI 10.1002/uog.13230; Himoto Y, 2014, J OBSTET GYNAECOL RE, V40, P1894, DOI 10.1111/jog.12441	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	APR	2015	41	4					651	651		10.1111/jog.12607		1	Obstetrics & Gynecology	Obstetrics & Gynecology	CF8DV	WOS:000352786800026		
J	Yokoyama, T; Takahashi, M; Kido, T; Hara, T				Yokoyama, T.; Takahashi, M.; Kido, T.; Hara, T.			Influence of cancer pain on the health-related quality of life of cancer patients: an internet-based survey	JOURNAL OF PAIN			English	Meeting Abstract									[Yokoyama, T.; Takahashi, M.; Kido, T.; Hara, T.] Kohsei Chuo Gen Hosp, Dept Med Oncol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	APR	2015	16	4		1		106	S2	S2				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CF7PK	WOS:000352748600008		
J	Rothman, MD; Mattio, L; Wernberg, T; Anderson, RJ; Uwai, S; Mohring, MB; Bolton, JJ				Rothman, Mark D.; Mattio, Lydiane; Wernberg, Thomas; Anderson, Robert J.; Uwai, Shinya; Mohring, Margaret B.; Bolton, John J.			A MOLECULAR INVESTIGATION OF THE GENUS ECKLONIA (PHAEOPHYCEAE, LAMINARIALES) WITH SPECIAL FOCUS ON THE SOUTHERN HEMISPHERE	JOURNAL OF PHYCOLOGY			English	Article						atp8; Ecklonia; ITS; kelp forests; Lessoniaceae; phylogeny; rbcL; trnWI	WAVE EXPOSURE; KELP; MORPHOLOGY; RADIATA; BIOGEOGRAPHY; AUSTRALIA; MAXIMA; ALGAE; DNA	Brown algae of the order Laminariales, commonly referred to as kelps, are the largest and most productive primary producers in the coastal inshore environment. The genus Ecklonia (Lessoniaceae, Phaeophyceae) consists of seven species with four species in the Northern Hemisphere and three in the Southern Hemisphere. It was recently transferred to the family Lessoniaceae based on phylogenetic analyses of nuclear and chloroplastic markers, though the type of the genus was not included and its relationship with allied genera Eckloniopsis and Eisenia remained unresolved. The present study is the first to produce a phylogeny focussed on the genus Ecklonia. It included sequences from nuclear, mitochondrial, and chloroplastic DNA, for most of the distribution range of the three current Southern Hemisphere species (Ecklonia radiata, Ecklonia maxima, and a sample of a putative Ecklonia brevipes specimen), sequences for East Asiatic species (Ecklonia cava, Ecklonia kurome, and Ecklonia stolonifera), as well as the closely related genera Eckloniopsis and Eisenia. Results confirmed E. radiata and E. maxima as two distinct species in South Africa, E. radiata as a single species throughout the Southern Hemisphere (in South Africa, Australia, and New Zealand) and East Asiatic species as a distinct lineage from the Southern Hemisphere clade. Results further pointed out a close sister relationship between Eckloniopsis radicosa and two Eisenia species (including the type species: Eisenia arborea) to the genus Ecklonia suggesting that the genera Eckloniopsis and Eisenia are superfluous.	[Rothman, Mark D.; Anderson, Robert J.] Dept Agr Forestry & Fisheries, ZA-8012 Cape Town, South Africa; [Rothman, Mark D.; Mattio, Lydiane; Anderson, Robert J.; Bolton, John J.] Univ Cape Town, Dept Biol Sci, ZA-7701 Cape Town, South Africa; [Rothman, Mark D.; Mattio, Lydiane; Anderson, Robert J.; Bolton, John J.] Univ Cape Town, Marine Res Inst, ZA-7701 Cape Town, South Africa; [Wernberg, Thomas; Mohring, Margaret B.] Univ Western Australia, UWA Oceans Inst, Crawley, WA 6009, Australia; [Wernberg, Thomas; Mohring, Margaret B.] Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia; [Uwai, Shinya] Niigata Univ, Fac Sci, Nishi Ku, Niigata 9502181, Japan	Rothman, MD (reprint author), Dept Agr Forestry & Fisheries, Private Bag X2, ZA-8012 Cape Town, South Africa.	mark.rothman@uct.ac.za	Mattio, Lydiane/C-2483-2014		Department of Agriculture, Forestry and Fisheries, South Africa; University of Cape Town; National Research Foundation (NRF); South African National Biodiversity Institute (SeaKeys); Australian Research Council; UWA Research Collaboration Award	This study was supported by the Department of Agriculture, Forestry and Fisheries, South Africa, the University of Cape Town, the National Research Foundation (NRF), and the South African National Biodiversity Institute (SeaKeys). The Japanese link was part of the NRF/JST international collaboration. T. Wernberg was supported by the Australian Research Council and a UWA Research Collaboration Award. Our sincere thanks to all who contributed taxa for analysis: K. Kogame, M. Okaji and T. de Bettignies. The authors thank T. Horiguchi and K. Kogame for translating the original Japanese descriptions. Thank you to T. Hedderson and M. Muasya for their assistance during this project. We are grateful to T. Silberfield and C. Lane for providing their published sequence alignments. Lastly thank you to C. Boothroyd, D. Kemp, M. Noffke, A. Plos, and S. Conrad for assisting with field work and sample collections.	Adams N. M., 1994, SEAWEEDS NZ ILLUSTRA, P8; Agardh J. G, 1877, LUNDS U ARSSK AFD MA, V14, P1; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; Wernberg T, 2005, AQUAT BOT, V83, P61, DOI 10.1016/j.aquabot.2005.05.007; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; HOMMERSAND MH, 1986, BOT MAR, V29, P257, DOI 10.1515/botm.1986.29.3.257; Wernberg T, 2003, MAR BIOL, V143, P47, DOI 10.1007/s00227-003-1069-9; Wing SR, 2007, LIMNOL OCEANOGR, V52, P1853, DOI 10.4319/lo.2007.52.5.1853; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wernberg T, 2010, J PHYCOL, V46, P153, DOI 10.1111/j.1529-8817.2009.00772.x; Bolton JJ, 2012, AFR J MAR SCI, V34, P147, DOI 10.2989/1814232X.2012.675125; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Bolton JJ, 2010, HELGOLAND MAR RES, V64, P263, DOI 10.1007/s10152-010-0211-6; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Yoon HS, 2001, MOL PHYLOGENET EVOL, V21, P231, DOI 10.1006/mpev.2001.1009; Fowler-Walker MJ, 2006, MAR BIOL, V148, P755, DOI 10.1007/s00227-005-0125-z; Areschoug J., 1876, BOT NOTISER, V1876, P65; Bolton John J., 1994, P385; Boo S. M., 2000, ALGAE, V15, P13; Boo Sung Min, 1999, Phycological Research, V47, P109, DOI 10.1111/j.1440-1835.1999.tb00291.x; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; De Clerck O., 2005, GUIDE SEAWEEDS KWA Z, V33, P1; Feldmann J., 1973, B SOC HIST NAT AFR N, V28, P325; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Huisman J. M., 2000, MARINE PLANTS AUSTR; John D.M., 2004, BEIH NOVA HEDWIGIA, V127, P1; Kjellman F. R., 1885, VEGA EXP VETENSK LAK, V4, P255; Lindauer V. W., 1961, NOVA HEDWIGIA, V3, P129; Luning K, 1990, SEAWEEDS THEIR ENV B; Maeda T, 2013, J APPL PHYCOL, V25, P337, DOI 10.1007/s10811-012-9868-3; Martin P., 2011, THESIS VICTORIA U WE; Miller MW, 2010, P GAT COMP ENV WORKS, P1, DOI DOI 10.1109/GCE.2010.5676129; Novaczek I., 1980, THESIS U AUCKLAND AU; Okamura K., 1892, ECKLONIA RADICOSA BO, V6, P1; Okamura K., 1927, ICONES JAPANESE ALGA, VV; Papenfuss GF, 1942, AM J BOT, V29, P15, DOI 10.2307/2436539; Rambaut A, 2007, TRACER V 1 4; Setchell W. A., 1905, U CALIFORNIA PUBL BO, V2, P115; Sheppard C., 1992, MARINE ECOLOGY ARABI; Stegenga H., 1997, CONTRIBUTIONS BOLUS, V18, P3; Steneck R. S., 2013, MARINE COMMUNITY ECO, P315; WOMERSLE.HB, 1967, AUST J BOT, V15, P189, DOI 10.1071/BT9670189; WOMERSLEY H.B.S., 1987, MARINE BENTHIC FLO 2; Yendo K, 1911, ANN BOT-LONDON, V25, P691; Yoshida T, 1998, MARINE ALGAE JAPAN	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	APR	2015	51	2					236	246		10.1111/jpy.12264		11	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CF5SO	WOS:000352617500004		
J	Nakanowatari, T; Mitsudera, H; Motoi, T; Ishikawa, I; Ohshima, KI; Wakatsuchi, M				Nakanowatari, Takuya; Mitsudera, Humio; Motoi, Tatsuo; Ishikawa, Ichiro; Ohshima, Kay I.; Wakatsuchi, Masaaki			Multidecadal-Scale Freshening at the Salinity Minimum in the Western Part of North Pacific: Importance of Wind-Driven Cross-Gyre Transport of Subarctic Water to the Subtropical Gyre	JOURNAL OF PHYSICAL OCEANOGRAPHY			English	Article							APPARENT OXYGEN UTILIZATION; SEA-SURFACE TEMPERATURE; INTERMEDIATE WATER; OKHOTSK SEA; OYASHIO WATER; DECADAL CHANGES; KURIL STRAITS; OCEAN; VARIABILITY; KUROSHIO	Using oceanographic observations and an eddy-resolving ice-ocean coupled model simulation from 1955 to 2004, the effects of the wind-driven ocean circulation change that occurred in the late 1970s during multidecadal-scale freshening of the North Pacific Intermediate Water (NPIW) at salinity minimum density (similar to 26.8 sigma(theta)) were investigated. An analysis of the observations revealed that salinity decreased significantly at the density range of 26.6-26.8 sigma(theta) in the western subtropical gyre, including the mixed water region (MWR). The temporal variability of the salinity is dominated by the marked change in the late 1970s. With results similar to the observations, the model, selectively forced by the interannual variability of the wind-driven ocean circulation, simulated significant freshening of the intermediate layer over the subtropical gyre. The significant freshening is related to the increase in southward transport of the Oyashio associated with the intensification of the Aleutian low. Accompanying these changes, the intrusion of fresh and low potential vorticity water, originating in the Okhotsk Sea, to the MWR increased, and the freshening signal propagated farther southward in the western subtropical gyre during the subsequent 6 yr, crossing the Kuroshio Extension. These results indicate that the multidecadal-scale freshening of the NPIW is partly caused by intensification of the wind-driven cross-gyre transport of the subarctic water to the subtropical gyre.	[Nakanowatari, Takuya; Mitsudera, Humio; Ohshima, Kay I.; Wakatsuchi, Masaaki] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Motoi, Tatsuo] Meteorol Coll, Kashiwa, Chiba, Japan; [Ishikawa, Ichiro] Japan Meteorol Agcy, Tokyo, Japan	Nakanowatari, T (reprint author), Japan Agcy Marine Earth Sci & Technol, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	nakanow@jamstec.go.jp	Ohshima, Kay/D-6909-2012		Core Research for Evolution Science and Technology (CREST), Japan Science and Technology Corporation (JST);  [19340131];  [22221001];  [22106010]	The Argo float data used in this study were collected and made freely available by the International Argo Project and the national programs that contribute to it. Part of the hydrographic data in the Okhotsk Sea was obtained in cooperation with the Far Eastern Regional Hydrometeorological Research Institute, Scripps Institute ofOceanography, and S. C. Riser of University of Washington. We thank Dr. G. Williams for carefully proofreading our manuscript. The model simulation and hydrographical data were analyzed on the Pan-Okhotsk Information System of ILTS. We thank three anonymous reviewers for their constructive comments. Some figures were produced with the GrADS package developed by B. Doty. This work was supported by a Grand-in-Aid for Scientific Research (19340131 and 22221001) and Scientific Research on Innovative Areas (22106010) and by a fund from the Core Research for Evolution Science and Technology (CREST), Japan Science and Technology Corporation (JST).	Andreev A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015021; MELLOR GL, 1989, J GEOPHYS RES-OCEANS, V94, P10937, DOI 10.1029/JC094iC08p10937; Durack PJ, 2010, J CLIMATE, V23, P4342, DOI 10.1175/2010JCLI3377.1; TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2; Yasuda T, 1997, J PHYS OCEANOGR, V27, P858, DOI 10.1175/1520-0485(1997)027<0858:DCITMW>2.0.CO;2; Yasuda I, 1996, J PHYS OCEANOGR, V26, P448, DOI 10.1175/1520-0485(1996)026<0448:DAMONP>2.0.CO;2; Masujima M, 2003, J OCEANOGR, V59, P855, DOI 10.1023/B:JOCE.0000009576.09079.f5; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Talley LD, 2008, PROG OCEANOGR, V78, P257, DOI 10.1016/j.pocean.2008.05.001; Minobe S, 1997, GEOPHYS RES LETT, V24, P683, DOI 10.1029/97GL00504; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; TALLEY LD, 1991, DEEP-SEA RES, V38, pS171; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Minobe S, 2000, PROG OCEANOGR, V47, P381, DOI 10.1016/S0079-6611(00)00042-2; BINDOFF NL, 1994, J PHYS OCEANOGR, V24, P1137, DOI 10.1175/1520-0485(1994)024<1137:DCCAOV>2.0.CO;2; Nakanowatari T, 2015, J CLIMATE, V28, P714, DOI 10.1175/JCLI-D-14-00172.1; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Ono T, 2001, GEOPHYS RES LETT, V28, P3285, DOI 10.1029/2001GL012948; NITTA T, 1989, J METEOROL SOC JPN, V67, P375; Shcherbina AY, 2003, SCIENCE, V302, P1952, DOI 10.1126/science.1088692; Deser C, 1996, J CLIMATE, V9, P1840, DOI 10.1175/1520-0442(1996)009<1840:UOTVIT>2.0.CO;2; Miller AJ, 1998, J CLIMATE, V11, P3112, DOI 10.1175/1520-0442(1998)011<3112:AWIDCI>2.0.CO;2; Nishioka J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004055; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Nakano T, 2005, J OCEANOGR, V61, P681, DOI 10.1007/s10872-005-0076-5; Yasuda I, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025237; Talley LD, 2003, J PHYS OCEANOGR, V33, P530, DOI 10.1175/1520-0485(2003)033<0530:SIADOC>2.0.CO;2; Schneider N, 1999, J PHYS OCEANOGR, V29, P1056, DOI 10.1175/1520-0485(1999)029<1056:SODNPT>2.0.CO;2; Deser C, 1999, J CLIMATE, V12, P1697, DOI 10.1175/1520-0442(1999)012<1697:EFAWDI>2.0.CO;2; Hunke EC, 1997, J PHYS OCEANOGR, V27, P1849, DOI 10.1175/1520-0485(1997)027<1849:AEVPMF>2.0.CO;2; Bond NA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018597; Nonaka M, 2008, J CLIMATE, V21, P6283, DOI 10.1175/2008JCLI2294.1; Yasuda I, 1997, J GEOPHYS RES-OCEANS, V102, P893, DOI 10.1029/96JC02938; Qiu B, 2002, J PHYS OCEANOGR, V32, P353, DOI 10.1175/1520-0485(2002)032<0353:LSVITM>2.0.CO;2; Fujii Y, 2013, J GEOPHYS RES-OCEANS, V118, P2035, DOI 10.1002/jgrc.20094; Antonov J., 1998, TEMPERATURE PACIFIC, V2, P28; Auad G, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001987; Bindoff NL, 2000, J PHYS OCEANOGR, V30, P1207, DOI 10.1175/1520-0485(2000)030<1207:DCAAIO>2.0.CO;2; Boyer T. P., 1998, SALINITY PACIFIC OCE, V5; Conkright M., 2002, INTRODUCTION, V1; Emerson S, 2004, J OCEANOGR, V60, P139, DOI 10.1023/B:JOCE.0000038323.62130.a0; Fujisaki A, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2009JC006007; Garnier V, 1999, J GEOPHYS RES-OCEANS, V104, P18087, DOI 10.1029/1999JC900070; Hill KL, 2003, ATMOS OCEAN, V41, P49, DOI 10.3137/ao.410104; Ishikawa I, 2009, J OCEANOGR, V65, P407, DOI 10.1007/s10872-009-0036-6; Isoguchi O, 1997, J GEOPHYS RES-OCEANS, V102, P12457, DOI 10.1029/97JC00447; Itoh M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001590; Itoh M, 2007, J OCEANOGR, V63, P637, DOI 10.1007/s10872-007-0056-z; Joyce TM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015225; Kashiwase H, 2014, PROG OCEANOGR, V126, P21, DOI 10.1016/j.pocean.2014.05.004; Kouketsu S, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002862; Kouketsu S, 2010, DEEP-SEA RES PT II, V57, P1177, DOI 10.1016/j.dsr2.2009.12.007; Kouketsu S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028499; Levitus S., 1994, TEMPERATURE, V4; Matsuda J, 2009, DEEP-SEA RES PT I, V56, P1401, DOI 10.1016/j.dsr.2009.04.014; Mitsudera H, 2004, J PHYS OCEANOGR, V34, P1174, DOI 10.1175/1520-0485(2004)034<1174:NSOTOW>2.0.CO;2; Mizuta G, 2003, J PHYS OCEANOGR, V33, P2430, DOI 10.1175/1520-0485(2003)033<2430:SASVOT>2.0.CO;2; Nakamura T, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003142; Nakano T, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031433; Nakanowatari T, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028243; Nakanowatari T., 2010, UMI SORA, V85, P141; Ohshima KI, 2014, PROG OCEANOGR, V126, P71, DOI 10.1016/j.pocean.2014.04.020; Reid J. L., 1965, INTERMEDIATE WATERS; SEKINE Y, 1988, J GEOPHYS RES-OCEANS, V93, P2247, DOI 10.1029/JC093iC03p02247; Shimizu Y, 2003, J PHYS OCEANOGR, V33, P220, DOI 10.1175/1520-0485(2003)033<0220:ARKAOW>2.0.CO;2; St Laurent L.C., 2002, GEOPHYS RES LETT, V29, DOI DOI 10.1029/2002GL015633; Sverdrup HU, 1942, OCEANS THEIR PHYS CH; Talley L. D., 1995, 2 PICES, V2; Talley LD, 2001, J PHYS OCEANOGR, V31, P1538, DOI 10.1175/1520-0485(2001)031<1538:TROCAD>2.0.CO;2; Tanaka Y, 2010, J PHYS OCEANOGR, V40, P2569, DOI 10.1175/2010JPO4506.1; Tourre YM, 1999, J PHYS OCEANOGR, V29, P1528, DOI 10.1175/1520-0485(1999)029<1528:EOIVIS>2.0.CO;2; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; VANSCOY KA, 1991, J GEOPHYS RES-OCEANS, V96, P16801, DOI 10.1029/91JC01783; Wong APS, 1999, NATURE, V400, P440; Wong APS, 2001, J CLIMATE, V14, P1613, DOI 10.1175/1520-0442(2001)014<1613:FAHCIT>2.0.CO;2; Wong CS, 1998, J GEOPHYS RES-OCEANS, V103, P15625, DOI 10.1029/98JC01008; Yasuda I, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001037; You YZ, 2000, J GEOPHYS RES-OCEANS, V105, P3253, DOI 10.1029/1999JC900304; You YZ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001285; Yun JY, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001482	81	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-3670	1520-0485		J PHYS OCEANOGR	J. Phys. Oceanogr.	APR	2015	45	4					988	1008		10.1175/JPO-D-13-0274.1		21	Oceanography	Oceanography	CF4SV	WOS:000352542800004		
J	Fujisawa, J				Fujisawa, Jun-ichi			Highly-selective absorption control in photosynthetic chlorin dyes	JOURNAL OF PORPHYRINS AND PHTHALOCYANINES			English	Article						selective absorption tuning; photosynthetic dyes; bacteriochlorophyll	DENSITY-FUNCTIONAL-THEORY; MOLECULAR-ORBITAL METHODS; GAUSSIAN-TYPE BASIS; ORGANIC-MOLECULES; AB-INITIO; BACTERIOCHLOROPHYLLS; ENERGIES; MODEL	Selective chemical control of light-absorption bands of dye molecules in which the wavelengths of two or more absorption bands are individually controlled by chemical modifications is an ultimate challenge in chemistry and an important subject for their wide applications. Recently, selective absorption tuning was first reported in photosynthetic bacteriochlorin dyes. In the bacteriochlorin dyes, either the visible or near IR band is selectively shifted by the chemical modifications almost retaining the other band. Fujisawa et al. clarified that the selective absorption tuning is accomplished by chemical control of configuration interactions in the two two-level systems. This paper reports on more highlyselective absorption tuning in photosynthetic chlorin dyes, bacteriochlorophylls (BChls) d and e and the mechanism. In BChls d and e, the near UV band (so-called Soret band) is selectively red-shifted by the chemical modifications of BChl d involving the formylation and methylation perfectly retaining the visible band (so-called Q(y)). Density functional theory (DFT) and time-dependent DFT analyses showed that the red-shift of the Soret band is predominantly attributed to the large stabilization of the second lowest unoccupied molecular orbital induced by the formylation. In contrast, the Q(y) absorption retention results from the perfect cancellation between the positive excitation-energy change due to the formylation and negative excitation-energy change due to the methylation, both of which are significantly contributed by configuration interactions. This work reveals that the highly-selective absorption control in BChls d and e is accomplished by the complicated control of configuration interactions in the four-level system.	[Fujisawa, Jun-ichi] Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan; [Fujisawa, Jun-ichi] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Fujisawa, J (reprint author), Univ Tokyo, RCAST, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	ufujisw@mail.ecc.u-tokyo.ac.jp					BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Harada J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00671; Linnanto J, 2001, J PHYS CHEM A, V105, P3855, DOI 10.1021/jp0021547; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; Marques MAL, 2004, ANNU REV PHYS CHEM, V55, P427, DOI 10.1146/annurev.physchem.55.091602.094449; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Escobedo JO, 2010, CURR OPIN CHEM BIOL, V14, P64, DOI 10.1016/j.cbpa.2009.10.022; DITCHFIE.R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fujisawa J, 2014, BIOPHYSICS-USSR, V10, P25; Gomer CJ, 1988, PHOTODYNAMIC THERAPY; Horiuchi T., 2009, DATA BOOK DYE SENSIT; Kalyanasundaram K., 2010, DYE SENSITIZED SOLAR; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Linnanto J, 2004, J COMPUT CHEM, V25, P123, DOI 10.1002/jcc.10344; Mimuro M, 2011, CHLOROPHYLLS STRUCTU; Oba T, 2002, PHOTOSYNTH RES, V74, P1, DOI 10.1023/A:1020816128794; Scheer H., 1991, CHLOROPHYLLS; Song JA, 2011, COMPUT THEOR CHEM, V965, P53, DOI 10.1016/j.comptc.2011.01.026; Sun S., 2005, ORGANIC PHOTOVOLTAIC; Sundholm D, 2003, PHYS CHEM CHEM PHYS, V5, P4265, DOI 10.1039/b306301a	24	0	0	WORLD SCI PUBL CO INC	HACKENSACK	27 WARREN ST, STE 401-402, HACKENSACK, NJ 07601 USA	1088-4246	1099-1409		J PORPHYR PHTHALOCYA	J. Porphyr. Phthalocyanines	APR	2015	19	4					601	609		10.1142/S1088424614501041		9	Chemistry, Multidisciplinary	Chemistry	CF9CY	WOS:000352860400005		
J	Takahashi, N; Hirota, K; Saga, Y				Takahashi, Naoya; Hirota, Keiya; Saga, Yoshitaka			Facile transformation of the five-membered exocyclic E-ring in 13(2)-demethoxycarbonyl chlorophyll derivatives by molecular oxygen with titanium oxide in the dark	JOURNAL OF PORPHYRINS AND PHTHALOCYANINES			English	Article						allomerization; chlorophyll; photosynthesis; titanium oxide	PHOTODYNAMIC THERAPY; SOLAR-CELLS; PHOTOSENSITIZERS; PYROPHEOPHORBIDE; ESTER; ALLOMERIZATION; INTERFACE; PATHWAYS; EFFICACY; ABILITY	Major photosynthetic pigments chlorophyll(Chl) s have a cyclic tetrapyrrole with a fivemembered exocyclic E-ring as photofunctional moieties. Its transformation is one promising methodology to develop functional pigments based on Chl chemistry. This paper report a facile conversion from Chl derivatives lacking the 13(2)-methoxycarbonyl moiety to the corresponding chlorophyllous pigments, whose exocyclic E-ring had two oxo groups at the 13(1)- and 13(2)-positions, by contact with the TiO2 particles in the presence of molecular oxygen in the dark. The conversion proceeded under mild conditions without hydrolysis of the ester group in the 17-propionate residue. This is in sharp contrast to the inevitable ester cleavage in the conventional synthesis of Chl derivatives that possess alpha-diketone in the E-ring. The reaction properties in the present method allowed us to perform a one-step conversion of Chl derivatives esterified with a natural isoprenoid alcohol phytol to the corresponding 13(2)-oxo-pigments. No removal of central Zn from the chlorin macrocycle occurred in the present conversions using Zn pyropheophytin a as a starting material.	[Takahashi, Naoya; Hirota, Keiya; Saga, Yoshitaka] Kinki Univ, Fac Sci & Engn, Dept Chem, Osaka 5778502, Japan	Saga, Y (reprint author), Kinki Univ, Fac Sci & Engn, Dept Chem, Osaka 5778502, Japan.	saga@chem.kindai.ac.jp	Saga, Yoshitaka/D-7714-2014		Japan Society for the Promotion of Science (JSPS) [25107525]; Tokuyama Science Foundation	We thank Prof. Tomohiro Miyatake of Ryukoku University, and Prof. Hitoshi Tamiaki and Dr. Yusuke Kinoshita of Ritsumeikan University, and Mr. Shota Yamada of Kinki University for HRMS measurements and experimental assistance. This work was partially supported by Grants-in-Aid for Scientific Research on Innovative Areas "Artificial Photosynthesis (AnApple)" (no. 25107525) from the Japan Society for the Promotion of Science (JSPS) and from the Tokuyama Science Foundation.	Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q; Connor PA, 1999, LANGMUIR, V15, P2402, DOI 10.1021/la980855d; Hadjiivanov KI, 1996, CHEM SOC REV, V25, P61, DOI 10.1039/cs9962500061; Kozyrev AN, 1998, CHEM COMMUN, P1083, DOI 10.1039/a801367e; Tamiaki H, 2011, HANDB PORPHYR SCI, V11, P223; Rosenfeld A, 2006, PHOTOCHEM PHOTOBIOL, V82, P626, DOI 10.1562/2005-09-29-RA-704; Pandey SK, 2009, BIOCONJUGATE CHEM, V20, P274, DOI 10.1021/bc8003638; Wang XF, 2011, J PHYS CHEM C, V115, P24394, DOI 10.1021/jp206206x; Tamiaki H, 1996, PHOTOCHEM PHOTOBIOL, V63, P92, DOI 10.1111/j.1751-1097.1996.tb02997.x; Nyman ES, 2004, J PHOTOCH PHOTOBIO B, V73, P1, DOI 10.1016/j.jphotobiol.2003.10.002; Sternberg ED, 1998, TETRAHEDRON, V54, P4151, DOI 10.1016/S0040-4020(98)00015-5; Imahori H, 2009, ACCOUNTS CHEM RES, V42, P1809, DOI 10.1021/ar900034t; Wang YW, 2012, J PHYS CHEM C, V116, P21244, DOI 10.1021/jp307423c; Wang XF, 2010, ENERG ENVIRON SCI, V3, P94, DOI 10.1039/b918464c; Hynninen PH, 2002, J ORG CHEM, V67, P4055, DOI 10.1021/jo010673f; HOOBER JK, 1988, PHOTOCHEM PHOTOBIOL, V48, P579, DOI 10.1111/j.1751-1097.1988.tb02867.x; Hynninen P. H., 1991, CHLOROPHYLLS, P145; Hynninen PH, 2006, TETRAHEDRON LETT, V47, P1663, DOI 10.1016/j.tetlet.2005.12.106; Kozyrev AN, 1998, CHEM COMMUN, P481, DOI 10.1039/a707805f; MORGAN AR, 1988, CANCER RES, V48, P194; Saga Y, 2013, INORG CHEM, V52, P204, DOI 10.1021/ic3016782; Saga Y, 2012, CHEM LETT, V41, P360, DOI 10.1246/cl.2012.360; Scheer H, 2006, CHLOROPHYLLS BACTERI, P1; Stefano AD, 2001, PHOTOCHEM PHOTOBIOL, V73, P290, DOI 10.1562/0031-8655(2001)073<0290:PICWLL>2.0.CO;2; Zheng G, 2000, BIOORG MED CHEM LETT, V10, P123, DOI 10.1016/S0960-894X(99)00649-6	26	0	0	WORLD SCI PUBL CO INC	HACKENSACK	27 WARREN ST, STE 401-402, HACKENSACK, NJ 07601 USA	1088-4246	1099-1409		J PORPHYR PHTHALOCYA	J. Porphyr. Phthalocyanines	APR	2015	19	4					631	637		10.1142/S1088424615500054		7	Chemistry, Multidisciplinary	Chemistry	CF9CY	WOS:000352860400008		
J	Kozai, T; Kayano, Y; Aoi, T; Tsurumachi, N; Nakanishi, S				Kozai, Takanori; Kayano, Yuya; Aoi, Takahito; Tsurumachi, Noriaki; Nakanishi, Shunsuke			Coherent molecular vibrational dynamics of CH2 stretching modes in polyethylene studied by femtosecond-CARS	JOURNAL OF RAMAN SPECTROSCOPY			English	Article						coherent anti-Stokes Raman spectroscopy; polyethylene; CH2 stretching modes; coherent molecular vibrational relaxation	STOKES-RAMAN SCATTERING; SPECTROSCOPY; STATE; RELAXATION; ABSORPTION; RESONANCE; STILBENE; MOTION	We have studied the coherent molecular vibrational dynamics of CH2 stretching modes in polyethylene by time-resolved femtosecond coherent anti-Stokes Raman spectroscopy. We observed that the coherent vibrational relaxation of symmetric CH2 stretching modes in polyethylene at room temperature is much faster than that previously measured in polyvinyl alcohol. In addition, it was detected that, at low temperature, the coherent vibrational relaxation of the symmetric stretching modes evidently becomes slower compared with that at room temperature. These temperature-dependent measurements enable us to discriminate the contribution of pure dephasing mechanism, due to phonons and two-level systems in polymer, from the contribution of lifetime of the vibrational excited state to the coherent vibrational relaxation of CH2 stretching modes. We conclude that the coherent vibrational relaxation of symmetric CH2 stretching modes at room temperature consists of the contribution of lifetime and approximately 1.5 times larger contribution of pure dephasing. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Kozai, Takanori; Kayano, Yuya; Aoi, Takahito; Tsurumachi, Noriaki; Nakanishi, Shunsuke] Kagawa Univ, Dept Adv Mat Sci, Takamatsu, Kagawa 760, Japan; [Kozai, Takanori] Anan Natl Coll Technol, Inst Natl Colleges Technol, Dept Elect & Elect Engn, Anan, Tokushima, Japan	Nakanishi, S (reprint author), Kagawa Univ, Dept Adv Mat Sci, Hayashi Cho 2217-20, Takamatsu, Kagawa 760, Japan.	nakanish@eng.kagawa-u.ac.jp					Liu TY, 2014, SPECTROCHIM ACTA A, V131, P153, DOI 10.1016/j.saa.2014.04.069; JOO T, 1993, J CHEM PHYS, V99, P3244, DOI 10.1063/1.466194; Kozai T, 2012, CHEM PHYS LETT, V553, P26, DOI 10.1016/j.cplett.2012.09.057; Siebert T, 2006, J RAMAN SPECTROSC, V37, P397, DOI 10.1002/jrs.1441; Vierheilig A, 1999, CHEM PHYS LETT, V312, P349, DOI 10.1016/S0009-2614(99)00904-5; Pestov D, 2006, J RAMAN SPECTROSC, V37, P392, DOI 10.1002/jrs.1482; LEONHARDT R, 1987, CHEM PHYS LETT, V133, P373, DOI 10.1016/0009-2614(87)87085-9; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142; Iwata K, 1997, J PHYS CHEM A, V101, P632, DOI 10.1021/jp962010l; Ishii K, 2004, CHEM PHYS LETT, V398, P400, DOI 10.1016/j.cplett.2004.09.075; Matsumoto Y, 2006, CHEM REV, V106, P4234, DOI 10.1021/cr050165w; Colthup N. B., 1975, INTRO INFRARED RAMAN; Dollish F. R., 1974, CHARACTERISTIC RAMAN; Heid M, 2001, J RAMAN SPECTROSC, V32, P771, DOI 10.1002/jrs.741; Kobayashi T, 2000, CHEM PHYS LETT, V321, P385, DOI 10.1016/S0009-2614(00)00282-7; Kox MHF, 2009, ANGEW CHEM INT EDIT, V48, P8990, DOI 10.1002/anie.200904282; Lang T, 1999, CHEM PHYS LETT, V310, P65, DOI 10.1016/S0009-2614(99)00787-3; Ma SH, 2005, COLLOID SURFACE A, V257-58, P357, DOI 10.1016/j.colsurfa.2004.10.084; MOHAN S, 1989, ASIAN J CHEM, V1, P162; Nakanishi S, 2007, J LUMIN, V124, P321, DOI 10.1016/j.jlumin.2006.03.017; NAKANISHI S, 1994, J CHEM PHYS, V100, P3442, DOI 10.1063/1.466387; Phillips W., 1972, J LOW TEMP PHYS, V7, P351, DOI DOI 10.1007/BF00660072; Shen Y. R., 1984, PRINCIPLES NONLINEAR; SILBEY R, 1987, J LUMIN, V36, P283, DOI 10.1016/0022-2313(87)90202-X; Takeuchi S, 2000, CHEM PHYS LETT, V326, P430, DOI 10.1016/S0009-2614(00)00822-8; Zhang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5424; Zhao Y, 2014, J RAMAN SPECTROSC, V45, P826, DOI 10.1002/jrs.4538	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0377-0486	1097-4555		J RAMAN SPECTROSC	J. Raman Spectrosc.	APR	2015	46	4					384	387		10.1002/jrs.4663		4	Spectroscopy	Spectroscopy	CF5ZR	WOS:000352636600005		
J	Kasashima-Shindo, Y; Fujiwara, T; Ushiba, J; Matsushika, Y; Kamatani, D; Oto, M; Ono, T; Nishimoto, A; Shindo, K; Kawakami, M; Tsuji, T; Liu, MG				Kasashima-Shindo, Yuko; Fujiwara, Toshiyuki; Ushiba, Junichi; Matsushika, Yayoi; Kamatani, Daiki; Oto, Misa; Ono, Takashi; Nishimoto, Atsuko; Shindo, Keiichiro; Kawakami, Michiyuki; Tsuji, Tetsuya; Liu, Meigen			BRAIN-COMPUTER INTERFACE TRAINING COMBINED WITH TRANSCRANIAL DIRECT CURRENT STIMULATION IN PATIENTS WITH CHRONIC SEVERE HEMIPARESIS: PROOF OF CONCEPT STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						event-related desynchronization; upper extremity motor function; stroke; rehabilitation; electroencephalography; brain stimulation; brain-machine interface	INDUCED MOVEMENT THERAPY; HUMAN MOTOR CORTEX; CHRONIC STROKE; RANDOMIZED-TRIAL; EXCITABILITY; DESYNCHRONIZATION; RECOVERY; REHABILITATION; INDIVIDUALS; RELIABILITY	Objective: Brain-computer interface technology has been applied to stroke patients to improve their motor function. Event-related desynchronization during motor imagery, which is used as a brain computer interface trigger, is sometimes difficult to detect in stroke patients. Anodal transcranial direct current stimulation (tDCS) is known to increase event-related desynchronization, This study investigated the adjunctive effect of anodal tDCS for brain computer interface training in patients with severe hemiparesis. Subjects: Eighteen patients with chronic stroke. Design: A non-randomized controlled study. Methods: Subjects were divided between a brain computer interface group and a tDCS-brain computer interface group and participated in a 10-day brain computer interface training. Event-related desynchronization was detected in the affected hemisphere during motor imagery of the affected fingers. The tDCS-brain-computer interface group received anodal tDCS before brain computer interface training. Event-related desynchronization was evaluated before and after the intervention. The Fugl-Meyer Assessment upper extremity motor score (FM-U) was assessed before, immediately after, and 3 months after, the intervention. Results: Event-related desynchronization was significantly increased in the tDCS-brain computer interface group. The FM-U was significantly increased in both groups. The FM-U improvement was maintained at 3 months in the tDCS-brain computer interface group. Conclusion: Anodal tDCS can be a conditioning tool for brain computer interface training in patients with severe hemiparetic stroke.	[Kasashima-Shindo, Yuko; Fujiwara, Toshiyuki; Kamatani, Daiki; Nishimoto, Atsuko; Shindo, Keiichiro; Kawakami, Michiyuki; Tsuji, Tetsuya; Liu, Meigen] Keio Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan; [Fujiwara, Toshiyuki] Tokai Univ, Sch Med, Dept Rehabil Med, Isehara, Kanagawa 2591193, Japan; [Ushiba, Junichi; Matsushika, Yayoi; Oto, Misa; Ono, Takashi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Tokyo, Kanagawa, Japan	Fujiwara, T (reprint author), Tokai Univ, Sch Med, Dept Rehabil Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	tofuji@xc5.so-net.ne.jp			Health Labour Sciences Research Grant [12102976]; Strategic Research Program for Brain Sciences (SRPBS) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was partially supported by Health Labour Sciences Research Grant (12102976) and the Strategic Research Program for Brain Sciences (SRPBS) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors thank Sawako Otaki for her contributions to this study.	Wolf SL, 2008, LANCET NEUROL, V7, P33, DOI 10.1016/S1474-4422(07)70294-6; Housman SJ, 2009, NEUROREHAB NEURAL RE, V23, P505, DOI 10.1177/1545968308331148; BOHANNON RW, 1987, PHYS THER, V67, P206; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166; Bolognini N, 2011, NEUROREHAB NEURAL RE, V25, P819, DOI 10.1177/1545968311411056; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Duncan PW, 2000, NEUROPHARMACOLOGY, V39, P835, DOI 10.1016/S0028-3908(00)00003-4; Shindo K, 2011, J REHABIL MED, V43, P951, DOI 10.2340/16501977-0859; Yuan H, 2011, J NEUROSCI, V31, P9585, DOI 10.1523/JNEUROSCI.5312-10.2011; Bastani A, 2012, CLIN NEUROPHYSIOL, V123, P644, DOI 10.1016/j.clinph.2011.08.029; Takemi M, 2013, J NEUROPHYSIOL, V110, P1158, DOI 10.1152/jn.01092.2012; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Mukaino M, 2014, J REHABIL MED, V46, P378, DOI 10.2340/16501977-1785; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369; Conroy SS, 2011, ARCH PHYS MED REHAB, V92, P1754, DOI 10.1016/j.apmr.2011.06.016; Fujiwara T, 2009, NEUROREHAB NEURAL RE, V23, P125, DOI 10.1177/1545968308321777; Kasashima Y, 2012, EXP BRAIN RES, V221, P263, DOI 10.1007/s00221-012-3166-9; Kothari Rashmi U., 1996, Stroke, V27, P1304; Li MF, 2014, INT J NEUROSCI, V124, P403, DOI 10.3109/00207454.2013.850082; Matsumoto J, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-27; Ochi M, 2013, J REHABIL MED, V45, P137, DOI 10.2340/16501977-1099; Platz TPC, 2005, ARM REHABILITATION M; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Reinkensmeyer David J, 2012, Am J Phys Med Rehabil, V91, pS232, DOI 10.1097/PHM.0b013e31826bce79	35	1	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2015	47	4					318	324		10.2340/16501977-1925		7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CF7RL	WOS:000352753900005		
J	Nakachi, Y; Iseki, M; Yokoo, T; Mizuno, Y; Okazaki, Y				Nakachi, Yutaka; Iseki, Mioko; Yokoo, Tomotaka; Mizuno, Yosuke; Okazaki, Yasushi			Gene Expression Profile of the Neonatal Female Mouse Brain After Administration of Testosterone Propionate	JOURNAL OF SEXUAL MEDICINE			English	Article						Brain; Sexual Differentiation; Gene Expression Profiling; Animal Model; Gender Dysphoria; Testosterone; Cross-Sex Hormone Treatment	GENDER IDENTITY DISORDER; SEX HORMONAL TREATMENT.; WHITE-MATTER; PROBE LEVEL; TO-MALE; TRANSSEXUALISM; ESTROGEN; BIOLOGY; DIFFERENTIATION; MICROSTRUCTURE	IntroductionClinical care decisions for peripubertal adolescents with gender dysphoria (GD) should be made carefully. Furthermore, the identification of biomarkers is very important for rapid and accurate diagnosis of GD in young people. AimThe aim of this study was to investigate gene expression profiles during masculinization of the neonatal female mouse brain by testosterone and to identify biomarkers related to GD. MethodsMicroarray analysis was performed using RNAs extracted from the brains of neonatal mice treated by intraperitoneal injection of testosterone propionate during the sexual determination period. Sequence motif enrichment analysis for sex hormone receptor responsive elements was performed for the flanking regions of genes that showed significant expression changes following administration of testosterone propionate. Main Outcome MeasuresWe revealed a gene set with marked changes in expression during brain masculinization of neonatal female mice following administration of testosterone propionate. ResultsWe identified 334 genes that showed differential expression in the masculinized neonatal female brain after testosterone propionate treatment. Interestingly, most of these genes are not reported to be expressed in a sexually dimorphic manner. Moreover, sequence motif enrichment analysis suggested that masculinization of the neonatal female brain by testosterone was controlled more by estrogen receptors than androgen receptors. ConclusionsDifferences in genes that are expressed differentially following administration of testosterone injection from known sexually dimorphic genes suggest that many GD-related genes are upregulated during female brain masculinization. The gene set identified in this study provides a basis to better understand the mechanisms of GD and delineate its associated biomarkers. Nakachi Y, Iseki M, Yokoo T, Mizuno Y, and Okazaki Y. Gene expression profile of the neonatal female mouse brain after administration of testosterone propionate. J Sex Med 2015;12:887-896.	[Nakachi, Yutaka; Iseki, Mioko; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Hidaka, Saitama 3501241, Japan; [Yokoo, Tomotaka] Saitama Med Univ, Res Ctr Genom Med, Anim Expt Lab, Hidaka, Saitama 3501241, Japan; [Mizuno, Yosuke; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Hidaka, Saitama 3501241, Japan	Okazaki, Y (reprint author), Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan.	nakachiy@saitama-med.ac.jp; okazaki@saitama-med.ac.jp			Kawano Masanori Memorial Foundation for the Promotion of Pediatrics; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	We thank Tomoko Hirata, Yumi Mizuno, Takashi Murofushi, Daisuke Muramatsu, Junko Itoh, and all colleagues at the Division of Translational Research, Division of Functional Genomics & Systems Medicine, and Experimental Animal Laboratory, Saitama Medical University for technical assistance and insightful discussions. This study was supported by the Kawano Masanori Memorial Foundation for the Promotion of Pediatrics, a noncommercial foundation. The authors are also supported in part by a grant-in-aid for the Support Project of the Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to Saitama Medical University Research Center for Genomic Medicine.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Swaab DF, 2004, GYNECOL ENDOCRINOL, V19, P301, DOI 10.1080/09513590400018231; Rametti G, 2011, J PSYCHIATR RES, V45, P199, DOI 10.1016/j.jpsychires.2010.05.006; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Yang CF, 2014, NEURON, V82, P261, DOI 10.1016/j.neuron.2014.03.029; Green R, 2000, ARCH SEX BEHAV, V29, P499, DOI 10.1023/A:1001947920872; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ngun TC, 2011, FRONT NEUROENDOCRIN, V32, P227, DOI 10.1016/j.yfrne.2010.10.001; Meyer-Bahlburg HFL, 2013, ENDOCRIN METAB CLIN, V42, P435, DOI 10.1016/j.ecl.2013.05.011; Heylens G, 2012, J SEX MED, V9, P751, DOI 10.1111/j.1743-6109.2011.02567.x; Fisher AD, 2014, J ENDOCRINOL INVEST, V37, P675, DOI 10.1007/s40618-014-0077-6; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Hare L, 2009, BIOL PSYCHIAT, V65, P93, DOI 10.1016/j.biopsych.2008.08.033; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; BAKKER A, 1993, ACTA PSYCHIAT SCAND, V87, P237, DOI 10.1111/j.1600-0447.1993.tb03364.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kauffman AS, 2009, PEPTIDES, V30, P83, DOI 10.1016/j.peptides.2008.06.014; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0; Ujike H, 2009, PROG NEURO-PSYCHOPH, V33, P1241, DOI 10.1016/j.pnpbp.2009.07.008; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Ashburner M, 2000, NAT GENET, V25, P25; Rametti G, 2011, J PSYCHIATR RES, V45, P949, DOI 10.1016/j.jpsychires.2010.11.007; Meyer-Bahlburg HFL, 2010, ARCH SEX BEHAV, V39, P461, DOI 10.1007/s10508-009-9532-4; Gomez-Gil E, 2010, ARCH SEX BEHAV, V39, P546, DOI 10.1007/s10508-009-9524-4; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Coolidge FL, 2002, BEHAV GENET, V32, P251, DOI 10.1023/A:1019724712983; Bao AM, 2011, FRONT NEUROENDOCRIN, V32, P214, DOI 10.1016/j.yfrne.2011.02.007; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Henningsson S, 2005, PSYCHONEUROENDOCRINO, V30, P657, DOI 10.1016/j.psyneuen.2005.02.006; Cohen-Kettenis PT, 2010, ARCH SEX BEHAV, V39, P499, DOI 10.1007/s10508-009-9562-y; Kruijver FPM, 2000, J CLIN ENDOCR METAB, V85, P2034, DOI 10.1210/jc.85.5.2034; Bentz EK, 2008, FERTIL STERIL, V90, P56, DOI 10.1016/j.fertnstert.2007.05.056; Terada S, 2011, PSYCHIAT RES, V190, P159, DOI 10.1016/j.psychres.2011.04.024; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; Coleman E, 2014, INT J TRANSGEND, V13, P165; desVries ALC, 2010, J SEX MED, V8, P2276; desVries ALC, 2014, PEDIATRICS, V134, P696; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giordano S, 2008, J Med Ethics, V34, P580, DOI 10.1136/jme.2007.021097; Kerr SM, 1996, HUM MOL GENET, V5, P1139, DOI 10.1093/hmg/5.8.1139; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; R Development Core Team, 2010, R LANG ENV STAT COMP; Rosenthal SM, 2014, J CLIN ENDOCR METAB, V99, P4379, DOI 10.1210/jc.2014-1919; Sohn M, 2007, J SEX MED, V4, P1193, DOI 10.1111/j.1743-6109.2007.00580.x; Steensma TD, 2013, HORM BEHAV, V64, P288, DOI 10.1016/j.yhbeh.2013.02.020; VALE JR, 1973, DEV PSYCHOBIOL, V6, P319, DOI 10.1002/dev.420060405; Wallien MSC, 2007, EUR CHILD ADOLES PSY, V16, P309, DOI 10.1007/s00787-007-0602-7; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	APR	2015	12	4					887	896		10.1111/jsm.12802		10	Urology & Nephrology	Urology & Nephrology	CF5UH	WOS:000352622100004		
J	Miyazaki, T; Ichikawa, M; Iino, H; Nishikawa, A; Tonozuka, T				Miyazaki, Takatsugu; Ichikawa, Megumi; Iino, Hitoshi; Nishikawa, Atsushi; Tonozuka, Takashi			Crystal structure and substrate-binding mode of GH63 mannosylglycerate hydrolase from Thermus thermophilus HB8	JOURNAL OF STRUCTURAL BIOLOGY			English	Article						Glycoside hydrolase family 63; Crystal structure; (alpha/alpha)(6)-Barrel; Trimer; Mannosylglycerate; Glucosylglycerate	ALPHA-GLUCOSIDASE-I; COMPATIBLE SOLUTES; PROTEIN; THERMOSTABILITY; SPECIFICITY; GLUCOSYLGLYCERATE; OLIGOMERIZATION; BIOSYNTHESIS; CARBOHYDRATE; ENVIRONMENTS	Glycoside hydrolase family 63 (GH63) proteins are found in eukaryotes such as processing alpha-glucosidase I and also many bacteria and archaea. Recent studies have identified two bacterial and one plant GH63 mannosylglycerate hydrolases that act on both glucosylglycerate and mannosylglycerate, which are compatible solutes found in many thermophilic prokaryotes and some plants. Here we report the 1.67-angstrom crystal structure of one of these GH63 mannosylglycerate hydrolases, Tt8MGH from Thermus thermophilus HB8, which is 99% homologous to mannosylglycerate hydrolase from T. thermophilus HB27. Tt8MGH consists of a single (alpha/alpha)(6)-barrel catalytic domain with two additional helices and two long loops which form a homotrimer. The structures of this protein in complexes with glucose or glycerate were also determined at 1.77- or 2.10-angstrom resolution, respectively. A comparison of these structures revealed that the conformations of three flexible loops were largely different from each other. The conformational changes may be induced by ligand binding and serve to form finger-like structures for holding substrates. These findings represent the first-ever proposed substrate recognition mechanism for GH63 mannosylglycerate hydrolase. (C) 2015 Elsevier Inc. All rights reserved.	[Miyazaki, Takatsugu; Ichikawa, Megumi; Nishikawa, Atsushi; Tonozuka, Takashi] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Iino, Hitoshi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	Tonozuka, T (reprint author), Tokyo Univ Agr & Technol, Dept Appl Biol Sci, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	tonozuka@cc.tuat.ac.jp	Tonozuka, Takashi/D-2268-2013		Japan Society for the Promotion of Science;  [26660277];  [25-7279]	We thank Seiki Kuramitsu (Osaka University) for useful comments. We also thank Hiromi Yoshida, Shigehiro Kamitori (Kagawa University), and Akiko Shimizu-Ibuka (Niigata University of Pharmacy and Applied Life Sciences) for help with diffraction data collection. This work was supported in part by a Grant-in-Aid for Scientific Research (T.T., No. 26660277; T.M., No. 25-7279) and a Research Fellowship (T.M.) of the Japan Society for the Promotion of Science. This research was performed with approval of the Photon Factory Advisory Committee, the National Laboratory for High Energy Physics, Tsukuba, Japan (2012G006 and 2014G512).	Alarico S, 2013, ENZYME MICROB TECH, V52, P77, DOI 10.1016/j.enzmictec.2012.10.008; Alarico S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06766; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Mhlongo NN, 2014, PROTEINS, V82, P1747, DOI 10.1002/prot.24528; Empadinhas N, 2011, ENVIRON MICROBIOL, V13, P2056, DOI 10.1111/j.1462-2920.2010.02390.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Faridmoayer A, 2005, GLYCOBIOLOGY, V15, P1341, DOI 10.1093/glycob/cwj009; Herscovics A, 1999, BBA-GEN SUBJECTS, V1473, P96, DOI 10.1016/S0304-4165(99)00171-3; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Davies GJ, 1997, BIOCHEM J, V321, P557; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Barker MK, 2013, J BIOL CHEM, V288, P13563, DOI 10.1074/jbc.M113.460436; Villeret V, 1998, P NATL ACAD SCI USA, V95, P2801, DOI 10.1073/pnas.95.6.2801; Borges N, 2014, EXTREMOPHILES, V18, P835, DOI 10.1007/s00792-014-0661-x; Colin H, 1939, CR HEBD ACAD SCI, V208, P1450; Dhanawansa R, 2002, GLYCOBIOLOGY, V12, P229, DOI 10.1093/glycob/12.3.229; Faridmoayer A, 2004, PROTEIN EXPRES PURIF, V33, P11, DOI 10.1016/j.pep.2003.09.013; Faridmoayer A, 2007, GLYCOCONJUGATE J, V24, P429, DOI 10.1007/s10719-007-9035-2; Frade-Perez MD, 2010, ANTON LEEUW INT J G, V98, P291, DOI 10.1007/s10482-010-9437-1; KALZFULLER B, 1995, EUR J BIOCHEM, V231, P344, DOI 10.1111/j.1432-1033.1995.tb20706.x; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; Lokanath NK, 2004, ACTA CRYSTALLOGR D, V60, P1816, DOI 10.1107/S0907444904020190; Miyazaki T, 2011, GLYCOCONJUGATE J, V28, P563, DOI 10.1007/s10719-011-9356-z; Miyazaki T, 2013, FEBS J, V280, P4560, DOI 10.1111/febs.12424; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nobre A, 2013, PLANTA, V237, P891, DOI 10.1007/s00425-012-1808-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palcic MM, 1999, GLYCOCONJUGATE J, V16, P351, DOI 10.1023/A:1007096011392; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	44	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1047-8477	1095-8657		J STRUCT BIOL	J. Struct. Biol.	APR	2015	190	1					21	30		10.1016/j.jsb.2015.02.006		10	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CG0ZX	WOS:000353003900003		
J	Wang, KZ; Xu, XX; Wu, YY; Liu, C; Dang, CB				Wang, Kaizheng; Xu, Xiaoxiao; Wu, Yangyang; Liu, Chao; Dang, Chaobin			Numerical investigation on heat transfer of supercritical CO2 in heated helically coiled tubes	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Numerical simulation; Helically coiled tube; Supercritical CO2; Heat transfer	CARBON-DIOXIDE; TURBULENCE MODELS; VERTICAL TUBE; WALL TURBULENCE; EPSILON-MODEL; FLUID-FLOW; CONVECTION; PRESSURES; SIMULATION; WATER	Numerical simulation on heat transfer of supercritical CO2 in heated helically coiled tubes is performed to evaluate the performance of turbulence models in predicting heat transfer of supercritical CO2 in the helically coiled tube, and to help better understanding the heat transfer mechanism. All turbulence models yield similar tendencies in heat transfer coefficient in the helically coiled tube. The SST (shear-stress transport) model gives the best prediction to the experimental data due to accurate predictions of flow separation under adverse pressure gradients. The parameter of Gr/Re-2.7 is incapable of predicting the buoyancy effect onset of supercritical CO2 in the helically coiled tube. The turbulent Prandtl number has little influence on the calculated heat transfer coefficient. (C) 2015 Elsevier B.V. All rights reserved.	[Wang, Kaizheng; Xu, Xiaoxiao; Wu, Yangyang; Liu, Chao] Chongqing Univ, Key Lab Low Grade Energy Utilizat Technol & Syst, Chongqing 400044, Peoples R China; [Dang, Chaobin] Univ Tokyo, Dept Human & Engn Environm Studies, Kashiwa, Chiba 2778563, Japan	Xu, XX (reprint author), Chongqing Univ, Key Lab Low Grade Energy Utilizat Technol & Syst, 174 Shazhengjie, Chongqing 400044, Peoples R China.	xuxiaoxiao@cqu.edu.cn			National Natural Science Foundation of China [51206197]; Fundamental Research Funds for the Central Universities [cdjzr12140032]; Chongqing Natural Science Foundation [CSTC2011BB6094]	The authors gratefully acknowledge National Natural Science Foundation of China (Project No. 51206197), Fundamental Research Funds for the Central Universities (Project No. cdjzr12140032) and Chongqing Natural Science Foundation (Project No. CSTC2011BB6094) for providing the financial support for this study.	ABID R, 1993, INT J ENG SCI, V31, P831, DOI 10.1016/0020-7225(93)90096-D; Chang KC, 1995, J FLUID ENG-T ASME, V117, P417, DOI 10.1115/1.2817278; Ferng YM, 2012, APPL THERM ENG, V36, P378, DOI 10.1016/j.applthermaleng.2011.10.052; Song JH, 2008, J SUPERCRIT FLUID, V44, P164, DOI 10.1016/j.supflu.2007.11.013; He S, 2008, APPL THERM ENG, V28, P1662, DOI 10.1016/j.applthermaleng.2007.11.001; He S, 2005, INT J THERM SCI, V44, P521, DOI 10.1016/j.ijthermalsci.2004.11.003; YANG Z, 1993, AIAA J, V31, P1191, DOI 10.2514/3.11752; Bruch A, 2009, INT J HEAT MASS TRAN, V52, P2589, DOI 10.1016/j.ijheatmasstransfer.2008.12.021; Jiang PX, 2013, INT J HEAT MASS TRAN, V56, P741, DOI 10.1016/j.ijheatmasstransfer.2012.08.038; ABE K, 1994, INT J HEAT MASS TRAN, V37, P139, DOI 10.1016/0017-9310(94)90168-6; Jaromin M, 2013, NUCL ENG DES, V264, P61, DOI 10.1016/j.nucengdes.2012.10.028; Jayakumar JS, 2010, COMPUT CHEM ENG, V34, P430, DOI 10.1016/j.compchemeng.2009.11.008; Di Piazza I, 2010, INT J THERM SCI, V49, P653, DOI 10.1016/j.ijthermalsci.2009.10.001; Jamshidi N, 2012, INT COMMUN HEAT MASS, V39, P311, DOI 10.1016/j.icheatmasstransfer.2011.11.013; Dang C, 2004, INT J REFRIG, V27, P736, DOI 10.1016/j.ijrefrig.2004.04.018; Akbaridoust F, 2013, INT J HEAT MASS TRAN, V58, P480, DOI 10.1016/j.ijheatmasstransfer.2012.11.064; Gupta S, 2013, NUCL ENG DES, V261, P116, DOI 10.1016/j.nucengdes.2013.02.048; LAM CKG, 1981, J FLUID ENG-T ASME, V103, P456; Wen QL, 2010, ANN NUCL ENERGY, V37, P1272, DOI 10.1016/j.anucene.2010.05.022; He S, 2004, P I MECH ENG C-J MEC, V218, P1281; He S, 2008, INT J HEAT MASS TRAN, V51, P4659, DOI 10.1016/j.ijheatmasstransfer.2007.12.028; Cao XL, 2011, APPL THERM ENG, V31, P2374, DOI 10.1016/j.applthermaleng.2011.03.038; Chen CN, 2011, THERMOCHIM ACTA, V512, P163, DOI 10.1016/j.tca.2010.09.020; Dang C, 2012, INT J REFRIG, V35, P1410, DOI 10.1016/j.ijrefrig.2012.03.015; Dang CB, 2004, INT J REFRIG, V27, P748, DOI 10.1016/j.ijrefrig.2004.04.017; Dang CB, 2010, INT J REFRIG, V33, P558, DOI 10.1016/j.ijrefrig.2009.12.010; Di Liberto M, 2013, INT J HEAT MASS TRAN, V59, P112, DOI 10.1016/j.ijheatmasstransfer.2012.12.011; Forooghi P, 2013, INT J HEAT MASS TRAN, V61, P310, DOI 10.1016/j.ijheatmasstransfer.2013.02.014; GANBIT, 2005, GANBIT US GUID GAMBI; Haruki N, 2013, INT J REFRIG, V36, P1285, DOI 10.1016/j.ijrefrig.2013.02.010; Jackson J.D., 1979, TURBULENT FORCED CON, P613; Jiang PX, 2009, INT J HEAT MASS TRAN, V52, P4748, DOI 10.1016/j.ijheatmasstransfer.2009.06.014; Jiang PX, 2006, J SUPERCRIT FLUID, V38, P339, DOI 10.1016/j.supflu.2005.12.004; Kim S. H., 2004, P INT C ADV NUCL POW, P1527; Launder B. E., 1974, Letters in Heat and Mass Transfer, V1, DOI 10.1016/0094-4548(74)90150-7; Lee HS, 2013, HEAT MASS TRANSFER, V49, P173, DOI 10.1007/s00231-012-1070-2; Lei XL, 2013, J HEAT TRANS-T ASME, V135, DOI 10.1115/1.4023747; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Niceno B, 2013, NUCL ENG DES, V261, P44, DOI 10.1016/j.nucengdes.2013.03.042; Oh HK, 2010, EXP THERM FLUID SCI, V34, P1230, DOI 10.1016/j.expthermflusci.2010.05.002; OWHADI A, 1967, INT J HEAT MASS TRAN, V10, P397, DOI 10.1016/0017-9310(67)90156-1; Schuler MJ, 2013, J SUPERCRIT FLUID, V75, P128, DOI 10.1016/j.supflu.2012.12.023; [王淑香 Wang Shuxiang], 2013, [化工学报, CIESC Journal], V64, P3917; Withag JAM, 2012, J SUPERCRIT FLUID, V70, P156, DOI 10.1016/j.supflu.2012.07.002; Yang FY, 2013, CHEM ENG TECHNOL, V36, P2051, DOI 10.1002/ceat.201300245	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	APR	2015	99						112	120		10.1016/j.supflu.2015.02.001		9	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CF9YQ	WOS:000352924200014		
J	Uchiyama, T; Nishibori, M; Einaga, H; Teraoka, Y				Uchiyama, Tomoki; Nishibori, Maiko; Einaga, Hisahiro; Teraoka, Yasutake			Formation of Tetravalent Fe Ions in LaFeO3 Perovskite Through Mechanochemical Modification by Ball Milling	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							CATALYTIC-PROPERTIES; OXIDES; LACOO3; CONDUCTIVITY; TEMPERATURE; OXIDATION; LA2O3	Mechanochemical modification of previously synthesized LaFeO3 perovskite-type oxide by a high-energy ball milling was investigated to introduce Fe4+ ions or transform some Fe3+ into Fe4+ in LaFeO3. X-ray absorption fine structure studies revealed that the formation of Fe4+ ions into LaFeO3 perovskite has been achieved at first time by ball milling at room temperature without any additives or replacement of La3+ ions by some divalent cations. The structural model of Fe4+ containing LaFeO3 could be described as with a modified perovskite having equal amounts of La and Fe vacancies, which is supported by a good correlation between the results of Fe K-edge XANES spectra and O-2-TPD. The synthesis of Fe4+-containing LaFeO3 perovskite by ball milling was able to produce the O-2 adsorption capacity of nonsubstituted perovskite-type oxide.	[Uchiyama, Tomoki] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Dept Mol & Mat Sci, Fukuoka 8168580, Japan; [Nishibori, Maiko; Einaga, Hisahiro; Teraoka, Yasutake] Kyushu Univ, Fac Engn Sci, Dept Energy & Mat Sci, Fukuoka 8168580, Japan	Nishibori, M (reprint author), Kyushu Univ, Fac Engn Sci, Dept Energy & Mat Sci, Fukuoka 8168580, Japan.	nishibori.maiko.511@m.kyushu-u.ac.jp	Hisahiro, Einaga/I-5440-2015	Hisahiro, Einaga/0000-0002-4819-9755	JSPS KAKENHI [24360334]	We thank Dr. K. Kato and Dr. K. Nitta of JASRI, Dr. K. Kamitani, Dr. T. Sugiyama and Dr. K. Hanada of KUBL, Dr. E. Nishibori of Tsukuba University, Dr. T. Tanabe of Kyushu University for technical supports and useful comments and discussions. This work was supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research (B), Grant Number 24360334. The synchrotron radiation experiments were performed at the BL01B1 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal no. 2012A1459, 2012B1702, 2013A1608) and at Kyushu University Beamline (SAGA-LS/BL06) with the proposal of no. 2013IK012.	Lee CW, 2011, J AM CERAM SOC, V94, P1931, DOI 10.1111/j.1551-2916.2010.04318.x; Ghasdi M, 2010, SENSOR ACTUAT B-CHEM, V148, P478, DOI 10.1016/j.snb.2010.05.056; Zhang QW, 2000, J ALLOY COMPD, V297, P99, DOI 10.1016/S0925-8388(99)00606-4; TERAOKA Y, 1993, J ALLOY COMPD, V193, P70, DOI 10.1016/0925-8388(93)90313-C; Brosha EL, 2000, SENSOR ACTUAT B-CHEM, V69, P171, DOI 10.1016/S0925-4005(00)00543-8; Taguchi H, 2005, MATER RES BULL, V40, P773, DOI 10.1016/j.materresbull.2005.02.009; TERAOKA Y, 1988, MATER RES BULL, V23, P51, DOI 10.1016/0025-5408(88)90224-3; Yamamoto T, 2008, X-RAY SPECTROM, V37, P572, DOI 10.1002/xrs.1103; SHIMIZU Y, 1990, J ELECTROCHEM SOC, V137, P3430, DOI 10.1149/1.2086234; Yamada I, 2008, ANGEW CHEM INT EDIT, V47, P7032, DOI 10.1002/anie.200801482; YAMAMOTO O, 1987, SOLID STATE IONICS, V22, P241, DOI 10.1016/0167-2738(87)90039-7; Zhang QW, 2001, J MATER SCI, V36, P2287, DOI 10.1023/A:1017520806922; Chen WT, 2012, SCI REP-UK, V2, DOI 10.1038/srep00449; Haas O, 2011, J SOLID STATE CHEM, V184, P3163, DOI 10.1016/j.jssc.2011.09.027; Szabo V, 2002, APPL CATAL B-ENVIRON, V37, P175, DOI 10.1016/S0926-3373(01)00328-9; Szabo V, 2003, APPL CATAL B-ENVIRON, V43, P81, DOI 10.1016/S0926-3373(02)00308-9; Teraoka Y, 2002, SOLID STATE IONICS, V152, P681, DOI 10.1016/S0167-2738(02)00409-5; TERAOKA Y, 1991, SOLID STATE IONICS, V48, P207, DOI 10.1016/0167-2738(91)90034-9; vansRoosmalen J. A. M., 1994, J SOLID STATE CHEM, V110, P100; Vracar M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174107; Yamazoe N., 1990, CATAL TODAY, V8, P175, DOI DOI 10.1016/0920-5861(90)87017-W	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	APR	2015	98	4					1047	1051		10.1111/jace.13513		5	Materials Science, Ceramics	Materials Science	CF5ZD	WOS:000352635100002		
J	Matsushima, Y; Koide, T; Hiro-Oka, M; Shida, M; Sato, A; Sugiyama, S; Ito, M				Matsushima, Yuta; Koide, Takuhiro; Hiro-Oka, Masahiro; Shida, Minori; Sato, Akane; Sugiyama, Sho; Ito, Michimasa			Self-Activated Vanadate Compounds Toward Realization of Rare-Earth-Free Full-Color Phosphors	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							CRYSTAL-STRUCTURE; PHOTOLUMINESCENCE PROPERTY; LUMINESCENCE PROPERTIES; CS; RB; EQUILIBRIA; COMPLEXES	Rare-earth-free phosphors based on vanadate compounds were investigated, where the vanadates included chloride vanadates ((M2VO4Cl)-V-II), pyrovanadates ((M2V2O7)-V-II), orthovanadates (M-3(II)(VO4)(2)) with divalent cations M-II of Mg, Sr, Ba, and Zn, and oxofluorovanadates (A(I)VOF(4)) with an alkali metal A(I). A chloride pyrolysis method and a liquid phase precipitation method were proposed for preparing the chloride vanadates and pyro- and orthovanadates, respectively. These vanadate compounds showed self-activated photoluminescence (PL) based on the VO4 clusters against the ultraviolet (UV) light irradiation. The colors of PL covered almost the whole visible-light region from blue to yellow as Sr2VO4Cl (deep blue), Ca2VO4Cl (sky blue), Ba2V2O7 (green), Sr2V2O7 (yellowish green), Zn-3(VO4)(2) (yellow), and Mg-3(VO4)(2) (yellow). A correlation was suggested from these compounds between the luminescent colors and the structural feature as the longer V-O distances in the VO4 tetrahedra in the crystal structures led to the longer wavelength in PL. This seemed to be also applicable for the oxofluorovanadates A(I)VOF(4) (A(I)=K and Cs) which contain the VOF4 polyhedra with one O2- ion and four F- ions as the ligands, as they exhibited the reddish PL.	[Matsushima, Yuta; Koide, Takuhiro; Hiro-Oka, Masahiro; Shida, Minori; Sato, Akane; Sugiyama, Sho] Yamagata Univ, Dept Chem & Chem Engn, Yonezawa, Yamagata 9928510, Japan; [Ito, Michimasa] Tokai Rika Co Ltd, Niwa, Aichi 4800195, Japan	Matsushima, Y (reprint author), Yamagata Univ, Dept Chem & Chem Engn, Yonezawa, Yamagata 9928510, Japan.	ymatsush@yz.yamagata-u.ac.jp			Nippon Sheet Glass Foundation for Materials Science and Engineering; MEXT KAKENHI [24560815]; JST A-STEP [AS231Z03637C]; Foundation for Promotion of Material Science and Technology of Japan	The authors acknowledge Prof. Ken-ichi Nakajima, Assoc. Prof. Hiroki Kodama and their students in Saga University for their help on measuring the quantum efficiency. This work is financially supported, in part, by Nippon Sheet Glass Foundation for Materials Science and Engineering (2011-2012), MEXT KAKENHI Grant Number 24560815, JST A-STEP AS231Z03637C and Foundation for Promotion of Material Science and Technology of Japan (2011).	ALBRECHT C, 1993, J SOLID STATE CHEM, V107, P218, DOI 10.1006/jssc.1993.1341; Chen X, 2013, J PHYS CHEM SOLIDS, V74, P1439, DOI 10.1016/j.jpcs.2013.05.002; Pitale SS, 2012, PHYSICA B, V407, P1485, DOI 10.1016/j.physb.2011.09.067; Huang QZ, 2011, J ANAL APPL PYROL, V91, P159, DOI 10.1016/j.jaap.2011.02.005; Nakajima T, 2009, J LUMIN, V129, P1598, DOI 10.1016/j.jlumin.2009.03.029; RIESKAMP H, 1973, Z ANORG ALLG CHEM, V401, P158, DOI 10.1002/zaac.19734010205; McCann N, 2013, DALTON T, V42, P2622, DOI 10.1039/c2dt31993d; RONDE H, 1978, J INORG NUCL CHEM, V40, P215, DOI 10.1016/0022-1902(78)80113-4; Zhu WL, 2011, OPT MATER, V33, P1162, DOI 10.1016/j.optmat.2011.01.019; Nakajima T, 2010, OPT MATER, V32, P1618, DOI 10.1016/j.optmat.2010.05.021; BUSHNELL GW, 1972, CAN J CHEMISTRY, V50, P3700, DOI 10.1139/v72-585; Luo Y, 2013, RSC ADV, V3, P22206, DOI 10.1039/c3ra42724b; BALLHAUSEN CJ, 1963, THEOR CHIM ACTA, V1, P285, DOI 10.1007/BF00528759; BANKS E, 1970, INORG CHEM, V9, P2259, DOI 10.1021/ic50092a010; BLASSE G, 1979, CHEM PHYS LETT, V63, P441, DOI 10.1016/0009-2614(79)80684-3; KRISHNAM.N, 1971, CAN J CHEMISTRY, V49, P1629, DOI 10.1139/v71-266; GOPAL R, 1971, CAN J CHEMISTRY, V49, P3056, DOI 10.1139/v71-510; Grandhe BK, 2012, OPT COMMUN, V285, P1194, DOI 10.1016/j.optcom.2011.10.013; HAWTHORNE FC, 1978, J SOLID STATE CHEM, V26, P345, DOI 10.1016/0022-4596(78)90169-X; HAZENKAMP MF, 1992, J SOLID STATE CHEM, V97, P115, DOI 10.1016/0022-4596(92)90015-N; HUANG JF, 1992, MATER RES BULL, V27, P581, DOI 10.1016/0025-5408(92)90146-Q; Luitel H. N., 2013, INT J PHOTOENER, V2013; MILSTEIN JB, 1972, INORG CHEM, V11, P1178, DOI 10.1021/ic50112a004; Mukhtar S., 2013, APPL NANOSCI, V3, P535; Ni SB, 2010, J ALLOY COMPD, V491, P378, DOI 10.1016/j.jallcom.2009.10.188; Roth R. S., 1981, PHASE DIAGRAMS CERAM; Shionoya S., 1999, PHOSPHOR HDB, P141; Slobodin BV, 2011, INORG MATER+, V47, P1126, DOI 10.1134/S0020168511100190; The University of Sheffield and WebElements Ltd UK, 2015, AB EARTHS CRUST PER; TRACEY AS, 1995, INORG CHEM, V34, P5680, DOI 10.1021/ic00126a043; Zubkov VG, 2009, SOLID STATE SCI, V11, P726, DOI 10.1016/j.solidstatesciences.2008.09.009	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	APR	2015	98	4					1236	1244		10.1111/jace.13463		9	Materials Science, Ceramics	Materials Science	CF5ZD	WOS:000352635100032		
J	Takahashi, K; Dierre, B; Cho, YJ; Sekiguchi, T; Xie, RJ; Hirosaki, N				Takahashi, Kohsei; Dierre, Benjamin; Cho, Yujin; Sekiguchi, Takashi; Xie, Rong-Jun; Hirosaki, Naoto			Microanalysis of Calcium Codoped LaAl(Si6-zAlz)(N10-zOz)(z similar to 1): Ce3+ Blue Phosphor	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							LIGHT-EMITTING-DIODES; OPTICAL-PROPERTIES; ALPHA-SIALON; LUMINESCENCE; PHOTOLUMINESCENCE; CONVERSION	Cathodoluminescence spectra of Ca codoped (La,Ce)Al(Si6-zAlz)(N10-zOz) (z similar to 1) (termed JEM phase) phosphors were analyzed microscopically. The as-prepared samples consisted of a major JEM phase and a small amount of -sialon and/or -sialon depending on the Ca concentration. A microscale distribution of three different emission spectra was clearly observed on one phosphor particle, which was originated from the blue-emitting JEM:Ce (430nm), -sialon:Ce (435nm) and Ca--sialon:Ce (475nm), respectively. The volume ratio of the three phases thus led to changes in the bandwidth and the maximum position of the emission spectrum, and the redshift of CL spectra with increasing Ca concentration was dominantly attributed to the enhanced emission from Ca--sialon. The microanalysis of phosphor particles with the aid of cathodoluminescence spectroscopy indicated a similar result of the phase assembly that was identified by the powder X-ray diffraction.	[Takahashi, Kohsei; Xie, Rong-Jun; Hirosaki, Naoto] Natl Inst Mat Sci, Sialon Unit, Tsukuba, Ibaraki 3050044, Japan; [Takahashi, Kohsei; Cho, Yujin; Sekiguchi, Takashi] Natl Inst Mat Sci, Nano Device Characterizat Grp, MANA, Tsukuba, Ibaraki 3050044, Japan; [Takahashi, Kohsei; Cho, Yujin; Sekiguchi, Takashi] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Dierre, Benjamin] Natl Inst Mat Sci, ICYS MANA, Tsukuba, Ibaraki 3050044, Japan	Takahashi, K (reprint author), Natl Inst Mat Sci, Sialon Unit, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	takahashi.kohsei@nims.go.jp			Tokodai Institute for Elemental Strategy (TIES)	Authors are grateful to Tokodai Institute for Elemental Strategy (TIES) conducted by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, for its funding.	Hirosaki N, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1935027; Xie RJ, 2002, J AM CERAM SOC, V85, P1229; Li YQ, 2008, CHEM MATER, V20, P6704, DOI 10.1021/cm801669x; Takahashi K, 2011, ELECTROCHEM SOLID ST, V14, pE38, DOI 10.1149/2.017111esl; Narukawa Y, 2002, JPN J APPL PHYS 2, V41, pL371, DOI 10.1143/JJAP.41.L371; Hoppe HA, 2000, J PHYS CHEM SOLIDS, V61, P2001, DOI 10.1016/S0022-3697(00)00194-3; Xie RJ, 2004, J AM CERAM SOC, V87, P1368, DOI 10.1111/j.1151-2916.2004.tb07738.x; Huh YD, 2003, J ELECTROCHEM SOC, V150, pH57, DOI 10.1149/1.1535914; Xie RJ, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.022401; Xie RJ, 2004, APPL PHYS LETT, V84, P5404, DOI 10.1063/1.1767596; Grins J, 2001, J MATER CHEM, V11, P2358, DOI 10.1039/b102340n; Sakuma K, 2004, OPT LETT, V29, P2001, DOI 10.1364/OL.29.002001; Takahashi K, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2779093; KANAYA K, 1972, J PHYS D APPL PHYS, V5, P43, DOI 10.1088/0022-3727/5/1/308; Uheda K, 2006, ELECTROCHEM SOLID ST, V9, pH22, DOI 10.1149/1.2173192; Gustafsson A, 1998, J APPL PHYS, V84, P1715, DOI 10.1063/1.368613; Xie RJ, 2004, J PHYS CHEM B, V108, P12027, DOI 10.1021/jp048295g; Dierre B, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/4/043001; Dierre B, 2009, J AM CERAM SOC, V92, P1272, DOI 10.1111/j.1551-2916.2009.03048.x; Ekstrom TC, 1997, J MATER CHEM, V7, P505, DOI 10.1039/a605992i; Fasol G., 1997, BLUE LASER DIODE GAN; GRINS J, 1995, J MATER CHEM, V5, P2001, DOI 10.1039/jm9950502001; Liu LH, 2010, J ELECTROCHEM SOC, V157, pH50, DOI 10.1149/1.3246839; Sato Y, 1996, JPN J APPL PHYS 2, V35, pL838, DOI 10.1143/JJAP.35.L838; Takahashi K, 2012, ECS J SOLID STATE SC, V1, pR109, DOI 10.1149/2.002204jss; vanskrevel J. W. H., 1998, J ALLOY COMPD, V268, P272; vansKrevel J. W. H., 2002, J SOLID STATE CHEM, V165, P19	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	APR	2015	98	4					1253	1258		10.1111/jace.13470		6	Materials Science, Ceramics	Materials Science	CF5ZD	WOS:000352635100034		
J	Takakura, H; Kojirna, R; Kamiya, M; Kobayashi, E; Komatsu, T; Ueno, T; Terai, T; Hanaoka, K; Nagano, T; Urano, Y				Takakura, Hideo; Kojirna, Ryosuke; Kamiya, Mako; Kobayashi, Eiji; Komatsu, Toru; Ueno, Tasuku; Terai, Takuya; Hanaoka, Kenjiro; Nagano, Tetsuo; Urano, Yasuteru			New Class of Bioluminogenic Probe Based on Bioluminescent Enzyme-Induced Electron Transfer: BioLeT	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							PROTEIN-PROTEIN INTERACTIONS; IN-VIVO; RATIONAL DESIGN; LIVING SUBJECTS; FLUORESCENCE PROPERTIES; FIREFLY LUCIFERASE; HYDROGEN-PEROXIDE; NITRIC-OXIDE; ACTIVATION; REPORTER	Bioluminescence imaging (BLI) has advantages for investigating biological phenomena in deep tissues of living animals, but few design strategies are available for functional bioluminescent substrates. We propose a new design strategy (designated as bioluminescent enzyme-induced electron transfer: BioLeT) for luciferin-based bioluminescence probes. Luminescence measurements of a series of aminoluciferin derivatives confirmed that bioluminescence can be controlled by means of BioLeT. Based on this concept, we developed bioluminescence probes for nitric oxide that enabled quantitative and sensitive detection even in vivo. Our design strategy should be applicable to develop a wide range of practically useful bioluminogenic probes.	[Takakura, Hideo; Kojirna, Ryosuke; Komatsu, Toru; Ueno, Tasuku; Terai, Takuya; Hanaoka, Kenjiro; Urano, Yasuteru] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Takakura, Hideo; Kamiya, Mako; Urano, Yasuteru] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Nagano, Tetsuo] Univ Tokyo, Open Innovat Ctr Drug Discovery, Bunkyo Ku, Tokyo 1130033, Japan; [Urano, Yasuteru] Japan Sci & Technol Agcy, Basic Res Program, Kawaguchi, Saitama 3320012, Japan; [Urano, Yasuteru] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Kamiya, Mako; Komatsu, Toru] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kobayashi, Eiji] Keio Univ, Sch Med, Dept Organ Fabricat, Shinjuku Ku, Tokyo 1608582, Japan	Urano, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	uranokun@m.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20117003, 23249004, 26111012]; Daiichi-Sankyo Foundation of Life Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Tokyo Society of Medical Sciences; JSPS Core-to-Core Program, Advanced Research Networks	This research was supported in part by a Grant-in-Aid for JSPS Fellows (to H.T. and R.K.), the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Scientific Research (KAKENHI), grants 20117003, 23249004, and 26111012 to Y.U.), by The Daiichi-Sankyo Foundation of Life Science (grant to Y.U.), by The Mochida Memorial Foundation for Medical and Pharmaceutical Research (grant to M.K.), and by The Tokyo Society of Medical Sciences (grant to M.K.), by JSPS Core-to-Core Program, Advanced Research Networks. E.K. is the Chief Scientific Advisor for Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan.	Yuan L, 2013, ACCOUNTS CHEM RES, V46, P1462, DOI 10.1021/ar300273v; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Maruyama S, 2002, J AM CHEM SOC, V124, P10650, DOI 10.1021/ja026442n; Paley MA, 2014, MEDCHEMCOMM, V5, P255, DOI 10.1039/c3md00288h; McQuade LE, 2010, CURR OPIN CHEM BIOL, V14, P43, DOI 10.1016/j.cbpa.2009.10.004; Sakabe M, 2013, J AM CHEM SOC, V135, P409, DOI 10.1021/ja309688m; Hickson J, 2010, CELL DEATH DIFFER, V17, P1003, DOI 10.1038/cdd.2009.205; Hakamata Y, 2006, TRANSPLANTATION, V81, P1179, DOI 10.1097/01.tp.0000203137.06587.4a; Cali JJ, 2006, EXPERT OPIN DRUG MET, V2, P629, DOI 10.1517/17425255.2.4.629; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Yao H, 2007, ANGEW CHEM INT EDIT, V46, P7031, DOI 10.1002/anie.200701931; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Van de Bittner GC, 2013, J AM CHEM SOC, V135, P1783, DOI 10.1021/ja309078t; Takakura H, 2011, CHEM-ASIAN J, V6, P1800, DOI 10.1002/asia.201000873; Dujols V, 1997, J AM CHEM SOC, V119, P7386, DOI 10.1021/ja971221g; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; Miura T, 2003, J AM CHEM SOC, V125, P8666, DOI 10.1021/ja035282s; Negrin RS, 2006, NAT REV IMMUNOL, V6, P484, DOI 10.1038/nri1879; Li J, 2013, CHEM SOC REV, V42, P662, DOI 10.1039/c2cs35249d; Qin XB, 2009, AM J HEMATOL, V84, P221, DOI 10.1002/ajh.21363; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; Chang YC, 2011, BIOORG MED CHEM LETT, V21, P3931, DOI 10.1016/j.bmcl.2011.05.023; Dragulescu-Andrasi A, 2011, P NATL ACAD SCI USA, V108, P12060, DOI 10.1073/pnas.1100923108; Dragulescu-Andrasi A, 2009, BIOCONJUGATE CHEM, V20, P1660, DOI 10.1021/bc9002508; Evans MS, 2014, NAT METHODS, V11, P393, DOI [10.1038/nmeth.2839, 10.1038/NMETH.2839]; Hattori M, 2014, ANAL SCI, V30, P539; Kojima R, 2013, ANGEW CHEM INT EDIT, V52, P1175, DOI 10.1002/anie.201205151; MISKA W, 1989, J BIOLUM CHEMILUM, V4, P119, DOI 10.1002/bio.1170040118; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248	36	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	APR 1	2015	137	12					4010	4013		10.1021/ja511014w		4	Chemistry, Multidisciplinary	Chemistry	CF0OT	WOS:000352244800002		
J	Nagata, Y; Nishikawa, T; Suginome, M				Nagata, Yuuya; Nishikawa, Tsuyoshi; Suginome, Michinori			Exerting Control over the Helical Chirality in the Main Chain of Sergeants-and-Soldiers-Type Poly(quinoxaline-2,3-diyl)s by Changing from Random to Block Copolymerization Protocols	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							OPTICALLY-ACTIVE POLYISOCYANATES; ASYMMETRIC CATALYSIS; MACROMOLECULAR STEREOCHEMISTRY; CONFORMATIONAL CHARACTERISTICS; POLYMERS; SENSE; BEARING; UNITS; PERTURBATIONS; AMPLIFICATION	Chiral random poly(quinoxaline-2,3-diyl) polymers of the sergeants-and-soldiers-type (sergeant units bearing (S)-3-octyloxymethyl groups) adopt an M- or P-helical conformation in the presence of achiral units bearing propoxymethyl or butoxy groups (soldier units), respectively. Unusual bidirectional induction of the helical sense can be observed for a copolymer with butoxy soldier units upon changing the mole fraction of the sergeant units. In the presence of 16-20% of sergeant units, the selective induction of a P-helix was observed, while the selective induction of an M-helix was observed for a mole fraction of sergeant units of more than 60%. This phenomenon could be successfully employed to control the helical chirality of copolymers by applying either random or block copolymerization protocols. Random or block copolymerization of sergeant and soldier monomers in a 18:82 ratio resulted in the formation of 250mers with almost absolute P- or M-helical conformation, respectively (>99% ee). Incorporation of a small amount of coordination sites into the random and block copolymers resulted in chiral macromolecular ligands, which allowed the enantioselective synthesis of both enantiomers in the Pd-catalyzed asymmetric hydrosilylation of beta-methylstyrene.	[Nagata, Yuuya; Nishikawa, Tsuyoshi; Suginome, Michinori] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6068501, Japan; [Suginome, Michinori] Japan Sci & Technol Agcy JST, CREST, Nishikyo Ku, Kyoto 6158510, Japan	Suginome, M (reprint author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6068501, Japan.	suginome@sbchem.kyoto-u.ac.jp			Japan Science and Technology Agency (CREST, "Development of High-performance Nanostructures for Process Integration" Area)	We thank Takumi Adachi and Keisuke Takagi for help with experiments and analyses. Financial support for this research was provided by the Japan Science and Technology Agency (CREST, "Development of High-performance Nanostructures for Process Integration" Area).	Yamada T, 2010, CHEM COMMUN, V46, P4914, DOI 10.1039/c001564d; Palmans ARA, 1997, ANGEW CHEM INT EDIT, V36, P2648, DOI 10.1002/anie.199726481; Pino P, 1960, J AM CHEM SOC, V82, P4745, DOI 10.1021/ja01502a077; Nagata Y, 2013, J AM CHEM SOC, V135, P10104, DOI 10.1021/ja403391m; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; Reggelin M, 2002, ANGEW CHEM INT EDIT, V41, P1614, DOI 10.1002/1521-3773(20020503)41:9<1614::AID-ANIE1614>3.0.CO;2-5; Cornelissen JJLM, 2001, CHEM REV, V101, P4039, DOI 10.1021/cr990126i; Roelfes G, 2005, ANGEW CHEM INT EDIT, V44, P3230, DOI 10.1002/anie.200500298; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Yamamoto T, 2010, J AM CHEM SOC, V132, P7899, DOI 10.1021/ja102428q; Yamamoto T, 2009, ANGEW CHEM INT EDIT, V48, P539, DOI 10.1002/anie.200803719; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Cheng RP, 2001, CHEM REV, V101, P3219, DOI 10.1021/cr000045i; Yashima E, 2004, CHEM-EUR J, V10, P42, DOI 10.1002/chem.200305295; Akai Y, 2012, J AM CHEM SOC, V134, P11092, DOI 10.1021/ja303506k; MILLICH F, 1969, MACROMOLECULES, V2, P122, DOI 10.1021/ma60008a003; Yamamoto T, 2011, ANGEW CHEM INT EDIT, V50, P8844, DOI 10.1002/anie.201103792; GOODMAN M, 1970, MACROMOLECULES, V3, P398, DOI 10.1021/ma60016a005; GREEN MM, 1989, J AM CHEM SOC, V111, P6452, DOI 10.1021/ja00198a084; Suginome M, 2012, PURE APPL CHEM, V84, P1759, DOI 10.1351/PAC-CON-11-08-23; CIARDELL.F, 1974, MACROMOLECULES, V7, P174, DOI 10.1021/ma60038a005; Deng JP, 2004, MACROMOLECULES, V37, P9715, DOI 10.1021/ma048177r; Gu H, 1998, MACROMOLECULES, V31, P6362, DOI 10.1021/ma980648k; Gu H, 1997, POLYM J, V29, P77, DOI 10.1295/polymj.29.77; Koe JR, 2001, MACROMOLECULES, V34, P1082, DOI 10.1021/ma001126j; LIFSON S, 1989, J AM CHEM SOC, V111, P8850, DOI 10.1021/ja00206a013; Maeda K, 1999, MACROMOLECULES, V32, P974, DOI 10.1021/ma981362i; Morino K, 2002, CHEM-EUR J, V8, P5112, DOI 10.1002/1521-3765(20021115)8:22<5112::AID-CHEM5112>3.0.CO;2-S; Sato T, 2002, MACROMOLECULES, V35, P5355, DOI 10.1021/ma020426t; Selinger JV, 1997, PHYS REV E, V55, P1728, DOI 10.1103/PhysRevE.55.1728; Tabei J, 2005, CHEM-EUR J, V11, P3591, DOI 10.1002/chem.200401009; Takei F, 2007, MACROMOLECULES, V40, P5245, DOI 10.1021/ma070891w; Teramoto A, 2001, PROG POLYM SCI, V26, P667, DOI 10.1016/S0079-6700(00)00037-X	33	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	APR 1	2015	137	12					4070	4073		10.1021/jacs.5b01422		4	Chemistry, Multidisciplinary	Chemistry	CF0OT	WOS:000352244800017		
J	Uematsu, R; Yamamoto, E; Maeda, S; Ito, H; Taketsugu, T				Uematsu, Ryohei; Yamamoto, Eiji; Maeda, Satoshi; Ito, Hajime; Taketsugu, Tetsuya			Reaction Mechanism of the Anomalous Formal Nucleophilic Borylation of Organic Halides with Silylborane: Combined Theoretical and Experimental Studies	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							CATION-PI INTERACTIONS; ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; HALOGEN-METAL INTERCONVERSION; MUKAIYAMA-ALDOL REACTION; ALKOXY DIBORON REAGENTS; CROSS-COUPLING REACTION; AROMATIC-AMINO-ACIDS; CATALYZED BORYLATION; EXCHANGE-REACTION; REACTION PATHWAYS	Theoretical and experimental studies have been conducted to elucidate the mechanism of the formal nucleophilic boryl substitution of aryl and alkyl bromides with silylborane in the presence of potassium methoxide. Density functional theory was used in conjunction with the artificial force induced reaction method in the current study to determine the mechanism of this reaction. The results of this analysis led to the identification of a unique carbanion-mediated mechanism involving the halogenophilic attack of a silyl nucleophile on the bromine atom of the substrate. These calculations have, therefore, provided a mechanistic rationale for this counterintuitive borylation reaction. Furthermore, the good functional group compatibility and high reactivity exhibited by this reaction toward sterically hindered substrates can be understood in terms of the low activation energy required for the reaction of the silyl nucleophile with the bromine atom of the substrate and the subsequent rapid and selective consumption of the carbanion species by the in situ generated boron electrophile. The results of an experimental study involving the capture of the anion intermediate provided further evidence in support of the generation of a carbanion species during the course of this reaction. The anomalous formal nucleophilic borylation mechanism reported in this study could be used to provide new insights into silicon and boron chemistry.	[Uematsu, Ryohei] Hokkaido Univ, Grad Sch Chem Sci & Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Yamamoto, Eiji; Ito, Hajime] Hokkaido Univ, Div Chem Proc Engn, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Yamamoto, Eiji; Ito, Hajime] Hokkaido Univ, Frontier Chem Ctr, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Maeda, Satoshi; Taketsugu, Tetsuya] Hokkaido Univ, Fac Sci, Dept Chem, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Maeda, S (reprint author), Hokkaido Univ, Fac Sci, Dept Chem, Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	smaeda@mail.sci.hokudai.ac.jp; hajito@eng.hokudai.ac.jp	Ito, Hajime/D-8337-2012; Maeda, Satoshi/H-3613-2014	Ito, Hajime/0000-0003-3852-6721; 	Japan Society for the Promotion of Science at Hokkaido University [23685004]; JSPS KAKENHI [26.2447]; Sasakawa Scientific Research Grant from the Japan Science Society for the Promotion of Science; Institute for Quantum Chemical Exploration (IQCE)	This work was supported in part by a grant from the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research (KAKENHI) no. 23685004 at Hokkaido University), JSPS KAKENHI grant no. 26.2447, and a Sasakawa Scientific Research Grant from the Japan Science Society for the Promotion of Science. Calculations were performed using computational resources at the Academic Center for Computing and Media Studies (ACCMS) of Kyoto University and the Research Center for Computational Science at the National Institute of Natural Sciences (NINS). A research fellowship for young scientists was awarded to R.U. by the Institute for Quantum Chemical Exploration (IQCE). A part of PhMe<INF>2</INF>Si-B(pin) was provided by Frontier Scientific, Inc.	Abe Y, 2008, ORGANOMETALLICS, V27, P1736, DOI 10.1021/om070110f; Ahman A, 2006, CHEM COMMUN, P1209, DOI 10.1039/b515143k; Ando K, 2006, J ORG CHEM, V71, P1837, DOI 10.1021/jo0519662; Lau JKC, 2003, CHEM-EUR J, V9, P3383, DOI 10.1002/chem.200204678; Kleeberg C, 2009, ANGEW CHEM INT EDIT, V48, P5350, DOI 10.1002/anie.200901879; O'Brien JM, 2011, J AM CHEM SOC, V133, P7712, DOI 10.1021/ja203031a; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Lam WH, 2003, ORGANOMETALLICS, V22, P473, DOI 10.1021/om020901b; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Kubota K, 2013, J AM CHEM SOC, V135, P2635, DOI 10.1021/ja3104582; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Davidson MG, 2011, CHEM-EUR J, V17, P3364, DOI 10.1002/chem.201003493; Green AG, 2014, J AM CHEM SOC, V136, P4575, DOI 10.1021/ja411699u; Dudnik AS, 2012, J AM CHEM SOC, V134, P10693, DOI 10.1021/ja304068t; Oestreich M, 2013, CHEM REV, V113, P402, DOI 10.1021/cr3003517; Zhao HT, 2008, J AM CHEM SOC, V130, P5586, DOI 10.1021/ja710659y; Clary JW, 2011, J ORG CHEM, V76, P9602, DOI 10.1021/jo201093u; MORI M, 1991, TETRAHEDRON LETT, V32, P6139, DOI 10.1016/0040-4039(91)80773-Y; Hartwig JF, 2005, J AM CHEM SOC, V127, P2538, DOI 10.1021/ja045090c; Sumimoto M, 2004, J AM CHEM SOC, V126, P10457, DOI 10.1021/ja040020r; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Chow WK, 2013, RSC ADV, V3, P12518, DOI 10.1039/c3ra22905j; Becke AD, 1997, J CHEM PHYS, V107, P8554, DOI 10.1063/1.475007; Bauernschmitt R, 1996, J CHEM PHYS, V104, P9047, DOI 10.1063/1.471637; ISHIYAMA T, 1995, J ORG CHEM, V60, P7508, DOI 10.1021/jo00128a024; Yi J, 2012, ADV SYNTH CATAL, V354, P1685, DOI 10.1002/adsc.201200136; Dang L, 2007, ORGANOMETALLICS, V26, P2824, DOI 10.1021/om070103r; BROWN HC, 1986, ORGANOMETALLICS, V5, P2300, DOI 10.1021/om00142a020; Iikura H, 2001, J CHEM PHYS, V115, P3540, DOI 10.1063/1.1383587; Ruan CH, 2004, J AM CHEM SOC, V126, P14600, DOI 10.1021/ja048297e; BROWN HC, 1983, ORGANOMETALLICS, V2, P1316, DOI 10.1021/om50004a009; Rosso VW, 1997, ORG PROCESS RES DEV, V1, P311, DOI 10.1021/op970107f; Armstrong DR, 2013, ORGANOMETALLICS, V32, P480, DOI 10.1021/om3009469; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; Liu BW, 2012, ORGANOMETALLICS, V31, P3410, DOI 10.1021/om3002153; Suginome M, 2000, ORGANOMETALLICS, V19, P4647, DOI 10.1021/om000254t; Maeda S, 2014, J COMPUT CHEM, V35, P166, DOI 10.1002/jcc.23481; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Zhang P, 2012, ORG LETT, V14, P1416, DOI 10.1021/ol3001552; Hata T, 2001, ANGEW CHEM INT EDIT, V40, P790, DOI 10.1002/1521-3773(20010216)40:4<790::AID-ANIE7900>3.3.CO;2-K; Bose SK, 2014, ANGEW CHEM INT EDIT, V53, P1799, DOI 10.1002/anie.201308855; Nakao Y, 2011, CHEM SOC REV, V40, P4893, DOI 10.1039/c1cs15122c; Dang L, 2008, ORGANOMETALLICS, V27, P1178, DOI 10.1021/om700999w; Tamura H, 2003, J AM CHEM SOC, V125, P16114, DOI 10.1021/ja0302937; Yamamoto E, 2012, J AM CHEM SOC, V134, P19997, DOI 10.1021/ja309578k; Ito H, 2012, CHEM COMMUN, V48, P8006, DOI 10.1039/c2cc32778c; Nagashima Y, 2013, J AM CHEM SOC, V135, P18730, DOI 10.1021/ja409748m; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Dang L, 2010, ORGANOMETALLICS, V29, P917, DOI 10.1021/om901047e; Dang L, 2008, ORGANOMETALLICS, V27, P4443, DOI 10.1021/om8006294; Ito H, 2012, ORG LETT, V14, P890, DOI 10.1021/ol203413w; SEEGER R, 1977, J CHEM PHYS, V66, P3045, DOI 10.1063/1.434318; Maeda S, 2013, PHYS CHEM CHEM PHYS, V15, P3683, DOI 10.1039/c3cp44063j; Vanchura BA, 2010, CHEM COMMUN, V46, P7724, DOI 10.1039/c0cc02041a; Nishikata T, 2004, ORGANOMETALLICS, V23, P4317, DOI 10.1021/om0498044; Murata M, 2000, TETRAHEDRON LETT, V41, P5877, DOI 10.1016/S0040-4039(00)00881-9; Stoll H, 2002, J COMPUT CHEM, V23, P767, DOI 10.1002/jcc.10037; BEAK P, 1992, J AM CHEM SOC, V114, P3420, DOI 10.1021/ja00035a039; Zhao HT, 2006, J AM CHEM SOC, V128, P15637, DOI 10.1021/ja063671r; Maeda S, 2011, J CHEM THEORY COMPUT, V7, P2335, DOI 10.1021/ct200290m; Webster CE, 2003, J AM CHEM SOC, V125, P858, DOI 10.1021/ja028394c; Baron O, 2005, ANGEW CHEM INT EDIT, V44, P3133, DOI 10.1002/anie.200462928; Borner C, 2014, EUR J INORG CHEM, P2486, DOI 10.1002/ejic.201402234; Cabarcos OM, 1999, J CHEM PHYS, V110, P8429, DOI 10.1063/1.478752; Cheung MS, 2011, ORGANOMETALLICS, V30, P3018, DOI 10.1021/om200115y; CHOI C, 1991, J CHEM PHYS, V94, P751, DOI 10.1063/1.460343; Clayden J., 2012, ORGANIC CHEM; Daschlein C, 2011, EUR J INORG CHEM, P1454, DOI 10.1002/ejic.201000834; De Wall SL, 1999, J AM CHEM SOC, V121, P8405, DOI 10.1021/ja991618f; FARNHAM WB, 1986, J AM CHEM SOC, V108, P2449, DOI 10.1021/ja00269a055; Forbes GC, 2002, ORGANOMETALLICS, V21, P5115, DOI 10.1021/om020596u; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fukin GK, 2002, J AM CHEM SOC, V124, P8329, DOI 10.1021/ja0203465; Hall DG, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, P1, DOI 10.1002/9783527639328; HARADA T, 1992, J ORG CHEM, V57, P5805, DOI 10.1021/jo00048a002; Hartwig JF, 2012, ACCOUNTS CHEM RES, V45, P864, DOI 10.1021/ar200206a; Hatanaka M, 2013, J AM CHEM SOC, V135, P13972, DOI 10.1021/ja407357c; Hatanaka M, 2013, J CHEM THEORY COMPUT, V9, P2882, DOI 10.1021/ct4002637; Hudrlik PF, 2011, TETRAHEDRON, V67, P10089, DOI 10.1016/j.tet.2011.09.127; Ilkhechi AH, 2005, J AM CHEM SOC, V127, P10656, DOI 10.1021/ja051544+; Ishiyama T, 2004, CHEM REC, V3, P271, DOI 10.1002/tcr.10068; Kawachi A, 2001, CHEM LETT, P1216; KUMPF RA, 1993, SCIENCE, V261, P1708, DOI 10.1126/science.8378771; Lari A, 2009, EUR J ORG CHEM, P2765, DOI 10.1002/ejoc.200900108; Lam KC, 2007, ORGANOMETALLICS, V26, P3149, DOI 10.1021/om0700314; Lam WH, 2004, DALTON T, P1556, DOI 10.1039/b402632b; Maeda S., 2010, J CHEM PHYS, V132; Maeda S., GRRM DEV VERSION; Maeda S, 2011, ANGEW CHEM INT EDIT, V50, P644, DOI 10.1002/anie.201005336; Pintaric C, 2010, J AM CHEM SOC, V132, P11825, DOI 10.1021/ja1052973; Primas N, 2010, TETRAHEDRON, V66, P8121, DOI 10.1016/j.tet.2010.08.001; ROGERS HR, 1982, J AM CHEM SOC, V104, P522, DOI 10.1021/ja00366a024; Siu FM, 2004, CHEM-EUR J, V10, P1966, DOI 10.1002/chem.200305519; Strohmann C, 2004, ANGEW CHEM INT EDIT, V43, P1011, DOI 10.1002/anie.200352700; Uematsu R, 2014, CHEM-ASIAN J, V9, P305, DOI 10.1002/asia.201301065; Wan XH, 2002, ORGANOMETALLICS, V21, P3703, DOI 10.1021/om020112u; Wilf P., 1993, SYNTHESIS-STUTTGART, V6, P527; WINKLER HJS, 1966, J AM CHEM SOC, V88, P969, DOI 10.1021/ja00957a020; WINKLER HJS, 1966, J AM CHEM SOC, V88, P964, DOI 10.1021/ja00957a019; Zhao Y., 2008, J CHEM PHYS, V125	100	7	7	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	APR 1	2015	137	12					4090	4099		10.1021/ja507675f		10	Chemistry, Multidisciplinary	Chemistry	CF0OT	WOS:000352244800022		
J	Kataoka, S; Banerjee, S; Kawai, A; Kamimura, Y; Choi, JC; Kodaira, T; Sato, K; Endo, A				Kataoka, Sho; Banerjee, Subhabrata; Kawai, Akiko; Kamimura, Yoshihiro; Choi, Jun-Chul; Kodaira, Tetsuya; Sato, Kazuhiko; Endo, Akira			Layered Hybrid Perovskites with Micropores Created by Alkylammonium Functional Silsesquioxane Interlayers	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							ORGANIC-INORGANIC PEROVSKITE; ORGANOMETAL HALIDE PEROVSKITES; SOLAR-CELLS; FILMS; POSS; COMPLEXES; POLYMERS; (C6H13NH3)(2)PBI4; STATE; CORE	Layered organic-inorganic hybrid perovskites that consist of metal halides and organic interlayers are a class of low-dimensional materials. Here, we report the fabrication of layered hybrid perovskites using metal halides and silsesquioxane with a cage-like structure. We used a silsesquioxane as an interlayer to produce a rigid structure and improve the functionality of perovskite layers. Propylammonium-functionalized silsesquioxane and metal halide salts (CuCl2, PdCl2, PbCl2, and MnCl2) were self-assembled to form rigid layered perovskite structures with high crystallinity. The rigid silsesquioxane structure produces micropores between the perovskite layers that can potentially be filled with different molecules to tune the dielectric constants of the interlayers. The obtained silsesquioxane-metal halide hybrid perovskites exhibit some characteristic properties of layered perovskites including magnetic ordering (CuCl42- and MnCl42-) and excitonic absorption/emission (PbCl42-). Our results indicate that inserting silsesquioxane interlayers into hybrid perovskites retains and enhances the low-dimensional properties of the materials.	[Kataoka, Sho; Banerjee, Subhabrata; Kawai, Akiko; Kamimura, Yoshihiro; Choi, Jun-Chul; Kodaira, Tetsuya; Sato, Kazuhiko; Endo, Akira] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Kataoka, S (reprint author), Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	s-kataoka@aist.go.jp; endo-akira@aist.go.jp			"Development of Innovative Catalytic Processes for Organosilicon Functional Materials" project from the New Energy and Industrial Technology Development Organization (NEDO)	This work was fully supported by the "Development of Innovative Catalytic Processes for Organosilicon Functional Materials" project from the New Energy and Industrial Technology Development Organization (NEDO). We are especially grateful to Drs. Norihisa Fukaya, Toshiaki Taira, and Noriyuki Takada (AIST) for fruitful discussions. We also thank Drs. Yasutaka Kuwahara, Toshikazu Takahashi, and Kunio Suzuki (AIST), and Mr. Susumu Mimura (Horiba Ltd., Japan) for their assistance with UV-vis, solid-state NMR, FE-SEM, and photoluminescence measurements. SQUID measurements were performed in Nano-Processing Facility (NPF) at JUST. We acknowledge Drs. Teruhisa Ootsuka and Masashi Yamazald (NPF) for their generous assistance during SQUID measurements.	Akhtar N, 2014, SMALL, V10, P4912, DOI 10.1002/smll.201400259; Hao F, 2014, NAT PHOTONICS, V8, P489, DOI 10.1038/nphoton.2014.82; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Tanaka K, 2009, MACROMOLECULES, V42, P3489, DOI 10.1021/ma900113j; Dasari A, 2009, POLYMER, V50, P1577, DOI 10.1016/j.polymer.2009.01.050; ISHIHARA T, 1989, SOLID STATE COMMUN, V69, P933, DOI 10.1016/0038-1098(89)90935-6; Papavassiliou GC, 1999, ADV MATER OPT ELECTR, V9, P265, DOI 10.1002/1099-0712(199911/12)9:6<265::AID-AMO390>3.0.CO;2-6; Goodgame DML, 2008, J MOL STRUCT, V890, P232, DOI 10.1016/j.molstruc.2008.05.013; Naka K, 2007, LANGMUIR, V23, P9057, DOI 10.1021/la7013286; Zhang ZJ, 2006, INORG CHEM, V45, P1972, DOI 10.1021/ic051350v; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Tanaka K, 2002, SOLID STATE COMMUN, V122, P249, DOI 10.1016/S0038-1098(02)00126-6; Bocek J, 2011, EUR POLYM J, V47, P861, DOI 10.1016/j.eurpolymj.2011.02.023; Mitzi DB, 1999, PROG INORG CHEM, V48, P1, DOI 10.1002/9780470166499.ch1; Liang KN, 1998, CHEM MATER, V10, P403, DOI 10.1021/cm970568f; Kaneko Y, 2012, J MATER CHEM, V22, P14475, DOI 10.1039/c2jm32355a; Ahari H, 1997, NATURE, V388, P857; Smith IC, 2014, ANGEW CHEM INT EDIT, V53, P11232, DOI 10.1002/anie.201406466; Gravel MC, 1999, APPL ORGANOMET CHEM, V13, P329, DOI 10.1002/(SICI)1099-0739(199904)13:4<329::AID-AOC870>3.0.CO;2-V; Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; WILLETT R, 1988, J AM CHEM SOC, V110, P8639, DOI 10.1021/ja00234a010; Braun M, 1999, CHEM PHYS LETT, V303, P157, DOI 10.1016/S0009-2614(99)00205-5; Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r; Zhang CX, 1998, J AM CHEM SOC, V120, P8380, DOI 10.1021/ja9808853; Kitazawa N, 1998, J MATER SCI, V33, P1441, DOI 10.1023/A:1004335306298; Era M, 1998, THIN SOLID FILMS, V331, P285, DOI 10.1016/S0040-6090(98)00932-8; BANEY RH, 1995, CHEM REV, V95, P1409, DOI 10.1021/cr00037a012; Carroll JB, 2003, MACROMOLECULES, V36, P6289, DOI 10.1021/ma034652u; Cheng ZY, 2010, CRYSTENGCOMM, V12, P2646, DOI 10.1039/c001929a; Cheng ZY, 2005, EUR J INORG CHEM, P218, DOI 10.1002/ejic.200400501; Cheng ZY, 2003, CHEM MATER, V15, P4705, DOI 10.1021/cm034472z; do Carmo DR, 2010, MATER RES BULL, V45, P1263, DOI 10.1016/j.materresbull.2010.05.005; ESTES WE, 1980, J CHEM PHYS, V72, P630, DOI 10.1063/1.438953; Feher FJ, 1998, CHEM COMMUN, P323, DOI 10.1039/a707140j; Kikuchi K, 2005, COLLOID SURFACE A, V257-58, P199, DOI 10.1016/j.colsurfa.2004.06.045; Mitzi DB, 1997, CHEM MATER, V9, P2990, DOI 10.1021/cm970352d; OVIATT HW, 1993, CHEM MATER, V5, P943, DOI 10.1021/cm00031a012; PAPAVASSILIOU GC, 1995, SYNTHETIC MET, V71, P1713, DOI 10.1016/0379-6779(94)03017-Z; Shibuya K, 2002, NUCL INSTRUM METH B, V194, P207, DOI 10.1016/S0168-583X(02)00671-7; Tanaka K., 2003, Science and Technology of Advanced Materials, V4, DOI 10.1016/j.stam.2003.09.019; Willett RD, 2012, EUR J INORG CHEM, P3342, DOI 10.1002/ejic.201101200; Xiao ZL, 2005, MAT SCI ENG B-SOLID, V117, P313, DOI 10.1016/j.mseb.2004.12.052; ZHOU P, 1990, J APPL PHYS, V67, P5755, DOI 10.1063/1.345953	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	APR 1	2015	137	12					4158	4163		10.1021/jacs.5b00290		6	Chemistry, Multidisciplinary	Chemistry	CF0OT	WOS:000352244800030		
J	Yuki, M; Sakata, K; Hirao, Y; Nonoyama, N; Nakajima, K; Nishibayashi, Y				Yuki, Masahiro; Sakata, Ken; Hirao, Yoshifumi; Nonoyama, Nobuaki; Nakajima, Kazunari; Nishibayashi, Yoshiaki			Thiolate-Bridged Dinuclear Ruthenium and Iron Complexes as Robust and Efficient Catalysts toward Oxidation of Molecular Dihydrogen in Protic Solvents	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							ELECTROCATALYTIC HYDROGEN EVOLUTION; H-2 PRODUCTION; LOW OVERPOTENTIALS; ELECTROCHEMICAL OXIDATION; COORDINATION SPHERES; ENERGY-STORAGE; PENDANT AMINES; ACTIVE-SITE; FUEL-CELL; WATER	Thiolate-bridged dinuclear ruthenium and iron complexes are found to work as efficient catalysts toward oxidation of molecular dihydrogen in protic solvents such as water and methanol under ambient reaction conditions. Heterolytic cleavage of the coordinated molecular dihydrogen at the dinuclear complexes and the sequential oxidation of the produced hydride complexes are involved as key steps to promote the present catalytic reaction. The catalytic activity of the dinuclear complexes toward the chemical oxidation of molecular dihydrogen achieves up to 10000 TON (turnover number), and electrooxidation of molecular dihydrogen proceeds quite rapidly. The result of the density functional theory (DFT) calculation on the reaction pathway indicates that a synergistic effect between the two ruthenium atoms plays an important role to realize the catalytic oxidation of molecular dihydrogen efficiently. The present dinuclear ruthenium complex is found to work as an efficient organometallic anode catalyst for the fuel cell. It is noteworthy that the present dinuclear complex worked not only as an effective catalyst toward chemical and electrochemical oxidation of molecular dihydrogen but also as a good anode catalyst for the fuel cell. We consider that the result described in this paper provides useful and valuable information to develop highly efficient and low-cost transition metal complexes as anode catalysts in the fuel cell.	[Yuki, Masahiro; Nakajima, Kazunari; Nishibayashi, Yoshiaki] Univ Tokyo, Sch Engn, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Sakata, Ken] Hoshi Univ, Fac Pharmaceut Sci, Shinagawa Ku, Tokyo 1428501, Japan; [Hirao, Yoshifumi; Nonoyama, Nobuaki] Toyota Motor Co Ltd, Fuel Cell Syst Dev Ctr, Mishu Ku, Shizuoka 4101193, Japan	Sakata, K (reprint author), Hoshi Univ, Fac Pharmaceut Sci, Shinagawa Ku, Tokyo 1428501, Japan.	sakata@hoshi.ac.jp; ynishiba@sogo.t.u-tokyo.ac.jp	Nishibayashi, Yoshiaki/E-9230-2010; Sakata, Ken/I-6275-2013	Sakata, Ken/0000-0002-6920-0735	Japan Society for the Promotion of Science (JSPS) [26288044, 26620075]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); ENEOS Hydrogen Trust Fund; Ministry of Education, Culture, Sports, Science and Technology, Japan [26105708, 26105756]	We express deepest appreciation to Dr. Haruyuki Nakanishi and Dr. Yukihisa Katayama of Toyota Motor Corporation for their great contribution and their generous support to the present project. Y.N. acknowledges Grants-in-Aid for Scientific Research (Nos. 26288044 and 26620075) from the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and ENEOS Hydrogen Trust Fund. We acknowledge Grants-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalyst" from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Nos. 26105708 to Y.N. and 26105756 to K.S.).	Ammal SC, 2005, J AM CHEM SOC, V127, P9428, DOI 10.1021/ja050298z; Connelly NG, 1996, CHEM REV, V96, P877, DOI 10.1021/cr940053x; Wang N, 2013, DALTON T, V42, P12059, DOI 10.1039/c3dt51371h; Stolley RM, 2014, CHEM COMMUN, V50, P3681, DOI 10.1039/c4cc00295d; Annen SP, 2010, ANGEW CHEM INT EDIT, V49, P7229, DOI 10.1002/anie.201002234; Wang WG, 2012, J AM CHEM SOC, V134, P4525, DOI 10.1021/ja211778j; Yang JY, 2010, CHEM COMMUN, V46, P8618, DOI 10.1039/c0cc03246h; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Wang N, 2013, J AM CHEM SOC, V135, P13688, DOI 10.1021/ja408376t; Matsumoto T, 2008, CHEM LETT, V37, P970, DOI 10.1246/cl.2008.970; Thoi VS, 2013, CHEM SOC REV, V42, P2388, DOI 10.1039/c2cs35272a; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Pullen S, 2013, J AM CHEM SOC, V135, P16997, DOI 10.1021/ja407176p; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Lense S, 2014, CHEM COMMUN, V50, P792, DOI 10.1039/c3cc46829a; Ghosh S, 2014, CHEM COMMUN, V50, P945, DOI 10.1039/c3cc46456c; Camara JM, 2012, NAT CHEM, V4, P26, DOI 10.1038/nchem.1180; Dutta A, 2013, J AM CHEM SOC, V135, P18490, DOI 10.1021/ja407826d; Liu TB, 2013, NAT CHEM, V5, P228, DOI 10.1038/NCHEM.1571; Bullock RM, 2014, CHEM COMMUN, V50, P3125, DOI 10.1039/c3cc46135a; Kubas GJ, 2007, CHEM REV, V107, P4152, DOI 10.1021/cr050197j; Simmons TR, 2014, COORDIN CHEM REV, V270, P127, DOI 10.1016/j.ccr.2013.12.018; Liu TB, 2014, ENERG ENVIRON SCI, V7, P3630, DOI 10.1039/c4ee01262c; Hu XL, 2007, J AM CHEM SOC, V129, P8988, DOI 10.1021/ja067876b; Yang JY, 2011, MRS BULL, V36, P39, DOI 10.1557/mrs.2010.8; Wilson AD, 2006, J AM CHEM SOC, V128, P358, DOI 10.1021/ja056442y; Ogo S, 2013, SCIENCE, V339, P682, DOI 10.1126/science.1231345; Barton BE, 2010, CURR OPIN BIOTECH, V21, P292, DOI 10.1016/j.copbio.2010.03.003; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; Helm ML, 2011, SCIENCE, V333, P863, DOI 10.1126/science.1205864; Khnayzer RS, 2013, J AM CHEM SOC, V135, P14068, DOI 10.1021/ja407816f; Rose MJ, 2012, J AM CHEM SOC, V134, P8310, DOI 10.1021/ja300534r; Ringenberg MR, 2008, J AM CHEM SOC, V130, P788, DOI 10.1021/ja076801k; Tong LP, 2014, J AM CHEM SOC, V136, P4881, DOI 10.1021/ja501257d; Appel AM, 2005, J AM CHEM SOC, V127, P12717, DOI 10.1021/ja054034o; Karunadasa HI, 2012, SCIENCE, V335, P698, DOI 10.1126/science.1215868; McCrory CCL, 2012, J AM CHEM SOC, V134, P3164, DOI 10.1021/ja210661k; Yang JY, 2013, J AM CHEM SOC, V135, P9700, DOI 10.1021/ja400705a; Darmon JM, 2014, ACS CATAL, V4, P1246, DOI 10.1021/cs500290w; Liu TB, 2014, ANGEW CHEM INT EDIT, V53, P5300, DOI 10.1002/anie.201402090; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; NICHOLSON RS, 1964, ANAL CHEM, V36, P706, DOI 10.1021/ac60210a007; Bonitatibus PJ, 2015, P NATL ACAD SCI USA, V112, P1687, DOI 10.1073/pnas.1420199112; Matsumoto T, 2013, CHEMCATCHEM, V5, P1368, DOI 10.1002/cctc.201200595; Gloaguen F, 2009, CHEM SOC REV, V38, P100, DOI 10.1039/b801796b; Camara JM, 2011, J AM CHEM SOC, V133, P8098, DOI 10.1021/ja201731q; Simmons TR, 2013, ANGEW CHEM INT EDIT, V52, P6143, DOI 10.1002/anie.201302908; Curtis CJ, 2003, INORG CHEM, V42, P216, DOI 10.1021/ic020610v; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; DuBois MR, 2009, CHEM SOC REV, V38, P62, DOI 10.1039/b801197b; DuBois DL, 2014, INORG CHEM, V53, P3935, DOI 10.1021/ic4026969; Artero V, 2005, COORDIN CHEM REV, V249, P1518, DOI 10.1016/j.ccr.2005.01.014; Matsumoto T, 2014, ANGEW CHEM INT EDIT, V53, P8895, DOI 10.1002/anie.201404701; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; McKone JR, 2014, CHEM SCI, V5, P865, DOI 10.1039/c3sc51711j; Carroll ME, 2012, J AM CHEM SOC, V134, P18843, DOI 10.1021/ja309216v; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Gimbert-Surinach C, 2014, J AM CHEM SOC, V136, P7655, DOI 10.1021/ja501489h; Canaguier S, 2008, DALTON T, P315, DOI 10.1039/b713567j; COLLMAN JP, 1992, J AM CHEM SOC, V114, P5654, DOI 10.1021/ja00040a027; Cotton F. A., 1999, ADV INORG CHEM; de Grotthuss C. J. T., 1806, ANN CHIM, V58, P54; DuBois DL, 2011, EUR J INORG CHEM, P1017, DOI 10.1002/ejic.201001081; DuBois M. R., 2010, CATALYSIS PRECIOUS M, P165; Dutta A, 2014, ANGEW CHEM INT EDIT, V53, P6487, DOI 10.1002/anie.201402304; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Ginovska-Pangovska B, 2014, ACCOUNTS CHEM RES, V47, P2621, DOI 10.1021/ar5001742; Hehre W. J., 1986, AB INITIO MOL ORBITA; Inoki D, 2013, EUR J INORG CHEM, V2013, P3978, DOI 10.1002/ejic.201300049; JESSOP PG, 1992, COORDIN CHEM REV, V121, P155, DOI 10.1016/0010-8545(92)80067-2; Matsumoto T, 2011, ANGEW CHEM INT EDIT, V50, P11202, DOI 10.1002/anie.201104498; Morris RH, 2008, COORDIN CHEM REV, V252, P2381, DOI 10.1016/j.ccr.2008.01.010; Ogo S, 2014, CHEM REC, V14, P397, DOI 10.1002/tcr.201402010; Ogo S, 2009, CHEM COMMUN, P3317, DOI 10.1039/b900297a; Scalmani G., 2010, J CHEM PHYS, V132; Shaw WJ, 2013, BBA-BIOENERGETICS, V1827, P1123, DOI 10.1016/j.bbabio.2013.01.003; Yuki M, 2010, ORGANOMETALLICS, V29, P5994, DOI 10.1021/om100852x	80	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	APR 1	2015	137	12					4173	4182		10.1016/jacs.b00584		10	Chemistry, Multidisciplinary	Chemistry	CF0OT	WOS:000352244800032		
J	Sarkar, SK; Sawai, A; Kanahara, K; Wentrup, C; Abe, M; Gudmundsdottir, AD				Sarkar, Sujan K.; Sawai, Asako; Kanahara, Kousei; Wentrup, Curt; Abe, Manabu; Gudmundsdottir, Anna D.			Direct Detection of a Triplet Vinylnitrene, 1,4-Naphthoquinone-2-ylnitrene, in Solution and Cryogenic Matrices	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							ELECTRON-SPIN RESONANCE; N BOND-CLEAVAGE; PHOTOELECTRON-SPECTROSCOPY; ALKYL NITRENES; PHOTOLYSIS; PHOTOCHEMISTRY; PHENYLNITRENE; INTERMEDIATE; DENSITY; AZIDE	The photolysis of 2-azido-1,4-naphthoquinone (1) in argon matrices at 8 K results in the corresponding triplet vinylnitrene (3)2, which was detected directly by IR spectroscopy. Vinylnitrene (3)2 is stable in argon matrices but forms 2-cyanoindane-1,3-dione (3) upon further irradiation. Similarly, the irradiation of azide 1 in 2-methyltetrahydrofuran (MTHF) matrices at 5 K resulted in the ESR spectrum of vinylnitrene (3)2, which is stable up to at least 100 K. The zero-field splitting parameters for nitrene (3)2, D/hc = 0.7292 cm(-1) and E/hc = 0.0048 cm(-1), verify that it has significant 1,3-biradical character. Vinylnitrene (3)2 (lambda(max) similar to 460 nm, tau = 22 mu s) is also observed directly in solution at ambient temperature with laser flash photolysis of 1. Density functional theory (DFT) calculations support the characterization of vinylnitrene (3)2 and the proposed mechanism for its formation. Because vinylnitrene (3)2 is relatively stable, it has potential use as a building-block for high-spin assemblies.	[Sarkar, Sujan K.; Gudmundsdottir, Anna D.] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA; [Sawai, Asako; Kanahara, Kousei; Abe, Manabu] Hiroshima Univ, Grad Sch Sci, Dept Chem, Hiroshima 7398526, Japan; [Wentrup, Curt] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia	Gudmundsdottir, AD (reprint author), Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA.	anna.gudmundsdottir@uc.edu	Abe, Manabu/A-9221-2008		National Science Foundation; Ohio Supercomputer Center; Ministry of Education, Culture, Sports, Science and Technology, Japan [24109008]	We thank the National Science Foundation and the Ohio Supercomputer Center for their generous support of this work. A.D.G. is grateful to the Fulbright Foundation for giving her the opportunity to be a Fulbright Scholar in Professor Abe's laboratory at Hiroshima University. This work was supported by a Grant-in-Aid for Science Research on Innovative Areas "Stimuli-responsive Chemical Species" (No. 24109008) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. ESR and MS measurements were performed at N-BARD, Hiroshima University.	Wijeratne NR, 2009, J PHYS CHEM A, V113, P9467, DOI 10.1021/jp9039594; GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Muthukrishnan S, 2009, ORG LETT, V11, P2345, DOI 10.1021/ol900754a; WASSERMAN E, 1964, J CHEM PHYS, V41, P1763, DOI 10.1063/1.1726156; SCHROCK AK, 1984, J AM CHEM SOC, V106, P5228, DOI 10.1021/ja00330a032; Gamage DW, 2013, J ORG CHEM, V78, P11349, DOI 10.1021/jo401819g; Nunes CM, 2011, J AM CHEM SOC, V133, P18911, DOI 10.1021/ja207717k; Nunes CM, 2013, J ORG CHEM, V78, P10657, DOI 10.1021/jo4015672; Zhang XM, 2014, J ORG CHEM, V79, P653, DOI 10.1021/jo402443w; Couladouros EA, 1997, J ORG CHEM, V62, P6, DOI 10.1021/jo9614708; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Michl J, 1996, J AM CHEM SOC, V118, P3568, DOI 10.1021/ja9538391; HAYES JC, 1990, J AM CHEM SOC, V112, P5879, DOI 10.1021/ja00171a038; Kvaskoff D, 2006, J ORG CHEM, V71, P4049, DOI 10.1021/jo052541i; Falvey D. E., 2013, WILEY SERIES REACTIV, V6; Foresman J.B., 1996, EXPLORING CHEM ELECT; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Frisch M. J., 2003, GAUSSIAN 03 REVISION; Gonzalez C., J PHYS CHEM, V190, P5523; Inui H, 2001, CHEM LETT, P832; Inui H, 2001, CHEM COMMUN, P1036, DOI 10.1039/b102384p; Jadhav AV, 2007, EUR POLYM J, V43, P2594, DOI 10.1016/j.eurpolymj.2007.03.016; KUCK VJ, 1972, J PHYS CHEM-US, V76, P3570, DOI 10.1021/j100668a011; NARUTA Y, 1986, J CHEM SOC CHEM COMM, P972, DOI 10.1039/c39860000972; Platz MS, 1997, PHOTOCHEM PHOTOBIOL, V65, P193, DOI 10.1111/j.1751-1097.1997.tb08544.x; Platz M. S., 2004, REACTIVE INTERMEDIAT; Rajam S, 2011, J ORG CHEM, V76, P9934, DOI 10.1021/jo200877k; Rajam S, 2014, J ORG CHEM, V79, P9325, DOI 10.1021/jo501898p; REISER A, 1966, NATURE, V211, P410, DOI 10.1038/211410a0; Singh PND, 2007, J AM CHEM SOC, V129, P16263, DOI 10.1021/ja077523s; Sterner O, 2013, LANGMUIR, V29, P13031, DOI 10.1021/la402168z; Tomioka H., 2004, REACTIVE INTERMEDIAT, P375, DOI 10.1002/0471721492.ch9; Travers MJ, 1999, J CHEM PHYS, V111, P5349, DOI 10.1063/1.479795; WASSERMAN E, 1964, J AM CHEM SOC, V86, P3166, DOI 10.1021/ja01069a049; Wenthold P. G., 2011, J ORG CHEM, V77, P208; Wentrup C, 2013, AUST J CHEM, V66, P286, DOI 10.1071/CH12502	37	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	APR 1	2015	137	12					4207	4214		10.1021/jacs.5b00998		8	Chemistry, Multidisciplinary	Chemistry	CF0OT	WOS:000352244800036		
J	Ishiki, A; Tomita, N; Une, K; Okinaga, S; Furukawa, K; Arai, H				Ishiki, A.; Tomita, N.; Une, K.; Okinaga, S.; Furukawa, K.; Arai, H.			Cognition and activities of daily living of elderly people affected by the Great East Japan Earthquake: A three-year cohort study	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Meeting Abstract	Annual Scientific Meeting of the American-Geriatrics-Society (AGS)	MAY 10-17, 2015	National Harbor, MD	Amer Geriatr Soc					[Ishiki, A.; Tomita, N.; Une, K.; Okinaga, S.; Furukawa, K.; Arai, H.] Tohoku Univ, Inst Dev Aging & Canc, Dept Geriatr & Gerontol, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2015	63			1	SI	D41	S250	S250				1	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5EL	WOS:000352578900704		
J	Khunti, K; Nauck, M; Araki, A; Crowe, S; Gong, Y; Clark, D; von Eynatten, M; Woerle, HJ				Khunti, K.; Nauck, M.; Araki, A.; Crowe, S.; Gong, Y.; Clark, D.; von Eynatten, M.; Woerle, H. J.			Risk of Hypoglycemia in People Receiving Linagliptin: Pooled Data From 1489 Adults Aged >= 65 Years With Type 2 Diabetes Mellitus (T2DM)	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Meeting Abstract	Annual Scientific Meeting of the American-Geriatrics-Society (AGS)	MAY 10-17, 2015	National Harbor, MD	Amer Geriatr Soc					[Khunti, K.] Univ Leicester, Leicester, Leics, England; [Nauck, M.] Diabet Zentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany; [Araki, A.] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; [Crowe, S.; Gong, Y.; Clark, D.; von Eynatten, M.; Woerle, H. J.] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2015	63			1	SI	A44	S33	S33				1	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5EL	WOS:000352578900090		
J	Kim, H; Kojima, N; Kim, M; Yoshida, H; Yoshida, Y; Hirano, H; Yamashiro, Y; Miyanaga, M; Suzuki, T				Kim, H.; Kojima, N.; Kim, M.; Yoshida, H.; Yoshida, Y.; Hirano, H.; Yamashiro, Y.; Miyanaga, M.; Suzuki, T.			Exercise and nutrition supplementation on hematological factors in community-dwelling Japanese frail elderly women - RCT placebo trial	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Meeting Abstract	Annual Scientific Meeting of the American-Geriatrics-Society (AGS)	MAY 10-17, 2015	National Harbor, MD	Amer Geriatr Soc					[Kim, H.; Kojima, N.; Kim, M.; Yoshida, H.; Yoshida, Y.; Hirano, H.] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Yamashiro, Y.; Miyanaga, M.] Kao Corp, Biol Sci Labs, Tokyo, Japan; [Suzuki, T.] Natl Inst Longev Sci, Obu, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2015	63			1	SI	A41	S32	S32				1	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5EL	WOS:000352578900087		
J	King, D; Hall, W; Takechi, H; Caprio, T				King, D.; Hall, W.; Takechi, H.; Caprio, T.			Comparitive Approaches to Elder Care: Lessons from Japan and the United States	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Meeting Abstract	Annual Scientific Meeting of the American-Geriatrics-Society (AGS)	MAY 10-17, 2015	National Harbor, MD	Amer Geriatr Soc					[King, D.; Hall, W.; Caprio, T.] Univ Rochester, Rochester, NY USA; [Takechi, H.] Kyoto Univ, Kyoto, Kyoto, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2015	63			1	SI	A141	S66	S67				2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5EL	WOS:000352578900187		
J	Sakurai, R; Ishii, K; Fujiwara, Y; Yasunaga, M; Sakuma, N; Shinkai, S; Odasso, MM				Sakurai, R.; Ishii, K.; Fujiwara, Y.; Yasunaga, M.; Sakuma, N.; Shinkai, S.; Odasso, M. Montero			Executive function, gait function, and cerebral glucose metabolism in healthy older women	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Meeting Abstract	Annual Scientific Meeting of the American-Geriatrics-Society (AGS)	MAY 10-17, 2015	National Harbor, MD	Amer Geriatr Soc					[Sakurai, R.; Fujiwara, Y.; Yasunaga, M.; Sakuma, N.; Shinkai, S.] Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo, Japan; [Sakurai, R.; Odasso, M. Montero] Univ Western Ontario, Gait & Brain Lab, Parkwood Inst, London, ON, Canada; [Sakurai, R.; Odasso, M. Montero] Lawson Hlth Res Inst, London, ON, Canada; [Ishii, K.] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2015	63			1	SI	P45	S17	S17				1	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5EL	WOS:000352578900046		
J	Uechi, M; Inaba, M; Chen, R; Ross, G; White, L; Abbott, R; Petrovich, H; Launer, L; Bell, C; Masaki, K				Uechi, M.; Inaba, M.; Chen, R.; Ross, G.; White, L.; Abbott, R.; Petrovich, H.; Launer, L.; Bell, C.; Masaki, K.			Slow Reaction Time Predicts Increased Risk of Incident Dementia: The Honolulu-Asia Aging Study	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Meeting Abstract	Annual Scientific Meeting of the American-Geriatrics-Society (AGS)	MAY 10-17, 2015	National Harbor, MD	Amer Geriatr Soc					[Uechi, M.; Inaba, M.; Ross, G.; White, L.; Abbott, R.; Petrovich, H.; Bell, C.; Masaki, K.] Univ Hawaii, Dept Geriatr Med, Honolulu, HI 96822 USA; [Chen, R.; Masaki, K.] Kuakini Med Ctr, Honolulu, HI USA; [Ross, G.] Vet Affairs Pacific Isl Hlth Care Syst, Honolulu, HI USA; [Abbott, R.] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 52021, Japan; [Launer, L.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2015	63			1	SI	B149	S144	S145				2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5EL	WOS:000352578900402		
J	Une, K; Furukawa, K; Arai, H				Une, K.; Furukawa, K.; Arai, H.			Improvement of drug adherence and glycemic control in elderly diabetic patients with dementia following a once-a-week medication for diabetes	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Meeting Abstract	Annual Scientific Meeting of the American-Geriatrics-Society (AGS)	MAY 10-17, 2015	National Harbor, MD	Amer Geriatr Soc					[Une, K.; Furukawa, K.; Arai, H.] Tohoku Univ, Geriatr & Gerontol, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2015	63			1	SI	A119	S59	S59				1	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CF5EL	WOS:000352578900165		
J	Singh, P; Suzuki, T; Akedo, J; Han, MF; Kuhn, S; Lee, RY; Son, JW; Fujishiro, Y				Singh, Prabhakar; Suzuki, Toshio; Akedo, Jun; Han, Min-Fang; Kuehn, Sascha; Lee, Ruey-yi; Son, Ji-Won; Fujishiro, Yoshinobu			Regional Editor's Special Issue "Trend of Current Research on Solid Oxide Electrochemical Cells, similar to Fabrication Processes and Characterization techniques" Preface	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Editorial Material									[Singh, Prabhakar] Univ Connecticut, Storrs, CT 06269 USA; [Suzuki, Toshio; Akedo, Jun; Fujishiro, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Han, Min-Fang] Tsinghua Univ, Beijing, Peoples R China; [Kuehn, Sascha] eZelleron GmbH, Dresden, Germany; [Lee, Ruey-yi] Inst Nucl Energy Res, Taipei, Taiwan; [Son, Ji-Won] Korea Inst Sci & Technol, Seoul, South Korea	Singh, P (reprint author), Univ Connecticut, Storrs, CT 06269 USA.				JSPS [252016]	This special issue is supported by JSPS Grants-in-Aid for Scientific Research (KAKENHI), Strengthening International Dissemination of Information, Grant Number 252016		0	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436								10.2109/jcersj2.123.4-1		2	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200001		
J	Hosoi, K; Hong, JE; Sakai, T; Ida, S; Ishihara, T				Hosoi, Kohei; Hong, Jong-Eun; Sakai, Takaaki; Ida, Shintaro; Ishihara, Tatsumi			Microtubular SOFC using doped LaGaO3 electrolyte film prepared with dip coating method	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						SOFC; Microtubular cell; Dip coting; LSGM; Ti-LDC	OXIDE FUEL-CELLS; LANTHANUM GALLATE ELECTROLYTE; INTERMEDIATE-TEMPERATURE; BUFFER LAYER; ION CONDUCTIVITY; THIN-ELECTROLYTE; PERFORMANCE; MAGNESIUM; STRONTIUM; CERIA	Preparation of Microtubular cell using doped lanthanum gallate (LSGM) electrolyte with a dip coating and co-sintering process was studied. In order to suppress Ni diffusion from Ni-based anode substrate to LSGM electrolyte layer, Ti added La-doped ceria (Ti-LDC) was inserted as buffer layer. The amount of Ni diffused in LSGM electrolyte was investigated by EDX analysis as a function of sintering temperatures. It was found that sintering at 1350 degrees C is suitable from the sintering density and the Ni diffusion. The cell sintered at 1350 degrees C exhibited the higher power density than that of the conventional LSGM micro-tubular cell, even though a small amount of Ni diffusion was still observed at the Ti-LDC buffer layer/LSGM electrolyte interface. The microtubular cell with around 50 mu m thickness showed the open circuit potential higher than 1.0 V and the maximum power density of 0.69, 0.31 and 0.12 W/cm(2) at 700, 600 and 500 degrees C, respectively, were achieved. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Hosoi, Kohei; Hong, Jong-Eun; Sakai, Takaaki; Ida, Shintaro; Ishihara, Tatsumi] Kyushu Univ, Fac Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Sakai, Takaaki] Kyushu Univ, Ctr Mol Syst, Nishi Ku, Fukuoka 8190395, Japan; [Ida, Shintaro; Ishihara, Tatsumi] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Ishihara, T (reprint author), Kyushu Univ, Fac Engn, Dept Appl Chem, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	ishihara@cstf.kyushu-u.ac.jp			Next Generation Solid Oxide Fuel Cell Development Project from New Energy Development Organization (NEDO), Japan	Part of this study was financially supported by Next Generation Solid Oxide Fuel Cell Development Project from New Energy Development Organization (NEDO), Japan.	Hong JE, 2012, J AM CERAM SOC, V95, P3588, DOI 10.1111/j.1551-2916.2012.05364.x; Zhen YD, 2008, J POWER SOURCES, V178, P69, DOI 10.1016/j.jpowsour.2007.11.113; Huang PN, 1996, J ELECTROCHEM SOC, V143, P1644, DOI 10.1149/1.1836692; Pikalova EY, 2011, INT J HYDROGEN ENERG, V36, P6175, DOI 10.1016/j.ijhydene.2011.01.132; Hong JE, 2011, INT J HYDROGEN ENERG, V36, P14632, DOI 10.1016/j.ijhydene.2011.08.046; Huang KQ, 1997, J ELECTROCHEM SOC, V144, P3620, DOI 10.1149/1.1838058; FENG M, 1994, EUR J SOL STATE INOR, V31, P663; Guo WM, 2008, ELECTROCHIM ACTA, V53, P4420, DOI 10.1016/j.electacta.2008.01.039; Djurado E, 1998, J EUR CERAM SOC, V18, P1397, DOI 10.1016/S0955-2219(98)00016-8; Ishihara T, 1999, CHEM MATER, V11, P2081, DOI 10.1021/cm981145w; Hrovat M, 1999, MATER RES BULL, V34, P2027, DOI 10.1016/S0025-5408(99)00220-2; Lin YB, 2006, ELECTROCHEM SOLID ST, V9, pA285, DOI 10.1149/1.2191132; Liang B, 2011, INT J HYDROGEN ENERG, V36, P10975, DOI 10.1016/j.ijhydene.2011.05.142; Huang KQ, 2001, J ELECTROCHEM SOC, V148, pA788, DOI 10.1149/1.1378289; Trofimenko N, 1999, SOLID STATE IONICS, V118, P215, DOI 10.1016/S0167-2738(98)00464-0; Andrievskaya ER, 2011, J EUR CERAM SOC, V31, P1277, DOI 10.1016/j.jeurceramsoc.2010.05.024; He TM, 2006, J AM CERAM SOC, V89, P2664, DOI 10.1111/j.1551-2916.2006.01105.x; Hong JE, 2012, J SOLID STATE ELECTR, V16, P1493, DOI 10.1007/s10008-011-1548-8; Ishihara T, 2004, SOLID STATE IONICS, V175, P319, DOI 10.1016/j.ssi.2004.03.036; Ishihara T., 1994, J AM CHEM SOC, V116, P801; Lee D, 2008, J POWER SOURCES, V185, P207, DOI 10.1016/j.jpowsour.2008.06.028; Leng Y. J., 1999, SOLID STATE IONICS, V118, P215; Zhang L, 2007, J POWER SOURCES, V170, P55, DOI 10.1016/j.jpowsour.2007.03.080; Zhao F, 2005, J POWER SOURCES, V141, P79, DOI 10.1016/j.jpowsour.2004.08.057	24	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436					182	186		10.2109/jcersj2.123.182		5	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200004		
J	Sumi, H; Yamaguchi, T; Suzuki, T; Shimada, H; Hamamoto, K; Fujishiro, Y				Sumi, Hirofumi; Yamaguchi, Toshiaki; Suzuki, Toshio; Shimada, Hiroyuki; Hamamoto, Koichi; Fujishiro, Yoshinobu			Direct hydrocarbon utilization in microtubular solid oxide fuel cells	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Solid oxide fuel cell (SOFC); Ni-ceria anode; Propane; Butane; Hydrocarbon cracking	SCANDIA-STABILIZED ZIRCONIA; SOFC ANODES; CARBON DEPOSITION; INTERNAL STEAM; METHANE; NI; OXIDATION; PERFORMANCE; DURABILITY; IMPACT	Solid oxide fuel cells (SOFCs) can, in principle, directly use hydrocarbon fuels. However, nickel-stabilized zirconia anode deteriorated rapidly under direct butane utilization due to carbon deposition. The cracking rate is faster, when carbon number is larger and straight chain is longer in methane, propane, i-butane and n-butane. However, microtubular SOFCs with nickel-gadolinia doped ceria (Ni-GDC) anode can generate power continuously at 650 degrees C over a period of 100 h in propane and butane, because the Ni-GDC has high catalytic activities of hydrocarbon reforming and carbon oxidation. The Ni-GDC is one of the desirable anodes for direct propane and butane utilization in SOFCs. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Sumi, Hirofumi; Yamaguchi, Toshiaki; Suzuki, Toshio; Shimada, Hiroyuki; Hamamoto, Koichi; Fujishiro, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Nagoya, Aichi 4638560, Japan	Sumi, H (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Nagoya, Aichi 4638560, Japan.	h-sumi@aist.go.jp	Shimada, Hiroyuki/F-9099-2015; Sumi, Hirofumi/B-5403-2012	Shimada, Hiroyuki/0000-0001-9793-8625; Sumi, Hirofumi/0000-0002-8439-0127	New Energy and Industrial Technology Development Organization (NEDO), under the program of "Technology Development for Promoting SOFC Commercialization"	This study was supported in part by the New Energy and Industrial Technology Development Organization (NEDO), under the program of "Technology Development for Promoting SOFC Commercialization".	Kendall K, 1998, J POWER SOURCES, V71, P268, DOI 10.1016/S0378-7753(97)02761-4; Sumi H, 2012, ELECTROCHIM ACTA, V67, P159, DOI 10.1016/j.electacta.2012.02.021; Suzuki T, 2007, ELECTROCHEM SOLID ST, V10, pA177, DOI 10.1149/1.2739211; Trimm DL, 1997, CATAL TODAY, V37, P233, DOI 10.1016/S0920-5861(97)00014-X; Sumi H, 2011, J POWER SOURCES, V196, P6048, DOI 10.1016/j.jpowsour.2011.03.092; Sumi H, 2010, J ELECTROCHEM SOC, V157, pB1118, DOI 10.1149/1.3435320; Park SD, 2000, NATURE, V404, P265; Eguchi K, 2002, SOLID STATE IONICS, V152, P411, DOI 10.1016/S0167-2738(02)00351-X; Murray EP, 1999, NATURE, V400, P649; Yashiro K, 2002, ELECTROCHEMISTRY, V70, P958; Kendall K, 2000, ELECTROCHEMISTRY, V68, P403; Lee SI, 2004, J ELECTROCHEM SOC, V151, pA1319, DOI 10.1149/1.1774184; Gorte RJ, 2002, J POWER SOURCES, V106, P10, DOI 10.1016/S0378-7753(01)01021-7; Suzuki T, 2009, SCIENCE, V325, P852, DOI 10.1126/science.1176404; Sumi H, 2004, SOLID STATE IONICS, V174, P151, DOI 10.1016/j.ssi.2004.06.016; Iida T, 2007, J ELECTROCHEM SOC, V154, pB234, DOI 10.1149/1.2405837; Jao Z., 2012, J ELECTROCHEM SOC, V159, pB285; Kishimoto H, 2004, SOLID STATE IONICS, V175, P107, DOI 10.1016/j.ssi.2004.09.042; Lee YH, 2013, J ELECTROCHEM SOC, V160, pF579, DOI 10.1149/2.075306jes; Sumi H, 2012, J POWER SOURCES, V220, P74, DOI 10.1016/j.jpowsour.2012.07.106; Sumi H, 2014, ELECTROCHEM COMMUN, V49, P34, DOI 10.1016/j.elecom.2014.10.006; Sumi H, 2013, ELECTROCHEMISTRY, V81, P86, DOI 10.5796/electrochemistry.81.86; Wang X, 2002, APPL CATAL A-GEN, V224, P209, DOI 10.1016/S0926-860X(01)00783-9; Yamaji K, 2008, SOLID STATE IONICS, V179, P1526, DOI 10.1016/j.ssi.2008.01.075	24	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436					213	216		10.2109/jcersj2.123.213		4	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200009		
J	Itagaki, Y; Shinohara, K; Yamaguchi, S; Yahiro, H				Itagaki, Yoshiteru; Shinohara, Kohei; Yamaguchi, Syuhei; Yahiro, Hidenori			Anodic performance of bilayer Ni-YSZ SOFC anodes formed by electrophoretic deposition	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						SOFC; Anode; Double layer; Electrophoretic deposition; Ni-YSZ	OXIDE FUEL-CELLS; FUNCTIONALLY GRADED CATHODES; ELECTRODE MICROSTRUCTURE; FILM YSZ; FABRICATION	Bilayer Ni-YSZ anode films for SOFCs were prepared by electrophoretic deposition (EPD). The thickness of each layer of the bilayer anode films, which consist of 50 wt% Ni-YSZ as the active layer and 70 wt% Ni-YSZ as the current collecting layer (50Ni-YSZ/70Ni-YSZ), were controlled by the deposition time of the EPD process. For the monolayer anodes, 70Ni-YSZ showed a better performance than 50Ni-YSZ. The bilayer film, 50Ni-YSZ/70Ni-YSZ, showed an even better performance than the 70Ni-YSZ monolayer film. Probably, 50Ni-YSZ anode has more reaction sites compared to 70Ni-YSZ; on the other hand, 70Ni-YSZ has higher porosity to be a gas diffusion (or current collecting) layer. The anodic performance of the bilayer film significantly depended on the film thickness of the 50Ni-YSZ layer, and 3 mu m was found to be the optimized thickness as the active layer, which suggests that the charge transfer reaction site extended up to a 3-mu m thickness from the anode/electrolyte interface. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Itagaki, Yoshiteru] Ehime Univ, Grad Sch Sci, Matsuyama, Ehime 8908577, Japan; Ehime Univ, Grad Sch Engn, Matsuyama, Ehime 8908577, Japan	Itagaki, Y (reprint author), Ehime Univ, Grad Sch Sci, Matsuyama, Ehime 8908577, Japan.	itagaki.yshiteru.mj@ehime-u.ac.jp					Virkar AV, 2000, SOLID STATE IONICS, V131, P189, DOI 10.1016/S0167-2738(00)00633-0; Kwon OH, 2006, SOLID STATE IONICS, V177, P3057, DOI 10.1016/j.ssi.2006.07.039; Zarabian M, 2013, J EUR CERAM SOC, V33, P1815, DOI 10.1016/j.jeurceramsoc.2013.01.032; Mori M, 1998, J ELECTROCHEM SOC, V145, P1374, DOI 10.1149/1.1838468; Will J, 2000, SOLID STATE IONICS, V131, P79, DOI 10.1016/S0167-2738(00)00624-X; Wang ZH, 2009, ELECTROCHEM COMMUN, V11, P1120, DOI 10.1016/j.elecom.2009.03.027; Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x; Zhu WZ, 2003, MAT SCI ENG A-STRUCT, V362, P228, DOI 10.1016/S0921-5093(03)00620-8; Lee JH, 2002, SOLID STATE IONICS, V148, P15, DOI 10.1016/S0167-2738(02)00050-4; Xu XY, 2005, SOLID STATE IONICS, V176, P1513, DOI 10.1016/j.ssi.2005.04.011; Wei B, 2014, ELECTROCHIM ACTA, V134, P136, DOI 10.1016/j.electacta.2014.04.140; Antunes R., 2010, J FUEL CELL SCI TECH, V7, P1; Gannon P, 2009, J APPL ELECTROCHEM, V39, P497, DOI 10.1007/s10800-008-9682-4; Hart NT, 2002, J POWER SOURCES, V106, P42, DOI 10.1016/S0378-7753(01)01035-7; Hatae T, 2004, J POWER SOURCES, V135, P25, DOI 10.1016/j.jpowsour.2004.03.075; Holtappels P, 2006, FUEL CELLS, V6, P113, DOI 10.1002/fuce.200500116; Holtappels P, 2002, J EUR CERAM SOC, V22, P41, DOI 10.1016/S0955-2219(01)00238-2; Itagaki Y, 2012, J POWER SOURCES, V214, P153, DOI 10.1016/j.jpowsour.2012.04.079; Kleitz M, 1996, SOLID STATE IONICS, V92, P65, DOI 10.1016/S0167-2738(96)00464-X; Schneider LCR, 2007, ELECTROCHIM ACTA, V52, P3190, DOI 10.1016/j.electacta.2006.09.071; Song HS, 2010, J POWER SOURCES, V195, P2628, DOI 10.1016/j.jpowsour.2009.11.067; Uchikoshi T., 2010, CERAMICS, V45, P88; Woolley RJ, 2014, SOLID STATE IONICS, V255, P1, DOI 10.1016/j.ssi.2013.11.041	23	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436					235	238		10.2109/jcersj2.123.235		4	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200013		
J	Suzuki, T; Suzuki, T; Yamaguchi, T; Sumi, H; Hamamoto, K; Fujishiro, Y; Shin, W				Suzuki, Tsukasa; Suzuki, Toshio; Yamaguchi, Toshiaki; Sumi, Hirofumi; Hamamoto, Koichi; Fujishiro, Yoshinobu; Shin, Wooscuk			Fabrication and characterization of YSZ thin films for SOFC application	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Thin film; YSZ	OXIDE FUEL-CELLS; DOPED BARIUM CERATE; PROTON CONDUCTING CERAMICS; BILAYER ELECTROLYTE; WATER-VAPOR; IT-SOFCS; STABILITY; PERFORMANCE; BACEO3; TEMPERATURES	Yttria stabilized zirconia (YSZ) thin films are deposited on thin Si3N4 layer coated Si substrates by RF-sputtering with different substrate temperatures, room temperature (YSZ-RT) and 550 degrees C (YSZ-550). Fine polycrystalline structure is observed for YSZ-RT (thickness = 620 nm), while columnar crystal structure (111) oriented for YSZ-550 (thickness = 660 nm), respectively. The conductivity measurement shows that the activation energies of YSZ-RT and YSZ-550 are 1.34 and 1.58 eV, respectively, indicating that grain boundary conduction is dominant. Shear strengths of the YSZ films are determined by using a micro-blade cutting system to be 150 MPa for YSZ-RT and 200 MPa for TSZ-550, respectively. YSZ-550 is found to be better for solid oxide fuel cell application from mechanical and electrically properties point of view. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Suzuki, Tsukasa; Fujishiro, Yoshinobu] Gifu Univ, Gifu, Japan; [Suzuki, Tsukasa; Suzuki, Toshio; Yamaguchi, Toshiaki; Sumi, Hirofumi; Hamamoto, Koichi; Fujishiro, Yoshinobu; Shin, Wooscuk] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Suzuki, T (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora Shimo Shidami, Nagoya, Aichi 4638560, Japan.	toshio.suzuki@aist.go.jp	Sumi, Hirofumi/B-5403-2012	Sumi, Hirofumi/0000-0002-8439-0127	Changwon National University	This research is financially supported by Changwon National University in 2014-2015.	Kreuer KD, 2001, SOLID STATE IONICS, V145, P295, DOI 10.1016/S0167-2738(01)00953-5; Norby T, 1999, SOLID STATE IONICS, V125, P1, DOI 10.1016/S0167-2738(99)00152-6; Fabbri E, 2008, SOLID STATE IONICS, V179, P558, DOI 10.1016/j.ssi.2008.04.002; Zhao F, 2010, INT J HYDROGEN ENERG, V35, P11194, DOI 10.1016/j.ijhydene.2010.06.073; Bohn HG, 2000, J AM CERAM SOC, V83, P768; Katahira K, 2000, SOLID STATE IONICS, V138, P91, DOI 10.1016/S0167-2738(00)00777-3; Fabbri E, 2008, ENERG ENVIRON SCI, V1, P355, DOI 10.1039/b806655h; Gawel R, 2014, J THERM ANAL CALORIM, V116, P895, DOI 10.1007/s10973-013-3562-9; Yokokawa H, 2008, J POWER SOURCES, V182, P400, DOI 10.1016/j.jpowsour.2008.02.016; IWAHARA H, 1995, SOLID STATE IONICS, V77, P289, DOI 10.1016/0167-2738(95)00051-7; Iwahara H, 1996, SOLID STATE IONICS, V86-8, P9, DOI 10.1016/0167-2738(96)00087-2; Bi L, 2008, ELECTROCHEM COMMUN, V10, P1598, DOI 10.1016/j.elecom.2008.08.024; Xie K, 2009, J ALLOY COMPD, V473, P323, DOI 10.1016/j.jallcom.2008.05.071; Bhide SV, 1999, J ELECTROCHEM SOC, V146, P2038, DOI 10.1149/1.1391888; Sawant P, 2012, INT J HYDROGEN ENERG, V37, P3848, DOI 10.1016/j.ijhydene.2011.04.106; Tanner CW, 1996, J ELECTROCHEM SOC, V143, P1386, DOI 10.1149/1.1836647; Bae K, 2014, J POWER SOURCES, V248, P1163, DOI 10.1016/j.jpowsour.2013.10.057; Choi S. M., 2014, INT J HYDROGEN ENERG, V39, P12821; Dailly J, 2013, J POWER SOURCES, V240, P323, DOI 10.1016/j.jpowsour.2013.04.028; Guo YM, 2010, INT J HYDROGEN ENERG, V35, P10513, DOI 10.1016/j.ijhydene.2010.07.179; Jingde L, 2008, J RARE EARTH, V26, P505; Jung MG, 2014, INT J HYDROGEN ENERG, V39, P16576, DOI 10.1016/j.ijhydene.2014.04.146; Lim DK, 2011, INT J HYDROGEN ENERG, V36, P9367, DOI 10.1016/j.ijhydene.2011.04.203; Lim HT, 2009, ECS TRANSACTIONS, V25, P447, DOI 10.1149/1.3205554; Lim HT, 2008, J POWER SOURCES, V185, P790, DOI 10.1016/j.jpowsour.2008.07.051; Liu RR, 2011, J POWER SOURCES, V196, P7090, DOI 10.1016/j.jpowsour.2010.08.014; Park Mi Young, 2014, [Journal of The Korean Ceramic Society, 한국세라믹학회지], V51, P289, DOI 10.4191/kcers.2014.51.4.289; Park MY, 2014, SOLID STATE IONICS, V262, P438, DOI 10.1016/j.ssi.2014.02.013; Qian J, 2014, J POWER SOURCES, V249, P131, DOI 10.1016/j.jpowsour.2013.10.120; Singhal S. C., 2004, HIGH TEMPERATURE SOL; Taniguchi N, 2001, SOLID STATE IONICS, V145, P349, DOI 10.1016/S0167-2738(01)00930-4; Virakr A. V., 2007, J POWER SOURCES, V172, P713; Wu ZL, 1997, J ELECTROCHEM SOC, V144, P2170, DOI 10.1149/1.1837759; Xie K, 2009, J ALLOY COMPD, V479, pL40, DOI 10.1016/j.jallcom.2009.01.011; Yoo Y, 2013, J POWER SOURCES, V229, P48, DOI 10.1016/j.jpowsour.2012.11.094; Zunic M, 2011, FUEL CELLS, V11, P165, DOI 10.1002/fuce.200900104	36	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436					250	262		10.2109/jcersj2.123.250		13	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200016		
J	Kobayashi, K; Hirai, K; Suzuki, TS; Uchikoshi, T; Akashi, T; Sakka, Y				Kobayashi, Kiyoshi; Hirai, Kenya; Suzuki, Tohru S.; Uchikoshi, Tetsuo; Akashi, Takaya; Sakka, Yoshio			Sinterable powder fabrication of lanthanum silicate oxyapatite based on solid-state reaction method	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Lanthanum silicate; Oxyapatite; Solid-state reaction; Planetary ball milling; Sinter	OXIDE FUEL-CELLS; IONIC-CONDUCTIVITY; NEUTRON-DIFFRACTION; CRYSTAL-STRUCTURE; LOW-TEMPERATURE; GEL SYNTHESIS; APATITE; ND; LA; LA9.33SI6O26	Sinterable lanthanum silicate oxyapatite (LSO) powders were prepared by the combination of solid-state reaction synthesis and particle size control via planetary ball-milling. We successfully fabricated the LSO ceramics with relative densities exceeding 94% at 1773K even though it was suggested that the densified LSO ceramics could not be obtained below 1923K using a powder synthesized by a solid-state reaction. Impurity phases resulting from contamination due to the ball and pod during the planetary ball milling were, in some cases, detected by the X-ray diffraction analysis of the sintered ceramics. The planetary ball-milling conditions were deemed important for the successful fabrication of the sinterable LSO powder. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Kobayashi, Kiyoshi; Suzuki, Tohru S.; Uchikoshi, Tetsuo; Sakka, Yoshio] Natl Inst Mat Sci, Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan; [Hirai, Kenya] Hosei Univ, Grad Sch Sci & Engn, Koganei, Tokyo 1848584, Japan; [Akashi, Takaya] Hosei Univ, Fac Biosci & Appl Chem, Koganei, Tokyo 1848584, Japan	Kobayashi, K (reprint author), Natl Inst Mat Sci, Mat Proc Unit, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	kiyoshi@nims.go.jp					Amezawa K, 2005, SOLID STATE IONICS, V176, P341, DOI 10.1016/j.ssi.2004.07.015; NAKAYAMA S, 1995, J MATER CHEM, V5, P1801, DOI 10.1039/jm9950501801; Ozawa M, 2006, J ALLOY COMPD, V408, P556, DOI 10.1016/j.jallcom.2004.12.073; TAKEDA Y, 1987, J ELECTROCHEM SOC, V134, P2656, DOI 10.1149/1.2100267; LABRINCHA JA, 1993, J MATER SCI, V28, P3809, DOI 10.1007/BF00353183; Kobayashi K, 2008, SOLID STATE IONICS, V179, P2209, DOI 10.1016/j.ssi.2008.07.023; Nakayama S, 1998, J EUR CERAM SOC, V18, P1413, DOI 10.1016/S0955-2219(98)00032-6; Liu W, 2013, J POWER SOURCES, V235, P62, DOI 10.1016/j.jpowsour.2013.01.194; Slater PR, 2004, CHEM REC, V4, P373, DOI 10.1002/tcr.20028; Celerier S, 2006, CERAM INT, V32, P271, DOI 10.1016/j.ceramint.2005.03.001; Tao SW, 2001, MATER RES BULL, V36, P1245, DOI 10.1016/S0025-5408(01)00625-0; Celerier S, 2006, ADV MATER, V18, P615, DOI 10.1002/adma.200501938; Fuentes AF, 2006, SOLID STATE IONICS, V177, P1869, DOI 10.1016/j.ssi.2006.02.032; Kobayashi K, 2011, SOLID STATE IONICS, V204, P91, DOI 10.1016/j.ssi.2011.10.011; Marrero-Lopez D, 2010, J POWER SOURCES, V195, P2496, DOI 10.1016/j.jpowsour.2009.11.068; Celerier S, 2005, J EUR CERAM SOC, V25, P2665, DOI 10.1016/j.jeurceramsoc.2005.03.197; Orera A, 2010, CHEM MATER, V22, P675, DOI 10.1021/cm902687z; YAMAMOTO O, 1987, SOLID STATE IONICS, V22, P241, DOI 10.1016/0167-2738(87)90039-7; Cao XG, 2013, INT J HYDROGEN ENERG, V38, P2421, DOI 10.1016/j.ijhydene.2012.12.043; Fukuda K, 2006, POWDER DIFFR, V21, P300, DOI 10.1154/1.2383066; Harvey EJ, 2005, J SOLID STATE CHEM, V178, P800, DOI 10.1016/j.jssc.2004.12.030; Kobayashi K, 2014, J CERAM SOC JPN, V122, P921, DOI 10.2109/jcersj2.122.921; Kobayashi K, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/4/045006; Kobayashi K, 2012, SOLID STATE IONICS, V225, P443, DOI 10.1016/j.ssi.2012.02.008; Matsushita Y, 2009, NUCL INSTRUM METH A, V600, P319, DOI 10.1016/j.nima.2008.11.081; Mihara S, 2014, KEY ENG MATER, V616, P120, DOI 10.4028/www.scientific.net/KEM.616.120; NAKAYAMA S, 1995, CHEM LETT, P431, DOI 10.1246/cl.1995.431; Schmalzried H, 1974, SOLID STATE REACTION; Suzuki T, 2008, J FUEL CELL SCI TECH, V5, DOI 10.1115/1.2928633; Takahashi S., 2014, J SOC INORG MAT JAP, V21, P155; Vojisavljevic K, 2014, ACTA CHIM SLOV, V61, P530; YOKOKAWA H, 1991, J ELECTROCHEM SOC, V138, P2719, DOI 10.1149/1.2086043	32	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436					274	279		10.2109/jcersj2.123.274		6	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200019		
J	Omura, T; Kodera, T; Ogihara, T				Omura, Takuya; Kodera, Takayuki; Ogihara, Takashi			Preparation and electrochemical property of Li4Mn5-xTixO12 cathode materials for lithium ion battery by spray pyrolysis	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Li4Mn5-xTixO12; Spray pyrolysis; Cathode; Lithium ion battery; Spinel; Powder	LI4MN5O12	Li4Mn5-xTixO12 (x = 0-0.5) powders were successfully prepared by ultrasonic spray pyrolysis. As-prepared Li4Mn5-xTixO12 powders were calcined from 500 to 700 degrees C. The chemical and physical properties of as-prepared Li4Mn5-xTixO12 powders and the calcined powders were characterized by XRD, TG-DTA, and SEM. The crystal phases of as-prepared Li4Mn5-xTixO12 powders crystallized to the spinel structure (Fd-3m) by the calcination at 500 degrees C. As-prepared Li4Mn5-xTixO12 powders and the calcined powders obtained by spray pyrolysis exhibited spherical morphology with approximately 2 mu m. The electrochemical measurement showed that the discharge capacity of the Li4Mn5-xTixO12 (x = 0) cathodes was 111mAh/g at the rate of 0.2 C. The discharge capacity of the Li4Mn5-xTixO12 cathodes increased with the concentration of Ti ion increased. The discharge capacity of the Li4Mn5-xTixO12 (x = 5) cathodes increased to 171mAh/g (0.2 C) with increasing up to x = 5. The retention rates of the Li4Mn5-xTixO12 (x = 0, 2, 3, 5) cathodes discharge capacities were approximately 84, 66, 61, and 98% after 100 cycles at the rate of 1C, respectively. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Omura, Takuya] Univ Fukui, Grad Sch Mat Engn, Fukui 9108507, Japan; [Kodera, Takayuki; Ogihara, Takashi] Univ Fukui, Grad Sch Mat Sci & Engn, Fukui 9108507, Japan	Ogihara, T (reprint author), Univ Fukui, Grad Sch Mat Sci & Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	ogihara@matse.u-fukui.ac.jp					Thackeray MM, 1996, J SOLID STATE CHEM, V125, P274, DOI 10.1006/jssc.1996.0297; Villevieille C, 2010, ELECTROCHIM ACTA, V55, P7080, DOI 10.1016/j.electacta.2010.06.052; Ivanova S, 2011, J MATER SCI, V46, P7098, DOI 10.1007/s10853-011-5409-8; Li ZH, 2009, J MATER SCI, V44, P2435, DOI 10.1007/s10853-009-3316-z; Zhang YC, 2002, MATER RES BULL, V37, P1411, DOI 10.1016/S0025-5408(02)00796-1; Yang JW, 2010, IONICS, V16, P425, DOI 10.1007/s11581-010-0422-5; Ebin B, 2014, CERAM INT, V40, P7029, DOI 10.1016/j.ceramint.2013.12.032; Ivanova S, 2013, J ALLOY COMPD, V561, P252, DOI 10.1016/j.jallcom.2013.02.022; Le MLP, 2011, J PHYS CHEM SOLIDS, V72, P124, DOI 10.1016/j.jpcs.2010.11.010; Ogihara T, 2011, MATER RES BULL, V46, P796, DOI 10.1016/j.materresbull.2011.02.041; Kim JH, 2013, J IND ENG CHEM, V19, P1204, DOI 10.1016/j.jiec.2012.12.019; Kodera T., 2006, J SOC POWDER TECHNOL, V43, P348; Minami R, 2014, J CERAM SOC JPN, V122, P386, DOI 10.2109/jcersj2.122.386	13	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436					280	284		10.2109/jcersj2.123.280		5	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200020		
J	Matsushima, Y; Kasuga, SN; Iwase, K				Matsushima, Yuta; Kasuga, Shin-nosuke; Iwase, Katsuhiko			Control of the doping sites of Ho3+ in BaTiO3 by a water-soluble precursor method	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Barium titanate; Water soluble precursor; Rare-earth; XAFS; Defect chemistry	DOPED BARIUM-TITANATE; RARE-EARTH CATIONS; DEFECT CHEMISTRY; SOLID SOLUBILITY; OCCUPANCY; HOLMIUM	Controlling the substitution sites of Ho3+ in BaTiO3 was demonstrated with a water-soluble precursor method in a relatively high concentration region. Ho3+ was added in three different manners to replace either Ba2+ or Ti4+, or both Ba2+ and Ti4+ as Ba1-xHoxTiO3 (A-site substitution), Ba Ti1-xHoxO3-x/2 (B-site substitution) and Ba1-x/2Hox/2Ti1-x/2Hox/2 O-3 (A/B-sites substitution). The substitution sites were carefully investigated with X-ray diffraction, elemental mapping analysis, X-ray absorption fine structure analysis and the electric properties measurements. The results revealed the difference in the properties such as solubility, local environments around the lanthanides and electric properties depending on the substitution site, which indicated the successful control of the substitution sites simply with the starting composition of the solution. The compositional uniformity of the watersoluble precursor was advantageous in controlling the substitution sites of a rare-earth in BaTiO3. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Matsushima, Yuta; Kasuga, Shin-nosuke; Iwase, Katsuhiko] Yamagata Univ, Dept Chem & Chem Engn, Yonezawa, Yamagata 9928510, Japan	Matsushima, Y (reprint author), Yamagata Univ, Dept Chem & Chem Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	ymatsush@yz.yamagata-u.ac.jp			MEXT KAKENHI [22760507]; Murata Science Foundation; Inamori Foundation	The authors thank Dr. H. Nitani and Dr. Y. Niwa (KEK, Japan) for their great help in the XAFS measurements. This work is financially supported in part by MEXT KAKENHI Grant Number 22760507 (2010-2011), The Murata Science Foundation (2010) and The Inamori Foundation (2009). The authors thank for Kuraray Co. Ltd. for offering Poval PVA-217.	Arima M, 1996, J AM CERAM SOC, V79, P2847, DOI 10.1111/j.1151-2916.1996.tb08718.x; Tsur Y, 2001, J ELECTROCERAM, V7, P25, DOI 10.1023/A:1012218826733; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Tsur Y, 2001, JPN J APPL PHYS 1, V40, P255, DOI 10.1143/JJAP.40.255; Kishi H, 2003, JPN J APPL PHYS 1, V42, P1, DOI 10.1143/JJAP.42.11; Kishi H, 1997, JPN J APPL PHYS 1, V36, P5954, DOI 10.1143/JJAP.36.5954; Kakihana M, 2001, INORG CHEM, V40, P891, DOI 10.1021/ic001098l; Hennings DFK, 2001, J EUR CERAM SOC, V21, P1637, DOI 10.1016/S0955-2219(01)00082-6; Morrison FD, 2001, INT J INORG MATER, V3, P1205, DOI 10.1016/S1466-6049(01)00128-3; Dunbar TD, 2004, J PHYS CHEM B, V108, P908, DOI 10.1021/jp036542v; Morrison FD, 2001, J AM CERAM SOC, V84, P474; CHAN NH, 1984, J AM CERAM SOC, V67, P285; Iwase K, 2012, J SOL-GEL SCI TECHN, V64, P170, DOI 10.1007/s10971-012-2844-1; Jeong JH, 2004, J ELECTROCERAM, V13, P805, DOI 10.1007/s10832-004-5196-6; KWEI GH, 1993, J PHYS CHEM-US, V97, P2368, DOI 10.1021/j100112a043; Levin E. M., 1964, PHASE DIAGRAMS CERAM; Liu Y, 2009, J EUR CERAM SOC, V29, P3249, DOI 10.1016/j.jeurceramsoc.2009.05.033; MAKOVEC D, 1995, J AM CERAM SOC, V78, P2193, DOI 10.1111/j.1151-2916.1995.tb08635.x; Makovec D, 2006, J AM CERAM SOC, V89, P3281, DOI 10.1111/j.1551-2916.2006.01204.x; Makovec D, 2004, J AM CERAM SOC, V87, P1324, DOI 10.1111/j.1151-2916.2004.tb07729.x; Moriwake H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KC03; NEWBURY RS, 1968, J CHEM PHYS, V48, P793, DOI 10.1063/1.1668713; Pechini M. P., 1967, U. S. Pat., Patent No. [3330697, 3 330 697]; Roth R. S., 1987, PHASE DIAGRAMS CERAM, VVI; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Tada M, 2002, SOLID STATE IONICS, V151, P293, DOI 10.1016/S0167-2738(02)00726-9; Umeda Y, 2012, CERAM INT, V38, pS25, DOI 10.1016/j.ceramint.2011.04.041	27	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436					285	291		10.2109/jcersj2.123.285		7	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200021		
J	Sokri, MNM; Daiko, Y; Honda, S; Iwamoto, Y				Sokri, Mohd Nazri Mohd; Daiko, Yusuke; Honda, Sawao; Iwamoto, Yuji			Synthesis of microporous amorphous silica from perhydropolysilazane chemically modified with alcohol derivatives	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Amorphous silica; Polymeric precursor; Perhydropolysilazane; Microporous; Nitrogen sorption	POLYMERIC PRECURSORS; CERAMICS; CONVERSION; PYROLYSIS; TEMPERATURE; HYDROGEN; NITRIDE	Perhydropolysilazane (PHPS) was chemical modified with alcohol derivative (ROH, R = CH3, i-C3H7, n-C5H11, n-C10H21) at the silicon (Si) of PHPS/ROH molar ratio of 4/1. The alkoxy group-functionalized PHPS was converted into amorphous silica powders by curing at 270 degrees C to promote oxidative crosslinking, followed by pyrolysis at 600 degrees C in air to complete the polymer/amorphous silica conversion. Thermogravimetric analysis in air of the 270 degrees C-crosslinked PHPS showed an approximately 18% weight gain at 200 to 500 degrees C. This weight gain was suppressed consistently with the number of carbon atoms of the alkoxy groups introduced to PHPS. Upon heating to 600 degrees C, the PHPS modified with n-C5H11OH showed a total weight loss of 12%, and further weight loss of 31% was observed for the PHPS modified with n-C10H21OH. The nitrogen sorption analysis revealed that micropore volume of the polymer-derived amorphous silica increased consistently with the weight loss during the pyrolysis up to 600 degrees C, and the amorphous silica derived from the PHPS modified with n-C10H21OH exhibited the highest micropore volume. Further increase in the micropore volume was achieved by increasing the Si/n-C10H21OH molar ratio from 4/1 to 2/1. The micropore volume and specific surface area of the resulting amorphous silica powders were 0.193 cm(3)/g and 370m(2)/g, respectively. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Sokri, Mohd Nazri Mohd; Daiko, Yusuke; Honda, Sawao; Iwamoto, Yuji] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Sokri, Mohd Nazri Mohd] Univ Teknol Malaysia, Fac Petr & Renewable Energy Engn, Dept Renewable Energy, Johor Baharu 81310, Malaysia; [Sokri, Mohd Nazri Mohd] Univ Teknol Malaysia, Fac Petr & Renewable Energy Engn, Adv Membrane Technol Res Ctr, Johor Baharu 81310, Malaysia; [Daiko, Yusuke; Honda, Sawao; Iwamoto, Yuji] Japan Sci & Technol Agcy, CREST, Showa Ku, Nagoya, Aichi 4668555, Japan	Iwamoto, Y (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	iwamoto.yuji@nitech.ac.jp					Kroke E, 2000, MAT SCI ENG R, V26, P97, DOI 10.1016/S0927-796X(00)00008-5; Iwamoto Y, 2005, J EUR CERAM SOC, V25, P257, DOI 10.1016/j.jeurceramsoc.2004.08.007; FUNAYAMA O, 1993, J AM CERAM SOC, V76, P717, DOI 10.1111/j.1151-2916.1993.tb03665.x; RICE RW, 1983, AM CERAM SOC BULL, V62, P889; FUNAYAMA O, 1990, NIPPON SERAM KYO GAK, V98, P104; WYNNE KJ, 1984, ANNU REV MATER SCI, V14, P297; Iwamoto Y, 1998, J MATER RES, V13, P353, DOI 10.1557/JMR.1998.0047; SEYFERTH D, 1995, CHEM MATER, V7, P2058, DOI 10.1021/cm00059a012; Iwamoto Y, 2000, J CERAM SOC JPN, V108, P350, DOI 10.2109/jcersj.108.1256_350; Iwamoto Y, 2007, J CERAM SOC JPN, V115, P947, DOI 10.2109/jcersj2.115.947; SAITO A, 1991, AICHE J, V37, P429, DOI 10.1002/aic.690370312; Kubo T, 2006, J CERAM SOC JPN, V114, P517, DOI 10.2109/jcersj.114.517; Riedel R, 1996, CERAM INT, V22, P233, DOI 10.1016/0272-8842(95)00097-6; Barrett P., 1951, J AM CHEM SOC, V73, P373, DOI DOI 10.1021/JA01145A126; Drezdzon M. A., 1986, MANIPULATION AIR SEN, P30; FUNAYAMA O, 1994, NIPPON SERAM KYO GAK, V102, P908; Seyferth D., 1983, J AM CERAM SOC, V66, pC, DOI 10.1111/j.1151-2916.1983.tb09979.x; Silverstein R. M., 1991, SPECTROMETRIC IDENTI	18	2	2	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436					292	297		10.2109/jcersj2.123.292		6	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200022		
J	Tani, J; Kido, H				Tani, Jun-ichi; Kido, Hiroyasu			Electrical properties of Mg2Si thin films on flexible polyimide substrates fabricated by radio-frequency magnetron sputtering	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Sputtering; Electrical properties; Semiconductors; Thin films	THERMOELECTRIC PROPERTIES; SEMICONDUCTING MG2SI; MG2GE	Mg2Si thin films were successfully fabricated on 125-mu m-thick flexible polyimide substrates by radio-frequency (RF) magnetron sputtering deposition using a sintered polycrystalline Mg2Si target. The crystalline orientation of the films was influenced by the substrate temperature (Ts). The produced films exhibit n-type carriers. The electron concentration and mobility of nondoped Mg2Si films at Ts = RT were 1.9 x 10(16) cm(-3) and 1.2 cm(2)/(V s), respectively. The Seebeck coefficient was -748 mu V/K at 336 K, and its absolute value decreased with increasing temperature. The power factor was 3.3 x 10(-7)W/(cmK(2)) at 710 K, which is approximately one order of magnitude lower than that of the bulk sintered Mg2Si sample. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Tani, Jun-ichi; Kido, Hiroyasu] Osaka Municipal Tech Res Inst, Elect Mat Res Div, Joto Ku, Osaka 5368553, Japan	Tani, J (reprint author), Osaka Municipal Tech Res Inst, Elect Mat Res Div, Joto Ku, 1-6-50 Morinomiya, Osaka 5368553, Japan.	tani@omtri.or.jp					Anders A, 2005, SURF COAT TECH, V200, P1893, DOI 10.1016/j.surfcoat.2005.08.018; Arnell RD, 1999, SURF COAT TECH, V112, P170, DOI 10.1016/S0257-8972(98)00749-X; Tani J, 2008, J ALLOY COMPD, V466, P335, DOI 10.1016/j.jallcom.2007.11.029; MORRIS RG, 1958, PHYS REV, V109, P1909, DOI 10.1103/PhysRev.109.1909; Balout H, 2014, J PHYS CHEM C, V118, P19635, DOI 10.1021/jp506323r; THORNTON JA, 1974, J VAC SCI TECHNOL, V11, P666, DOI 10.1116/1.1312732; Jund P, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/3/035403; Kato A, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/20/205801; Tani J, 2005, PHYSICA B, V364, P218, DOI 10.1016/j.physb.2005.04.017; Kelly PJ, 2000, VACUUM, V56, P159, DOI 10.1016/S0042-207X(99)00189-X; Brauer G, 2010, VACUUM, V84, P1354, DOI 10.1016/j.vacuum.2009.12.014; Goncalves LM, 2007, J MICROMECH MICROENG, V17, pS168, DOI 10.1088/0960-1317/17/7/S14; Fedorov M.I., 2012, THERMOELECTRICS ITS; Francioso L, 2013, PROC SPIE, V8763, DOI 10.1117/12.2017385; Hasapis T. C., 2011, MAT RES SOC P, V1325, P23; Kato T, 2011, J APPL PHYS, V110, DOI 10.1063/1.3642965; Ogawa S, 2014, J ELECTRON MATER, V43, P2269, DOI 10.1007/s11664-014-3040-6; SCOULER WJ, 1969, PHYS REV, V178, P1353, DOI 10.1103/PhysRev.178.1353; STELLA A, 1964, J PHYS CHEM SOLIDS, V25, P1253, DOI 10.1016/0022-3697(64)90023-X; Tani J., 2013, MAT RES SOC P, V1490, P229; Vantomme A, 1997, APPL PHYS LETT, V70, P1086, DOI 10.1063/1.118492; Vining C. B., 1995, CRC HDB THERMOELECTR, P277; Xiao QQ, 2011, PHYSCS PROC, V11, P130, DOI 10.1016/j.phpro.2011.01.021; Yamaguchi T., 2005, J JPN POWDER POWDER, V52, P276, DOI 10.2497/jjspm.52.276; Zaitsev V. K., 2006, THERMOELECTRICS HDB	25	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	APR	2015	123	1436					298	301		10.2109/jcersj2.123.298		4	Materials Science, Ceramics	Materials Science	CF5DH	WOS:000352575200023		
J	Ono, S; Nagano, H; Nishikawa, Y; Mishiro, M; Tachikawa, S; Ogawa, H				Ono, Shoya; Nagano, Hosei; Nishikawa, Yasushi; Mishiro, Makoto; Tachikawa, Sumitaka; Ogawa, Hiroyuki			Thermophysical Properties of High-Thermal-Conductivity Graphite Sheet and Application to Deployable/Stowable Radiator	JOURNAL OF THERMOPHYSICS AND HEAT TRANSFER			English	Article; Proceedings Paper	43rd International Conference on Environmental Systems	JUL 14-18, 2013	Vail, CO				AC CALORIMETRIC METHOD; DIFFUSIVITY; FILMS	This study proposes a passively deployed radiator for use as a new thermal control device for small satellites. This radiator can control the amount of heat dissipation by varying its heat rejection area depending on the temperature. This radiator consists of a fin, a baseplate, and an actuator. First, thermal diffusivity, specific heat capacity, total hemispherical emissivity, and solar absorptance of graphite sheets, which are a part of this radiator fin, were measured. From these measurements, it was determined that the thermal conductivity of the graphite sheet varied from 950 to 1490 W/m K, the total hemispherical emissivity varied from 0.22 to 0.31, and the solar absorptance was 0.66. Second, the performance of the radiator was calculated via thermal analysis as a function of size and thickness, and a half-scaled test model of this radiator was designed. Third, the test model was fabricated and its thermal performance was tested under vacuum conditions. The testing showed that the thermal dissipation of this half-scaled radiator was 54 W at 60 degrees C, the fin efficiency difference between the deployed and stowed positions was 0.35, and the specific heat rejection was 188 W/kg.	[Ono, Shoya; Nagano, Hosei] Nagoya Univ, Dept Aerosp Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nishikawa, Yasushi; Mishiro, Makoto] Kaneka Corp, Elect Mat Res & Dev Grp, Elect & Elect Mat Div, Osaka 5660072, Japan; [Tachikawa, Sumitaka; Ogawa, Hiroyuki] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan	Ono, S (reprint author), Nagoya Univ, Dept Aerosp Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.						MURAKAMI M, 1986, APPL PHYS LETT, V48, P1594, DOI 10.1063/1.96827; Fukuzawa K, 2002, INT J THERMOPHYS, V23, P319, DOI 10.1023/A:1013933917245; GU YQ, 1991, JPN J APPL PHYS 1, V30, P1137, DOI 10.1143/JJAP.30.1137; Gilmore D. G., 2002, SPACECRAFT THERMAL C, V1, P211; Nagano H, 2001, INT J THERMOPHYS, V22, P301, DOI 10.1023/A:1006780208048; Nagano H, 2009, J SPACECRAFT ROCKETS, V46, P185, DOI 10.2514/1.30170; Takahashi F, 1999, JPN J APPL PHYS 1, V38, P5278, DOI 10.1143/JJAP.38.5278; Tanaka K., 2005, T JAPAN SOC MECH E B, V71, P1655; Yonezawa K., 2003, Journal of the National Institute of Information and Communications Technology, V50	9	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0887-8722	1533-6808		J THERMOPHYS HEAT TR	J. Thermophys. Heat Transf.	APR	2015	29	2					403	411		10.2514/1.T4247		9	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CF5GG	WOS:000352584700019		
J	Nomura, S; Komurasaki, K; Takayanagi, H; Fujita, K; Arakawa, Y				Nomura, Satoshi; Komurasaki, Kimiya; Takayanagi, Hiroki; Fujita, Kazuhisa; Arakawa, Yoshihiro			Cavity-Enhanced Absorption Spectroscopy in an Arc-Heated Wind Tunnel	JOURNAL OF THERMOPHYSICS AND HEAT TRANSFER			English	Article; Proceedings Paper	49th AIAA Aerospace Sciences Meeting Including the New Horizons Forum and Aerospace Exposition	JAN 03-07, 2011	Orlando, FL	AIAA			ATOMIC-OXYGEN; LASER; GENERATOR; FACILITY; PLASMA; RING		[Nomura, Satoshi; Takayanagi, Hiroki; Fujita, Kazuhisa] Japan Aerosp Explorat Agcy, Inst Aerosp Technol, Chofu, Tokyo 1828522, Japan; [Komurasaki, Kimiya] Univ Tokyo, Dept Adv Energy, Kashiwa, Chiba 2770882, Japan; [Arakawa, Yoshihiro] Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan	Nomura, S (reprint author), Japan Aerosp Explorat Agcy, Inst Aerosp Technol, 7-44-1 Jindaiji Higashimachi, Chofu, Tokyo 1828522, Japan.	nomura.satoshi2@jaxa.jp					Romanini D, 1997, CHEM PHYS LETT, V264, P316, DOI 10.1016/S0009-2614(96)01351-6; O'Keefe A, 1999, CHEM PHYS LETT, V307, P343, DOI 10.1016/S0009-2614(99)00547-3; Engeln R, 1998, REV SCI INSTRUM, V69, P3763, DOI 10.1063/1.1149176; Black ED, 2001, AM J PHYS, V69, P79, DOI 10.1119/1.1286663; Mazurenka M, 2005, ANN RP CH C, V101, P100, DOI 10.1039/b408909j; BAER DS, 1993, J QUANT SPECTROSC RA, V50, P621, DOI 10.1016/0022-4073(93)90030-L; Demtroeder W, 2002, LASER SPECTROSCOPY, P132; Gherman T, 2004, CHEM PHYS LETT, V390, P290, DOI 10.1016/j.cplett.2004.04.029; Kim S, 2004, THESIS STANFORD U ST; Lohle S, 2007, J THERMOPHYS HEAT TR, V21, P790, DOI 10.2514/1.30543; Matsui M, 2005, AIAA J, V43, P2060, DOI 10.2514/1.14128; Matsui M, 2004, VACUUM, V73, P341, DOI 10.1016/j.vacuum.2003.12.046; Park C, 2006, J THERMOPHYS HEAT TR, V20, P672, DOI 10.2514/1.15744; van Leeuwen NJ, 2003, APPL OPTICS, V42, P3670, DOI 10.1364/AO.42.003670	14	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0887-8722	1533-6808		J THERMOPHYS HEAT TR	J. Thermophys. Heat Transf.	APR	2015	29	2					415	+		10.2514/1.T4109		3	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CF5GG	WOS:000352584700021		
J	Iwata, T; Washio, K; Yoshida, T; Ishikawa, I; Ando, T; Yamato, M; Okano, T				Iwata, Takanori; Washio, Kaoru; Yoshida, Toshiyuki; Ishikawa, Isao; Ando, Tomohiro; Yamato, Masayuki; Okano, Teruo			Cell sheet engineering and its application for periodontal regeneration	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Review						cell sheet engineering; clinical research; cytotherapy; periodontal regeneration; stem cells; translational research; temperature-responsive polymer	MESENCHYMAL STEM-CELLS; FUNCTIONAL 3-DIMENSIONAL TISSUES; PLATELET-RICH PLASMA; EXPANDED EX-VIVO; LIGAMENT CELLS; CANINE MODEL; IN-VITRO; TRANSPLANTATION IMPROVES; HISTOMETRIC EVALUATION; CARDIOMYOCYTE SHEETS	Periodontitis is a inflammation induced by a bacterial infection that causes the destruction of the attachment apparatus of dental roots. Several materials, such as bone graft materials, barrier membranes and protein products have been developed and used to treat periodontal defects clinically; however, it is difficult to regenerate the complete periodontal tissue structure. Recently, cytotherapeutic approaches have been introduced to overcome the limitation of conventional procedures. The in vitro-expanded autologous cells derived from several kinds of tissues have already been used in several clinical trials. These cytotherapeutic treatments have been shown to be safe and effective for the treatment of periodontitis. Our strategy has been to integrate stem cell biology and cell sheet engineering, in which a temperature-responsive intelligent polymer is grafted onto the surface of cell culture dish to create a cell sheet', to achieve a novel treatment method for periodontitis. By simple reduction of the temperature to below 32 degrees C, a contiguous cell sheet, which is capable of keeping extracellular matrix proteins and cell-cell interactions intact, can be harvested for transplantation without the use of scaffolds. This technology has already been employed in clinical trials, confirming the safety and efficacy of the treatment. In this review, we introduce recent progress in the engineering of cell sheets and review the potential of cell sheet technology for periodontal regenerative medicine. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Iwata, Takanori; Washio, Kaoru; Yoshida, Toshiyuki; Ishikawa, Isao; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan; [Iwata, Takanori; Ando, Tomohiro] Tokyo Womens Med Univ, Dept Oral & Maxillofacial Surg, Shinjuku Ku, Tokyo 1628666, Japan	Okano, T (reprint author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tokano@abmes.twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This study was supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems 'Cell Sheet Tissue Engineering Center (CSTEC)' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Nakajima K, 2001, BIOMATERIALS, V22, P1213, DOI 10.1016/S0142-9612(00)00270-2; Kim CS, 2004, J PERIODONTOL, V75, P229, DOI 10.1902/jop.2004.75.2.229; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Hasegawa M, 2005, TISSUE ENG, V11, P469, DOI 10.1089/ten.2005.11.469; Trubiani O, 2005, INT J IMMUNOPATH PH, V18, P213; Iwata T, 2010, J CLIN PERIODONTOL, V37, P1088, DOI 10.1111/j.1600-051X.2010.01597.x; Tobita M, 2008, TISSUE ENG PT A, V14, P945, DOI 10.1089/ten.tea.2007.0048; Hoashi T, 2009, J THORAC CARDIOV SUR, V138, P460, DOI 10.1016/j.jtcvs.2009.02.018; Shimizu H, 2009, BIOMATERIALS, V30, P5943, DOI 10.1016/j.biomaterials.2009.07.042; Shimizu T, 2006, TISSUE ENG, V12, P499, DOI 10.1089/ten.2006.12.499; Kawaguchi H, 2004, J PERIODONTOL, V75, P1281, DOI 10.1902/jop.2004.75.9.1281; CATON J, 1980, J CLIN PERIODONTOL, V7, P224, DOI 10.1111/j.1600-051X.1980.tb01965.x; Kaneshiro N, 2006, BIOCHEM BIOPH RES CO, V349, P723, DOI 10.1016/j.bbrc.2006.08.096; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P281, DOI 10.1111/j.1600-051X.1981.tb02039.x; Tsumanuma Y, 2011, BIOMATERIALS, V32, P5819, DOI 10.1016/j.biomaterials.2011.04.071; Kanzaki M, 2008, EUR J CARDIO-THORAC, V34, P864, DOI 10.1016/j.ejcts.2008.05.048; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Murakami D, 2006, BIOMATERIALS, V27, P5518, DOI 10.1016/j.biomaterials.2006.05.042; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Ding G, 2010, STEM CELLS, V28, P1829, DOI 10.1002/stem.512; Bartold PM, 2006, PERIODONTOL 2000, V41, P123, DOI 10.1111/j.1600-0757.2006.00156.x; Shiroyanagi Y, 2003, TISSUE ENG, V9, P1005, DOI 10.1089/107632703322495646; Hata H, 2006, J THORAC CARDIOV SUR, V132, P918, DOI 10.1016/j.jtcvs.2006.01.024; Washio K, 2010, CELL TISSUE RES, V341, P397, DOI 10.1007/s00441-010-1009-1; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Pirraco RP, 2011, TISSUE ENG PT A, V17, P1507, DOI [10.1089/ten.TEA.2010.0470, 10.1089/ten.tea.2010.0470]; Ishikawa I, 2009, PERIODONTOL 2000, V51, P220, DOI 10.1111/j.1600-0757.2009.00312.x; Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517; Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734; Yaji N, 2009, BIOMATERIALS, V30, P797, DOI 10.1016/j.biomaterials.2008.10.045; Lindroos B, 2008, BIOCHEM BIOPH RES CO, V368, P329, DOI 10.1016/j.bbrc.2008.01.081; Asakawa N, 2010, BIOMATERIALS, V31, P3903, DOI 10.1016/j.biomaterials.2010.01.105; Esposito M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub3; Yamada Y, 2006, INT J PERIODONT REST, V26, P363; Murakami S, 2011, PERIODONTOL 2000, V56, P188, DOI 10.1111/j.1600-0757.2010.00365.x; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Grzesik WJ, 2002, CRIT REV ORAL BIOL M, V13, P474; Burillon C, 2012, INVEST OPHTH VIS SCI, V53, P1325, DOI 10.1167/iovs.11-7744; Asano T, 2006, TISSUE ENG, V12, P2629, DOI 10.1089/ten.2006.12.2629; Chen FM, 2012, BIOMATERIALS, V33, P6320, DOI 10.1016/j.biomaterials.2012.05.048; Haraguchi Y, 2006, BIOMATERIALS, V27, P4765, DOI 10.1016/j.biomaterials.2006.04.034; Kumashiro Y, 2010, ANN BIOMED ENG, V38, P1977, DOI 10.1007/s10439-010-0035-1; Kondoh H, 2006, CARDIOVASC RES, V69, P466, DOI 10.1016/j.cardiores.2005.11.005; Jiang J, 2010, CYTOTECHNOLOGY, V62, P235, DOI 10.1007/s10616-010-9284-y; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032; Flores MG, 2008, J PERIODONTAL RES, V43, P364, DOI 10.1111/j.1600-0765.2007.01046.x; Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Hasegawa N, 2006, J PERIODONTOL, V77, P1003, DOI 10.1902/jop.2006.050341; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x; Izumi Y, 2011, PERIODONTOL 2000, V56, P166, DOI 10.1111/j.1600-0757.2010.00366.x; Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019; Yang Y, 2010, BIOMATERIALS, V31, P8574, DOI 10.1016/j.biomaterials.2010.06.026; Hayashida Y, 2005, INVEST OPHTH VIS SCI, V46, P1632, DOI 10.1167/iovs.04-0813; Feng F, 2010, ORAL DIS, V16, P20, DOI 10.1111/j.1601-0825.2009.01593.x; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Kanzaki M, 2007, BIOMATERIALS, V28, P4294, DOI 10.1016/j.biomaterials.2007.06.009; Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje; Vaquette C, 2012, BIOMATERIALS, V33, P5560, DOI 10.1016/j.biomaterials.2012.04.038; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; Arauchi A, 2009, TISSUE ENG PT A, V15, P3943, DOI 10.1089/ten.TEA.2009.0119; Asano T, 2005, BJU INT, V96, P1409, DOI 10.1111/j.1464-410X.2005.05816.x; BLOMLOF L, 1981, SCAND J DENT RES, V89, P43; Bosshardt DD, 2005, CELL TISSUE RES, V320, P399, DOI 10.1007/s00441-005-1106-8; Collier TO, 2002, J BIOMED MATER RES, V59, P136, DOI 10.1002/jbm.1225; des Oliveiras C, 2010, BMJ-BRIT MED J, V340, pc2451; Flores MG, 2008, J CLIN PERIODONTOL, V35, P1066, DOI 10.1111/j.1600-051X.2008.01326.x; Food and Drug Administration, 2008, GOOD MAN PRACT GMP G; Kim CS, 2011, PERIODONTOL 2000, V56, P209, DOI 10.1111/j.1600-0757.2010.00372.x; Kubota A, 2006, BIOMATERIALS, V27, P3639, DOI 10.1016/j.biomaterials.2006.02.018; MacNeil RL, 1999, PERIODONTOL 2000, V19, P8, DOI 10.1111/j.1600-0757.1999.tb00144.x; McGuire MK, 2011, J PERIODONTOL, V82, P1414, DOI 10.1902/jop.2011.100671; Mizuno H, 2006, TISSUE ENG, V12, P1227, DOI 10.1089/ten.2006.12.1227; Murakami Daisuke, 2006, J Artif Organs, V9, P185, DOI 10.1007/s10047-006-0342-3; Ohkis T, 2009, GASTROINTEST ENDOSC, V69; Okuda K, 2004, INT J PERIODONT REST, V24, P119; Okuda Kazuhiro, 2009, J Int Acad Periodontol, V11, P206; RAGNARSSON B, 1985, J DENT RES, V64, P1026, DOI 10.1177/00220345850640080101; Sakaguchi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01316; Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406; Seos BM, 2004, LANCET, V364, P149; Shiroyanagi Y, 2004, BJU INT, V93, P1069, DOI 10.1111/j.1464-410X.2004.04783.x; Takagi R, 2011, J TISSUE ENG REGEN M, V5, pE63, DOI 10.1002/term.337; Xus J, 2009, STEM CELLS DEV, V18, P487; Yamada N, 1990, RAPID COMMUN, V11, P571; Yamamiya K, 2008, J PERIODONTOL, V79, P811, DOI 10.1902/jop.2008.070518 ; Yoshidas T, 2012, INT J DENT, V2012	98	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	APR	2015	9	4					343	356		10.1002/term.1785		14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CG1LM	WOS:000353034100003		
J	Yang, JJ; Liu, JF; Kurokawa, T; Kitada, K; Gong, JP				Yang, Jing Jing; Liu, Jian Fang; Kurokawa, Takayuki; Kitada, Kazuhiro; Gong, Jian Ping			Hydrogels as feeder-free scaffolds for long-term self-renewal of mouse induced pluripotent stem cells	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						hydrogels; induced pluripotent stem cells; self-renewal; undifferentiated; differentiated; teratoma	UNDIFFERENTIATED GROWTH; RECOMBINANT VITRONECTIN; GENE-EXPRESSION; ES CELLS; DIFFERENTIATION; CULTURE; FIBROBLASTS; ACTIVATION; GENERATION; EFFICIENCY	Expanding undifferentiated induced pluripotent stem (iPS) cells in vitro is a basic requirement for application of iPS cells in both fundamental research and clinical regeneration. In this study, we intended to establish a simple, low cost and efficient method for the long-term self-renewal of mouse induced pluripotent stem (miPS) cells without using feeder-cells and adhesive proteins. Three scaffolds were selected for the long-term subculture of miPS cells over two months starting from passages 14 to 29: 1) a gelatin coated polystyrene (Gelatin-PS) that is a widely used scaffold for self-renewal of mouse embryonic stem (mES) cells; 2) a neutral hydrogel poly(N,N-dimethylacrylamide) (PDMAAm); and 3) a negatively charged hydrogel poly(2-acrylamido-2-methyl-propane sulfonic acid sodium salt) (PNaAMPS). Each passaged miPS cells on these scaffolds were cryopreserved successfully and the revived cells showed high viability and proliferation. The passaged miPS cells maintained a high undifferentiated state on all three scaffolds and a high level of pluripotency by expressing differentiation markers in vitro and forming teratomas in SCID mice with derivatives of all three germ layers. Compared to Gelatin-PS, the two hydrogels exhibited much better self-renewal performance in terms of high proliferation rate and level of expression of undifferentiated gene markers as well as efficiency in pluripotent teratoma formation. Furthermore, the PNaAMPS hydrogel demonstrated a slightly higher efficiency and simpler operation of cell expansion than the PDMAAm hydrogel. To conclude, PNaAMPS hydrogel is an excellent feeder-free scaffold because of its simplicity, low cost and high efficiency in expanding a large number of miPS cells in vitro. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Yang, Jing Jing; Kurokawa, Takayuki; Gong, Jian Ping] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Liu, Jian Fang] Hokkaido Univ, Grad Sch Sci, Dept Biol Sci, Sapporo, Hokkaido 0600810, Japan; [Kurokawa, Takayuki] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan; [Kitada, Kazuhiro] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Gong, JP (reprint author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan.	gong@mail.sci.hokudai.ac.jp	Gong, Jian Ping/B-7019-2009; Kurokawa, Takayuki/B-7061-2009	Gong, Jian Ping/0000-0003-2228-2750; Kurokawa, Takayuki/0000-0001-6834-684X	Ministry of Education, Science, Sports and Culture of Japan [18002002]	The authors thank Yukiko Hane for hydrogel preparations. This study was supported by a Grant-in-Aid for Specially Promoted Research (No. 18002002) from the Ministry of Education, Science, Sports and Culture of Japan.	Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Yang JJ, 2010, TISSUE ENG PT A, V16, P2529, DOI 10.1089/ten.TEA.2009.0647; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Biswas A, 2007, STEM CELLS DEV, V16, P213, DOI 10.1089/scd.2006.0081; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Amit M, 2010, STEM CELL REV REP, V6, P248, DOI 10.1007/s12015-010-9149-y; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Robertson JA, 2001, NAT REV GENET, V2, P74, DOI 10.1038/35047594; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McLaren A, 2001, NATURE, V414, P129, DOI 10.1038/35102194; Chen YM, 2011, CHINESE J POLYM SCI, V29, P23, DOI 10.1007/s10118-010-1021-7; Hes S, 2009, CELL DEV BIO, V25, P377; Hochemeyers D, 2008, CELL STEM CELL, V3, P346; Iwamuro M, 2010, CELL TRANSPLANT, V19, P831, DOI 10.3727/096368910X508951; Kojimas H, 2001, CANC BIOTHER RADIO, V16, P431; Lius JF, 2011, TISSUE ENG PART A, V17, P2343; Lius SV, 2008, STEM CELLS DEV, V17, P391; Lohs YH, 2006, NAT GENET, V38, P431; Martins GR, 1981, SCIENCES, V78, P7634, DOI DOI 10.1073/PNAS.78.12.7634); Xus C, 2001, NAT BIOTECHNOL, V19, P971; Yang JJ, 2010, J BIOMED MATER RES A, V95A, P531, DOI 10.1002/jbm.a.32875; Yasudas K, 2009, MACROMOL BIOSCI, V9, P309	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	APR	2015	9	4					375	388		10.1002/term.1640		14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CG1LM	WOS:000353034100006		
J	Zaidi, AA; Tsuji, T; Tanaka, T				Zaidi, Ali Abbas; Tsuji, Takuya; Tanaka, Toshitsugu			Direct numerical simulations of inertial settling of non-Brownian particles	KOREAN JOURNAL OF CHEMICAL ENGINEERING			English	Article						Hindered Settling Velocity; Sedimentation; Particle Structuring; Moderate Reynolds Number; Direct Numerical Simulation	VELOCITY FLUCTUATIONS; SEDIMENTING SUSPENSIONS; HYDRODYNAMIC DIFFUSION; INDUCED TURBULENCE; REYNOLDS-NUMBER; SELF-DIFFUSION; HARD SPHERES; CLUSTERS; FLUIDIZATION; MONODISPERSE	The dynamics of particles settling at moderate Reynolds number is studied with periodic boundary conditions. The particle Reynolds number ranges from 0.1 to 50, and the solid volume fraction ranges from single sphere to 0.4. Particle-fluid interactions are solved by immersed boundary method and particle-particle interactions are solved by discrete element method. The principal results are the average settling velocity and the structure formation of particles. The average sedimentation velocities of particles for moderate Reynolds number showed deviation from the well-known power law, and the difference keeps on increasing with decrease in solid volume fractions. This deviation is removed by proposing the division of the power law into three regions of Reynolds number for dilute and non-dilute regimes. By analyzing the particle structures, this difference is due to the particle arrangements by the wake interactions at moderate Reynolds number.	[Zaidi, Ali Abbas; Tsuji, Takuya; Tanaka, Toshitsugu] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan	Zaidi, AA (reprint author), Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan.	ali@cf.mech.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science & Technology, Japan	We would like to acknowledge the Ministry of Education, Culture, Sports, Science & Technology, Japan for providing financial assistance. We are also grateful to Cybermedia Center, Osaka University and Center for Computing & Media Studies, Kyoto University for providing computational resources.	ALNAAFA MA, 1992, AICHE J, V38, P1618, DOI 10.1002/aic.690381012; Kajishima T, 2004, INT J HEAT FLUID FL, V25, P721, DOI 10.1016/j.ijheatfluidflow.2004.05.007; WERTHEIM MS, 1963, PHYS REV LETT, V10, P321, DOI 10.1103/PhysRevLett.10.321; Wylie JJ, 2000, PHYS FLUIDS, V12, P964, DOI 10.1063/1.870351; Ladd AJC, 2001, J STAT PHYS, V104, P1191, DOI 10.1023/A:1010414013942; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; GARSIDE J, 1977, IND ENG CHEM PROC DD, V16, P206, DOI 10.1021/i260062a008; Beetstra R, 2007, AICHE J, V53, P489, DOI 10.1002/aic.11065; BOSSIS G, 1987, J CHEM PHYS, V87, P5437, DOI 10.1063/1.453708; FORTES AF, 1987, J FLUID MECH, V177, P467, DOI 10.1017/S0022112087001046; NICOLAI H, 1995, PHYS FLUIDS, V7, P12, DOI 10.1063/1.868733; BATCHELOR GK, 1972, J FLUID MECH, V52, P245, DOI 10.1017/S0022112072001399; Kajishima T, 2002, INT J HEAT FLUID FL, V23, P639, DOI 10.1016/S0142-727X(02)00159-5; Brenner MP, 1999, PHYS FLUIDS, V11, P754, DOI 10.1063/1.869948; Padding JT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031402; NICOLAI H, 1995, PHYS FLUIDS, V7, P3, DOI 10.1063/1.868727; DAVIS RH, 1988, AICHE J, V34, P123, DOI 10.1002/aic.690340114; HAM JM, 1988, INT J MULTIPHAS FLOW, V14, P533, DOI 10.1016/0301-9322(88)90056-0; Nicolai H, 1996, PHYS FLUIDS, V8, P855, DOI 10.1063/1.868885; Swan JW, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2803837; Padding JT, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.220601; CHEN YM, 1991, CHEM ENG SCI, V46, P2253, DOI 10.1016/0009-2509(91)85124-G; TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7; Padding JT, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011402; Kajishima T, 2001, JSME INT J B-FLUID T, V44, P526, DOI 10.1299/jsmeb.44.526; CAFLISCH RE, 1985, PHYS FLUIDS, V28, P759, DOI 10.1063/1.865095; Cunha FR, 2002, J FLUID ENG-T ASME, V124, P957, DOI 10.1115/1.1502665; Di Felice R, 1999, INT J MULTIPHAS FLOW, V25, P559, DOI 10.1016/S0301-9322(98)00084-6; Doychev T., 2013, P 8 INT C MULT FLOW, P320; Hamid A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022310; HARTMAN M, 1992, CHEM ENG SCI, V47, P3162, DOI 10.1016/0009-2509(92)87021-H; HERRMANN HJ, 1984, J PHYS A-MATH GEN, V17, pL261, DOI 10.1088/0305-4470/17/5/008; Hoogerbrugge P.J., 1992, EPL-EUROPHYS LETT, V19, P5; KOCH DL, 1993, PHYS FLUIDS A-FLUID, V5, P1141, DOI 10.1063/1.858600; Koo S, 2011, KOREAN J CHEM ENG, V28, P364, DOI 10.1007/s11814-010-0416-z; Nguyen NQ, 2005, J FLUID MECH, V525, P73, DOI 10.1017/S0022112004002563; Nishiura D, 2006, KAGAKU KOGAKU RONBUN, V32, P331, DOI 10.1252/kakoronbunshu.32.331; Richardson J. F., 1954, T I CHEM ENG-LOND, V32, pS82, DOI DOI 10.1016/S0263-8762(97)80006-8; Simeonov JA, 2012, INT J MULTIPHAS FLOW, V46, P38, DOI 10.1016/j.ijmultiphaseflow.2012.05.008; Stockie JM, 2009, COMPUT STRUCT, V87, P701, DOI 10.1016/j.compstruc.2008.11.001; Talini L, 1998, J MAGN RESON, V132, P287, DOI 10.1006/jmre.1998.1389; THIELE E, 1963, J CHEM PHYS, V39, P474, DOI 10.1063/1.1734272; Xiong QG, 2010, CHEM ENG SCI, V65, P5356, DOI 10.1016/j.ces.2010.06.035	43	0	0	KOREAN INSTITUTE CHEMICAL  ENGINEERS	SEOUL	F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA	0256-1115	1975-7220		KOREAN J CHEM ENG	Korean J. Chem. Eng.	APR	2015	32	4					617	628		10.1007/s11814-014-0241-x		12	Chemistry, Multidisciplinary; Engineering, Chemical	Chemistry; Engineering	CF5TS	WOS:000352620600006		
J	Nanko, K; Giambelluca, TW; Sutherland, RA; Mudd, RG; Nullet, MA; Ziegler, AD				Nanko, K.; Giambelluca, T. W.; Sutherland, R. A.; Mudd, R. G.; Nullet, M. A.; Ziegler, A. D.			EROSION POTENTIAL UNDER MICONIA CALVESCENS STANDS ON THE ISLAND OF HAWAI'I	LAND DEGRADATION & DEVELOPMENT			English	Article						alien plant invasion; splash detachment; accelerated erosion; throughfall	SPLASH DETACHMENT; RAINDROP-IMPACT; SOIL DETACHMENT; RUNOFF; ENERGY; MELASTOMATACEAE; PRECIPITATION; INFILTRATION; PLANTATION; FORESTS	This study provides evidence that Miconia calvescens has the potential to accelerate surface erosion in stands where it invades by (i) reducing under-canopy light levels, thereby reducing the establishment of ground cover vegetation, and (ii) producing highly erosive throughfall drops on large leaves in a single-layer canopy. The throughfall energy in a stand of invasive miconia on the Island of Hawaii (USA), assessed by measuring the drop size and drop velocity distributions with a laser disdrometer, was significantly higher than that in a stand of native hia (Metrosideros polymorpha) and ambient rainfall. Median throughfall drop size for miconia (383mm) was twice that of ambient rainfall (162mm). Highly erosive throughfall resulted from large drops forming on large miconia leaves and relatively high fall velocities associated with the single-story miconia canopy. In contrast, multi-storied natural hia had a larger median drop size; however, a lower fall height reduced throughfall effective kinetic energy. Furthermore, the effective kinetic energy for miconia was high because large drops (> 38mm) with high kinetic energy accounted for 60 per cent of the total energy (versus 30-40 per cent for other vegetation types). Consequently, unit kinetic energy of throughfall was 28Jm(-2)mm(-1) under miconia, compared with <24Jm(-2)mm(-1) for rainfall and <20Jm(-2)mm(-1) under hia. These data, combined with the observation of limited protective ground cover under miconia, show the potential for accelerated erosion occurring on forest floors in stands of invasive miconia. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Nanko, K.] Forestry & Forest Prod Res Inst, Dept Forest Site Environm, Tsukuba, Ibaraki 3058687, Japan; [Giambelluca, T. W.; Sutherland, R. A.; Mudd, R. G.; Nullet, M. A.] Univ Hawaii, Dept Geog, Honolulu, HI 96822 USA; [Ziegler, A. D.] Natl Univ Singapore, Dept Geog, Singapore 117570, Singapore	Nanko, K (reprint author), Forestry & Forest Prod Res Inst, Dept Forest Site Environm, Matsunosato 1, Tsukuba, Ibaraki 3058687, Japan.	nanko-kazuki@gi.main.jp	Nanko, Kazuki/F-4833-2010	Nanko, Kazuki/0000-0002-1157-9287	Hawai'i Department of Land and Natural Resources/Hawai'i Invasive Species Council Award "Ecological, Hydrological, and Economic Impacts of miconia in Hawai'i"; US Fish and Wildlife Service [122004J001]; Pacific Island Ecosystems Research Center (PIERC), USGS	The authors are grateful to Kim Burnett, Donna Lee, and Ryan Smith for their help in designing the study and finding suitable study sites. We thank the Hawai'i Tropical Botanical Garden (HTBG), and especially Sean Callahan, Horticulturist and Garden Manager, for guiding us to miconia-infested sites and allowing us to conduct measurements on HTBG land. Jan Schipper and Jean Franklin of the Big Island Invasive Species Committee kindly provided a map of the miconia distribution on Hawai'i Island. This research was supported by Hawai'i Department of Land and Natural Resources/Hawai'i Invasive Species Council Award "Ecological, Hydrological, and Economic Impacts of miconia in Hawai'i", US Fish and Wildlife Service Agreement number 122004J001, and by the Pacific Island Ecosystems Research Center (PIERC), USGS. Lastly, we acknowledge Lloyd Loope of PIERC whose leadership and dedication to understanding and mitigating species invasion in Hawai'i have been a great service to the ecosystems and people of Hawai'i.	AGASSI M, 1985, GEODERMA, V36, P263, DOI 10.1016/0016-7061(85)90007-2; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; ATLAS D, 1973, REV GEOPHYS, V11, P1, DOI 10.1029/RG011i001p00001; Wakiyama Y, 2010, EARTH SURF PROC LAND, V35, P993, DOI 10.1002/esp.1844; Meyer JY, 1996, J BIOGEOGR, V23, P775, DOI 10.1111/j.1365-2699.1996.tb00038.x; Smets T, 2008, PROG PHYS GEOG, V32, P654, DOI 10.1177/0309133308101473; Austin AT, 2000, J ECOL, V88, P129, DOI 10.1046/j.1365-2745.2000.00437.x; Nanko K, 2006, J HYDROL, V329, P422, DOI 10.1016/j.jhydrol.2006.02.036; Nanko K, 2008, CATENA, V72, P348, DOI 10.1016/j.catena.2007.07.002; Salles C, 2000, WATER RESOUR RES, V36, P2721, DOI 10.1029/2000WR900024; Zhou GY, 2002, CATENA, V49, P231, DOI 10.1016/S0341-8162(02)00030-9; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; WANG PK, 1977, J APPL METEOROL, V16, P275, DOI 10.1175/1520-0450(1977)016<0275:ATTVOC>2.0.CO;2; GILLEY JE, 1986, T ASAE, V29, P157; Murphy HT, 2008, BIOL INVASIONS, V10, P925, DOI 10.1007/s10530-008-9246-x; BLANCHARD DC, 1953, J METEOROL, V10, P457, DOI 10.1175/1520-0469(1953)010<0457:RSDIHR>2.0.CO;2; Loch RJ, 2000, AUST J SOIL RES, V38, P299, DOI 10.1071/SR99030; Onda Y, 2010, HYDROL PROCESS, V24, P527, DOI 10.1002/hyp.7548; Brandts J., 1990, EARTH SURF PROCESSES, V15, P687; Cordell S., 1999, Selbyana, V20, P350; ELWELL HA, 1976, GEODERMA, V15, P61, DOI 10.1016/0016-7061(76)90071-9; FOSBERG F R, 1992, Pacific Science, V46, P232; Giambellucas TW, 2010, P INT MIC C KEAN MAU; Goarants AC, 2010, P INT MIC C KEAN MAU; Halls RL, 1993, J GEOPHYS RES, V90, P465, DOI 10.1029/93JD01498; KINNELL PIA, 1981, SOIL SCI SOC AM J, V45, P153; Kinnell PIA, 2005, HYDROL PROCESS, V19, P2815, DOI 10.1002/hyp.5788; Lohs RKH, 2004, THESIS U HAWAII MNOA; Loopes L, 2009, PREVENTION EARLY DET, P36; Loopes LL, 2011, ENCY BIOL INVASIONS, P309; Marshalls J, 1948, J METEOROL, V5, P65; Medeiros AC, 1997, BISHOP MUSEUM OCCASI, V48, P23; Meyer Jean-Yves, 2004, Pacific Science, V58, P357, DOI 10.1353/psc.2004.0032; Meyer Jean-Yves, 1996, Pacific Science, V50, P66; Meyers J-Y, 1994, THESIS U MONTPELLIER; Miura S., 2002, J FOR RES, V7, P201, DOI 10.1007/BF02763133; Morgan R.P.C., 2005, SOIL EROSION CONSERV, P304; Motookas P, 2003, WEEDS HAWAIIS PASTUR; Mueller-Domboiss D, 1998, VEGETATION TROPICAL; Nanko K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033010; Nanko K, 2010, HYDROL PROCESS, V24, P567, DOI 10.1002/hyp.7551; OSBORN B., 1954, Journal of Soil and Water Conservation, V9, P70; Shainberg I, 2003, SOIL SCI, V168, P54, DOI 10.1097/01.ss.0000049731.22043.83; SHARMA PP, 1995, SOIL SCI SOC AM J, V59, P727; vansDijk AIJM, 2002, J HYDROL, V261, P1, DOI [10.1016/S0022-1694(02)00020-3., DOI 10.1016/S0022-1694(02)00020-3]; Whittakers RJ, 1998, ISLAND BIOGEOGRAPHY; Woos M-K, 1990, PHYSICAL GEOGR, V11, P1	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1085-3278	1099-145X		LAND DEGRAD DEV	Land Degrad. Dev.	APR	2015	26	3					218	226		10.1002/ldr.2200		9	Environmental Sciences; Soil Science	Environmental Sciences & Ecology; Agriculture	CF9DS	WOS:000352863300003		
J	Sakama, C; Caminada, M; Herzig, A				Sakama, Chiaki; Caminada, Martin; Herzig, Andreas			A formal account of dishonesty	LOGIC JOURNAL OF THE IGPL			English	Article						Dishonesty; multi-modal logic; belief and intention; communication	AGENT COMMUNICATION; MODAL LOGIC; DECEPTION; BELIEF; KNOWLEDGE; ROBOTS; LIE	This article provides formal accounts of dishonest attitudes of agents. We introduce a propositional multi-modal logic that can represent an agent's belief and intention as well as communication between agents. Using the language, we formulate different categories of dishonesty. We first provide two different definitions of lies and provide their logical properties. We then consider an incentive behind the act of lying and introduce lying with objectives. We subsequently define bullshit, withholding information and half-truths, and analyse their formal properties. We compare different categories of dishonesty in a systematic manner, and examine their connection to deception. We also propose maxims for dishonest communication that agents should ideally try to satisfy.	[Sakama, Chiaki] Wakayama Univ, Dept Comp & Commun Sci, Wakayama 6408510, Japan; [Caminada, Martin] Univ Aberdeen, Dept Comp Sci, Aberdeen AB24 3UE, Scotland; [Herzig, Andreas] Univ Toulouse, Toulouse, France; [Herzig, Andreas] CNRS, F-75700 Paris, France	Sakama, C (reprint author), Wakayama Univ, Dept Comp & Commun Sci, Wakayama 6408510, Japan.	sakama@sys.wakayama-u.ac.jp; martin.caminada@abdn.ac.uk; herzig@irit.fr			National Research Fund, Luxembourg (LAAMI project); Engineering and Physical Sciences Research Council (EPSRC, UK) [EP/J012084/1]	We thank the reviewers for their valuable comments on the manuscript. Martin Caminada has been supported by the National Research Fund, Luxembourg (LAAMI project) and by the Engineering and Physical Sciences Research Council (EPSRC, UK), grant ref. EP/J012084/1 (SAsSy project).	Adler J.E., 1997, J PHILOS, V94, P435, DOI 10.2307/2564617; Anderson M., 2011, MACHINE ETHICS; Fallis D, 2009, J PHILOS, V106, P29; Ettinger D, 2010, AM ECON J-MICROECON, V2, P1, DOI 10.1257/mic.2.1.1; Carrion RE, 2010, COGNITION, V114, P105, DOI 10.1016/j.cognition.2009.05.014; Liau CJ, 2003, ARTIF INTELL, V149, P31, DOI 10.1016/S0004-3702(03)00063-8; Rowell JT, 2006, AM NAT, V168, pE180, DOI 10.1086/508809; Mitri S, 2009, P NATL ACAD SCI USA, V106, P15786, DOI 10.1073/pnas.0903152106; COHEN PR, 1990, ARTIF INTELL, V42, P213, DOI 10.1016/0004-3702(90)90055-5; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; de Rosis F, 2003, COMPUT INTELL, V19, P235, DOI 10.1111/1467-8640.00223; Carson TL, 2006, NOUS, V40, P284, DOI 10.1111/j.0029-4624.2006.00610.x; Singh MP, 1998, COMPUTER, V31, P40, DOI 10.1109/2.735849; ARIELY D., 2012, HONEST TRUTH DISHONE; Arkoudas K., 2009, J SOFTWARE INFORM, V3, P47; Baltag A., 2006, P ESSLLI WORKSH RAT; Bok Sissela, 1999, LYING MORAL CHOICE P; BONATTI PA, 1995, IEEE T KNOWL DATA EN, V7, P406, DOI 10.1109/69.390247; Bratman M. E., 1987, INTENTIONS PLANS PRA; Bronson P., 2008, NEW YORK MAGAZINE; Caminada M., 2009, P IJCAI WORKSH SOC S; Caminada M., 2011, P 22 INT JOINT C ART, P121; Carson Thomas, 2010, LYING DECEPTION THEO; Castelfranchi C., 2001, TRUST DECEPTION VIRT, P91; Castelfranchi C., 2000, Ethics and Information Technology, V2, DOI 10.1023/A:1010025403776; Clark M., 2011, P AAAI FALL S; Cohen GA, 2002, CONTOURS OF AGENCY, P321; Colombetti M, 1999, MATH SOC SCI, V38, P171, DOI 10.1016/S0165-4896(97)00014-0; Crawford VP, 2003, AM ECON REV, V93, P133, DOI 10.1257/000282803321455197; DEMOS R, 1960, J PHILOS, V57, P588, DOI 10.2307/2023611; Fagin R., 1995, REASONING KNOWLEDGE; Firozabadi B. S., 2001, TRUST DECEPTION VIRT, P157; FIROZABADI BS, 1999, NORMS LOGICS INFORM, V49, P275; Frankfurt HG, 2005, ON BULLSHIT, P1; Ganascia J.-G., 2006, ETHICS INF TECHNOL, V9, P39; Grice H. P., 1989, STUDIES WAYS WORDS; Isaac AMC, 2014, COGN SYST RES, V28, P12, DOI 10.1016/j.cogsys.2013.07.001; KRAUS S, 1988, THEOR COMPUT SCI, V58, P155, DOI 10.1016/0304-3975(88)90024-2; KUPFER J, 1982, REV METAPHYS, V36, P103; Leslie I., 2011, BORN LIARS WHY WE CA; Livingstone Smith D., 2007, WHY WE LIE EVOLUTION; Lying Augustine., 1952, TREATISES VARIOUS SU, V56, P45; Mahon J. E., 2007, J APPL PHILOS, V21, P181; Mahon J. E., 2008, J APPL PHILOS, V22, P211; Mahon James Edwin, 2008, STANFORD ENCY PHILOS; Mintz A. P., 2002, INFORM TODAY; Mitchell RW, 1986, DECEPTION PERSPECTIV; Moore GE, 1993, GE MOORE SELECTED WR, P207; O'Neill B., 2003, JER C BIBL EC; Pan Y., 2007, P 2007 IEEE S FDN CO, P228; Pereira L. M., 2011, MACHINE ETHICS, P398; Pitt J, 2000, LECT NOTES ARTIF INT, V1916, P46; Porn I., 1989, LOGIC METHODOLOGY PH; Rahwan I, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P251; Sakama C, 2012, FRONT ARTIF INTEL AP, V245, P177, DOI 10.3233/978-1-61499-111-3-177; Sakama C., 2011, P 14 INT WORKSH TRUS; Sakama C., 2012, LECT NOTES ARTIF INT, V7842, P225; Sakama C., 2011, P 22 IJCAI, P1063; Sakama C., 2010, P 30 YEARS NONM REAS; Sakama C, 2010, LECT NOTES ARTIF INT, V6341, P286, DOI 10.1007/978-3-642-15675-5_25; Sandu G., 1986, THESIS U HELSINKI; Searle J R., 1969, SPEECH ACTS; Searle John, 1979, STUDIES THEORY SPEEC; SIEGLER FA, 1966, AM PHILOS QUART, V3, P128; Sklar E, 2005, LECT NOTES COMPUT SC, V3366, P251; Sober E., 1994, CAMBRIDGE STUDIES PH, P71; Son TC, 2014, ACM T COMPUT LOG, V15, DOI 10.1145/2526270; Staab E., 2011, LECT NOTES COMPUTER, V6532, P76; Trivers Robert, 2011, FOLLY FOOLS LOGIC DE; Turing Alan M., 1950, MIND, V59, P433, DOI DOI 10.1093/MIND/LIX.236.433; Tzouvaras A, 1998, J PHILOS LOGIC, V27, P85, DOI 10.1023/A:1017946620987; Van Der Hoek W., 1993, Journal of Logic and Computation, V3, DOI 10.1093/logcom/3.2.173; van Ditmarsch H., 2011, LNAI FOLLI; van Ditmarsch H, 2014, SYNTHESE, V191, P745, DOI 10.1007/s11229-013-0275-3; Vincent J. M., 1979, STUDIES LANGUAGE COM, V7, P749; Wagner AR, 2011, INT J SOC ROBOT, V3, P5, DOI 10.1007/s12369-010-0073-8; Wallach W., 2009, MORAL MACHINES TEACH; Warwick K., 2014, AI SOC; Zlotkin G., 1991, P 12 INT JOINT C ART, P225	79	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-0751	1368-9894		LOG J IGPL	Log. J. IGPL	APR	2015	23	2					259	294		10.1093/jigpal/jzu043		36	Mathematics, Applied; Mathematics; Logic	Mathematics; Science & Technology - Other Topics	CF4HJ	WOS:000352509100007		
J	Qi, BW; Kujawa, P; Toita, S; Beaune, G; Winnik, FM				Qi, Baowen; Kujawa, Piotr; Toita, Sayaka; Beaune, Gregory; Winnik, Francoise M.			Phosphorylcholine-Modified Chitosan Films as Effective Promoters of Cell Aggregation: Correlation Between the Films Properties and Cellular Response	MACROMOLECULAR BIOSCIENCE			English	Article						adsorption; biopolymers; chitosan; polyelectroylte; thin films	VEIN ENDOTHELIAL-CELLS; SURFACE; ADHESION; POLYMER; BIOMATERIALS; TOPOGRAPHY; ADSORPTION; HYDROGELS; PROTEINS; BEHAVIOR	This study describes chitosan-phosphorylcholine (CH-PC) films able to support the formation of cell aggregates (spheroids), which are important for tissue engineering and pharmacological studies. The surface topography, charge, thickness, and rheology of CH-PC thin films were characterized by AFM, zeta-potential measurements, SPR spectroscopy, and QCM-D measurements. The CH-PC films are highly hydrated gels, independently of the level of PC incorporation (15-40 mol-% PC/glucosamine units). QCM-D studies established that the amount of fibrinogen adsorbed on CH-PC films decreased with increasing PC content. CH-PC surfaces underwent a transition from moderately cell-adhesive (CH-PC15) to non-adhesive (CH-PC40). Optical micrographs of HUVEC and MCF-7 cell lines cultured on CH-PC surfaces showed that they form spheroids on CH-PC25 and CH-PC40 films.	[Qi, Baowen; Toita, Sayaka; Winnik, Francoise M.] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Qi, Baowen; Toita, Sayaka; Winnik, Francoise M.] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [Kujawa, Piotr; Beaune, Gregory; Winnik, Francoise M.] Natl Inst Mat Sci, World Premier Int WPI Res Ctr Initiat, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan	Winnik, FM (reprint author), Univ Montreal, Fac Pharm, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	francoise.winnik@umontreal.ca			World Premier International Research Center Initiative (WPI) MEXT, Japan; NIMS Internship Program; Chinese Scholarship Council (CSC)	The authors thank Dr. A. Badia (Universite de Montreal) for helpful discussions on SPR data analysis and Dr. J. Nakanishi (WPI-MANA) for providing access to cell biology equipment. The technical assistance of Dr. K. Iiyama (WPI-MANA) in the use of the AFM equipment is also acknowledged. This work was supported by the World Premier International Research Center Initiative (WPI) MEXT, Japan. B. Qi was supported by the NIMS Internship Program 2013 and a doctoral scholarship from the Chinese Scholarship Council (CSC).	Aggarwal N, 2013, MACROMOL BIOSCI, V13, P1327, DOI 10.1002/mabi.201300153; Tu TY, 2014, ADV HEALTHC MATER, V3, P609, DOI 10.1002/adhm.201300151; Meng S, 2007, CARBOHYD POLYM, V70, P82, DOI 10.1016/j.carbpol.2007.03.006; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Kitano H, 2005, MACROMOL BIOSCI, V5, P314, DOI 10.1002/mabi.200400212; Beaune G, 2014, P NATL ACAD SCI USA, V111, P8055, DOI 10.1073/pnas.1323788111; Tardif K, 2011, BIOMATERIALS, V32, P5046, DOI 10.1016/j.biomaterials.2011.04.002; Eisele NB, 2012, BIOMACROMOLECULES, V13, P2322, DOI 10.1021/bm300577s; Yang S, 2008, J BIOMED MATER RES A, V84A, P837, DOI 10.1002/jbm.a.31418; Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012; Bernard AB, 2012, TISSUE ENG PART C-ME, V18, P583, DOI [10.1089/ten.TEC.2011.0504, 10.1089/ten.tec.2011.0504]; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Schlenoff JB, 2014, LANGMUIR, V30, P9625, DOI 10.1021/la500057j; Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h; Cha C, 2012, ACS NANO, V6, P9353, DOI 10.1021/nn304773b; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196; Benien P, 2014, FUTURE ONCOL, V10, P1311, DOI 10.2217/fon.13.274; Cai LH, 2011, MACROMOLECULES, V44, P7853, DOI 10.1021/ma201583q; Chen YH, 2009, TISSUE ENG PT A, V15, P2001, DOI 10.1089/ten.tea.2008.0251; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; Cavallari G, 2007, TRANSPL P, V39, P2018, DOI 10.1016/j.transproceed.2007.05.016; Douezan S, 2012, SOFT MATTER, V8, P784, DOI 10.1039/c1sm06399e; Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001; Morisaku T, 2008, POLYMER, V49, P4652, DOI 10.1016/j.polymer.2008.08.025; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8; Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x; Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Kuijpers AJ, 2000, MACROMOLECULES, V33, P3705, DOI 10.1021/ma9917702; Badia A, 2013, SENSOR ACTUAT B-CHEM, V176, P736, DOI 10.1016/j.snb.2012.09.002; Bhang SH, 2012, TISSUE ENG PT A, V18, P310, DOI [10.1089/ten.TEA.2011.0193, 10.1089/ten.tea.2011.0193]; Ferry JD, 1980, VISCOELASTIC PROPERT; HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11; Hook F, 2007, SPRINGER SER CHEM SE, V5, P425, DOI 10.1007/5346_034; Hsu S.-H., 2010, J MED BIOL ENG, V32, P85; Hulander M, 2013, COLLOID SURFACE B, V110, P261, DOI 10.1016/j.colsurfb.2013.04.010; Kujawa P, 2013, LANGMUIR, V29, P7354, DOI 10.1021/la4014619; Levinger I, 2014, ADV CANCER RES, V121, P383, DOI 10.1016/B978-0-12-800249-0.00009-3; Ligler FS, 2001, LANGMUIR, V17, P5082, DOI 10.1021/la010148b; Martins V., 2010, MACROMOL BIOSCI, V10, P1444; Miao ZM, 2012, BIOMACROMOLECULES, V13, P4098, DOI 10.1021/bm301394w; Miyazawa K, 2002, MACROMOLECULES, V35, P9536, DOI 10.1021/ma021129r; Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002; Rubinstein M., 2003, POLYM PHYS; Stirbat TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052554; Tiera MJ, 2006, BIOMACROMOLECULES, V7, P3151, DOI 10.1021/bm060381u; Zhu AP, 2002, J BIOMAT SCI-POLYM E, V13, P501, DOI 10.1163/15685620260178364	51	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	APR	2015	15	4					490	500		10.1002/mabi.201400439		11	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	CF8LI	WOS:000352810800005		
J	Tanaka, T; Sasayama, S; Yamamoto, K; Kimura, Y; Kadokawa, J				Tanaka, Tomonari; Sasayama, Shota; Yamamoto, Kazuya; Kimura, Yoshiharu; Kadokawa, Jun-ichi			Evaluating Relative Chain Orientation of Amylose and Poly(L-lactide) in Inclusion Complexes Formed by Vine-Twining Polymerization Using Primer-Guest Conjugates	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						amylose; chain orientation; inclusion complex; polylactide; vine-twining polymerization	CATALYZED ENZYMATIC POLYMERIZATION; ALPHA-GLUCAN PHOSPHORYLASE; SELECTIVELY INCLUDES; SYNTHETIC-POLYMERS; HELICAL CHANNEL; POLYSACCHARIDES; POLYETHERS; BEHAVIOR; POLY(EPSILON-CAPROLACTONE); POLYTETRAHYDROFURAN	The relative chain orientation of amylose and poly(l-lactide) (PLLA) in inclusion complexes formed by phosphorylase-catalyzed enzymatic polymerization is made clear, by using primer-guest conjugates according to a vine-twining polymerization manner. The conjugates, which have a maltoheptaosyl moiety at COOH- or OH-terminus of poly(l- and d-lactide)s, are synthesized by copper(I)-catalyzed click chemistry using propargyl-terminated polylactides (PLAs) and maltoheptaosyl azide. The cavity of amylose includes PLLA, regardless of the chain orientation, when the conjugates composed of PLLA are used on the vine-twining polymerization. On the other hand, amylose-poly(d-lactide) (PDLA) diblock copolymers, which are noninclusion products, are produced when the conjugates composed of PDLA are used. X-ray diffraction (XRD) patterns of products and gel permeation chromatography (GPC) analyses of their alkaline hydrolysates strongly support that the amylose-PLLA inclusion supramolecular polymers are produced, probably owing to the same helical direction of amylose as that of PLLA, which is responsibly induced by its chirality, regardless of the chain orientation on complexation.	[Tanaka, Tomonari; Kimura, Yoshiharu] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan; [Sasayama, Shota; Yamamoto, Kazuya; Kadokawa, Jun-ichi] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan; [Kadokawa, Jun-ichi] Muroran Inst Technol, Res Ctr Environm Friendly Mat Engn, Muroran, Hokkaido 0508585, Japan	Tanaka, T (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan.	t-tanaka@kit.ac.jp; kadokawa@eng.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24350062]; Izumi Science and Technology Foundation	This work was financially supported by a Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 24350062) and a grant from Izumi Science and Technology Foundation. The authors acknowledge the gift of phosphorylase from Ezaki Glico Co. Ltd., Osaka, Japan.	Abhari S. A., 2014, STARCH, V66, P251; Ohdan K, 2006, BIOCATAL BIOTRANSFOR, V24, P77, DOI 10.1080/10242420600598152; Kobayashi S, 2009, CHEM REV, V109, P5288, DOI 10.1021/cr900165z; Shoda S, 2003, B CHEM SOC JPN, V76, P1, DOI 10.1246/bcsj.76.1; Seibel J, 2006, BIOCATAL BIOTRANSFOR, V24, P311, DOI 10.1080/10242420600986811; Kadokawa J, 2011, CHEM REV, V111, P4308, DOI 10.1021/cr100285v; Kaneko Y, 2011, MACROMOL BIOSCI, V11, P1407, DOI 10.1002/mabi.201100133; Yanase M, 2005, APPL ENVIRON MICROB, V71, P5433, DOI 10.1128/AEM.71.9.5433-5439.2005; Kadokawa J, 2010, CURR OPIN CHEM BIOL, V14, P145, DOI 10.1016/j.cbpa.2009.11.020; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35; ZIEGAST G, 1987, CARBOHYD RES, V160, P185, DOI 10.1016/0008-6215(87)80311-7; Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l; Fujii K, 2003, BIOCATAL BIOTRANSFOR, V21, P167, DOI 10.1080/1024240310001614379; Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A; DESANTIS P, 1968, BIOPOLYMERS, V6, P299, DOI 10.1002/bip.1968.360060305; Yanase M, 2006, J SCI FOOD AGR, V86, P1631, DOI 10.1002/jsfa.2513; Kobayashi S, 2005, MACROMOL SYMP, V226, P147, DOI 10.1002/masy.200550814; Kadokawa J, 2014, PURE APPL CHEM, V86, P701, DOI 10.1515/pac-2013-1116; Bhuiyan SH, 2003, J MOL CATAL B-ENZYM, V22, P173, DOI 10.1016/S1381-1177(03)00029-8; Braunmuhl V. V., 1995, MACROMOLECULES, V28, P17, DOI 10.1021/ma00105a003; Choi LS, 1998, MACROMOLECULES, V31, P9406, DOI 10.1021/ma981151d; Ikeda M, 2006, ANGEW CHEM INT EDIT, V45, P6491, DOI 10.1002/anie.200602134; Kadokawa Jun-Ichi, 2013, Biomolecules, V3, P369, DOI 10.3390/biom3030369; Kadokawa J, 2001, MACROMOLECULES, V34, P6536, DOI 10.1021/ma010606n; Kadokawa J, 2003, MACROMOL CHEM PHYSIC, V204, P1451, DOI 10.1002/macp.200350004; Kadokawa J, 2002, CHEM-EUR J, V8, P3321, DOI 10.1002/1521-3765(20020802)8:15<3321::AID-CHEM3321>3.0.CO;2-E; Kadokawa J, 2012, POLYMERS-BASEL, V4, P116, DOI 10.3390/polym4010116; Kadokawa J, 2001, CHEM COMMUN, P449, DOI 10.1039/b008180i; Kaneko Y, 2008, MACROMOLECULES, V41, P5665, DOI 10.1021/ma801002p; Kaneko Y, 2005, CHEM REC, V5, P36, DOI 10.1002/tcr.20031; Kaneko Y, 2007, BIOMACROMOLECULES, V8, P2983, DOI 10.1021/bm700670m; Kaneko Y, 2009, POLYM J, V41, P279, DOI 10.1295/polymj.PJ2008242; Kaneko Y, 2008, MACROMOL CHEM PHYSIC, V209, P1037, DOI 10.1002/macp.200800006; Kaneko Y, 2009, POLYM J, V41, P792, DOI 10.1295/polymj.PJ2009104; Kaneko Y, 2006, J BIOMAT SCI-POLYM E, V17, P1269, DOI 10.1163/156856206778667479; Kida T, 2007, CHEM COMMUN, P1559, DOI 10.1039/b616231b; Kim OK, 1996, J AM CHEM SOC, V118, P12220, DOI 10.1021/ja961890e; Kim OK, 2006, J AM CHEM SOC, V128, P4532, DOI 10.1021/ja060122c; Kobayashi S, 2006, ADV POLYM SCI, V194, P159, DOI 10.1007/12_032; Lalush I, 2005, BIOMACROMOLECULES, V6, P121, DOI 10.1021/bm049644f; Nomura S, 2011, POLYM J, V43, P971, DOI 10.1038/pj.2011.96; Rachmawati R, 2013, BIOMACROMOLECULES, V14, P575, DOI 10.1021/bm301994u; Rachmawati R, 2014, MACROMOL BIOSCI, V14, P56, DOI 10.1002/mabi.201300174; Rachmawati R, 2013, MACROMOL BIOSCI, V13, P767, DOI 10.1002/mabi.201300022; Sanji T, 2006, MACROMOLECULES, V39, P7508, DOI 10.1021/ma061791d; Sanji T, 2005, ANGEW CHEM INT EDIT, V44, P7301, DOI 10.1002/anie.200502073; Sanji T, 2006, ORG LETT, V8, P235, DOI 10.1021/ol052494g; SHOGREN RL, 1991, J APPL POLYM SCI, V42, P1701, DOI 10.1002/app.1991.070420625; SHOGREN RL, 1993, CARBOHYD POLYM, V22, P93, DOI 10.1016/0144-8617(93)90071-B; Tanaka T, 2013, CHEM LETT, V42, P197, DOI 10.1246/cl.2013.197; Tanaka T, 2013, MACROMOL CHEM PHYS, V214, P2829, DOI 10.1002/macp.201300525; Tanaka T., 2009, CHEM COMMUN, P378	52	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	APR	2015	216	7					794	800		10.1002/macp.201400603		7	Polymer Science	Polymer Science	CF5DP	WOS:000352576100010		
J	Tsuji, H; Sugimoto, S				Tsuji, Hideto; Sugimoto, Shinya			Accelerated Stereocomplex Crystallization of Poly(L-lactide)/Poly(D-lactide) Blends by Long Terminal Linear Alkyl Groups	MACROMOLECULAR MATERIALS AND ENGINEERING			English	Article						blends; crystallization; nucleation; poly(lactic acid); stereocomplex	POLY(L-LACTIC ACID) CRYSTALLIZATION; NONISOTHERMAL CRYSTALLIZATION; POLY(D-LACTIC ACID); MOLECULAR-WEIGHT; THERMAL-PROPERTIES; SPHERULITE GROWTH; POLY(LACTIC ACID); NUCLEATING-AGENT; PHASE-CHANGE; MELT	The accelerating effect of terminal n-alkyl groups (TAGs) on the non-isothermal crystallization of poly(L-lactide)/poly(D-lactide) blends increased with TAG length in the low temperature range below 100 degrees C and that on isothermal stereocomplex crystallization of poly(L-lactide)/poly(D-lactide) blends became maximal at terminal n-hexyl group in the high temperature range above 165 degrees C. However, the decelerating effect on isothermal stereocomplex crystallization was observed for terminal n-docosyl group in the high temperature range above 165 degrees C. The TAG length did not alter the crystallite growth morphology during non-isothermal crystallization, the formed crystalline species (only stereocomplex crystallites) and the crystallite growth mechanism during isothermal crystallization.	[Tsuji, Hideto; Sugimoto, Shinya] Toyohashi Univ Technol, Grad Sch Engn, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Tsuji, H (reprint author), Toyohashi Univ Technol, Grad Sch Engn, Dept Environm & Life Sci, Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	tsuji@ens.tut.ac.jp			JSPS KAKANHI [24550251]	This research was supported by JSPS KAKANHI Grant Number 24550251.	Tsuji H, 2008, POLYMER, V49, P1385, DOI 10.1016/j.polymer.2008.01.029; TSUJI H, 1995, POLYMER, V36, P2709, DOI 10.1016/0032-3861(95)93647-5; Narita J, 2013, POLYM INT, V62, P936, DOI 10.1002/pi.4381; Chow WS, 2009, J THERM ANAL CALORIM, V95, P627, DOI 10.1007/s10973-007-8975-x; HOFFMAN JD, 1975, J RES NBS A PHYS CH, V79, P671, DOI 10.6028/jres.079A.026; BROCHU S, 1995, MACROMOLECULES, V28, P5230, DOI 10.1021/ma00119a010; Tsuji H, 2014, POLYMER, V55, P4786, DOI 10.1016/j.polymer.2014.07.012; Fukushima K, 2010, POLYM DEGRAD STABIL, V95, P1063, DOI 10.1016/j.polymdegradstab.2010.02.029; Krikorian V, 2004, MACROMOLECULES, V37, P6480, DOI 10.1021/ma049283w; Lewitus D, 2006, J POLYM ENVIRON, V14, P171, DOI 10.1007/s10924-006-0007-6; Tsuji H, 2004, BIOMACROMOLECULES, V5, P1181, DOI 10.1021/bm049835i; Lee JH, 2003, BIOMATERIALS, V24, P2773, DOI 10.1016/S0142-9612(03)00080-2; Narita J, 2013, MACROMOL MATER ENG, V298, P270, DOI 10.1002/mame.201200060; Tsuji H, 2005, BIOMACROMOLECULES, V6, P244, DOI 10.1021/bm049552q; Papageorgiou GZ, 2010, THERMOCHIM ACTA, V511, P129, DOI 10.1016/j.tca.2010.08.004; IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034; Urayama H, 2003, POLYMER, V44, P5635, DOI 10.1016/S0032-3861(03)00583-4; FLORY PJ, 1949, J CHEM PHYS, V17, P223, DOI 10.1063/1.1747230; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; VERT M, 1995, J MACROMOL SCI PURE, VA32, P787, DOI 10.1080/10601329508010289; Fukushima K, 2006, POLYM INT, V55, P626, DOI 10.1002/pi.2010; Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872; Narita J, 2011, MACROMOL MATER ENG, V296, P887, DOI 10.1002/mame.201100024; Ke TY, 2003, J APPL POLYM SCI, V89, P1203, DOI 10.1002/app.12162; Schmidt SC, 2001, J POLYM SCI POL PHYS, V39, P300, DOI 10.1002/1099-0488(20010201)39:3<300::AID-POLB1002>3.0.CO;2-M; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6; Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435; Ray SS, 2003, J NANOSCI NANOTECHNO, V3, P503, DOI 10.1166/jnn.2003.220; Tsuji H, 1996, MACROMOL CHEM PHYSIC, V197, P3483, DOI 10.1002/macp.1996.021971033; Tsuji H, 2006, MACROMOL MATER ENG, V291, P325, DOI 10.1002/mame.200500371; Yamane H, 2003, POLYMER, V44, P2569, DOI 10.1016/S0032-3861(03)00092-2; Tsuji H, 2006, POLYMER, V47, P3826, DOI 10.1016/j.polymer.2006.03.074; Thakur KAM, 1996, MACROMOLECULES, V29, P8844, DOI 10.1021/ma960828z; OKIHARA T, 1991, J MACROMOL SCI PHYS, VB30, P119, DOI 10.1080/00222349108245788; Nam PH, 2006, POLYM ENG SCI, V46, P39, DOI 10.1002/pen.20436; Tsuji H, 2005, MACROMOL BIOSCI, V5, P569, DOI 10.1002/mabi.200500062; Slager J, 2003, ADV DRUG DELIVER REV, V55, P549, DOI 10.1016/S0169-409X(03)00042-5; FOX TG, 1955, J POLYM SCI, V15, P371, DOI 10.1002/pol.1955.120158006; Anderson KS, 2006, POLYMER, V47, P2030, DOI 10.1016/j.polymer.2006.01.062; Baez JE, 2011, J POLYM RES, V18, P1137, DOI 10.1007/s10965-010-9517-y; Tsuji H, 2008, MACROMOL MATER ENG, V293, P947, DOI 10.1002/mame.200800217; Auras R, 2010, WILEY SERIES POLYM E; Avrami M., 1940, Journal of Chemical Physics, V8, DOI 10.1063/1.1750631; Di Lorenzo A. T., 2007, POLYM TEST, V26, P222; Gedde U. W., 1995, POLYM PHYSICS, P170; Hartmann M. H., 1998, BIOPOLYMERS RENEWABL, P367; Hoffman J. D., 1976, TREATISE SOLID STATE, V3; KHARAS GB, 1994, PLASTICS MICROBES, P93; Mandelkern L., 1964, CRYSTALLIZATION POLY; Ogata N., 1997, J POLYM SCI B, V35, P38; Tsuji H., 2014, WILEY SERIES RENEWAB, P171; Young R. J., 1991, INTRO POLYM, P241	52	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1438-7492	1439-2054		MACROMOL MATER ENG	Macromol. Mater. Eng.	APR	2015	300	4					391	402		10.1002/mame.201400401		12	Materials Science, Multidisciplinary; Polymer Science	Materials Science; Polymer Science	CF6DD	WOS:000352646000002		
J	Sun, Y; Finne-Wistrand, A; Waag, T; Xing, Z; Yassin, M; Yamamoto, A; Mustafa, K; Steinmuller-Nethl, D; Krueger, A; Albertsson, AC				Sun, Yang; Finne-Wistrand, Anna; Waag, Thilo; Xing, Zhe; Yassin, Mohamed; Yamamoto, Akihito; Mustafa, Kamal; Steinmueller-Nethl, Doris; Krueger, Anke; Albertsson, Ann-Christine			Reinforced Degradable Biocomposite by Homogenously Distributed Functionalized Nanodiamond Particles	MACROMOLECULAR MATERIALS AND ENGINEERING			English	Article						composites; reinforcement; grafting from; nanodiamond; polylactide	MARROW STROMAL CELLS; MECHANICAL-PROPERTIES; DETONATION NANODIAMOND; EPOXY COMPOSITES; SCAFFOLDS; DIFFERENTIATION; NANOCOMPOSITES; DELIVERY; CARRIERS; DIAMOND	Severe phase separation was observed in blending nanodiamond particle (n-DP) in poly (L-lactide-co-e-caprolactone) (poly(LLA-co-CL)) scaffold. In this study we optimized the scaffold by the addition of 1-50% (w/w) polylactide modified n-DP (n-DP-PLA) or benzoquinone-modified n-DP (n-DP-BQ). Composed by 10% n-DP-PLA, composite had 6 times higher E-modulus in tensile test, whereas the maximum reinforcement can be higher than 15 times. However, n-DP-BQ composites conserved the mechanical properties, and thermal properties of the polymer substrate. The attachment, spreading and growth of UE7T13 cells on modified n-DP composites were similar to poly(LLA-co-CL), and independent to n-DP concentrations. In summary, a proper modified n-DP is the key to reinforce poly(LLA-co-CL) for tissue engineering.	[Sun, Yang; Finne-Wistrand, Anna; Albertsson, Ann-Christine] Royal Inst Technol, KTH, Sch Chem Sci & Engn, Fibre & Polymer Technol, S-10044 Stockholm, Sweden; [Waag, Thilo; Krueger, Anke] Univ Wurzburg, Inst Organ Chem, D-97074 Wurzburg, Germany; [Xing, Zhe; Yassin, Mohamed; Mustafa, Kamal] Univ Bergen, Ctr Clin Dent Res, Dept Clin Dent, N-5009 Bergen, Norway; [Yamamoto, Akihito] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Steinmueller-Nethl, Doris] DiaCoating GmbH, A-6020 Innsbruck, Austria	Albertsson, AC (reprint author), Royal Inst Technol, KTH, Sch Chem Sci & Engn, Fibre & Polymer Technol, Teknikringen 56-58, S-10044 Stockholm, Sweden.	aila@kth.se			Deutsche Forschungsgemeinschaft [KR3316/1-2]; European Commission (FP7 Health project Vascubone) [242175]	Dr. Michele Fox (University of Arkansas For Medical Sciences) is gratefully acknowledged for the language correction and helpful discussions. This research is supported by the Deutsche Forschungsgemeinschaft (KR3316/1-2) and the European Commission (FP7 Health project Vascubone, contract number 242175).	Morimune S, 2011, MACROMOLECULES, V44, P4415, DOI 10.1021/ma200176r; Sun Y, 2014, BIOMACROMOLECULES, V15, P1259, DOI 10.1021/bm401818e; Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Zhao YQ, 2010, COMPOS PART B-ENG, V41, P646, DOI 10.1016/j.compositesb.2010.09.003; FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927; Martinez-Vazquez FJ, 2010, ACTA BIOMATER, V6, P4361, DOI 10.1016/j.actbio.2010.05.024; Ciprari D, 2006, MACROMOLECULES, V39, P6565, DOI 10.1021/ma0602270; Xing Z, 2013, TISSUE ENG PT A, V19, P1783, DOI [10.1089/ten.TEA.2012.0336, 10.1089/ten.tea.2012.0336]; d'Almeida JRM, 2007, J REINF PLAST COMP, V26, P321, DOI 10.1177/0731684407072516; Ozawa M, 2007, ADV MATER, V19, P1201, DOI 10.1002/adma.200601452; Plikk P, 2009, BIOMACROMOLECULES, V10, P1259, DOI 10.1021/bm900093r; Korobko AP, 2007, DIAM RELAT MATER, V16, P2141, DOI 10.1016/j.diamond.2007.07.021; Moore L, 2013, J DENT RES, V92, P976, DOI 10.1177/0022034513504952; Zhang QW, 2011, BIOMATERIALS, V32, P87, DOI 10.1016/j.biomaterials.2010.08.090; Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005; Choi NS, 2002, J APPL POLYM SCI, V86, P1892, DOI 10.1002/app.11134; Ishimine H, 2013, BIOCHEM BIOPH RES CO, V438, P753, DOI 10.1016/j.bbrc.2013.07.081; Krueger A, 2012, ADV FUNCT MATER, V22, P890, DOI 10.1002/adfm.201102670; Krueger A, 2008, DIAM RELAT MATER, V17, P1367, DOI 10.1016/j.diamond.2008.01.033; Hsin YL, 2011, J MATER CHEM, V21, P13213, DOI 10.1039/c1jm10903k; Neitzel I, 2012, POLYMER, V53, P5965, DOI 10.1016/j.polymer.2012.10.037; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Krueger A, 2011, J MATER CHEM, V21, P12571, DOI 10.1039/c1jm11674f; Purtov KV, 2010, NANOSCALE RES LETT, V5, P631, DOI 10.1007/s11671-010-9526-0; Danmark S, 2010, J BIOACT COMPAT POL, V25, P207, DOI 10.1177/0883911509358812; Kruger A, 2005, CARBON, V43, P1722, DOI 10.1016/j.carbon.2005.02.020; BRANDT J, 1975, BIOCHIM BIOPHYS ACTA, V386, P196, DOI 10.1016/0005-2795(75)90259-7; Gupta B, 2012, J APPL POLYM SCI, V123, P1944, DOI 10.1002/app.34728; Mateescu M.-A., 1990, BIOL MET, V3, P98, DOI 10.1007/BF01179513; Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/nnano.2011.209, 10.1038/NNANO.2011.209]; Pedersen TO, 2014, CURR STEM CELL RES T, V5, P23; Steinmuller-Nethl D, 2006, BIOMATERIALS, V27, P4547, DOI 10.1016/j.biomaterials.2006.04.036; Suliman S, 2015, J CONTROL RELEASE, V197, P148, DOI 10.1016/j.jconrel.2014.11.003; Sun Y, 2015, PART PART SYST CHAR, V32, P35, DOI 10.1002/ppsc.201400098; Sun Y, 2012, J BIOMED MATER RES A, V100A, P2739, DOI 10.1002/jbm.a.34210	35	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1438-7492	1439-2054		MACROMOL MATER ENG	Macromol. Mater. Eng.	APR	2015	300	4					436	447		10.1002/mame.201400387		12	Materials Science, Multidisciplinary; Polymer Science	Materials Science; Polymer Science	CF6DD	WOS:000352646000006		
J	Imaoka, T; Bukeo, N; Yamamoto, K				Imaoka, Takane; Bukeo, Noriko; Yamamoto, Kimihisa			A Self-Assembling Dendritic Reactor: Versatile Formation of Characteristic Patterns with Nanoscale Dimension	MACROMOLECULAR RAPID COMMUNICATIONS			English	Article						dendrimers; nanoscale; patterning; reactors; self-assembly	FINGERING INSTABILITY; METALLOPORPHYRIN CORE; DENDRIMERS; FILMS; CLUSTERS; DENDRON; MICA; SIZE	Spherical dendrimers with phenylazomethine backbones are modified onto atomically flat mica or graphite substrates with a simple solvent based spin-coating method, and the resulting surfaces are observed by atomic force microscopy. Especially on the mica substrate, dendrimers form very fine and highly regular patterns with aligned nano-dot arrays and lines. An important observation is that the interval of each dot or line is approximate to 400 nm whereas previously reported self-assembling patterns exhibit longer intervals than 5 m. It is revealed that spherical dendrimers with relatively low intermolecular interactions without any terminal modifications are suitable for the fine self-assembling pattern formation. This fact suggests that the regular pattern arises from a physical dissipative structure formation due to a fingering instability induced by Marangoni convection but not by anisotropic intermolecular interactions.	[Imaoka, Takane; Bukeo, Noriko; Yamamoto, Kimihisa] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan	Yamamoto, K (reprint author), Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan.	yamamoto@res.titech.ac.jp	Imaoka, Takane/E-5450-2014	Imaoka, Takane/0000-0001-9023-2080	CREST program of the Japan Science and Technology (JST) Agency; JSPS KAKENHI [25410086, 24350116]	This work was supported in part by the CREST program of the Japan Science and Technology (JST) Agency, and JSPS KAKENHI Grant Nos. 25410086 and 24350116.	Kato T, 2006, ANGEW CHEM INT EDIT, V45, P38, DOI 10.1002/anie.200501384; Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q; Pang XC, 2013, NAT NANOTECHNOL, V8, P426, DOI [10.1038/nnano.2013.85, 10.1038/NNANO.2013.85]; Yamamoto K, 2014, ACCOUNTS CHEM RES, V47, P1127, DOI 10.1021/ar400257s; Yamamoto K, 2009, NAT CHEM, V1, P397, DOI [10.1038/nchem.288, 10.1038/NCHEM.288]; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Lin Y, 2005, NATURE, V434, P55, DOI 10.1038/nature03310; Shi ZL, 2009, J AM CHEM SOC, V131, P5376, DOI 10.1021/ja900499b; Nishihara H, 2014, CHEM LETT, V43, P388, DOI 10.1246/cl.140010; Han W, 2012, ANGEW CHEM INT EDIT, V51, P1534, DOI 10.1002/anie.201104454; Feng CW, 2014, CHEM MATER, V26, P6058, DOI 10.1021/cm503108z; Imaoka T, 2013, J AM CHEM SOC, V135, P13089, DOI 10.1021/ja405922m; Cai Y, 2008, J AM CHEM SOC, V130, P6076, DOI 10.1021/ja801438u; TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381; Tomalia DA, 2009, J NANOPART RES, V11, P1251, DOI 10.1007/s11051-009-9632-z; CAZABAT AM, 1990, NATURE, V346, P824, DOI 10.1038/346824a0; Coen MC, 1996, MACROMOLECULES, V29, P8069, DOI 10.1021/ma951545u; Imaoka T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3581; Imaoka T, 2005, J AM CHEM SOC, V127, P13896, DOI 10.1021/ja0524797; Karthaus O, 1998, THIN SOLID FILMS, V327, P829, DOI 10.1016/S0040-6090(98)00771-8; Karthaus O, 1996, CHEM LETT, P821, DOI 10.1246/cl.1996.821; Kimoto A, 2004, MACROMOLECULES, V37, P5531, DOI 10.1021/ma0499674; Larson RG, 2012, ANGEW CHEM INT EDIT, V51, P2546, DOI 10.1002/anie.201108008; Madueno R, 2008, NATURE, V454, P618, DOI 10.1038/nature07096; Pollak KW, 1998, CHEM MATER, V10, P30, DOI 10.1021/cm970312+; Tanaka H, 2003, LANGMUIR, V19, P3103, DOI 10.1021/la027076o; Tao AR, 2008, ACCOUNTS CHEM RES, V41, P1662, DOI 10.1021/ar8000525; TROIAN SM, 1989, PHYS REV LETT, V62, P1496, DOI 10.1103/PhysRevLett.62.1496; Uemura S, 2009, ANGEW CHEM INT EDIT, V48, P7825, DOI 10.1002/anie.200902801	29	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1336	1521-3927		MACROMOL RAPID COMM	Macromol. Rapid Commun.	APR	2015	36	7			SI		616	620		10.1002/marc.201400655		5	Polymer Science	Polymer Science	CF5DF	WOS:000352575000006		
J	Matsumura, Y; Fukuda, K; Inagi, S; Tomita, I				Matsumura, Yoshimasa; Fukuda, Katsura; Inagi, Shinsuke; Tomita, Ikuyoshi			Parallel Synthesis of Photoluminescent pi-Conjugated Polymers by Polymer Reactions of an Organotitanium Polymer with a Titanacyclopentadiene Unit	MACROMOLECULAR RAPID COMMUNICATIONS			English	Article						elements-containing -conjugated polymers; organometallic polymers; parallel synthesis; photoluminescence; polymer reactions	FLUORENE-BASED COPOLYMERS; LIGHT-EMITTING-DIODES; ORGANIC SOLAR-CELLS; MAIN-CHAIN; ORGANOMETALLIC POLYMERS; ORGANOCOBALT POLYMERS; COBALTACYCLOPENTADIENE MOIETIES; POLARIZED ELECTROLUMINESCENCE; ALTERNATING FLUORENE; TRANSFORMATION	A regioregular organometallic polymer with titanacyclopentadiene unit, obtained by the reaction of a 2,7-diethynylfluorene derivative and a low-valent titanium complex, is subjected to the reaction with three kinds of electrophiles (i.e., sulfur monochloride, hydrochloric acid, and dichlorophenylphosphine) to give -conjugated polymers possessing both fluorene and building blocks originated from the transformation of the titanacycles in the main chain. For example, a phosphole-containing polymer whose number-average molecular weight is estimated as 5000 is obtained in 50% yield. The obtained thiophene, butadiene, and phosphole-containing polymers exhibit efficient photoluminescence (PL) with emission colors of blue, green, and yellow, respectively. For example, the phosphole-containing polymer exhibits yellow PL with an emission maximum (E-max) of 533 nm and a quantum yield (phi) of 0.37.	[Matsumura, Yoshimasa; Fukuda, Katsura; Inagi, Shinsuke; Tomita, Ikuyoshi] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Tomita, I (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, Nagatsuta Cho 4259-G1-9, Yokohama, Kanagawa 2268502, Japan.	tomita@echem.titech.ac.jp	Inagi, Shinsuke/F-4552-2010	Inagi, Shinsuke/0000-0002-9867-1210	Ministry of Education, Culture, Sports, Science, and Technology, Japan [2401, 24102007]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks (No.2401)" (24102007) of The Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors are grateful to Prof. Ryoji Kanno, Prof. Masaaki Hirayama, and Mr. Michihiro Yamamoto in their department for their kind assistance in X-ray diffraction analyses.	Pei QB, 1996, J AM CHEM SOC, V118, P7416, DOI 10.1021/ja9615233; OHMORI Y, 1991, JPN J APPL PHYS 2, V30, pL1941; Hou Q, 2002, J MATER CHEM, V12, P2887, DOI 10.1039/b203862e; Matsumura Y, 2015, ACS MACRO LETT, V4, P124, DOI 10.1021/mz500693r; Nishiyama H, 2012, MACROMOL RAPID COMM, V33, P545, DOI 10.1002/marc.201100751; Kularatne RS, 2013, J POLYM SCI POL CHEM, V51, P743, DOI 10.1002/pola.26425; Hamada T, 1999, J AM CHEM SOC, V121, P7342, DOI 10.1021/ja9905694; Grimsdale AC, 2009, CHEM REV, V109, P897, DOI 10.1021/cr000013v; Grell M, 1997, ADV MATER, V9, P798, DOI 10.1002/adma.19970091006; Wang F, 2005, MACROMOLECULES, V38, P2253, DOI 10.1021/ma047561l; Yamaguchi S, 1998, J ORG CHEM, V63, P10060, DOI 10.1021/jo981533h; Maji MS, 2010, CHEM-EUR J, V16, P5872, DOI 10.1002/chem.201000236; Kreyenschmidt M, 1998, MACROMOLECULES, V31, P1099, DOI 10.1021/ma970914e; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Grell M, 1999, ADV MATER, V11, P671, DOI 10.1002/(SICI)1521-4095(199906)11:8<671::AID-ADMA671>3.0.CO;2-E; Ranger M, 1997, MACROMOLECULES, V30, P7686, DOI 10.1021/ma970920a; Atami K, 2009, SYNTHETIC MET, V159, P949, DOI 10.1016/j.synthmet.2009.02.003; Bouillud A. D., 2000, CHEM MATER, V12, P1931; Cho NS, 2004, MACROMOLECULES, V37, P5265, DOI 10.1021/ma049728g; FUKUDA M, 1989, JPN J APPL PHYS 2, V28, pL1433; Kino T, 2010, APPL ORGANOMET CHEM, V24, P558, DOI 10.1002/aoc.1593; Lee J, 2007, J POLYM SCI POL CHEM, V45, P1236, DOI 10.1002/pola.21890; Lee JC, 1997, MACROMOLECULES, V30, P5205, DOI 10.1021/ma961739p; Lee SH, 2001, ORG LETT, V3, P2005, DOI 10.1021/ol010069r; Lin HC, 2005, POLYMER, V46, P9810, DOI 10.1016/j.polymer.2005.07.075; Liu B, 2002, SYNTHETIC MET, V129, P129, DOI 10.1016/S0379-6779(02)00014-0; Lu S, 2002, THIN SOLID FILMS, V417, P215, DOI 10.1016/S0040-6090(02)00577-1; McQuade DT, 2000, CHEM REV, V100, P2537, DOI 10.1021/cr9801014; Nishiyama H., 2010, MACROMOL CHEM PHYS, V20, P2248; Rozhanskii IL, 1996, MACROMOLECULES, V29, P1934, DOI 10.1021/ma951180d; Cho HN, 1999, MACROMOLECULES, V32, P1476, DOI 10.1021/ma981340w; Tomita I, 1998, APPL ORGANOMET CHEM, V12, P735, DOI 10.1002/(SICI)1099-0739(199810/11)12:10/11<735::AID-AOC780>3.0.CO;2-L; Tomita I, 2005, J INORG ORGANOMET P, V15, P511, DOI 10.1007/s10904-006-9005-3; TOMITA I, 1994, MACROMOLECULES, V27, P7009, DOI 10.1021/ma00101a050; Tomita I., 2007, ACS POLYM PREPR, V48, P652; TOMITA I, 1993, POLYM BULL, V30, P179, DOI 10.1007/BF00296847; TOMITA I, 1995, MACROMOLECULES, V28, P3042, DOI 10.1021/ma00113a005; Tomita I, 2000, J ORGANOMET CHEM, V611, P570, DOI 10.1016/S0022-328X(00)00393-4; Zhou WM, 2008, POLYM BULL, V61, P603, DOI 10.1007/s00289-008-0990-y	39	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1336	1521-3927		MACROMOL RAPID COMM	Macromol. Rapid Commun.	APR	2015	36	7			SI		660	664		10.1002/marc.201400667		5	Polymer Science	Polymer Science	CF5DF	WOS:000352575000013		
J	Jeoung, E; Yeh, YC; Nelson, T; Kushida, T; Wang, LS; Mout, R; Li, XN; Saha, K; Gupta, A; Tonga, GY; Lannutti, JJ; Rotello, VM				Jeoung, Eunhee; Yeh, Yi-Cheun; Nelson, Tyler; Kushida, Takashi; Wang, Li-Sheng; Mout, Rubul; Li, Xiaoning; Saha, Krishnendu; Gupta, Akash; Tonga, Guelen Y.; Lannutti, John J.; Rotello, Vincent M.			Fabrication of Functional Nanofibers Through Post-Nanoparticle Functionalization	MACROMOLECULAR RAPID COMMUNICATIONS			English	Article						dithiocarbamate; immobilization; nanofibers; nanoparticles; supramolecular structures	GOLD NANOPARTICLES; SURFACE MODIFICATION; QUANTUM DOTS; ELECTROSPUN NANOFIBERS; GRAFT-POLYMERIZATION; METAL NANOPARTICLES; PLASMA TREATMENT; FIBERS; COMPOSITE; CELLS	A facile method is developed to functionalize nanofiber surfaces with nanoparticles (NPs) through dithiocarbamate chemistry. Gold nanoparticles (AuNPs) and quantum dots (QDs) are immobilized on the nanofiber surface. These surfaces provide scaffolds for further supramolecular functionalization, as demonstrated through the Forster resonance energy transfer (FRET) pairing of QD-decorated fibers and fluorescent proteins.	[Jeoung, Eunhee; Yeh, Yi-Cheun; Kushida, Takashi; Wang, Li-Sheng; Mout, Rubul; Li, Xiaoning; Saha, Krishnendu; Gupta, Akash; Tonga, Guelen Y.; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Jeoung, Eunhee] Gangneung Wonju Natl Univ, Dept Chem, Kangnung, Gangwon Do, South Korea; [Nelson, Tyler; Lannutti, John J.] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA; [Kushida, Takashi] Teijin Ltd, Integrat Technol Res Inst, Hino, Tokyo 1918512, Japan	Lannutti, JJ (reprint author), Ohio State Univ, Dept Mat Sci & Engn, 116 W 19Th Ave, Columbus, OH 43210 USA.	lannutti.1@osu.edu; rotello@chem.umass.edu	Saha, Krishnendu/K-1209-2012		NIH [GM077173]; Center for Hierarchical Manufacturing (NSF) [DMI-0531171]	E.J. and Y.-C.Y. contributed equally to this work. This work was supported in part by a grant from the NIH (GM077173, V.M.R) and through the Center for Hierarchical Manufacturing (NSF Grant DMI-0531171). E.J. acknowledges the academic research development grant of Gangneung-Wonju National University (2011).	Sapsford KE, 2006, ANGEW CHEM INT EDIT, V45, P4562, DOI 10.1002/anie.200503873; Dubois F, 2007, J AM CHEM SOC, V129, P482, DOI 10.1021/ja067742y; Jiang XS, 2011, INTERFACE FOCUS, V1, P725, DOI 10.1098/rsfs.2011.0033; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; Dong H, 2006, CHEM MATER, V18, P2008, DOI 10.1021/cm052436p; Hocker H, 2002, PURE APPL CHEM, V74, P423, DOI 10.1351/pac200274030423; Zhao Y, 2005, J AM CHEM SOC, V127, P7328, DOI 10.1021/ja050432f; Hu DM, 2014, J MATER CHEM A, V2, P2323, DOI 10.1039/c3ta13966b; He XL, 2012, J MATER CHEM, V22, P18471, DOI 10.1039/c2jm33078d; Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y; Schaub TF, 1996, MACROMOLECULES, V29, P3982, DOI 10.1021/ma9510810; He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574; Dong H, 2008, CHEM MATER, V20, P6627, DOI 10.1021/cm801077p; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Rana S, 2015, NAT NANOTECHNOL, V10, P65, DOI [10.1038/nnano.2014.285, 10.1038/NNANO.2014.285]; Wang HM, 2013, CHEM COMMUN, V49, P5568, DOI 10.1039/c3cc41753k; Gill RS, 2013, ACS APPL MATER INTER, V5, P9949, DOI 10.1021/am401864j; Zhang D, 2009, POLYMER, V50, P4189, DOI 10.1016/j.polymer.2009.06.062; Yeh YC, 2013, NANOSCALE, V5, P12140, DOI 10.1039/c3nr04037b; Agarwal S, 2013, PROG POLYM SCI, V38, P963, DOI 10.1016/j.progpolymsci.2013.02.001; Persano L, 2015, PROG POLYM SCI, V43, P48, DOI 10.1016/j.progpolymsci.2014.10.001; Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007; Uzun SD, 2014, ACS APPL MATER INTER, V6, P5235, DOI 10.1021/am5005927; Yang SY, 2011, J AM CHEM SOC, V133, P8412, DOI 10.1021/ja201194d; Fang X, 2011, J MATER CHEM, V21, P4493, DOI 10.1039/c0jm03987j; Duwez AS, 2006, MACROMOLECULES, V39, P2729, DOI 10.1021/ma0602829; Yuan XY, 2003, POLYM DEGRAD STABIL, V79, P45, DOI 10.1016/S0141-3910(02)00237-9; Clapp AR, 2006, CHEMPHYSCHEM, V7, P47, DOI 10.1002/cphc.200500217; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Carroll P., 2010, PLOS ONE, V23, pe9823; Jiang Y.S., 2014, ANGEW CHEM INT EDIT, V53, P1; Kim T, 2014, NANOSCALE, V6, P2847, DOI 10.1039/c3nr05538h; Kou RQ, 2003, LANGMUIR, V19, P6869, DOI 10.1021/la0345486; LADIZESKY NH, 1995, J MATER SCI-MATER M, V6, P497, DOI 10.1007/BF00151029; MORI M, 1994, J POLYM SCI POL CHEM, V32, P1683, DOI 10.1002/pola.1994.080320910; Nandwana V, 2013, J INORG ORGANOMET P, V23, P227, DOI 10.1007/s10904-012-9772-y; Park MH, 2008, ADV MATER, V20, P4185, DOI 10.1002/adma.200801155; Shi Q, 2013, J APPL POLYM SCI, V128, P1219, DOI 10.1002/app.38465; Tang R, 2014, ADV MATER, V26, P3310, DOI 10.1002/adma.201306030; Yang X. C., 2011, ANGEW CHEM, V123, P497, DOI 10.1002/ange.201005662; Yeh YC, 2014, ANGEW CHEM INT EDIT, V53, P5137, DOI 10.1002/anie.201400559	41	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1336	1521-3927		MACROMOL RAPID COMM	Macromol. Rapid Commun.	APR	2015	36	7			SI		678	683		10.1002/marc.201400744		6	Polymer Science	Polymer Science	CF5DF	WOS:000352575000016		
J	Tanaka, K; Hirose, A; Tamashima, K; Chujo, Y				Tanaka, Kazuo; Hirose, Amane; Tamashima, Kenji; Chujo, Yoshiki			Synthesis of a Platinum Diketonate-Containing Polymer Showing Oxygen-Resistant Phosphorescence	MACROMOLECULAR RAPID COMMUNICATIONS			English	Article						platinum complexes; diketonate; oxygen; conjugated polymers	LIGHT-EMITTING DEVICES; AGGREGATION-INDUCED EMISSION; CRYSTALLIZATION-INDUCED EMISSION; CONJUGATED POLYMERS; OPTICAL-PROPERTIES; DISSOLVED-OXYGEN; MAIN-CHAIN; COMPLEXES; BORON; EFFICIENT	The synthesis of a platinum diketonate-based alternating copolymer containing a fluorene unit and its oxygen-resistant phosphorescence are reported. The polymerization is executed via palladium-catalyzed Suzuki-Miyaura coupling reaction. The synthesized polymer shows good solubility in common organic solvents and processability to form homogeneous films. By optical measurements it is found that the synthesized polymer shows phosphorescence from a triplet -* ligand-centered transition, and interestingly, the emission is hardly influenced by oxygen. Phosphorescence is observed from both solution and film samples under aerobic conditions. The new idea of obtaining emissive materials based on conjugated polymers showing oxygen-resistant phosphorescence is presented here.	[Tanaka, Kazuo; Hirose, Amane; Tamashima, Kenji; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan	Tanaka, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	kazuo123@chujo.synchem.kyoto-u.ac.jp; chujo@chujo.synchem.kyoto-u.ac.jp			JFE 21st Century Foundation; Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology, Japan [2401, 24102013]	This work was partially supported by the JFE 21st Century Foundation (for K.T.) "the Adaptable and Seamless Technology Transfer Program" through target-driven R&D, Japan Science and Technology Agency (JST) and a Grant-in-Aid for Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks (No. 2401)" (24102013) of The Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Park EJ, 2005, J MATER CHEM, V15, P2913, DOI 10.1039/b502981c; Yoshii R, 2014, J AM CHEM SOC, V136, P18131, DOI 10.1021/ja510985v; Amao Y, 2003, MICROCHIM ACTA, V143, P1, DOI 10.1007/s00604-003-0037-x; Shigehiro T, 2013, J PHYS CHEM C, V117, P532, DOI 10.1021/jp307853t; Jimenez-Cadena G, 2007, ANALYST, V132, P1083, DOI 10.1039/b704562j; Zhou GJ, 2010, J PHOTOCH PHOTOBIO C, V11, P133, DOI 10.1016/j.jphotochemrev.2011.01.001; Yeo H, 2012, J POLYM SCI POL CHEM, V50, P4433, DOI 10.1002/pola.26249; Kappaun S, 2008, INT J MOL SCI, V9, P1527, DOI 10.3390/ijms9081527; Yoshii R, 2014, MACROMOLECULES, V47, P2268, DOI 10.1021/ma500082e; Yeo H, 2015, POLYMER, V60, P228, DOI 10.1016/j.polymer.2015.01.056; Duan PF, 2015, J AM CHEM SOC, V137, P1887, DOI 10.1021/ja511061h; Lu X, 2001, CHEM MATER, V13, P3449, DOI 10.1021/cm011029k; Tanaka K, 2013, MACROMOLECULES, V46, P2969, DOI 10.1021/ma400368e; Kohler A, 2009, MAT SCI ENG R, V66, P71, DOI 10.1016/j.mser.2009.09.001; Yoshii R, 2014, MACROMOL RAPID COMM, V35, P1315, DOI 10.1002/marc.201400198; Kajiwara Y, 2013, J MATER CHEM C, V1, P4437, DOI 10.1039/c3tc30276h; Yeo H, 2013, MACROMOLECULES, V46, P2599, DOI 10.1021/ma400015d; Yoshii R, 2014, CHEM-EUR J, V20, P8320, DOI 10.1002/chem.201402946; Yoshii R, 2013, CHEM-EUR J, V19, P4506, DOI 10.1002/chem.201203703; Yook KS, 2014, ADV MATER, V26, P4218, DOI 10.1002/adma.201306266; Jiang JX, 2005, MACROMOLECULES, V38, P4072, DOI 10.1021/ma0474473; Evans RC, 2006, COORDIN CHEM REV, V250, P2093, DOI 10.1016/j.ccr.2006.02.007; Zhang GQ, 2009, NAT MATER, V8, P747, DOI [10.1038/nmat2509, 10.1038/NMAT2509]; Tanaka K, 2012, MACROMOL RAPID COMM, V33, P1235, DOI 10.1002/marc.201200239; Furuta PT, 2004, J AM CHEM SOC, V126, P15388, DOI 10.1021/ja0446247; Tokito S, 2003, ORG ELECTRON, V4, P105, DOI 10.1016/j.orgel.2003.08.005; Holder E, 2005, ADV MATER, V17, P1109, DOI 10.1002/adma.200400284; Hanaoka K, 2007, J AM CHEM SOC, V129, P13502, DOI 10.1021/ja073392j; Wang XD, 2014, CHEM SOC REV, V43, P3666, DOI 10.1039/c4cs00039k; Deng L, 2006, CHEM MATER, V18, P386, DOI 10.1021/cm051922+; Galbrecht F., 2005, CHEM COMMUN, P2378; Godbert N, 2007, EUR J INORG CHEM, P5105, DOI 10.1002/ejic.200700639; Hirose A, 2014, TETRAHEDRON LETT, V55, P6477, DOI 10.1016/j.tetlet.2014.10.012; Sakurai Y, 2012, PHYS STATUS SOLIDI C, V9, P2557, DOI 10.1002/pssc.201200450; Jung YK, 2008, J POLYM SCI POL CHEM, V46, P3573, DOI 10.1002/pola.22696; Koseki S, 2013, J PHYS CHEM C, V117, P5314, DOI 10.1021/jp312032s; Montalti M., 2005, HDB PHOTOCHEMISTRY; MURPHY SM, 1992, BIOMATERIALS, V13, P979, DOI 10.1016/0142-9612(92)90148-H; Okada H, 2014, POLYM J, V46, P800, DOI 10.1038/pj.2014.67; Okada H, 2014, BIOORGAN MED CHEM, V22, P3141, DOI 10.1016/j.bmc.2014.04.020; Palmer GM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523363; Sung HH, 2004, MACROMOLECULES, V37, P7945, DOI 10.1021/ma0489927; Thomas S. W., 2005, J MATER CHEM, V15, P2829; Tokito S, 2004, J PHOTOPOLYM SCI TEC, V17, P307, DOI 10.2494/photopolymer.17.307; Tokito S, 2008, ELECTROCHEMISTRY, V76, P24; Unesaki H, 2014, INORG CHEM, V53, P8270, DOI 10.1021/ic500550y	46	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1336	1521-3927		MACROMOL RAPID COMM	Macromol. Rapid Commun.	APR	2015	36	7			SI		684	688		10.1002/marc.201500104		5	Polymer Science	Polymer Science	CF5DF	WOS:000352575000017		
J	Kim, HJ; Suga, K; Kim, BM; Rhee, JS; Lee, JS; Hagiwara, A				Kim, Hee-Jin; Suga, Koushirou; Kim, Bo-Mi; Rhee, Jae-Sung; Lee, Jae-Seong; Hagiwara, Atsushi			Light-dependent transcriptional events during resting egg hatching of the rotifer Brachionus manjavacas	MARINE GENOMICS			English	Article						Rotifera; Resting egg; Hatching; Light; Transcriptional expression	OXIDATIVE STRESS; PLICATILIS MULLER; MESSENGER-RNA; TEMPERATURE; MITOCHONDRIA; DORMANCY; GENES; INDUCTION; OOCYTES; BIOLOGY	Rotifer resting eggs often have to endure harsh environmental conditions during the diapause phase. They are stimulated by light to hatch. In order to study the hatching mechanism, we observed resting eggs and measured their transcriptional expression under different light exposure periods (total darkness, and after 30 min, and 4 h light). By using differential-display reverse transcription PCR (DDRT-PCR), we isolated 80 genes that displayed different expression patterns in response to the three light treatments: 20 genes were expressed in total darkness, 40 different genes were differentially expressed under 30 min light, and 20 further genes were expressed after 4 h of light. The resting eggs showed no phenotypic differences in embryonic development during the 4 h illumination period. In general, the expression patterns of the analyzed genes in resting eggs were differentially modulated by light exposure time. In total darkness, resting eggs mainly expressed genes encoding cell defense and homeostasis functions. In the 30 min illumination group, we found enriched expression of genes encoding fatty acid metabolism-related components, including Acyl-CoA dehydrogenase (ACAD). Genes encoding cellular and embryonic developmental functions were highly observed in the 30 min-illuminated group but were not observed in the 4 h-illuminated group. Real-time RT-PCR revealed that several transcripts such as encoding V-type H(+)-translocating pyrophosphatase (V-PPase) and Meckelin had prolonged expression levels when exposed to light for 4 h. In the 4 h illuminated group, the RecQ protein-like 5 (RECQL5) gene was enriched. This RECQL5 gene may be expressed to protect the developing embryo from continuous light exposure. The data presented in this study indicate that DDRT-PCR-aided gene screening can be helpful to isolate candidate genes involved in the hatching process. (C) 2015 Elsevier B.V. All rights reserved.	[Kim, Hee-Jin; Suga, Koushirou; Hagiwara, Atsushi] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan; [Kim, Bo-Mi; Lee, Jae-Seong] Sungkyunkwan Univ, Coll Sci, Dept Biol Sci, Suwon 440746, South Korea; [Rhee, Jae-Sung] Incheon Natl Univ, Coll Nat Sci, Dept Marine Sci, Inchon 406772, South Korea	Kim, HJ (reprint author), Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Bunkyo 1-14, Nagasaki 8528521, Japan.	heejin@nagasaki-u.ac.jp	Lee, Jae-Seong/H-6013-2015	Lee, Jae-Seong/0000-0003-0944-5172	Ministry of Education, Culture, Sports, Science, and Technology [21380125, 24380108]	We thank Prof. Hans-U. Dahms for his comments on the manuscript, and also thank two anonymous reviewers for their constructive comments on the manuscript. This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology grant-in-aid for scientific research (B) (2009-2011, No. 21380125 and 2012-2014, No. 24380108) funded to A. H.	Abele D, 2007, FRONT BIOSCI, V12, P933, DOI 10.2741/2115; Almeselmani M, 2006, PLANT SCI, V171, P382, DOI 10.1016/j.plantsci.2006.04.009; Hagiwara A, 2007, AQUACULTURE, V268, P44, DOI 10.1016/j.aquaculture.2007.04.029; Dahms HU, 2011, AQUAT TOXICOL, V101, P1, DOI 10.1016/j.aquatox.2010.09.006; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; DAHMS HU, 1995, HYDROBIOLOGIA, V306, P199, DOI 10.1007/BF00017691; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Kim RO, 2013, ENVIRON SCI TECHNOL, V47, P13804, DOI 10.1021/es403269v; Ricci C, 2001, HYDROBIOLOGIA, V446, P1, DOI 10.1023/A:1017548418201; Courcelle J, 1999, MOL GEN GENET, V262, P543; Abele D, 1998, COMP BIOCHEM PHYS B, V120, P425, DOI 10.1016/S0305-0491(98)10028-7; Vinagre C, 2014, J THERM BIOL, V41, P38, DOI 10.1016/j.jtherbio.2014.02.005; Abele D, 2002, J EXP BIOL, V205, P1831; Keller M, 2004, J EXP BIOL, V207, P2529, DOI 10.1242/jeb.01050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; An MI, 2010, COMP BIOCHEM PHYS B, V155, P34, DOI 10.1016/j.cbpb.2009.09.008; Kim RO, 2011, AQUAT TOXICOL, V101, P529, DOI 10.1016/j.aquatox.2010.12.005; GILBERT JJ, 1974, T AM MICROSC SOC, V93, P490, DOI 10.2307/3225154; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Leaver MJ, 2011, COMP BIOCHEM PHYS D, V6, P62, DOI 10.1016/j.cbd.2010.04.002; Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a; Manefield M, 2002, MICROBIOL-SGM, V148, P1119; Araujo A, 2005, HYDROBIOLOGIA, V546, P553, DOI 10.1007/s10750-005-4297-9; Callejas S, 2003, MOL BIOL REP, V30, P215, DOI 10.1023/A:1026389829741; Cooper G. M., 2000, CELL MOL APPROACH; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x; Gallardo WG, 2000, J EXP MAR BIOL ECOL, V252, P97, DOI 10.1016/S0022-0981(00)00240-9; Garcia-Descalzo L., 2011, CELL STRESS CHAPERON, V16, P203; Gilbert JJ, 2007, FRESHWATER BIOL, V52, P1417, DOI 10.1111/j.1365-2427.2007.01782.x; Gilbert John J., 2004, Journal of Limnology, V63, P32; Gilbert JJ, 2003, EVOL DEV, V5, P19, DOI 10.1046/j.1525-142X.2003.03004.x; HAGIWARA A, 1989, HYDROBIOLOGIA, V186, P415, DOI 10.1007/BF00048940; HAGIWARA A, 1989, MAR BIOL, V103, P327, DOI 10.1007/BF00397266; Hagiwara A, 1995, HYDROBIOLOGIA, V313, P223, DOI 10.1007/BF00025955; HAGIWARA A, 1994, ISR J AQUACULT-BAMID, V46, P13; HAGIWARA A, 1991, NIPPON SUISAN GAKK, V57, P1645; Kim B.-M., 2014, CHEMOSPHERE, V120, P470; Kim HJ, 2014, J EXP MAR BIOL ECOL, V460, P177, DOI 10.1016/j.jembe.2014.07.005; Kim HJ, 2011, HYDROBIOLOGIA, V662, P107, DOI 10.1007/s10750-010-0486-2; Hagiwara Atsushi, 1993, TML Conference Proceedings, V3, P61; Lubzens E, 2010, TOP CURR GENET, V21, P1, DOI 10.1007/978-3-642-12422-8_1; Medini M, 2009, AFR J BIOTECHNOL, V8, P4441; Motta LS, 2009, INSECT BIOCHEM MOLEC, V39, P198, DOI 10.1016/j.ibmb.2008.11.003; Rhee J.-S., 2011, BRACHIONUS SP CMOP C, V154, P19; Segers H., 2006, 2 EDITION BIOL ECCOL, P68; Siquieroli ACS, 2009, BIOL RES, V42, P107, DOI [/S0716-97602009000100011, 10.4067/S0716-97602009000100011]; Snell T.W., 1983, HYDROBIOLOGIA, V104, P89; SNELL TW, 1987, HYDROBIOLOGIA, V144, P105, DOI 10.1007/BF00014523; Wheelock CE, 1999, ARCH ENVIRON CON TOX, V36, P281	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-7787	1876-7478		MAR GENOM	Mar. Genom.	APR	2015	20						25	31		10.1016/j.margen.2015.02.003		7	Genetics & Heredity; Marine & Freshwater Biology	Genetics & Heredity; Marine & Freshwater Biology	CF6KS	WOS:000352666200009		
J	Adachi, S				Adachi, Shinji			The existence of multiple positive solutions for a class of non-local elliptic problem in R-N	MATHEMATISCHE NACHRICHTEN			English	Article						Non-local elliptic equation; Nehari manifold; 35J20; 35J60; 58E30	KIRCHHOFF TYPE EQUATIONS; SIGN-CHANGING WEIGHT; CONVEX NONLINEARITIES; CONCAVE	This paper is concerned with the existence of at least two positive solutions for a class of non-local elliptic equations in RN. Using variational methods and the decomposition of the Nehari manifold, we show multiple existence of positive solutions.	Shizuoka Univ, Fac Engn, Dept Math & Syst Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Adachi, S (reprint author), Shizuoka Univ, Fac Engn, Dept Math & Syst Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	tsadati@ipc.shizuoka.ac.jp					Alves CO, 2005, COMPUT MATH APPL, V49, P85, DOI 10.1016/j.camwa.2005.01.008; Alves C.O., 2010, DIFFER EQU APPL, V2, P409; Drabek P, 1997, P ROY SOC EDINB A, V127, P703; Chen CY, 2011, J DIFFER EQUATIONS, V250, P1876, DOI 10.1016/j.jde.2010.11.017; Chen KJ, 2009, J MATH ANAL APPL, V355, P767, DOI 10.1016/j.jmaa.2009.02.029; Brown KJ, 2003, J DIFFER EQUATIONS, V193, P481, DOI 10.1016/S0022-0396(03)00121-9; Hsu TS, 2010, J MATH ANAL APPL, V365, P758, DOI 10.1016/j.jmaa.2009.12.004; Figueiredo GM, 2013, J MATH ANAL APPL, V401, P706, DOI 10.1016/j.jmaa.2012.12.053; Correa FJSA, 2004, NONLINEAR ANAL-THEOR, V59, P1147, DOI 10.1016/j.na.2004.08.010; Chipot M, 1997, NONLINEAR ANAL-THEOR, V30, P4619, DOI 10.1016/S0362-546X(97)00169-7; AMBROSETTI A, 1994, J FUNCT ANAL, V122, P519, DOI 10.1006/jfan.1994.1078; Figueiredo GM, 2014, ARCH RATION MECH AN, V213, P931, DOI 10.1007/s00205-014-0747-8; Wu TF, 2010, J FUNCT ANAL, V258, P99, DOI 10.1016/j.jfa.2009.08.005; Brown K.J., 2007, ELECT J DIFFERENTIAL, V69, P1; Correa FJSA, 2011, MATH COMPUT MODEL, V54, P2293, DOI 10.1016/j.mcm.2011.05.038; Kirchhoff G., 1883, MECHANIK; Sun JJ, 2014, COMMUN PUR APPL ANAL, V13, P483, DOI 10.3934/cpaa.2014.13.483; TARANTELLO G, 1992, ANN I H POINCARE-AN, V9, P281; Wu TF, 2011, NONLINEAR ANAL-THEOR, V74, P4112, DOI 10.1016/j.na.2011.03.045	19	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0025-584X	1522-2616		MATH NACHR	Math. Nachr.	APR	2015	288	5-6					486	497		10.1002/mana.201400017		12	Mathematics	Mathematics	CG1LP	WOS:000353034400002		
J	Inoue, M; Yoshimur, M; Sato, S; Nakamura, M; Yamada, M; Hirata, K; Sasaki, M; Fujimoto, T; Ogura, M; Hiraoka, M				Inoue, Minoru; Yoshimur, Michio; Sato, Sayaka; Nakamura, Mitsuhiro; Yamada, Masahiro; Hirata, Kimiko; Sasaki, Makoto; Fujimoto, Takahiro; Ogura, Masakazu; Hiraoka, Masahiro			Improvement of registration accuracy in accelerated partial breast irradiation using the point-based rigid-body registration algorithm for patients with implanted fiducial markers	MEDICAL PHYSICS			English	Article						breast cancer; APBI; image-guided radiotherapy; fiducial marker; point-based rigid-body registration algorithm	IMAGE-GUIDED RADIOTHERAPY; BEAM COMPUTED-TOMOGRAPHY; LUMPECTOMY CAVITY; CLINICAL-EXPERIENCE; RADIATION-THERAPY; SURGICAL CLIPS; SETUP; LOCALIZATION; GUIDANCE; CANCER	Purpose: To investigate image-registration errors when using fiducial markers with a manual method and the point-based rigid-body registration (PRBR) algorithm in accelerated partial breast irradiation (APBI) patients, with accompanying fiducial deviations. Methods: Twenty-two consecutive patients were enrolled in a prospective trial examining 10-fraction APBI. Titanium clips were implanted intraoperatively around the seroma in all patients. For image-registration, the positions of the clips in daily kV x-ray images were matched to those in the planning digitally reconstructed radiographs. Fiducial and gravity registration errors (FREs and GREs, respectively), representing resulting misalignments of the edge and center of the target, respectively, were compared between the manual and algorithm-based methods. Results: In total, 218 fractions were evaluated. Although the mean FRE/GRE values for the manual and algorithm-based methods were within 3 mm (2.3/1.7 and 1.3/0.4 mm, respectively), the percentages of fractions where FRE/GRE exceeded 3 mm using the manual and algorithm-based methods were 18.8%/7.3% and 0%/0%, respectively. Manual registration resulted in 18.6% of patients with fractions of FRE/GRE exceeding 5 mm. The patients with larger clip deviation had significantly more fractions showing large FRE/GRE using manual registration. Conclusions: For image-registration using fiducial markers in APBI, the manual registration results in more fractions with considerable registration error due to loss of fiducial objectivity resulting from their deviation. The authors recommend the PRBR algorithm as a safe and effective strategy for accurate, image-guided registration and PTV margin reduction. (C) 2015 American Association of Physicists in Medicine.	[Inoue, Minoru; Yoshimur, Michio; Sato, Sayaka; Nakamura, Mitsuhiro; Yamada, Masahiro; Hirata, Kimiko; Ogura, Masakazu; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto 6068507, Japan; [Sasaki, Makoto; Fujimoto, Takahiro] Kyoto Univ Hosp, Div Clin Radiol Serv, Kyoto 6068507, Japan	Yoshimur, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto 6068507, Japan.	myossy@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, of Japan [25253078]	This research was supported, in part, by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, of Japan (Grant No. 25253078). The authors report no conflicts of interest in conducting the research.	van Herk M, 2004, SEMIN RADIAT ONCOL, V14, P52, DOI 10.1053/j.semradonc.2003.10.003; Prendergast B, 2009, INT J RADIAT ONCOL, V74, P695, DOI 10.1016/j.ijrobp.2008.08.044; Kim LH, 2007, INT J RADIAT ONCOL, V69, P1305, DOI 10.1016/j.ijrobp.2007.07.2365; Fatunase T, 2008, INT J RADIAT ONCOL, V70, P1025, DOI 10.1016/j.ijrobp.2007.07.2344; Bert C, 2006, INT J RADIAT ONCOL, V64, P1265, DOI 10.1016/j.ijrobp.2005.11.008; Leonard CE, 2010, INT J RADIAT ONCOL, V76, P528, DOI 10.1016/j.ijrobp.2009.02.001; Weed DW, 2004, INT J RADIAT ONCOL, V60, P484, DOI 10.1016/j.ijrobp.2004.03.012; Sharma R, 2009, INT J RADIAT ONCOL, V75, P89, DOI 10.1016/j.ijrobp.2008.10.037; Park CK, 2012, INT J RADIAT ONCOL, V82, pE425, DOI 10.1016/j.ijrobp.2011.07.027; Fitzpatrick JM, 2000, HDB MED IMAGING, V2, P447; Gierga DP, 2008, INT J RADIAT ONCOL, V70, P1239, DOI 10.1016/j.ijrobp.2007.11.020; Hasan Y, 2008, INT J RADIAT ONCOL, V70, P619, DOI 10.1016/j.ijrobp.2007.08.079; Miyabe Y, 2011, MED PHYS, V38, P2535, DOI 10.1118/1.3578607; Sasaki Makoto, 2014, Nihon Hoshasen Gijutsu Gakkai Zasshi, V70, P467; Spadea MF, 2006, RADIOTHER ONCOL, V79, P170, DOI 10.1016/j.radonc.2006.02.011; Topolnjak R, 2011, INT J RADIAT ONCOL, V81, pE187, DOI 10.1016/j.ijrobp.2010.12.027; Truong Minh Tam, 2013, J Appl Clin Med Phys, V14, P4243, DOI 10.1120/jacmp.v14i2.4243; White EA, 2007, INT J RADIAT ONCOL, V68, P547, DOI 10.1016/j.ijrobp.2007.01.048; Yamashita H, 2012, INT J RADIAT ONCOL, V84, P331, DOI 10.1016/j.ijrobp.2011.12.030; Yue NJ, 2013, MED PHYS, V40, DOI 10.1118/1.4788644	20	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	APR	2015	42	4					1904	1910		10.1118/1.4915534		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF0ZL	WOS:000352273200044		
J	Takahashi, A; Himuro, K; Yamashita, Y; Komiya, I; Baba, S; Sasaki, M				Takahashi, Akihiko; Himuro, Kazuhiko; Yamashita, Yasuo; Komiya, Isao; Baba, Shingo; Sasaki, Masayuki			Monte Carlo simulation of PET and SPECT imaging of Y-90	MEDICAL PHYSICS			English	Article						yittrium-90; PET; bremsstrahlung SPECT; Monte Carlo simulation	INTERNAL PAIR PRODUCTION; BREMSSTRAHLUNG; RESOLUTION	Purpose: Yittrium-90 (Y-90) is traditionally thought of as a pure beta emitter, and is used in targeted radionuclide therapy, with imaging performed using bremsstrahlung single-photon emission computed tomography (SPECT). However, because Y-90 also emits positrons through internal pair production with a very small branching ratio, positron emission tomography (PET) imaging is also available. Because of the insufficient image quality of Y-90 bremsstrahlung SPECT, PET imaging has been suggested as an alternative. In this paper, the authors present the Monte Carlo-based simulation-reconstruction framework for Y-90 to comprehensively analyze the PET and SPECT imaging techniques and to quantitatively consider the disadvantages associated with them. Methods: Our PET and SPECT simulation modules were developed using Monte Carlo simulation of Electrons and Photons (MCEP), developed by Dr. S. Uehara. PET code (MCEP-PET) generates a sinogram, and reconstructs the tomography image using a time-of-flight ordered subset expectation maximization (TOF-OSEM) algorithm with attenuation compensation. To evaluate MCEP-PET, simulated results of F-18 PET imaging were compared with the experimental results. The results confirmed that MCEP-PET can simulate the experimental results very well. The SPECT code (MCEP-SPECT) models the collimator and NaI detector system, and generates the projection images and projection data. To save the computational time, the authors adopt the prerecorded Y-90 bremsstrahlung photon data calculated by MCEP. The projection data are also reconstructed using the OSEM algorithm. The authors simulated PET and SPECT images of a water phantom containing six hot spheres filled with different concentrations of Y-90 without background activity. The amount of activity was 163 MBq, with an acquisition time of 40 min. Results: The simulated Y-90-PET image accurately simulated the experimental results. PET image is visually superior to SPECT image because of the lowbackground noise. The simulation reveals that the detected photon number in SPECT is comparable to that of PET, but the large fraction (approximately 75%) of scattered and penetration photons contaminates SPECT image. The lower limit of Y-90 detection in SPECT image was approximately 200 kBq/ml, while that in PET image was approximately 100 kBq/ml. Conclusions: By comparing the background noise level and the image concentration profile of both the techniques, PET image quality was determined to be superior to that of bremsstrahlung SPECT. The developed simulation codes will be very useful in the future investigations of PET and bremsstrahlung SPECT imaging of Y-90. (C) 2015 American Association of Physicists in Medicine.	[Takahashi, Akihiko; Sasaki, Masayuki] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka 8128582, Japan; [Himuro, Kazuhiko; Yamashita, Yasuo; Komiya, Isao] Kyushu Univ Hosp, Dept Med Technol, Div Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Baba, Shingo] Kyushu Univ Hosp, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan	Takahashi, A (reprint author), Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takahsr@hs.med.kyushu-u.ac.jp					Zaidi H, 1999, MED PHYS, V26, P574, DOI 10.1118/1.598559; Fabbri C, 2009, CANCER BIOTHER RADIO, V24, P145, DOI 10.1089/cbr.2008.0543; Rong X, 2012, MED PHYS, V39, P2346, DOI 10.1118/1.3700174; Ljungberg M, 2011, ACTA ONCOL, V50, P981, DOI 10.3109/0284186X.2011.584559; Levin CS, 1999, PHYS MED BIOL, V44, P781, DOI 10.1088/0031-9155/44/3/019; Mansberg R, 2007, EUR J NUCL MED MOL I, V34, P1887, DOI 10.1007/s00259-007-0536-9; Witzig TE, 2002, J CLIN ONCOL, V20, P3262, DOI 10.1200/JCO.2002.11.017; Gates VL, 2011, J NUCL MED, V52, P72, DOI 10.2967/jnumed.110.080986; Surti S, 2006, IEEE T MED IMAGING, V25, P529, DOI 10.1109/TMI.2006.871419; Lhommel R, 2010, EUR J NUCL MED MOL I, V37, P1654, DOI 10.1007/s00259-010-1470-9; Baba S., 2011, J NUCL MED S1, V52, P1987; Barber TW, 2013, J MED IMAG RADIAT ON, V57, P567, DOI 10.1111/1754-9485.12049; Carlier T, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-11; DAUBEWITHERSPOON ME, 1987, J NUCL MED, V28, P1717; Elschot M, 2013, J NUCL MED, V54, P1557, DOI 10.2967/jnumed.112.119131; Elschot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055742; Ito S, 2009, ANN NUCL MED, V23, P257, DOI 10.1007/s12149-009-0233-9; Lhommel R, 2009, EUR J NUCL MED MOL I, V36, P1696, DOI 10.1007/s00259-009-1210-1; Matthias M., 2010, EUR J NUCL MED MOL I, V37, P407; Minarik D, 2009, PHYS MED BIOL, V54, P5873, DOI 10.1088/0031-9155/54/19/014; Minarik D, 2008, PHYS MED BIOL, V53, P5689, DOI 10.1088/0031-9155/53/20/008; Moore SC, 2012, IEEE NUCL SCI CONF R, P2699; Rault E, 2010, MED PHYS, V37, P2943, DOI 10.1118/1.3431998; Selwyn RG, 2007, APPL RADIAT ISOTOPES, V65, P318, DOI 10.1016/j.apradiso.2006.08.009; Stewart J. S., 1988, INT J CANC S3, V41, P71, DOI 10.1002/ijc.2910410815; Tanaka M, 2007, PHYS MED BIOL, V52, P4409, DOI 10.1088/0031-9155/52/15/004; UEHARA S, 1991, RADIAT PHYS CHEM, V38, P11; UEHARA S, 1986, NUCL INSTRUM METH B, V14, P559, DOI 10.1016/0168-583X(86)90154-0; Uehara S, 1998, HEALTH PHYS, V74, P30, DOI 10.1097/00004032-199801000-00004; UEHARA S, 1988, HEALTH PHYS, V54, P249, DOI 10.1097/00004032-198803000-00001; VRIESENDORP HM, 1989, INT J RADIAT ONCOL, V17, P815; Walrand S, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-32; Walrand Stephan, 2014, Front Oncol, V4, P149, DOI 10.3389/fonc.2014.00149; Yoshida Eiji, 2014, Radiol Phys Technol, V7, P235, DOI 10.1007/s12194-014-0258-1	34	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	APR	2015	42	4					1926	1935		10.1118/1.4915545		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF0ZL	WOS:000352273200047		
J	Depeursinge, A; Yanagawa, M; Leung, AN; Rubin, DL				Depeursinge, Adrien; Yanagawa, Masahiro; Leung, Ann N.; Rubin, Daniel L.			Predicting adenocarcinoma recurrence using computational texture models of nodule components in lung CT	MEDICAL PHYSICS			English	Article						lung cancer; texture analysis; steerable Riesz wavelets; quantitative imaging biomarkers; radiomics	GROUND-GLASS OPACITY; RADIOLOGIC-PATHOLOGICAL CORRELATION; COMPUTED-TOMOGRAPHY; REGULARIZATION PATHS; COORDINATE DESCENT; FLEISCHNER-SOCIETY; PROGNOSTIC-FACTORS; CANCER; STAGE; SURVIVAL	Purpose: To investigate the importance of presurgical computed tomography (CT) intensity and texture information from ground-glass opacities (GGO) and solid nodule components for the prediction of adenocarcinoma recurrence. Methods: For this study, 101 patients with surgically resected stage I adenocarcinoma were selected. During the follow-up period, 17 patients had disease recurrence with six associated cancer-related deaths. GGO and solid tumor components were delineated on presurgical CT scans by a radiologist. Computational texture models of GGO and solid regions were built using linear combinations of steerable Riesz wavelets learned with linear support vector machines (SVMs). Unlike other traditional texture attributes, the proposed texture models are designed to encode local image scales and directions that are specific to GGO and solid tissue. The responses of the locally steered models were used as texture attributes and compared to the responses of unaligned Riesz wavelets. The texture attributes were combined with CT intensities to predict tumor recurrence and patient hazard according to disease-free survival (DFS) time. Two families of predictive models were compared: LASSO and SVMs, and their survival counterparts: Cox-LASSO and survival SVMs. Results: The best-performing predictive model of patient hazard was associated with a concordance index (C-index) of 0.81 +/- 0.02 and was based on the combination of the steered models and CT intensities with survival SVMs. The same feature group and the LASSO model yielded the highest area under the receiver operating characteristic curve (AUC) of 0.8 +/- 0.01 for predicting tumor recurrence, although no statistically significant difference was found when compared to using intensity features solely. For all models, the performance was found to be significantly higher when image attributes were based on the solid components solely versus using the entire tumors (p < 3.08 x 10(-5)). Conclusions: This study constitutes a novel perspective on how to interpret imaging information from CT examinations by suggesting that most of the information related to adenocarcinoma aggressiveness is related to the intensity and morphological properties of solid components of the tumor. The prediction of adenocarcinoma relapse was found to have low specificity but very high sensitivity. Our results could be useful in clinical practice to identify patients for which no recurrence is expected with a very high confidence using a presurgical CT scan only. It also provided an accurate estimation of the risk of recurrence after a given duration t from surgical resection (i.e., C-index = 0.81 +/- 0.02). (C) 2015 American Association of Physicists in Medicine.	[Depeursinge, Adrien; Yanagawa, Masahiro; Leung, Ann N.; Rubin, Daniel L.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Depeursinge, Adrien] Univ Appl Sci Western Switzerland HES SO, Business Informat Syst, CH-3960 Sierre, Switzerland; [Yanagawa, Masahiro] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka 5650871, Japan	Depeursinge, A (reprint author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	adrien.depeursinge@hevs.ch			Swiss National Science Foundation [PBGEP2_142283, PZ00P2_154891, 205320_141300/1]; National Cancer Institute, National Institutes of Health [U01-CA-142555]	This work was supported by the Swiss National Science Foundation (under Grant Nos. PBGEP2_142283, PZ00P2_154891, and 205320_141300/1), and the National Cancer Institute, National Institutes of Health (U01-CA-142555).	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Xu JJ, 2012, MED PHYS, V39, P5405, DOI 10.1118/1.4739507; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Suzuki K, 2006, ANN THORAC SURG, V81, P413, DOI 10.1016/j.athoracsur.2005.07.058; Yanagawa M, 2014, RADIOLOGY, V272, P557, DOI 10.1148/radiol.14131903; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Kido S, 2003, J COMPUT ASSIST TOMO, V27, P56, DOI 10.1097/00004728-200301000-00011; Evers L, 2008, BIOINFORMATICS, V24, P1632, DOI 10.1093/bioinformatics/btn253; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; BARSKY SH, 1994, CANCER-AM CANCER SOC, V73, P1163, DOI 10.1002/1097-0142(19940215)73:4<1163::AID-CNCR2820730407>3.0.CO;2-J; Mattonen SA, 2014, MED PHYS, V41, DOI 10.1118/1.4866219; Depeursinge A, 2014, IEEE T IMAGE PROCESS, V23, P898, DOI 10.1109/TIP.2013.2295755; Al-Kadi OS, 2008, IEEE T BIO-MED ENG, V55, P1822, DOI 10.1109/TBME.2008.919735; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Lee KH, 2014, J THORAC ONCOL, V9, P74, DOI 10.1097/JTO.0000000000000019; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Suzuki K, 2002, ANN THORAC SURG, V74, P1635, DOI 10.1016/S0003-4975(02)03895-X; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Tateishi U, 2001, J COMPUT ASSIST TOMO, V25, P23, DOI 10.1097/00004728-200101000-00004; Yanagawa M, 2010, LUNG CANCER, V70, P286, DOI 10.1016/j.lungcan.2010.03.009; Simon N, 2011, J STAT SOFTW, V39, P1; Friedman J, 2010, J STAT SOFTW, V33, P1; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Kodama K, 2001, LUNG CANCER-J IASLC, V33, P17, DOI 10.1016/S0169-5002(01)00185-4; Bagci U, 2011, LECT NOTES COMPUT SC, V6893, P215, DOI 10.1007/978-3-642-23626-6_27; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Depeursinge A., 2012, LECT NOTES COMPUTER, V7512, P517; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kido S., 2002, J COMPUT ASSISTED TO, V26, P537; Matsuguma H, 2004, EUR J CARDIO-THORAC, V25, P1102, DOI 10.1016/j.ejcts.2004.02.004; Matsuguma H, 2013, ANN THORAC SURG, V95, P1878, DOI 10.1016/j.athoracsur.2013.02.022; Meert AP, 2002, BRIT J CANCER, V87, P694, DOI 10.1038/sj.bjc.6600551; Mougiakakou SG, 2007, ARTIF INTELL MED, V41, P25, DOI 10.1016/j.artmed.2007.05.002; Tao Y, 2009, LECT NOTES COMPUT SC, V5762, P715; Unser M, 2011, IEEE T IMAGE PROCESS, V20, P2705, DOI 10.1109/TIP.2011.2138147; Yokose T, 2000, LUNG CANCER-J IASLC, V29, P179, DOI 10.1016/S0169-5002(00)00103-3	38	1	1	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	APR	2015	42	4					2054	2063		10.1118/1.4916088		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF0ZL	WOS:000352273200059		
J	Usui, T; Jones, JH; Mittlefehldt, DW				Usui, Tomohiro; Jones, John H.; Mittlefehldt, David W.			A partial melting study of an ordinary (H) chondrite composition with application to the unique achondrite Graves Nunataks 06128 and 06129	METEORITICS & PLANETARY SCIENCE			English	Article							HIGHLY-SIDEROPHILE-ELEMENT; EARLY SOLAR-SYSTEM; DEGREES-C; EXPERIMENTAL PETROLOGY; POLYMICT UREILITE; OSMIUM ISOTOPE; LOOP TECHNIQUE; CORE FORMATION; SILICATE MELT; PARENT BODY	Melting experiments of a synthesized, alkali-bearing, H-chondrite composition were conducted at ambient pressure with three distinct oxygen fugacity conditions (IW-1, IW, and IW+2). Oxygen fugacity conditions significantly influence the compositions of partial melts. Partial melts at IW-1 are distinctly enriched in SiO2 relative to those of IW and IW+2 melts. The silica-enriched, reduced (IW-1) melts are characterized by high alkali contents and have silica-oversaturated compositions. In contrast, the silica-depleted, oxidized (IW) melts, which are also enriched in alkali contents, have distinctly silica-undersaturated compositions. These experimental results suggest that alkali-rich, felsic, asteroidal crusts as represented by paired achondrites Graves Nunataks 06128 and 06129 should originate from a low-degree, relatively reduced partial melt from a parent body having near-chondritic compositions. Based on recent chronological constraints and numerical considerations as well as our experimental results, we propose that such felsic magmatism should have occurred in a parent body that is smaller in size and commenced accreting later than those highly differentiated asteroids having basaltic crusts and metallic cores.	[Usui, Tomohiro; Jones, John H.; Mittlefehldt, David W.] NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Mail Code KR, Houston, TX 77058 USA	Usui, T (reprint author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528551, Japan.	tomohirousui@geo.titech.ac.jp			NASA	We thank L. Le for technical assistance in the JSC Experimental Petrology Lab; A. H. Peslier, G. A. Robinson, and D. K. Ross for assistance with electron microprobe analyses; and T. Kuritani and M. Ushioda for insightful discussions during the revision. We also acknowledge A. Treiman for soliciting our participation in his consortium for GRA 06128/9. We are grateful to A. Jurewicz and two anonymous reviewers for constructive reviews, and N. Chabot for editorial handling. Finally, discussions with John Longhi, throughout this project, have been illuminating. This research was supported in part by NASA Postdoctoral Program (administrated by ORAU) to TU, NASA Cosmochemistry Program grants to JHJ and to DWM.	GROVE TL, 1989, CONTRIB MINERAL PETR, V103, P287, DOI 10.1007/BF00402916; Mittlefehldt DW, 2003, METEORIT PLANET SCI, V38, P1601; JUREWICZ AJG, 1995, GEOCHIM COSMOCHIM AC, V59, P391, DOI 10.1016/0016-7037(94)00328-J; Keil K, 2000, PLANET SPACE SCI, V48, P887, DOI 10.1016/S0032-0633(00)00054-4; Cohen BA, 2004, GEOCHIM COSMOCHIM AC, V68, P4249, DOI 10.1016/j.gca.2004.01.027; Libourel G, 1999, CONTRIB MINERAL PETR, V136, P63, DOI 10.1007/s004100050524; Toplis MJ, 2005, CONTRIB MINERAL PETR, V149, P22, DOI 10.1007/s00410-004-0629-4; TAKEDA H, 1994, METEORITICS, V29, P830; ELREFAIE FA, 1983, METALL TRANS B, V14, P85, DOI 10.1007/BF02670873; Ghosh A, 1998, ICARUS, V134, P187, DOI 10.1006/icar.1998.5956; Righter K, 1997, METEORIT PLANET SCI, V32, P929; Yoshino T, 2003, NATURE, V422, P154, DOI 10.1038/nature01459; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; JUREWICZ AJG, 1993, GEOCHIM COSMOCHIM AC, V57, P2123, DOI 10.1016/0016-7037(93)90098-H; Gardner-Vandy KG, 2013, GEOCHIM COSMOCHIM AC, V122, P36, DOI 10.1016/j.gca.2013.07.035; Goodrich CA, 2004, CHEM ERDE-GEOCHEM, V64, P283, DOI 10.1016/j.chemer.2004.08.001; Kita NT, 2004, GEOCHIM COSMOCHIM AC, V68, P4213, DOI 10.1016/j.gca.2004.03.020; Benedix GK, 1998, GEOCHIM COSMOCHIM AC, V62, P2535, DOI 10.1016/S0016-7037(98)00166-5; Day JMD, 2012, NAT GEOSCI, V5, P614, DOI 10.1038/ngeo1527; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; McSween HY, 2013, METEORIT PLANET SCI, V48, P2090, DOI 10.1111/maps.12108; GRIMM RE, 1993, SCIENCE, V259, P653; Shearer CK, 2010, GEOCHIM COSMOCHIM AC, V74, P1172, DOI 10.1016/j.gca.2009.10.029; Markowski A, 2007, EARTH PLANET SC LETT, V262, P214, DOI 10.1016/j.epsl.2007.07.035; JUREWICZ AJG, 1991, SCIENCE, V252, P695, DOI 10.1126/science.252.5006.695; Keil K, 1997, METEORIT PLANET SCI, V32, P349; IRVINE TN, 1971, CAN J EARTH SCI, V8, P523, DOI 10.1139/e71-055; SMITH JV, 1983, J GEOPHYS RES, V88, pB229, DOI 10.1029/JB088iS01p0B229; Day JMD, 2012, GEOCHIM COSMOCHIM AC, V81, P94, DOI 10.1016/j.gca.2011.12.017; Riches AJV, 2012, EARTH PLANET SC LETT, V353, P208, DOI 10.1016/j.epsl.2012.08.006; Day JMD, 2009, NATURE, V457, P179, DOI 10.1038/nature07651; KUSHIRO I, 1975, AM J SCI, V275, P411; LONGHI J, 1991, AM MINERAL, V76, P785; Arai T., 2008, 39 LUN PLAN SCI C; Arculus R, 2009, NATURE, V459, pE1, DOI 10.1038/nature08077; Borisov A, 1999, AM MINERAL, V84, P1528; Carmichael ISE, 1967, CONTRIB MINERAL PETR, V14, P36, DOI DOI 10.1007/BF00370985; Day JMD, 2009, NATURE, V459, pE1, DOI 10.1038/nature08078; DONALDSON CH, 1979, MINERAL MAG, V43, P115, DOI 10.1180/minmag.1979.043.325.08; Faure G., 1986, PRINCIPLES ISOTOPE G; FUJII CT, 1968, T METALL SOC AIME, V242, P1259; GEVA S, 1990, METALL TRANS B, V21, P743, DOI 10.1007/BF02654253; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Ghosh A., 2009, METEORITES EARLY SOL; Ikeda Y, 2001, METEORIT PLANET SCI, V36, P481; Jurewicz A. J. G., 1993, 104774 NASA; JUREWICZ AJG, 1988, CONTRIB MINERAL PETR, V99, P176, DOI 10.1007/BF00371459; KATSURA T, 1964, T METALL SOC AIME, V230, P77; Kushiro I., 1979, P 4 S ANT MET, V15, P165; Lindsay FN, 2014, GEOCHIM COSMOCHIM AC, V129, P96, DOI 10.1016/j.gca.2013.12.023; Lykasov AA, 2003, INORG MATER+, V39, P1088, DOI 10.1023/A:1026003628580; McCoy T., 2006, METEORITES EARLY SOL; Mikouchi T., 2008, LUNAR PLANET SCI, V39; Mittlefehldt D. W., 2003, METEORITES COMETS PL, P291; Mittlefehldt D. W., 1998, REV MINERAL, V36, P1; Nichols R. H., 2006, METEORITES EARLY SOL; Nyquist L.E., 2009, LUNAR PLANET SCI, V40, P1290; Righter K., 2006, METEORITES EARLY SOL, VII, P803; Sessler R., 1982, LUNAR PLANET SCI, VXIII, P710; Shearer CK, 2008, AM MINERAL, V93, P1937, DOI 10.2138/am.2008.3056; STOLPER E, 1977, GEOCHIM COSMOCHIM AC, V41, P587, DOI 10.1016/0016-7037(77)90300-3; TORMEY DR, 1987, CONTRIB MINERAL PETR, V96, P121, DOI 10.1007/BF00375227; Treiman A.H., 2008, LUNAR PLANET SCI, V39; van Acken D, 2012, METEORIT PLANET SCI, V47, P1606, DOI 10.1111/j.1945-5100.2012.01425.x; Wadhwa M., 2006, METEORITES EARLY SOL; Wang K, 2014, EARTH PLANET SC LETT, V392, P124, DOI 10.1016/j.epsl.2014.02.022; Warren P.H., 1989, P LUNAR PLANET SCI C, V19, P475; Zeigler R. A., 2008, 39 LUN PLAN SCI C	68	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	APR	2015	50	4					759	781		10.1111/maps.12392		23	Geochemistry & Geophysics	Geochemistry & Geophysics	CF5VL	WOS:000352625200015		
J	Senoh, M; Iwaki, M; Yamamoto, A; Kato, H; Fukuda, T; Shibayama, K				Senoh, Mitsutoshi; Iwaki, Masaaki; Yamamoto, Akihiko; Kato, Haru; Fukuda, Tadashi; Shibayama, Keigo			Inhibition of adhesion of Clostridium difficile to human intestinal cells after treatment with serum and intestinal fluid isolated from mice immunized with nontoxigenic C-difficile membrane fraction	MICROBIAL PATHOGENESIS			English	Article						Clostridium difficile; Membrane fraction; Adhesion; Vaccine	PROTECTS HAMSTERS; TOXIN-B; INFECTION; COLONIZATION; PROTEINS; BINDING; EPIDEMIOLOGY; CHALLENGE; HOSPITALS; DISEASE	Diarrhea and pseudomembrane colitis caused by Clostridium difficile infection is a global health concern because of the high recurrence rate after standard antibiotic therapy. Vaccination presents a powerful countermeasure against disease recurrence. In this study, mice vaccinated with the nontoxigenic Clostridium difficile membrane fraction generated a marked immune response to the antigen, as demonstrated by the serum IgG and intestinal fluid IgA levels. Significantly, pretreatment with harvested IgG- and IgA-containing fluids was sufficient to prevent in vitro adhesion of Clostridium difficile to human Caco-2 intestinal cells. These results highlight the potential of nontoxigenic Clostridium difficile membrane fraction as a vaccine candidate for Clostridium difficile infection. (C) 2015 Elsevier Ltd. All rights reserved.	[Senoh, Mitsutoshi; Iwaki, Masaaki; Yamamoto, Akihiko; Kato, Haru; Fukuda, Tadashi; Shibayama, Keigo] Natl Inst Infect Dis, Tokyo 2080011, Japan	Senoh, M (reprint author), Natl Inst Infect Dis, Dept Bacteriol 2, 4-7-1 Gakuen, Tokyo 2080011, Japan.	senoh@niid.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25860327]	This study was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Research Project No., 25860327).	Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461; Kovacs-Simon A, 2014, J INFECT DIS, V210, P274, DOI 10.1093/infdis/jiu070; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cerquetti M, 2002, FEMS IMMUNOL MED MIC, V32, P211, DOI 10.1111/j.1574-695X.2002.tb00556.x; Tulli L, 2013, CELL MICROBIOL, V15, P1674, DOI 10.1111/cmi.12139; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; Nagaro KJ, 2013, ANTIMICROB AGENTS CH, V57, P5266, DOI 10.1128/AAC.00580-13; Venugopal AA, 2012, CLIN INFECT DIS, V54, P568, DOI 10.1093/cid/cir830; Kato H, 2010, J MED MICROBIOL, V59, P556, DOI 10.1099/jmm.0.016147-0; Kato H, 2001, J CLIN MICROBIOL, V39, P1391, DOI 10.1128/JCM.39.4.1391-1395.2001; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Donald RGK, 2013, MICROBIOL-SGM, V159, P1254, DOI 10.1099/mic.0.066712-0; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Maroo S, 2006, GASTROENTEROLOGY, V130, P1311, DOI 10.1053/j.gastro.2006.02.044; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Ricciardi R, 2012, J HOSP INFECT, V80, P156, DOI 10.1016/j.jhin.2011.11.002; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Mukherjee K, 2002, MICROBIOL-SGM, V148, P2245; Barketi-Klai A, 2011, J MED MICROBIOL, V60, P1155, DOI 10.1099/jmm.0.029553-0; Iv Edward C Oldfield, 2014, World J Gastrointest Pharmacol Ther, V5, P1, DOI 10.4292/wjgpt.v5.i1.1; Kelly C.P., 2012, NEW ENGL J MED, V59, P1932; Ní Eidhin Déirdre B, 2008, FEMS Immunol Med Microbiol, V52, P207, DOI 10.1111/j.1574-695X.2007.00363.x; Pang ZD, 2014, P NATL ACAD SCI USA, V111, pE1256, DOI 10.1073/pnas.1322009111; Pechine S, 2007, VACCINE, V25, P3946, DOI 10.1016/j.vaccine.2007.02.055; Pechine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081112; Siddiqui F, 2012, J INFECT DIS, V205, P128, DOI 10.1093/infdis/jir688; Tickler I.A., 2014, ANTIMICROB AGENTS CH, V58, P4214	29	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0882-4010			MICROB PATHOGENESIS	Microb. Pathog.	APR	2015	81						1	5		10.1016/j.micpath.2015.03.001		5	Immunology; Microbiology	Immunology; Microbiology	CF9ZC	WOS:000352925400001		
J	Nishino, Y; Onoue, Y; Kojima, S; Homma, M				Nishino, Yuuki; Onoue, Yasuhiro; Kojima, Seiji; Homma, Michio			Functional chimeras of flagellar stator proteins between E-coli MotB and Vibrio PomB at the periplasmic region in Vibrio or E-coli	MICROBIOLOGYOPEN			English	Article						Basal body; flagellar motor; T ring; V. alginolyticus	CONSERVED CHARGED RESIDUES; NA+-DRIVEN; BACTERIAL MOTILITY; CRYSTAL-STRUCTURE; CYTOPLASMIC LOOP; BASAL BODY; H+-DRIVEN; ROTOR; ALGINOLYTICUS; COMPONENT	The bacterial flagellar motor has a stator and a rotor. The stator is composed of two membrane proteins, MotA and MotB in Escherichia coli and PomA and PomB in Vibrio alginolyticus. The Vibrio motor has a unique structure, the T ring, which is composed of MotX and MotY. Based on the structural information of PomB and MotB, we constructed three chimeric proteins between PomB and MotB, named PotB(91), PotB(129,) and PotB(138), with various chimeric junctions. When those chimeric proteins were produced with PomA in a motAB strain of E. coli or in pomAB and pomAB motX strains of Vibrio, all chimeras were functional in E. coli or Vibrio, either with or without the Tring, although the motilities were very weak in E. coli. Furthermore, we could isolate some suppressors in E. coli and identified the mutation sites on PomA or the chimeric B subunit. The weak function of chimeric PotBs in E. coli is derived mainly from the defect in the rotational switching of the flagellar motor. In addition, comparing the motilities of chimera strains in pomAB, PotB(138) had the highest motility. The difference between the origin of the 1 and 2 helices, E. coli MotB or Vibro PomB, seems to be important for motility in E. coli and especially in Vibrio.	[Nishino, Yuuki; Onoue, Yasuhiro; Kojima, Seiji; Homma, Michio] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Homma, M (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	g44416a@cc.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) of KAKENHI [24117004, 23247024]; Integrative Graduate Education and Research program of Nagoya University [24657087]	This work was supported by the Japan Society for the Promotion of Science (JSPS) of KAKENHI grant numbers 24117004 and 23247024 to M. H., KAKENHI grant number 24657087 to S. K. Y. N. was partly supported by the Integrative Graduate Education and Research program of Nagoya University.	Paul K, 2011, P NATL ACAD SCI USA, V108, P17171, DOI 10.1073/pnas.1110111108; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Zhou JD, 1998, J BACTERIOL, V180, P2729; Blair DF, 2003, FEBS LETT, V545, P86, DOI 10.1016/S0014-5793(03)00397-1; Asai Y, 2003, J MOL BIOL, V327, P453, DOI 10.1016/S0022-2836(03)00096-2; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Li N, 2011, GENES CELLS, V16, P985, DOI 10.1111/j.1365-2443.2011.01545.x; Terashima H, 2010, J BACTERIOL, V192, P5609, DOI 10.1128/JB.00720-10; Li N, 2011, J BACTERIOL, V193, P3773, DOI 10.1128/JB.00113-11; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Lloyd SA, 1999, NATURE, V400, P472; MACNAB RM, 1992, ANNU REV GENET, V26, P131; Yorimitsu T, 2001, BBA-BIOENERGETICS, V1505, P82, DOI 10.1016/S0005-2728(00)00279-6; BLAIR DF, 1991, J BACTERIOL, V173, P4049; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Yorimitsu T, 1999, J BACTERIOL, V181, P5103; Terashima H, 2006, MOL MICROBIOL, V62, P1170, DOI 10.1111/j.1365-2958.2006.05435.x; Terauchi T, 2011, MICROBIOL-SGM, V157, P2422, DOI 10.1099/mic.0.048488-0; Fukuoka H, 2005, J MOL BIOL, V351, P707, DOI 10.1016/j.jmb.2005.06.037; Nishiyama M, 2012, INT J MOL SCI, V13, P9225, DOI 10.3390/ijms13079225; Zhu SW, 2014, P NATL ACAD SCI USA, V111, P13523, DOI 10.1073/pnas.1324201111; GUZMAN LM, 1995, J BACTERIOL, V177, P4121; Sato K, 2000, J BIOL CHEM, V275, P20223, DOI 10.1074/jbc.M002236200; Asai Y, 1997, J BACTERIOL, V179, P5104; CHUN SY, 1988, SCIENCE, V239, P276, DOI 10.1126/science.2447650; Garza AG, 1996, J MOL BIOL, V258, P270, DOI 10.1006/jmbi.1996.0249; Hosking ER, 2006, J MOL BIOL, V364, P921, DOI 10.1016/j.jmb.2006.09.035; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi0354051; Kojima S, 2008, P NATL ACAD SCI USA, V105, P7696, DOI 10.1073/pnas.0800308105; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Morimoto YV, 2010, MOL MICROBIOL, V78, P1117, DOI 10.1111/j.1365-2958.2010.07391.x; Morimoto Yusuke V, 2014, Biomolecules, V4, P217, DOI 10.3390/biom4010217; Morimoto YV, 2013, J BACTERIOL, V195, P474, DOI 10.1128/JB.01971-12; Okabe M, 2005, J BIOL CHEM, V280, P25659, DOI 10.1074/jbc.M500263200; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P11699, DOI 10.1021/bi901517n; Takekawa N, 2014, J BACTERIOL, V196, P1377, DOI 10.1128/JB.01392-13; Takekawa N, 2013, J BIOCHEM, V153, P441, DOI 10.1093/jb/mvt011; Terashima H, 2010, J MOL BIOL, V397, P689, DOI 10.1016/j.jmb.2010.01.050; Yakushi T, 2006, J BACTERIOL, V188, P1466, DOI 10.1128/JB.188.4.1466-1472.2006; Yorimitsu T, 2002, J MOL BIOL, V320, P403, DOI 10.1016/S0022-2836(02)00426-6	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-8827			MICROBIOLOGYOPEN	MicrobiologyOpen	APR	2015	4	2					323	331		10.1002/mbo3.240		9	Microbiology	Microbiology	CF5DN	WOS:000352575900010		
J	Guan, X; Li, AH; Cai, ZP; Ohtsuki, T				Guan, Xin; Li, Aohan; Cai, Zhipeng; Ohtsuki, Tomoaki			Coalition Graph Game for Robust Routing in Cooperative Cognitive Radio Networks	MOBILE NETWORKS & APPLICATIONS			English	Article						Cooperative cognitive radio networks; Multi-hop; Coalition graph theory; Robust routing selection	WIRELESS SENSOR NETWORKS; EFFICIENT	This paper mainly studies on the problem of robust multi-hop routing selection in Cooperative Cognitive Radio Networks (CCRNs). Our objective is to improve the throughput of Primary Users (PUs) while increase the opportunity that Secondary Users (SUs) can access the licensed spectrum. We combine the multi-hop routing selection problem with the graph-based cooperative game and bipartite graph model. A novel effective multi-hop routing selection algorithm called GBRA is proposed for CCRNs. The effect of relays to the routing path on throughput is considered. A novel method is introduced to divide coalition. A fair allocation rule to allocate the total profits of one coalition to its members is also introduced. Finally, based on the proposed coalition division method and the proposed profits allocation scheme in one coalition, the stability of the multi-hop routing path selected by GBRA is proved. Theoretical analysis and performance evaluation show that both PUs and SUs can improve their communication performance when they cooperate with each other.	[Guan, Xin] Heilongjiang Univ, Sch Informat Sci & Technol, Harbin 150080, Heilongjiang, Peoples R China; [Li, Aohan] Heilongjiang Univ, Sch Elect Engn, Harbin 150080, Heilongjiang, Peoples R China; [Cai, Zhipeng] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA; [Ohtsuki, Tomoaki] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan	Guan, X (reprint author), Heilongjiang Univ, Sch Informat Sci & Technol, Harbin 150080, Heilongjiang, Peoples R China.	guanxin.hlju@gmail.com; liaohan1989@gmail.com; zcai@gsu.edu; ohtsuki@ics.keio.ac.jp			National Science Foundation (NSF) [CNS-1252292]; Heilongjiang Province Education Department Foundation, China [12531Z007]; Natural Science Foundation of Heilongjiang Province, China [F201019]	This work was supported in part by the National Science Foundation (NSF) under Grants No. CNS-1252292. Heilongjiang Province Education Department Foundation (12531Z007), China, and Natural Science Foundation of Heilongjiang Province, China (F201019).	Li W, 2013, IEEE INFOCOM SER, P971; Cheng SY, 2013, IEEE INFOCOM SER, P3084; Cheng XZ, 2008, WIREL NETW, V14, P347, DOI 10.1007/s11276-006-0724-8; Wang BB, 2011, IEEE J-STSP, V5, P5, DOI 10.1109/JSTSP.2010.2093210; Zhang Y, 2012, IEEE NETWORK, V26, P6; Xie SL, 2010, IEEE T VEH TECHNOL, V59, P4079, DOI 10.1109/TVT.2010.2056943; Cheng XZ, 2003, NETWORKS, V42, P202, DOI 10.1002/net.10097; Peha JM, 2005, IEEE COMMUN MAG, V43, P10, DOI 10.1109/MCOM.2005.1404581; Boukerche A., 2003, P 6 ACM INT WORKSH M, P42; Cao B, 2012, GLOB TELECOMM CONF, P1114; Cao B, 2013, IEEE INFOCOM SER, P1726; Cao B, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P3096; Han GJ, 2014, INT J AD HOC UBIQ CO, V15, P57, DOI 10.1504/IJAHUC.2014.059900; Han G., 2014, WIRELESS COMMUNICATI; Jiang J, 2014, IEEE T PARALLEL DIST; Jing T, 2013, IEEE INFOCOM SER, P175; Li J., 2014, INT J HYDRO IN PRESS, P1, DOI 10.1109/NOMS.2014.6838393; Myerson R. B., 1977, Mathematics of Operations Research, V2, DOI 10.1287/moor.2.3.225; Qu Z., 2011, P GLOBECOM HOUST, P1, DOI 10.1109/APPEEC.2011.5748832; Toroujeni SMM, 2013, IEEE T VEH TECHNOL, V62, P2131, DOI 10.1109/TVT.2012.2231102; Wei T, 2013, COMMUNICATIONS ICC, P6317; Yu R, 2012, IEEE WIREL COMMUN, V19, P30; Zhai L, 2012, P GLOBECOM AN CA, P1818; Zhang GP, 2012, GLOB TELECOMM CONF, P4916; Zhang N, 2012, IEEE ICC, P1763	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1383-469X	1572-8153		MOBILE NETW APPL	Mobile Netw. Appl.	APR	2015	20	2					147	156		10.1007/s11036-015-0589-0		10	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CF6UK	WOS:000352691700004		
J	Calafate, CT; Ji, YS; Fazio, P				Calafate, Carlos T.; Ji, Yusheng; Fazio, Peppino			Editorial for Special Issue on "Advances on Vehicular Communication Systems"	MOBILE NETWORKS & APPLICATIONS			English	Editorial Material									[Calafate, Carlos T.; Fazio, Peppino] Univ Politecn Valencia, Valencia, Spain; [Ji, Yusheng] Natl Inst Informat, Tokyo, Japan; [Fazio, Peppino] Univ Calabria, DIMES Dept, I-87036 Arcavacata Di Rende, Italy; [Fazio, Peppino] Univ Ostrava, CZ-70103 Ostrava, Czech Republic	Calafate, CT (reprint author), Univ Politecn Valencia, Valencia, Spain.	calafate@disca.upv.es	Calafate, Carlos/A-4215-2009	Calafate, Carlos/0000-0001-5729-3041				0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1383-469X	1572-8153		MOBILE NETW APPL	Mobile Netw. Appl.	APR	2015	20	2					201	202		10.1007/s11036-015-0581-8		2	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CF6UK	WOS:000352691700008		
J	Tsukamoto, K; Oie, Y; Kremo, H; Altintas, O; Tanaka, H; Fujii, T				Tsukamoto, Kazuya; Oie, Yuji; Kremo, Haris; Altintas, Onur; Tanaka, Hideaki; Fujii, Takeo			Implementation and Performance Evaluation of Distributed Autonomous Multi-Hop Vehicle-to-Vehicle Communications over TV White Space	MOBILE NETWORKS & APPLICATIONS			English	Article						White space; Multi-hop vehicular communication; Channel selection, Spectrum sensing; Dynamic spectrum access	COGNITIVE RADIO NETWORKS	This paper presents design and experimental evaluation of a distributed autonomous multi-hop vehicle-to-vehicle (V2V) communication system over TV white space performed in Japan. We propose the two-layer control channel model, which consists of the Zone Aware Control Channel (ZACC) and the Swarm Aware Control Channel (SACC), to establish the multi-hop network. Several vehicles construct a swarm using location information shared through ZACC, and share route and channel information, and available white space information through SACC. To evaluate the system we carried out field experiments with swarm made of three vehicles in a convoy. The vehicles observe channel occupancy via energy detection and agree on the control and the data channels autonomously. For coarse synchronization of quiet periods for sensing we use GPS driven oscillators, and introduce a time margin to accommodate for remaining drift. When a primary user is detected in any of the borrowed channels, the vehicles switch to a vacant channel without disrupting the ongoing multi-hop communication. We present the experimental results in terms of the time to establish control channel, channel switching time, delivery ratio of control message exchange, and throughput. As a result, we showed that our implementation can provide efficient and stable multi-hop V2V communication by using dynamic spectrum access (DSA) techniques.	[Tsukamoto, Kazuya; Oie, Yuji] Kyushu Inst Technol, Dept Comp Sci & Elect, Iizuka, Fukuoka 8208502, Japan; [Kremo, Haris; Altintas, Onur; Tanaka, Hideaki] Toyota InfoTechnol Ctr, Tokyo 1070052, Japan; [Fujii, Takeo] Univ Electrocommun, Chofu, Tokyo 1820021, Japan	Tsukamoto, K (reprint author), Kyushu Inst Technol, Dept Comp Sci & Elect, Iizuka, Fukuoka 8208502, Japan.	tsukamoto@cse.kyutech.ac.jp; onur@jp.toyota-itc.com; fujii@awcc.uec.ac.jp					Altintas O, 2011, P IEEE WIVEC; Altintas O, 2013, P ACM SIGMOBILE MOB, V16, P54; Haykin S, 2005, IEEE J SEL AREA COMM, V23, P201, DOI 10.1109/JSAC.2004.839380; Hassan MI, 2011, IEEE T VEH TECHNOL, V60, P3882, DOI 10.1109/TVT.2011.2162755; [Anonymous], 2011, 8022220111680 IEEE; Liang YC, 2008, IEEE T WIREL COMMUN, V7, P1326, DOI 10.1109/TWC.2008.060869; [Anonymous], 2 MEMORANDUM OPINION; Ettus Research, 2012, USRP N200 N210 NETW; Kay S, 2011, FUNDAMENTALS STAT SI; Kremo H, 2012, P SDR 12 WINNCOMM EU; Ma X, 2009, EURASIP J WIREL COMM; Mitola III J., 1999, P IEEE INT WORKSH MO, V1, P3; Tsukamoto K, 2009, P IEEE VTC FALL; Tsukamoto K, 2008, P WAVE; Wang CL, 2012, IEEE WCNC, P1293	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1383-469X	1572-8153		MOBILE NETW APPL	Mobile Netw. Appl.	APR	2015	20	2					203	219		10.1007/s11036-015-0576-5		17	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CF6UK	WOS:000352691700009		
J	Kondo, K; Ishida, T; Yasuda, T; Nakajima, H; Mori, K; Tanaka, N; Mori, T; Monguchi, T; Shinohara, M; Irino, Y; Toh, R; Rikitake, Y; Kiyomizu, K; Tomiyama, Y; Yamamoto, J; Hirata, K				Kondo, Kensuke; Ishida, Tatsuro; Yasuda, Tomoyuki; Nakajima, Hideto; Mori, Kenta; Tanaka, Nobuaki; Mori, Takeshige; Monguchi, Tomoko; Shinohara, Masakazu; Irino, Yasuhiro; Toh, Ryuji; Rikitake, Yoshiyuki; Kiyomizu, Kazunobu; Tomiyama, Yoshiaki; Yamamoto, Junichiro; Hirata, Ken-ichi			Trans-fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll-like receptors	MOLECULAR NUTRITION & FOOD RESEARCH			English	Article						Endothelial dysfunction; Inflammation; Thrombosis; Toll-like receptor; Trans-fatty acid	LOW-DENSITY-LIPOPROTEIN; PLATELET-AGGREGATION; SIGNALING PATHWAYS; CHOLESTEROL LEVELS; NADPH OXIDASE; INFLAMMATION; CELLS; WOMEN; TLR4; RISK	Scope: Since excessive intake of trans-fatty acid (TFA) increases the risk of myocardial infarction, we investigated the effects of TFA on thrombus formation using animal and cell culture experiments. Methods and results: C57BL/6 mice were fed a diet containing TFA or cis-fatty acid (5% each of total calories) or a chow diet for 4 weeks, and thrombus formation was induced in the carotid artery by He-Ne laser irradiation. The high-TFA diet significantly promoted thrombus formation in the carotid artery compared to the chow or cis-fatty acid diet. TFA activated the inflammatory signaling pathway in cultured endothelial cells and in mice; aortic gene expression levels of antithrombogenic molecules, including thrombomodulin and tissue factor pathway inhibitor, were decreased, and the expression levels of prothrombogenic molecules were increased in TFA-treated mice. TFA markedly upregulated the prothrombogenic molecules and downregulated the antithrombogenic molecules in endothelial cells. In addition, TFA induced phosphorylation of c-Jun N-terminal kinase, extracellular signal-regulated kinase, and nuclear factor-kappa B. The TFA-activated signal pathways and prothrombogenic phenotypic changes of endothelial cells were inhibited by genetic or pharmacological inactivation of Toll-like receptors 2 and 4. Conclusion: TFA aggravates the antithrombogenic phenotypes of vascular endothelial cells via Toll-like receptors and promotes thrombus formation in mice.	[Kondo, Kensuke; Ishida, Tatsuro; Yasuda, Tomoyuki; Nakajima, Hideto; Mori, Kenta; Tanaka, Nobuaki; Mori, Takeshige; Monguchi, Tomoko; Shinohara, Masakazu; Irino, Yasuhiro; Toh, Ryuji; Rikitake, Yoshiyuki; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Irino, Yasuhiro; Toh, Ryuji] Kobe Univ, Grad Sch Med, Div Evidence Based Lab Med, Kobe, Hyogo 6500017, Japan; [Kiyomizu, Kazunobu; Tomiyama, Yoshiaki] Osaka Univ, Dept Hematol & Oncol, Grad Sch Med, Suita, Osaka, Japan; [Tomiyama, Yoshiaki] Osaka Univ Hosp, Dept Blood Transfus, Suita, Osaka, Japan; [Yamamoto, Junichiro] Kobe Gakuin Univ, Fac Nutr, Physiol Lab, Kobe, Hyogo 65121, Japan	Ishida, T (reprint author), Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ishida@med.kobe-u.ac.jp					Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Matthan NR, 2004, ARTERIOSCL THROM VAS, V24, P1092, DOI 10.1161/01.ATV.0000128410.23161.be; ASCHERIO A, 1994, CIRCULATION, V89, P94; Yu WF, 2004, J BIOL CHEM, V279, P52160, DOI 10.1074/jbc.M409640200; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Chen CL, 2011, J NUTR BIOCHEM, V22, P649, DOI 10.1016/j.jnutbio.2010.05.004; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Petaja J, 2011, THROMB RES, V127, pS34, DOI 10.1016/S0049-3848(10)70153-5; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Wang L, 2010, HYPERTENSION, V56, P598, DOI 10.1161/HYPERTENSIONAHA.110.154187; Abbate R, 2012, THROMB RES, V129, P235, DOI 10.1016/j.thromres.2011.12.026; Hara T, 2009, MICROVASC RES, V77, P348, DOI 10.1016/j.mvr.2009.01.002; Liu YL, 2012, J NUTR, V142, P2017, DOI 10.3945/jn.112.164947; Rumbaut RE, 2006, AM J PHYSIOL-HEART C, V290, pH1671, DOI 10.1152/ajpheart.00305.2005; Bassett CMC, 2009, METABOLISM, V58, P1802, DOI 10.1016/j.metabol.2009.06.010; Lopez-Garcia E, 2005, J NUTR, V135, P562; Harvey KA, 2012, LIPIDS, V47, P647, DOI 10.1007/s11745-012-3681-2; Oomen CM, 2001, LANCET, V357, P746, DOI 10.1016/S0140-6736(00)04166-0; Korporaal SJA, 2007, ARTERIOSCL THROM VAS, V27, P2476, DOI 10.1161/ATVBAHA.107.150698; Armstrong RA, 2000, THROMB RES, V100, P133, DOI 10.1016/S0049-3848(00)00309-1; Bendsen NT, 2011, J LIPID RES, V52, P1821, DOI 10.1194/jlr.M014738; Brouwer IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009434; FALK E, 1989, AM J CARDIOL, V63, pE114, DOI 10.1016/0002-9149(89)90242-7; Granados N, 2011, BRIT J NUTR, V105, P1226, DOI 10.1017/S0007114510004885; Iwata NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029600; Kato H, 2005, J THROMB HAEMOST, V3, P763, DOI 10.1111/j.1538-7836.2005.01235.x; Kato H, 2006, ARTERIOSCL THROM VAS, V26, P224, DOI 10.1161/01.ATV.0000194076.84568.81; Krieglstein J, 2010, PLOS ONE, V5, pA61, DOI 10.1371/journal.pone.0009561; Li DY, 1999, ARTERIOSCL THROM VAS, V19, P378; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; Richard MN, 2007, J THROMB HAEMOST, V5, P424, DOI 10.1111/j.1538-7836.2007.02327.x; SATO T, 1987, BIOCHIM BIOPHYS ACTA, V931, P157, DOI 10.1016/0167-4889(87)90201-1; Satomi-Kobayashi S, 2009, HYPERTENSION, V54, P825, DOI 10.1161/HYPERTENSIONAHA.109.130443; Schwingshackl L, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-154; Stark RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041254; Turpeinen AM, 1998, ARTERIOSCL THROM VAS, V18, P316; Yamashita T, 2005, THROMB RES, V116, P393, DOI 10.1016/j.thromres.2005.01.011	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1613-4125	1613-4133		MOL NUTR FOOD RES	Mol. Nutr. Food Res.	APR	2015	59	4					729	740		10.1002/mnfr.201400537		12	Food Science & Technology	Food Science & Technology	CF8CK	WOS:000352782800011		
J	Ueda, H; Wakabayashi, S; Kikuchi, J; Ida, Y; Kadota, K; Tozuka, Y				Ueda, Hiroshi; Wakabayashi, Shinobu; Kikuchi, Junko; Ida, Yasuo; Kadota, Kazunori; Tozuka, Yuichi			Anomalous Role Change of Tertiary Amino and Ester Groups as Hydrogen Acceptors in Eudragit E Based Solid Dispersion Depending on the Concentration of Naproxen	MOLECULAR PHARMACEUTICS			English	Article						amorphous; solid dispersion; naproxen; Eudragit E; glass transition temperature; intermolecular interaction; stability; solid state-NMR	GLASS-TRANSITION TEMPERATURE; HOT-MELT EXTRUSION; PHYSICAL STABILITY; STATE NMR; IN-VIVO; PHYSICOCHEMICAL CHARACTERIZATION; CRYSTALLIZATION TENDENCY; MOLECULAR DISPERSIONS; AMORPHOUS STATE; INDOMETHACIN	Eudragit E (EGE) is a basic polymer incorporating tertiary amino and ester groups. The role of the functional groups of EGE in the formation of solid dispersion (SD) with Naproxen (NAP) was investigated. The glass transition temperature (T-g) of EGE decreased with the plasticizing effect of NAP up to 20% weight ratio. Addition of NAP at over 30% induced a rise in Tg, with the maximum value being reached at 60% NAP. Further addition of NAP led to a rapid drop of the T-g. A dramatic difference of physical stability between the SDs including 60 and 70% NAP was confirmed. The SD including 70% NAP rapidly crystallized at 40 degrees C with 75% relative humidity, while the amorphous state could be maintained over 6 months in the SD with 60% NAP. The infrared and C-13 solid state-NMR spectra of the SDs suggested a formation of ionic interaction between the carboxylic acid of NAP and the amino group of EGE. The SD with 20% NAP raised the C-13 spinlattice relaxation (T-1) of the amino group, but it decreased with over 30% NAP. The change in the C-13-T-1 disappeared with 70% NAP. The C-13-T-1 of the ester group rose depending on the amount of NAP. From these findings, we concluded that the role as hydrogen acceptor shifted from the amine to the ester group with an increase in amount of NAP. Furthermore, the amino group of EGE did not contribute to the interaction at over 70% NAP. These phenomena could be strongly correlated with T-g and stability.	[Ueda, Hiroshi; Wakabayashi, Shinobu; Kikuchi, Junko; Ida, Yasuo] Shionogi & Co Ltd, Innovat Drug Discovery Res Labs, Appl Chem Drug Discovery, Physicochem & Preformulat, Toyonaka, Osaka 5610825, Japan; [Ueda, Hiroshi; Kadota, Kazunori; Tozuka, Yuichi] Osaka Univ Pharmaceut Sci, Lab Formulat Design & Pharmaceut Technol, Takatsuki, Osaka 5691094, Japan	Ueda, H (reprint author), Shionogi & Co Ltd, Innovat Drug Discovery Res Labs, Appl Chem Drug Discovery, Physicochem & Preformulat, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan.	hiroshi.ueda@shionogi.co.jp					Al-Obaidi H, 2013, INT J PHARMACEUT, V443, P95, DOI 10.1016/j.ijpharm.2012.12.045; Andronis V, 1997, J PHARM SCI, V86, P346, DOI 10.1021/js9602711; Kawakami K, 2005, J PHARM SCI-US, V94, P948, DOI 10.1002/jps.20298; Kojima T, 2012, PHARM RES-DORDR, V29, P2777, DOI 10.1007/s11095-011-0655-7; Valizadeh H, 2007, DRUG DEV IND PHARM, V33, P45, DOI 10.1080/03639040600814965; Maniruzzaman M, 2012, EUR J PHARM BIOPHARM, V80, P433, DOI 10.1016/j.ejpb.2011.10.019; Nagy ZK, 2012, J PHARM SCI-US, V101, P322, DOI 10.1002/jps.22731; Rumondor ACF, 2010, MOL PHARMACEUT, V7, P477, DOI 10.1021/mp9002283; Marsac PJ, 2010, J PHARM SCI-US, V99, P169, DOI 10.1002/jps.21809; Baird JA, 2010, J PHARM SCI-US, V99, P3787, DOI 10.1002/jps.22197; Wegiel LA, 2014, PHARM DEV TECHNOL, V19, P976, DOI 10.3109/10837450.2013.846374; Pham TN, 2010, MOL PHARMACEUT, V7, P1667, DOI 10.1021/mp100205g; Sinclair W, 2011, J PHARM SCI-US, V100, P4687, DOI 10.1002/jps.22658; CHIOU WL, 1971, J PHARM SCI, V60, P1281, DOI 10.1002/jps.2600600902; Linn M, 2012, EUR J PHARM SCI, V45, P336, DOI 10.1016/j.ejps.2011.11.025; Chokshi RJ, 2008, J PHARM SCI-US, V97, P2286, DOI 10.1002/jps.21174; Qian F, 2010, INT J PHARMACEUT, V395, P232, DOI 10.1016/j.ijpharm.2010.05.033; Ando S, 2012, J PHARM SCI-US, V101, P3214, DOI 10.1002/jps.23158; Lobmann K, 2011, MOL PHARMACEUT, V8, P1919, DOI 10.1021/mp2002973; Konno H, 2006, J PHARM SCI-US, V95, P2692, DOI 10.1002/jps.20697; Lobmann K, 2013, INT J PHARMACEUT, V453, P80, DOI 10.1016/j.ijpharm.2012.05.016; Liu HJ, 2012, J PHARM SCI-US, V101, P2204, DOI 10.1002/jps.23075; YOSHIOKA M, 1994, J PHARM SCI, V83, P1700, DOI 10.1002/jps.2600831211; Taylor LS, 1997, PHARMACEUT RES, V14, P1691, DOI 10.1023/A:1012167410376; Rumondor ACF, 2011, AAPS PHARMSCITECH, V12, P1209, DOI 10.1208/s12249-011-9686-y; TORCHIA DA, 1978, J MAGN RESON, V30, P613, DOI 10.1016/0022-2364(78)90288-3; Lipinski CA, 2000, J PHARMACOL TOXICOL, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Ueda H, 2014, J PHARM SCI-US, V103, P2829, DOI 10.1002/jps.24023; BVogt F. G., 2009, CRYST GROWTH DES, V9, P921; Calucci L, 2004, BIOMACROMOLECULES, V5, P1536, DOI 10.1021/bm0499177; Chauhan H, 2014, PHARM RES-DORDR, V31, P500, DOI 10.1007/s11095-013-1178-1; Claeys B, 2013, EUR J PHARM BIOPHARM, V85, P1206, DOI 10.1016/j.ejpb.2013.01.027; Horisawa E, 2000, DRUG DEV IND PHARM, V26, P1271, DOI 10.1081/DDC-100102308; Kawakami K, 2003, PHARMACEUT RES, V20, P1430, DOI 10.1023/A:1025710311428; Konno H, 2007, PHARM RES, V25, P969; Lim AR, 2000, POLYMER, V41, P2431, DOI 10.1016/S0032-3861(99)00431-0; Litvinov VM, 2012, MOL PHARMACEUT, V9, P2924, DOI 10.1021/mp300280k; Luo HJ, 1998, POLYMER, V39, P943, DOI 10.1016/S0032-3861(97)00296-6; Matsumoto T, 1999, PHARMACEUT RES, V16, P1722, DOI 10.1023/A:1018906132279; Nunes TG, 2014, MOL PHARMACEUT, V11, P727, DOI 10.1021/mp400455r; Policianova O, 2014, MOL PHARMACEUT, V11, P516, DOI 10.1021/mp400495h; Priemel PA, 2013, EUR J PHARM BIOPHARM, V85, P1259, DOI 10.1016/j.ejpb.2013.09.010; Sakurai A, 2012, CHEM PHARM BULL, V60, P459; Ueda H, 2014, INT J PHARMACEUT, V462, P115, DOI 10.1016/j.ijpharm.2013.12.025; Yua X., 2014, MOL PHARM, V11, P329	45	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	APR	2015	12	4					1050	1061		10.1021/mp5005417		12	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CF4KQ	WOS:000352518400005		
J	Ueda, K; Higashi, K; Yamamoto, K; Moribe, K				Ueda, Keisuke; Higashi, Kenjirou; Yamamoto, Keiji; Moribe, Kunikazu			Equilibrium State at Supersaturated Drug Concentration Achieved by Hydroxypropyl Methylcellulose Acetate Succinate: Molecular Characterization Using H-1 NMR Technique	MOLECULAR PHARMACEUTICS			English	Article						hydroxypropyl methylcellulose acetate succinate; amorphous drug; supersaturated solution; crystallization inhibition; H-1 NMR measurement	MAGNETIC-RESONANCE MEASUREMENTS; WATER-SOLUBLE DRUGS; SOLID DISPERSION; AQUEOUS-SOLUTIONS; NMR-SPECTROSCOPY; POLYMER TYPE; DISSOLUTION; CRYSTALLIZATION; PROFILE; SOLUBILIZATION	The maintenance mechanism of the supersaturated state of poorly water-soluble drugs, glibenclamide (GLB) and chlorthalidone (CLT), in hydroxypropyl methylcellulose acetate succinate (HPMC-AS) solution was investigated at a molecular level. HPMC-AS suppressed drug crystallization from supersaturated drug solution and maintained high supersaturated level of drugs with small amount of HPMC-AS for 24 h. However, the dissolution of crystalline GLB into HPMC-AS solution failed to produce supersaturated concentrations, although supersaturated concentrations were achieved by adding amorphous GLB to HPMC-AS solution. HPMC-AS did not improve drug dissolution and/or solubility but efficiently inhibited drug crystallization from supersaturated drug solutions. Such an inhibiting effect led to the long-term maintenance of the amorphous state of GLB in HPMC-AS solution. NMR measurements showed that HPMC-AS suppressed the molecular mobility of CLT depending on their supersaturation level. Highly supersaturated CLT in HPMC-AS solution formed a gel-like structure with HPMC-AS in which the molecular mobility of the CLT was strongly suppressed. The gel-like structure of HPMC-AS could inhibit the reorganization from drug prenuclear aggregates to the crystal nuclei and delay the formation of drug crystals. The prolongation subsequently led to the redissolution of the aggregated drugs in aqueous solution and formed the equilibrium state at the supersaturated drug concentration in HPMC-AS solution. The equilibrium state formation of supersaturated drugs by HPMC-AS should be an essential mechanism underlying the marked drug concentration improvement.	[Ueda, Keisuke; Higashi, Kenjirou; Yamamoto, Keiji; Moribe, Kunikazu] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Moribe, K (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	moribe@faculty.chiba-u.jp			Health and Labor Sciences Research Grants for Research on Development of New Drugs; Japan Society for the Promotion of Sciences [24590045, 25460032, 24790041]	This study was partly supported by Health and Labor Sciences Research Grants for Research on Development of New Drugs and by Grants-in-Aid for Scientific Research (C) (JSPS, 24590045 and 25460032) for Young Scientist (B) (JSPS, 24790041) from the Japan Society for the Promotion of Sciences. K.U. is a Research Fellow of Japan Society for the Promotion of Science. We also thank the Shin-Etsu Chemical Co. (Tokyo, Japan) for providing HPMC-AS.	Hancock BC, 2000, PHARMACEUT RES, V17, P397, DOI 10.1023/A:1007516718048; Ilevbare GA, 2012, CRYST GROWTH DES, V12, P3133, DOI 10.1021/cg300325p; Ueda K, 2013, MOL PHARMACEUT, V10, P3801, DOI 10.1021/mp400278j; Ueda K, 2012, MOL PHARMACEUT, V9, P3023, DOI 10.1021/mp300083e; Raghavan SL, 2001, INT J PHARM, V212, P213, DOI 10.1016/S0378-5173(00)00610-4; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; Konno H, 2008, EUR J PHARM BIOPHARM, V70, P493, DOI 10.1016/j.ejpb.2008.05.023; Moribe K, 2014, INT J PHARMACEUT, V469, P190, DOI 10.1016/j.ijpharm.2014.04.005; Jung JY, 1999, INT J PHARM, V187, P209, DOI 10.1016/S0378-5173(99)00191-X; Hauss DJ, 2007, ADV DRUG DELIVER REV, V59, P667, DOI 10.1016/j.addr.2007.05.006; Fujita H, 1999, MACROMOLECULES, V32, P2534, DOI 10.1021/ma9814550; Wiedmann TS, 2002, PHARMACEUT RES, V19, P1203, DOI 10.1023/A:1019858428449; HARTEL AJ, 1982, EUR J BIOCHEM, V129, P343, DOI 10.1111/j.1432-1033.1982.tb07057.x; Anwar J, 2009, ANGEW CHEM INT EDIT, V48, P1596, DOI 10.1002/anie.200804553; CHIOU WL, 1971, J PHARM SCI, V60, P1281, DOI 10.1002/jps.2600600902; Friesen DT, 2008, MOL PHARMACEUT, V5, P1003, DOI 10.1021/mp8000793; Singh T, 2007, J PHYS CHEM B, V111, P7843, DOI 10.1021/jp0726889; Erdemir D, 2009, ACCOUNTS CHEM RES, V42, P621, DOI 10.1021/ar800217x; Abu-Diak OA, 2011, MOL PHARMACEUT, V8, P1362, DOI 10.1021/mp200157b; Kadam Y, 2009, COLLOID SURFACE B, V72, P141, DOI 10.1016/j.colsurfb.2009.03.027; SARKAR N, 1995, CARBOHYD POLYM, V26, P195, DOI 10.1016/0144-8617(94)00107-5; Xu S, 2013, INT J PHARMACEUT, V453, P36, DOI 10.1016/j.ijpharm.2013.05.013; Higashi K, 2010, J PHARM SCI-US, V99, P4192, DOI 10.1002/jps.22133; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Serajuddin ATM, 1999, J PHARM SCI, V88, P1058, DOI 10.1021/js980403l; Debnath S, 2004, PHARM RES, V21, P149, DOI 10.1023/B:PHAM.0000012163.89163.f8; Greco K, 2010, MOL PHARMACEUT, V7, P1406, DOI 10.1021/mp1000197; Guijarro JI, 1998, J MOL BIOL, V276, P657, DOI 10.1006/jmbi.1997.1553; Higashi K, 2014, CRYST GROWTH DES, V14, P2773, DOI 10.1021/cg401934v; Ilevbare G.A., 2012, CRYST GROWTH DES, V13, P740; Itch K., 2002, INT J PHARMACEUT, V246, P75; Jha PK, 2014, MOL PHARMACEUT, V11, P1676, DOI 10.1021/mp500068w; Lipinski CA, 2002, AM PHARM REV, V5, P82; Musumeci D, 2010, CRYST GROWTH DES, V10, P1661, DOI 10.1021/cg901225b; Pongpeerapat A, 2006, PHARM RES, V23, P2566, DOI 10.1007/s11095-006-9089-z; Ueda K, 2014, INT J PHARMACEUT, V464, P205, DOI 10.1016/j.ijpharm.2014.01.005; Zhang JY, 2012, INT J PHARMACEUT, V423, P571, DOI 10.1016/j.ijpharm.2011.11.028	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	APR	2015	12	4					1096	1104		10.1021/mp500588x		9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CF4KQ	WOS:000352518400009		
J	Nguyen, TT; Matsui, M; Eto, K				Tao Thien Nguyen; Matsui, Masafumi; Eto, Koshiro			Mitochondrial phylogeny of an Asian tree frog genus Theloderma (Anura: Rhacophoridae)	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Article						Biogeography; Character evolution; mtDNA phylogeny; Nyctixalus; Southeast Asia	SPECIES AMPHIBIA RHACOPHORIDAE; 1ST RECORD; FAMILY RHACOPHORIDAE; VIETNAM; PHILAUTUS; SEQUENCE; CHIROMANTIS; MODELS; BORNEO; GENERA	We assessed phylogenetic and systematic relationships among 17 out of 23 species of Theloderma and all three species of Nyctixalus from 2412 bp sequences of the mitochondrial DNA genes of 12S rRNA, tRNA(val), and 16S rRNA using maximum likelihood and Bayesian inference methods. With the exception of T. moloch, Theloderma and Nyctixalus are confirmed to form a clade, in which each genus also forms a clade. Theloderma moloch is phylogenetically outside these clades and closer to samples from Chiromantis, Feihyla, Gracixalus, Kurixalus, Philautus, Polypedates, Raorchestes, and Rhacophorus. Within Theloderma, T. horridum and T. stellatum form the sister taxon to a clade comprising the remaining species. The basal split within the latter clade groups T. asperum, T. licin, T. petilum, and T. ryabovi as the sister to a clade comprising T. bicolor, T. chuyangsinense, T. corticale, T. gordoni, T. laeve, T. lateriticum, T. nebulosum, T. rhododiscus, and T. truongsonense. Our phylogenetic results indicate homoplastic evolution of four morphological characters: small vs. large body size, presence of vomerine teeth, presence of a vocal opening in males, and interdigital webbing on hands. The common ancestor of Theloderma and Nyctixalus is inferred to have arisen in the area including the current Sunda region. (C) 2015 Elsevier Inc. All rights reserved.	[Tao Thien Nguyen] Vietnam Acad Sci & Technol, Vietnam Natl Museum Nat, Hanoi, Vietnam; [Matsui, Masafumi; Eto, Koshiro] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Eto, Koshiro] Kyoto Univ Museum, Sakyo Ku, Kyoto 6068501, Japan	Matsui, M (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan.	nguyenthientao@gmail.com; fumi@zoo.zool.kyoto-u.ac.jp; koshiro.eto@gmail.com			JSPS RON-PAKU Program the Project of the National Program Tay Nguyen III [TN3/T13, STMVQG. 06G14-16]; Monbusho through JSPS [06041066, 08041144, 20405013, 20405014]; UKM [OUP-PLW-14-59/2008]; TJTTP-OECF	We are grateful to K. Araya, A. Hamidy, J.-P. Jang, K. Nishikawa, and N. Orlov for providing tissue samples, and N. Kuraishi for help in the laboratory. MM thanks the National Research Council of Thailand, the Royal Forest Department of Thailand, the Economic-Planning Unit (former Socio-Economic Research Unit) of Malaysia, and the State Government of Sarawak for permitting to conduct the project, Chulalongkorn University, University Malaya, Universiti Kebangsaan Malaysia (UKM), and the Forest Department, Sarawak for kindly providing all the facilities, and the following for their companionship: N. Ahmad, K. Araya, D. Belabut, K.-O. Chan, T. Hikida, J.-P. Jang, W. Khonsue, the late J. Nabitabhata, K. Nishikawa, H. Ota, S. Panha, and M. Toda. We are also grateful to A. Larson and anonymous reviewers for valuable comments on the manuscript. This research was partly supported by the JSPS RON-PAKU Program the Project TN3/T13 of the National Program Tay Nguyen III and STMVQG. 06G14-16 to T.T. Nguyen, and Grants-in Aid from the Monbusho through JSPS (Field Research, Nos. 06041066, 08041144, 20405013, and 20405014), UKM (OUP-PLW-14-59/2008), and TJTTP-OECF to M. Matsui. T.T. Nguyen is grateful to M. Motokawa for support of work in Japan.	Ahl E., 1931, TIERREICH, V55, P1; Annandale N., 1912, AMPHIBIA REC IND MUS, V8, P7; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Yu GH, 2009, MOL PHYLOGENET EVOL, V50, P571, DOI 10.1016/j.ympev.2008.11.023; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; Leache AD, 2002, SYSTEMATIC BIOL, V51, P44, DOI 10.1080/106351502753475871; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Li JT, 2013, P NATL ACAD SCI USA, V110, P3441, DOI 10.1073/pnas.1300881110; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Bain RH, 2009, ZOOTAXA, P58; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; DUBOIS A, 1981, MONIT ZOOL ITAL, V15, P225; Frost D.R., 2014, AMPHIBIAN SPECIES WO; Frost D.R., 1985, AMPHIBIAN SPECIES WO; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hillis David M., 1996, P321; Jobb G, 2011, TREEFINDER VERSION M; Kuraishi N, 2013, ZOOL SCR, V42, P54, DOI 10.1111/j.1463-6409.2012.00562.x; Li JT, 2008, MOL PHYLOGENET EVOL, V48, P302, DOI 10.1016/j.ympev.2008.03.023; LIEM S S, 1970, Fieldiana Zoology, V57, P1; Liu C., 1962, ACTA ZOOL SINICA, V14, P73; Matsui M., 2015, ZOOL SCI IN PRESS, V32; Matsui M, 2014, ZOOL SCI, V31, P45, DOI 10.2108/zsj.31.45; Matsui Masafumi, 2013, Current Herpetology, V32, P112, DOI 10.5358/hsj.32.112; Tao Tiben Nguyen, 2014, Current Herpetology, V33, P29, DOI 10.5358/hsj.33.29; Nguyen T. T., 2014, CURR HERPETOL, V34, P101; Tao Thien Nguyen, 2014, Current Herpetology, V33, P112, DOI 10.5358/hsj.33.112; Orlov Nikolai L., 2012, Russian Journal of Herpetology, V19, P23; Orlov Nikolai L., 2005, Russian Journal of Herpetology, V12, P135; Orlow Nikolaj, 1997, Herpetofauna (Weinstadt), V19, P5; Myasnikovich M. V., 2006, Russian Journal of Herpetology, V13, P165; Rambaut A, 2009, TRACER VERSION 1 5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowley JJL, 2011, ZOOTAXA, P1; Sano N, 2004, GENES GENET SYST, V79, P151, DOI 10.1266/ggs.79.151; Tavare S., 1986, LECTURES MATH LIFE S, V17, P57; TAYLOR EDWARD H., 1962, UNIV KANSAS SCI BULL, V43, P265; Vences M., 2005, FRONT ZOOL, V2, P5, DOI DOI 10.1186/1742-9994-2-5; Wilkinson JA, 2002, MOL PHYLOGENET EVOL, V24, P265, DOI 10.1016/S1055-7903(02)00212-9; Yu Guo-hua, 2007, Zoological Research, V28, P437	42	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903	1095-9513		MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	APR	2015	85						59	67		10.1016/j.ympev.2015.02.003		9	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CF8PZ	WOS:000352825700007		
J	Yang, L; Sado, T; Hirt, MV; Pasco-Viel, E; Arunachalam, M; Li, JB; Wang, XZ; Freyhof, J; Saitoh, K; Simons, AM; Miya, M; He, SP; Mayden, RL				Yang, Lei; Sado, Tetsuya; Hirt, M. Vincent; Pasco-Viel, Emmanuel; Arunachalam, M.; Li, Junbing; Wang, Xuzhen; Freyhof, Joerg; Saitoh, Kenji; Simons, Andrew M.; Miya, Masaki; He, Shunping; Mayden, Richard L.			Phylogeny and polyploidy: Resolving the classification of cyprinine fishes (Teleostei: Cypriniformes)	MOLECULAR PHYLOGENETICS AND EVOLUTION			English	Article						Biogeography; Cyprinidae; Evolution; Hexaploids; Taxonomy; Tetraploids	CYTOCHROME-B SEQUENCES; GENUS SCHIZOTHORAX TELEOSTEI; MOLECULAR PHYLOGENY; PARTITIONING SCHEMES; SPECIES CYPRINIDAE; SPINED LOACH; MISSING DATA; SMALL BARBUS; EVOLUTION; GENOME	Cyprininae is the largest subfamily (>1300 species) of the family Cyprinidae and contains more polyploid species (similar to 400) than any other group of fishes. We examined the phylogenetic relationships of the Cyprininae based on extensive taxon, geographical, and genomic sampling of the taxa, using both mitochondria] and nuclear genes to address the phylogenetic challenges posed by polyploidy. Four datasets were analyzed in this study: two mitochondria] gene datasets (465 and 791 taxa, 5604 bp), a mitogenome dataset (85 taxa, 14,771 bp), and a cloned nuclear RAG1 dataset (97 taxa, 1497 bp). Based on resulting trees, the subfamily Cyprininae was subdivided into 11 tribes: Probarbini (new; Probarbus + Catlocarpio), Labeonini Bleeker, 1859 (Labeo & allies), Torini Karaman, 1971 (Tor, Labeobarbus & allies), Smiliogastrini Bleeker, 1863 (Puntius, Enteromius & allies), Poropuntiini (Poropuntius & allies), Cyprinini Rafinesque, 1815 (Cyprinus & allies), Acrossocheilini (new; Acrossocheilus & allies), Spinibarbini (new; Spinibarbus), Schizothoracini McClelland, 1842 (Schizothorax & allies), Schizopygopsini Mirza, 1991 (Schizopygopsis & allies), and Barbini Bleeker, 1859 (Barbus & allies). Phylogenetic relationships within each tribe were discussed. Two or three distinct RAG1 lineages were identified for each of the following tribes Torini, Cyprinini, Spinibarbini, and Barbini, indicating their hybrid origin. The hexaploid African Labeobarbus & allies and Western Asian Capoeta are likely derived from two independent hybridization events between their respective maternal tetraploid ancestors and Cyprinion. (C) 2015 Elsevier Inc. All rights reserved.	[Yang, Lei; Mayden, Richard L.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Sado, Tetsuya; Miya, Masaki] Nat Hist Museum & Inst, Dept Zool, Chuo Ku, Chiba 2608682, Japan; [Hirt, M. Vincent] Univ Minnesota, Grad Program Ecol Evolut & Behav, St Paul, MN 55108 USA; [Pasco-Viel, Emmanuel] Univ Lyon 1, Ecole Normale Super Lyon, UMR CNRS 5242, Evodevo Vertebrate Dentit,IGFL, F-69007 Lyon, France; [Pasco-Viel, Emmanuel] Univ Lyon 1, Ecole Normale Super Lyon, UMR CNRS 5242, Mol Zool,IGFL, F-69007 Lyon, France; [Arunachalam, M.] Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Environm Sci, Alwarkurichi 627412, Tamil Nadu, India; [Li, Junbing; Wang, Xuzhen; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, Lab Fish Phylogenet & Biogeog, Wuhan 430072, Peoples R China; [Freyhof, Joerg] German Ctr Integrat Biodivers Res iDiv, Halle Jena Leipzig, D-04103 Leipzig, Germany; [Saitoh, Kenji] Natl Res Inst Fisheries Sci, Aquat Genom Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; [Simons, Andrew M.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Simons, Andrew M.] Univ Minnesota, Bell Museum Nat Hist, St Paul, MN 55108 USA	Yang, L (reprint author), St Louis Univ, Dept Biol, 3507 Laclede Ave, St Louis, MO 63103 USA.	leiyangslu@gmail.com; cypriniformes@gmail.com			USA National Science Foundation; Cypriniformes Tree of Life initiative (CToL) [EF 0431326, EF 0431132]; Collaborative PBI All Cypriniformes Species - Phase II of An Inventory of the Otophysi (ACSI-II) [DEB1021840]; Japan Society for the Promotion of Science [17207007, 22370035]; Saint Louis University, St. Louis, Missouri	This study was developed from the Ph.D. Dissertation of LY (Saint Louis University, 2010; Advisor: RLM). LY would like to express his gratitude to Larry Page, Jonathan Armbruster, Milton Tan, Jarungjit Grudpan, and Chaiwut Grudpan and his students for either organizing or participating in the fieldwork in Thailand. Preserved specimens in Saint Louis University, University of Kansas, and Auburn University and some type materials stored at Institute of Hydrobiology (Wuhan), Kunming Institute of Zoology, Institute of Zoology (Beijing) were examined for this study. We thank Wei-Jen Chen, Mary Agnew and Qiu Ren for help with data collection. Kevin Tang, Lanping Zheng, and Leyang Yuan are thanked for helpful discussion. David Neely is thanked for providing samples. We are grateful to Hsin-Hui Wu and Joe Besser for help using the Cluster computing system. Maurice Kottelat and Carl Ferraris are thanked for discussion on the availability of several family-group names. Maurice Kottelat kindly commented on the discussion part of this paper. LY sincerely appreciates the enormous support from Gavin Naylor. We are very grateful to the associate editor and two anonymous reviewers for their valuable comments and suggestions that helped improve this paper. This research was supported in part by personal funds of RLM, by the USA National Science Foundation grants including The Cypriniformes Tree of Life initiative (CToL) (EF 0431326 to RLM; EF 0431132 to AMS) and the Collaborative PBI All Cypriniformes Species - Phase II of An Inventory of the Otophysi (ACSI-II) (DEB1021840 to RLM), by the Japan Society for the Promotion of Science (17207007 and 22370035) and by Saint Louis University, St. Louis, Missouri.	Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Evans BJ, 2005, MOL BIOL EVOL, V22, P1193, DOI 10.1093/molbev/msi104; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Yang J, 2012, J ZOOL SYST EVOL RES, V50, P184, DOI 10.1111/j.1439-0469.2012.00661.x; Saitoh K, 2010, MOL PHYLOGENET EVOL, V56, P1001, DOI 10.1016/j.ympev.2010.04.021; Chen WJ, 2013, EVOLUTION, V67, P2218, DOI 10.1111/evo.12104; Machordom A, 2001, P ROY SOC B-BIOL SCI, V268, P1297, DOI 10.1098/rspb.2001.1654; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Van Der Laan R, 2014, ZOOTAXA, V3882, P1, DOI 10.11646/zootaxa.3882.1.1; Wang XZ, 2007, MOL PHYLOGENET EVOL, V42, P157, DOI 10.1016/j.ympev.2006.06.014; Tsigenopoulos CS, 2003, BIOL J LINN SOC, V80, P207, DOI 10.1046/j.1095-8312.2003.00237.x; Kottelat M, 2013, RAFFLES B ZOOL, P1; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Saitoh K, 2011, ZOOL J LINN SOC-LOND, V161, P633, DOI 10.1111/j.1096-3642.2010.00651.x; Yang L, 2012, MOL PHYLOGENET EVOL, V65, P362, DOI 10.1016/j.ympev.2012.06.007; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; Arai R, 2011, FISH KARYOTYPES CHEC; BANARESCU P, 1971, Revue Roumaine de Biologie Serie de Zoologie, V16, P241; Borkenhagen K, 2014, ENVIRON BIOL FISH, V97, P1179, DOI 10.1007/s10641-014-0315-y; Borkenhagen K, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.339.4903; Cao W.-x, 1981, COLLECTION STUDIES P, P118; Cavender T.M., 1993, P293; Chen X.-l., 1984, Acta Zootaxonomica Sinica, V9, P424; Chen Yiyu, 1989, Bulletin of the British Museum (Natural History) Zoology, V55, P109; Chu X. L., 1989, FISHES YUNNAN CHIN 1; CUI J, 1991, Cytologia (Tokyo), V56, P425; Donsakul T., 2012, P 50 KAS U ANN C KAS, V1, P439; Eschmeyer W.N., 2015, CATALOG FISHES; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Ganai FA, 2011, CARYOLOGIA, V64, P435; GOLUBTSOV AS, 1993, J FISH BIOL, V42, P445; He SP, 2004, SCI CHINA SER C, V47, P130, DOI 10.1360/03yc0034; Howes G. J., 1991, CYPRINID FISHES SYST, P1; Howes G.J., 1987, Bulletin of the British Museum (Natural History) Zoology, V52, P165; International Commission on Zoological Nomenclature (ICZN), 1999, INT CODE ZOOLOGICAL; Janse A. J. T, 1933, MOTHS S AFRICA; Kong XiangHui, 2007, Sci China C Life Sci, V50, P780, DOI 10.1007/s11427-007-0076-3; Kottelat M, 1993, FRESHWATER FISHES W; Kottelat M., 2001, FRESHWATER FISHES NO; Kullander SO, 1999, RIVER JHELUM KASHMIR, P99; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Levin BA, 2012, MOL PHYLOGENET EVOL, V62, P542, DOI 10.1016/j.ympev.2011.09.004; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; McClelland J., 1842, CALCUTTA J NATURAL H, V2, P560; MIRZA M R, 1991, Pakistan Journal of Zoology, V23, P339; Nelson JS, 1994, FISHES WORLD; Nelson JS, 2006, FISHES WORLD; Pasco-Viel E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2688; Pethiyagoda R, 2013, ZOOTAXA, V3646, P199; Pethiyagoda R, 2012, ICHTHYOL EXPLOR FRES, V23, P69; Phillips MJ, 2001, P ROY SOC B-BIOL SCI, V268, P1533; Rab P, 1995, CARYOLOGIA, V48, P299; Raghavan Rajeev, 2013, Journal of Threatened Taxa, V5, P4932; Rainboth W.J., 1981, THESIS U MICHIGAN AN; Rainboth W.J., 1996, TAXONOMY SYSTEMATICS, V129, p[i, 1]; Rainboth W.J., 1996, FISHES CAMBODIAN MEK; Rainboth WJ, 1991, CYPRINID FISHES SYST, P156; Rainboth W.J., 2012, FISHES GREATER MEKON, V201, p[i, 1]; REID GM, 1982, J NAT HIST, V16, P497, DOI 10.1080/00222938200770401; Reid G.Mc.G., 1985, REVISION AFRICAN SPE, V6, P1; Ruber L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-38; Roberts T.R., 1992, Ichthyological Exploration of Freshwaters, V3, P37; Sahoo P.K., 2009, Asian Fisheries Science, V22, P501; Saitoh K, 2008, GENE, V423, P92, DOI 10.1016/j.gene.2008.06.025; Saitoh K, 2003, FOLIA BIOL-KRAKOW, V51, P101; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Shan X.H., 2000, FAUNA SINICA OSTEICH, P3; Smith A.G., 1994, ATLAS MESOZOIC CENOZ, P778; Smith H. M., 1945, B AM MUS NAT HIST, V188; Stamatakis A, 2014, BIOINFORMATICS; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; TAKI Y, 1974, Japanese Journal of Ichthyology, V21, P129; Tomoda Y, 2011, ICHTHYOL RES, V58, P288, DOI 10.1007/s10228-011-0214-6; Tsigenopoulos CS, 2000, MOL PHYLOGENET EVOL, V14, P165, DOI 10.1006/mpev.1999.0702; Tsigenopoulos CS, 2010, MOL PHYLOGENET EVOL, V56, P851, DOI 10.1016/j.ympev.2010.02.006; VANCOUVERING JAH, 1977, COPEIA, P163; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061827; Wu H.W., 1977, CYPRINID FISHES CHIN, P229; Wu RL, 2001, GENETICS, V159, P869; Wu Yun-fei, 1999, Zoological Research, V20, P258; Xiao Heng, 2002, Zoological Research, V23, P195; Yang JX, 1994, ZOOL RES, V15, P1; Yang L, 2012, ZOOTAXA, P26; Yang L, 2010, MOL PHYLOGENET EVOL, V54, P254, DOI 10.1016/j.ympev.2009.09.027; Yang L, 2010, ZOOL SCR, V39, P527, DOI 10.1111/j.1463-6409.2010.00443.x; Yue P. Q., 2000, FAUNA SINICA OSTEICH, VIII, P1; Zhou Wei, 1996, Ichthyological Exploration of Freshwaters, V7, P131	93	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1055-7903	1095-9513		MOL PHYLOGENET EVOL	Mol. Phylogenet. Evol.	APR	2015	85						97	116		10.1016/j.ympev.2015.01.014		20	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CF8PZ	WOS:000352825700011		
J	Fujimoto, T; Mizukubo, T; Abe, H; Seo, S				Fujimoto, Taketo; Mizukubo, Takayuki; Abe, Hiroshi; Seo, Shigemi			Sclareol Induces Plant Resistance to Root-Knot Nematode Partially Through Ethylene-Dependent Enhancement of Lignin Accumulation	MOLECULAR PLANT-MICROBE INTERACTIONS			English	Article							ACID SIGNALING PATHWAY; ARABIDOPSIS-THALIANA; MELOIDOGYNE-JAVANICA; 2ND-STAGE JUVENILES; LEUCINE-ZIPPER; ABSCISIC-ACID; BIOSYNTHESIS; TOMATO; JASMONATE; TRANSPORTER	The root-knot nematode (RKN) is one of the most devastating parasitic nematodes of plants. Although some secondary metabolites released by the host plant play roles as defense substances against parasitic nematodes, the mechanism underlying the induction of such defense responses is not fully understood. We found that sclareol, a natural diterpene known as an antimicrobial and defense-related molecule, inhibited RKN penetration of tomato and Arabidopsis roots. Sclareol induced genes related to ethylene (ET) biosynthesis and signaling and phenylpropanoid metabolism in Arabidopsis roots. In roots of ein2-1, an ET-insensitive mutant line, both sclareol-induced inhibition of RKN penetration and sclareol-induced enhancement of lignin accumulation were abolished. A mutant defective in lignin accumulation did not exhibit such inhibition. Sclareol also activated MPK3 and MPK6, Arabidopsis mitogen-activated protein kinases whose activation is required for triggering ET biosynthesis. Sclareol-induced inhibition of RKN penetration was exhibited by mutants of neither MPK3 nor MPK6. Treatment with a biosynthetic precursor of ET was insufficient compared with sclareol treatment to inhibit RKN penetration, suggesting the existence of an ET-independent signaling pathway leading to RKN resistance. These results suggested that sclareol induced resistance to RKN penetration partially through ET-dependent accumulation of lignin in roots.	[Fujimoto, Taketo; Mizukubo, Takayuki] Natl Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan; [Fujimoto, Taketo; Seo, Shigemi] Natl Inst Agrobiol Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Fujimoto, Taketo] Japan Soc Promot Sci, Tokyo, Japan; [Abe, Hiroshi] RIKEN BioResource Ctr, Dept Biol Syst, Tsukuba, Ibaraki 3050074, Japan	Seo, S (reprint author), Natl Inst Agrobiol Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki 3058602, Japan.	mizu@affrc.go.jp; sseo71@affrc.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japanese Program for the Promotion of Basic and Applied Research for Innovation in Bio-oriented Industry (BRAIN), Japan; Cross-Ministerial Strategic Innovation Promotion Program, (SIP) of Council for Science, Technology and Innovation Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; the Japanese Program for the Promotion of Basic and Applied Research for Innovation in Bio-oriented Industry (BRAIN), Japan; and a grant from Cross-Ministerial Strategic Innovation Promotion Program, (SIP) of Council for Science, Technology and Innovation Japan. We thank Y. Takeuchi (Graduate School of Agriculture, Kyoto University) for critical reading of the manuscript and Y. Osakabe (RIKEN) for help with lignin measurements.	Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Abe H, 2008, PLANT CELL PHYSIOL, V49, P68, DOI 10.1093/pcp/pcm168; Fujimoto T, 2011, J PLANT PHYSIOL, V168, P1084, DOI 10.1016/j.jplph.2010.12.002; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Cheng AX, 2007, J INTEGR PLANT BIOL, V49, P179, DOI 10.1111/j.1744-7909.2007.00395.x; BAILEY JA, 1975, NATURE, V255, P328, DOI 10.1038/255328a0; GLAZER I, 1985, J NEMATOL, V17, P145; Fujimoto Taketo, 2011, Nematological Research, V41, P9; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Fudali SL, 2013, MOL PLANT MICROBE IN, V26, P75, DOI 10.1094/MPMI-05-12-0107-R; Leon-Reyes A, 2009, PLANT PHYSIOL, V149, P1797, DOI 10.1104/pp.108.133926; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Milligan SB, 1998, PLANT CELL, V10, P1307; Cano-Delgado AI, 2000, DEVELOPMENT, V127, P3395; Chen SY, 2000, J NEMATOL, V32, P117; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wuyts N, 2006, J EXP BOT, V57, P2825, DOI 10.1093/jxb/erl044; Schmelz EA, 2003, PLANTA, V216, P665, DOI 10.1007/s00425-002-0898-y; Caniard A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-119; GLAZER I, 1983, J NEMATOL, V15, P539; Grec S, 2003, PLANT J, V35, P237, DOI 10.1046/j.1365-313X.2003.01792.x; KENNEDY BS, 1992, J CHEM ECOL, V18, P1467, DOI 10.1007/BF00993221; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; McBeth C. W., 1941, P HELM SOC WASH, V16, P3; Pedras MSC, 2000, PHYTOCHEMISTRY, V53, P161, DOI 10.1016/S0031-9422(99)00494-X; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Seo S, 2012, PLANT CELL PHYSIOL, V53, P1432, DOI 10.1093/pcp/pcs085; Seo S, 2007, PLANT J, V49, P899, DOI 10.1111/j.1365-313X.2006.03003.x; Sokal RR, 1995, BIOMETRY; Suzuki S, 2009, PLANT BIOTECHNOL, V26, P337, DOI 10.5511/plantbiotechnology.26.337; VOLKMAR KM, 1991, J NEMATOL, V23, P425; Wang CL, 2009, NEMATOLOGY, V11, P453, DOI 10.1163/156854109X447024; WYSS U, 1992, NEMATOLOGICA, V38, P98	40	0	0	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0894-0282	1943-7706		MOL PLANT MICROBE IN	Mol. Plant-Microbe Interact.	APR	2015	28	4					398	407		10.1094/MPMI-10-14-0320-R		10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Plant Sciences	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Plant Sciences	CF8HI	WOS:000352796500003		
J	Hayashita-Kinoh, H; Yugeta, N; Okada, H; Nitahara-Kasahara, Y; Chiyo, T; Okada, T; Takeda, S				Hayashita-Kinoh, Hiromi; Yugeta, Naoko; Okada, Hironori; Nitahara-Kasahara, Yuko; Chiyo, Tomoko; Okada, Takashi; Takeda, Shin'ichi			Intra-Amniotic rAAV-Mediated Microdystrophin Gene Transfer Improves Canine X-Linked Muscular Dystrophy and May Induce Immune Tolerance	MOLECULAR THERAPY			English	Article							HUMAN-FACTOR-IX; IN-UTERO; ADENOASSOCIATED VIRUS; PULMONARY EPITHELIUM; TRANSGENE PRODUCT; SKELETAL-MUSCLE; AMNIOTIC-FLUID; HEMOPHILIA-B; FETAL SHEEP; MDX-MOUSE	Duchenne muscular dystrophy (DMD) is a severe congenital disease due to mutations in the dystrophin gene. Supplementation of dystrophin using recombinant adeno-associated virus vector has promise as a treatment of DMD, although therapeutic benefit of the truncated dystrophin still remains to be elucidated. Besides, host immune responses against the vector as well as transgene products have been denoted in the clinical gene therapy studies. Here, we transduced dystrophic dogs fetuses to investigate the therapeutic effects of an AAV vector expressing microdystrophin under conditions of immune tolerance. rAAV-CMV-microdystrophin and a rAAV-CAG-luciferase were injected into the amniotic fluid surrounding fetuses. We also reinjected rAAV9-CMV-microdystrophin into the jugular vein of an infant dystrophic dog to induce systemic expression of microdystrophin. Gait and cardiac function significantly improved in the rAAV-microdystrophin-injected dystrophic dog, suggesting that an adequate treatment of rAAV-microdystrophin with immune modulation induces successful long-term transgene expression to analyze improved dystrophic phenotype.	[Hayashita-Kinoh, Hiromi; Yugeta, Naoko; Okada, Hironori; Nitahara-Kasahara, Yuko; Chiyo, Tomoko; Okada, Takashi; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1870031, Japan	Okada, T (reprint author), Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1138602, Japan.	t-okada@nms.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology	We thank James M Wilson for providing a helper plasmid pAAV2/9. The authors also thank JCR Pharmaceuticals Co., Ltd. (Hyogo, Japan), Yoko Fujii, Tetsuya Nagata, Masanori Kobayashi, Takashi Saitoh, Mutsuki Kuraoka, and Yuko Shimizu-Motohashi for technical advice, support, and helpful discussion; Kazue Kinoshita for rAAV preparation; Ryoko Nakagawa and Satoru Masuda for technical assistance; and Hideki Kita, Shin-ichi Ichikawa, Yumiko Yahata-Kobayashi, Aya Kuriyama, Takashi Machida, and other staff members of JAC Co. for their care of the dogs. This work was financially supported by Grants-in-Aid for Scientific Research on Nervous and Mental Disorders and Health Sciences Research Grants for Research on Human Genome and Gene Therapy from the Ministry of Health, Labor and Welfare of Japan and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology. The authors declare no conflict of interest.	MOISE NS, 1991, J AM COLL CARDIOL, V17, P812; Shin JH, 2013, MOL THER, V21, P750, DOI 10.1038/mt.2012.283; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; Day MJ, 2007, J COMP PATHOL, V137, pS10, DOI 10.1016/j.jcpa.2007.04.005; Shelton GD, 2005, NEUROMUSCULAR DISORD, V15, P127, DOI 10.1016/j.nmd.2004.10.019; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zhang P, 2012, HUM GENE THER, V23, P460, DOI 10.1089/hum.2011.063; Gregorevic P, 2008, MOL THER, V16, P657, DOI 10.1038/mt.2008.28; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Yoshimura M, 2004, MOL THER, V10, P821, DOI 10.1016/j.ymthe.2004.07.025; Pichavant C, 2010, MOL THER, V18, P1002, DOI 10.1038/mt.2010.23; Wang ZJ, 2012, MOL THER, V20, P1501, DOI 10.1038/mt.2012.111; Yuasa K, 2007, GENE THER, V14, P1249, DOI 10.1038/sj.gt.3302984; David A, 2003, HUM GENE THER, V14, P353, DOI 10.1089/104303403321208952; Gayraud J, 2007, J MUSCLE RES CELL M, V28, P29, DOI 10.1007/s10974-007-9101-1; Kornegay JN, 2010, MOL THER, V18, P1501, DOI 10.1038/mt.2010.94; Shin JH, 2012, HUM GENE THER, V23, P202, DOI 10.1089/hum.2011.147; Yuasa K, 2002, GENE THER, V9, P1576, DOI 10.1038/sj.gt.3301829; Wang ZJ, 2007, MOL THER, V15, P1160, DOI 10.1038/sj.mt.6300161; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; MCCLURKIN AW, 1984, CAN J COMP MED, V48, P156; Muller J, 2001, J MUSCLE RES CELL M, V22, P133, DOI 10.1023/A:1010305801236; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Bennett M, 2001, HUM GENE THER, V12, P1857, DOI 10.1089/104303401753153910; Bilbao R, 2005, HUM GENE THER, V16, P678, DOI 10.1089/hum.2005.16.678; Boyle MP, 2003, HUM GENE THER, V14, P365, DOI 10.1089/104303403321208961; Boyle MP, 2001, MOL THER, V4, P115, DOI 10.1006/mthe.2001.0428; BRACE RA, 1995, PLACENTA, V16, P1, DOI 10.1016/0143-4004(95)90077-2; Douar AM, 1997, GENE THER, V4, P883, DOI 10.1038/sj.gt.3300498; Duan D., 2011, RES REP BIOL, V2011, P31; Herzog RW, 2002, HUM GENE THER, V13, P1281, DOI 10.1089/104303402760128513; HOLZINGER A, 1995, PEDIATR RES, V38, P844, DOI 10.1203/00006450-199512000-00004; Kobayashi M, 2009, MUSCLE NERVE, V40, P815, DOI 10.1002/mus.21384; Koo T, 2011, J GENE MED, V13, P497, DOI 10.1002/jgm.1602; Koppanati BM, 2010, GENE THER, V17, P1355, DOI 10.1038/gt.2010.84; Larson JE, 2000, MOL THER, V2, P631, DOI 10.1006/mthe.2000.0209; MALMQUIS.WA, 1968, J AM VET MED ASSOC, V152, P763; Mitchell M, 2000, GENE THER, V7, P1986, DOI 10.1038/sj.gt.3301332; Miyazato LG, 2011, VET PATHOL, V48, P655, DOI 10.1177/0300985810387070; Ohshima S, 2009, MOL THER, V17, P73, DOI 10.1038/mt.2008.225; Okada T, 2009, HUM GENE THER, V20, P1013, DOI 10.1089/hum.2009.006; Sabatino DE, 2007, MOL THER, V15, P1677, DOI 10.1038/sj.mt.6300219; SEKHON HS, 1995, NAT MED, V1, P1201, DOI 10.1038/nm1195-1201; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Shimatsu Y, 2003, EXP ANIM TOKYO, V52, P93, DOI 10.1538/expanim.52.93; Shin JH, 2011, GENE THER, V18, P910, DOI 10.1038/gt.2011.36; Takano H, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-23; Unzu C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-122; VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; Waddington SN, 2004, BLOOD, V104, P2714, DOI 10.1182/blood-2004-02-0627; Yang EY, 1999, SEMIN PERINATOL, V23, P524, DOI 10.1016/S0146-0005(99)80031-7; Yugeta Naoko, 2006, BMC Cardiovasc Disord, V6, P47, DOI 10.1186/1471-2261-6-47	55	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	APR	2015	23	4					627	637		10.1038/mt.2015.5		11	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CF4EB	WOS:000352500400008		
J	Fujita, Y; Yagishita, S; Hagiwara, K; Yoshioka, Y; Kosaka, N; Takeshita, F; Fujiwara, T; Tsuta, K; Nokihara, H; Tamura, T; Asamura, H; Kawaishi, M; Kuwano, K; Ochiya, T				Fujita, Yu; Yagishita, Shigehiro; Hagiwara, Keitaro; Yoshioka, Yusuke; Kosaka, Nobuyoshi; Takeshita, Fumitaka; Fujiwara, Tomohiro; Tsuta, Koji; Nokihara, Hiroshi; Tamura, Tomohide; Asamura, Hisao; Kawaishi, Makoto; Kuwano, Kazuyoshi; Ochiya, Takahiro			The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer	MOLECULAR THERAPY			English	Article							B7-H1 EXPRESSION; IN-VITRO; MICRORNA; POLYMORPHISMS; RESISTANT; GENES; RISK	Programmed cell death ligand-1 (PD-L1) has recently gained considerable attention for its role in tumor immune escape. Here, we identify a miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer (NSCLC), independent of immunoinhibitory signals. miR-197 is downregulated in platinum-resistant NSCLC specimens, resulting in the promotion of chemoresistance, tumorigenicity, and pulmonary metastasis in vitro and in vivo. Mechanistic investigations reveal that a miR-197-mediated CKS1B/STAT3 axis exerts tumor progression regulated by various oncogenic genes (Bcl-2, c-Myc, and cyclin D1), and PD-L1 is a putative biomarker of this axis. Furthermore, we demonstrate that a miR-197 mimic sensitizes PD-L1(high) drug-resistant cells to chemotherapy. These results indicate that the biological interaction between PD-L1 and chemoresistance occurs through the microRNA regulatory cascade. More importantly, expression levels of miR-197 are inversely correlated with PD-L1 expression (n = 177; P = 0.026) and are associated with worse overall survival (P = 0.015). Our discoveries suggest that the miR-197/CKS1B/STAT3-mediated network can drive tumor PD-L1 expression as a biomarker of this cascade, and miR-197 replacement therapy may be a potential treatment strategy for chemoresistant NSCLC.	[Fujita, Yu; Hagiwara, Keitaro; Yoshioka, Yusuke; Kosaka, Nobuyoshi; Takeshita, Fumitaka; Fujiwara, Tomohiro; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 1040045, Japan; [Fujita, Yu; Kawaishi, Makoto; Kuwano, Kazuyoshi] Jikei Univ, Sch Med, Dept Internal Med, Div Resp Dis, Tokyo, Japan; [Yagishita, Shigehiro; Nokihara, Hiroshi; Tamura, Tomohide] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; [Tsuta, Koji] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Asamura, Hisao] Natl Canc Ctr, Dept Thorac Surg, Tokyo, Japan	Ochiya, T (reprint author), Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tochiya@ncc.go.jp		Fujita, Yu/0000-0002-8916-7303	Foundation for Promotion of Cancer Research (Japan); National Cancer Center Research and Development Fund, Japan	We thank Luc Gailhouste for carefully reading the manuscript. This work was supported in part by a grant-in-aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control of Japan including Awardee of Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan). National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan. T.O., Y.F., M.K., and K.K. conceived the idea and coordinated the project. Y.F., K.H., and Y.Y. performed a significant amount of the experimental work. S.Y., H.N., and T.T. analyzed the clinical data. K.T. and H.A. provided tumor specimens. T.O., Y.F., S.Y., Y.Y., and N.K. wrote the manuscript and prepared the figures and tables. The authors have declared that no conflict of interest exists.	Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; PEARSON WR, 1993, AM J HUM GENET, V53, P220; Liberal V, 2012, P NATL ACAD SCI USA, V109, P2754, DOI 10.1073/pnas.1102434108; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Shi L, 2010, ONCOTARGET, V1, P22; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; OHMORI T, 1993, JPN J CANCER RES, V84, P83; Dai YM, 2011, HEAD NECK-J SCI SPEC, V33, P786, DOI 10.1002/hed.21540; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Hung RJ, 2003, CARCINOGENESIS, V24, P875, DOI 10.1093/carcin/bgg026; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Keutgen XM, 2012, CLIN CANCER RES, V18, P2032, DOI 10.1158/1078-0432.CCR-11-2487; Zhou JF, 2010, ONCOL REP, V23, P121, DOI 10.3892/or_00000613; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Hamada S, 2013, J CELL PHYSIOL, V228, P1255, DOI 10.1002/jcp.24280; Benhamou S, 2002, CARCINOGENESIS, V23, P1343, DOI 10.1093/carcin/23.8.1343; Garnis C, 2005, HUM MOL GENET, V14, P475, DOI 10.1093/hmg/ddi043; Ghebeh H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2605; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Onn A, 2003, CLIN CANCER RES, V9, P5532; Pan HJ, 2005, CANCER RES, V65, P1664, DOI 10.1158/0008-5472.CAN-04-3297; Shen J., 2012, EXPERT OPIN MED DIAG, V6, P197; Tsai YHS, 2005, IUBMB LIFE, V57, P583, DOI 10.1080/15216540500215531; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	31	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	APR	2015	23	4					717	727		10.1038/mt.2015.10		11	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CF4EB	WOS:000352500400017		
J	Schrock, LE; Mink, JW; Woods, DW; Porta, M; Servello, D; Visser-Vandewalle, V; Silburn, PA; Foltynie, T; Walker, HC; Shahed-Jimenez, J; Savica, R; Klassen, BT; Machado, AG; Foote, KD; Zhang, JG; Hu, W; Ackermans, L; Temel, Y; Mari, Z; Changizi, BK; Lozano, A; Auyeung, M; Kaido, T; Agid, Y; Welter, ML; Khandhar, SM; Mogilner, AY; Pourfar, MH; Walter, BL; Juncos, JL; Gross, RE; Kuhn, J; Leckman, JF; Neimat, JA; Okun, MS				Schrock, Lauren E.; Mink, Jonathan W.; Woods, Douglas W.; Porta, Mauro; Servello, Dominico; Visser-Vandewalle, Veerle; Silburn, Peter A.; Foltynie, Thomas; Walker, Harrison C.; Shahed-Jimenez, Joohi; Savica, Rodolfo; Klassen, Bryan T.; Machado, Andre G.; Foote, Kelly D.; Zhang, Jian-Guo; Hu, Wei; Ackermans, Linda; Temel, Yasin; Mari, Zoltan; Changizi, Barbara K.; Lozano, Andres; Auyeung, M.; Kaido, Takanobu; Agid, Yves; Welter, Marie L.; Khandhar, Suketu M.; Mogilner, Alon Y.; Pourfar, Michael H.; Walter, Benjamin L.; Juncos, Jorge L.; Gross, Robert E.; Kuhn, Jens; Leckman, James F.; Neimat, Joseph A.; Okun, Michael S.		Tourette Syndrome Assoc Int	Tourette Syndrome Deep Brain Stimulation: A Review and Updated Recommendations	MOVEMENT DISORDERS			English	Review						Tourette syndrome; DBS; guidelines; deep brain stimulation	OBSESSIVE-COMPULSIVE DISORDER; GLOBUS-PALLIDUS INTERNUS; QUALITY STANDARDS SUBCOMMITTEE; RANDOMIZED CONTROLLED-TRIAL; ACADEMY-OF-NEUROLOGY; THALAMIC-STIMULATION; PARKINSON-DISEASE; LONG-TERM; MOVEMENT-DISORDERS; PRACTICE PARAMETER	Deep brain stimulation (DBS) may improve disabling tics in severely affected medication and behaviorally resistant Tourette syndrome (TS). Here we review all reported cases of TS DBS and provide updated recommendations for selection, assessment, and management of potential TS DBS cases based on the literature and implantation experience. Candidates should have a Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM V) diagnosis of TS with severe motor and vocal tics, which despite exhaustive medical and behavioral treatment trials result in significant impairment. Deep brain stimulation should be offered to patients only by experienced DBS centers after evaluation by a multidisciplinary team. Rigorous preoperative and postoperative outcome measures of tics and associated comorbidities should be used. Tics and comorbid neuropsychiatric conditions should be optimally treated per current expert standards, and tics should be the major cause of disability. Psychogenic tics, embellishment, and malingering should be recognized and addressed. We have removed the previously suggested 25-year-old age limit, with the specification that a multidisciplinary team approach for screening is employed. A local ethics committee or institutional review board should be consulted for consideration of cases involving persons younger than 18 years of age, as well as in cases with urgent indications. Tourette syndrome patients represent a unique and complex population, and studies reveal a higher risk for post-DBS complications. Successes and failures have been reported for multiple brain targets; however, the optimal surgical approach remains unknown. Tourette syndrome DBS, though still evolving, is a promising approach for a subset of medication refractory and severely affected patients. (c) 2014 International Parkinson and Movement Disorder Society	[Schrock, Lauren E.; Savica, Rodolfo] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Mink, Jonathan W.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Woods, Douglas W.] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA; [Porta, Mauro] IRCCS Galeazzi Hosp, Tourette Ctr, Milan, Italy; [Servello, Dominico] IRCCS Galeazzi Milano, Funct Neurosurg Unit, Milan, Italy; [Visser-Vandewalle, Veerle] Univ Cologne, Dept Stereotact & Funct Neurosurg, D-50931 Cologne, Germany; [Silburn, Peter A.] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Brisbane, Qld, Australia; [Foltynie, Thomas] UCL, Inst Neurol, London, England; [Walker, Harrison C.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Shahed-Jimenez, Joohi] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Klassen, Bryan T.; Hu, Wei] Mayo Clin, Dept Neurol, Rochester, MN USA; [Machado, Andre G.] Cleveland Clin, Neurol Inst, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Foote, Kelly D.; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurol, Gainesville, FL USA; [Foote, Kelly D.; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurosurg, Gainesville, FL USA; [Foote, Kelly D.; Okun, Michael S.] Univ Florida, Dept Psychiat, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA; [Zhang, Jian-Guo; Hu, Wei] Capital Univ Med Sci, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Ackermans, Linda; Temel, Yasin] Maastricht Univ, Med Ctr, Dept Neurosurg, NL-6200 MD Maastricht, Netherlands; [Mari, Zoltan] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Changizi, Barbara K.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Changizi, Barbara K.] Ohio State Univ, Dept Psychiat, Wexner Med Ctr, Columbus, OH 43210 USA; [Lozano, Andres] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Auyeung, M.] Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Kaido, Takanobu] NCNP, Natl Ctr Hosp, Dept Neurosurg, Tokyo, Japan; [Agid, Yves] CHU Pitie Salpetriere, Inst Cerveau & Moelle Epiniere ICM, Paris, France; [Welter, Marie L.] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, Paris, France; [Khandhar, Suketu M.] Kaiser Permanente No Calif, Surg Movement Disorders Program, Sacramento, CA USA; [Mogilner, Alon Y.; Pourfar, Michael H.] NYU, Dept Neurosurg, Langone Med Ctr, New York, NY 10016 USA; [Mogilner, Alon Y.; Pourfar, Michael H.] NYU, Dept Neurol, Langone Med Ctr, New York, NY 10016 USA; [Walter, Benjamin L.] Univ Hosp, Neurol Inst, Movement Disorders Ctr, South Euclid, OH USA; [Walter, Benjamin L.] Case Western Reserve Univ, Sch Med, South Euclid, OH USA; [Juncos, Jorge L.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Gross, Robert E.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Kuhn, Jens] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Leckman, James F.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Leckman, James F.] Yale Univ, Sch Med, Yale Ctr Clin Invest, New Haven, CT USA; [Neimat, Joseph A.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA	Okun, MS (reprint author), Ctr Movement Disorders & Neurorestorat, Dept Neurol, 3450 Hull Rd, Gainesville, FL 32607 USA.	okun@neurology.ufl.edu					Ackermans Linda, 2007, Neurosurgery, V61, pE1100; Ackermans L, 2010, J NEUROL NEUROSUR PS, V81, P1068, DOI 10.1136/jnnp.2009.176859; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Ackermans L, 2011, BRAIN, V134, P832, DOI 10.1093/brain/awq380; Ackermans L, 2006, MOVEMENT DISORD, V21, P709, DOI 10.1002/mds.20816; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD; Wilhelm S, 2012, ARCH GEN PSYCHIAT, V69, P795, DOI 10.1001/archgenpsychiatry.2011.1528; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; Mink JW, 2006, MOVEMENT DISORD, V21, P1831, DOI 10.1002/mds.21039; Piacentini J, 2010, JAMA-J AM MED ASSOC, V303, P1929, DOI 10.1001/jama.2010.607; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; Greenberg BD, 2010, NEUROPSYCHOPHARMACOL, V35, P317, DOI 10.1038/npp.2009.128; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Dehning S, 2008, MOVEMENT DISORD, V23, P1300, DOI 10.1002/mds.21930; Greenberg BD, 2003, NEUROSURG CLIN N AM, V14, P199, DOI 10.1016/S1042-3680(03)00005-6; Leckman JF, 2006, J CHILD NEUROL, V21, P642, DOI 10.2310/7010.2006.00167; Porta M, 2009, NEUROLOGY, V73, P1375, DOI 10.1212/WNL.0b013e3181bd809b; Cavanna AE, 2012, EUR J PAEDIATR NEURO, V16, P605, DOI 10.1016/j.ejpn.2012.02.004; French J, 2008, NEUROLOGY, V71, P1634, DOI 10.1212/01.wnl.0000336533.19610.1b; Duits A, 2012, EUR CHILD ADOLES PSY, V21, P529, DOI 10.1007/s00787-012-0285-6; Diederich NJ, 2005, MOVEMENT DISORD, V20, P1496, DOI 10.1002/mds.20551; Servello D, 2008, J NEUROL NEUROSUR PS, V79, P136, DOI 10.1136/jnnp.2006.104067; Ostrem JL, 2008, NEUROTHERAPEUTICS, V5, P320, DOI 10.1016/j.nurt.2008.01.002; Okun MS, 2005, ARCH NEUROL-CHICAGO, V62, P1250, DOI 10.1001/archneur.62.8.noc40425; Savica R, 2012, MAYO CLIN PROC, V87, P59, DOI 10.1016/j.mayocp.2011.08.005; Cavanna AE, 2011, BRIT J NEUROSURG, V25, P38, DOI 10.3109/02688697.2010.534200; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Houeto JL, 2005, J NEUROL NEUROSUR PS, V76, P992, DOI 10.1136/jnnp.2004.043273; Chen JJ, 2012, CLIN THER, V34, P1487, DOI 10.1016/j.clinthera.2012.06.010; Cavanna AE, 2013, BEHAV NEUROL, V27, P83, DOI 10.3233/BEN-120296; Porta M, 2012, ACTA NEUROCHIR, V154, P2029, DOI 10.1007/s00701-012-1497-8; Burdick A, 2010, NEUROCASE, V16, P321, DOI 10.1080/13554790903560422; Shahed J, 2007, NEUROLOGY, V68, P159, DOI 10.1212/01.wnl.0000250354.81556.90; Welter ML, 2008, ARCH NEUROL-CHICAGO, V65, P952, DOI 10.1001/archneur.65.7.952; Air EL, 2011, J NEUROSURG-PEDIATR, V8, P566, DOI 10.3171/2011.8.PEDS11153; Kuhn J, 2007, J NEUROL, V254, P963, DOI 10.1007/s00415-006-0404-8; Martinez-Torres I, 2009, NEUROLOGY, V72, P1787, DOI 10.1212/WNL.0b013e3181a60a0c; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; Mathews CA, 2004, J NEUROL NEUROSUR PS, V75, P1149, DOI 10.1136/jnnp.2003.020693; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Piedad JCP, 2012, NEUROSURGERY, V71, P173, DOI 10.1227/NEU.0b013e3182535a00; Abelson JL, 2005, BIOL PSYCHIAT, V57, P510, DOI 10.1016/j.biopsych.2004.11.042; Zabek M, 2008, NEUROL NEUROCHIR POL, V42, P554; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Servello D, 2011, ACTA NEUROCHIR, V153, P629, DOI 10.1007/s00701-010-0851-y; Muller-Vahl KR, 2011, EUR CHILD ADOLES PSY, V20, P209, DOI 10.1007/s00787-011-0166-4; Eddy CM, 2011, MOVEMENT DISORD, V26, P735, DOI 10.1002/mds.23434; [Anonymous], 2013, DIAGN STAT MAN MENT, Vxliv, P947; Shprecher D, 2009, MOVEMENT DISORD, V24, P15, DOI 10.1002/mds.22378; Kuhn J, 2012, BIOL PSYCHIAT, V71, pE11, DOI 10.1016/j.biopsych.2011.09.035; Servello D, 2010, NEUROMODULATION, V13, P187, DOI 10.1111/j.1525-1403.2009.00253.x; Maciunas RJ, 2007, J NEUROSURG, V107, P1004, DOI 10.3171/JNS-07/11/1004; Cannon E, 2012, AM J PSYCHIAT, V169, P860, DOI 10.1176/appi.ajp.2012.11101583; Cheung MYC, 2007, MOVEMENT DISORD, V22, P1743, DOI 10.1002/mds.21599; Servello D, 2009, J NEUROL, V256, P1533, DOI 10.1007/s00415-009-5159-6; Dueck A, 2009, NEUROPEDIATRICS, V40, P239, DOI 10.1055/s-0030-1247519; Shields DC, 2008, STEREOT FUNCT NEUROS, V86, P87, DOI 10.1159/000112429; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Marceglia S, 2010, MOVEMENT DISORD, V25, P300, DOI 10.1002/mds.22982; Leckman JF, 1998, PEDIATRICS, V102, P14, DOI 10.1542/peds.102.1.14; Bajwa RJ, 2007, MOVEMENT DISORD, V22, P1346, DOI 10.1002/mds.21398; Bloch Michael H, 2006, Arch Pediatr Adolesc Med, V160, P65, DOI 10.1001/archpedi.160.1.65; Bronte-Stewart H, 2011, MOVEMENT DISORD, V26, pS5, DOI 10.1002/mds.23482; Dehning S, 2011, MOVEMENT DISORD, V26, P2440, DOI 10.1002/mds.23892; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dong S, 2012, J INT MED RES, V40, P2021; DOOLEY JM, 1994, J CHILD NEUROL, V9, P50; ERENBERG G, 1987, ANN NEUROL, V22, P383, DOI 10.1002/ana.410220317; Farris Sierra, 2013, Surg Neurol Int, V4, P69, DOI 10.4103/2152-7806.112612; Filho OV, 2007, STEREOT FUNCT NEUROS, V85, P42; Fins JJ, 2006, NEUROSURGERY, V59, P713, DOI 10.1227/01.NEU.0000243605.89270.6C; Flaherty AW, 2005, NEUROSURGERY, pE403; Gallagher CL, 2006, NEUROLOGY, V66, pE12, DOI 10.1212/01.wnl.0000190258.92496.a4; Goetz CG, 1999, MOVEMENT DISORD, V14, P502, DOI 10.1002/1531-8257(199905)14:3<502::AID-MDS1020>3.0.CO;2-G; Greenberg BD, 2005, KAPLAN SADOCKS COMPR; Idris Z, 2010, J CLIN NEUROSCI, V17, P1343, DOI 10.1016/j.jocn.2010.01.054; Isaacs JD, 2010, NEUROLOGY, V74, P697, DOI 10.1212/WNL.0b013e3181d0cc77; Kaido T, 2011, NEUROMODULATION, V14, P123, DOI 10.1111/j.1525-1403.2010.00324.x; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Krumholz A, 2005, IMITATORS EPILEPSY; Kuhn J, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.51; KURLAN R, 1992, J NEUROPSYCH CLIN N, V4, P347; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lee Michael W. Y., 2011, Hong Kong Medical Journal, V17, P147; Lehman LL, 2011, NEUROLOGY, V77, P1706, DOI 10.1212/WNL.0b013e318238253c; Lyons KE, 2008, NEUROTHERAPEUTICS, V5, P331, DOI 10.1016/j.nurt.2008.01.004; Maling N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044215; Martinez-Fernandez R, 2011, MOVEMENT DISORD, V26, P1922, DOI 10.1002/mds.23734; Motlagh MG, 2013, TREMOR OTHER HYPERKI, P3; Neuner Irene, 2009, Biol Psychiatry, V65, pe5, DOI 10.1016/j.biopsych.2008.09.030; Okun MS, 2012, ARCH NEUROL-CHICAGO, P1, DOI [10.1001/jamaneurol.2013.580., DOI 10.1001/JAMANEUROL.2013.580]; Okun MS, 2008, J NEUROL NEUROSUR PS, V79, P111, DOI 10.1136/jnnp.2007.135715; Piedimonte F, 2013, NEUROMODULATION, V16, P55, DOI 10.1111/j.1525-1403.2012.00526.x; Porta M, 2008, CLIN DRUG INVEST, V28, P443, DOI 10.2165/00044011-200828070-00006; Poysky J, 2007, MOVEMENT DISORD, V22, P1366, DOI 10.1002/mds.21529; Shahed J, 2007, MOVEMENT DISORD, V22, pS283; Tan EK, 2004, J CHILD NEUROL, V19, P976; Vernaleken Ingo, 2009, Biol Psychiatry, V66, pe15, DOI 10.1016/j.biopsych.2009.06.025; Visser-Vandewalle V, 2003, J NEUROSURG, V99, P1094, DOI 10.3171/jns.2003.99.6.1094	100	13	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	APR	2015	30	4					448	471		10.1002/mds.26094		24	Clinical Neurology	Neurosciences & Neurology	CF5RH	WOS:000352614200003		
J	Matsumoto, M				Matsumoto, Masayuki			Dopamine Signals and Physiological Origin of Cognitive Dysfunction in Parkinson's Disease	MOVEMENT DISORDERS			English	Review						Parkinson's disease; cognitive dysfunction; dopamine neuron; reward; salience	VENTRAL TEGMENTAL AREA; SELECTIVE VISUAL-ATTENTION; SPATIAL WORKING-MEMORY; BASAL GANGLIA; MIDBRAIN DOPAMINE; PREFRONTAL CORTEX; LATERAL HABENULA; SUBSTANTIA-NIGRA; CAUDATE-NUCLEUS; INDIRECT PATHWAYS	The pathological hallmark of Parkinson's disease (PD) is the degeneration of midbrain dopamine neurons. Cognitive dysfunction is a feature of PD patients even at the early stages of the disease. Electrophysiological studies on dopamine neurons in awake animals provide contradictory accounts of the role of dopamine. These studies have established that dopamine neurons convey a unique signal associated with rewards rather than cognitive functions. Emphasizing their role in reward processing leads to difficulty in developing hypothesis as to how cognitive impairments in PD are associated with the degeneration of dopamine circuitry. A hint to resolve this contradiction came from recent electrophysiological studies reporting that dopamine neurons transmit more diverse signals than previously thought. These studies suggest that dopamine neurons are divided into at least two functional subgroups, one signaling motivational value and the other signaling salience. The former subgroup fits well with the conventional reward theory, whereas the latter subgroup has been shown to transmit signals related to salient but non-rewarding experiences such as aversive stimulations and cognitively demanding situations. This article reviews recent advances in understanding the non-reward functions of dopamine, and then discusses the possibility that cognitive dysfunction in PD is at least partially caused by the degeneration of the dopamine neuron subgroup signaling the salience of events in the environment. 2015 International Parkinson and Movement Disorder Society	Univ Tsukuba, Lab Cognit & Behav Neurosci, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki 3058577, Japan	Matsumoto, M (reprint author), Univ Tsukuba, Lab Cognit & Behav Neurosci, Div Biomed Sci, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	mmatsumoto@md.tsukuba.ac.jp			Cabinet Office, Government of Japan [LS074]; Ministry of Education, Science, Sports, Culture, and Technology of Japan [26120707, 26710001]; Takeda Science Foundation; Inamori Foundation; Uehara Memorial Foundation	M.M. is supported by Funding Program for Next Generation World-Leading Researchers (LS074) from Cabinet Office, Government of Japan; Grants-in-Aid for Scientific Research (26120707 and 26710001) from the Ministry of Education, Science, Sports, Culture, and Technology of Japan; the Takeda Science Foundation; the Inamori Foundation; and the Uehara Memorial Foundation.	Zahrt J, 1997, J NEUROSCI, V17, P8528; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515; Pimlott SL, 2004, NEUROPSYCHOPHARMACOL, V29, P108, DOI 10.1038/sj.npp.1300302; AUBERT I, 1992, J NEUROCHEM, V58, P529, DOI 10.1111/j.1471-4159.1992.tb09752.x; Matsumoto M, 2013, NEURON, V79, P1011, DOI 10.1016/j.neuron.2013.07.002; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P625, DOI 10.1016/0306-4522(94)90182-1; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Hollerman JR, 1998, NAT NEUROSCI, V1, P304; Puig MV, 2012, NEURON, V74, P874, DOI 10.1016/j.neuron.2012.04.018; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Fiorillo CD, 2013, SCIENCE, V341, P546, DOI 10.1126/science.1238699; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1998, J NEUROPHYSIOL, V80, P1; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Bruck A, 2001, NEUROSCI LETT, V311, P81, DOI 10.1016/S0304-3940(01)02124-3; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795; Carbon M, 2004, NEUROIMAGE, V21, P1497, DOI 10.1016/j.neuroimage.2003.12.014; Gottlieb JP, 1998, NATURE, V391, P481; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Shohamy D, 2004, BRAIN, V127, P851, DOI 10.1093/brain/awh100; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; KATO M, 1995, J NEUROSCI, V15, P912; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Smith Y, 1998, NEUROSCIENCE, V86, P353; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; MORRIS RG, 1988, J NEUROL NEUROSUR PS, V51, P757, DOI 10.1136/jnnp.51.6.757; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; GOTHAM AM, 1986, LANCET, V2, P970; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; RICHARDSON RT, 1991, ADV EXP MED BIOL, V295, P233; PARENT A, 1981, BRAIN RES BULL, V6, P23, DOI 10.1016/S0361-9230(81)80066-4; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1938/nrn2022; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Haber SN, 2000, J NEUROSCI, V20, P2369; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Bruck A, 2005, NEUROBIOL AGING, V26, P891, DOI 10.1016/j.neurobiolaging.2004.07.014; Cools R, 2011, CURR OPIN NEUROBIOL, V21, P402, DOI 10.1016/j.conb.2011.04.002; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; Narayanan NS, 2013, REV NEUROSCIENCE, V24, P267, DOI 10.1515/revneuro-2013-0004; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Bohnen NI, 2003, ARCH NEUROL-CHICAGO, V60, P1745, DOI 10.1001/archneur.60.12.1745; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; WHITEHOUSE PJ, 1983, PSYCHOPHARMACOL BULL, V19, P437; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Fiorillo CD, 2013, J NEUROSCI, V33, P4693, DOI 10.1523/JNEUROSCI.3886-12.2013; Enomoto K, 2011, P NATL ACAD SCI USA, V108, P15462, DOI 10.1073/pnas.1014457108; Jokinen P, 2009, PARKINSONISM RELAT D, V15, P88, DOI 10.1016/j.parkreldis.2008.03.005; Sawamoto N, 2008, BRAIN, V131, P1294, DOI 10.1093/brain/awn054; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; COOPER JA, 1992, BRAIN, V115, P1701, DOI 10.1093/brain/115.6.1701; Ekman U, 2012, LANCET NEUROL, V11, P679, DOI 10.1016/S1474-4422(12)70138-2; Bohnen NI, 2006, J NEUROL, V253, P242, DOI 10.1007/s00415-005-0971-0; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Gesi M, 2000, NEUROSCI BIOBEHAV R, V24, P655, DOI 10.1016/S0149-7634(00)00028-2; Montague PR, 1996, J NEUROSCI, V16, P1936; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Owen AM, 1997, NEUROPSYCHOLOGIA, V35, P519, DOI 10.1016/S0028-3932(96)00101-7; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; Phillips GD, 2010, PSYCHOPHARMACOLOGY, V210, P303, DOI 10.1007/s00213-010-1813-z; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Emre M, 2003, LANCET NEUROL, V2, P229, DOI 10.1016/S1474-4422(03)00351-X; SCATTON B, 1983, BRAIN RES, V275, P321, DOI 10.1016/0006-8993(83)90993-9; Fiorillo CD, 2013, J NEUROSCI, V33, P4710, DOI 10.1523/JNEUROSCI.3883-12.2013; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; THIERRY AM, 1976, NATURE, V263, P242, DOI 10.1038/263242a0; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; KORI A, 1995, J NEUROSCI, V15, P928; BERNHEIM.H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bokura H, 2005, NEUROPSYCHOLOGIA, V43, P967, DOI 10.1016/j.neuropsychologia.2004.08.010; BRADLEY VA, 1989, J NEUROL NEUROSUR PS, V52, P1228, DOI 10.1136/jnnp.52.11.1228; CANAVAN AGM, 1989, NEUROPSYCHOLOGIA, V27, P141, DOI 10.1016/0028-3932(89)90167-X; Carter RM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.021.2009; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fiorillo CD, 2008, NAT NEUROSCI; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giladi N, 2003, ACTA NEUROL SCAND, V108, P368, DOI 10.1034/j.1600-0404.2003.00211.x; GRACE AA, 1984, J NEUROSCI, V4, P2866; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hong S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00015; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Murty VP, 2014, NEUROIMAGE, V100, P580, DOI 10.1016/j.neuroimage.2014.06.047; PORRINO LJ, 1982, J COMP NEUROL, V205, P63, DOI 10.1002/cne.902050107; RANSMAYR G, 1987, J NEUROL, V235, P99, DOI 10.1007/BF00718018; Rinne JO, 2000, ARCH NEUROL-CHICAGO, V57, P470, DOI 10.1001/archneur.57.4.470; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schmaljohann J, 2006, NUCL MED BIOL, V33, P305, DOI 10.1016/j.nucmedbio.2005.12.012; STEINFELS GF, 1983, BRAIN RES, V258, P217, DOI 10.1016/0006-8993(83)91145-9; WHITEHOUSE PJ, 1983, ANN NEUROL, V13, P243, DOI 10.1002/ana.410130304	134	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	APR	2015	30	4					472	483		10.1002/mds.26177		12	Clinical Neurology	Neurosciences & Neurology	CF5RH	WOS:000352614200004		
J	Gross, A; Hosoya, T; Zhao, YJ; Baral, HO				Gross, A.; Hosoya, T.; Zhao, Y. -J.; Baral, H. -O.			Hymenoscyphus linearis sp nov: another close relative of the ash dieback pathogen H. fraxineus	MYCOLOGICAL PROGRESS			English	Article						Chalara fraxinea; Hymenoscyphus pseudoalbidus; Molecular phylogeny; Fraxinus platypoda; Hymenoscyphus albidus; Virulence assay	FUNGAL PLANT-PATHOGENS; PHYLOGENETIC ANALYSES; GENUS HYMENOSCYPHUS; PSEUDOALBIDUS; SPECIATION; HELOTIALES; EXCELSIOR; SELECTION; COMPLEX; HYBRIDS	Hymenoscyphus is a large fungal genus containing a single known severe pathogen (H. fraxineus) causing ash dieback in Europe. Here, the closely related species Hymenoscyphus linears sp. nov. is described from Japan. Apothecia of this fungus emerge from linear, black pseudosclerotia on rachises and petioles of Fraxinus platypoda. In culture, the species forms a Chalara anamorph similar to that of H. fraxineus. In addition, a Sporotrichum-like synanamorph is produced. Spores of neither anamorphic forms germinate on malt extract agar and might act solely as spermatia. After prolonged incubation, ascocarps are produced directly on agar plates, indicating the ability to self-fertilize. Phylogenetic investigations using four sequence markers placed the species alongside H. albidus, H. albidoides, and H. fraxineus. Eight fungal strains, co-occurring with H. linearis on petioles of F. platypoda, were isolated and identified by sequencing the ITS region of the rDNA. Seven different species were revealed, showing that there is no other dominant fungus on petioles of F. platypoda. Pathogenicity tests on Fraxinus excelsior and its native host F. platypoda revealed that the fungus is avirulent. The close phylogenetic relationship with H. fraxineus and the avirulence of H. linearis offer an opportunity to study the evolution of pathogenicity of H. fraxineus in further detail in the future.	[Gross, A.] ETH, Dept Environm Syst Sci Forest Pathol & Dendrol, Inst Integrat Biol IBZ, CH-8092 Zurich, Switzerland; [Hosoya, T.; Zhao, Y. -J.] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan	Gross, A (reprint author), ETH, Dept Environm Syst Sci Forest Pathol & Dendrol, Inst Integrat Biol IBZ, CH-8092 Zurich, Switzerland.	andrin.gross@usys.ethz.ch			ETH Zurich [ETH-04 10-1]	We would like to thank N. Kamata for guidance in the Chichibu forest and W. Gams for his help regarding the description of the synanamorph. Further thanks go to O. Holdenrieder, T. Sieber and V. Queloz for interesting discussions and suggestions to M. Berchtold and S. Stroheker for excellent technical assistance and to C. Syrad for manuscript proofreading. We would also like to extend our thanks to the Genetic Diversity Center of ETH Zurich for providing laboratory facilities. This study was supported by a grant from the ETH Zurich (ETH-04 10-1).	Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Gross A, 2014, MOL ECOL, V23, P2943, DOI 10.1111/mec.12792; Queloz V, 2011, FOREST PATHOL, V41, P133, DOI 10.1111/j.1439-0329.2010.00645.x; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Plattner A, 2009, MYCOLOGIA, V101, P878, DOI 10.3852/08-132; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Kirisits T, 2013, FOREST PATHOL, V43, P386, DOI 10.1111/efp.12042; Brasier CM, 2010, PLANT PATHOL, V59, P186, DOI 10.1111/j.1365-3059.2009.02157.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Pautasso M, 2013, BIOL CONSERV, V158, P37, DOI 10.1016/j.biocon.2012.08.026; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Stukenbrock EH, 2013, NEW PHYTOL, V199, P895, DOI 10.1111/nph.12374; Yang ZL, 2000, MYCOTAXON, V75, P117; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Kowalski T, 2009, FOREST PATHOL, V39, P304, DOI 10.1111/j.1439-0329.2008.00589.x; Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; McKinney LV, 2014, PLANT PATHOL, V63, P485, DOI 10.1111/ppa.12196; [Anonymous], 2005, PANT COL BRIDG COAT; Baral HO, 2013, MYCOL PROG, V12, P475, DOI 10.1007/s11557-012-0854-6; Baral HO, 1996, MYCOTAXON, V60, P249; Baral H. O., 2013, Mycosystema, V32, P386; Baral HO, 2006, SYDOWIA, V58, P145; Baral Hans-Otto, 2014, IMA Fungus, V5, P79, DOI 10.5598/imafungus.2014.05.01.09; Blair C, 2011, J HERED, V102, P130, DOI 10.1093/jhered/esq092; Carmichael JW, 1980, GENERA HYPHOMYCETES; Drenkhan R., 2010, New Disease Reports, V22, P16, DOI 10.5197/j.2044-0588.2010.022.016; Drummond A, 2008, TRACER; Et-Touil A, 1999, MOL PLANT MICROBE IN, V12, P6, DOI 10.1094/MPMI.1999.12.1.6; Gross A, 2012, FUNGAL GENET BIOL, V49, P977, DOI 10.1016/j.fgb.2012.08.008; Gross A., 2014, MOL PLANT PATHOL, V15, P109; Gross A, 2013, FOREST PATHOL, V43, P168, DOI 10.1111/efp.12022; Grunig CR, 2007, FUNGAL GENET BIOL, V44, P773, DOI 10.1016/j.fgb.2006.12.008; Han JG, 2008, MYCOTAXON, V103, P189; Hosoya Tsuyoshi, 1993, Transactions of the Mycological Society of Japan, V34, P429; Kirk P. M., 2008, AINSWORTH BISBYS DIC, P771; Marciulyniene D, 2013, COST ACT FP1103 FRAX, P42; Olson A, 2002, MICROBES INFECT, V4, P1353, DOI 10.1016/S1286-4579(02)00005-9; Rintoul TL, 2012, METHODS MOL BIOL, V835, P549, DOI 10.1007/978-1-61779-501-5_34; Slippers B, 2005, TRENDS ECOL EVOL, V20, P420, DOI 10.1016/j.tree.2005.05.002; Sokolski S, 2004, MYCOLOGIA, V96, P1261, DOI 10.2307/3762143; Taylor John W., 1994, P166; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zhang YH, 2004, NOVA HEDWIGIA, V78, P475, DOI 10.1127/0029-5035/2004/0078-0475; Zhao YJ, 2012, MYCOTAXON, V122, P25, DOI 10.5248/122.25; Zheng HD, 2014, MYCOL PROG, V13, P625, DOI 10.1007/s11557-013-0945-z	45	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-416X	1861-8952		MYCOL PROG	Mycol. Prog.	APR	2015	14	4							20	10.1007/s11557-015-1041-3		15	Mycology	Mycology	CF7CY	WOS:000352715000004		
J	Moreno, C; Stetsovych, O; Shimizu, TK; Custance, O				Moreno, Cesar; Stetsovych, Oleksandr; Shimizu, Tomoko K.; Custance, Oscar			Imaging Three-Dimensional Surface Objects with Submolecular Resolution by Atomic Force Microscopy	NANO LETTERS			English	Article						Noncontact atomic force microscopy (NC-AFM); submolecular resolution; three-dimensional dynamic force spectroscopy; high-resolution imaging	SINGLE-MOLECULE; REAL-SPACE; IDENTIFICATION; PROBE	Submolecular imaging by atomic force microscopy (AFM) has recently been established as a stunning technique to reveal the chemical structure of unknown molecules, to characterize intramolecular charge distributions and bond ordering, as well as to study chemical transformations and intermolecular interactions. So far, most of these feats were achieved on planar molecular systems because high-resolution imaging of three-dimensional (3D) surface structures with AFM remains challenging. Here we present a method for high-resolution imaging of nonplanar molecules and 3D surface systems using AFM with silicon cantilevers as force sensors. We demonstrate this method by resolving the step-edges of the (101) anatase surface at the atomic scale by simultaneously visualizing the structure of a pentacene molecule together with the atomic positions of the substrate and by resolving the contour and probe-surface force field on a C-60 molecule with intramolecular resolution. The method reported here holds substantial promise for the study of 3D surface systems such as nanotubes, clusters, nanoparticles, polymers, and biomolecules using AFM with high resolution.	[Moreno, Cesar; Stetsovych, Oleksandr; Shimizu, Tomoko K.; Custance, Oscar] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Moreno, Cesar] Natl Inst Mat Sci, Int Ctr Young Scientists, Tsukuba, Ibaraki 3050047, Japan; [Stetsovych, Oleksandr; Shimizu, Tomoko K.] Acad Sci Czech Republic, Inst Phys, Prague, Czech Republic; [Stetsovych, Oleksandr; Shimizu, Tomoko K.] PRESTO, JST, Kawaguchi, Saitama 3320012, Japan	Moreno, C (reprint author), Catalan Inst Nanosci & Nanotechnol ICN2, Barcelona 08193, Spain.	cesar.moreno@icn.cat	Moreno, Cesar/G-5011-2012	Moreno, Cesar/0000-0003-2682-211X	Japanese Ministry for Education, Science, and Technology through International Center for Young Scientist (ICYS) program; Charles University [GAUK 339311]; Charles University-NIMS International Cooperative Graduate School Program; Kao Foundation for Arts and Sciences; MEXT KAKENHI [26104540]; NIMS [AA002, AF006]	We thank Leo Gross and Ruben Perez for fruitful discussions, and Emilio Palomares and James William Ryan for supplying the anatase substrates. C.M. was supported by the Japanese Ministry for Education, Science, and Technology through International Center for Young Scientist (ICYS) program. O.S. acknowledges financial support from Charles University (GAUK 339311) and the Charles University-NIMS International Cooperative Graduate School Program. T.K.S. acknowledges the financial support by the Kao Foundation for Arts and Sciences and the MEXT KAKENHI Grant 26104540. Work supported by the NIMS (AA002 and AF006 projects).	Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; [Anonymous], 1996, MULTIMODE TM SPM INS; de Oteyza DG, 2013, SCIENCE, V340, P1434, DOI 10.1126/science.1238187; Chiutu C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268302; Schuler B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.106103; Mohn F, 2012, NAT NANOTECHNOL, V7, P227, DOI [10.1038/nnano.2012.20, 10.1038/NNANO.2012.20]; Kaiser U, 2007, NATURE, V446, P522, DOI 10.1038/nature05617; Chiang CL, 2014, SCIENCE, V344, P885, DOI 10.1126/science.1253405; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Zhang J, 2013, SCIENCE, V342, P611, DOI 10.1126/science.1242603; Boneschanscher MP, 2014, ACS NANO, V8, P3006, DOI 10.1021/nn500317r; Sugimoto Y, 2005, NAT MATER, V4, P156, DOI 10.1038/nmat1297; Pawlak R, 2011, ACS NANO, V5, P6349, DOI 10.1021/nn201462g; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/nchem.765, 10.1038/NCHEM.765]; Hapala P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085421; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; Albrecht F, 2013, J AM CHEM SOC, V135, P9200, DOI 10.1021/ja404084p; Kawai S, 2013, ACS NANO, V7, P9098, DOI 10.1021/nn403672m; Albers BJ, 2009, NAT NANOTECHNOL, V4, P307, DOI [10.1038/nnano.2009.57, 10.1038/NNANO.2009.57]; Mohn F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3619829; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Boneschanscher MP, 2012, ACS NANO, V6, P10216, DOI 10.1021/nn3040155; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; Ashino M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.136101; GIESSIBL FJ, 2000, J APPL PHYS LETT, V76, P1470; Gross L, 2009, SCIENCE, V324, P1428, DOI 10.1126/science.1172273; Kawai S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.220801; Kuhn S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.235417; SPONG JK, 1989, NATURE, V338, P137, DOI 10.1038/338137a0; Sweetman AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4931; Sweetman A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.165425	36	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	APR	2015	15	4					2257	2262		10.1021/nl504182w		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CF7QA	WOS:000352750200007		
J	Mahboob, I; Perrissin, N; Nishiguchi, K; Hatanaka, D; Okazaki, Y; Fujiwara, A; Yamaguchi, H				Mahboob, I.; Perrissin, N.; Nishiguchi, K.; Hatanaka, D.; Okazaki, Y.; Fujiwara, A.; Yamaguchi, H.			Dispersive and Dissipative Coupling in a Micromechanical Resonator Embedded with a Nanomechanical Resonator	NANO LETTERS			English	Article						Nanomechanical resonator; coupled resonators; nonlinear coupling; Van der Pol resonator	MECHANICAL RESONATORS; OSCILLATOR; BIFURCATION; SYSTEMS	A micromechanical resonator embedded with a nanomechanical resonator is developed whose dynamics can be captured by the coupled-Van der PolDuffing equations. Activating the nanomechanical resonator can dispersively shift the micromechanical resonance by more than 100 times its bandwidth and concurrently increase its energy dissipation rate to the point where it can even be deactivated. The coupled-Van der Pol-Duffing equations also suggest the possibility of self-oscillations. In the limit of strong excitation for the nanomechanical resonator, the dissipation in the micromechanical resonator can not only be reduced, resulting in a quality factor of >3x 10(6), it can even be eliminated entirely resulting in the micromechanical resonator spontaneously vibrating.	[Mahboob, I.; Perrissin, N.; Nishiguchi, K.; Hatanaka, D.; Okazaki, Y.; Fujiwara, A.; Yamaguchi, H.] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan	Mahboob, I (reprint author), NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan.	imran.mahboob@lab.ntt.co.jp	Yamaguchi, Hiroshi/E-6123-2010		JSPS KAKENHI [23241046]	The authors are grateful to S. Miyashita for growing the GaAs/AlGaAs sample. This work was partly supported by JSPS KAKENHI Grant 23241046.	Imboden M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4794907; Shim SB, 2007, SCIENCE, V316, P95, DOI 10.1126/science.1137307; Westra HJR, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.134305; Okamoto H, 2013, NAT PHYS, V9, P480, DOI [10.1038/nphys2665, 10.1038/NPHYS2665]; Matheny MH, 2013, NANO LETT, V13, P1622, DOI 10.1021/nl400070e; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Eichler A, 2011, NAT NANOTECHNOL, V6, P339, DOI [10.1038/nnano.2011.71, 10.1038/NNANO.2011.71]; Westra HJR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.117205; Mahboob I, 2012, NAT PHYS, V8, P387, DOI [10.1038/nphys2277, 10.1038/NPHYS2277]; Mahboob I, 2008, NAT NANOTECHNOL, V3, P275, DOI 10.1038/nnano.2008.84; KAO YH, 1993, PHYS REV E, V48, P2514, DOI 10.1103/PhysRevE.48.2514; Truitt PA, 2013, J APPL PHYS, V114, DOI 10.1063/1.4821273; Verbridge SS, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2822406; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Gil-Santos E, 2009, NANO LETT, V9, P4122, DOI 10.1021/nl902350b; Venkatesan A, 1997, PHYS REV E, V56, P6321, DOI 10.1103/PhysRevE.56.6321; Zaitsev S, 2012, NONLINEAR DYNAM, V67, P859, DOI 10.1007/s11071-011-0031-5; Imboden M, 2014, PHYS REP, V534, P89, DOI 10.1016/j.physrep.2013.09.003; Karabalin RB, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.165309; Castellanos-Gomez A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.041402; Chaste J, 2012, NAT NANOTECHNOL, V7, P300, DOI [10.1038/nnano.2012.42, 10.1038/NNANO.2012.42]; Cleland A., 2003, FDN NANOMECHANICS; Dorignac J, 2008, J APPL PHYS, V104, DOI 10.1063/1.2996031; Ekinci KL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1927327; Gaidarzhy A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3604797; Imboden M, 2013, NANO LETT, V13, P4014, DOI 10.1021/nl401978p; Kozinsky I, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209211; Lulla KJ, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/113040; Mahboob I, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3528454; Mahboob I, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1201; Nayfeh A. H., 1995, NONLINEAR OSCILLATIO	31	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	APR	2015	15	4					2312	2317		10.1021/nl5044264		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CF7QA	WOS:000352750200015		
J	Mamyouda, S; Ito, H; Shibata, Y; Kashiwaya, S; Yamaguchi, M; Akazaki, T; Tamura, H; Ootuka, Y; Nomura, S				Mamyouda, Syuhei; Ito, Hironori; Shibata, Yusuke; Kashiwaya, Satoshi; Yamaguchi, Masumi; Akazaki, Tatsushi; Tamura, Hiroyuki; Ootuka, Youiti; Nomura, Shintaro			Circularly Polarized Near-Field Optical Mapping of Spin-Resolved Quantum Hall Chiral Edge States	NANO LETTERS			English	Article						near-field optical microscope; quantum Hall effect; edge state; spin injection; chiral; nanophotonics; circular polarization; scanning probe microscopy	MICROSCOPE; CHANNELS; INSULATOR; FIBER; PROBE	We have successfully developed a circularly polarized near-field scanning optical microscope (NSOM) that enables us to irradiate circularly polarized light with spatial resolution below the diffraction limit. As a demonstration, we perform real-space mapping of the quantum Hall chiral edge states near the edge of a Hall-bar structure by injecting spin polarized electrons optically at low temperature. The obtained real-space mappings show that spin-polarized electrons are injected optically to the two-dimensional electron layer. Our general method to locally inject spins using a circularly polarized NSOM should be broadly applicable to characterize a variety of nanomaterials and nanostructures.	[Mamyouda, Syuhei; Ito, Hironori; Shibata, Yusuke; Ootuka, Youiti; Nomura, Shintaro] Univ Tsukuba, Div Phys, Tsukuba, Ibaraki 3058571, Japan; [Kashiwaya, Satoshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Yamaguchi, Masumi; Akazaki, Tatsushi; Tamura, Hiroyuki] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan	Nomura, S (reprint author), Univ Tsukuba, Div Phys, Tsukuba, Ibaraki 3058571, Japan.	nomura.shintaro.ge@u.tsukuba.ac.jp	Kashiwaya, Satoshi/J-8681-2015		Kakenhi [25103704, 26610079]	We thank M. Make at AIST for technical assistance. A part of this work was done in Nano-Processing Facility, AIST. This work was partly supported by Kakenhi Nos. 25103704, 26610079.	Cruz JL, 1996, APPL OPTICS, V35, P922, DOI 10.1364/AO.35.000922; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Ihnatsenka S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155314; HAROOTUNIAN A, 1986, APPL PHYS LETT, V49, P674, DOI 10.1063/1.97565; Frenkel J, 1938, PHYS REV, V54, P647, DOI 10.1103/PhysRev.54.647; ANDO T, 1974, J PHYS SOC JPN, V37, P1044, DOI 10.1143/JPSJ.37.1044; ZENHAUSERN F, 1994, APPL PHYS LETT, V65, P1623, DOI 10.1063/1.112931; SMITH AM, 1978, APPL OPTICS, V17, P52, DOI 10.1364/AO.17.000052; Wiesendanger R, 2009, REV MOD PHYS, V81, P1495, DOI 10.1103/RevModPhys.81.1495; MERZ R, 1993, PHYS REV LETT, V70, P651, DOI 10.1103/PhysRevLett.70.651; Shashkin AA, 1997, PHYS REV LETT, V79, P5114, DOI 10.1103/PhysRevLett.79.5114; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; MANOLESCU A, 1995, PHYS REV B, V51, P1703, DOI 10.1103/PhysRevB.51.1703; HALPERIN BI, 1982, PHYS REV B, V25, P2185, DOI 10.1103/PhysRevB.25.2185; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Ji Y, 2003, NATURE, V422, P415, DOI 10.1038/nature01503; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Nomura S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.096803; Neumann L, 2011, NANO LETT, V11, P355, DOI 10.1021/nl102657m; CHKLOVSKII DB, 1992, PHYS REV B, V46, P4026, DOI 10.1103/PhysRevB.46.4026; Abdulrahman NA, 2012, NANO LETT, V12, P977, DOI 10.1021/nl204055r; Dallapiccola R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3152291; Nomura S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085318; Ito H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.256803; Day JK, 2010, ACS NANO, V4, P7566, DOI 10.1021/nn102003c; Saiki T, 1996, APPL PHYS LETT, V68, P2612, DOI 10.1063/1.116198; LIER K, 1994, PHYS REV B, V50, P7757, DOI 10.1103/PhysRevB.50.7757; Johnson TW, 2012, ACS NANO, V6, P9168, DOI 10.1021/nn303496g; Ben Dor O, 2014, NANO LETT, V14, P6042, DOI 10.1021/n1502391t; DEMPSEY J, 1993, PHYS REV LETT, V70, P3639, DOI 10.1103/PhysRevLett.70.3639; INOUYE Y, 1994, OPT LETT, V19, P159, DOI 10.1364/OL.19.000159; Klitzing K. V., 1980, PHYS REV LETT, V45, P494, DOI DOI 10.1103/PHYSREVLETT.45.494; Meier F., 1984, OPTICAL ORIENTATION; Morgenstern M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.136806; van Zalinge H, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235303; VANHAREN RJF, 1995, PHYS REV LETT, V74, P1198, DOI 10.1103/PhysRevLett.74.1198; VANLABEKE D, 1995, J OPT SOC AM A, V12, P695; van Zalinge H, 2004, SEMICOND SCI TECH, V19, P1153, DOI [10.1088/0268-1242/19/9/015, 10.1088/0268-1242/19/90/015]; Wang Q. H., 2012, NAT NANO, V7, P799	39	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	APR	2015	15	4					2417	2421		10.1021/nl504767w		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CF7QA	WOS:000352750200031		
J	Iwaki, M; Iwane, AH; Ikezaki, K; Yanagida, T				Iwaki, Mitsuhiro; Iwane, Atsuko H.; Ikezaki, Keigo; Yanagida, Toshio			Local Heat Activation of Single Myosins Based on Optical Trapping of Gold Nanoparticles	NANO LETTERS			English	Article						Motor protein; optical trap; single molecule; gold nanoparticle; local heating	LIVING CELLS; MOTOR; DNA; NUCLEOTIDE; PROTEINS; CHANNELS; BINDING; SHAPES; MODEL	Myosin is a mechano-enzyme that hydrolyzes ATP in order to move unidirectionally along actin filaments. Here we show by single molecule imaging that myosin V motion can be activated by local heat. We constructed a dark-field microscopy that included optical tweezers to monitor 80 nm gold nanoparticles (GNP) bound to single myosin V molecules with nanometer and submillisecond accuracy. We observed 34 nm processive steps along actin filaments like those seen when using 200 nm polystyrene beads (PB) but dwell times (ATPase activity) that were 4.5 times faster. Further, by using DNA nanotechnology (DNA origami) and myosin V as a nanometric thermometer, the temperature gradient surrounding optically trapped GNP could be estimated with nanometer accuracy. We propose our single molecule measurement system should advance quantitative analysis of the thermal control of biological and artificial systems like nanoscale thermal ratchet motors.	[Iwaki, Mitsuhiro; Iwane, Atsuko H.; Yanagida, Toshio] RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650874, Japan; [Iwaki, Mitsuhiro; Iwane, Atsuko H.; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650874, Japan; [Ikezaki, Keigo] Univ Tokyo, Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Yanagida, Toshio] NICT, Ctr Informat & Neural Networks, Suita, Osaka 5650874, Japan	Iwaki, M (reprint author), RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650874, Japan.	iwaki@fbs.osaka-u.ac.jp			MEXT; JSPS	We thank colleagues of the Riken Quantitative Biology Center for discussions and Peter Karagianins for reading the manuscript. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (MEXT), Grant-in-Aids for Young Scientists (B) (JSPS).	Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002; Urban AS, 2009, NANO LETT, V9, P2903, DOI 10.1021/nl901201h; Oyama K, 2012, BIOCHEM BIOPH RES CO, V417, P607, DOI 10.1016/j.bbrc.2011.12.015; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Kiyonaka S, 2013, NAT METHODS, V10, P1232, DOI [10.1038/nmeth.2690, 10.1038/NMETH.2690]; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Kyrsting A, 2011, NANO LETT, V11, P888, DOI 10.1021/nl104280c; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Oyama K, 2012, LAB CHIP, V12, P1591, DOI 10.1039/c2lc00014h; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Peterman EJG, 2003, BIOPHYS J, V84, P1308; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Vilfan A, 2005, BIOPHYS J, V88, P3792, DOI 10.1529/biophysj.104.046763; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/nnano.2010.125, 10.1038/NNANO.2010.125]; Bendix PM, 2010, ACS NANO, V4, P2256, DOI 10.1021/nn901751w; Seol Y, 2006, OPT LETT, V31, P2429, DOI 10.1364/OL.31.002429; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Gobin AM, 2007, NANO LETT, V7, P1929, DOI 10.1021/nl070610y; Block S. M., 1990, NONINVASIVE TECHNIQU; Feynman R P, 1963, FEYNMAN LECT PHYS, V1; Fujita K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1934; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Phillips RB, 2009, PHYS BIOL CELL; Robblee JP, 2005, BIOCHEMISTRY-US, V44, P10238, DOI 10.1021/bi050232g; Savin A. V., 2010, PHYS REV B, V83; Sellers J. R, 2008, MYOSINS SUPELFAMILY; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x	32	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	APR	2015	15	4					2456	2461		10.1021/nl5049059		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CF7QA	WOS:000352750200037		
J	Marinova, M; Rault, JE; Gloter, A; Nemsak, S; Palsson, GK; Rueff, JP; Fadley, CS; Carretero, C; Yamada, H; March, K; Garcia, V; Fusil, S; Barthelemy, A; Stephan, O; Colliex, C; Bibes, M				Marinova, Maya; Rault, Julien E.; Gloter, Alexandre; Nemsak, Slavomir; Palsson, Gunnar K.; Rueff, Jean-Pascal; Fadley, Charles S.; Carretero, Cecile; Yamada, Hiroyuki; March, Katia; Garcia, Vincent; Fusil, Stephane; Barthelemy, Agnes; Stephan, Odile; Colliex, Christian; Bibes, Manuel			Depth Profiling Charge Accumulation from a Ferroelectric into a Doped Mott Insulator	NANO LETTERS			English	Article						Aberration-corrected; STEM-EELS; Mott insulator; ferroelectricity; interface charge accumulation; interface physics; HAXPES	RAY ABSORPTION-SPECTROSCOPY; NEAR-EDGE STRUCTURE; ELECTRONIC-STRUCTURE; MANGANITES; VALENCE; TRANSITION; INTERFACE; STATE; FIELD; PHOTOEMISSION	The electric field control of functional properties is a crucial goal in oxide-based electronics. Nonvolatile switching between different resistivity or magnetic states in an oxide channel can be achieved through charge accumulation or depletion from an adjacent ferroelectric. However, the way in which charge distributes near the interface between the ferroelectric and the oxide remains poorly known, which limits our understanding of such switching effects. Here, we use a first-of-a-kind combination of scanning transmission electron microscopy with electron energy loss spectroscopy, near-total-reflection hard X-ray photoemission spectroscopy, and ab initio theory to address this issue. We achieve a direct, quantitative, atomic-scale characterization of the polarization-induced charge density changes at the interface between the ferroelectric BiFeO3 and the doped Mott insulator Ca1-xCexMnO3, thus providing insight on how interface-engineering can enhance these switching effects.	[Marinova, Maya; Gloter, Alexandre; March, Katia; Stephan, Odile; Colliex, Christian] Univ Paris 11, CNRS UMR 8502, Phys Solides Lab, F-91405 Orsay, France; [Rault, Julien E.; Rueff, Jean-Pascal] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Nemsak, Slavomir; Fadley, Charles S.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Nemsak, Slavomir; Fadley, Charles S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Nemsak, Slavomir] Forschungszentrum Julich, Peter Grunberg Inst PGI 6, D-52425 Julich, Germany; [Palsson, Gunnar K.] Uppsala Univ, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Palsson, Gunnar K.] Inst Laue Langevin, F-38000 Grenoble, France; [Carretero, Cecile; Yamada, Hiroyuki; Garcia, Vincent; Fusil, Stephane; Barthelemy, Agnes; Bibes, Manuel] Unite Mixte Phys CNRS Thales, F-91767 Palaiseau, France; [Carretero, Cecile; Yamada, Hiroyuki; Garcia, Vincent; Fusil, Stephane; Barthelemy, Agnes; Bibes, Manuel] Univ Paris 11, F-91405 Orsay, France; [Yamada, Hiroyuki] PRESTO, JST, Natl Inst Adv Ind Sci & Technol AIST, Tsukuba, Ibaraki 3058562, Japan	Marinova, M (reprint author), Univ Paris 11, CNRS UMR 8502, Phys Solides Lab, F-91405 Orsay, France.	maya.marinova@univ-lille1.fr; alexandre.gloter@u-psud.fr	Garcia, Vincent/C-9359-2012; 	Rueff, Jean-Pascal/0000-0003-3594-918X	French Agence Nationale de la Recherche NOMILOPS project [ANR-11-BS10-0016]; EU [312483]; European Research Council (ERC Advanced Grant FEMMES) [267579]; ERC Consolidator Grant MINT [615759]; Army Research Office, under the Multidisciplinary University Research Initiative [W911-NF-09-1-0398]; Office of Science, Office of Basic Energy Sciences, the Materials Sciences and Engineering Division under the Department of Energy [DE-AC02-05CH11231]	This work was supported by the French Agence Nationale de la Recherche NOMILOPS project (ANR-11-BS10-0016) and seventh framework EU program ESTEEM2 (grant agreement 312483). We acknowledge financial support from the European Research Council (ERC Advanced Grant FEMMES, No. 267579) and ERC Consolidator Grant MINT, No. 615759. J.E.R., J.P.R., and C.S.F. acknowledge the support of a public grant from the "Laboratoire d'Excellence Physics Atom Light Matter" (LabEx PALM) overseen by the ANR as part of the "Investissements d'Avenir" program (reference: ANR-10-LABX-0039). S.N. and C.S.F. acknowledge partial support from the Army Research Office, under the Multidisciplinary University Research Initiative Grant W911-NF-09-1-0398. C.S.F. is also supported for salary from the Director, Office of Science, Office of Basic Energy Sciences, the Materials Sciences and Engineering Division under the Department of Energy Contract No. DE-AC02-05CH11231), and Beam line 9.3.1 of the Advanced Light Source, at which some of the HAXPES was performed, is also supported under the same contract.	HUDSON LT, 1993, PHYS REV B, V47, P10832, DOI 10.1103/PhysRevB.47.10832; Abbate M, 1997, SOLID STATE COMMUN, V103, P9, DOI 10.1016/S0038-1098(97)00131-2; Ahn CH, 2006, REV MOD PHYS, V78, P1185, DOI 10.1103/RevModPhys.78.1185; Gray AX, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205116; Garvie LAJ, 1999, J PHYS CHEM SOLIDS, V60, P1943, DOI 10.1016/S0022-3697(99)00218-8; Tokura Y, 1996, J APPL PHYS, V79, P5288, DOI 10.1063/1.361353; Ederer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257601; Vaz CAF, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.127202; ESKES H, 1991, PHYS REV LETT, V67, P1035, DOI 10.1103/PhysRevLett.67.1035; Tebano A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214407; Pickett WE, 1996, PHYS REV B, V53, P1146, DOI 10.1103/PhysRevB.53.1146; Nelson CT, 2011, NANO LETT, V11, P828, DOI 10.1021/nl1041808; Subias G, 2002, SURF REV LETT, V9, P1071, DOI 10.1142/S0218625X02003366; Burton JD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.174406; Tan HY, 2012, ULTRAMICROSCOPY, V116, P24, DOI 10.1016/j.ultramic.2012.03.002; ABBATE M, 1992, PHYS REV B, V46, P4511, DOI 10.1103/PhysRevB.46.4511; Scherwitzl R, 2010, ADV MATER, V22, P5517, DOI 10.1002/adma.201003241; Varela M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085117; Doring S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165444; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; Chen HH, 2014, NANO LETT, V14, P4965, DOI 10.1021/nl501209p; Kim YM, 2014, NAT MATER, V13, P1019, DOI [10.1038/nmat4058, 10.1038/NMAT4058]; Bea H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.217603; Chang CP, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.075129; Chang CP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4522; Gray AX, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/17004; Kanamori H, 2012, J ELECTRON SPECTROSC, V185, P129, DOI 10.1016/j.elspec.2012.03.003; Kuepper K, 2005, J PHYS CHEM B, V109, P9354, DOI 10.1021/jp044447w; Liu RS, 1996, J SOLID STATE CHEM, V125, P112, DOI 10.1006/jssc.1996.0272; Minohara M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235322; Mundy JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4464; Rauh J. E., 2013, PHYS REV LETT, V111; Riedl T, 2007, MICRON, V38, P224, DOI 10.1016/j.micron.2006.06.017; Spurgeon SR, 2014, ACS NANO, V8, P894, DOI 10.1021/nn405636c; TAGUCHI H, 1985, PHYS STATUS SOLIDI B, V131, pK59, DOI 10.1002/pssb.2221310152; Vanacore GM, 2010, SURF SCI, V604, P1674, DOI 10.1016/j.susc.2010.06.012; van der Heide PAW, 2006, J ELECTRON SPECTROSC, V151, P79, DOI 10.1016/j.elspec.2005.11.001; Xiang PH, 2011, ADV MATER, V23, P5822, DOI 10.1002/adma.201102968; Yamada H., 2013, ACS NANO, P5385; Yamada H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02834; Yang SH, 2013, J APPL PHYS, V113, DOI 10.1063/1.4790171; Yu P., 2012, P NATL ACAD SCI USA, P9710	42	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	APR	2015	15	4					2533	2541		10.1021/acs.nanolett.5b00104		9	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CF7QA	WOS:000352750200048		
J	Abecassis, B; Bouet, C; Garnero, C; Constantin, D; Lequeux, N; Ithurria, S; Dubertret, B; Pauw, BR; Pontoni, D				Abecassis, Benjamin; Bouet, Cecile; Garnero, Cyril; Constantin, Dora; Lequeux, Nicolas; Ithurria, Sandrine; Dubertret, Benoit; Pauw, Brian Richard; Pontoni, Diego			Real-Time in Situ Probing of High-Temperature Quantum Dots Solution Synthesis	NANO LETTERS			English	Article						quantum dots; CdSe; mochanism; nucleation; nanoparticle; SAXS	SEMICONDUCTOR NANOCRYSTAL GROWTH; X-RAY-SCATTERING; CDSE NANOCRYSTALS; GOLD NANOPARTICLES; OPTICAL-PROPERTIES; LIQUID PARAFFIN; HOT-INJECTION; RESOLVED SAXS; NUCLEATION; KINETICS	Understanding the formation mechanism of colloidal nanocrystals is of paramount importance in order to design new nanostructures and synthesize them in a predictive fashion. However, reliable data on the pathways leading from molecular precursors to nanocrystals are not available yet. We used synchrotron-based time-resolved in situ small and wide-angle X-ray scattering to experimentally monitor the formation of CdSe quantum dots synthesized in solution through the heating up of precursors in octadecene at 240 degrees C. Our experiment yields a complete movie of the structure of the solution from the self-assembly of the precursors to the formation of the quantum dots. We show that the initial cadmium precursor lamellar structure melts into small micelles at 100 degrees C and that the first CdSe nuclei appear at 218.7 degrees C. The size distributions and concentration in nanocrystals are measured in a quantitative fashion as a function of time. We show that a short nucleation burst lasting 30 s is followed by a slow decrease of nanoparticle concentration. The rate-limiting process of the quantum dot formation is found to be the thermal activation of selenium.	[Abecassis, Benjamin; Garnero, Cyril; Constantin, Dora] Univ Paris 11, CNRS, UMR 8502, Phys Solides Lab, F-91405 Orsay, France; [Bouet, Cecile; Lequeux, Nicolas; Ithurria, Sandrine; Dubertret, Benoit] Univ Paris 06, Univ Paris 04, LPEM, ESPCI ParisTech,PSL Res Univ,CNRS,UMR 8213, F-75005 Paris, France; [Pauw, Brian Richard] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Pontoni, Diego] ESRF European Synchrotron, F-38000 Grenoble, France	Abecassis, B (reprint author), Univ Paris 11, CNRS, UMR 8502, Phys Solides Lab, F-91405 Orsay, France.	benjamin.abecassis@u-psud.fr	Pauw, Brian/C-8392-2013; Constantin, Doru/H-8495-2013; 	Pauw, Brian/0000-0002-8605-838X; Constantin, Doru/0000-0001-5623-9633; ABECASSIS, Benjamin/0000-0002-1629-9671			Abe S., 2011, ACS NANO, V6, P42; Pauw BR, 2013, J APPL CRYSTALLOGR, V46, P365, DOI 10.1107/S0021889813001295; Rempel JY, 2009, J AM CHEM SOC, V131, P4479, DOI 10.1021/ja809156t; Sun YG, 2010, NANO LETT, V10, P3747, DOI 10.1021/nl102458k; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI [10.1038/nphoton.2012.328, 10.1038/NPHOTON.2013.328]; Buck MR, 2013, ANGEW CHEM INT EDIT, V52, P6154, DOI 10.1002/anie.201207240; Xie RG, 2009, J AM CHEM SOC, V131, P15457, DOI 10.1021/ja9063102; Graetzel M, 2012, NATURE, V488, P304, DOI 10.1038/nature11476; Owen JS, 2010, J AM CHEM SOC, V132, P18206, DOI 10.1021/ja106777j; Finney EE, 2008, J COLLOID INTERF SCI, V317, P351, DOI 10.1016/j.jcis.2007.05.092; Abe S, 2013, ACS NANO, V7, P943, DOI 10.1021/nn3059168; Takesue M, 2011, J AM CHEM SOC, V133, P14164, DOI 10.1021/ja202815y; Bullen C, 2010, CHEM MATER, V22, P4135, DOI 10.1021/cm903813r; Garcia-Rodriguez R, 2013, CHEM MATER, V25, P1233, DOI 10.1021/cm3035642; Liao HG, 2012, SCIENCE, V336, P1011, DOI 10.1126/science.1219185; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104; Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425; Li Z, 2011, J AM CHEM SOC, V133, P17248, DOI 10.1021/ja204538f; van Embden J, 2005, LANGMUIR, V21, P10226, DOI 10.1021/la051081l; Polte J, 2010, ACS NANO, V4, P1076, DOI 10.1021/nn901499c; Abecassis B, 2007, NANO LETT, V7, P1723, DOI 10.1021/nl0707149; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; Sun YG, 2013, PART PART SYST CHAR, V30, P399, DOI 10.1002/ppsc.201300033; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Tao F, 2011, SCIENCE, V331, P171, DOI 10.1126/science.1197461; Harada M, 2011, J PHYS CHEM C, V115, P14081, DOI 10.1021/jp203119a; Pontoni D, 2002, LANGMUIR, V18, P56, DOI 10.1021/la015503c; Bullen CR, 2004, NANO LETT, V4, P2303, DOI 10.1021/nl0496724; Yordanov GG, 2008, COLLOID SURFACE A, V322, P177, DOI 10.1016/j.colsurfa.2008.03.002; Wang FD, 2014, CHEM MATER, V26, P5, DOI 10.1021/cm402139r; Schaak RE, 2012, ACS NANO, V6, P8492, DOI 10.1021/nn304375v; Yang YA, 2005, ANGEW CHEM INT EDIT, V44, P6712, DOI 10.1002/anie.200502279; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165; Capek RK, 2010, J PHYS CHEM C, V114, P6371, DOI 10.1021/jp1001989; Pauw BR, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/38/383201; Kwon SG, 2011, SMALL, V7, P2685, DOI 10.1002/smll.201002022; Qu LH, 2004, NANO LETT, V4, P465, DOI 10.1021/nl035211r; de Nolf K., 2015, J AM CHEM SOC, V137; Guinier A., 1955, SMALL SCALE SCATTERI; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Spalla O., 2002, NEUTRON XRAYS LIGHT, V1st; Yordanov GG, 2008, COLLOID POLYM SCI, V286, P813, DOI 10.1007/s00396-008-1840-z; Yordanov GG, 2008, COLLOID SURFACE A, V316, P37, DOI 10.1016/j.colsurfa.2007.08.014	43	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	APR	2015	15	4					2620	2626		10.1021/acs.nanolett.5b00199		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CF7QA	WOS:000352750200061		
J	Bastiaens, P; Birtwistle, MR; Bluthgen, N; Bruggeman, FJ; Cho, KH; Cosentino, C; de la Fuente, A; Hoek, JB; Kiyatkin, A; Klamt, S; Kolch, W; Legewie, S; Mendes, P; Naka, T; Santra, T; Sontag, E; Westerhoff, HV; Kholodenko, BN				Bastiaens, Philippe; Birtwistle, Marc R.; Bluethgen, Nils; Bruggeman, Frank J.; Cho, Kwang-Hyun; Cosentino, Carlo; de la Fuente, Alberto; Hoek, Jan B.; Kiyatkin, Anatoly; Klamt, Steffen; Kolch, Walter; Legewie, Stefan; Mendes, Pedro; Naka, Takashi; Santra, Tapesh; Sontag, Eduardo; Westerhoff, Hans V.; Kholodenko, Boris N.			Silence on the relevant literature and errors in implementation	NATURE BIOTECHNOLOGY			English	Letter							GENE NETWORKS; MICROARRAY DATA; VARIABLE SELECTION; EXPRESSION; PROTEIN; SWITCH; LASSO; QUANTIFICATION; RESPONSES; TOPOLOGY		[Bastiaens, Philippe] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44139 Dortmund, Germany; [Birtwistle, Marc R.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Bluethgen, Nils] Charite, Inst Pathol, D-13353 Berlin, Germany; [Bluethgen, Nils] Humboldt Univ, Integrat Res Inst Life Sci, D-10099 Berlin, Germany; [Bruggeman, Frank J.] Vrije Univ Amsterdam, Syst Bioinformat, Amsterdam, Netherlands; [Cho, Kwang-Hyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Cosentino, Carlo] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [de la Fuente, Alberto] Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Dept Biomath & Bioinformat, Dummerstorf, Mecklenburg Vor, Germany; [Hoek, Jan B.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Kiyatkin, Anatoly] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Klamt, Steffen] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Kolch, Walter; Santra, Tapesh; Kholodenko, Boris N.] Univ Coll Dublin, Syst Biol Ireland, Dublin 2, Ireland; [Kolch, Walter; Kholodenko, Boris N.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Kolch, Walter; Kholodenko, Boris N.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Legewie, Stefan] Inst Mol Biol, Mainz, Germany; [Mendes, Pedro; Westerhoff, Hans V.] Univ Manchester, Manchester Inst Biotechnol, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England; [Mendes, Pedro] Univ Manchester, Manchester Inst Biotechnol, Sch Comp Sci, Manchester, Lancs, England; [Mendes, Pedro] Univ Connecticut, Ctr Hlth, Ctr Quantitat Med, Farmington, CT USA; [Naka, Takashi] Kyushu Sangyo Univ, Fac Informat Sci, Higashi Ku, Fukuoka, Japan; [Sontag, Eduardo] Rutgers State Univ, Dept Math, Piscataway, NJ USA; [Sontag, Eduardo] Rutgers State Univ, Canc Inst New Jersey, Piscataway, NJ USA; [Westerhoff, Hans V.] Vrije Univ Amsterdam, Mol Cell Physiol, Amsterdam, Netherlands; [Westerhoff, Hans V.] Univ Amsterdam, Swammerdam Inst Life Sci, Synthet Syst Biol, Fac Sci, Amsterdam, Netherlands	Bastiaens, P (reprint author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	boris.kholodenko@ucd.ie	Cho, Kwang-Hyun/C-1684-2011; Cosentino, Carlo/C-5677-2011; Westerhoff, Hans/I-5762-2012; Kiyatkin, Anatoly/A-8707-2009; 	Cosentino, Carlo/0000-0001-5768-1829; Westerhoff, Hans/0000-0002-0443-6114; Kiyatkin, Anatoly/0000-0002-5060-6081; Mendes, Pedro/0000-0001-6507-9168; Kholodenko, Boris/0000-0002-9483-4975			de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Andrec M, 2005, J THEOR BIOL, V232, P427, DOI 10.1016/j.jtbi.2004.08.022; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Barzel B, 2013, NAT BIOTECHNOL, V31, P720, DOI 10.1038/nbt.2601; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Selvarajoo Kumar, 2009, Journal of Bioinformatics and Computational Biology, V7, P243, DOI 10.1142/S0219720009003947; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Sontag E, 2004, BIOINFORMATICS, V20, P1877, DOI 10.1093/bioinformatics/bth173; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Zou H, 2005, J ROY STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI DOI 10.1145/1143844.1143874; de la Fuente A., 2004, METABOLIC ENG POSTGE; de la Fuente A, 2006, IEE P SYST BIOL, V153, P257, DOI 10.1049/ip-syb:20050061; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961; Kholodenko BN, 1997, FEBS LETT, V414, P430, DOI 10.1016/S0014-5793(97)01018-1; Kholodenko B.N., 2002, ARXIVPHYSICS0205003; Kholodenko BN, 2007, NAT CELL BIOL, V9, P247, DOI 10.1038/ncb0307-247; Santra T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-57; Schachter KA, 2006, J BIOL CHEM, V281, P19134, DOI 10.1074/jbc.M603324200; Klinger B, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.29; Scheinine A, 2009, ANN NY ACAD SCI, V1158, P287, DOI 10.1111/j.1749-6632.2008.04100.x; Shimamura T, 2007, GENOME INFORM SER, V19, P142; Shimoni Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000828; Sontag ED, 2008, ESSAYS BIOCHEM, V45, P161, DOI 10.1042/BSE0450161; Soucek T, 1997, ONCOGENE, V14, P2251, DOI 10.1038/sj.onc.1201061; Stark J, 2003, TRENDS BIOTECHNOL, V21, P290, DOI 10.1016/S0167-7799(03)00140-9; Stelniec-Klotz I, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.32; Veiga DFT, 2007, GENET MOL RES, V6, P730	40	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					336	339		10.1038/nbt.3185		5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CF2AE	WOS:000352348500013		
J	Kotani, O; Iwata-Yoshikawa, N; Suzuki, T; Sato, Y; Nakajima, N; Koike, S; Iwasaki, T; Sata, T; Yamashita, T; Minagawa, H; Taguchi, F; Hasegawa, H; Shimizu, H; Nagata, N				Kotani, Osamu; Iwata-Yoshikawa, Naoko; Suzuki, Tadaki; Sato, Yuko; Nakajima, Noriko; Koike, Satoshi; Iwasaki, Takuya; Sata, Tetsutaro; Yamashita, Teruo; Minagawa, Hiroko; Taguchi, Fumihiro; Hasegawa, Hideki; Shimizu, Hiroyuki; Nagata, Noriyo			Establishment of a panel of in-house polyclonal antibodies for the diagnosis of enterovirus infections	NEUROPATHOLOGY			English	Article						enterovirus; immunohistochemistry; paraffin-embedded tissue; polyclonal antibody; viral encephalitis	PARAFFIN-EMBEDDED TISSUE; ACUTE FLACCID PARALYSIS; CENTRAL-NERVOUS-SYSTEM; CAPSID PROTEIN VP1; MOUTH-DISEASE; 71 ENCEPHALOMYELITIS; MONOCLONAL-ANTIBODY; SYNTHETIC PEPTIDES; CYNOMOLGUS MONKEYS; LINEAR EPITOPES	The aim of this study was to establish a reliable method of virus detection for the diagnosis of critical enterovirus infections such as acute infective encephalitis, encephalomyelitis and myocarditis. Because histopathological and immunohistochemical analyses of paraffin-embedded tissues play an important role in recognizing infectious agents in tissue samples, six in-house polyclonal antibodies raised against three representative enteroviruses using an indirect immunofluorescence assay and immunohistochemistry were examined. This panel of polyclonal antibodies recognized three serotypes of enterovirus. Two of the polyclonal antibodies were raised against denatured virus particles from enterovirus A71, one was raised against the recombinant VP1 protein of coxsackievirus B3, and the other for poliovirus type 1 were raised against denatured virus particles, the recombinant VP1 protein and peptide 2C. Western blot analysis revealed that each of these antibodies recognized the corresponding viral antigen and none cross-reacted with non-enteroviruses within the family Picornaviridae. However, all cross-reacted to some extent with the antigens derived from other serotypes of enterovirus. Indirect immunofluorescence assay and immunohistochemistry revealed that the virus capsid and non-structural proteins were localized in the cytoplasm of affected culture cells, and skeletal muscles and neurons in neonatal mice experimentally-infected with human enterovirus. The antibodies also recognized antigens derived from recent clinical isolates of enterovirus A71, coxsackievirus B3 and poliovirus. In addition, immunohistochemistry revealed that representative antibodies tested showed the same recognition pattern according to each serotype. Thus, the panel of in-house anti-enterovirus polyclonal antibodies described herein will be an important tool for the screening and pathological diagnosis for enterovirus infections, and may be useful for the classification of different enterovirus serotypes, including coxsackieviruses A and B, echoviruses, enterovirus A71 and poliovirus.	[Kotani, Osamu; Iwata-Yoshikawa, Naoko; Suzuki, Tadaki; Sato, Yuko; Nakajima, Noriko; Iwasaki, Takuya; Sata, Tetsutaro; Hasegawa, Hideki; Nagata, Noriyo] Nippon Vet & Life Sci Univ, Natl Inst Infect Dis, Dept Pathol, Tokyo, Aichi, Japan; [Shimizu, Hiroyuki] Nippon Vet & Life Sci Univ, Natl Inst Infect Dis, Dept Virol 2, Tokyo, Aichi, Japan; [Kotani, Osamu; Taguchi, Fumihiro] Nippon Vet & Life Sci Univ, Dept Virol & Viral Infect, Fac Vet Med, Tokyo, Aichi, Japan; [Koike, Satoshi] Tokyo Metropolitan Inst Med Sci, Neurovirol Project, Tokyo, Aichi, Japan; [Yamashita, Teruo; Minagawa, Hiroko] Aichi Prefectural Inst Publ Hlth, Dept Microbiol & Med Zool, Nagoya, Aichi, Japan	Nagata, N (reprint author), 4-7-1 Gakuen, Tokyo 2080011, Japan.	nnagata@niid.go.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23590554]; Ministry of Health, Labor, and Welfare, Japan	We wish to thank Dr. Takushi Hosomi (The Meat Inspection Center of Kochi Prefecture, Kochi, Japan) for providing the JPN08-404 isolate of Saffold virus, Dr. Cara Burns (Centers for Disease Control and Prevention, Atlanta, USA) for vaccine-derived type 2 polioviruses and Dr. Kazuya Shirato (Department Virology III) from the National Institute of Infectious Diseases for providing the EMCV. We are also grateful to Dr. Chikako Kataoka from the Department Virology II in the National Institute of Infectious Diseases for help with virus genome sequencing. We also thank Ms. Ayako Harashima, Ms. Mihoko Fujino and Ms. Moeko Aida for technical assistance and Dr. Harutaka Katano from our own department for valuable discussions. This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology, Japan (grant-in-aid for scientific research no. 23590554); and the Ministry of Health, Labor, and Welfare, Japan (grant-in aid for research on emerging and re-emerging infectious diseases. Research no. H23-Shinko-Ippan-007, H25-Shinko-Ippan-012). The authors have no conflict of interest to disclose.	Mao QY, 2012, J VIROL, V86, P11967, DOI 10.1128/JVI.00902-12; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Abe Y, 2012, J VIROL, V86, P185, DOI 10.1128/JVI.05245-11; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Cree BC, 2003, ARCH NEUROL-CHICAGO, V60, P107; Apostol LN, 2012, J MED VIROL, V84, P624, DOI 10.1002/jmv.23242; Abed Y, 2008, EMERG INFECT DIS, V14, P834, DOI 10.3201/eid1405.071675; Selvarangan R, 2011, PEDIATR INFECT DIS J, V30, P238, DOI 10.1097/INF.0b013e3181fbefc8; Krafft AE, 1997, MOL DIAGN, V2, P217, DOI 10.1016/S1084-8592(97)80032-X; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Chiu CY, 2010, J VIROL, V84, P4407, DOI 10.1128/JVI.02536-09; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Piralla A, 2012, J MED VIROL, V84, P686, DOI 10.1002/jmv.23197; Hansson SF, 2013, J PATHOL, V229, P719, DOI 10.1002/path.4166; Miao LY, 2009, J CLIN MICROBIOL, V47, P3108, DOI 10.1128/JCM.00479-09; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Shaukat S, 2012, VIRUS RES, V170, P164, DOI 10.1016/j.virusres.2012.09.010; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Zhang JH, 2012, VIRUS RES, V167, P337, DOI 10.1016/j.virusres.2012.05.019; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Nagata N, 2002, J MED VIROL, V67, P207, DOI 10.1002/jmv.2209; Yang Y, 2009, HUM PATHOL, V40, P1288, DOI 10.1016/j.humpath.2009.01.015; Liu JN, 2010, VACCINE, V28, P7444, DOI [10.1016/j.vaccine.2010.08.080, 10.1016/j.vaccine.2010.08.80]; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Wong KT, 2008, J NEUROPATH EXP NEUR, V67, P162, DOI 10.1097/nen.0b013e318163a990; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Arbustini E, 2000, HEART, V83, P86, DOI 10.1136/heart.83.1.86; Baasner A, 2003, LAB INVEST, V83, P1451, DOI 10.1097/01.LAB.0000092232.51370.66; Banerjee R, 2004, J VIROL, V78, P9243, DOI 10.1128/JVI.78.17.9243-9256.2004; Bates PJ, 1997, J VIROL METHODS, V67, P153, DOI 10.1016/S0166-0934(97)00095-5; CELLO J, 1993, J CLIN MICROBIOL, V31, P911; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Ezyaguirre EJ, 2010, DIAGNOSTIC IMMUNOHIS, P58; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; FOULIS AK, 1990, DIABETOLOGIA, V33, P290, DOI 10.1007/BF00403323; Guarner J, 2007, HUM PATHOL, V38, P1412, DOI 10.1016/j.humpath.2007.02.012; Hammerstad SS, 2013, J MED VIROL, V85, P512, DOI 10.1002/jmv.23476; Harlow E, 1988, ANTIBODIES LAB MANUA, P53; Harlow E, 1999, USING ANTIBODIES, P151; Himeda T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-110; KALLAJOKI M, 1990, LAB INVEST, V63, P669; KAMEI S, 1990, ACTA NEUROPATHOL, V80, P216; King AM, 2012, VIRUS TAXONOMY CLASS, V9; KLUMP WM, 1990, J VIROL, V64, P1573; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001476; Li Y, 2000, HEART, V83, P696, DOI 10.1136/heart.83.6.696; McKinney MD, 2009, J CLIN VIROL, V44, P39, DOI 10.1016/j.jcv.2008.09.003; National Institute of Infectious Diseases, 2012, INFECT AGENTS SURVEI; Odoom John Kofi, 2012, Pan Afr Med J, V12, P74; Oikarinen M, 2010, J CLIN VIROL, V47, P224, DOI 10.1016/j.jcv.2009.12.020; Oka K, 2005, VIRCHOWS ARCH, V446, P259, DOI 10.1007/s00428-004-1173-3; SAIZ JC, 1991, J VIROL, V65, P2518; SHIROKI K, 1995, J VIROL, V69, P6825; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; TRABELSI A, 1995, J CLIN MICROBIOL, V33, P2454; van der Marel P, 1983, Vaccine, V1, P17, DOI 10.1016/0264-410X(83)90007-5; vansZwol AL, 2009, BMJ CASE REP, V2009; Wong KT, 2012, NEUROPATH APPL NEURO, V38, P443, DOI 10.1111/j.1365-2990.2011.01247.x; Yeung WL, 1997, LANCET, V350, P1594, DOI 10.1016/S0140-6736(97)09514-7; YOUSEF GE, 1987, INTERVIROLOGY, V28, P163; Zhang HY, 2000, J HISTOCHEM CYTOCHEM, V48, P579; Zhang YC, 2012, PATHOL INT, V62, P565, DOI 10.1111/j.1440-1827.2012.02837.x; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416; ZUCKERMAN MA, 1993, J CLIN PATHOL, V46, P865, DOI 10.1136/jcp.46.9.865	75	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	APR	2015	35	2					107	121		10.1111/neup.12171		15	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CF5WV	WOS:000352628900002		
J	Takayama, Y; Nobusawa, S; Ochiai, I; Watanabe, H; Ishigame, H; Ikota, H; Hirato, J; Nakayama, J; Yokoo, H				Takayama, Yoshiyasu; Nobusawa, Sumihito; Ochiai, Ikuo; Watanabe, Hitoshi; Ishigame, Hiroki; Ikota, Hayato; Hirato, Junko; Nakayama, Jun; Yokoo, Hideaki			Malignant meningioma with adenocarcinoma-like metaplasia: Demonstration of intestinal phenotype	NEUROPATHOLOGY			English	Article						adenocarcinoma; anaplasia; intestinal phenotype; meningioma; metaplasia	EXPRESSION; CARCINOMA; CYTOKERATIN; METASTASIS; CDX2	Meningiomas show a diverse histopathologic appearance, often referred to as metaplastic changes; however, adenocarcinoma-like metaplasia is an extremely rare condition. Here, we present a novel case. A dura-based bulky mass located in the right frontotemporal region was identified radiologically in an 83-year-old woman. The tumor, yellow to ash-gray in color, was subtotally removed. Histopathological examination revealed robust adenocarcinoma-like structures within a conventional meningothelial neoplasm. Meningioma elements showed a WHO grade I to III histology. Morphological and immunophenotypic transition between meningothelial and columnar epithelial cells was confirmed on detailed observation. It was of note that the adenocarcinomatous components shared an immunophenotype with intestinal epithelium, expressing CDX2, MUC2 and cytokeratin 20. The present case could be differentiated from secretory meningioma based on distinct cellular atypia, lack of intracytoplasmic lumina and pseudosammoma bodies, and the intact status of the KLF4 gene. In addition, the morphological and immunophenotypic transition excluded the possibility of metastatic carcinoma within meningioma. This is the first reported case of meningioma with adenocarcinoma-like metaplasia harboring an intestinal immunophenotype.	[Takayama, Yoshiyasu; Nobusawa, Sumihito; Ikota, Hayato; Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 3718511, Japan; [Takayama, Yoshiyasu; Hirato, Junko] Gunma Univ Hosp, Dept Pathol, Maebashi, Gumma, Japan; [Ochiai, Ikuo; Watanabe, Hitoshi] Saku Cent Hosp, Dept Neurosurg, Saku, Japan; [Ishigame, Hiroki] Saku Cent Hosp, Dept Clin Pathol, Saku, Japan; [Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 390, Japan	Takayama, Y (reprint author), Gunma Univ, Grad Sch Med, Dept Human Pathol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	m13702004@gunma-u.ac.jp					Moody P, 2012, INT J CLIN EXP PATHO, V5, P367; Werling RW, 2003, AM J SURG PATHOL, V27, P303, DOI 10.1097/00000478-200303000-00003; BLANK M, 1994, INT J CANCER, V59, P301, DOI 10.1002/ijc.2910590302; Reuss DE, 2013, ACTA NEUROPATHOL, V125, P351, DOI 10.1007/s00401-013-1093-x; Patil S, 2011, NEUROSURGERY, V69, P884, DOI 10.1227/NEU.0b013e318222dc6f; Chu PG, 2000, MODERN PATHOL, V13, P962, DOI 10.1038/modpathol.3880175; Liu YL, 2004, MODERN PATHOL, V17, P1129, DOI 10.1038/modpathol.3800162; Caroli E, 2006, NEUROSURG REV, V29, P49, DOI 10.1007/s10143-005-0395-4; Heimberger AB, 2002, CLIN NEUROPATHOL, V21, P258; Ikeda Hidetoshi, 2003, Ann Diagn Pathol, V7, P214, DOI 10.1016/S1092-9134(03)00049-2; LUGO M, 1984, ARCH PATHOL LAB MED, V108, P185; NAKAZATO Y, 1982, LAB INVEST, V46, P621; Perry A, 2007, WHO CLASSIFICATION T, V1, P164; Shin JH, 2010, JPN J CLIN ONCOL, V40, P208, DOI 10.1093/jjco/hyp150; Yamaguchi H, 1980, No To Shinkei, V32, P1055	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	APR	2015	35	2					158	164		10.1111/neup.12155		7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CF5WV	WOS:000352628900007		
J	Kim, H; Yoshida, H; Hu, XY; Saito, K; Yoshida, Y; Kim, M; Hirano, H; Kojima, N; Hosoi, E; Suzuki, T				Kim, Hunkyung; Yoshida, Hideyo; Hu, Xiuying; Saito, Kyoko; Yoshida, Yuko; Kim, Miji; Hirano, Hirohiko; Kojima, Narumi; Hosoi, Erika; Suzuki, Takao			Association between Self-Reported Urinary Incontinence and Musculoskeletal Conditions in Community-Dwelling Elderly Women: A Cross-Sectional Study	NEUROUROLOGY AND URODYNAMICS			English	Article						elderly women; musculoskeletal conditions; low back pain; urinary incontinence	LOW-BACK-PAIN; MANAGEMENT; CONTINENCE; SYMPTOMS; INCREASE; URGE	Aims: Urinary incontinence (UI) and musculoskeletal conditions, particularly low back pain (LBP), and osteoarthritis (OA), are common problems that have been associated with mobility limitations and future dependence in activities of daily living in the elderly. The purpose of this study was to explore the relationship between UI, UI types, and musculoskeletal conditions in elderly community-dwelling women.Methods: A cross-sectional study was performed on 1,399 community-dwelling Japanese women aged 75-84 years. Face-to-face interviews, body composition, and physical function, including grip strength, and usual walking speed, were conducted. UI was defined as experience of urine leakage episodes more than once per week. Self-reported presence and degree of pain, LBP, and OA were assessed. Student's t-tests and chi-square tests were used to analyze continuous and categorical variables. Associations between selected variables, UI, and UI types were assessed using stepwise multiple logistic regression models.Results: A total of 260 participants had UI (18.6%) and 399 had LBP (28.5%). Participants with UI were more likely to experience pain (76.0%) and LBP (36.2%) than those without UI (P<0.001 and P=0.002, respectively). Age, body mass index, falls, walking speed, grip strength, LBP, and pain coupled with OA were significantly associated with UI. There were significant associations between urge UI and mild (odds ratio (OR)=1.653, 95% confidence interval (CI)=1.031-2.650) and severe LBP (OR=2.617, 95% CI=1.193-5.739).Conclusions: This study showed that UI was significantly associated with musculoskeletal conditions, including LBP, and the combination of pain and OA. The risk of urge UI was greater with increasing severity of LBP. Neurourol. Urodynam. 34:322-326, 2015. (C) 2014 Wiley Periodicals, Inc.	[Kim, Hunkyung; Yoshida, Hideyo; Saito, Kyoko; Yoshida, Yuko; Kim, Miji; Hirano, Hirohiko; Kojima, Narumi; Hosoi, Erika] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo 1730015, Japan; [Hu, Xiuying] Sichuan Univ, West China Hosp, West China Sch Med, Chengdu 610064, Peoples R China; [Suzuki, Takao] Natl Inst Longev Sci, Aichi, Japan	Kim, H (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.	kimhk@tmig.or.jp			Ministry of Health and Welfare of Japan; Scientific Research B of the Japan Society for the Promotion of Science [22300243]	Research Grant of the Ministry of Health and Welfare of Japan;; Scientific Research B of the Japan Society for the Promotion of Science; Grant number: 22300243	Abrams P, 2003, BJU INT, V91, P355, DOI 10.1046/j.1464-4096.2003.04105.x; Ahmadi B, 2010, INT UROGYNECOL J, V21, P453, DOI 10.1007/s00192-009-1031-6; Fritel X, 2013, BJOG-INT J OBSTET GY, V120, P1566, DOI 10.1111/1471-0528.12316; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Wyman JF, 1998, AM J OBSTET GYNECOL, V179, P999, DOI 10.1016/S0002-9378(98)70206-6; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Jackson RA, 2004, OBSTET GYNECOL, V104, P301, DOI 10.1097/01.AOG.0000133482.20685.d1; Buckley BS, 2010, UROLOGY, V76, P265, DOI 10.1016/j.urology.2009.11.078; Chiarelli PE, 2009, AUST J PHYSIOTHER, V55, P89; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; EISENSTEIN SM, 1994, SPINE, V19, P1148, DOI 10.1097/00007632-199405001-00010; Eliasson K, 2008, MANUAL THER, V13, P206, DOI 10.1016/j.math.2006.12.006; Finkelstein MM, 2002, CAN FAM PHYSICIAN, V48, P96; Gerwin R D, 2001, Curr Pain Headache Rep, V5, P412, DOI 10.1007/s11916-001-0052-8; Guralnick ML, 2010, INT UROGYNECOL J, V21, P325, DOI 10.1007/s00192-009-1030-7; Kim Ji Seon, 2010, Int Neurourol J, V14, P220, DOI 10.5213/inj.2010.14.4.220; NORTON PA, 1994, OBSTET GYNECOL, V84, P770; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; Smith MD, 2009, J PAIN, V10, P876, DOI 10.1016/j.jpain.2009.03.003; Smith MD, 2006, AUST J PHYSIOTHER, V52, P11; TURNERSTOKES L, 1992, J ROY SOC MED, V85, P389	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	APR	2015	34	4					322	326		10.1002/nau.22567		5	Urology & Nephrology	Urology & Nephrology	CF8NF	WOS:000352817700005		
J	Aizawa, N; Homma, Y; Igawa, Y				Aizawa, Naoki; Homma, Yukio; Igawa, Yasuhiko			Effects of L-Arginine, Mirabegron, and Oxybutynin on the Primary Bladder Afferent Nerve Activities Synchronized With Reflexic, Rhythmic Bladder Contractions in the Rat	NEUROUROLOGY AND URODYNAMICS			English	Article						afferent; beta 3-adrenoceptor; nitric oxide; Sprague-Dawley rats; urinary bladder	URINARY-BLADDER; BETA(3)-ADRENOCEPTOR AGONIST; OVERACTIVE BLADDER; MICTURITION; FIBERS	Aims: We measured single-unit mechanosensitive afferent activities (SAAs) during reflexic, rhythmic bladder contractions (RBCs), and examined whether L-arginine, an NO substrate, and mirabegron, beta 3-adrenoceptor agonist, and oxybutynin, an antimuscarinic agent, can affect the SAAs in such condition. Methods: Twenty-nine female Sprague-Dawley rats were anesthetized. SAA was identified by electro-stimulation of the left pelvic nerve and by bladder distension, and was divided into A delta- or C-fibers by conduction velocity. To produce the RBCs, right L6 dorsal roots were kept intact. Under an isovolumetric condition, vehicle and L-arginine (300mg/kg) or mirabegron (1mg/kg) or oxybutynin (1mg/kg) were administered intravenously. Results: All of the A delta- (n=26) and C-fibers (n=29) capable of responding to bladder distention were also responsive to bladder contractions during RBCs. The amplitude and duration of RBCs significantly decreased after mirabegron- and oxybutynin-administrations, but not after L-arginine-administration. The interval of RBC was significantly elongated after L-arginine- and mirabegron-administrations. Regarding the SAAs, the peaks of firing rate (FR) during RBCs and FR during the non-contractile phase were decreased after L-arginine-administration, which were more remarkable for A delta-fibers than C-fibers. Similar results were observed after mirabegron-administration only for A delta-fibers. After oxybutynin-administration, the peak of FR of both fiber-SAAs significantly decreased, but the change was not significant when the value was normalized by the amplitude of RBCs. Conclusions: The present results indicate that mechanosensitive A delta- and C-fibers were also responsive to bladder contractions, and that NO production and 3 beta-adrenoceptor stimulation can inhibit SAAs mainly of A delta-fibers synchronized with RBCs. (C) 2014 Wiley Periodicals, Inc.	[Aizawa, Naoki; Igawa, Yasuhiko] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138655, Japan; [Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138655, Japan	Igawa, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Continence Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yigawa-jua@umin.ac.jp			Astellas Pharma Inc. (Tokyo, Japan);  [40159588];  [80595257]	Grant sponsor: Grant-in-Aid for Scientific Research (YI and NA); Grant numbers: 40159588; 80595257; Grant sponsor: Astellas Pharma Inc. (Tokyo, Japan)	Chuang YC, 2001, AM J PHYSIOL-REG I, V281, pR1302; Jung SY, 1999, J UROLOGY, V162, P204, DOI 10.1097/00005392-199907000-00069; de Groat WC, 2004, UROLOGY, V64, P7, DOI 10.1016/j.urology.2004.08.063; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; HABLER HJ, 1993, J PHYSIOL-LONDON, V463, P449; Gabella G, 1998, J NEUROCYTOL, V27, P141, DOI 10.1023/A:1006903507321; Aizawa N, 2010, NEUROUROL URODYNAM, V29, P771, DOI 10.1002/nau.20826; Aizawa N, 2011, EUR UROL, V59, P264, DOI 10.1016/j.eururo.2010.10.035; Takasu T, 2007, J PHARMACOL EXP THER, V321, P642, DOI 10.1124/jpet.106.115840; Aizawa N, 2012, EUR UROL, V62, P1165, DOI 10.1016/j.eururo.2012.08.056; IGGO A, 1955, J PHYSIOL-LONDON, V128, P593; Morrison J, 1999, Scand J Urol Nephrol Suppl, V201, P73; Ouslander JG, 2004, NEW ENGL J MED, V350, P786; SENGUPTA JN, 1994, J NEUROPHYSIOL, V72, P2420; Shea VK, 2000, J NEUROPHYSIOL, V84, P1924; Uchida M, 2004, J PHARMACOL SCI, V94, P122, DOI 10.1254/jphs.94.122; Vera PL, 2000, BRAIN RES, V883, P107, DOI 10.1016/S0006-8993(00)02732-3	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	APR	2015	34	4					368	374		10.1002/nau.22571		7	Urology & Nephrology	Urology & Nephrology	CF8NF	WOS:000352817700013		
J	Kaneiwa, K; Mizoguchi, R; Nguyen, PHP				Kaneiwa, Ken; Mizoguchi, Riichiro; Nguyen, Philip H. P.			A Logical and Ontological Framework for Compositional Concepts of Objects and Properties	NEW GENERATION COMPUTING			English	Article						Compositional Concepts; Upper Ontology; Object and Property; Monadic Second-order Logic; Resource Description Framework (RDF)		In order to formalize complex and compositional concepts, we propose a logical framework based on an upper ontology constructed from the composition of basic concepts such as properties and objects. In particular, ontologically distinct compositions (called ontological compositions) that are not easily defined by using ISA and PART-OF relations are classified into characterizing, temporal, and spatial compositions (e.g., 'red face' and 'today'). In this paper, we precisely model such ontological compositions by using monadic second-order logic; properties and objects are expressed as predicates, and attributes are expressed as predicates of predicates. The proposed approach provides a novel technique for the classification of attributes as higher-order concepts, and it clarifies illegal compositions of properties and objects and the uniqueness of temporal attributes. Moreover, our composition ontology is described by a set of RDF triples using the metamodeling of concepts in RDF Schema.	[Kaneiwa, Ken] Univ Electrocommun, Dept Commun Engn & Informat, Chofu, Tokyo 1828585, Japan; [Mizoguchi, Riichiro] Japan Adv Inst Sci & Technol, Res Ctr Serv Sci, Nomi, Ishikawa 9231292, Japan; [Nguyen, Philip H. P.] Govt South Australia, Attorney Gen Dept, Adelaide, SA 5000, Australia	Kaneiwa, K (reprint author), Univ Electrocommun, Dept Commun Engn & Informat, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	kaneiwa@uec.ac.jp; mizo@jaist.ac.jp; philip.nguyen@sa.gov.au					ROSENKRANTZ G, 1991, PHILOS PHENOMEN RES, V51, P835, DOI 10.2307/2108184; Welty C, 2001, DATA KNOWL ENG, V39, P51, DOI 10.1016/S0169-023X(01)00030-1; Baget JF, 2010, LECT NOTES ARTIF INT, V6208, P28, DOI 10.1007/978-3-642-14197-3_7; Bettini C., 2000, TIME GRANULARITIES D; Brickley D., 2004, TECHNICAL REPORT, P2; Chen WD, 1995, LECT NOTES COMPUT SC, V893, P252; Dershowitz N., 1997, CALENDRICAL CALCULAT; Gandon F., 2014, RDF 1 1 XML SYNTAX W; Grenon P., 2004, SPAT COGN COMPUT, V4, P69, DOI DOI 10.1207/S15427633SCC0401_5; Guarino N, 2000, LECT NOTES ARTIF INT, V1937, P97; Kaneiwa K, 2005, LECT NOTES ARTIF INT, V3702, P169; Kaneiwa K, 2009, J WEB SEMANT, V7, P252, DOI 10.1016/j.websem.2009.05.003; Kaneiwa K., 2004, P 9 INT C PRINC KNOW, P278; Kaneiwa K, 2004, ARTIF INTELL, V158, P155, DOI 10.1016/j.artint.2004.05.001; Loux M., 2003, OXFORD HDB METAPHYSI; Lowe E. J., 2005, 4 CATEGORY ONTOLOGY; Manzano M., 1993, Many-sorted logic and its applications; Masolo C., 2002, WONDERWEB DELIVERABL; Materna P., 1997, ACTA PHILOS FENNICA, V63; Motik B, 2007, J LOGIC COMPUT, V17, P617, DOI 10.1093/logcom/exm027; Ohlbach H. J., 1998, J APPL NONCLASSICAL, V8, P4; Smith B., 1998, FORMAL ONTOLOGY INFO; THARP LH, 1973, J SYMBOLIC LOGIC, V38, P481, DOI 10.2307/2273046; Welty C., 2005, APPL ONTOL, V1, P107	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0288-3635	1882-7055		NEW GENERAT COMPUT	New Gener. Comput.	APR	2015	33	2					149	172		10.1007/s00354-015-0203-9		24	Computer Science, Hardware & Architecture; Computer Science, Theory & Methods	Computer Science	CF8IX	WOS:000352802100003		
J	Wu, YH; Xue, XP; Shen, TL				Wu, Yuhu; Xue, Xiaoping; Shen, Tielong			Absolute stability of the axially moving Kirchhoff string with a sector boundary feedback control	NONLINEAR DYNAMICS			English	Article						Axially moving Kirchhoff string; Absolute stability; Sector condition; Boundary control	ACTIVE VIBRATION CONTROL; NONLINEAR VIBRATIONS; SUPPORT CONDITIONS; VARYING TENSION; STABILIZATION; DYNAMICS; BEAM; CONTINUA; SYSTEMS; LURE	In this study, the absolute stability problem for the axially moving Kirchhoff string with nonlinear boundary feedback control has been investigated. Based on the generalized Hamilton's variational principle, the nonlinear governing equations of the motion and boundary conditions have been deduced. The proposed boundary control, which satisfies a sector constraint condition, is a negative feedback of the transversal velocity at the right end of the string. Applying the integral-type multiplier method, the absolute stability of the axially moving Kirchhoff system is established. To validate the proposed theoretical results, numerical simulations are expressed by the finite element method.	[Wu, Yuhu; Shen, Tielong] Sophia Univ, Dept Engn & Appl Sci, Tokyo 102, Japan; [Xue, Xiaoping] Harbin Inst Technol, Dept Math, Harbin 150006, Peoples R China	Wu, YH (reprint author), Sophia Univ, Dept Engn & Appl Sci, Tokyo 102, Japan.	wuyuhu51@gmail.com; xiaopingxue@hit.edu.cn; tetu-sin@sophia.ac.jp			NNSFC [11271099, 11401142]	The first author would like to express his gratitude to Prof. T. Nagashima of the Department of Mechanical Engineering at Sophia University for his helpful suggestion to the simulation results. This work was partially supported by the NNSFC under Grant 11271099, and 11401142.	Abrate S., 1992, MECH MACH THEORY, V16, P534; He W, 2011, AUTOMATICA, V47, P722, DOI 10.1016/j.automatica.2011.01.064; KALMAN RE, 1963, P NATL ACAD SCI USA, V49, P201, DOI 10.1073/pnas.49.2.201; Riedel CH, 2002, INT J NONLINEAR MECH, V37, P101, DOI 10.1016/S0020-7462(00)00100-1; Yang KJ, 2004, J SOUND VIB, V273, P1007, DOI 10.1016/S0022-460X(03)00519-4; CHEN G, 1979, J MATH PURE APPL, V58, P249; LAGNESE JE, 1988, SIAM J CONTROL OPTIM, V26, P1250, DOI 10.1137/0326068; Park P, 2002, IEEE T AUTOMAT CONTR, V47, P308; Shahruz SM, 1997, J SOUND VIB, V201, P145, DOI 10.1006/jsvi.1996.0754; Li TC, 2008, AUTOMATICA, V44, P498, DOI 10.1016/j.automatica.2007.06.004; Ghayesh MH, 2012, J SOUND VIB, V331, P5107, DOI 10.1016/j.jsv.2012.06.018; Pellicano F, 2000, J VIB ACOUST, V122, P21, DOI 10.1115/1.568433; Ghayesh MH, 2012, NONLINEAR DYNAM, V70, P335, DOI 10.1007/s11071-012-0458-3; WICKERT JA, 1990, J APPL MECH-T ASME, V57, P738, DOI 10.1115/1.2897085; Bagdatli SM, 2013, NONLINEAR DYNAM, V74, P237, DOI 10.1007/s11071-013-0961-1; Bagdatli SM, 2011, J VIB ACOUST, V133, DOI 10.1115/1.4003205; BAPAT VA, 1967, J APPL MECH, V34, P775; Beikmann RS, 1996, J VIB ACOUST, V118, P406, DOI 10.1115/1.2888197; Chen L., 2005, APPL MECH REV, V58, P91, DOI 10.1115/1.1849169; CHUNG CH, 1995, J VIB ACOUST, V117, P49, DOI 10.1115/1.2873866; Curtain RF, 2004, P ROY SOC A-MATH PHY, V460, P2171, DOI 10.1098/rspa.2003.1261; FUNG RF, 1995, INT J MECH SCI, V37, P985, DOI 10.1016/0020-7403(94)00103-Q; Jayawardhana B., 2008, COMMUNICATIONS INFOR, V8, P413; Kartik V, 2006, J SOUND VIB, V291, P419, DOI 10.1016/j.jsv.2005.06.021; Khalil H.K., 2002, NONLINEAR SYSTEMS; Kim CW, 2005, INT J CONTROL AUTOM, V3, P601; Kirchhoff G., 1877, VORLESUNGER MATH PHY; Komornik V., 1994, EXACT CONTROLLABILIT; Lee SY, 1996, J DYN SYST-T ASME, V118, P66, DOI 10.1115/1.2801153; Li TC, 2006, J SOUND VIB, V296, P861, DOI 10.1016/j.jsv.2006.03.012; Lur'e A. I., 1944, APPL MATH MECH, V8, P246; Popov VM, 1962, AUTOMAT REM CONTR+, V22, P857; Rao S.S., 2007, VIBRATION CONTINUOUS; Shahruz SM, 1998, AUTOMATICA, V34, P1273, DOI 10.1016/S0005-1098(98)00074-0; Wang JJ, 2004, J VIB CONTROL, V10, P475, DOI 10.1177/1077546304035605; Wu YH, 2014, AUTOMATICA, V50, P1915, DOI 10.1016/j.automatica.2014.05.006; Yurddas A, 2014, J VIB CONTROL, V20, P518, DOI 10.1177/1077546312463760; Yurddas A, 2013, NONLINEAR DYNAM, V73, P1223, DOI 10.1007/s11071-012-0650-5; Zhang S, 2012, IEEE-ASME T MECH, V17, P1196, DOI 10.1109/TMECH.2011.2160960	39	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0924-090X	1573-269X		NONLINEAR DYNAM	Nonlinear Dyn.	APR	2015	80	1-2					9	22		10.1007/s11071-014-1847-6		14	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CF6VR	WOS:000352695100002		
J	Tanaka, K; Ishiguro, F; Jeon, JH; Hiraoka, T; Chujo, Y				Tanaka, Kazuo; Ishiguro, Fumiyasu; Jeon, Jong-Hwan; Hiraoka, Tatsuhiro; Chujo, Yoshiki			POSS ionic liquid crystals	NPG ASIA MATERIALS			English	Article							CORE DENDRIMERS; DERIVATIVES; ELECTROLYTE; BEHAVIOR; FILMS	Here we report the use of unique organic - inorganic hybrid materials composed of octa-substituted polyhedral oligomeric silsesquioxane (POSS) cores as ionic liquid (IL) crystals. These materials have a wide temperature range in which they exist in liquid crystal (LC) phase because of the stabilizing effect of the POSS core. We synthesized ion pairs composed of alkyl chain-substituted imidazolium and carboxylates of various lengths that were or were not connected to the POSS core; then the thermal properties of these materials were investigated. It was found that both ion salts and the octadecyl-substituted imidazolium ion pairs with or without connection to POSS could form LCs. Interestingly, the LC phase of the POSS-tethered ion salts was maintained until decomposition. In contrast, the octadecyl-substituted imidazolium ion salts that were not tethered to the POSS core showed a clearance point during heating. The highly symmetric structure of POSS contributes not only to the suppression of the molecular motion of the ion salts, but also results in the formation of regular structures, leading to thermally stable, thermotropic IL crystals.	[Tanaka, Kazuo; Ishiguro, Fumiyasu; Jeon, Jong-Hwan; Hiraoka, Tatsuhiro; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto 6158510, Japan	Chujo, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	kazuo123@chujo.synchem.kyoto-u.ac.jp; chujo@chujo.synchem.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (Japan) [2401, 25102521]	We thank Professor Susumu Kitagawa and Dr Satoshi Horike (Kyoto University) for the use of the VT-XRD instrument and Professor Hirokazu Hasegawa and Dr Kenji Saijo (Kyoto University) for the use of the SAXS instrument. We acknowledge Professor Kazuo Akagi and Dr Munju Goh (Kyoto University) for their advice concerning the structural analysis of the liquid crystals. This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'New Polymeric Materials Based on Element-Blocks (No. 2401)' (25102521) from The Ministry of Education, Culture, Sports, Science, and Technology (Japan).	Carmichael AJ, 2001, MOL PHYS, V99, P795, DOI 10.1080/00268970010012301; Binnemans K, 2005, CHEM REV, V105, P4148, DOI 10.1021/cr0400919; Tanaka K, 2011, POLYM J, V43, P708, DOI 10.1038/pj.2011.54; Naka K, 2012, POLYM J, V44, P353, DOI 10.1038/pj.2011.145; Yoshio M, 2004, J AM CHEM SOC, V126, P994, DOI 10.1021/ja0382516; Yoshio M, 2006, J AM CHEM SOC, V128, P5570, DOI 10.1021/ja0606935; Tanaka K, 2013, POLYM J, V45, P247, DOI 10.1038/pj.2012.154; Kohler FTU, 2011, CHEMPHYSCHEM, V12, P3539, DOI 10.1002/cphc.201100379; Nakato T, 2014, SOFT MATTER, V10, P3161, DOI 10.1039/c3sm52311j; Axenov KV, 2011, MATERIALS, V4, P206, DOI 10.3390/ma4010206; Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313; Shi F, 2005, CHEM-EUR J, V11, P5279, DOI 10.1002/chem.200500107; Tanaka K, 2010, J AM CHEM SOC, V132, P17649, DOI 10.1021/ja105631j; Wezenberg SJ, 2013, RSC ADV, V3, P22845, DOI 10.1039/c3ra44883e; Goh M, 2012, J MATER CHEM, V22, P25011, DOI 10.1039/c2jm35282f; Tanaka K, 2012, J MATER CHEM, V22, P1733, DOI 10.1039/c1jm14231c; Kaneko Y, 2014, CHEM-EUR J, V20, P9394, DOI 10.1002/chem.201402011; Yamamoto E, 2014, CHEM MATER, V26, P2927, DOI 10.1021/cm500619p; Kuroda K, 2014, CHEM MATER, V26, P211, DOI 10.1021/cm4023387; Subianto S, 2009, ACS APPL MATER INTER, V1, P1173, DOI 10.1021/am900020w; Holbrey JD, 1999, J CHEM SOC DALTON, P2133, DOI 10.1039/a902818h; Ishii T, 2014, B CHEM SOC JPN, V87, P155, DOI 10.1246/bcsj.20130246; Jeon JH, 2014, J MATER CHEM A, V2, P624, DOI 10.1039/c3ta14039c; Jeon JH, 2013, RSC ADV, V3, P2422, DOI 10.1039/c2ra22683a; Jovanovski V., 2006, INT J PHOTOENERGY, V8, P1; Jovanovski V, 2005, J PHYS CHEM B, V109, P14387, DOI 10.1021/jp051270c; Naka K, 2014, POLYM J, V46, P42, DOI 10.1038/pj.2013.60; Tanaka K, 2013, B CHEM SOC JPN, V86, P1231, DOI 10.1246/bcsj.20130182; Toyodome H, 2013, J NANOSCI NANOTECHNO, V13, P3074, DOI 10.1166/jnn.2013.7416; Vuk AS, 2008, SOL ENERG MAT SOL C, V92, P126, DOI 10.1016/j.solmat.2007.01.023	30	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1884-4049	1884-4057		NPG ASIA MATER	NPG Asia Mater.	APR	2015	7								e174	10.1038/am.2015.28		6	Materials Science, Multidisciplinary	Materials Science	CG2OK	WOS:000353113900005		
J	Wang, X; Liu, DQ; Weng, QH; Liu, JW; Liang, QF; Zhang, C				Wang, Xi; Liu, Dequan; Weng, Qunhong; Liu, Jiangwei; Liang, Qifeng; Zhang, Chao			Cu/Li4Ti5O12 scaffolds as superior anodes for lithium-ion batteries	NPG ASIA MATERIALS			English	Article							LI4TI5O12 ANODE; RATE CAPABILITY; STORAGE; PERFORMANCE; SPINEL; ELECTRODES; CAPACITY; ORIGINS; DESIGN; CHARGE	Nanostructured active materials with both high-capacity and high-rate capability have attracted considerable attention, but they remain a great challenge to be realized. Herein, we report a new route to fabricate a bicontinuous Cu/Li4Ti5O12 scaffold that consists of Li4Ti5O12 nanoparticles (LTO NPs) with highly exposed (111) facets and nanoporous Cu scaffolds, which enable simultaneous high-capacity and high-rate lithium storage. It is a 'one stone, two birds' strategy. When tested as the anode in lithium-ion batteries LIBs, Cu/LTO showed superior performance, such as a lifespan greater than 2000 cycles and an ultrafast charging time (<45 s). Notably, the ultrahigh capacity slightly larger than the theoretical value was also observed in Cu/LTO at low current density. Density functional theory calculations and detailed characterizations revealed that the highly exposed (111) facets on the edge are the reason for its unique storage mechanism (8a+16c), which is different from the transition between 8a and 16c in bulk LTO.	[Wang, Xi; Liu, Dequan; Weng, Qunhong; Liu, Jiangwei; Zhang, Chao] Natl Inst Mat Sci, Ctr Mat Nanoarchitecton MANA, WPI, ICYS, Tsukuba, Ibaraki 3050044, Japan; [Liu, Dequan] Lanzhou Univ, Sch Phys Sci & Technol, Lanzhou 730000, Peoples R China; [Liang, Qifeng] Shaoxing Univ, Dept Phys, Shaoxing, Peoples R China	Wang, X (reprint author), Natl Inst Mat Sci, Ctr Mat Nanoarchitecton MANA, WPI, ICYS, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan.	wangxicas@gmail.com; qfliang@usx.edu.cn	Weng, Qunhong/G-9665-2014; Liu, Jiangwei/N-7332-2014	Weng, Qunhong/0000-0002-9805-0393; 	International Center for Young Scientists, World Premier International Research Center on Materials Nanoarchitectonics, MEXT, Japan	This work was supported by the International Center for Young Scientists, World Premier International Research Center on Materials Nanoarchitectonics, MEXT, Japan. We greatly thank Dr Xizheng Liu at AIST, Japan for kind discussions and help.	Chen WN, 2014, CHEM COMMUN, V50, P8856, DOI 10.1039/c4cc02886d; Lu X, 2012, ADV MATER, V24, P3233, DOI 10.1002/adma.201200450; Yu Y, 2013, ADV ENERGY MATER, V3, P281, DOI 10.1002/aenm.201200496; Borghols WJH, 2009, J AM CHEM SOC, V131, P17786, DOI 10.1021/ja902423e; Wang X, 2014, NANO LETT, V14, P1164, DOI 10.1021/nl4038592; Wang YG, 2008, ANGEW CHEM INT EDIT, V47, P7461, DOI 10.1002/anie.200802539; Hirayama M, 2011, DALTON T, V40, P2882, DOI 10.1039/c0dt01477j; Shen LF, 2012, ADV MATER, V24, P6502, DOI 10.1002/adma.201203151; Pfanzelt M, 2011, J POWER SOURCES, V196, P6815, DOI 10.1016/j.jpowsour.2010.09.109; Liu DQ, 2013, NANOSCALE, V5, P1917, DOI 10.1039/c2nr33383j; Kang B, 2009, NATURE, V458, P190, DOI 10.1038/nature07853; Zhang HG, 2011, NAT NANOTECHNOL, V6, P277, DOI [10.1038/nnano.2011.38, 10.1038/NNANO.2011.38]; Wang YQ, 2012, J AM CHEM SOC, V134, P7874, DOI 10.1021/ja301266w; Song H, 2012, ENERG ENVIRON SCI, V5, P9903, DOI 10.1039/c2ee22734g; Ganapathy S, 2012, ACS NANO, V6, P8702, DOI 10.1021/nn302278m; Shen LF, 2012, ADV ENERGY MATER, V2, P691, DOI 10.1002/aenm.201100720; Yang SB, 2013, NANO LETT, V13, P1596, DOI 10.1021/nl400001u; Li BH, 2012, ENERG ENVIRON SCI, V5, P9595, DOI 10.1039/c2ee22591c; Liu J, 2014, NANO LETT, V14, P2597, DOI 10.1021/nl5004174; Prakash AS, 2010, CHEM MATER, V22, P2857, DOI 10.1021/cm100071z; Zhang QY, 2013, INT J ELECTROCHEM SC, V8, P6449; Kim JG, 2014, CHEMSUSCHEM, V7, P1451, DOI 10.1002/cssc.201301393; Fujita T, 2012, NAT MATER, V11, P775, DOI [10.1038/nmat3391, 10.1038/NMAT3391]; Liu N, 2014, NAT NANOTECHNOL, V9, P187, DOI [10.1038/nnano.2014.6, 10.1038/NNANO.2014.6]; Liu DQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02543; Pikul JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2747	26	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1884-4049	1884-4057		NPG ASIA MATER	NPG Asia Mater.	APR	2015	7								e171	10.1038/am.2015.23		7	Materials Science, Multidisciplinary	Materials Science	CG2OK	WOS:000353113900002		
J	Sasaki, T; Nabaa, B; Takahashi, K; Okizaki, A; Ishitoya, S				Sasaki, Tomoaki; Nabaa, Basim; Takahashi, Koji; Okizaki, Atsutaka; Ishitoya, Shunta			Non-contrast-enhanced computed tomography attenuation in the parotid glands before radioiodine therapy for thyroid carcinoma could be a predictor of radiovulnerability	NUCLEAR MEDICINE COMMUNICATIONS			English	Article						adverse effect; computed tomography attenuation; radioiodine therapy; salivary gland; well-differentiated thyroid carcinoma	SALIVARY; CANCER; DYSFUNCTION; DAMAGE	Objective This study aimed to determine a predictive factor for the effect of radioiodine therapy (RIT) on salivary gland dysfunction through a multiple regression analysis. Methods We retrospectively assessed 40 patients with thyroid carcinoma, including 13 men (age range, 21-80 years) and 27 women (age range, 28-75 years), who underwent total thyroidectomy and were treated with RIT. We used multiple regression analysis to evaluate whether factors such as age, sex, dose number, prescintigraphy grade, computed tomography (CT) attenuation, and CT volume of the salivary glands affected the postscintigraphy grade. Receiver operating characteristics analysis was performed for predicting worsening scintigraphy grade of the parotid glands in 20 patients after RIT. Results The postscintigraphy grade of the parotid glands was positively associated with the dose number and prescintigraphy grade and negatively associated with CT attenuation (beta = 0.48, P < 0.01; beta = 0.47, P < 0.01; and beta = -0.26, P < 0.05, respectively; adjusted R-2 = 0.50, P < 0.05). In the submandibular glands, the postscintigraphy grade was only positively correlated with dose number (beta = 0.58, P < 0.01; adjusted R-2 = 0.32, P < 0.01). Area under the curve was 0.775 (P < 0.05) and the cutoff CT attenuation was -18.8 HU (sensitivity 0.714 and specificity 0.846). Conclusion The RIT dose number, prescintigraphy grade, and CT attenuation may be important predictors of parotid gland dysfunction after RIT, whereas the dose number alone may be a significant predictor of submandibular gland dysfunction. Nucl Med Commun 36: 350-355 Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Sasaki, Tomoaki; Nabaa, Basim; Takahashi, Koji; Okizaki, Atsutaka; Ishitoya, Shunta] Asahikawa Med Univ, Dept Radiol, Asahikawa, Hokkaido 0788510, Japan	Sasaki, T (reprint author), Asahikawa Med Univ, Dept Radiol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	tomoaki3est@gmail.com					SAMAAN NA, 1992, J CLIN ENDOCR METAB, V75, P714, DOI 10.1210/jc.75.3.714; Solans R, 2001, J NUCL MED, V42, P738; Raza H, 2006, NUCL MED COMMUN, V27, P495, DOI 10.1097/00006231-200606000-00004; Nabaa B, 2012, AM J NEURORADIOL, V33, P1964, DOI 10.3174/ajnr.A3063; Alexander C, 1998, J NUCL MED, V39, P1551; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; Caglar M, 2002, CLIN NUCL MED, V27, P767, DOI 10.1097/01.RLU.0000031607.42515.B3; Nakada K, 2005, J NUCL MED, V46, P261; Jentzen W, 2006, NUCL MED COMMUN, V27, P669, DOI 10.1097/00006231-200608000-00009; Malpani BL, 1996, INT J RADIAT ONCOL, V35, P535, DOI 10.1016/S0360-3016(96)80016-2; BRYAN RN, 1982, AM J ROENTGENOL, V139, P547; Hermann GA, 1999, CLIN NUCL MED, V24, P167, DOI 10.1097/00003072-199903000-00006; Lam MGEH, 2005, J NUCL MED, V46, P2118; Liem IH, 1996, EUR J NUCL MED, V23, P1485, DOI 10.1007/BF01254473; McDougall IR, 1992, THYROID DIS CLIN PRA, V1st; Newkirk K A, 2000, Ear Nose Throat J, V79, P460; STEPHENS LC, 1991, CANCER, V67, P1539, DOI 10.1002/1097-0142(19910315)67:6<1539::AID-CNCR2820670613>3.0.CO;2-Q; Vissink A, 1996, Spec Care Dentist, V16, P95, DOI 10.1111/j.1754-4505.1996.tb00842.x; Wartofsky L., 2000, THYROID CANC COMPREH	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0143-3636	1473-5628		NUCL MED COMMUN	Nucl. Med. Commun.	APR	2015	36	4					350	355		10.1097/MNM.0000000000000250		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF7JJ	WOS:000352732000007		
J	Hirata, Y; Asada, T; Komita, H; Suzuki, T; Aizawa, R				Hirata, Yosuke; Asada, Takatoshi; Komita, Hideo; Suzuki, Tetsu; Aizawa, Rie			Pressure Drop of Annular Flow Channel Electromagnetic Pump Examined Using Divided Flow Channel Model	NUCLEAR SCIENCE AND ENGINEERING			English	Article							LINEAR INDUCTION PUMP; MAGNETOHYDRODYNAMIC INSTABILITY	It has been reported that operating an annular flow channel electromagnetic pump (EMP) near the peak of the head pressure and flow rate curve sometimes suffers a drop of head pressure. This phenomenon was attributed to nonuniform distribution of inlet flow or magnetic field, but its mechanism has not been clarified. For fear of this undesired head pressure drop, current EMP design is sometimes too conservative in that the rated efficiency is set low compared with experimentally achieved values. Understanding this phenomenon clearly, therefore, will prospectively make possible more proper design. We modeled the annular channel with parallel divided channels to examine the response of the EMP for distributed inlet flow. For each of the divided channels, the equation of fluid motion is numerically solved including the pressure from the external flow loop. Since the time constant of the pressure from the external loop is slow compared with that of the divided channels, decreased flow in some divided channels can undergo reversed pressure and become unstable in certain cases. Transient behaviors, such as the total head pressure and the flow rate of the EMP, were examined, and conditions of this pressure drop occurrence were clarified, making possible more proper EMP design.	[Hirata, Yosuke; Asada, Takatoshi; Komita, Hideo] Toshiba Co Ltd, Power & Ind Syst R&D Ctr, Isogo Ku, Yokohama, Kanagawa 2358523, Japan; [Suzuki, Tetsu; Aizawa, Rie] Toshiba Co Ltd, Adv Energy Design & Engn Dept, Isogo Ku, Yokohama, Kanagawa 2358523, Japan	Hirata, Y (reprint author), Toshiba Co Ltd, Power & Ind Syst R&D Ctr, Isogo Ku, 8 Shinsugita Cho, Yokohama, Kanagawa 2358523, Japan.	yosuke.hirata@toshiba.co.jp					Araseki H, 2004, NUCL ENG DES, V227, P29, DOI 10.1016/j.nucengdes.2003.07.001; Araseki H, 2006, NUCL ENG DES, V236, P965, DOI 10.1016/j.nucengdes.2005.09.007; GAELMS A., 1975, MAGN GIDRODIN, V11, P87; Ota H, 2004, J NUCL SCI TECHNOL, V41, P511, DOI 10.3327/jnst.41.511	4	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	APR	2015	179	4					355	363				9	Nuclear Science & Technology	Nuclear Science & Technology	CF3QL	WOS:000352463500001		
J	Turnbull, JA; Yagnik, SK; Hirai, M; Staicu, DM; Walker, CT				Turnbull, J. A.; Yagnik, S. K.; Hirai, M.; Staicu, D. M.; Walker, C. T.			An Assessment of the Fuel Pulverization Threshold During LOCA-Type Temperature Transients	NUCLEAR SCIENCE AND ENGINEERING			English	Article								To investigate the potential disintegration to powder of high-burnup fuel pellets during a rapid temperature transient, the Nuclear Fuels Industry Research (NFIR) Program commissioned two independent scoping studies. The first investigated the effect of hydrostatic restraint pressure on fission gas release during a series of fast temperature ramps. In the second study laser heating was used to investigate the temperature at which small samples of fuel fragmented. From the observations made in these studies, local burnup and temperature thresholds of 71 MWdl kg HM and 645 degrees C were identified for fuel pulverization during a loss-ofcoolant accident (LOCA). It is shown that fine fragment production in integral LOCA tests peiformed in other independent investigations at Studsvik and Halden was generally well predicted using these thresholds of burnup and temperature. The NFIR investigations also reveal that the degree of pulverization and resulting fragment size are dependent on the temperature ramp rate. Moreover, they confirm that pulverization can be substantially reduced by the imposition of hydrostatic pressure.	[Turnbull, J. A.] Independent Consultant, Arlington, VA 22209 USA; [Yagnik, S. K.] Elect Power Res Inst, Palo Alto, CA USA; [Hirai, M.] Nippon Nucl Fuel Dev Co Ltd, Ibaraki, Japan; [Staicu, D. M.; Walker, C. T.] Commiss European Communities, Joint Res Ctr, Inst Transuranium Elements, Karlsruhe, Germany	Turnbull, JA (reprint author), Independent Consultant, Arlington, VA 22209 USA.	syagnik@epri.com			Electric Power Research Institute-led NFIR Program	This work was carried out under the auspices of the Electric Power Research Institute-led NFIR Program. The authors wish to acknowledge technical inputs from NFIR members and thank them for permission to publish the results. Many fruitful discussions with N. Waeckel (EDF-Septen) are especially acknowledged.	Hiernaut JP, 2008, J NUCL MATER, V377, P313, DOI 10.1016/j.jnucmat.2008.03.006; ASKELJUNG P., 2012, P 2012 TOP FUEL C MA; FLANAGAN M., 2013, P LWR FUEL PERF M TO; FLANAGAN M., 2013, NUREG2160 US NUCL RE; KINOSHITA M., 2004, P 2004 INT M LWR FUE; Raynaud P, 2012, NUREG2121 US NUCL RE; RAYNAUD P. A. C., 2013, P LWR FUEL PERF M TO; SCHEINDLIN M., 1998, REV SCI INSTRUM, V69, P1426; UNE K., 2005, P WAT REACT FUEL PER; WIESENACK W., 2013, COMMUNICATION; WIESENACK W., 2010, NEACSNIR20105; WIESENACK W., 2013, P ENL HALD PROGR GRO	12	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	APR	2015	179	4					477	485				9	Nuclear Science & Technology	Nuclear Science & Technology	CF3QL	WOS:000352463500009		
J	Kiguchi, N; Kobayashi, Y; Saika, F; Sakaguchi, H; Maeda, T; Kishioka, S				Kiguchi, Norikazu; Kobayashi, Yuka; Saika, Fumihiro; Sakaguchi, Haruka; Maeda, Takehiko; Kishioka, Shiroh			Peripheral interleukin-4 ameliorates inflammatory macrophage-dependent neuropathic pain	PAIN			English	Article						Chemokine; Cytokine; STAT6; Inflammation; IL-4	DORSAL-ROOT GANGLIA; NERVE INJURY; SCIATIC-NERVE; BEHAVIORAL HYPERSENSITIVITY; UP-REGULATION; IMMUNE CELLS; MODEL; RAT; PROTEIN-1-ALPHA; PATHOPHYSIOLOGY	There is increasing evidence that inflammatory (M1-polarized) macrophages drive the nonresolving neuroinflammation that causes neuropathic pain after nerve injury. As interleukin-4 (IL-4) promotes the suppressive (M2-polarized) state in macrophages, we examined whether exploiting an IL-4-mediated pathway could ameliorate M1 macrophage-dependent neuropathic pain. The mRNA and protein expression of IL-4 receptor a chain (IL-4R alpha) were upregulated in accumulating F4/80(+) macrophages in injured sciatic nerve (SON). In mouse macrophage cell line J774A. 1, IL-4 downregulated the mRNA expression of M1 macrophage-specific molecules (IL-1 beta, CC chemokine ligand 3, and CD86) normally provoked by lipopolysaccharide, while increasing the mRNA expression of M2 macrophage-specific molecules (arginase-1, IL-10, and CD206) through a STAT6-mediated pathway. In ex vivo SON culture, M1 molecules were highly expressed in the injured SCN on day 7 after partial SON ligation (PSL) but were decreased by IL-4 treatment. In contrast, M2 molecules were upregulated by IL-4. IL-4 also increased phosphorylated STAT6 (pSTAT6) expression and shifted IL-1 beta(+) M1 macrophages toward a CD206(+) M2 phenotype. Perineural administration of IL-4 in mice subject to PSL ameliorated development and maintenance of tactile allodynia and thermal hyperalgesia. These effects of IL-4 were based on that IL-4 treatment increased the proportions of pSTAT6(+) and CD206(+) macrophages in injured SON on day 14 after PSL. We found that neuropathic pain can be ameliorated by IL-4 treatment, which exerts its therapeutic effect on accumulating macrophages through a STAT6-dependent pathway. A shift in macrophage phenotype from the inflammatory to the suppressive phenotype, driven by IL-4R signaling, may have benefits in the treatment of neuropathic pain.	[Kiguchi, Norikazu; Kobayashi, Yuka; Saika, Fumihiro; Sakaguchi, Haruka; Kishioka, Shiroh] Wakayama Med Univ, Dept Pharmacol, Wakayama 6410012, Japan; [Maeda, Takehiko] Niigata Univ Pharm & Appl Life Sci, Dept Pharmacol, Niigata, Japan	Kishioka, S (reprint author), Wakayama Med Univ, Dept Pharmacol, 811-1 Kimiidera, Wakayama 6410012, Japan.	kishioka@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24592356, 24590730]	This work was supported by two types of grant-in-aid for Scientific Research (C: 24592356, C: 24590730) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Liu T, 2000, PAIN, V86, P25, DOI 10.1016/S0304-3959(99)00306-1; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Zelenka M, 2005, PAIN, V116, P257, DOI 10.1016/j.pain.2005.04.018; Ma WY, 2006, J NEUROCHEM, V98, P180, DOI 10.1111/j.1471-4159.2006.03856.x; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Tsuda M, 2013, GLIA, V61, P55, DOI 10.1002/glia.22379; Liou JT, 2012, PAIN, V153, P1283, DOI 10.1016/j.pain.2012.03.008; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Kiguchi N, 2012, J PHARMACOL EXP THER, V340, P577, DOI 10.1124/jpet.111.187724; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Chiba Y, 2009, AM J RESP CELL MOL, V41, P516, DOI 10.1165/rcmb.2008-0163OC; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Liou JT, 2013, PAIN, V154, P2150, DOI 10.1016/j.pain.2013.06.042; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Ristoiu V, 2013, LIFE SCI, V93, P870, DOI 10.1016/j.lfs.2013.10.005; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Gouwy M, 2005, CYTOKINE GROWTH F R, V16, P561, DOI 10.1016/j.cytogfr.2005.03.005; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Kiguchi N, 2012, CURR OPIN PHARMACOL, V12, P55, DOI 10.1016/j.coph.2011.10.007; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Fujita R, 2007, NEUROCHEM INT, V50, P351, DOI 10.1016/j.neuint.2006.09.003; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Komori T, 2011, NEUROREPORT, V22, P911, DOI 10.1097/WNR.0b013e32834cd76a; Morin N, 2007, J NEUROIMMUNOL, V184, P164, DOI 10.1016/j.jneuroim.2006.12.009; Uceyler N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028205	44	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	APR	2015	156	4					684	693		10.1097/j.pain.0000000000000097		10	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	CF1TN	WOS:000352330900015		
J	Hayashi, K; Arai, YCP; Morimoto, A; Aono, S; Yoshimoto, T; Nishihara, M; Osuga, T; Inoue, S; Ushida, T				Hayashi, Kazuhiro; Arai, Young-Chang P.; Morimoto, Atsuko; Aono, Shuichi; Yoshimoto, Takahiko; Nishihara, Makoto; Osuga, Tomoaki; Inoue, Shinsuke; Ushida, Takahiro			Associations Between Pain drawing and Psychological Characteristics of Different Body Region Pains	PAIN PRACTICE			English	Article						pain assessment; psychology; pain drawing; headache; neck pain; back pain; nonorganic pain drawing	LOW-BACK-PAIN; FUSION SURGERY; SPONDYLOLISTHESIS; DEPRESSION; DISABILITY; ANXIETY; PREDICT; SCALE; SIGNS	BackgroundPain drawings have frequently been used for documentation of pain and a convenient diagnosis tool. Pain drawings were found to be associated with psychological states in chronic patients with low back pain. Few researchers have investigated pain drawings except in low back pain. The aim of this study was to investigate the pain, pain drawings, psychological characteristics, and pain interference in the head, neck-shoulder (NS), and low-back/lower-limb (LB-LL) regions among patients with chronic pain. MethodsWe included a total of 291 patients with new chronic pain (headache, 62; NS pain, 87; LB-LL pain, 142). The pain drawings and scores of 10-cm Visual Analogue Scale (VAS), Hospital Anxiety and Depression Scale (HADS), Pain Catastrophizing Scale (PCS), Short-Form McGill Pain Questionnaire (SF-MPQ), and Pain Disability Assessment Scale (PDAS) were extracted from medical records. A subset of 60 pain drawings was scored by senior and junior evaluators to assess inter-rater agreement. We investigated the correlation between pain drawings and VAS, HADS, PCS, SF-MPQ, and PDAS in each body region group at the initial visit. Moreover, almost all patients received nonsurgical treatment as a follow-up and were investigated using VAS after treatment. ResultsThe reliability of pain drawings was substantial with an interevaluator reliability in headache, NS, and LB-LL pain. Nonorganic pain drawings were associated with psychological disturbances in NS and LB-LL pain, but not headache. Poor outcomes were associated with nonorganic drawings in LB-LL pain, but not in the case of headache or NS pain. ConclusionsOur results suggest that the characteristics of patients with nonorganic drawings differ according to body regions.	[Hayashi, Kazuhiro; Arai, Young-Chang P.; Morimoto, Atsuko; Aono, Shuichi; Yoshimoto, Takahiko; Nishihara, Makoto; Osuga, Tomoaki; Inoue, Shinsuke; Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 4801195, Japan	Arai, YCP (reprint author), Aichi Med Univ, Ctr Multidisciplinary Pain, 21 Karimata, Nagakute, Aichi 4801195, Japan.	arainon@aichi-med-u.ac.jp					PARKER H, 1995, SPINE, V20, P236, DOI 10.1097/00007632-199501150-00022; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; POULSEN DL, 1987, PSYCHOTHER PSYCHOSOM, V48, P60; CHAN CW, 1993, SPINE, V18, P1717, DOI 10.1097/00007632-199310000-00001; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Hagg O, 2003, EUR SPINE J, V12, P2, DOI 10.1007/s00586-002-0427-5; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI [10.1586/ern.09.34, 10.1586/ERN.09.34]; Thompson M, 2011, CURR PAIN HEADACHE R, V15, P144, DOI 10.1007/s11916-010-0170-2; Broadbent E, 2009, J PSYCHOSOM RES, V66, P465, DOI 10.1016/j.jpsychores.2008.09.006; Carnes D, 2006, CLIN J PAIN, V22, P449, DOI 10.1097/01.ajp.0000208245.41122.ac; Beattie PF, 2004, PAIN, V110, P189, DOI 10.1016/j.pain.2004.03.026; Dahl B, 2001, EUR SPINE J, V10, P211, DOI 10.1007/s005860100266; UDEN A, 1988, SPINE, V13, P389; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037//1040-3590.7.4.524; Yamashiro K, 2011, CLIN J PAIN, V27, P338, DOI 10.1097/AJP.0b013e318204858a; MANN NH, 1993, SPINE, V18, P41, DOI 10.1097/00007632-199301000-00008; Andersen T, 2010, SPINE J, V10, P372, DOI 10.1016/j.spinee.2010.02.002; BURCHIEL KJ, 1995, NEUROSURGERY, V36, P1101; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Ekman P, 2009, SPINE, V34, P1204, DOI 10.1097/BRS.0b013e3181a19e66; Masruha MR, 2012, PEDIATR INT, V54, P393, DOI 10.1111/j.1442-200X.2011.03555.x; Matsudaira T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-42; Matsuoka H, 2007, JPN J PSYCHOSOM MED, V47, P95; Moller H, 2000, SPINE, V25, P683, DOI 10.1097/00007632-200003150-00006; Nicholson RA, 2003, HEADACHE, V43, P651, DOI 10.1046/j.1526-4610.2003.03108.x; Pallant Julie F, 2005, Health Qual Life Outcomes, V3, P82, DOI 10.1186/1477-7525-3-82; Toomingas A, 1999, INT ARCH OCC ENV HEA, V72, P98, DOI 10.1007/s004200050344	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1530-7085	1533-2500		PAIN PRACT	Pain Pract.	APR	2015	15	4					300	307		10.1111/papr.12173		8	Anesthesiology; Clinical Neurology	Anesthesiology; Neurosciences & Neurology	CF4AY	WOS:000352492000002		
J	Ortakand, MS; Hasegawa, S; Matsumoto, R				Ortakand, Mahsa Saeidi; Hasegawa, Shiro; Matsumoto, Ryo			Biostratigraphic and palaeoecologic evaluation of the Japan Sea's Joetsu Basin based on the study of foraminifera	PALEONTOLOGICAL RESEARCH			English	Article						biostratigraphy; cluster analysis; foraminifera; Japan Sea; late Quaternary; palaeoceanography	STAINED BENTHIC FORAMINIFERA; STABLE ISOTOPIC COMPOSITION; GULF-OF-MEXICO; HYDROCARBON-SEEP; LATE QUATERNARY; MONTEREY BAY; 36 KYR; OXYGEN; CALIFORNIA; SEDIMENTS	Foraminiferal assemblage distribution was used to reconstruct the palaeoenvironmental conditions that prevailed during the deposition of the core MD179-3312 in the eastern margin of the Japan Sea. One hundred six benthic foraminifera species belonging to 50 genera and seven planktonic foraminifera species belonging to three genera were identified in this core. Cluster analyses of both benthic and planktonic foraminifera data led to the identification of seven biofacies which demonstrate the palaeoceanographic history of the Japan Sea since 130 cal kyr BP. Species diversity, evenness and dominance were measured to understand effects of environmental changes on benthic foraminifera distribution. The results indicate that changes in organic matter and oxygen content throughout the core clearly influence community structure of benthic foraminiferal assemblages and species diversity. The light colored non-laminated layers found in particular at the lowermost and uppermost core areas indicate both high diversity and equitability, corresponding to high vertical mixing and good ventilation of subsurface water which would produce suitable living environments for most species; conversely, the dark colored thinly laminated layers (TL layers), in particular TL-1 and TL-2, indicate both low diversity and equitability, corresponding to dysoxic conditions caused by a severe decrease in bottom water oxygenation which would produce unsuitable living environments for most species, with only a few species adapted to this depleted oxygen condition able to survive.	[Ortakand, Mahsa Saeidi; Hasegawa, Shiro] Kumamoto Univ, Grad Sch Sci & Technol, Chuo Ku, Kumamoto 8608555, Japan; [Matsumoto, Ryo] Meiji Univ, Global Front, Fac Agr, Gas Hydrate Lab,Chiyoda Ku, Tokyo 1018301, Japan	Ortakand, MS (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	mahsa.saeidi333@yahoo.com			Japan Society for the Promotion of Science	This research project would not have been possible without the support of many people. The authors wish to express their deepest gratitude to the cooperative research project of the MH21 Research Consortium Japan and the Grant-in-Aid from the Japan Society for the Promotion of Science for providing financial support. Special thanks to the IPEV coring experts, the crew and the captain of R/V Marion Dufresne for collecting data, and all researchers of the MD179 expedition for sharing the data analysis and invaluable assistance. We are very much obliged to William Baerg of Kumamoto University for carefully reading the manuscript and offering valuable suggestions, which enabled us to improve the manuscript structure. The authors would also like to convey thanks to Yasufumi Iryu, the editor in chief of Paleontological Research, for his editorial work and two anonymous reviewers for their valuable comments and suggestions to improve the quality of the paper.	Akimoto K., 1989, MEM GEOL SOC JPN, P229; Akimoto K., 1994, PACIFIC NEOGENE EVEN, P11; Tomaru H, 2007, CHEM GEOL, V236, P350, DOI 10.1016/j.chemgeo.2006.10.008; Husum K, 2004, J FORAMIN RES, V34, P34, DOI 10.2113/0340034; Rathburn AE, 2000, MAR MICROPALEONTOL, V38, P247, DOI 10.1016/S0377-8398(00)00005-0; Ohkushi K, 2003, QUATERNARY SCI REV, V22, P1477, DOI 10.1016/S0277-3791(03)00082-9; OSTERMAN LE, 1989, CAN J EARTH SCI, V26, P2236, DOI 10.1139/e89-190; Freire AFM, 2011, MAR PETROL GEOL, V28, P1967, DOI 10.1016/j.marpetgeo.2010.10.004; Xu XD, 1999, MAR GEOL, V156, P285, DOI 10.1016/S0025-3227(98)00183-2; CORLISS BH, 1993, MAR GEOL, V111, P323, DOI 10.1016/0025-3227(93)90138-L; Crusius J, 1999, PALEOCEANOGRAPHY, V14, P248, DOI 10.1029/1998PA900023; Tada R, 1999, PALEOCEANOGRAPHY, V14, P236, DOI 10.1029/1998PA900016; Bernhard JM, 2001, DEEP-SEA RES PT I, V48, P2233, DOI 10.1016/S0967-0637(01)00017-6; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; HALD M, 1992, J FORAMIN RES, V22, P347; RHOADS DC, 1971, LETHAIA, V4, P413, DOI 10.1111/j.1502-3931.1971.tb01864.x; SAVRDA CE, 1984, AAPG BULL, V68, P1179; Ishiwatari R, 2001, ORG GEOCHEM, V32, P57, DOI 10.1016/S0146-6380(00)00151-0; Oba T, 1991, PALEOCEANOGRAPHY, V6, P499, DOI 10.1029/91PA00560; HUNT AS, 1993, MAR MICROPALEONTOL, V20, P321, DOI 10.1016/0377-8398(93)90041-U; KAIHO K, 1994, GEOLOGY, V22, P719, DOI 10.1130/0091-7613(1994)022<0719:BFDOIA>2.3.CO;2; Aoyama C, 2009, J GEOGR, V118, P156; Asano K., 1950, ILLUSTRATED CATALOGU; BANDY OL, 1964, LIMNOL OCEANOGR, V9, P124; Be A. W. H., 1977, OCEANIC MICROPALEONT, V1, P1; CEDHAGEN T, 1991, OPHELIA, V33, P17; Chang S. K., 1987, STUDY HOLOCENE PALEO; CORLISS BH, 1991, MAR MICROPALEONTOL, V17, P195, DOI 10.1016/0377-8398(91)90014-W; Domitsu Hanako, 2005, Paleontological Research, V9, P255, DOI 10.2517/prpsj.9.255; Freire A. F. M., 2009, J SEDIMENTOLOGICAL S, V68, P117; Freire A. F. M., 2010, THESIS U TOKYO TOKYO; Hald M, 1997, J FORAMIN RES, V27, P101; Hama T., 1997, J OCEANOGR, V53, P41, DOI 10.1007/BF02700748; Hasegawa S., 1988, BENTHOS, V86, P803; Horibe Y., 1983, J OCEANOGR SOC JAPAN, V39, P220, DOI 10.1007/BF02070392; Ishihama S, 2014, J ASIAN EARTH SCI, V90, P254, DOI 10.1016/j.jseaes.2013.12.020; Ishiwatari R, 1999, PALEOCEANOGRAPHY, V14, P260, DOI 10.1029/1998PA900014; Itaki T, 2004, PALAEOGEOGR PALAEOCL, V208, P263, DOI 10.1016/j.palaeo.2004.03.010; Jones RW, 1994, CHALLENGER FORAMINIF; Kakuwa Y., 2013, J JAPANESE ASS PETRO, V78, P97; Kato M., 1992, Proceedings of the Ocean Drilling Program Scientific Results, V127-128, P365, DOI 10.2973/odp.proc.sr.127128-1.142.1992; Kitazato Hiroshi, 1996, Fossils (Tokyo), V60, P48; Korsun S, 2000, J FORAMIN RES, V30, P251, DOI 10.2113/0300251; Lim D. B., 1971, J OCEANOL SOC KOREA, V6, P85; LOEBLICH A. R., 1988, FORAMINIFERAL GENERA; LUDWIG WJ, 1975, GEOL SOC AM BULL, V86, P651, DOI 10.1130/0016-7606(1975)86<651:SASOTJ>2.0.CO;2; MASUZAWA T, 1984, GEOCHEM J, V18, P167; Matoba Y., 1983, BENTHOS, V83, P409; Matoba Y., 2009, J GEOGR, V118, P136; Matsui Hiroyuki, 1998, Quaternary Research (Tokyo), V37, P221; Matsumoto R., 2011, P 7 INT C GAS HYDR I, P459; Matsumoto R., 2005, P 5 INT C GAS HYDR T, P749; Matsumoto R, 2011, MAR PETROL GEOL, V28, P1751, DOI 10.1016/j.marpetgeo.2011.09.009; Miller G. H., 1996, SPECIAL PUBLICATION, V111, P11; MONTAGNA PA, 1989, J MAR RES, V47, P657, DOI 10.1357/002224089785076226; Moriyasu S, 1972, KUROSHIO ITS PHYSICA, P353; Murauchi S., 1972, KAGAKU, V42, P367; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Nakagawa H., 2009, J GEOGR, V118, P969; Nakajima T., 1996, J GEOL SOC JAPAN, V102, P125; Nakamura Y., 2013, J JAPANESE ASS PETRO, V78, P79; Oba Tadamichi, 1995, Quaternary Research (Tokyo), V34, P289; Oba T., 1984, GEKKAN TIKYU, V6, P558; Oba T., 1983, GEKKAN CHIKYU, V5, P37; Oda Motoyoshi, 1992, Quaternary Research (Tokyo), V31, P341; Oi T., 2011, THESIS KUMAMOTO U KU; PHLEGER F B, 1973, Micropaleontology (New York), V19, P110, DOI 10.2307/1484973; Rathburn AE, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000595; Saidova Kh, 1961, ECOLOGY FORAMINIFERA; Saito T, 1981, SYSTEMATIC INDEX REC; SATO H, 1994, J GEOPHYS RES-SOL EA, V99, P22261, DOI 10.1029/94JB00854; Sawara T., 1979, SEA AND SKY, V54, P135; Scientific Longman, 1991, ECOLOGY PALAEOECOLOG; Scott D. B., 2004, MONITORING COASTAL E; SenGupta BK, 1997, J FORAMIN RES, V27, P292; SENGUPTA BK, 1994, GEO-MAR LETT, V14, P88, DOI 10.1007/BF01203719; Tada R, 2004, GEOPH MONOG SERIES, V149, P283, DOI 10.1029/149GM15; Takayanagi Y., 1983, GEKKAN KAIYO, V15, P138; Tanaka T., 1984, 91 ANN M GEOL SOC JA, P245; Uda M., 1934, J IMP FISHER EXP STA, V5, P57; UJIIE H, 1983, Bulletin of the National Science Museum Series C (Geology and Paleontology), V9, P41; Ujiie H., 1973, T P PALEONTOL SOC JP, V91, P137; Wang P., 1988, FORAMINIFERA OSTRACO; Watanabe S, 2007, PALAEOGEOGR PALAEOCL, V247, P50, DOI 10.1016/j.palaeo.2006.11.021; WETZEL A, 1991, PALAEOGEOGR PALAEOCL, V85, P47, DOI 10.1016/0031-0182(91)90025-M	86	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	APR	2015	19	2					79	106		10.2517/2014PR031		28	Paleontology	Paleontology	CF3YZ	WOS:000352486400001		
J	Shigeta, Y; Nishimura, T; Nifuku, K				Shigeta, Yasunari; Nishimura, Tomohiro; Nifuku, Ko			Middle and late Maastrichtian (latest Cretaceous) ammonoids from the Akkeshi Bay area, eastern Hokkaido, northern Japan and their biostratigraphic implications	PALEONTOLOGICAL RESEARCH			English	Article						Akkeshi; ammonoid; Cretaceous; Hokkaido; Maastrichtian; Senpohshi Formation	MAGNETOSTRATIGRAPHY; MATSUMOTO	Nine ammonoid species are reported from the Maastrichtian Senpohshi Formation exposed along the western coast of Akkeshi Bay, eastern Hokkaido, and their respective chronologic assignments are discussed on the basis of a previous magnetostratigraphic study. Pachydiscus flexuosus occurs in the lower and middle parts of the formation (= polarity chron C31n, i.e., middle to upper middle Maastrichtian). Gaudryceras makarovense, Anagaudryceras matsumotoi and Diplomoceras cf. notabile and P. flexuosus as well occur in the lower part (middle middle Maastrichtian). The uppermost part of the formation (= probably the lower part of polarity chron C30n, i.e., lower upper Maastrichtian) is fossiliferous and yields a diverse ammonoid assemblage including Neophylloceras sp., Pseudophyllites sp., Zelandites varuna, A. matsumotoi, Gaudryceras cf. seymouriense, Gaudryceras sp., and D. cf. notabile. Integration of bio- and magnetostratigraphy in the Senpohshi Formation makes it possible to determine precise and detailed chronologic assignment of strata containing similar faunas in the Northwest Pacific realm.	[Shigeta, Yasunari] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan; [Nishimura, Tomohiro] Hobetsu Museum, Mukawa, Hokkaido 0540211, Japan; [Nifuku, Ko] INPEX Corp, Minato Ku, Tokyo 1076332, Japan	Shigeta, Y (reprint author), Natl Museum Nat & Sci, Dept Geol & Paleontol, 4-1-1 Amakubo, Tsukuba, Ibaraki 3050005, Japan.	shigeta@kahaku.go.jp			Japan Society for Promotion of Science [25400502]; Japan Science Society [22-234]	We thank Akihiro Misaki (Kitakyushu Museum of Natural History and Human History, Kitakyushu) and the other reviewer for their valuable comments on the first draft. We are also grateful to the Japan Petroleum Exploration Co., Ltd. (Tokyo) and Hideo Kido (Bali, Indonesia) for providing information regarding fossil localities along the western coast of Akkeshi Bay, and staff personnel of the Akkeshi Marine Station (Akkeshi, Hokkaido) and Masataka Izukura (Sapporo, Hokkaido) for their help during our field work. We are also indebted to Kyushu University (Fukuoka) and Kyoto University (Kyoto) for kindly providing us the opportunity to examine their Cretaceous ammonoid specimens from the Senpohshi Formation. Thanks are extended to Jim Jenks (West Jordan, Utah) for his helpful suggestions and improvement of the English text. This study was supported by a Grant-in-Aid for Scientific Research of the Japan Society for Promotion of Science (No. 25400502) to Y. Shigeta and the Sasakawa Scientific Research Grant from the Japan Science Society (No. 22-234) to T. Nishimura.	Alabushev Alexey, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V244, P1; Ando Hisao, 2001, Journal of the Geological Society of Japan, V107, P142; Ifrim C, 2004, PALAEONTOLOGY, V47, P1575, DOI 10.1111/j.0031-0239.2004.00426.x; KENNEDY WJ, 1992, PALAEONTOLOGY, V35, P381; ARKELL W. J., 1950, JOUR PALEONTOL, V24, P354; Asano K., 1962, Contributions from the Institute of Geology and Paleontology Tohoku University, V57, P1; Burnett J.A., 1998, P132; de Grossouvre A., 1894, MEMOIRES SERVICE CAR, P1, DOI 10.5962/bhl.title.46845; Defrance M. J. L., 1816, DICT SCI NATURELLES; Forbes E., 1846, T GEOLOGICAL SOC LON, V7, P97; Gill T, 1871, SMITHSONIAN MISCELLA, V227; GORKA HANNA, 1957, ACTA PALEONTOL POLONICA, V2, P235; Haggart J. W., 1989, GEOLOGICAL SURVEY CA, V396, P181; Hauer F. R. von, 1866, SITZUNGSBERICHTE KAI, V53, P300; Hauer F. R. von, 1858, BEITRAGE PALAONTOLOG, V1, P7; Hoffmann Rene, 2010, Revue de Paleobiologie, V29, P1; Hyatt A., 1889, SMITHSONIAN CONTRIBU, P1; Hyatt A., 1900, TXB PALAEONTOLOGY, P502; Jones D., 1963, US GEOLOGICAL SURVEY, P1; Kennedy W.J., 1979, Bulletin of the British Museum (Natural History) Geology, V31, P121; KENNEDY W J, 1977, Annals of the South African Museum, V73, P149; Kiminami K., 1983, J GEOLOGICAL SOC JAP, V89, P607; Kiminami K., 1978, CHIK KAG, V32, P120; Kodama Kazuto, 2002, Journal of the Geological Society of Japan, V108, P366; Kodama K, 2000, CRETACEOUS RES, V21, P469, DOI 10.1006/cres.2000.0219; Kossmat F., 1895, BEITR PALAONT GEOL O, P97; Macellari C. E., 1986, PALEONTOLOGICAL SOC, V18; Maeda Haruyoshi, 2005, National Science Museum Monographs, V31, P25; Maeda H., 2005, NATL SCI MUSEUM MONO, V31, P126; MARSHALL P., 1926, TRANS & PROC NEW ZEALAND INST, V56, P129; Matsumoto T., 1984, PALAEONTOLOGICAL SOC, P5; Matsumoto T., 1979, MEMOIRS FS KYUSHU D, V24, P67; Matsumoto T., 1985, SCI REPORT YOKOSUKA, P22; Matsumoto T., 1954, CREATACEOUS SYSTEM J; Matsumoto T., 1979, MEMOIRS FS KYUSHU D, V24, P50; Matsumoto T., 1979, T P PALAEONTOLOGICAL, P65; MATSUMOTO T, 1988, Science Reports of the Tohoku University Second Series (Geology), V59, P177; Matsumoto T., 1942, P IMPERIAL ACAD TOK, V18, P674; Matsumoto T, 1942, MEMOIRS FS KYUSHU D, V1, P129; Matsumoto T., 1984, PALAEONTOLOGICAL SOC, P33; Matsumoto T., 1995, PALAEONTOLOGICAL SOC, P1; Matsumoto T., 1952, J GEOGR, V61, P67; MATSUMOTO T, 1980, Bulletin of the Osaka Museum of Natural History, P1; Matsumoto T., 1980, SCIENCE REPORTS DEP, V13, P265; Matsumoto T., 1938, JAPANESE J GEOLOGY G, V15, P137; MATSUMOTO T, 1984, Science Report of the Yokosuka City Museum, P1; MEEK F. B., 1857, T ALBANY I, V4, P37; Moore R. C., 1957, TREATISE INVERTEBRAT; MOROZUMI Y, 1985, Bulletin of the Osaka Museum of Natural History, P1; Murphy M. A., 2006, U CALIFORNIA RIVERSI, V7, P1; Naruse Hajime, 2000, Journal of the Geological Society of Japan, V106, P161; Naruse H, 2003, CRETACEOUS RES, V24, P55, DOI 10.1016/S0195-6671(03)00024-7; Nifuku K, 2009, PALAEOGEOGR PALAEOCL, V271, P84, DOI 10.1016/j.palaeo.2008.09.012; Ogg J.G., 2012, GEOLOGIC TIME SCALE, V2, P793, DOI DOI 10.1016/B978-0-444-59425-9.00027-5; OKADA H, 1987, Journal of the Geological Society of Japan, V93, P329; Pergament M. A., 1974, T GEOLOGICHESKOGO I, V260, P1; Poyarkova Z. N., 1987, REFERENCE SECTION CR; Salfeld H., 1924, BEDEUTUNG KONSERVATI; Shigeta Y, 2010, PALEONTOL RES, V14, P202, DOI 10.2517/1342-8144-14.3.202; Shigeta Y, 2012, PALEONTOL RES, V16, P244, DOI 10.2517/1342-8144-16.3.244; Shigeta Y., 2005, NATL SCI MUSEUM MONO, V31, P54; Shigeta Y, 2013, PALEONTOL RES, V17, P47, DOI 10.2517/1342-8144-17.1.47; Shimizu S., 1934, IWANAMIS LECT SERIES, P1; SPATH L. F., 1926, GEOL MAG [LONDON], V63, P77; Spath L. F., 1922, Transactions of the Royal Society of South Africa, V10, P113; SPATH L. F., 1927, MEM GEOL SURV INDIA PALAEONT INDICA, V9, P1; Steinmann G., 1895, NEUES JB MINERALOGIE, V10, P64; STINNESBECK W, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V194, P99; Suess E., 1866, SITZUNGSBERICHTE AKA, V52, P71; Toshimitsu Seiichi, 1995, Journal of the Geological Society of Japan, V101, P19; Usher J. L., 1952, GEOLOGICAL SURVEY CA, V21, P1; Vereshchagin V. N., 1968, T VSEGEI, V143, P45; Whiteaves J., 1903, GEOLOGICAL SURVEY CA, V1, P309; Wiedmann J., 1966, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V127, P13; Yamaguchi M., 1984, Bulletin, Fruit Tree Research Station, Japan, A (Yatabe), P15; Yazykova E. A., 1992, T VSEGEI, V350, P192; Yazykova E. A., 1994, ACTA GEOL POL, V44, P277; Zakharov Yu.D., 1984, P41; Zittel K. A., 1895, GRUNDZUGE PALAONTOE; Zittel K. A., 1884, HDB PALAONTOLOGIE, V1, P329; Zonova T. D., 1993, ATLAS INDEX FOSSILS	81	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	APR	2015	19	2					107	127		10.2517/2014PR034		21	Paleontology	Paleontology	CF3YZ	WOS:000352486400002		
J	Amano, K; Jenkins, RG; Nishida, K				Amano, Kazutaka; Jenkins, Robert G.; Nishida, Kozue			A new Paleocene species of Bentharca (Bivalvia; Arcidae) from eastern Hokkaido, with remarks on evolutionary adaptation of suspension feeders to the deep sea	PALEONTOLOGICAL RESEARCH			English	Article						Bentharca; Bivalvia; deep sea; Japan; Paleocene	JAPAN	We describe a new deep-sea arcid species, Bentharca steffeni sp. nov., from the Paleocene Katsuhira Formation in Urahoro Town, eastern Hokkaido. This is the oldest certain record of this genus. Shell microstructure of this new species is similar to the Recent species, B. asperula (Dall, 1891) in having an outer layer composed of thin simple lamellar fibrous prismatic and crossed lamellar structures and an inner layer composed of irregular complex crossed lamellar and irregular prismatic structures. Of these, the simple lamellar fibrous prismatic and the irregular prismatic structures have never previously been recognized even in B. asperula. From the occurrence of the new species, it has been elucidated that the genus Bentharca adapted to the deep sea as a refuge at least in the Paleocene.	[Amano, Kazutaka] Joetsu Univ Educ, Dept Geosci, Joetsu 9438512, Japan; [Jenkins, Robert G.] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Nishida, Kozue] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058568, Japan	Amano, K (reprint author), Joetsu Univ Educ, Dept Geosci, Joetsu 9438512, Japan.	amano@juen.ac.jp	Jenkins, Robert/A-8006-2011	Jenkins, Robert/0000-0003-1347-9041	Japan Society for Promotion of Science [23540456, 26400500]; Japan Science and Technology Agency (JST)	We thank Geerat J. Vermeij (University of California at Davis) for his critical reading of the manuscript and useuful suggestions. We also thank Graham P. Oliver (National Museum of Wales), Alan G. Beu (GNS Science), Katsuo Sashida and Sachiko Agematsu (University of Tsukuba), Hiroshi Nishi and Jun Nemoto (Tohoku university Museum, Tohoku University), and Hiroaki Karasawa (Mizunami Fossil Museum) for their information and help in examining fossil specimens. Especially Graham P. Oliver kindly allowed us to use his original information on Bentharca nodulosa. We thank Graham P. Oliver yet again and Yukito Kurihara (Mie University) for their review and many useful comments. This study was partly supported by a Grant-in-aid for Scientific Research from the Japan Society for Promotion of Science (C, 23540456, 2011-2013) to KA, (C, 26400500, 2014-2016) to KA and RGJ, and a grant from the Program to Disseminate Tenure Tracking System (Japan Science and Technology Agency (JST)) to RGJ.	Amano K, 2014, PALEONTOL RES, V18, P33, DOI 10.2517/2014PR003; Amano K, 2014, ACTA PALAEONTOL POL, V59, P163, DOI 10.4202/app.2012.0002; Vrijenhoek RC, 2013, DEEP-SEA RES PT II, V92, P189, DOI 10.1016/j.dsr2.2012.12.004; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; Kiel S, 2006, SCIENCE, V313, P1429, DOI 10.1126/science.1126286; Oliver PG, 2006, ZOOL J LINN SOC-LOND, V148, P237, DOI 10.1111/j.1096-3642.2006.00256.x; Thomas E, 2007, GEOL SOC AM SPEC PAP, V424, P1, DOI 10.1130/2007.2424(01); Alegret L, 2009, PALAIOS, V24, P318, DOI 10.2110/palo.2008.p08-057r; Dutton A, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001098; Adatte T, 2002, PALAEOGEOGR PALAEOCL, V178, P165, DOI 10.1016/S0031-0182(01)00395-9; BARNARD K. H., 1962, ANN NATAL MUS, V15, P247; Beets C., 1942, Leidsche Geologische Mededelingen, V13, P255; Beu A.G., 2005, Scripta Geologica (Leiden), V130, P1; Beu AG, 1990, NZ GEOLOGICAL SURVEY, V58, P1; Bralower T. J., 2002, GSA TODAY, V11, P4; Carter J. G, 1990, SKELETAL BIOMINERALI, V1, P321; Carter J.G., 1990, SKELETAL BIOMINERALI, V1, P609; Carter J.G., 1990, P135; Dall WH, 1881, B MUS COMP ZOOL HARV, V9, P33; Eagle M. K., 2000, RECORDS AUCKLAND MUS, V36, P141; Gray J. E., 1857, ANN MAGAZINE NATURAL, V19, P369; Habe T., 1958, PUBLICATIONS SETO MA, V6, P241; Hayami I, 1993, TOKYO U MUS B, V35, P1; Heinberg C., 1978, Bulletin of the Geological Society of Denmark, V27, P105; Higo S, 1999, CATALOGUE BIBLIO MAR; Hourdez S, 2005, J INORG BIOCHEM, V99, P130, DOI 10.1016/j.jinorgbio.2004.09.017; HUBER M, 2010, COMPENDIUM BIVALVES; Itoigawa J., 1958, Memoirs of the College of Science Kyoto University, V24B, P249; Itoigawa J., 1975, B MIZUNAMI FOSSIL MU, P15; Kaiho K., 1984, BIOSTRATIGRAPHY INT, P35; Kamenev GM, 2007, MALACOLOGIA, V49, P351, DOI 10.4002/0076-2997-49.2.351; Knudsen J, 1970, GALATHEA REP, V11, P1; Knudsen J., 1967, J MURRAY EXPEDITION, V11, P237; KOBAYASHI I, 1980, Venus the Japanese Journal of Malacology, V39, P178; Kurihara Yukito, 2010, National Museum of Nature and Science Monographs, P1; Kuroda T., 1929, VENUS S, V1, P9; La Perna R., 1998, B MALACOLOGICO, V33, P11; Lamarck J. B., 1809, PHILOS ZOOLOGIQUE EX, V2; Lamarck J.-B., 1809, PHILOS ZOOLOGIQUE EX, V1; Lutz R. A., 1980, TOPICS GEOBIOLOGY, P203; Malchus N, 2010, J MOLLUS STUD, V76, P401, DOI 10.1093/mollus/eyq030; Matsukuma A., 2000, MARINE MOLLUSKS JAPA, P844; Muller O.F., 1776, ZOOLOGIAE DANICAE PR; Nishida K, 2011, PALEONTOL RES, V15, P193, DOI 10.2517/1342-8144-15.4.193; Noda H., 1988, SAITO HO ON KAI SPEC, P107; Noda H., 1980, SCI REPORTS I GEOS B, V1, P1; NODA H, 1966, Science Reports of the Tohoku University Second Series (Geology), V38, P1; NOMURA SITIHEI, 1934, SCI REPT TOHOKU IMP UNIV [GEOL], V16, P109; Oliver P. G, 1980, PHILOS T R SOC B, V291, P45; Oliver P. Graham, 1992, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V14, P293; Ozaki H., 1958, Bulletin of the National Science Museum Tokyo, V4, P1; Passos Flávio Dias, 2009, Biota Neotrop., V9, P281, DOI 10.1590/S1676-06032009000400032; Philippi R.A, 1844, ENUMERATIO MOLLUSCOR; Sacco F., 1898, MOLLUSCHI TERRENI 26; Smith AB, 2005, P ROY SOC B-BIOL SCI, V272, P865, DOI 10.1098/rspb.2004.2996; Thiele J., 1931, HDB SYSTEMATISCHEN W; Vermeij G.J., 1987, EVOLUTION ESCALATION; VERRILL AE, 1898, P US NATL MUS, V20, P775; Waller T.R., 1980, Smithsonian Contributions to Zoology, P1	59	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	APR	2015	19	2					128	138		10.2517/2015PR001		11	Paleontology	Paleontology	CF3YZ	WOS:000352486400003		
J	Handa, N				Handa, Naoto			A Pleistocene rhinocerotid (Mammalia, Perissodactyla) from Yage, Shizuoka Prefecture, central Japan	PALEONTOLOGICAL RESEARCH			English	Article						Japan; lower incisor; Pleistocene; Rhinocerotidae; Shizuoka Prefecture; Yage	CHINA	A fossil rhinocerotid tooth from the Yage Formation (Middle to Late Pleistocene), Yage in Shizuoka Prefecture, is described. The present specimen shows the following characteristics of the second lower incisor: tusk-like shape, enamel on the labial side, a teardrop-shaped cross section of the tooth crown, and an oval cross section of the root. The specimen is similar to the genus Rhinoceros in having a large and robust shape. However, owing to a lack of other elements, generic and specific identification are not possible. Previously, several large mammal fossils had been reported from the Yage area, but there were no rhinocerotids among them. Thus, this report is the first record of a rhinocerotid from the area. The Yage specimen suggests rhinocerotids were widely distributed during the Pleistocene of Far East Asia.	Shinshushinmachi Fossil Museum, Shinshushinmachi, Nagano 3812404, Japan	Handa, N (reprint author), Shinshushinmachi Fossil Museum, 88-3 Kamijo, Shinshushinmachi, Nagano 3812404, Japan.	k1552325@kadai.jp			Nagano Society for the Promotion of Science, Japan	I am grateful to Hakuichi Koike (Shinshushinmachi Fossil Museum, Nagano, Japan) for preparation of the Yage specimen. I also thank Mitsuharu Oshima and Hiroko Hirotani (Kanagawa Prefectural Museum of Natural History, Kanagawa, Japan), Shinichiro Kawada (National Museum of Nature and Science, Tsukuba, Japan), and Gunma Museum of Natural History, Gunma, Japan, for providing access to other rhinocerotid specimens for comparison. I also thank Tao Deng (Institute of Vertebrate Paleontology and Paleoanthropology, Beijing, China), Claude Guerin (Laboratoire de Geologie de Lyon, Terre, Planetes, Environnement et Departement des Sciences de la Terre, Universite Claude Bernard-Lyon I, Lyon, France) and Hideo Nakaya (Kagoshima University) whose comments and suggestions improved the original and revised manuscripts. This study was partly supported by funding from the Nagano Society for the Promotion of Science, Japan.	Schepartz LA, 2010, INT J OSTEOARCHAEOL, V20, P253, DOI 10.1002/oa.1025; KAWAMURA Y, 1977, Journal of the Geological Society of Japan, V83, P59; KAWAMURA Y, 1989, Quaternary Research (Tokyo), V28, P95; Li Y., 1961, VERTEBRAT PALASIATIC, V2, P143; Mermier E., 1895, ANN SOC LINNEENNE LY, V42, P163; Nagasawa J., 1961, T P PALAEONTOLOGICAL, V42, P63; Nakajima H., 1982, 89 ANN M GEOL SOC JA, P331; Nishizawa T., 1972, KASEKI NO TOMO, V6, P7; Nojima Koji, 2002, Geoscience Reports of Shizuoka University, V29, P1; Ogino S, 2009, PALEONTOL RES, V13, P367, DOI 10.2517/1342-8144-13.4.367; Okazaki Y., 2007, JUBILEE PUBLICATION, P135; Osborn H. F., 1898, MEMOIRS AM MUSEUM NA, V1, P75; Otsuka H., 1984, Journal of Taiwan Museum, V37, P1; Owen R., 1848, ARCHETYPE HOMOLOGIES; Owen R, 1845, ODONTOGRAPHY TREATIS; Prothero D. R., 2005, EVOLUTION N AM RHINO; PROTHERO DR, 1986, ZOOL J LINN SOC-LOND, V87, P341, DOI 10.1111/j.1096-3642.1986.tb01340.x; Shikama T., 1967, COMMITTEE COMMEMORAT, P117; Shikama T., 1967, B NATL SCI MUSEUM, V10, P455; Takai F., 1958, QUATERNARY RES, V1, P58; Taruno H., 1988, VERTEBRATE FOSSILS S, P11; Tomida S., 1978, B MIZUNAMI FOSSIL MU, V5, P113; Tong HW, 2009, GEOBIOS-LYON, V42, P525, DOI 10.1016/j.geobios.2009.02.001; Tong H.-W., 2000, ACTA ANTHR SINICA S, V19, P257; Tong HW, 2012, CR PALEVOL, V11, P555, DOI 10.1016/j.crpv.2012.06.002	25	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	APR	2015	19	2					139	142		10.2517/2014PR033		4	Paleontology	Paleontology	CF3YZ	WOS:000352486400004		
J	Yagihashi, S				Yagihashi, Soroku			Advances in pathology of diabetes from pancreatic islets to neuropathy-a tribute to Paul Langerhans	PATHOLOGY INTERNATIONAL			English	Review						islets; Langerhans; neuropathy; type 2 diabetes	BETA-CELL MASS; GLYCATION END-PRODUCTS; HUMAN ALDOSE REDUCTASE; DNA-DAMAGE; B-CELLS; TYPE-2; MELLITUS; MICE; INFLAMMATION; HUMANS	There emerges a world epidemic of diabetes, afflicting over 3.8 billion people globally. The socio-economic burden of this disorder is tremendous and there is an urgent need to solve the problems incurred from this disorder and to establish an efficient way of prevention and treatment. Fundamental pathology of diabetes has been too diverse to reach a simple etiology and the mechanisms of how the lesions specific to diabetes develop are yet to be clear. Nevertheless, there has been slow but significant advancement in the understanding of the disease based on characterization of the salient features of pathological lesions in human diabetic subjects. Progressive decline of islet cells associated with increased cell volume density was found to account for clinical manifestation of hypoinsulinemia and hyperglucagonemia in type 2 diabetes. Concurrently, signs of complications represented by distal nerve fiber loss in the skin commences from the beginning of this disease. Thus the pathological studies disclosed the major attributes in this disorder targeting the islet of pancreas and epidermal nerve, both of which were discovered by Paul Langerhans more than 140 years ago. In this review, I attempt to summarize the progress in pathology of diabetes which Langerhans opened this field.	Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori 0368562, Japan	Yagihashi, S (reprint author), Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	yagihasi@cc.hirosaki-u.ac.jp			Japanese Ministry of Education, Science, Culture, and Sports; Japanese Ministry of Health and Welfare; Japan Diabetes Foundation; Juvenile Diabetes Research Foundation International	The author's were supported by grants in aid from the Japanese Ministry of Education, Science, Culture, and Sports and the Japanese Ministry of Health and Welfare, and the Japan Diabetes Foundation, and Juvenile Diabetes Research Foundation International.	Baggio LL, 2006, ANNU REV MED, V57, P265, DOI 10.1146/annurev.med.57.110104.115624; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Smith AG, 2006, DIABETES CARE, V29, P1294, DOI 10.2337/dc06-0224; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; RAHIER J, 1983, DIABETOLOGIA, V24, P366; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Yagihashi S, 2001, BRAIN, V124, P2448, DOI 10.1093/brain/124.12.2448; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Kunisch E, 2004, ANN RHEUM DIS, V63, P774, DOI 10.1136/ard.2003.013029; Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Vinik AI, 2013, ENDOCRIN METAB CLIN, V42, P747, DOI 10.1016/j.ecl.2013.06.001; Ziegler D, 2011, DIABETES CARE, V34, P2054, DOI 10.2337/dc11-0503; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854; Opie EL, 1901, J EXP MED, V5, P527, DOI 10.1084/jem.5.5.527; Banting FG, 1922, J LAB CLIN MED, V7, P464; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Donath MY, 2013, DIABETES OBES METAB, V15, P193, DOI 10.1111/dom.12172; Ho ECM, 2006, DIABETES, V55, P1946, DOI 10.2337/db05-1497; Kamata K, 2014, AMYLOID, V21, P1; Laguesse E., 1893, CR SOC BIOL, V5, P622; Langerhans P., 1869, THESIS BERLIN GUSTAV; Langerhans P., 1868, ARCH PATHOL ANAT, V44, P325; Mizukami H, 2014, J DIABETES INVEST, V5, P38, DOI 10.1111/jdi.12118; Nishizawa Y, 2010, J DIABETES INVEST, V1, P40, DOI 10.1111/j.2040-1124.2009.00002.x; SAITO K, 1979, TOHOKU J EXP MED, V129, P273; Sugimoto K, 2008, CURR PHARM DESIGN, V14, P953, DOI 10.2174/138161208784139774; Sugimoto K, 1997, DIABETOLOGIA, V40, P1380, DOI 10.1007/s001250050839; Vinik AI, 2013, DIABETES, V62, P3976; Wada R, 2005, ANN NY ACAD SCI, V1043, P598, DOI 10.1196/annals.1338.067; Yagihashi S, 2012, J DIABETES INVEST, V3, P1, DOI 10.1111/j.2040-1124.2011.00192.x; Yagihashi S, 1996, DIABETES, V45, P56, DOI 10.2337/diabetes.45.1.56; Yamagishi SI, 2003, J NEUROCHEM, V87, P497, DOI 10.1046/j.1471-4159.2003.02011.x; Yoneda S, 2013, J Clin Endocrinol Metab, V98, P2053, DOI 10.1210/jc.2012-3832; Zao HL, 2003, DIABETES, V52, P2759	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	APR	2015	65	4					157	169		10.1111/pin.12263		13	Pathology	Pathology	CF4YG	WOS:000352559600002		
J	Komohara, Y; Niino, D; Ohnishi, K; Ohshima, K; Takeya, M				Komohara, Yoshihiro; Niino, Daisuke; Ohnishi, Koji; Ohshima, Koichi; Takeya, Motohiro			Role of tumor-associated macrophages in hematological malignancies	PATHOLOGY INTERNATIONAL			English	Review						CD163; CD204; leukemia-lymphoma; macrophage; TAM; tumor microenvironment	CLASSICAL HODGKIN LYMPHOMA; B-CELL LYMPHOMA; INDEPENDENT PROGNOSTIC-FACTOR; FOLLICULAR LYMPHOMA; POOR-PROGNOSIS; HUMAN NEOPLASMS; BREAST-CANCER; EXPRESSION; MICROENVIRONMENT; PROGRESSION	The tumor microenvironment consists of many non-tumor cells such as leukocytes, endothelial cells, and fibroblasts, and phenotypic changes in a tumor microenvironment are believed to be involved in tumor progression and resistance to anticancer treatments. In hematological malignancies, tumor-associated macrophages (TAMs) that have infiltrated lymphoma or leukemia tissues may be involved in tumor progression, and many researchers have studied phenotypic changes in TAMs. This review article summarizes the publications related to TAMs in hematological malignancies, with an emphasis on CD163(+) protumoral TAMs, which seem to be associated with disease progression. Cell-cell interactions between protumoral TAMs and lymphoma or leukemia cells may play an important role in lymphoma or leukemia microenvironments. Although detailed molecular mechanisms of these cell-cell interactions have not yet been clarified, phenotypic characterization of TAMs is thought to be a useful approach for evaluating clinical prognosis. In addition, targeting TAMs may be a new strategy for treating malignant hematological diseases.	[Komohara, Yoshihiro; Ohnishi, Koji; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan; [Niino, Daisuke; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan	Komohara, Y (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Tyuou Ku, Honjo 1-1-1, Kumamoto 8608556, Japan.	ycomo@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI) [25460497, 25293089]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI #25460497, #25293089). Yoshihiro Komohara has been announced as the winner of The Japanese Society of Pathology; Pathology Research Award in 2013.	Alvaro T, 2006, J CLIN ONCOL, V24, P5350, DOI 10.1200/JCO.2006.06.4766; Byers RJ, 2008, BLOOD, V111, P4764, DOI 10.1182/blood-2007-10-115915; Zheng YH, 2009, BLOOD, V114, P3625, DOI 10.1182/blood-2009-05-220285; Andjelic B, 2012, APPL IMMUNOHISTO M M, V20, P41, DOI 10.1097/PAI.0b013e318223ef29; Suyani E, 2013, ANN HEMATOL, V92, P669, DOI 10.1007/s00277-012-1652-6; Taskinen M, 2007, CLIN CANCER RES, V13, P5784, DOI 10.1158/1078-0432.CCR-07-0778; Klein JL, 2014, AM J CLIN PATHOL, V141, P381, DOI 10.1309/AJCP61TLMXLSLJYS; Kube D, 2001, BLOOD, V98, P762, DOI 10.1182/blood.V98.3.762; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463; Casulo C, 2013, LEUKEMIA RES, V37, P1178, DOI 10.1016/j.leukres.2013.03.021; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Zaki MAA, 2011, VIRCHOWS ARCH, V459, P361, DOI 10.1007/s00428-011-1140-8; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Koh YW, 2014, AM J CLIN PATHOL, V141, P573, DOI 10.1309/AJCPR92TDDFARISU; Sugaya M, 2012, J DERMATOL SCI, V68, P45, DOI 10.1016/j.jdermsci.2012.07.007; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Canioni D, 2008, J CLIN ONCOL, V26, P440, DOI 10.1200/JCO.2007.12.8298; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Nie XC, 2013, ANAL QUANT CYTOL, V35, P301; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Jakovic LR, 2011, LEUKEMIA LYMPHOMA, V52, P1913, DOI 10.3109/10428194.2011.580026; Yoon DH, 2012, EUR J HAEMATOL, V88, P292, DOI 10.1111/j.1600-0609.2011.01731.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Panico L, 2013, LEUKEMIA LYMPHOMA, V54, P2418, DOI 10.3109/10428194.2013.778405; Barros MHM, 2012, CLIN CANCER RES, V18, P3762, DOI 10.1158/1078-0432.CCR-12-0129; Zheng Y, 2013, LEUKEMIA, V27, P702, DOI 10.1038/leu.2012.272; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; Kayal S, 2014, LEUKEMIA LYMPHOMA, V55, P1031, DOI 10.3109/10428194.2013.824079; Komohara Y, 2013, CANCER SCI, V104, P945, DOI 10.1111/cas.12167; Hasselblom S, 2008, PATHOL INT, V58, P529, DOI 10.1111/j.1440-1827.2008.02268.x; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Clear AJ, 2010, BLOOD, V115, P5053, DOI 10.1182/blood-2009-11-253260; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Niino D, 2010, PATHOL INT, V60, P278, DOI 10.1111/j.1440-1827.2010.02514.x; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Richendollar BG, 2011, HUM PATHOL, V42, P552, DOI 10.1016/j.humpath.2010.08.015; Azambuja D, 2012, ANN ONCOL, V23, P736, DOI 10.1093/annonc/mdr157; Bai Bing, 2013, J Clin Exp Hematop, V53, P127; COPPLESO.LW, 1973, J NATL CANCER I, V51, P379; desJong D, 2009, HAEMATOLOGICA, V94, P70; Gunther C, 2011, AM J PATHOL, V179, P1434, DOI 10.1016/j.ajpath.2011.05.040; Harris JA, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-12; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Kaku Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087400; Kelley T, 2007, LEUKEMIA LYMPHOMA, V48, P2403, DOI 10.1080/10428190701665954; Koh YW, 2014, HEMATOL ONCOL, V32, P178, DOI 10.1002/hon.2106; Komohara Yoshihiro, 2011, J Clin Exp Hematop, V51, P93; Koulis A, 2014, HISTOPATHOLOGY, V65, P749, DOI 10.1111/his.12458; LAUDER I, 1977, J CLIN PATHOL, V30, P563, DOI 10.1136/jcp.30.6.563; Marchesi F, 2014, HEMATOL ONCOL, DOI [10.1002/hon, DOI 10.1002/HON.2142]; MONIS B, 1961, CANCER, V14, P369, DOI 10.1002/1097-0142(196103/04)14:2<369::AID-CNCR2820140217>3.0.CO;2-X; Nam SJ, 2014, LEUKEMIA LYMPHOMA, V55, P2466, DOI 10.3109/10428194.2013.879713; Pedersen MB, 2014, HISTOPATHOLOGY, V65, P490, DOI 10.1111/his.12407; REE HJ, 1985, CANCER, V56, P333, DOI 10.1002/1097-0142(19850715)56:2<333::AID-CNCR2820560222>3.0.CO;2-0; Ross J, 2002, MACROPHAGES TUMOR BI; Saito Yoichi, 2014, J Clin Exp Hematop, V54, P59; Sakai Akira, 2014, J Clin Exp Hematop, V54, P49; Sanchez-Espiridion B, 2012, HAEMATOL-HEMATOL J, V97, P1080, DOI 10.3324/haematol.2011.055459; UNDERWOO.JC, 1972, VIRCHOWS ARCH B, V12, P39; Wada N, 2012, HISTOPATHOLOGY, V60, P313, DOI 10.1111/j.1365-2559.2011.04096.x; Yamamoto W, 2014, LEUKEMIA LYMPHOMA, V55, P2721, DOI 10.3109/10428194.2014.893311; Yoshida N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078730	67	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	APR	2015	65	4					170	176		10.1111/pin.12259		7	Pathology	Pathology	CF4YG	WOS:000352559600003		
J	Sasaki, H; Kido, M; Miki, K; Aoki, M; Takahashi, H; Dokiya, T; Yamanaka, H; Fukushima, M; Egawa, S				Sasaki, Hiroshi; Kido, Masahito; Miki, Kenta; Aoki, Manabu; Takahashi, Hiroyuki; Dokiya, Takushi; Yamanaka, Hidetoshi; Fukushima, Masanori; Egawa, Shin			Results of central pathology review of prostatic biopsies in a contemporary series from a phase III, multicenter, randomized controlled trial (SHIP0804)	PATHOLOGY INTERNATIONAL			English	Article						central pathology review (CPR); intermediate-risk; iodine-125; prostate cancer; transperineal prostate brachytherapy (TPPB)	RADICAL PROSTATECTOMY SPECIMENS; GLEASON GRADING SYSTEM; INTEROBSERVER REPRODUCIBILITY; INTERNATIONAL-SOCIETY; NEEDLE BIOPSIES; CANCER; CARCINOMA; IMPACT; BRACHYTHERAPY	To investigate contemporary rates of variation in the biopsy Gleason grading in prostate cancer, between local and central pathologists, based on central review of the pathological slides from Seed and Hormone for Intermediate-risk Prostate Cancer (SHIP) 0804, a phase III, multicenter, randomized, controlled study. From April 2008 to May 2011, 18 Japanese institutions participated. All H&E slides were reviewed independently, without clinical information, and a tumor grade was assigned according to the modified Gleason grading system proposed by the International Society of Urological Pathology (ISUP). Prostate biopsy specimens of 642 cases were available for evaluation. An exact concordance rate of Gleason score (GS) between local and central pathologists was determined to be 65.3%; with the under-grading and over-grading of grades to be 14.6% and 20.1%, respectively. The central review resulted in numbers of tumor-bearing cores reassigned in 99 of 616 cases in which such information by the local pathologists was available (16.1%). Discordance in biopsy Gleason grading was still found in one third of the cases in the SHIP0804 study. This information is valuable in extrapolating the diagnostic error range in contemporary clinical studies conducted without central pathological review.	[Sasaki, Hiroshi; Kido, Masahito; Miki, Kenta; Egawa, Shin] Jikei Univ, Sch Med, Dept Urol, Tokyo 1058461, Japan; [Aoki, Manabu] Jikei Univ, Sch Med, Dept Radiol, Tokyo 1058461, Japan; [Takahashi, Hiroyuki] Jikei Univ, Sch Med, Dept Pathol, Tokyo 1058461, Japan; [Dokiya, Takushi] Saitama Med Univ, Dept Radiat Oncol, Saitama, Japan; [Yamanaka, Hidetoshi] Kurosawa Hosp, Inst Prevent Med, Gunma, Japan; [Fukushima, Masanori] Translat Res Informat Ctr, Kobe, Hyogo, Japan	Sasaki, H (reprint author), Jikei Univ, Sch Med, Dept Urol, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	hs06@jikei.ac.jp			 [SHIP0804 (NCT00664456)]	This study was supported in part by a grant, SHIP0804 (NCT00664456).	Allsbrook WC, 2001, HUM PATHOL, V32, P74, DOI 10.1053/hupa.2001.21134; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Vainer B, 2011, HISTOPATHOLOGY, V58, P211, DOI 10.1111/j.1365-2559.2011.03741.x; Kvale R, 2009, BJU INT, V103, P1647, DOI 10.1111/j.1464-410X.2008.08255.x; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Nguyen PL, 2004, UROL ONCOL-SEMIN ORI, V22, P295, DOI 10.1016/S1078-1439(03)00236-9; Allsbrook WC, 2001, HUM PATHOL, V32, P81, DOI 10.1053/hupa.2001.21135; CATALONA WJ, 1982, J UROLOGY, V127, P919; disLoreto C, 1991, AM J CLIN PATHOL, V96, P70; Eble JN, 2004, PATHOLOGY GENETICS T; Egevad L, 2012, ARCH PATHOL LAB MED, V136, P426, DOI 10.5858/arpa.2011-0495-RA; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Gupta D, 2000, AM J SURG PATHOL, V24, P280, DOI 10.1097/00000478-200002000-00014; Jacques SM, 1998, INT J GYNECOL PATHOL, V17, P42, DOI 10.1097/00004347-199801000-00008; Jacques SM, 1998, INT J GYNECOL PATHOL, V17, P36, DOI 10.1097/00004347-199801000-00007; Kishimoto R, 2012, WORLD J UROL, V30, P375, DOI 10.1007/s00345-011-0738-4; Kuroiwa K, 2010, J UROLOGY, V183, P952, DOI 10.1016/j.juro.2009.11.024; Manion E, 2008, AM J SURG PATHOL, V32, P732, DOI 10.1097/PAS.0b013e31815a04f5; Miki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-572; Oyama T, 2005, ARCH PATHOL LAB MED, V129, P1004; Ozdamar S. O., 1996, International Urology and Nephrology, V28, P73, DOI 10.1007/BF02550141; Ozok HU, 2010, INT J SURG PATHOL, V18, P248, DOI 10.1177/1066896909346272; Saito S, 2014, INT J CLIN ONCOL; Weir MM, 2003, AM J CLIN PATHOL, V120, P405, DOI 10.1309/Q2HXBQ174A1R8H5Y; Wurzer JC, 1998, CANCER, V83, P753, DOI 10.1002/(SICI)1097-0142(19980815)83:4<753::AID-CNCR18>3.0.CO;2-R	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	APR	2015	65	4					177	182		10.1111/pin.12260		6	Pathology	Pathology	CF4YG	WOS:000352559600004		
J	Nakashima, H; Jiang, SX; Sato, Y; Hoshi, K; Matsumoto, T; Nagashio, R; Kobayashi, M; Matsuo, Y; Shiomi, K; Hayakawa, K; Saegusa, M; Satoh, Y				Nakashima, Hiroyasu; Jiang, Shi-Xu; Sato, Yuichi; Hoshi, Keika; Matsumoto, Toshihide; Nagashio, Ryo; Kobayashi, Makoto; Matsuo, Yukiko; Shiomi, Kazu; Hayakawa, Kazushige; Saegusa, Makoto; Satoh, Yukitoshi			Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance	PATHOLOGY INTERNATIONAL			English	Article						2-dimensional gel electrophoresis; immunohistochemistry; lung adenocarcinoma; micropapillary adenocarcinoma; proteomics; vimentin	DISTINCT PATHOLOGICAL MARKER; POOR-PROGNOSIS; CELL CARCINOMA; MESENCHYMAL TRANSITIONS; INTERMEDIATE-FILAMENTS; BREAST-CANCER; PATTERN; PAPILLARY; ASSOCIATION; METASTASES	The factors conferring the increased malignancy on lung adenocarcinoma with micropapillary component (AC-MPC) remain to be elucidated. On proteomics based on 2-dimensional gel electrophoresis, 19 proteins differentially expressed by more than 1.5-fold between AC-MPC and conventional adenocarcinoma (CAC); in particular, vimentin, one of the proteins, was 3.5-fold up-regulated in AC-MPC. Subsequent semi-quantitative investigation by immunohistochemistry with large cohorts comprised 101 AC-MPC and 119 CAC, respectively, of different stages revealed that vimentin was expressed in MPC of 95 (94.1%) AC-MPC and the expression scores were higher than those of well- and moderately differentiated CAC, as well as the background non-MPC of the AC-MPC (P < 0.0001), but not significantly different from those of poorly differentiated CAC (P = 0.561). Even within the AC-MPC entity, higher vimentin expression was correlated with more frequent vascular invasion and more advanced node metastasis (P < 0.02), and multivariate analysis showed that high vimentin expression and worse node statuses were independent indicators of adverse prognosis (P < 0.048). In conclusion, vimentin expression is prevalent and markedly up-regulated in MPC, which might reflect the biological essence of poorer differentiation or dedifferentiation of MPC, and this might have a role in the acquisition and increase of invasiveness and consequent more malignant nature of MPC.	[Nakashima, Hiroyasu; Matsuo, Yukiko; Shiomi, Kazu; Satoh, Yukitoshi] Kitasato Univ, Sch Med, Dept Thorac Surg, Sagamihara, Kanagawa 2520374, Japan; [Nakashima, Hiroyasu; Jiang, Shi-Xu; Matsumoto, Toshihide; Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 2520374, Japan; [Hoshi, Keika] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 2520374, Japan; [Hayakawa, Kazushige] Kitasato Univ, Sch Med, Dept Radiol, Sagamihara, Kanagawa 2520374, Japan; [Sato, Yuichi; Nagashio, Ryo; Kobayashi, Makoto] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa 2520374, Japan	Jiang, SX (reprint author), Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, Kitasato 1-15-1, Sagamihara, Kanagawa 2520374, Japan.	sxjiang@med.kitasato-u.ac.jp			JSPS KAKENHI, Japan [24590427, 24592099, 26461896]	This work was supported by JSPS KAKENHI Grant Numbers 24590427, 24592099 and 26461896, Japan. And the authors also thank A. Umezawa for her skillful technical assistance.	SIRIAUNKGUL S, 1993, MODERN PATHOL, V6, P660; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Prudkin L, 2009, MODERN PATHOL, V22, P668, DOI 10.1038/modpathol.2009.19; Ninomiya H, 2009, LUNG CANCER, V63, P235, DOI 10.1016/j.lungcan.2008.04.017; Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; AMIN MB, 1994, AM J SURG PATHOL, V18, P1224, DOI 10.1097/00000478-199412000-00005; Pelosi G, 2012, ANTICANCER RES, V32, P1463; Kamiya K, 2008, MODERN PATHOL, V21, P992, DOI 10.1038/modpathol.2008.79; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Nassar H, 2004, MODERN PATHOL, V17, P1045, DOI 10.1038/modpathol.3800166; Dauphin M, 2013, LUNG CANCER, V81, P117, DOI 10.1016/j.lungcan.2013.03.011; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Amin MB, 2002, AM J SURG PATHOL, V26, P358, DOI 10.1097/00000478-200203000-00010; Gilles C, 1999, J CELL SCI, V112, P4615; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; De Oliveira Duarte Achcar R, 2009, AM J CLIN PATHOL, V131, P694; Gilles C, 1996, J PATHOL, V180, P175, DOI 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G; Hirano H, 2014, ONCOL LETT, V8, P1107, DOI 10.3892/ol.2014.2284; Kawakami T, 2007, MODERN PATHOL, V20, P514, DOI 10.1038/modpathol.3800765; Maeda J, 2008, BRIT J CANCER, V98, P596, DOI 10.1038/sj.bjc.6604197; Makimoto Y, 2005, HISTOPATHOLOGY, V46, P677, DOI 10.1111/j.1365-2559.2005.02.126.x; Matsumoto T, 2012, INT J ONCOL, V40, P1957, DOI 10.3892/ijo.2012.1405; MCDIVITT RW, 1982, AM J SURG PATHOL, V6, P401, DOI 10.1097/00000478-198207000-00002; Miyoshi T, 2003, AM J SURG PATHOL, V27, P101, DOI 10.1097/00000478-200301000-00011; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Nagano T, 2010, LUNG CANCER, V67, P282, DOI 10.1016/j.lungcan.2009.04.014; Roh MS, 2004, HISTOPATHOLOGY, V45, P580, DOI 10.1111/j.1365-2559.2004.01953.x; Silver SA, 1997, AM J SURG PATHOL, V21, P43, DOI 10.1097/00000478-199701000-00005; Sobin LH, 2009, TNM CLASSIFICATION M; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; The Japan Lung, 2010, GEN RUL CLIN PATH RE, V7th; Travis WD, 2004, WHO CLASSIFICATION T; Tsutsumida H, 2007, MODERN PATHOL, V20, P638, DOI 10.1038/modpathol.3800780; Zhang J, 2011, HISTOPATHOLOGY, V59, P1204, DOI 10.1111/j.1365-2559.2011.04050.x	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	APR	2015	65	4					183	192		10.1111/pin.12257		10	Pathology	Pathology	CF4YG	WOS:000352559600005		
J	Nagasaka, T; Murakami, Y; Sasaki, E; Hosoda, W; Nakanishi, T; Yatabe, Y				Nagasaka, Toru; Murakami, Yoshiko; Sasaki, Eiichi; Hosoda, Waki; Nakanishi, Toru; Yatabe, Yasushi			Minute perivascular epithelioid cell (PEC) nests in the abdominal lymph nodes-a putative precursor of PEComa	PATHOLOGY INTERNATIONAL			English	Article						angiomyolipoma; lymphangioleiomyomatosis; PEComa; perivascular epithelioid cell	TUBEROUS SCLEROSIS; LYMPHANGIOLEIOMYOMATOSIS; UTERINE; TUMOR	A perivascular epithelioid cell tumor (PEComa) is a peculiar growth defined as a mesenchymal tumor composed of histologically and immunohistochemically distinct perivascular epithelioid cells (PECs). Because neither normal counterparts nor precursor lesions of PEComa have been identified, we examined minute PEC nests, ranged from 0.8mm to 10mm, to investigate the possible origin of the PEComa. We examined a total of 80677 para-aortic and pelvic lymph nodes that were systematically dissected from 1656 patients for gynecological malignancies. The identified lesions were confirmed immunohistochemically with multiple PEC markers, including smooth muscle actin, HMB45, melan-A, MiTF, ER and PgR. A total of 66 minute PEC nests were found in 21 patients (1.3% of the total population) with an average frequency of 3.1 lesions per patient. In cases of multiple involvement, 11 of 13 nests were located at the same level of multiple lymph node or on continuous levels. The lesions were preferentially distributed at the level of para-aortic and high pelvic lymph nodes. All nests were positive for actin and HMB45, whereas the other markers were positive with varying frequencies. The minute PEC nests may be associated with the possible normal counterpart of PEComas.	[Nagasaka, Toru; Murakami, Yoshiko; Sasaki, Eiichi; Hosoda, Waki; Yatabe, Yasushi] Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Nagoya, Aichi 4648681, Japan; [Nakanishi, Toru] Aichi Canc Ctr Hosp, Dept Gynecol Oncol, Nagoya, Aichi 464, Japan	Yatabe, Y (reprint author), Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	yyatabe@aichi-cc.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [11-25670183]	This work was supported in part by a Grant-in-Aid (11-25670183) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Liang SX, 2008, INT J GYNECOL PATHOL, V27, P86, DOI 10.1097/p2p.0b013e318150df37; Pan CC, 2008, J PATHOL, V214, P387, DOI 10.1002/path.2289; BONETTI F, 1992, AM J SURG PATHOL, V16, P307, DOI 10.1097/00000478-199203000-00013; Clay MR, 2011, INT J GYNECOL PATHOL, V30, P71, DOI 10.1097/PGP.0b013e3181efe08d; Fletcher CDM, 2002, PATHOLOGY GENETICS T; Fletcher Ch, 2013, WHO CLASSIFICATION T; Hayashi T, 2011, AM J SURG PATHOL, V35, P1776, DOI 10.1097/PAS.0b013e318235edbd; Henske EP, 1996, AM J HUM GENET, V59, P400; Iwasa Y, 2011, INT J GYNECOL PATHOL, V30, P470, DOI 10.1097/PGP.0b013e318212e1e6; Yang Wang, 2012, Diagn Pathol, V7, P23, DOI 10.1186/1746-1596-7-23	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	APR	2015	65	4					193	196		10.1111/pin.12262		4	Pathology	Pathology	CF4YG	WOS:000352559600006		
J	Shintaku, M; Tado, H; Inayama, K; Murakami, T; Suzuki, T				Shintaku, Masayuki; Tado, Hiroki; Inayama, Kumiko; Murakami, Takaaki; Suzuki, Takahisa			Ductulo-insular pancreatic endocrine tumor with amyloid deposition: Report of a case	PATHOLOGY INTERNATIONAL			English	Article						amyloid; ductulo-insular pancreatic endocrine tumor; insulin	ISLET CELL TUMOR; CARCINOMA; DIFFERENTIATION; METASTASIS; EXOCRINE; GROWTH; ORIGIN	We report a case of ductulo-insular pancreatic endocrine tumor (DI-PET) in a 50-year-old woman. The patient presented with symptoms and signs of hypoglycemia, and a small tumor in the uncus of the pancreas was extirpated. The tumor predominantly consisted of a neuroendocrine tumor (NET) of grade 2, which surrounded a minor component of ductular proliferation accompanied by a desmoplastic stroma. Both components were largely juxtaposed but admixed with each other in small areas. The NET component was immunoreactive for insulin and accompanied by the marked deposition of amyloid in the stroma. The ductular component consisted of a haphazard proliferation of ductules showing mildly atypical cytological features and immunoreactivities for cytokeratins 7 and 19. DI-PET is a rare composite neoplasm that should be distinguished from mixed ductal-neuroendocrine carcinoma because of the marked differences in treatment modalities and prognoses between the tumors. DI-PET associated with stromal amyloid deposition has not been reported to date. The transdifferentiation' of NET cells into ductular cells is considered as the most plausible histogenetic mechanism of this tumor, although other possibilities, such as an origin from a primitive endodermal stem cell or the induction of ductular proliferation by stimulation with NET-derived humoral factors, cannot be excluded.	[Shintaku, Masayuki; Tado, Hiroki; Inayama, Kumiko] Osaka Red Cross Hosp, Dept Pathol, Osaka 5438555, Japan; [Murakami, Takaaki] Osaka Red Cross Hosp, Dept Diabet & Endocrinol, Osaka 5438555, Japan; [Suzuki, Takahisa] Takamatsu Red Cross Hosp, Dept Surg, Takamatsu, Kagawa, Japan	Shintaku, M (reprint author), Osaka Red Cross Hosp, Dept Pathol, Tennoji Ku, Osaka 5438555, Japan.	masa-s@sings.jp					Yuan SY, 1996, DIFFERENTIATION, V61, P67, DOI 10.1046/j.1432-0436.1996.6110067.x; Deshpande V, 2003, AM J SURG PATHOL, V27, P461, DOI 10.1097/00000478-200304000-00005; van Eeden S, 2004, AM J SURG PATHOL, V28, P813, DOI 10.1097/01.pas.0000112546.57641.c7; BANI D, 1985, VIRCHOWS ARCH B, V48, P19, DOI 10.1007/BF02890112; Bosman FT, 2010, WHO CLASSIFICATION T, V13-14, P279; Kamisawa T, 1996, PATHOL RES PRACT, V192, P901; KASHIWABARA K, 1991, ACTA PATHOL JAPON, V41, P636; Kloppel G, 2000, SEMIN DIAGN PATHOL, V17, P104; Leteurtre E, 2000, ARCH PATHOL LAB MED, V124, P284; NONOMURA A, 1989, ACTA PATHOL JAPON, V39, P328; Ohike N, 2003, VIRCHOWS ARCH, V442, P258, DOI 10.1007/s00428-002-0751-5; Pauser U, 2005, AM J SURG PATHOL, V29, P797, DOI 10.1097/01.pas.0000157748.18591.d7; PERMERT J, 1992, INT J PANCREATOL, V11, P23; Peters J, 2000, VIRCHOWS ARCH, V436, P527, DOI 10.1007/s004280000208; Pour PM, 1997, AM J PATHOL, V150, P2167; Regitnig P, 2001, VIRCHOWS ARCH, V438, P624, DOI 10.1007/s004280100406; REID JD, 1982, CANCER, V49, P908, DOI 10.1002/1097-0142(19820301)49:5<908::AID-CNCR2820490514>3.0.CO;2-J; Terada T, 1999, VIRCHOWS ARCH, V435, P606, DOI 10.1007/s004280050447; Terada T, 2002, PATHOL INT, V52, P740, DOI 10.1046/j.1440-1827.2002.01416.x; TOMITA T, 1981, HUM PATHOL, V12, P850, DOI 10.1016/S0046-8177(81)80091-3	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	APR	2015	65	4					197	201		10.1111/pin.12255		5	Pathology	Pathology	CF4YG	WOS:000352559600007		
J	Ota, H; Yamaguchi, D; Iwaya, M; Kobayashi, M; Tateiwa, N; Iwaya, Y; Momose, M; Uehara, T				Ota, Hiroyoshi; Yamaguchi, Dai; Iwaya, Mai; Kobayashi, Mikiko; Tateiwa, Nobuyuki; Iwaya, Yugo; Momose, Masanobu; Uehara, Takeshi			Principal cells in gastric neoplasia of fundic gland (chief cell predominant) type show characteristics of immature chief cells	PATHOLOGY INTERNATIONAL			English	Letter							ADENOCARCINOMA; DIFFERENTIATION; PROPOSAL; MUCOSA		[Ota, Hiroyoshi] Shinshu Univ, Grad Sch Med, Dept Hlth & Med Sci, Matsumoto, Nagano 390, Japan; [Yamaguchi, Dai] Shinshu Univ, Grad Sch Med, Dept Clin Lab Sci, Matsumoto, Nagano 390, Japan; [Kobayashi, Mikiko] Shinshu Univ, Grad Sch Med, Dept Pathol, Matsumoto, Nagano 390, Japan; [Uehara, Takeshi] Shinshu Univ, Grad Sch Med, Dept Lab Med, Matsumoto, Nagano 390, Japan; [Iwaya, Mai] Nagano Municipal Hosp, Dept Pathol, Nagano, Japan; [Iwaya, Yugo] Nagano Municipal Hosp, Dept Gastroenterol, Nagano, Japan; [Tateiwa, Nobuyuki] Tateiwa Clin, Nagano, Japan; [Momose, Masanobu] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan	Ota, H (reprint author), Shinshu Univ, Grad Sch Med, Dept Hlth & Med Sci, Matsumoto, Nagano 390, Japan.						Singhi AD, 2012, AM J SURG PATHOL, V36, P1030, DOI 10.1097/PAS.0b013e31825033e7; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Kushima R, 2013, PATHOL INT, V63, P318, DOI 10.1111/pin.12070; Ueyama H, 2010, AM J SURG PATHOL, V34, P609, DOI 10.1097/PAS.0b013e3181d94d53; KATSUYAMA T, 1978, J HISTOCHEM CYTOCHEM, V26, P233; CORNAGGIA M, 1986, HISTOCHEMISTRY, V85, P5, DOI 10.1007/BF00508647; Hanisch FG, 2014, J BIOL CHEM, V40, P27363; Ota H, 2001, AM J CLIN PATHOL, V115, P69; Ota H, 2006, HISTOCHEM CELL BIOL, V126, P617, DOI 10.1007/s00418-006-0197-y; Tsukamoto T, 2007, PATHOL INT, V57, P517, DOI 10.1111/j.1440-1827.2007.02134.x	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	APR	2015	65	4					202	204		10.1111/pin.12244		3	Pathology	Pathology	CF4YG	WOS:000352559600008		
J	Shintaku, M; Ashihara, T; Koyama, T				Shintaku, Masayuki; Ashihara, Takahito; Koyama, Takashi			Myxoid leiomyosarcoma of the uterus with mature adipocytes and numerous bizarre multinucleated giant cells	PATHOLOGY INTERNATIONAL			English	Letter							UTERINE; DIFFERENTIATION; LEIOMYOMA		[Shintaku, Masayuki] Osaka Red Cross Hosp, Dept Pathol, Osaka, Japan; [Ashihara, Takahito] Osaka Red Cross Hosp, Dept Gynecol & Obstet, Osaka, Japan; [Koyama, Takashi] Kurashiki Cent Hosp, Dept Diagnost Radiol, Kurashiki, Okayama, Japan	Shintaku, M (reprint author), Osaka Red Cross Hosp, Dept Pathol, Osaka, Japan.						Sioletic S, 2013, HISTOPATHOLOGY, V62, P287, DOI 10.1111/j.1365-2559.2012.04348.x; Burch DM, 2011, HISTOPATHOLOGY, V59, P1144, DOI 10.1111/j.1365-2559.2011.04053.x; Folpe AL, 2002, AM J SURG PATHOL, V26, P742, DOI 10.1097/01.PAS.0000016311.09846.57; Yanai H, 2010, PATHOL INT, V60, P506, DOI 10.1111/j.1440-1827.2010.02549.x; Mittal KR, 2009, MODERN PATHOL, V22, P1303, DOI 10.1038/modpathol.2009.96; BAPAT K, 1989, INT J GYNECOL OBSTET, V28, P71, DOI 10.1016/0020-7292(89)90547-X; Jha A, 2007, N J OBSTET GYNAECOL, V2, P67; Lee HP, 2012, INT J GYNECOL PATHOL, V31, P358, DOI 10.1097/PGP.0b013e31823f841f; SCURRY J, 1990, GYNECOL ONCOL, V39, P381, DOI 10.1016/0090-8258(90)90271-L; VAKIANI M, 1982, INT J GYNECOL PATHOL, V1, P211, DOI 10.1097/00004347-198202000-00008	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	APR	2015	65	4					205	207		10.1111/pin.12251		3	Pathology	Pathology	CF4YG	WOS:000352559600009		
J	Motobayashi, M; Inaba, Y; Nishimura, T; Kobayashi, N; Nakazawa, Y; Koike, K				Motobayashi, Mitsuo; Inaba, Yuji; Nishimura, Takafumi; Kobayashi, Norimoto; Nakazawa, Yozo; Koike, Kenichi			An Increase in Circulating B Cell-Activating Factor in Childhood-Onset Ocular Myasthenia Gravis	PEDIATRIC NEUROLOGY			English	Article						childhood-onset ocular myasthenia gravis; B-cell activating factor; IL-17; Th17	SYSTEMIC-LUPUS-ERYTHEMATOSUS; LYMPHOCYTE STIMULATOR; BAFF; MICE; EXPRESSION; DISORDERS; RECEPTOR; NICHES; IMMUNE; BLYS	BACICGROUND: Myasthenia gravis is a B cell-mediated autoimmune disorder. The pathophysiology of childhood-onset ocular myasthenia gravis remains unclear. We investigated serum B cell-activating factor levels and other immunological parameters in child patients with ocular myasthenia gravis. METHODS: Blood samples were obtained from 9 children with ocular myasthenia gravis and 20 age-matched controls. We assayed serum concentrations of B cell-activating factor, anti-acetylcholine receptor antibody titers, 7 types of cytokines (interleukins-2, -4, -6, -10, and -17A; interferon-gamma; tumor necrosis factor-alpha) as well as the percentages of peripheral blood CD4+, CD8+, and CD19+ cells. RESULTS: Serum B cell-activating factor levels were significantly higher before immunosuppressive therapy in patients. with childhood-onset ocular myasthenia gravis than in controls and decreased after immunosuppressive therapy. A significant positive correlation was observed between serum B cell activating factor levels and anti-acetylcholine receptor antibody titers in patients with myasthenia gravis. Serum B cell activating factor concentrations did not correlate with the percentages of CD4+, CD8+, and CD19+ cells or the CD4+/CD8+ ratio. No significant differences were observed in the levels of the 7 different types of cytokines examined, including interleukin-17A, between preimmunosuppressive therapy myasthenia gravis patients and controls. CONCLUSIONS: Circulating B cell-activating factor may play a key role in the pathophysiology of childhood-onset ocular myasthenia gravis.	[Motobayashi, Mitsuo; Inaba, Yuji; Nishimura, Takafumi; Kobayashi, Norimoto; Nakazawa, Yozo; Koike, Kenichi] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan	Inaba, Y (reprint author), Shinshu Univ, Sch Med, Dept Pediat, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	inabay@shinshu-u.ac.jp					Uzawa A, 2014, CLIN EXP IMMUNOL, V176, P232, DOI 10.1111/cei.12272; Stohl W, 2011, CURR OPIN RHEUMATOL, V23, P305, DOI 10.1097/BOR.0b013e328344c15e; Wang ZY, 1999, NEUROLOGY, V52, P484; Jaretzki A, 2000, NEUROLOGY, V55, P16; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Kim JY, 2008, J NEUROIMMUNOL, V199, P151, DOI 10.1016/j.jneuroim.2008.05.010; Chiang LM, 2009, MUSCLE NERVE, V39, P423, DOI 10.1002/mus.21195; Berrih-Aknin S, 2013, AUTOIMMUN REV, V12, P885, DOI 10.1016/j.autrev.2013.03.011; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; HOHLFELD R, 1984, NATURE, V310, P244, DOI 10.1038/310244a0; Shinomiya N, 2004, CLIN IMMUNOL, V110, P154, DOI 10.1016/j.clim.2003.10.004; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Masuda M, 2010, J NEUROIMMUNOL, V225, P123, DOI 10.1016/j.jneuroim.2010.03.016; KAUL R, 1994, J IMMUNOL, V152, P3152; Cheema GS, 2001, ARTHRITIS RHEUM, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Ragheb S, 2008, ARCH NEUROL-CHICAGO, V65, P1358, DOI 10.1001/archneur.65.10.1358; Zhang J, 2001, J IMMUNOL, V166, P6; Zheng S, 2013, SCAND J IMMUNOL, V78, P98, DOI 10.1111/sji.12057; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Espinosa G, 2010, Drugs Today (Barc), V46, P891, DOI 10.1358/dot.2010.46.12.1544336; Evoli A, 1998, NEUROMUSCULAR DISORD, V8, P561, DOI 10.1016/S0960-8966(98)00077-7; Finnis MF, 2011, AUTOIMMUNE DIS, V2011; Haliloglu G, 2002, J CHILD NEUROL, V17, P390, DOI 10.1177/088307380201700516; HOHLFELD R, 1982, J NEUROL SCI, V57, P265, DOI 10.1016/0022-510X(82)90033-8; Lindner A, 1997, J NEUROL, V244, P515, DOI 10.1007/s004150050135; McGrogan A, 2010, NEUROEPIDEMIOLOGY, V34, P171, DOI 10.1159/000279334; Mu LL, 2009, IMMUNOLOGY, V128, pe826, DOI 10.1111/j.1365-2567.2009.03089.x; NATH A, 1990, NEUROLOGY, V40, P581; Pineles SL, 2010, AM J OPHTHALMOL, V150, P453, DOI 10.1016/j.ajo.2010.05.002; Ragheb S, 2011, AUTOIMMUNE DIS, V2011; Rodig SJ, 2005, HUM PATHOL, V36, P1113, DOI 10.1016/j.humpath.2005.08.005; Scuderi F, 2011, J NEUROL, V258, P2284, DOI 10.1007/s00415-011-6092-z	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	APR	2015	52	4					404	409		10.1016/j.pediatrneurol.2014.12.006		6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CF1US	WOS:000352334000005		
J	Adachi, M; Takasugi, M; Sugiyama, M; Iida, J; Tanaka, A; Fukuyama, H				Adachi, Masayoshi; Takasugi, Mari; Sugiyama, Masashi; Iida, Junji; Tanaka, Akikazu; Fukuyama, Hiroyuki			Polarity inversion and growth mechanism of AlN layer grown on nitrided sapphire substrate using Ga-Al liquid-phase epitaxy	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						AlN; Ga-Al solutions; liquid-phase epitaxy; nitrided sapphire; oxygen partial pressure; polarity	CRYSTALLINE QUALITY; ALUMINUM NITRIDE; FILMS	Previously, we developed Ga-Al liquid-phase epitaxy (LPE) to grow AlN layers on a surface nitrided sapphire substrate using Ga-Al solutions. We found that polarity inversion occurs at the interface between the nitrided sapphire layer and the LPE layer. As the partial pressure of oxygen influences LPE growth, our current study investigated this growth by controlling oxygen in supplying nitrogen gas. Combined with the previous study, we discuss these results in light of the polarity inversion model and growth mechanism for the Ga-Al LPE technique. Oxygen atoms are believed to dissolve in the solution and get trapped on the surface of nitrided sapphire. The trapped oxygen atoms form a symmetrical octahedral structure, which resets the polarity of the nitrided sapphire. Consequently, chemically stable aluminum-polar AlN can be grown in the solution. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Adachi, Masayoshi; Takasugi, Mari; Fukuyama, Hiroyuki] Tohoku Univ, IMRAM, Sendai, Miyagi 9808577, Japan; [Sugiyama, Masashi; Iida, Junji; Tanaka, Akikazu] Sumitomo Met Min Co Ltd, Ichikawa Res Lab, Ichikawa 2728588, Japan	Fukuyama, H (reprint author), Tohoku Univ, IMRAM, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	adachi@tagen.tohoku.ac.jp; fukuyama@tagen.tohoku.ac.jp			JSPS KAKENHI [26706013]; Cabinet Office, Government of Japan, through its Funding Program for Next Generation World-Leading Researchers	One of the authors (MA) is grateful for the financial support from JSPS KAKENHI Grant Number 26706013. This research was funded by the Cabinet Office, Government of Japan, through its Funding Program for Next Generation World-Leading Researchers.	Adachi M, 2011, PHYS STATUS SOLIDI A, V208, P1494, DOI 10.1002/pssa.201001014; Adachi M, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.091001; Adachi M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.101001; Herro ZG, 2010, J CRYST GROWTH, V312, P2519, DOI 10.1016/j.jcrysgro.2010.04.005; Miyagawa R, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.025501; Banal RG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937445; YOUNGMAN RA, 1990, J AM CERAM SOC, V73, P3238, DOI 10.1111/j.1151-2916.1990.tb06444.x; Hirayama H, 2005, J APPL PHYS, V97, DOI 10.1063/1.1899760; Adachi M, 2012, MATER TRANS, V53, P1295, DOI 10.2320/matertrans.MBW201112; Epelbaum BM, 2007, J CRYST GROWTH, V305, P317, DOI 10.1016/j.jcrysgro.2007.04.008; Fukuyama H, 2010, J APPL PHYS, V107, DOI 10.1063/1.3272692; Fukuyama H, 2006, J APPL PHYS, V100, DOI 10.1063/1.2214217; Kumagai Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.055504; Kumada T, 2012, PHYS STATUS SOLIDI C, V9, P515, DOI 10.1002/pssc.201100489; Hirayama H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2770662; Hironaka K, 2010, J CRYST GROWTH, V312, P2527, DOI 10.1016/j.jcrysgro.2010.04.007; Imura M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364460; Kangawa Y, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.095501; Kumada T, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000890; Ueno K, 2014, PHYS STATUS SOLIDI-R, V8, P256, DOI 10.1002/pssr.201308275; Wong MH, 2010, J APPL PHYS, V108, DOI 10.1063/1.3524473	21	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	APR	2015	252	4					743	747		10.1002/pssb.201451426		5	Physics, Condensed Matter	Physics	CF6CI	WOS:000352643900014		
J	Nomura, Y; Tachi, T; Kawae, T; Morimoto, A				Nomura, Yukihiro; Tachi, Takashi; Kawae, Takeshi; Morimoto, Akiharu			Temperature dependence of ferroelectric properties and the activation energy of polarization reversal in (Pr,Mn)-codoped BiFeO3 thin films	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						activation energy; BiFeO3; ferroelectric thin films; polarization reversal	E HYSTERESIS LOOP; TOP ELECTRODES; RETENTION; CAPACITORS; MODEL; HETEROSTRUCTURES; SRBI2TA2O9; KINETICS	We applied Vopsaroiu's model to (Bi, Pr)(Fe, Mn)O-3 (BPFM) and Pb(Zr, Ti)O-3 (PZT) ferroelectric thin films fabricated by chemical solution deposition. The temperature dependences of the saturation polarization and the coercive field were measured in a low-temperature region from 100 to 200 K. The saturation polarizations of BPFM thin films decreased on decreasing the measurement temperature due to the polarization pinning effect, while that of PZT thin film was almost unchanged over the temperature region. The coercive fields of all the thin films were increased linearly on decreasing the measurement temperature. The activation energies for polarization reversal in as-grown BPFM, postannealed BPFM, and PZT thin films were 1.18, 1.25, and 0.95 eV, respectively. These results indicate that BPFM thin films have large activation energies for polarization reversal compared with PZT thin films. In addition, the postannealed BPFM thin film has a larger activation energy than the as-grown BPFM thin film. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Nomura, Yukihiro; Tachi, Takashi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Kawae, Takeshi; Morimoto, Akiharu] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan	Morimoto, A (reprint author), Kanazawa Univ, Coll Sci & Engn, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	amorimot@ec.t.kanazawa-u.ac.jp			JSPS KAKENHI [26630126]	This work was partly supported by JSPS KAKENHI Grant Number 26630126.	Shvartsman VV, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2731312; Lebeugle D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024116; Vopsaroiu M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.024109; ORIHARA H, 1994, J PHYS SOC JPN, V63, P1031, DOI 10.1143/JPSJ.63.1031; Lohse O, 2001, J APPL PHYS, V89, P2332, DOI 10.1063/1.1331341; HASHIMOTO S, 1994, J PHYS SOC JPN, V63, P1601, DOI 10.1143/JPSJ.63.1601; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Jo JY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.267602; Tagantsev AK, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.214109; Lou XJ, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/1/012207; Kamel TM, 2007, J EUR CERAM SOC, V27, P2471, DOI 10.1016/j.jeurceramsoc.2006.08.014; Shur V, 1998, J APPL PHYS, V84, P445, DOI 10.1063/1.368047; Meng XJ, 2002, APPL PHYS LETT, V81, P4035, DOI 10.1063/1.1522833; Avrami M., 1940, Journal of Chemical Physics, V8, DOI 10.1063/1.1750631; Belov AY, 2006, ACTA MATER, V54, P3463, DOI 10.1016/j.actamat.2006.03.038; de Araujo A.-P., 1995, NATURE, V374, P627; GONG JP, 1994, PHYS REV B, V50, P3280, DOI 10.1103/PhysRevB.50.3280; Jo W, 2000, APPL PHYS LETT, V76, P390, DOI 10.1063/1.125763; Kang BS, 2004, APPL PHYS LETT, V84, P3127, DOI 10.1063/1.1710715; Kawae T, 2010, J CERAM SOC JPN, V118, P652, DOI 10.2109/jcersj2.118.652; Kawae T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CH03; Kim S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2135898; Kolmogorov A N, 1937, IZV AKAD NAUK SSSR M, V3, P355; Noguchi Y, 2001, JPN J APPL PHYS 1, V40, P5812, DOI 10.1143/JJAP.40.5812; Nomura Y, 2014, PHYS STATUS SOLIDI-R, V8, P536, DOI 10.1002/pssr.201309022; Shur V., 1994, FERROELECTRICS, V172, P361; So YW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1870126; Stolichnov I, 2005, J APPL PHYS, V98, DOI 10.1063/1.2112174; Vopson MM, 2011, IEEE T ULTRASON FERR, V58, P1867, DOI 10.1109/TUFFC.2011.2025; Wang Y., 2002, J APPL PHYS, V99; Wang Y, 2009, J APPL PHYS, V106, DOI 10.1063/1.3253740; Yuan GL, 2004, APPL PHYS LETT, V84, P954, DOI 10.1063/1.1644056; Yun KY, 2004, JPN J APPL PHYS 2, V43, pL647, DOI 10.1143/JJAP.43.L647	33	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	APR	2015	252	4					833	838		10.1002/pssb.201451553		6	Physics, Condensed Matter	Physics	CF6CI	WOS:000352643900027		
J	Fukushima, K; Usui, N; Ogawa, R; Tokuchi, N				Fukushima, Keitaro; Usui, Nobuaki; Ogawa, Ryo; Tokuchi, Naoko			Impacts of moso bamboo (Phyllostachys pubescens) invasion on dry matter and carbon and nitrogen stocks in a broad-leaved secondary forest located in Kyoto, western Japan	PLANT SPECIES BIOLOGY			English	Article						allocation pattern; bamboo invasion; carbon and nitrogen stocks; Phyllostachys pubescens; stand structure	BAMBUSOIDES STAND; NET PRODUCTION; DYNAMICS; DIVERSITY; TROPICS; GROWTH	In western and central Japan, the expansion of exotic moso bamboo (Phyllostachys pubescens Mazel ex J. Houz.) populations into neighboring vegetation has become a serious problem. Although the effects of bamboo invasion on biodiversity have been well studied, shifts in nutrient stocks and cycling, which are fundamental for ecosystem functioning, are not fully understood. To explore the effects of P.pubescens invasion on ecosystem functions we examined above- and below-ground dry matter and carbon (C) and nitrogen (N) stocks in a pure broad-leaved tree stand, a pure bamboo stand, and two tree-bamboo mixed stands with different vegetation mix ratios in the secondary forest of Kyoto, western Japan. In the process of invasion, bamboo shoots offset broad-leaved tree deaths; thus, no clear trend was apparent in total above- or below-ground biomass or in plant C and N stocks during invasion. However, the ratio of above-ground to below-ground biomass (T/R ratio at the stand level) decreased with increasing bamboo dominance, especially in the early stages of invasion. This shift indicates that rapid bamboo rhizomatous growth is a main driver of substantial changes in stand structure. We also detected rises in the C/N ratio of forest-floor organic matter during bamboo invasion. Thus major impacts of P.pubescens invasion into broad-leaved forests include not only early shifts in biomass allocation, but also changes in the distribution pattern of C and N stored in plants and soil.	[Fukushima, Keitaro; Tokuchi, Naoko] Kyoto Univ, Field Sci Educ & Res Ctr, Kyoto, Japan; [Usui, Nobuaki; Ogawa, Ryo] Kyoto Univ, Grad Sch Agr, Kyoto, Japan	Fukushima, K (reprint author), Tokyo Metropolitan Univ, Fac Urban Environm Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	ktaro.f@gmail.com			Sasakawa Scientific Research Grant from The Japan Science Society; ESPEC Foundation for Global Environment Research and Technology; Ministry of Education, Culture, Sports, Science and Technology, Japan [22780145, 26660127]; Suntory Holdings Limited, Japan	We thank Ms Satomi Yoneda, Ms Momoko Sakai, and Dr Shuhei Matsuyama (Kyoto University) for their assistance in data collection. We also thank Dr Yuhei Abe (Kagawa Prefecture) for sharing data and Dr Takahito Yoshioka (Kyoto University) for helpful comments. Funding was provided by a Sasakawa Scientific Research Grant from The Japan Science Society, ESPEC Foundation for Global Environment Research and Technology (ESPEC Prize for the Encouragement of Environmental Studies), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (no. 22780145 and 26660127), to KF, and a grant from Suntory Holdings Limited, Japan, to NT.	Abe Y., 2009, J JAPANESE SOC REVEG, V35, P57; Akutsu H., 2012, B UTSUNOMIYA U FORES, V48, P139; Li R, 1998, PLANT SOIL, V201, P113, DOI 10.1023/A:1004322812651; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Yen TM, 2011, FOREST ECOL MANAG, V261, P995, DOI 10.1016/j.foreco.2010.12.015; Lovett GM, 2004, BIOGEOCHEMISTRY, V67, P289, DOI 10.1023/B:BIOG.0000015786.65466.f5; ISAGI Y, 1994, ECOL RES, V9, P47, DOI 10.1007/BF02347241; Komatsu H, 2010, FOREST ECOL MANAG, V260, P1295, DOI 10.1016/j.foreco.2010.06.040; Goodale CL, 2001, ECOL APPL, V11, P253, DOI 10.1890/1051-0761(2001)011[0253:TLTEOL]2.0.CO;2; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Isagi Y, 1997, PLANT ECOL, V130, P41, DOI 10.1023/A:1009711814070; Tripathi SK, 1996, ECOL RES, V11, P149, DOI 10.1007/BF02347681; VITOUSEK PM, 1979, SCIENCE, V204, P469, DOI 10.1126/science.204.4392.469; Johnson DW, 2000, SOIL SCI SOC AM J, V64, P1503; Umemura M, 2014, ECOL RES, V29, P501, DOI 10.1007/s11284-014-1150-5; Austin AT, 2012, FUNCT ECOL, V26, P265, DOI 10.1111/j.1365-2435.2011.01910.x; Bai Shangbin, 2013, Shengwu Duoyangxing, V21, P288, DOI 10.3724/SP.J.1003.2013.08258; Dannoura M., 2006, Journal of the Japanese Forest Society, V88, P120, DOI 10.4005/jjfs.88.120; FFPRI, 2009, DEV METH EST CARB AC, P4; Fukushima K, 2011, J FOREST RES-JPN, V16, P394, DOI 10.1007/s10310-011-0286-1; Fukuzawa K, 2015, PLANT SPEC BIOL, V30, P104, DOI 10.1111/1442-1984.12086; Goto S., 2008, J JAPANESE AGR SYSTE, V24, P243; Goto Yoshiaki, 2006, Bulletin of the Forestry and Forest Products Research Institute, V5, P215; Goto Y, 2003, B FFPRI, V387, P115; Hasegawa M., 1989, J TOYAMA FORESTRY FO, V2, P5; Isagi Y., 1998, Journal of Sustainable Forestry, V6, P127; ISAGI Y, 1993, ECOL RES, V8, P123, DOI 10.1007/BF02348524; IWAKI HIDEO, 1958, JAPANESE JOUR BOT, V16, P210; Kai S., 1984, B MIYAZAKI U FORESTS, V10, P1; Katagiri S., 1975, J JAPANESE FORESTRY, V57, P412; KATAGIRI S, 1988, Japanese Journal of Ecology (Tokyo), V38, P135; Katakura M., 2007, RES B NAGANO PREFECT, V22, P33; Kumemuras A, 2009, RES B KAGOSHIMA U FO, V36, P1; Makita Akifumi, 1998, Plant Species Biology, V13, P85, DOI 10.1111/j.1442-1984.1998.tb00251.x; McClaugherty C, 2014, PLANT LITTER DECOMPO; Nagano M., 1978, JIBP SYNTHESIS, V18, P69; Nakai A., 2006, B FAC BIORESOUR MIE, V33, P21; Nishioka M, 1982, B REPORT MONKEYS MIN, P117; O'Connor PJ, 2000, J TROP ECOL, V16, P499, DOI 10.1017/S0266467400001541; Ogawa H., 1977, JIBP SYNTHESIS, V16, P15; Ogino K., 1977, JIBP SYNTHESIS, V16, P172; Okutomi K, 1996, J VEG SCI, V7, P723, DOI 10.2307/3236383; R Development Core Team, 2010, R LANG ENV STAT COMP; Saito H., 1989, FOREST ECOLOGY, P43; Segawa Y., 1970, ANN REPORT TOHOKU BR, V11, P188; Shibata S., 2003, J JAPANESE SOC REVEG, V28, P406; Suzuki S, 2015, PLANT SPEC BIOL, V30, P63, DOI 10.1111/1442-1984.12067; Suzuki S., 1978, INDEX JAPANESE BAMBU; Suzuki S, 2011, ECOL RES MONOGR, P211, DOI 10.1007/978-4-431-87799-8_15; Tokuchi N., 2010, WATER SCI, V54, P90; Torii Atsushi, 1998, Japanese Journal of Ecology (Tokyo), V48, P37; Torii Atsushi, 1997, Japanese Journal of Ecology (Tokyo), V47, P31; Tripathi SK, 2005, FOREST ECOL MANAG, V212, P278, DOI 10.1016/j.foreco.2005.03.030; TSUTSUMI T, 1968, Journal of the Japanese Forestry Society, V50, P66; Tu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075862; Umemura M, 2015, PLANT SPEC BIOL, V30, P72, DOI 10.1111/1442-1984.12038; Watanabe T, 2013, J FOREST RES-JPN, V18, P129, DOI 10.1007/s10310-011-0330-1; Zhang CS, 2010, ENVIRON MANAGE, V45, P779, DOI 10.1007/s00267-010-9429-y	58	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0913-557X	1442-1984		PLANT SPEC BIOL	Plant Spec. Biol.	APR	2015	30	2					81	95		10.1111/1442-1984.12066		15	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CF8JG	WOS:000352803700001		
J	Shinohara, Y; Otsuki, K				Shinohara, Yoshinori; Otsuki, Kyoichi			Comparisons of soil-water content between a Moso bamboo (Phyllostachys pubescens) forest and an evergreen broadleaved forest in western Japan	PLANT SPECIES BIOLOGY			English	Article						bamboo forest; canopy transpiration; soil moisture; soil water budget method; spatial variability	SAP-FLOW; EVAPOTRANSPIRATION; CATCHMENT; INTERCEPTION; TEMPERATURE; COMPONENTS; VEGETATION; BALANCE; CANOPY; CHINA	In Japan, forests of Moso bamboo (Phyllostachys pubescens, an exotic invasive giant bamboo) have naturalized and expanded rapidly, replacing surrounding broadleaved and coniferous forests. To evaluate impacts caused by these forest-type replacements on the hydrological cycle, soil-water content and its spatial variability in a Moso bamboo forest were compared with those in an adjacent evergreen broadleaved forest, in a case study of a stand in western Japan (northern Kyushu). The volumetric soil-water content averaged over depths between 0 and 60cm was consistently higher in the bamboo stand than that in the broadleaved stand. These results contrast with previous studies comparing the soil-water content in Moso bamboo forests with that in other forest types. The sum of canopy transpiration and soil evaporation (E) in the bamboo stand tended to be larger than that in the broadleaved stand. Small canopy interception loss was reported in the bamboo forest. Therefore, the large amount of E would counterbalance the small canopy interception loss in the bamboo forest. Differences in soil characteristics between the two stands may be the main factor causing differences in soil-water content. Spatial variation in soil-water content in the bamboo stand was larger than that in the broadleaved stand, confirming findings in a previous series of our study. This could happen because the well-developed root-system in the bamboo forest enhances preferential flow in the soil. To evaluate the effects of aggressive invasion of alien giant bamboo on the ecosystem functions, we recommend further studies measuring various hydrological components in various Moso bamboo forests.	[Shinohara, Yoshinori] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Otsuki, Kyoichi] Kyushu Univ, Kasuya Res Forest, Fukuoka 812, Japan	Shinohara, Y (reprint author), Kyushu Univ, Fac Agr, Fukuoka 812, Japan.	shinohara@agr.kyushu-u.ac.jp			Kyushu University; Faculty of Agriculture, Kyushu University;  [25850109]	We thank Dr. Hikaru Komatsu (Kyoto University), Yuka Onozawa (Fukuoka Prefectural Office) and members of the Laboratory of Ecohydrology in Kyushu University Forest for their help and cooperation with our work at the Kaguya site. This research was supported by Kyushu University Interdisciplinary Programs in Education and Projects in Research Development, a research grant for young investigators from the Faculty of Agriculture, Kyushu University, and a Grant-in-Aid for Young Scientists (No. 25850109).	Vertessy RA, 2001, FOREST ECOL MANAG, V143, P13, DOI 10.1016/S0378-1127(00)00501-6; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Kume T, 2010, FOREST ECOL MANAG, V260, P1287, DOI 10.1016/j.foreco.2010.07.012; SWANK WT, 1974, SCIENCE, V185, P857, DOI 10.1126/science.185.4154.857; Komatsu H, 2010, FOREST ECOL MANAG, V260, P1295, DOI 10.1016/j.foreco.2010.06.040; Johnson MS, 2006, ECOSCIENCE, V13, P324, DOI 10.2980/i1195-6860-13-3-324.1; Chen XG, 2009, FOREST ECOL MANAG, V258, P1489, DOI 10.1016/j.foreco.2009.06.051; Shinohara Y, 2013, HYDROL PROCESS, V27, P2041, DOI 10.1002/hyp.9359; Isagi Y, 1997, PLANT ECOL, V130, P41, DOI 10.1023/A:1009711814070; Onozawa Y, 2009, J FOREST RES-JPN, V14, P111, DOI 10.1007/s10310-008-0108-2; Sidle RC, 2007, HYDROL PROCESS, V21, P3237, DOI 10.1002/hyp.6876; Komatsu H, 2007, J HYDROL, V336, P361, DOI 10.1016/j.jhydrol.2007.01.009; Wilson KB, 2001, AGR FOREST METEOROL, V106, P153, DOI 10.1016/S0168-1923(00)00199-4; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Chung MJ, 2009, J WOOD SCI, V55, P197, DOI 10.1007/s10086-008-1014-0; Daikoku K, 2008, HYDROL PROCESS, V22, P4083, DOI 10.1002/hyp.7010; FRAZER G W., 1999, GAP LIGHT ANAL GLA V, P1; Fukushima K, 2015, PLANT SPEC BIOL, V30, P81, DOI 10.1111/1442-1984.12066; Gray D., 1996, BIOTECHNICAL SOIL BI; Hattoris S, 1989, SUIRIKAGAKU, V186, P34; Hiura H., 2004, LANDSLIDES, V41, P323; Ide J., 2010, HYDROLOGICAL RES LET, V4, P80, DOI DOI 10.3178/HRL.4.80; Iida S, 2006, J HYDROL, V326, P166, DOI 10.1016/j.jhydrol.2005.11.002; Imawaka S, 2008, B KYUSHU U FOREST, V89, P75; Ishiga H., 2001, GEOSCI REP SHIMANE U, V20, P83; Kawai H., 2008, Journal of the Japanese Forest Society, V90, P151, DOI 10.4005/jjfs.90.151; Kobayashi T., 2010, SHINRIN KAGAKU, V53, P6; Komatsu H, 2008, J HYDROL, V348, P330, DOI 10.1016/j.jhydrol.2007.10.006; Komatsu H, 2010, HYDROL PROCESS, V24, P1896, DOI 10.1002/hyp.7622; Komatsu H, 2011, HYDROL PROCESS, V25, P302, DOI 10.1002/hyp.7898; Kume T, 2007, FOREST ECOL MANAG, V238, P220, DOI 10.1016/j.foreco.2006.10.019; Kuramoto K., 2011, Journal of Japan Society of Hydrology and Water Resources, V24, P360, DOI 10.3178/jjshwr.24.360; Liang W. L., 2010, J JAPAN SOC EROSION, V63, P22; Liang WL, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009856; Miyamoto H., 2009, SHOKUBUTSU KANKYO KO, V21, P86; Nishikawa R., 2005, Journal of the Japanese Forest Society, V87, P402; Okutomi K, 1996, J VEG SCI, V7, P723, DOI 10.2307/3236383; Onozawa Y., 2009, Journal of the Japanese Forest Society, V91, P366; Saito T., 2008, J JAPANESE SOC SOIL, V109, P15; Suzuki S, 2015, PLANT SPEC BIOL, V30, P63, DOI 10.1111/1442-1984.12067; Suzuki S, 2008, ECOL RES, V23, P641, DOI 10.1007/s11284-007-0422-8; Torii A., 2007, J ENV INFORM SCI, V35, P80; Tsukamoto Y., 1998, CONSERVATION FOREST; Umemura M, 2014, PLANT SPEC BIOL, DOI [10.1111/1442-1984.12038, DOI 10.1111/1442-1984.12038]; Wang YL, 2010, J FOREST RES-JPN, V15, P241, DOI 10.1007/s10310-010-0184-y; WANG YH, 1995, HYDROL PROCESS, V9, P797, DOI 10.1002/hyp.3360090706; Yokoos K, 2005, KYUSHU J FOREST RES, V58, P195	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0913-557X	1442-1984		PLANT SPEC BIOL	Plant Spec. Biol.	APR	2015	30	2					96	103		10.1111/1442-1984.12076		8	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CF8JG	WOS:000352803700002		
J	Fukuzawa, K; Shibata, H; Takagi, K; Satoh, F; Koike, T; Sasa, K				Fukuzawa, Karibu; Shibata, Hideaki; Takagi, Kentaro; Satoh, Fuyuki; Koike, Takayoshi; Sasa, Kaichiro			Roles of dominant understory Sasa bamboo in carbon and nitrogen dynamics following canopy tree removal in a cool-temperate forest in northern Japan	PLANT SPECIES BIOLOGY			English	Article						biomass; fine roots; nitrogen leaching; soil respiration; soil solution	BETULA-ERMANII FOREST; FINE-ROOT DYNAMICS; DWARF BAMBOO; SOIL; KURILENSIS; VEGETATION; ECOSYSTEM; REGENERATION; SENANENSIS; LITTERFALL	To clarify the role of dense understory vegetation in the stand structure, and in carbon (C) and nitrogen (N) dynamics of forest ecosystems with various conditions of overstory trees, we: (i) quantified the above- and below-ground biomasses of understory dwarf bamboo (Sasa senanensis) at the old canopy-gap area and the closed-canopy area and compared the stand-level biomasses of S.senanensis with that of overstory trees; (ii) determined the N leaching, soil respiration rates, fine-root dynamics, plant area index (PAI) of S. senanensis, and soil temperature and moisture at the tree-cut patches (cut) and the intact closed-canopy patches (control). The biomass of S. senanensis in the canopy-gap area was twice that at the closed-canopy area. It equated to 12% of total biomass above ground but 41% below ground in the stand. The concentrations of NO3- and NH4+ in the soil solution and soil respiration rates did not significantly change between cut and control plots, indicating that gap creation did not affect the C or N dynamics in the soil. Root-length density and PAI of S. senanensis were significantly greater at the cut plots, suggesting the promotion of S. senanensis growth following tree cutting. The levels of soil temperature and soil moisture were not changed following tree cutting. These results show that S. senanensis is a key component species in this cool-temperate forest ecosystem and plays significant roles in mitigating the loss of N and C from the soil following tree cutting by increasing its leaf and root biomass and stabilizing the soil environment.	[Fukuzawa, Karibu; Shibata, Hideaki; Takagi, Kentaro; Satoh, Fuyuki; Koike, Takayoshi; Sasa, Kaichiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Northern Forestry & Dev Off, Nayoro, Hokkaido, Japan	Fukuzawa, K (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Northern Forestry & Dev Off, Nayoro, Hokkaido, Japan.	caribu@fsc.hokudai.ac.jp	Takagi, Kentaro/C-2222-2012		JSPS KAKENHI [22248016]	This study was conducted in the Teshio Experimental Forest of Hokkaido University (Northern Hokkaido Forest), which is a JaLTER core site, as part of the CC-LaG (Carbon Cycle and Larch Growth) collaboration between the National Institute for Environmental Studies, Hokkaido Electric Power Co., Inc., and Hokkaido University. We are grateful to the staff at the forest for supporting our field work. This study was supported in part by JSPS KAKENHI (No. 22248016).	HENDRICKS JJ, 1993, TRENDS ECOL EVOL, V8, P174, DOI 10.1016/0169-5347(93)90143-D; MATTSON KG, 1989, BIOL FERT SOILS, V7, P247, DOI 10.1007/BF00709656; EWEL KC, 1987, CAN J FOREST RES, V17, P325, DOI 10.1139/x87-054; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.1890/1540-9295(2005)003[0421:UVAAFE]2.0.CO;2; YARIE J, 1980, ECOLOGY, V61, P1498, DOI 10.2307/1939057; Ohtsuka T, 2007, ECOSYSTEMS, V10, P324, DOI 10.1007/s10021-007-9017-z; Tripathi SK, 2006, BIOL FERT SOILS, V43, P237, DOI 10.1007/s00374-006-0100-y; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Takagi K, 2009, GLOBAL CHANGE BIOL, V15, P1275, DOI 10.1111/j.1365-2486.2008.01795.x; McGuire JP, 2001, CAN J FOREST RES, V31, P765, DOI 10.1139/cjfr-31-5-765; Schroeer AE, 1999, ECOSCIENCE, V6, P548; MARKS PL, 1972, SCIENCE, V176, P914, DOI 10.1126/science.176.4037.914; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; PARSONS WFJ, 1994, CAN J FOREST RES, V24, P1531, DOI 10.1139/x94-200; Noguchi M, 2004, FOREST ECOL MANAG, V190, P335, DOI 10.1016/j.foreco.2003.10.024; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Food and Agriculture Organization, 1988, WORLD SOIL RES REP; Fukushima K., 2014, PLANT SPEC BIOL, V30, P81; Fukuzawa K, 2007, ECOL RES, V22, P485, DOI 10.1007/s11284-006-0031-y; Fukuzawa K, 2006, FOREST ECOL MANAG, V225, P257, DOI 10.1016/j.foreco.2006.01.001; Fukuzawa K., 2007, THESIS HOKKAIDO U; Jones RH, 2003, OECOLOGIA, V134, P132, DOI 10.1007/s00442-002-1098-y; Karizumi N, 1974, B GOV FOR EXP STA, V267, P1; Kobayashi T, 2015, PLANT SPEC BIOL, V30, P42, DOI 10.1111/1442-1984.12075; Kobayashi Tsuyoshi, 2004, Plant Species Biology, V19, P33, DOI 10.1111/j.1442-1984.2004.00099.x; Moore PT, 2007, CAN J FOREST RES, V37, P2689, DOI 10.1139/X07-115; NAKASHIZUKA T, 1988, Ecological Research, V3, P21, DOI 10.1007/BF02348692; Nishimura Noboru, 2004, Japanese Journal of Ecology (Otsu), V54, P143; Oshima Y., 1961, Bot. Mag., V74, P280; Sakai T, 2005, AGR FOREST METEOROL, V134, P60, DOI 10.1016/j.agrformet.2005.11.004; Sakai T, 2006, FOREST ECOL MANAG, V236, P259, DOI 10.1016/j.foreco.2006.09.022; Satomura T, 2006, ECOL RES, V21, P741, DOI 10.1007/s11284-006-0182-x; Satomura T., 2007, Plant Root, V1, P34, DOI 10.3117/plantroot.1.34; Shugart HH, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000993; Stuefer J. F., 2002, ECOLOGY EVOLUTIONARY, P223; Takagi K., 2010, Eurasian Journal of Forest Research, V13-1, P1; Takahashi K, 2003, ECOL RES, V18, P767, DOI 10.1007/s11284-003-0594-9; Toyooka H., 1985, T M HOKKAIDO BRANCH, V34, P89; Tripathi SK, 2006, ECOL RES, V21, P315, DOI 10.1007/s11284-005-0119-9; Tripathi SK, 2005, FOREST ECOL MANAG, V212, P278, DOI 10.1016/j.foreco.2005.03.030; Vitousek P. M., 1979, FOREST SCI, V25, P615	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0913-557X	1442-1984		PLANT SPEC BIOL	Plant Spec. Biol.	APR	2015	30	2					104	115		10.1111/1442-1984.12086		12	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CF8JG	WOS:000352803700003		
J	Nagata, S; Yamaji, K; Nomura, N; Ishimoto, H				Nagata, Satoshi; Yamaji, Keiko; Nomura, Nobuhiko; Ishimoto, Hiroshi			Root endophytes enhance stress-tolerance of Cicuta virosa L. growing in a mining pond of eastern Japan	PLANT SPECIES BIOLOGY			English	Article						Cicuta virosaL; endophytes; heavy metal; mine; pond	MEDIATED IRON UPTAKE; PSEUDOMONAS-AERUGINOSA; CONTAMINATED SOILS; INDOLEACETIC-ACID; WATER HEMLOCK; SIDEROPHORE; GROWTH; PHYTOSTABILIZATION; BACTERIA; METALS	Cicuta virosaL. plants can grow in a pond subjected to heavy-metal inputs at the Hitachi mine, eastern Japan. They accumulate heavy-metal elements, especially high concentrations of zinc (Zn), in their roots. We focused on the role that root bacterial endophytes play in the heavy-metal uptake of plants and the provision of heavy-metal tolerance within plants. Our purpose was to clarify the effects of endophytes on: (i) Zn accumulation in C.virosa roots; (ii) growth of C.virosa seedlings; and (iii) heavy-metal tolerance of C.virosa plants. Root endophytic Pseudomonas putida and Rhodopseudomonas sp., which induced the high production of Zn-chelating compounds, were selected for the seedling inoculation test. The results of the inoculation test demonstrated that both strains of endophytes increased Zn accumulation in C.virosa roots by solubilizing Zn in the sediment. Both strains also increased the growth of seedlings by possible production of indole-3-acetic acid in the plant. The heavy-metal tolerance of C.virosa seedlings was likely promoted by producing metal-chelating compounds that detoxify the metals in the plant tissues, and by decreasing the heavy-metal contents in the tissues via rapid seedling growth. Thus, such mutualistic interactions between plants and bacteria contribute to the persistence of C.virosa in this severe environment.	[Nagata, Satoshi; Yamaji, Keiko; Nomura, Nobuhiko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ishimoto, Hiroshi] Mitsui Chem Agro, Res Dev Div, Agrochem Res Ctr, Tokyo, Japan	Yamaji, K (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	yamaji.keiko.fp@u.tsukuba.ac.jp					Ajima M., 1999, ACTINIA, V12, P159; Brunetti G, 2009, PLANT SOIL, V318, P285, DOI 10.1007/s11104-008-9838-3; Mendez MO, 2008, ENVIRON HEALTH PERSP, V116, P278, DOI 10.1289/ehp.10608; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Broadley M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P191, DOI 10.1016/B978-0-12-384905-2.00007-8; McGrath SP, 2003, CURR OPIN BIOTECH, V14, P277, DOI 10.1016/S0958-1669(03)00060-0; Whiting SN, 2001, ENVIRON SCI TECHNOL, V35, P3144, DOI 10.1021/es001938v; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Ma Y, 2011, BIOTECHNOL ADV, V29, P248, DOI 10.1016/j.biotechadv.2010.12.001; Brooks RR, 1998, TRENDS PLANT SCI, V3, P359, DOI 10.1016/S1360-1385(98)01283-7; Frerot H, 2006, PLANT SOIL, V282, P53, DOI 10.1007/s11104-005-5315-4; Schep LJ, 2009, CLIN TOXICOL, V47, P270, DOI 10.1080/15563650902904332; Appendino G, 2009, J NAT PROD, V72, P962, DOI 10.1021/np8007717; Baysse C, 2000, MICROBIOL-UK, V146, P2425; Boyd R. S., 1992, P279; BUYER JS, 1989, BIOL FERT SOILS, V8, P97; Committee of Soil Environment Analysis, 1997, METH SOIL ENV AN; Cornelis P, 2002, ENVIRON MICROBIOL, V4, P787, DOI 10.1046/j.1462-2920.2002.00369.x; Cornelis Pierre, 2007, V12, P193; FONES H, 2010, PLOS PATHOG, V6, DOI DOI 10.1371/J0URNAL.PPAT.1001093; GLICK BR, 1995, CAN J MICROBIOL, V41, P109; Hata K., 1997, T MYCOL SOC JPN, V38, P110; Jacobson CA, 1915, J AM CHEM SOC, V37, P916, DOI 10.1021/ja02169a021; Japan Wildlife Research Center, 2010, RED LIST THREAT SPEC; Kamiga M., 2003, J GEOLOGICAL SOC JAP, V109, P533; Kubota M., 1986, JPN J SOIL SCI PLANT, V57, P142; Lane D. J., 1991, NUCL ACID TECHNIQUES, V4, P115, DOI DOI 10.1002/JOBM.3620310616; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lee KH, 2008, J MICROBIOL, V46, P641, DOI 10.1007/s12275-008-0159-2; MOODY MD, 1984, ARCH BIOCHEM BIOPHYS, V234, P178, DOI 10.1016/0003-9861(84)90339-4; Nagata S, 2014, THESIS U TSUKUBA IBA; Review Committee on Rare and Wild Flora and Fauna in Kumamoto Prefecture, 2009, RED DAT BOOK KUM 200; Sebat JL, 2001, APPL ENVIRON MICROB, V67, P3934, DOI 10.1128/AEM.67.9.3934-3942.2001; Smith S. E., 2008, MYCORRHIZAL SYMBIOSI, P523; Tsuda S., 1993, J PHYTOGEOGRAPHY TAX, V41, P85; VISCA P, 1992, APPL ENVIRON MICROB, V58, P2886; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Zaets I., 2012, TOXICITY HEAVY METAL, P203	41	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0913-557X	1442-1984		PLANT SPEC BIOL	Plant Spec. Biol.	APR	2015	30	2					116	125		10.1111/1442-1984.12039		10	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CF8JG	WOS:000352803700004		
J	Mishio, M; Kawakubo, N				Mishio, Masako; Kawakubo, Nobumitsu			Variations in leaf morpho-anatomy and photosynthetic traits between sun and shade populations of Eurya japonica (Pentaphylacaceae) whose seeds are dispersed by birds across habitats	PLANT SPECIES BIOLOGY			English	Article						chlorophyll fluorescence; leaf lamina thickness; leaf nitrogen concentration; leaf tissue density; stomatal density	TEMPERATE RAIN-FOREST; PLANTAGO-LANCEOLATA; SILENE LATIFOLIA; YAKUSHIMA ISLAND; LIGHT-INTENSITY; JAPAN; IRRADIANCE; LEAVES; TREE; REGENERATION	Eurya japonica occurs in diverse light environments through seed dispersal by birds. As the seed size is extremely small, we hypothesized that newly germinated seedlings with restricted depth of roots and length of the hypocotyl would suffer high mortality due to increased transpiration in sunny habitats and low light in shady habitats. We also expected that surviving seedlings would differ in leaf traits between habitats as a result of selection. We aimed to determine how photosynthetic traits differ between habitats and how leaf structure is related to this difference. We examined photosynthesis and leaf morpho-anatomy for plants cloned from cuttings collected from the forest understory (shade population) and neighboring roadsides and cut-over areas (sun population) and then grown under two irradiances (18.5% and 100% sunlight) in an experimental garden. Under growth in 100% sunlight, cloned plants from the sun population exhibited significantly greater area-based photosynthetic capacity compared to cloned plants from the shade population at a comparable stomatal conductance, which was attributable to a higher area-based leaf nitrogen concentration. On the other hand, mean values of photosynthetic capacity did not significantly differ between the two populations. Cloned plants from the sun population had significantly thicker leaf laminas and spongy tissue and lower stomatal density compared to cloned plants from the shade population. Thickened leaf lamina might have increased leaf tolerance to physical stresses in open habitats. The variation in leaf morpho-anatomy between the two populations can be explained in terms of the economy of leaf photosynthetic tissue.	[Mishio, Masako; Kawakubo, Nobumitsu] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan	Kawakubo, N (reprint author), Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan.	kawakubo@gifu-u.ac.jp			JSPS KAKENHI [23657065]	We thank Yuko T. Hanba for helpful comments and suggestions on this work. This work was supported partly by grants-in-aid from JSPS KAKENHI (No. 23657065).	Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Arntz AM, 2001, OECOLOGIA, V127, P455, DOI 10.1007/s004420100650; Saldana A, 2007, EVOL ECOL, V21, P651, DOI 10.1007/s10682-006-9143-7; Osada N, 2003, ECOL RES, V18, P711, DOI 10.1111/j.1440-1703.2003.00590.x; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Laporte MM, 1996, OECOLOGIA, V106, P63; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Niinemets U, 2009, J EXP BOT, V60, P2249, DOI 10.1093/jxb/erp036; HEYWOOD JS, 1991, ANNU REV ECOL SYST, V22, P335, DOI 10.1146/annurev.es.22.110191.002003; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87; DAWSON TE, 1993, ECOLOGY, V74, P798, DOI 10.2307/1940807; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; BJORKMAN O, 1963, PHYSIOL PLANTARUM, V16, P889, DOI 10.1111/j.1399-3054.1963.tb08366.x; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Cao KF, 2000, CAN J BOT, V78, P1245, DOI 10.1139/cjb-78-10-1245; GAUHL E, 1976, OECOLOGIA, V22, P275, DOI 10.1007/BF00344797; GEHRING JL, 1994, AM J BOT, V81, P166, DOI 10.2307/2445630; Goto Y, 1996, VEGETATIO, V122, P157, DOI 10.1007/BF00044698; Hirata R., 2006, Journal of the Japanese Forest Society, V88, P515, DOI 10.4005/jjfs.88.515; Hosogi D, 2006, ECOL ENG, V26, P123, DOI 10.1016/j.ecoleng.2005.06.014; JACKSON LWR, 1967, ECOLOGY, V48, P498, DOI 10.2307/1932686; Kamijo T, 2002, FOLIA GEOBOT, V37, P71, DOI 10.1007/BF02803192; KOHYAMA T, 1994, FUNCT ECOL, V8, P229, DOI 10.2307/2389906; Lambers H., 1998, PLANT PHYSL ECOLOGY; Leishman M. R., 2000, SEEDS ECOLOGY REGENE, V2, P31, DOI DOI 10.1016/J.MOLP.2015.01.015; Manabe T., 1991, J JPN SOC REVEGET TE, V17, P27; Mishio M, 2007, PLANT SPEC BIOL, V22, P117, DOI 10.1111/j.1442-1984.2007.00183.x; MURATA H, 1991, Journal of Japanese Botany, V66, P229; Nitta I, 1997, PLANT ECOL, V130, P71, DOI 10.1023/A:1009735709258; OSMOND CB, 1990, BOT ACTA, V103, P226; Pigliucci M., 2001, PHENOTYPIC PLASTICIT; Sims DA, 1998, NEW PHYTOL, V140, P75, DOI 10.1046/j.1469-8137.1998.00248.x; Suzuki AA, 2005, AM J BOT, V92, P2003, DOI 10.3732/ajb.92.12.2003; SUZUKI E, 1987, BOT MAG TOKYO, V100, P223, DOI 10.1007/BF02492832; TAGAWA H, 1965, JPN J BOT, V19, P127; TERAMURA AH, 1979, CAN J BOT, V57, P2559; Terashima I., 2010, PLANT PHYSIOL, V155, P108; Tsujino R, 2004, ECOL RES, V19, P291, DOI 10.1111/j.1440-1703.2004.00638.x; Tuyama T., 1989, WILD FLOWERS JAPAN W, P138; Uto Seiichiro, 2002, Japanese Journal of Ecology (Otsu), V52, P11	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0913-557X	1442-1984		PLANT SPEC BIOL	Plant Spec. Biol.	APR	2015	30	2					147	158		10.1111/1442-1984.12045		12	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CF8JG	WOS:000352803700007		
J	Itagaki, T; Kimura, MK; Lian, C; Sakai, S				Itagaki, Tomoyuki; Kimura, Megumi K.; Lian, Chunlan; Sakai, Satoki			Development of microsatellite markers for Aquilegia buergeriana var. oxysepala (Ranunculaceae), a vulnerable Japanese herb	PLANT SPECIES BIOLOGY			English	Article						Aquilegia buergeriana var; oxysepala; Ranunculaceae; simple sequence repeat; vulnerable plant species		Aquilegia buergeriana var. oxysepala is a vulnerable herb, for which 20 microsatellite markers were developed. The applicability of these markers was confirmed by genotyping of 66 individuals collected from four natural populations in Japan. Of the 20 loci, 15 showed polymorphism. For the 15 polymorphic markers, the number of alleles per locus ranged from 2 to 12, and the expected and observed heterozygosities ranged from 0.13 to 0.77 and 0.02 to 0.65, respectively. The markers described here are sufficiently polymorphic and informative to investigate the genetic diversity and population genetic structure of A. buergeriana var. oxysepala.	[Itagaki, Tomoyuki; Sakai, Satoki] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Kimura, Megumi K.; Lian, Chunlan] Univ Tokyo, Asian Nat Environm Sci Ctr, Tokyo, Japan	Itagaki, T (reprint author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	itagakitomo@gmail.com					SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Lian CL, 2003, MOL ECOL, V12, P609, DOI 10.1046/j.1365-294X.2003.01756.x; Goudet J, 1995, J HERED, V86, P485; Lian CL, 2006, J PLANT RES, V119, P415, DOI 10.1007/s10265-006-0274-2; Itagaki T, 2006, AM J BOT, V93, P1320, DOI 10.3732/ajb.93.9.1320; Lian C, 2002, MOL ECOL NOTES, V2, P211, DOI 10.1046/j.1471-8278.2002.00213.x; Fu D. -Z., 2001, FLORA CHINA, V6, P279; Kadota Y., 2006, FLORA OF JAPAN A, V2a, P328; Luferov A. N., 1995, PLANTAE VASCULARES O, V7, P27; Tokyo Metropolitan Government, 2010, 2010 RED LIST THREAT	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0913-557X	1442-1984		PLANT SPEC BIOL	Plant Spec. Biol.	APR	2015	30	2					159	162		10.1111/1442-1984.12044		4	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CF8JG	WOS:000352803700008		
J	Faria, T; Muroya, Y				Faria, Teresa; Muroya, Yoshiaki			Global attractivity and extinction for Lotka-Volterra systems with infinite delay and feedback controls	PROCEEDINGS OF THE ROYAL SOCIETY OF EDINBURGH SECTION A-MATHEMATICS			English	Article							INSTANTANEOUS NEGATIVE FEEDBACKS; POSITIVE PERIODIC-SOLUTION; COMPETITION SYSTEM; STABILITY; PERMANENCE; EXISTENCE; EQUATIONS	The paper deals with a multiple species Lotka-Volterra model with infinite distributed delays and feedback controls, for which we assume a weak form of diagonal dominance of the instantaneous negative intra-specific terms over the infinite delay effect in both the population variables and controls. General sufficient conditions for the existence and attractivity of a saturated equilibrium are established. When the saturated equilibrium is on the boundary of R-+(n), sharper criteria for the extinction of all or part of the populations are given. While the literature usually treats the case of competitive systems only, here no restrictions on the signs of the intra-and inter-specific delayed terms are imposed. Moreover, our technique does not require the construction of Lyapunov functionals.	[Faria, Teresa] Univ Lisbon, Fac Ciencias, Dept Matemat, P-1749016 Lisbon, Portugal; [Faria, Teresa] Univ Lisbon, Fac Ciencias, Ctr Matemat & Aplicacoes Fundamentals, P-1749016 Lisbon, Portugal; [Muroya, Yoshiaki] Waseda Univ, Dept Math, Shinjuku Ku, Tokyo 1698555, Japan	Faria, T (reprint author), Univ Lisbon, Fac Ciencias, Dept Matemat, P-1749016 Lisbon, Portugal.	teresa.faria@fc.ul.pt; ymuroya@waseda.jp			Fundacao para a Ciencia e a Tecnologia (Portugal) [PEst-OE/MAT/UI0209/2013]; Japan Society for the Promotion of Science [24540219]	The research of T.F. was supported by Fundacao para a Ciencia e a Tecnologia (Portugal) (Grant no. PEst-OE/MAT/UI0209/2013) and the research of Y.M. was supported by Scientific Research (c) (Grant no. 24540219) of the Japan Society for the Promotion of Science.	Gopalsamy K, 2003, COMPUT MATH APPL, V45, P665, DOI 10.1016/S0898-1221(03)00026-9; Li Z, 2013, NONLINEAR ANAL-REAL, V14, P402, DOI 10.1016/j.nonrwa.2012.07.004; Chen FD, 2006, NONLINEAR ANAL-REAL, V7, P133, DOI 10.1016/j.nonrwa.2005.01.006; Campbell SA, 2008, NONLINEARITY, V21, P2671, DOI 10.1088/0951-7715/21/11/010; COOKE KL, 1982, J MATH ANAL APPL, V86, P592, DOI 10.1016/0022-247X(82)90243-8; Nie LL, 2009, MATH COMPUT MODEL, V49, P295, DOI 10.1016/j.mcm.2008.05.004; de Oca FM, 2006, NONLINEAR ANAL-REAL, V7, P1042, DOI 10.1016/j.nonrwa.2005.09.005; Faria T, 2008, J DIFFER EQUATIONS, V244, P1049, DOI 10.1016/j.jde.2007.12.005; Shi CL, 2012, NONLINEAR ANAL-REAL, V13, P2214, DOI 10.1016/j.nonrwa.2012.01.016; Berman A., 1979, NONNEGATIVE MATRICES; Faria T, 2011, APPL MATH COMPUT, V217, P9646, DOI 10.1016/j.amc.2011.04.049; Faria T, 2010, J DYN DIFFER EQU, V22, P299, DOI 10.1007/s10884-010-9166-1; Fiedler M., 1986, SPECIAL MATRICES AND; Haddock J., 1988, FUNKC EKVACIOJ-SER I, V31, P349; HADDOCK JR, 1989, TOHOKU MATH J, V41, P689, DOI 10.2748/tmj/1178227739; Hale J., 1978, FUNKC EKVACIOJ-SER I, V21, P11; Hale J. K., 1988, ASYMPTOTIC BEHAVIOR; Hino Y., 1993, FUNCTIONAL DIFFERENT; Hotbauer J., 1988, THE THEORY OF EVOLUT; KUANG Y, 1995, J DIFFER EQUATIONS, V119, P503, DOI 10.1006/jdeq.1995.1100; MILLER RK, 1966, SIAM J APPL MATH, V14, P446, DOI 10.1137/0114039; Muroya Y, 2003, DYNAM SYST APPL, V12, P295; Smith H.L., 1995, MONOTONE DYNAMICAL S; TABOAS P, 1990, P ROY SOC EDINB A, V116, P85; Weng PX, 2000, COMPUT MATH APPL, V40, P747, DOI 10.1016/S0898-1221(00)00193-0; Xiao DM, 2001, J DIFFER EQUATIONS, V176, P494, DOI 10.1006/jdeq.2000.3982; Xu R, 2002, APPL ANAL, V80, P107; Zhang ZQ, 2008, MATH COMPUT MODEL, V48, P749, DOI 10.1016/j.mcm.2007.10.015	28	2	2	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0308-2105	1473-7124		P ROY SOC EDINB A	Proc. R. Soc. Edinb. Sect. A-Math.	APR	2015	145	2					301	330		10.1017/S0308210513001194		30	Mathematics, Applied; Mathematics	Mathematics	CF3UP	WOS:000352474500003		
J	Baramee, S; Phitsuwan, P; Waeonukul, R; Pason, P; Tachaapaikoon, C; Kosugi, A; Ratanakhanokchai, K				Baramee, Sirilak; Phitsuwan, Paripok; Waeonukul, Rattiya; Pason, Patthra; Tachaapaikoon, Chakrit; Kosugi, Akihiko; Ratanakhanokchai, Khanok			Alkaline xylanolytic-cellulolytic multienzyme complex from the novel anaerobic alkalithermophilic bacterium Cellulosibacter alkalithermophilus and its hydrolysis of insoluble polysaccharides under neutral and alkaline conditions	PROCESS BIOCHEMISTRY			English	Article						Anaerobic alkalithermophilic bacterium; Cellulosibacter alkalithermophilus; Insoluble polysaccharide; Multienzyme complex; Xylanolytic-cellulolytic enzymes	CURDLANOLYTICUS STRAIN B-6; CLOSTRIDIUM-THERMOCELLUM; MOLECULAR-CLONING; XYLANASE; PURIFICATION; CELLULASE; ENZYME; CELLULOSOME; BINDING; DEGRADATION	The multienzyme complex of the novel anaerobic alkalithermophilic bacterium Cellulosibacter alkalithermophilus was isolated by a corn hull column and Sephacryl S-500 gel filtration chromatography. The isolated multienzyme complex showed a single band upon native-polyacrylamide gel electrophoresis (native-PAGE). The molecular weight of the isolated multienzyme complex was greater than 2000 kDa. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) revealed at least 19 proteins bands in the multienzyme complex with predominantly xylanase activity (at least 9 xylanases) and with beta-xylosidase, arabinofuranosidase, acetyl esterase, carboxymethylcellulase (CMCase) (at least 5 CMCases), avicelase, cellobiohydrolase, and beta-glucosidase activities. The multienzyme complex was active and stable under neutral and alkaline pH ranges at high temperature. Moreover, the multienzyme complex also showed effective hydrolysis of xylan, cellulose, and untreated corn hull and rice straw to monosaccharides, xylose and glucose. These results revealed that C. alkalithermophilus produces an alkali-tolerant thermophilic xylanolytic-cellulolytic multienzyme complex, which has never been reported in the genus Cellulosibacter. (C) 2015 Elsevier Ltd. All rights reserved.	[Baramee, Sirilak; Phitsuwan, Paripok; Ratanakhanokchai, Khanok] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bangkok 10150, Thailand; [Waeonukul, Rattiya; Pason, Patthra; Tachaapaikoon, Chakrit] King Mongkuts Univ Technol Thonburi, Pilot Plant Dev & Training Inst, Bangkok 10150, Thailand; [Kosugi, Akihiko] Japan Int Res Ctr Agr Sci, Biol Resources & Postharvest Div, Tsukuba, Ibaraki 3058686, Japan	Ratanakhanokchai, K (reprint author), King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bangkok 10150, Thailand.	khanok.rat@kmutt.ac.th			Royal Golden jubilee Ph.D. program of the Thailand Research Fund [PHD/0069/2556]; King Mongkut's University of Technology Thonburi, Thailand, under the Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission; Japan International Research Center for Agricultural Sciences	The authors gratefully acknowledge the financial support given by the Royal Golden jubilee Ph.D. program of the Thailand Research Fund (PHD/0069/2556), King Mongkut's University of Technology Thonburi, Thailand, under the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (2014-2015), and the Japan International Research Center for Agricultural Sciences (2014-2015).	Nelson N, 1944, J BIOL CHEM, V153, P375; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Kosugi A, 2002, APPL ENVIRON MICROB, V68, P6399, DOI 10.1128/AEM.68.12.6399-6402.2002; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; LAMED R, 1983, J BACTERIOL, V156, P828; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735; Dong JL, 2010, J MICROBIOL, V48, P393, DOI 10.1007/s12275-010-9361-0; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Rodrigues AC, 2012, BIORESOURCE TECHNOL, V110, P526, DOI 10.1016/j.biortech.2012.01.140; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Gal L, 1997, APPL ENVIRON MICROB, V63, P903; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Beguin P, 1998, BIOCHEM SOC T, V26, P178; Bahkali AH, 1996, BIORESOURCE TECHNOL, V57, P265, DOI 10.1016/S0960-8524(96)00074-0; Chang KL, 2011, BIORESOURCE TECHNOL, V102, P519, DOI 10.1016/j.biortech.2010.09.060; Chimtong S, 2014, BIORESOURCES, V9, P2471; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Ellis J, 2012, ISRN MICROBIOL, V2012, P1, DOI [DOI 10.5402/2012/517524, 10.5402/2012/517524]; Hou PB, 2006, ENZYME MICROB TECH, V38, P273, DOI 10.1016/j.enzmictec.2004.08.044; Jiang ZQ, 2004, BIOTECHNOL LETT, V26, P431, DOI 10.1023/B:BILE.0000018266.75248.03; Ko CH, 2010, PROCESS BIOCHEM, V45, P1638, DOI 10.1016/j.procbio.2010.06.015; KOHRING S, 1990, APPL ENVIRON MICROB, V56, P3798; Lopez-Fernandez CL, 1998, APPL MICROBIOL BIOT, V50, P284; Ohtsuki T, 2005, LETT APPL MICROBIOL, V40, P111, DOI 10.1111/j.1472-765X.2004.01644.x; Pai CK, 2010, APPL MICROBIOL BIOT, V85, P1451, DOI 10.1007/s00253-009-2175-5; Pason P, 2006, APPL ENVIRON MICROB, V72, P2483, DOI 10.1128/AEM.72.4.2483-2490.2006; Phitsuwan P, 2010, J MICROBIOL BIOTECHN, V20, P893, DOI 10.4014/jmb.0911.11025; POHLSCHRODER M, 1994, J BACTERIOL, V176, P70; Sajjakulnukit B, 2005, BIOMASS BIOENERG, V29, P214, DOI 10.1016/j.biombioe.2005.03.009; Sanchez MM, 2003, EUR J BIOCHEM, V270, P2913, DOI 10.1046/j.1432-1033.2003.03673.x; Sornyotha S, 2007, FOOD CHEM, V104, P1750, DOI 10.1016/j.foodchem.2006.10.071; Tachaapaikoon C, 2012, BIODEGRADATION, V23, P57, DOI 10.1007/s10532-011-9486-9; Tachaapaikoon C, 2006, PROCESS BIOCHEM, V41, P2441, DOI 10.1016/j.procbio.2006.07.004; Turner P., 2007, MICROB CELL FACT, V6, P1; van Dyk JS, 2009, ENZYME MICROB TECH, V45, P372, DOI 10.1016/j.enzmictec.2009.06.016; Waeonukul R, 2008, BIOSCI BIOTECH BIOCH, V72, P321, DOI 10.1271/bbb.70333; Watthanalamloet A, 2012, INT J SYST EVOL MICR, V62, P2330, DOI 10.1099/ijs.0.027854-0	41	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-5113	1873-3298		PROCESS BIOCHEM	Process Biochem.	APR	2015	50	4					643	650		10.1016/j.procbio.2015.01.019		8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering, Chemical	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering	CG1YW	WOS:000353073100017		
J	Zargar, SM; Kurata, R; Inaba, S; Oikawa, A; Fukui, R; Ogata, Y; Agrawal, GK; Rakwal, R; Fukao, Y				Zargar, Sajad Majeed; Kurata, Rie; Inaba, Shoko; Oikawa, Akira; Fukui, Risa; Ogata, Yoshiyuki; Agrawal, Ganesh Kumar; Rakwal, Randeep; Fukao, Yoichiro			Quantitative proteomics of Arabidopsis shoot microsomal proteins reveals a cross-talk between excess zinc and iron deficiency	PROTEOMICS			English	Article						Arabidopsis; Excess Zn; Fe deficiency; iTRAQ-OFFGEL; Plant proteomics; Sugar	SINK REGULATION; CELL-WALL; TRANSPORTER; EXPRESSION; PLANTS; SUGAR; PHOTOSYNTHESIS; CARBOHYDRATE; INVERTASE; GROWTH	Iron (Fe) deficiency significantly effects plant growth and development. Plant symptoms under excess zinc (Zn) resemble symptoms of Fe-deficient plants. To understand cross-talk between excess Zn and Fe deficiency, we investigated physiological parameters of Arabidopsis plants and applied iTRAQ-OFFGEL quantitative proteomic approach to examine protein expression changes in microsomal fraction from Arabidopsis shoots under those physiological conditions. Arabidopsis plants manifested shoot inhibition and chlorosis symptoms when grown on Fe-deficient media compared to basal MGRL solid medium. iTRAQ-OFFGEL approach identified 909 differentially expressed proteins common to all three biological replicates; the majority were transporters or proteins involved in photosynthesis, and ribosomal proteins. Interestingly, protein expression changes between excess Zn and Fe deficiency showed similar pattern. Further, the changes due to excess Zn were dramatically restored by the addition of Fe. To obtain biological insight into Zn and Fe cross-talk, we focused on transporters, where STP4 and STP13 sugar transporters were predominantly expressed and responsive to Fe-deficient conditions. Plants grown on Fe-deficient conditions showed significantly increased level of sugars. These results suggest that Fe deficiency might lead to the disruption of sugar synthesis and utilization.	[Zargar, Sajad Majeed; Inaba, Shoko; Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Global Educ Project, Nara 6300192, Japan; [Zargar, Sajad Majeed] SK Univ Agr Sci & Technol, Sch Biotechnol, Jammu, Jammu & Kashmir, India; [Kurata, Rie; Fukao, Yoichiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Oikawa, Akira] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata, Japan; [Fukui, Risa; Ogata, Yoshiyuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 591, Japan; [Agrawal, Ganesh Kumar; Rakwal, Randeep] Res Lab Biotechnol & Biochem RLABB, Kathmandu, Nepal; [Agrawal, Ganesh Kumar; Rakwal, Randeep] GRADE Acad Pvt Ltd, Birgunj, Nepal; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki, Japan	Fukao, Y (reprint author), Nara Inst Sci & Technol, Plant Global Educ Project, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	fukao@bs.naist.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19039022]; Nara Institute of Science and Technology - Ministry of Education, Culture, Sports, Science and Technology, Japan; DBT, New Delhi, India; Japan Advanced Plant Science Network	This work was supported by a Grant-in-Aid for Organelle Differentiation as the Strategy for Environmental Adaptation in Plants for Scientific Research of Priority Areas (No. 19039022 to Y.F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Grant-in-Aid for Scientific Research from Nara Institute of Science and Technology supported by The Ministry of Education, Culture, Sports, Science and Technology, Japan. S.M.Z. acknowledges the DBT, New Delhi, India for award of CREST, Overseas fellowship. This research was supported by Japan Advanced Plant Science Network. Authors appreciate the INPPO initiative (www.inppo.com) for connecting plant proteomic researchers between India and Japan.	Agrawal G. K., 2008, PLANT PROTEOMICS TEC; KRAPP A, 1993, PLANT J, V3, P817, DOI 10.1111/j.1365-313X.1993.00817.x; Sugimoto M, 2012, J AGR FOOD CHEM, V60, P2586, DOI 10.1021/jf2048993; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Roitsch T, 1999, CURR OPIN PLANT BIOL, V2, P198, DOI 10.1016/S1369-5266(99)80036-3; JANG JC, 1994, PLANT CELL, V6, P1665; Norholm MHH, 2006, FEBS LETT, V580, P2381, DOI 10.1016/j.febslet.2006.03.064; Lemoine R, 2000, BBA-BIOMEMBRANES, V1465, P246, DOI 10.1016/S0005-2736(00)00142-5; Fukao Y, 2011, PLANT PHYSIOL, V155, P1893, DOI 10.1104/pp.110.169730; Fotopoulos V, 2003, PLANT PHYSIOL, V132, P821, DOI 10.1104/pp.103.021428; Jeannette E, 2000, PLANT CELL ENVIRON, V23, P61, DOI 10.1046/j.1365-3040.2000.00519.x; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Shanmugam V, 2013, FRONT PLANT SCI, V4, P1; Timperio AM, 2007, J EXP BOT, V58, P3695, DOI 10.1093/jxb/erm219; VONSCHAEWEN A, 1990, EMBO J, V9, P3033; Zargar S. M., 2013, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.26892	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	APR	2015	15	7					1196	1201		10.1002/pmic.201400467		6	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CF4IL	WOS:000352512100003		
J	Kashihara, J				Kashihara, Jun			EXAMINATION OF STIGMATIZING BELIEFS ABOUT DEPRESSION AND STIGMA-REDUCTION EFFECTS OF EDUCATION BY USING IMPLICIT MEASURES	PSYCHOLOGICAL REPORTS			English	Article							MENTAL-ILLNESS; ASSOCIATION TEST; HELP-SEEKING; ATTITUDES; EXPLICIT; SCHIZOPHRENIA; PROGRAM; MODEL; EXPLANATIONS; ATTRIBUTION	Stigmatizing beliefs about depression have been viewed as a barrier to seeking professional treatments. To reconsider frameworks used in previous research, the present study utilized Brief Implicit Association Tests (BIATs) and examined the following two topics: (i) whether participants tend to hold dangerous beliefs about depression, and (ii) whether stigmatizing beliefs can be reduced through education. Japanese university students (48 women, 82 men; M age = 20.2 yr.) voluntarily participated in the study and were randomly assigned to three conditions in which they received different educational texts (biomedical, psychosocial, and bio-psychosocial). Participants completed repeated assessments (baseline, post-education, and 4-wk. follow-up), in which they were administered BIATs measuring beliefs about being weak-willed and dangerousness of people with depression, along with explicit measures of blameworthiness, dangerous beliefs, and of other related variables. BIATs at baseline indicated that the participants did not tend to hold the belief about dangerousness. There was no significant reduction of beliefs about being weak-willed and dangerousness of people with depression, which were measured by BIATs, after reading the educational texts.	Univ Tokyo, Grad Sch Educ, Dept Clin Psychol, Bunkyo Ku, Tokyo 1130033, Japan	Kashihara, J (reprint author), Univ Tokyo, Grad Sch Educ, Dept Clin Psychol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	junkshr@p.u-tokyo.ac.jp					Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Schlomer GL, 2010, J COUNS PSYCHOL, V57, P1, DOI 10.1037/a0018082; Nieuwsma JA, 2010, J MENT HEALTH, V19, P52, DOI 10.3109/09638230903469095; Corrigan PW, 2012, PSYCHIAT SERV, V63, P963, DOI [10.1176/appi.ps.201100529, 10.1176/appi.ps.005292011]; Lincoln TM, 2008, SCHIZOPHRENIA BULL, V34, P984, DOI 10.1093/schbul/sbm131; [Anonymous], 2012, DEPR GLOB PUBL HLTH; Han DY, 2006, PSYCHIAT CLIN NEUROS, V60, P662, DOI 10.1111/j.1440-1819.2006.01580.x; Maison D, 2004, J CONSUM PSYCHOL, V14, P405, DOI 10.1207/s15327663jcp1404_9; Chan JYN, 2009, SOC SCI MED, V68, P1521, DOI 10.1016/j.socscimed.2009.02.016; Corrigan PW, 2002, SCHIZOPHRENIA BULL, V28, P293; Holmes EP, 1999, SCHIZOPHRENIA BULL, V25, P447; Jorm AF, 2008, BRIT J PSYCHIAT, V192, P144, DOI 10.1192/bjp.bp.107.039404; Angermeyer MC, 2003, SOC PSYCH PSYCH EPID, V38, P526, DOI 10.1007/s00127-003-0676-6; Paykel ES, 1998, BRIT J PSYCHIAT, V173, P519, DOI 10.1192/bjp.173.6.519; O'Driscoll C, 2012, J CHILD PSYCHOL PSYC, V53, P1054, DOI 10.1111/j.1469-7610.2012.02580.x; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; Gilbody S, 2012, BRIT J PSYCHIAT, V200, P442, DOI 10.1192/bjp.bp.111.103598; Rusch N, 2010, PSYCHIAT RES, V179, P328, DOI 10.1016/j.psychres.2009.09.010; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Crisp AH, 2000, BRIT J PSYCHIAT, V177, P4, DOI 10.1192/bjp.177.1.4; Dasgupta N, 2000, J EXP SOC PSYCHOL, V36, P316, DOI 10.1006/jesp.1999.1418; Rusch LC, 2009, J NERV MENT DIS, V197, P104, DOI 10.1097/NMD.0b013e318192416f; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Corrigan P, 2003, J HEALTH SOC BEHAV, V44, P162, DOI 10.2307/1519806; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Gerrits JH, 2009, APPETITE, V53, P407, DOI 10.1016/j.appet.2009.08.008; Corrigan PW, 2010, CLIN PSYCHOL REV, V30, P907, DOI 10.1016/j.cpr.2010.06.004; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Clark D.C., 1992, SUICIDE GUIDELINES A, P16; Cohen J., 1988, STAT POWER ANAL BEHA; Corrigan P. W., 2005, STIGMA MENTAL ILLNES; DAVISON G. C., 2003, ABNORMAL PSYCHOL; Finkelstein J, 2007, INT J MED INFORM, V76, P726, DOI 10.1016/j.ijmedinf.2006.07.004; Goldstein B., 2003, J MENTAL HLTH, V12, P551, DOI DOI 10.1080/09638230310001627919; Hammer JH, 2013, J COUNS PSYCHOL, V60, P83, DOI 10.1037/a0030449; Holmes EK, 1998, PSYCHOL REP, V83, P3, DOI 10.2466/PR0.83.5.3-11; IBM Corp. Released, 2012, IBM SPSS STAT WIND V; MILLISECOND SOFTWARE, 2012, INQ 3 0 6 0; Monteith LL, 2011, J SOC CLIN PSYCHOL, V30, P484; NOSEK BA, 2007, SOCIAL PSYCHOL UNCON, V7, P265; Royston P., 2004, STATA J, V4, P227, DOI DOI 10.1037//1082-989X.7.2.147; Rüsch Nicolas, 2010, Eur Arch Psychiatry Clin Neurosci, V260, P617, DOI 10.1007/s00406-010-0111-4; Sherwood C, 2007, BEHAV COGN PSYCHOTH, V35, P541, DOI 10.1017/S1352465807003815; Stata Corporation, 2011, STAT STAT SOFTW REL; Stuart H, 2006, CAN J PSYCHIAT, V51, P647; Teachman BA, 2006, J SOC CLIN PSYCHOL, V25, P75, DOI 10.1521/jscp.2006.25.1.75; World Health Organization, 2001, MENT HLTH CALL ACT W	48	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0033-2941			PSYCHOL REP	Psychol. Rep.	APR	2015	116	2					337	362		10.2466/15.PR0.116k20w9		26	Psychology, Multidisciplinary	Psychology	CG0SJ	WOS:000352978000002		
J	Watanabe, K; Yokoyama, K; Furukawa, TA				Watanabe, K.; Yokoyama, K. .; Furukawa, T. A.			RELIABILITY AND VALIDITY OF THE JAPANESE VERSION OF THE COPING INVENTORY FOR ADULTS FOR STRESSFUL SITUATIONS IN HEALTHY PEOPLE	PSYCHOLOGICAL REPORTS			English	Article							YOUNG-ADULTS; STYLES; DISORDERS	The present study examined the validity and reliability of the Japanese version of the Coping Inventory for Stressful Situations-2nd Edition T (CISS; hereafter the CISS-J). The participants were 1,268 healthy Japanese individuals. The factor analyses yielded three major scales (task- ,emotion-, and avoidance-oriented coping) corresponding to the original version. In addition, the avoidance-oriented scale of the CISS-J contained two subscales (Distraction and Social diversion), as in the original version. Cronbach's a coefficient was found to be.75-.89 for the three scales and two subscales. Results show that the CISS-J is useful for assessing the coping strategies among this sample of Japanese individuals.	[Watanabe, K.; Yokoyama, K. .] Juntendo Univ, Fac Med, Dept Epidemiol & Environm Hlth, Tokyo 1138421, Japan; [Furukawa, T. A.] Kyoto Univ, Dept Hlth Promot & Human Behav, Kyoto 6068501, Japan; [Furukawa, T. A.] Kyoto Univ, Dept Clin Epidemiol, Kyoto 6068501, Japan	Yokoyama, K (reprint author), Juntendo Univ, Fac Med, Dept Epidemiol & Environm Hlth, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kyokoya@juntendo.ac.jp			Kanekoshobo, Inc.	The authors would like to express sincere appreciation to the participants and stakeholders who cooperated in the present study. This research was supported by Kanekoshobo, Inc., which publishes the CISS-J with the consent of Multi-Health Systems, Inc. (Yokoyama, Furukawa, & Watanabe, 2012).	Cosway R, 2000, J APPL BIOBEHAV RES, V5, P121, DOI 10.1111/j.1751-9861.2000.tb00069.x; Dabrowska A, 2010, J INTELL DISABIL RES, V54, P266, DOI 10.1111/j.1365-2788.2010.01258.x; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Rafnsson FD, 2006, PERS INDIV DIFFER, V40, P1247, DOI 10.1016/j.paid.2005.11.011; Antonovsky A, 1987, UNRAVELING MYSTERY H; Antonovsky A., 1979, HLTH STRESS COPING N; Ariff F, 2011, SINGAP MED J, V52, P29; Berne E, 1964, GAMES PEOPLE PLAY; Calsbeek H, 2006, PSYCHOL HEALTH, V21, P447, DOI 10.1080/14768320500410910; Cui JA, 2009, PSYCHIAT CLIN NEUROS, V63, P147, DOI 10.1111/j.1440-1819.2009.01934.x; Dusay J M, 1977, EGOGRAMS I SEE YOU Y; Endler N. S., 1994, PSYCHOL ASSESSMENT, V6, P50, DOI [10.1037/1040-3590.6.1.50, DOI 10.1037/1040-3590.6.1.50]; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037//0022-3514.58.5.844; Endler N. S., 1999, COPING INVENTORY STR; Endler NS, 1990, COPING INVENTORY STR; Folkman S., 1984, STRESS APPRAISAL COP; Furukawa T, 1993, Seishin Shinkeigaku Zasshi, V95, P602; JAPAN SOCIETY FOR OCCUPATIONAL HEALTH, 2012, MENT HLTH MEAS AR RE; KOHSAKA Y., 2010, B SOCIAL MED JSSM RE, V27, P1; Lazarus R. S., 1999, STRESS EMOTION NEW S; Lewandowska Katarzyna, 2009, Pneumonol Alergol Pol, V77, P31; MINISTRY OF HEALTH LABOUR AND WELFARE, 2013, OV 2012 LAB HLTH SUR; NAGANO J., 2001, JPN J HLTH PROMOTION, V3, P107; Sakano J., 2008, INTRO SENSE COHERENC; Sesar K, 2010, CROAT MED J, V51, P406, DOI 10.3325/cmj.2010.51.406; Stewart I., 1987, TA TODAY NEW INTRO T; Sun KS, 2011, AFR J BUS MANAGE, V5, P2865; Togari T, 2008, JPN J HLTH HUM ECOL, V74, P71; TOKYO DAIGAKU IGAKUBU SINNRYO-NAIKA TEG KENKYU-KAI, 1984, TOK U EG; TOKYO DAIGAKU IGAKUBU SINNRYO-NAIKA TEG KENKYU-KAI, 2006, TOK U EG NEW VER 2; TOKYO DAIGAKU IGAKUBU SINNRYO-NAIKA TEG KENKYU-KAI, 2009, TOK U EG NEW VER 2 K; YAMAZAKI Y., 1999, QUAL NURS, V5, P81; YOKOYAMA K., 2012, COPING INVENTORY STR	34	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0033-2941			PSYCHOL REP	Psychol. Rep.	APR	2015	116	2					447	469		10.2466/08.02.PR0.116k23w6		23	Psychology, Multidisciplinary	Psychology	CG0SJ	WOS:000352978000010		
J	Izawa, S; Miki, K; Tsuchiya, M; Mitani, T; Midorikawa, T; Fuchu, T; Komatsu, T; Togo, F				Izawa, Shuhei; Miki, Keiichi; Tsuchiya, Masao; Mitani, Takeshi; Midorikawa, Toru; Fuchu, Tatsuya; Komatsu, Taiki; Togo, Fumiharu			Cortisol level measurements in fingernails as a retrospective index of hormone production	PSYCHONEUROENDOCRINOLOGY			English	Article						Cortisot; Fingernail; Stress; Hair	HAIR CORTISOL; INTEGRATION	The cortisol Level in fingernails may reflect the hormone's cumulative production over a long period, but the notions have not been fully established. In this study, we investigated the association of cortisol in fingernails with cortisol accumulation over a long period (hair cortisol) and over a relatively short period (salivary cortisol). In study 1, hair and fingernail samples were collected from 58 middle-aged and elderly men. The cortisol level in hair samples was moderately associated with the level in fingernail samples (r=0.29, p < 0.05 and r(5)=0.36, p < 0.01). In study 2, 37 workers provided 4 saliva samples over the course of one day (at awakening, 30 min after awakening, before lunch, and after work) and another set a month later. Further, the workers were asked to provide fingernail samples during a six-month period. We found that the cortisol level in saliva over the whole day (area under the curve for cortisol) was moderately associated with the cortisol level measured in fingernail samples that were collected 4 months (r=0.43, p < 0.05 and r(s)=0.50, p < 0.01) and 5 months later (r=0.45, p < 0.05 and r(s)=0.53, p < 0.01). These results indicated that the cortisol level in fingernail samples might retrospectively represent hormone production during a given period. The cortisol level in fingernail samples may be useful in the investigation of the link between psychosocial stress and health. (C) 2015 Elsevier Ltd. All rights reserved.	[Izawa, Shuhei; Miki, Keiichi; Tsuchiya, Masao] Natl Inst Occupat Safety & Hlth, Hlth Adm & Psychosocial Factor Res Grp, Kawasaki, Kanagawa 2148585, Japan; [Mitani, Takeshi; Midorikawa, Toru; Fuchu, Tatsuya] Med Corp Doaikai, Hlth Care Facil, Hosp Watanabe, Ibaraki 3140343, Japan; [Komatsu, Taiki] Tokyo Univ Technol, Sch Hlth Sci, Dept Phys Therapy, Tokyo 1448535, Japan; [Togo, Fumiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo 1130033, Japan	Izawa, S (reprint author), Natl Inst Occupat Safety & Hlth, Hlth Adm & Psychosocial Factor Res Grp, Tama Ku, 6-21-1 Nagao, Kawasaki, Kanagawa 2148585, Japan.	izawa0810@gmail.com			National Institute of Occupational Safety and Health, Japan [H23008, H24001]	This study was supported by a fundamental research grant from the National Institute of Occupational Safety and Health, Japan (H24001, H23008).	Manenschijn L, 2011, STEROIDS, V76, P1032, DOI 10.1016/j.steroids.2011.04.005; McGrath RE, 2006, PSYCHOL METHODS, V11, P386, DOI 10.1037/1082-989X.11.4.386; Granger DA, 2007, PHYSIOL BEHAV, V92, P583, DOI 10.1016/j.physbeh.2007.05.004; de Berker D. A. R., 2007, International Journal of Cosmetic Science, V29, P241, DOI 10.1111/j.1467-2494.2007.00372.x; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Warnock F, 2010, NEUROPSYCH DIS TREAT, V6, P1; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Gow R, 2011, CLIN ENDOCRINOL, V74, P687, DOI 10.1111/j.1365-2265.2011.04001.x; Gupta G.R., 2005, JIAFM, V27, P87; Nomura S., 1994, SHINBAN SHINSHINIGAK, P126; Sauve B, 2007, CLIN INVEST MED, V30, P183	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4530			PSYCHONEUROENDOCRINO	Psychoneuroendocrinology	APR	2015	54						24	30		10.1016/j.psyneuen.2015.01.015		7	Endocrinology & Metabolism; Neurosciences; Psychiatry	Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry	CF7PE	WOS:000352748000003		
J	Boylan, J; Kitayama, S; Park, J; Miyamoto, Y; Levine, C; Markus, H; Karasawa, M; Coe, C; Kawakami, N; Love, G; Ryff, C				Boylan, Jennifer; Kitayama, Shinobu; Park, Jiyoung; Miyamoto, Yuri; Levine, Cynthia; Markus, Hazel; Karasawa, Mayumi; Coe, Christopher; Kawakami, Norito; Love, Gayle; Ryff, Carol			ANGER EXPRESSION AND ILL-HEALTH IN TWO CULTURES: AN EXAMINATION OF INFLAMMATION AND CARDIOVASCULAR RISK	PSYCHOSOMATIC MEDICINE			English	Meeting Abstract	73rd Annual Meeting of the American-Psychosomatic-Society	MAR 18-21, 2015	Savannah, GA	Amer Psychosomat Soc					[Boylan, Jennifer] Univ Pittsburgh, Psychiat, Pittsburgh, PA USA; [Kitayama, Shinobu] Univ Michigan, Psychol, Ann Arbor, MI 48109 USA; [Park, Jiyoung] Univ Calif San Francisco, Hlth Psychol, San Francisco, CA 94143 USA; [Miyamoto, Yuri; Coe, Christopher; Ryff, Carol] Univ Wisconsin, Psychol, Madison, WI USA; [Levine, Cynthia] Northwestern Univ, Psychol, Evanston, IL USA; [Markus, Hazel] Stanford Univ, Psychol, Stanford, CA 94305 USA; [Karasawa, Mayumi] Tokyo Womans Christian Univ, Comparat Psychol, Tokyo, Tokyo, Japan; [Kawakami, Norito] Univ Tokyo, Mental Hlth, Tokyo, Tokyo, Japan; [Love, Gayle] Univ Wisconsin, Inst Aging, Madison, WI USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	APR	2015	77	3				2534	A8	A8				1	Psychiatry; Psychology; Psychology, Multidisciplinary	Psychiatry; Psychology	CF9CU	WOS:000352860000025		
J	Oka, T				Oka, Takakazu			ISOMETRIC YOGA REDUCES FATIGUE AND PAIN IN PATIENTS WITH CHRONIC FATIGUE SYNDROME WHO ARE RESISTANT TO CONVENTIONAL THERAPY: A RANDOMIZED, CONTROLLED TRIAL	PSYCHOSOMATIC MEDICINE			English	Meeting Abstract	73rd Annual Meeting of the American-Psychosomatic-Society	MAR 18-21, 2015	Savannah, GA	Amer Psychosomat Soc					[Oka, Takakazu] Kyushu Univ, Grad Sch Med Sci, Psychosomat Med, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	APR	2015	77	3				2607	A9	A9				1	Psychiatry; Psychology; Psychology, Multidisciplinary	Psychiatry; Psychology	CF9CU	WOS:000352860000028		
J	Reyes, JAL				Reyes, Joseph Anthony L.			Cross-section analyses of attitudes towards science and nature from the International Social Survey Programme 1993, 2000, and 2010 surveys	PUBLIC UNDERSTANDING OF SCIENCE			English	Article						dominant social paradigm; environmental attitudes; knowledge orientations; new environmental paradigm	PARADIGM SCALE; ENVIRONMENTAL ATTITUDES; ECOLOGICAL PARADIGM; ENDORSEMENT; BELIEFS; STATES	This paper explores public attitudes towards science and nature in twelve countries using data from the International Social Survey Programme environment modules of 1993, 2000, and 2010. Analysis of attitude items indicates technocentric and pessimistic dimensions broadly related to the Dominant Social Paradigm and New Environmental Paradigm. A bi-axial dimension scale is utilized to classify respondents among four environmental knowledge orientations. Discernible and significant patterns are found among countries and their populations. Relationships with other substantial variables in the surveys are discussed and findings show that the majority of industrialized countries are clustered in the rational ecologist categorization with respondents possessing stronger ecological consciousness and optimism towards the role of modern institutions, science, and technology in solving environmental problems.	[Reyes, Joseph Anthony L.] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan	Reyes, JAL (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-20 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	reyes@cneas.tohoku.ac.jp		Reyes, Joseph Anthony Lazareto/0000-0002-2545-2295			Franzen A, 2010, EUR SOCIOL REV, V26, P219, DOI 10.1093/esr/jcp018; Brulle RJ, 2010, HANDB SOCIOL SOC RES, P385, DOI 10.1007/978-0-387-68930-2_21; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Allum N, 2008, PUBLIC UNDERST SCI, V17, P35, DOI 10.1077/0963662506070159; Wiseman M, 2003, PERS INDIV DIFFER, V34, P783, DOI 10.1016/S0191-8869(02)00071-5; Corral-Verdugo V, 2008, ENVIRON BEHAV, V40, P703, DOI 10.1177/0013916507308786; DUNLAP RE, 1978, J ENVIRON EDUC, V9, P10; Milfont TL, 2004, J ENVIRON PSYCHOL, V24, P289, DOI 10.1016/j.jenvp.2004.09.001; Bechtel RB, 1999, J CROSS CULT PSYCHOL, V30, P122, DOI 10.1177/0022022199030001008; GOODLAND R, 1995, ANNU REV ECOL SYST, V26, P1; Hadler M, 2011, INT SOCIOL, V26, P315, DOI 10.1177/0268580910392258; Dunlap RE, 2008, J ENVIRON EDUC, V40, P3, DOI 10.3200/JOEE.40.1.3-18; [Anonymous], 2006, ENVIRON EDUC RES, DOI 10.1080/13504620601053662; Aoyagi-Usui M, 1999, ASIAN GEOGRAPHER, V18, P123; Aoyagi-Usui Midori, 2003, HUMAN ECOLOGY REV, V10.1, P23, DOI DOI 10.1177/0013916505285933; Backstrand K, 2007, SOCIAL CONSTRUCTION, P123; BARRETT B, 2002, INT RES GEOGRAPHICAL, V0011; Bogner FX, 2002, EUR PSYCHOL, V7, P225, DOI 10.1027//1016-9040.7.3.225; Cohen M, 2000, DISSENT, V47, P1; Corral-Verdugo V., 2000, J ENVIRON EDUC, V31, P25; Diekmann A, 1999, ENVIRON BEHAV, V31, P540, DOI 10.1177/00139169921972227; Erdogan N, 2009, AFR J AGR RES, V4, P1023; Ester Peter, 2004, Ambient. soc., V7, P45, DOI 10.1590/S1414-753X2004000200004; Field A., 2009, DISCOVERING STAT USI; Franzen A, 2013, GLOBAL ENVIRON CHANG, V23, P1001, DOI 10.1016/j.gloenvcha.2013.03.009; Garling T, 2002, HDB ENV PSYCHOL, P85; GOOCH GD, 1995, ENVIRON BEHAV, V27, P513, DOI 10.1177/0013916595274004; Kelly M, 2003, CULTURAL SOURCES SUP; Milbrath L. W., 1984, ENV VANGUARD NEW SOC; Motherway B, 2003, 1 U COLL DUBL DEP SO; Pirages D. C., 1974, ARK 2 SOCIAL RESPONS; Tabachnick B. G., 2006, USING MULTIVARIATE S; United Nations Development Programme, 2011, INT HUM DEV IND; Wolfe M., 1993, INSTRUMENT DEV AFFEC; World Bank, 2008, WORLD DEV IND	35	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0963-6625	1361-6609		PUBLIC UNDERST SCI	Public Underst. Sci.	APR	2015	24	3					338	357		10.1177/0963662513503261		20	Communication; History & Philosophy Of Science	Communication; History & Philosophy of Science	CF4WF	WOS:000352553100008		
J	Miura, N; Yuki, D; Minami, N; Kakehi, A; Futamura, Y				Miura, Naoki; Yuki, Dai; Minami, Naoki; Kakehi, Aoi; Futamura, Yasuyuki			A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Biomarkers; Exposure; Cigarette; Smoking; Smokeless tobacco; Clinical study	HEATED CIGARETTE; LUNG CARCINOGEN; THIOCYANATE; URINE; MUTAGENS; KINETICS	In a clinical study, changes in 14 biomarkers of exposures (BOEs) from 10 tobacco smoke constituents and mutagens detected by the urine mutagenicity test were investigated using a non-combustion inhaler type of tobacco product (NCIT) by switching from a conventional cigarette. This study was conducted in 80 Japanese healthy adult males with a 4-week residential, controlled, open-label, parallel group design. After randomization, 40 smokers used NCIT with approximately 750 aspirations, other 20 smokers smoked approximately 20 pieces of an assigned 1-mg ISO tar conventional cigarette (CC1) every day. Twenty non-smokers (NS) did not use any tobacco product. Under this study condition, switching from cigarette to NCIT showed significant reduction in all BOEs measured. On day 29, the levels of these BOEs were almost the same as those in the NS group, except BOEs of nicotine and 4-(methylnitrosamino)-1-(3pyridy1)-1-butanone(NNK). This suggested that the exposure to 8 constituents and mutagens in the NCIT group was similar to that in the NS group, while the exposure to nicotine was higher. Although the precise exposure level to NNK was not estimated because of the long half-life of its BOE, it would be substantially lower in the NCIT group than in the CC1 group. (C) 2015 Elsevier Inc. All rights reserved.	[Miura, Naoki; Yuki, Dai; Minami, Naoki; Kakehi, Aoi; Futamura, Yasuyuki] Japan Tobacco Inc, R&D Grp, Prod Sci Div, Yokohama, Kanagawa 227, Japan	Miura, N (reprint author), Japan Tobacco Inc, Corp Sci & Regulatory Affairs Grp, Minato Ku, 2-2-1 Toranomon, Tokyo 1058422, Japan.	naoki.miura@jt.com			Japan Tobacco Inc.	This work was funded by Japan Tobacco Inc., and all authors are employees of the company.	Scherer G, 2006, EXP TOXICOL PATHOL, V58, P101, DOI 10.1016/j.etp.2006.07.001; KADO NY, 1983, MUTAT RES, V121, P25, DOI 10.1016/0165-7992(83)90082-9; Hecht SS, 1999, CANCER RES, V59, P590; Rainey CL, 2011, J AGR FOOD CHEM, V59, P2745, DOI 10.1021/jf103295d; YAMASAKI E, 1977, P NATL ACAD SCI USA, V74, P3555, DOI 10.1073/pnas.74.8.3555; Goniewicz ML, 2009, CANCER EPIDEM BIOMAR, V18, P3421, DOI 10.1158/1055-9965.EPI-09-0874; Buchhalter A R, 2000, Nicotine Tob Res, V2, P39; DOOLITTLE DJ, 1989, FOOD CHEM TOXICOL, V27, P657, DOI 10.1016/0278-6915(89)90120-8; Health Canada, 1999, SOR2000272 HLTH CAN; Institute of Medicine, 2012, SCI STAND STUD MOD R; International Agency for Research on Cancer, 2007, IARC MONOGR EVAL CAR, V89, P1; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83, P1; International Organization for Standardization, 2000, ISO3308; JUNGE B, 1985, BRIT MED J, V291, P22; KADO NY, 1985, MUTAT RES, V157, P227, DOI 10.1016/0165-1218(85)90120-X; Miura N, 2013, REGUL TOXICOL PHARM, V67, P198, DOI 10.1016/j.yrtph.2013.07.008; Okuzono H, 1976, Rinsho Byori, V24, P616; PEREZSTABLE EJ, 1992, AM REV RESPIR DIS, V145, P53; Sakaguchi C, 2014, REGUL TOXICOL PHARM, V69, P338, DOI 10.1016/j.yrtph.2014.04.016; Scherer G, 2005, EXP TOXICOL PATHOL, V57, P75, DOI 10.1016/j.etp.2005.05.007; Schorp MK, 2012, REGUL TOXICOL PHARM, V64, pS1, DOI 10.1016/j.yrtph.2012.08.008; Vesey CJ, 1999, J ANAL TOXICOL, V23, P134	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	APR	2015	71	3					498	506		10.1016/j.yrtph.2015.02.007		9	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CF8PG	WOS:000352823800016		
J	Mitobe, Y; Yokomoto, Y; Ohashi-Doi, K				Mitobe, Yuko; Yokomoto, Yasuki; Ohashi-Doi, Katsuyo			Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Allergen extract; Japanese cedar pollen; Allergen specific immunotherapy; Sublingual immunotherapy; Safety evaluation; Genotoxicity; Repeated toxicity; Oral mucosal irritation	CLINICAL-EFFICACY; MAJOR ALLERGEN; POLLINOSIS; RATS; IDENTIFICATION; RHINITIS; TABLET; TRIAL; CELLS; IGE	Japanese cedar (JC) pollinosis is caused by Japanese cedar pollen (JCP) and most common seasonal allergic disease in Japan. Subcutaneous immunotherapy (SOT) with allergen extract of JCP (JCP-allergen extract) is well established for JC pollinosis treatment with improvement of symptoms. However, major drawbacks for SCIT are repeated painful injections, frequent hospital visits and anaphylactic risk. Currently, sublingual immunotherapy (SLIT) has received much attention as an advanced alternative application with lower incidence of systemic reactions because the liquid or tablet form of allergen is placed under the tongue. The aim of this study was safety evaluation of standardized JCP-allergen extract currently developed for SLIT in JC pollinosis. JCP-allergen extract showed no potential genotoxicity. No systemic effects were observed in rats administered JCP-allergen extract orally for 26 weeks followed by 4-week recovery period. Mild local reactions such as hyperplasia and increased globule leukocytes resulting from vehicle (glycerin)-induced irritation were observed in stomach. No-observed-adverse-effect level was greater than 10,000 JAU/kg/day for systemic toxicity, equivalent to 300-fold the human dose. No local irritation was found in rabbits oral mucosae by 7-day sublingual administration. These results demonstrate the safe profile of standardized JCP-allergen extract, suggesting it is suitable for SLIT in JC pollinosis. (C) 2015 Elsevier Inc. All rights reserved.	[Mitobe, Yuko; Ohashi-Doi, Katsuyo] Torii Pharmaceut Co Ltd, Res Lab, Ota Ku, Sakura, Chiba 2850808, Japan; [Mitobe, Yuko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Yokomoto, Yasuki] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Toxicol Res Labs, Hadanoshi, Kanagawa 2570014, Japan	Mitobe, Y (reprint author), Torii Pharmaceut Co Ltd, Res Lab, Ota Ku, 2183-1 Teranosaku, Sakura, Chiba 2850808, Japan.	yuko.mitobe@torii.co.jp					Di Felice G, 2001, INT ARCH ALLERGY IMM, V125, P280, DOI 10.1159/000053828; Nelson HS, 2011, J ALLERGY CLIN IMMUN, V127, P72, DOI 10.1016/j.jaci.2010.11.035; Canonica GW, 2003, J ALLERGY CLIN IMMUN, V111, P437, DOI 10.1067/mai.2003.129; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Cox LS, 2012, J ALLERGY CLIN IMMUN, V130, P1327, DOI 10.1016/j.jaci.2012.08.032; Fujimura T, 2011, CLIN IMMUNOL, V139, P65, DOI 10.1016/j.clim.2010.12.022; SAKAGUCHI M, 1990, ALLERGY, V45, P309, DOI 10.1111/j.1398-9995.1990.tb00501.x; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X; Bernstein DI, 2004, J ALLERGY CLIN IMMUN, V113, P1129, DOI 10.1016/j.jaci.2004.02.006; Cox L, 2010, J ALLERGY CLIN IMMUN, V125, P569, DOI 10.1016/j.jaci.2009.10.060; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint. 11-RAI-0334, 10.2332/allergolint.11-RAI-0334]; Didier A, 2011, J ALLERGY CLIN IMMUN, V128, P559, DOI 10.1016/j.jaci.2011.06.022; Bousquet J., 1998, Allergy (Copenhagen), V53, P1; Canonica Giorgio Walter, 2014, World Allergy Organ J, V7, P6, DOI 10.1186/1939-4551-7-6; Cappella A, 2012, HUM VACC IMMUNOTHER, V8, P1499, DOI 10.4161/hv.21629; Eifan AO, 2013, EXPERT OPIN BIOL TH, V13, P1543, DOI 10.1517/14712598.2013.844226; Horiguchi S, 2008, INT ARCH ALLERGY IMM, V146, P76, DOI 10.1159/000112506; HUNTLEY JF, 1992, J COMP PATHOL, V107, P349, DOI 10.1016/0021-9975(92)90010-R; IKEDA Y, 1993, CELL TISSUE RES, V273, P447, DOI 10.1007/BF00333699; Kaneko Y, 2005, INT ARCH ALLERGY IMM, V136, P365, DOI 10.1159/000084256; Mailing H.J., 1993, ALLERGY, V48, P9; Narama I, 1999, TOXICOL PATHOL, V27, P318, DOI 10.1177/019262339902700307; Ohbayashi A., 1998, YAKUGAKU ZASSHI, V108, P232; Okubo Kimihiro, 2008, Allergol Int, V57, P265, DOI 10.2332/allergolint.O-07-514; STAPLES R, 1967, J PHARM SCI, V56, P398, DOI 10.1002/jps.2600560321; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002; Yasue H, 1996, Arerugi, V45, P416	27	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	APR	2015	71	3					529	540		10.1016/j.yrtph.2015.02.009		12	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CF8PG	WOS:000352823800019		
J	Ayaki, M; Negishi, K; Suzukamo, Y; Tsubota, K				Ayaki, Masahiko; Negishi, Kazuno; Suzukamo, Yoshimi; Tsubota, Kazuo			Color of Intra-Ocular Lens and Cataract Type Are Prognostic Determinants of Health Indices After Visual and Photoreceptive Restoration by Surgery	REJUVENATION RESEARCH			English	Article							BLUE-LIGHT; SLEEP QUALITY; ULTRAVIOLET-BLOCKING; GAIT SPEED; IMPAIRMENT; BENEFITS; IMPACT; TRANSMISSION; PHOTOPHOBIA; FALLS	Background: This study compared post-operative quality of life and sleep according to the type of cataract opacity and color of the implanted intra-ocular lens (IOL). Methods: This is a cohort study and participants were 206 patients (average age 74.1 years) undergoing cataract surgery with the implantation of a clear ultra-violet (UV)-blocking IOL (C) or a yellow blue-light-blocking IOL (Y). Participants were evaluated using the National Eye Institute Visual Function Questionnaire (VFQ-25) and Pittsburgh Sleep Quality Index (PSQI) before surgery and 2 and 7 months after surgery. Changes in sub-scale scores of VFQ-25 and PSQI were compared. Results: Sub-scale analyses for improvement after surgery revealed significant differences in ocular pain scores on the VFQ-25 (Y>C; the higher the score, the better the outcome). Furthermore, there were significant differences between the two IOLs in terms of the sleep latency score (C>Y) and sleep disturbances score (C>Y). A posterior sub-capsular cataract was significantly correlated with improvements in ocular pain and sleep latency scores. These effects were successfully represented by the change in scores rather than absolute post-operative scores because individual standard of response may often change after intervention, recognized as a response shift phenomenon in patient-reported outcome study. Regarding seasonal differences, patients who had surgery in summer exhibited relatively better sleep quality than those who had surgery in winter. Conclusions: Analysis of sub-scales of health indices demonstrated characteristic prognoses for each IOL and cataract type. Cataract surgery may potentially contribute to systemic health in older adults.	[Ayaki, Masahiko; Negishi, Kazuno; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Suzukamo, Yoshimi] Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Sendai, Miyagi 980, Japan	Ayaki, M (reprint author), Keio Univ, Dept Ophthalmol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	mayaki@olive.ocn.ne.jp			JSPS KAKENHI [24592643]	The authors thank Dr. Takayuki Abe for help with the statistical analysis. The authors acknowledge the assistance of Inter-Biotech (www.inter-biotech.com) with the English language editing of this manuscript. This work was supported by a grant from JSPS KAKENHI (no. 24592643).	Alexander I, 2014, INVEST OPHTH VIS SCI, V55, P4999, DOI 10.1167/iovs.14-14054; Schmoll C, 2014, BRIT J OPHTHALMOL, V98, P124, DOI 10.1136/bjophthalmol-2013-304024; Ishikawa T, 2013, J CATARACT REFR SURG, V39, P1593, DOI 10.1016/j.jcrs.2013.08.033; Wei X, 2013, J CLIN SLEEP MED, V9, P741, DOI 10.5664/jcsm.2908; Ayaki M, 2013, REJUV RES, V16, P35, DOI 10.1089/rej.2012.1369; Schmack I, 2012, J CATARACT REFR SURG, V38, P823, DOI 10.1016/j.jcrs.2011.12.028; Kessel L, 2011, SLEEP, V34, P1215, DOI 10.5665/SLEEP.1242; Moulton EA, 2009, PAIN, V145, P358, DOI 10.1016/j.pain.2009.07.018; de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8; Fong CSU, 2014, AM J OPHTHALMOL, V157, P163, DOI 10.1016/j.ajo.2013.08.018; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Stephenson KM, 2012, SLEEP MED REV, V16, P445, DOI 10.1016/j.smrv.2011.09.002; Artigas JM, 2012, INVEST OPHTH VIS SCI, V53, P4076, DOI 10.1167/iovs.12-9471; Turner PL, 2010, SLEEP MED REV, V14, P269, DOI 10.1016/j.smrv.2009.11.002; Kim YH, 2012, AGING CLIN EXP RES, V24, P663, DOI 10.3275/8501; Ayaki M, 2014, REJUV RES, V17, P359, DOI 10.1089/rej.2014.1550; Obayashi K, 2012, J CLIN ENDOCR METAB, V97, P4166, DOI 10.1210/jc.2012-1873; Ishii K, 2008, AM J OPHTHALMOL, V146, P404, DOI 10.1016/j.ajo.2008.05.014; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Schwartz CE, 2010, ARCH PHYS MED REHAB, V91, pS38, DOI 10.1016/j.apmr.2009.11.029; Campbell AJ, 2005, BRIT MED J, V331, P817, DOI 10.1136/bmj.38601.447731.55; Mainster MA, 2010, SURV OPHTHALMOL, V55, P272, DOI 10.1016/j.survophthal.2009.07.006; Ayaki Masahiko, 2014, Asia Pac J Ophthalmol (Phila), V3, P267, DOI 10.1097/APO.0000000000000033; Cuthbertson FM, 2009, J CATARACT REFR SURG, V35, P1281, DOI 10.1016/j.jcrs.2009.04.017; Henderson BA, 2010, SURV OPHTHALMOL, V55, P284, DOI 10.1016/j.survophthal.2009.07.007; Kurlansik SL, 2012, AM FAM PHYSICIAN, V86, P1037; Matynia A, 2012, EXP EYE RES, V105, P60, DOI 10.1016/j.exer.2012.09.012; Meuleners LB, 2014, AGE AGEING, V43, P341, DOI 10.1093/ageing/aft177; Noseda R, 2013, HEADACHE, V53, P1679, DOI 10.1111/head.12230; Porela-Tiihonen S, 2013, J CATARACT REFR SURG, V39, P789, DOI 10.1016/j.jcrs.2013.03.012; Stringham JM, 2004, INVEST OPHTH VIS SCI, V45, P3838, DOI 10.1167/iovs.04-0038; Suzukamo Yoshimi, 2005, Health Qual Life Outcomes, V3, P65, DOI 10.1186/1477-7525-3-65; Tanito M, 2012, JPN J OPHTHALMOL, V56, P82, DOI 10.1007/s10384-011-0100-9; Zhu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033013	34	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1549-1684	1557-8577		REJUV RES	Rejuv. Res.	APR 1	2015	18	2					145	152		10.1089/rej.2014.1613		8	Geriatrics & Gerontology	Geriatrics & Gerontology	CG4WE	WOS:000353287300005		
J	Gan, HJ; He, HW; Sato, A; Hatta, H; Nakao, M; Somamoto, T				Gan, Hongjian; He, Haiwen; Sato, Atsushi; Hatta, Hajime; Nakao, Miki; Somamoto, Tomonori			Ulcer disease prophylaxis in koi carp by bath immersion with chicken egg yolk containing anti-Aeromonas salmonicida IgY	RESEARCH IN VETERINARY SCIENCE			English	Article						Ulcer disease; Koi; Passive immunization; IgY; Bath immersion	CARASSIUS-AURATUS L; PASSIVE-IMMUNIZATION; CYPRINUS-CARPIO; RAINBOW-TROUT; CRUCIAN CARP; IMMUNOGLOBULINS; INFECTION; FISH; PROTECTION; ANTIBODIES	Ulcer disease, caused by atypical Aeromonas salmonicida, is a serious concern in ornamental koi carp, because it induces skin ulceration, disfiguring ornamental fish and causing economic loses. The present study aimed to establish a novel prophylaxis with chicken egg yolk immunoglobulin, IgY, against ulcer disease and to assess its feasibility in the ornamental fish industry. Addition of egg yolk powder containing anti-A. salmonicida IgY to rearing water provided significant protection against an A. salmonicida bath infection, whereas administration of non-specific IgY did not. Consecutive immersion of fish into rearing water containing specific IgY completely prevented ulcer disease resulting from cohabitation infection, indicating that this prophylaxis could prevent infection from such type of contact. Thus, passive immunization induced by immersing fish into aquarium water containing specific IgY is a prospective prophylaxis against diseases caused by pathogens that invade the skin and gills. (C) 2015 Elsevier Ltd. All rights reserved.	[Gan, Hongjian; He, Haiwen; Nakao, Miki; Somamoto, Tomonori] Kyushu Univ, Dept Biosci & Biotechnol, Marine Biochem Lab, Grad Sch Bioresource & Bioenvironme Sci, Fukuoka 8128581, Japan; [Sato, Atsushi] Kyorin Co Ltd, Himeji, Hyogo, Japan; [Hatta, Hajime] Kyoto Womens Univ, Dept Food & Nutr, Kyoto, Japan	Somamoto, T (reprint author), Kyushu Univ, Dept Biosci & Biotechnol, Marine Biochem Lab, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	somamoto@agr.kyushu-u.ac.jp			MEXT Project for Developing Innovation Systems (Regional Innovation Strategy Support Program "Kyoto Environmental Nanotechnology Cluster); Research Grant for Young Investigators of the Faculty of Agriculture, Kyushu University	This work was partly supported by MEXT Project for Developing Innovation Systems (Regional Innovation Strategy Support Program "Kyoto Environmental Nanotechnology Cluster 2008-2013"). The authors would like to thank Enago (www.enago.jp) for the English language review. The costs of publication were supported, in part, by a Research Grant for Young Investigators of the Faculty of Agriculture, Kyushu University.	YOKOYAMA H, 1992, INFECT IMMUN, V60, P998; Wiklund T, 1998, DIS AQUAT ORGAN, V32, P49, DOI 10.3354/dao032049; Xu YP, 2011, BIOTECHNOL ADV, V29, P860, DOI 10.1016/j.biotechadv.2011.07.003; da Silva WD, 2010, VET IMMUNOL IMMUNOP, V135, P173, DOI 10.1016/j.vetimm.2009.12.011; HATTA H, 1990, AGR BIOL CHEM TOKYO, V54, P2531; HATTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1077; GUTIERREZ MA, 1993, J FISH DIS, V16, P113, DOI 10.1111/j.1365-2761.1993.tb00854.x; Kweon CH, 2000, J VET MED SCI, V62, P961, DOI 10.1292/jvms.62.961; Arasteh N, 2004, AQUACULTURE, V231, P23, DOI 10.1016/j.aquaculture.2003.11.004; Spillner E, 2012, BIOLOGICALS, V40, P313, DOI 10.1016/j.biologicals.2012.05.003; Dobiasova H, 2014, VET MICROBIOL, V171, P413, DOI 10.1016/j.vetmic.2014.02.011; Wu CJ, 2011, FISH SHELLFISH IMMUN, V30, P1042, DOI 10.1016/j.fsi.2011.01.026; Kovacs-Nolan J, 2012, ANNU REV FOOD SCI T, V3, P163, DOI 10.1146/annurev-food-022811-101137; Cizek A, 2010, VET MICROBIOL, V142, P435, DOI 10.1016/j.vetmic.2009.10.001; ELLIOTT DG, 1980, J FISH DIS, V3, P133, DOI 10.1111/j.1365-2761.1980.tb00196.x; ELLIOTT DG, 1980, J FISH DIS, V3, P145, DOI 10.1111/j.1365-2761.1980.tb00197.x; Goodwin AE, 2009, J AQUAT ANIM HEALTH, V21, P98, DOI 10.1577/H08-042.1; Hunt Craig J-G, 2006, Vet Clin North Am Exot Anim Pract, V9, P723, DOI 10.1016/j.cvex.2006.05.027; Jin LJ, 2013, AQUAC RES, V44, P928, DOI 10.1111/j.1365-2109.2012.03099.x; Lee SB, 2000, J AGR FOOD CHEM, V48, P110, DOI 10.1021/jf9906073; Li CH, 2014, FISH SHELLFISH IMMUN, V37, P108, DOI 10.1016/j.fsi.2014.01.018; Matoyama H, 1999, FISH PATHOL, V34, P189; Rakus K, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-85; Somamoto T, 2014, DEV COMP IMMUNOL, V44, P111, DOI 10.1016/j.dci.2013.12.008; Torche AM, 2006, VET IMMUNOL IMMUNOP, V109, P209, DOI 10.1016/j.vetimm.2005.08.016	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0034-5288	1532-2661		RES VET SCI	Res. Vet. Sci.	APR	2015	99						82	86		10.1016/j.rvsc.2015.01.016		5	Veterinary Sciences	Veterinary Sciences	CF1SB	WOS:000352327100015		
J	Yamazaki, H; Takagi, S; Hosoya, K; Okumura, M				Yamazaki, Hiroki; Takagi, Satoshi; Hosoya, Kenji; Okumura, Masahiro			Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models	RESEARCH IN VETERINARY SCIENCE			English	Article						Chemoresistance; Dog; Histiocytic sarcoma; Survivin	SMALL-MOLECULE SUPPRESSOR; CELL LUNG-CANCER; P-GLYCOPROTEIN; PHASE-II; MULTIDRUG-RESISTANCE; BREAST-CANCER; UP-REGULATION; EXPRESSION; DOGS; TRANSCRIPTION	Histiocytic sarcoma (HS) in dogs exhibits aggressive clinical and biological behavior. Currently, no effective treatments are available for dogs with HS. Survivin, a member of a family of apoptosis protein inhibitors, could serve as a potential therapeutic target in several canine cancers. Sepantronium bromide (YM155) has recently been established as a novel survivin-targeting agent. The aim of this study was to use YM155 as a tool for evaluating survivin-targeted therapies against dogs with HS, and to investigate how YM155 treatment affects antitumor and chemotherapeutic efficacies in murine xenograft models using canine HS cells. The results showed that in HS cells with lomustine (CCNU) resistance, YM155 treatment suppressed both the cell-growth potential and cell resistance to CCNU, which essentially increases the chemotherapy efficacy in the murine models. The evidence presented here supports the favorable preclinical evaluation that survivin-targeted therapies might be effective against HS in dogs. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamazaki, Hiroki; Hosoya, Kenji; Okumura, Masahiro] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Surg, Sapporo, Hokkaido 0600818, Japan; [Yamazaki, Hiroki] Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Kagoshima 890, Japan; [Takagi, Satoshi] Hokkaido Univ, Grad Sch Vet Med, Vet Teaching Hosp, Sapporo, Hokkaido 0600818, Japan	Takagi, S (reprint author), Hokkaido Univ, Grad Sch Vet Med, Vet Teaching Hosp, Dept Vet Clin Sci,Kita Ku, N18 W9, Sapporo, Hokkaido 0600818, Japan.	staka@vetmed.hokudai.ac.jp					Amin Md Lutful, 2013, Drug Target Insights, V7, P27, DOI 10.4137/DTI.S12519; Amarasingh S, 2009, J NEURO-ONCOL, V91, P117, DOI 10.1007/s11060-008-9697-z; Iwai M, 2011, DRUG METAB DISPOS, V39, P2314, DOI 10.1124/dmd.111.040733; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Shoeneman JK, 2012, CANCER RES, V72, P249, DOI 10.1158/0008-5472.CAN-11-2315; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Shen X, 2012, AM J MED SCI, V344, P52, DOI 10.1097/MAJ.0b013e318239c4ee; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Liu F, 2007, BIOL PHARM BULL, V30, P2279, DOI 10.1248/bpb.30.2279; Liu F, 2010, ONCOL REP, V23, P1469, DOI 10.3892/or_00000786; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Rodel F, 2012, CURR MED CHEM, V19, P3679; Kanwar JR, 2013, MED RES REV, V33, P765, DOI 10.1002/med.21264; Cai XP, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-52; Endoh T, 2005, EXP CELL RES, V305, P300, DOI 10.1016/j.yexcr.2004.12.014; Hori M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055710; Klahn SL, 2011, JAVMA-J AM VET MED A, V239, P90, DOI 10.2460/javma.239.1.90; McKenzie JA, 2010, CANCER RES, V70, P7927, DOI 10.1158/0008-5472.CAN-10-0194; Nakahara T, 2011, ANTI-CANCER DRUG, V22, P454, DOI 10.1097/CAD.0b013e328344ac68; Okugawa K, 2004, J CANCER RES CLIN, V130, P178, DOI 10.1007/s00432-003-0516-9; Rassnick KM, 2010, J VET INTERN MED, V24, P1528, DOI 10.1111/j.1939-1676.2010.0588.x; Stepien KM, 2012, PHARMACOL REP, V64, P1011; Wang Z., 2008, CANC THERAPY, V6, P603; Yamazaki H, 2014, J VET INTERN MED, V28, P204, DOI 10.1111/jvim.12244; Yamazaki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079810	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0034-5288	1532-2661		RES VET SCI	Res. Vet. Sci.	APR	2015	99						137	144		10.1016/j.rvsc.2015.02.003		8	Veterinary Sciences	Veterinary Sciences	CF1SB	WOS:000352327100023		
J	Ishikawa, S; Takemitsu, H; Li, GB; Mori, N; Yamamoto, I; Arai, T				Ishikawa, Shingo; Takemitsu, Hiroshi; Li, Gebin; Mori, Nobuko; Yamamoto, Ichiro; Arai, Toshiro			Short communication: Molecular characterization of dog and cat p65 subunits of NF-kappaB	RESEARCH IN VETERINARY SCIENCE			English	Article						NF-kappaB; Dog; Cat; Pro-inflammatory cytokine; Inflammation	FELINE DIABETES-MELLITUS; CANINE; INFLAMMATION; FIBROBLASTS; EXPRESSION; PATHWAY; DISEASE; CELLS	Nuclear factor kappa B (NF-kappa B) plays an important role in the immune system. The p65 subunit is an important part of NF-kappa B unit, and studies of dog and cat p65 subunits of NF-kappa B (dp65 and cp65) are important in understanding their immune function. In this study, we described the molecular characterization of dp65 and cp65. The dp65 and cp65 complementary DNA encoded 542 and 555 amino acids, respectively, showing a high sequence homology with the mammalian p65 subunit (>87.5%). Quantitative polymerase chain reaction revealed that the p65 messenger RNA is highly expressed in the dog stomach and cat heart and adipose tissue. Functional NF-kappa B promoter-luciferase reporter vectors revealed that our isolated dp65 and cp65 cDNA encodes a functionally active protein. Transiently expressed dp65 and cp65 up-regulated pro-inflammatory cytokine expression levels in dog and cat, respectively. These findings suggest that dp65 and cp65 play important roles in regulating immune function. (C) 2015 Elsevier Ltd. All rights reserved.	[Ishikawa, Shingo; Takemitsu, Hiroshi; Li, Gebin; Mori, Nobuko; Yamamoto, Ichiro; Arai, Toshiro] Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Basic Vet Med, Musashino, Tokyo 1808602, Japan	Yamamoto, I (reprint author), Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Basic Vet Med, 1-7-1 Kyonancho, Musashino, Tokyo 1808602, Japan.	ichiroy@nvlu.ac.jp					Whitley NT, 2011, J SMALL ANIM PRACT, V52, P70, DOI 10.1111/j.1748-5827.2011.01024.x; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; O'Brien TD, 2002, MOL CELL ENDOCRINOL, V197, P213, DOI 10.1016/S0303-7207(02)00265-4; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; Fukuyama A, 2012, LIFE SCI, V90, P484, DOI 10.1016/j.lfs.2011.12.024; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Laflamme DP, 2012, J ANIM SCI, V90, P1653, DOI 10.2527/jas.2011-4571; Smith RS, 1997, AM J PATHOL, V151, P317; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Chen FE, 1999, PROTEIN ENG, V12, P423, DOI 10.1093/protein/12.5.423; Day MJ, 2010, J COMP PATHOL, V141, pS60, DOI 10.1016/j.jepa.2009.10.011; Doleschall M, 2007, DEV COMP IMMUNOL, V31, P945, DOI 10.1016/j.dci.2006.12.007; Ito K, 2013, VET J, V198, P577, DOI 10.1016/j.tvjl.2013.08.003; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li HG, 2011, MOL IMMUNOL, V48, P914, DOI 10.1016/j.molimm.2010.12.015; Multhoff G, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00098; Rand JS, 2004, J NUTR, V134, p2072S; Tamamoto T, 2013, VET IMMUNOL IMMUNOP, V155, P190, DOI 10.1016/j.vetimm.2013.06.010	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0034-5288	1532-2661		RES VET SCI	Res. Vet. Sci.	APR	2015	99						145	148		10.1016/j.rvsc.2015.02.009		4	Veterinary Sciences	Veterinary Sciences	CF1SB	WOS:000352327100024		
J	Hu, LF; Yan, J; Kim, Y; Fei, GT; Watanabe, K; Sekiguchi, T; Zhang, LD; Fang, XS				Hu, Linfeng; Yan, Jian; Kim, Yong; Fei, Guangtao; Watanabe, Kentaro; Sekiguchi, Takashi; Zhang, Lide; Fang, Xiaosheng			Cathodoluminescence and Photoconductive Characteristics of Single-Crystal Ternary CdS/CdSe/CdS Biaxial Nanobelts	SMALL			English	Article							CDSE/CDS CORE/SHELL NANOCRYSTALS; CDS NANOBELTS; NANOWIRES; GROWTH; CELL; PHOTODETECTORS; PERFORMANCE; NANOSAWS		[Hu, Linfeng; Fang, Xiaosheng] Dept Mat Sci, Shanghai 200433, Peoples R China; [Yan, Jian] Hefei Univ Technol, Sch Mat Sci & Engn, Hefei 230009, Anhui, Peoples R China; [Kim, Yong] Dong A Univ, Dept Phys, Busan 604714, South Korea; [Fei, Guangtao; Zhang, Lide] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Solid State Phys, Key Lab Mat Phys, Hefei 230031, Peoples R China; [Fei, Guangtao; Zhang, Lide] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Solid State Phys, Anhui Key Lab Nanomat & Nanostruct, Hefei 230031, Peoples R China; [Watanabe, Kentaro; Sekiguchi, Takashi] NIMS, WPI Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan	Fang, XS (reprint author), Dept Mat Sci, Shanghai 200433, Peoples R China.	xshfang@fudan.edu.cn	Fang, Xiaosheng/A-8695-2008; Watanabe, Kentaro/M-4936-2013; Yan, Jian/F-8028-2012; takashi, Sekiguchi/D-2603-2010	Watanabe, Kentaro/0000-0002-9104-7458; 	National Basic Research Program of China [2012CB932303]; National Natural Science Foundation of China [51471051, 51372040]; Shanghai Pujiang Program [12PJ1400300]; Innovation Program of Shanghai Municipal Education Commission [14ZZ003]; Shanghai Shu Guang Project [12SG01]; Science and Technology Commission of Shanghai Municipality [13NM1400300]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Program for New Century Excellent Talents in University [NCET-11-0102]	LFH and JY contributed equally to this work. This work was supported by the National Basic Research Program of China (Grant No. 2012CB932303), the National Natural Science Foundation of China (Grant Nos. 51471051 and 51372040), Shanghai Pujiang Program (12PJ1400300), Innovation Program of Shanghai Municipal Education Commission (14ZZ003), Shanghai Shu Guang Project (12SG01), Science and Technology Commission of Shanghai Municipality (13NM1400300), the Programs for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and for New Century Excellent Talents in University (NCET-11-0102). The part of work by YK was partially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2002076).	Li L, 2010, ADV MATER, V22, P3161, DOI 10.1002/adma.201000144; Jie JS, 2006, NANO LETT, V6, P1887, DOI 10.1021/nl060867g; Kim YL, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145602; Tian BZ, 2007, NATURE, V449, P885, DOI 10.1038/nature06181; Lee YL, 2010, CHEM MATER, V22, P922, DOI 10.1021/cm901762h; Nan WN, 2012, J AM CHEM SOC, V134, P19685, DOI 10.1021/ja306651x; Liao L, 2010, NATURE, V467, P305, DOI 10.1038/nature09405; Peng XG, 1997, J AM CHEM SOC, V119, P7019, DOI 10.1021/ja970754m; Hu LF, 2012, ADV MATER, V24, P2305, DOI 10.1002/adma.201200512; Hu LF, 2013, NANO LETT, V13, P1941, DOI 10.1021/nl3046552; Erwin SC, 2005, NATURE, V436, P91, DOI 10.1038/nature03832; Ma RM, 2007, NANO LETT, V7, P868, DOI 10.1021/nl062329+; Chong LW, 2010, J POWER SOURCES, V195, P5109, DOI 10.1016/j.jpowsour.2010.01.044; Greytak AB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2089157; Lieber CM, 2007, MRS BULL, V32, P99, DOI 10.1557/mrs2007.41; Pal BN, 2012, NANO LETT, V12, P331, DOI 10.1021/nl203620f; Lee YL, 2009, ADV FUNCT MATER, V19, P604, DOI 10.1002/adfm.200800940; Zhao JW, 2006, CRYST GROWTH DES, V6, P2643, DOI 10.1021/cg060445k; Duan XF, 2003, NATURE, V421, P241, DOI 10.1038/nature01353; Ma C, 2005, ADV MATER, V17, P2635, DOI 10.1002/adma.200500805; Jiang Y, 2007, ADV FUNCT MATER, V17, P1795, DOI 10.1002/adfm.200600351; Garcia-Santamaria F, 2011, NANO LETT, V11, P687, DOI 10.1021/nl103801e; Kung SC, 2011, ACS NANO, V5, P7627, DOI 10.1021/nn202728f; Moore D, 2004, CHEM PHYS LETT, V385, P8, DOI 10.1016/j.cplett.2003.12.063; Wang ZL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.185502; Yang PD, 2012, MRS BULL, V37, P806, DOI 10.1557/mrs.2012.200	26	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1613-6810	1613-6829		SMALL	Small	APR 1	2015	11	13					1531	1536		10.1002/smll.201402545		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CF4WV	WOS:000352555000005		
J	Toe, DHC; Kubota, T				Toe, Doris Hooi Chyee; Kubota, Tetsu			Comparative assessment of vernacular passive cooling techniques for improving indoor thermal comfort of modern terraced houses in hot-humid climate of Malaysia	SOLAR ENERGY			English	Article						Passive cooling; Vernacular architecture; Thermal comfort; Hot-humid climate	COURTYARD	The main objectives of this study were to investigate vernacular passive cooling techniques and their potential application for improving indoor thermal comfort of naturally ventilated, modern brick terraced houses in Malaysia. Field measurement was conducted in two traditional timber Malay houses and two traditional masonry Chinese shophouses to examine their indoor thermal environments. The results of the former showed that the indoor air temperatures were higher than the outdoor air temperatures by 1 degrees C during daytime under open window conditions and 2 degrees C at night under closed window conditions on average. The emphasis was on reducing the temperature of the outdoor air before entering the lightweight house for bodily cooling by cross ventilation. The outdoor air temperature at the Malay house sites was lower than that of the terraced house site by 1.7 degrees C on average. The results of the latter revealed that indoor air temperatures in rooms that were adjacent to small internal courtyards were lower than the immediate outdoors by about 5 degrees C on average at the peak period. At night, the indoor air temperatures maintained values that were similar to the outdoors. The small courtyards were effective to cool the high thermal mass structures through nocturnal ventilative and radiative cooling. When assessed using an adaptive thermal comfort equation for hot humid climates, the periods of indoor operative temperatures exceeding the 80% comfortable upper limit in the Malay houses, Chinese shophouses, daytime ventilated and night ventilated terraced houses were 47%, 7-8%, 91% and 42%, respectively, on fair weather days. Potential passive cooling techniques for the existing terraced houses including night ventilation, roof or ceiling insulation, window and wall shading, small courtyard concept, and microclimate modification and/or urban heat island mitigation were discussed. (C) 2015 Elsevier Ltd. All rights reserved.	[Toe, Doris Hooi Chyee] Univ Teknol Malaysia, Fac Built Environm, Utm Skudai 81310, Johor, Malaysia; [Kubota, Tetsu] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Hiroshima 7398529, Japan	Toe, DHC (reprint author), Univ Teknol Malaysia, Fac Built Environm, Utm Skudai 81310, Johor, Malaysia.	doristhc@yahoo.com	KUBOTA, TETSU/N-1527-2013		Asahi Glass Foundation; Nichias Corporation; Hitachi Scholarship Foundation; G.ecbo/GELS Winter Internship Program	This study was funded by the Asahi Glass Foundation and the Nichias Corporation. Special thanks are extended to The Hitachi Scholarship Foundation, G.ecbo/GELS Winter 2010 Internship Program and Grants-in-Aid for GELS Students' Research FY2011. We deeply thank the Malay households, the National University of Singapore (TTCLC, Department of Architecture) and all who helped with the field work.	Kubota T, 2009, ENERG BUILDINGS, V41, P829, DOI 10.1016/j.enbuild.2009.03.008; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Bowler DE, 2010, LANDSCAPE URBAN PLAN, V97, P147, DOI 10.1016/j.landurbplan.2010.05.006; Santamouris M, 2013, ENERG BUILDINGS, V57, P74, DOI 10.1016/j.enbuild.2012.11.002; ASHRAE, 2010, 552010 ASHRAE ANSIAS; BAKER N., 2000, ENERGY ENV ARCHITECT; BSI, 2008, 152512007 BSI EN; Chen V. F., 1998, ENCY MALAYSIA, V05; Cook J., 1989, PASSIVE COOLING; Department of Statistics Malaysia, 2005, GEN REP POP HOUS CEN; Department of Statistics Malaysia, 2012, CHAR LIV QUART POP H; Edwards Brian, 2006, COURTYARD HOUSING PR; Hassan Ahmad Sanusi, 2010, American Journal of Engineering and Applied Sciences, V3, DOI 10.3844/ajeassp.2010.521.528; Hens H.L.S.C., 2009, HDB SUSTAINABLE BUIL, P211; KIMURA K, 1994, RENEW ENERG, V5, P900, DOI 10.1016/0960-1481(94)90110-4; Knapp R.G., 1999, CHINAS OLD DWELLINGS; Kubota T, 2014, J ASIAN ARCHIT BUILD, V13, P247; Kubota T., 2006, J ASIAN ARCHIT BUILD, V5, P199, DOI 10.3130/jaabe.5.199; Levine M., 2007, CLIMATE CHANGE 2007, P387; Lim Jee Yuan, 1987, MALAY HOUSE REDISCOV; Liu F., 2010, 204 WORLD BANK; Liu JP, 2011, BUILD ENVIRON, V46, P1709, DOI 10.1016/j.buildenv.2011.02.012; Mahlia TMI, 2004, ENERG POLICY, V32, P1783, DOI 10.1016/S0301-4215(03)00170-8; Meir I.A., 2006, VERNACULAR ARCHITECT, P215; Ministry of Culture Arts and Heritage Malaysia, 2007, HIST CIT STRAITS MAL; Ministry of Energy Communications and Multimedia Malaysia, 2002, NAT EN BAL 2002; Ministry of Energy Water and Communications Malaysia, 2009, NAT EN BAL 2007; Mochida A, 2006, SOL ENERGY, V80, P371, DOI 10.1016/j.solener.2005.08.014; Muhaisen AS, 2006, BUILD ENVIRON, V41, P1731, DOI 10.1016/j.buildenv.2005.07.016; Nguyen AT, 2011, BUILD ENVIRON, V46, P2088, DOI 10.1016/j.buildenv.2011.04.019; Oliver Paul, 2006, BUILT MEET NEEDS CUL; Rapoport A., 2007, TDSR, V18, P57; Rapoport A., 2006, VERNACULAR ARCHITECT, P179; Ryu Y, 2009, BUILD ENVIRON, V44, P18, DOI 10.1016/j.buildenv.2008.01.007; Sivak M, 2009, ENERG POLICY, V37, P1382, DOI 10.1016/j.enpol.2008.11.031; Toe D.H.C., 2013, AIJ J TECHNOL DES, V19, P219; Toe Doris Hooi Chyee, 2013, [Frontiers of Architectural Research, 建筑学研究前沿], V2, P278; WMO, 2013, WORLD WEATH INF SERV; Yang XY, 2012, BUILD ENVIRON, V57, P38, DOI 10.1016/j.buildenv.2012.03.022	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-092X			SOL ENERGY	Sol. Energy	APR	2015	114						229	258		10.1016/j.solener.2015.01.035		30	Energy & Fuels	Energy & Fuels	CG2BU	WOS:000353080700021		
J	Matsumoto, S; Suda, K; Iimoto, S; Yasui, K; Komatsu, M; Ushiku, C; Takahata, M; Kobayashi, Y; Tojo, Y; Fujita, K; Minami, A				Matsumoto, S.; Suda, K.; Iimoto, S.; Yasui, K.; Komatsu, M.; Ushiku, C.; Takahata, M.; Kobayashi, Y.; Tojo, Y.; Fujita, K.; Minami, A.			Prospective study of deep vein thrombosis in patients with spinal cord injury not receiving anticoagulant therapy	SPINAL CORD			English	Article							VENOUS THROMBOEMBOLISM; DIAGNOSIS	Study Design: Prospective cross-sectional study. Objectives: To investigate the timing of deep vein thrombosis (DVT) onset secondary to spinal cord injury without anticoagulant therapies. Setting: Spinal Cord Injury Center in Hokkaido, Japan. Methods: Between November 2012 and June 2013, patients with spinal cord injury who were admitted to our hospital within 1 day after the injury and treated surgically within 24 h underwent a neurological examination, leg vein ultrasonography and D-dimer test 1, 3, 7, 14 and 28 days after surgery. All patients received treatment with intermittent pneumatic compression and elastic stockings, but without any anticoagulant. Results: DVT developed in 12 patients (11 men and 1 women), with a mean age of 62.2 years (range, 41-80 years; mean age of total sample, 63.2 years (range, 25-78 years)), all distal to the popliteal vein. DVT occurred more often with a more severe paralysis (66.3%, AIS A and B). The median (+/- standard error) length of time from the operation to DVT detection was 7.5 +/- 2.2 days. The mean D-dimer level upon DVT detection was 14.6 +/- 11.8 mu gml(-1), with no significant differences between those who developed DVT and those who did not at any of the time points. Conclusion: These results suggest that DVT can develop at the very-acute stage of spinal cord injury and the incidence increases with a more severe paralysis. DVT detection was more reliable with ultrasonography, which should be used with DVT-preventive measures, beginning immediately after the injury, for the management of patients with spinal cord injury.	[Matsumoto, S.; Suda, K.; Iimoto, S.; Yasui, K.; Komatsu, M.; Ushiku, C.; Takahata, M.; Kobayashi, Y.; Tojo, Y.; Fujita, K.; Minami, A.] Hokkaido Chuo Rosai Hosp, Spinal Cord Injury Ctr, Bibai, Hokkaido 0720015, Japan	Matsumoto, S (reprint author), Hokkaido Chuo Rosai Hosp, Spinal Cord Injury Ctr, Higashi 4 Minami 1, Bibai, Hokkaido 0720015, Japan.	satmatsatmat@hokkaidoh-s.rofuku.go.jp					Miranda AR, 2000, HEMATOL ONCOL CLIN N, V14, P401, DOI 10.1016/S0889-8588(05)70141-6; Sugimoto Y, 2009, J ORTHOP SCI, V14, P374, DOI 10.1007/s00776-009-1342-y; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Mattos MA, 1996, J VASC SURG, V24, P738, DOI 10.1016/S0741-5214(96)70006-X; Teasell RW, 2009, ARCH PHYS MED REHAB, V90, P232, DOI 10.1016/j.apmr.2008.09.557; Jones T, 2005, ARCH PHYS MED REHAB, V86, P2240, DOI 10.1016/j.apmr.2005.07.286; Chen Chung-Jen, 2008, Thromb J, V6, P5, DOI 10.1186/1477-9560-6-5; Christie S, 2011, J NEUROTRAUM, V28, P1509, DOI 10.1089/neu.2009.1155-A; COMEROTA AJ, 1990, J VASC SURG, V11, P53; Furlan JC, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E13; Hirsh JGuyattG, 2008, CHEST, V133, p71S; PERSSON AV, 1989, ARCH SURG-CHICAGO, V124, P593; Shiota Naofumi, 2002, J Orthop Sci, V7, P444, DOI 10.1007/s007760200077; Merli G, 2003, J TRAUMA, V54, P1116, DOI 10.1097/01.TA.0000066385.10596.71; Spinal Cord Thromboprophylaxis Investigators, 2003, J TRAUMA, V54, P1125; WARING WP, 1991, PARAPLEGIA, V29, P8	16	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	APR	2015	53	4					306	309		10.1038/sc.2015.4		4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF7GX	WOS:000352725500009		
J	Nakazawa, K; Naya, H				Nakazawa, Koji; Naya, Hiroto			Strong Reduction of Combinatory Calculus with Streams	STUDIA LOGICA			English	Article						Combinatory logic; Lambda-mu calculus; Strong reduction; Confluence	LAMBDA-MU-CALCULUS	This paper gives the strong reduction of the combinatory calculus SCL, which was introduced as a combinatory calculus corresponding to the untyped Lambda-mu calculus. It proves the confluence of the strong reduction. By the confluence, it also proves the conservativity of the extensional equality of SCL over the combinatory calculus CL, and the consistency of SCL.	[Nakazawa, Koji] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Naya, Hiroto] FORCIA Inc, Tokyo, Japan	Nakazawa, K (reprint author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	knak@kuis.kyoto-u.ac.jp					David R, 2009, THEOR COMPUT SCI, V410, P4204, DOI 10.1016/j.tcs.2009.04.017; Dehornoy P., 2008, LOGICAL MODELS REASO; Hindley R., 2008, LAMBDA CALCULUS COMB; Komori Y., 2013, STUDIA LOGICA, V102, P175; Minari P, 2009, ARCH MATH LOGIC, V48, P159, DOI 10.1007/s00153-008-0109-z; Nakazawa K., 2012, ELECT P THEORETICAL, V97, P35; PARIGOT M, 1992, LECT NOTES ARTIF INT, V624, P190, DOI 10.1007/BFb0013061; Saurin A., 2005, 20 ANN IEEE S LOG CO, P356, DOI 10.1109/LICS.2005.48; Saurin A, 2010, ACM T COMPUT LOG, V11, DOI 10.1145/1805950.1805958; Saurin A, 2010, LECT NOTES COMPUT SC, V6009, P134, DOI 10.1007/978-3-642-12251-4_11	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0039-3215			STUD LOGICA	Stud. Log.	APR	2015	103	2					375	387		10.1007/s11225-014-9570-3		13	Mathematics; Logic; Philosophy	Mathematics; Science & Technology - Other Topics; Philosophy	CF5UY	WOS:000352623900006		
J	Nagashima, H				Nagashima, Hideo			Efficient Transition Metal-Catalyzed Reactions of Carboxylic Acid Derivatives with Hydrosilanes and Hydrosiloxanes, Afforded by Catalyst Design and the Proximity Effect of Two Si-H Groups	SYNLETT			English	Article						homogeneous catalysis; reduction; hydrosilylation; amides; carboxylic acids; esters; metal complexes	TRIRUTHENIUM CARBONYL CLUSTER; RING-OPENING POLYMERIZATION; EN CHIMIE ORGANIQUE; SELECTIVE REDUCTION; TERTIARY AMIDES; REDUCING AGENT; ALKYL ETHERS; ENANTIOSELECTIVE HYDROSILYLATION; ASYMMETRIC HYDROSILYLATION; UNSATURATED MOLECULES	The discovery of the ruthenium cluster (3),-((2):(3):(5)-acenaphythylene)Ru-3(CO)(7) (1), which is active in catalytic reactions involving Si-H bond activation, and the rate enhancement by the proximity effect of two Si-H groups enabled the reduction of carboxylic acid derivatives with hydrosilanes under mild reaction conditions. A judicious choice of the hydrosilane and of the additives led to a remarkably selective reduction. Besides simple reduction, the treatment of carboxylic acid derivatives with hydrosilanes in the presence of 1 led to new reactions involving several C-O and C-C bond-forming as well as C-O bond-cleavage steps. These reactions included polymerization, rearrangement, and aromatic substitution. The use of inexpensive 1,1,3,3-tetramethyldisiloxane (TMDS) facilitated the efficient reduction of amides to amines using either 1, commercially available platinum compounds, or environmentally friendly iron complexes. The conversion of tertiary amides into aldenamines was achieved by iridium catalysis. In the ruthenium-, iridium-, platinum-, and iron-catalyzed reduction of amides, the use of the reducing reagent polymethylhydrosiloxane (PMHS) resulted in self-encapsulation of the residual metal species into the formed silicone gel to give the metal-free' product in a straightforward way. 1 Introduction 2 Two Key Preliminary Investigations 2.1 A Ruthenium Cluster for Si-H Bond Activation 2.2 Proximity Effect of Two Si-H Groups for Rate Enhancement 3 Ruthenium-Catalyzed Reduction of Carboxylic Acid Derivatives 3.1 From Ketones to Less Reactive Carboxylic Acid Derivatives 3.2 Self-Encapsulation of the Residual Metals into Silicone Gel 4 Extension to C-O and C-C Bond-Forming Reactions 4.1 Reduction versus Ring-Opening Polymerization of Cyclic Ethers 4.2 Polymerization versus Rearrangement of Vinyl Ethers 4.3 Is R3Si+' Involved in the Reactions? 4.4 Applications of R3Si+'-Mediated Reactions 5 Reductions with Unique Selectivity 6 Surfing the Periodic Table 7 Concluding Remarks	[Nagashima, Hideo] Kyushu Univ, Inst Mat Chem & Engn, Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Nagashima, Hideo] Japan Sci & Technol Agcy JST, CREST, Kasuga, Fukuoka 8168580, Japan	Nagashima, H (reprint author), Kyushu Univ, Inst Mat Chem & Engn, Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan.	nagasima@cm.kyush-u.ac.jp					Andersson P. G., 2008, MODERN REDUCTION MET; Inamoto Y, 2013, ORG LETT, V15, P3452, DOI 10.1021/ol4015317; Yang JA, 2010, ANGEW CHEM INT EDIT, V49, P10186, DOI 10.1002/anie.201005055; Parks DJ, 1996, J AM CHEM SOC, V118, P9440, DOI 10.1021/ja961536g; Gunanathan C, 2011, ACCOUNTS CHEM RES, V44, P588, DOI 10.1021/ar2000265; Castro LCM, 2012, CHEM COMMUN, V48, P151, DOI 10.1039/c1cc14403k; Revunova K, 2014, CHEM-EUR J, V20, P839, DOI 10.1002/chem.201302728; BRUNNER H, 1990, ANGEW CHEM INT EDIT, V29, P1131, DOI 10.1002/anie.199011311; WEST CT, 1973, J ORG CHEM, V38, P2675, DOI 10.1021/jo00955a022; Enthaler S, 2013, ACS CATAL, V3, P150, DOI 10.1021/cs300685q; Motoyama Y, 2011, CHEM-ASIAN J, V6, P78, DOI 10.1002/asia.201000527; CULLEN WR, 1987, INORG CHEM, V26, P514, DOI 10.1021/ic00251a007; Coetzee J, 2013, CHEM-EUR J, V19, P11039, DOI 10.1002/chem.201204270; Castro LCM, 2012, CHEM COMMUN, V48, P10514, DOI 10.1039/c2cc35727e; Ojima I, 1998, CHEM FUNCT, V2, P1687, DOI 10.1002/0470857250.ch29; Ruddy AJ, 2013, ORGANOMETALLICS, V32, P5581, DOI 10.1021/om400883u; Paspirgelyte R, 2009, SYNTHETIC MET, V159, P1014, DOI 10.1016/j.synthmet.2009.01.015; Fernandes AC, 2007, J MOL CATAL A-CHEM, V272, P60, DOI 10.1016/j.molcata.2007.03.019; Li HQ, 2013, ANGEW CHEM INT EDIT, V52, P8045, DOI 10.1002/anie.201303003; Metsanen TT, 2014, J AM CHEM SOC, V136, P6912, DOI 10.1021/ja503254f; Park S, 2010, ORGANOMETALLICS, V29, P6057, DOI 10.1021/om100818y; Gutsulyak DV, 2010, J AM CHEM SOC, V132, P5950, DOI 10.1021/ja101583m; BERK SC, 1991, J AM CHEM SOC, V113, P5093, DOI 10.1021/ja00013a074; Yang YF, 2014, J ORG CHEM, V79, P8856, DOI 10.1021/jo501730n; MOORE EJ, 1986, J AM CHEM SOC, V108, P2257, DOI 10.1021/ja00269a022; Olah GA, 1996, MACROMOLECULES, V29, P1857, DOI 10.1021/ma951283w; Nolin KA, 2007, J AM CHEM SOC, V129, P14684, DOI 10.1021/ja074477n; Zheng JX, 2013, CHEM COMMUN, V49, P10010, DOI 10.1039/c3cc45349a; NAGASHIMA H, 1995, ORGANOMETALLICS, V14, P2868, DOI 10.1021/om00006a036; Shirobokov OG, 2011, J AM CHEM SOC, V133, P6487, DOI 10.1021/ja111748u; Reeves JT, 2013, ADV SYNTH CATAL, V355, P47, DOI 10.1002/adsc.201200835; Rendler S, 2007, ANGEW CHEM INT EDIT, V46, P498, DOI 10.1002/aine.200602668; BARR KJ, 1994, J ORG CHEM, V59, P4323, DOI 10.1021/jo00094a056; Dombray T, 2013, ADV SYNTH CATAL, V355, P3358, DOI 10.1002/adsc.201300664; MAO ZB, 1995, J AM CHEM SOC, V117, P10139, DOI 10.1021/ja00145a036; Sunada Y, 2008, ORGANOMETALLICS, V27, P3502, DOI 10.1021/om800151w; Gansauer A, 2012, ANGEW CHEM INT EDIT, V51, P8891, DOI 10.1002/anie.201202818; Piers WE, 2011, INORG CHEM, V50, P12252, DOI 10.1021/ic2006474; Blom B, 2013, J AM CHEM SOC, V135, P18108, DOI 10.1021/ja410234x; Kuwano R, 1998, TETRAHEDRON LETT, V39, P1017, DOI 10.1016/S0040-4039(97)10804-8; Das S, 2010, J AM CHEM SOC, V132, P1770, DOI 10.1021/ja910083q; CORRIU RJP, 1982, J ORGANOMET CHEM, V228, P301, DOI 10.1016/S0022-328X(00)84331-4; Zhou S, 2009, ANGEW CHEM INT EDIT, V48, P9507, DOI 10.1002/anie.200904677; REDING MT, 1995, J ORG CHEM, V60, P7884, DOI 10.1021/jo00129a031; Hosokawa S, 2010, ORGANOMETALLICS, V29, P5773, DOI 10.1021/om1009186; PETASIS NA, 1995, J AM CHEM SOC, V117, P6394, DOI 10.1021/ja00128a044; Park S, 2012, J AM CHEM SOC, V134, P640, DOI 10.1021/ja209567m; Tsutsumi H, 2011, CHEM COMMUN, V47, P6581, DOI 10.1039/c1cc10636h; Dub PA, 2012, ACS CATAL, V2, P1718, DOI 10.1021/cs300341g; FRY JL, 1978, J ORG CHEM, V43, P374, DOI 10.1021/jo00396a056; Langlotz BK, 2008, ANGEW CHEM INT EDIT, V47, P4670, DOI 10.1002/anie.200801150; Verdaguer X, 1995, J AM CHEM SOC, V117, P12641, DOI 10.1021/ja00155a031; Verdaguer X, 1997, J ORG CHEM, V62, P8522, DOI 10.1021/jo971560s; Tondreau AM, 2009, ORGANOMETALLICS, V28, P3928, DOI 10.1021/om900224e; Mwangi MT, 2006, J AM CHEM SOC, V128, P14434, DOI 10.1021/ja0642212; Gaillard S, 2008, CHEMSUSCHEM, V1, P505, DOI 10.1002/cssc.200800071; Yang J, 2008, ANGEW CHEM INT EDIT, V47, P4141, DOI 10.1002/anie.200705359; Igarashi M, 2001, TETRAHEDRON LETT, V42, P1945, DOI 10.1016/S0040-4039(01)00039-9; Wang WM, 2014, ORGANOMETALLICS, V33, P847, DOI 10.1021/om400634w; Shaikh NS, 2008, ANGEW CHEM INT EDIT, V47, P2497, DOI 10.1002/anie.200705624; Diez-Gonzalez S, 2006, ORGANOMETALLICS, V25, P2355, DOI 10.1021/om0600487; Muther K, 2011, CHEM COMMUN, V47, P334, DOI 10.1039/c0cc02139c; Gevorgyan V, 2000, J ORG CHEM, V65, P6179, DOI 10.1021/jo000726d; OCONNOR JM, 1987, CHEM REV, V87, P307, DOI 10.1021/cr00078a002; HAYASHI T, 1976, J ORGANOMET CHEM, V112, P253, DOI 10.1016/S0022-328X(00)87108-9; Sunada Y, 2009, ANGEW CHEM INT EDIT, V48, P9511, DOI 10.1002/anie.200905025; Igarashi M, 2001, TETRAHEDRON LETT, V42, P2149, DOI 10.1016/S0040-4039(01)00094-6; WARD DE, 1989, CAN J CHEM, V67, P1206, DOI 10.1139/v89-182; Zuo ZY, 2014, DALTON T, V43, P11716, DOI 10.1039/c4dt00944d; Vankelecom IFJ, 1996, ANGEW CHEM INT EDIT, V35, P1346, DOI 10.1002/anie.199613461; Sakai N, 2011, TETRAHEDRON LETT, V52, P3133, DOI 10.1016/j.tetlet.2011.04.029; Sunada Y, 2013, DALTON T, V42, P16687, DOI 10.1039/c3dt52598h; Junge K, 2011, CHEM COMMUN, V47, P4849, DOI 10.1039/c0cc05733a; Parks DJ, 2000, J ORG CHEM, V65, P3090, DOI 10.1021/jo991828a; Ohta T, 2005, B CHEM SOC JPN, V78, P1856, DOI 10.1246/bcsj.78.1856; Belanger G, 2006, J ORG CHEM, V71, P7481, DOI 10.1021/jo0611061; Motoyama Y, 2009, ORG LETT, V11, P1345, DOI 10.1021/ol9001366; OJIMA I, 1982, ORGANOMETALLICS, V1, P1390, DOI 10.1021/om00070a024; Nagashima H, 2000, ORGANOMETALLICS, V19, P3579, DOI 10.1021/om0003887; Zhao H, 2014, ORGANOMETALLICS, V33, P3535, DOI 10.1021/om500429r; Zhang J, 2006, ANGEW CHEM INT EDIT, V45, P1113, DOI 10.1002/anie.200503771; Carpentier JF, 2002, CURR ORG CHEM, V6, P913, DOI 10.2174/1385272023373851; Goethals EJ, 2007, PROG POLYM SCI, V32, P220, DOI 10.1016/j.progpolymsci.2007.01.001; Addis D, 2011, ANGEW CHEM INT EDIT, V50, P6004, DOI 10.1002/anie.201100145; Fernandez-Salas JA, 2013, CHEM COMMUN, V49, P9758, DOI 10.1039/c3cc45930f; Yang J, 2008, J AM CHEM SOC, V130, P17509, DOI 10.1021/ja806419h; Diez-Gonzalez S, 2008, ACCOUNTS CHEM RES, V41, P349, DOI 10.1021/ar7001655; Hanada S, 2006, TETRAHEDRON LETT, V47, P6173, DOI 10.1016/j.tetlet.2006.06.165; Sinicropi JA, 1997, CHEM PHYS, V218, P331, DOI 10.1016/S0301-0104(97)00081-5; Le Bailly BAF, 2011, RSC ADV, V1, P1435, DOI 10.1039/c1ra00476j; Motoyama Y, 2005, J AM CHEM SOC, V127, P13150, DOI 10.1021/ja0544531; JUNG ME, 1977, J ORG CHEM, V42, P3761, DOI 10.1021/jo00443a033; CORRIU RJP, 1983, TETRAHEDRON, V39, P999, DOI 10.1016/S0040-4020(01)88599-9; Matsubara K, 2002, J ORG CHEM, V67, P4985, DOI 10.1021/jo025726n; Tsutsumi H, 2011, ORGANOMETALLICS, V30, P68, DOI 10.1021/om100867f; Manas MG, 2014, NEW J CHEM, V38, P1694, DOI 10.1039/c3nj01485a; MURAI T, 1990, J ORG CHEM, V55, P449, DOI 10.1021/jo00289a014; Das S, 2012, ANGEW CHEM INT EDIT, V51, P1662, DOI 10.1002/anie.201108155; Cheng C, 2012, J AM CHEM SOC, V134, P11304, DOI 10.1021/ja304547s; FUJITA M, 1984, J AM CHEM SOC, V106, P4629, DOI 10.1021/ja00328a062; Hanada S, 2009, J AM CHEM SOC, V131, P15032, DOI 10.1021/ja9055307; BROWN HC, 1979, TETRAHEDRON, V35, P567, DOI 10.1016/0040-4020(79)87003-9; Mimoun H, 1999, J ORG CHEM, V64, P2582, DOI 10.1021/jo982314z; Bezier D, 2013, ORG LETT, V15, P496, DOI 10.1021/ol303296a; Hanada S, 2007, J ORG CHEM, V72, P7551, DOI 10.1021/jo070591c; Gutsulyak DV, 2010, ANGEW CHEM INT EDIT, V49, P7553, DOI 10.1002/anie.201003069; Yang J, 2009, ADV SYNTH CATAL, V351, P175, DOI 10.1002/adsc.200800528; Arias-Ugarte R, 2012, J AM CHEM SOC, V134, P848, DOI 10.1021/ja2101246; Auge J., 2007, SYNTHESIS, P1739; Augustine JK, 2008, SYNLETT, P2429, DOI 10.1055/s-2008-1078207; Augustine R. L, 1996, HETEROGENEOUS CATALY; Baay Y. L., 1967, INORG NUCL CHEM LETT, V3, P159, DOI 10.1016/0020-1650(67)80013-8; Beddie C, 2004, J AM CHEM SOC, V126, P13564, DOI 10.1021/ja046525z; BROWN HC, 1987, J ORG CHEM, V52, P5400, DOI 10.1021/jo00233a018; BROWN HC, 1977, J ORG CHEM, V42, P4169, DOI 10.1021/jo00445a049; Brunner H, 2002, APPL HOMOGENOUS CATA, DOI 10.1002/9783527618231.ch2b; Bullock RM, 2007, ANGEW CHEM INT EDIT, V46, P7360, DOI 10.1002/anie.200703053; CALAS R, 1962, CR HEBD ACAD SCI, V254, P2357; CHALK AJ, 1970, J CHEM SOC CHEM COMM, P847, DOI 10.1039/c29700000847; CHALK AJ, 1967, J AM CHEM SOC, V89, P1640, DOI 10.1021/ja00983a020; Chaloner P. A., 2010, HOMOGENEOUS HYDROGEN; Chandrasekhar S, 1998, TETRAHEDRON LETT, V39, P909, DOI 10.1016/S0040-4039(97)10688-8; CHO CG, 1992, MACROMOLECULES, V25, P2081, DOI 10.1021/ma00034a004; CHUIT C, 1982, SYNTHESIS-STUTTGART, P981; Committee for Medicinal Products for Human Use (CHMP), 2008, GUID SPEC LIM RES ME; Cook A. G., 1992, SYNTHESIS STRUCTURE; CRIVELLO JV, 1993, J POLYM SCI POL CHEM, V31, P3121, DOI 10.1002/pola.1993.080311228; Crivello JV, 1997, TETRAHEDRON, V53, P15167, DOI 10.1016/S0040-4020(97)00955-1; Das S, 2012, CHEM COMMUN, V48, P10742, DOI 10.1039/c2cc32142d; Drees M, 2007, INORG CHEM, V46, P10850, DOI 10.1021/ic7017314; FRAINNET E, 1962, CR HEBD ACAD SCI, V254, P1814; Fujihara T, 2013, ADV SYNTH CATAL, V355, P3420, DOI 10.1002/adsc.201300451; Gansauer A, 2003, ADV SYNTH CATAL, V345, P1017, DOI 10.1002/adsc.200303059; Glaser PB, 2003, J AM CHEM SOC, V125, P13640, DOI 10.1021/ja037620v; Goossen LJ, 2002, CHEM COMMUN, P836, DOI 10.1039/b201577n; Hajos A., 1979, COMPLEX HYDRIDES; Hanada S, 2010, EUR J ORG CHEM, P1021, DOI 10.1002/ejoc.200901279; Hanada S, 2008, EUR J ORG CHEM, P4097, DOI 10.1002/ejoc.200800523; Harada N, 2011, B CHEM SOC JPN, V84, P26, DOI 10.1246/bcsj.20100155; Harada NA, 2012, TETRAHEDRON, V68, P3243, DOI 10.1016/j.tet.2012.02.025; Hog DT, 2009, EUR J ORG CHEM, P5047, DOI 10.1002/ejoc.200900796; HRKACH JS, 1990, MACROMOLECULES, V23, P4042, DOI 10.1021/ma00220a003; HUBERT TD, 1984, J ORG CHEM, V49, P2279, DOI 10.1021/jo00186a038; IZAWA T, 1979, B CHEM SOC JPN, V52, P555, DOI 10.1246/bcsj.52.555; Junge K, 2013, EUR J ORG CHEM, P2061, DOI 10.1002/ejoc.201300039; KIRA M, 1992, CHEM LETT, P555, DOI 10.1246/cl.1992.555; KRISHNAMURTHY S, 1981, J ORG CHEM, V46, P4628, DOI 10.1021/jo00335a082; Kuroiwa Y, 2008, SYNLETT, P2523, DOI 10.1055/s-2008-1078217; KURSANOV DN, 1974, SYNTHESIS-STUTTGART, P633; LANE CF, 1976, CHEM REV, V76, P773, DOI 10.1021/cr60304a005; Larson G. L., 2010, IONIC ORGANOMETALLIC; Lavis J. M., 2011, HDB REAGENTS ORGANIC, P427; Lawrence N. J., 1999, J CHEM SOC P1, P3381; Luzt R. P., 1984, CHEM REV, V84, P206; Marciniec B., 2009, HYDROSILYLATION, P289; Marciniec B., 1992, COMPREHENSIVE HDB HY, P139; Martinez JL, 2014, ORGANOMETALLICS, V33, P2964, DOI 10.1021/om500439p; Matsubara K, 2002, ORGANOMETALLICS, V21, P3023, DOI 10.1021/om0200050; Matsubara K, 2002, J ORGANOMET CHEM, V660, P145, DOI 10.1016/S0022-328X(02)01816-8; Matyjaszewski K., 1996, CATIONIC POLYMERIZAT; Mayr H, 1997, TETRAHEDRON LETT, V38, P1013, DOI 10.1016/S0040-4039(96)02484-7; Mewald M, 2012, CHEM-EUR J, V18, P14079, DOI 10.1002/chem.201202693; Miyamoto K, 2012, CHEM LETT, V41, P229, DOI 10.1246/cl.2012.229; MORI A, 1986, TETRAHEDRON LETT, V27, P987, DOI 10.1016/S0040-4039(00)84156-8; Motoyama Y, 2010, CHEM COMMUN, V46, P2256, DOI 10.1039/b923213c; Motoyama Y, 2008, CHEM COMMUN, P5321, DOI 10.1039/b809937e; Motoyama Y, 2009, CHEM COMMUN, P1574, DOI 10.1039/b821317h; Motoyama Y., 2005, ORG SYNTH, V82, P188; MURAKI M, 1974, CHEM LETT, P1447, DOI 10.1246/cl.1974.1447; Nagashima H, 2011, TETRAHEDRON, V67, P7667, DOI 10.1016/j.tet.2011.08.033; NAGASHIMA H, 1989, ORGANOMETALLICS, V8, P2495, DOI 10.1021/om00112a041; NAGASHIMA H, 1993, J AM CHEM SOC, V115, P10430, DOI 10.1021/ja00075a097; Nagashima H., 2014, IRON PROMOTED REDUCT, P325; NAGASHIMA H, 1989, J CHEM SOC PERK T 1, P1707, DOI 10.1039/p19890001707; Nagashima H, 2004, ORGANOMETALLICS, V23, P5779, DOI 10.1021/om049499m; Nagashima H, 1996, J AM CHEM SOC, V118, P687, DOI 10.1021/ja953742e; Nakatani N., UNPUB; Nishikata T, 2012, ANGEW CHEM INT EDIT, V51, P5363, DOI 10.1002/anie.201201426; Nishimura S., 2001, HDB HETEROGENEOUS CA; Nishiyama H., 2004, TRANSITION METALS OR, V2, P182; Nishiyama H, 2007, CHEM COMMUN, P760, DOI 10.1039/b617388h; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Ohta T, 2003, CHEM COMMUN, P1192, DOI 10.1039/b302124f; Ojima I., 1989, CHEM ORGANIC SILICON, V1, P1479; Palani N., 1995, TETRAHEDRON LETT, V52, P9527; Park S, 2011, CHEM COMMUN, V47, P3643, DOI 10.1039/c0cc05714b; Piseiwicz S., 2014, EUR J ORG CHEM, P2345; Prakash GKS, 2002, J ORG CHEM, V67, P1297, DOI 10.1021/jo0109974; RANU BC, 1993, SYNLETT, P885; RIGO B, 1986, TETRAHEDRON LETT, V27, P347, DOI 10.1016/S0040-4039(00)84015-0; Sakai N, 2011, EUR J ORG CHEM, P3178, DOI 10.1002/ejoc.201100161; Sakaki S., 1999, COORDIN CHEM REV, V190-192, P933, DOI 10.1016/S0010-8545(99)00130-7; Sasakuma H, 2007, CHEM COMMUN, P4916, DOI 10.1039/b711743d; SATO F, 1981, SYNTHESIS-STUTTGART, P871; Seyden-Penne J., 1997, REDUCTION ALUMINO BO; Smith AB, 1999, ORG LETT, V1, P909, DOI 10.1021/ol990830l; Smith M. B., 2007, MARCHS ADV ORGANIC C, P1786; du Roizel B, 2000, CHEM COMMUN, P1507, DOI 10.1039/b003277h; Sunada Y, 2013, ORGANOMETALLICS, V32, P2112, DOI 10.1021/om3012322; Sunada Y, 2010, ORGANOMETALLICS, V29, P6157, DOI 10.1021/om100889w; Tahara A., UNPUB; Thayer A., 2005, CHEM ENG NEWS, V83, P55; Toh CK, 2012, ORGANOMETALLICS, V31, P3880, DOI 10.1021/om2012634; Volkov A, 2013, EUR J ORG CHEM, P2066, DOI 10.1002/ejoc.201300010; Wolfson A, 2002, CHEM COMMUN, P388, DOI 10.1039/b109234k; Yumino S, 2014, CHEM LETT, V43, P1829, DOI 10.1246/cl.140731; Zell T, 2014, ANGEW CHEM INT EDIT, V53, P4685, DOI 10.1002/anie.201311221; Zeynizadeh B, 2003, B CHEM SOC JPN, V76, P317, DOI 10.1246/bcsj.76.317; Zhou SL, 2009, CHEM COMMUN, P4883, DOI 10.1039/b910145d	209	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	APR	2015	26	7					866	890		10.1055/s-0034-1379989		25	Chemistry, Organic	Chemistry	CF8HG	WOS:000352796300004		
J	Iwai, T; Matsumoto, F; Hida, K; Moriwaki, K; Takao, Y; Ito, T; Mizuno, T; Ohno, T				Iwai, Toshiyuki; Matsumoto, Fukashi; Hida, Koichi; Moriwaki, Kazuyuki; Takao, Yuko; Ito, Takatoshi; Mizuno, Takumi; Ohno, Toshinobu			Facile Synthesis of Methanofullerenes in an Aqueous Two-Phase System under Photoirradiation Conditions	SYNLETT			English	Article						photovoltaics; fullerenes; hydrazones; methanofullerenes; PCBM	HETEROJUNCTION SOLAR-CELLS; FULLERENE DERIVATIVES; PHOTOVOLTAIC CELLS; LUMO-LEVEL; C-60; EFFICIENT; ACCEPTOR; PERFORMANCE; DESIGN; SOLUBILITY	Methanofullerenes, such as [6,6]-phenyl-C-61-butyric acid methyl ester {[6,6]PC61BM (1a)}, were synthesized in good yields from the corresponding tosylhydrazones in an aqueous two-phase (o-dichlorobenzene-H2O) system under photoirradiation conditions. This simple and convenient procedure was adopted for the synthesis of thienyl analogues of PC61BM and its C-70 analogue, PC71BM.	[Iwai, Toshiyuki; Matsumoto, Fukashi; Hida, Koichi; Moriwaki, Kazuyuki; Takao, Yuko; Ito, Takatoshi; Mizuno, Takumi; Ohno, Toshinobu] Osaka Municipal Tech Res Inst, Joto Ku, Osaka 5368553, Japan	Iwai, T (reprint author), Osaka Municipal Tech Res Inst, Joto Ku, 1-6-50 Morinomiya, Osaka 5368553, Japan.	iwai@omtri.or.jp; ohno@omtri.or.jp			Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST); JSPS KAKENHI [23750232, 22550176]	This research was supported in part by Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST) and JSPS KAKENHI Grant Number 23750232 and 22550176.	Matsumoto F, 2012, J ORG CHEM, V77, P9038, DOI 10.1021/jo3015159; JANSSEN RAJ, 1995, J AM CHEM SOC, V117, P544, DOI 10.1021/ja00106a068; He YJ, 2010, J AM CHEM SOC, V132, P1377, DOI 10.1021/ja908602j; Price SC, 2011, J AM CHEM SOC, V133, P4625, DOI 10.1021/ja1112595; Gendron D, 2011, MACROMOLECULES, V44, P7188, DOI 10.1021/ma2013496; Dang MT, 2013, CHEM REV, V113, P3734, DOI 10.1021/cr300005u; Li CZ, 2011, CHEM COMMUN, V47, P10082, DOI 10.1039/c1cc14446d; Matsuo Y, 2012, CHEM LETT, V41, P754, DOI 10.1246/cl.2012.754; Piliego C, 2010, J AM CHEM SOC, V132, P7595, DOI 10.1021/ja103275u; Morinaka Y, 2013, CHEM COMMUN, V49, P3670, DOI 10.1039/c3cc41084f; Troshin PA, 2009, ADV FUNCT MATER, V19, P779, DOI 10.1002/adfm.200801189; RUOFF RS, 1993, J PHYS CHEM-US, V97, P3379, DOI 10.1021/j100115a049; Dennler G, 2009, ADV MATER, V21, P1323, DOI 10.1002/adma.200801283; SCRIVENS WA, 1993, J CHEM SOC CHEM COMM, P1207, DOI 10.1039/c39930001207; Dang MT, 2011, ADV MATER, V23, P3597, DOI 10.1002/adma.201100792; Service RF, 2011, SCIENCE, V332, P293, DOI 10.1126/science.332.6027.293; Kooistra FB, 2007, ORG LETT, V9, P551, DOI 10.1021/ol062666p; Meng XY, 2012, CHEM COMMUN, V48, P425, DOI 10.1039/c1cc15508c; Lenes M, 2009, ADV FUNCT MATER, V19, P3002, DOI 10.1002/adfm.200900459; Brabec CJ, 2010, ADV MATER, V22, P3839, DOI 10.1002/adma.200903697; Shu CY, 2009, ORG LETT, V11, P1753, DOI 10.1021/ol9002527; Li G, 2005, J APPL PHYS, V98, DOI 10.1063/1.2008386; Wienk MM, 2003, ANGEW CHEM INT EDIT, V42, P3371, DOI 10.1002/anie.200351647; HUMMELEN JC, 1995, J ORG CHEM, V60, P532, DOI 10.1021/jo00108a012; Shaheen SE, 2001, APPL PHYS LETT, V78, P841, DOI 10.1063/1.1345834; Matsuo Y, 2008, J AM CHEM SOC, V130, P15429, DOI 10.1021/ja8041299; Brabec CJ, 2001, ADV FUNCT MATER, V11, P15, DOI 10.1002/1616-3028(200102)11:1<15::AID-ADFM15>3.0.CO;2-A; Zhao HY, 2010, J MATER CHEM, V20, P3092, DOI 10.1039/b925089a; Su MS, 2011, ADV MATER, V23, P3315, DOI 10.1002/adma.201101274; Seyler H, 2011, J ORG CHEM, V76, P3551, DOI 10.1021/jo2001879; Jonczyk A, 2001, TETRAHEDRON, V57, P2827, DOI 10.1016/S0040-4020(01)00133-8; BAMFORD WR, 1952, J CHEM SOC, P4735, DOI 10.1039/jr9520004735; Bouwer RKM, 2010, CHEM-EUR J, V16, P11250, DOI 10.1002/chem.201000537; Lens M., 2008, ADV MATER, V20, P2116; LI J, 1993, J CHEM SOC CHEM COMM, P1784, DOI 10.1039/c39930001784; Matsumoto F, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.33; Yoshimura K, 2012, TETRAHEDRON, V68, P3605, DOI 10.1016/j.tet.2012.02.080; Moriwaki K, 2010, TETRAHEDRON, V66, P7316, DOI 10.1016/j.tet.2010.06.089; Rossi E., 2010, ENERG ENVIRON SCI, V4, P725; Shapiro R. H., 1976, ORG REACTIONS, V23, P405	40	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	APR	2015	26	7					960	964		10.1055/s-0034-1380127		5	Chemistry, Organic	Chemistry	CF8HG	WOS:000352796300019		
J	Adachi, M; Torii, M; Nishikawa, T				Adachi, Masaatsu; Torii, Mai; Nishikawa, Toshio			Stereocontrolled Synthesis of ABC Tricycle of Solanoeclepin A	SYNLETT			English	Article						solanoeclepin A; natural products; radical cyclization; iodoetherification; enyne metathesis	INTRAMOLECULAR 2+2 PHOTOCYCLOADDITIONS; RADICAL CONJUGATE ADDITIONS; LEFT-HAND SUBSTRUCTURE; ENYNE METATHESIS; ALLENE BUTENOLIDE; NATURAL-PRODUCTS; A SYNTHESIS; RING; HETEROCYCLES; SEGMENT	A tricyclic compound possessing oxabicyclo[2.2.1]heptane and seven-membered ring of solanoeclepin A, the most active hatching agent of potato cyst nematode, was synthesized from d-pantolactone. The synthesis features a tin-mediated 6-exo-trig radical cyclization followed by iodoetherification and ring-closing enyne metathesis.	[Adachi, Masaatsu; Torii, Mai; Nishikawa, Toshio] Nagoya Univ, Grad Sch Bioagr Sci, Organ Chem Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Adachi, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Organ Chem Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	madachi@agr.nagoya-u.ac.jp; nisikawa@agr.nagoya-u.ac.jp			MEXT; Yamada Science Foundation; Daiichi Sankyo Foundation of Life Science; SUNBOR GRANT from the Suntory Institute for Bioorganic Research	This work was financially supported by Grants-in-Aid for Young Scientists ( Start-up and B) and for Scientific Research C, and on Innovative Areas 'Chemical Biology of Natural Products'<SUP>22</SUP> from MEXT, the Yamada Science Foundation, the Daiichi Sankyo Foundation of Life Science, and a SUNBOR GRANT from the Suntory Institute for Bioorganic Research.	Adachi M, 2009, SYNLETT, P1157, DOI 10.1055/s-0028-1088108; Mori M, 2007, ADV SYNTH CATAL, V349, P121, DOI 10.1002/adsc.200600484; Mori M, 1998, J ORG CHEM, V63, P6082, DOI 10.1021/jo980896e; Chattopadhyay SK, 2007, TETRAHEDRON, V63, P3919, DOI 10.1016/j.tet.2007.01.063; Zhang W, 2001, TETRAHEDRON, V57, P7237, DOI 10.1016/S0040-4020(01)00634-2; Hoye TR, 1999, ORG LETT, V1, P1123, DOI 10.1021/ol990947+; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4490, DOI 10.1002/anie.200500369; Ueda M, 2012, CHEM LETT, V41, P658, DOI 10.1246/cl.2012.658; Srikanth GSC, 2005, TETRAHEDRON, V61, P10377, DOI 10.1016/j.tet.2005.07.077; Villar H, 2007, CHEM SOC REV, V36, P55, DOI 10.1039/b508899m; BECKWITH ALJ, 1980, J CHEM SOC PERK T 2, P1083, DOI 10.1039/p29800001083; Benningshof JCJ, 2002, J CHEM SOC PERK T 1, P1701, DOI 10.1039/b202020n; Benningshof JCJ, 2002, J CHEM SOC PERK T 1, P1693, DOI 10.1039/b201987f; Benningshof JCJ, 2000, CHEM COMMUN, P1465, DOI 10.1039/b003757p; Blaauw RH, 2000, CHEM COMMUN, P1463, DOI 10.1039/b003755i; Blaauw RH, 2001, J ORG CHEM, V66, P233, DOI 10.1021/jo0056500; Briere JF, 2001, EUR J ORG CHEM, P2371, DOI 10.1002/1099-0690(200106)2001:12<2371::AID-EJOC2371>3.0.CO;2-O; Bruneau C., 2006, ANGEW CHEM INT EDIT, V45, P2716; Brunel Y, 1996, J ORG CHEM, V61, P5793, DOI 10.1021/jo960506t; Chuang HY, 2014, ORG LETT, V16, P4166, DOI 10.1021/ol501858w; Hue BTB, 2006, EUR J ORG CHEM, P127, DOI 10.1002/ejoc.200500609; FRIED J, 1969, TETRAHEDRON LETT, P1379; GODFREY AG, 1990, TETRAHEDRON LETT, V31, P4825; Hue BTB, 2003, ORG BIOMOL CHEM, V1, P4364, DOI 10.1039/b311415e; Kato K, 1998, SYNTHESIS-STUTTGART, P1527; Komada T, 2012, CHEM LETT, V41, P287, DOI 10.1246/cl.2012.287; Lin YT, 2014, ORG LETT, V16, P5948, DOI 10.1021/ol5029755; Lutteke G, 2011, EUR J ORG CHEM, P3146, DOI 10.1002/ejoc.201100245; Mori M., 2010, METATHESIS NATURAL S, V1, P183; Mulder J. G., 1993, [No title captured], Patent No. [WO 9302083, 9302083]; Paquette LA, 2001, J AM CHEM SOC, V123, P4492, DOI 10.1021/ja010313+; Schenk H, 1999, CROAT CHEM ACTA, V72, P593; Shiina I, 2001, B CHEM SOC JPN, V74, P113, DOI 10.1246/bcsj.74.113; Tanino K, 2011, NAT CHEM, V3, P484, DOI [10.1038/nchem.1044, 10.1038/NCHEM.1044]; Tojo S, 2005, SYNTHESIS-STUTTGART, P1237, DOI 10.1055/s-2005-86529; Tsao KW, 2012, ORG LETT, V14, P5274, DOI 10.1021/ol302432d; Blaauw RH, 2001, J CHEM SOC PERK T 1, P2250, DOI 10.1039/b104165g; Zard S. Z., 2003, RADICAL REACTIONS OR, P58	38	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	APR	2015	26	7					965	969		10.1055/s-0034-1380399		5	Chemistry, Organic	Chemistry	CF8HG	WOS:000352796300020		
J	Ueki, T; Nagayoshi, K; Manabe, T; Maeyama, R; Yokomizo, A; Yamamoto, H; Oda, Y; Tanaka, M				Ueki, T.; Nagayoshi, K.; Manabe, T.; Maeyama, R.; Yokomizo, A.; Yamamoto, H.; Oda, Y.; Tanaka, M.			Laparoscopic en bloc excision of gastrointestinal stromal tumors of the rectum after neoadjuvant imatinib therapy: anteriorly extended intersphincteric resection combined with partial resection of the prostate	TECHNIQUES IN COLOPROCTOLOGY			English	Article						Laparoscopic intersphincteric resection; Partial resection of the prostate; Rectal gastrointestinal stromal tumor; Neoadjuvant imatinib therapy	LOCAL RECURRENCE; CANCER	We herein present a novel technique for laparoscopic en bloc excision involving anteriorly extended intersphincteric resection with partial resection of the posterior lobe of the prostate for large rectal gastrointestinal stromal tumors (GISTs). The sequence of neoadjuvant imatinib therapy and this less invasive surgery for marginally resectable rectal GISTs has the potential to obviate the need for urinary reconstruction and permanent stomas without jeopardizing the tumor margin status.	[Ueki, T.; Nagayoshi, K.; Manabe, T.; Maeyama, R.; Tanaka, M.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, Fukuoka 8128582, Japan; [Yokomizo, A.] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, Fukuoka 8128582, Japan; [Yamamoto, H.; Oda, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan	Ueki, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tueki@surg1.med.kyushu-u.ac.jp					Agaimy A, 2013, INT J COLORECTAL DIS, V28, P1057, DOI 10.1007/s00384-013-1655-3; Amato A, 2010, TECH COLOPROCTOL, V14, pS91, DOI 10.1007/s10151-010-0631-y; Casali PG, 2009, ANN ONCOL, V20, P64, DOI 10.1093/annonc/mdp131; Machlenkin S, 2011, COLORECTAL DIS, V13, P1110, DOI 10.1111/j.1463-1318.2010.02442.x; Park JS, 2011, ANN SURG, V254, P941, DOI 10.1097/SLA.0b013e318236c448; Fujimoto Y, 2014, INT J COLORECTAL DIS, V29, P111, DOI 10.1007/s00384-013-1769-7; Hohenberger P, 2010, BRIT J SURG, V97, P1854, DOI 10.1002/bjs.7222; Smedh K, 2006, DIS COLON RECTUM, V49, P833, DOI 10.1007/s10350-006-0539-9	8	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1123-6337	1128-045X		TECH COLOPROCTOL	Tech. Coloproctology	APR	2015	19	4					247	251		10.1007/s10151-014-1261-6		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF8JY	WOS:000352806500007		
J	Kamauchi, H; Kinoshita, K; Takatori, K; Sugita, T; Takahashi, K; Koyama, K				Kamauchi, Hitoshi; Kinoshita, Kaoru; Takatori, Kazuhiko; Sugita, Takashi; Takahashi, Kunio; Koyama, Kiyotaka			New sesquiterpenoids isolated from Atractylodes lancea fermented by marine fungus	TETRAHEDRON			English	Article						Fermentation; Diversity; Atractylodes lancea; Marine fungi; Sesquiterpenoid		The diversity of natural compounds is extensive but not unlimited. Fermentation of rhizomes of Atractylodes lancea by marine fungus (Cladosporium cladosporioides) enhanced the diversity of natural compounds. From the fermented rhizomes of A. lancea, two new spirovetivane-type sesquiterpenoids, 2-oxo-12-hydroxy-hinesol (1) and 2-oxo-15-hydroxy-hinesol (2); a new guaiane-type sesquiterpenoid atractylol A (3); and three new eudesmane-type sesquiterpenoids, 14-hydroxy-isopterocarpolone (4), 3 alpha-hydroxy-pterocarpol (5), and (11R)-2, 11, 12-trihydroxy-beta-selinene (6), were isolated along with known sesquiterpenoids (7-10). The structures of these compounds were established using NMR, MS, and IR methods. These compounds (1-6) were not observed in A. lancea extracts by TLC and HPLC analysis, suggesting that these compounds were generated during the fermentation process. (C) 2015 Elsevier Ltd. All rights reserved.	[Kamauchi, Hitoshi; Kinoshita, Kaoru; Takahashi, Kunio; Koyama, Kiyotaka] Meiji Pharmaceut Univ, Dept Pharmacognosy & Phytochem, Kiyose, Tokyo 2048588, Japan; [Takatori, Kazuhiko] Meiji Pharmaceut Univ, Dept Synthet Organ Chem, Kiyose, Tokyo 2048588, Japan; [Sugita, Takashi] Meiji Pharmaceut Univ, Dept Microbiol, Kiyose, Tokyo 2048588, Japan	Koyama, K (reprint author), Meiji Pharmaceut Univ, Dept Pharmacognosy & Phytochem, Noshio 2-522-1, Kiyose, Tokyo 2048588, Japan.	kiyotaka@my-pharm.ac.jp					Morita M, 1996, CHEM PHARM BULL, V44, P1603; Yoon NY, 2009, J AGR FOOD CHEM, V57, P4124, DOI 10.1021/jf900006f; Kitajima J, 2003, CHEM PHARM BULL, V51, P673, DOI 10.1248/cpb.51.673; Koyama K, 2004, TETRAHEDRON LETT, V45, P6947, DOI 10.1016/j.tetlet.2004.07.071; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Felek J., 1997, CHIRALITY, V9, P578; Gianluca N., 1981, PHYTOCHEMISTRY, V20, P514; Kamauchi H, 2014, TETRAHEDRON LETT, V55, P7203, DOI 10.1016/j.tetlet.2014.11.012; Kikuchi H, 2014, ORG LETT, V16, P1916, DOI 10.1021/ol5004324; Miyazawa M., 2009, Jpn. Patent, Patent No. [JP2009114089A, 2009114089]; Pascual Teresa J., 1978, TETRAHEDRON LETT, V43, P4141; Tsuakada M., 2011, J NAT PRODUCTS, V74, P1645	12	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	APR 1	2015	71	13					1909	1914		10.1016/j.tet.2015.02.041		6	Chemistry, Organic	Chemistry	CF7PD	WOS:000352747900002		
J	Tamiaki, H; Tanaka, T				Tamiaki, Hitoshi; Tanaka, Takuya			Synthesis and physical properties of carbonylated chlorophyll derivatives	TETRAHEDRON			English	Article						Electrochemical oxidation; Fluorescence emission property; Pyropheophorbide; Substitution effect; Visible absorption spectrum	EXCITED-STATE PROPERTIES; SELF-AGGREGATION; BACTERIOPHEOPHORBIDES-C; CHLOROBACULUM-TEPIDUM; BACTERIOCHLOROPHYLL-A; PYROPHEOPHORBIDE-A; OPTICAL-PROPERTIES; LEAF SENESCENCE; FORMYL GROUP; F ANALOGS	Methyl pyropheophorbide-a, one of the chlorophyll-a derivatives, was modified to chlorins possessing/lacking oxo groups at the peripheral 3(1)-, 8(1)-, and 13(1)-positions. Since the carbonyl groups were directly conjugated with the chlorin it-system in a molecule, such electron-withdrawing groups affected visible absorption and fluorescence emission spectra, emission efficiencies, and emission lifetimes as well as oxidation potentials of the semi-synthetic chlorophyll derivatives in a solution. The substitution effect was dependent on the connecting positions. (C) 2015 Elsevier Ltd. All rights reserved.	[Tamiaki, Hitoshi; Tanaka, Takuya] Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan	Tamiaki, H (reprint author), Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan.	tamiaki@fc.ritsumei.ac.jp			Japan Society for the Promotion of Science (JSPS) [22245030, 24107002]	We thank Dr. Yusuke Kinoshita of Ritsumeikan University for preparation of the manuscript. This work was partially supported by Grants-in-Aid for Scientific Research (A) (No. 22245030) as well as on Innovative Areas 'Artificial Photosynthesis (AnApple)' (No. 24107002) from the Japan Society for the Promotion of Science (JSPS).	Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/nchembio.1555, 10.1038/NCHEMBIO.1555]; Sobotka R, 2014, PHOTOSYNTH RES, V119, P223, DOI 10.1007/s11120-013-9797-2; Tamiaki H, 2007, PHOTOCHEM PHOTOBIOL, V83, P152, DOI 10.1562/2006-02-27-IR-819; Cogdell RJ, 2006, Q REV BIOPHYS, V39, P227, DOI 10.1017/S0033583506004434; Ito H, 2014, PLANT CELL PHYSIOL, V55, P593, DOI 10.1093/pcp/pct203; Schliep M, 2013, PLANT CELL ENVIRON, V36, P521, DOI 10.1111/pce.12000; Pickering MD, 2013, GEOCHIM COSMOCHIM AC, V104, P111, DOI 10.1016/j.gca.2012.11.021; Tsukatani Y, 2013, PHOTOCH PHOTOBIO SCI, V12, P2195, DOI 10.1039/c3pp50253h; Niedzwiedzki DM, 2014, PHOTOSYNTH RES, V121, P25, DOI 10.1007/s11120-014-9981-z; Alvarez S, 2013, ORG LETT, V15, P4430, DOI 10.1021/ol4019826; INAMOTO N, 1982, CHEM LETT, P1003, DOI 10.1246/cl.1982.1003; Tamiaki H, 2013, TETRAHEDRON, V69, P8412, DOI 10.1016/j.tet.2013.07.060; Tamiaki H, 2011, HANDB PORPHYR SCI, V11, P223; Karcz D, 2014, MOLECULES, V19, P15938, DOI 10.3390/molecules191015938; SMITH KM, 1985, J AM CHEM SOC, V107, P4946, DOI 10.1021/ja00303a021; Senge MO, 2014, SYMMETRY-BASEL, V6, P781, DOI 10.3390/sym6030781; Kinoshita Y, 2013, INORG CHEM, V52, P9275, DOI 10.1021/ic400509q; Hortensteiner S, 2013, PLANT MOL BIOL, V82, P505, DOI 10.1007/s11103-012-9940-z; Bina D, 2013, PHOTOSYNTH RES, V116, P11, DOI 10.1007/s11120-013-9878-2; Hartzler DA, 2014, J PHYS CHEM B, V118, P7221, DOI 10.1021/jp500539w; Willows RD, 2013, ORG LETT, V15, P1588, DOI 10.1021/ol400327j; SMITH KM, 1980, J ORG CHEM, V45, P2218, DOI 10.1021/jo01299a036; Christ B, 2014, J PLANT GROWTH REGUL, V33, P4, DOI 10.1007/s00344-013-9392-y; Wang JJ, 2011, B KOREAN CHEM SOC, V32, P3473, DOI 10.5012/bkcs.2011.32.9.3473; Niedzwiedzki DM, 2010, PHOTOSYNTH RES, V106, P227, DOI 10.1007/s11120-010-9598-9; Tamiaki H, 2003, TETRAHEDRON, V59, P4337, DOI 10.1016/S0040-4020(03)00638-0; Christ B, 2013, PLANT CELL, V25, P1868, DOI 10.1105/tpc.113.112151; Mizoguchi T, 2014, PHOTOSYNTH RES, V121, P3, DOI 10.1007/s11120-014-9977-8; Oba T, 2014, TETRAHEDRON LETT, V55, P725, DOI 10.1016/j.tetlet.2013.12.006; Guyer L, 2014, PLANT PHYSIOL, V166, P44, DOI 10.1104/pp.114.239541; Canniffe DP, 2014, BIOCHEM J, V462, P433, DOI 10.1042/BJ20140163; Chen M, 2013, J PORPHYR PHTHALOCYA, V17, P1, DOI 10.1142/S1088424612300108; Christ B, 2014, PLANT CELL ENVIRON, V37, P2521, DOI 10.1111/pce.12308; de Oliveira KT, 2014, CURR ORG SYNTH, V11, P42, DOI 10.2174/15701794113106660085; Fukusumi T, 2013, J PORPHYR PHTHALOCYA, V17, P1188, DOI 10.1142/S1088424613500983; Harada J, 2014, PHOTOSYNTH RES, V121, P13, DOI 10.1007/s11120-014-0007-7; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; Harada J, 2014, J BIOL CHEM, V289, P12716, DOI 10.1074/jbc.M113.546739; Kashiyama Y, 2013, FEBS LETT, V587, P2578, DOI 10.1016/j.febslet.2013.06.036; Kashiyama Y, 2014, CHEM LETT, V43, P148, DOI 10.1246/cl.131005; Kobayashi M., 2013, PHOTOSYNTHESIS; Kunieda M, 2004, TETRAHEDRON, V60, P11349, DOI 10.1016/j.tet.2004.09.091; Kunieda M, 2007, J PHOTOCH PHOTOBIO A, V185, P321, DOI 10.1016/j.jphotochem.2006.06.027; Loughkin R C., 2014, SCI REP, V4, P6069; MARUYAMA K, 1991, PHOTOCHEM PHOTOBIOL, V53, P617, DOI 10.1111/j.1751-1097.1991.tb08488.x; Mizoguchi T, 2015, J PHOTOCH PHOTOBIO B, V142, P244, DOI 10.1016/j.jphotobiol.2014.12.013; Niedzwiedzki DM, 2014, J PHYS CHEM B, V118, P2295, DOI 10.1021/jp409495m; Rios JJ, 2014, J AGR FOOD CHEM, V62, P10576, DOI 10.1021/jf503619s; Sadaoka K, 2014, J PORPHYR PHTHALOCYA, V18, P506, DOI 10.1142/S1088424614500242; Sasaki S, 2004, J PHOTOCH PHOTOBIO A, V162, P307, DOI 10.1016/s1010-6030(03)00373-3; Tamiaki H., 2013, TETRAHEDRON-ASYMMETR, V24, P967; Tamiaki H, 2008, BIOORG MED CHEM LETT, V18, P6037, DOI 10.1016/j.bmcl.2008.10.031; Tamiaki H, 1998, TETRAHEDRON, V54, P6699, DOI 10.1016/S0040-4020(98)00338-X; Tamiaki H, 1998, BIOORGAN MED CHEM, V6, P2171, DOI 10.1016/S0968-0896(98)00154-0; Tamiaki H, 2008, TETRAHEDRON, V64, P5721, DOI 10.1016/j.tet.2008.04.025; Tamiaki H, 2013, TETRAHEDRON, V69, P1987, DOI 10.1016/j.tet.2012.12.072; Tsukatani Y, 2013, BBA-BIOENERGETICS, V1827, P1200, DOI 10.1016/j.bbabio.2013.06.007; Tsukatani Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01217; Xu MY, 2014, BIOORG MED CHEM LETT, V24, P3997, DOI 10.1016/j.bmcl.2014.06.022; Yagai S, 1999, J PHOTOCH PHOTOBIO B, V52, P74, DOI 10.1016/S1011-1344(99)00105-0	60	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	APR 1	2015	71	13					1915	1923		10.1016/j.tet.2015.02.026		9	Chemistry, Organic	Chemistry	CF7PD	WOS:000352747900003		
J	Suzuki, T; Nagasawa, T; Enomoto, M; Kuwahara, S				Suzuki, Tomomi; Nagasawa, Tomohiro; Enomoto, Masaru; Kuwahara, Shigefumi			Stereoselective total synthesis of amicoumacin C	TETRAHEDRON			English	Article						Amicoumacin; Isocoumarin; Diastereoselective reduction; Antibacterial; Total synthesis	BIOLOGICALLY-ACTIVE METABOLITES; BACTERIUM BACILLUS-SUBTILIS; MICROBIAL AGENT AI-77-B; GASTROPROTECTIVE SUBSTANCE; PUMILUS AI-77; ISOCOUMARIN; PRODUCTS; BACIPHELACIN; ANTIBIOTICS; DERIVATIVES	The enantio- and diastereoselective total synthesis of amicoumacin C was achieved from L-phenylalanine in 17% overall yield through 13 steps via condensation between an amine and an acid segment. The amine segment was prepared from L-leucine in 42% yield by a 7-step sequence involving a diastereoselective reduction of an alpha-dibenzylamino ketone intermediate, while the acid segment was obtained from L-phenylalanine by using acidic hydrolysis of an acetonide-protected amide accompanied by concomitant lactonization as a key step. (C) 2015 Elsevier Ltd. All rights reserved.	[Suzuki, Tomomi; Nagasawa, Tomohiro; Kuwahara, Shigefumi] Tohoku Univ, Grad Sch Agr Sci, Lab Appl Bioorgan Chem, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Enomoto, Masaru] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido 0628517, Japan	Kuwahara, S (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Appl Bioorgan Chem, Aoba Ku, Sendai, Miyagi 9818555, Japan.	skuwahar@biochem.tohoku.ac.jp					Kawase Y, 2010, SYNTHESIS-STUTTGART, P1673, DOI 10.1055/s-0029-1218707; Enomoto M, 2009, J ORG CHEM, V74, P7566, DOI 10.1021/jo9014968; Pinchuk IV, 2001, ANTIMICROB AGENTS CH, V45, P3156, DOI 10.1128/AAC.45.11.3156-3161.2001; CARLSEN PHJ, 1981, J ORG CHEM, V46, P3936, DOI 10.1021/jo00332a045; Kotsuki H, 1999, ORG LETT, V1, P499, DOI 10.1021/ol990102y; Ma DW, 1996, TETRAHEDRON-ASYMMETR, V7, P2365; OKAZAKI H, 1975, J ANTIBIOT, V28, P717; Pinchuk IV, 2002, RES MICROBIOL, V153, P269, DOI 10.1016/S0923-2508(02)01320-7; Gebhardt K, 2002, FEMS MICROBIOL LETT, V217, P199, DOI 10.1016/S0378-1097(02)01065-0; HAMADA Y, 1991, TETRAHEDRON, V47, P8635, DOI 10.1016/S0040-4020(01)82406-6; Azumi M, 2008, TETRAHEDRON, V64, P6420, DOI 10.1016/j.tet.2008.04.076; Bai J, 2014, TETRAHEDRON LETT, V55, P6286, DOI 10.1016/j.tetlet.2014.09.100; Broady SD, 1999, J CHEM SOC PERK T 1, P1083, DOI 10.1039/a900334g; BROADY SD, 1991, J CHEM SOC CHEM COMM, P708, DOI 10.1039/c39910000708; Canedo LM, 1997, J ANTIBIOT, V50, P175; CARRASCO L, 1987, BIOCHIMIE, V69, P797, DOI 10.1016/0300-9084(87)90206-9; Curran DP, 1999, TETRAHEDRON, V55, P5681, DOI 10.1016/S0040-4020(99)00237-9; DURGNAT JM, 1993, HELV CHIM ACTA, V76, P222, DOI 10.1002/hlca.19930760116; Enomoto M, 2009, ANGEW CHEM INT EDIT, V48, P1144, DOI 10.1002/anie.200804571; Enomoto M, 2010, BIOSCI BIOTECH BIOCH, V74, P2535, DOI 10.1271/bbb.100646; Ghosh AK, 2003, EUR J ORG CHEM, P821; Ghosh AK, 2001, ORG LETT, V3, P2677, DOI 10.1021/ol0101279; HAMADA Y, 1989, J AM CHEM SOC, V111, P1524, DOI 10.1021/ja00186a071; Huang YF, 2006, J ANTIBIOT, V59, P355; ITOH J, 1982, AGR BIOL CHEM TOKYO, V46, P2659; ITOH J, 1982, AGR BIOL CHEM TOKYO, V46, P1255; ITOH J, 1981, J ANTIBIOT, V34, P611; JOUIN P, 1987, J CHEM SOC PERK T 1, P1177, DOI 10.1039/p19870001177; Katsuta R, 2008, TETRAHEDRON LETT, V49, P7042, DOI 10.1016/j.tetlet.2008.09.141; Lama A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034037; Li YX, 2012, MAR DRUGS, V10, P319, DOI 10.3390/md10020319; Liu SW, 2013, J ANTIBIOT, V66, P281, DOI 10.1038/ja.2012.118; MCINERNEY BV, 1991, J NAT PROD, V54, P785, DOI 10.1021/np50075a006; Ochoa-Teran A, 2008, ARKIVOC, P330; Polikanov Y. S., 2014, CELL, V56, P531; Rao MV, 2014, TETRAHEDRON LETT, V55, P5921, DOI 10.1016/j.tetlet.2014.09.009; REETZ MT, 1990, TETRAHEDRON-ASYMMETR, V1, P375, DOI 10.1016/0957-4166(90)90037-B; SATO T, 1992, J ANTIBIOT, V45, P1949; SHIMOJIMA Y, 1982, AGR BIOL CHEM TOKYO, V46, P1823; SHIMOJIMA Y, 1982, TETRAHEDRON LETT, V23, P5435; TSUJI T, 1979, TETRAHEDRON LETT, P2793; WARD RA, 1995, TETRAHEDRON, V51, P12301; WARD RA, 1992, TETRAHEDRON LETT, V33, P3359, DOI 10.1016/S0040-4039(00)92088-4	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	APR 1	2015	71	13					1992	1997		10.1016/j.tet.2015.02.014		6	Chemistry, Organic	Chemistry	CF7PD	WOS:000352747900013		
J	Miyabe, K				Miyabe, Kenshi			Schnorr Triviality and Its Equivalent Notions	THEORY OF COMPUTING SYSTEMS			English	Article						Algorithmic randomness; Schnorr randomness; Schnorr triviality; Uniform relativization; Lowness for uniform Schnorr randomness	LOWNESS NOTIONS; RANDOM SETS; RANDOMNESS	We give some characterizations of Schnorr triviality. In concrete terms, we introduce a reducibility related to decidable prefix-free machines and show the equivalence with Schnorr reducibility. We also give a uniform-Schnorr-randomness version of the equivalence of LR-reducibility and LK-reducibility. Finally we prove a base-type characterization of Schnorr triviality.	Kyoto Univ, Math Sci Res Inst, Kyoto, Japan	Miyabe, K (reprint author), Kyoto Univ, Math Sci Res Inst, Kyoto, Japan.	kmiyabe@kurims.kyoto-u.ac.jp			GCOE, Kyoto University; JSPS KAKENHI [23740072]	The author thanks Takayuki Kihara triggering this study and Laurent Bienvenu for crucial discussion on the proof of (iv)double right arrow(v) of Theorem 5.1. This work was partly supported by GCOE, Kyoto University and JSPS KAKENHI 23740072.	Kjos-Hanssen B, 2012, J LOND MATH SOC, V85, P869, DOI 10.1112/jlms/jdr072; KUCERA A, 1985, LECT NOTES MATH, V1141, P245; Franklin JNY, 2010, J SYMBOLIC LOGIC, V75, P501, DOI 10.2178/jsl/1268917492; Nies A, 2005, ADV MATH, V197, P274, DOI 10.1016/j.aim.2004.10.006; Bienvenu L, 2007, LECT NOTES COMPUT SC, V4596, P643; Bienvenu L, 2012, ANN PURE APPL LOGIC, V163, P506, DOI 10.1016/j.apal.2011.06.009; Brattka V., 2008, NEW COMPUTATIONAL PA, P425, DOI 10.1007/978-0-387-68546-5_18; Brattka V., 2003, COMPUTABILITY MODELS, P93; Diamondstone D., 2013, P 12 AS LOG C, P115; Downey RG, 2010, THEOR APPL COMPUT, P401, DOI 10.1007/978-0-387-68441-3; Downey R, 2004, MATH LOGIC QUART, V50, P613, DOI 10.1002/malq.200310121; Downey R., 2008, LECT NOTES SERIES 2, P79; Downey RG, 2004, J SYMBOLIC LOGIC, V69, P533, DOI 10.2178/jsl/1082418542; Franklin JNY, 2011, B LOND MATH SOC, V43, P721, DOI 10.1112/blms/bdr007; Hirschfeldt DR, 2007, J LOND MATH SOC, V75, P610, DOI 10.1112/jlms/jdm041; Holzl R, 2010, IFIP ADV INF COMM TE, V323, P301; Kihara T., UNIFORM KURTZ UNPUB; Kjos-Hanssen B., 2005, SIAM J COMPUT, V35, P647, DOI DOI 10.1137/S0097539704446323.MR2201451; MARTINLO.P, 1966, INFORM CONTROL, V9, P602, DOI 10.1016/S0019-9958(66)80018-9; Merkle W, 2002, LECT NOTES COMPUT SC, V2420, P568; Miyabe K., 2013, P 12 AS LOG C, P251; Miyabe K, 2011, MATH LOGIC QUART, V57, P323, DOI 10.1002/malq.200910128; Nies A., 2009, COMPUTABILITY RANDOM; Schnorr C.-P., 1971, LECT NOTES MATH, V218; Terwijn SA, 2001, J SYMBOLIC LOGIC, V66, P1199, DOI 10.2307/2695101; Weihrauch K., 2000, COMPUTABLE ANAL INTR; Weihrauch K, 2009, J UNIVERS COMPUT SCI, V15, P1381	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-4350	1433-0490		THEOR COMPUT SYST	Theor. Comput. Syst.	APR	2015	56	3			SI		465	486		10.1007/s00224-013-9506-8		22	Computer Science, Theory & Methods; Mathematics	Computer Science; Mathematics	CF8MK	WOS:000352814700003		
J	Tadaki, K; Doi, N				Tadaki, Kohtaro; Doi, Norihisa			Cryptography and Algorithmic Randomness	THEORY OF COMPUTING SYSTEMS			English	Article						Cryptography; Random oracle model; Generic group model; Provable security; Algorithmic randomness; Computable analysis	RANDOM-ORACLE-MODEL; SEQUENCES	The secure instantiation of the random oracle is one of the major open problems in modern cryptography. We investigate this problem using concepts and methods of algorithmic randomness. In modern cryptography, the random oracle model is widely used as an imaginary framework in which the security of a cryptographic scheme is discussed. In the random oracle model, the cryptographic hash function used in a cryptographic scheme is formulated as a random variable uniformly distributed over all possibility of the function, called the random oracle. The main result of this paper is to show that, for any secure signature scheme in the random oracle model, there exists a specific computable function which can instantiate the random oracle while keeping the security originally proved in the random oracle model. In modern cryptography the generic group model is used also for a similar purpose to the random oracle model. We show that the same results hold for the generic group model. In the process of proving the results, we introduce the notion of effective security, demonstrating the importance of this notion in modern cryptography.	[Tadaki, Kohtaro; Doi, Norihisa] Chuo Univ, Res & Dev Initiat, Bunkyo Ku, Tokyo 1128551, Japan	Tadaki, K (reprint author), Chuo Univ, Res & Dev Initiat, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	tadaki@kc.chuo-u.ac.jp; doi@doi.ics.keio.ac.jp			JSPS KAKENHI [23340020]; Ministry of Economy, Trade and Industry of Japan	This work was supported by JSPS KAKENHI Grant Number 23340020 and by the Ministry of Economy, Trade and Industry of Japan.	Fischlin M, 2010, LECT NOTES COMPUT SC, V6477, P303, DOI 10.1007/978-3-642-17373-8_18; CHAITIN GJ, 1975, J ACM, V22, P329, DOI 10.1145/321892.321894; SOLOMONOFF RJ, 1964, INFORM CONTROL, V7, P224, DOI 10.1016/S0019-9958(64)90131-7; Canetti R, 2004, J ACM, V51, P557, DOI 10.1145/1008731.1008734; Miller JS, 2008, T AM MATH SOC, V360, P3193, DOI 10.1090/S0002-9947-08-04395-X; Leurent G, 2009, LECT NOTES COMPUT SC, V5677, P445, DOI 10.1007/978-3-642-03356-8_26; Dent AW, 2002, LECT NOTES COMPUT SC, V2501, P100; Bellare M., 1993, P ACM CCS, V1993, P62, DOI DOI 10.1145/168588.168596; Bellare M, 2004, LECT NOTES COMPUT SC, V3027, P171; Bienvenu L., 2011, P 28 S THEOR ASP COM, P452; Brattka V., 2012, RANDOMNESS DIFFERENT; CHAITIN GJ, 1966, J ACM, V13, P547, DOI 10.1145/321356.321363; Chaitin Gregory, 1987, ALGORITHMIC INFORM T; Downey RG, 2010, THEOR APPL COMPUT, P401, DOI 10.1007/978-0-387-68441-3; Goldreich O., 2004, FDN CRYPTOGRAPHY, V2; Goldreich Oded, 2001, FDN CRYPTOGRAPHY, V1; Impagliazzo R., 1990, LNCS, V403, P8; Katz J., 2007, INTRO MODERN CRYPTOG; Kolmogorov A.N., 1965, Problems of Information Transmission, V1; MARTINLO.P, 1966, INFORM CONTROL, V9, P602, DOI 10.1016/S0019-9958(66)80018-9; Maurer U, 1998, LECT NOTES COMPUT SC, V1403, P72; Maurer U, 2005, LECT NOTES COMPUT SC, V3796, P1; Moriyama D., 2011, IND APPL MATH SERIES, V2; Nies A., 2009, COMPUTABILITY RANDOM; Pour-El M., 1989, PERSPECTIVES MATH LO; Schnorr C. P., 1973, Journal of Computer and System Sciences, V7, DOI 10.1016/S0022-0000(73)80030-3; Schnorr C. P., 1971, Mathematical Systems Theory, V5, DOI 10.1007/BF01694181; Shoup V., 1997, LECT NOTES COMPUTER, V1233, P256; Solovay R.M., 1975, DRAFT PAPER SERIES P, P215; Weihrauch K., 2000, COMPUTABLE ANAL	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-4350	1433-0490		THEOR COMPUT SYST	Theor. Comput. Syst.	APR	2015	56	3			SI		544	580		10.1007/s00224-014-9545-9		37	Computer Science, Theory & Methods; Mathematics	Computer Science; Mathematics	CF8MK	WOS:000352814700007		
J	Saijo, T; Joki, N; Inishi, Y; Muto, M; Saijo, M; Hase, H				Saijo, Tomokatsu; Joki, Nobuhiko; Inishi, Yoji; Muto, Mikako; Saijo, Motohiko; Hase, Hiroki			Occult Hepatitis B Virus Infection in Hemodialysis Patients in Japan	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Hemodialysis; Hepatitis B core antibody; Hepatitis B virus; Occult hepatitis B virus infection; Surveillance	HBV INFECTION; SURFACE-ANTIGEN; BLOOD-TRANSFUSION; TRANSMISSION; DONORS; DNA; TRANSPLANTATION; MULTICENTER; GENOTYPE; ANTIBODY	Hepatitis B surface antigen is widely used in hepatitis B virus surveillance; patients who test negative for the antigen are judged to be uninfected. However, occult hepatitis B virus infection has been confirmed with hepatitis B virus DNA at low levels in the liver and peripheral blood in patients positive for hepatitis B core antibody or hepatitis B surface antibody, even if they test negative for hepatitis B surface antigen. To investigate the prevalence of occult hepatitis B virus in hemodialysis patients, we performed cross-sectional analysis of 161 hemodialysis patients in two related institutions for hepatitis B surface antigen, hepatitis B core antibody, and hepatitis B surface antibody. Hepatitis B surface antigen, hepatitis B core antibody, or hepatitis B surface antibody was present in 45 patients (28.0%). Hepatitis B virus DNA was present in six patients (3.7%), all of whom also tested positive for hepatitis B core antibody. Hepatitis B surface antibody positivity was unrelated in only one of the six patients. Four of the six patients were positive for hepatitis B surface antigen; however, two (1.3%) of these with occult hepatitis B virus infection were found to be hepatitis B surface antigen negative. Occult hepatitis B virus infection may be missed in hepatitis B virus surveillance using hepatitis B surface antigen alone; therefore, routine hepatitis B core antibody screening is necessary. Patients who test positive for hepatitis B core antibody should undergo further hepatitis B virus DNA testing to enable accurate hepatitis B virus screening.	[Saijo, Tomokatsu; Muto, Mikako] Saijo Clin Takaban, Tokyo 1520004, Japan; [Joki, Nobuhiko; Hase, Hiroki] Toho Univ, Ohashi Med Ctr, Div Nephrol, Tokyo, Japan; [Inishi, Yoji] Sawai Clin, Tokyo, Japan; [Saijo, Motohiko] Saijo Clin Shimouma, Tokyo, Japan	Saijo, T (reprint author), Saijo Clin Takaban, Dept Nephrol, Meguro Ku, 3-16-9 Takaban, Tokyo 1520004, Japan.	tomokatsuolly@gmail.com					Abu El Makarem Mona A, 2012, Hepat Mon, V12, P253, DOI 10.5812/hepatmon.665; Ando R, 2009, J JPN SOC DIAL THER, V42, P423; Orito E, 2001, HEPATOLOGY, V34, P590, DOI 10.1053/jhep.2001.27221; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gast.2004.09.014; BRECHOT C, 1985, NEW ENGL J MED, V312, P270, DOI 10.1056/NEJM198501313120503; Aghakhani A, 2010, THER APHER DIAL, V14, P349, DOI 10.1111/j.1744-9987.2009.00798.x; Dhedin N, 1998, TRANSPLANTATION, V66, P616; Fabrizi F, 2005, ALIMENT PHARM THERAP, V21, P1341, DOI 10.1111/j.1365-2036.2005.02501.x; Yotsuyanagi H, 2001, TRANSFUSION, V41, P1093, DOI 10.1046/j.1537-2995.2001.41091093.x; Taira R, 2013, TRANSFUSION, V53, P1393, DOI 10.1111/j.1537-2995.2012.03909.x; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Dickson RC, 1997, GASTROENTEROLOGY, V113, P1668, DOI 10.1053/gast.1997.v113.pm9352871; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; ELGHOUZZI MH, 1995, LANCET, V346, P964, DOI 10.1016/S0140-6736(95)91583-4; Kato J, 1996, HEPATOLOGY, V23, P389; Kobayashi M, 2002, J MED VIROL, V68, P522, DOI 10.1002/jmv.10239; Komiya Y, 2008, TRANSFUSION, V48, P286, DOI 10.1111/j.1537-2995.2007.01522.x; LIAW YF, 1991, HEPATOLOGY, V13, P627, DOI 10.1016/0270-9139(91)92555-M; Mina P, 2010, WORLD J GASTROENTERO, V16, P225, DOI 10.3748/wjg.v16.i2.225; Satoh K, 2008, VOX SANG, V95, P174, DOI 10.1111/j.1423-0410.2008.01091.x; Tsubouchi H, 2009, KANZO, V50, P38; Yuen MF, 2011, CLIN INFECT DIS, V52, P624, DOI 10.1093/cid/ciq247	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	APR	2015	19	2					125	130		10.1111/1744-9987.12241		6	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CF8EC	WOS:000352787500004		
J	Kuji, T; Toya, Y; Fujikawa, T; Kakimoto-Shino, M; Nishihara, M; Shibata, K; Tamura, K; Hirawa, N; Satta, H; Kawata, S; Kouguchi, N; Umemura, S				Kuji, Tadashi; Toya, Yoshiyuki; Fujikawa, Tetsuya; Kakimoto-Shino, Midori; Nishihara, Masahiro; Shibata, Kazuhiko; Tamura, Kouichi; Hirawa, Nobuhito; Satta, Hidehisa; Kawata, Sei-ichi; Kouguchi, Naoaki; Umemura, Satoshi			Acceleration of Iron Utilization After Intravenous Iron Administration During Activated Erythropoiesis in Hemodialysis Patients: A Randomized Study	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Continuous erythropoietin receptor activator; Hemodialysis; Iron utilization; Renal anemia; Reticulocyte hemoglobin equivalent	STAGE RENAL-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; CHRONIC KIDNEY-DISEASE; ANEMIA; MORTALITY; THERAPY; GUIDELINES; REGIMENS; OUTCOMES; EPOETIN	This study aimed to evaluate the effect of different timings of iron administration during erythropoiesis activated by continuous erythropoietin receptor activator (CERA) on reticulocyte iron uptake in hemodialysis patients. In total, 110 patients were randomized to receive 40mg intravenous elemental iron doses at all three hemodialysis sessions in the first week (IW1 group: n = 57) or in the third week (IW3 group: n = 53) after CERA administration. Following CERA administration at day 0, reticulocyte count increased, peaking at day 7. At days 7 and 14, the observed changes in Ret-He were higher in the IW1 group than in the IW3 group. Increases in total reticulocyte hemoglobin at day 7 were higher in the IW1 group than in the IW3 group. In contrast, there was only tendency toward greater total reticulocyte hemoglobin after iron administration in the third week in the IW3 group. Intravenous iron supplementation in the first week of CERA administration increases reticulocyte iron uptake; however, iron supplementation in the third week does not. The findings indicate that iron should be intravenously administered to increase the efficacy of CERA within 1 week of CERA administration during highly active erythropoiesis.	[Kuji, Tadashi; Kawata, Sei-ichi] Yokodai Cent Clin, Yokohama, Kanagawa, Japan; [Kuji, Tadashi; Toya, Yoshiyuki; Fujikawa, Tetsuya; Kakimoto-Shino, Midori; Tamura, Kouichi; Hirawa, Nobuhito; Umemura, Satoshi] Yokohama City Univ, Dept Med Sci & Cardiorenal Med, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Kuji, Tadashi; Toya, Yoshiyuki; Fujikawa, Tetsuya; Kakimoto-Shino, Midori; Tamura, Kouichi; Hirawa, Nobuhito; Umemura, Satoshi] Sch Med, Yokohama, Kanagawa 2360004, Japan; [Fujikawa, Tetsuya] Yokohama Natl Univ, Ctr Hlth Serv Sci, Yokohama, Kanagawa 240, Japan; [Nishihara, Masahiro] Toshin Clin, Yokohama, Kanagawa, Japan; [Shibata, Kazuhiko] Yokohama Minami Clin, Yokohama, Kanagawa, Japan; [Satta, Hidehisa] Kasama Clin, Yokohama, Kanagawa, Japan	Fujikawa, T (reprint author), Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	tftf@yokohama-cu.ac.jp					Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Jonckheere S, 2010, ACTA HAEMATOL-BASEL, V124, P27, DOI 10.1159/000313785; Bullen JJ, 2005, FEMS IMMUNOL MED MIC, V43, P325, DOI 10.1016/j.femsim.2004.11.010; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Thomas L, 2005, CLIN CHEM LAB MED, V43, P1193, DOI 10.1515/CCLM.2005.207; Brewster UC, 2006, SEMIN DIALYSIS, V19, P285; Drueke T, 2001, NEPHROL DIAL TRANSPL, V16, P25; Goodnough LT, 2000, BLOOD, V96, P823; Feldman HI, 2002, J AM SOC NEPHROL, V13; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Fishbane S, 1997, KIDNEY INT, V52, P217, DOI 10.1038/ki.1997.323; Coyne DW, 2007, J AM SOC NEPHROL, V18, P975, DOI 10.1681/ASN.2006091034; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Besarab A, 1999, AM J KIDNEY DIS, V34, P21, DOI 10.1016/S0272-6386(99)70103-4; Chanu P, 2010, J CLIN PHARMACOL, V50, P507, DOI 10.1177/0091270009343931; Fujikawa T, 2012, NEPHRON CLIN PRACT, V122, P24, DOI 10.1159/000346740; Goldstein SL, 2013, AM J KIDNEY DIS, V61, P588, DOI 10.1053/j.ajkd.2012.10.019; Kakimoto-Shino M, 2014, THER APHER DIAL, V18, P421, DOI 10.1111/1744-9987.12161; Lopez-Gomez JM, 2008, KIDNEY INT, V74, pS75, DOI 10.1038/ki.2008.523; Macdougall IC, 1999, AM J KIDNEY DIS, V34, pS40, DOI 10.1053/ajkd.1999.v34.aajkd0344b0040; Macdougall IC, 2000, NEPHROL DIAL TRANSPL, V15, P20; Mocks J, 1997, PATHOGENETIC AND THERAPEUTIC ASPECTS OF CHRONIC RENAL FAILURE, P163; Moreno F, 1996, AM J KIDNEY DIS, V27, P548, DOI 10.1016/S0272-6386(96)90166-3; Richardson D, 2002, NEPHROL DIAL TRANSPL, V17, P53, DOI 10.1093/ndt/17.suppl_1.53	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	APR	2015	19	2					131	137		10.1111/1744-9987.12237		7	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CF8EC	WOS:000352787500005		
J	Morikami, Y; Fujimori, A; Okada, S; Kumei, M; Mizobuchi, N; Sakai, M				Morikami, Yuki; Fujimori, Akira; Okada, Shioko; Kumei, Mai; Mizobuchi, Noriko; Sakai, Makoto			Twice-Monthly Administration of a Lower Dose of Epoetin Beta Pegol Can Maintain Adequate Hemoglobin Levels in Hemodialysis Patients	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Anemia; Epoetin beta pegol; Ferritin; Hemodialysis; Hepcidin-25	CHRONIC KIDNEY-DISEASE; DARBEPOETIN-ALPHA; MAINTENANCE HEMODIALYSIS; DIALYSIS PATIENTS; HEPCIDIN; IRON; ERYTHROPOIETIN; NEOCYTOLYSIS; INTERVALS; OVERLOAD	Epoetin beta pegol is a continuous erythropoietin receptor activator (CERA) with a long half-life. Although CERA has been shown to maintain adequate hemoglobin (Hb) levels at prolonged dosing intervals, the optimal dosing schedule remains unclear. We therefore compared the efficacy of maintaining hemoglobin levels with administration of twice-monthly CERA (TWICE) versus once-monthly CERA (ONCE). Twenty hemodialysis patients receiving epoetin beta (EPO) were enrolled in this crossover study. Patients were assigned to either the TWICE or the ONCE group based on matching Hb levels and EPO doses. After 6 months of treatment, the CERA dosage was interchanged between the groups and the study was continued for an additional 6 months. The effect of the different regimens on iron metabolism was also assessed during the first 6 months of the study. Hb levels significantly increased in the TWICE group, allowing for a reduction in CERA dosage, while the dose of CERA required to maintain Hb levels in the ONCE group remained unchanged. After the interchange, a decrease in Hb levels with incremental increase in CERA dosage was observed in the TWICEONCE group, with the opposite effect observed in the ONCETWICE group. Although increases in ferritin and hepcidin-25 levels in the ONCE group were noted at one month, they disappeared at 6 months. Although Hb levels were maintained in both the ONCE and TWICE groups, a twice-monthly administration was advantageous, as it required a lower dose of CERA.	[Morikami, Yuki; Fujimori, Akira; Okada, Shioko; Kumei, Mai] Kohnan Hosp, Blood Purificat & Kidney Ctr, Kobe, Hyogo 6580064, Japan; [Mizobuchi, Noriko; Sakai, Makoto] Kohnan Hosp, Dept Internal Med, Kobe, Hyogo 6580064, Japan	Fujimori, A (reprint author), Kohnan Hosp, Blood Purificat & Kidney Ctr, Higashinada Ku, Kamokogahara 1-5-16, Kobe, Hyogo 6580064, Japan.	louie@kc.zaq.ne.jp					Akizawa T, 2007, THER APHER DIAL, V11, P220, DOI 10.1111/j.1744-9987.2007.00474.x; Alfrey CP, 2007, NEPHRON CLIN PRACT, V106, P149, DOI 10.1159/000104425; Dallalio G, 2006, BLOOD, V107, P2702, DOI 10.1182/blood-2005-07-2854; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Shoji S, 2013, EUR J HAEMATOL, V90, P237, DOI 10.1111/ejh.12067; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; Levin NW, 2007, LANCET, V370, P1415, DOI 10.1016/S0140-6736(07)61599-2; Hasuike Y, 2010, CLIN EXP NEPHROL, V14, P349, DOI 10.1007/s10157-010-0288-x; Babitt JL, 2010, AM J KIDNEY DIS, V55, P726, DOI 10.1053/j.ajkd.2009.12.030; Kuragano T, 2010, AM J NEPHROL, V31, P534, DOI 10.1159/000312381; Sasaki Y, 2012, INT J HEMATOL, V96, P692, DOI 10.1007/s12185-012-1217-4; Ghoti H, 2012, EUR J HAEMATOL, V89, P87, DOI 10.1111/j.1600-0609.2012.01783.x; Fukuhara S, 2008, THER APHER DIAL, V12, P72, DOI 10.1111/j.1744-9987.2007.00544.x; Hayashi T, 2010, JPN PHARMACOL THER, V38, P1175; Kuragano T, 2011, NEPHROL DIAL TRANSPL, V26, P2663, DOI 10.1093/ndt/gfq760; Macdougall IC, 2007, NEPHROL DIAL TRANSPL, V22, P2, DOI 10.1093/ndt/gfm160; Morikami Y, 2014, THER APHER DIAL, V18, P414, DOI 10.1111/1744-9987.12164; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Trial J, 2001, J INVEST MED, V49, P335, DOI 10.2310/6650.2001.33899	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	APR	2015	19	2					138	143		10.1111/1744-9987.12248		6	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CF8EC	WOS:000352787500006		
J	Gu, XZ; Itoh, K				Gu, Xiuzhu; Itoh, Kenji			Factors Behind Dialysis Patient Satisfaction: Exploring Their Effects on Overall Satisfaction	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Dialysis; Patient satisfaction; Personal loyalty; Quality of life; Validity	PERITONEAL-DIALYSIS; HEALTH-STATUS; QUALITY; CARE; QUESTIONNAIRE; SCALE	We would establish a construct of dialysis patients' satisfaction and identify their contribution to overall satisfaction. We also seek to identify present satisfaction levels of Japanese dialysis patients and some important characteristics of their satisfaction/dissatisfaction. A self-administered questionnaire for measuring dialysis patient satisfaction was developed, which comprised 32 closed-ended satisfaction question items that were facet-specific, three items on overall satisfaction, four items on respondent's health status and quality of life as well as demographic information. Reliability and validity of the questionnaire was verified. A questionnaire-based survey was conducted between July and September 2013. A total of 807 valid responses (63% of response rate) were collected from dialysis patients in 22 facilities located in most regions of Japan. Seven satisfaction factors were derived with 65% of cumulative variance accounted for by applying principal component analysis to responses to facet-specific satisfaction items. More than 80% of patients expressed positive overall satisfaction and that they wished to continue dialysis therapy in the current facility (they can change dialysis facilities if they wish to). Dialysis patients' overall satisfaction was formulated significantly by five out of seven satisfaction factors by regression analysis. Japanese dialysis patients expressed their high satisfaction with and strong loyalty to the facility where they currently receive dialysis therapy (i.e., patient loyalty). The more satisfied dialysis patients were with the facility, the stronger loyalty they would like to maintain. The overall satisfaction was critically determined by their satisfaction with clinical environment, equipment, treatment and therapy. In addition, patients' quality of life was highly associated with their overall satisfaction.	[Gu, Xiuzhu; Itoh, Kenji] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Ind Engn & Management, Tokyo 152, Japan	Gu, XZ (reprint author), W9-55,2-12-1 Oh Okayama,Meguro Ku, Tokyo 1528552, Japan.	xiuzhu.g.aa@m.titech.ac.jp	GU, XIUZHU/B-9348-2015	GU, XIUZHU/0000-0003-2641-1740	Japan Society for the Promotion of Science [23241048]	This work was in part supported by Grant-in-Aid for Scientific Research (A) (No. 23241048), Japan Society for the Promotion of Science. We would like to acknowledge Takashi Akiba, Professor, and Satoshi Suzuki, Chief dialysis technologist, Tokyo Women's Medical University, for their insightful discussions and comments. We are grateful to all patients who participated in our survey and to staff who assisted in data collection.	Acorn S, 1999, Can Nurse, V95, P33; Wu AW, 2001, AM J KIDNEY DIS, V37, P11, DOI 10.1053/ajkd.2001.20571; [Anonymous], 1951, PSYCHOMETRIKA; Liu K, 2011, J ADV NURS, V67, P1012, DOI 10.1111/j.1365-2648.2010.05569.x; Williams B, 1998, SOC SCI MED, V47, P1351, DOI 10.1016/S0277-9536(98)00213-5; Grogan S, 2000, QUAL HEALTH CARE, V9, P210, DOI 10.1136/qhc.9.4.210; Wasserfallen JB, 2006, SWISS MED WKLY, V136, P210; Sitzia J, 1999, INT J QUAL HEALTH C, V11, P319, DOI 10.1093/intqhc/11.4.319; Meakin R, 2002, FAM PRACT, V19, P257, DOI 10.1093/fampra/19.3.257; Kirchgessner J, 2006, KIDNEY INT, V70, P1325, DOI 10.1038/sj.ki.5001755; WILLIAMS B, 1994, SOC SCI MED, V38, P509, DOI 10.1016/0277-9536(94)90247-X; Dagger TS, 2007, J SERV RES-US, V10, P123, DOI 10.1177/1094670507309594; Argentero P, 2008, AM J KIDNEY DIS, V51, P80, DOI 10.1053/j.ajkd.2007.09.011; Baumann C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-150; Bendall-Lyon D., 2004, J SERV MARK, V18, P114, DOI 10.1108/08876040410528719; Charalambous Andreas, 2012, BMC Nurs, V11, P27, DOI 10.1186/1472-6955-11-27; Cohen G, 1996, SOC SCI MED, V42, P1085, DOI 10.1016/0277-9536(95)00315-0; Crow R, 2002, Health Technol Assess, V6, P1; Donabedian A., 1980, EXPLORATIONS QUALITY, VI; Elleuch Amira, 2008, Int J Health Care Qual Assur, V21, P692, DOI 10.1108/09526860810910168; Fottler M D, 1997, Best Pract Benchmarking Healthc, V2, P227; Gill L, 2009, LEADERSHIP HLTH SERV, V22, P8; Heidegger Thomas, 2006, Best Pract Res Clin Anaesthesiol, V20, P331, DOI 10.1016/j.bpa.2005.10.010; Hofstede Geert H., 1984, CULTURES CONSEQUENCE; MUNRO BH, 1994, RES NURS HEALTH, V17, P119, DOI 10.1002/nur.4770170207; Kessler Daniel P, 2011, Int J Health Care Qual Assur, V24, P266; Nunnaly J.C., 1978, PSYCHOMETRIC THEORY; RISSER NL, 1975, NURS RES, V24, P45; RUBIN HR, 1990, MED CARE, V28, pS17, DOI 10.1097/00005650-199009001-00005; The Japanese Society for Dialysis Therapy, 2012, CURR STAT CHRON DIAL; Thiedke C Carolyn, 2007, Fam Pract Manag, V14, P33; Vuori H, 1991, Qual Assur Health Care, V3, P183; Ware J E Jr, 1983, Eval Program Plann, V6, P247, DOI 10.1016/0149-7189(83)90005-8; Wolf M H, 1978, J Behav Med, V1, P391, DOI 10.1007/BF00846695; Wonca Europe, 2012, EUR DEF GEN PRACT FA; Wuerth DB, 2000, AM J KIDNEY DIS, V35, P638, DOI 10.1016/S0272-6386(00)70010-2	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	APR	2015	19	2					162	170		10.1111/1744-9987.12246		9	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CF8EC	WOS:000352787500009		
J	Masuzawa, Y; Mori, M; Hara, T; Inaba, A; Oba, MS; Yokota, S				Masuzawa, Yuko; Mori, Masaaki; Hara, Takuma; Inaba, Aya; Oba, Mari S.; Yokota, Shumpei			Elevated D-Dimer Level is a Risk Factor for Coronary Artery Lesions Accompanying Intravenous Immunoglobulin-Unresponsive Kawasaki Disease	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Coronary artery lesions; Endothelial cells; Kawasaki disease; Plasma exchange; Vasculitis	PLASMA-EXCHANGE; GAMMA-GLOBULIN; INFLIXIMAB TREATMENT; OPEN-LABEL; EFFICACY; CHILDREN; IMPACT	Although there are many reports on the resistance of Kawasaki disease (KD) to initial intravenous immunoglobulin (IVIg) therapy, risk factors for coronary artery lesions in such cases remain to be established. The objective of this study was to explore when additional therapies should be administered and to identify factors helpful for selecting a therapeutic option. Based on their written clinical records, we performed a retrospective review of KD patients who did not respond to initial IVIg therapy and who therefore then underwent plasma exchange (PE) therapy. This was a case-control study to compare the presence or absence of acute coronary lesions in patients treated by PE for IVIg-unresponsive KD at Yokohama City University Hospital or at Yokohama City University Medical Center. Fifteen of 44 patients had acute coronary artery lesions (CAL) correlating with high levels of white blood cells (WBC) (P = 0.045), d-dimer (P = 0.008), and fibrin/fibrinogen degradation products (P = 0.009) and lower levels of fibrinogen (P = 0.013) prior to PE therapy. There was a strong correlation between pre-PE levels of albumin and d-dimer (Pearson's correlation coefficient of 0.610). Multivariate analyses revealed that the odds ratio for CAL when d-dimer was 4.5g/mL was 25.06 (95% CI, 2.56-244.91, P = 0.006). d-dimer elevation and albumin decline in IVIg-unresponsive KD patients could be risk factors for acute CAL, suggesting the possibility that angitis has spread throughout the arterial system, as far as the coronary artery.	[Masuzawa, Yuko; Mori, Masaaki; Hara, Takuma; Inaba, Aya] Yokohama City Univ, Dept Pediat, Med Ctr, Yokohama, Kanagawa 2320024, Japan; [Oba, Mari S.] Yokohama City Univ, Dept Biostat & Epidemiol, Yokohama, Kanagawa 2320024, Japan; [Yokota, Shumpei] Yokohama City Univ, Sch Med, Dept Pediat, Yokohama, Kanagawa 2320024, Japan	Masuzawa, Y (reprint author), Yokohama City Univ, Dept Pediat, Med Ctr, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	yuko728yuko@hotmail.com					Mori M, 2000, J PEDIATR-US, V137, P177, DOI 10.1067/mpd.2000.107890; Suzuki H, 2011, PEDIATR INFECT DIS J, V30, P871, DOI 10.1097/INF.0b013e318220c3cf; Burns JC, 2005, J PEDIATR-US, V146, P662, DOI 10.1016/j.jpeds.2004.12.022; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; FURUSHO K, 1984, LANCET, V2, P1055; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; Harada T, 2008, THER APHER DIAL, V12, P176, DOI 10.1111/j.1744-9987.2008.00566.x; Hokosaki T, 2012, PEDIATR INT, V54, P99, DOI 10.1111/j.1442-200X.2011.03487.x; Imagawa T, 2004, EUR J PEDIATR, V163, P263, DOI 10.1007/s00431-003-1267-y; Imamura T, 2005, EUR J PEDIATR, V164, P526, DOI 10.1007/s00431-005-1699-7; Levi M, 2010, HAMOSTASEOLOGIE, V30; Lin MT, 2005, PEDIATR INT, V47, P126, DOI 10.1111/j.1442-200x.2005.02025.x; Mori M, 2012, J RHEUMATOL, V39, P864, DOI 10.3899/jrheum.110877; Mori Masaaki, 2004, Mod Rheumatol, V14, P43, DOI 10.1007/s10165-003-0264-3; National Survey Group for Kawasaki Disease, 2013, 22 RES RES NAT SURV; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Orenstein J.M., 2012, NATL I HLTH, V7, P1; Research Committee on Kawasaki Disease, 1984, REP SUBM STAND DIAGN; Sakai M, 2001, CLIN APPL THROMB-HEM, V7, P214, DOI 10.1177/107602960100700306; Terai M, 2003, CIRCULATION, V108, P325, DOI 10.1161/01.CIR.0000079166.93475.5F; The clinical guideline for medical treatment of acute stage Kawasaki disease from the scientific committee, 2012, PEDIAT CARDIOLOGY S3, V28, P1	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	APR	2015	19	2					171	177		10.1111/1744-9987.12235		7	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CF8EC	WOS:000352787500010		
J	Tsuchida, Y; Iino, N; Narita, I				Tsuchida, Yohei; Iino, Noriaki; Narita, Ichiei			Pelvic Abscess Induced by a Dormant Peritoneal Dialysis Catheter Without Obvious Intestinal Perforation	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Tsuchida, Yohei] Niigata Univ, Grad Sch Med & Dent Sci, Nagaoka Chuo Gen Hosp, Dept Nephrol, Niigata, Japan; [Iino, Noriaki; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan	Tsuchida, Y (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Nagaoka Chuo Gen Hosp, Dept Nephrol, Niigata, Japan.	yoheyyohei@yahoo.co.jp					Moncrief J W, 1993, ASAIO J, V39, P62, DOI 10.1097/00002480-199301000-00014; Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; KIERNAN L, 1995, AM J KIDNEY DIS, V25, P461, DOI 10.1016/0272-6386(95)90109-4; WAKEEN MJ, 1994, PERITON DIALYSIS INT, V14, P371	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	APR	2015	19	2					191	192		10.1111/1744-9987.12236		2	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CF8EC	WOS:000352787500013		
J	Tagawa, T; Suzuki, H; Nakajima, T; Iwata, T; Mizobuchi, T; Yoshida, S; Yoshino, I				Tagawa, Tetsuzo; Suzuki, Hidemi; Nakajima, Takahiro; Iwata, Takekazu; Mizobuchi, Teruaki; Yoshida, Shigetoshi; Yoshino, Ichiro			Long-Term Outcomes of Surgery for Thymic Carcinoma: Experience of 25 Cases at a Single Institution	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						thymus; mediastinum; surgery	TUMORS; PROGNOSIS; STAGE; CHEMOTHERAPY; THYMOMAS	Background Thymic carcinoma, a relatively rare entity, often presents as locally advanced disease, and sometimes as distantmetastatic disease. The treatment strategy, long-term surgical outcomes and clinical prognostic factors have yet to be fully elucidated. Methods Clinical charts of 25 patients who underwent surgery for thymic carcinoma at our institution from 1991 to 2014 were retrospectively reviewed. Results The Masaoka stage was stage I in three patients (12%), II in eight (32%), III in four (16%), IVa in four (16%), and IVb in six (24%). Histologic subtypes were squamous cell carcinoma in 12 patients, well-differentiated neuroendocrine carcinoma in 5, undifferentiated carcinoma in 3, adenocarcinoma in 1, and others in 4. Three patients had paraneoplastic syndrome including myasthenia gravis, multiple endocrine neoplasia type 1 (MEN1), and Cushing syndrome. Neoadjuvant chemotherapy was administered to five patients (20%). Complete resection was achieved in 17 patients (68%). There were no perioperative deaths. Twelve patients received postoperative therapy. The 5- and 10-year overall survival rates were 76.2 and 63.5%, respectively. The 5-and 10-year survival rates of patients with Masaoka stage I-III were 88.9 and 74.1%, respectively, whereas the 5-year survival rate of stage IV was 50.0%. The 5-and 10-year survival rates of 17 patients who underwent complete resection were 88.9 and 71.1%, respectively. Of the 17 patients with complete resection, 3 patients experienced recurrence including lung and supraclavicular lymph node. Conclusion Even for this highly malignant disease, surgery could contribute to favorable long-term outcomes in the setting of multimodality therapy.	[Tagawa, Tetsuzo; Suzuki, Hidemi; Nakajima, Takahiro; Iwata, Takekazu; Mizobuchi, Teruaki; Yoshida, Shigetoshi; Yoshino, Ichiro] Chiba Univ, Dept Gen Thorac Surg, Chiba 2608670, Japan	Tagawa, T (reprint author), Chiba Univ, Dept Gen Thorac Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	ttagawa@surg2.med.kyushu-u.ac.jp					Korst RJ, 2014, J THORAC CARDIOV SUR, V147, P36, DOI 10.1016/j.jtcvs.2013.08.061; Agatsuma T, 2011, J THORAC ONCOL, V6, P2130, DOI 10.1097/JTO.0b013e31822e71c0; Venuta F, 2010, EUR J CARDIO-THORAC, V37, P13, DOI 10.1016/j.ejcts.2009.05.038; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Venuta F, 2003, ANN THORAC SURG, V76, P1866, DOI 10.1016/S0003-4975(03)01020-8; Okuma Y, 2013, LUNG CANCER, V80, P75, DOI 10.1016/j.lungcan.2012.12.012; Ruffini E, 2011, J THORAC ONCOL, V6, P614, DOI 10.1097/JTO.0b013e318207cd74; Ogawa K, 2002, CANCER, V94, P3115, DOI 10.1002/cncr.10588; Yano M, 2008, J THORAC ONCOL, V3, P265, DOI 10.1097/JTO.0b013e3181653c71; Lucchi M, 2005, ANN THORAC SURG, V79, P1840, DOI 10.1016/j.athoracsur.2004.12.047; Weksler B, 2013, ANN THORAC SURG, V95, P299, DOI 10.1016/j.athoracsur.2012.09.006; Chalabreysse L, 2004, HISTOPATHOLOGY, V44, P367, DOI 10.1111/j.1365-2559.2004.01796.x; Evans Tracey L, 2005, Semin Thorac Cardiovasc Surg, V17, P41, DOI 10.1053/j.semtcvs.2004.11.003; Filosso PL, 2014, LUNG CANCER, V83, P205, DOI 10.1016/j.lungcan.2013.11.015; Hosaka Y, 2010, ANN THORAC SURG, V89, P912, DOI 10.1016/j.athoracsur.2009.11.057; Kondo K, 2003, ANN THORAC SURG, V76, P884; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; Korst RJ, 2014, J THORAC CARDIOVASC, V147, P46; Marx A, 2004, PATHOLOGY GENETICS T, P152; Okuma Y, 2014, LUNG CANCER, V84, P175, DOI 10.1016/j.lungcan.2014.02.012; Ruffini E, 2014, EUR J CARDIO-THORAC, V46, P361, DOI 10.1093/ejcts/ezt649; TAGAWA T, 2013, ITMIG 2013 4 INT THY, V8, P46; Tseng YL, 2003, ANN THORAC SURG, V76, P1041, DOI 10.1016/S0003-4975(03)00831-2; Weissferdt A, 2012, AM J CLIN PATHOL, V138, P103, DOI 10.1309/AJCP88FZTWANLRCB	24	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	APR	2015	63	3					212	216		10.1055/s-0034-1396927		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CG1IJ	WOS:000353026000008		
J	Murashita, T; Okada, Y; Kanemitsu, H; Fukunaga, N; Konishi, Y; Nakamura, K; Koyaam, T				Murashita, Takashi; Okada, Yukikatsu; Kanemitsu, Hideo; Fukunaga, Naoto; Konishi, Yasunobu; Nakamura, Ken; Koyaam, Tadaaki			Long-Term Outcomes after Mitral Valve Repair for Degenerative Mitral Regurgitation with Persistent Atrial Fibrillation	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						warfarin therapy; mitral valve surgery; outcomes	MAZE PROCEDURE; SURGICAL ABLATION; SURGERY; CONCOMITANT; IMPACT	Background Atrial fibrillation (AF) adversely affects surgical outcomes of mitral valve surgery. However, the long-term impact of Maze procedure has not been clear yet. Patients and Methods We retrospectively investigated 159 patients who underwent mitral valve repair for degenerative mitral regurgitation with persistent AF between 1991 and 2010. The mean age of patients was 63.1 +/- 10.5 years. After we started performing Maze procedure in 2002, 65 patients underwent concomitant Maze procedure. The median follow-up time was 7.5 years. Results There was one operative death (0.63%). The overall survival rate was 91.0 +/- 2.6% at 5 years and 79.1 +/- 4.7% at 10 years. Survival was significantly better in patients who underwent Maze procedure than those who did not. The rate of freedom from AF in patients who underwent Maze procedure was 86.4 +/- 4.5% at 1 year and 81.1 +/- 5.6% at 5 years. The freedom rate from stroke was higher in patients who underwent Maze procedure than those who did not. Patients with postoperative AF had larger left ventricular systolic and diastolic diameters at follow-up and higher New York Heart Association functional class than patients without postoperative AF (1.4 +/- 0.5 vs. 1.1 +/- 0.3, p < 0.001). Conclusion Maze procedure can have a positive effect on long-term survival, freedom from stroke, and cardiac function.	[Murashita, Takashi; Okada, Yukikatsu; Kanemitsu, Hideo; Fukunaga, Naoto; Konishi, Yasunobu; Nakamura, Ken; Koyaam, Tadaaki] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Surg, Kobe, Hyogo 6500047, Japan	Murashita, T (reprint author), Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Surg, Chuo Ku, 2-1-1 Minatozimaminami, Kobe, Hyogo 6500047, Japan.	tmurashita@gmail.com					Ngaage DL, 2007, ANN THORAC SURG, V84, P434, DOI 10.1016/j.athoracsur.2007.04.036; Lim E, 2001, CIRCULATION, V104, pI59; CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323; Mohty D, 2001, CIRCULATION, V104, pI1; Worku B, 2011, ANN THORAC SURG, V92, P2085, DOI 10.1016/j.athoracsur.2011.07.058; Braunberger E, 2001, CIRCULATION, V104, pI8; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; Khargi K, 2005, EUR J CARDIO-THORAC, V27, P258, DOI 10.1016/j.ejcts.2004.11.003; Bando K, 2005, J THORAC CARDIOV SUR, V129, P1032, DOI 10.1016/j.jtcvs.2004.10.037; Carpentier A, 1990, PERSPECTIVES PEDIA 3, P97; DAVID TE, 1991, J THORAC CARDIOV SUR, V101, P495; Fujita T, 2010, J THORAC CARDIOV SUR, V140, P1332, DOI 10.1016/j.jtcvs.2010.01.030; Funatsu T, 2009, EUR J CARDIO-THORAC, V36, P267, DOI 10.1016/j.ejcts.2009.03.032; Itoh A, 2006, EUR J CARDIO-THORAC, V29, P1030, DOI 10.1016/j.ejcts.2006.03.028; Lee CH, 2014, ANN THORAC SURG, V97, P124, DOI 10.1016/j.athoracsur.2013.07.073; Nakajima H, 2002, CIRCULATION, V106, pI46, DOI 10.1161/01.cir.0000032883.55215.49; Ngaage DL, 2007, ANN THORAC SURG, V84, P442; Wi J, 2013, CIRC J, V77, P109, DOI 10.1253/circj.CJ-12-0550	18	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	APR	2015	63	3					243	249		10.1055/s-0034-1383719		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CG1IJ	WOS:000353026000013		
J	Furuta, RA; Ma, GY; Matsuoka, M; Otani, S; Matsukura, H; Hirayama, F				Furuta, Rika A.; Ma, Guangyong; Matsuoka, Masao; Otani, Satoshi; Matsukura, Harumichi; Hirayama, Fumiya			Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors	TRANSFUSION			English	Article							SPASTIC PARAPARESIS HAM/TSP; IN-VIVO EXPRESSION; HTLV-I; PROVIRAL LOAD; ANTIBODY; PROTEIN; HBZ; QUANTIFICATION; PROLIFERATION; DIAGNOSIS	BackgroundRecently, Japanese Red Cross blood centers have changed the confirmatory test method from an indirect immunofluorescence (IF) technique to Western blotting (WB) for antibodies against human T-cell leukemia virus Type 1 (HTLV-1). In this study, these HTLV-1 tests were assessed using another sensitive method, that is, a luciferase immunoprecipitation system (LIPS), to identify a better confirmatory test for HTLV-1 infection. Study Design and MethodsPlasma samples from 54 qualified donors and 114 HTLV-1 screening-positive donors were tested by LIPS for antibodies against HTLV-1 Gag, Tax, Env, and HBZ recombinant proteins. The donors were categorized into six groups, namely, (Group I) qualified donors, screening positive; (Group II) IF positive; (Group III) IF negative; (Group IV) WB positive; (Group V) WB negative; and (Group VI) screening positive in the previous blood donation, but WB-indeterminate during this study period. ResultsIn Groups II and IV, all plasma samples tested positive by LIPS for antibodies against Gag and Env proteins. In Group V, all samples tested negative by LIPS, whereas some Group III samples reacted with single or double antigens in LIPS. In Group VI, the LIPS test identified a donor with suspected HTLV-1 infection. The first case of a blood donor with plasma that reacted with HBZ was identified by LIPS. ConclusionReevaluation of the current HTLV-1 screening method using the LIPS test showed that both confirmatory tests had similar sensitivity and specificity only when WB indeterminate results were eliminated. LIPS is a promising method for detecting and characterizing HTLV-1 antibodies.	[Furuta, Rika A.; Otani, Satoshi; Matsukura, Harumichi; Hirayama, Fumiya] Kinki Block Blood Ctr, Japanese Red Cross, Osaka, Japan; [Ma, Guangyong; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Lab Virus Control, Kyoto 606, Japan	Furuta, RA (reprint author), 7-5-17 Saito Asagi, Ibaragi City, Osaka 5670085, Japan.	r-furuta@kk.bbc.jrc.or.jp			Blood Service Headquarters, Japanese Red Cross Society	Supported by Blood Service Headquarters, Japanese Red Cross Society.	Manns A, 1999, J INFECT DIS, V180, P1487, DOI 10.1086/315088; Thorstensson R, 2002, TRANSFUSION, V42, P780, DOI 10.1046/j.1537-2995.2002.00114.x; Waters A, 2011, J CLIN VIROL, V52, P38, DOI 10.1016/j.jcv.2011.05.022; Berini CA, 2008, J VIROL METHODS, V147, P322, DOI 10.1016/j.jviromet.2007.09.012; Enose-Akahata Y, 2012, BLOOD, V119, P2829, DOI 10.1182/blood-2011-11-390807; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Hilburn S, 2011, J INFECT DIS, V203, P529, DOI 10.1093/infdis/jiq078; Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410; Burbelo PD, 2007, BIOCHEM BIOPH RES CO, V352, P889, DOI 10.1016/j.bbrc.2006.11.140; Burbelo PD, 2012, J VIROL, V86, P6171, DOI 10.1128/JVI.00250-12; Filippone C, 2012, J CLIN MICROBIOL, V50, P1663, DOI 10.1128/JCM.06540-11; Arnold J, 2006, BLOOD, V107, P3976, DOI 10.1182/blood-2005-11-4551; Burbelo PD, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-96; Burbelo PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022576; Enose-Akahata Y, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-19; Etoh K, 1999, INT J CANCER, V81, P859, DOI 10.1002/(SICI)1097-0215(19990611)81:6<859::AID-IJC4>3.0.CO;2-K; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; INABA S, 1989, TRANSFUSION, V29, P7, DOI 10.1046/j.1537-2995.1989.29189101168.x; Lu SC, 2003, INT J HEMATOL, V77, P412, DOI 10.1007/BF02982654; MacNamara A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001117; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Saito M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-19; Suemori K, 2009, J GEN VIROL, V90, P1806, DOI 10.1099/vir.0.010199-0; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	APR	2015	55	4					880	889		10.1111/trf.12911		10	Hematology	Hematology	CF7KN	WOS:000352735200026		
J	Seo, T; Kusakabe, T; Asakura, Y				Seo, Toru; Kusakabe, Takahiko; Asakura, Yasuo			Estimation of flow and density using probe vehicles with spacing measurement equipment	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article						Probe vehicle; Lagrangian sensing; Traffic flow; Traffic state estimation; Advanced driver assistance system	TRACKING; SENSOR; SYSTEM	Probe vehicles provide some of the most useful data for road traffic monitoring because they can acquire wide-ranging and spatiotemporally detailed information at a relatively low cost compared with traditional fixed-point observation. However, current GPS-equipped probe vehicles cannot directly provide us volume-related variables such as flow and density. In this paper, we propose a new probe vehicle-based estimation method for obtaining volume-related variables by assuming that a probe vehicle can measure the spacing to its leading one. This assumption can be realized by utilizing key technologies in advanced driver assistance systems that are expected to spread in the near future. We developed a method of estimating the flow, density, and speed from the probe vehicle data without exogenous assumptions on traffic flow characteristics, such as a fundamental diagram. In order to quantify the characteristics of the method, we performed a field experiment at a real-world urban expressway by employing prototypes of the probe vehicles with spacing measurement equipment. The result showed that the proposed method could accurately estimate the 5 min and hourly traffic volumes with probe vehicle penetration rate of 3.5% and 0.2%, respectively. (C) 2015 Elsevier Ltd. All rights reserved.	[Seo, Toru; Kusakabe, Takahiko; Asakura, Yasuo] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 1528552, Japan	Seo, T (reprint author), Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, 2-12-1-M1-20, Tokyo 1528552, Japan.	t.seo@plan.cv.titech.ac.jp; t.kusakabe@plan.cv.titech.ac.jp; asakura@plan.cv.titech.ac.jp	Kusakabe, Takahiko/C-1893-2015	Kusakabe, Takahiko/0000-0003-3019-5243	Research Fellow (DC2) program of the Japan Society for the Promotion of Science (KAKENHI) [26010218]	The traffic detector data was kindly provided by Metropolitan Expressway Co., Ltd. We would like to thank Prof. Carlos F. Daganzo (University of California, Berkeley) for his valuable advice on the estimation method, Ms. Kiko Yamada-Kawai (Tokyo Institute of Technology) and anonymous reviewers for their insightful comments on the earlier versions of this paper, Mr. Shuichi Yamaguchi (Japan Expressway International Co., Ltd.), Dr. Hiroshi Warita (Metropolitan Expressway Co., Ltd.), Dr. Yasuhiro Nonaka and Mr. Takashi Ishida (Highway Planning Co., Ltd.) for their technical advice on the field experiment, and Survey Research Center Co., Ltd. for their technical and professional assistance with the experiment. Part of this work was financially supported by the Research Fellow (DC2) program of the Japan Society for the Promotion of Science (KAKENHI Grant-in-Aid for JSPS Fellows #26010218).	Reddy S, 2010, ACM T SENSOR NETWORK, V6, DOI 10.1145/1689239.1689243; Nanthawichit C, 2003, TRANSPORT RES REC, P49; Mehran B, 2012, TRANSPORT RES C-EMER, V20, P144, DOI 10.1016/j.trc.2011.05.006; Herrera JC, 2010, TRANSPORT RES C-EMER, V18, P568, DOI 10.1016/j.trc.2009.10.006; ZITO R, 1995, TRANSPORT RES C-EMER, V3, P193, DOI 10.1016/0968-090X(95)00006-5; Papageorgiou M, 2003, P IEEE, V91, P2043, DOI 10.1109/JPROC.2003.819610; Yuan YF, 2012, IEEE T INTELL TRANSP, V13, P59, DOI 10.1109/TITS.2011.2178837; Quddus MA, 2007, TRANSPORT RES C-EMER, V15, P312, DOI 10.1016/j.trc.2007.05.002; Murakami E, 1999, TRANSPORT RES C-EMER, V7, P149, DOI 10.1016/S0968-090X(99)00017-0; Asakura Y, 2004, TRANSPORT RES C-EMER, V12, P273, DOI 10.1016/j.trc.2004.07.010; Coifman B, 1998, TRANSPORT RES C-EMER, V6, P271, DOI 10.1016/S0968-090X(98)00019-9; Daganzo C. F., 1997, FUNDAMENTALS TRANSPO; Edie L.C., 1963, P 2 INT S THEOR TRAF, P139; Geroliminis N, 2008, TRANSPORT RES B-METH, V42, P759, DOI 10.1016/j.trb.2008.02.002; HILBERT EE, 1980, IEEE T VEH TECHNOL, V29, P208, DOI 10.1109/T-VT.1980.23842; Redmill KA, 2011, IEEE INT C INTELL TR, P1089, DOI 10.1109/ITSC.2011.6083132; Saneyoshi K, 1996, PROCEEDINGS OF THE 1996 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P230, DOI 10.1109/IVS.1996.566383; Seo T., 2013, 2 S EUR ASS RES TRAN; Seo T., 2012, P INFRASTRUCTURE PLA, V46; Shiraishi T., 2012, P 32 C JAP SOC TRAFF; Wardrop J.G., 1954, ICE P ENG DIVISION, P158; Yokoi K., 2013, P 20 ITS WORLD C	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	APR	2015	53						134	150		10.1016/j.trc.2015.01.033		17	Transportation Science & Technology	Transportation	CG2BN	WOS:000353080000009		
J	Azuma, A; Ban, Y; Sato, A; Kono, A; Shiraishi, M; Yakushiji, H; Kobayashi, S				Azuma, Akifumi; Ban, Yusuke; Sato, Akihiko; Kono, Atsushi; Shiraishi, Mikio; Yakushiji, Hiroshi; Kobayashi, Shozo			MYB diplotypes at the color locus affect the ratios of tri/di-hydroxylated and methylated/non-methylated anthocyanins in grape berry skin	TREE GENETICS & GENOMES			English	Article						Anthocyanin; Grape; MYB; Quantitative trait loci (QTL); Skin color	VITIS-VINIFERA L.; FLAVONOID 3',5'-HYDROXYLASE GENES; LINKAGE MAPS; VVMYBA1; 3'-HYDROXYLASE; EXPRESSION; ALLELE; BIOSYNTHESIS; MECHANISMS; EVOLUTION	Color variation in grape skin is mainly determined by the quantity and composition of anthocyanins. Anthocyanin quantities are mainly determined by the myeloblastosis (MYB) diplotypes at the color locus. We investigated whether MYB diplotypes also control the anthocyanin composition. Using a population derived from an interspecific hybrid (Vitis labruscana x Vitis vinifera) cross, we performed quantitative trait locus (QTL) analyses for the ratios of tri/di-hydroxylated and methylated/non-methylated anthocyanins. We detected the color locus on LG2 as a major QTL for the ratio of tri/di-hydroxylated anthocyanins. We also found two major QTLs, the color locus on LG2 and a region close to the anthocyanin O-methyltransferase (AOMT) locus on LG1, for the ratio of methylated/non-methylated anthocyanins. Using the same population and a population from another interspecific hybrid cross, we investigated the relationship between the genotypes of the markers closest to the major QTLs, the ratios of tri/di-hydroxylated and methylated/non-methylated anthocyanins, and the expression levels of the genes for flavonoid 3',5'-hydroxylase (F3'5'H), flavonoid 3'-hydroxylase (F3'H), and AOMT. We suggest that MYB diplotypes at the color locus affect the ratio of tri/di-hydroxylated anthocyanins through trans-regulation of F3'5'H/F3'H expression ratio. We also suggest that MYB diplotypes and the AOMT genotypes affect the ratio of methylated/non-methylated anthocyanins through the regulation of AOMT expression. Our findings provide new knowledge about the genetic control of anthocyanin composition and contribute to a better understanding of the genetic mechanisms that control grape skin color.	[Azuma, Akifumi; Ban, Yusuke; Sato, Akihiko; Kono, Atsushi; Yakushiji, Hiroshi; Kobayashi, Shozo] Natl Agr & Food Res Org, Grape & Persimmon Res Stn, Inst Fruit Tree Sci, Hiroshima 7392494, Japan; [Shiraishi, Mikio] Fukuoka Agr Res Ctr, Fukuoka 8188549, Japan	Azuma, A (reprint author), Natl Agr & Food Res Org, Grape & Persimmon Res Stn, Inst Fruit Tree Sci, 301-2 Akitsu, Hiroshima 7392494, Japan.	azumaa@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [C-3-2030]	We thank Tamami Nakasumi and Junko Azuma (NIFTS) for technical assistance. This study was supported in part by a grant from the research program "Development of mitigation and adaptation techniques to global warming in the sectors of agriculture, forestry, and fisheries, C-3-2030" provided by the Ministry of Agriculture, Forestry and Fisheries of Japan.	Yakushiji H, 2006, BIOSCI BIOTECH BIOCH, V70, P1506, DOI 10.1271/bbb.50647; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Fournier-Level A, 2010, HEREDITY, V104, P351, DOI 10.1038/hdy.2009.148; Kobayashi S, 2005, J JPN SOC HORTIC SCI, V74, P196, DOI 10.2503/jjshs.74.196; Jeong ST, 2006, PLANT SCI, V170, P61, DOI 10.1016/j.plantsci.2005.07.025; CHURCHILL GA, 1994, GENETICS, V138, P963; Azuma A, 2011, THEOR APPL GENET, V122, P1427, DOI 10.1007/s00122-011-1542-7; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Fournier-Level A, 2009, GENETICS, V183, P1127, DOI 10.1534/genetics.109.103929; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; Shiraishi M, 2007, J JPN SOC HORTIC SCI, V76, P28, DOI 10.2503/jjshs.76.28; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; This P, 2007, THEOR APPL GENET, V114, P723, DOI 10.1007/s00122-006-0472-2; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Azuma A, 2008, THEOR APPL GENET, V117, P1009, DOI 10.1007/s00122-008-0840-1; Ban Y, 2014, EUPHYTICA, V198, P101, DOI 10.1007/s10681-014-1087-3; Salvi S, 2005, TRENDS PLANT SCI, V10, P297, DOI 10.1016/j.tplants.2005.04.008; Castellarin SD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-12; Azuma A, 2009, PLANT SCI, V176, P470, DOI 10.1016/j.plantsci.2008.12.015; Bayo-Canha A, 2012, EUPHYTICA, V186, P393, DOI 10.1007/s10681-012-0622-3; Castellarin SD, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-46; Deng JZ, 1996, SINO OVERSEAS GRAPEV, V2, P25; Falginella L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-562; Fournier-Level A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-179; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Guo Y, 2013, THEOR APPL GENET, V126, P1445, DOI 10.1007/s00122-013-2063-3; Jackman R. L., 1996, NATURAL FOOD COLORAN, P244; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Liang ZC, 2009, EUPHYTICA, V167, P113, DOI 10.1007/s10681-008-9868-1; Moreau C, 2012, PLANT PHYSIOL, V159, P759, DOI 10.1104/pp.112.197517; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; SARNI P, 1995, J SCI FOOD AGR, V69, P385, DOI 10.1002/jsfa.2740690317; Song SR, 2014, EUPHYTICA, V195, P259, DOI 10.1007/s10681-013-0994-z; Van Ooijen J. W., 2009, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2006, JOINMAP 4 SOFTWARE C	39	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	APR	2015	11	2							31	10.1007/s11295-015-0855-0		13	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CF8AP	WOS:000352777900002		
J	Kawamura, K; Hibrand-Saint Oyant, L; Thouroude, T; Jeauffre, J; Foucher, F				Kawamura, Koji; Hibrand-Saint Oyant, Laurence; Thouroude, Tatiana; Jeauffre, Julien; Foucher, Fabrice			Inheritance of garden rose architecture and its association with flowering behaviour	TREE GENETICS & GENOMES			English	Article						Flowering behaviour; Garden rose; Genetic map; Heritability; Inheritance; Plant architecture; QTL	GENETIC-LINKAGE MAPS; PLANT ARCHITECTURE; GROWTH HABIT; QUANTITATIVE GENETICS; STEM GROWTH; LOCUS T; ARABIDOPSIS; APPLE; TREES; MODEL	Understanding the genetic basis of plant architecture is limited for woody plants due to the challenges of assessing the inheritance of their complex architecture. We aimed to evaluate the genetic variability of plant form and stature in a garden rose population, analyse the inheritance of plant architecture and its linkage with flowering behaviour and identify the quantitative trait loci (QTLs) controlling garden rose architecture. A total of 98 F-1 hybrids were derived from the cross between two diploid roses, The Fairy (TF) and Rosa x wichurana (RW) that differed in stature and flowering behaviour. The TF exhibits continuous flowering (CF) and has erect stature. The RW is once flowering (OF) and prostrate in stature. Three clones per genotype were multiplied, and a total of 300 plants were cultivated in a field. Flowering behaviour, plant form, plant height, stem diameter and internode length were scored during each of 2 years. All architectural traits had significant genetic variances (29-61% of their respective phenotypic variances), and their broad-sense heritability estimates were 0.76-0.92. The majority of CF progeny was erect, whereas the OF progeny was prostrate, suggesting a linkage between plant form and flowering behaviour. The QTL analysis identified eight major QTLs controlling architectural traits. Several candidate genes involved in gibberellin biosynthesis and auxin signalling were identified in the vicinity of the QTLs. High heritability estimates obtained for garden rose architecture indicated that architectural characteristics are feasible targets of rose breeding. Linkage of plant form and flowering behaviour, however, prevents independent selection of these traits. The candidate genes identified can be good targets for future physiological studies.	[Kawamura, Koji; Hibrand-Saint Oyant, Laurence; Thouroude, Tatiana; Jeauffre, Julien; Foucher, Fabrice] INRA, Inst Rech Hort & Semences, UMR1345, F-49071 Beaucouze, France; [Kawamura, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Hort Sci Lab, Nagoya, Aichi 4648601, Japan; [Kawamura, Koji] Osaka Inst Technol, Dept Environm Engn, Asahi Ku, Osaka 5358585, Japan; [Hibrand-Saint Oyant, Laurence; Thouroude, Tatiana; Jeauffre, Julien; Foucher, Fabrice] Univ Angers, PRES UNAM, SFR QUASAV 4207, Inst Rech Hort & Semences UMR1345, F-49045 Angers, France; [Hibrand-Saint Oyant, Laurence; Thouroude, Tatiana; Jeauffre, Julien; Foucher, Fabrice] Agrocampus Ouest, Inst Rech Hort & Semences UMR1345, F-49045 Angers, France	Foucher, F (reprint author), INRA, Inst Rech Hort & Semences, UMR1345, F-49071 Beaucouze, France.	koji.kawamura@oit.ac.jp; fabrice.foucher@angers.inra.fr			Departement de Genetique et d'Amelioration des Plantes; INRA; Region Pays de la Loire; Japan Society for the Promotion of Science KAKENHI [24688004]	We thank Drs. Philippe Morel and Gilles Galopin (SAGAH, INRA Angers) for their helpful advice on plant measurements; Charles-Eric Durel, Sylvain Gaillard, Fabrice Dupuis and Alix Pernet (GenHort, INRA Angers) for the statistical analyses. This work was supported by grants from the Departement de Genetique et d'Amelioration des Plantes, INRA, Region Pays de la Loire and Japan Society for the Promotion of Science KAKENHI (24688004).	Ando K., 2007, CAB REV PERSPECTIVES, V2, DOI [10.1079/PAVSNNR20072026, DOI 10.1079/PAVSNNR20072026]; Oyant LHS, 2008, TREE GENET GENOMES, V4, P11, DOI 10.1007/s11295-007-0084-2; Bendahmane M, 2013, J EXP BOT, V64, P847, DOI 10.1093/jxb/ers387; Buck-Sorlin G, 2011, ANN BOT-LONDON, V108, P1121, DOI 10.1093/aob/mcr190; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; DIETERS MJ, 1995, THEOR APPL GENET, V91, P15, DOI 10.1007/BF00220853; NAKAMURA T, 1994, PLANT CELL PHYSIOL, V35, P523; Wu R, 1997, HEREDITY, V78, P124; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Nugroho WD, 2012, ANN BOT-LONDON, V110, P887, DOI 10.1093/aob/mcs148; Spiller M, 2011, THEOR APPL GENET, V122, P489, DOI 10.1007/s00122-010-1463-x; Ratcliffe OJ, 1998, DEVELOPMENT, V125, P1609; James KR, 2006, AM J BOT, V93, P1522, DOI 10.3732/ajb.93.10.1522; VIA S, 1984, EVOLUTION, V38, P896, DOI 10.2307/2408399; Pearcy RW, 2005, NEW PHYTOL, V166, P791, DOI 10.1111/j.1469-8137.2005.01328.x; Niwa M, 2013, PLANT CELL, V25, P1228, DOI 10.1105/tpc.112.109090; Kawamura K, 2011, THEOR APPL GENET, V122, P661, DOI 10.1007/s00122-010-1476-5; McCulloh KA, 2005, TREE PHYSIOL, V25, P257; Busov VB, 2008, NEW PHYTOL, V177, P589, DOI 10.1111/j.1469-8137.2007.02324.x; Boumaza R, 2009, J SENS STUD, V24, P774, DOI 10.1111/j.1745-459X.2009.00238.x; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Segura V, 2008, NEW PHYTOL, V178, P302, DOI [10.1111/j.1469-8137.2007.02374.x, 10.1111/j.1469-8137.2008.02374.x]; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Morel P, 2009, SCI HORTIC-AMSTERDAM, V120, P391, DOI 10.1016/j.scienta.2008.11.039; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Busov VB, 2003, PLANT PHYSIOL, V132, P1283, DOI 10.1104/pp.103.020354; Crespel L, 2013, EUPHYTICA, V191, P129, DOI 10.1007/s10681-013-0902-6; Sakamoto T, 2004, CURR OPIN BIOTECH, V15, P144, DOI 10.1016/j.copbio.2004.02.003; Remay A, 2009, THEOR APPL GENET, V119, P767, DOI 10.1007/s00122-009-1087-1; AULD TD, 1992, AUST J BOT, V40, P1, DOI 10.1071/BT9920001; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Beavis WD, 1998, MOL DISSECTION COMPL, V3, P145; COSTES E, 2004, ACTA HORTIC, V663, P349; Crespel L, 2014, PLANT BREEDING, V133, P412, DOI 10.1111/pbr.12157; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Debener T., 2003, ENCY ROSE SCI, P286; Djennane S, 2014, PLANT CELL ENVIRON, V37, P742, DOI 10.1111/pce.12191; DUBOIS LAM, 1987, EUPHYTICA, V36, P535, DOI 10.1007/BF00041499; Foucher F, 2003, PLANT CELL, V15, P2742, DOI 10.1105/tpc.015701; Foucher F, 2008, GENOME, V51, P827, DOI 10.1139/G08-067; Gudin S., 2000, Plant Breeding Reviews, V17, P159; Holland J. B., 2003, Plant Breeding Reviews, V22, P9, DOI 10.1002/9780470650202.ch2; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Kawamura K, 2010, ECOL RES, V25, P733, DOI 10.1007/s11284-009-0688-0; Kawamura K, 2014, J THEOR BIOL, V342, P83, DOI 10.1016/j.jtbi.2013.10.016; Larson SR, 2006, CROP SCI, V46, P2526, DOI 10.2135/cropsci2005.12.0472; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Mirzaie-Nodoushan H, 1999, J HERED, V90, P550, DOI 10.1093/jhered/90.5.550; Mohamed R, 2010, PLANT J, V62, P674, DOI 10.1111/j.1365-313X.2010.04185.x; Nybom Hilde, 2009, V6, P339, DOI 10.1007/978-0-387-77491-6_16; Rajapakse S, 2001, THEOR APPL GENET, V103, P575, DOI 10.1007/PL00002912; Randoux M, 2014, NEW PHYTOL, V202, P161, DOI 10.1111/nph.12625; Roberts AV, 1999, J PLANT GROWTH REGUL, V18, P113, DOI 10.1007/PL00007058; Segura V, 2006, TREE GENET GENOMES, V2, P140, DOI 10.1007/s11295-006-0037-1; Van Ooijen JW, 2004, MAPQTL 5 0 SOFTWARE; Wei W, 2013, P NATL ACAD SCI USA, V110, P19149, DOI 10.1073/pnas.1318489110; WHITE J, 1979, ANNU REV ECOL SYST, V10, P109, DOI 10.1146/annurev.es.10.110179.000545; Wissemann V, 2006, TREES-STRUCT FUNCT, V20, P340, DOI 10.1007/s00468-005-0046-y; Wolters PJ, 2013, NEW PHYTOL, V200, P993, DOI 10.1111/nph.12580; Yan Z, 2007, EUPHYTICA, V154, P53, DOI 10.1007/s10681-006-9269-2; Zhang F, 2012, MOL BREEDING, V30, P1027, DOI 10.1007/s11032-011-9686-3; Zhang YG, 2012, PLANT MOL BIOL REP, V30, P957, DOI 10.1007/s11105-011-0396-0	65	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	APR	2015	11	2							22	10.1007/s11295-015-0844-3		12	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CF8AP	WOS:000352777900012		
J	Parfitt, DE; Yonemori, K; Honsho, C; Nozaka, M; Kanzaki, S; Sato, A; Yamada, M				Parfitt, Dan E.; Yonemori, Keizo; Honsho, Chitose; Nozaka, Mitsunori; Kanzaki, Shinya; Sato, Akihiko; Yamada, Masahiko			Relationships among Asian persimmon cultivars, astringent and non-astringent types	TREE GENETICS & GENOMES			English	Article						Diospyros kaki; AFLP polymorphism; Cluster analysis; AMOVA; Structure	DIOSPYROS-KAKI THUNB.; MULTILOCUS GENOTYPE DATA; GENETIC-RELATIONSHIPS; POLLINATION-CONSTANT; MARKERS; CHINA; IDENTIFICATION; DIVERSITY; INFERENCE; TRAIT	A molecular marker analysis for Asian persimmon cultivar relationships and pollination status was conducted with 496 amplified fragment length polymorphism (AFLP) markers and 146 cultivars of Asian origin. Cultivars from China, Korea, and Japan were evaluated for marker composition and pollination status, which strongly influences fruit characteristics. Separation of Chinese, Korean, and Japanese cultivar groups and pollination type by neighbor-joining clustering, multidimensional scaling, and STRUCTURE was only weakly supported and not genetically significant. Significant differences for cultivar origin and pollination status were found for analysis of molecular variance (AMOVA), but most of the variation was among cultivars, not classification groups. All of the cultivar groups were genetically similar at the molecular level with most polymorphism due to individual cultivar differences.	[Parfitt, Dan E.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Yonemori, Keizo; Nozaka, Mitsunori] Kyoto Univ, Grad Sch Agr, Lab Pomol, Sakyo Ku, Kyoto 6068502, Japan; [Honsho, Chitose] Miyazaki Univ, Lab Pomol, Fac Agr, Miyazaki 8892192, Japan; [Kanzaki, Shinya] Kinki Univ, Hort Sci Lab, Fac Agr, Nara 6318505, Japan; [Sato, Akihiko] Natl Agr & Food Res Org, Natl Inst Fruit Tree Sci, Grape & Persimmon Res Stn, Higashi Ku, Hiroshima 7392494, Japan; [Yamada, Masahiko] Natl Agr & Food Res Org, Natl Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan	Parfitt, DE (reprint author), Univ Calif Davis, Dept Plant Sci, MS 2, Davis, CA 95616 USA.	deparfitt@ucdavis.edu		Honsho, Chitose/0000-0002-8959-5519	University of California Agricultural Experiment Station	The technical assistance of Ms. Helen Chan is gratefully acknowledged. Research was supported in part by funds from the University of California Agricultural Experiment Station.	Agricultural Research Station, 1912, B AGR RES STA, V28, P1; Akagi T, 2009, TREE GENET GENOMES, V5, P483, DOI 10.1007/s11295-009-0202-4; Akagi T, 2012, TREE GENET GENOMES, V8, P195, DOI 10.1007/s11295-011-0432-0; Akagi T, 2010, J AM SOC HORTIC SCI, V135, P59; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pritchard JK, 2000, GENETICS, V155, P945; Guo DL, 2011, GENET MOL RES, V10, P1060, DOI 10.4238/vol10-2gmr1100; Roldan-Ruiz I, 2000, MOL BREEDING, V6, P125, DOI 10.1023/A:1009680614564; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Falush D, 2003, GENETICS, V164, P1567; Badenes M, 2003, GENET RESOUR CROP EV, V50, P579, DOI 10.1023/A:1024474719036; CHO S K, 1965, Research Reports of the Office of Rural Development (Suweon), V8, P147; Doyle J. L. ., 1987, PHYTOCHEMISTRY B, V19, P11; Du X, 2009, ACTA HORTIC, V833, P97; Guo DL, 2006, GENET RESOUR CROP EV, V53, P1597, DOI 10.1007/s10722-005-8717-5; Hume H, 1913, P AM SOC HORTIC SCI, V10, P88; Hume H. H., 1914, J HERED, V5, P400; Ikegami A, 2011, J JPN SOC HORTIC SCI, V80, P150, DOI 10.2503/jjshs1.80.150; Ikegami A, 2006, HORTSCIENCE, V41, P561; Kajiura, 1946, BREED HORTIC, V1, P175; Kanzaki S, 2001, J AM SOC HORTIC SCI, V126, P51; Kanzaki S, 2000, J JPN SOC HORTIC SCI, V69, P665; Kanzaki S, 2010, J JPN SOC HORTIC SCI, V79, P150; Kikuchi, 1948, POMOLOGY I, P347; Naval MD, 2010, TREE GENET GENOMES, V6, P677, DOI 10.1007/s11295-010-0283-0; Pritchard J. K., 2007, DOCUMENTATION STRUCT; Renzi W, 1997, ACTA HORTIC, V436, P43; ROHLF F.J., 1998, NTSYS PC NUMERICAL T; Tamura M, 1998, J JPN SOC HORTIC SCI, V67, P306; Yamagishi M, 2005, SCI HORTIC-AMSTERDAM, V105, P283, DOI 10.1016/j.scienta.2005.01.020; Yonemori K, 2005, ACTA HORTIC, P77; Yonemori K., 2008, Advances in Horticultural Science, V22, P261; Yonemori K., 2000, Plant Breeding Reviews, V19, P191; Yonemori K, 2008, GENET RESOUR CROP EV, V55, P81, DOI 10.1007/s10722-007-9216-7	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	APR	2015	11	2							24	10.1007/s11295-015-0848-z		9	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CF8AP	WOS:000352777900009		
J	Yoshii, Y				Yoshii, Yuichi			REPLY TO RELIABILITY OF AUTOMATIC VIBRATORY EQUIPMENT FOR ULTRASONIC STRAIN MEASUREMENT OF THE MEDIAN NERVE: COMMON MISTAKE	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Letter									Tokyo Med Univ, Ibaraki Med Ctr, Dept Orthopaed Surg, Endowed Dept Human Resources Dev Community Med, Ami, Ibaraki, Japan	Yoshii, Y (reprint author), Tokyo Med Univ, Ibaraki Med Ctr, Dept Orthopaed Surg, Endowed Dept Human Resources Dev Community Med, Ami, Ibaraki, Japan.	Yy12721@yahoo.co.jp					Yoshii Y, 2014, ULTRASOUND MED BIOL, V40, P2352, DOI 10.1016/j.ultrasmedbio.2014.04.005	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-5629	1879-291X		ULTRASOUND MED BIOL	Ultrasound Med. Biol.	APR	2015	41	4					1120	1120		10.1016/j.ultrasmedbio.2014.10.016		1	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CF8JK	WOS:000352804100023		
J	Aboellail, MAM; Tanaka, H; Mori, N; Tanaka, A; Kubo, H; Shimono, R; Hata, T				Aboellail, M. A. M.; Tanaka, H.; Mori, N.; Tanaka, A.; Kubo, H.; Shimono, R.; Hata, T.			HDlive imaging of meconium peritonitis	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Editorial Material							PRENATAL-DIAGNOSIS		[Aboellail, M. A. M.; Tanaka, H.; Mori, N.; Hata, T.] Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, Miki, Kagawa 7610739, Japan; [Tanaka, A.; Kubo, H.; Shimono, R.] Kagawa Univ, Grad Sch Med, Dept Pediat Surg, Miki, Kagawa 7610739, Japan	Hata, T (reprint author), Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, 1750-1 Ikenobe, Miki, Kagawa 7610739, Japan.	toshi28@med.kagawa-u.ac.jp					Wang CN, 2008, TAIWAN J OBSTET GYNE, V47, P391, DOI 10.1016/S1028-4559(09)60004-8; Kagan KO, 2011, ULTRASOUND OBST GYN, V38, P607, DOI 10.1002/uog.10112; FOSTER MA, 1987, RADIOLOGY, V165, P661; Lee W, 2005, J ULTRAS MED, V24, P201; Saleh N, 2009, J PERINAT MED, V37, P535, DOI 10.1515/JPM.2009.097	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	APR	2015	45	4					494	496		10.1002/uog.14778		3	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CF4QY	WOS:000352536900023		
J	Rehman, AU; Kihara, K; Matsumoto, A; Ohtsuka, S				Rehman, Anis Ur; Kihara, Ken; Matsumoto, Akiko; Ohtsuka, Sakuichi			Attentive tracking of moving objects in real 3D space	VISION RESEARCH			English	Article						Multiple object tracking; Attention; Depth perception; 3D space	3-DIMENSIONAL SPACE; FOCUSED ATTENTION; MULTIPLE; VISION; LIMITS; SCENE; DEPTH	Results of earlier multiple object tracking (MOT) studies imply that humans can track several moving targets in a 2D environment simultaneously. Recently, a study suggested that stereoscopic depth has positive effect on tracking multiple objects when the objects are presented separately on multiple planes. However, it remains unclear whether or not humans can track moving targets in a real 3D environment. In this study, we investigated this issue displaying four targets and four distractors on near and/or far depth planes separated physically by 6, 10 or 50 cm using a half-mirror and two CRT-monitors. In addition we also tested whether participants could track the targets when either a target or a distractor changed depth during tracking. Our results suggested that performance dropped if the targets were presented on both depth planes especially when the distance between the planes was 50 cm. In addition, participants could track a depth-changed target if targets were presented on both planes before the start of a motion phase regardless of whether the initial state of targets distribution randomly varied or not, whereas they failed to track the target if all targets were presented on a single plane before MOT. In conclusion, humans have the ability to set attention on a wide range for MOT in a real 3D environment, with the provision that the efficiency of the tracking is critically dependent not only on the distance in depth but also on an initial state of distribution of the targets without the predictability of the initial state. (C) 2015 Elsevier Ltd. All rights reserved.	[Rehman, Anis Ur; Kihara, Ken; Matsumoto, Akiko; Ohtsuka, Sakuichi] Kagoshima Univ, Kagoshima 8900065, Japan	Kihara, K (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	kihara@ibe.kagoshima-u.ac.jp	Kihara, Ken/M-7249-2015	Kihara, Ken/0000-0002-5956-0913	JSPS KAKENHI [25730095, 24500149]	We thank two anonymous reviewers for their critical and constructive comments which significantly improved the manuscript. We also thank Rehman H. U. for helpful comments on a draft of this manuscript. This work was supported by JSPS KAKENHI Grant Numbers 25730095 and 24500149.	Alvarez GA, 2007, J VISION, V7, DOI 10.1167/7.13.14; ANDERSEN GJ, 1990, PERCEPT PSYCHOPHYS, V47, P112, DOI 10.3758/BF03205975; ANDERSEN GJ, 1993, PERCEPT PSYCHOPHYS, V53, P658, DOI 10.3758/BF03211742; Franconeri SL, 2008, PSYCHON B REV, V15, P802, DOI 10.3758/PBR.15.4.802; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Patterson R, 2009, J SOC INF DISPLAY, V17, P987, DOI 10.1889/JSID17.12.987; Grove PM, 2014, PERCEPTION, V43, P155, DOI 10.1068/p7513; Viswanathan L, 2002, PERCEPTION, V31, P1415, DOI 10.1068/p3432; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; Wolfe JM, 2007, PSYCHON B REV, V14, P344, DOI 10.3758/BF03194075; Theeuwes J, 2003, PSYCHON B REV, V10, P616, DOI 10.3758/BF03196523; Zelinsky GJ, 2008, VIS COGN, V16, P553, DOI 10.1080/13506280802000752; Liu G, 2005, J EXP PSYCHOL HUMAN, V31, P235, DOI 10.1037/0096-1523.31.2.235; Fehd HM, 2008, COGNITION, V108, P201, DOI 10.1016/j.cognition.2007.11.008; Pylyshyn ZW, 2001, COGNITION, V80, P127, DOI 10.1016/S0010-0277(00)00156-6; Cavanagh P., 2005, TRENDS COGN SCI, V9, P334; Fehd HM, 2010, J VISION, V10, DOI 10.1167/10.4.19; FENDER D, 1967, J OPT SOC AM, V57, P819, DOI 10.1364/JOSA.57.000819; Kleiner M., 2007, PERC 36 ECVP S; Nakayama K., 1986, NATURE, V320; Palmer D.A., 1961, Optica Acta, V8; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; St Clair R, 2010, J VISION, V10, DOI 10.1167/10.4.18; Vidakovic V, 2010, PSIHOLOGIJA, V43, P389, DOI 10.2298/PSI1004389V	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	APR	2015	109		A				1	10		10.1016/j.visres.2015.02.004		10	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CF9ZV	WOS:000352927300001		
J	Urabe, Y; Tanaka, S; Saito, Y; Igarashi, M; Watanabe, T; Sugihara, K				Urabe, Y.; Tanaka, S.; Saito, Y.; Igarashi, M.; Watanabe, T.; Sugihara, K.			Impact of revisions of the JSCCR guidelines on the treatment of T1 colorectal carcinomas in Japan	ZEITSCHRIFT FUR GASTROENTEROLOGIE			English	Article						T1 colorectal carcinoma; questionnaires; endoscopic resection; additional surgical resection; JSCCR guideline 2005; JSCCR guideline 2009/10	LYMPH-NODE METASTASIS; ENDOSCOPIC MUCOSAL RESECTION; RISK-FACTORS; SUBMUCOSAL DISSECTION; CANCER; TUMORS; INVASION; CRITERIA; COLON; STANDARDIZATION	Purpose: In 1977, the Japanese Society for Cancer of the Colon and Rectum (JSCCR) published the first edition of the general guidelines that described how to record clinical and histopathological findings of colorectal carcinomas (CRCs) and how to treat these cancers, and since then, the guidelines were revised several times. The aim of this study was to examine the impact of the revisions of the JSCCR guidelines on the treatment of submucosal CRCs (T1-CRCs) in Japanese clinical settings. Methods: Questionnaires were sent to all 391 member institutions of the JSCCR. The questionnaires consisted of 2 parts: details of the institutions and treatment strategies for T1-CRCs. Results: 73 (19 %) institutions responded to the survey. The number of treated T1-CRCs has increased year by year, and the rate of endoscopic resection for T1-CRCs has significantly increased with revisions of the guidelines (1417 [47 %] of 2985 T1-CRCs in 2003 - 2005, 2110 [50 %] of 4212 in 2006 - 2008, and 2546 [54 %] of 4686 in 2009 - 2011, P<.05). Conclusion: The revisions of the JSCCR guidelines have influenced the treatment of T1-CRCs in Japanese clinical settings. There is room to revise the criteria for curative endoscopic resection to avoid unnecessary surgeries.	[Urabe, Y.; Tanaka, S.] Hiroshima Univ, Endoscopy, Hiroshima 7348551, Japan; [Saito, Y.] Natl Canc Ctr, Endoscopy, Tokyo, Japan; [Igarashi, M.] Canc Inst Ariake Hosp, Gastroenterol, Tokyo, Japan; [Watanabe, T.] Univ Tokyo, Surg Oncol, Tokyo, Japan; [Sugihara, K.] Tokyo Med & Dent Univ, Grad Sch, Surg Oncol, Tokyo, Japan	Tanaka, S (reprint author), Hiroshima Univ, Endoscopy, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	colon@hiroshima-u.ac.jp			Japanese Society for Cancer of the Colon and Rectum	This work supported by the Japanese Society for Cancer of the Colon and Rectum. Yuji Urabe, Shinji Tanaka, Yutaka Saito, Masahiro Igarashi, Toshiaki Watanabe, and Kenichi Sugihara have no conflicts of interest or financial ties to disclose.	Ogawa T, 2009, SCAND J GASTROENTERO, V44, P605, DOI 10.1080/00365520902718911; KUDO S, 1994, J CLIN PATHOL, V47, P880, DOI 10.1136/jcp.47.10.880; Yasuda K, 2007, DIS COLON RECTUM, V50, P1370, DOI 10.1007/s10350-007-0263-0; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Watanabe T, 2009, DIS COLON RECTUM, V52, P1941, DOI 10.1007/DCR.0b013e3181b53684; Ikematsu H, 2013, GASTROENTEROLOGY, V144, P551, DOI 10.1053/j.gastro.2012.12.003; Terasaki M, 2012, J GASTROEN HEPATOL, V27, P734, DOI 10.1111/j.1440-1746.2011.06977.x; Kanao H, 2009, GASTROINTEST ENDOSC, V69, P631, DOI 10.1016/j.gie.2008.08.028; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Tanaka S, 2007, GASTROINTEST ENDOSC, V66, P100, DOI 10.1016/j.gie.2007.02.032; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Qi GY, 2009, ONCOL REP, V22, P557, DOI 10.3892/or_00000471; Boland CR, 1998, CANCER RES, V58, P5248; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4; Nakadoi K, 2012, J GASTROEN HEPATOL, V27, P1057, DOI 10.1111/j.1440-1746.2011.07041.x; KIKUCHI R, 1995, DIS COLON RECTUM, V38, P1286, DOI 10.1007/BF02049154; TANAKA S, 1995, J GASTROENTEROL, V30, P710, DOI 10.1007/BF02349636; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Li DW, 2013, CLIN CANCER RES, V19, P62, DOI 10.1158/1078-0432.CCR-12-1588; Macafee DAL, 2008, BRIT J CANCER, V99, P1991, DOI 10.1038/sj.bjc.6604788; Berg M, 2013, MOL MED; COOPER HS, 1983, AM J SURG PATHOL, V7, P613, DOI 10.1097/00000478-198310000-00002; Higuchi T, J IPN SOC COLOPROCTO, V59, P857; Japanese Society for Cancer of the Colon and Rectum, 2009, JSCCR GUID 2009 TREA; Japanese Society for Cancer of the Colon and Rectum, 1980, GEN RUL CLIN PATH ST; Japanese Society for Cancer of the Colon and Rectum, 2005, JSCCR GUID 2005 TREA; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Nakajima T, SURG ENDOSC, V27, P3262; Oka S, 2011, DIGEST ENDOSC, V23, P190, DOI 10.1111/j.1443-1661.2010.01072.x; Oka S, 2013, DIGEST ENDOSC, V25, P21, DOI 10.1111/den.12089; Stock C, 2012, GASTROINTEST ENDOSC, V75, P621, DOI 10.1016/j.gie.2011.10.025; Tanaka S, 2000, ONCOL REP, V7, P783; Tanaka Shinji, 1999, Stomach and Intestine (Tokyo), V34, P757; Tanaka S, 1998, EARLY COLORECTAL CAN, V2, P655; Ueno H, 2013, J GASTROENTEROL; WILCOX GM, 1986, CANCER, V57, P160, DOI 10.1002/1097-0142(19860101)57:1<160::AID-CNCR2820570132>3.0.CO;2-N; Yoshii S, CLIN GASTROENTEROL H, V12, P292	37	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-2771	1439-7803		Z GASTROENTEROL	Z. Gastroent.	APR	2015	53	4					291	301		10.1055/s-0034-1385764		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF8KO	WOS:000352808300003		
J	Sailaja, GS; Zhang, P; Anilkumar, GM; Yamaguchi, T				Sailaja, G. S.; Zhang, Peilin; Anilkumar, Gopinathan M.; Yamaguchi, Takeo			Aniosotropically Organized LDH on PVDF: A Geometrically Templated Electrospun Substrate for Advanced Anion Conducting Membranes	ACS APPLIED MATERIALS & INTERFACES			English	Article						PVDF-LDH substrate; electrospinning; geometric templating; pore-filling anion conducting membrane; solid-state alkaline fuel cell	LAYERED DOUBLE HYDROXIDES; TEMPERATURE FUEL-CELLS; EXCHANGE MEMBRANES; POLY(VINYLIDENE FLUORIDE); ELECTROLYTE MEMBRANES; IONIC-CONDUCTIVITY; POLYMER; PLASMA	A bioinspired geometric templating of an electrospun PVDF substrate with hexagonal platelets of Mg-Al layered double hydroxide (LDH), an intrinsic anion conductor, is presented. The distinctive morphology restructures the internal pore geometry and modulates the dynamic wetting profile of PVDF, transforming it into a highly functional substrate for SAFC anion conducting membranes. The membrane fabricated with PVDF-LDH substrate exhibited exceptionally high durability (>140 degrees C), high anionic conductivity, ion exchange capacity (IEC), restricted swelling, and improved tensile strength, overcoming critical challenges associated with PVDF electrospun substrates and validating its immense potential as a high-temperature-stable and durable substrate for advanced fuel cell membrane applications.	[Sailaja, G. S.; Yamaguchi, Takeo] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Zhang, Peilin; Anilkumar, Gopinathan M.] Noritake Co Ltd, Res & Dev Ctr, Miyoshi, Aichi 4700293, Japan	Yamaguchi, T (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259, Yokohama, Kanagawa 2268503, Japan.	yamag@res.titech.ac.jp	Yamaguchi, Takeo/H-1607-2011	Yamaguchi, Takeo/0000-0001-9043-4408	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)	This work was supported by the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST) and their support is gratefully acknowledged. The authors thank Dr. Hidenori Ohashi and Dr. Shoji Miyanishi of Tokyo Institute of Technology for their valuable support.	Duan QJ, 2013, J POWER SOURCES, V243, P773, DOI 10.1016/j.jpowsour.2013.06.095; Ross GJ, 2000, POLYMER, V41, P1685, DOI 10.1016/S0032-3861(99)00343-2; Zhang PL, 2013, J POWER SOURCES, V230, P225, DOI 10.1016/j.jpowsour.2012.12.064; Bottino A, 2002, DESALINATION, V146, P35, DOI 10.1016/S0011-9164(02)00469-1; Yamaguchi T, 2007, ADV MATER, V19, P592, DOI 10.1002/adma.200601086; Varcoe JR, 2005, FUEL CELLS, V5, P187, DOI 10.1002/fuce.200400045; Kwak NS, 2012, MACROMOL RES, V20, P205, DOI 10.1007/s13233-012-0032-3; Cao XC, 2006, APPL SURF SCI, V253, P2003, DOI 10.1016/j.apsusc.2006.03.090; Yamaguchi T, 2003, ADV MATER, V15, P1198, DOI 10.1002/adma.200304926; Song JY, 1999, J POWER SOURCES, V77, P183, DOI 10.1016/S0378-7753(98)00193-1; Cavaliere S, 2011, ENERG ENVIRON SCI, V4, P4761, DOI 10.1039/c1ee02201f; Asazawa K, 2007, ANGEW CHEM INT EDIT, V46, P8024, DOI 10.1002/anie.200701334; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Merle G, 2011, J MEMBRANE SCI, V377, P1, DOI 10.1016/j.memsci.2011.04.043; Luo YT, 2012, ELECTROCHEM COMMUN, V16, P65, DOI 10.1016/j.elecom.2012.01.005; Ying L, 2002, MACROMOLECULES, V35, P673, DOI 10.1021/ma0112568; Jung HM, 2011, J MEMBRANE SCI, V373, P107, DOI 10.1016/j.memsci.2011.02.044; Yamaguchi T, 2005, ELECTROCHEM COMMUN, V7, P730, DOI 10.1016/j.elecom.2005.04.030; YAMAGUCHI T, 1991, MACROMOLECULES, V24, P5522, DOI 10.1021/ma00020a006; Clark TJ, 2009, J AM CHEM SOC, V131, P12888, DOI 10.1021/ja905242r; Lee MS, 2012, J MATER CHEM, V22, P13928, DOI 10.1039/c2jm32628k; Poynton SD, 2010, SOLID STATE IONICS, V181, P219, DOI 10.1016/j.ssi.2009.01.019; Zhao YH, 2007, LANGMUIR, V23, P5779, DOI 10.1021/la070139o; Duca MD, 1998, POLYM DEGRAD STABIL, V61, P65, DOI 10.1016/S0141-3910(97)00130-4; Evans DG, 2006, CHEM COMMUN, P485, DOI 10.1039/b510313b; Grew K., 2010, J ELECTROCHEM SOC, V157, P327; Hietala S, 1999, POLYMER, V40, P5567, DOI 10.1016/S0032-3861(98)00768-X; Sun T., 2005, ACCOUNTS CHEM RES, V38, P8; Williams GR, 2006, J MATER CHEM, V16, P3065, DOI 10.1039/b604895a; Zhang PL, 2014, RSC ADV, V4, P41051, DOI 10.1039/c4ra05628k	30	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	APR 1	2015	7	12					6397	6401		10.1021/acsami.5b00532		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CF0PM	WOS:000352246700005		
J	Septina, W; Kurihara, M; Ikeda, S; Nakajima, Y; Hirano, T; Kawasaki, Y; Harada, T; Matsumura, M				Septina, Wilman; Kurihara, Masaaki; Ikeda, Shigeru; Nakajima, Yasuhiro; Hirano, Toshiyuki; Kawasaki, Yoshihito; Harada, Takashi; Matsumura, Michio			Cu(In,Ga)(S,Se)(2) Thin Film Solar Cell with 10.7% Conversion Efficiency Obtained by Selenization of the Na-Doped Spray-Pyrolyzed Sulfide Precursor Film	ACS APPLIED MATERIALS & INTERFACES			English	Article						Cu(In,Ga)(S,Se-2); spray pyrolysis; sodium addition; selenization; aqueous solution	POLYCRYSTALLINE CU(IN,GA)SE-2; SODIUM; CUINSE2; PERFORMANCE; DEPOSITION; ABSORBERS; GROWTH; CU(IN	Selenium-rich Cu(In,Ga)(S,Se)(2) (CIGSSe) thin films on an Mo-coated soda-lime glass substrate were fabricated by spray pyrolysis of an aqueous precursor solution containing Cu(NO3)(2), In(NO3)(3), Ga(NO3)(3), and thiourea followed by selenization at 560 degrees C for 10 min. We studied the effects of intentional sodium addition on the structural and morphological properties of the fabricated CIGSSe films by dissolving NaNO3 in the aqueous precursor solution. The addition of sodium was found to affect the morphology of the final CIGSSe film: the film had denser morphology than that of the CIGSSe film obtained without addition of NaNO3. Photoelectrochemical measurements also revealed that the acceptor density of the nondoped CIGSSe film was relatively high (N-a = 7.2 x 10(17) cm(-3)) and the addition of sodium led to a more favorable value for solar cell application (N-a = 1.8 x 10(17) cm(-3)). As a result, a solar cell based on the sodium-modified CIGSSe film exhibited maximum conversion efficiency of 8.8%, which was significantly higher than that of the cell based on nondoped CIGSSe (4.4%). In addition, by applying MgF2 antireflection coating to the device, the maximum efficiency was further improved to 10.7%.	[Septina, Wilman; Ikeda, Shigeru; Kawasaki, Yoshihito; Harada, Takashi; Matsumura, Michio] Osaka Univ, Res Ctr Solar Energy Chem, Toyonaka, Osaka 5608531, Japan; [Kurihara, Masaaki; Nakajima, Yasuhiro; Hirano, Toshiyuki] Asahi Kasei Corp, Corp Res & Dev, Energy & Environm R&D Ctr, Renewable Energy Mat Dev Grp,Kawasaki Ku, Kawasaki, Kanagawa 2100863, Japan	Ikeda, S (reprint author), Osaka Univ, Res Ctr Solar Energy Chem, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	sikeda@chem.es.osaka-u.ac.jp			MEXT Japan	S.I. acknowledges for financial support by a Grant-in-Aid for Scientific Research on Innovative Areas (All Nippon Artificial Photosynthesis Project for Living Earth) from MEXT Japan. Dr. Takeshi Yamauchi and Mr. Tatsuya Nakao (Analysis Simulation Center, Asahi Kasei Corporation) are gratefully acknowledged for their analyses in SIMS and SSRM measurements.	ALBIN DS, 1995, J ELECTRON MATER, V24, P351, DOI 10.1007/BF02659698; Kushiya K, 2014, SOL ENERG MAT SOL C, V122, P309, DOI 10.1016/j.solmat.2013.09.014; Todorov T, 2010, EUR J INORG CHEM, P17, DOI 10.1002/ejic.200900837; Eisenbarth T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3277043; Hibberd CJ, 2010, PROG PHOTOVOLTAICS, V18, P434, DOI 10.1002/pip.914; Werner JH, 2005, THIN SOLID FILMS, V480, P399, DOI 10.1016/j.tsf.2004.11.052; Wei SH, 1998, APPL PHYS LETT, V72, P3199, DOI 10.1063/1.121548; Scragg JJ, 2008, ELECTROCHEM COMMUN, V10, P639, DOI 10.1016/j.elecom.2008.02.008; Nakada T, 1997, JPN J APPL PHYS 1, V36, P732, DOI 10.1143/JJAP.36.732; Dullweber T, 2001, THIN SOLID FILMS, V387, P11, DOI 10.1016/S0040-6090(00)01726-0; PETER LM, 1990, CHEM REV, V90, P753, DOI 10.1021/cr00103a005; Lee SM, 2012, ELECTROCHIM ACTA, V79, P189, DOI 10.1016/j.electacta.2012.06.103; Braunger D, 2000, THIN SOLID FILMS, V361, P161, DOI 10.1016/S0040-6090(99)00777-4; Ho JCW, 2014, ACS APPL MATER INTER, V6, P6638, DOI 10.1021/am500317m; Hossain MA, 2015, J MATER CHEM A, V3, P4147, DOI 10.1039/c4ta05783j; Bhattacharya RN, 2000, THIN SOLID FILMS, V361, P396, DOI 10.1016/S0040-6090(99)00809-3; Jackson P, 2015, PHYS STATUS SOLIDI-R, V9, P28, DOI 10.1002/pssr.201409520; Burgelman M, 1997, PROG PHOTOVOLTAICS, V5, P121, DOI 10.1002/(SICI)1099-159X(199703/04)5:2<121::AID-PIP159>3.0.CO;2-4; Reinhard P, 2013, SOL ENERG MAT SOL C, V119, P287, DOI 10.1016/j.solmat.2013.08.030; Siebentritt S, 2013, SOL ENERG MAT SOL C, V119, P18, DOI 10.1016/j.solmat.2013.04.014; Guo QJ, 2013, PROG PHOTOVOLTAICS, V21, P64, DOI 10.1002/pip.2200; Kronik L, 1998, ADV MATER, V10, P31, DOI 10.1002/(SICI)1521-4095(199801)10:1<31::AID-ADMA31>3.0.CO;2-3; Ikeda S, 2013, CATAL SCI TECHNOL, V3, P1849, DOI 10.1039/c3cy00020f; Cai YG, 2013, ACS APPL MATER INTER, V5, P1533, DOI 10.1021/am303057z; Yan Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.205501; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Blosch P, 2014, SOL ENERG MAT SOL C, V124, P10, DOI 10.1016/j.solmat.2014.01.020; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/nmat3789, 10.1038/NMAT3789]; Eslamian Morteza, 2014, Coatings, V4, DOI 10.3390/coatings4010060; Mansfield L.M., 2011, PHOT SPEC C PVSC 201; Minoura S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4790174; Negami T, 2001, SOL ENERG MAT SOL C, V67, P1, DOI 10.1016/S0927-0248(00)00257-9; Nichterwitz M., 2013, J APPL PHYS, V114; Nichterwitz M, 2013, J APPL PHYS, V113, DOI 10.1063/1.4788827; Rudigier E, 2003, THIN SOLID FILMS, V431, P110, DOI 10.1016/S0040-6090(03)00214-1; Shirakata S, 1999, JPN J APPL PHYS 1, V38, P4997, DOI 10.1143/JJAP.38.4997; Shirakata S, 1996, JPN J APPL PHYS 1, V35, P191, DOI 10.1143/JJAP.35.191; Yan Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235504	39	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	APR 1	2015	7	12					6472	6479		10.1021/am507684x		8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CF0PM	WOS:000352246700016		
J	Usui, H; Yoshioka, S; Wasada, K; Shimizu, M; Sakaguchi, H				Usui, Hiroyuki; Yoshioka, Sho; Wasada, Kuniaki; Shimizu, Masahiro; Sakaguchi, Hiroki			Nb-Doped Rutile TiO2: a Potential Anode Material for Na-Ion Battery	ACS APPLIED MATERIALS & INTERFACES			English	Article						rutile-type titanium oxide; Nb doping Na-ion battery; Li-ion battery; gas deposition; thick-film electrode	NEGATIVE ELECTRODE; GAS-DEPOSITION; SODIUM STORAGE; LITHIUM; LI; NANOPARTICLES; PERFORMANCE; INSERTION; TEMPERATURE; MECHANISM	The electrochemical properties of the rutile-type TiO2 and Nb-doped TiO2 were investigated for the first time as Na-ion battery anodes. Ti1-xNbxO2 thick-film electrodes without a binder and a conductive additive were prepared using a sol-gel method followed by a gas-deposition method. The TiO2 electrode showed reversible reactions of Na insertion/extraction accompanied by expansion/contraction of the TiO2 lattice. Among the Ti1-xNbxO2 electrodes with x = 0-0.18, the Ti0.94Nb0.06O2 electrode exhibited the best cycling performance, with a reversible capacity of 160 mA h g(-1) at the 50th cycle. As the Li-ion battery anode, this electrode also attained an excellent rate capability, with a capacity of 120 mA h g(-1) even at the high current density of 16.75 A g(-1) (50C). The improvements in the performances are attributed to a 3 orders of magnitude higher electronic conductivity of Ti0.94Nb0.06O2 compared to that of TiO2. This offers the possibility of Nb-doped rutile TiO2 as a Na-ion battery anode as well as a Li-ion battery anode.	Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Koyama, Tottori 6808552, Japan; Tottori Univ, Ctr Res Green Sustainable Chem, Koyama, Tottori 6808552, Japan		sakaguch@chem.tottori-u.ac.jp	Usui, Hiroyuki/C-1168-2009; Shimizu, Masahiro/A-5059-2014	Usui, Hiroyuki/0000-0002-1156-0340; Shimizu, Masahiro/0000-0003-1084-7486	Japan Society for the Promotion of Science KAKENHI [24350094]; Japan Association for Chemical Innovation; Kyoto Technoscience Center	This work has been partially supported by a Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research (B) (Grant 24350094). A part of this work was supported by the Japan Association for Chemical Innovation and the Kyoto Technoscience Center. The authors thank reviewers of this article for their helpful suggestions and comments.	Oh SM, 2014, ACS APPL MATER INTER, V6, P11295, DOI 10.1021/am501772a; Hu YS, 2006, ADV MATER, V18, P1421, DOI 10.1002/adma.200502723; Wang JW, 2012, NANO LETT, V12, P5897, DOI 10.1021/nl303305c; Zhao J, 2013, J ELECTROCHEM SOC, V160, pA3077, DOI 10.1149/2.007305jes; Komaba S, 2012, ELECTROCHEM COMMUN, V21, P65, DOI 10.1016/j.elecom.2012.05.017; Yabuuchi N, 2012, NAT MATER, V11, P512, DOI [10.1038/nmat3309, 10.1038/NMAT3309]; Huang JP, 2013, RSC ADV, V3, P12593, DOI 10.1039/c3ra42413h; Darwiche A, 2012, J AM CHEM SOC, V134, P20805, DOI 10.1021/ja310347x; Yan ZC, 2014, J POWER SOURCES, V269, P37, DOI 10.1016/j.jpowsour.2014.06.150; Yamamoto T, 2012, J POWER SOURCES, V217, P479, DOI 10.1016/j.jpowsour.2012.05.110; Wu LM, 2014, J POWER SOURCES, V251, P379, DOI 10.1016/j.jpowsour.2013.11.083; Baudrin E, 2007, ELECTROCHEM COMMUN, V9, P337, DOI 10.1016/j.elecom.2006.09.022; Guidi V, 2003, J PHYS CHEM B, V107, P120, DOI 10.1021/jp013572u; Senguttuvan P, 2011, CHEM MATER, V23, P4109, DOI 10.1021/cm202076g; Fullenwarth J, 2014, J MATER CHEM A, V2, P2050, DOI 10.1039/c3ta13976j; Usui H, 2012, THIN SOLID FILMS, V520, P7006, DOI 10.1016/j.tsf.2012.07.093; Yu PF, 2014, J PHYS CHEM C, V118, P10616, DOI 10.1021/jp5010693; Koudriachova MV, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235423; Shimizu M, 2014, J POWER SOURCES, V248, P378, DOI 10.1016/j.jpowsour.2013.09.046; Shen K, 2014, INORG CHEM, V53, P8250, DOI 10.1021/ic5004269; Nam DH, 2014, J POWER SOURCES, V247, P423, DOI 10.1016/j.jpowsour.2013.08.095; Kitajou A, 2014, J POWER SOURCES, V247, P391, DOI 10.1016/j.jpowsour.2013.08.123; Komaba S, 2011, ADV FUNCT MATER, V21, P3859, DOI 10.1002/adfm.201100854; Hariharan S, 2013, PHYS CHEM CHEM PHYS, V15, P2945, DOI 10.1039/c2cp44572g; Sakaguchi H, 2007, ELECTROCHEM SOLID ST, V10, pJ146, DOI 10.1149/1.2772409; Wu L, 2014, ENERG ENVIRON SCI, V7, P323, DOI 10.1039/c3ee42944j; Ruiz AM, 2004, CHEM MATER, V16, P862, DOI 10.1021/cm0351238; Barpanda P., 2014, NAT COMMUN, V5; Kim K.-T., 2014, NANO LETT, V16, P412; OHZUKU T, 1995, J ELECTROCHEM SOC, V142, P1431, DOI 10.1149/1.2048592; Qian J., 2013, ANGEW CHEM, V125, P4731; Usui H, 2013, ELECTROCHIM ACTA, V111, P575, DOI 10.1016/j.electacta.2013.08.015	32	18	18	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	APR 1	2015	7	12					6567	6573		10.1021/am508670z		7	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CF0PM	WOS:000352246700026		
J	Ahn, H; Ju, YM; Takahashi, H; Williams, DF; Yoo, JJ; Lee, SJ; Okano, T; Atala, A				Ahn, Hyunhee; Ju, Young Min; Takahashi, Hironobu; Williams, David F.; Yoo, James J.; Lee, Sang Jin; Okano, Teruo; Atala, Anthony			Engineered small diameter vascular grafts by combining cell sheet engineering and electrospinning technology	ACTA BIOMATERIALIA			English	Article						Electrospinning; Smooth muscle cells; Cell sheet engineering; Vascular tissue engineering	SMOOTH-MUSCLE-CELLS; BLOOD-VESSELS; IN-VIVO; BIODEGRADABLE SCAFFOLDS; TISSUE; RECONSTRUCTION; BIOREACTOR; DETACHMENT; COCULTURE; INFECTION	Tissue engineering offers an attractive approach to creating functional small-diameter (<5 mm) blood vessels by combining autologous cells with a natural and/or synthetic scaffold under suitable culture conditions, which results in a tubular construct that can be implanted in vivo. We have previously developed a vascular scaffold fabricated by electrospinning poly(epsilon-caprolactone) (PCL) and type I collagen that mimics the structural and biomechanical properties of native vessels. In this study, we investigated whether a smooth muscle cell (SMC) sheet could be combined with the electrospun vascular scaffolds to produce a more mature smooth muscle layer as compared to the conventional cell seeding method. The pre-fabricated SMC sheet, wrapped around the vascular scaffold, provided high cell seeding efficiency (approx. 100%) and a mature smooth muscle layer that expressed strong cell-to-cell junction, connexin 43 (CX43), and contractile proteins, a smooth muscle actin (alpha-SMA) and myosin light chain kinase (MLCK). Moreover, bioreactor-associated preconditioning of the SMC sheet-combined vascular scaffold maintained high cell viability (95.9 +/- 2.7%) and phenotypes and improved cellular infiltration and mechanical properties (35.7% of tensile strength, 47.5% of elasticity, and 113.2% of elongation at break). (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Ahn, Hyunhee; Ju, Young Min; Williams, David F.; Yoo, James J.; Lee, Sang Jin; Atala, Anthony] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA; [Takahashi, Hironobu; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan	Lee, SJ (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	sjlee@wakehealth.edu; okano.teruo@twmu.ac.jp			Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Material Command (USAMRMC) [W81XWH-07-1-0718]	We would like to give special thanks to Ms. Mime Egami for initiating the collaboration. We would also like to thank Dr. Heather Hatcher for editorial assistance and Dr. Sang-Hyug Park for technical assistance. This study was supported, in part, by the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Material Command (USAMRMC) through award W81XWH-07-1-0718.	Androjna C, 2008, TISSUE ENG PT A, V14, P559, DOI 10.1089/tea.2006.0361; Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8; Iwasaki K, 2008, CIRCULATION, V118, pS52, DOI 10.1161/CIRCULATIONAHA.107.757369; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; OWENS GK, 1995, PHYSIOL REV, V75, P487; Asakawa N, 2010, BIOMATERIALS, V31, P3903, DOI 10.1016/j.biomaterials.2010.01.105; Isenberg BC, 2008, BIOMATERIALS, V29, P2565, DOI 10.1016/j.biomaterials.2008.02.023; Neff LP, 2011, J VASC SURG, V53, P426, DOI 10.1016/j.jvs.2010.07.054; Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S; Bujan J, 2004, BIOTECHNOL APPL BIOC, V39, P17, DOI 10.1042/BA20030111; Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Edelman ER, 1999, CIRC RES, V85, P1115; Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x; Roh JD, 2007, J PEDIATR SURG, V42, P198, DOI 10.1016/j.jpedsurg.2006.09.054; Melchiorri AJ, 2013, TISSUE ENG PART B-RE, V19, P292, DOI [10.1089/ten.TEB.2012.0577, 10.1089/ten.teb.2012.0577]; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026; Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus; Pawlowski KJ, 2004, FRONT BIOSCI-LANDMRK, V9, P1412, DOI 10.2741/1302; Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.0.CO;2-7; Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032; Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Nikolovski J, 2003, FASEB J, V17, P455, DOI 10.1096/fj.02-0459fje; Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256; Dora KA, 2001, VASC MED, V6, P43; Furuta A, 2006, CIRC RES, V98, P705, DOI 10.1161/01.RES.0000209515.59115.70; Hamdi H, 2011, CARDIOVASC RES, V91, P483, DOI 10.1093/cvr/cvr099; Hernandez-Richter T, 2003, EUR J VASC ENDOVASC, V26, P550, DOI 10.1016/S1078-5884(03)00344-7; Heydarkhan-Hagvall S, 2003, J CELL BIOCHEM, V89, P1250, DOI 10.1002/jcb.10583; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Lee SJ, 2012, HANDBOOK OF INTELLIGENT SCAFFOLDS FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P201; Lichtenberg A, 2006, CIRCULATION, V114, pI559, DOI 10.1161/CIRCULATIONAHA.105.001206; Matsuura K, J CONTROL RELEASE; Roh JD, 2007, TISSUE ENG, V13, P2743, DOI 10.1089/ten.2007.0171; Sacar M, 2005, J SURG RES, V129, P329, DOI 10.1016/j.jss.2005.05.017; Woods HA, 2008, J EXP BIOL, V211, P790, DOI 10.1242/jeb.014613; Yazdani S, 2008, PRINCIPLES REGENERAT, P978, DOI 10.1016/B978-012369410-2.50059-0; Yazdani SK, 2009, TISSUE ENG PT A, V15, P827, DOI 10.1089/ten.tea.2008.0092; Yazdani SK, 2010, J VASC SURG, V51, P174, DOI 10.1016/j.jvs.2009.08.074	46	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	APR 1	2015	16						14	22		10.1016/j.actbio.2015.01.030		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CE6WJ	WOS:000351978600002		
J	Zhao, J; Chai, YD; Zhang, J; Huang, PF; Nakashima, K; Gong, YK				Zhao, Jing; Chai, Yu-Dong; Zhang, Jing; Huang, Peng-Fei; Nakashima, Kenichi; Gong, Yong-Kuan			Long circulating micelles of an amphiphilic random copolymer bearing cell outer membrane phosphorylcholine zwitterions	ACTA BIOMATERIALIA			English	Article						Polymeric micelles; Cell membrane mimetic; Phosphorylcholine; Long-circulation; Biodistribution	PEG CHAIN-LENGTH; ACCELERATED BLOOD CLEARANCE; LARGE UNILAMELLAR LIPOSOMES; PEGYLATED LIPOSOMES; DRUG-DELIVERY; POLY(ETHYLENE GLYCOL); REPEATED INJECTIONS; IN-VIVO; POLYMERIC NANOPARTICLES; PROTEIN ADSORPTION	Polymeric micelles with cell outer membrane mimetic structure were prepared in water from amphiphilic random copolymers bearing both the hydrophilic phosphorylcholine zwitterions and hydrophobic octadecyl side chains of cell outer membrane. The polymeric micelles showed sizes ranging from 80 nm to 120 nm in hydrodynamic diameter and zeta-potentials from -6.4 mV to -2.4 mV by dynamic light scattering measurements. The micelles loaded with 6-coumarin as a fluorescence probe were stable to investigate their blood circulation and biodistribution. The in vitro phagocytosis results using murine peritoneal macrophages showed 10-fold reduction compared with a reference micelle. The in vivo blood circulation half-life of the polymeric micelles following intravenous administration in New Zealand Rabbits was increased from 0.55 h to 90.5 h. More interestingly, tissue distribution results showed that the concentration of the micelles in the kidney is 4-fold higher than that in the liver and other organs 48 h after administration. The results of this work show great promise for designing more effective stealth drug carriers that can minimize reticuloendothelial system clearance and circulate for long time to reach target by using simple cell membrane mimetic random copolymer micelles. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Zhao, Jing; Chai, Yu-Dong; Zhang, Jing; Huang, Peng-Fei; Gong, Yong-Kuan] Northwest Univ, Coll Chem & Mat Sci, Key Lab Synthet & Nat Funct Mol Chem, Minist Educ, Xian 710127, Shaanxi, Peoples R China; [Zhao, Jing] Xian Polytech Univ, Sch Environm & Chem Engn, Xian 710048, Shaanxi, Peoples R China; [Nakashima, Kenichi] Saga Univ, Fac Sci & Engn, Dept Chem, Saga 8408502, Japan	Gong, YK (reprint author), Northwest Univ, Coll Chem & Mat Sci, Key Lab Synthet & Nat Funct Mol Chem, Minist Educ, Xian 710127, Shaanxi, Peoples R China.	nakashik@cc.saga-u.ac.jp; gongyk@nwu.edu.cn			National Natural Science Foundation of China [21244001, 21374087]; Research Project of Science and Technology Department of Shaanxi Province [2014K13-12]; Doctoral Scientific Research Foundation of Xi'an Polytechnic University [BS1333]	This work was supported by the National Natural Science Foundation of China (Nos. 21244001, 21374087), the Research Project of Science and Technology Department of Shaanxi Province (No. 2014K13-12) and the Doctoral Scientific Research Foundation of Xi'an Polytechnic University (No. BS1333).	ALLEN TM, 1987, FEBS LETT, V223, P42, DOI 10.1016/0014-5793(87)80506-9; Wilhelm C, 2002, LANGMUIR, V18, P8148, DOI 10.1021/la0257337; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; CHONN A, 1992, J BIOL CHEM, V267, P18759; Shan XQ, 2009, COLLOID SURFACE B, V72, P303, DOI 10.1016/j.colsurfb.2009.04.017; Ishida T, 2003, J CONTROL RELEASE, V88, P35, DOI 10.1016/S0168-3659(02)00462-5; Ishida T, 2006, J CONTROL RELEASE, V112, P15, DOI 10.1016/j.jconrel.2006.01.005; Fella C, 2008, EUR J PHARM SCI, V34, P309, DOI 10.1016/j.ejps.2008.05.004; Lewis AL, 2001, BIOMATERIALS, V22, P99, DOI 10.1016/S0142-9612(00)00083-1; Westedt U, 2007, J CONTROL RELEASE, V119, P41, DOI 10.1016/j.jconrel.2007.01.009; Ishida T, 2003, INT J PHARM, V255, P167, DOI 10.1016/S0378-5173(03)00085-1; Gao WW, 2013, ADV MATER, V25, P3549, DOI 10.1002/adma.201300638; Li SD, 2009, BBA-BIOMEMBRANES, V1788, P2259, DOI 10.1016/j.bbamem.2009.06.022; Zahr AS, 2006, LANGMUIR, V22, P8178, DOI 10.1021/la060951b; Sheng Y, 2009, BIOMATERIALS, V30, P2340, DOI 10.1016/j.biomaterials.2008.12.070; Mosqueira VCF, 2001, PHARMACEUT RES, V18, P1411, DOI 10.1023/A:1012248721523; Yang S, 2008, J BIOMED MATER RES A, V84A, P837, DOI 10.1002/jbm.a.31418; Ishida T, 2007, J CONTROL RELEASE, V122, P349, DOI 10.1016/j.jconrel.2007.05.015; Wang YB, 2014, J MEMBRANE SCI, V452, P29, DOI 10.1010/j.memsci.2013.10.032; Perry JL, 2012, NANO LETT, V12, P5304, DOI 10.1021/nl302638g; Lu W, 2005, J CONTROL RELEASE, V107, P428, DOI 10.1016/j.jconrel.2005.03.027; Parveen S, 2011, EUR J PHARMACOL, V670, P372, DOI 10.1016/j.ejphar.2011.09.023; Iwasaki Y, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064101; Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c; Ruiz A, 2013, ACTA BIOMATER, V9, P6421, DOI 10.1016/j.actbio.2012.12.032; Gong YK, 2012, NANOSCALE, V4, P360, DOI 10.1039/c1nr11297j; Matsuno R, 2011, NANO TODAY, V6, P61, DOI 10.1016/j.nantod.2010.12.009; STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A; Zuckerman JE, 2012, P NATL ACAD SCI USA, V109, P3137, DOI 10.1073/pnas.1200718109; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Wu J, 2012, LANGMUIR, V28, P7436, DOI 10.1021/la300394c; Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108; Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI [10.1038/nnano.2012.212, 10.1038.nnano.2012.212]; Hu CMJ, 2014, NANOSCALE, V6, P65, DOI 10.1039/c3nr05444f; Hong RL, 1999, CLIN CANCER RES, V5, P3645; Hatakeyama H, 2011, ADV DRUG DELIVER REV, V63, P152, DOI 10.1016/j.addr.2010.09.001; Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X; Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3; Lee SY, 2013, BIOMATERIALS, V34, P552, DOI 10.1016/j.biomaterials.2012.09.065; Ishida T, 2006, J CONTROL RELEASE, V115, P251, DOI 10.1016/j.jconret.2006.08.017; Amoozgar Z, 2012, WIRES NANOMED NANOBI, V4, P219, DOI 10.1002/wnan.1157; Fang RH, 2012, EXPERT OPIN BIOL TH, V12, P385, DOI 10.1517/14712598.2012.661710; Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407; Yoo JW, 2010, MACROMOL RAPID COMM, V31, P142, DOI 10.1002/marc.200900592; Dams ETM, 2000, J PHARMACOL EXP THER, V292, P1071; Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108; ALLEN TM, 1989, BIOCHIM BIOPHYS ACTA, V981, P27, DOI 10.1016/0005-2736(89)90078-3; GABIZON A, 1988, P NATL ACAD SCI USA, V85, P6949, DOI 10.1073/pnas.85.18.6949; Gong M, 2008, APPL SURF SCI, V255, P555, DOI 10.1016/j.apsusc.2008.06.148; Gong M, 2013, SOFT MATTER, V9, P4501, DOI 10.1039/c3sm00086a; LIU D, 1995, PHARMACEUT RES, V12, P1775, DOI 10.1023/A:1016286310475; Liu Y, 2010, CURR NANOSCI, V6, P347; Malek A, 2009, TOXICOL APPL PHARM, V236, P263; Owens IIIDE, 2006, INT J PHARMACEUT, V307, P93, DOI DOI 10.1016/J.IJPHARM.2005.10.010; Pozzi D, 2014, NANOSCALE, V6, P2782, DOI 10.1039/c3nr05559k; Revesz C, 2011, GENE THERAPY APPL, P97; Tamura M, 2011, ACTA BIOMATER, V7, P3354, DOI 10.1016/j.actbio.2011.05.027; Zhang J, 2011, J CONTROL RELEASE, V152, pE23, DOI 10.1016/j.jconrel.2011.08.099; Zhang TT, 2013, PLOS ONE, V8, P78619; Zhao J, 2007, BIOMATERIALS, V28, P1414, DOI 10.1016/j.biomaterials.2006.10.012	65	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	APR 1	2015	16						94	102		10.1016/j.actbio.2015.01.019		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CE6WJ	WOS:000351978600009		
J	Mori, H; Kuge, H; Watanabe, M; Tanaka, TH				Mori, Hidetoshi; Kuge, Hiroshi; Watanabe, Mayumi; Tanaka, Tim Hideaki			Near-infrared spectroscopy and hydrogen clearance: is there any difference between these two methods of muscle blood volume estimation?	ACUPUNCTURE IN MEDICINE			English	Letter						VASCULAR MEDICINE			[Mori, Hidetoshi; Kuge, Hiroshi; Watanabe, Mayumi; Tanaka, Tim Hideaki] Tsukuba Univ Technol, Dept Hlth, Fac Hlth Sci, Tsukuba, Ibaraki, Japan; [Kuge, Hiroshi] Osaka Med Coll Hosp, Dept Anesthesiol, Osaka, Japan	Tanaka, TH (reprint author), 80 Bloor St West,Suite 1100, Toronto, ON M5S2V1, Canada.	tanaka@pacificwellness.ca					Homma S, 1996, J APPL PHYSIOL, V80, P1279; Aukland K, 1965, Acta Neurol Scand Suppl, V14, P42; Lee B Y, 1987, J Rehabil Res Dev, V24, P1; Nakamura Y, 2005, J ORAL REHABIL, V32, P545, DOI 10.1111/j.1365-2842.2005.01461.x; World Health Organization, 2008, WORLD HLTH STAT 2008, P110	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0964-5284	1759-9873		ACUPUNCT MED	Acupunct. Med.	APR	2015	33	2					166	167		10.1136/acupmed-2014-010672		2	Integrative & Complementary Medicine	Integrative & Complementary Medicine	CF4NQ	WOS:000352526800013		
J	Kawamura, K				Kawamura, Katsunori			Classification of Sub-Cuntz States	ALGEBRAS AND REPRESENTATION THEORY			English	Article						Extension of state; Sub-Cuntz state; Tensor product formula; Matricization; Free semigroup	O-N; PERMUTATION REPRESENTATIONS; POLYNOMIAL ENDOMORPHISMS; FUNCTION SYSTEMS; BRANCHING LAWS; CAR ALGEBRA; PURE STATES; EXTENSIONS; TENSOR; B(H)	Let O-n denote the Cuntz algebra for . With respect to a homogeneous embedding of into , an extension of a Cuntz state on to is called a sub-Cuntz state, which was introduced by Bratteli and Jorgensen. We show (i) a necessary and sufficient condition of the uniqueness of the extension,(ii) the complete classification of pure sub-Cuntz states up to unitary equivalence of their GNS representations, and (iii) the decomposition formula of a mixing sub-Cuntz state into a convex hull of pure sub-Cuntz states. Invariants of GNS representations of pure sub-Cuntz states are realized as conjugacy classes of nonperiodic homogeneous unit vectors in a tensor-power vector space. It is shown that this state parameterization satisfies both the U(n)-covariance and the compatibility with a certain tensor product.For proofs of main theorems, matricizations of state parameters and properties of free semigroups are used.	Ritsumeikan Univ, Coll Sci & Engn, Kusatsu, Shiga 5258577, Japan	Kawamura, K (reprint author), Ritsumeikan Univ, Coll Sci & Engn, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	kawamurakk3@gmail.com					Abe M, 2003, INT J MOD PHYS A, V18, P607, DOI 10.1142/S0217751X0301379X; Abe M., 2008, J MATH PHYS, V49; CUNTZ J, 1977, COMMUN MATH PHYS, V57, P173, DOI 10.1007/BF01625776; Davidson KR, 1999, P LOND MATH SOC, V78, P401, DOI 10.1112/S002461159900180X; ARAKI H, 1984, J OPERAT THEOR, V12, P247; Bergmann W. R., 2003, ANN MAT PUR APPL, V182, P271, DOI 10.1007/s10231-002-0065-x; Bhatia R, 1997, MATRIX ANAL; Bratteli O, 1997, J FUNCT ANAL, V145, P323, DOI 10.1006/jfan.1996.3033; Bratteli O, 1999, MEM AM MATH SOC, V139, P1; Bratteli O, 2000, J OPERAT THEOR, V43, P97; Bratteli O., 1994, P S PURE MATH, V59, P93; Bratteli O., 2004, MEM AM MATH SOC, V168, P1; Clifford A.H., 1967, AM MATH SOC, V2; Davidson KR, 1998, MATH ANN, V311, P275, DOI 10.1007/s002080050188; DIXMIER J, 1977, C ALGEBRAS; Dunford N., 1963, LINEAR OPERATORS 2; Dutkay DE, 2015, J MATH ANAL APPL, V421, P215, DOI 10.1016/j.jmaa.2014.07.005; Elden L, 2009, SIAM J MATRIX ANAL A, V31, P248, DOI 10.1137/070688316; Evans D.E., 1980, PUBL RIMS KYOTO U, V16, P915, DOI 10.2977/prims/1195186936; Fowler NJ, 2000, J OPERAT THEOR, V44, P113; Gabriel MJ, 2002, CAN J MATH, V54, P694, DOI 10.4153/CJM-2002-026-5; GLIMM J, 1961, ANN MATH, V73, P572, DOI 10.2307/1970319; Howie J. M., 1995, FUNDAMENTALS SEMIGRO; IZUMI M, 1993, COMMUN MATH PHYS, V155, P157, DOI 10.1007/BF02100056; Jeong E.-C., 2005, P AM MATH SOC, V134, P99; Jeong EC, 1999, P AM MATH SOC, V127, P3583, DOI 10.1090/S0002-9939-99-05018-2; Kawamura K, 2013, ALGEBR REPRESENT TH, V16, P1397, DOI 10.1007/s10468-012-9362-2; Kawamura K, 2005, J MATH PHYS, V46, DOI 10.1063/1.1939989; Kawamura K, 2005, J MATH PHYS, V46, DOI 10.1063/1.2000209; Kawamura K, 2009, LETT MATH PHYS, V87, P199, DOI 10.1007/s11005-009-0304-9; Kawamura K, 2009, J NUMBER THEORY, V129, P3069, DOI 10.1016/j.jnt.2009.06.003; Kawamura K., ARXIVMATH0505101; Kawamura K, 2010, LETT MATH PHYS, V93, P229, DOI 10.1007/s11005-010-0413-5; Kawamura K, 2008, J ALGEBRA, V319, P3935, DOI 10.1016/j.jalgebra.2008.01.037; Kawamura K, 2005, LETT MATH PHYS, V71, P149, DOI 10.1007/s11005-005-0344-8; Kawamura K, 2007, LETT MATH PHYS, V82, P91, DOI 10.1007/s11005-007-0192-9; Kawamura K, 2007, INT J ALGEBR COMPUT, V17, P1389, DOI 10.1142/S0218196707004207; Kawamura K, 2006, LETT MATH PHYS, V77, P111, DOI 10.1007/s11005-006-0050-1; Kawamura K, 2013, LINEAR ALGEBRA APPL, V438, P573, DOI 10.1016/j.laa.2012.08.006; Kobayashi T., 2005, SUGAKU EXPOSITIONS, V18, P1; Laca M., 1993, J OPERAT THEOR, V30, P381; Lang S., 2002, ALGEBRA; Lathauwer LD, 2000, SIAM J MATRIX ANAL A, V21, P1253; Lawson MV, 2009, PERIOD MATH HUNG, V58, P189, DOI 10.1007/s10998-009-10189-2; Lee JR, 2004, P AM MATH SOC, V132, P2115, DOI 10.1090/S0002-9939-04-07395-2; Lothaire M., 1983, COMBINATORICS WORDS; Shin Dong-Yun, 2002, [Bulletin of the KMS, 대한수학회보], V39, P471; Van Loan C. F., 1996, MATRIX COMPUTATIONS; Vasilescu M.A.O., 2002, P EUR C COMP VIS ECC, V2350, P447	49	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1386-923X	1572-9079		ALGEBR REPRESENT TH	Algebr. Represent. Theory	APR	2015	18	2					555	584		10.1007/s10468-014-9509-4		30	Mathematics	Mathematics	CG0PX	WOS:000352969700015		
J	Nagayama, T; Hirooka, Y; Kishi, T; Mukai, Y; Inoue, S; Takase, S; Takemoto, M; Chishaki, A; Sunagawa, K				Nagayama, Tomomi; Hirooka, Yoshitaka; Kishi, Takuya; Mukai, Yasushi; Inoue, Shujiro; Takase, Susumu; Takemoto, Masao; Chishaki, Akiko; Sunagawa, Kenji			Blockade of Brain Angiotensin II Type 1 Receptor Inhibits the Development of Atrial Fibrillation in Hypertensive Rats	AMERICAN JOURNAL OF HYPERTENSION			English	Article						atrial fibrillation; blood pressure; brain angiotensin type 1 receptor; hypertension; sympathetic nervous system	BLOOD-PRESSURE; HEART; SYMPATHOEXCITATION; RISK; ARRHYTHMIAS; ANTAGONIST; PREVENTION; ELEVATION; MORTALITY; LOSARTAN	BACKGROUND Hypertension is a powerful risk factor of atrial fibrillation (AF). The pathophysiology of AF with hypertension is associated with sympathoexcitation or the renin-angiotensin system; however, current therapies cannot sufficiently prevent its development. We previously revealed that brain angiotensin II type 1 receptor (AT(1)R) blockade causes a depressor response via sympathoinhibition. Herein, we evaluated whether brain AT(1)R contributes to AF development in hypertensive rats. METHODS We divided the stroke-prone spontaneously hypertensive rats (SHRSP) treated with intracerebroventricular (ICV) infusion of vehicle (S-VEH), ICV infusion of losartan (S-LOS), or oral administration of hydralazine (S-HYD); and Wistar Kyoto rats treated with ICV infusion of vehicle. RESULTS Two weeks later, systolic blood pressure was significantly lower in the S-LOS group than in the S-VEH group and was even lower in the S-HYD group. Urinary norepinephrine excretion for 24 h, an indirect marker of sympathoexcitation, significantly reduced in the S-LOS group but increased in the S-HYD group despite depressor response. AF was induced by transesophageal burst pacing. AF duration was significantly shorter in the S-LOS group than in the S-VEH group (5.0 +/- 0.4 vs. 15.2 +/- 3.7 s; n = 8 each; P < 0.05). However, it was significantly longer in the S-HYD group than in the S-VEH group. Interstitial atrial fibrosis and echocardiographic parameters did not differ between the SHRSP groups. CONCLUSIONS Brain AT(1)R blockade suppresses AF inducibility and maintenance independent of depressor response in hypertensive rats.	[Nagayama, Tomomi; Mukai, Yasushi; Inoue, Shujiro; Takase, Susumu; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Hirooka, Yoshitaka] Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, Fukuoka 812, Japan; [Kishi, Takuya] Kyushu Univ, Grad Sch Med Sci, Dept Adv Therapeut Cardiovasc Dis, Fukuoka 812, Japan; [Takemoto, Masao] Munakata Suikokai Gen Hosp, Fukuoka, Japan; [Chishaki, Akiko] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka 812, Japan	Hirooka, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, Fukuoka 812, Japan.	hyoshi@cardiol.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24390198]; Takeda Medical Research Foundation	This study was supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (24390198 to Y.H.) and in part by the Grant from Takeda Medical Research Foundation to T.K.	Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Linz D, 2014, J AM COLL CARDIOL, V63, P215, DOI 10.1016/j.jacc.2013.09.020; Fisher JP, 2012, J HUM HYPERTENS, V26, P463, DOI 10.1038/jhh.2011.66; Kishi T, 2010, HYPERTENSION, V55, P291, DOI 10.1161/HYPERTENSIONAHA.109.138636; Manolis AJ, 2012, J HYPERTENS, V30, P239, DOI 10.1097/HJH.0b013e32834f03bf; Magnani JW, 2011, HEART RHYTHM, V8, P93, DOI 10.1016/j.hrthm.2010.09.020; Fisher JP, 2010, EXP PHYSIOL, V95, P572, DOI 10.1113/expphysiol.2009.047332; Fukui A, 2013, CIRC-ARRHYTHMIA ELEC, V6, P402, DOI 10.1161/CIRCEP.111.000104; Okazaki H, 2006, HYPERTENS RES, V29, P277, DOI 10.1291/hypres.29.277; Shen MJ, 2012, NAT REV CARDIOL, V9, P30, DOI 10.1038/nrcardio.2011.139; Diness JG, 2010, CIRC-ARRHYTHMIA ELEC, V3, P380, DOI 10.1161/CIRCEP.110.957407; Vidaillet H, 2002, AM J MED, V113, P365, DOI 10.1016/S0002-9343(02)01253-6; Peterson JR, 2006, CURR HYPERTENS REP, V8, P232, DOI 10.1007/s11906-006-0056-1; Ciaroni S, 2000, AM HEART J, V139, P814, DOI 10.1016/S0002-8703(00)90012-7; Benjamin EJ, 1998, CIRCULATION, V98, P946; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Azibani F, 2012, HYPERTENSION, V59, P1179, DOI 10.1161/HYPERTENSIONAHA.111.190512; Nagae A, 2009, CIRCULATION, V119, P978, DOI 10.1161/CIRCULATIONAHA.108.824730; De Bacquer D, 2007, AM J CARDIOL, V100, P850, DOI 10.1016/j.amjcard.2007.04.017; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Marott SCW, 2014, EUR HEART J, V35, P1205, DOI 10.1093/eurheartj/eht507; Wachtell K, 2005, J AM COLL CARDIOL, V45, P712, DOI 10.1016/j.jacc.2004.10.068; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Castiglioni P, 2013, AUTON NEUROSCI-BASIC, V178, P44, DOI 10.1016/j.autneu.2013.02.008; Go Orson, 2009, Curr Cardiol Rep, V11, P430; Huang BS, 1998, HYPERTENSION, V32, P1028; Ishida K, 2010, HEART RHYTHM, V7, P289, DOI 10.1016/j.hrthm.2009.11.012; KAWANO Y, 1994, AM J HYPERTENS, V7, P536; Kirchhof P, 2010, EUR J HEART FAIL, V12, P1019, DOI 10.1093/eurjhf/hfq155; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Lally JA, 2007, J CARDIOVASC ELECTR, V18, P1222, DOI 10.1111/j.1540-8167.2007.00874.x; Lau DH, 2010, HEART RHYTHM, V7, P1282, DOI 10.1016/j.hrthm.2010.05.010; Nakashima H, 2000, CIRCULATION, V101, P2612; Navar LG, 2000, HYPERTENS RES, V23, P291, DOI 10.1291/hypres.23.291; Neubecker TA, 1998, J CHROMATOGR B, V718, P225, DOI 10.1016/S0378-4347(98)00377-6; Sugiyama A, 2005, J PHARMACOL SCI, V98, P315, DOI 10.1254/jphs.SCJ05002X; Xiao B, 2011, J HYPERTENS, V29, P257, DOI 10.1097/HJH.0b013e32834137cd; YAMAKAWA T, 1995, HYPERTENSION, V25, P146	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	APR	2015	28	4					444	451		10.1093/ajh/hpu196		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF0AP	WOS:000352205200003		
J	Tomiyama, H; Nishikimi, T; Matsumoto, C; Kimura, K; Odaira, M; Shiina, K; Yamashina, A				Tomiyama, Hirofumi; Nishikimi, Toshio; Matsumoto, Chisa; Kimura, Kazutaka; Odaira, Mari; Shiina, Kazuki; Yamashina, Akira			Longitudinal Changes in Late Systolic Cardiac Load and Serum NT-proBNP Levels in Healthy Middle-Aged Japanese Men	AMERICAN JOURNAL OF HYPERTENSION			English	Article						blood pressure; cardiac hemodynamic stress; central blood pressure; hypertension; late systolic cardiac load; natriuretic peptides	LEFT-VENTRICULAR HYPERTROPHY; ALL-CAUSE MORTALITY; NATRIURETIC PEPTIDE LEVELS; PULSE-WAVE VELOCITY; CARDIOVASCULAR EVENTS; HEART-FAILURE; ARTERIAL STIFFNESS; EJECTION FRACTION; BLOOD-PRESSURE; WALL STRESS	BACKGROUND We determined whether any significant association exists between change in late systolic cardiac load with time, estimated by radial pressure waveform analysis, and development of cardiac hemodynamic stress in individuals with preserved cardiac function. METHODS Brachial-ankle pulse wave velocity, radial augmentation index (rAI), first peak of the radial pressure waveform (SP1), systolic and pulse pressure at the second peak of the radial pressure waveform (SP2 and PP2), and serum levels of N-terminal fragment B-type natriuretic peptide (NT-proBNP) were measured at the start (first examination) and at the end (second examination) of this 3-year study in healthy Japanese men (n = 1,851). RESULTS A stepwise multivariate linear regression analysis demonstrated that among the parameters of radial pressure waveform analysis and markers of arterial stiffness analyzed, only PP2 was significantly associated with serum NT-proBNP levels in study participants at both the first and second examinations. Furthermore, among the parameters analyzed, only change in PP2 was significantly correlated with the change in serum NT-proBNP levels during the study period (beta = 0.131, P < 0.001). CONCLUSIONS Sustained late systolic cardiac load might be a more significant determinant of the development of cardiac hemodynamic stress than sustained early systolic cardiac load or arterial stiffening in individuals with preserved cardiac function.	[Tomiyama, Hirofumi; Matsumoto, Chisa; Kimura, Kazutaka; Odaira, Mari; Shiina, Kazuki; Yamashina, Akira] Tokyo Med Univ, Dept Internal Med 2, Tokyo 1608402, Japan; [Nishikimi, Toshio] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto 6068501, Japan	Tomiyama, H (reprint author), Tokyo Med Univ, Dept Internal Med 2, Tokyo 1608402, Japan.	tomiyama@tokyo-med.ac.jp			OMRON Health Care, Kyoto, Japan	This study was supported, in part, by funding from OMRON Health Care, Kyoto, Japan.	O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Tomiyama H, 2009, HYPERTENS RES, V32, P122, DOI 10.1038/hr.2008.20; Borlaug BA, 2007, J AM COLL CARDIOL, V50, P1570, DOI 10.1016/j.jacc.2007.07.032; Ho JE, 2013, CIRC-HEART FAIL, V6, P279, DOI 10.1161/CIRCHEARTFAILURE.112.972828; Nishikimi T, 1996, HYPERTENSION, V28, P22; Chirinos JA, 2010, AM J PHYSIOL-HEART C, V298, pH320, DOI 10.1152/ajpheart.00334.2009; Chirinos JA, 2009, CIRCULATION, V119, P2798, DOI 10.1161/CIRCULATIONAHA.108.829366; Yeo KTJ, 2003, CLIN CHIM ACTA, V338, P107, DOI 10.1016/j.cccn.2003.08.016; Maeder MT, 2010, HYPERTENSION, V56, P682, DOI 10.1161/HYPERTENSIONAHA.110.156547; Roman MJ, 2010, J HYPERTENS, V28, P384, DOI 10.1097/HJH.0b013e328333d228; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Hashimoto J, 2007, AM J HYPERTENS, V20, P378, DOI 10.1016/j.amjhyper.2006.09.019; Tomiyama H, 2010, J AM COLL CARDIOL, V55, P1979, DOI 10.1016/j.jacc.2009.12.042; Weber T, 2013, J AM COLL CARDIOL, V61, P1874, DOI 10.1016/j.jacc.2013.02.013; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Chirinos JA, 2012, J AM COLL CARDIOL, V60, P2170, DOI 10.1016/j.jacc.2012.07.054; Chirinos JA, 2013, HYPERTENSION, V61, P296, DOI 10.1161/HYPERTENSIONAHA.111.00530; deFilippi CR, 2010, J AM COLL CARDIOL, V55, P441, DOI 10.1016/j.jacc.2009.07.069; Laurent S, 2007, HYPERTENSION, V49, P1202, DOI 10.1161/HYPERTENSIONAHA.106.076166; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Kobayashi S, 1996, CIRCULATION, V94, P3362; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Neeland IJ, 2013, J AM COLL CARDIOL, V61, P187, DOI 10.1016/j.jacc.2012.10.012; Odaira M, 2012, CIRC J, V76, P1928, DOI 10.1253/circj.CJ-12-0044; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Ding FH, 2013, J HYPERTENS, V31, P86, DOI 10.1097/HJH.0b013e32835a8eca; Doi Y, 2011, ARTERIOSCL THROM VAS, V31, P2997, DOI 10.1161/ATVBAHA.111.223669; JACOB R, 1991, BASIC RES CARDIOL, V86, P113; Nishikimi Toshio, 2011, Curr Heart Fail Rep, V8, P140, DOI 10.1007/s11897-011-0051-y; Ooi Henry, 2008, Congest Heart Fail, V14, P31, DOI 10.1111/j.1751-7133.2008.07210.x; Pannier B, 2011, BLOOD PURIFICAT, V31, P107, DOI 10.1159/000322104; Wu LZ, 2012, J HYPERTENS, V30, P1862, DOI 10.1097/HJH.0b013e3283563418	33	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	APR	2015	28	4					452	458		10.1093/ajh/hpu174		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF0AP	WOS:000352205200004		
J	Morris, BJ; Carnes, BA; Chen, RD; Donlon, TA; He, QM; Grove, JS; Masaki, KH; Elliott, A; Willcox, DC; Allsopp, R; Willcox, BJ				Morris, Brian J.; Carnes, Bruce A.; Chen, Randi; Donlon, Timothy A.; He, Qimei; Grove, John S.; Masaki, Kamal H.; Elliott, Ayako; Willcox, Donald C.; Allsopp, Richard; Willcox, Bradley J.			Genetic Variation in the Raptor Gene Is Associated With Overweight But Not Hypertension in American Men of Japanese Ancestry	AMERICAN JOURNAL OF HYPERTENSION			English	Article							LIFE-SPAN; MAMMALIAN TARGET; SKELETAL-MUSCLE; BINDING PARTNER; HUMAN LONGEVITY; EXTENDS LIFE; RAPAMYCIN; MTOR; MICE; PATHWAY	BACKGROUND The mechanistic target of rapamycin (mTOR) pathway is pivotal for cell growth. Regulatory associated protein of mTOR complex I (Raptor) is a unique component of this pro-growth complex. The present study tested whether variation across the raptor gene (RPTOR) is associated with overweight and hypertension. METHODS We tested 61 common (allele frequency >= 0.1) tagging single nucleotide polymorphisms (SNPs) that captured most of the genetic variation across RPTOR in 374 subjects of normal lifespan and 439 subjects with a lifespan exceeding 95 years for association with overweight/obesity, essential hypertension, and isolated systolic hypertension. Subjects were drawn from the Honolulu Heart Program, a homogeneous population of American men of Japanese ancestry, well characterized for phenotypes relevant to conditions of aging. Hypertension status was ascertained when subjects were 45-68 years old. Statistical evaluation involved contingency table analysis, logistic regression, and the powerful method of recursive partitioning. RESULTS After analysis of RPTOR genotypes by each statistical approach, we found no significant association between genetic variation in RPTOR and either essential hypertension or isolated systolic hypertension. Models generated by recursive partitioning analysis showed that RPTOR SNPs significantly enhanced the ability of the model to accurately assign individuals to either the overweight/obese or the nonoverweight/obese groups (P = 0.008 by 1-tailed Z test). CONCLUSION Common genetic variation in RPTOR is associated with overweight/obesity but does not discernibly contribute to either essential hypertension or isolated systolic hypertension in the population studied.	[Morris, Brian J.; Chen, Randi; Donlon, Timothy A.; He, Qimei; Grove, John S.; Masaki, Kamal H.; Elliott, Ayako; Willcox, Donald C.; Willcox, Bradley J.] Kuakini Med Ctr, Dept Res, Honolulu Heart Program, Honolulu Asia Aging Study, Honolulu, HI 96817 USA; [Morris, Brian J.; Masaki, Kamal H.; Willcox, Donald C.; Willcox, Bradley J.] Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA; [Morris, Brian J.] Univ Sydney, Sch Med Sci, Basic & Clin Genom Lab, Sydney, NSW 2006, Australia; [Carnes, Bruce A.] Univ Oklahoma, Hlth Sci Ctr, Reynolds Dept Geriatr Med, Oklahoma City, OK USA; [Grove, John S.] Univ Hawaii Manoa, John A Burns Sch Med, Publ Hlth Sci, Honolulu, HI 96822 USA; [Willcox, Donald C.] Okinawa Int Univ, Dept Human Welf, Okinawa, Japan; [Allsopp, Richard] Univ Hawaii, Inst Biogenesis Res, Honolulu, HI 96822 USA	Morris, BJ (reprint author), Kuakini Med Ctr, Dept Res, Honolulu Heart Program, Honolulu Asia Aging Study, Honolulu, HI 96817 USA.	brian.morris@sydney.edu.au			Kuakini Medical Center; National Heart, Lung, and Blood Institute [NO1-HC-05102]; National Institute on Aging [NO1-AG-4-2149, U01-AG-019349, R01-AG-038707, R01-AG-027060]; Hawaii Community Foundation [2004-0463]	The authors thank Maarit Tiirikainen and Sayaka Mitsuhashi for their helpful assistance in the research conducted. This work was supported by the Kuakini Medical Center, the National Heart, Lung, and Blood Institute (contract NO1-HC-05102), the National Institute on Aging (contract NO1-AG-4-2149 and grants U01-AG-019349, R01-AG-038707, and R01-AG-027060), and Hawaii Community Foundation grant 2004-0463.	Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Passtoors WM, 2013, AGING CELL, V12, P24, DOI 10.1111/acel.12015; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Sarbassov DD, 2004, CURR BIOL, V14, P1296; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Mendelsohn AR, 2012, REJUV RES, V15, P334, DOI 10.1089/rej.2012.1347; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Pan Y, 2012, GERONTOLOGY, V58, P524, DOI 10.1159/000342204; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Wang MY, 2014, TRENDS ENDOCRIN MET, V25, P72, DOI 10.1016/j.tem.2013.10.002; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; KAGAN A, 1974, J CHRON DIS, V27, P345, DOI 10.1016/0021-9681(74)90014-9; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Fadini GP, 2011, AGING CELL, V10, P10, DOI 10.1111/j.1474-9726.2010.00642.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Yang Z, 2012, OBES REV, V13, P58, DOI 10.1111/j.1467-789X.2012.01038.x; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Zhang YQ, 2014, J GERONTOL A-BIOL, V69, P119, DOI 10.1093/gerona/glt056; Barba C, 2004, LANCET, V363, P157; Chambers SM, 1996, NAT GENET, V12, P122, DOI 10.1038/ng0296-122; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; HEDRICK PW, 1987, GENETICS, V117, P331; Kagan A, 1996, HONOLULU HEART PROGR; Martinez-Martinez E, 2014, J HYPERTENS, V32, P1104; Morris BJ, 2014, J GERONTOL A; Nordyke EC, 1984, PAPERS E W POPUL I, V91, P13; Statistical Analysis for the Social Sciences, 1990, STAT AN SOC SCI SAS; Sun C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001178; Weir BS, 1996, GENETIC DATA ANAL; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6; Xu XH, 2014, HYPERTENSION, V63, P729, DOI 10.1161/HYPERTENSIONAHA.113.02526	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	APR	2015	28	4					508	517		10.1093/ajh/hpu188		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF0AP	WOS:000352205200011		
J	Edison, ES; Yano, Y; Hoshide, S; Kario, K				Edison, Eijiro Sugiyama; Yano, Yuichiro; Hoshide, Satoshi; Kario, Kazuomi			Association of Electrocardiographic Left Ventricular Hypertrophy With Incident Cardiovascular Disease in Japanese Older Hypertensive Patients	AMERICAN JOURNAL OF HYPERTENSION			English	Article						ambulatory blood pressure; blood pressure; cardiovascular disease; hemostatic factors; hypertension; left ventricular hypertrophy; neurohumoral	CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE; PROGNOSTIC IMPLICATIONS; DIASTOLIC FUNCTION; STROKE RISK; EVENTS; PREDICTOR; MASS; ATHEROSCLEROSIS; NOREPINEPHRINE	BACKGROUND Our aim was to assess whether electrocardiographic left ventricular hypertrophy (ECG-LVH) is associated with a higher risk of cardiovascular disease (CVD) events, independent of 24-hour blood pressure (BP) and circulating levels of norepinephrine and hemostatic factors. METHODS In 514 older hypertensive patients (mean age 72.3 years; 37% men), we assessed ambulatory BP values, circulating levels of norepinephrine and hemostatic factors (plasma fibrinogen, prothrombin fragment 1+2 (F1+2), von Willebrand factor (vWF), and plasminogen activator inhibitor-1 (PAI-1)), and the presence or absence of ECG-LVH (Sokolow-Lyon voltage >= 3.5 mV). The incidence of CVD events (i.e., myocardial infarction and stroke) was prospectively ascertained. RESULTS During an average 41 months of follow-up (1,751 person-years), 43 stroke and 3 myocardial infarction events occurred. At baseline, patients with ECG-LVH had higher mean 24-hour BP (148.8/83.8 mm Hg vs. 135.7/77.2 mm Hg) and circulating norepinephrine levels (404.6 pg/ml vs. 336.3 pg/ml) compared to those without ECG-LVH; the differences remained unchanged after adjustment for age, gender, smoking status, presence of diabetes, and antihypertensive medication uses at follow-up time (all P < 0.01). Cox proportional hazards models suggested that the hazard ratio (HR; 95% confidence interval (CI)) of CVD events for those with ECG-LVH was 4.4 (2.3-8.2), and the association between ECG-LVH and incident CVD events remained significant after adjustment for high 24-hour BP (>= 130/80 mm Hg), nocturnal SBP, circulating norepinephrine and fibrinogen levels (HRs, 3.5-4.2, all P < 0.001). CONCLUSIONS In older hypertensive patients, ECG-LVH was associated with a higher risk of CVD events, independent of ambulatory BP parameters and circulating norepinephrine and fibrinogen levels.	[Edison, Eijiro Sugiyama; Yano, Yuichiro; Hoshide, Satoshi; Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan	Kario, K (reprint author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.	kkario@jichi.ac.jp					Andrikou I, 2013, HYPERTENS RES, V36, P967, DOI 10.1038/hr.2013.64; LEVY D, 1994, CIRCULATION, V90, P1786; GOLDSTEIN DS, 1983, HYPERTENSION, V5, P86; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; VERDECCHIA P, 1990, CIRCULATION, V81, P528; Schlaich MP, 2003, CIRCULATION, V108, P560, DOI 10.1161/01.CIR.0000081775.72651.B6; Greenwood JP, 2001, J AM COLL CARDIOL, V38, P1711, DOI 10.1016/S0735-1097(01)01600-X; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Verdecchia P, 2001, CIRCULATION, V104, P2039, DOI 10.1161/hc4201.097944; Catena C, 2013, AM J HYPERTENS, V26, P111, DOI 10.1093/ajh/hps006; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Ishikawa J, 2007, STROKE, V38, P911, DOI 10.1161/01.STR.0000258115.46765.f1; Lutsey PL, 2006, J THROMB HAEMOST, V4, P2629, DOI 10.1111/j.1538-7836.2006.02237.x; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; NODA A, 1995, CHEST, V107, P1538, DOI 10.1378/chest.107.6.1538; HEIMANN JC, 1991, J CARDIOVASC PHARM, V17, pS122, DOI 10.1097/00005344-199117002-00028; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105; Okin PM, 2004, HYPERTENSION, V44, P48, DOI 10.1161/01.HYP.0000132556.91792.6a; EISENHOFER G, 1992, CIRCULATION, V85, P1775; Pierdomenico SD, 2008, AM J HYPERTENS, V21, P464, DOI 10.1038/ajh.2008.2; Blann AD, 1999, BLOOD COAGUL FIBRIN, V10, P375, DOI 10.1097/00001721-199909000-00008; Catena C, 2013, J HYPERTENS, V31, P2077, DOI 10.1097/HJH.0b013e328362d951; Cowan BR, 2009, CURR HYPERTENS REP, V11, P167, DOI 10.1007/s11906-009-0030-9; Desai CS, 2012, HEART, V98, P330, DOI 10.1136/heartjnl-2011-300819; Garcia MA, 2012, AM J RESP CRIT CARE, V186, P909; Grosse P., 2005, J HYPERTENS S1, V23, pS27; Jissho S, 2010, CIRC J, V74, P938, DOI 10.1253/circj.CJ-09-0722; Kario K, 2011, EUR HEART J, V32, P574, DOI 10.1093/eurheartj/ehq444; Lip GYH, 1997, AM J CARDIOL, V80, P1566, DOI 10.1016/S0002-9149(97)00749-2; Lowe GDO, 1999, FIBRINOLYSIS PROTEOL, V13, P91, DOI 10.1016/S0268-9499(99)90084-X; Peterson GE, 2013, HYPERTENSION, V62, P518, DOI 10.1161/HYPERTENSIONAHA.111.00904; Redondo FJ, 2012, J HYPERTENS, V30, P1460; Strazzullo P, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4567; Uusimaa P, 2004, INT J CARDIOL, V97, P251, DOI 10.1016/j.ijcard.2003.10.015; Yano Y, 2011, ATHEROSCLEROSIS, V219, P273, DOI 10.1016/j.atherosclerosis.2011.05.031	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	APR	2015	28	4					527	534		10.1093/ajh/hpu184		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF0AP	WOS:000352205200013		
J	Iwai, H; Motoyoshi, M; Uchida, Y; Matsuoka, M; Shimizu, N				Iwai, Hiroaki; Motoyoshi, Mitsuru; Uchida, Yasuki; Matsuoka, Miho; Shimizu, Noriyoshi			Effects of tooth root contact on the stability of orthodontic anchor screws in the maxilla: Comparison between self-drilling and self-tapping methods	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							BEAM COMPUTED-TOMOGRAPHY; MINI-IMPLANT ANCHORAGE; RANDOMIZED CONTROLLED-TRIAL; CORTICAL BONE THICKNESS; EN-MASSE RETRACTION; MINISCREW IMPLANTS; DISTAL MOVEMENT; ANTERIOR TEETH; FAILURE RATES; PULL HEADGEAR	Introduction: We evaluated the effects of screw placement angle on the frequency of root contact and the effects of root contact on screw stability, comparing self-drilling and self-tapping methods. Methods: In total, 80 patients with 142 screws (diameter, 1.6 mm; length, 8.0 mm) were included. Cone-beam computed tomography images were taken. Cortical bone thickness, interroot distance, shortest distance between the screw and adjacent tooth root, and screw placement angle were measured. Results: The success rates of the screws were 91.5% for the self-drilling method and 94.4% for the self-tapping method (P>0.05). The self-drilling screws tended to contact the distal tooth roots in the right maxilla. In the self-drilling method, the failure rate was significantly higher in the root contact group than in the no-contact group (P <0.05). Conclusions: The success rate was not significantly different between the self-drilling and the self-tapping methods in the maxilla. Avoidance of tooth root contact may improve the success rate more in the self-drilling method than in the self-tapping method.	[Iwai, Hiroaki; Matsuoka, Miho] Nihon Univ, Sch Dent, Dept Orthodont, Tokyo 1018310, Japan; [Motoyoshi, Mitsuru; Uchida, Yasuki; Shimizu, Noriyoshi] Nihon Univ, Sch Dent, Dept Orthodont, Div Clin Res,Dent Res Ctr, Tokyo 1018310, Japan	Motoyoshi, M (reprint author), Nihon Univ, Sch Dent, Dept Orthodont, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	motoyoshi.mitsuru@nihon-u.ac.jp					Schatzle M, 2009, CLIN ORAL IMPLAN RES, V20, P1351, DOI 10.1111/j.1600-0501.2009.01754.x; Chung K, 2005, ANGLE ORTHOD, V75, P119; Chen Y, 2009, AM J ORTHOD DENTOFAC, V135, P284, DOI 10.1016/j.ajodo.2007.08.017; Kim TW, 2006, AM J ORTHOD DENTOFAC, V130, P676, DOI 10.1016/j.ajodo.2005.07.013; Miyazawa K, 2010, EUR J ORTHODONT, V32, P735, DOI 10.1093/ejo/cjq012; Sugawara J, 2004, AM J ORTHOD DENTOFAC, V125, P130, DOI 10.1016/S0889-5406(03)00682-6; Papadopoulos MA, 2011, J DENT RES, V90, P969, DOI 10.1177/0022034511409236; Kim H, 2011, AM J ORTHOD DENTOFAC, V139, P752, DOI 10.1016/j.ajodo.2009.06.042; Motoyoshi M, 2009, INT J ORAL MAX SURG, V38, P13, DOI 10.1016/j.ijom.2008.09.006; Kim SH, 2010, AM J ORTHOD DENTOFAC, V138, P264, DOI 10.1016/j.ajodo.2008.07.026; Motoyoshi M, 2007, INT J ORAL MAX IMPL, V22, P779; Min KI, 2012, ANGLE ORTHOD, V82, P1014, DOI 10.2319/091311-593.1; Chen YH, 2008, CLIN ORAL IMPLAN RES, V19, P99, DOI 10.1111/j.1600-0501.2007.01418.x; Ohnishi H, 2005, ANGLE ORTHOD, V75, P444; Papageorgiou SN, 2012, AM J ORTHOD DENTOFAC, V142, P577, DOI 10.1016/j.ajodo.2012.05.016; Yadav S, 2012, AM J ORTHOD DENTOFAC, V141, P538, DOI 10.1016/j.ajodo.2011.12.016; Lee J, 2013, AM J ORTHOD DENTOFAC, V144, P238, DOI 10.1016/j.ajodo.2013.03.020; Herman RJ, 2006, AM J ORTHOD DENTOFAC, V130, P228, DOI 10.1016/j.ajodo.2006.02.029; Chen Y, 2008, AM J ORTHOD DENTOFAC, V133, P44, DOI 10.1016/j.ajodo.2007.01.023; Park HS, 2005, ANGLE ORTHOD, V75, P602; Jung YR, 2013, AM J ORTHOD DENTOFAC, V143, P173, DOI 10.1016/j.ajodo.2012.09.011; Reynders RAM, 2012, AM J ORTHOD DENTOFAC, V142, P596, DOI 10.1016/j.ajodo.2012.06.013; Upadhyay M, 2008, AM J ORTHOD DENTOFAC, V134, P803, DOI 10.1016/j.ajodo.2006.10.025; Costa A, 1998, Int J Adult Orthodon Orthognath Surg, V13, P201; Deguchi T, 2006, AM J ORTHOD DENTOFAC, V129, pe7; Heidemann W, 2001, J CRANIO MAXILL SURG, V29, P69, DOI 10.1054/jcms.2000.0179; Holmgren E P, 1998, J Oral Implantol, V24, P80, DOI 10.1563/1548-1336(1998)024<0080:EPOODI>2.3.CO;2; Inaba Mizuki, 2009, J Oral Sci, V51, P347; Kim SH, 2007, AM J ORTHOD DENTOFAC, V131, pS82, DOI 10.1016/j.ajodo.2006.01.027; Koyama I, 2011, EUR J ORTHODONT, V33, P126, DOI 10.1093/ejo/cjq047; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, pS68, DOI 10.1016/j.ajodo.2006.06.017; Li F, 2011, ANGLE ORTHOD, V81, P915, DOI 10.2319/101410-603.1; Nagaraj K, 2008, AM J ORTHOD DENTOFAC, V134, P583, DOI 10.1016/j.ajodo.2006.09.055; Park SH, 2004, AM J ORTHOD DENTOFAC, V126, P627; Reynders R, 2009, AM J ORTHOD DENTOFAC, V135, P564, DOI 10.1016/j.ajodo.2009.02.003; Sawa Y, 2001, ORTHODONTIC WAVES, V60, P328; Shigeeda T, 2014, J ORAL SCI, V56, P59, DOI 10.2334/josnusd.56.59; Shinohara A, 2013, AM J ORTHOD DENTOFAC, V144, P50, DOI 10.1016/j.ajodo.2013.02.021; Son S, 2014, AM J ORTHOD DENTOFAC, V145, P480, DOI 10.1016/j.ajodo.2013.12.020; Tachibana R, 2012, INT J ORAL MAX SURG, V41, P1439, DOI 10.1016/j.ijom.2012.05.031; Tsutsumi K, 2011, INT J ORAL MAX IMPL, V26, P91; Upadhyay M, 2008, AM J ORTHOD DENTOFAC, V134, P18, DOI 10.1016/j.ajodo.2007.03.025; Upadhyay M, 2010, AM J ORTHOD DENTOFAC, V138, P96, DOI 10.1016/j.ajodo.2010.03.014; Yu JJ, 2012, ANGLE ORTHOD, V82, P275, DOI 10.2319/060811-374.1	44	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	APR	2015	147	4					483	491		10.1016/j.ajodo.2014.12.017		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE9BI	WOS:000352137900016		
